Citrus Sinensis ID: 045286

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------26
Protein Sequence
MNTNITILTIVHRKYRGHAVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY
Secondary Structure (PSIPRED)
ccccccEEEEcccccccccHHHHHHccccccccEEcccccccccEEEccccccEEEEEEcccEEEEEEEEcccccHHHHHHHHHHHHHHHHcccccEEEEEEEEcccccEEEEEEEcccccHHHHHHcccccccHHHHHHHHHHHHHHHHHHccccccccccccccEEEEccccEEEccccccEEEEccccccccccccccccHHHHccccccccccHHHHHHHHHHHHccccccccccHHHHHHHccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccccccHHHHHHHHccccHHHccccccccEEEEEEccccEEEEEEEccccccccccccHHHHHHHHcccccccEccEEEEccccccccEEEEcccccEHHHHHccccccccHHHHHHHHHHHHHHHHHHHHcccccccccHHHEEEcccccEEEccccccccccccccEccccccHHHccHHHHHcccccccccHHHHHHHHHHHHccccccccccccccHHHHHHHccccccccc
Coil and Loop (DISEMBL)
MNTNITILTIVHRKYRGHAVEKAIESQTKSEDWEIDRRLLKTgeriasgscgdlyrgvylGQDVAVKVLRSehlndtleDEFVQEVAILREVQHRNVVRFigastksphlcivteympggslydylhknhnvlklpQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVarfqnkggvmtaetgtyrwmapevinhqpydqkadVFSFAIVLWELVTAkvpydsmtplqAALGVRQVCTSLCQPIY
Flexible Loop (DISEMBL)
mntnitiltivhrkyrghavekaiesqtksedweIDRRLLKtgeriasgscgdlyrGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRfigastksphlcIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGvarfqnkggvMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY
Low Complexity Region (SEG)
MNTNITILTIVHRKYRGHAVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY
Disordered region (IsUnstruct)
****ITILTIVHRKYRGHAVEKAI*******DWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQ***
Disordered Region (DISOPRED)
*********************************EIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC********
Disordered Region (DISEMBL)
MNTNITILTIVHRKYRGHAVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY
Disordered Region (DISPRO)
*************************SQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLC****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MNTNITILTIVHRKYRGHAVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	259	2.2.26 [Sep-21-2011]
Q2MHE4	390	Serine/threonine-protein	no	no	0.918	0.610	0.451	1e-54
Q55GU0	916	Probable serine/threonine	yes	no	0.938	0.265	0.394	5e-50
Q7T6Y2	1624	Putative serine/threonine	N/A	no	0.884	0.141	0.418	4e-47
Q54H45	690	Probable serine/threonine	no	no	0.822	0.308	0.430	2e-46
Q05609	821	Serine/threonine-protein	no	no	0.876	0.276	0.422	3e-46
Q54H46	642	Probable serine/threonine	no	no	0.915	0.369	0.404	3e-46
Q54TA1	749	Probable serine/threonine	no	no	0.853	0.295	0.437	4e-44
Q9FPR3	933	Serine/threonine-protein	no	no	0.806	0.224	0.424	2e-43
Q7T6X2	1657	Putative serine/threonine	N/A	no	0.868	0.135	0.393	2e-42
Q55A09	1331	Probable serine/threonine	no	no	0.830	0.161	0.406	8e-42

>sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1

 Score =  213 bits (542), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 112/248 (45%), Positives = 150/248 (60%), Gaps = 10/248 (4%)

Query: 20  VEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLR----SEHLN 75
           VE    S+ + E+W  D   L  G + ASG+   +YRG+Y  + VAVK++R     E   
Sbjct: 66  VETWEASKGEREEWTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETR 125

Query: 76  DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV-LK 134
             LE +F  EVA+L  + H N+V+FI A  K P  CI+TEYM  G+L  YL+K     L 
Sbjct: 126 AKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLS 185

Query: 135 LPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTA 194
           +  +LR A+DI +GMEYLH + +IHRDLK+ NLL++    VKVADFG +  + +      
Sbjct: 186 IETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDEMRVKVADFGTSCLETQCREAKG 245

Query: 195 ETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGV-----RQ 249
             GTYRWMAPE+I  +PY +K DV+SF IVLWEL TA +P+  MTP+QAA  V     R 
Sbjct: 246 NMGTYRWMAPEMIKEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKNERP 305

Query: 250 VCTSLCQP 257
              + CQP
Sbjct: 306 PLPASCQP 313

Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2).
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1

 Score =  197 bits (502), Expect = 5e-50,   Method: Composition-based stats.
 Identities = 97/246 (39%), Positives = 149/246 (60%), Gaps = 3/246 (1%)

Query: 14  KYRGHAVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLR-SE 72
           K  G  VE   + Q    D EI    LK   ++  G+ G +Y+G++ G  VA+K ++ +E
Sbjct: 636 KNSGSVVEPPSQQQQYFSDIEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINE 695

Query: 73  HLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV 132
            +N+ + +EF +E+ IL  ++H N+V  + A T  P+LC +TEY+PGGSLYD LH     
Sbjct: 696 DVNNQVLEEFRKELTILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIK 755

Query: 133 LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM 192
           + +    + AI I +GM YLH   +IHRD+K+ NLL+D H  VK+ DFG+++ ++K   M
Sbjct: 756 MNMQLYKKLAIQIAQGMNYLHLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEM 815

Query: 193 TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT 252
           T   G+  WM+PE++  + Y +K DV++F I+LWEL T ++PY  +  +Q AL V     
Sbjct: 816 TKSIGSPIWMSPELLMGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAV--TTK 873

Query: 253 SLCQPI 258
           SL  PI
Sbjct: 874 SLRPPI 879

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2

 Score =  187 bits (476), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 100/239 (41%), Positives = 148/239 (61%), Gaps = 10/239 (4%)

Query: 27   QTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEV 86
             T + DWEID   L+ GE + +G  G++Y+ ++ G +VAVK++ S+H++  +E  F +EV
Sbjct: 773  NTTNNDWEIDFSELEIGETLGTGGYGEVYKSIWKGTEVAVKLISSKHVSKDMERSFFEEV 832

Query: 87   AILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL--RFAID 144
             I+  ++H NVV F+ ASTKSP++CIV E+M  GSLYD L  N  + ++P  L  + A  
Sbjct: 833  KIMTSLRHPNVVLFMAASTKSPNMCIVMEFMSLGSLYDLL-GNELIPEIPYALKIKMAYQ 891

Query: 145  ICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ---NKGGVMTAETGTYRW 201
              KGM +LH   I+HRDLK+ NLL+D+   VKV+DFG+ + +   +K        GT  W
Sbjct: 892  ASKGMHFLHSSGIVHRDLKSLNLLLDSKWNVKVSDFGLTKVKSELDKKKTNDNIIGTIHW 951

Query: 202  MAPEVINHQPYDQK--ADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPI 258
            +APE++N         ADV+SF I+LWEL+T + PY  MTP  AA+ V  +   +  PI
Sbjct: 952  IAPEILNDSTEVDYILADVYSFGIILWELLTREQPYKGMTP--AAIAVSVIRDGMRPPI 1008

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1

 Score =  186 bits (471), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 93/216 (43%), Positives = 135/216 (62%), Gaps = 3/216 (1%)

Query: 34  EIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ 93
           +ID + +K G RI  G+ G++Y G + G  VAVK L + ++N+ +  EF +E+ +++ ++
Sbjct: 385 DIDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMKNLR 444

Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
           H NV++F+G+   SP +CI TEYMP GSLY  LH     +    + R  ID  KG+ YLH
Sbjct: 445 HPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAKGIIYLH 504

Query: 154 QRN--IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQP 211
                I+HRDLK+ NLL+D +  VKVADFG++  + +G  MTA  GT  W +PEV+  Q 
Sbjct: 505 GSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATMTA-CGTPCWTSPEVLRSQR 563

Query: 212 YDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGV 247
           Y +KADV+SF I+LWE  T + PY  + P Q    V
Sbjct: 564 YTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAV 599

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1

 Score =  185 bits (469), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 98/232 (42%), Positives = 145/232 (62%), Gaps = 5/232 (2%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           +D +I    L   E+I +GS G ++R  + G DVAVK+L  +  +    +EF++EVAI++
Sbjct: 542 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMK 601

Query: 91  EVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF--AIDICKG 148
            ++H N+V F+GA T+ P+L IVTEY+  GSLY  LHK+    +L +  R   A D+ KG
Sbjct: 602 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 661

Query: 149 MEYLHQRN--IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT-AETGTYRWMAPE 205
           M YLH RN  I+HRDLK+ NLL+D    VKV DFG++R +    + + +  GT  WMAPE
Sbjct: 662 MNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE 721

Query: 206 VINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQP 257
           V+  +P ++K+DV+SF ++LWEL T + P+ ++ P Q    V   C  L  P
Sbjct: 722 VLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP 773

Acts as a negative regulator in the ethylene response pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1

 Score =  185 bits (469), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 98/242 (40%), Positives = 147/242 (60%), Gaps = 5/242 (2%)

Query: 10  IVHRKYRGHAVEKAIESQ-TKSEDW-EIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVK 67
           ++  +YR     K  ++  T+ +D  +ID   +K G RI  G+ G++Y G + G  VAVK
Sbjct: 342 LIRNRYRSSGYYKPDKNDYTQIKDGKDIDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVK 401

Query: 68  VLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH 127
            L + ++N+ +  EF +E+ +++ ++H NV++F+G+    P +CI TEYMP GSLY  LH
Sbjct: 402 KLPAHNINENILKEFHREINLMKNLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILH 461

Query: 128 KNHNVLKLPQLLRFAIDICKGMEYLHQRN--IIHRDLKTANLLMDTHNVVKVADFGVARF 185
                L+   L++  ID  KG+ YLH     I+HRDLK+ NLL+D +  VKVADFG++  
Sbjct: 462 DQALQLQWSLLIKMMIDAAKGVIYLHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTI 521

Query: 186 QNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL 245
           + +G  MTA  GT  W +PEV+  Q Y +KADV+SF I+LWE  T + PY  + P Q   
Sbjct: 522 EQQGATMTA-CGTPCWTSPEVLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIF 580

Query: 246 GV 247
            V
Sbjct: 581 AV 582

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1

 Score =  178 bits (451), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 101/231 (43%), Positives = 138/231 (59%), Gaps = 10/231 (4%)

Query: 27  QTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLED---EFV 83
           +T  E   ID   +    RI  GSC +++ G + G  VA+K  +++ LN+  ED   E  
Sbjct: 478 KTLFEIKPIDISEIVVQNRIGRGSCAEVFTGTWRGIIVAIK--KAKLLNEDDEDFLNELA 535

Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
           QE  I+ +++H N+ +F+G     P + IV EYMP GSLY  LH     L  P++   A+
Sbjct: 536 QEATIMSQLRHPNICQFLGTCNNPPEILIVMEYMPLGSLYRILHDPSISLDWPRMKSMAL 595

Query: 144 DICKGMEYLHQRN--IIHRDLKTANLLMDTHNVVKVADFGVA-RFQNKGGVMTAET--GT 198
           DI KGM YLH  +  +IHRDLK+ NLL+D H  VK++DFG++ RF+      TA T  GT
Sbjct: 596 DIAKGMNYLHCCDPIVIHRDLKSHNLLVDEHYRVKISDFGLSTRFKKHLDKKTAMTPVGT 655

Query: 199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
             W APEV+ + PY +KADVFSFAIVLWE+VT + PY  M   Q  + V Q
Sbjct: 656 PCWTAPEVLRNDPYTEKADVFSFAIVLWEIVTREDPYQGMPTFQIVISVGQ 706

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1

 Score =  176 bits (446), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 90/212 (42%), Positives = 133/212 (62%), Gaps = 3/212 (1%)

Query: 34  EIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ 93
           EI    L   ERI  GS G++Y   + G +VAVK    +  +     EF  EV I+R ++
Sbjct: 663 EIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSEVRIMRRLR 722

Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
           H NVV F+GA T+ P+L IVTE++P GSLY  LH+  + +   + ++ A+D+  GM  LH
Sbjct: 723 HPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDVAMGMNCLH 782

Query: 154 QR--NIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET-GTYRWMAPEVINHQ 210
                I+HRDLKT NLL+D +  VKV DFG++R ++   + +  T GT  WMAPEV+ ++
Sbjct: 783 TSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 842

Query: 211 PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQ 242
           P ++K DV+SF ++LWEL T ++P+  M P+Q
Sbjct: 843 PSNEKCDVYSFGVILWELATLRLPWRGMNPMQ 874

MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2

 Score =  172 bits (437), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 91/231 (39%), Positives = 140/231 (60%), Gaps = 6/231 (2%)

Query: 10   IVHRKYRGHAVEKAIESQTKSE---DWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAV 66
            + H+ Y+ HA  +  E    S     W I+   +K GE+I  GS G +YRG +   DVA+
Sbjct: 1366 VPHQAYQYHAAIENNERYLTSAGLCSWVINYDEIKMGEQIGLGSYGVVYRGKWKNVDVAI 1425

Query: 67   KVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL 126
            K    + +++       +E+A L+++ H N++  +GAS K P++CIVTEYM  G+L D +
Sbjct: 1426 KKFIKQKIDENHLLGIREEIAFLKKLHHPNIITMVGASLKKPNICIVTEYMAKGNLRDAM 1485

Query: 127  HKNHNVLKLPQLLRFAIDICKGMEYLHQRN--IIHRDLKTANLLMDTHNVVKVADFGVAR 184
                  L+  Q ++  ++I KG+ YLH  +  IIHRD+K +N+L+D +  VK+ADFG AR
Sbjct: 1486 RTCTPKLEWHQKIKILVNIAKGISYLHSFDPPIIHRDIKPSNILIDENWNVKIADFGFAR 1545

Query: 185  FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
             + +  +MT   GT  W APE+I +  YD+K DVFSF IV+WE++T K P+
Sbjct: 1546 IKEENAIMT-RCGTPCWTAPEIIRNDIYDEKVDVFSFGIVMWEVLTCKEPF 1595

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1

 Score =  170 bits (431), Expect = 8e-42,   Method: Composition-based stats.
 Identities = 94/231 (40%), Positives = 137/231 (59%), Gaps = 16/231 (6%)

Query: 40   LKTGERIASGSCGDLYRGVYLGQDVAVKVLRS--EHLNDTLEDEFVQEVAILREVQHRNV 97
            +K  + I  G    + +G + G+DVAVK L S  +   + +  EF  EV +L  +QH N+
Sbjct: 1073 IKIDKEIGKGHFSKVLKGNWKGKDVAVKKLNSNKDKAREEMIQEFKAEVELLGSLQHPNL 1132

Query: 98   VRFIGASTKSPHLCIVTEYMPGGSLYDYLH----KNHNVLKLPQLLRFAI--DICKGMEY 151
            V   G S     +CIV E++P G+L++ +H    +    +KL   L  AI  DI +GM++
Sbjct: 1133 VTCYGYSLNP--MCIVMEFLPSGNLFELIHSKPSEQQQSIKLDSTLILAIAFDIARGMQH 1190

Query: 152  LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQP 211
            LH RNIIHRDLK++NLLMD H  +K+AD G+AR  +    MT   GT  W APE++ H+ 
Sbjct: 1191 LHTRNIIHRDLKSSNLLMDKHFNIKIADLGIARETSFTQTMTT-IGTVAWTAPEILRHES 1249

Query: 212  YDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL-----GVRQVCTSLCQP 257
            Y+QKADV+S+AIVL+EL+T + PY  + P+ A +     G+R      C P
Sbjct: 1250 YNQKADVYSYAIVLYELLTGEEPYQGIPPMNAGILVASKGLRPELPDNCDP 1300

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	259
296088117	550	unnamed protein product [Vitis vinifera]	0.891	0.42	0.904	1e-123
359493032	555	PREDICTED: serine/threonine-protein kina	0.891	0.416	0.904	1e-122
356534057	552	PREDICTED: serine/threonine-protein kina	0.915	0.429	0.852	1e-118
147844711	444	hypothetical protein VITISV_005118 [Viti	0.891	0.520	0.822	1e-118
255584578	561	protein kinase, putative [Ricinus commun	0.891	0.411	0.874	1e-118
357443713	760	Serine/threonine protein kinase atg1 [Me	0.891	0.303	0.844	1e-114
224062914	494	predicted protein [Populus trichocarpa]	0.880	0.461	0.850	1e-114
449497118	497	PREDICTED: tyrosine-protein kinase Srms-	0.903	0.470	0.821	1e-111
449446516	552	PREDICTED: serine/threonine-protein kina	0.884	0.414	0.834	1e-110
218186483	524	hypothetical protein OsI_37582 [Oryza sa	0.891	0.440	0.753	1e-102

>gi|296088117|emb|CBI35506.3| unnamed protein product [Vitis vinifera]

 Score =  445 bits (1145), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 209/231 (90%), Positives = 220/231 (95%)

Query: 19  AVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTL 78
           AVEKA+ +Q KS DWEIDRRLLK GERIASGSCGDLYRGVYLGQDVAVK+LRSEHLN++L
Sbjct: 264 AVEKALAAQVKSGDWEIDRRLLKIGERIASGSCGDLYRGVYLGQDVAVKILRSEHLNESL 323

Query: 79  EDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQL 138
           EDEF QEVAILREVQHRNVVRFIGA T+SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQL
Sbjct: 324 EDEFEQEVAILREVQHRNVVRFIGACTRSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQL 383

Query: 139 LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT 198
           L+FAID+CKGM YLHQ NIIHRDLKTANLLMDTHNVVKVADFGVARFQN+ GVMTAETGT
Sbjct: 384 LKFAIDVCKGMGYLHQNNIIHRDLKTANLLMDTHNVVKVADFGVARFQNQEGVMTAETGT 443

Query: 199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
           YRWMAPEVINH PYDQKADVFSFAIVLWEL TAK+PYD+MTPLQAALGVRQ
Sbjct: 444 YRWMAPEVINHLPYDQKADVFSFAIVLWELTTAKIPYDNMTPLQAALGVRQ 494

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359493032|ref|XP_002264745.2| PREDICTED: serine/threonine-protein kinase HT1-like [Vitis vinifera]

 Score =  445 bits (1144), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 209/231 (90%), Positives = 220/231 (95%)

Query: 19  AVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTL 78
           AVEKA+ +Q KS DWEIDRRLLK GERIASGSCGDLYRGVYLGQDVAVK+LRSEHLN++L
Sbjct: 269 AVEKALAAQVKSGDWEIDRRLLKIGERIASGSCGDLYRGVYLGQDVAVKILRSEHLNESL 328

Query: 79  EDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQL 138
           EDEF QEVAILREVQHRNVVRFIGA T+SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQL
Sbjct: 329 EDEFEQEVAILREVQHRNVVRFIGACTRSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQL 388

Query: 139 LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT 198
           L+FAID+CKGM YLHQ NIIHRDLKTANLLMDTHNVVKVADFGVARFQN+ GVMTAETGT
Sbjct: 389 LKFAIDVCKGMGYLHQNNIIHRDLKTANLLMDTHNVVKVADFGVARFQNQEGVMTAETGT 448

Query: 199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
           YRWMAPEVINH PYDQKADVFSFAIVLWEL TAK+PYD+MTPLQAALGVRQ
Sbjct: 449 YRWMAPEVINHLPYDQKADVFSFAIVLWELTTAKIPYDNMTPLQAALGVRQ 499

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356534057|ref|XP_003535574.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max]

 Score =  431 bits (1109), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 203/238 (85%), Positives = 220/238 (92%), Gaps = 1/238 (0%)

Query: 13  RKYRGH-AVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRS 71
           R  + H AVEKA+ ++ KS DWEIDR+LLK GE+IASGS GDLYRGVYLG+DVAVKVLRS
Sbjct: 260 RSLKSHSAVEKALATEGKSGDWEIDRKLLKLGEKIASGSSGDLYRGVYLGEDVAVKVLRS 319

Query: 72  EHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHN 131
           E LND LEDEF QEVAILR+V H+NVVRFIGA TK PHLCI+TEYMPGGSLYDY+HKNHN
Sbjct: 320 EQLNDALEDEFAQEVAILRQVHHKNVVRFIGACTKCPHLCIITEYMPGGSLYDYVHKNHN 379

Query: 132 VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV 191
           VL+L QLL+FAID+CKGMEYLHQ NIIHRDLKTANLLMDTHNVVKVADFGVARF N+GGV
Sbjct: 380 VLELSQLLKFAIDVCKGMEYLHQSNIIHRDLKTANLLMDTHNVVKVADFGVARFLNQGGV 439

Query: 192 MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
           MTAETGTYRWMAPEVINHQPYDQKADVFSF+IVLWELVTAKVPYD+MTPLQAALGVRQ
Sbjct: 440 MTAETGTYRWMAPEVINHQPYDQKADVFSFSIVLWELVTAKVPYDTMTPLQAALGVRQ 497

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147844711|emb|CAN80049.1| hypothetical protein VITISV_005118 [Vitis vinifera]

 Score =  431 bits (1108), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 209/254 (82%), Positives = 220/254 (86%), Gaps = 23/254 (9%)

Query: 19  AVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTL 78
           AVEKA+ +Q KS DWEIDRRLLK GERIASGSCGDLYRGVYLGQDVAVK+LRSEHLN++L
Sbjct: 113 AVEKALAAQVKSGDWEIDRRLLKIGERIASGSCGDLYRGVYLGQDVAVKILRSEHLNESL 172

Query: 79  EDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQL 138
           EDEF QEVAILREVQHRNVVRFIGA T+SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQL
Sbjct: 173 EDEFEQEVAILREVQHRNVVRFIGACTRSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQL 232

Query: 139 LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT 198
           L+FAID+CKGM YLHQ NIIHRDLKTANLLMDTHNVVKVADFGVARFQN+ GVMTAETGT
Sbjct: 233 LKFAIDVCKGMGYLHQNNIIHRDLKTANLLMDTHNVVKVADFGVARFQNQEGVMTAETGT 292

Query: 199 YRWMAP-----------------------EVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           YRWMAP                       EVINH PYDQKADVFSFAIVLWEL TAK+PY
Sbjct: 293 YRWMAPEVIDGKYGKEEGGWNSCEVRDGYEVINHLPYDQKADVFSFAIVLWELTTAKIPY 352

Query: 236 DSMTPLQAALGVRQ 249
           D+MTPLQAALGVRQ
Sbjct: 353 DNMTPLQAALGVRQ 366

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255584578|ref|XP_002533015.1| protein kinase, putative [Ricinus communis] gi|223527204|gb|EEF29369.1| protein kinase, putative [Ricinus communis]

 Score =  430 bits (1106), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 202/231 (87%), Positives = 216/231 (93%)

Query: 19  AVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTL 78
           AV KA+ +  +S DWEIDRRL+K GERIASGSCGDLY GVY GQDVAVKVLRSE LNDT 
Sbjct: 268 AVNKALAAAARSGDWEIDRRLIKIGERIASGSCGDLYHGVYFGQDVAVKVLRSEQLNDTQ 327

Query: 79  EDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQL 138
           E+EF QEVAILR+V+HRN+VRFIGA TKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQL
Sbjct: 328 EEEFAQEVAILRQVKHRNIVRFIGACTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQL 387

Query: 139 LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT 198
           L+F ID+C+GMEYLHQ NIIHRDLKTANLLMDTHNVVKVADFGVARFQN+ GVMTAETGT
Sbjct: 388 LKFGIDVCRGMEYLHQNNIIHRDLKTANLLMDTHNVVKVADFGVARFQNQEGVMTAETGT 447

Query: 199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
           YRWMAPEVINHQPYDQKAD+FSFAIVLWELVTAKVPYD+MTPLQAALGVRQ
Sbjct: 448 YRWMAPEVINHQPYDQKADIFSFAIVLWELVTAKVPYDTMTPLQAALGVRQ 498

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357443713|ref|XP_003592134.1| Serine/threonine protein kinase atg1 [Medicago truncatula] gi|355481182|gb|AES62385.1| Serine/threonine protein kinase atg1 [Medicago truncatula]

 Score =  416 bits (1068), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 195/231 (84%), Positives = 213/231 (92%)

Query: 19  AVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTL 78
           AVEKA+ ++ KS DWEIDRR LK GE+IASGSCGDL+ GVYLG+DVAVKVL+S+ LND L
Sbjct: 423 AVEKALAAEGKSGDWEIDRRSLKIGEKIASGSCGDLHHGVYLGEDVAVKVLKSDQLNDAL 482

Query: 79  EDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQL 138
           EDEF QE+AILR+V+H+NVVRFIGA TK PHLCIVTEYM GGSLYDYLHKNHNVL+L QL
Sbjct: 483 EDEFTQEIAILRQVEHKNVVRFIGACTKCPHLCIVTEYMTGGSLYDYLHKNHNVLELSQL 542

Query: 139 LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT 198
           L+FAID+CKGMEYLH  NIIHRDLKTANLLMD HNVVKVADFGVARF  +GGVMTAETGT
Sbjct: 543 LKFAIDVCKGMEYLHGNNIIHRDLKTANLLMDAHNVVKVADFGVARFLIQGGVMTAETGT 602

Query: 199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
           YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAK+PYD+MTPLQAALGVRQ
Sbjct: 603 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKIPYDTMTPLQAALGVRQ 653

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224062914|ref|XP_002300929.1| predicted protein [Populus trichocarpa] gi|222842655|gb|EEE80202.1| predicted protein [Populus trichocarpa]

 Score =  416 bits (1068), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 194/228 (85%), Positives = 208/228 (91%)

Query: 19  AVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTL 78
           +++KA+ +  K  DWEIDRRLLK GE IASGS GDLYRGVY GQDVA+K+ RSE LNDT 
Sbjct: 222 SIDKALAAGAKPGDWEIDRRLLKIGESIASGSSGDLYRGVYFGQDVAIKIFRSEQLNDTQ 281

Query: 79  EDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQL 138
           E+EF QEVAILREVQHRNVVRFIGA TKSP LCIVTE+MPGGSLYDYLHK HN+L+LPQL
Sbjct: 282 EEEFAQEVAILREVQHRNVVRFIGACTKSPRLCIVTEFMPGGSLYDYLHKKHNILELPQL 341

Query: 139 LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT 198
           L+F ID+CKGMEYLHQ NIIHRDLKTANLLMDT NVVKVADFGVARFQN+GGVMTAETGT
Sbjct: 342 LKFVIDVCKGMEYLHQNNIIHRDLKTANLLMDTQNVVKVADFGVARFQNQGGVMTAETGT 401

Query: 199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALG 246
           YRWMAPEVINH PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALG
Sbjct: 402 YRWMAPEVINHLPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALG 449

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449497118|ref|XP_004160317.1| PREDICTED: tyrosine-protein kinase Srms-like [Cucumis sativus]

 Score =  406 bits (1044), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 193/235 (82%), Positives = 211/235 (89%), Gaps = 1/235 (0%)

Query: 20  VEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLE 79
           V+K +++Q KS DWEIDRRLLK GERIASGSCGDLY G YLGQDVAVK+LRSE LN  LE
Sbjct: 262 VKKTLDAQVKSADWEIDRRLLKIGERIASGSCGDLYHGFYLGQDVAVKILRSEDLNADLE 321

Query: 80  DEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL 139
           DEF QEV ILR+VQH+N+VRF+GA T SPHLCIVTEYMPGGSLYDYLHKNH VLKL QLL
Sbjct: 322 DEFNQEVTILRKVQHKNIVRFVGACTSSPHLCIVTEYMPGGSLYDYLHKNHCVLKLSQLL 381

Query: 140 RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           +F+ID+C+GMEYLH  NIIHRDLKTANLLMDT  VVKVADFGVAR+Q++ GVMTAETGTY
Sbjct: 382 KFSIDVCEGMEYLHLNNIIHRDLKTANLLMDTQQVVKVADFGVARYQSQ-GVMTAETGTY 440

Query: 200 RWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL 254
           RWMAPEVINH PYDQKAD+FSFAIVLWELVTAKVPYDSMTPLQAALGVRQ+   L
Sbjct: 441 RWMAPEVINHLPYDQKADIFSFAIVLWELVTAKVPYDSMTPLQAALGVRQISPLL 495

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449446516|ref|XP_004141017.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus]

 Score =  404 bits (1037), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 192/230 (83%), Positives = 209/230 (90%), Gaps = 1/230 (0%)

Query: 20  VEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLE 79
           V+K +++Q KS DWEIDRRLLK GERIASGSCGDLY G YLGQDVAVK+LRSE LN  LE
Sbjct: 262 VKKTLDAQVKSADWEIDRRLLKIGERIASGSCGDLYHGFYLGQDVAVKILRSEDLNADLE 321

Query: 80  DEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL 139
           DEF QEV ILR+VQH+N+VRF+GA T SPHLCIVTEYMPGGSLYDYLHKNH VLKL QLL
Sbjct: 322 DEFNQEVTILRKVQHKNIVRFVGACTSSPHLCIVTEYMPGGSLYDYLHKNHCVLKLLQLL 381

Query: 140 RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           +F+ID+C+GMEYLH  NIIHRDLKTANLLMDT  VVKVADFGVAR+Q++ GVMTAETGTY
Sbjct: 382 KFSIDVCEGMEYLHLNNIIHRDLKTANLLMDTQQVVKVADFGVARYQSQ-GVMTAETGTY 440

Query: 200 RWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
           RWMAPEVINH PYDQKAD+FSFAIVLWELVTAKVPYDSMTPLQAALGVRQ
Sbjct: 441 RWMAPEVINHLPYDQKADIFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 490

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|218186483|gb|EEC68910.1| hypothetical protein OsI_37582 [Oryza sativa Indica Group]

 Score =  378 bits (970), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 174/231 (75%), Positives = 199/231 (86%)

Query: 19  AVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTL 78
           A E+ +  Q K  +WEID+RLLK G  IASGSCGDLY G YLG+DVAVK+LRSEHLN  +
Sbjct: 230 AAERTLPFQVKGGEWEIDKRLLKMGGMIASGSCGDLYHGTYLGEDVAVKILRSEHLNKNV 289

Query: 79  EDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQL 138
            +EF QEV ILREVQH NVVRFIGA TK P  CI+TEYM GGSLYD++HK HNVL LP L
Sbjct: 290 WNEFTQEVYILREVQHTNVVRFIGACTKPPQFCIITEYMSGGSLYDFVHKQHNVLDLPTL 349

Query: 139 LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT 198
           L+FA+D+C+GM YLHQR IIHRDLK+ANLLMD  +VVKVADFGVARFQ++GG MTAETGT
Sbjct: 350 LKFAVDVCRGMCYLHQRGIIHRDLKSANLLMDKDHVVKVADFGVARFQDQGGNMTAETGT 409

Query: 199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
           YRWMAPEVINHQPYD KADVFSFAIVLWEL+T+K+PY++MTPLQAA+GVRQ
Sbjct: 410 YRWMAPEVINHQPYDNKADVFSFAIVLWELITSKIPYNTMTPLQAAVGVRQ 460

Source: Oryza sativa Indica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	259
TAIR|locus:2121154	575	STY46 "serine/threonine/tyrosi	0.837	0.377	0.709	9.4e-82
TAIR|locus:2128043	570	STY17 "serine/threonine/tyrosi	0.918	0.417	0.610	2.7e-77
TAIR|locus:2827943	546	STY8 "serine/threonine/tyrosin	0.918	0.435	0.610	2.7e-75
TAIR|locus:2126311	412	AT4G31170 [Arabidopsis thalian	0.903	0.567	0.483	1.1e-55
TAIR|locus:2061092	411	AT2G24360 [Arabidopsis thalian	0.903	0.569	0.471	9.9e-55
TAIR|locus:2154573	525	AT5G58950 [Arabidopsis thalian	0.872	0.430	0.429	2.9e-48
TAIR|locus:2200296	765	AT1G67890 [Arabidopsis thalian	0.864	0.292	0.429	9.2e-48
TAIR|locus:2027794	1030	AT1G73660 [Arabidopsis thalian	0.814	0.204	0.453	9.2e-48
DICTYBASE|DDB_G0267514	916	DDB_G0267514 "protein kinase,	0.938	0.265	0.394	5.2e-46
TAIR|locus:2170106	385	AT5G50000 [Arabidopsis thalian	0.498	0.335	0.480	2e-45

TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)]

 Score = 820 (293.7 bits), Expect = 9.4e-82, P = 9.4e-82
 Identities = 154/217 (70%), Positives = 179/217 (82%)

Query:    33 WEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV 92
             WEI+ + LK G +IASGS GDLY+G Y  Q+VA+KVL+ E L+  LE EF QEV I+R+V
Sbjct:   283 WEINLKHLKFGHKIASGSYGDLYKGTYCSQEVAIKVLKPERLDSDLEKEFAQEVFIMRKV 342

Query:    93 QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYL 152
             +H+NVV+FIGA TK PHLCIVTE+MPGGS+YDYLHK   V KLP L + AIDICKGM YL
Sbjct:   343 RHKNVVQFIGACTKPPHLCIVTEFMPGGSVYDYLHKQKGVFKLPTLFKVAIDICKGMSYL 402

Query:   153 HQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPY 212
             HQ NIIHRDLK ANLLMD + VVKVADFGVAR + + GVMTAETGTYRWMAPEVI H+PY
Sbjct:   403 HQNNIIHRDLKAANLLMDENEVVKVADFGVARVKAQTGVMTAETGTYRWMAPEVIEHKPY 462

Query:   213 DQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
             D KADVFS+ IVLWEL+T K+PY+ MTPLQAA+GV Q
Sbjct:   463 DHKADVFSYGIVLWELLTGKLPYEYMTPLQAAVGVVQ 499

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 778 (278.9 bits), Expect = 2.7e-77, P = 2.7e-77
 Identities = 146/239 (61%), Positives = 184/239 (76%)

Query:    12 HRKYRGHAVEKAIESQTKSED-WEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLR 70
             H K     +   +E  T   D WEID + LK  +++A GS G+L+RG Y  Q+VA+K+L+
Sbjct:   263 HDKSTNELLPACVEIPTDGTDEWEIDMKQLKIEKKVACGSYGELFRGTYCSQEVAIKILK 322

Query:    71 SEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH 130
              E +N  +  EF QEV I+R+V+H+NVV+FIGA T+SP+LCIVTE+M  GS+YD+LHK+ 
Sbjct:   323 PERVNAEMLREFSQEVYIMRKVRHKNVVQFIGACTRSPNLCIVTEFMTRGSIYDFLHKHK 382

Query:   131 NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG 190
              V K+  LL+ A+D+ KGM YLHQ NIIHRDLKTANLLMD H VVKVADFGVAR Q + G
Sbjct:   383 GVFKIQSLLKVALDVSKGMNYLHQNNIIHRDLKTANLLMDEHEVVKVADFGVARVQTESG 442

Query:   191 VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
             VMTAETGTYRWMAPEVI H+PYD +ADVFS+AIVLWEL+T ++PY  +TPLQAA+GV Q
Sbjct:   443 VMTAETGTYRWMAPEVIEHKPYDHRADVFSYAIVLWELLTGELPYSYLTPLQAAVGVVQ 501

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 759 (272.2 bits), Expect = 2.7e-75, P = 2.7e-75
 Identities = 146/239 (61%), Positives = 180/239 (75%)

Query:    12 HRKYRGHAVEKAIESQTKSED-WEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLR 70
             H K     +   IE  T   D WEID   LK  +++ASGS GDL+RG Y  Q+VA+K L+
Sbjct:   257 HDKSSNELIPACIEIPTDGTDEWEIDVTQLKIEKKVASGSYGDLHRGTYCSQEVAIKFLK 316

Query:    71 SEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH 130
              + +N+ +  EF QEV I+R+V+H+NVV+F+GA T+SP LCIVTE+M  GS+YD+LHK  
Sbjct:   317 PDRVNNEMLREFSQEVFIMRKVRHKNVVQFLGACTRSPTLCIVTEFMARGSIYDFLHKQK 376

Query:   131 NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG 190
                KL  LL+ A+D+ KGM YLHQ NIIHRDLKTANLLMD H +VKVADFGVAR Q + G
Sbjct:   377 CAFKLQTLLKVALDVAKGMSYLHQNNIIHRDLKTANLLMDEHGLVKVADFGVARVQIESG 436

Query:   191 VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
             VMTAETGTYRWMAPEVI H+PY+ KADVFS+AIVLWEL+T  +PY  +TPLQAA+GV Q
Sbjct:   437 VMTAETGTYRWMAPEVIEHKPYNHKADVFSYAIVLWELLTGDIPYAFLTPLQAAVGVVQ 495

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)]

 Score = 574 (207.1 bits), Expect = 1.1e-55, P = 1.1e-55
 Identities = 118/244 (48%), Positives = 154/244 (63%)

Query:    25 ESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLN----DTLED 80
             E     E+W ID R L  G   A G+ G LYRG Y G+DVA+K+L     N      LE 
Sbjct:   116 EGLVNYEEWTIDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQALEQ 175

Query:    81 EFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHN-VLKLPQLL 139
             +F QEV++L  ++H N+VRFIGA  K    CIVTEY  GGS+  +L K  N  + L   +
Sbjct:   176 QFQQEVSMLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKLAV 235

Query:   140 RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
               A+D+ +GM Y+H+RN IHRDLK+ NLL+     +K+ADFGVAR + +   MT ETGTY
Sbjct:   236 MQALDVARGMAYVHERNFIHRDLKSDNLLISADRSIKIADFGVARIEVQTEGMTPETGTY 295

Query:   200 RWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL-----GVRQVCTSL 254
             RWMAPE+I H+PY QK DV+SF IVLWEL+T  +P+ +MT +QAA      GVR    + 
Sbjct:   296 RWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVPAD 355

Query:   255 CQPI 258
             C P+
Sbjct:   356 CLPV 359

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006914 "autophagy" evidence=RCA

GO:0010053 "root epidermal cell differentiation" evidence=IMP

TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)]

 Score = 565 (203.9 bits), Expect = 9.9e-55, P = 9.9e-55
 Identities = 115/244 (47%), Positives = 158/244 (64%)

Query:    25 ESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVL-RSEHLNDT---LED 80
             E  T  ++W ID R L  G   A G+ G LY+G Y G+DVA+K+L R E+  +    +E 
Sbjct:   115 EGLTNYDEWTIDLRKLNMGPAFAQGAFGKLYKGTYNGEDVAIKILERPENSPEKAQFMEQ 174

Query:    81 EFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHN-VLKLPQLL 139
             +F QEV++L  ++H N+VRFIGA  K    CIVTEY  GGS+  +L +  N  + L   +
Sbjct:   175 QFQQEVSMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAV 234

Query:   140 RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
             + A+D+ +GM Y+H RN IHRDLK+ NLL+     +K+ADFGVAR + +   MT ETGTY
Sbjct:   235 KQALDVARGMAYVHGRNFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTY 294

Query:   200 RWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL-----GVRQVCTSL 254
             RWMAPE+I H+ Y+QK DV+SF IVLWEL+T  +P+ +MT +QAA      GVR    + 
Sbjct:   295 RWMAPEMIQHRAYNQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVPND 354

Query:   255 CQPI 258
             C P+
Sbjct:   355 CLPV 358

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IDA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)]

 Score = 504 (182.5 bits), Expect = 2.9e-48, P = 2.9e-48
 Identities = 100/233 (42%), Positives = 146/233 (62%)

Query:    22 KAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDT---- 77
             + + +   SE++ +D   L  G + A G    LY G Y  + VAVK++     +D     
Sbjct:   189 RRVSAVEASEEFRVDMSKLFFGLKFAHGLYSRLYHGKYEDKAVAVKLITVPDDDDNGCLG 248

Query:    78 --LEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHN-VLK 134
               LE +F +EV +L  + H NV++F+GA    P  C++T+Y+P GSL  +LHK  N  L 
Sbjct:   249 ARLEKQFTKEVTLLSRLTHPNVIKFVGAYKDPPVYCVLTQYLPEGSLRSFLHKPENRSLP 308

Query:   135 LPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTA 194
             L +L+ FAIDI +GMEY+H R IIHRDLK  N+L+D    +K+ADFG+A  +    ++  
Sbjct:   309 LKKLIEFAIDIARGMEYIHSRRIIHRDLKPENVLIDEEFHLKIADFGIACEEEYCDMLAD 368

Query:   195 ETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGV 247
             + GTYRWMAPE+I  +P+ +KADV+SF +VLWE+V   +PY+ M P+QAA  V
Sbjct:   369 DPGTYRWMAPEMIKRKPHGRKADVYSFGLVLWEMVAGAIPYEDMNPIQAAFAV 421

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)]

 Score = 503 (182.1 bits), Expect = 9.2e-48, P = 9.2e-48
 Identities = 97/226 (42%), Positives = 151/226 (66%)

Query:    19 AVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTL 78
             +V   ++  +   D+EI    L  GE+I  GSCG +Y G++ G DVAVKV   +  ++ +
Sbjct:   466 SVMNKVDMDSDCLDYEILWEDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYSEEI 525

Query:    79 EDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQL 138
                F QEV++++ ++H NV+ F+GA      LCIVTE++P GSL+  L +N + L L + 
Sbjct:   526 ITSFKQEVSLMKRLRHPNVLLFMGAVASPQRLCIVTEFLPRGSLFRLLQRNKSKLDLRRR 585

Query:   139 LRFAIDICKGMEYLHQRN--IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET 196
             +  A DI +GM YLH  +  IIHRDLK++NLL+D +  VKVADFG++R +++  + T   
Sbjct:   586 IHMASDIARGMNYLHHCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHETYLTTNGR 645

Query:   197 GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQ 242
             GT +WMAPEV+ ++  D+K+DV+SF +VLWELVT K+P++++  +Q
Sbjct:   646 GTPQWMAPEVLRNEAADEKSDVYSFGVVLWELVTEKIPWENLNAMQ 691

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004871 "signal transducer activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005737 "cytoplasm" evidence=ISM

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)]

 Score = 486 (176.1 bits), Expect = 9.2e-48, Sum P(2) = 9.2e-48
 Identities = 97/214 (45%), Positives = 142/214 (66%)

Query:    32 DWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
             D EI    +  GERI  GS G++YRG + G +VAVK    + L     +EF  EV I+++
Sbjct:   740 DCEILWEEITVGERIGLGSYGEVYRGDWHGTEVAVKKFLDQDLTGEALEEFRSEVRIMKK 799

Query:    92 VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
             ++H N+V F+GA T+ P+L IVTE++P GSLY  +H+ +N L   + LR A+D  +GM Y
Sbjct:   800 LRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERRRLRMALDAARGMNY 859

Query:   152 LHQRN--IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET-GTYRWMAPEVIN 208
             LH  N  I+HRDLK+ NLL+D + VVKV DFG++R ++   + +  T GT  WMAPEV+ 
Sbjct:   860 LHSCNPMIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHSTYLSSKSTAGTAEWMAPEVLR 919

Query:   209 HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQ 242
             ++P D+K DV+S+ ++LWEL T + P+  M P+Q
Sbjct:   920 NEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQ 953

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0004709 "MAP kinase kinase kinase activity" evidence=ISS

GO:0009651 "response to salt stress" evidence=IMP

GO:0048573 "photoperiodism, flowering" evidence=RCA

DICTYBASE|DDB_G0267514 DDB_G0267514 "protein kinase, TKL group" [Dictyostelium discoideum (taxid:44689)]

 Score = 491 (177.9 bits), Expect = 5.2e-46, P = 5.2e-46
 Identities = 97/246 (39%), Positives = 149/246 (60%)

Query:    14 KYRGHAVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLR-SE 72
             K  G  VE   + Q    D EI    LK   ++  G+ G +Y+G++ G  VA+K ++ +E
Sbjct:   636 KNSGSVVEPPSQQQQYFSDIEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINE 695

Query:    73 HLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV 132
              +N+ + +EF +E+ IL  ++H N+V  + A T  P+LC +TEY+PGGSLYD LH     
Sbjct:   696 DVNNQVLEEFRKELTILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIK 755

Query:   133 LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM 192
             + +    + AI I +GM YLH   +IHRD+K+ NLL+D H  VK+ DFG+++ ++K   M
Sbjct:   756 MNMQLYKKLAIQIAQGMNYLHLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEM 815

Query:   193 TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT 252
             T   G+  WM+PE++  + Y +K DV++F I+LWEL T ++PY  +  +Q AL V     
Sbjct:   816 TKSIGSPIWMSPELLMGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAV--TTK 873

Query:   253 SLCQPI 258
             SL  PI
Sbjct:   874 SLRPPI 879

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

TAIR|locus:2170106 AT5G50000 [Arabidopsis thaliana (taxid:3702)]

 Score = 342 (125.4 bits), Expect = 2.0e-45, Sum P(2) = 2.0e-45
 Identities = 63/131 (48%), Positives = 89/131 (67%)

Query:   111 CIVTEYMPGGSLYDYLHKNHN-VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM 169
             C+V EY+PGG+L  YL KN    L    +++ A+D+ +G+ YLH + I+HRD+KT N+L+
Sbjct:   176 CVVVEYLPGGALKSYLIKNRRRKLTFKIVVQLALDLARGLSYLHSQKIVHRDVKTENMLL 235

Query:   170 DTHNVVKVADFGVARFQ-NKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWEL 228
             D    VK+ADFGVAR + +    MT ETGT  +MAPEV+N  PY++K DV+SF I LWE+
Sbjct:   236 DKTRTVKIADFGVARVEASNPNDMTGETGTLGYMAPEVLNGNPYNRKCDVYSFGICLWEI 295

Query:   229 VTAKVPYDSMT 239
                 +PY  +T
Sbjct:   296 YCCDMPYPDLT 306

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0009506 "plasmodesma" evidence=IDA

GO:0000394 "RNA splicing, via endonucleolytic cleavage and ligation" evidence=RCA

GO:0006084 "acetyl-CoA metabolic process" evidence=RCA

GO:0009086 "methionine biosynthetic process" evidence=RCA

GO:0016126 "sterol biosynthetic process" evidence=RCA

GO:0016132 "brassinosteroid biosynthetic process" evidence=RCA

GO:0019344 "cysteine biosynthetic process" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00002272001 SubName- Full=Chromosome undetermined scaffold_129, whole genome shotgun sequence; (553 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	259
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-78
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-78
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	9e-78
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-71
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-69
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-68
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-63
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	7e-58
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-57
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-57
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-56
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-54
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-54
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-52
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-50
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-50
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-48
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-48
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	9e-48
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-47
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-47
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-46
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-46
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-45
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	8e-45
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-44
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-44
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-44
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-44
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-43
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-43
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	7e-43
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	7e-43
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-42
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-42
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-42
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-41
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-41
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-41
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-41
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-41
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-40
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-39
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-39
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-39
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	7e-39
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-38
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-38
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-38
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-38
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-37
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-37
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-37
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-37
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-36
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-36
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-36
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-36
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-36
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-36
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	7e-36
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	9e-36
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-35
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-35
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-35
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-35
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-35
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-35
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-35
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-35
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-34
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-34
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-34
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-33
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-33
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-33
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-32
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-32
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-32
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-32
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	8e-32
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-31
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-31
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-31
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-31
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-31
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-31
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	8e-31
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	9e-31
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-30
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-30
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-30
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-30
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-30
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-30
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-30
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-30
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-30
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-30
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	9e-30
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-29
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-29
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-29
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-29
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-29
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-29
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-29
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-29
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-28
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-28
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-28
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-28
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-28
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-28
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-28
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-28
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-28
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-28
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	7e-28
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	8e-28
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	9e-28
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	9e-28
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	9e-28
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-27
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-27
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-27
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-27
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-27
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-27
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	9e-27
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-26
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-26
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-26
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-26
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-26
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	8e-26
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	9e-26
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-25
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-25
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-25
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-25
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-25
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-25
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-25
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	9e-25
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-24
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-24
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-24
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-24
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-24
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-24
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-24
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-24
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-24
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-24
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-23
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-23
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-23
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-23
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-23
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-23
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-23
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	8e-23
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-22
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-22
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-22
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-22
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-22
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-22
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-22
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-22
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-22
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-22
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-22
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	8e-22
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	8e-22
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-22
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-21
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-21
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-21
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-21
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-21
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-21
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-21
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-21
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-21
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-21
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	8e-21
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-20
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-20
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-20
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-20
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-20
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-19
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-19
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-19
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-19
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-19
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-19
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-19
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-19
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-19
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	6e-19
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	9e-19
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-18
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-18
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-18
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-18
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-18
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-18
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-18
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-18
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-18
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-18
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-18
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	8e-18
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	9e-18
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-17
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-17
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-17
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-17
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-17
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-17
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-17
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-17
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-17
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-17
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-17
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-17
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-17
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-17
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-17
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-17
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-17
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	8e-17
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	9e-17
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-16
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-16
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-16
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-16
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-16
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-16
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-16
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-16
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-16
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-16
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-16
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	7e-16
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	7e-16
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-16
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	8e-16
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	9e-16
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-15
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-15
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-15
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-15
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-15
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-15
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-15
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-15
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-15
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-15
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-15
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-15
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-15
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	7e-15
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-15
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	8e-15
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	9e-15
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-14
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-14
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-14
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-14
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	5e-14
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	6e-14
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	8e-14
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-13
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-13
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-13
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-13
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	6e-13
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-12
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	5e-12
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	5e-12
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-12
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	6e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	7e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	8e-12
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	8e-12
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-11
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-11
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-11
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	9e-11
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-10
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	2e-09
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	6e-09
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-09
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-08
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	2e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-07
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	1e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	6e-06
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-04
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	3e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	6e-04
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	0.001
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	0.003

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  237 bits (607), Expect = 1e-78
 Identities = 83/219 (37%), Positives = 123/219 (56%), Gaps = 10/219 (4%)

Query: 40  LKTGERIASGSCGDLYRGVYLG------QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ 93
           L  G+++  G+ G++Y+G   G       +VAVK L+ +     +E EF++E  I+R++ 
Sbjct: 1   LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIE-EFLREARIMRKLD 59

Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
           H NVV+ +G  T+   L IV EYM GG L  YL KN   L L  LL FA+ I +GMEYL 
Sbjct: 60  HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119

Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETG--TYRWMAPEVINHQP 211
            +N IHRDL   N L+  + VVK++DFG++R            G    RWMAPE +    
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179

Query: 212 YDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQ 249
           +  K+DV+SF ++LWE+ T  + PY  M+  +    ++ 
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKN 218

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  235 bits (602), Expect = 7e-78
 Identities = 81/220 (36%), Positives = 128/220 (58%), Gaps = 11/220 (5%)

Query: 40  LKTGERIASGSCGDLYRGVYLG------QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ 93
           L+ G+++  G+ G++Y+G   G        VAVK L+ E  ++   +EF++E +I++++ 
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLK-EGASEEEREEFLEEASIMKKLS 59

Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
           H N+VR +G  T+   L IVTEYMPGG L D+L K+   L L  LL+ A+ I KGMEYL 
Sbjct: 60  HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119

Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---RWMAPEVINHQ 210
            +N +HRDL   N L+  + VVK++DFG++R   +        G     +WMAPE +   
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDG 179

Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQ 249
            +  K+DV+SF ++LWE+ T  + PY  M+  +    +  
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLED 219

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  235 bits (602), Expect = 9e-78
 Identities = 83/214 (38%), Positives = 125/214 (58%), Gaps = 11/214 (5%)

Query: 40  LKTGERIASGSCGDLYRGVYLG------QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ 93
           L  G+++  G+ G++Y+G   G       +VAVK L+ +  ++   +EF++E  I+R++ 
Sbjct: 1   LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA-SEQQIEEFLREARIMRKLD 59

Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYL 152
           H N+V+ +G  T+   L IV EYMPGG L DYL KN    L L  LL FA+ I +GMEYL
Sbjct: 60  HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119

Query: 153 HQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETG--TYRWMAPEVINHQ 210
             +N IHRDL   N L+  + VVK++DFG++R          + G    RWMAPE +   
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179

Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQA 243
            +  K+DV+SF ++LWE+ T  + PY  M+  + 
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEV 213

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  219 bits (560), Expect = 2e-71
 Identities = 78/216 (36%), Positives = 120/216 (55%), Gaps = 18/216 (8%)

Query: 44  ERIASGSCGDLYRGVYLG-----QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVV 98
           +++  G+ G++Y+G   G      +VAVK L+ +   +  +D F++E  +++++ H NVV
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKD-FLKEARVMKKLGHPNVV 59

Query: 99  RFIGASTKSPHLCIVTEYMPGGSLYDYLHKN--------HNVLKLPQLLRFAIDICKGME 150
           R +G  T+   L +V EYM GG L DYL K+         + L L  LL FAI I KGME
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---RWMAPEVI 207
           YL  +  +HRDL   N L+    VVK++DFG++R          +TG     RWMAPE +
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179

Query: 208 NHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQ 242
               +  K+DV+SF ++LWE+ T    PY  ++  +
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE 215

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  213 bits (544), Expect = 5e-69
 Identities = 78/202 (38%), Positives = 115/202 (56%), Gaps = 5/202 (2%)

Query: 40  LKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNV 97
            +   ++ SGS G +Y+  +   G+ VAVK+L+        +    +E+ ILR + H N+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
           VR I A     HL +V EY  GG L+DYL +    L   +  + A+ I +G+EYLH   I
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR-GGPLSEDEAKKIALQILRGLEYLHSNGI 119

Query: 158 IHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMTAETGTYRWMAPEVIN-HQPYDQK 215
           IHRDLK  N+L+D + VVK+ADFG+A+   K    +T   GT  +MAPEV+     Y  K
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179

Query: 216 ADVFSFAIVLWELVTAKVPYDS 237
            DV+S  ++L+EL+T K P+  
Sbjct: 180 VDVWSLGVILYELLTGKPPFSG 201

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  210 bits (537), Expect = 4e-68
 Identities = 70/207 (33%), Positives = 112/207 (54%), Gaps = 4/207 (1%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVV 98
           +  E++  GS G +Y       G+ VA+KV++ + +    E   ++E+ IL++++H N+V
Sbjct: 2   EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRER-ILREIKILKKLKHPNIV 60

Query: 99  RFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNII 158
           R          L +V EY  GG L+D L K    L   +   +   I   +EYLH + I+
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHSKGIV 119

Query: 159 HRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADV 218
           HRDLK  N+L+D    VK+ADFG+AR  + G  +T   GT  +MAPEV+  + Y +  D+
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDI 179

Query: 219 FSFAIVLWELVTAKVPYDSMTPLQAAL 245
           +S  ++L+EL+T K P+     L    
Sbjct: 180 WSLGVILYELLTGKPPFPGDDQLLELF 206

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  196 bits (501), Expect = 4e-63
 Identities = 70/188 (37%), Positives = 113/188 (60%), Gaps = 6/188 (3%)

Query: 46  IASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA 103
           +  G  G +Y       G+ VA+K+++ E  +  LE E ++E+ IL+++ H N+V+  G 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLE-ELLREIEILKKLNHPNIVKLYGV 59

Query: 104 STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLK 163
                HL +V EY  GGSL D L +N   L   ++LR  + I +G+EYLH   IIHRDLK
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119

Query: 164 TANLLMDTHN-VVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEVINHQP-YDQKADVFS 220
             N+L+D+ N  VK+ADFG+++   +   ++    GT  +MAPEV+  +  Y +K+D++S
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179

Query: 221 FAIVLWEL 228
             ++L+EL
Sbjct: 180 LGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  184 bits (469), Expect = 7e-58
 Identities = 83/206 (40%), Positives = 125/206 (60%), Gaps = 8/206 (3%)

Query: 44  ERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           E+I  G+ GD+Y+GV  G  +VAVK  RS  L   L+ +F+QE  IL++  H N+V+ IG
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRST-LPPDLKRKFLQEAEILKQYDHPNIVKLIG 59

Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
              +   + IV E +PGGSL  +L K  N L + +LL+ ++D   GMEYL  +N IHRDL
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDL 119

Query: 163 KTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT----YRWMAPEVINHQPYDQKADV 218
              N L+  +NV+K++DFG++R + +GG+ T   G      +W APE +N+  Y  ++DV
Sbjct: 120 AARNCLVGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178

Query: 219 FSFAIVLWELVT-AKVPYDSMTPLQA 243
           +S+ I+LWE  +    PY  M+  Q 
Sbjct: 179 WSYGILLWETFSLGDTPYPGMSNQQT 204

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  182 bits (464), Expect = 4e-57
 Identities = 90/237 (37%), Positives = 136/237 (57%), Gaps = 18/237 (7%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV 92
           W I+ + LK G  I  G  GD+  G Y GQ VAVK L+    + T    F+ E +++  +
Sbjct: 1   WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKD---DSTAAQAFLAEASVMTTL 57

Query: 93  QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKGMEY 151
           +H N+V+ +G   +   L IVTEYM  GSL DYL  +   V+ L Q L FA+D+C+GMEY
Sbjct: 58  RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117

Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEVINH 209
           L ++N +HRDL   N+L+    V KV+DFG+A+  ++G     ++G    +W APE +  
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG----QDSGKLPVKWTAPEALRE 173

Query: 210 QPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAAL-----GVRQVCTSLCQP-IY 259
           + +  K+DV+SF I+LWE+ +  +VPY  + PL+  +     G R      C P +Y
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPHVEKGYRMEAPEGCPPEVY 229

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  181 bits (463), Expect = 7e-57
 Identities = 74/212 (34%), Positives = 111/212 (52%), Gaps = 12/212 (5%)

Query: 43  GERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF 100
           GE +  GS G +Y  +    G+ +AVK +     ++   +   +E+ IL  +QH N+VR+
Sbjct: 5   GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64

Query: 101 IGASTKSP--HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL--RFAIDICKGMEYLHQRN 156
            G+        L I  EY+ GGSL   L K     KLP+ +  ++   I +G+ YLH   
Sbjct: 65  YGSERDEEKNTLNIFLEYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG 121

Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET---GTYRWMAPEVINHQPYD 213
           I+HRD+K AN+L+D+  VVK+ADFG A+               GT  WMAPEVI  + Y 
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181

Query: 214 QKADVFSFAIVLWELVTAKVPYDSMTPLQAAL 245
           + AD++S    + E+ T K P+  +    AAL
Sbjct: 182 RAADIWSLGCTVIEMATGKPPWSELGNPMAAL 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  180 bits (459), Expect = 3e-56
 Identities = 89/238 (37%), Positives = 130/238 (54%), Gaps = 15/238 (6%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEI R  LK   ++ +G  G+++ G + G   VAVK L+   +  + E  F+QE  I+++
Sbjct: 1   WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM--SPEA-FLQEAQIMKK 57

Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGME 150
           ++H  +V+     ++   + IVTEYM  GSL D+L       L+LPQL+  A  I +GM 
Sbjct: 58  LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMA 117

Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMAPEVI 207
           YL  RN IHRDL   N+L+  + V K+ADFG+AR   +    TA  G     +W APE  
Sbjct: 118 YLESRNYIHRDLAARNILVGENLVCKIADFGLARLI-EDDEYTAREGAKFPIKWTAPEAA 176

Query: 208 NHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL----QAALGVRQVCTSLC-QPIY 259
           N+  +  K+DV+SF I+L E+VT  +VPY  MT      Q   G R      C + +Y
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELY 234

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  175 bits (446), Expect = 2e-54
 Identities = 77/219 (35%), Positives = 123/219 (56%), Gaps = 17/219 (7%)

Query: 35  IDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILREVQ 93
           ID   L   + + SG  G ++ G + G+ DVA+K++R   ++   ED+F++E  ++ ++ 
Sbjct: 1   IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---EDDFIEEAKVMMKLS 57

Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
           H N+V+  G  TK   + IVTEYM  G L +YL +    L    LL    D+C+ MEYL 
Sbjct: 58  HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117

Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM----TAETGT---YRWMAPEV 206
               IHRDL   N L+   NVVKV+DFG+AR+     V+    T+  GT    +W  PEV
Sbjct: 118 SNGFIHRDLAARNCLVGEDNVVKVSDFGLARY-----VLDDQYTSSQGTKFPVKWAPPEV 172

Query: 207 INHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAA 244
            ++  +  K+DV+SF +++WE+ +  K+PY+  +  +  
Sbjct: 173 FDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV 211

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  174 bits (443), Expect = 6e-54
 Identities = 76/207 (36%), Positives = 120/207 (57%), Gaps = 4/207 (1%)

Query: 39  LLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRN 96
           L +  E+I  G  G++Y+  +   G++VA+KV++    +   +++ + E+ IL++ +H N
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK--LESKEKKEKIINEIQILKKCKHPN 58

Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
           +V++ G+  K   L IV E+  GGSL D L   +  L   Q+     ++ KG+EYLH   
Sbjct: 59  IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118

Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKA 216
           IIHRD+K AN+L+ +   VK+ DFG++   +         GT  WMAPEVIN +PYD KA
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKA 178

Query: 217 DVFSFAIVLWELVTAKVPYDSMTPLQA 243
           D++S  I   EL   K PY  + P++A
Sbjct: 179 DIWSLGITAIELAEGKPPYSELPPMKA 205

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  169 bits (430), Expect = 5e-52
 Identities = 81/235 (34%), Positives = 125/235 (53%), Gaps = 14/235 (5%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEIDR  ++   ++ +G  G+++ G++     VAVK L+   ++     +F+ E  I+++
Sbjct: 1   WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKK 57

Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGME 150
           ++H  +++     T    + IVTE M  GSL +YL       LKLPQL+  A  +  GM 
Sbjct: 58  LRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA 117

Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMAPEVI 207
           YL  +N IHRDL   N+L+  +N+ KVADFG+AR   K  +  A  G     +W APE  
Sbjct: 118 YLEAQNYIHRDLAARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKFPIKWTAPEAA 176

Query: 208 NHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQA----ALGVRQVCTSLCQP 257
            +  +  K+DV+SF I+L E+VT  ++PY  MT  +       G R  C   C  
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPK 231

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  167 bits (424), Expect = 1e-50
 Identities = 73/215 (33%), Positives = 118/215 (54%), Gaps = 16/215 (7%)

Query: 37  RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH 94
           R L K  E+I  G+ G++Y+      G++VA+K +R   L    ++  + E+ I+++ +H
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR---LRKQNKELIINEILIMKDCKH 74

Query: 95  RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
            N+V +  +      L +V EYM GGSL D + +N   +  PQ+     ++ +G+EYLH 
Sbjct: 75  PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134

Query: 155 RNIIHRDLKTANLLMDTHNVVKVADFGVA------RFQNKGGVMTAETGTYRWMAPEVIN 208
           +N+IHRD+K+ N+L+     VK+ADFG A      + +    V     GT  WMAPEVI 
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-----GTPYWMAPEVIK 189

Query: 209 HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQA 243
            + Y  K D++S  I+  E+   + PY    PL+A
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA 224

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  164 bits (416), Expect = 7e-50
 Identities = 77/205 (37%), Positives = 122/205 (59%), Gaps = 12/205 (5%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLE-DEFVQEVAIL 89
           WE++R  +    ++  G  G++Y GV+      VAVK L+     DT+E +EF++E A++
Sbjct: 1   WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVM 56

Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDICKG 148
           +E++H N+V+ +G  T+ P   I+TE+M  G+L DYL + N   +    LL  A  I   
Sbjct: 57  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 116

Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMAPE 205
           MEYL ++N IHRDL   N L+  +++VKVADFG++R    G   TA  G     +W APE
Sbjct: 117 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPE 175

Query: 206 VINHQPYDQKADVFSFAIVLWELVT 230
            + +  +  K+DV++F ++LWE+ T
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  160 bits (407), Expect = 2e-48
 Identities = 70/206 (33%), Positives = 112/206 (54%), Gaps = 8/206 (3%)

Query: 43  GERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF 100
           G+ I  G+ G +Y+G+ L  G  VA+K +  E + +      +QE+ +L+ ++H N+V++
Sbjct: 5   GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKY 64

Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL--RFAIDICKGMEYLHQRNII 158
           IG+   S  L I+ EY   GSL   + K       P+ L   +   + +G+ YLH++ +I
Sbjct: 65  IGSIETSDSLYIILEYAENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQGVI 121

Query: 159 HRDLKTANLLMDTHNVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKAD 217
           HRD+K AN+L     VVK+ADFGVA +  +      +  GT  WMAPEVI        +D
Sbjct: 122 HRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASD 181

Query: 218 VFSFAIVLWELVTAKVPYDSMTPLQA 243
           ++S    + EL+T   PY  + P+ A
Sbjct: 182 IWSLGCTVIELLTGNPPYYDLNPMAA 207

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  159 bits (404), Expect = 4e-48
 Identities = 72/209 (34%), Positives = 123/209 (58%), Gaps = 9/209 (4%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV 92
           W ++ + L  GE I  G  G + +G Y GQ VAVK ++     D     F++E A++ ++
Sbjct: 1   WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKC----DVTAQAFLEETAVMTKL 56

Query: 93  QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKGMEY 151
            H+N+VR +G    +  L IV E M  G+L ++L  +   ++ + QLL+F++D+ +GMEY
Sbjct: 57  HHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115

Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQP 211
           L  + ++HRDL   N+L+    V KV+DFG+AR  + G  +       +W APE + H+ 
Sbjct: 116 LESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKHKK 173

Query: 212 YDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           +  K+DV+S+ ++LWE+ +  + PY  M+
Sbjct: 174 FSSKSDVWSYGVLLWEVFSYGRAPYPKMS 202

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  159 bits (404), Expect = 9e-48
 Identities = 74/214 (34%), Positives = 109/214 (50%), Gaps = 28/214 (13%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E I  GS G++Y+ +     Q VA+KV+  E   D +ED   QE+  L + +   + ++ 
Sbjct: 7   ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED-IQQEIQFLSQCRSPYITKYY 65

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI-----DICKGMEYLHQRN 156
           G+  K   L I+ EY  GGS  D       +LK  +L    I     ++  G+EYLH+  
Sbjct: 66  GSFLKGSKLWIIMEYCGGGSCLD-------LLKPGKLDETYIAFILREVLLGLEYLHEEG 118

Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET-------GTYRWMAPEVINH 209
            IHRD+K AN+L+     VK+ADFGV+      G +T+         GT  WMAPEVI  
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVS------GQLTSTMSKRNTFVGTPFWMAPEVIKQ 172

Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQA 243
             YD+KAD++S  I   EL   + P   + P++ 
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV 206

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  158 bits (402), Expect = 2e-47
 Identities = 72/205 (35%), Positives = 112/205 (54%), Gaps = 13/205 (6%)

Query: 38  RLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           R LK  +++  G  G +    Y       G+ VAVK L          D F +E+ ILR 
Sbjct: 4   RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD-FEREIEILRT 62

Query: 92  VQHRNVVRFIGASTKS--PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGM 149
           + H N+V++ G   K     L ++ EY+P GSL DYL ++ + + L +LL F+  ICKGM
Sbjct: 63  LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122

Query: 150 EYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETGTY--RWMAPE 205
           +YL  +  IHRDL   N+L+++ ++VK++DFG+A+   ++K      E G     W APE
Sbjct: 123 DYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182

Query: 206 VINHQPYDQKADVFSFAIVLWELVT 230
            +    +   +DV+SF + L+EL T
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  157 bits (399), Expect = 3e-47
 Identities = 59/198 (29%), Positives = 111/198 (56%), Gaps = 6/198 (3%)

Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA 103
           I  GS G   L R    G+   +K +   ++++   ++ + EV IL+++ H N++++  +
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67

Query: 104 STKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLP--QLLRFAIDICKGMEYLHQRNIIHR 160
             +   LCIV EY  GG L   + K        P  Q+L + + +C  ++YLH R I+HR
Sbjct: 68  FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHR 127

Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVF 219
           D+K  N+ + ++ +VK+ DFG+++   +   +     GT  +++PE+  ++PY+ K+D++
Sbjct: 128 DIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIW 187

Query: 220 SFAIVLWELVTAKVPYDS 237
           S   VL+EL T K P++ 
Sbjct: 188 SLGCVLYELCTLKHPFEG 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  155 bits (394), Expect = 2e-46
 Identities = 78/237 (32%), Positives = 125/237 (52%), Gaps = 13/237 (5%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WE  R       ++ SG  G+++ G++  +  VA+K+L+S+  +   + +F +EV  L+ 
Sbjct: 1   WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKR 58

Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDICKGME 150
           ++H++++      +    + I+TE M  GSL  +L      VL +  L+  A  + +GM 
Sbjct: 59  LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMA 118

Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT--YRWMAPEVIN 208
           YL ++N IHRDL   N+L+    V KVADFG+AR   K  V  +      Y+W APE  +
Sbjct: 119 YLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLI-KEDVYLSSDKKIPYKWTAPEAAS 177

Query: 209 HQPYDQKADVFSFAIVLWELVT-AKVPYDSMTP----LQAALGVRQVCTSLCQP-IY 259
           H  +  K+DV+SF I+L+E+ T  +VPY  M       Q   G R  C + C   IY
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIY 234

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  153 bits (389), Expect = 8e-46
 Identities = 77/213 (36%), Positives = 125/213 (58%), Gaps = 11/213 (5%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLG-QDVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WE+ R  LK  +++ +G  G+++ G Y G   VA+K L+   ++    + F+ E  ++++
Sbjct: 1   WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQ 57

Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICKGME 150
           +QH  +VR     T+ P + I+TEYM  GSL D+L     + L + +L+  A  I +GM 
Sbjct: 58  LQHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMA 116

Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMAPEVI 207
           ++ ++N IHRDL+ AN+L+      K+ADFG+AR   +    TA  G     +W APE I
Sbjct: 117 FIERKNYIHRDLRAANILVSETLCCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAI 175

Query: 208 NHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           N+  +  K+DV+SF I+L E+VT  ++PY  MT
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT 208

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  152 bits (385), Expect = 3e-45
 Identities = 79/210 (37%), Positives = 118/210 (56%), Gaps = 9/210 (4%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFV----QEVAILREVQH 94
           + GE + SGS G +Y G+ L  G   AVK + S   +     E V    QE+A+L ++QH
Sbjct: 3   RKGELLGSGSFGSVYEGLNLDDGDFFAVKEV-SLADDGQTGQEAVKQLEQEIALLSKLQH 61

Query: 95  RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
            N+V+++G   +  +L I  E +PGGSL   L K +     P +  +   I  G+EYLH 
Sbjct: 62  PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHD 120

Query: 155 RNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQ-PYD 213
           RN +HRD+K AN+L+DT+ VVK+ADFG+A+   +     +  G+  WMAPEVI  Q  Y 
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYG 180

Query: 214 QKADVFSFAIVLWELVTAKVPYDSMTPLQA 243
             AD++S    + E+ T K P+  +  + A
Sbjct: 181 LAADIWSLGCTVLEMATGKPPWSQLEGVAA 210

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  150 bits (381), Expect = 8e-45
 Identities = 81/221 (36%), Positives = 125/221 (56%), Gaps = 11/221 (4%)

Query: 44  ERIASGSCGDLYRGVYLGQD-VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           E +  G+ G++++G    +  VAVK  + E L   L+ +F+ E  IL++  H N+V+ IG
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPVAVKTCK-EDLPQELKIKFLSEARILKQYDHPNIVKLIG 59

Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
             T+   + IV E +PGG    +L K  + LK  QL++FA+D   GM YL  +N IHRDL
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDL 119

Query: 163 KTANLLMDTHNVVKVADFGVARFQNKGGVMTA---ETGTYRWMAPEVINHQPYDQKADVF 219
              N L+  +NV+K++DFG++R Q   G+ ++   +    +W APE +N+  Y  ++DV+
Sbjct: 120 AARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVW 178

Query: 220 SFAIVLWELVTAKV-PYDSMTPLQA----ALGVRQVCTSLC 255
           S+ I+LWE  +  V PY  MT  QA      G R  C   C
Sbjct: 179 SYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKC 219

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  150 bits (381), Expect = 1e-44
 Identities = 85/236 (36%), Positives = 131/236 (55%), Gaps = 19/236 (8%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV 92
           W ++ + LK  + I  G  GD+  G Y G  VAVK ++    ND     F+ E +++ ++
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 56

Query: 93  QHRNVVRFIGASTKSP-HLCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKGME 150
           +H N+V+ +G   +    L IVTEYM  GSL DYL  +  +VL    LL+F++D+C+ ME
Sbjct: 57  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 116

Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEVIN 208
           YL   N +HRDL   N+L+   NV KV+DFG+     K    T +TG    +W APE + 
Sbjct: 117 YLEANNFVHRDLAARNVLVSEDNVAKVSDFGL----TKEASSTQDTGKLPVKWTAPEALR 172

Query: 209 HQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAAL-----GVRQVCTSLCQPI 258
            + +  K+DV+SF I+LWE+ +  +VPY  + PL+  +     G +      C P+
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPV 227

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  151 bits (382), Expect = 1e-44
 Identities = 70/213 (32%), Positives = 117/213 (54%), Gaps = 22/213 (10%)

Query: 40  LKTGERIASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQ 93
           L+  + + SG+ G +Y+GV++ +       VA+KVLR E      + E + E  ++  V 
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANK-EILDEAYVMASVD 67

Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
           H +VVR +G    S  + ++T+ MP G L DY+  + + +    LL + + I KGM YL 
Sbjct: 68  HPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE 126

Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVAR--------FQNKGGVMTAETGTYRWMAPE 205
           ++ ++HRDL   N+L+ T   VK+ DFG+A+        +  +GG +       +WMA E
Sbjct: 127 EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV-----PIKWMALE 181

Query: 206 VINHQPYDQKADVFSFAIVLWELVT-AKVPYDS 237
            I H+ Y  K+DV+S+ + +WEL+T    PY+ 
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  150 bits (380), Expect = 2e-44
 Identities = 67/197 (34%), Positives = 104/197 (52%), Gaps = 12/197 (6%)

Query: 44  ERIASGSCGDLYRGVYLGQ-----DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVV 98
           +++  GS G + RG +         VAVK L+S+ L+D ++D F++E AI+  + H N++
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD-FLKEAAIMHSLDHENLI 59

Query: 99  RFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNI 157
           R  G     P L +VTE  P GSL D L K+      +  L  +A+ I  GM YL  +  
Sbjct: 60  RLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF 118

Query: 158 IHRDLKTANLLMDTHNVVKVADFGVARFQNKGG---VMTAETGT-YRWMAPEVINHQPYD 213
           IHRDL   N+L+ + + VK+ DFG+ R   +     VM       + W APE +  + + 
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178

Query: 214 QKADVFSFAIVLWELVT 230
             +DV+ F + LWE+ T
Sbjct: 179 HASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  150 bits (380), Expect = 3e-44
 Identities = 74/214 (34%), Positives = 121/214 (56%), Gaps = 10/214 (4%)

Query: 35  IDRRLLKTGERIASGSCGDLYRGVYL--GQ---DVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           ID   +   + I  G  G++ RG     G+   DVA+K L++   +D    +F+ E +I+
Sbjct: 1   IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIM 59

Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGM 149
            +  H N++R  G  TKS  + I+TEYM  GSL  +L +N     + QL+     I  GM
Sbjct: 60  GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGM 119

Query: 150 EYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF-QNKGGVMTAETG--TYRWMAPEV 206
           +YL + N +HRDL   N+L++++ V KV+DFG++R  ++     T + G    RW APE 
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEA 179

Query: 207 INHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           I ++ +   +DV+SF IV+WE+++  + PY  M+
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS 213

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  147 bits (372), Expect = 2e-43
 Identities = 75/224 (33%), Positives = 125/224 (55%), Gaps = 17/224 (7%)

Query: 35  IDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILREVQ 93
           ID + L   + + +G  G +  G + GQ DVA+K+++   ++   EDEF++E  ++ ++ 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLS 57

Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
           H  +V+  G  TK   + IVTEYM  G L +YL ++    +  QLL    D+C+GM YL 
Sbjct: 58  HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE 117

Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM----TAETGT---YRWMAPEV 206
            +  IHRDL   N L+D    VKV+DFG++R+     V+    T+  G+    RW  PEV
Sbjct: 118 SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRY-----VLDDEYTSSVGSKFPVRWSPPEV 172

Query: 207 INHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQ 249
           + +  +  K+DV++F +++WE+ +  K+PY+     +    V Q
Sbjct: 173 LLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ 216

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  147 bits (373), Expect = 2e-43
 Identities = 69/204 (33%), Positives = 108/204 (52%), Gaps = 9/204 (4%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E++  GS G +Y+ ++   GQ VA+KV+  E     +     +E++IL++     +V++ 
Sbjct: 9   EKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEII----KEISILKQCDSPYIVKYY 64

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
           G+  K+  L IV EY   GS+ D +   +  L   ++        KG+EYLH    IHRD
Sbjct: 65  GSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRD 124

Query: 162 LKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADVF 219
           +K  N+L++     K+ADFGV+  Q    +    T  GT  WMAPEVI    Y+ KAD++
Sbjct: 125 IKAGNILLNEEGQAKLADFGVS-GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIW 183

Query: 220 SFAIVLWELVTAKVPYDSMTPLQA 243
           S  I   E+   K PY  + P++A
Sbjct: 184 SLGITAIEMAEGKPPYSDIHPMRA 207

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  146 bits (370), Expect = 7e-43
 Identities = 73/212 (34%), Positives = 115/212 (54%), Gaps = 10/212 (4%)

Query: 41  KTGERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDE---FVQEVAILREVQHR 95
           + G+ +  G+ G +Y    V  G+++AVK +  +  +   + E      E+ +L+ +QH 
Sbjct: 5   RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHE 64

Query: 96  NVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR 155
            +V++ G       L I  EYMPGGS+ D L K +  L      ++   I +G+EYLH  
Sbjct: 65  RIVQYYGCLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTRQILEGVEYLHSN 123

Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVA-RFQN---KGGVMTAETGTYRWMAPEVINHQP 211
            I+HRD+K AN+L D+   VK+ DFG + R Q     G  M + TGT  WM+PEVI+ + 
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183

Query: 212 YDQKADVFSFAIVLWELVTAKVPYDSMTPLQA 243
           Y +KADV+S    + E++T K P+     + A
Sbjct: 184 YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA 215

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  146 bits (370), Expect = 7e-43
 Identities = 75/212 (35%), Positives = 110/212 (51%), Gaps = 20/212 (9%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           +RI SG+ GD+Y+   +  G+ VA+KV++ E   D  E    QE+++L+E +H N+V + 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLE-PGDDFEI-IQQEISMLKECRHPNIVAYF 66

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
           G+  +   L IV EY  GGSL D        L   Q+     +  KG+ YLH+   IHRD
Sbjct: 67  GSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRD 126

Query: 162 LKTANLLMDTHNVVKVADFGVARFQNKGGVMTAE-------TGTYRWMAPEVIN---HQP 211
           +K AN+L+     VK+ADFGV+        +TA         GT  WMAPEV        
Sbjct: 127 IKGANILLTEDGDVKLADFGVS------AQLTATIAKRKSFIGTPYWMAPEVAAVERKGG 180

Query: 212 YDQKADVFSFAIVLWELVTAKVPYDSMTPLQA 243
           YD K D+++  I   EL   + P   + P++A
Sbjct: 181 YDGKCDIWALGITAIELAELQPPMFDLHPMRA 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  145 bits (366), Expect = 2e-42
 Identities = 73/214 (34%), Positives = 119/214 (55%), Gaps = 17/214 (7%)

Query: 35  IDRRLLKTGERIASGSCGDLYRGVYLGQD-VAVKVLRSEHLNDTLEDEFVQEVAILREVQ 93
           I    L   + I SG  G ++ G +L +  VA+K +R   ++   E++F++E  ++ ++ 
Sbjct: 1   IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLS 57

Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
           H  +V+  G  T+   +C+V E+M  G L DYL           LL   +D+C+GM YL 
Sbjct: 58  HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117

Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM----TAETGT---YRWMAPEV 206
             N+IHRDL   N L+  + VVKV+DFG+ RF     V+    T+ TGT    +W +PEV
Sbjct: 118 SSNVIHRDLAARNCLVGENQVVKVSDFGMTRF-----VLDDQYTSSTGTKFPVKWSSPEV 172

Query: 207 INHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
            +   Y  K+DV+SF +++WE+ +  K PY++ +
Sbjct: 173 FSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score =  144 bits (364), Expect = 3e-42
 Identities = 76/212 (35%), Positives = 122/212 (57%), Gaps = 9/212 (4%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEI R  LK  +++ +G  G+++   Y     VAVK ++   ++    + F+ E  +++ 
Sbjct: 1   WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKT 57

Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGME 150
           +QH  +V+     TK P + I+TE+M  GSL D+L  +  +   LP+L+ F+  I +GM 
Sbjct: 58  LQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 116

Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEVIN 208
           ++ QRN IHRDL+ AN+L+    V K+ADFG+AR          E   +  +W APE IN
Sbjct: 117 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 176

Query: 209 HQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
              +  K+DV+SF I+L E+VT  ++PY  M+
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 208

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  144 bits (364), Expect = 4e-42
 Identities = 77/212 (36%), Positives = 123/212 (58%), Gaps = 8/212 (3%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEI R  +K  +++ +G  G+++ G Y     VAVK L+   ++      F++E  +++ 
Sbjct: 1   WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---VQAFLEEANLMKT 57

Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGME 150
           +QH  +VR     TK   + I+TEYM  GSL D+L  +    + LP+L+ F+  I +GM 
Sbjct: 58  LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117

Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEVIN 208
           Y+ ++N IHRDL+ AN+L+    + K+ADFG+AR          E   +  +W APE IN
Sbjct: 118 YIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 177

Query: 209 HQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
              +  K+DV+SF I+L+E+VT  K+PY  M+
Sbjct: 178 FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  143 bits (361), Expect = 1e-41
 Identities = 78/218 (35%), Positives = 127/218 (58%), Gaps = 19/218 (8%)

Query: 43  GERIASGSCGDLYRGVYL--GQDVAVKVL-------RSEHLNDTLEDEFVQEVAILREVQ 93
           G  I SGS G +Y G+    G+ +AVK +        S+    ++ D   +E+A+L+E+Q
Sbjct: 5   GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64

Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
           H N+V+++G+S  + HL I  EY+PGGS+   L+ N+   +   +  F   I KG+ YLH
Sbjct: 65  HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN-NYGAFEETLVRNFVRQILKGLNYLH 123

Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYR--------WMAPE 205
            R IIHRD+K AN+L+D    +K++DFG+++ + +   ++ +T   R        WMAPE
Sbjct: 124 NRGIIHRDIKGANILVDNKGGIKISDFGISK-KLEANSLSTKTNGARPSLQGSVFWMAPE 182

Query: 206 VINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQA 243
           V+    Y +KAD++S   ++ E++T K P+   T LQA
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA 220

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score =  142 bits (359), Expect = 2e-41
 Identities = 81/223 (36%), Positives = 123/223 (55%), Gaps = 13/223 (5%)

Query: 44  ERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           ERI  G+ G+++ G     +  VAVK  R E L   L+ +F+QE  IL++  H N+VR I
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLI 59

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
           G  T+   + IV E + GG    +L      LK+ +L++   +   GMEYL  ++ IHRD
Sbjct: 60  GVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRD 119

Query: 162 LKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT----YRWMAPEVINHQPYDQKAD 217
           L   N L+   NV+K++DFG++R + + GV  +  G      +W APE +N+  Y  ++D
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESD 178

Query: 218 VFSFAIVLWELVT-AKVPYDSMTPLQA----ALGVRQVCTSLC 255
           V+SF I+LWE  +   VPY +++  Q       GVR  C  LC
Sbjct: 179 VWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELC 221

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  142 bits (359), Expect = 4e-41
 Identities = 74/179 (41%), Positives = 106/179 (59%), Gaps = 14/179 (7%)

Query: 61  GQDVAVKVLR---SEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA--STKSPHLCIVTE 115
           G+ VAVK L+   +EHL D     F +E+ IL+ +QH N+V++ G   S    +L +V E
Sbjct: 33  GEVVAVKKLQHSTAEHLRD-----FEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVME 87

Query: 116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVV 175
           Y+P GSL DYL K+   L   +LL +A  ICKGMEYL  +  +HRDL T N+L+++ N V
Sbjct: 88  YLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRV 147

Query: 176 KVADFGVARF--QNKGGVMTAETGTYR--WMAPEVINHQPYDQKADVFSFAIVLWELVT 230
           K+ DFG+ +   Q+K      E G     W APE +    +   +DV+SF +VL+EL T
Sbjct: 148 KIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  141 bits (358), Expect = 4e-41
 Identities = 67/202 (33%), Positives = 106/202 (52%), Gaps = 6/202 (2%)

Query: 40  LKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNV 97
           L+  + +  GS G +Y+  +   G+  A+K +  +  ++    + ++E+  LR  +   V
Sbjct: 3   LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG-DEEFRKQLLRELKTLRSCESPYV 61

Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ-RN 156
           V+  GA  K   + IV EYM GGSL D L K    +  P L   A  I KG++YLH  R+
Sbjct: 62  VKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLHTKRH 120

Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAE-TGTYRWMAPEVINHQPYDQK 215
           IIHRD+K +NLL+++   VK+ADFG+++             GT  +M+PE I  + Y   
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYA 180

Query: 216 ADVFSFAIVLWELVTAKVPYDS 237
           AD++S  + L E    K P+  
Sbjct: 181 ADIWSLGLTLLECALGKFPFLP 202

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  141 bits (358), Expect = 5e-41
 Identities = 66/203 (32%), Positives = 112/203 (55%), Gaps = 9/203 (4%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLEDEFVQEVA 87
           +EI R  +  G  I  G  GD+Y+GVY+  +     VAVK  ++   + ++ ++F+QE  
Sbjct: 1   YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC-TSPSVREKFLQEAY 59

Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICK 147
           I+R+  H ++V+ IG  T++P + IV E  P G L  YL  N   L L  L+ ++  +  
Sbjct: 60  IMRQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118

Query: 148 GMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPE 205
            + YL  +  +HRD+   N+L+ + + VK+ DFG++R+        A  G    +WMAPE
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178

Query: 206 VINHQPYDQKADVFSFAIVLWEL 228
            IN + +   +DV+ F + +WE+
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  139 bits (353), Expect = 2e-40
 Identities = 76/232 (32%), Positives = 116/232 (50%), Gaps = 20/232 (8%)

Query: 44  ERIASGSCGDLYRGVYL---GQ--DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVV 98
           + +  G+ G + +GVYL   G+  +VAVK L+ EH     + EF++E +++ ++ H  +V
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH-IAAGKKEFLREASVMAQLDHPCIV 59

Query: 99  RFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNII 158
           R IG   K   L +V E  P G L  YL K   +  +  L   A  +  GM YL  ++ +
Sbjct: 60  RLIGV-CKGEPLMLVMELAPLGPLLKYLKKRREI-PVSDLKELAHQVAMGMAYLESKHFV 117

Query: 159 HRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMTAETG---TYRWMAPEVINHQPYDQ 214
           HRDL   N+L+   +  K++DFG++R    G     A T      +W APE IN+  +  
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSS 177

Query: 215 KADVFSFAIVLWELVT--AKVPYDSMTPLQAAL----GVRQVCTSLC-QPIY 259
           K+DV+S+ + LWE  +  AK PY  M   +       G R      C Q IY
Sbjct: 178 KSDVWSYGVTLWEAFSYGAK-PYGEMKGAEVIAMLESGERLPRPEECPQEIY 228

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  137 bits (346), Expect = 2e-39
 Identities = 61/196 (31%), Positives = 109/196 (55%), Gaps = 6/196 (3%)

Query: 49  GSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK 106
           GS G +Y+   L   Q  A+K +    ++    ++ V E+ IL  V H N++ +  A   
Sbjct: 11  GSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD 70

Query: 107 SPHLCIVTEYMPGGSLYDYLHKNH---NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLK 163
              LCIV EY P G L   + K      ++   ++ R  I + +G++ LH++ I+HRDLK
Sbjct: 71  GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLK 130

Query: 164 TANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAI 223
           +AN+L+  +++VK+ D G+++   K  +   + GT  +MAPEV   +PY  K+D++S   
Sbjct: 131 SANILLVANDLVKIGDLGISKVL-KKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGC 189

Query: 224 VLWELVTAKVPYDSMT 239
           +L+E+ T   P+++ +
Sbjct: 190 LLYEMATFAPPFEARS 205

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  137 bits (345), Expect = 2e-39
 Identities = 83/233 (35%), Positives = 126/233 (54%), Gaps = 15/233 (6%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEI R  L+   ++  G  G+++ G + G   VA+K L+   ++    + F+QE  ++++
Sbjct: 1   WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKK 57

Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHN-VLKLPQLLRFAIDICKGME 150
           ++H  +V+     ++ P + IVTEYM  GSL D+L       L+LPQL+  A  I  GM 
Sbjct: 58  LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 116

Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMAPEVI 207
           Y+ + N +HRDL+ AN+L+  + V KVADFG+AR   +    TA  G     +W APE  
Sbjct: 117 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAA 175

Query: 208 NHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL----QAALGVRQVCTSLC 255
            +  +  K+DV+SF I+L EL T  +VPY  M       Q   G R  C   C
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 228

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  136 bits (344), Expect = 3e-39
 Identities = 84/235 (35%), Positives = 128/235 (54%), Gaps = 15/235 (6%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEI R  L+  +++ +G  G+++ G + G   VAVK L+   ++    + F++E  I+++
Sbjct: 1   WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKK 57

Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHN-VLKLPQLLRFAIDICKGME 150
           ++H  +V+     ++ P + IVTEYM  GSL D+L       LKLP L+  A  +  GM 
Sbjct: 58  LRHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 116

Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMAPEVI 207
           Y+ + N IHRDL++AN+L+    V K+ADFG+AR   +    TA  G     +W APE  
Sbjct: 117 YIERMNYIHRDLRSANILVGDGLVCKIADFGLARLI-EDNEYTARQGAKFPIKWTAPEAA 175

Query: 208 NHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL----QAALGVRQVCTSLCQP 257
            +  +  K+DV+SF I+L ELVT  +VPY  M       Q   G R  C   C  
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPI 230

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  136 bits (345), Expect = 7e-39
 Identities = 68/195 (34%), Positives = 100/195 (51%), Gaps = 24/195 (12%)

Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VAVKVLR    +D   ++F++EV IL  +   N+ R +G  T  P LC++ EYM  G L 
Sbjct: 49  VAVKVLR-PDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107

Query: 124 DYLHK--------NHNVLKLPQ--LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN 173
            +L K          N   L    LL  A  I  GM YL   N +HRDL T N L+  + 
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNY 167

Query: 174 VVKVADFGVAR-------FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLW 226
            +K+ADFG++R       ++ +G          RWMA E +    +  K+DV++F + LW
Sbjct: 168 TIKIADFGMSRNLYSSDYYRVQGRAPLP----IRWMAWESVLLGKFTTKSDVWAFGVTLW 223

Query: 227 ELVT--AKVPYDSMT 239
           E++T   + PY+ +T
Sbjct: 224 EILTLCREQPYEHLT 238

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  134 bits (340), Expect = 3e-38
 Identities = 72/232 (31%), Positives = 108/232 (46%), Gaps = 39/232 (16%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLED--EFV 83
           WE+ R  +     +  GS G +Y G+  G         VA+K +   + N ++ +  EF+
Sbjct: 1   WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTV---NENASMRERIEFL 57

Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK------NHNVLKLPQ 137
            E ++++E    +VVR +G  +      +V E M  G L  YL        N+  L  P 
Sbjct: 58  NEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPT 117

Query: 138 LLRF---AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTA 194
           L +F   A +I  GM YL  +  +HRDL   N ++     VK+ DFG+ R          
Sbjct: 118 LQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY------- 170

Query: 195 ETGTY----------RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
           ET  Y          RWMAPE +    +  K+DV+SF +VLWE+ T A+ PY
Sbjct: 171 ETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY 222

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  134 bits (339), Expect = 4e-38
 Identities = 74/226 (32%), Positives = 116/226 (51%), Gaps = 19/226 (8%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDV--AVKVLRSEHLNDTLEDEFVQEVAI 88
           + WEI       GE +  G+ G +Y+  +    +  A K+++ E   + LED F+ E+ I
Sbjct: 5   DIWEI------IGE-LGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELED-FMVEIDI 55

Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
           L E +H N+V    A      L I+ E+  GG+L   + +    L  PQ+      + + 
Sbjct: 56  LSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEA 115

Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GTYRWMAPEV 206
           + +LH   +IHRDLK  N+L+     VK+ADFGV+  +NK  +   +T  GT  WMAPEV
Sbjct: 116 LNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSA-KNKSTLQKRDTFIGTPYWMAPEV 174

Query: 207 IN-----HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGV 247
           +        PYD KAD++S  I L EL   + P+  + P++  L +
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKI 220

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  133 bits (337), Expect = 4e-38
 Identities = 66/201 (32%), Positives = 112/201 (55%), Gaps = 7/201 (3%)

Query: 46  IASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAS 104
           + SG  G ++ G +  Q  VA+K +    ++   E++F++E  ++ ++ H  +V+  G  
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 105 TKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKT 164
           T+   L IVTE+M  G L +YL +    L    LL    D+C+GMEYL + + IHRDL  
Sbjct: 69  TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAA 128

Query: 165 ANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEVINHQPYDQKADVFSFA 222
            N L+ +  VVKV+DFG+ R+       ++    +  +W  PEV N   Y  K+DV+SF 
Sbjct: 129 RNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFG 188

Query: 223 IVLWELVT-AKVPYDSMTPLQ 242
           +++WE+ T  K+P++  +  +
Sbjct: 189 VLMWEVFTEGKMPFEKKSNYE 209

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  133 bits (337), Expect = 7e-38
 Identities = 74/219 (33%), Positives = 108/219 (49%), Gaps = 21/219 (9%)

Query: 43  GERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVR 99
            E I  G+ G +Y+  +   GQ VA+K++    + +  E+E  +E  ILR+   H N+  
Sbjct: 11  VEVIGEGTYGKVYKARHKKTGQLVAIKIM---DIIEDEEEEIKEEYNILRKYSNHPNIAT 67

Query: 100 FIGASTKSPHLC------IVTEYMPGGSLYDY---LHKNHNVLKLPQLLRFAIDICKGME 150
           F GA  K           +V E   GGS+ D    L K    LK   +     +  +G+ 
Sbjct: 68  FYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLA 127

Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEVI-- 207
           YLH+  +IHRD+K  N+L+  +  VK+ DFGV+    +  G      GT  WMAPEVI  
Sbjct: 128 YLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIAC 187

Query: 208 NHQP---YDQKADVFSFAIVLWELVTAKVPYDSMTPLQA 243
           + QP   YD ++DV+S  I   EL   K P   M P++A
Sbjct: 188 DEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA 226

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  135 bits (339), Expect = 2e-37
 Identities = 68/212 (32%), Positives = 106/212 (50%), Gaps = 16/212 (7%)

Query: 41  KTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDE-FVQEVAILREVQH-RNVV 98
           +   ++  GS G++Y      + VA+KVL  +  + + E E F++E+ IL  + H  N+V
Sbjct: 3   RILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61

Query: 99  RFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLP--QLLRFAIDICKGMEYLHQRN 156
           +          L +V EY+ GGSL D L K      L   + L     I   +EYLH + 
Sbjct: 62  KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG 121

Query: 157 IIHRDLKTANLLMDTH-NVVKVADFGVARFQNKGGV-------MTAETGTYRWMAPEVI- 207
           IIHRD+K  N+L+D    VVK+ DFG+A+     G         +   GT  +MAPEV+ 
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 208 --NHQPYDQKADVFSFAIVLWELVTAKVPYDS 237
             +       +D++S  I L+EL+T   P++ 
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEG 213

Length = 384

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  132 bits (332), Expect = 2e-37
 Identities = 85/233 (36%), Positives = 128/233 (54%), Gaps = 15/233 (6%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEI R  L+   ++  G  G+++ G + G   VA+K L+   +   + + F+QE  I+++
Sbjct: 1   WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---MPEAFLQEAQIMKK 57

Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDICKGME 150
           ++H  +V      ++ P + IVTE+M  GSL D+L + +   LKLPQL+  A  I  GM 
Sbjct: 58  LRHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMA 116

Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMAPEVI 207
           Y+ + N IHRDL+ AN+L+  + V K+ADFG+AR   +    TA  G     +W APE  
Sbjct: 117 YIERMNYIHRDLRAANILVGDNLVCKIADFGLARLI-EDNEYTARQGAKFPIKWTAPEAA 175

Query: 208 NHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL----QAALGVRQVCTSLC 255
            +  +  K+DV+SF I+L ELVT  +VPY  M       Q   G R  C   C
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGC 228

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  131 bits (330), Expect = 4e-37
 Identities = 65/220 (29%), Positives = 115/220 (52%), Gaps = 9/220 (4%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
            +I  GS G +++ V     +  A+K +    +N    +E + E  +L ++    ++R+ 
Sbjct: 6   NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
            +      L IV EY   G L+  L       L   Q+ RF I I  G+ +LH + I+HR
Sbjct: 66  ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHR 125

Query: 161 DLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADV 218
           D+K+ NL +D ++ VK+ D GVA+  +      A T  GT  +++PE+   +PY++K+DV
Sbjct: 126 DIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-ANTIVGTPYYLSPELCEDKPYNEKSDV 184

Query: 219 FSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPI 258
           ++  +VL+E  T K P+D+    Q AL + ++   +  P+
Sbjct: 185 WALGVVLYECCTGKHPFDANN--QGAL-ILKIIRGVFPPV 221

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  130 bits (330), Expect = 5e-37
 Identities = 71/209 (33%), Positives = 107/209 (51%), Gaps = 11/209 (5%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E I  G+   +Y  + L   + VA+K +  E    ++ DE  +EV  + +  H NVV++ 
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV-DELRKEVQAMSQCNHPNVVKYY 65

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI--DICKGMEYLHQRNIIH 159
            +      L +V  Y+ GGSL D +  ++    L + +   +  ++ KG+EYLH    IH
Sbjct: 66  TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIH 125

Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET-----GTYRWMAPEVIN-HQPYD 213
           RD+K  N+L+     VK+ADFGV+     GG  T +      GT  WMAPEV+     YD
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD 185

Query: 214 QKADVFSFAIVLWELVTAKVPYDSMTPLQ 242
            KAD++SF I   EL T   PY    P++
Sbjct: 186 FKADIWSFGITAIELATGAAPYSKYPPMK 214

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  129 bits (326), Expect = 2e-36
 Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 20/210 (9%)

Query: 46  IASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA 103
           + +G+ G +        G+ +AVK +R E +N+ ++ + ++E+ IL +     +V F GA
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILRELDILHKCNSPYIVGFYGA 67

Query: 104 STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH-QRNIIHRDL 162
              +  + I  EYM GGSL   L +    +    L + A+ + KG+ YLH +  IIHRD+
Sbjct: 68  FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDV 127

Query: 163 KTANLLMDTHNVVKVADFGVARFQNKGGVMT-----AETGTYRWMAPEVINHQPYDQKAD 217
           K +N+L+++   +K+ DFGV+      G +         GT  +MAPE I    Y  K+D
Sbjct: 128 KPSNILVNSRGQIKLCDFGVS------GQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSD 181

Query: 218 VFSFAIVLWELVTAKVPY-----DSMTPLQ 242
           ++S  + L EL T + PY           +
Sbjct: 182 IWSLGLSLIELATGRFPYPPENDPPDGIFE 211

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  129 bits (327), Expect = 3e-36
 Identities = 71/233 (30%), Positives = 116/233 (49%), Gaps = 34/233 (14%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD-------VAVKVLRSEHLNDTLEDEFVQE 85
           WE+ R  L  G+ +  G+ G + +   +G D       VAVK+L+ +     L D  V E
Sbjct: 7   WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSD-LVSE 65

Query: 86  VAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV------------ 132
           + +++ + +H+N++  +G  T+   L +V EY   G+L D+L                  
Sbjct: 66  MEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125

Query: 133 ---LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR----- 184
              L    L+ FA  + +GME+L  +  IHRDL   N+L+   +V+K+ADFG+AR     
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHI 185

Query: 185 -FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
            +  K    T      +WMAPE +  + Y  ++DV+SF ++LWE+ T    PY
Sbjct: 186 DYYRK---TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  129 bits (325), Expect = 4e-36
 Identities = 76/204 (37%), Positives = 111/204 (54%), Gaps = 10/204 (4%)

Query: 44  ERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           ERI  GS G++++G+     Q VA+K++  E   D +ED   QE+ +L +     V ++ 
Sbjct: 10  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIED-IQQEITVLSQCDSPYVTKYY 68

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
           G+  K   L I+ EY+ GGS  D L     +  ++  +L+   +I KG++YLH    IHR
Sbjct: 69  GSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHSEKKIHR 125

Query: 161 DLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADV 218
           D+K AN+L+     VK+ADFGVA  Q     +   T  GT  WMAPEVI    YD KAD+
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAG-QLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADI 184

Query: 219 FSFAIVLWELVTAKVPYDSMTPLQ 242
           +S  I   EL   + P   M P++
Sbjct: 185 WSLGITAIELAKGEPPNSDMHPMR 208

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  129 bits (324), Expect = 4e-36
 Identities = 74/208 (35%), Positives = 108/208 (51%), Gaps = 6/208 (2%)

Query: 38  RLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHR 95
            L    ERI  GS G++Y+G+     + VA+K++  E   D +ED   QE+ +L +    
Sbjct: 4   ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIED-IQQEITVLSQCDSP 62

Query: 96  NVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR 155
            + R+ G+  K   L I+ EY+ GGS  D L      L+   +     +I KG++YLH  
Sbjct: 63  YITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLHSE 120

Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQPYDQ 214
             IHRD+K AN+L+     VK+ADFGVA +  +         GT  WMAPEVI    YD 
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF 180

Query: 215 KADVFSFAIVLWELVTAKVPYDSMTPLQ 242
           KAD++S  I   EL   + P   + P++
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDLHPMR 208

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score =  129 bits (325), Expect = 6e-36
 Identities = 71/226 (31%), Positives = 113/226 (50%), Gaps = 24/226 (10%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSE-HLNDTLEDEF 82
             WE  R  L  G+ + +G+ G +      G         VAVK+L+   H ++   +  
Sbjct: 28  LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER--EAL 85

Query: 83  VQEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKN-HNVLKLPQLLR 140
           + E+ I+  +  H N+V  +GA T    + ++TEY   G L ++L +   + L L  LL 
Sbjct: 86  MSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS 145

Query: 141 FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-------FQNKGGVMT 193
           F+  + KGM +L  +N IHRDL   N+L+    +VK+ DFG+AR       +  KG    
Sbjct: 146 FSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205

Query: 194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKV-PYDSM 238
                 +WMAPE I +  Y  ++DV+S+ I+LWE+ +    PY  M
Sbjct: 206 P----VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM 247

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  128 bits (323), Expect = 7e-36
 Identities = 74/213 (34%), Positives = 110/213 (51%), Gaps = 15/213 (7%)

Query: 37  RRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           +R LK    +  G  G +    Y       G+ VAVK L+ E         + +E+ IL+
Sbjct: 3   KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILK 61

Query: 91  EVQHRNVVRFIGASTKS--PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
            + H N+V++ G  ++     L ++ EY+P GSL DYL K+   L L QLL FA  IC+G
Sbjct: 62  TLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEG 119

Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM--TAETGTYR--WMAP 204
           M YLH ++ IHRDL   N+L+D   +VK+ DFG+A+   +G       E G     W A 
Sbjct: 120 MAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAV 179

Query: 205 EVINHQPYDQKADVFSFAIVLWELVTAKVPYDS 237
           E +    +   +DV+SF + L+EL+T      S
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score =  128 bits (323), Expect = 7e-36
 Identities = 69/207 (33%), Positives = 112/207 (54%), Gaps = 13/207 (6%)

Query: 36  DRRLLKTGERIASGSCGDLY------RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           ++R LK    +  G  G +        G   G+ VAVK L+ E   + + D   +E+ IL
Sbjct: 2   EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD-LKKEIEIL 60

Query: 90  REVQHRNVVRFIGASTKSPHLCI--VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICK 147
           R + H N+V++ G  T+     I  + E++P GSL +YL +N N + L Q L++A+ ICK
Sbjct: 61  RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICK 120

Query: 148 GMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAE---TGTYRWMA 203
           GM+YL  R  +HRDL   N+L+++ + VK+ DFG+ +  +      T +        W A
Sbjct: 121 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA 180

Query: 204 PEVINHQPYDQKADVFSFAIVLWELVT 230
           PE +    +   +DV+SF + L+EL+T
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  128 bits (324), Expect = 9e-36
 Identities = 58/195 (29%), Positives = 101/195 (51%), Gaps = 9/195 (4%)

Query: 44  ERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E++  G+ G +Y+      G+ VA+K +R ++  + +    ++E+++L+E++H N+V+ +
Sbjct: 5   EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLL 64

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
                   L +V EY     L  YL K    L    +      + +G+ Y H   I+HRD
Sbjct: 65  DVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRD 123

Query: 162 LKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGT--YRWMAPEVI-NHQPYDQKAD 217
           LK  N+L++   V+K+ADFG+AR F       T E  T  YR  APE++   + Y    D
Sbjct: 124 LKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYR--APEILLGSKHYSTAVD 181

Query: 218 VFSFAIVLWELVTAK 232
           ++S   +  E++T K
Sbjct: 182 IWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  127 bits (321), Expect = 1e-35
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 11/203 (5%)

Query: 43  GERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF 100
           G +I  G+ G +Y  V L  G+ +AVK +R +  +     E   E+ +L  ++H N+V++
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64

Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
            G       + I  EY  GG+L + L  +  +L    +  + + + +G+ YLH   I+HR
Sbjct: 65  YGVEVHREKVYIFMEYCSGGTLEELLE-HGRILDEHVIRVYTLQLLEGLAYLHSHGIVHR 123

Query: 161 DLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAE-----TGTYRWMAPEVINHQPYDQK 215
           D+K AN+ +D + V+K+ DFG A           E      GT  +MAPEVI        
Sbjct: 124 DIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGH 183

Query: 216 ---ADVFSFAIVLWELVTAKVPY 235
              AD++S   V+ E+ T K P+
Sbjct: 184 GRAADIWSLGCVVLEMATGKRPW 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  127 bits (320), Expect = 2e-35
 Identities = 74/230 (32%), Positives = 111/230 (48%), Gaps = 33/230 (14%)

Query: 34  EIDRRLLKTGERIASGSCGDLYRG----VYLGQD---VAVKVLRSEHLNDTLEDEFVQEV 86
            + R  +     +  G+ G ++ G    +    D   VAVK L+    ND  +D F +E 
Sbjct: 1   HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKD-FEREA 59

Query: 87  AILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKN-------------HNVL 133
            +L   QH N+V+F G  T+     +V EYM  G L  +L  +                L
Sbjct: 60  ELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119

Query: 134 KLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-------FQ 186
            L QLL+ A+ I  GM YL  ++ +HRDL T N L+    VVK+ DFG++R       ++
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR 179

Query: 187 NKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
             G  M       RWM PE I ++ +  ++DV+SF +VLWE+ T  K P+
Sbjct: 180 VGGHTMLP----IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  127 bits (321), Expect = 2e-35
 Identities = 56/193 (29%), Positives = 97/193 (50%), Gaps = 6/193 (3%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVV 98
           K   RI  G+ G +++      G+ VA+K +    L   + ++ ++E+  L+  QH  VV
Sbjct: 3   KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVV 62

Query: 99  RFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNII 158
           + +          +V EYMP   L + L      L   Q+  +   + KG+ Y+H   I+
Sbjct: 63  KLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIM 121

Query: 159 HRDLKTANLLMDTHNVVKVADFGVARFQNKGG--VMTAETGTYRWMAPEVI-NHQPYDQK 215
           HRDLK ANLL+    V+K+ADFG+AR  ++    + + +  T  + APE++   + YD  
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPG 181

Query: 216 ADVFSFAIVLWEL 228
            D+++   +  EL
Sbjct: 182 VDLWAVGCIFAEL 194

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  126 bits (318), Expect = 3e-35
 Identities = 73/202 (36%), Positives = 109/202 (53%), Gaps = 6/202 (2%)

Query: 44  ERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  GS G++++G+     + VA+K++  E   D +ED   QE+ +L +     V ++ 
Sbjct: 10  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIED-IQQEITVLSQCDSPYVTKYY 68

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
           G+  K   L I+ EY+ GGS  D L      L   Q+     +I KG++YLH    IHRD
Sbjct: 69  GSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSEKKIHRD 126

Query: 162 LKTANLLMDTHNVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFS 220
           +K AN+L+  H  VK+ADFGVA +  +         GT  WMAPEVI    YD KAD++S
Sbjct: 127 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWS 186

Query: 221 FAIVLWELVTAKVPYDSMTPLQ 242
             I   EL   + P+  + P++
Sbjct: 187 LGITAIELAKGEPPHSELHPMK 208

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  126 bits (318), Expect = 3e-35
 Identities = 71/217 (32%), Positives = 119/217 (54%), Gaps = 13/217 (5%)

Query: 35  IDRRLLKTGERIASGSCGDLYRG--VYLGQD---VAVKVLRSEHLNDTLEDEFVQEVAIL 89
           ID   +K  E I +G  G++ RG     G+    VA+K L+S +  +    +F+ E +I+
Sbjct: 1   IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIM 59

Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGM 149
            +  H N++   G  TKS  + I+TE+M  G+L  +L +N     + QL+     I  GM
Sbjct: 60  GQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGM 119

Query: 150 EYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY------RWMA 203
           +YL + N +HRDL   N+L++++ V KV+DFG++RF          T +       RW A
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179

Query: 204 PEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           PE I ++ +   +DV+S+ IV+WE+++  + PY  M+
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  126 bits (317), Expect = 4e-35
 Identities = 65/209 (31%), Positives = 112/209 (53%), Gaps = 13/209 (6%)

Query: 41  KTGERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQ----EVAILREVQH 94
             G+++ +G+    Y  R V  G  +AVK +       + ++E V+    E+ ++  + H
Sbjct: 3   LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH 62

Query: 95  RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
            +++R +GA+ +  H  +  E+M GGS+   L K +   K   ++ +   + +G+ YLH+
Sbjct: 63  PHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHE 121

Query: 155 RNIIHRDLKTANLLMD-THNVVKVADFGVARFQNKGGVMTAE-----TGTYRWMAPEVIN 208
             IIHRD+K ANLL+D T   +++ADFG A      G    E      GT  +MAPEV+ 
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181

Query: 209 HQPYDQKADVFSFAIVLWELVTAKVPYDS 237
            + Y +  DV+S   V+ E+ TAK P+++
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPPWNA 210

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  126 bits (318), Expect = 4e-35
 Identities = 70/213 (32%), Positives = 115/213 (53%), Gaps = 22/213 (10%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQ-EVAIL---REVQHRNV 97
           E I  G+ G +YRG ++  G+ VA+K++  +  +D + D  +Q EVA+L   R+ Q  N+
Sbjct: 7   ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSD--IQREVALLSQLRQSQPPNI 64

Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLH-----KNHNVLKLPQLLRFAIDICKGMEYL 152
            ++ G+  K P L I+ EY  GGS+   +      + +  + + ++L         ++Y+
Sbjct: 65  TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVL-------VALKYI 117

Query: 153 HQRNIIHRDLKTANLLMDTHNVVKVADFGV-ARFQNKGGVMTAETGTYRWMAPEVINH-Q 210
           H+  +IHRD+K AN+L+     VK+ DFGV A         +   GT  WMAPEVI   +
Sbjct: 118 HKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGK 177

Query: 211 PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQA 243
            YD KAD++S  I ++E+ T   PY  +   +A
Sbjct: 178 YYDTKADIWSLGITIYEMATGNPPYSDVDAFRA 210

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  126 bits (318), Expect = 6e-35
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 26/210 (12%)

Query: 44  ERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRN 96
           E +  G+ G +Y+G   G         VA+K L+       ++ EF QE  ++ ++QH N
Sbjct: 11  EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK-VQQEFRQEAELMSDLQHPN 69

Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKN---------------HNVLKLPQLLRF 141
           +V  +G  TK    C++ EY+  G L+++L +N                + L     L  
Sbjct: 70  IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129

Query: 142 AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG---VMTAETGT 198
           AI I  GMEYL   + +HRDL   N L+     VK++DFG++R         V +     
Sbjct: 130 AIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 199 YRWMAPEVINHQPYDQKADVFSFAIVLWEL 228
            RWM PE I +  +  ++D++SF +VLWE+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  126 bits (319), Expect = 1e-34
 Identities = 69/206 (33%), Positives = 113/206 (54%), Gaps = 18/206 (8%)

Query: 40  LKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNV 97
           L+   RI SG+ G +Y+ ++   G+  A+KV+   H  DT+  +  +E+ ILR+V H NV
Sbjct: 76  LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNV 134

Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
           V+       +  + ++ E+M GGSL     +  ++     L   A  I  G+ YLH+R+I
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSL-----EGTHIADEQFLADVARQILSGIAYLHRRHI 189

Query: 158 IHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM---TAETGTYRWMAPEVI----NHQ 210
           +HRD+K +NLL+++   VK+ADFGV+R   +   M    +  GT  +M+PE I    NH 
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQ--TMDPCNSSVGTIAYMSPERINTDLNHG 247

Query: 211 PYDQKA-DVFSFAIVLWELVTAKVPY 235
            YD  A D++S  + + E    + P+
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGRFPF 273

Length = 353

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  123 bits (309), Expect = 5e-34
 Identities = 68/213 (31%), Positives = 111/213 (52%), Gaps = 13/213 (6%)

Query: 43  GERIASGSCGDLYRG-VYLGQDVAVKVLRSEHLN-DTLEDEFV---QEVAILREVQHRNV 97
           GE +  G+ G +Y G    GQ +AVK +  +  N    E E+    +EV +L+ ++H N+
Sbjct: 5   GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
           V+++G       + I  E++PGGS+   L      L  P   ++   I  G+ YLH   +
Sbjct: 65  VQYLGTCLDDNTISIFMEFVPGGSISSIL-NRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123

Query: 158 IHRDLKTANLLMDTHNVVKVADFGVAR-------FQNKGGVMTAETGTYRWMAPEVINHQ 210
           +HRD+K  N+++  + ++K+ DFG AR             ++ +  GT  WMAPEVIN  
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183

Query: 211 PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQA 243
            Y +K+D++S    ++E+ T K P  SM  L A
Sbjct: 184 GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA 216

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  122 bits (309), Expect = 5e-34
 Identities = 57/176 (32%), Positives = 92/176 (52%), Gaps = 5/176 (2%)

Query: 65  AVKVLRSEHLNDTLEDEFVQ-EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           A+KVL+ + +    E E    E  IL  + H  +V+   A      L +V EY PGG L+
Sbjct: 22  AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELF 81

Query: 124 DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA 183
            +L K        +   +A +I   +EYLH   II+RDLK  N+L+D    +K+ DFG+A
Sbjct: 82  SHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLA 140

Query: 184 RFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS 237
           + +         T  GT  ++APEV+  + Y +  D +S  ++L+E++T K P+ +
Sbjct: 141 K-ELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score =  123 bits (310), Expect = 1e-33
 Identities = 72/214 (33%), Positives = 122/214 (57%), Gaps = 22/214 (10%)

Query: 40  LKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDTLEDEFVQEVAILREVQ 93
           LK  + + SG+ G +Y+G+++ +       VA+K+L +E        EF+ E  I+  + 
Sbjct: 9   LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKIL-NETTGPKANVEFMDEALIMASMD 67

Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
           H ++VR +G    SP + +VT+ MP G L DY+H++ + +    LL + + I KGM YL 
Sbjct: 68  HPHLVRLLGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126

Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVAR--------FQNKGGVMTAETGTYRWMAPE 205
           +R ++HRDL   N+L+ + N VK+ DFG+AR        +   GG M       +WMA E
Sbjct: 127 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI-----KWMALE 181

Query: 206 VINHQPYDQKADVFSFAIVLWELVT-AKVPYDSM 238
            I+++ +  ++DV+S+ + +WEL+T    PYD +
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  122 bits (306), Expect = 2e-33
 Identities = 69/204 (33%), Positives = 111/204 (54%), Gaps = 11/204 (5%)

Query: 46  IASGSCGDLYRGVYL--GQD---VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF 100
           I +G  G+++RG+    G+    VA+K L+  +     +D F+ E +I+ +  H N++R 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD-FLSEASIMGQFSHHNIIRL 71

Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
            G  TK     I+TEYM  G+L  YL  +       QL+     I  GM+YL   N +HR
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHR 131

Query: 161 DLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETGT--YRWMAPEVINHQPYDQKA 216
           DL   N+L++++   KV+DFG++R    +  G  T   G    RW APE I ++ +   +
Sbjct: 132 DLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSAS 191

Query: 217 DVFSFAIVLWELVT-AKVPYDSMT 239
           DV+SF IV+WE+++  + PY  M+
Sbjct: 192 DVWSFGIVMWEVMSFGERPYWDMS 215

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score =  121 bits (304), Expect = 9e-33
 Identities = 75/241 (31%), Positives = 126/241 (52%), Gaps = 30/241 (12%)

Query: 38  RLLKTGE-----RIASGSCGDLYRGVYL--GQD----VAVKVLRSEHLNDTLEDEFVQEV 86
           R+LK  E      + SG+ G +Y+G+++  G+     VA+K LR E  +     E + E 
Sbjct: 2   RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEA 60

Query: 87  AILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDIC 146
            ++  V + +V R +G    S  + ++T+ MP G L DY+ ++ + +    LL + + I 
Sbjct: 61  YVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 119

Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY------- 199
           KGM YL +R ++HRDL   N+L+ T   VK+ DFG+A+      ++ A+   Y       
Sbjct: 120 KGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAK------LLGADEKEYHAEGGKV 173

Query: 200 --RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQ 256
             +WMA E I H+ Y  ++DV+S+ + +WEL+T    PYD + P      + +    L Q
Sbjct: 174 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 232

Query: 257 P 257
           P
Sbjct: 233 P 233

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score =  119 bits (300), Expect = 3e-32
 Identities = 71/215 (33%), Positives = 113/215 (52%), Gaps = 22/215 (10%)

Query: 46  IASGSCGDLYRGVY----LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRF 100
           I  G+ G + R +     L  + A+K+L+ E  ++    +F  E+ +L ++  H N++  
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLK-EFASENDHRDFAGELEVLCKLGHHPNIINL 68

Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNH---------------NVLKLPQLLRFAIDI 145
           +GA     +L I  EY P G+L D+L K+                + L   QLL+FA D+
Sbjct: 69  LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128

Query: 146 CKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPE 205
             GM+YL ++  IHRDL   N+L+  +   K+ADFG++R +      T      RWMA E
Sbjct: 129 ATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIE 188

Query: 206 VINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
            +N+  Y  K+DV+SF ++LWE+V+    PY  MT
Sbjct: 189 SLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  118 bits (297), Expect = 5e-32
 Identities = 69/222 (31%), Positives = 114/222 (51%), Gaps = 28/222 (12%)

Query: 43  GERIASGSCGDLYRG--VYLGQDVAVKVL--------RSEHLNDTLEDEFVQEVAILREV 92
           GE I  G+ G +Y    V  G+ +AVK +        R +     +      E+  L+++
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 93  QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAID-ICKGMEY 151
            H N+V+++G  T   +L I  EY+PGGS+   L + +   +  QL+RF  + + +G+ Y
Sbjct: 66  DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL-RTYGRFE-EQLVRFFTEQVLEGLAY 123

Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR--------FQNKGGVMTAETGTYRWMA 203
           LH + I+HRDLK  NLL+D   + K++DFG+++         QN      +  G+  WMA
Sbjct: 124 LHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN-----MSMQGSVFWMA 178

Query: 204 PEVIN--HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQA 243
           PEVI+   Q Y  K D++S   V+ E+   + P+     + A
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA 220

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score =  118 bits (296), Expect = 5e-32
 Identities = 63/190 (33%), Positives = 103/190 (54%), Gaps = 15/190 (7%)

Query: 61  GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS------PHLCIVT 114
            Q VAVK+L+++  + +  +EF++E A ++E  H NV++ IG S +S      P   ++ 
Sbjct: 27  FQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVIL 86

Query: 115 EYMPGGSLYDYLHKNH---NVLKLPQ--LLRFAIDICKGMEYLHQRNIIHRDLKTANLLM 169
            +M  G L+ +L  +        LP   L+RF IDI  GMEYL  +N IHRDL   N ++
Sbjct: 87  PFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML 146

Query: 170 DTHNVVKVADFGVARFQNKGGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLW 226
           + +  V VADFG+++    G       A     +W+A E +    Y   +DV++F + +W
Sbjct: 147 NENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMW 206

Query: 227 ELVT-AKVPY 235
           E++T  + PY
Sbjct: 207 EIMTRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  118 bits (297), Expect = 7e-32
 Identities = 67/207 (32%), Positives = 110/207 (53%), Gaps = 15/207 (7%)

Query: 44  ERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFV-QEVAILREVQHRNVVRF 100
           E+I  G+ G +Y    V  GQ+VA+K +   +L    + E +  E+ ++RE +H N+V +
Sbjct: 25  EKIGQGASGTVYTAIDVATGQEVAIKQM---NLQQQPKKELIINEILVMRENKHPNIVNY 81

Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
           + +      L +V EY+ GGSL D +      +   Q+     +  + +E+LH   +IHR
Sbjct: 82  LDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQVIHR 139

Query: 161 DLKTANLLMDTHNVVKVADFG----VARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKA 216
           D+K+ N+L+     VK+ DFG    +   Q+K   M    GT  WMAPEV+  + Y  K 
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVVTRKAYGPKV 196

Query: 217 DVFSFAIVLWELVTAKVPYDSMTPLQA 243
           D++S  I+  E+V  + PY +  PL+A
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRA 223

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  117 bits (296), Expect = 8e-32
 Identities = 69/223 (30%), Positives = 111/223 (49%), Gaps = 23/223 (10%)

Query: 37  RRLLKTGERIASGSCG--DLYRGVYLGQDVAVKV--LRSEHLNDTLEDEFVQEVAILREV 92
           R  L    +I  GS G   +      G+ VAVK   LR +   + L      EV I+R+ 
Sbjct: 18  RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELL----FNEVVIMRDY 73

Query: 93  QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYL 152
           QH N+V    +      L +V E++ GG+L D +   H  +   Q+    + + K + +L
Sbjct: 74  QHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLAVLKALSFL 131

Query: 153 HQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET-------GTYRWMAPE 205
           H + +IHRD+K+ ++L+ +   VK++DFG          ++ E        GT  WMAPE
Sbjct: 132 HAQGVIHRDIKSDSILLTSDGRVKLSDFGFC------AQVSKEVPRRKSLVGTPYWMAPE 185

Query: 206 VINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVR 248
           VI+  PY  + D++S  I++ E+V  + PY +  PLQA   +R
Sbjct: 186 VISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR 228

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  117 bits (294), Expect = 1e-31
 Identities = 61/196 (31%), Positives = 105/196 (53%), Gaps = 5/196 (2%)

Query: 45  RIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAS 104
           R A G    L R     + V +K +  E +          E  +L+ + H N++ +    
Sbjct: 10  RGAFGIV-HLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF 68

Query: 105 TKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ--LLRFAIDICKGMEYLHQRNIIHRDL 162
            +   L IV EY PGG+L +Y+ K  N L L +  +L F + I   + ++H + I+HRDL
Sbjct: 69  LEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFVQILLALHHVHTKLILHRDL 127

Query: 163 KTANLLMDTH-NVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSF 221
           KT N+L+D H  VVK+ DFG+++  +         GT  +++PE+   +PY+QK+D+++ 
Sbjct: 128 KTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWAL 187

Query: 222 AIVLWELVTAKVPYDS 237
             VL+EL + K  +++
Sbjct: 188 GCVLYELASLKRAFEA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  117 bits (294), Expect = 1e-31
 Identities = 67/220 (30%), Positives = 115/220 (52%), Gaps = 8/220 (3%)

Query: 34  EIDRRLLKTGERI--ASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           E +    + GER+    G+ G +Y    L   V + +      +        +E+A+   
Sbjct: 2   EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61

Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKL--PQLLRFAIDICKGM 149
           ++HRN+V+++G+ +++    I  E +PGGSL   L      LK     ++ +   I +G+
Sbjct: 62  LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGL 121

Query: 150 EYLHQRNIIHRDLKTANLLMDTHN-VVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVI 207
           +YLH   I+HRD+K  N+L++T++ VVK++DFG + R           TGT ++MAPEVI
Sbjct: 122 KYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVI 181

Query: 208 NHQP--YDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL 245
           +  P  Y   AD++S    + E+ T K P+  +   QAA+
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM 221

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  117 bits (295), Expect = 1e-31
 Identities = 76/230 (33%), Positives = 114/230 (49%), Gaps = 29/230 (12%)

Query: 34  EIDRRLLKTGERIASGSCGDLYRGVYLGQD-------VAVKVLRSEHLNDTLEDEFVQEV 86
           E+ R  +     +  G+ G++Y G+Y G+D       VAVK L  E  ++  E +F+ E 
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLP-ESCSEQDESDFLMEA 60

Query: 87  AILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHN------VLKLPQLLR 140
            I+ +  H+N+VR IG S +     I+ E M GG L  +L +N         L +  LL 
Sbjct: 61  LIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120

Query: 141 FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVAR------FQNKGG- 190
            A D+ KG +YL + + IHRD+   N L+       V K+ADFG+AR      +  KGG 
Sbjct: 121 CARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180

Query: 191 VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
            M       +WM PE      +  K DV+SF ++LWE+ +   +PY   T
Sbjct: 181 AMLP----IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  116 bits (292), Expect = 2e-31
 Identities = 68/207 (32%), Positives = 102/207 (49%), Gaps = 26/207 (12%)

Query: 46  IASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLE-DEFVQEVAILREVQHRNVVR 99
           I  G  G +Y G  +  D      AVK L    + D  E ++F++E  I+++  H NV+ 
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSL--NRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 100 FIG---ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
            +G    S  SP   +V  YM  G L +++    +   +  L+ F + + KGMEYL  + 
Sbjct: 61  LLGICLPSEGSPL--VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118

Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVAR---------FQNKGGVMTAETGTYRWMAPEVI 207
            +HRDL   N ++D    VKVADFG+AR           N  G         +WMA E +
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP----VKWMALESL 174

Query: 208 NHQPYDQKADVFSFAIVLWELVTAKVP 234
             Q +  K+DV+SF ++LWEL+T   P
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =  116 bits (291), Expect = 3e-31
 Identities = 63/181 (34%), Positives = 101/181 (55%), Gaps = 6/181 (3%)

Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VA+K L++ +      D F+ E +I+ +  H N++   G  TKS  + IVTEYM  GSL 
Sbjct: 35  VAIKTLKAGYTEKQRRD-FLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLD 93

Query: 124 DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA 183
            +L K+     + QL+     I  GM+YL     +HRDL   N+L++++ V KV+DFG++
Sbjct: 94  AFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLS 153

Query: 184 RF--QNKGGVMTAETGT--YRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSM 238
           R    +     T   G    RW APE I ++ +   +DV+S+ IV+WE+++  + PY  M
Sbjct: 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM 213

Query: 239 T 239
           +
Sbjct: 214 S 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score =  115 bits (290), Expect = 4e-31
 Identities = 70/215 (32%), Positives = 111/215 (51%), Gaps = 22/215 (10%)

Query: 46  IASGSCGDLYRGVY----LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRF 100
           I  G+ G + +       L  D A+K ++ E+ +     +F  E+ +L ++  H N++  
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNH---------------NVLKLPQLLRFAIDI 145
           +GA     +L +  EY P G+L D+L K+                + L   QLL FA D+
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 146 CKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPE 205
            +GM+YL Q+  IHRDL   N+L+  + V K+ADFG++R Q      T      RWMA E
Sbjct: 122 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIE 181

Query: 206 VINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
            +N+  Y   +DV+S+ ++LWE+V+    PY  MT
Sbjct: 182 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  115 bits (289), Expect = 8e-31
 Identities = 54/192 (28%), Positives = 98/192 (51%), Gaps = 7/192 (3%)

Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
            +I  G+ G +Y  R    G+ VA+K ++    ++ +    ++E+ +L+E+ H N+++ +
Sbjct: 5   GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
                   L +V E+M    LY  +      L    +  +   + +G+ + H   I+HRD
Sbjct: 65  DVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRD 123

Query: 162 LKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWM-APEVI-NHQPYDQKADV 218
           LK  NLL++T  V+K+ADFG+AR F +     T    T RW  APE++   + Y    D+
Sbjct: 124 LKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVT-RWYRAPELLLGDKGYSTPVDI 182

Query: 219 FSFAIVLWELVT 230
           +S   +  EL++
Sbjct: 183 WSVGCIFAELLS 194

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  115 bits (289), Expect = 9e-31
 Identities = 56/166 (33%), Positives = 86/166 (51%), Gaps = 6/166 (3%)

Query: 75  NDTLEDEFVQEVAILREVQHRNVVRFIGA--STKSPHLCIVTEYMPGGSL---YDYLHKN 129
           N  L+ + ++E+ I +  +   +V++ GA     S  + I  EY  GGSL   Y  + K 
Sbjct: 39  NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR 98

Query: 130 HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG 189
              +    L + A  + KG+ YLH R IIHRD+K +N+L+     VK+ DFGV+      
Sbjct: 99  GGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158

Query: 190 GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
              T  TGT  +MAPE I  +PY   +DV+S  + L E+   + P+
Sbjct: 159 LAGTF-TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  114 bits (287), Expect = 1e-30
 Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 38/225 (16%)

Query: 40  LKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDTLEDEFVQEVAILREVQ 93
           LK G+ +  G  G +  G  L QD      VAVK ++ +    +  +EF+ E A +++  
Sbjct: 1   LKLGKILGEGEFGSVMEGQ-LSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD 59

Query: 94  HRNVVRFIGASTKS------PHLCIVTEYMPGGSLYDYL-----HKNHNVLKLPQLLRFA 142
           H NV++ IG   ++      P   ++  +M  G L+ +L           L L  LL+F 
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119

Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--- 199
           +DI  GMEYL  RN IHRDL   N ++     V VADFG+++           +G Y   
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK--------KIYSGDYYRQ 171

Query: 200 --------RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
                   +W+A E +  + Y  K+DV++F + +WE+ T  + PY
Sbjct: 172 GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score =  115 bits (289), Expect = 1e-30
 Identities = 67/197 (34%), Positives = 101/197 (51%), Gaps = 18/197 (9%)

Query: 60  LGQDVAVKVLRSEHLNDTLEDEFVQEVAIL-REVQHRNVVRFIGASTKSPHLCIVTEYMP 118
           L  D A+K ++     D   D F  E+ +L +   H N++  +GA     +L +  EY P
Sbjct: 33  LRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 91

Query: 119 GGSLYDYL---------------HKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLK 163
            G+L D+L               +   + L   QLL FA D+ +GM+YL Q+  IHRDL 
Sbjct: 92  HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLA 151

Query: 164 TANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAI 223
             N+L+  + V K+ADFG++R Q      T      RWMA E +N+  Y   +DV+S+ +
Sbjct: 152 ARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV 211

Query: 224 VLWELVT-AKVPYDSMT 239
           +LWE+V+    PY  MT
Sbjct: 212 LLWEIVSLGGTPYCGMT 228

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  113 bits (286), Expect = 2e-30
 Identities = 64/204 (31%), Positives = 100/204 (49%), Gaps = 21/204 (10%)

Query: 55  YRGVYL------GQDVAVKVL-RSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS 107
           Y  V+L      G   A+KV+ +++ +     D+ + E  IL + Q   VV+   +    
Sbjct: 6   YGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGK 65

Query: 108 PHLCIVTEYMPGGSLYDYLHKNHNVLKLP-QLLRFAI-DICKGMEYLHQRNIIHRDLKTA 165
            +L +V EY+PGG L   L    NV  L   + R  I +I   +EYLH   IIHRDLK  
Sbjct: 66  KNLYLVMEYLPGGDLASLLE---NVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPD 122

Query: 166 NLLMDTHNVVKVADFGVARF-----QNKGGVMTAET----GTYRWMAPEVINHQPYDQKA 216
           N+L+D++  +K+ DFG+++      Q        E     GT  ++APEVI  Q + +  
Sbjct: 123 NILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTV 182

Query: 217 DVFSFAIVLWELVTAKVPYDSMTP 240
           D +S   +L+E +    P+   TP
Sbjct: 183 DWWSLGCILYEFLVGIPPFHGETP 206

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  113 bits (285), Expect = 2e-30
 Identities = 65/198 (32%), Positives = 104/198 (52%), Gaps = 18/198 (9%)

Query: 44  ERIASGSCGDLYRGVYLGQDV------AVKVLRSEHLNDTLEDEFVQ---EVAILREVQH 94
           +R+  GS G     VYL +D        +KVL+   + +   +E VQ   E  +L ++ H
Sbjct: 6   QRLGKGSFGT----VYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61

Query: 95  RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH---KNHNVLKLPQLLRFAIDICKGMEY 151
             +V+F  +  +    CI+TEY  G  L   L         L   Q+  + I +  G+ Y
Sbjct: 62  PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121

Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF-QNKGGVMTAETGTYRWMAPEVINHQ 210
           +HQR I+HRDLK  N+ +  +N++K+ DFGV+R       + T  TGT  +M+PE + HQ
Sbjct: 122 MHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQ 180

Query: 211 PYDQKADVFSFAIVLWEL 228
            YD K+D++S   +L+E+
Sbjct: 181 GYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  114 bits (287), Expect = 2e-30
 Identities = 58/191 (30%), Positives = 99/191 (51%), Gaps = 20/191 (10%)

Query: 61  GQDVAVKVLRS---------EHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC 111
           G+  A+K+L           EH+ +        E  IL+ ++H  +V   G+     +L 
Sbjct: 26  GKYYALKILSKAKIVKLKQVEHVLN--------EKRILQSIRHPFLVNLYGSFQDDSNLY 77

Query: 112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT 171
           +V EY+PGG L+ +L K+      P    +A  +   +EYLH  +I++RDLK  NLL+D+
Sbjct: 78  LVMEYVPGGELFSHLRKSGR-FPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDS 136

Query: 172 HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTA 231
              +K+ DFG A+   KG   T   GT  ++APE+I  + Y +  D ++  I+++E++  
Sbjct: 137 DGYIKITDFGFAKRV-KGRTYTL-CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194

Query: 232 KVPYDSMTPLQ 242
             P+    P+Q
Sbjct: 195 YPPFFDDNPIQ 205

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  114 bits (286), Expect = 3e-30
 Identities = 69/247 (27%), Positives = 115/247 (46%), Gaps = 33/247 (13%)

Query: 34  EIDRRLLKTGERIASGSCGDLYR----GVYLGQD---VAVKVLRSEHLNDTLEDEFVQEV 86
           E  R  ++    I  G+ G +++    G+   +    VAVK+L+ E   D  + +F +E 
Sbjct: 1   EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM-QADFQREA 59

Query: 87  AILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKN---------HNVLKL-- 135
           A++ E  H N+V+ +G       +C++ EYM  G L ++L            H+      
Sbjct: 60  ALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARK 119

Query: 136 ----------PQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR- 184
                      + L  A  +  GM YL +R  +HRDL T N L+  + VVK+ADFG++R 
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 179

Query: 185 --FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKV-PYDSMTPL 241
               +       +    RWM PE I +  Y  ++DV+++ +VLWE+ +  + PY  M   
Sbjct: 180 IYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239

Query: 242 QAALGVR 248
           +    VR
Sbjct: 240 EVIYYVR 246

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score =  113 bits (285), Expect = 3e-30
 Identities = 63/195 (32%), Positives = 104/195 (53%), Gaps = 17/195 (8%)

Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VAVK+LR++ +  T  ++F++E+ I+  +++ N++R +G       LC++TEYM  G L 
Sbjct: 47  VAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105

Query: 124 DYLH---------KNHNV--LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH 172
            +L            +N+  + +  LL  A+ I  GM+YL   N +HRDL T N L+  H
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNH 165

Query: 173 NVVKVADFGVARFQNKGG---VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELV 229
             +K+ADFG++R    G    +        RWMA E I    +   +DV++F + LWE+ 
Sbjct: 166 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMF 225

Query: 230 T--AKVPYDSMTPLQ 242
           T   + PY  ++  Q
Sbjct: 226 TLCKEQPYSLLSDEQ 240

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  112 bits (281), Expect = 7e-30
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 11/209 (5%)

Query: 54  LYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV 113
           LYR       V  K +    L++    + + E+ IL  +QH N++ +         L I 
Sbjct: 18  LYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE 77

Query: 114 TEYMPGGSLYDYL-HKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH 172
            EY  GG+LYD +  +   + +   +L +   I   + Y+H+  I+HRD+KT N+ +   
Sbjct: 78  MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA 137

Query: 173 NVVKVADFGVARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
            ++K+ DFG+++       M AET  GT  +M+PE+     Y+ K+D+++   VL+EL+T
Sbjct: 138 GLIKLGDFGISKILGSEYSM-AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT 196

Query: 231 AKVPYDSMTPLQAALGVRQVCTSLCQPIY 259
            K  +D+  PL        +   + Q  Y
Sbjct: 197 LKRTFDATNPL-------NLVVKIVQGNY 218

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  112 bits (282), Expect = 7e-30
 Identities = 66/220 (30%), Positives = 111/220 (50%), Gaps = 15/220 (6%)

Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E I  GS G +   R    G+ +  K +   ++ +  + + V EV ILRE++H N+VR+ 
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 102 G--ASTKSPHLCIVTEYMPGGSLYDYLHK---NHNVLKLPQLLRFAIDICKGMEYLHQRN 156
                  +  L IV EY  GG L   + K       ++   + R    +   +   H R+
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125

Query: 157 -----IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GTYRWMAPEVINH 209
                ++HRDLK AN+ +D +N VK+ DFG+A+         A+T  GT  +M+PE +NH
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG-HDSSFAKTYVGTPYYMSPEQLNH 184

Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
             YD+K+D++S   +++EL     P+ +   LQ A  +++
Sbjct: 185 MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE 224

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  112 bits (281), Expect = 7e-30
 Identities = 60/194 (30%), Positives = 111/194 (57%), Gaps = 6/194 (3%)

Query: 44  ERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           ++I  GS G   L +    G+   +K +    ++    +E  +EVA+L  ++H N+V++ 
Sbjct: 6   KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVL-KLPQLLRFAIDICKGMEYLHQRNIIHR 160
            +  ++ +L IV +Y  GG LY  ++    VL    Q+L + + IC  ++++H R I+HR
Sbjct: 66  ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHR 125

Query: 161 DLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADV 218
           D+K+ N+ +     +K+ DFG+AR  N   V  A T  GT  +++PE+  ++PY+ K+D+
Sbjct: 126 DIKSQNIFLTKDGTIKLGDFGIARVLNS-TVELARTCIGTPYYLSPEICENRPYNNKSDI 184

Query: 219 FSFAIVLWELVTAK 232
           ++   VL+E+ T K
Sbjct: 185 WALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score =  113 bits (284), Expect = 9e-30
 Identities = 74/232 (31%), Positives = 119/232 (51%), Gaps = 30/232 (12%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLEDEFV 83
           WE+ R  L  G+ +  G  G +     +G D         VAVK+L+ +  +  L D  V
Sbjct: 7   WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSD-LV 65

Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK--------NHNVLK 134
            E+ +++ + +H+N++  +GA T+   L ++ EY   G+L +YL          + +  K
Sbjct: 66  SEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 125

Query: 135 LPQ-------LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-FQ 186
           LP+       L+  A  + +GMEYL  +  IHRDL   N+L+   NV+K+ADFG+AR   
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVH 185

Query: 187 NKGGVMTAETGTY--RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
           N         G    +WMAPE +  + Y  ++DV+SF ++LWE+ T    PY
Sbjct: 186 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  111 bits (281), Expect = 1e-29
 Identities = 59/194 (30%), Positives = 96/194 (49%), Gaps = 6/194 (3%)

Query: 46  IASGSCGDLYRGVYLGQDV--AVKVLRSEHLNDT-LEDEFVQEVAILREVQHRNVVRFIG 102
           +  G  G +       ++   A+K ++  H+ +T  ++    E  IL E  H  +V+   
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAID-ICKGMEYLHQRNIIHRD 161
                 ++ ++ EY  GG L+  L       +     RF I  +    EYLH R II+RD
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE--YTARFYIACVVLAFEYLHNRGIIYRD 118

Query: 162 LKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSF 221
           LK  NLL+D++  VK+ DFG A+    G       GT  ++APE+I ++ YD   D +S 
Sbjct: 119 LKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSL 178

Query: 222 AIVLWELVTAKVPY 235
            I+L+EL+T + P+
Sbjct: 179 GILLYELLTGRPPF 192

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score =  112 bits (281), Expect = 1e-29
 Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 24/202 (11%)

Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VAVK+LR +  N    ++F++EV IL  ++  N++R +G       LC++TEYM  G L 
Sbjct: 49  VAVKILRPD-ANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107

Query: 124 DYLHKNH------------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTA 165
            +L  +H                    +    LL  A+ I  GM+YL   N +HRDL T 
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATR 167

Query: 166 NLLMDTHNVVKVADFGVARFQNKGG---VMTAETGTYRWMAPEVINHQPYDQKADVFSFA 222
           N L+  +  +K+ADFG++R    G    +        RWMA E I    +   +DV++F 
Sbjct: 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFG 227

Query: 223 IVLWEL--VTAKVPYDSMTPLQ 242
           + LWE+  +  + PY  +T  Q
Sbjct: 228 VTLWEILMLCKEQPYGELTDEQ 249

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score =  112 bits (281), Expect = 2e-29
 Identities = 69/226 (30%), Positives = 112/226 (49%), Gaps = 29/226 (12%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLEDEFV 83
           WE+ R  L  G+ +  G  G +     +G D         VAVK+L+S+     L D  +
Sbjct: 13  WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSD-LI 71

Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL---------------H 127
            E+ +++ + +H+N++  +GA T+   L ++ EY   G+L +YL                
Sbjct: 72  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ 131

Query: 128 KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN 187
                L    L+  A  + +GMEYL  +  IHRDL   N+L+   NV+K+ADFG+AR  +
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 191

Query: 188 KGGVMTAETG---TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
                   T      +WMAPE +  + Y  ++DV+SF ++LWE+ T
Sbjct: 192 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  111 bits (279), Expect = 3e-29
 Identities = 61/203 (30%), Positives = 109/203 (53%), Gaps = 7/203 (3%)

Query: 44  ERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G ++    V  GQ+VA+K +  +      ++  + E+ +++E+++ N+V F+
Sbjct: 25  EKIGQGASGTVFTAIDVATGQEVAIKQINLQ--KQPKKELIINEILVMKELKNPNIVNFL 82

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
            +      L +V EY+ GGSL D +      +   Q+     +  + +E+LH   +IHRD
Sbjct: 83  DSFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLHANQVIHRD 140

Query: 162 LKTANLLMDTHNVVKVADFG-VARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFS 220
           +K+ N+L+     VK+ DFG  A+   +    +   GT  WMAPEV+  + Y  K D++S
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 200

Query: 221 FAIVLWELVTAKVPYDSMTPLQA 243
             I+  E+V  + PY +  PL+A
Sbjct: 201 LGIMAIEMVEGEPPYLNENPLRA 223

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score =  112 bits (280), Expect = 3e-29
 Identities = 69/226 (30%), Positives = 116/226 (51%), Gaps = 29/226 (12%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLEDEFV 83
           WE  R  L  G+ +  G  G +     LG D         VAVK+L+ +     L D  V
Sbjct: 10  WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LV 68

Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK--------NHNVLK 134
            E+ +++ + +H+N++  +GA T+   L ++ EY   G+L +YL          ++++ +
Sbjct: 69  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR 128

Query: 135 LPQ-------LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN 187
           +P        L+     + +GMEYL  +  IHRDL   N+L+  +NV+K+ADFG+AR  N
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVN 188

Query: 188 KGGVMTAETG---TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
                   T      +WMAPE +  + Y  ++DV+SF +++WE+ T
Sbjct: 189 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  110 bits (277), Expect = 3e-29
 Identities = 70/218 (32%), Positives = 109/218 (50%), Gaps = 34/218 (15%)

Query: 46  IASGSCGDLYRGVYLGQD--------VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNV 97
           + SG+ G++Y G              VAVK LR +   D  + EF++E  ++    H N+
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR-KGATDQEKKEFLKEAHLMSNFNHPNI 61

Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHN------VLKLPQLLRFAIDICKGMEY 151
           V+ +G    +    I+ E M GG L  YL           +L L +LL   +D+ KG  Y
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 152 LHQRNIIHRDLKTANLLM-----DTHNVVKVADFGVAR-------FQNKG-GVMTAETGT 198
           L Q + IHRDL   N L+     D   VVK+ DFG+AR       ++ +G G++      
Sbjct: 122 LEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV---- 177

Query: 199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
            RWMAPE +    +  ++DV+SF +++WE++T  + PY
Sbjct: 178 -RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY 214

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score =  110 bits (277), Expect = 3e-29
 Identities = 73/221 (33%), Positives = 120/221 (54%), Gaps = 27/221 (12%)

Query: 38  RLLKTGER-----IASGSCGDLYRGVYL--GQD----VAVKVLRSEHLNDTLEDEFVQEV 86
           R+LK  E      + SG+ G +Y+G+++  G++    VA+KVLR E+ +     E + E 
Sbjct: 2   RILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLR-ENTSPKANKEILDEA 60

Query: 87  AILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDIC 146
            ++  V    V R +G    S  + +VT+ MP G L DY+ +N + +    LL + + I 
Sbjct: 61  YVMAGVGSPYVCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIA 119

Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR--------FQNKGGVMTAETGT 198
           KGM YL +  ++HRDL   N+L+ + N VK+ DFG+AR        +   GG +      
Sbjct: 120 KGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPI---- 175

Query: 199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSM 238
            +WMA E I H+ +  ++DV+S+ + +WEL+T    PYD +
Sbjct: 176 -KWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score =  111 bits (278), Expect = 5e-29
 Identities = 67/227 (29%), Positives = 109/227 (48%), Gaps = 29/227 (12%)

Query: 32  DWEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLEDEF 82
            WE  R  L  G+ +  G  G + R    G D         VAVK+L+    +  L D  
Sbjct: 6   KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLAD-L 64

Query: 83  VQEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK------------- 128
           + E+ +++ + +H+N++  +G  T+   L ++ EY   G+L ++L               
Sbjct: 65  ISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDIT 124

Query: 129 --NHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ 186
                 L    L+  A  + +GMEYL  R  IHRDL   N+L+   NV+K+ADFG+AR  
Sbjct: 125 KVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGV 184

Query: 187 NKGGVMTAETG---TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
           +        +      +WMAPE +  + Y  ++DV+SF I++WE+ T
Sbjct: 185 HDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  109 bits (273), Expect = 1e-28
 Identities = 63/166 (37%), Positives = 94/166 (56%), Gaps = 10/166 (6%)

Query: 85  EVAILREVQHRNVVRFIGA--STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFA 142
           E+ +L+ +QH  +V++ G         L I  EYMPGGS+ D L K +  L      ++ 
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYT 112

Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA-RFQN---KGGVMTAETGT 198
             I +GM YLH   I+HRD+K AN+L D+   VK+ DFG + R Q     G  + + TGT
Sbjct: 113 RQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172

Query: 199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVP---YDSMTPL 241
             WM+PEVI+ + Y +KADV+S    + E++T K P   Y++M  +
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI 218

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  109 bits (273), Expect = 1e-28
 Identities = 62/165 (37%), Positives = 94/165 (56%), Gaps = 7/165 (4%)

Query: 85  EVAILREVQHRNVVRFIGA--STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFA 142
           E+ +L+ ++H  +V++ G     +   L I  EYMPGGS+ D L K +  L      R+ 
Sbjct: 54  EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYT 112

Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA-RFQN---KGGVMTAETGT 198
             I +G+ YLH   I+HRD+K AN+L D+   VK+ DFG + R Q     G  + + TGT
Sbjct: 113 RQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGT 172

Query: 199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQA 243
             WM+PEVI+ + Y +KADV+S A  + E++T K P+     + A
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA 217

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score =  108 bits (270), Expect = 2e-28
 Identities = 64/231 (27%), Positives = 118/231 (51%), Gaps = 27/231 (11%)

Query: 46  IASGSCGDLYRGVY----LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           + SG+ G + +G+Y      + VAVK+L++++ +  L+DE ++E  +++++ +  +VR I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
           G   ++    +V E    G L  +L KN +V     +      +  GM+YL + N +HRD
Sbjct: 63  GI-CEAESWMLVMELAELGPLNKFLQKNKHV-TEKNITELVHQVSMGMKYLEETNFVHRD 120

Query: 162 LKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY----------RWMAPEVINHQP 211
           L   N+L+ T +  K++DFG+++       + A+   Y          +W APE +N+  
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSK------ALGADENYYKAKTHGKWPVKWYAPECMNYYK 174

Query: 212 YDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAAL----GVRQVCTSLCQP 257
           +  K+DV+SF +++WE  +  + PY  M   +       G R  C   C P
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPP 225

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  108 bits (272), Expect = 2e-28
 Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 28/204 (13%)

Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VAVK+L+    +  L D  + E  +L++V H +V++  GA ++   L ++ EY   GSL 
Sbjct: 33  VAVKMLKENASSSELRD-LLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLR 91

Query: 124 DYLHKNHNV-----------------------LKLPQLLRFAIDICKGMEYLHQRNIIHR 160
            +L ++  V                       L +  L+ FA  I +GM+YL +  ++HR
Sbjct: 92  SFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHR 151

Query: 161 DLKTANLLMDTHNVVKVADFGVAR--FQNKGGVMTAETGT-YRWMAPEVINHQPYDQKAD 217
           DL   N+L+     +K++DFG++R  ++    V  ++     +WMA E +    Y  ++D
Sbjct: 152 DLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSD 211

Query: 218 VFSFAIVLWELVT-AKVPYDSMTP 240
           V+SF ++LWE+VT    PY  + P
Sbjct: 212 VWSFGVLLWEIVTLGGNPYPGIAP 235

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  108 bits (270), Expect = 3e-28
 Identities = 68/206 (33%), Positives = 111/206 (53%), Gaps = 9/206 (4%)

Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           +R+ SG+ GD+Y  R ++ G+  AVK+++ E  +D       QE+ +++E +H N+V + 
Sbjct: 15  QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDF--SLIQQEIFMVKECKHCNIVAYF 72

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
           G+      L I  EY  GGSL D  H    + +L Q+     +  +G+ YLH +  +HRD
Sbjct: 73  GSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL-QIAYVCRETLQGLAYLHSKGKMHRD 131

Query: 162 LKTANLLMDTHNVVKVADFGV-ARFQNKGGVMTAETGTYRWMAPEVI---NHQPYDQKAD 217
           +K AN+L+  +  VK+ADFGV A+         +  GT  WMAPEV     +  Y+Q  D
Sbjct: 132 IKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCD 191

Query: 218 VFSFAIVLWELVTAKVPYDSMTPLQA 243
           +++  I   EL   + P   + P++A
Sbjct: 192 IWAVGITAIELAELQPPMFDLHPMRA 217

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  108 bits (271), Expect = 4e-28
 Identities = 58/204 (28%), Positives = 102/204 (50%), Gaps = 18/204 (8%)

Query: 44  ERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
            +I  G+ G +Y+      G+ VA+K +R E+  +      ++E+ +L++++H N+VR  
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 102 G--ASTKSPHLCIVTEYMPGGSLYDY--LHKNHNV-LKLPQLLRFAIDICKGMEYLHQRN 156
               S     + +V EYM     +D   L  +  V     Q+  +   + +G++YLH   
Sbjct: 65  EIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120

Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVARFQNK--GGVMTAETGT--YRWMAPEVINHQP- 211
           I+HRD+K +N+L++   V+K+ADFG+AR   K      T    T  YR   PE++     
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYR--PPELLLGATR 178

Query: 212 YDQKADVFSFAIVLWELVTAKVPY 235
           Y  + D++S   +L EL   K  +
Sbjct: 179 YGPEVDMWSVGCILAELFLGKPIF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  108 bits (270), Expect = 4e-28
 Identities = 67/203 (33%), Positives = 105/203 (51%), Gaps = 30/203 (14%)

Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VAVK L+    +++   +F +E  +L  +QH+++VRF G  T+   L +V EYM  G L 
Sbjct: 38  VAVKALKE--ASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLN 95

Query: 124 DYLHKNHN---------------VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLL 168
            +L ++H                 L L Q+L  A  I  GM YL   + +HRDL T N L
Sbjct: 96  RFL-RSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCL 154

Query: 169 MDTHNVVKVADFGVAR-------FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSF 221
           +    VVK+ DFG++R       ++  G  M       RWM PE I ++ +  ++D++SF
Sbjct: 155 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP----IRWMPPESILYRKFTTESDIWSF 210

Query: 222 AIVLWELVT-AKVPYDSMTPLQA 243
            +VLWE+ T  K P+  ++  +A
Sbjct: 211 GVVLWEIFTYGKQPWYQLSNTEA 233

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  107 bits (269), Expect = 6e-28
 Identities = 51/152 (33%), Positives = 78/152 (51%), Gaps = 1/152 (0%)

Query: 85  EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSL-YDYLHKNHNVLKLPQLLRFAI 143
           E  IL +V  R +V    A      LC+V   M GG L Y   +         + + +A 
Sbjct: 43  EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA 102

Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMA 203
            I  G+E+LHQR I++RDLK  N+L+D H  V+++D G+A     G  +    GT  +MA
Sbjct: 103 QIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMA 162

Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           PEV+  + YD   D F+    L+E++  + P+
Sbjct: 163 PEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  107 bits (269), Expect = 7e-28
 Identities = 63/204 (30%), Positives = 108/204 (52%), Gaps = 9/204 (4%)

Query: 44  ERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFV-QEVAILREVQHRNVVRF 100
           E+I  G+ G +Y    V  GQ+VA+   R  +L    + E +  E+ ++RE ++ N+V +
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAI---RQMNLQQQPKKELIINEILVMRENKNPNIVNY 82

Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
           + +      L +V EY+ GGSL D +      +   Q+     +  + +E+LH   +IHR
Sbjct: 83  LDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140

Query: 161 DLKTANLLMDTHNVVKVADFG-VARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVF 219
           D+K+ N+L+     VK+ DFG  A+   +    +   GT  WMAPEV+  + Y  K D++
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200

Query: 220 SFAIVLWELVTAKVPYDSMTPLQA 243
           S  I+  E++  + PY +  PL+A
Sbjct: 201 SLGIMAIEMIEGEPPYLNENPLRA 224

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  106 bits (267), Expect = 7e-28
 Identities = 60/179 (33%), Positives = 103/179 (57%), Gaps = 8/179 (4%)

Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVL-KLPQLLRFA 142
           +EV +L +++H N+V F  +  ++  L IV EY  GG L   +++   VL    Q+L + 
Sbjct: 48  KEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF 107

Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHNVV-KVADFGVARFQNKGGVMTAET--GTY 199
           + I  G++++H R I+HRD+K+ N+ +  + +V K+ DFG+AR  N   +  A T  GT 
Sbjct: 108 VQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS-MELAYTCVGTP 166

Query: 200 RWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPI 258
            +++PE+  ++PY+ K D++S   VL+EL T K P++     Q  L   ++C     PI
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL---KICQGYFAPI 222

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  107 bits (269), Expect = 7e-28
 Identities = 71/217 (32%), Positives = 116/217 (53%), Gaps = 11/217 (5%)

Query: 37  RRLLKTGERIASGSCGD--LYRGVYLGQDVAVKV--LRSEHLNDTLEDEFVQEVAILREV 92
           R LL+   +I  GS G   + R  + G+ VAVK+  LR +   + L      EV I+R+ 
Sbjct: 20  RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELL----FNEVVIMRDY 75

Query: 93  QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYL 152
           QH+NVV    +      L ++ E++ GG+L D + +    L   Q+      + + + YL
Sbjct: 76  QHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR--LNEEQIATVCESVLQALCYL 133

Query: 153 HQRNIIHRDLKTANLLMDTHNVVKVADFG-VARFQNKGGVMTAETGTYRWMAPEVINHQP 211
           H + +IHRD+K+ ++L+     VK++DFG  A+         +  GT  WMAPEVI+  P
Sbjct: 134 HSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTP 193

Query: 212 YDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVR 248
           Y  + D++S  I++ E+V  + PY S +P+QA   +R
Sbjct: 194 YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR 230

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  107 bits (267), Expect = 8e-28
 Identities = 68/214 (31%), Positives = 113/214 (52%), Gaps = 12/214 (5%)

Query: 41  KTGERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQ---EVAILREVQHR 95
           + G+ +  G+ G +Y       G+++AVK ++ +  +     E      E+ +L+ + H 
Sbjct: 5   RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHE 64

Query: 96  NVVRFIGASTKSPH--LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
            +V++ G         L I  E+MPGGS+ D L K++  L      ++   I +G+ YLH
Sbjct: 65  RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEGVSYLH 123

Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVA-RFQN---KGGVMTAETGTYRWMAPEVINH 209
              I+HRD+K AN+L D+   VK+ DFG + R Q     G  M + TGT  WM+PEVI+ 
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183

Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQA 243
           + Y +KAD++S    + E++T K P+     + A
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA 217

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score =  107 bits (268), Expect = 9e-28
 Identities = 59/211 (27%), Positives = 111/211 (52%), Gaps = 12/211 (5%)

Query: 40  LKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDTLEDEFVQEVAILREVQ 93
           L+  + + SG  G +++G+++ +       VA+K ++      T + E    +  +  + 
Sbjct: 9   LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQ-EITDHMLAMGSLD 67

Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
           H  +VR +G       L +VT+  P GSL D++ ++ + L   +LL + + I KGM YL 
Sbjct: 68  HAYIVRLLGI-CPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE 126

Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVARF---QNKGGVMTAETGTYRWMAPEVINHQ 210
           +  ++HR+L   N+L+ + ++V++ADFGVA      +K    +      +WMA E I   
Sbjct: 127 EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186

Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTP 240
            Y  ++DV+S+ + +WE+++    PY  M P
Sbjct: 187 RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP 217

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  107 bits (268), Expect = 9e-28
 Identities = 60/203 (29%), Positives = 108/203 (53%), Gaps = 7/203 (3%)

Query: 44  ERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y    +  GQ+VA+K +  +      ++  + E+ ++RE ++ N+V ++
Sbjct: 25  EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYL 82

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
            +      L +V EY+ GGSL D +      +   Q+     +  + +++LH   +IHRD
Sbjct: 83  DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLHSNQVIHRD 140

Query: 162 LKTANLLMDTHNVVKVADFG-VARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFS 220
           +K+ N+L+     VK+ DFG  A+   +    +   GT  WMAPEV+  + Y  K D++S
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 200

Query: 221 FAIVLWELVTAKVPYDSMTPLQA 243
             I+  E+V  + PY +  PL+A
Sbjct: 201 LGIMAIEMVEGEPPYLNENPLRA 223

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score =  106 bits (266), Expect = 9e-28
 Identities = 64/225 (28%), Positives = 116/225 (51%), Gaps = 15/225 (6%)

Query: 46  IASGSCGDLYRGVYLGQ----DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           + SG+ G + +GVY  +    DVA+KVL++E+   ++ DE ++E  I+ ++ +  +VR I
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
           G   ++  L +V E   GG L  +L    + + +  ++     +  GM+YL  +N +HRD
Sbjct: 62  GV-CEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRD 120

Query: 162 LKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETG---TYRWMAPEVINHQPYDQKAD 217
           L   N+L+   +  K++DFG+++          A +      +W APE IN + +  ++D
Sbjct: 121 LAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSD 180

Query: 218 VFSFAIVLWELVT-AKVPYDSMTPLQAAL----GVRQVCTSLCQP 257
           V+S+ I +WE  +  + PY  M   +       G R  C + C P
Sbjct: 181 VWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPP 225

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  107 bits (268), Expect = 1e-27
 Identities = 51/193 (26%), Positives = 90/193 (46%), Gaps = 24/193 (12%)

Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG-ASTKSPHLCIVTEYMPGGSL 122
           V VK L+     +   + F +E+ + R++ H+NVVR +G      PH  ++ EY   G L
Sbjct: 38  VLVKALQKTKDENLQSE-FRRELDMFRKLSHKNVVRLLGLCREAEPH-YMILEYTDLGDL 95

Query: 123 YDYLHKNHNV--------LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV 174
             +L    +         L   Q +     I  GM++L     +HRDL   N L+ +   
Sbjct: 96  KQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE 155

Query: 175 VKVADFGVARFQNKGGVMTAETGTY-------RWMAPEVINHQPYDQKADVFSFAIVLWE 227
           VKV+   +++      V  +E           RW+APE +    +  K+DV+SF +++WE
Sbjct: 156 VKVSLLSLSK-----DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWE 210

Query: 228 LVT-AKVPYDSMT 239
           + T  ++P+  ++
Sbjct: 211 VFTQGELPFYGLS 223

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  106 bits (266), Expect = 1e-27
 Identities = 67/206 (32%), Positives = 110/206 (53%), Gaps = 9/206 (4%)

Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           +RI SG+ GD+Y  R V  G+  A+KV++ E   D       QE+ ++++ +H N+V + 
Sbjct: 15  QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDF--AVVQQEIIMMKDCKHSNIVAYF 72

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
           G+  +   L I  E+  GGSL D  H    + +  Q+   + +  +G+ YLH +  +HRD
Sbjct: 73  GSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSES-QIAYVSRETLQGLYYLHSKGKMHRD 131

Query: 162 LKTANLLMDTHNVVKVADFGV-ARFQNKGGVMTAETGTYRWMAPEVINHQP---YDQKAD 217
           +K AN+L+  +  VK+ADFGV A+         +  GT  WMAPEV   +    Y+Q  D
Sbjct: 132 IKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCD 191

Query: 218 VFSFAIVLWELVTAKVPYDSMTPLQA 243
           +++  I   EL   + P   + P++A
Sbjct: 192 IWAVGITAIELAELQPPMFDLHPMRA 217

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  107 bits (268), Expect = 1e-27
 Identities = 73/227 (32%), Positives = 116/227 (51%), Gaps = 19/227 (8%)

Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVA 87
           +E WEI       GE +  G+ G +Y+      G   A KV+ ++   + LED  V E+ 
Sbjct: 11  NEVWEI------IGE-LGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMV-EIE 61

Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICK 147
           IL    H  +V+ +GA      L I+ E+ PGG++   + +    L  PQ+      + +
Sbjct: 62  ILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLE 121

Query: 148 GMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GTYRWMAPE 205
            ++YLH   IIHRDLK  N+L+     +K+ADFGV+  +N   +   ++  GT  WMAPE
Sbjct: 122 ALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSA-KNVKTLQRRDSFIGTPYWMAPE 180

Query: 206 VI-----NHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGV 247
           V+        PYD KAD++S  I L E+   + P+  + P++  L +
Sbjct: 181 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI 227

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  107 bits (267), Expect = 1e-27
 Identities = 67/217 (30%), Positives = 113/217 (52%), Gaps = 11/217 (5%)

Query: 37  RRLLKTGERIASGSCGDLYRGV--YLGQDVAVKV--LRSEHLNDTLEDEFVQEVAILREV 92
           R  L +  +I  GS G +      + G+ VAVK   LR +   + L      EV I+R+ 
Sbjct: 21  REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELL----FNEVVIMRDY 76

Query: 93  QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYL 152
            H NVV    +      L +V E++ GG+L D +   H  +   Q+    + + + + YL
Sbjct: 77  HHENVVDMYNSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLRALSYL 134

Query: 153 HQRNIIHRDLKTANLLMDTHNVVKVADFG-VARFQNKGGVMTAETGTYRWMAPEVINHQP 211
           H + +IHRD+K+ ++L+ +   +K++DFG  A+   +     +  GT  WMAPEVI+  P
Sbjct: 135 HNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP 194

Query: 212 YDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVR 248
           Y  + D++S  I++ E++  + PY +  PLQA   +R
Sbjct: 195 YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR 231

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score =  105 bits (263), Expect = 4e-27
 Identities = 70/233 (30%), Positives = 111/233 (47%), Gaps = 27/233 (11%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFVQE 85
           WE+ R  +     +  GS G +Y G+  G         VA+K + +E  +     EF+ E
Sbjct: 1   WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNE 59

Query: 86  VAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH------KNHNVLKLPQL- 138
            ++++E    +VVR +G  ++     ++ E M  G L  YL       +N+ V   P L 
Sbjct: 60  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119

Query: 139 --LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR------FQNKGG 190
             ++ A +I  GM YL+    +HRDL   N ++     VK+ DFG+ R      +  KGG
Sbjct: 120 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179

Query: 191 VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQ 242
                    RWM+PE +    +   +DV+SF +VLWE+ T A+ PY  M+  Q
Sbjct: 180 KGLLPV---RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ 229

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score =  105 bits (263), Expect = 5e-27
 Identities = 62/228 (27%), Positives = 111/228 (48%), Gaps = 19/228 (8%)

Query: 35  IDRRLLKTGERIASGSCGDLYRGVYLG------QDVAVKVLRSEHLNDTLEDEFVQEVAI 88
           I R  +   + +  G+ G ++ G+ +       ++V VK ++ +H ++      +QE  +
Sbjct: 3   ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVK-DHASEIQVTLLLQESCL 61

Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTE-YMPGGSLYDYLHK-------NHNVLKLPQLLR 140
           L  + H+N++  +    +      V   YM  G+L  +L +       N   L   QL+ 
Sbjct: 62  LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH 121

Query: 141 FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR--FQNKGGVM-TAETG 197
            AI I  GM YLH+R +IH+D+   N ++D    VK+ D  ++R  F      +   E  
Sbjct: 122 MAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR 181

Query: 198 TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAA 244
             +WMA E + ++ Y   +DV+SF ++LWEL+T  + PY  + P + A
Sbjct: 182 PVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA 229

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  104 bits (261), Expect = 9e-27
 Identities = 77/244 (31%), Positives = 119/244 (48%), Gaps = 26/244 (10%)

Query: 27  QTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDT-----LEDE 81
               E WEI       GE +  G+ G +Y+     Q+    VL +  + DT     LED 
Sbjct: 1   LNPEEFWEI------IGE-LGDGAFGKVYKA----QNKETGVLAAAKVIDTKSEEELEDY 49

Query: 82  FVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF 141
            V E+ IL    H N+V+ + A     +L I+ E+  GG++   + +    L  PQ+   
Sbjct: 50  MV-EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVV 108

Query: 142 AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GTY 199
                + + YLH+  IIHRDLK  N+L      +K+ADFGV+  +N   +   ++  GT 
Sbjct: 109 CKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTP 167

Query: 200 RWMAPEVI-----NHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGV-RQVCTS 253
            WMAPEV+       +PYD KADV+S  I L E+   + P+  + P++  L + +    +
Sbjct: 168 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT 227

Query: 254 LCQP 257
           L QP
Sbjct: 228 LAQP 231

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  104 bits (261), Expect = 2e-26
 Identities = 57/192 (29%), Positives = 98/192 (51%), Gaps = 19/192 (9%)

Query: 58  VYLGQD------VAVKVLRSEHL---NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP 108
           VY  +D      VA+K ++        D +    ++E+ +L+E++H N++  +       
Sbjct: 16  VYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKS 75

Query: 109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLL 168
           ++ +V E+M    L   +     VL    +  + +   +G+EYLH   I+HRDLK  NLL
Sbjct: 76  NINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLL 134

Query: 169 MDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWM-APEVI---NHQPYDQKADVFSFAI 223
           + +  V+K+ADFG+AR F +    MT +  T RW  APE++    H  Y    D++S   
Sbjct: 135 IASDGVLKLADFGLARSFGSPNRKMTHQVVT-RWYRAPELLFGARH--YGVGVDMWSVGC 191

Query: 224 VLWELVTAKVPY 235
           +  EL+  +VP+
Sbjct: 192 IFAELLL-RVPF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score =  104 bits (260), Expect = 2e-26
 Identities = 59/194 (30%), Positives = 99/194 (51%), Gaps = 16/194 (8%)

Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VAVK+LR +  N    ++F++E+ I+  ++  N++R +     S  LC++TEYM  G L 
Sbjct: 49  VAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107

Query: 124 DYLHK----------NHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN 173
            +L +          +   +    L+  A  I  GM+YL   N +HRDL T N L+  + 
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY 167

Query: 174 VVKVADFGVARFQNKGG---VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
            +K+ADFG++R    G    +        RWM+ E I    +   +DV++F + LWE++T
Sbjct: 168 TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Query: 231 --AKVPYDSMTPLQ 242
              + PY  ++  Q
Sbjct: 228 LCKEQPYSQLSDEQ 241

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  103 bits (259), Expect = 3e-26
 Identities = 58/232 (25%), Positives = 101/232 (43%), Gaps = 40/232 (17%)

Query: 43  GERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDTLEDEFVQEVAILREV---- 92
           G+ I  GS       V L ++       A+K+L    L    E + V+ V I +EV    
Sbjct: 6   GKIIGEGSFST----VVLAKEKETNKEYAIKILDKRQLI--KEKK-VKYVKIEKEVLTRL 58

Query: 93  -QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
             H  +++         +L  V EY P G L  Y+ K  + L       +A +I   +EY
Sbjct: 59  NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS-LDEKCTRFYAAEILLALEY 117

Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET--------------- 196
           LH + IIHRDLK  N+L+D    +K+ DFG A+  +      +                 
Sbjct: 118 LHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177

Query: 197 ------GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQ 242
                 GT  +++PE++N +P  + +D+++   ++++++T K P+       
Sbjct: 178 RFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  102 bits (256), Expect = 4e-26
 Identities = 52/198 (26%), Positives = 109/198 (55%), Gaps = 7/198 (3%)

Query: 45  RIASGSCGDLYRGVYL--GQDVAVKVLRS-EHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           +I  G    +Y+ + L  G+ VA+K ++  E ++     + ++E+ +L+++ H NV++++
Sbjct: 9   KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68

Query: 102 GASTKSPHLCIVTEYMPGGSL---YDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNII 158
            +  ++  L IV E    G L     +  K   ++    + ++ + +C  +E++H + I+
Sbjct: 69  ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIM 128

Query: 159 HRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEVINHQPYDQKAD 217
           HRD+K AN+ +    VVK+ D G+ R F +K     +  GT  +M+PE I+   Y+ K+D
Sbjct: 129 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSD 188

Query: 218 VFSFAIVLWELVTAKVPY 235
           ++S   +L+E+   + P+
Sbjct: 189 IWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  102 bits (255), Expect = 4e-26
 Identities = 72/216 (33%), Positives = 110/216 (50%), Gaps = 19/216 (8%)

Query: 44  ERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRF 100
           E + +G+ G +Y+G  V  GQ  A+KV+    +    E+E  QE+ +L++   HRN+  +
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHHRNIATY 68

Query: 101 IGASTKS------PHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLH 153
            GA  K         L +V E+   GS+ D +     N LK   +     +I +G+ +LH
Sbjct: 69  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH 128

Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGV-ARFQNKGGVMTAETGTYRWMAPEVI--NHQ 210
           Q  +IHRD+K  N+L+  +  VK+ DFGV A+     G      GT  WMAPEVI  +  
Sbjct: 129 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDEN 188

Query: 211 P---YDQKADVFSFAIVLWELVTAKVPYDSMTPLQA 243
           P   YD K+D++S  I   E+     P   M P++A
Sbjct: 189 PDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA 224

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  102 bits (254), Expect = 8e-26
 Identities = 71/216 (32%), Positives = 111/216 (51%), Gaps = 19/216 (8%)

Query: 44  ERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRF 100
           E + +G+ G +Y+G  V  GQ  A+KV+    + +  E+E   E+ +L++   HRN+  +
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTEDEEEEIKLEINMLKKYSHHRNIATY 78

Query: 101 IGA-STKSP-----HLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLH 153
            GA   KSP      L +V E+   GS+ D +     N LK   +     +I +G+ +LH
Sbjct: 79  YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH 138

Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGV-ARFQNKGGVMTAETGTYRWMAPEVI--NHQ 210
              +IHRD+K  N+L+  +  VK+ DFGV A+     G      GT  WMAPEVI  +  
Sbjct: 139 AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDEN 198

Query: 211 P---YDQKADVFSFAIVLWELVTAKVPYDSMTPLQA 243
           P   YD ++D++S  I   E+     P   M P++A
Sbjct: 199 PDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA 234

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  101 bits (254), Expect = 9e-26
 Identities = 69/210 (32%), Positives = 109/210 (51%), Gaps = 20/210 (9%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E +  G+ G +Y+  +L   + +AVKV+  + +   L+ + + E+ IL +     ++ F 
Sbjct: 7   EILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ--LLRFAIDICKGMEYLHQRNIIH 159
           GA      + I TE+M GGSL  Y        K+P+  L R A+ + KG+ YL    I+H
Sbjct: 66  GAFFVENRISICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLKILH 118

Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVF 219
           RD+K +N+L++T   VK+ DFGV+  Q    +     GT  +MAPE I+ + Y   +DV+
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVST-QLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVW 177

Query: 220 SFAIVLWELVTAKVPY-------DSMTPLQ 242
           S  I   EL   + PY        S+ PLQ
Sbjct: 178 SLGISFMELALGRFPYPQIQKNQGSLMPLQ 207

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  102 bits (254), Expect = 1e-25
 Identities = 62/191 (32%), Positives = 102/191 (53%), Gaps = 9/191 (4%)

Query: 61  GQDVAVKV--LRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMP 118
           G+ VAVK   LR +   + L      EV I+R+ QH NVV    +      L +V E++ 
Sbjct: 45  GKLVAVKKMDLRKQQRRELL----FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100

Query: 119 GGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVA 178
           GG+L D +   H  +   Q+    + + K +  LH + +IHRD+K+ ++L+     VK++
Sbjct: 101 GGALTDIV--THTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLS 158

Query: 179 DFG-VARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS 237
           DFG  A+   +     +  GT  WMAPE+I+  PY  + D++S  I++ E+V  + PY +
Sbjct: 159 DFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 218

Query: 238 MTPLQAALGVR 248
             PL+A   +R
Sbjct: 219 EPPLKAMKMIR 229

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  101 bits (253), Expect = 1e-25
 Identities = 63/200 (31%), Positives = 98/200 (49%), Gaps = 29/200 (14%)

Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VAVK L+   L      +F +E  +L  +QH ++V+F G       L +V EYM  G L 
Sbjct: 38  VAVKALKDPTL--AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 95

Query: 124 DYLH---------------KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLL 168
            +L                +    L L Q+L  A  I  GM YL  ++ +HRDL T N L
Sbjct: 96  KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL 155

Query: 169 MDTHNVVKVADFGVAR-------FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSF 221
           +  + +VK+ DFG++R       ++  G  M       RWM PE I ++ +  ++DV+SF
Sbjct: 156 VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP----IRWMPPESIMYRKFTTESDVWSF 211

Query: 222 AIVLWELVT-AKVPYDSMTP 240
            ++LWE+ T  K P+  ++ 
Sbjct: 212 GVILWEIFTYGKQPWFQLSN 231

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  100 bits (252), Expect = 1e-25
 Identities = 46/154 (29%), Positives = 77/154 (50%), Gaps = 1/154 (0%)

Query: 83  VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFA 142
           + E  IL+E+ H  +V    +     ++ +V + + GG L  +L +        Q+  + 
Sbjct: 48  LNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWI 106

Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWM 202
            +I   +EYLH + IIHRD+K  N+L+D    V + DF +A       + T+ +GT  +M
Sbjct: 107 CEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYM 166

Query: 203 APEVINHQPYDQKADVFSFAIVLWELVTAKVPYD 236
           APEV+  Q Y    D +S  +  +E +  K PY 
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR 200

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  101 bits (254), Expect = 2e-25
 Identities = 54/177 (30%), Positives = 99/177 (55%), Gaps = 8/177 (4%)

Query: 65  AVKVLRSEHLNDTLEDEFVQ-EVAILREVQHRN---VVRFIGASTKSPHLCIVTEYMPGG 120
           AVKVL+ + +    + E    E  +L  +  ++           TK   L  V EY+ GG
Sbjct: 24  AVKVLKKDVILQDDDVECTMTEKRVL-ALAGKHPFLTQLHSCFQTKD-RLFFVMEYVNGG 81

Query: 121 SLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADF 180
            L  ++ ++      P+   +A +I  G+++LH+R II+RDLK  N+L+D+   +K+ADF
Sbjct: 82  DLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADF 140

Query: 181 GVARFQNKGGVMTAE-TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYD 236
           G+ +    GGV T+   GT  ++APE++++QPY    D ++  ++L+E++  + P++
Sbjct: 141 GMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score =  100 bits (251), Expect = 2e-25
 Identities = 69/244 (28%), Positives = 116/244 (47%), Gaps = 31/244 (12%)

Query: 44  ERIASGSCGDLYRG-VYL-----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNV 97
           E +   + G +Y+G +YL      Q VA+K L+ +  N     EF QE +++ E+ H N+
Sbjct: 11  EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-DINNPQQWGEFQQEASLMAELHHPNI 69

Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYL-----HKN-----------HNVLKLPQLLRF 141
           V  +G  T+   +C++ EY+  G L+++L     H +            + L     L  
Sbjct: 70  VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129

Query: 142 AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY-- 199
           AI I  GMEYL     +H+DL   N+L+     VK++D G++R          +  +   
Sbjct: 130 AIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 200 -RWMAPEVINHQPYDQKADVFSFAIVLWELVTAKV-PYDSMTPLQAALGVRQ----VCTS 253
            RWM PE I +  +   +D++SF +VLWE+ +  + PY   +  +    VR+     C+ 
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSE 249

Query: 254 LCQP 257
            C P
Sbjct: 250 DCPP 253

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  101 bits (253), Expect = 3e-25
 Identities = 67/211 (31%), Positives = 100/211 (47%), Gaps = 12/211 (5%)

Query: 46  IASGSCGDLY--RGVYLGQDVAVKVL--RSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           I  GS G +Y  R V   + VA+K +    +  N+  +D  ++EV  L++++H N + + 
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQQLRHPNTIEYK 81

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
           G   +     +V EY  G S  D L  +   L+  ++        +G+ YLH    IHRD
Sbjct: 82  GCYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRD 140

Query: 162 LKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI---NHQPYDQKADV 218
           +K  N+L+     VK+ADFG A   +         GT  WMAPEVI   +   YD K DV
Sbjct: 141 IKAGNILLTEPGTVKLADFGSASLVSPANSF---VGTPYWMAPEVILAMDEGQYDGKVDV 197

Query: 219 FSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
           +S  I   EL   K P  +M  + A   + Q
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQ 228

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score =  100 bits (249), Expect = 3e-25
 Identities = 64/219 (29%), Positives = 107/219 (48%), Gaps = 27/219 (12%)

Query: 40  LKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLEDEFVQEVAILREVQH 94
           L  G+ +  G  G +  G  L QD     VAVK ++      +  ++F+ E   ++E  H
Sbjct: 1   LALGKTLGEGEFGSVMEGQ-LNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDH 59

Query: 95  RNVVRFIGASTKS------PHLCIVTEYMPGGSLYDYL---HKNHNVLKLPQ--LLRFAI 143
            NV+R IG   ++      P   ++  +M  G L+ +L           LP   L++F  
Sbjct: 60  PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119

Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR------FQNKGGVMTAETG 197
           DI  GMEYL  ++ IHRDL   N +++ +  V VADFG+++      +  +G +      
Sbjct: 120 DIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV- 178

Query: 198 TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
             +W+A E +  + Y  K+DV+SF + +WE+ T  + PY
Sbjct: 179 --KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY 215

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 98.8 bits (246), Expect = 9e-25
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 9/214 (4%)

Query: 34  EIDRRLLKTGERIASGSCGDLYRG-VYLGQD----VAVKVLRSEHLNDTLEDEFVQEVAI 88
           E+D + +K    + +G  G+L RG + L       VA+  LR+   +D     F+ E   
Sbjct: 1   ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG-CSDKQRRGFLAEALT 59

Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
           L +  H N+VR  G  T+   + IVTEYM  G+L  +L K+   L   QL+     +  G
Sbjct: 60  LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASG 119

Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETG--TYRWMAPEV 206
           M+YL +   +H+ L    +L+++  V K++ F   +      + T  +G     W APE 
Sbjct: 120 MKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEA 179

Query: 207 INHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           I +  +   +DV+SF IV+WE+++  + PY  M+
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS 213

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 99.3 bits (247), Expect = 1e-24
 Identities = 69/234 (29%), Positives = 110/234 (47%), Gaps = 29/234 (12%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVY-------LGQDVAVK-VLRSEHLNDTLEDEFVQ 84
           WE+ R  +     +  GS G +Y G             VAVK V  S  L + +E  F+ 
Sbjct: 1   WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLN 58

Query: 85  EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH-----KNHNVLKLP--- 136
           E ++++     +VVR +G  +K     +V E M  G L  YL        +N  + P   
Sbjct: 59  EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 118

Query: 137 -QLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR------FQNKG 189
            ++++ A +I  GM YL+ +  +HRDL   N ++     VK+ DFG+ R      +  KG
Sbjct: 119 QEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 178

Query: 190 GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQ 242
           G         RWMAPE +    +   +D++SF +VLWE+ + A+ PY  ++  Q
Sbjct: 179 GKGLLPV---RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 229

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 98.7 bits (246), Expect = 1e-24
 Identities = 47/170 (27%), Positives = 93/170 (54%), Gaps = 5/170 (2%)

Query: 80  DEFVQEVAILRE-VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDY---LHKNHNVLKL 135
            + V EV I++E ++H N+VR+     ++  L IV + + G  L ++   L +       
Sbjct: 53  GDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTE 112

Query: 136 PQLLRFAIDICKGMEYLH-QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTA 194
            ++    + +   + YLH ++ I+HRDL   N+++   + V + DFG+A+ +     +T+
Sbjct: 113 ERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS 172

Query: 195 ETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAA 244
             GT  +  PE++ ++PY +KADV++F  +L+++ T + P+ S   L  A
Sbjct: 173 VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA 222

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 98.3 bits (245), Expect = 1e-24
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 16/203 (7%)

Query: 46  IASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHR-----NVV 98
           I+ G+ G +Y  +    G   A+KVL+    +D +    V  V   R +         V 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKK---SDMIAKNQVTNVKAERAIMMIQGESPYVA 60

Query: 99  RFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNII 158
           +   +     +L +V EY+ GG     L K    L      ++  ++  G+E LHQR II
Sbjct: 61  KLYYSFQSKDYLYLVMEYLNGGDC-ASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGII 119

Query: 159 HRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAE-TGTYRWMAPEVINHQPYDQKAD 217
           HRD+K  NLL+D    +K+ DFG++R     G+   +  GT  ++APE I     D+ +D
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRN----GLENKKFVGTPDYLAPETILGVGDDKMSD 175

Query: 218 VFSFAIVLWELVTAKVPYDSMTP 240
            +S   V++E +    P+ + TP
Sbjct: 176 WWSLGCVIFEFLFGYPPFHAETP 198

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 99.4 bits (248), Expect = 1e-24
 Identities = 54/183 (29%), Positives = 95/183 (51%), Gaps = 13/183 (7%)

Query: 61  GQDVAVKVLRSEHL--NDTLE----DEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT 114
           G+  A+K L+   +   D +E    ++ + E A     +H  +V          H+C V 
Sbjct: 24  GELYAIKALKKGDIIARDEVESLMCEKRIFETA--NSERHPFLVNLFACFQTEDHVCFVM 81

Query: 115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV 174
           EY  GG L  ++H +  V   P+ + +A  +  G++YLH+  I++RDLK  NLL+DT   
Sbjct: 82  EYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF 139

Query: 175 VKVADFGVARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAK 232
           VK+ADFG+ + +  G      T  GT  ++APEV+    Y +  D +   ++++E++  +
Sbjct: 140 VKIADFGLCK-EGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGE 198

Query: 233 VPY 235
            P+
Sbjct: 199 SPF 201

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 98.2 bits (244), Expect = 2e-24
 Identities = 61/224 (27%), Positives = 115/224 (51%), Gaps = 20/224 (8%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRS-EHLNDTLEDEFVQEVAILREVQHRNVVRF 100
           ++I  G   ++YR   L   + VA+K ++  E ++     + V+E+ +L+++ H NV+++
Sbjct: 8   KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKY 67

Query: 101 IGASTKSPHLCIVTEYMPGGSLYD---YLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
           + +  +   L IV E    G L     Y  K   ++    + ++ + +C  +E++H R +
Sbjct: 68  LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRV 127

Query: 158 IHRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEVINHQPYDQKA 216
           +HRD+K AN+ +    VVK+ D G+ R F +K     +  GT  +M+PE I+   Y+ K+
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKS 187

Query: 217 DVFSFAIVLWELVTAKVPY--DSMTPLQAALGVRQVCTSLCQPI 258
           D++S   +L+E+   + P+  D M              SLCQ I
Sbjct: 188 DIWSLGCLLYEMAALQSPFYGDKMNLF-----------SLCQKI 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 98.0 bits (244), Expect = 2e-24
 Identities = 71/222 (31%), Positives = 113/222 (50%), Gaps = 18/222 (8%)

Query: 52  GDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC 111
           G+ +RG+   + V VK LR+    D  +  F+QEV   RE+ H NV++ +G   +S    
Sbjct: 14  GEAHRGMSKAR-VVVKELRASATPDE-QLLFLQEVQPYRELNHPNVLQCLGQCIESIPYL 71

Query: 112 IVTEYMPGGSLYDYLHKNH-NVLKLPQ---LLRFAIDICKGMEYLHQRNIIHRDLKTANL 167
           +V E+ P G L +YL  N   V ++ Q   L R A ++  G+ +LHQ + IH DL   N 
Sbjct: 72  LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNC 131

Query: 168 LMDTHNVVKVADFGVARFQNKGG-VMTAETGTY--RWMAPEVI-----NHQPYDQ--KAD 217
            +     VK+ D+G+A  Q      +T +      RW+APE++     +  P DQ  K++
Sbjct: 132 QLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSN 191

Query: 218 VFSFAIVLWELVT-AKVPYDSMTPLQA-ALGVRQVCTSLCQP 257
           ++S  + +WEL T A  PY  ++  Q     VR+    L +P
Sbjct: 192 IWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP 233

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 97.8 bits (243), Expect = 2e-24
 Identities = 54/199 (27%), Positives = 106/199 (53%), Gaps = 7/199 (3%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDT-LEDEFVQEVAILREVQHRNVVRF 100
           ++I  G   ++YR   L  G  VA+K ++   L D     + ++E+ +L+++ H NV+++
Sbjct: 8   KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67

Query: 101 IGASTKSPHLCIVTEYMPGGSL---YDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
             +  +   L IV E    G L     +  K   ++    + ++ + +C  +E++H R +
Sbjct: 68  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRV 127

Query: 158 IHRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEVINHQPYDQKA 216
           +HRD+K AN+ +    VVK+ D G+ R F +K     +  GT  +M+PE I+   Y+ K+
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKS 187

Query: 217 DVFSFAIVLWELVTAKVPY 235
           D++S   +L+E+   + P+
Sbjct: 188 DIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 98.3 bits (245), Expect = 2e-24
 Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 27/205 (13%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y+G     GQ VA+K +R E   + +    ++E+++L+E+QH N+V   
Sbjct: 6   EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65

Query: 102 GASTKSPHLCIVTEYM-----------PGGSLYDYLHKNHNVLKLPQLLR-FAIDICKGM 149
               +   L ++ E++           P G   D            +L++ +   I +G+
Sbjct: 66  DVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMD-----------AELVKSYLYQILQGI 114

Query: 150 EYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEVI- 207
            + H R ++HRDLK  NLL+D   V+K+ADFG+AR F     V T E  T  + APEV+ 
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLL 174

Query: 208 NHQPYDQKADVFSFAIVLWELVTAK 232
               Y    D++S   +  E+ T K
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 97.0 bits (241), Expect = 4e-24
 Identities = 59/198 (29%), Positives = 110/198 (55%), Gaps = 7/198 (3%)

Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA 103
           +  GS G+  L R    G+   +K L   + +        QE  +L +++H N+V +  +
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 104 -STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLP--QLLRFAIDICKGMEYLHQRNIIHR 160
              +   L IV  +  GG LY  L +    L LP  Q++ + + I   ++YLH+++I+HR
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL-LPENQVVEWFVQIAMALQYLHEKHILHR 126

Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVF 219
           DLKT N+ +   N++KV D G+AR  +N+  + +   GT  +M+PE+ +++PY+ K+DV+
Sbjct: 127 DLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVW 186

Query: 220 SFAIVLWELVTAKVPYDS 237
           +    ++E+ T K  +++
Sbjct: 187 ALGCCVYEMATLKHAFNA 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 97.4 bits (243), Expect = 5e-24
 Identities = 52/175 (29%), Positives = 90/175 (51%), Gaps = 8/175 (4%)

Query: 61  GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGG 120
           G+ VA+K  +    ++ ++   ++EV +LR+++H N+V    A  +   L +V EY+   
Sbjct: 26  GEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER- 84

Query: 121 SLYDYLHKNHNVLKLPQLLRFAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVAD 179
           +L + L  +   L  P  +R  I  + + + Y H  NIIHRD+K  N+L+    V+K+ D
Sbjct: 85  TLLELLEASPGGLP-PDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCD 143

Query: 180 FGVARF--QNKGGVMTAETGTYRWM-APEV-INHQPYDQKADVFSFAIVLWELVT 230
           FG AR         +T    T RW  APE+ +    Y +  DV++   ++ EL+ 
Sbjct: 144 FGFARALRARPASPLTDYVAT-RWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 96.0 bits (239), Expect = 1e-23
 Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 25/219 (11%)

Query: 52  GDLYRGVY----------LGQDVAVKVLRSEHLNDTLEDEFVQEVAI-LREVQHRNVVRF 100
            +L RG Y           G  +AVK +R+  +N   +   + ++ I +R V     V F
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTIMAVKRIRAT-VNSQEQKRLLMDLDISMRSVDCPYTVTF 65

Query: 101 IGASTKSPHLCIVTEYMPGGSLYD-YLHKNHNVLKLPQ--LLRFAIDICKGMEYLHQR-N 156
            GA  +   + I  E M   SL   Y       L +P+  L + A+ I K +EYLH + +
Sbjct: 66  YGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124

Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN----HQPY 212
           +IHRD+K +N+L++ +  VK+ DFG++ +       T + G   +MAPE IN     + Y
Sbjct: 125 VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGY 184

Query: 213 DQKADVFSFAIVLWELVTAKVPYDSM-TPLQAALGVRQV 250
           D K+DV+S  I + EL T + PYDS  TP Q    ++QV
Sbjct: 185 DVKSDVWSLGITMIELATGRFPYDSWKTPFQQ---LKQV 220

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 96.8 bits (242), Expect = 2e-23
 Identities = 60/196 (30%), Positives = 102/196 (52%), Gaps = 38/196 (19%)

Query: 61  GQDVAVKVLRSEHLNDTLEDEF-----VQEVAILREVQHRNVVRFI-----GASTKSPHL 110
           G+ VA+K +     ++  +D       ++E+ +LR ++H N++  +      +      +
Sbjct: 25  GRKVAIKKI-----SNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79

Query: 111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLL------RFAIDICKGMEYLHQRNIIHRDLKT 164
            IVTE M      D LHK   V+K PQ L       F   I +G++YLH  N+IHRDLK 
Sbjct: 80  YIVTELMET----D-LHK---VIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKP 131

Query: 165 ANLLMDTHNVVKVADFGVARFQN----KGGVMTAETGT--YRWMAPEVI-NHQPYDQKAD 217
           +N+L++++  +K+ DFG+AR  +    + G +T    T  YR  APE++ +   Y +  D
Sbjct: 132 SNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR--APELLLSSSRYTKAID 189

Query: 218 VFSFAIVLWELVTAKV 233
           ++S   +  EL+T K 
Sbjct: 190 IWSVGCIFAELLTRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 95.5 bits (238), Expect = 2e-23
 Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 18/206 (8%)

Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFV-----QEVAILREVQHRN 96
           E+I  G+ G +Y  R    G+ VA+K +R E      EDE V     +E+++L+E+ H N
Sbjct: 5   EKIGEGTYGVVYKARDKLTGEIVALKKIRLET-----EDEGVPSTAIREISLLKELNHPN 59

Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLR-FAIDICKGMEYLHQR 155
           +VR +        L +V E++    L  Y+  +      P L++ +   + +G+ Y H  
Sbjct: 60  IVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118

Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEVINHQP-YD 213
            ++HRDLK  NLL+D    +K+ADFG+AR F       T E  T  + APE++     Y 
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYS 178

Query: 214 QKADVFSFAIVLWELVTAK--VPYDS 237
              D++S   +  E+V  +   P DS
Sbjct: 179 TPVDIWSIGCIFAEMVNRRPLFPGDS 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 95.0 bits (236), Expect = 2e-23
 Identities = 54/178 (30%), Positives = 98/178 (55%), Gaps = 3/178 (1%)

Query: 62  QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGS 121
           Q  A+K +R    +  +ED   +E  +L +++H N+V F  +     HL IV EY  GG 
Sbjct: 26  QKYAMKEIRLPKSSSAVEDS-RKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGD 84

Query: 122 LYDYLHKNHNVLKLPQ-LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADF 180
           L   +      L     +L++ + +C G++++H++ ++HRD+K+ N+ +  +  VK+ DF
Sbjct: 85  LMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDF 144

Query: 181 GVAR-FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS 237
           G AR   + G       GT  ++ PE+  + PY+ K+D++S   +L+EL T K P+ +
Sbjct: 145 GSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 94.9 bits (236), Expect = 4e-23
 Identities = 51/164 (31%), Positives = 92/164 (56%), Gaps = 11/164 (6%)

Query: 78  LEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
           +  + ++E+ I+ E +   +V F GA     ++C+  E+M  GSL D ++K    + +  
Sbjct: 46  VRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEI 104

Query: 138 LLRFAIDICKGMEYLH-QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT--A 194
           L + A+ + +G+ YL+    I+HRD+K +N+L+++   +K+ DFGV+     G ++   A
Sbjct: 105 LGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIA 159

Query: 195 ET--GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYD 236
           +T  GT  +M+PE I    Y  K+DV+S  I + EL   K P+ 
Sbjct: 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFA 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 94.7 bits (235), Expect = 5e-23
 Identities = 62/196 (31%), Positives = 98/196 (50%), Gaps = 26/196 (13%)

Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VAVK L+    +D    +F +E  +L  +QH ++V+F G   +   L +V EYM  G L 
Sbjct: 38  VAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLN 95

Query: 124 DYLHKNH------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT 171
            +L  +               L   Q+L  A  I  GM YL  ++ +HRDL T N L+  
Sbjct: 96  KFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE 155

Query: 172 HNVVKVADFGVAR-------FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIV 224
           + +VK+ DFG++R       ++  G  M       RWM PE I ++ +  ++DV+S  +V
Sbjct: 156 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLP----IRWMPPESIMYRKFTTESDVWSLGVV 211

Query: 225 LWELVT-AKVPYDSMT 239
           LWE+ T  K P+  ++
Sbjct: 212 LWEIFTYGKQPWYQLS 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 94.5 bits (236), Expect = 6e-23
 Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 15/201 (7%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVL--RSEHLNDTLEDEFVQEVAILREVQ-HR 95
           K  +++  G+ G +Y       G+ VA+K +  +     + +    ++EV  LR++  H 
Sbjct: 2   KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN---LREVKSLRKLNEHP 58

Query: 96  NVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI--DICKGMEYLH 153
           N+V+      ++  L  V EYM G +LY  L K+       + +  +I   I +G+ ++H
Sbjct: 59  NIVKLKEVFRENDELYFVFEYMEG-NLYQ-LMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWM-APEVINHQP- 211
           +    HRDLK  NLL+    VVK+ADFG+AR        T    T RW  APE++     
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVST-RWYRAPEILLRSTS 175

Query: 212 YDQKADVFSFAIVLWELVTAK 232
           Y    D+++   ++ EL T +
Sbjct: 176 YSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 93.9 bits (233), Expect = 8e-23
 Identities = 49/154 (31%), Positives = 82/154 (53%), Gaps = 1/154 (0%)

Query: 83  VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSL-YDYLHKNHNVLKLPQLLRF 141
           + E  IL +V  R VV    A      LC+V   M GG L +   H      +  + + +
Sbjct: 48  LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFY 107

Query: 142 AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRW 201
           A +IC G+E LHQ  I++RDLK  N+L+D H  ++++D G+A    +G  +    GT  +
Sbjct: 108 AAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGY 167

Query: 202 MAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           MAPEV+ ++ Y    D ++   +L+E++  + P+
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 94.6 bits (235), Expect = 1e-22
 Identities = 49/145 (33%), Positives = 73/145 (50%), Gaps = 1/145 (0%)

Query: 85  EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAID 144
           E  +L+ V H +V+R           C+V  +     LY YL K    L + Q L     
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ 165

Query: 145 ICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAP 204
           I +G+ YLH + IIHRD+KT N+ ++  + V + D G A+F           GT    AP
Sbjct: 166 ILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAP 225

Query: 205 EVINHQPYDQKADVFSFAIVLWELV 229
           EV+    Y+ KAD++S  IVL+E++
Sbjct: 226 EVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 93.3 bits (232), Expect = 3e-22
 Identities = 62/205 (30%), Positives = 108/205 (52%), Gaps = 11/205 (5%)

Query: 61  GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGG 120
           GQ  A+KVL+   L          E  IL EV H  +V+   A      L ++ +++ GG
Sbjct: 24  GQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGG 83

Query: 121 SLYDYLHKNHNVLKLPQLLRFAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVAD 179
            L+  L K   V+   + ++F + ++   +++LH   II+RDLK  N+L+D    +K+ D
Sbjct: 84  DLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTD 141

Query: 180 FGVARFQNKGGVMTAE-TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY--- 235
           FG+++             GT  +MAPEV+N + + Q AD +SF ++++E++T  +P+   
Sbjct: 142 FGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK 201

Query: 236 ---DSMTP-LQAALGVRQVCTSLCQ 256
              ++MT  L+A LG+ Q  +   Q
Sbjct: 202 DRKETMTMILKAKLGMPQFLSPEAQ 226

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 92.5 bits (230), Expect = 3e-22
 Identities = 60/205 (29%), Positives = 107/205 (52%), Gaps = 13/205 (6%)

Query: 44  ERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDTLEDEFVQ-EVAILREVQHRN 96
           ERI +   G   R V+L +D       A+KV+    +    +++ V  E  +L+EV H  
Sbjct: 4   ERIKTVGTGTFGR-VHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62

Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
           ++R          L ++ EY+PGG L+ YL +N         L +A +I   +EYLH + 
Sbjct: 63  IIRLFWTEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFYASEIVCALEYLHSKE 121

Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEVINHQPYDQK 215
           I++RDLK  N+L+D    +K+ DFG A+  +++   +    GT  ++APEVI  + +++ 
Sbjct: 122 IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL---CGTPEYLAPEVIQSKGHNKA 178

Query: 216 ADVFSFAIVLWELVTAKVPYDSMTP 240
            D ++  I+++E++    P+    P
Sbjct: 179 VDWWALGILIYEMLVGYPPFFDDNP 203

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 92.3 bits (229), Expect = 3e-22
 Identities = 48/158 (30%), Positives = 84/158 (53%), Gaps = 1/158 (0%)

Query: 79  EDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV-LKLPQ 137
           E   + E  IL +V  + VV    A      LC+V   M GG L  +++   N   +  +
Sbjct: 44  ESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEER 103

Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETG 197
            L +A +I  G+E LH+ N ++RDLK  N+L+D +  ++++D G+A    +G  +    G
Sbjct: 104 ALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVG 163

Query: 198 TYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           T  +MAPEV+N+Q Y    D +    +++E++  + P+
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 92.2 bits (229), Expect = 4e-22
 Identities = 51/155 (32%), Positives = 81/155 (52%), Gaps = 4/155 (2%)

Query: 85  EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH---KNHNVLKLPQLLRF 141
           E  IL +V  R +V    A      LC+V   M GG L  +++   + +     P+   +
Sbjct: 43  EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY 102

Query: 142 AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT-AETGTYR 200
              I  G+E+LHQR II+RDLK  N+L+D    V+++D G+A     G   T    GT  
Sbjct: 103 TAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPG 162

Query: 201 WMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           +MAPE++  + YD   D F+  + L+E++ A+ P+
Sbjct: 163 FMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 92.8 bits (231), Expect = 4e-22
 Identities = 65/228 (28%), Positives = 111/228 (48%), Gaps = 31/228 (13%)

Query: 28  TKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQE 85
           +K  D+EI  +L   GE    G+ G++Y+   +  G+ VA+K +   +  D      ++E
Sbjct: 5   SKLRDYEILGKL---GE----GTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALRE 57

Query: 86  VAILREVQHRNVVRFI------GASTKSPHLCI--VTEYMPGGSLYDYLHKNHNVLKLPQ 137
           + IL++++H NVV  I         +K     +  VT YM    L   L      L   Q
Sbjct: 58  IKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVKLTESQ 116

Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR--------FQNKG 189
           +  + + + +G+ YLH+ +I+HRD+K AN+L+D   ++K+ADFG+AR         +  G
Sbjct: 117 IKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176

Query: 190 GVMTAE-TG--TYRWM-APEVINH-QPYDQKADVFSFAIVLWELVTAK 232
           G  T + T     RW   PE++   + Y    D++    V  E+ T +
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 92.7 bits (230), Expect = 4e-22
 Identities = 52/178 (29%), Positives = 95/178 (53%), Gaps = 4/178 (2%)

Query: 61  GQDVAVKVLRSE--HLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMP 118
            Q  A+K L+ +   ++D +E   V++  +    +H  +           +L  V EY+ 
Sbjct: 20  NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN 79

Query: 119 GGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVA 178
           GG L  ++   H    LP+   +A +I  G+++LH + I++RDLK  N+L+DT   +K+A
Sbjct: 80  GGDLMFHIQSCHK-FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIA 138

Query: 179 DFGVARFQNKGGVMTAE-TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           DFG+ +    G   T    GT  ++APE++  Q Y+   D +SF ++L+E++  + P+
Sbjct: 139 DFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 92.8 bits (230), Expect = 5e-22
 Identities = 46/128 (35%), Positives = 80/128 (62%), Gaps = 2/128 (1%)

Query: 110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM 169
           L  V EY+ GG L  ++ +     K PQ + +A +I  G+ +LH+R II+RDLK  N+++
Sbjct: 76  LYFVMEYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML 134

Query: 170 DTHNVVKVADFGVARFQNKGGVMTAE-TGTYRWMAPEVINHQPYDQKADVFSFAIVLWEL 228
           D+   +K+ADFG+ +     GV T    GT  ++APE+I +QPY +  D +++ ++L+E+
Sbjct: 135 DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEM 194

Query: 229 VTAKVPYD 236
           +  + P+D
Sbjct: 195 LAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 92.4 bits (230), Expect = 5e-22
 Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 15/198 (7%)

Query: 45  RIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF-- 100
           RI  G+ G +YR      G+ VA+K +R ++  D +    ++E+ +L  ++H N+V    
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73

Query: 101 --IGASTKSPHLCIVTEYMPG--GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
             +G    S  L  V EY      SL D            Q+    + + +G++YLH+  
Sbjct: 74  VVVGKHLDSIFL--VMEYCEQDLASLLD---NMPTPFSESQVKCLMLQLLRGLQYLHENF 128

Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEVI-NHQPYDQ 214
           IIHRDLK +NLL+     +K+ADFG+AR +      MT +  T  + APE++     Y  
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTT 188

Query: 215 KADVFSFAIVLWELVTAK 232
             D+++   +L EL+  K
Sbjct: 189 AIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 92.1 bits (228), Expect = 6e-22
 Identities = 69/219 (31%), Positives = 103/219 (47%), Gaps = 12/219 (5%)

Query: 38  RLLKTGERIASGSCGDLY--RGVYLGQDVAVKVLR--SEHLNDTLEDEFVQEVAILREVQ 93
           +L      I  GS G +Y  R V   + VA+K +    +  N+  +D  ++EV  L+ ++
Sbjct: 25  KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD-IIKEVKFLQRIK 83

Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
           H N + + G   +     +V EY  G S  D L  +   L+  ++        +G+ YLH
Sbjct: 84  HPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 142

Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI---NHQ 210
             N+IHRD+K  N+L+     VK+ADFG A   +         GT  WMAPEVI   +  
Sbjct: 143 SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF---VGTPYWMAPEVILAMDEG 199

Query: 211 PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
            YD K DV+S  I   EL   K P  +M  + A   + Q
Sbjct: 200 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 238

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 91.6 bits (227), Expect = 7e-22
 Identities = 60/228 (26%), Positives = 106/228 (46%), Gaps = 27/228 (11%)

Query: 34  EIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFVQEV 86
           EI+   ++  E +     G +Y+G   G       Q VA+K L+ +     L +EF  E 
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKHEA 59

Query: 87  AILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL-----HKN----------HN 131
            +   +QH N+V  +G  TK   L ++  Y     L+++L     H +           +
Sbjct: 60  MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119

Query: 132 VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR---FQNK 188
            L+    +     I  GME+L   +++H+DL T N+L+     VK++D G+ R     + 
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY 179

Query: 189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKV-PY 235
             +M       RWM+PE I +  +   +D++S+ +VLWE+ +  + PY
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 92.2 bits (229), Expect = 8e-22
 Identities = 68/241 (28%), Positives = 109/241 (45%), Gaps = 37/241 (15%)

Query: 17  GHAVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGD--LYRGVYLGQDVAVKVLRS-EH 73
            +   K   S  K  D+E+       GE + +GS G   + +    G+  A+K L+  E 
Sbjct: 4   AYMFTKPDTSSWKLSDFEM-------GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI 56

Query: 74  LNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVL 133
           L         QE +IL E+ H  +V  + +      +  + E++ GG L+ +L K     
Sbjct: 57  LKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG--- 113

Query: 134 KLPQLLRFAIDICK--------GMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF 185
                 RF  D+ K          EYLH ++II+RDLK  NLL+D    VKV DFG A+ 
Sbjct: 114 ------RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK- 166

Query: 186 QNKGGVMTAET----GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPL 241
                 +   T    GT  ++APEVI  + + +  D ++  ++L+E +    P+   TP 
Sbjct: 167 -----KVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF 221

Query: 242 Q 242
           +
Sbjct: 222 R 222

Length = 329

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 91.2 bits (226), Expect = 8e-22
 Identities = 76/246 (30%), Positives = 113/246 (45%), Gaps = 28/246 (11%)

Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVA 87
           S+ WEI        E I  G+ G +++ +    G   AVK+L   H    +++E   E  
Sbjct: 17  SDTWEII-------ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYN 66

Query: 88  ILREVQ-HRNVVRFIGASTKSP-----HLCIVTEYMPGGSLYDYLH---KNHNVLKLPQL 138
           IL+ +  H NVV+F G   K        L +V E   GGS+ D +    K    ++ P +
Sbjct: 67  ILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPII 126

Query: 139 LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGV-ARFQNKGGVMTAETG 197
                +   G+++LH    IHRD+K  N+L+ T   VK+ DFGV A+  +         G
Sbjct: 127 AYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVG 186

Query: 198 TYRWMAPEVINHQ-----PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGV-RQVC 251
           T  WMAPEVI  +      YD + DV+S  I   EL     P   + P++A   + R   
Sbjct: 187 TPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP 246

Query: 252 TSLCQP 257
            +L QP
Sbjct: 247 PTLHQP 252

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 91.4 bits (227), Expect = 9e-22
 Identities = 62/202 (30%), Positives = 107/202 (52%), Gaps = 9/202 (4%)

Query: 44  ERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y+       + +A+K +R E  ++ +    ++E+++L+E+QH N+VR  
Sbjct: 8   EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLR-FAIDICKGMEYLHQRNIIHR 160
                   L +V EY+    L  ++  + +  K P+L++ +   I +G+ Y H   ++HR
Sbjct: 68  DVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHR 126

Query: 161 DLKTANLLMD-THNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKAD 217
           DLK  NLL+D   N +K+ADFG+AR F       T E  T  + APE+ +  + Y    D
Sbjct: 127 DLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVD 186

Query: 218 VFSFAIVLWELVTAK--VPYDS 237
           ++S   +  E+V  K   P DS
Sbjct: 187 IWSVGCIFAEMVNQKPLFPGDS 208

Length = 294

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 91.6 bits (227), Expect = 1e-21
 Identities = 69/211 (32%), Positives = 103/211 (48%), Gaps = 12/211 (5%)

Query: 46  IASGSCGDLY--RGVYLGQDVAVKVLR--SEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           I  GS G +Y     +  + VAVK +    +  N+  +D  ++EV  L++++H N + + 
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQD-IIKEVKFLQQLKHPNTIEYK 87

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
           G   K     +V EY  G S  D L  +   L+  ++        +G+ YLH  N+IHRD
Sbjct: 88  GCYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 146

Query: 162 LKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI---NHQPYDQKADV 218
           +K  N+L+     VK+ADFG A   +K     +  GT  WMAPEVI   +   YD K DV
Sbjct: 147 IKAGNILLTEPGQVKLADFGSA---SKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDV 203

Query: 219 FSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
           +S  I   EL   K P  +M  + A   + Q
Sbjct: 204 WSLGITCIELAERKPPLFNMNAMSALYHIAQ 234

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 91.3 bits (226), Expect = 1e-21
 Identities = 68/219 (31%), Positives = 104/219 (47%), Gaps = 12/219 (5%)

Query: 38  RLLKTGERIASGSCGDLY--RGVYLGQDVAVKVLR--SEHLNDTLEDEFVQEVAILREVQ 93
           +L      I  GS G +Y  R V   + VA+K +    +  N+  +D  ++EV  L++++
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKLR 73

Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
           H N +++ G   +     +V EY  G S  D L  +   L+  ++        +G+ YLH
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132

Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI---NHQ 210
             N+IHRD+K  N+L+    +VK+ DFG A             GT  WMAPEVI   +  
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEG 189

Query: 211 PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
            YD K DV+S  I   EL   K P  +M  + A   + Q
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 91.4 bits (227), Expect = 1e-21
 Identities = 57/179 (31%), Positives = 100/179 (55%), Gaps = 14/179 (7%)

Query: 65  AVKVLRSEHLNDTLEDEFVQEVAILREV-----QHRNVVR-FIGASTKSPHLCIVTEYMP 118
           A+K L+ + +   LED+ V+   + R V     +H  +   F    TK  HL  V EY+ 
Sbjct: 24  AIKALKKDVV---LEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE-HLFFVMEYLN 79

Query: 119 GGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVA 178
           GG L  ++  +       +   +A +I  G+++LH++ II+RDLK  N+L+D    +K+A
Sbjct: 80  GGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIA 138

Query: 179 DFGVARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           DFG+ + +N  G   A T  GT  ++APE++  Q Y++  D +SF ++L+E++  + P+
Sbjct: 139 DFGMCK-ENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 90.6 bits (225), Expect = 2e-21
 Identities = 45/128 (35%), Positives = 77/128 (60%), Gaps = 2/128 (1%)

Query: 110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM 169
           L  V EY+ GG L  ++ +     K P  + +A +I  G+ +LH + II+RDLK  N+++
Sbjct: 76  LYFVMEYVNGGDLMYHIQQVGK-FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134

Query: 170 DTHNVVKVADFGVARFQNKGGVMTAE-TGTYRWMAPEVINHQPYDQKADVFSFAIVLWEL 228
           D    +K+ADFG+ +    GG  T    GT  ++APE+I +QPY +  D ++F ++L+E+
Sbjct: 135 DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 194

Query: 229 VTAKVPYD 236
           +  + P+D
Sbjct: 195 LAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 90.5 bits (224), Expect = 3e-21
 Identities = 57/197 (28%), Positives = 104/197 (52%), Gaps = 6/197 (3%)

Query: 46  IASGSCGDLYRGVYLGQDV--AVKVLRSEHLNDTLEDEFV--QEVAILREVQHRNVVRFI 101
           I  GS G +    +  ++   AVKVL+ + +    E++ +  +   +L+ V+H  +V   
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
            +   +  L  V +Y+ GG L+ +L +    L+ P+   +A +I   + YLH  NI++RD
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRERCFLE-PRARFYAAEIASALGYLHSLNIVYRD 121

Query: 162 LKTANLLMDTHNVVKVADFGVARFQ-NKGGVMTAETGTYRWMAPEVINHQPYDQKADVFS 220
           LK  N+L+D+   + + DFG+ +      G  +   GT  ++APEV++ QPYD+  D + 
Sbjct: 122 LKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWC 181

Query: 221 FAIVLWELVTAKVPYDS 237
              VL+E++    P+ S
Sbjct: 182 LGAVLYEMLYGLPPFYS 198

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 89.8 bits (223), Expect = 3e-21
 Identities = 51/219 (23%), Positives = 101/219 (46%), Gaps = 16/219 (7%)

Query: 29  KSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLN-DTLEDEFVQEVA 87
           +S+D +    +L     I       +Y+G++  ++V ++  +  H     L D    E+ 
Sbjct: 16  ESDDIDKYTSVL-----IKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIK 70

Query: 88  ILREVQHRNVVR----FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
            LR +   N+++     I      P L ++ EY   G L + L K  + L     L  AI
Sbjct: 71  NLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD-LSFKTKLDMAI 129

Query: 144 DICKGMEYLHQR-NIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWM 202
           D CKG+  L++  N  +++L + + L+  +  +K+   G+ +  +           Y   
Sbjct: 130 DCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYF-- 187

Query: 203 APEVINH--QPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           + +++N     Y  K D++S  +VLWE+ T K+P++++T
Sbjct: 188 SYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226

Length = 283

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 90.1 bits (223), Expect = 4e-21
 Identities = 54/186 (29%), Positives = 95/186 (51%), Gaps = 7/186 (3%)

Query: 54  LYRGVYLGQDVAVKVLRSEHLNDTLEDEF---VQEVAILREVQHRNVVRFIGASTKSPHL 110
           L R    G+  A+K+LR E +    +DE    V E  +L+  +H  +     A      L
Sbjct: 13  LVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 70

Query: 111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD 170
           C V EY  GG L+ +L +   V    +   +  +I   +EYLH R++++RD+K  NL++D
Sbjct: 71  CFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 129

Query: 171 THNVVKVADFGVARFQ-NKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELV 229
               +K+ DFG+ +   + G  M    GT  ++APEV+    Y +  D +   +V++E++
Sbjct: 130 KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189

Query: 230 TAKVPY 235
             ++P+
Sbjct: 190 CGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 90.1 bits (223), Expect = 5e-21
 Identities = 45/128 (35%), Positives = 77/128 (60%), Gaps = 2/128 (1%)

Query: 110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM 169
           L  V EY+ GG L  Y  +     K P  + +A +I  G+ +LH + II+RDLK  N+++
Sbjct: 76  LYFVMEYVNGGDLM-YQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134

Query: 170 DTHNVVKVADFGVARFQNKGGVMTAE-TGTYRWMAPEVINHQPYDQKADVFSFAIVLWEL 228
           D+   +K+ADFG+ +     GV T    GT  ++APE+I +QPY +  D ++F ++L+E+
Sbjct: 135 DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 194

Query: 229 VTAKVPYD 236
           +  + P++
Sbjct: 195 LAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 89.3 bits (221), Expect = 5e-21
 Identities = 72/231 (31%), Positives = 106/231 (45%), Gaps = 27/231 (11%)

Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVA 87
           ++ WEI        E I  G+ G +Y+      G   AVK+L  + ++D +++E   E  
Sbjct: 21  TDTWEII-------ETIGKGTYGKVYKVTNKKDGSLAAVKIL--DPISD-VDEEIEAEYN 70

Query: 88  ILREV-QHRNVVRFIGASTKSPH-----LCIVTEYMPGGSLYDY---LHKNHNVLKLPQL 138
           IL+ +  H NVV+F G   K+       L +V E   GGS+ +    L      L    +
Sbjct: 71  ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMI 130

Query: 139 LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGV-ARFQNKGGVMTAETG 197
                    G+++LH   IIHRD+K  N+L+ T   VK+ DFGV A+  +         G
Sbjct: 131 SYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVG 190

Query: 198 TYRWMAPEVINHQ-----PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQA 243
           T  WMAPEVI  +      YD + DV+S  I   EL     P   M P++ 
Sbjct: 191 TPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT 241

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 88.7 bits (220), Expect = 7e-21
 Identities = 46/152 (30%), Positives = 80/152 (52%), Gaps = 1/152 (0%)

Query: 85  EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAI 143
           E  IL +V  R VV    A      LC+V   M GG L  +++   N      + + +A 
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109

Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMA 203
           +I  G+E LH+  I++RDLK  N+L+D +  ++++D G+A    +G  +    GT  +MA
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMA 169

Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           PEV+ ++ Y    D +    +++E++  K P+
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 88.5 bits (219), Expect = 8e-21
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 1/152 (0%)

Query: 85  EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSL-YDYLHKNHNVLKLPQLLRFAI 143
           E  IL +V    +V    A     HLC+V   M GG L Y   +     L++ +++ ++ 
Sbjct: 43  EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102

Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMA 203
            I  G+ +LH  +I++RD+K  N+L+D     +++D G+A     G  +T   GT  +MA
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMA 162

Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           PE++  +PY    D F+    ++E+V  + P+
Sbjct: 163 PEILKEEPYSYPVDWFAMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 88.2 bits (219), Expect = 1e-20
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 15/214 (7%)

Query: 40  LKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLED-EFVQEV-AILREVQHR 95
           LK    I  G+ G + + ++   G  +AVK +RS    D  E    + ++  ++R     
Sbjct: 6   LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRST--VDEKEQKRLLMDLDVVMRSSDCP 63

Query: 96  NVVRFIGASTKSPHLCIVTEYMPGG--SLYDYLHKNHNVLKLPQ--LLRFAIDICKGMEY 151
            +V+F GA  +     I  E M       Y Y+++      +P+  L + A+   K + Y
Sbjct: 64  YIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKS-VIPEEILGKIAVATVKALNY 122

Query: 152 LHQR-NIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN-- 208
           L +   IIHRD+K +N+L+D +  +K+ DFG++         T + G   +MAPE I+  
Sbjct: 123 LKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS 182

Query: 209 -HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPL 241
               YD ++DV+S  I L+E+ T K PY     +
Sbjct: 183 ARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV 216

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 88.9 bits (220), Expect = 1e-20
 Identities = 56/180 (31%), Positives = 95/180 (52%), Gaps = 12/180 (6%)

Query: 65  AVKVLRSEHLNDTLEDEFV--QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSL 122
           AVKVL+ + +    E   +  +   +L+ ++H  +V    +   +  L  V +Y+ GG L
Sbjct: 24  AVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGEL 83

Query: 123 YDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGV 182
           + +L +    L+ P+   +A ++   + YLH  NII+RDLK  N+L+D+   V + DFG+
Sbjct: 84  FFHLQRERCFLE-PRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGL 142

Query: 183 ARFQNKGGVMTAET-----GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS 237
                K GV   ET     GT  ++APEV+  +PYD+  D +    VL+E++    P+ S
Sbjct: 143 C----KEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS 198

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 88.0 bits (218), Expect = 3e-20
 Identities = 41/107 (38%), Positives = 65/107 (60%), Gaps = 4/107 (3%)

Query: 133 LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR--FQNKGG 190
           L L  L+ ++  + +GME+L  R  IHRDL   N+L+  +NVVK+ DFG+AR  +++   
Sbjct: 170 LTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 229

Query: 191 VMTAETG-TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
           V   +     +WMAPE I  + Y  ++DV+SF ++LWE+ +    PY
Sbjct: 230 VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 87.0 bits (215), Expect = 3e-20
 Identities = 61/198 (30%), Positives = 100/198 (50%), Gaps = 11/198 (5%)

Query: 46  IASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA 103
           I  G  G++Y  R    G+  A+K L  + +     +       I+  +       FI  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 104 STKSPH----LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            T + H    LC + + M GG L+ +L + H V    ++  +A +I  G+E++H R +++
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVY 120

Query: 160 RDLKTANLLMDTHNVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINH-QPYDQKAD 217
           RDLK AN+L+D H  V+++D G+A  F  K     A  GT+ +MAPEV+     YD  AD
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPEVLQKGTAYDSSAD 178

Query: 218 VFSFAIVLWELVTAKVPY 235
            FS   +L++L+    P+
Sbjct: 179 WFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 86.5 bits (214), Expect = 4e-20
 Identities = 46/128 (35%), Positives = 75/128 (58%), Gaps = 5/128 (3%)

Query: 110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM 169
           L  + + M GG L+ +L + H V    ++  +A +I  G+E++H R +++RDLK AN+L+
Sbjct: 72  LSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 130

Query: 170 DTHNVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWE 227
           D H  V+++D G+A  F  K     A  GT+ +MAPEV+     YD  AD FS   +L++
Sbjct: 131 DEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFK 188

Query: 228 LVTAKVPY 235
           L+    P+
Sbjct: 189 LLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 86.2 bits (213), Expect = 1e-19
 Identities = 43/109 (39%), Positives = 66/109 (60%), Gaps = 4/109 (3%)

Query: 131 NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR--FQNK 188
            VL L  L+ ++  + KGME+L  R  IHRDL   N+L+  +NVVK+ DFG+AR  +++ 
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP 233

Query: 189 GGVMTAETG-TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
             V   +     +WMAPE I  + Y  ++DV+SF ++LWE+ +    PY
Sbjct: 234 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 85.6 bits (212), Expect = 2e-19
 Identities = 64/228 (28%), Positives = 111/228 (48%), Gaps = 19/228 (8%)

Query: 46  IASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFV--QEVAILREVQHRNVVRFI 101
           I  GS G +   +    G+  AVKVL+ + +    E + +  +   +L+ V+H  +V   
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
            +   +  L  V +Y+ GG L+ +L +  +  + P+   +A +I   + YLH  NII+RD
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPE-PRARFYAAEIASALGYLHSLNIIYRD 121

Query: 162 LKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADVF 219
           LK  N+L+D+   V + DFG+ + +      T  T  GT  ++APEV+  QPYD+  D +
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWW 180

Query: 220 SFAIVLWELVTAKVP---------YDSM--TPLQAALGVRQVCTSLCQ 256
               VL+E++    P         YD++   PL+    +      L +
Sbjct: 181 CLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLE 228

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 84.9 bits (210), Expect = 2e-19
 Identities = 57/201 (28%), Positives = 105/201 (52%), Gaps = 8/201 (3%)

Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 6   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++     + + LP +  +   + +G+ + H   ++HR
Sbjct: 66  DVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 124

Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F       T E  T  + APE+ +  + Y    D+
Sbjct: 125 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 184

Query: 219 FSFAIVLWELVTAKV--PYDS 237
           +S   +  E+VT +   P DS
Sbjct: 185 WSLGCIFAEMVTRRALFPGDS 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 84.8 bits (210), Expect = 2e-19
 Identities = 53/181 (29%), Positives = 96/181 (53%), Gaps = 5/181 (2%)

Query: 61  GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGG 120
           GQ VA+K       +  ++   ++E+ +L++++H N+V  I    +   L +V E++   
Sbjct: 26  GQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV-DH 84

Query: 121 SLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADF 180
           ++ D L K  N L   ++ ++   I +G+E+ H  NIIHRD+K  N+L+    VVK+ DF
Sbjct: 85  TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDF 144

Query: 181 GVARFQNKGGVMTAETGTYRWM-APE-VINHQPYDQKADVFSFAIVLWELVTAK--VPYD 236
           G AR     G +  +    RW  APE ++    Y +  D+++   ++ E++T +   P D
Sbjct: 145 GFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204

Query: 237 S 237
           S
Sbjct: 205 S 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 84.4 bits (209), Expect = 2e-19
 Identities = 54/195 (27%), Positives = 98/195 (50%), Gaps = 5/195 (2%)

Query: 44  ERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +++       + VA+K +R +  ++ +    ++E+ +L+E++H+N+VR  
Sbjct: 6   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
                   L +V EY     L  Y    +  +    +  F   + KG+ + H  N++HRD
Sbjct: 66  DVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRD 124

Query: 162 LKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEVI-NHQPYDQKADVF 219
           LK  NLL++ +  +K+ADFG+AR F       +AE  T  +  P+V+   + Y    D++
Sbjct: 125 LKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMW 184

Query: 220 SFAIVLWELVTAKVP 234
           S   +  EL  A  P
Sbjct: 185 SAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 85.1 bits (210), Expect = 2e-19
 Identities = 55/182 (30%), Positives = 98/182 (53%), Gaps = 12/182 (6%)

Query: 61  GQDVAVKVLRSEHLNDTLEDEFV--QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMP 118
           G+  AVKVL+ + + +  E + +  +   +L+ V+H  +V    +   +  L  V +++ 
Sbjct: 20  GKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN 79

Query: 119 GGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVA 178
           GG L+ +L +  +  + P+   +A +I   + YLH  NI++RDLK  N+L+D+   V + 
Sbjct: 80  GGELFFHLQRERSFPE-PRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLT 138

Query: 179 DFGVARFQNKGGVMTAET-----GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKV 233
           DFG+     K G+  ++T     GT  ++APEVI  QPYD   D +    VL+E++    
Sbjct: 139 DFGLC----KEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLP 194

Query: 234 PY 235
           P+
Sbjct: 195 PF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 84.5 bits (209), Expect = 4e-19
 Identities = 48/179 (26%), Positives = 91/179 (50%), Gaps = 7/179 (3%)

Query: 61  GQDVAVKVLRSEHLNDTLEDEF---VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYM 117
           G+  A+K+L+ E +    +DE    + E  +L+  +H  +     +      LC V EY 
Sbjct: 20  GKYYAMKILKKEVI--IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYA 77

Query: 118 PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKV 177
            GG L+ +L +   V    +   +  +I   + YLH  ++++RDLK  NL++D    +K+
Sbjct: 78  NGGELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKI 136

Query: 178 ADFGVARFQ-NKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
            DFG+ +   + G  M    GT  ++APEV+    Y +  D +   +V++E++  ++P+
Sbjct: 137 TDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 83.8 bits (208), Expect = 5e-19
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 21/201 (10%)

Query: 45  RIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDE-F----VQEVAILREVQHRNV 97
           RI  G+ G +YR      G+ VA+K L+ E      E E F    ++E+ IL ++QH N+
Sbjct: 12  RIEEGTYGVVYRARDKKTGEIVALKKLKMEK-----EKEGFPITSLREINILLKLQHPNI 66

Query: 98  V--RFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR 155
           V  + +   +    + +V EY+    L   +          ++    + +  G+ +LH  
Sbjct: 67  VTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN 125

Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGT--YRWMAPEVINHQP- 211
            I+HRDLKT+NLL++   ++K+ DFG+AR + +     T    T  YR  APE++     
Sbjct: 126 WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYR--APELLLGAKE 183

Query: 212 YDQKADVFSFAIVLWELVTAK 232
           Y    D++S   +  EL+T K
Sbjct: 184 YSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 85.1 bits (210), Expect = 6e-19
 Identities = 43/122 (35%), Positives = 65/122 (53%), Gaps = 4/122 (3%)

Query: 118 PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKV 177
           P  +  D L      L    L+ F+  +  GME+L  +N +HRDL   N+L+    +VK+
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKI 280

Query: 178 ADFGVARFQNKGGVMTAETGTY---RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKV 233
            DFG+AR   +     ++  T+   +WMAPE I +  Y   +DV+SF I+LWE+ T    
Sbjct: 281 CDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGT 340

Query: 234 PY 235
           PY
Sbjct: 341 PY 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 84.0 bits (207), Expect = 6e-19
 Identities = 51/183 (27%), Positives = 92/183 (50%), Gaps = 15/183 (8%)

Query: 61  GQDVAVKVLRSEHLNDTLEDEFVQ---EVAILREVQHRNVVRFIGASTKSPHLCIVTEYM 117
           G+  A+K+L+ E +    +DE      E  +L+  +H  +     +      LC V EY+
Sbjct: 20  GKYYAMKILKKEVI--IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYV 77

Query: 118 PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKV 177
            GG L+ +L +   V    +   +  +I   ++YLH   I++RDLK  NL++D    +K+
Sbjct: 78  NGGELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKI 136

Query: 178 ADFGVARFQNKGGVMTAET-----GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAK 232
            DFG+     K G+  A T     GT  ++APEV+    Y +  D +   +V++E++  +
Sbjct: 137 TDFGLC----KEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Query: 233 VPY 235
           +P+
Sbjct: 193 LPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 83.1 bits (205), Expect = 9e-19
 Identities = 46/154 (29%), Positives = 81/154 (52%), Gaps = 1/154 (0%)

Query: 83  VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRF 141
           + E  IL +V  R VV    A      LC+V   M GG L  +++   N      + + +
Sbjct: 48  LNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFY 107

Query: 142 AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRW 201
           A ++C G+E L +  I++RDLK  N+L+D    ++++D G+A    +G  +    GT  +
Sbjct: 108 AAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGY 167

Query: 202 MAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           MAPEVIN++ Y    D +    +++E++  + P+
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 83.2 bits (206), Expect = 1e-18
 Identities = 58/195 (29%), Positives = 92/195 (47%), Gaps = 14/195 (7%)

Query: 55  YRGVYLGQD------VAVKVLRSEHLNDTLEDEFV-QEVAILREVQHRNVVRFIGASTKS 107
           Y  V+L +       VA+K ++   L    E   V  E  IL   +   +V+ + A    
Sbjct: 14  YGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD 73

Query: 108 PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANL 167
            +L +  EY+PGG     L  N  VL       +  ++ + ++ LH+   IHRDLK  N 
Sbjct: 74  EYLYLAMEYVPGGDFRTLL-NNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENF 132

Query: 168 LMDTHNVVKVADFGVARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADVFSFAIVL 225
           L+D    +K+ DFG++    KG V  A +  G+  +MAPEV+  + YD   D +S   +L
Sbjct: 133 LIDASGHIKLTDFGLS----KGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCML 188

Query: 226 WELVTAKVPYDSMTP 240
           +E +    P+   TP
Sbjct: 189 YEFLCGFPPFSGSTP 203

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 82.5 bits (204), Expect = 2e-18
 Identities = 63/236 (26%), Positives = 109/236 (46%), Gaps = 30/236 (12%)

Query: 46  IASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA 103
           I  G+ G +Y+      G+ VA+K +R ++  +      ++E+ ILR++ HRN+V     
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74

Query: 104 ST----------KSPHLCIVTEYMPGGSLYDYL-------HKNHNVLKLPQLLRFAIDIC 146
            T                +V EYM    L   L        ++H    + QLL       
Sbjct: 75  VTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGLVHFSEDHIKSFMKQLL------- 126

Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG--VMTAETGTYRWMAP 204
           +G+ Y H++N +HRD+K +N+L++    +K+ADFG+AR  N       T +  T  +  P
Sbjct: 127 EGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPP 186

Query: 205 E-VINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY 259
           E ++  + Y    DV+S   +L EL T K  + +   L     + ++C S C  ++
Sbjct: 187 ELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 82.8 bits (204), Expect = 2e-18
 Identities = 50/180 (27%), Positives = 93/180 (51%), Gaps = 8/180 (4%)

Query: 61  GQDVAVKVLRSEHLNDTLEDEFVQ---EVAILREVQHRNVVRFIGASTKSPHLCIVTEYM 117
           G+  A+K+L+ E +    +DE      E  +L+  +H  +     +      LC V EY 
Sbjct: 20  GRYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 77

Query: 118 PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH-QRNIIHRDLKTANLLMDTHNVVK 176
            GG L+ +L +   V    +   +  +I   ++YLH ++N+++RDLK  NL++D    +K
Sbjct: 78  NGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIK 136

Query: 177 VADFGVARFQNK-GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           + DFG+ +   K G  M    GT  ++APEV+    Y +  D +   +V++E++  ++P+
Sbjct: 137 ITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 82.7 bits (204), Expect = 2e-18
 Identities = 41/111 (36%), Positives = 63/111 (56%), Gaps = 12/111 (10%)

Query: 133 LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-------F 185
           L +  L+ ++  + +GME+L  R  IHRDL   N+L+  +NVVK+ DFG+AR       +
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 230

Query: 186 QNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
             KG          +WMAPE I  + Y  ++DV+SF ++LWE+ +    PY
Sbjct: 231 VRKGSARLP----LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 83.0 bits (205), Expect = 2e-18
 Identities = 43/112 (38%), Positives = 63/112 (56%), Gaps = 8/112 (7%)

Query: 133 LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGV 191
           L L  LLRF+  + +GM++L  +N IHRD+   N+L+    V K+ DFG+AR   N    
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268

Query: 192 MTAETGTYR----WMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSM 238
           +    G  R    WMAPE I    Y  ++DV+S+ I+LWE+ +  K PY  +
Sbjct: 269 VV--KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI 318

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 82.0 bits (203), Expect = 3e-18
 Identities = 65/222 (29%), Positives = 100/222 (45%), Gaps = 24/222 (10%)

Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLR----SEHLNDTLEDEFV 83
            + +  D   L+    I SG+CG +Y+  +   G  +AVK +R     E     L D  V
Sbjct: 7   GQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDV 66

Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK--NHNVLKLPQ--LL 139
               +L+      +V+  G       + I  E M   +  D L K     +   P+  L 
Sbjct: 67  ----VLKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPI---PEDILG 117

Query: 140 RFAIDICKGMEYLHQR-NIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT 198
           +  + I K + YL ++  +IHRD+K +N+L+D    VK+ DFG++         T   G 
Sbjct: 118 KMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGC 177

Query: 199 YRWMAPEVINHQP----YDQKADVFSFAIVLWELVTAKVPYD 236
             +MAPE I+       YD +ADV+S  I L EL T + PY 
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK 219

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 82.4 bits (203), Expect = 3e-18
 Identities = 54/183 (29%), Positives = 100/183 (54%), Gaps = 8/183 (4%)

Query: 62  QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRN--VVRFIGASTKSPHLCIVTEYMPG 119
           Q  A+KV++ E ++D  + ++VQ    + E    N  +V        +  L +V EY+ G
Sbjct: 21  QIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80

Query: 120 GSLYDYLHKNHNVLKLPQ-LLRF-AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKV 177
           G L  ++ +     KLP+   RF A +IC  + +LH+R II+RDLK  N+L+D    +K+
Sbjct: 81  GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKL 137

Query: 178 ADFGVARFQNKGGVMTAE-TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYD 236
            D+G+ +     G  T+   GT  ++APE++  + Y    D ++  ++++E++  + P+D
Sbjct: 138 TDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Query: 237 SMT 239
            +T
Sbjct: 198 IIT 200

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 81.8 bits (202), Expect = 4e-18
 Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 34/214 (15%)

Query: 55  YRGVYL------GQDVAVKVLRSEH--LNDTLEDEFVQEVAILREVQHRNVVRFIGASTK 106
           Y  VYL       Q  A+K +  ++  L + ++  FV E  IL   ++  VV    +   
Sbjct: 14  YGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAENPFVVSMFCSFET 72

Query: 107 SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTAN 166
             HLC+V EY+ GG     L KN   L +     +  +    +EYLH   I+HRDLK  N
Sbjct: 73  KRHLCMVMEYVEGGDCATLL-KNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDN 131

Query: 167 LLMDTHNVVKVADFGVARFQNKGGVMTAET--------------------GTYRWMAPEV 206
           LL+ +   +K+ DFG++    K G+M+  T                    GT  ++APEV
Sbjct: 132 LLITSMGHIKLTDFGLS----KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEV 187

Query: 207 INHQPYDQKADVFSFAIVLWELVTAKVPYDSMTP 240
           I  Q Y +  D ++  I+L+E +   VP+   TP
Sbjct: 188 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 221

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 82.0 bits (203), Expect = 4e-18
 Identities = 64/221 (28%), Positives = 107/221 (48%), Gaps = 37/221 (16%)

Query: 33  WEIDRRLLKTGERIASGSCGDL--YRGVYLGQDVAVKVLR-----SEHLNDTLEDEFVQE 85
           WE+  R       + SG+ G +        G+ VA+K L      + H   T      +E
Sbjct: 11  WEVPDRYQNL-SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY-----RE 64

Query: 86  VAILREVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL- 138
           + +L+ + H NV+  +   T +  L       +VT  M G  L       +N++K  +L 
Sbjct: 65  LRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-------NNIVKCQKLS 116

Query: 139 ---LRFAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTA 194
              ++F +  I +G++Y+H   IIHRDLK +N+ ++    +K+ DFG+AR  +    MT 
Sbjct: 117 DDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--MTG 174

Query: 195 ETGTYRW-MAPEVI-NHQPYDQKADVFSFAIVLWELVTAKV 233
              T RW  APE++ N   Y+Q  D++S   ++ EL+T K 
Sbjct: 175 YVAT-RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 81.6 bits (201), Expect = 5e-18
 Identities = 52/177 (29%), Positives = 97/177 (54%), Gaps = 8/177 (4%)

Query: 65  AVKVLRSEHLNDTLEDEFVQ-EVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSL 122
           A+KV++ E +ND  + ++VQ E  +  +   H  +V           L  V EY+ GG L
Sbjct: 24  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 83

Query: 123 YDYLHKNHNVLKLPQ-LLRF-AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADF 180
             ++ +     KLP+   RF + +I   + YLH+R II+RDLK  N+L+D+   +K+ D+
Sbjct: 84  MFHMQRQR---KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDY 140

Query: 181 GVARFQNKGGVMTAE-TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYD 236
           G+ +   + G  T+   GT  ++APE++  + Y    D ++  ++++E++  + P+D
Sbjct: 141 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 81.6 bits (201), Expect = 6e-18
 Identities = 47/160 (29%), Positives = 89/160 (55%), Gaps = 7/160 (4%)

Query: 78  LEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
           + ++ ++E+ +L E     +V F GA      + I  E+M GGSL   L K     ++P+
Sbjct: 46  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPE 102

Query: 138 --LLRFAIDICKGMEYLHQRN-IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTA 194
             L + +I + KG+ YL +++ I+HRD+K +N+L+++   +K+ DFGV+  Q    +  +
Sbjct: 103 QILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANS 161

Query: 195 ETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVP 234
             GT  +M+PE +    Y  ++D++S  + L E+   + P
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 81.2 bits (200), Expect = 8e-18
 Identities = 63/227 (27%), Positives = 108/227 (47%), Gaps = 26/227 (11%)

Query: 25  ESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD---VAVKVL-RSEHLNDTLED 80
           +++ K ED+   R L        +GS G +    Y  +D   VA+K   +S+ +     D
Sbjct: 24  KNKMKYEDFNFIRTL-------GTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVD 76

Query: 81  EFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLR 140
               E  IL  + H   V   G+     +L +V E++ GG  + +L +N    + P  + 
Sbjct: 77  HVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK---RFPNDVG 133

Query: 141 --FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET-- 196
             +A  I    EYL   NI++RDLK  NLL+D    +K+ DFG A+      V+   T  
Sbjct: 134 CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK------VVDTRTYT 187

Query: 197 --GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPL 241
             GT  ++APE++ +  + + AD ++  I ++E++    P+ +  PL
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL 234

Length = 340

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 81.6 bits (201), Expect = 9e-18
 Identities = 40/110 (36%), Positives = 60/110 (54%), Gaps = 4/110 (3%)

Query: 133 LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM 192
           L    LL F   + +GME+L  +N +HRDL   N+L+    +VK+ DFG+AR        
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNY 293

Query: 193 TAETGTY---RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSM 238
            ++  T+   +WMAPE I    Y   +DV+S+ I+LWE+ +    PY  M
Sbjct: 294 VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 80.8 bits (199), Expect = 1e-17
 Identities = 55/182 (30%), Positives = 90/182 (49%), Gaps = 10/182 (5%)

Query: 60  LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL------CIV 113
           LG +VAVK L     N T      +E+ +L+ V H+N++  +   T    L       +V
Sbjct: 45  LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104

Query: 114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN 173
            E M   +L   +H   +  ++  LL     +  G+++LH   IIHRDLK +N+++ +  
Sbjct: 105 MELM-DANLCQVIHMELDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 160

Query: 174 VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKV 233
            +K+ DFG+AR      +MT    T  + APEVI    Y +  D++S   ++ ELV   V
Sbjct: 161 TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSV 220

Query: 234 PY 235
            +
Sbjct: 221 IF 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 80.1 bits (197), Expect = 2e-17
 Identities = 46/160 (28%), Positives = 89/160 (55%), Gaps = 7/160 (4%)

Query: 78  LEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
           + ++ ++E+ +L E     +V F GA      + I  E+M GGSL   L +     ++P+
Sbjct: 46  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK---RIPE 102

Query: 138 --LLRFAIDICKGMEYLHQRN-IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTA 194
             L + +I + +G+ YL +++ I+HRD+K +N+L+++   +K+ DFGV+  Q    +  +
Sbjct: 103 EILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANS 161

Query: 195 ETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVP 234
             GT  +M+PE +    Y  ++D++S  + L EL   + P
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 79.5 bits (196), Expect = 2e-17
 Identities = 52/182 (28%), Positives = 92/182 (50%), Gaps = 23/182 (12%)

Query: 61  GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR----FIGASTKSPHLCIVTEY 116
           GQ+VA+K +        L     +E+ +L+ ++H N++     FI        +  VTE 
Sbjct: 35  GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED---IYFVTEL 91

Query: 117 MPGGSLYDYLHKNHNVLKL----PQLLR-FAIDICKGMEYLHQRNIIHRDLKTANLLMDT 171
           + G  L       H +L       Q ++ F   I +G++Y+H   ++HRDLK +N+L++ 
Sbjct: 92  L-GTDL-------HRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINE 143

Query: 172 HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWELVT 230
           +  +K+ DFG+AR Q+    MT    T  + APE+ +  Q YD + D++S   +  E++ 
Sbjct: 144 NCDLKICDFGLARIQDPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLE 201

Query: 231 AK 232
            K
Sbjct: 202 GK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 79.9 bits (197), Expect = 3e-17
 Identities = 42/112 (37%), Positives = 61/112 (54%), Gaps = 8/112 (7%)

Query: 133 LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGV 191
           L    LL F+  + KGM +L  +N IHRDL   N+L+    + K+ DFG+AR  +N    
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270

Query: 192 MTAETGTYR----WMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSM 238
           +    G  R    WMAPE I +  Y  ++DV+S+ I+LWE+ +    PY  M
Sbjct: 271 VV--KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 79.1 bits (195), Expect = 3e-17
 Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 16/202 (7%)

Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRN-VVRF 100
           E+I  G+ G +Y  R    G+ VA+K  R E   + +    ++E+++L+ +     +VR 
Sbjct: 7   EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66

Query: 101 IGA-STKS----PHLCIVTEYMPGGSLYDYL----HKNHNVLKLPQLLRFAIDICKGMEY 151
           +     +     P L +V EY+    L  ++          L    +  F   + KG+ +
Sbjct: 67  LDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125

Query: 152 LHQRNIIHRDLKTANLLMDTH-NVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-IN 208
            H+  ++HRDLK  NLL+D    ++K+AD G+ R F       T E  T  + APEV + 
Sbjct: 126 CHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLG 185

Query: 209 HQPYDQKADVFSFAIVLWELVT 230
              Y    D++S   +  E+  
Sbjct: 186 STHYSTPVDIWSVGCIFAEMSR 207

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 79.8 bits (197), Expect = 3e-17
 Identities = 54/184 (29%), Positives = 92/184 (50%), Gaps = 18/184 (9%)

Query: 60  LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST--KS----PHLCIV 113
            GQ+VA+K L     N T      +E+ +++ V H+N++  +   T  KS      + +V
Sbjct: 40  TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLV 99

Query: 114 TEYMPGGSLYDYLHK--NHNVLK--LPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM 169
            E M   +L   +    +H  +   L Q+L      C G+++LH   IIHRDLK +N+++
Sbjct: 100 MELM-DANLCQVIQMDLDHERMSYLLYQML------C-GIKHLHSAGIIHRDLKPSNIVV 151

Query: 170 DTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELV 229
            +   +K+ DFG+AR      +MT    T  + APEVI    Y +  D++S   ++ E++
Sbjct: 152 KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 211

Query: 230 TAKV 233
              V
Sbjct: 212 RGTV 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 79.2 bits (195), Expect = 3e-17
 Identities = 50/179 (27%), Positives = 96/179 (53%), Gaps = 6/179 (3%)

Query: 61  GQDVAVKVLRSE--HLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMP 118
           G+  AVK L+ +   ++D +E   V++  +    ++  +           HL  V E++ 
Sbjct: 20  GEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN 79

Query: 119 GGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVA 178
           GG L  ++ ++     L +   +A +I  G+++LH + II+RDLK  N+++D    +K+A
Sbjct: 80  GGDLMFHI-QDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIA 138

Query: 179 DFGVARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           DFG+ + +N  G   A T  GT  ++APE++    Y    D +SF ++L+E++  + P+
Sbjct: 139 DFGMCK-ENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 80.3 bits (198), Expect = 3e-17
 Identities = 35/97 (36%), Positives = 63/97 (64%), Gaps = 3/97 (3%)

Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN---KGGVMTAETGTY 199
           I +   + ++H +++IHRD+K+AN+L+ ++ +VK+ DFG ++         V     GT 
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP 209

Query: 200 RWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYD 236
            ++APE+   +PY +KAD+FS  ++L+EL+T K P+D
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 79.9 bits (197), Expect = 4e-17
 Identities = 51/164 (31%), Positives = 75/164 (45%), Gaps = 27/164 (16%)

Query: 85  EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMP--GGSLYDYLHKNHNVLKLPQLLRFA 142
           E+ IL+ + HR ++  I A      +C+V   MP     L+ Y+ +       P  L  A
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYVDR-----SGPLPLEQA 187

Query: 143 IDICKGM----EYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA--------RFQNKGG 190
           I I + +     YLH R IIHRD+KT N+ +D      + DFG A          Q  G 
Sbjct: 188 ITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGW 247

Query: 191 VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVP 234
             T ET +     PE++   PY  K D++S  +VL+E+    V 
Sbjct: 248 SGTLETNS-----PELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 79.1 bits (195), Expect = 4e-17
 Identities = 50/177 (28%), Positives = 95/177 (53%), Gaps = 8/177 (4%)

Query: 65  AVKVLRSEHLNDTLEDEFVQEVAILREV--QHRNVVRFIGASTKSPHLCIVTEYMPGGSL 122
           A+KV++ E +ND  + ++VQ    + E    H  +V           L  V E++ GG L
Sbjct: 24  AMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDL 83

Query: 123 YDYLHKNHNVLKLPQ-LLRF-AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADF 180
             ++ +     KLP+   RF + +I   + +LH+R II+RDLK  N+L+D    +K+ D+
Sbjct: 84  MFHMQRQR---KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDY 140

Query: 181 GVARFQNKGGVMTAE-TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYD 236
           G+ +   + G  T+   GT  ++APE++  + Y    D ++  ++++E++  + P+D
Sbjct: 141 GMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 79.3 bits (195), Expect = 5e-17
 Identities = 64/226 (28%), Positives = 114/226 (50%), Gaps = 20/226 (8%)

Query: 20  VEKAIESQTKSEDWEIDRRLLKTGERIASGSCGD--LYRGVYLGQDVAVKVL-RSEHLND 76
           + K  + + K+ED+E+ +        I  G+ G+  L R     +  A+K+L + E +  
Sbjct: 32  INKIRDLRMKAEDYEVVKV-------IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR 84

Query: 77  TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLP 136
           +    F +E  I+       VV+   A     +L +V EYMPGG L + L  N++V +  
Sbjct: 85  SDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPE-- 141

Query: 137 QLLRF-AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAE 195
           +  RF   ++   ++ +H    IHRD+K  N+L+D    +K+ADFG     NK G++  +
Sbjct: 142 KWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 201

Query: 196 T--GTYRWMAPEVINHQP----YDQKADVFSFAIVLWELVTAKVPY 235
           T  GT  +++PEV+  Q     Y ++ D +S  + L+E++    P+
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 78.6 bits (194), Expect = 5e-17
 Identities = 46/155 (29%), Positives = 84/155 (54%), Gaps = 7/155 (4%)

Query: 83  VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ--LLR 140
           ++E+ +L E     +V F GA      + I  E+M GGSL   L K     ++P+  L +
Sbjct: 47  IRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPENILGK 103

Query: 141 FAIDICKGMEYLHQ-RNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
            +I + +G+ YL +   I+HRD+K +N+L+++   +K+ DFGV+  Q    +  +  GT 
Sbjct: 104 ISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTR 162

Query: 200 RWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVP 234
            +M+PE +    Y  ++D++S  + L E+   + P
Sbjct: 163 SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 78.1 bits (192), Expect = 6e-17
 Identities = 55/195 (28%), Positives = 98/195 (50%), Gaps = 13/195 (6%)

Query: 46  IASGSCGDLYRGVYL---GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ---HRNVVR 99
           I  G+ G +++   L   G+ VA+K +R +   + +    ++EVA+LR ++   H NVVR
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 100 FIGASTKS-----PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLR-FAIDICKGMEYLH 153
                T S       L +V E++    L  YL K        + ++     + +G+++LH
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127

Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYD 213
              ++HRDLK  N+L+ +   +K+ADFG+AR  +    +T+   T  + APEV+    Y 
Sbjct: 128 SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYA 187

Query: 214 QKADVFSFAIVLWEL 228
              D++S   +  E+
Sbjct: 188 TPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 78.3 bits (193), Expect = 6e-17
 Identities = 54/184 (29%), Positives = 94/184 (51%), Gaps = 8/184 (4%)

Query: 57  GVYLGQDVAVKVLRSEHL----NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCI 112
           G   G+  A+KVL+   +     DT   +   E  IL  V+H  +V  I A      L +
Sbjct: 20  GADTGKIFAMKVLKKATIVRNQKDTAHTK--AERNILEAVKHPFIVDLIYAFQTGGKLYL 77

Query: 113 VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH 172
           + EY+ GG L+ +L +    ++       + +I   +E+LHQ+ II+RDLK  N+L+D  
Sbjct: 78  ILEYLSGGELFMHLEREGIFMEDTACFYLS-EISLALEHLHQQGIIYRDLKPENILLDAQ 136

Query: 173 NVVKVADFGVARFQNKGGVMTAE-TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTA 231
             VK+ DFG+ +     G +T    GT  +MAPE++    + +  D +S   ++++++T 
Sbjct: 137 GHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196

Query: 232 KVPY 235
             P+
Sbjct: 197 APPF 200

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 78.0 bits (192), Expect = 6e-17
 Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 15/204 (7%)

Query: 44  ERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           + +  G+ G +Y+ ++   G  +A+K +R E L+++  ++ + E+ IL +     +V F 
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFY 65

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKL---PQLLRFAIDICKGMEYL-HQRNI 157
           GA      + +  EYM  GSL D L+      +      L R    + KG+++L  + NI
Sbjct: 66  GAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI 124

Query: 158 IHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI-----NHQP- 211
           IHRD+K  N+L++ +  VK+ DFGV+       +     G   +MAPE I     N  P 
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSG-NLVASLAKTNIGCQSYMAPERIKSGGPNQNPT 183

Query: 212 YDQKADVFSFAIVLWELVTAKVPY 235
           Y  ++DV+S  + + E+   + PY
Sbjct: 184 YTVQSDVWSLGLSILEMALGRYPY 207

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 78.5 bits (194), Expect = 6e-17
 Identities = 66/250 (26%), Positives = 107/250 (42%), Gaps = 42/250 (16%)

Query: 45  RIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQ----EVAILREVQHRNVV 98
            I  G+ G+  L R    GQ  A+KVLR     D ++   +     E  IL +     +V
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKS---DMIKRNQIAHVRAERDILADADSPWIV 64

Query: 99  RFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI-DICKGMEYLHQRNI 157
           +   +     HL +V EYMPGG L + L +  +V    +  RF I ++   ++ +H+   
Sbjct: 65  KLYYSFQDEEHLYLVMEYMPGGDLMNLLIR-KDVFP-EETARFYIAELVLALDSVHKLGF 122

Query: 158 IHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET--------------------- 196
           IHRD+K  N+L+D    +K+ADFG+ +  NK                             
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182

Query: 197 ---------GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGV 247
                    GT  ++APEV+   PY  + D +S  ++L+E++    P+ S T  +    +
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKI 242

Query: 248 RQVCTSLCQP 257
                SL  P
Sbjct: 243 INWKESLRFP 252

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 78.7 bits (194), Expect = 7e-17
 Identities = 51/177 (28%), Positives = 90/177 (50%), Gaps = 37/177 (20%)

Query: 83  VQEVAILREVQHRNVVRF--------------IGASTKSPHLCIVTEYMPGGSLYDYLHK 128
           ++E+ I+R + H N+V+               +G+ T+   + IV EYM    L + L +
Sbjct: 50  LREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQ 108

Query: 129 -----NHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN-VVKVADFGV 182
                 H  L + QLLR       G++Y+H  N++HRDLK AN+ ++T + V+K+ DFG+
Sbjct: 109 GPLSEEHARLFMYQLLR-------GLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGL 161

Query: 183 AR-----FQNKGGV-MTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAK 232
           AR     + +KG +     T  YR  +P ++     Y +  D+++   +  E++T K
Sbjct: 162 ARIVDPHYSHKGYLSEGLVTKWYR--SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 78.3 bits (193), Expect = 8e-17
 Identities = 55/232 (23%), Positives = 104/232 (44%), Gaps = 38/232 (16%)

Query: 34  EIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLR-SEHLNDTLEDE--------- 81
            I  R ++ G  +  G+ G + +      G+ VA+K ++  E  ND  +D          
Sbjct: 5   SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIH 64

Query: 82  --FVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK--NHNV-LKLP 136
              ++E+ I+ E++H N++  +    +   + +V + M      D L K  +  + L   
Sbjct: 65  FTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA----SD-LKKVVDRKIRLTES 119

Query: 137 QLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGV---- 191
           Q+    + I  G+  LH+   +HRDL  AN+ +++  + K+ADFG+AR +          
Sbjct: 120 QVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179

Query: 192 ----------MTAETGTYRWMAPEVI-NHQPYDQKADVFSFAIVLWELVTAK 232
                     MT++  T  + APE++   + Y    D++S   +  EL+T K
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 77.7 bits (191), Expect = 9e-17
 Identities = 51/193 (26%), Positives = 99/193 (51%), Gaps = 6/193 (3%)

Query: 44  ERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           +++  G+   +Y+G     D  VA+K +R EH  +      ++EV++L++++H N+V   
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
                   L +V EY+    L  YL    N + +  +  F   + +G+ Y H+R ++HRD
Sbjct: 71  DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRD 129

Query: 162 LKTANLLMDTHNVVKVADFGVARFQN-KGGVMTAETGTYRWMAPEV-INHQPYDQKADVF 219
           LK  NLL++    +K+ADFG+AR ++      + E  T  +  P++ +    Y  + D++
Sbjct: 130 LKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMW 189

Query: 220 SFAIVLWELVTAK 232
               + +E+ T +
Sbjct: 190 GVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 77.4 bits (191), Expect = 1e-16
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 23/204 (11%)

Query: 38  RLLKTGERIASGSCGDLY--RGVYLGQDVAVK-VLRSEHLNDTLEDEFVQEVAILREV-- 92
           +L K GE    GS G ++  R    GQ VA+K  + SE      +D  ++++A LRE+  
Sbjct: 5   KLSKIGE----GSYGVVFKCRNRETGQIVAIKKFVESE------DDPVIKKIA-LREIRM 53

Query: 93  ----QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
               +H N+V  I    +   L +V EY    ++ + L KN   +    + +      + 
Sbjct: 54  LKQLKHPNLVNLIEVFRRKRKLHLVFEYC-DHTVLNELEKNPRGVPEHLIKKIIWQTLQA 112

Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWM-APEVI 207
           + + H+ N IHRD+K  N+L+     +K+ DFG AR     G    +    RW  APE++
Sbjct: 113 VNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELL 172

Query: 208 -NHQPYDQKADVFSFAIVLWELVT 230
                Y    DV++   V  EL+T
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 77.7 bits (191), Expect = 1e-16
 Identities = 50/193 (25%), Positives = 100/193 (51%), Gaps = 6/193 (3%)

Query: 44  ERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E++  G+   +++G     +  VA+K +R EH  +      ++EV++L++++H N+V   
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
                   L +V EY+    L  Y+    N++ +  +  F   I +G+ Y H+R ++HRD
Sbjct: 71  DIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRD 129

Query: 162 LKTANLLMDTHNVVKVADFGVARFQN-KGGVMTAETGTYRWMAPEV-INHQPYDQKADVF 219
           LK  NLL++    +K+ADFG+AR ++      + E  T  +  P+V +    Y  + D++
Sbjct: 130 LKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMW 189

Query: 220 SFAIVLWELVTAK 232
               + +E+ + +
Sbjct: 190 GVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 77.8 bits (192), Expect = 1e-16
 Identities = 52/162 (32%), Positives = 81/162 (50%), Gaps = 23/162 (14%)

Query: 85  EVAILREVQHRNVVRFIGASTKSPH------LCIVTEYMPGGSLYDYLHKNHNVLKLPQL 138
           E+ +LR + H NV+  I      PH      + IV E M      D     H +++  Q 
Sbjct: 54  EIKLLRHLDHENVIA-IKDIMPPPHREAFNDVYIVYELMDT----DL----HQIIRSSQT 104

Query: 139 LR------FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN-KGGV 191
           L       F   + +G++Y+H  N++HRDLK +NLL++ +  +K+ DFG+AR  + KG  
Sbjct: 105 LSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF 164

Query: 192 MTAETGTYRWMAPEVI-NHQPYDQKADVFSFAIVLWELVTAK 232
           MT    T  + APE++ N   Y    DV+S   +  EL+  K
Sbjct: 165 MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 78.1 bits (192), Expect = 1e-16
 Identities = 63/227 (27%), Positives = 115/227 (50%), Gaps = 22/227 (9%)

Query: 20  VEKAIESQTKSEDWEIDRRLLKTGERIASGSCGD--LYRGVYLGQDVAVKVL-RSEHLND 76
           V K  + Q K+ED+++ +        I  G+ G+  L R     +  A+K+L + E +  
Sbjct: 32  VRKIRKLQMKAEDYDVVKV-------IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKR 84

Query: 77  TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLP 136
           +    F +E  I+       VV+   A     +L +V EYMPGG L + L  N++V   P
Sbjct: 85  SDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDV---P 140

Query: 137 QLLR--FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTA 194
           +     +  ++   ++ +H   +IHRD+K  N+L+D H  +K+ADFG     ++ G++  
Sbjct: 141 EKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRC 200

Query: 195 ET--GTYRWMAPEVINHQP----YDQKADVFSFAIVLWELVTAKVPY 235
           +T  GT  +++PEV+  Q     Y ++ D +S  + L+E++    P+
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 76.4 bits (188), Expect = 2e-16
 Identities = 54/195 (27%), Positives = 99/195 (50%), Gaps = 8/195 (4%)

Query: 44  ERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E++  G+   +Y+G     G+ VA+K +  +    T     ++E+++++E++H N+VR  
Sbjct: 6   EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGT-PSTAIREISLMKELKHENIVRLH 64

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYL--HKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
                   L +V EYM    L  Y+  H     L    +  F   + KG+ + H+  ++H
Sbjct: 65  DVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLH 123

Query: 160 RDLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEVI-NHQPYDQKAD 217
           RDLK  NLL++    +K+ADFG+AR F       + E  T  + AP+V+   + Y    D
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSID 183

Query: 218 VFSFAIVLWELVTAK 232
           ++S   ++ E++T +
Sbjct: 184 IWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 76.6 bits (188), Expect = 2e-16
 Identities = 50/171 (29%), Positives = 89/171 (52%), Gaps = 4/171 (2%)

Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VA+K +R EH  +      ++EV++L+ ++H N+V           L +V EY+    L 
Sbjct: 33  VALKEIRLEH-EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLK 90

Query: 124 DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA 183
            YL    N++ +  +  F   + +G+ Y H+R I+HRDLK  NLL++    +K+ADFG+A
Sbjct: 91  QYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLA 150

Query: 184 RFQN-KGGVMTAETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
           R ++      + E  T  +  P+V +    Y    D++    +L+E+ T +
Sbjct: 151 RAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 77.1 bits (190), Expect = 2e-16
 Identities = 39/122 (31%), Positives = 69/122 (56%), Gaps = 9/122 (7%)

Query: 130 HNVLKLPQLLR------FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA 183
           H ++  PQ L       F   I +G++YLH   I+HRD+K  NLL++++ V+K+ DFG+A
Sbjct: 91  HKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLA 150

Query: 184 RFQ--NKGGVMTAETGTYRWMAPEVINHQP-YDQKADVFSFAIVLWELVTAKVPYDSMTP 240
           R +  ++   MT E  T  + APE++     Y    D++S   +  EL+  ++ + + +P
Sbjct: 151 RVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP 210

Query: 241 LQ 242
           +Q
Sbjct: 211 IQ 212

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 77.0 bits (189), Expect = 4e-16
 Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 14/155 (9%)

Query: 83  VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMP--GGSLYDYLHKNHNVLKLPQLLR 140
             E  ILR + H ++++  G  T +   C++   +P     LY YL    N + +  +L 
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRN-IAICDILA 186

Query: 141 FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF-----QNKGGVMTAE 195
               + + ++YLH+  IIHRD+K  N+ ++    V + DFG A F      NK       
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK---YYGW 243

Query: 196 TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
            GT    APE++   PY    D++S  IVL+E+ T
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278

Length = 391

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 76.2 bits (188), Expect = 4e-16
 Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 35/217 (16%)

Query: 46  IASGSCGDLYRGVYL----GQDVAVKVLRSEHLNDT-LEDEFVQEVAILREVQHRNVVR- 99
           I  G+ G +Y+        G++ A+K  + +    T +     +E+A+LRE++H NVV  
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 100 ---FIGASTKSPHLCIVTEYMPGGSLYDYLH--KNHNVLKLPQLLRFAI-----DICKGM 149
              F+  + KS +L  + +Y    + +D     K H   K   +    +      I  G+
Sbjct: 68  VEVFLEHADKSVYL--LFDY----AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121

Query: 150 EYLHQRNIIHRDLKTANLLM----DTHNVVKVADFGVAR-FQNKGGVMTAETG---TYRW 201
            YLH   ++HRDLK AN+L+        VVK+ D G+AR F      +        T  +
Sbjct: 122 HYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY 181

Query: 202 MAPEVI---NHQPYDQKADVFSFAIVLWELVTAKVPY 235
            APE++    H  Y +  D+++   +  EL+T +  +
Sbjct: 182 RAPELLLGARH--YTKAIDIWAIGCIFAELLTLEPIF 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 75.5 bits (186), Expect = 5e-16
 Identities = 57/167 (34%), Positives = 85/167 (50%), Gaps = 44/167 (26%)

Query: 38  RLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDE-----FVQEVAILR 90
           +L K GE    GS   +Y+G     GQ VA+K +R EH      +E      ++E ++L+
Sbjct: 9   KLDKLGE----GSYATVYKGRSKLTGQLVALKEIRLEH------EEGAPFTAIREASLLK 58

Query: 91  EVQHRNVVRF--IGASTKSPHLCIVTEYM-----------PGGSLYDYLHKNHNVLKLPQ 137
           +++H N+V    I  + K+  L +V EY+            GG     L  ++  L L Q
Sbjct: 59  DLKHANIVTLHDIIHTKKT--LTLVFEYLDTDLKQYMDDCGGG-----LSMHNVRLFLFQ 111

Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR 184
           LLR       G+ Y HQR ++HRDLK  NLL+     +K+ADFG+AR
Sbjct: 112 LLR-------GLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 76.2 bits (188), Expect = 5e-16
 Identities = 58/190 (30%), Positives = 96/190 (50%), Gaps = 30/190 (15%)

Query: 61  GQDVAVKVLRS-EHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC------IV 113
           G  VA+K +   EH   T     ++E+ ILR  +H N++  I    + P         IV
Sbjct: 30  GVKVAIKKISPFEH--QTFCQRTLREIKILRRFKHENIIG-ILDIIRPPSFESFNDVYIV 86

Query: 114 TEYMPGGSLYDYLHKNHNVLKLPQLLR-----FAIDICKGMEYLHQRNIIHRDLKTANLL 168
            E M        L+K   ++K   L       F   I +G++Y+H  N++HRDLK +NLL
Sbjct: 87  QELMETD-----LYK---LIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLL 138

Query: 169 MDTHNVVKVADFGVARFQNK----GGVMTAETGTYRWM-APEV-INHQPYDQKADVFSFA 222
           ++T+  +K+ DFG+AR  +      G +T    T RW  APE+ +N + Y +  D++S  
Sbjct: 139 LNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT-RWYRAPEIMLNSKGYTKAIDIWSVG 197

Query: 223 IVLWELVTAK 232
            +L E+++ +
Sbjct: 198 CILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 74.9 bits (184), Expect = 7e-16
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 17/216 (7%)

Query: 44  ERIASGSCGDLYRG-VYLGQDVAVKVLRSEHLNDTL--EDEFVQEVAILREVQHRNVVRF 100
           + I +G  G +    +Y    VA  V++    N +   ++EF+Q+    R +QH N+++ 
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL---RFAIDICKGMEYLHQRNI 157
           +G   ++    +V EY   G L  YL +     +  QLL   R A +I  G+ ++H+ N 
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNF 120

Query: 158 IHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---RWMAPEVINH----- 209
           +H DL   N  + +   VKV D+G+   + K   +  E       RW+APE++       
Sbjct: 121 LHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGL 180

Query: 210 --QPYDQKADVFSFAIVLWELV-TAKVPYDSMTPLQ 242
                 + ++V++  + LWEL   A  PY  ++  +
Sbjct: 181 ITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE 216

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 75.1 bits (184), Expect = 7e-16
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 6/206 (2%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E++  GS   +Y+G     G+ VA+KV+R +    T     ++E ++L+ ++H N+V   
Sbjct: 11  EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKHANIVLLH 69

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
                   L +V EY+    L  Y+ K+   L    +  F   + +G+ Y+HQR I+HRD
Sbjct: 70  DIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRD 128

Query: 162 LKTANLLMDTHNVVKVADFGVARFQN-KGGVMTAETGTYRWMAPEV-INHQPYDQKADVF 219
           LK  NLL+     +K+ADFG+AR ++      + E  T  +  P+V +    Y    D++
Sbjct: 129 LKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMW 188

Query: 220 SFAIVLWELVTAKVPYDSMTPLQAAL 245
               +  E++     +  M  +Q  L
Sbjct: 189 GVGCIFVEMIQGVAAFPGMKDIQDQL 214

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 75.0 bits (184), Expect = 8e-16
 Identities = 60/201 (29%), Positives = 101/201 (50%), Gaps = 18/201 (8%)

Query: 46  IASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ---HRNVVRF 100
           I  G+ G +Y  R  + G  VA+K +R +   D L    V+EVA+L+ ++   H N+VR 
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 101 --IGASTKSPH---LCIVTEYMPGGSLYDYLHK----NHNVLKLPQLLRFAIDICKGMEY 151
             + A++++     + +V E++    L  YL K          +  L+R      +G+++
Sbjct: 68  MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMR---QFLRGLDF 123

Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQP 211
           LH   I+HRDLK  N+L+ +   VK+ADFG+AR  +    +T    T  + APEV+    
Sbjct: 124 LHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQST 183

Query: 212 YDQKADVFSFAIVLWELVTAK 232
           Y    D++S   +  E+   K
Sbjct: 184 YATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 74.7 bits (183), Expect = 8e-16
 Identities = 47/168 (27%), Positives = 89/168 (52%), Gaps = 5/168 (2%)

Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VA+K  +    N+ +++  ++E+ +LR ++  N+V    A  +   L +V EY+    L 
Sbjct: 29  VAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE 88

Query: 124 DYLHKNHNVLKLPQLLR-FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGV 182
             L +       P+ +R +   + K + + H+ +I+HRD+K  NLL+  ++V+K+ DFG 
Sbjct: 89  --LLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGF 146

Query: 183 ARFQNKG--GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWEL 228
           AR  ++G     T    T  + +PE++   PY +  D++S   +L EL
Sbjct: 147 ARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 74.6 bits (184), Expect = 9e-16
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 40/213 (18%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ---HR 95
           +    I  G+ G +Y+   L  G+ VA+K +R     + +    ++E+A+L++++   H 
Sbjct: 2   EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHP 61

Query: 96  NVVRFIGAS-----TKSPHLCIVTEYMPGGSLYDYL----------HKNHNVLKLPQLLR 140
           N+VR +         +   L +V E++    L  YL              ++++  QLLR
Sbjct: 62  NIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMR--QLLR 118

Query: 141 FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR---FQNKGGVMTAETG 197
                  G+++LH   I+HRDLK  N+L+ +   VK+ADFG+AR   F+     +T+   
Sbjct: 119 -------GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVV 168

Query: 198 T--YRWMAPEVINHQPYDQKADVFSFAIVLWEL 228
           T  YR  APEV+    Y    D++S   +  EL
Sbjct: 169 TLWYR--APEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 74.9 bits (184), Expect = 1e-15
 Identities = 61/231 (26%), Positives = 106/231 (45%), Gaps = 24/231 (10%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R     +++ SG+ G +   +    G+ VA+K L     ++       +E+ +L+
Sbjct: 11  WELPERYTSL-KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLK 69

Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI- 143
            +QH NV+  +   T +          +V  YM        L K          +++ + 
Sbjct: 70  HMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYM-----QTDLQKIMGHPLSEDKVQYLVY 124

Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMA 203
            +  G++Y+H   IIHRDLK  NL ++    +K+ DFG+AR  +    MT    T  + A
Sbjct: 125 QMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD--AEMTGYVVTRWYRA 182

Query: 204 PEVI-NHQPYDQKADVFSFAIVLWELVTAKVPY------DSMTPLQAALGV 247
           PEVI N   Y+Q  D++S   ++ E++T K  +      D +T +    GV
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 233

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 73.7 bits (181), Expect = 1e-15
 Identities = 49/202 (24%), Positives = 92/202 (45%), Gaps = 27/202 (13%)

Query: 55  YRGVYLGQDVAV--KVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCI 112
              V  GQ+V+V  KVL S+H +      F +  +++ ++ H+++V+  G   +  ++ +
Sbjct: 22  LDIVGPGQEVSVVLKVLGSDHRDS---LAFFETASLMSQLSHKHLVKLYGVCVRDENI-M 77

Query: 113 VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH 172
           V EY+  G L  +LH+  N + L   L  A  +   + YL  + ++H ++   N+L+  +
Sbjct: 78  VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARY 137

Query: 173 NV-------VKVADFGVARFQNKGGVMTAETGTYR--WMAPEVIN--HQPYDQKADVFSF 221
            +       +K++D G+        V++ E    R  W+APE I          AD +SF
Sbjct: 138 GLNEGYVPFIKLSDPGIPI-----TVLSREERVERIPWIAPECIRNGQASLTIAADKWSF 192

Query: 222 AIVLWELVTAKVPYDSMTPLQA 243
              L E+       +   PL  
Sbjct: 193 GTTLLEIC-----SNGEEPLST 209

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 73.9 bits (182), Expect = 2e-15
 Identities = 52/201 (25%), Positives = 90/201 (44%), Gaps = 13/201 (6%)

Query: 54  LYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV 113
           L +       VAVK +  +  +        QE+   R++QH N++ ++ +      L +V
Sbjct: 18  LAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVV 77

Query: 114 TEYMPGGSLYDYLHKNHNVLKLPQLL-RFAI-DICKGMEYLHQRNIIHRDLKTANLLMDT 171
           +  M  GS  D L K H    LP+L   F + D+   ++Y+H +  IHR +K +++L+  
Sbjct: 78  SPLMAYGSCEDLL-KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSG 136

Query: 172 HNVVKVADFGVARFQNKGGVMTA--------ETGTYRWMAPEVI--NHQPYDQKADVFSF 221
              V ++    +    K G                  W++PEV+  N Q Y++K+D++S 
Sbjct: 137 DGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSV 196

Query: 222 AIVLWELVTAKVPYDSMTPLQ 242
            I   EL    VP+  M   Q
Sbjct: 197 GITACELANGHVPFKDMPATQ 217

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 73.5 bits (180), Expect = 3e-15
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 32/203 (15%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEF--VQEVAILREVQHRNVVR 99
           E++  GS   +Y+G+    GQ VA+KV+    +       F  ++E ++L+ ++H N+V 
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVI---SMKTEEGVPFTAIREASLLKGLKHANIVL 67

Query: 100 FIGASTKSPHLCIVTEYM-----------PGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
                     L  V EYM           PGG     LH  +  L + QLLR       G
Sbjct: 68  LHDIIHTKETLTFVFEYMHTDLAQYMIQHPGG-----LHPYNVRLFMFQLLR-------G 115

Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN-KGGVMTAETGTYRWMAPEVI 207
           + Y+H ++I+HRDLK  NLL+     +K+ADFG+AR ++      ++E  T  +  P+V+
Sbjct: 116 LAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVL 175

Query: 208 -NHQPYDQKADVFSFAIVLWELV 229
                Y    D++    +  E++
Sbjct: 176 LGATDYSSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 73.0 bits (179), Expect = 3e-15
 Identities = 57/193 (29%), Positives = 96/193 (49%), Gaps = 20/193 (10%)

Query: 52  GDLYRGVYLGQDVAVKVLRSEHLNDTLEDE--FVQEVAILREVQHRNVVRFIGASTKSPH 109
           G++  G    Q V VK LR    + +++++  F++E    R +QH N+++ +G  T+   
Sbjct: 14  GEVNSGYTPAQ-VVVKELRV---SASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTP 69

Query: 110 LCIVTEYMPGGSLYDYLH---KNHNVLKLPQLL-RFAIDICKGMEYLHQRNIIHRDLKTA 165
             +V E+ P G L  YL    K   +   P  L R A +I  G+ +LH+ N IH DL   
Sbjct: 70  YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALR 129

Query: 166 NLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---RWMAPEVI-----NHQPYDQ--K 215
           N L+     VK+ D+G++  + K          +   RW+APE++     N    DQ  +
Sbjct: 130 NCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKE 189

Query: 216 ADVFSFAIVLWEL 228
           ++V+S  + +WEL
Sbjct: 190 SNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 73.8 bits (181), Expect = 3e-15
 Identities = 46/182 (25%), Positives = 89/182 (48%), Gaps = 4/182 (2%)

Query: 61  GQDVAVKVLRSEHL--NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMP 118
           G+  AVKVL+ + +  +D +E    ++  +     H  + +          L  V E++ 
Sbjct: 20  GRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN 79

Query: 119 GGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVA 178
           GG L  ++ K+       +   +A +I   + +LH + II+RDLK  N+L+D     K+A
Sbjct: 80  GGDLMFHIQKSRR-FDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLA 138

Query: 179 DFGVARFQNKGGVMTAE-TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS 237
           DFG+ +     G  T+   GT  ++APE++    Y    D ++  ++L+E++    P+++
Sbjct: 139 DFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA 198

Query: 238 MT 239
             
Sbjct: 199 EN 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 73.9 bits (181), Expect = 3e-15
 Identities = 50/180 (27%), Positives = 88/180 (48%), Gaps = 10/180 (5%)

Query: 60  LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL------CIV 113
           L ++VA+K L     N T      +E+ +++ V H+N++  +   T    L       IV
Sbjct: 48  LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 107

Query: 114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN 173
            E M   +L   +    +  ++  LL     +  G+++LH   IIHRDLK +N+++ +  
Sbjct: 108 MELM-DANLCQVIQMELDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 163

Query: 174 VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKV 233
            +K+ DFG+AR      +MT    T  + APEVI    Y +  D++S   ++ E++   V
Sbjct: 164 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 223

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 73.5 bits (181), Expect = 3e-15
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 26/186 (13%)

Query: 61  GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVV--RFIGASTKS--PHLCIVTEY 116
           G+ VA+K +       TL    ++E+ ILR  +H N++  R I     +    + +V + 
Sbjct: 30  GKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL 89

Query: 117 MPGGSLYDYLHKN------HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD 170
           M    L+  +H +      H    L QLLR       G++Y+H  N+IHRDLK +NLL++
Sbjct: 90  M-ESDLHHIIHSDQPLTEEHIRYFLYQLLR-------GLKYIHSANVIHRDLKPSNLLVN 141

Query: 171 THNVVKVADFGVARF-----QNKGGVMTAETGTYRWM-APEVI-NHQPYDQKADVFSFAI 223
               +++ DFG+AR            MT    T RW  APE++ +   Y    D++S   
Sbjct: 142 EDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT-RWYRAPELLLSLPEYTTAIDMWSVGC 200

Query: 224 VLWELV 229
           +  E++
Sbjct: 201 IFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 72.9 bits (179), Expect = 3e-15
 Identities = 39/136 (28%), Positives = 73/136 (53%), Gaps = 17/136 (12%)

Query: 110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM 169
           L ++ +Y+ GG L+ +L++  +     ++  +  +I   +++LHQ  II+RD+K  N+L+
Sbjct: 80  LHLILDYVNGGELFTHLYQREH-FTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL 138

Query: 170 DTHNVVKVADFGVARFQNKGGVMTAET--------GTYRWMAPEVINHQP--YDQKADVF 219
           D+   V + DFG+++         AE         GT  +MAPEVI      +D+  D +
Sbjct: 139 DSEGHVVLTDFGLSK------EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWW 192

Query: 220 SFAIVLWELVTAKVPY 235
           S  ++ +EL+T   P+
Sbjct: 193 SLGVLTFELLTGASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 73.4 bits (180), Expect = 4e-15
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 13/208 (6%)

Query: 33  WEID---RRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           WE+    R L + G       C  L R    G  VA+K L     ++       +E+ +L
Sbjct: 11  WEVPDRYRDLKQVGSGAYGTVCSALDRRT--GAKVAIKKLYRPFQSELFAKRAYRELRLL 68

Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEY---MP-GGSLYDYLHKNHNVLKLPQLLRFAIDI 145
           + ++H NV+  +   T    L    ++   MP  G+    L K H  L   ++      +
Sbjct: 69  KHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-HEKLSEDRIQFLVYQM 127

Query: 146 CKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPE 205
            KG++Y+H   IIHRDLK  NL ++    +K+ DFG+AR  +    MT    T  + APE
Sbjct: 128 LKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE--MTGYVVTRWYRAPE 185

Query: 206 VI-NHQPYDQKADVFSFAIVLWELVTAK 232
           VI N   Y Q  D++S   ++ E++T K
Sbjct: 186 VILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 72.7 bits (179), Expect = 4e-15
 Identities = 46/181 (25%), Positives = 85/181 (46%), Gaps = 21/181 (11%)

Query: 61  GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-------HRNVVRFIGASTKSPH--LC 111
           G+  A+K      +    +   +++V  LRE+Q       H N++R I          L 
Sbjct: 24  GKYYAIK-----CMKKHFKS--LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA 76

Query: 112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT 171
           +V E M   +LY+ +      L   ++  +   + K ++++H+  I HRD+K  N+L+  
Sbjct: 77  LVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK- 134

Query: 172 HNVVKVADFGVARFQNKGGVMTAETGTYRWM-APE-VINHQPYDQKADVFSFAIVLWELV 229
            +++K+ADFG  R        T    T RW  APE ++    Y  K D+++   V +E++
Sbjct: 135 DDILKLADFGSCRGIYSKPPYTEYIST-RWYRAPECLLTDGYYGPKMDIWAVGCVFFEIL 193

Query: 230 T 230
           +
Sbjct: 194 S 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 73.0 bits (179), Expect = 5e-15
 Identities = 47/197 (23%), Positives = 95/197 (48%), Gaps = 6/197 (3%)

Query: 46  IASGSCGDLYRGVYLGQD--VAVKVLRSEHL--NDTLEDEFVQEVAILREVQHRNVVRFI 101
           +  GS G +      G D   A+KVL+ + +  +D ++    ++  +    +H  +    
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
                   L  V EY+ GG L   + ++      P+   +A ++   + +LH+  +I+RD
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDLMFQIQRSRK-FDEPRSRFYAAEVTLALMFLHRHGVIYRD 121

Query: 162 LKTANLLMDTHNVVKVADFGVARFQNKGGVMTAE-TGTYRWMAPEVINHQPYDQKADVFS 220
           LK  N+L+D     K+ADFG+ +     GV T    GT  ++APE++    Y    D ++
Sbjct: 122 LKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWA 181

Query: 221 FAIVLWELVTAKVPYDS 237
             ++++E++  + P+++
Sbjct: 182 LGVLMYEMMAGQPPFEA 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 73.3 bits (180), Expect = 5e-15
 Identities = 52/197 (26%), Positives = 91/197 (46%), Gaps = 26/197 (13%)

Query: 52  GDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG----ASTKS 107
           GD+Y         A+KV++   L       F +E    R++   +   +I     A    
Sbjct: 26  GDIY---------AMKVMKKSVLLAQETVSFFEEE---RDILSISNSPWIPQLQYAFQDK 73

Query: 108 PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI-DICKGMEYLHQRNIIHRDLKTAN 166
            +L +V EY PGG L   L++  +      + +F + ++   +  +HQ   +HRD+K  N
Sbjct: 74  DNLYLVMEYQPGGDLLSLLNRYEDQFD-EDMAQFYLAELVLAIHSVHQMGYVHRDIKPEN 132

Query: 167 LLMDTHNVVKVADFG-VARF-QNKGGVMTAETGTYRWMAPEV---INHQP---YDQKADV 218
           +L+D    +K+ADFG  AR   NK        GT  ++APEV   +N      Y  + D 
Sbjct: 133 VLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDW 192

Query: 219 FSFAIVLWELVTAKVPY 235
           +S  ++ +E++  + P+
Sbjct: 193 WSLGVIAYEMIYGRSPF 209

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 72.8 bits (178), Expect = 7e-15
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 44/220 (20%)

Query: 61  GQDVAVKVLRSEHLNDTLEDEFVQEVA----ILREVQHRNVVRFIGASTKSPHLCIVTEY 116
           G   A+K+LR     D LE E V  +     IL E     VV+   +     +L ++ E+
Sbjct: 26  GHIYAMKILRKA---DMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82

Query: 117 MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVK 176
           +PGG +   L K  + L       +  +    ++ +HQ   IHRD+K  NLL+D    VK
Sbjct: 83  LPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVK 141

Query: 177 VADFGVA-----------------------RFQNKGGVMTAET-------------GTYR 200
           ++DFG+                         FQN      AET             GT  
Sbjct: 142 LSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPD 201

Query: 201 WMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTP 240
           ++APEV     Y++  D +S  ++++E++    P+ S TP
Sbjct: 202 YIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 72.8 bits (178), Expect = 7e-15
 Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 44/220 (20%)

Query: 61  GQDVAVKVLRSEHLNDTLEDEFV----QEVAILREVQHRNVVRFIGASTKSPHLCIVTEY 116
           G   A+K+LR     D LE E V     E  IL E     VV+   +     +L ++ E+
Sbjct: 26  GHVYAMKILRKA---DMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82

Query: 117 MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVK 176
           +PGG +   L K  + L   +   +  +    ++ +HQ   IHRD+K  NLL+D+   VK
Sbjct: 83  LPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVK 141

Query: 177 VADFGVA-----------------------RFQNKGGVMTAET-------------GTYR 200
           ++DFG+                         FQN      AET             GT  
Sbjct: 142 LSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPD 201

Query: 201 WMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTP 240
           ++APEV     Y++  D +S  ++++E++    P+ S TP
Sbjct: 202 YIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 72.9 bits (179), Expect = 8e-15
 Identities = 63/227 (27%), Positives = 114/227 (50%), Gaps = 20/227 (8%)

Query: 19  AVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGD--LYRGVYLGQDVAVKVL-RSEHLN 75
           A EK  + + K+ED+     ++K    I  G+ G+  L R     Q  A+K+L + E + 
Sbjct: 31  AAEKITKLRMKAEDF----DVIKV---IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIK 83

Query: 76  DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKL 135
            +    F +E  I+       +V+   A     +L +V EYMPGG L + L  N+++ + 
Sbjct: 84  RSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPE- 141

Query: 136 PQLLRFAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTA 194
            +  RF   ++   ++ +H    IHRD+K  N+L+D    +K+ADFG     +  G++  
Sbjct: 142 -KWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRC 200

Query: 195 ET--GTYRWMAPEVINHQ----PYDQKADVFSFAIVLWELVTAKVPY 235
           +T  GT  +++PEV+  Q     Y ++ D +S  + L+E++    P+
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 73.0 bits (179), Expect = 9e-15
 Identities = 47/151 (31%), Positives = 71/151 (47%), Gaps = 10/151 (6%)

Query: 83  VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPG--GSLYDYLHKNHNVLKLPQLLR 140
           V E  +LR + H  V+  +         C+V   +P     LY YL      L L Q+  
Sbjct: 208 VHEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQVTA 264

Query: 141 FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT----AET 196
            A  +   ++Y+H   IIHRD+KT N+L++    + + DFG A F  +G   T       
Sbjct: 265 VARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFA-RGSWSTPFHYGIA 323

Query: 197 GTYRWMAPEVINHQPYDQKADVFSFAIVLWE 227
           GT    APEV+   PY    D++S  +V++E
Sbjct: 324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 72.4 bits (177), Expect = 1e-14
 Identities = 50/187 (26%), Positives = 92/187 (49%), Gaps = 20/187 (10%)

Query: 60  LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPG 119
           L ++VA+K L     N T      +E+ +++ V H+N++  +   T    L    E+   
Sbjct: 41  LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL---EEFQDV 97

Query: 120 GSLYDYLHKNHNVLKLPQLLRFAID-----------ICKGMEYLHQRNIIHRDLKTANLL 168
             + + +  N     L Q+++  +D           +C G+++LH   IIHRDLK +N++
Sbjct: 98  YLVMELMDAN-----LCQVIQMELDHERMSYLLYQMLC-GIKHLHSAGIIHRDLKPSNIV 151

Query: 169 MDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWEL 228
           + +   +K+ DFG+AR      +MT    T  + APEVI    Y +  D++S   ++ E+
Sbjct: 152 VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211

Query: 229 VTAKVPY 235
           V  K+ +
Sbjct: 212 VRHKILF 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 72.1 bits (177), Expect = 2e-14
 Identities = 55/227 (24%), Positives = 95/227 (41%), Gaps = 42/227 (18%)

Query: 46  IASGSCGDLYRGVYLGQD------VAVKVLRSEHL--NDTLEDEFVQEVAILREVQHRNV 97
           I  G  G+    VYL  D      VA+K +R E L  N  L+  F++E  I  ++ H  +
Sbjct: 10  IGKGGMGE----VYLAYDPVCSRRVALKKIR-EDLSENPLLKKRFLREAKIAADLIHPGI 64

Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLY---------DYLHKNHNV-LKLPQLLRFAIDICK 147
           V      +    +     Y+ G +L          + L K       +   L     IC 
Sbjct: 65  VPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124

Query: 148 GMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN------------KGGVMTAE 195
            +EY+H + ++HRDLK  N+L+     V + D+G A F+             +  +  + 
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184

Query: 196 -------TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
                   GT  +MAPE +   P  +  D+++  ++L++++T   PY
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 71.2 bits (174), Expect = 4e-14
 Identities = 49/183 (26%), Positives = 91/183 (49%), Gaps = 8/183 (4%)

Query: 61  GQDVAVKVL-RSEHLNDTLEDEFVQ-EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMP 118
           G D   KV+ +   LND  +  + + E+  L    H  +V+          L ++ EY  
Sbjct: 89  GSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148

Query: 119 GGSLYDYLH---KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVV 175
           GG L   +    K H   +  ++      I   ++ +H R ++HRDLK+AN+ +    ++
Sbjct: 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGII 208

Query: 176 KVADFGVARFQNKG---GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAK 232
           K+ DFG ++  +      V ++  GT  ++APE+   + Y +KAD++S  ++L+EL+T  
Sbjct: 209 KLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLH 268

Query: 233 VPY 235
            P+
Sbjct: 269 RPF 271

Length = 478

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 69.5 bits (171), Expect = 5e-14
 Identities = 33/126 (26%), Positives = 61/126 (48%), Gaps = 5/126 (3%)

Query: 112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT 171
           ++ +Y+  G L+D L K    L   ++ +    + + +  LH+ NIIH D+K  N+L D 
Sbjct: 86  LIMDYIKDGDLFDLLKKEGK-LSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDR 144

Query: 172 HNV-VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
               + + D+G+ +            GT  + +PE I    YD   D ++  ++ +EL+T
Sbjct: 145 AKDRIYLCDYGLCKIIGTPSCYD---GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLT 201

Query: 231 AKVPYD 236
            K P+ 
Sbjct: 202 GKHPFK 207

Length = 267

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 70.5 bits (172), Expect = 5e-14
 Identities = 59/215 (27%), Positives = 104/215 (48%), Gaps = 25/215 (11%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R       + SG+ G +       L Q VAVK L     +        +E+ +L+
Sbjct: 11  WEVPERYQNL-TPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLK 69

Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  +       +VT  M G  L       +N++K  +L    ++
Sbjct: 70  HMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADL-------NNIVKCQKLSDEHVQ 121

Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  + +G++Y+H   IIHRDLK +N+ ++    +++ DFG+AR  +    MT    T 
Sbjct: 122 FLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE--MTGYVATR 179

Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAKV 233
            + APE+ +N   Y+Q  D++S   ++ EL+  K 
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKA 214

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 70.1 bits (171), Expect = 6e-14
 Identities = 56/184 (30%), Positives = 95/184 (51%), Gaps = 22/184 (11%)

Query: 61  GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL------CIVT 114
           G  VAVK L     +        +E+ +L+ ++H NV+  +   T +  L       +VT
Sbjct: 42  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101

Query: 115 EYMPGGSLYDYLHKNHNVLKLPQL----LRFAI-DICKGMEYLHQRNIIHRDLKTANLLM 169
             M G  L       +N++K  +L    ++F I  I +G++Y+H  +IIHRDLK +NL +
Sbjct: 102 HLM-GADL-------NNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 153

Query: 170 DTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWEL 228
           +    +K+ DFG+AR  +    MT    T  + APE+ +N   Y+Q  D++S   ++ EL
Sbjct: 154 NEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 211

Query: 229 VTAK 232
           +T +
Sbjct: 212 LTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 69.7 bits (171), Expect = 7e-14
 Identities = 45/161 (27%), Positives = 80/161 (49%), Gaps = 21/161 (13%)

Query: 37  RRLLKTGERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH 94
            +L K G+    G+ G+++  R     Q VA+K +  E+  +      ++E+ IL+ ++H
Sbjct: 15  EKLAKIGQ----GTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKH 70

Query: 95  RNVVRFI--------GASTKSPHLCIVTEYMPGGSLYDY--LHKNHNV-LKLPQLLRFAI 143
            NVV  I          +       +V E+      +D   L  N NV   L ++ +   
Sbjct: 71  ENVVNLIEICRTKATPYNRYKGSFYLVFEFCE----HDLAGLLSNKNVKFTLSEIKKVMK 126

Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR 184
            +  G+ Y+H+  I+HRD+K AN+L+    ++K+ADFG+AR
Sbjct: 127 MLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 70.6 bits (173), Expect = 8e-14
 Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 14/186 (7%)

Query: 61  GQDVAVKVLRSEHLNDT-LEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCI-VTEYMP 118
           G +VA+K+LR++   +      F +E A+   + H N+V  + +    P L   V EY+P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 119 GGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV---V 175
           G +L + L      L   +  R  + +   +   H + I+HRDLK  N+++    V    
Sbjct: 63  GRTLREVL-AADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121

Query: 176 KVADFGVARFQNKGG-----VMTAET---GTYRWMAPEVINHQPYDQKADVFSFAIVLWE 227
           KV DFG+              +T  T   GT  + APE +  +P    +D++++ ++  E
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE 181

Query: 228 LVTAKV 233
            +T + 
Sbjct: 182 CLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 68.8 bits (168), Expect = 1e-13
 Identities = 37/130 (28%), Positives = 71/130 (54%), Gaps = 7/130 (5%)

Query: 110 LCIVTEYMPGGSLYDYLHKNHNVLKLP-QLLRFAI-DICKGMEYLHQRNIIHRDLKTANL 167
           L +VT+YM GG L+ +L K     +      +F I ++   +E+LH+ +I++RDLK  N+
Sbjct: 71  LYLVTDYMSGGELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENI 127

Query: 168 LMDTHNVVKVADFGVARFQ-NKGGVMTAETGTYRWMAPEV-INHQPYDQKADVFSFAIVL 225
           L+D    + + DFG+++             GT  ++APEV ++ + Y +  D +S  +++
Sbjct: 128 LLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLV 187

Query: 226 WELVTAKVPY 235
           +E+     P+
Sbjct: 188 FEMCCGWSPF 197

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 68.9 bits (168), Expect = 2e-13
 Identities = 60/225 (26%), Positives = 110/225 (48%), Gaps = 29/225 (12%)

Query: 25  ESQTKSEDWEIDR---RLLKTGERIASGSCGDLYRGVYL--GQDVAVK-VLRSEHLNDTL 78
           E + K  D +I+R   +  K G  I +GS G +Y  + +   + VA+K VL+     +  
Sbjct: 50  EDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN-- 107

Query: 79  EDEFVQEVAILREVQHRNVVRF--------IGASTKSPHLCIVTEYMPGGSLYDYL-HKN 129
                +E+ I++ + H N++             + K+  L +V E++P  +++ Y+ H  
Sbjct: 108 -----RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYA 161

Query: 130 HNVLKLPQLL--RFAIDICKGMEYLHQRNIIHRDLKTANLLMD--THNVVKVADFGVARF 185
            N   LP  L   ++  +C+ + Y+H + I HRDLK  NLL+D  TH  +K+ DFG A+ 
Sbjct: 162 RNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHT-LKLCDFGSAKN 220

Query: 186 QNKGGVMTAETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWELV 229
              G    +   +  + APE+ +    Y    D++S   ++ E++
Sbjct: 221 LLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265

Length = 440

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 67.4 bits (165), Expect = 5e-13
 Identities = 39/100 (39%), Positives = 57/100 (57%), Gaps = 10/100 (10%)

Query: 141 FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR------FQNKGGVMTA 194
           F   I  G++Y+H  N++HRDLK  NLL++    +K+ DFG+AR       +N  G MT 
Sbjct: 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENA-GFMTE 168

Query: 195 ETGTYRWM-APEV-INHQPYDQKADVFSFAIVLWELVTAK 232
              T RW  APE+ ++ Q Y +  DV+S   +L EL+  K
Sbjct: 169 YVAT-RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 67.3 bits (164), Expect = 5e-13
 Identities = 39/129 (30%), Positives = 77/129 (59%), Gaps = 4/129 (3%)

Query: 110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM 169
           L ++ +Y+ GG ++ +L++  N     ++  ++ +I   +E+LH+  I++RD+K  N+L+
Sbjct: 80  LHLILDYVSGGEMFTHLYQRDN-FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL 138

Query: 170 DTHNVVKVADFGVAR-FQNKGGVMTAE-TGTYRWMAPEVINHQPYDQKA-DVFSFAIVLW 226
           D+   V + DFG+++ F ++    T    GT  +MAPE+I  +    KA D +S  I+++
Sbjct: 139 DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIF 198

Query: 227 ELVTAKVPY 235
           EL+T   P+
Sbjct: 199 ELLTGASPF 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 67.5 bits (165), Expect = 6e-13
 Identities = 51/212 (24%), Positives = 89/212 (41%), Gaps = 55/212 (25%)

Query: 85  EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKL----PQLLR 140
           E  IL E  +  VV+   +     +L  V +Y+PGG +   L      ++L      L R
Sbjct: 51  ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL------IRLGIFEEDLAR 104

Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGV---------ARFQNKGG 190
           F I ++   +E +H+   IHRD+K  N+L+D    +K+ DFG+         +++  KG 
Sbjct: 105 FYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGD 164

Query: 191 VMTAET-----------------------------------GTYRWMAPEVINHQPYDQK 215
               ++                                   GT  ++APEV+    Y Q 
Sbjct: 165 HHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 224

Query: 216 ADVFSFAIVLWELVTAKVPYDSMTPLQAALGV 247
            D +S  ++L+E++  + P+ + TP +  L V
Sbjct: 225 CDWWSVGVILYEMLVGQPPFLADTPAETQLKV 256

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 66.3 bits (161), Expect = 2e-12
 Identities = 46/200 (23%), Positives = 95/200 (47%), Gaps = 31/200 (15%)

Query: 67  KVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA--STKSPHLCIVTEYMPGGSLYD 124
           K +    L +  + + V EV ++RE++H+N+VR+I    +  +  L I+ E+   G L  
Sbjct: 44  KAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSR 103

Query: 125 YLHK---------NHNVLKLPQLLRFAIDICKGM-EYLHQRNIIHRDLKTANLLMDT--- 171
            + K          H ++ + + L  A+  C  + +  +   ++HRDLK  N+ + T   
Sbjct: 104 NIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163

Query: 172 --------------HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQ--PYDQK 215
                           + K+ DFG+++      +  +  GT  + +PE++ H+   YD K
Sbjct: 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDK 223

Query: 216 ADVFSFAIVLWELVTAKVPY 235
           +D+++   +++EL + K P+
Sbjct: 224 SDMWALGCIIYELCSGKTPF 243

Length = 1021

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 63.8 bits (155), Expect = 5e-12
 Identities = 47/189 (24%), Positives = 92/189 (48%), Gaps = 22/189 (11%)

Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           V +KVL   H + +L   F +  +++R+V H+++V   G   +     +V E++  G L 
Sbjct: 35  VILKVLDPSHRDISLA--FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD 92

Query: 124 DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV-------VK 176
            ++H+  +VL  P   + A  +   + YL  ++++H ++ T N+L+    +       +K
Sbjct: 93  LFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIK 152

Query: 177 VADFGVARFQNKGGVMTAETGTYR--WMAPE-VINHQPYDQKADVFSFAIVLWELVTAKV 233
           ++D G+        V++ +    R  W+APE V + +     AD +SF   LWE+     
Sbjct: 153 LSDPGIPI-----TVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEIC---- 203

Query: 234 PYDSMTPLQ 242
            Y+   PL+
Sbjct: 204 -YNGEIPLK 211

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 64.6 bits (157), Expect = 5e-12
 Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 54/234 (23%)

Query: 65  AVKVLRSEH-LNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           A+K LR +  LN         E  IL E  +  VV+   +     +L  V +Y+PGG + 
Sbjct: 30  AMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMM 89

Query: 124 DYLHKNHNVLKLPQLL-RFAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFG 181
             L +   +   P++L RF I ++   +E +H+   IHRD+K  N+L+D    +K+ DFG
Sbjct: 90  SLLIR---MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFG 146

Query: 182 V---------ARFQNKGG------------------------VMTAE------------- 195
           +         +++  KG                         + T E             
Sbjct: 147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAH 206

Query: 196 --TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGV 247
              GT  ++APEV+  + Y Q  D +S  ++L+E++  + P+ + TP +  L V
Sbjct: 207 SLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKV 260

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (156), Expect = 5e-12
 Identities = 50/182 (27%), Positives = 91/182 (50%), Gaps = 10/182 (5%)

Query: 65  AVKVLRSEHLNDTLE-DEFVQEVAILREVQHRNVV--RFIGASTKSPH-LCIVTEYMPGG 120
           A+K +R  H+    E    + E  +L +V    +V  +F   S +SP  L +V  ++ GG
Sbjct: 22  ALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF---SFQSPEKLYLVLAFINGG 78

Query: 121 SLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADF 180
            L+ +L +      L +   +  ++   +E LH+ N+I+RDLK  N+L+D    + + DF
Sbjct: 79  ELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDF 137

Query: 181 GVARFQNKGGVMTAE-TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVP-YDSM 238
           G+ +   K    T    GT  ++APE++    Y +  D ++  ++L+E++T   P YD  
Sbjct: 138 GLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN 197

Query: 239 TP 240
             
Sbjct: 198 VN 199

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 63.7 bits (155), Expect = 6e-12
 Identities = 49/205 (23%), Positives = 91/205 (44%), Gaps = 27/205 (13%)

Query: 44  ERIASGSCGDLYRGVYLGQ---------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQH 94
           E +  G+   +++G+             +V +KVL   H N +  + F +  +++ ++ H
Sbjct: 1   ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYS--ESFFEAASMMSQLSH 58

Query: 95  RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
           +++V   G         +V EY+  GSL  YL KN N++ +   L  A  +   + +L  
Sbjct: 59  KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED 118

Query: 155 RNIIHRDLKTANLLM--------DTHNVVKVADFGVARFQNKGGVMTAETGTYR--WMAP 204
           + + H ++   N+L+             +K++D G++       V+  E    R  W+ P
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI-----TVLPKEILLERIPWVPP 173

Query: 205 EVI-NHQPYDQKADVFSFAIVLWEL 228
           E I N Q     AD +SF   LWE+
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEI 198

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 63.9 bits (155), Expect = 7e-12
 Identities = 37/130 (28%), Positives = 78/130 (60%), Gaps = 5/130 (3%)

Query: 110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM 169
           L ++ +Y+ GG L+ +L +     K  ++  ++ +I   +E+LH+  II+RD+K  N+L+
Sbjct: 80  LHLILDYINGGELFTHLSQRER-FKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL 138

Query: 170 DTHNVVKVADFGVARFQNKGGVMTAET--GTYRWMAPEVI--NHQPYDQKADVFSFAIVL 225
           D++  V + DFG+++  ++  V  A +  GT  +MAP+++      +D+  D +S  +++
Sbjct: 139 DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLM 198

Query: 226 WELVTAKVPY 235
           +EL+T   P+
Sbjct: 199 YELLTGASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 63.7 bits (156), Expect = 8e-12
 Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 16/104 (15%)

Query: 137 QLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF------QNKGG 190
           QLL       K ++Y+H  N+IHRDLK +N+L+++   VK+ADFG+AR         +  
Sbjct: 115 QLL-------KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENP 167

Query: 191 VMTAETGTYRWM-APEV-INHQPYDQKADVFSFAIVLWELVTAK 232
           V+T    T RW  APE+ +    Y +  D++S   +L E++  K
Sbjct: 168 VLTDYVAT-RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 8e-12
 Identities = 54/225 (24%), Positives = 94/225 (41%), Gaps = 45/225 (20%)

Query: 52  GDLYRGVYLGQD------VAVKVL-RSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAS 104
           GD+ R V+L +        A+KVL + E +        + E  IL  + H  +     + 
Sbjct: 12  GDVGR-VFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF 70

Query: 105 TKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRF-AIDICKGMEYLHQRNIIHRDL 162
               +LC+V +Y PGG L+  L +     L   ++ RF A ++   +EYLH   I++RDL
Sbjct: 71  QTETYLCLVMDYCPGGELFRLLQRQPGKCLS-EEVARFYAAEVLLALEYLHLLGIVYRDL 129

Query: 163 KTANLLM--DTHNVVKVADF---------GVARFQNKGG-------------VMTAET-- 196
           K  N+L+    H  + ++DF              +                   + E   
Sbjct: 130 KPENILLHESGH--IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSF 187

Query: 197 ------GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
                 GT  ++APEVI+   +    D ++  I+L+E++    P+
Sbjct: 188 RSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF 232

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 66/258 (25%), Positives = 106/258 (41%), Gaps = 60/258 (23%)

Query: 54  LYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVA----ILREVQHRNVVRFIGASTKSPH 109
           L R V      A+K LR +   D L    V  V     IL E  +  VVR   +     +
Sbjct: 19  LARKVDTKALYAMKTLRKK---DVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN 75

Query: 110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQ-LLRFAI-DICKGMEYLHQRNIIHRDLKTANL 167
           L  V +Y+PGG +   L +   +   P+ L RF I ++   +E +H+   IHRD+K  N+
Sbjct: 76  LYFVMDYIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNI 132

Query: 168 LMDTHNVVKVADFGV--------------------------------------------- 182
           L+D    +K+ DFG+                                             
Sbjct: 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPL 192

Query: 183 ---ARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
              A  Q++  +  +  GT  ++APEV+    Y Q  D +S  ++L+E++  + P+ + T
Sbjct: 193 ERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQT 252

Query: 240 PLQAALGVRQVCTSLCQP 257
           PL+  + V    TSL  P
Sbjct: 253 PLETQMKVINWQTSLHIP 270

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 62.7 bits (152), Expect = 2e-11
 Identities = 37/136 (27%), Positives = 74/136 (54%), Gaps = 11/136 (8%)

Query: 109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQ-LLRFAI-DICKGMEYLHQRNIIHRDLKTAN 166
           +L +V +Y  GG L   L K  +  +LP+ + RF I ++   +  +HQ + +HRD+K  N
Sbjct: 75  YLYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDN 132

Query: 167 LLMDTHNVVKVADFGVARFQNKGGVM--TAETGTYRWMAPEVINHQ-----PYDQKADVF 219
           +L+D +  +++ADFG     N+ G +  +   GT  +++PE++         Y  + D +
Sbjct: 133 VLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWW 192

Query: 220 SFAIVLWELVTAKVPY 235
           S  + ++E++  + P+
Sbjct: 193 SLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 62.1 bits (151), Expect = 3e-11
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 43/216 (19%)

Query: 44  ERIASGSCGDLYRGV--YLGQDVAVKVLRS--EHLNDTLEDEFVQEVAILREVQHRNVVR 99
           E I  GS G +   +  + G+ VA+K +    EH++D      ++E+ +LR ++H ++V 
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR--ILREIKLLRLLRHPDIVE 63

Query: 100 ----FIGASTKS-PHLCIVTEYMPGGSLY------DYLHKNHNVLKLPQLLRFAIDICKG 148
                +  S +    + +V E M    L+      D L   H+   L QLLR        
Sbjct: 64  IKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLR-------A 115

Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---------Y 199
           ++Y+H  N+ HRDLK  N+L +    +K+ DFG+AR      V   +T T          
Sbjct: 116 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR------VAFNDTPTAIFWTDYVAT 169

Query: 200 RWM-APEVIN--HQPYDQKADVFSFAIVLWELVTAK 232
           RW  APE+       Y    D++S   +  E++T K
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 60.7 bits (147), Expect = 9e-11
 Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 17/206 (8%)

Query: 54  LYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV 113
           L R    G  V V++   E+  +        EV +    +H N++      T    L ++
Sbjct: 18  LARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVI 77

Query: 114 TEYMPGGS----LYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM 169
           + +M  GS    L  Y  +  +   +  +L  A+   +G+ YLHQ   IHR++K +++L+
Sbjct: 78  SPFMAYGSANSLLKTYFPEGMSEALIGNILFGAL---RGLNYLHQNGYIHRNIKASHILI 134

Query: 170 DTHNVVKVAD----FGVARFQNKGGVM----TAETGTYRWMAPEVINH--QPYDQKADVF 219
               +V ++     + + R   K  V+       T    W++PE++      Y+ K+D++
Sbjct: 135 SGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIY 194

Query: 220 SFAIVLWELVTAKVPYDSMTPLQAAL 245
           S  I   EL T +VP+  M   Q  L
Sbjct: 195 SVGITACELATGRVPFQDMLRTQMLL 220

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 59.7 bits (144), Expect = 2e-10
 Identities = 37/136 (27%), Positives = 75/136 (55%), Gaps = 11/136 (8%)

Query: 109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQ-LLRFAI-DICKGMEYLHQRNIIHRDLKTAN 166
           +L +V +Y  GG L   L K  +  +LP+ + RF + ++   ++ +HQ + +HRD+K  N
Sbjct: 75  NLYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDN 132

Query: 167 LLMDTHNVVKVADFGVA-RFQNKGGVMTA-ETGTYRWMAPEVINHQP-----YDQKADVF 219
           +LMD +  +++ADFG   +    G V ++   GT  +++PE++         Y  + D +
Sbjct: 133 ILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWW 192

Query: 220 SFAIVLWELVTAKVPY 235
           S  + ++E++  + P+
Sbjct: 193 SLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 54.7 bits (132), Expect = 2e-09
 Identities = 33/126 (26%), Positives = 52/126 (41%), Gaps = 12/126 (9%)

Query: 120 GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVAD 179
            SL D L      L   ++    +     +  LH++      L T + L        +  
Sbjct: 1   VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGL--------LKL 52

Query: 180 FGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
            G   F+       +    Y +MAPEVI  Q Y +KAD++S  I L+E +  ++PY+   
Sbjct: 53  DGSVAFK---TPEQSRPDPY-FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER 108

Query: 240 PLQAAL 245
            L A L
Sbjct: 109 ELSAIL 114

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 56.3 bits (136), Expect = 3e-09
 Identities = 37/136 (27%), Positives = 73/136 (53%), Gaps = 11/136 (8%)

Query: 109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQ-LLRFAI-DICKGMEYLHQRNIIHRDLKTAN 166
           +L +V +Y  GG L   L K  +  +LP+ + RF + ++   ++ +HQ   +HRD+K  N
Sbjct: 75  NLYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDN 132

Query: 167 LLMDTHNVVKVADFGVA-RFQNKGGVMTA-ETGTYRWMAPEVINHQP-----YDQKADVF 219
           +L+D +  +++ADFG   R    G V +    GT  +++PE++         Y  + D +
Sbjct: 133 VLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWW 192

Query: 220 SFAIVLWELVTAKVPY 235
           S  + ++E++  + P+
Sbjct: 193 SLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 56.8 bits (137), Expect = 3e-09
 Identities = 40/147 (27%), Positives = 70/147 (47%), Gaps = 34/147 (23%)

Query: 58  VYLGQD------VAVKVLR-SEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP-- 108
           VYLG+        AVKV++ ++ +N  +  +   E         R+ +    A +KSP  
Sbjct: 20  VYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAE---------RDAL----ALSKSPFI 66

Query: 109 -HLC----------IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
            HL           +V EY+ GG +   LH  +        +++  ++   ++YLH+  I
Sbjct: 67  VHLYYSLQSANNVYLVMEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGI 125

Query: 158 IHRDLKTANLLMDTHNVVKVADFGVAR 184
           IHRDLK  N+L+     +K+ DFG+++
Sbjct: 126 IHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 55.4 bits (134), Expect = 6e-09
 Identities = 52/223 (23%), Positives = 89/223 (39%), Gaps = 49/223 (21%)

Query: 64  VAVKVLRSEHLNDTLEDEFVQEVA----ILREVQHRNVVRFIGASTKSPHLCIVTEYMPG 119
            A+K LR    ++ LE E V  V     IL E  +  VV+   +     +L ++ EY+PG
Sbjct: 29  YAMKKLRK---SEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPG 85

Query: 120 GSLYDYLHKNHNVLKLPQLLRFAIDICK-GMEYLHQRNIIHRDLKTANLLMDTHNVVKVA 178
           G +   L K  +     +  RF I      ++ +H+   IHRD+K  NLL+D    +K++
Sbjct: 86  GDMMTLLMK-KDTFT-EEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLS 143

Query: 179 DFGVAR--------------FQNKGGVMTAET-------------------------GTY 199
           DFG+                                                     GT 
Sbjct: 144 DFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTP 203

Query: 200 RWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQ 242
            ++APEV     Y+++ D +S  ++++E++    P+ S  P +
Sbjct: 204 DYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQE 246

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 56.0 bits (135), Expect = 6e-09
 Identities = 45/196 (22%), Positives = 88/196 (44%), Gaps = 19/196 (9%)

Query: 46  IASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST 105
           I+ G  G  Y+G  +   +   V     +N     E       + ++QH N+V+ IG   
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLCR 753

Query: 106 KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR---NIIHRDL 162
                 ++ EY+ G +L + L      L   +  + AI I K + +LH R    ++  +L
Sbjct: 754 SEKGAYLIHEYIEGKNLSEVL----RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNL 809

Query: 163 KTANLLMDTHNV--VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFS 220
               +++D  +   ++++  G+     K  + +A      ++APE    +   +K+D++ 
Sbjct: 810 SPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSA------YVAPETRETKDITEKSDIYG 863

Query: 221 FAIVLWELVTAKVPYD 236
           F ++L EL+T K P D
Sbjct: 864 FGLILIELLTGKSPAD 879

Length = 968

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 54.7 bits (131), Expect = 1e-08
 Identities = 49/178 (27%), Positives = 85/178 (47%), Gaps = 40/178 (22%)

Query: 84  QEVAILREVQHRNVVR----FIGASTKSPHLCIVTEYMPGGSLYDY----------LHK- 128
           +E+A+LRE++H NV+     F+  S +   L           L+DY           H+ 
Sbjct: 47  REIALLRELKHPNVIALQKVFLSHSDRKVWL-----------LFDYAEHDLWHIIKFHRA 95

Query: 129 ---NHNVLKLPQLLRFAI--DICKGMEYLHQRNIIHRDLKTANLLM----DTHNVVKVAD 179
              N   ++LP+ +  ++   I  G+ YLH   ++HRDLK AN+L+         VK+AD
Sbjct: 96  SKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 155

Query: 180 FGVARFQNKGGVMTAETG----TYRWMAPE-VINHQPYDQKADVFSFAIVLWELVTAK 232
            G AR  N      A+      T+ + APE ++  + Y +  D+++   +  EL+T++
Sbjct: 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 45/200 (22%), Positives = 84/200 (42%), Gaps = 17/200 (8%)

Query: 61  GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGG 120
           G+ V V+ +  E   + +      E+ + +   H N+V +         L +VT +M  G
Sbjct: 25  GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 84

Query: 121 SLYD----YLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVK 176
           S  D    +     + L +  +L     + K ++Y+H    +HR +K +++L+     V 
Sbjct: 85  SAKDLICTHFMDGMSELAIAYIL---QGVLKALDYIHHMGYVHRSVKASHILISVDGKVY 141

Query: 177 VA----DFGVARFQNKGGVM----TAETGTYRWMAPEVI--NHQPYDQKADVFSFAIVLW 226
           ++    +  +     +  V+            W++PEV+  N Q YD K+D++S  I   
Sbjct: 142 LSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITAC 201

Query: 227 ELVTAKVPYDSMTPLQAALG 246
           EL    VP+  M   Q  L 
Sbjct: 202 ELANGHVPFKDMPATQMLLE 221

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 53.1 bits (127), Expect = 3e-08
 Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 40/178 (22%)

Query: 84  QEVAILREVQHRNVVR----FIGASTKSPHLCIVTEYMPGGSLYDY----------LHKN 129
           +E+A+LRE++H NV+     F+  + +   L           L+DY           H+ 
Sbjct: 47  REIALLRELKHPNVISLQKVFLSHADRKVWL-----------LFDYAEHDLWHIIKFHRA 95

Query: 130 HNVLKLP-QLLRFAI-----DICKGMEYLHQRNIIHRDLKTANLLM----DTHNVVKVAD 179
               K P QL R  +      I  G+ YLH   ++HRDLK AN+L+         VK+AD
Sbjct: 96  SKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 155

Query: 180 FGVARFQNKGGVMTAETG----TYRWMAPE-VINHQPYDQKADVFSFAIVLWELVTAK 232
            G AR  N      A+      T+ + APE ++  + Y +  D+++   +  EL+T++
Sbjct: 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 53.1 bits (127), Expect = 4e-08
 Identities = 36/107 (33%), Positives = 53/107 (49%), Gaps = 9/107 (8%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFVQE 85
           WE  R  L  G  + SG+ G +  G   G         VAVK+L+      + +   + E
Sbjct: 32  WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSE 90

Query: 86  VAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHN 131
           + I+  +  H N+V  +GA TKS  + I+TEY   G L +YLHKN +
Sbjct: 91  LKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRD 137

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 52.7 bits (126), Expect = 6e-08
 Identities = 37/111 (33%), Positives = 55/111 (49%), Gaps = 10/111 (9%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFVQE 85
           WE+ R  L  G  + SG+ G +      G         VAVK+L+S     + +   + E
Sbjct: 32  WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKST-ARSSEKQALMSE 90

Query: 86  VAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKN-HNVLK 134
           + I+  +  H N+V  +GA TK   + I+TEY   G L DYLH+N H  L+
Sbjct: 91  LKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQ 141

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.0 bits (122), Expect = 2e-07
 Identities = 40/139 (28%), Positives = 70/139 (50%), Gaps = 17/139 (12%)

Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRG--VYLGQD-----VAVKVLRSEHLNDTLEDEF 82
           +E WE  R  L+ G+ + +G+ G +       LG++     VAVK+L++    D  E   
Sbjct: 30  NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDERE-AL 88

Query: 83  VQEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-----NHNVLKLP 136
           + E+ IL  + QH+N+V  +GA T    + ++TEY   G L ++L K      + V+ LP
Sbjct: 89  MSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALP 148

Query: 137 QLLRFAID---ICKGMEYL 152
           ++   + D   I    +Y+
Sbjct: 149 EISETSSDYKNITLEKKYI 167

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 49.9 bits (119), Expect = 3e-07
 Identities = 44/188 (23%), Positives = 80/188 (42%), Gaps = 18/188 (9%)

Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           V +KVL   H +  L   F +  +++ +V H ++    G   +     +V E++  G L 
Sbjct: 47  VVLKVLDPSHRDIALA--FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD 104

Query: 124 DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM-------DTHNVVK 176
             L K    + +   +  A  +   + YL  +N++H ++   N+L+        T   +K
Sbjct: 105 VCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIK 164

Query: 177 VADFGVARFQNKGGVMTAETGTYR--WMAPEVI-NHQPYDQKADVFSFAIVLWELV-TAK 232
           ++D GV+        ++ E    R  W+APE +         AD +SF   L E+    +
Sbjct: 165 LSDPGVSF-----TALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGE 219

Query: 233 VPYDSMTP 240
           VP    TP
Sbjct: 220 VPLKERTP 227

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 47.2 bits (113), Expect = 1e-06
 Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 16/154 (10%)

Query: 43  GERIASGSCGDLYRGVYLGQDVAVKVLRSE-HLNDTLEDEFVQEVAILREVQHRNVVRFI 101
            + I  G+  ++Y G +LG    +K    + + +  L++   +E    RE +  +  R  
Sbjct: 1   MKLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTR-REARIMSRARKA 59

Query: 102 GASTKSPHLC------IVTEYMPGGSLYDYLHKNHNVLKLPQLLR-FAIDICKGMEYLHQ 154
           G +  + +        IV EY+ G  L D +  N N ++  +L R     + K    LH 
Sbjct: 60  GVNVPAVYFVDPENFIIVMEYIEGEPLKDLI--NSNGMEELELSREIGRLVGK----LHS 113

Query: 155 RNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK 188
             IIH DL T+N+++    +  + DFG+A F   
Sbjct: 114 AGIIHGDLTTSNMILSGGKIY-LIDFGLAEFSKD 146

Length = 211

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 47.5 bits (113), Expect = 2e-06
 Identities = 31/121 (25%), Positives = 59/121 (48%), Gaps = 3/121 (2%)

Query: 112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT 171
           +V ++  GG L+ ++ K  N+ +   + R+A ++   ++ LH+  I+ RDL   N+L+D 
Sbjct: 62  LVLQHAEGGKLWSHISKFLNIPE-ECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDD 120

Query: 172 HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTA 231
              +++  F   R+         E     + APEV       +  D +S   +L+EL+T 
Sbjct: 121 RGHIQLTYFS--RWSEVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTG 178

Query: 232 K 232
           K
Sbjct: 179 K 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 46.4 bits (110), Expect = 5e-06
 Identities = 43/193 (22%), Positives = 76/193 (39%), Gaps = 51/193 (26%)

Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICK-GMEYLHQR 155
           VV    +   + +L ++ E++PGG L   L K     +   + RF +  C   +E +H+ 
Sbjct: 63  VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSE--DVTRFYMAECVLAIEAVHKL 120

Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVA-----------------------RFQNKGGVM 192
             IHRD+K  N+L+D    +K++DFG++                       R  N+  V 
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180

Query: 193 T-------------------------AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWE 227
                                     +  GT  ++APE+   Q Y Q+ D +S   +++E
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240

Query: 228 LVTAKVPYDSMTP 240
            +    P+ S   
Sbjct: 241 CLIGWPPFCSENS 253

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 46.6 bits (110), Expect = 6e-06
 Identities = 40/180 (22%), Positives = 80/180 (44%), Gaps = 25/180 (13%)

Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           +A +V         LE+E    +  L  + H N+++ I    +S     +        LY
Sbjct: 196 IAKRVKAGSRAAIQLENE----ILALGRLNHENILK-IEEILRSEANTYMITQKYDFDLY 250

Query: 124 DYLH------KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKV 177
            +++      K+  +LK  Q       +   +EY+H + +IHRD+K  N+ ++    + +
Sbjct: 251 SFMYDEAFDWKDRPLLK--QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVL 308

Query: 178 ADFGVAR-FQNK------GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
            DFG A  F+ +      G V T  T +     PE++    Y +  D++S  ++L ++++
Sbjct: 309 GDFGTAMPFEKEREAFDYGWVGTVATNS-----PEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 45.7 bits (108), Expect = 1e-05
 Identities = 39/150 (26%), Positives = 66/150 (44%), Gaps = 25/150 (16%)

Query: 107 SPHLCIVTEYMP--GGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH-QRNIIHRDLK 163
           + H+CIV   MP  G  L D++ K H       L +        ++Y H + +++H DLK
Sbjct: 204 TGHMCIV---MPKYGPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLK 259

Query: 164 TANLLMDTHNV----------------VKVADFGVARFQNKGGVMTAETGTYRWMAPEVI 207
             N+LM+T +                 V++ D G    +         T  YR  +PEV+
Sbjct: 260 PENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYR--SPEVV 317

Query: 208 NHQPYDQKADVFSFAIVLWELVTAKVPYDS 237
               +    D++S   +++EL T K+ YD+
Sbjct: 318 LGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347

Length = 467

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 42.1 bits (99), Expect = 1e-04
 Identities = 36/115 (31%), Positives = 52/115 (45%), Gaps = 22/115 (19%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD-------VAVKVLR-----SEHLNDTLED 80
           WE  R  LK G+ +  G+ G + +    G +       VAVK+L+     SE+       
Sbjct: 2   WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEY------K 55

Query: 81  EFVQEVAILREV-QHRNVVRFIGASTKS--PHLCIVTEYMPGGSLYDYLHKNHNV 132
             + E+ IL  +  H NVV  +GA TK   P + IV EY   G+L +YL      
Sbjct: 56  ALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIV-EYCKFGNLSNYLRSKREC 109

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 41.6 bits (97), Expect = 2e-04
 Identities = 34/109 (31%), Positives = 50/109 (45%), Gaps = 12/109 (11%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD-------VAVKVLRSEHLNDTLEDEFVQE 85
           WE  R  LK G+ +  G+ G +      G D       VAVK+L+ E    +     + E
Sbjct: 2   WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSE 60

Query: 86  VAILREV-QHRNVVRFIGASTK--SPHLCIVTEYMPGGSLYDYLHKNHN 131
           + IL  +  H NVV  +GA TK   P L ++ E+   G+L +YL     
Sbjct: 61  LKILIHIGHHLNVVNLLGACTKPGGP-LMVIVEFCKFGNLSNYLRSKRG 108

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 41.8 bits (98), Expect = 2e-04
 Identities = 36/136 (26%), Positives = 60/136 (44%), Gaps = 18/136 (13%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLR-SEHLNDTLEDEFVQ 84
           WE  R  L  G+ + +G+ G +      G         VAVK+L+ S HL  T  +  + 
Sbjct: 30  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--TEREALMS 87

Query: 85  EVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
           E+ +L  +  H N+V  +GA T      ++TEY   G L ++L +  +    P+    A 
Sbjct: 88  ELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHA- 146

Query: 144 DICKGMEYLHQRNIIH 159
                 E    +N++H
Sbjct: 147 ------EAALYKNLLH 156

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 41.1 bits (96), Expect = 3e-04
 Identities = 32/104 (30%), Positives = 51/104 (49%), Gaps = 12/104 (11%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD-------VAVKVLRSEHLNDTLEDEFVQE 85
           WE  R  L+ G+ +  G+ G +      G D       VAVK+L+ E    +     + E
Sbjct: 2   WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLK-EGATASEHKALMSE 60

Query: 86  VAILREV-QHRNVVRFIGASTKSPH--LCIVTEYMPGGSLYDYL 126
           + IL  +  H NVV  +GA TK P+  L ++ E+   G+L ++L
Sbjct: 61  LKILIHIGNHLNVVNLLGACTK-PNGPLMVIVEFCKYGNLSNFL 103

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 40.7 bits (96), Expect = 3e-04
 Identities = 40/153 (26%), Positives = 66/153 (43%), Gaps = 23/153 (15%)

Query: 46  IASGSCGDLYRGVYLGQDVAVKV-----LRSEHLNDTLEDE-FVQEVAILREVQHRNV-- 97
           I  G+   +Y   +LG    VK       R   L++ L  E   +E  IL + +   V  
Sbjct: 4   IKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPV 63

Query: 98  --VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR 155
             V  +          IV EY+ G  L D L +       P LLR   ++ + +  LH+ 
Sbjct: 64  PIVYDVDPDNGL----IVMEYIEGELLKDALEEA-----RPDLLR---EVGRLVGKLHKA 111

Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARFQNK 188
            I+H DL T+N+++    +  + DFG+  F ++
Sbjct: 112 GIVHGDLTTSNIILSGGRIYFI-DFGLGEFSDE 143

Length = 204

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 40.4 bits (94), Expect = 6e-04
 Identities = 17/36 (47%), Positives = 23/36 (63%)

Query: 148 GMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA 183
           G+  LH+  I+HRD+K  NLL+     VK+ DFG A
Sbjct: 321 GLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 38.4 bits (90), Expect = 0.001
 Identities = 35/162 (21%), Positives = 60/162 (37%), Gaps = 41/162 (25%)

Query: 46  IASGSCGDLYRGVYLGQDVAVKV--------------LRSEHLNDTLEDEFVQEVAILRE 91
           IA G+   +Y G +LG    +K               +R E            E  +L  
Sbjct: 2   IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERT--------RNEARLLSR 53

Query: 92  VQHRN-----VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDIC 146
              +      VV  +    K+    IV EY+ G  L D +           L      + 
Sbjct: 54  A-RKAGVNTPVVYDVDPDNKT----IVMEYIEGKPLKDVI----EEGNDELLREIGRLVG 104

Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK 188
           K    LH+  I+H DL T+N+++    +  + DFG+ ++ ++
Sbjct: 105 K----LHKAGIVHGDLTTSNIIVRDDKLY-LIDFGLGKYSDE 141

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 38.3 bits (90), Expect = 0.003
 Identities = 39/153 (25%), Positives = 67/153 (43%), Gaps = 24/153 (15%)

Query: 43  GERIASGSCGDLYRGVYLGQDVAVKV-----LRSEHLNDTLEDE-FVQEVAILREVQ--- 93
              I  G+  D+ +G YLG+D  +K       R   L++ L  E    E  +L E +   
Sbjct: 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAG 397

Query: 94  -HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYL 152
               V+  +    K+    IV EY+ G  L D L  N  +++     +    + K    L
Sbjct: 398 VPTPVIYDVDPEEKT----IVMEYIGGKDLKDVLEGNPELVR-----KVGEIVAK----L 444

Query: 153 HQRNIIHRDLKTANLLMDTHNVVKVADFGVARF 185
           H+  I+H DL T+N ++    +  + DFG+ ++
Sbjct: 445 HKAGIVHGDLTTSNFIVRDDRLY-LIDFGLGKY 476

Length = 535

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	259
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	99.98
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.98
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.92
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
PLN00181	793	protein SPA1-RELATED; Provisional	99.9
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.88
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
PRK14879	211	serine/threonine protein kinase; Provisional	99.85
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.84
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
PRK10345	210	hypothetical protein; Provisional	99.83
smart00090	237	RIO RIO-like kinase.	99.83
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.82
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.82
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.79
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.75
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.75
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.73
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.68
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.63
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.61
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.61
KOG3087	229	consensus Serine/threonine protein kinase [General	99.6
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.59
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.58
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.57
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.57
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.56
KOG1243	690	consensus Protein kinase [General function predict	99.53
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.5
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.42
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.39
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.36
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.36
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.32
COG4248	637	Uncharacterized protein with protein kinase and he	99.29
PRK09902	216	hypothetical protein; Provisional	99.17
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.15
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.14
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.11
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	99.05
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	99.04
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.04
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.03
COG0661	517	AarF Predicted unusual protein kinase [General fun	99.03
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.98
PF01636	239	APH: Phosphotransferase enzyme family This family	98.93
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.79
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.77
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.61
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.53
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.51
PLN02876	822	acyl-CoA dehydrogenase	98.49
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.47
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	98.46
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.45
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.44
PRK05231	319	homoserine kinase; Provisional	98.42
PRK10593	297	hypothetical protein; Provisional	98.4
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	98.32
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.28
KOG2268	465	consensus Serine/threonine protein kinase [Signal	98.27
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	98.27
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.19
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	98.13
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.13
KOG2270	520	consensus Serine/threonine protein kinase involved	98.08
PLN02756	418	S-methyl-5-thioribose kinase	97.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.93
PLN02236	344	choline kinase	97.86
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.76
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.75
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.66
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.66
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.65
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	97.58
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.54
PRK12396	409	5-methylribose kinase; Reviewed	97.48
COG2334	331	Putative homoserine kinase type II (protein kinase	97.4
PRK06148	1013	hypothetical protein; Provisional	97.39
PTZ00384	383	choline kinase; Provisional	97.28
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.24
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	97.06
PTZ00296	442	choline kinase; Provisional	96.95
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.9
PRK11768	325	serine/threonine protein kinase; Provisional	96.72
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	96.6
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	96.43
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.29

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-49  Score=316.94  Aligned_cols=215  Identities=35%  Similarity=0.606  Sum_probs=200.0

Q ss_pred             hhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      .+|.+.+.||.|+|++||+|..  .+..||||.+......+...+.+..|+.+|++++||||+.++++....+.+|+|||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            4677777899999999999986  47899999999998888888889999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC------CeEEEeeeccceeccCC
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH------NVVKVADFGVARFQNKG  189 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~------~~i~l~D~~~~~~~~~~  189 (259)
                      ||+||+|.++++..+ .+++..++.++.||+.++.+||+++|+||||||.|||++.+      -.+||.|||+++...++
T Consensus        90 yC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~  168 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG  168 (429)
T ss_pred             eCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence            999999999997665 49999999999999999999999999999999999999775      45899999999999999


Q ss_pred             CccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          190 GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       190 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ......||++.|||||++...+|+.++|+||+|+++|+|++|+.||...+..+....++++-.-
T Consensus       169 ~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~  232 (429)
T KOG0595|consen  169 SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI  232 (429)
T ss_pred             hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc
Confidence            8889999999999999999999999999999999999999999999999999999888866443

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-46  Score=309.76  Aligned_cols=225  Identities=28%  Similarity=0.467  Sum_probs=206.0

Q ss_pred             eechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC--Cc
Q 045286           34 EIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS--PH  109 (259)
Q Consensus        34 ~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~  109 (259)
                      +...+.|+..++||+|.||.||+|++.  |+-||+|.++.+...+.......||+.+|++|+||||+++.+.....  ..
T Consensus       113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s  192 (560)
T KOG0600|consen  113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS  192 (560)
T ss_pred             ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence            344578899999999999999999975  78899999999988888888899999999999999999999988665  78


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG  189 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~  189 (259)
                      +|+|+||++ .+|.-++....-.+++.++..+++||+.+|.|+|++|++|||||.+|||++.+|.+||.|||+|.+....
T Consensus       193 iYlVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  193 IYLVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             EEEEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            999999995 5999988766667999999999999999999999999999999999999999999999999999976655


Q ss_pred             C--ccccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCccCC
Q 045286          190 G--VMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY  259 (259)
Q Consensus       190 ~--~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~  259 (259)
                      .  ..+...-|..|+|||++.|. .|+.++|+||+||++.||+.|+++|.+.+..++++.|-+.|+.++...|
T Consensus       272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W  344 (560)
T KOG0600|consen  272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW  344 (560)
T ss_pred             CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence            3  56777889999999999876 7999999999999999999999999999999999999999999998776

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-47  Score=306.94  Aligned_cols=222  Identities=24%  Similarity=0.395  Sum_probs=195.2

Q ss_pred             hhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchH-----HHHHHHHHHHHHHhcCCCCcceeeeeeecCCc
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDT-----LEDEFVQEVAILREVQHRNVVRFIGASTKSPH  109 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~  109 (259)
                      ++.|.+.+.||+|+||.|-+|..  +++.||+|+++.......     ......+|+++|++|+||+|+++++++...+.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            57888999999999999999985  589999999997654331     22446799999999999999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC---CeEEEeeeccceec
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH---NVVKVADFGVARFQ  186 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~---~~i~l~D~~~~~~~  186 (259)
                      .|+|+||++||.|.+++..... +.+.....+++|++.++.|||++||+||||||+|||++.+   -.+||+|||++...
T Consensus       251 ~YmVlE~v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~  329 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS  329 (475)
T ss_pred             eEEEEEEecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence            9999999999999999965543 8888899999999999999999999999999999999776   56999999999999


Q ss_pred             cCCCccccCCCcccccCccccCCCCC--C-CchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHhhhccCCCCccCC
Q 045286          187 NKGGVMTAETGTYRWMAPEVINHQPY--D-QKADVFSFAIVLWELVTAKVPYDSMTP-LQAALGVRQVCTSLCQPIY  259 (259)
Q Consensus       187 ~~~~~~~~~~~~~~~~~PE~~~~~~~--~-~~~Di~slG~~~~~ll~g~~p~~~~~~-~~~~~~i~~~~~~~~~~~~  259 (259)
                      ...+.+...|||+.|.|||++.+...  . .++|+||+||++|-+|+|.+||.+... ..+-++|.+|.-...|+.|
T Consensus       330 g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w  406 (475)
T KOG0615|consen  330 GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW  406 (475)
T ss_pred             ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence            99999999999999999999976643  3 488999999999999999999986444 4488888888777776665

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.7e-46  Score=292.60  Aligned_cols=218  Identities=24%  Similarity=0.388  Sum_probs=202.0

Q ss_pred             hhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      +.|....++|.|++|+||+|++  +|+-||||.+..+..++...+-.+||+++|++++|+|++.++++|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            3678888999999999999985  58999999999988888888889999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc-CCCcccc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN-KGGVMTA  194 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~-~~~~~~~  194 (259)
                      |++. ++.+.++..+...+...+..++.|++.++.|+|+++++||||||+|||++.+|.+||||||.|+... ++...+.
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTD  160 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTD  160 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhh
Confidence            9955 6667777777779999999999999999999999999999999999999999999999999999877 6677788


Q ss_pred             CCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          195 ETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      +..|..|+|||++.+ .+|+..+|||++||++.||++|.+-|++.++.+++..|++.++...|
T Consensus       161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~p  223 (396)
T KOG0593|consen  161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIP  223 (396)
T ss_pred             hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCH
Confidence            899999999999987 68999999999999999999999999999999999999999888765

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-46  Score=295.95  Aligned_cols=222  Identities=26%  Similarity=0.400  Sum_probs=199.9

Q ss_pred             echhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCch-HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEE
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~  111 (259)
                      +.-+.+++.+.||+|+||+||+++.  +++-+|+|++++....+ ...+..++|..+|++++||+|+.+.-.|+..+..|
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy  101 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY  101 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence            3357889999999999999999984  68899999999876544 35677889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-C
Q 045286          112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-G  190 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~  190 (259)
                      +|+||+.||.|...+++.+ .+++..++-++.+|+.||.|||+.||+|||+||+|||++.+|.++|+|||++...... .
T Consensus       102 lVld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             EEEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            9999999999999996554 4889989999999999999999999999999999999999999999999999855444 3


Q ss_pred             ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          191 VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       191 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      .....|||+.|+|||.+.+.+|+.++|.||||+++|+|++|..||.+.+...+.++|.++.....|+
T Consensus       181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~  247 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPG  247 (357)
T ss_pred             ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCc
Confidence            4455699999999999999999999999999999999999999999999999999999888665554

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-46  Score=291.25  Aligned_cols=220  Identities=24%  Similarity=0.447  Sum_probs=199.2

Q ss_pred             hhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeee-eeecCCc-EEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG-ASTKSPH-LCI  112 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~-~~~~~~~-~~l  112 (259)
                      ...|++.++||.|+||.||++..  ++..+|.|.+.....+....+....|+.+|++|+||||+++++ .+.++.. +++
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            46899999999999999999885  5899999999988888888899999999999999999999998 4444444 899


Q ss_pred             EEecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh--CC--cccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          113 VTEYMPGGSLYDYLHK---NHNVLKLPQLLRFAIDICKGMEYLHQ--RN--IIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~--~~--i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                      +||++++|+|...+..   ....+++..+|.++.|++.+|..+|.  ..  +.||||||.||+++.+|.+||+|||++.+
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            9999999999999853   34569999999999999999999999  55  99999999999999999999999999998


Q ss_pred             ccCCC-ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          186 QNKGG-VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       186 ~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      +.+.. ......|||.|++||.+.+.+|+.+|||||+||++|||+.-..||.+.+-.+...+|+++--+++|
T Consensus       178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p  249 (375)
T KOG0591|consen  178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP  249 (375)
T ss_pred             hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc
Confidence            87664 445778999999999999999999999999999999999999999999999999999999766666

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.4e-45  Score=279.38  Aligned_cols=221  Identities=23%  Similarity=0.406  Sum_probs=204.3

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ++|...+.||.|.||.||+|.+.  |+.||+|.++..+..+.......||+..|++++|+||+.++++|.+.+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            47888899999999999999985  8999999999988777777889999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcc-cc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM-TA  194 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~-~~  194 (259)
                      |+ ..+|...+......++...+..++.+++++++|||.+.|+|||+||.|+|++.+|.+||.|||+++...++... ..
T Consensus        82 fm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~  160 (318)
T KOG0659|consen   82 FM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH  160 (318)
T ss_pred             ec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence            99 56999999877778999999999999999999999999999999999999999999999999999987766444 33


Q ss_pred             CCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCccCC
Q 045286          195 ETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY  259 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~  259 (259)
                      ...+..|+|||++.|. .|+..+|+||+||++.||+.|.+.|++.++.+++..|-+.++++.+..|
T Consensus       161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~W  226 (318)
T KOG0659|consen  161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQW  226 (318)
T ss_pred             ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccC
Confidence            4678999999998765 7899999999999999999999999999999999999999999988777

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=289.69  Aligned_cols=222  Identities=31%  Similarity=0.486  Sum_probs=196.3

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC-c
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP-H  109 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~  109 (259)
                      ..+.-.+++..+.||.|+.|+||++.+.  ++-+|+|++. -..++.....+.+|++++++.+||+|+.++++|.... .
T Consensus        74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~  152 (364)
T KOG0581|consen   74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE  152 (364)
T ss_pred             cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence            3444568999999999999999999975  8899999994 4456778899999999999999999999999999888 5


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ-RNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      +.++||||++++|+.++... +.+++..+..++.+++++|.|||+ .+|+||||||+|+|++..|.+||+|||.+....+
T Consensus       153 isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn  231 (364)
T KOG0581|consen  153 ISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN  231 (364)
T ss_pred             EEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence            99999999999999998655 459999999999999999999996 9999999999999999999999999999987666


Q ss_pred             CCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHhhhccCCCCcc
Q 045286          189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSM-----TPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       189 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~-----~~~~~~~~i~~~~~~~~~~  257 (259)
                      . ......||..|||||.+.+..|+.++||||||+.++|+.+|+-||...     +..+.+..|...-.+..|.
T Consensus       232 S-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~  304 (364)
T KOG0581|consen  232 S-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE  304 (364)
T ss_pred             h-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc
Confidence            5 556778999999999999999999999999999999999999999764     6667777776655555444

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-44  Score=304.15  Aligned_cols=215  Identities=29%  Similarity=0.452  Sum_probs=197.7

Q ss_pred             echhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEE
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLN-DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~  111 (259)
                      ....+|..++.||.|+|+.+|.+++  .|+.||+|++...... ....+.+.+|+++.++|+||||+.++++|++.++.|
T Consensus        15 ~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVY   94 (592)
T KOG0575|consen   15 PRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVY   94 (592)
T ss_pred             CCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceE
Confidence            3347899999999999999999997  5899999999885443 345578889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-C
Q 045286          112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-G  190 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~  190 (259)
                      +|.|.|+.++|-+++. ..+.+++.+++.+++||+.+|.|||+.+|+|||+|..|+|++.+-++||+|||+|+....+ .
T Consensus        95 ivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   95 IVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            9999999999999985 6667999999999999999999999999999999999999999999999999999988865 6


Q ss_pred             ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          191 VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       191 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      .....||||-|.|||++.....+..+||||+||++|.||.|++||+..+-.+...+|+..
T Consensus       174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~  233 (592)
T KOG0575|consen  174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN  233 (592)
T ss_pred             ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc
Confidence            667889999999999999999999999999999999999999999999988888888743

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-44  Score=296.28  Aligned_cols=222  Identities=47%  Similarity=0.820  Sum_probs=200.9

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEcCce-EEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC-
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP-  108 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~-v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-  108 (259)
                      ..+.++...+...+.||+|+||+||++.+.|.. ||+|.+.....+......+.+|+.++.+++||||+++++++.... 
T Consensus        34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~  113 (362)
T KOG0192|consen   34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG  113 (362)
T ss_pred             cceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            568899999999999999999999999999998 999999988766655789999999999999999999999998877 


Q ss_pred             cEEEEEecCCCCChHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCCCcEEEccCC-eEEEeeecccee
Q 045286          109 HLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDICKGMEYLHQRN-IIHRDLKTANLLMDTHN-VVKVADFGVARF  185 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~-i~H~di~p~Nilv~~~~-~i~l~D~~~~~~  185 (259)
                      ..++||||+++|+|.+++.. ....++...+..++.||+.++.|||+++ |+|+|+||+|+|++.++ .+||+|||++..
T Consensus       114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE  193 (362)
T ss_pred             ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence            79999999999999999987 4667999999999999999999999999 99999999999999997 999999999987


Q ss_pred             ccCC-CccccCCCcccccCccccC--CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          186 QNKG-GVMTAETGTYRWMAPEVIN--HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       186 ~~~~-~~~~~~~~~~~~~~PE~~~--~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      .... .......||..|+|||++.  ..+++.++|+||||+++|||+||..||.+.++.+....+.....
T Consensus       194 ~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~  263 (362)
T KOG0192|consen  194 KVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGL  263 (362)
T ss_pred             eccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC
Confidence            7654 3344468999999999999  56999999999999999999999999999998777777763333

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=301.16  Aligned_cols=226  Identities=38%  Similarity=0.670  Sum_probs=206.0

Q ss_pred             cccceechhhhhccceeccccceEEEEEEEcCc-eEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~-~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      .+.|+++.+.+.+.+.||+|-||.||.+.+++. +|++|.++......   +.+.+|++++++|+|++|+++++++..+.
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~  274 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQE  274 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence            577999999999999999999999999999987 99999999864443   67889999999999999999999999988


Q ss_pred             cEEEEEecCCCCChHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          109 HLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      .++||+||++.|+|.+++.. ....+.......++.||+++.+||++++++||||...||||+++..+||+|||+++...
T Consensus       275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~  354 (468)
T KOG0197|consen  275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG  354 (468)
T ss_pred             ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC
Confidence            99999999999999999986 55568999999999999999999999999999999999999999999999999999554


Q ss_pred             CCCcc--ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCccC
Q 045286          188 KGGVM--TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQPI  258 (259)
Q Consensus       188 ~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~  258 (259)
                      .....  ...-....|.|||.+....++.+||+||||+++|||.| |+.||.+++..+.+..+.+|++.++|+.
T Consensus       355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~  428 (468)
T KOG0197|consen  355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEG  428 (468)
T ss_pred             CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCC
Confidence            43221  22234678999999999999999999999999999999 9999999999999999999999999873

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-43  Score=272.83  Aligned_cols=217  Identities=27%  Similarity=0.463  Sum_probs=197.4

Q ss_pred             chhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCch-HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCI  112 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l  112 (259)
                      .-++++..+.||.|+||.|.+++.  .+..+|+|++.....-+ ...+...+|.++|+.+.||+++++.+.+.+.++.++
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym  121 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM  121 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence            346788999999999999999986  48899999999875543 344778899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcc
Q 045286          113 VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM  192 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~  192 (259)
                      ||||++|+.|.+++++.++ +++..++-++.|++.+|+|||+.+|++||+||+|||++.+|-+||+|||.+..+...  .
T Consensus       122 vmeyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T  198 (355)
T KOG0616|consen  122 VMEYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--T  198 (355)
T ss_pred             EEeccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--E
Confidence            9999999999999976554 999999999999999999999999999999999999999999999999999877665  4


Q ss_pred             ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCC
Q 045286          193 TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLC  255 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~  255 (259)
                      -..||||.|+|||.+.+++++.++|-|+||+++|||+.|..||-..++.+..++|.++.-.-+
T Consensus       199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP  261 (355)
T KOG0616|consen  199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFP  261 (355)
T ss_pred             EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCC
Confidence            567999999999999999999999999999999999999999999999999999988765443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-43  Score=293.07  Aligned_cols=212  Identities=25%  Similarity=0.435  Sum_probs=188.3

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCch-HHHHHHHHHHHHHHhc-CCCCcceeeeeeecCCcEEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND-TLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      .+|.+++.||.|+|++|++|+..  ++.+|+|++......+ ....-+.+|-.+|.+| .||.|++++-.|+++..+|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            67889999999999999999864  7899999998876544 3345567899999999 699999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcc-
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM-  192 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~-  192 (259)
                      +||+++|+|.+++.+.+ .+++.+++.++.+|+.+|+|||++||+||||||+|||++.++.++|.|||.+..+...... 
T Consensus       153 Le~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~  231 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQ  231 (604)
T ss_pred             EEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccc
Confidence            99999999999997765 4999999999999999999999999999999999999999999999999999765432211 


Q ss_pred             -------------ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          193 -------------TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       193 -------------~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                                   ....||..|.+||++.+...++++|||+|||++|+|+.|..||.+.+..-..++|...
T Consensus       232 ~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l  302 (604)
T KOG0592|consen  232 ENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL  302 (604)
T ss_pred             cCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh
Confidence                         2356899999999999999999999999999999999999999999887777766643

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-42  Score=289.33  Aligned_cols=218  Identities=28%  Similarity=0.549  Sum_probs=194.7

Q ss_pred             echhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCc---hHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCC
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLN---DTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSP  108 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~  108 (259)
                      ....+|.+++.||.|+||+|+.|..  .++.||+|++......   ......+.+|+.+++.+. ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3356899999999999999999986  4799999977765222   134466779999999999 999999999999988


Q ss_pred             cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC-CeEEEeeeccceec-
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH-NVVKVADFGVARFQ-  186 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~-~~i~l~D~~~~~~~-  186 (259)
                      .+++||||+.|++|.+++.. .+.+.+.++..+++|+++++.|+|+.|++||||||+||+++.+ +++||+|||++... 
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence            99999999999999999987 5669999999999999999999999999999999999999999 99999999999988 


Q ss_pred             cCCCccccCCCcccccCccccCCCC-CC-CchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          187 NKGGVMTAETGTYRWMAPEVINHQP-YD-QKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       187 ~~~~~~~~~~~~~~~~~PE~~~~~~-~~-~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      .........+|++.|.|||++.+.. |+ .++|+||+|+++|.|++|..||...+...+...|.++.-.
T Consensus       173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~  241 (370)
T KOG0583|consen  173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFK  241 (370)
T ss_pred             CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCcc
Confidence            5666778889999999999999988 85 7899999999999999999999999988888887766443

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-43  Score=288.09  Aligned_cols=221  Identities=22%  Similarity=0.374  Sum_probs=201.9

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCC-cEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSP-HLCI  112 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~-~~~l  112 (259)
                      .++|.+.++||.|.||.||+|+..  ++.||||..+.....-+ ...-+||+..|++++ ||||+++.+++.+.+ .+++
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            468999999999999999999864  78899999988754421 133458999999999 999999999998887 8999


Q ss_pred             EEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcc
Q 045286          113 VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM  192 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~  192 (259)
                      |||++ ...|.+++..+++.+++..+..|+.||+++|+++|.+|++|||+||+|||++.+..+||.|||+|+......+.
T Consensus        88 VfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY  166 (538)
T KOG0661|consen   88 VFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY  166 (538)
T ss_pred             eHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCc
Confidence            99999 67999999888888999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCccCC
Q 045286          193 TAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY  259 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~  259 (259)
                      +.+..|..|+|||++.. .-|+.+.|||++||+++|+.+-++.|++.+..+++.+|...++++....|
T Consensus       167 TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~  234 (538)
T KOG0661|consen  167 TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW  234 (538)
T ss_pred             chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence            99999999999999754 56899999999999999999999999999999999999999999876654

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.3e-42  Score=274.02  Aligned_cols=221  Identities=25%  Similarity=0.380  Sum_probs=201.5

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC--CcEEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS--PHLCIV  113 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv  113 (259)
                      +.|+..+.|+.|.||.||+|++.  ++-||+|.++.+...+...-..+||+.+|.+.+||||+.+-++....  +.+|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            68899999999999999999985  78999999999877766777788999999999999999998877543  579999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-Ccc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVM  192 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~  192 (259)
                      |||++ .+|...+.....++...++..++.|+++++.|||++.|+|||+|++|+|++..|.+|++|||+|+....+ ..+
T Consensus       156 Me~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~  234 (419)
T KOG0663|consen  156 MEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPY  234 (419)
T ss_pred             HHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccC
Confidence            99994 5999999998888999999999999999999999999999999999999999999999999999987766 456


Q ss_pred             ccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCccCC
Q 045286          193 TAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY  259 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~  259 (259)
                      +...-|..|+|||++.+. .|+.+.|+||+||++.+|+++++.|++.+..+++.+|-+.++.+.-..|
T Consensus       235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iw  302 (419)
T KOG0663|consen  235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIW  302 (419)
T ss_pred             cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccC
Confidence            677789999999999876 6899999999999999999999999999999999999999988876655

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.3e-42  Score=273.39  Aligned_cols=222  Identities=25%  Similarity=0.419  Sum_probs=199.3

Q ss_pred             hhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCC-cceeeeeeecCC-----
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRN-VVRFIGASTKSP-----  108 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~-----  108 (259)
                      -..|...++||.|++|+||+|..  +|+.||+|+++.+...+.......+|+.++++++|+| |+++++++....     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            45788888899999999999996  4889999999988665556677889999999999999 999999987766     


Q ss_pred             -cEEEEEecCCCCChHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccce
Q 045286          109 -HLCIVTEYMPGGSLYDYLHKNH---NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR  184 (259)
Q Consensus       109 -~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~  184 (259)
                       ..++|+||. ..+|..++....   ..++...+..++.||+.+|+|||+++|+|||+||.||+++.+|.+||+|||++.
T Consensus        90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr  168 (323)
T KOG0594|consen   90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR  168 (323)
T ss_pred             ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence             789999999 669999997766   347778899999999999999999999999999999999999999999999998


Q ss_pred             ecc-CCCccccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCccCC
Q 045286          185 FQN-KGGVMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY  259 (259)
Q Consensus       185 ~~~-~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~  259 (259)
                      ... +.........|..|+|||++.+. .|+...||||+||+++||+++...|++.+..+++..|-+..+++....|
T Consensus       169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            666 33446777889999999999887 7899999999999999999999999999999999999999999988777

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.4e-42  Score=278.39  Aligned_cols=220  Identities=25%  Similarity=0.495  Sum_probs=203.0

Q ss_pred             hhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCch-HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      ..+|.+.+.||+|.+|.|-+|..  .|+.||+|.++.+...+ ...-.+.+|++++..|+||||+.++++|+..+.+.+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            56899999999999999999985  48999999999876643 4557788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT  193 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~  193 (259)
                      |||..++.|.+++.+.. .+++.+++.+++||.+++.|+|+++++|+|+|.+|||++.++++||.|||++..........
T Consensus       132 MEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLq  210 (668)
T KOG0611|consen  132 MEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQ  210 (668)
T ss_pred             EEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHH
Confidence            99999999999997665 49999999999999999999999999999999999999999999999999999999998889


Q ss_pred             cCCCcccccCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc-cCCCCcc
Q 045286          194 AETGTYRWMAPEVINHQPY-DQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV-CTSLCQP  257 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~-~~~~~~~  257 (259)
                      ..||++.|.+||.+.|.+| ++.+|.||||+++|.+..|..||++.+...++.+|.+| ++.+..|
T Consensus       211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~P  276 (668)
T KOG0611|consen  211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETP  276 (668)
T ss_pred             HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCC
Confidence            9999999999999999998 68999999999999999999999999999999999865 4444443

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6e-42  Score=291.00  Aligned_cols=217  Identities=32%  Similarity=0.560  Sum_probs=202.4

Q ss_pred             hhhhccceeccccceEEEEEEE--cCceEEEEEeecc-cCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSE-HLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      .-|++++.||.|+.|.|-+|++  +|+.+|||++... .........+.+|+.+++-++|||+++++++++....+|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            3577889999999999999997  5999999999876 455566688999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTA  194 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~  194 (259)
                      ||++||-|.+++...+ .+.+.+++.++.||+.++.|+|..+|+|+|+||+|+|++..++|||.|||.|.....+.....
T Consensus        92 Eyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeT  170 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLET  170 (786)
T ss_pred             EecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccccc
Confidence            9999999999996655 499999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCcccccCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCC
Q 045286          195 ETGTYRWMAPEVINHQPY-DQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLC  255 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~  255 (259)
                      .||.+.|.+||.+.|.+| +.++||||.|+++|.||+|++||++.+.+..+.++++|.-.++
T Consensus       171 SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP  232 (786)
T KOG0588|consen  171 SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP  232 (786)
T ss_pred             cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC
Confidence            999999999999999999 6799999999999999999999999999999999999987665

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.1e-41  Score=281.78  Aligned_cols=217  Identities=24%  Similarity=0.390  Sum_probs=191.3

Q ss_pred             eechhhhhccceeccccceEEEEEE--EcCceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcE
Q 045286           34 EIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL  110 (259)
Q Consensus        34 ~~~~~~~~~~~~lg~G~~~~V~~~~--~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~  110 (259)
                      .+.-+++.+.++||+|+||.||+|.  ++|+-+|+|+++.... ..+....+..|-.+|....++.|++++-.|++.+++
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            4566889999999999999999997  5799999999998644 345667888999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC--
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK--  188 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~--  188 (259)
                      |+||||++||++-.++...+ .+++..++-++.+++-|+..+|+.|++|+||||+|+|++..|.+||+|||++.-...  
T Consensus       217 YLiMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~  295 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH  295 (550)
T ss_pred             EEEEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence            99999999999999995544 599999999999999999999999999999999999999999999999999742110  


Q ss_pred             -------------------CCccc---------------------------cCCCcccccCccccCCCCCCCchhHHHHH
Q 045286          189 -------------------GGVMT---------------------------AETGTYRWMAPEVINHQPYDQKADVFSFA  222 (259)
Q Consensus       189 -------------------~~~~~---------------------------~~~~~~~~~~PE~~~~~~~~~~~Di~slG  222 (259)
                                         +....                           ...|||.|+|||++.+..|+...|.||||
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG  375 (550)
T KOG0605|consen  296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG  375 (550)
T ss_pred             hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence                               00000                           11489999999999999999999999999


Q ss_pred             HHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          223 IVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       223 ~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      |++||||.|.+||...++.+...+|..-.
T Consensus       376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr  404 (550)
T KOG0605|consen  376 CIMYEMLVGYPPFCSETPQETYRKIVNWR  404 (550)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            99999999999999999999999988544

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7e-41  Score=271.16  Aligned_cols=213  Identities=31%  Similarity=0.520  Sum_probs=180.9

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC--cEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP--HLCI  112 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~l  112 (259)
                      ..++..++.||+|+||.||++...  ++..|||.........  .+.+.+|+.+|.+++||+|+++++......  .+++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            457889999999999999999986  6999999999873222  577899999999999999999999744433  6999


Q ss_pred             EEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc-CCeEEEeeeccceeccC---
Q 045286          113 VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT-HNVVKVADFGVARFQNK---  188 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~-~~~i~l~D~~~~~~~~~---  188 (259)
                      +|||+++++|.+++...++.+++..+..+++|++++|.|||++|++|+||||+|||++. ++.+||.|||.+.....   
T Consensus        94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            99999999999999876657999999999999999999999999999999999999999 79999999999876663   


Q ss_pred             -CCccccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHhhhcc
Q 045286          189 -GGVMTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDS-MTPLQAALGVRQVC  251 (259)
Q Consensus       189 -~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~-~~~~~~~~~i~~~~  251 (259)
                       ........|++.|+|||++.+ ....+++|||||||++.+|+||+.||.. ....+.+..+....
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~  239 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED  239 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC
Confidence             222345679999999999985 3345699999999999999999999998 45555554444333

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3e-41  Score=282.38  Aligned_cols=213  Identities=33%  Similarity=0.532  Sum_probs=192.6

Q ss_pred             hhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ++|.+.+.||.|+||.||+|+-  +.+.||+|.+.+....+.....+.+|++++++++||||+.++++|+.....|+|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            3677889999999999999984  57899999999988777777889999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-cccc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMTA  194 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~~  194 (259)
                      |+.| +|..++... +.++++.+..++.++.++|.|||+++|.|+|+||.||++..+|.+|++|||+++-+..+. ....
T Consensus        82 ~a~g-~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlts  159 (808)
T KOG0597|consen   82 YAVG-DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTS  159 (808)
T ss_pred             hhhh-hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeee
Confidence            9976 999999554 459999999999999999999999999999999999999999999999999998766553 3345


Q ss_pred             CCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          195 ETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      .-|+|.|+|||++.+.+|+..+|+|||||++||++.|++||=..+..+.++.|...-.
T Consensus       160 ikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v  217 (808)
T KOG0597|consen  160 IKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPV  217 (808)
T ss_pred             ccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCC
Confidence            5699999999999999999999999999999999999999998888888888775433

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=285.75  Aligned_cols=225  Identities=37%  Similarity=0.653  Sum_probs=204.3

Q ss_pred             cccceechhhhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCc
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPH  109 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~  109 (259)
                      .++|+|+...+.+...||+|+||+||+|.|-| .||||++......++..+.|++|+..+++-+|.||+-+.+++...+.
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            37799999999999999999999999999976 78999999999999999999999999999999999999999987655


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG  189 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~  189 (259)
                       .+|..|++|.+|..+++....+++....+.|++|++.++.|||.++|+|+|+|..|||+.+++.++|+|||++......
T Consensus       463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w  541 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW  541 (678)
T ss_pred             -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence             8999999999999999877778999999999999999999999999999999999999999999999999999755443


Q ss_pred             ---CccccCCCcccccCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          190 ---GVMTAETGTYRWMAPEVIN---HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       190 ---~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                         .......+...|+|||++.   ..+|++++|+||||+++|||++|.+||...+.++.+..+-+|+.++.+
T Consensus       542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~  614 (678)
T KOG0193|consen  542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDL  614 (678)
T ss_pred             ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccc
Confidence               2334456788999999985   458999999999999999999999999999999999999998776543

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.6e-40  Score=279.27  Aligned_cols=211  Identities=26%  Similarity=0.410  Sum_probs=183.1

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      +|++.+.||+|++|+||++.+.  ++.||+|++..... .......+.+|..++++++|++|+++++.+......++|||
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E   81 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME   81 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence            5788899999999999999874  78999999986432 22344667889999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-----
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-----  190 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-----  190 (259)
                      |+++++|.+++... ..+++..+..++.|++.+|.+||+.|++||||||+||+++.++.++|+|||++.......     
T Consensus        82 ~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~  160 (363)
T cd05628          82 FLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY  160 (363)
T ss_pred             CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence            99999999999654 358999999999999999999999999999999999999999999999999986432210     


Q ss_pred             -------------------------------ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 045286          191 -------------------------------VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT  239 (259)
Q Consensus       191 -------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  239 (259)
                                                     .....+|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~  240 (363)
T cd05628         161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (363)
T ss_pred             ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence                                           0113468999999999999999999999999999999999999999988


Q ss_pred             HHHHHHHhhhc
Q 045286          240 PLQAALGVRQV  250 (259)
Q Consensus       240 ~~~~~~~i~~~  250 (259)
                      ..+....+...
T Consensus       241 ~~~~~~~i~~~  251 (363)
T cd05628         241 PQETYKKVMNW  251 (363)
T ss_pred             HHHHHHHHHcC
Confidence            88877777653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-41  Score=280.36  Aligned_cols=213  Identities=31%  Similarity=0.557  Sum_probs=192.7

Q ss_pred             chhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      +..+|...++||+|++|.||.|...  ++.||+|.+.......  .+.+.+|+.+++..+|+||+.+++.+...+.+|+|
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV  348 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV  348 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence            3578888999999999999999864  6789999998875543  37788999999999999999999999888999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-cc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VM  192 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~  192 (259)
                      |||++|++|.+.+....  +++.++..++++++.||++||.+||+|+|||.+|||.+.+|++||+|||++....... ..
T Consensus       349 MEym~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR  426 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR  426 (550)
T ss_pred             EeecCCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence            99999999999986655  8999999999999999999999999999999999999999999999999998766543 56


Q ss_pred             ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          193 TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      ....||+.|+|||++....|+++.||||||++++||+.|..||-+.++...+..|...-.
T Consensus       427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~  486 (550)
T KOG0578|consen  427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT  486 (550)
T ss_pred             ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCC
Confidence            677899999999999999999999999999999999999999999999888888775433

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.4e-41  Score=270.15  Aligned_cols=211  Identities=27%  Similarity=0.426  Sum_probs=185.5

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC-----cE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP-----HL  110 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~  110 (259)
                      -.|...+++|+|+||.||+|...  ++.+|||....+..-      -.+|+++++.+.||||+++.-+|....     ..
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l   97 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL   97 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence            36777899999999999999864  689999999876432      347999999999999999998875421     45


Q ss_pred             EEEEecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC-CeEEEeeeccceec
Q 045286          111 CIVTEYMPGGSLYDYLHK---NHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH-NVVKVADFGVARFQ  186 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~-~~i~l~D~~~~~~~  186 (259)
                      .+||||+ ..+|.+.+..   ....++...+.-++.||+++|.|||..||+||||||.|+||+.+ |.+||||||+|...
T Consensus        98 nlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen   98 NLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            7899999 4599998864   24558888899999999999999999999999999999999986 89999999999998


Q ss_pred             cCCCccccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCC
Q 045286          187 NKGGVMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLC  255 (259)
Q Consensus       187 ~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~  255 (259)
                      ..+.+...+.-+..|+|||++.|. .|+.+.||||.||++.||+.|++.|++.+..+++..|.+.++.+.
T Consensus       177 ~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt  246 (364)
T KOG0658|consen  177 VKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPT  246 (364)
T ss_pred             ccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCC
Confidence            888887788889999999998876 789999999999999999999999999999999999999888765

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.7e-41  Score=278.59  Aligned_cols=222  Identities=25%  Similarity=0.469  Sum_probs=206.2

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCc-EEEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPH-LCIVT  114 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv~  114 (259)
                      +.|..++.+|.|+||.++++...  +..+++|.+......+...+...+|+.+++++.||||+.+.+.|...+. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57888999999999999988764  6789999999988887777789999999999999999999999988888 99999


Q ss_pred             ecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-cc
Q 045286          115 EYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VM  192 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~  192 (259)
                      +|++|+++.+.+.+.. ..++++.++.++-|++.++.|||+++|+|||+|+.|||.+.++.|+|.|||++...++.. ..
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a  163 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLA  163 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhhh
Confidence            9999999999997655 568999999999999999999999999999999999999999999999999999888876 67


Q ss_pred             ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCccCC
Q 045286          193 TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY  259 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~  259 (259)
                      ....||+.|++||.+.+.+|+.++|||||||++|+|++-+++|...+..+.+-+|.++...+.|..|
T Consensus       164 ~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~y  230 (426)
T KOG0589|consen  164 STVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMY  230 (426)
T ss_pred             heecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccc
Confidence            7889999999999999999999999999999999999999999999999999999999977777654

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-40  Score=269.91  Aligned_cols=210  Identities=26%  Similarity=0.411  Sum_probs=184.2

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN-DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      +|++.++||+|++|.||+|.+.  ++.|++|++...... ......+.+|+.+++.++||||+++++.+.+.+..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   81 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME   81 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence            5788899999999999999975  789999999765332 2344668899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccccC
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAE  195 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~~  195 (259)
                      |+++++|.+++.... .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+......  ....
T Consensus        82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~~  158 (291)
T cd05612          82 YVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWTL  158 (291)
T ss_pred             CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--cccc
Confidence            999999999986544 5888999999999999999999999999999999999999999999999998765432  2234


Q ss_pred             CCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          196 TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       196 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      .+++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+....+..+.
T Consensus       159 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~  214 (291)
T cd05612         159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK  214 (291)
T ss_pred             cCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence            68899999999999999999999999999999999999999988877777776554

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.1e-39  Score=268.06  Aligned_cols=218  Identities=24%  Similarity=0.424  Sum_probs=186.3

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ++|++.++||.|++|.||+|.+.  ++.|++|++...... .....+.+|+.+++.++|+||+++++++...+..++|+|
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            56888999999999999999874  789999999765322 223567789999999999999999999998889999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-cccc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMTA  194 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~~  194 (259)
                      ++++ +|.+++......++...+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+....... ....
T Consensus        84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~  162 (288)
T cd07871          84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN  162 (288)
T ss_pred             CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccC
Confidence            9965 8999887666668889999999999999999999999999999999999999999999999987544322 2234


Q ss_pred             CCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          195 ETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      ..+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+..+.+..+.+..+.+.+.
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  226 (288)
T cd07871         163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEE  226 (288)
T ss_pred             ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChH
Confidence            467889999999865 568999999999999999999999999999888888887766655443

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-40  Score=274.22  Aligned_cols=209  Identities=24%  Similarity=0.391  Sum_probs=183.9

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN-DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      .|++.++||+|++|.||+|.+.  ++.|++|++...... ......+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            5788899999999999999974  789999999865332 2344668889999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccccC
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAE  195 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~~  195 (259)
                      |+++++|.+++.... .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.....  .....
T Consensus        82 ~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~~  158 (333)
T cd05600          82 YVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSV  158 (333)
T ss_pred             CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCCc
Confidence            999999999996543 588999999999999999999999999999999999999999999999999875544  22345


Q ss_pred             CCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          196 TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       196 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      .+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+..+....+...
T Consensus       159 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~  213 (333)
T cd05600         159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW  213 (333)
T ss_pred             ccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc
Confidence            6899999999999989999999999999999999999999998887777666543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-40  Score=266.87  Aligned_cols=218  Identities=30%  Similarity=0.510  Sum_probs=192.2

Q ss_pred             cccccceechhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeee
Q 045286           28 TKSEDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST  105 (259)
Q Consensus        28 ~~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~  105 (259)
                      .....|.+..+.|.+...||.|..++||+|.-  .++.||||++..+.-+.. .+.+.+|+..++.++||||+.++..|.
T Consensus        16 ~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFv   94 (516)
T KOG0582|consen   16 SSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFV   94 (516)
T ss_pred             cccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence            34456899999999999999999999999985  479999999998876555 688999999999999999999999999


Q ss_pred             cCCcEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccce
Q 045286          106 KSPHLCIVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR  184 (259)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~  184 (259)
                      .+..+|+||+++.+|++.+.+... ...+++..+..++++++++|.|||++|.+|||||+.|||++.+|.++|.|||.+.
T Consensus        95 v~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa  174 (516)
T KOG0582|consen   95 VDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSA  174 (516)
T ss_pred             ecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeee
Confidence            999999999999999999999643 4459999999999999999999999999999999999999999999999999875


Q ss_pred             ecc-CCCcc----ccCCCcccccCccccC--CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 045286          185 FQN-KGGVM----TAETGTYRWMAPEVIN--HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALG  246 (259)
Q Consensus       185 ~~~-~~~~~----~~~~~~~~~~~PE~~~--~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~  246 (259)
                      .+. .+...    ....+++.|+|||++.  ...|+.++||||||+++.|+.+|+.||....+.+++..
T Consensus       175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~  243 (516)
T KOG0582|consen  175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL  243 (516)
T ss_pred             eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH
Confidence            432 22222    3347999999999964  34799999999999999999999999999999888743

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-40  Score=264.29  Aligned_cols=223  Identities=26%  Similarity=0.414  Sum_probs=197.9

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec--
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK--  106 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--  106 (259)
                      ..|+++. +|...+.||.|++|.|..+.+.  ++.||+|++...........+..||+.+|+.++|+||+.+.+++..  
T Consensus        16 ~~~~i~~-~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~   94 (359)
T KOG0660|consen   16 ELFEIPR-YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPS   94 (359)
T ss_pred             eEEeccc-eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccc
Confidence            3466654 5555899999999999999874  8999999999888888888999999999999999999999999865  


Q ss_pred             ---CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccc
Q 045286          107 ---SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA  183 (259)
Q Consensus       107 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~  183 (259)
                         -.-+|+|+|.+ +.+|...+... ..+++..+..++.|++.+|.|+|+.+++|||+||+|++++.+..+|++|||+|
T Consensus        95 ~~~f~DvYiV~elM-etDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen   95 RDKFNDVYLVFELM-ETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             ccccceeEEehhHH-hhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccce
Confidence               23579999999 77899888544 44999999999999999999999999999999999999999999999999999


Q ss_pred             eeccC---CCccccCCCcccccCccccC-CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          184 RFQNK---GGVMTAETGTYRWMAPEVIN-HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       184 ~~~~~---~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      +....   ...++....|..|.|||++. ...|+.+.||||+||++.||++|+..|++.+...++..|....+++.+
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~  249 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE  249 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence            87753   55667788999999999975 558999999999999999999999999999999999999998888754

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1e-39  Score=273.91  Aligned_cols=218  Identities=24%  Similarity=0.381  Sum_probs=189.3

Q ss_pred             cceechhhhhccceeccccceEEEEEEEc---CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 045286           32 DWEIDRRLLKTGERIASGSCGDLYRGVYL---GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKS  107 (259)
Q Consensus        32 ~~~~~~~~~~~~~~lg~G~~~~V~~~~~~---~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~  107 (259)
                      ...+..+.|.+.+.||.|++|.||+|.+.   +..|++|.+..... .......+.+|+.+++.++||||+++++++...
T Consensus        24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~  103 (340)
T PTZ00426         24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE  103 (340)
T ss_pred             CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence            35566788999999999999999999864   25799999876432 223446788999999999999999999999999


Q ss_pred             CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      +..++||||+++++|.+++.... .+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+....
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            99999999999999999996544 48899999999999999999999999999999999999999999999999987654


Q ss_pred             CCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          188 KGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       188 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      ..  .....+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+.++..
T Consensus       183 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~  245 (340)
T PTZ00426        183 TR--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII  245 (340)
T ss_pred             CC--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Confidence            32  2345689999999999998899999999999999999999999999888777777766543

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.4e-39  Score=272.11  Aligned_cols=211  Identities=27%  Similarity=0.406  Sum_probs=185.9

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN-DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      ..|.+.+.||+|++|.||+|.+.  ++.|++|++...... ......+.+|+.++++++||||+++++.+...+..+++|
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            67889999999999999999974  789999999865322 233467889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTA  194 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~  194 (259)
                      ||+++++|.+++.... .+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+.......  ..
T Consensus        98 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~  174 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--FT  174 (329)
T ss_pred             cCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--ce
Confidence            9999999999986543 58888999999999999999999999999999999999999999999999987664432  23


Q ss_pred             CCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          195 ETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ..+++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+....+..+.
T Consensus       175 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~  231 (329)
T PTZ00263        175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR  231 (329)
T ss_pred             ecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC
Confidence            468999999999999999999999999999999999999999888877777776553

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=276.43  Aligned_cols=211  Identities=24%  Similarity=0.382  Sum_probs=182.7

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      +|++.+.||+|+||.||+|.+.  ++.||+|++..... .......+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME   81 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence            6788899999999999999974  78999999986532 23344667889999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc----
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV----  191 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~----  191 (259)
                      |+++++|.+++.... .+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+........    
T Consensus        82 ~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (364)
T cd05599          82 YLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY  160 (364)
T ss_pred             CCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence            999999999986544 589999999999999999999999999999999999999999999999999864322110    


Q ss_pred             -----------------------------------cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 045286          192 -----------------------------------MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYD  236 (259)
Q Consensus       192 -----------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~  236 (259)
                                                         .....|++.|+|||++.+..++.++|+|||||++|+|++|..||.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~  240 (364)
T cd05599         161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC  240 (364)
T ss_pred             ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence                                               012358899999999999899999999999999999999999999


Q ss_pred             CCCHHHHHHHhhhc
Q 045286          237 SMTPLQAALGVRQV  250 (259)
Q Consensus       237 ~~~~~~~~~~i~~~  250 (259)
                      ..+..+....+...
T Consensus       241 ~~~~~~~~~~i~~~  254 (364)
T cd05599         241 SDNPQETYRKIINW  254 (364)
T ss_pred             CCCHHHHHHHHHcC
Confidence            98887777766543

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5.2e-40  Score=279.72  Aligned_cols=213  Identities=29%  Similarity=0.427  Sum_probs=190.8

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcC-C-----CCcceeeeeeecCCc
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-H-----RNVVRFIGASTKSPH  109 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~-----~~i~~~~~~~~~~~~  109 (259)
                      .+|.+.+.||+|+||+|.+|.+.  ++.||||+++..   +........|+.+|..++ |     -|+++++++|...++
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            48889999999999999999984  789999999986   344466778999999997 3     599999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC--eEEEeeeccceec
Q 045286          110 LCIVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN--VVKVADFGVARFQ  186 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~--~i~l~D~~~~~~~  186 (259)
                      .|+|+|.+ +.+|.+++..+ ...++...++.++.||+.+|..||..||+|+||||+|||+..-+  .||+||||++++.
T Consensus       263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            99999999 77999999654 34589999999999999999999999999999999999996543  6999999999988


Q ss_pred             cCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          187 NKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       187 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      ...--  .+..+..|+|||++.|.+|+.+.|||||||+++||++|.+.|++.+..+++..|.+.++.+++
T Consensus       342 ~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~  409 (586)
T KOG0667|consen  342 SQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP  409 (586)
T ss_pred             CCcce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence            77633  667888999999999999999999999999999999999999999999999999999996654

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.7e-39  Score=264.34  Aligned_cols=217  Identities=26%  Similarity=0.416  Sum_probs=182.3

Q ss_pred             hhhccceeccccceEEEEEEEc---CceEEEEEeecccCchHHHHHHHHHHHHHHhc---CCCCcceeeeeee-----cC
Q 045286           39 LLKTGERIASGSCGDLYRGVYL---GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV---QHRNVVRFIGAST-----KS  107 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~---~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~-----~~  107 (259)
                      +|++.+.||+|+||.||+|.+.   ++.||+|.+............+.+|+.+++.+   +||||+++++++.     ..
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            6888899999999999999873   57899999887654443344566777777766   5999999999874     34


Q ss_pred             CcEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                      ...++++|+++ ++|.+++.... ..+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+...
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY  160 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence            56899999995 58999886543 34888999999999999999999999999999999999999999999999999766


Q ss_pred             cCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          187 NKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       187 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      ..........+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+.+..+......+.+
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~  230 (290)
T cd07862         161 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  230 (290)
T ss_pred             cCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence            5544444556889999999998888999999999999999999999999999988888888766554433

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-40  Score=275.89  Aligned_cols=210  Identities=27%  Similarity=0.439  Sum_probs=185.6

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCch-HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      +|.+.+.||+|++|+||+|.+.  ++.||+|++....... .....+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            6788999999999999999986  8899999998653322 344678899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-----
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-----  190 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-----  190 (259)
                      |+++++|.+++... ..+++..++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+.......     
T Consensus        82 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (350)
T cd05573          82 YMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY  160 (350)
T ss_pred             CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence            99999999999765 458999999999999999999999999999999999999999999999999987654432     


Q ss_pred             -------------------------ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 045286          191 -------------------------VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL  245 (259)
Q Consensus       191 -------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~  245 (259)
                                               ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+..+...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~  240 (350)
T cd05573         161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN  240 (350)
T ss_pred             ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHH
Confidence                                     1233458899999999999999999999999999999999999999988877777


Q ss_pred             Hhhh
Q 045286          246 GVRQ  249 (259)
Q Consensus       246 ~i~~  249 (259)
                      .+..
T Consensus       241 ~i~~  244 (350)
T cd05573         241 KIIN  244 (350)
T ss_pred             HHhc
Confidence            7765

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.2e-39  Score=263.58  Aligned_cols=201  Identities=26%  Similarity=0.442  Sum_probs=175.8

Q ss_pred             hhccceeccccceEEEEEEE--cCceEEEEEeecccCc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           40 LKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLN-DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      |+..+.||+|+||.||++.+  .++.||+|.+...... ......+.+|+.+++.++|++|+++.+.+...+..++++||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            56788999999999999986  4889999998765432 22335678899999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccccC
Q 045286          117 MPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAE  195 (259)
Q Consensus       117 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~~  195 (259)
                      +++++|...+... ...+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+............
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  161 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR  161 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCC
Confidence            9999999887543 335888999999999999999999999999999999999999999999999999876544444455


Q ss_pred             CCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 045286          196 TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTP  240 (259)
Q Consensus       196 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~  240 (259)
                      .++..|+|||.+.+..++.++|+|||||++|+|++|..||...+.
T Consensus       162 ~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~  206 (285)
T cd05631         162 VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE  206 (285)
T ss_pred             CCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence            789999999999999999999999999999999999999987554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.4e-39  Score=274.54  Aligned_cols=219  Identities=22%  Similarity=0.359  Sum_probs=187.5

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKS  107 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~  107 (259)
                      ....+..++|++.+.||+|+||.||++.+.  ++.+|+|++..... .......+.+|+.+++.++||||+++++.+..+
T Consensus        36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (370)
T cd05621          36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD  115 (370)
T ss_pred             HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            446667789999999999999999999974  68899999875322 223345677899999999999999999999999


Q ss_pred             CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      +..++||||+++++|.+++...  .+++..+..++.|++.+|.+||+.|++||||||+||+++.++.++|+|||.+....
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            9999999999999999998654  37888999999999999999999999999999999999999999999999997664


Q ss_pred             CCCc--cccCCCcccccCccccCCCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          188 KGGV--MTAETGTYRWMAPEVINHQP----YDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       188 ~~~~--~~~~~~~~~~~~PE~~~~~~----~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ....  .....+++.|+|||.+.+..    ++.++|+||+||++|+|++|..||...+..+...++....
T Consensus       194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~  263 (370)
T cd05621         194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK  263 (370)
T ss_pred             cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence            3322  23456899999999987643    6789999999999999999999999888877777776543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-39  Score=276.05  Aligned_cols=210  Identities=23%  Similarity=0.341  Sum_probs=179.9

Q ss_pred             hhhccceeccccceEEEEEEE--cCceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           39 LLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      +|.+.++||+|+||.||++.+  .++.||+|++..... .......+.+|+.+++.++||||+++++.+...+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E   81 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME   81 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence            577889999999999999987  478999999876432 23345678889999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-----
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-----  190 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-----  190 (259)
                      |+++++|.+++... ..+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||++.......     
T Consensus        82 ~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  160 (377)
T cd05629          82 FLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY  160 (377)
T ss_pred             CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence            99999999998654 458899999999999999999999999999999999999999999999999885321100     


Q ss_pred             -------------------------------------------ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHH
Q 045286          191 -------------------------------------------VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWE  227 (259)
Q Consensus       191 -------------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~  227 (259)
                                                                 ......+++.|+|||.+.+..++.++|+|||||++|+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e  240 (377)
T cd05629         161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE  240 (377)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence                                                       0002358899999999999999999999999999999


Q ss_pred             HHcCCCCCCCCCHHHHHHHhhh
Q 045286          228 LVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       228 ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                      |++|..||...+..+....+..
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~  262 (377)
T cd05629         241 CLIGWPPFCSENSHETYRKIIN  262 (377)
T ss_pred             hhcCCCCCCCCCHHHHHHHHHc
Confidence            9999999998887777666654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.6e-39  Score=269.04  Aligned_cols=206  Identities=23%  Similarity=0.424  Sum_probs=177.9

Q ss_pred             ceeccccceEEEEEEE--cCceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCCCC
Q 045286           44 ERIASGSCGDLYRGVY--LGQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGG  120 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~  120 (259)
                      +.||+|+||.||++.+  .++.||+|++..... .......+.+|+.++++++||||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4799999999999986  478999999986532 2334466788999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC-CCccccCCCcc
Q 045286          121 SLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMTAETGTY  199 (259)
Q Consensus       121 ~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~-~~~~~~~~~~~  199 (259)
                      +|.+++... ..+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+..... ........+++
T Consensus        81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  159 (323)
T cd05571          81 ELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCc
Confidence            999988654 3588999999999999999999999999999999999999999999999999865322 22233456899


Q ss_pred             cccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          200 RWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       200 ~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      .|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+...
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~  210 (323)
T cd05571         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME  210 (323)
T ss_pred             cccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC
Confidence            999999999999999999999999999999999999888777666665543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3e-39  Score=275.49  Aligned_cols=210  Identities=24%  Similarity=0.394  Sum_probs=179.9

Q ss_pred             hhhccceeccccceEEEEEEE--cCceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           39 LLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      +|...++||+|+||.||+|.+  .++.+|+|++..... .......+.+|+.+++.++|++|+++++.+...+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            577889999999999999987  468899999876432 23445678899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC------
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG------  189 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~------  189 (259)
                      |+++++|.+++... ..+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||++......      
T Consensus        82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence            99999999998654 35888999999999999999999999999999999999999999999999986422100      


Q ss_pred             ------------------------------------------CccccCCCcccccCccccCCCCCCCchhHHHHHHHHHH
Q 045286          190 ------------------------------------------GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWE  227 (259)
Q Consensus       190 ------------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~  227 (259)
                                                                .......+++.|+|||++.+..++.++|+|||||++|+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e  240 (382)
T cd05625         161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  240 (382)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence                                                      00112358899999999999999999999999999999


Q ss_pred             HHcCCCCCCCCCHHHHHHHhhh
Q 045286          228 LVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       228 ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                      |++|..||...+..+....+..
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~  262 (382)
T cd05625         241 MLVGQPPFLAQTPLETQMKVIN  262 (382)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHc
Confidence            9999999998888776666654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.8e-39  Score=274.69  Aligned_cols=209  Identities=25%  Similarity=0.403  Sum_probs=179.2

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      .|+..+.||+|+||+||+|.+.  ++.||+|++..... .......+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5778899999999999999874  67899999986533 33445678899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC------
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG------  189 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~------  189 (259)
                      |+++++|.+++.... .+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||++......      
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~  160 (381)
T cd05626          82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY  160 (381)
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence            999999999986543 4888899999999999999999999999999999999999999999999986432100      


Q ss_pred             ------------------------------------------CccccCCCcccccCccccCCCCCCCchhHHHHHHHHHH
Q 045286          190 ------------------------------------------GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWE  227 (259)
Q Consensus       190 ------------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~  227 (259)
                                                                .......+++.|+|||.+.+..++.++|+|||||++|+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e  240 (381)
T cd05626         161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE  240 (381)
T ss_pred             cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence                                                      00112358899999999999899999999999999999


Q ss_pred             HHcCCCCCCCCCHHHHHHHhh
Q 045286          228 LVTAKVPYDSMTPLQAALGVR  248 (259)
Q Consensus       228 ll~g~~p~~~~~~~~~~~~i~  248 (259)
                      |++|..||...+..+....+.
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~  261 (381)
T cd05626         241 MLVGQPPFLAPTPTETQLKVI  261 (381)
T ss_pred             HHhCCCCCcCCCHHHHHHHHH
Confidence            999999999887766655554

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-40  Score=278.90  Aligned_cols=215  Identities=26%  Similarity=0.439  Sum_probs=192.2

Q ss_pred             eechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCCc
Q 045286           34 EIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPH  109 (259)
Q Consensus        34 ~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~  109 (259)
                      .+.-+++.+.++||.|+||+|+++...  ++.+|||++++... .++..+..+.|.+++.-.+ ||.++.++..|+..++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            444578899999999999999999875  68999999998755 3455677888888888886 9999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc-C
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN-K  188 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~-~  188 (259)
                      .|+||||+.|+++....  ..+.+++..+.-++..++.+|.|||++||+|||+|.+|||++.+|.+||+|||++.... .
T Consensus       444 l~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             EEEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence            99999999999954443  33459999999999999999999999999999999999999999999999999998655 6


Q ss_pred             CCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       189 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      +......|||+.|+|||++.+..|+.++|.||||+++|+||.|..||++.+.++.-+.|...
T Consensus       522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d  583 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND  583 (694)
T ss_pred             CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC
Confidence            66777889999999999999999999999999999999999999999999999988888754

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.1e-39  Score=273.28  Aligned_cols=220  Identities=23%  Similarity=0.345  Sum_probs=188.0

Q ss_pred             cccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeec
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTK  106 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~  106 (259)
                      .....+..++|.+.+.||+|+||.||++.+.  ++.+|+|++..... .......+.+|..+++.++||||+++++.+..
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            4456777899999999999999999999874  78899999875332 22334557789999999999999999999999


Q ss_pred             CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          107 SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                      .+..++||||+++++|.+++...  .+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+...
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~  192 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence            99999999999999999998654  3788889999999999999999999999999999999999999999999998765


Q ss_pred             cCCC--ccccCCCcccccCccccCCCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          187 NKGG--VMTAETGTYRWMAPEVINHQP----YDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       187 ~~~~--~~~~~~~~~~~~~PE~~~~~~----~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ....  ......+++.|+|||++.+..    ++.++|+|||||++|+|++|..||...+..+....+....
T Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~  263 (371)
T cd05622         193 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK  263 (371)
T ss_pred             CcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence            4332  123456899999999987543    7889999999999999999999999988877777776543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-41  Score=256.17  Aligned_cols=222  Identities=24%  Similarity=0.411  Sum_probs=201.2

Q ss_pred             hhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      .+.|++.+.||+|+|+.|+++..  +|+.+++|++..........+.+.+|+++.+.|+||||+++++........++|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            46899999999999999998875  5889999999887776666788999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC---CeEEEeeeccceeccCCCc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH---NVVKVADFGVARFQNKGGV  191 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~---~~i~l~D~~~~~~~~~~~~  191 (259)
                      |+++|++|..-+... ...++..+-..++||+++|.|+|.+||+|||++|+|+++-..   .-+||+|||.+.....+..
T Consensus        90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~  168 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA  168 (355)
T ss_pred             ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence            999999998877555 347788888999999999999999999999999999999433   4599999999999887777


Q ss_pred             cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCccCC
Q 045286          192 MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY  259 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~  259 (259)
                      .....|+|.|++||++...+|+..+|||+.|+++|-+|.|.+||-+.+.....++|+++.-..++|-|
T Consensus       169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w  236 (355)
T KOG0033|consen  169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEW  236 (355)
T ss_pred             cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCccc
Confidence            77889999999999999999999999999999999999999999999999999999999888877766

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.6e-39  Score=276.63  Aligned_cols=210  Identities=24%  Similarity=0.387  Sum_probs=179.4

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      .|++.++||+|++|.||++.+.  ++.||+|++..... .......+.+|+.++++++|+||+++++.+...+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            5788999999999999999874  78999999875432 22334667899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC------
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG------  189 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~------  189 (259)
                      |+++++|.+++.... .+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||++......      
T Consensus        82 ~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~  160 (376)
T cd05598          82 YIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (376)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence            999999999996543 5888999999999999999999999999999999999999999999999987422100      


Q ss_pred             --------------------------------------CccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcC
Q 045286          190 --------------------------------------GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTA  231 (259)
Q Consensus       190 --------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g  231 (259)
                                                            .......|++.|+|||++.+..++.++|+|||||++|+|++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G  240 (376)
T cd05598         161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG  240 (376)
T ss_pred             ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence                                                  000123588999999999999999999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHhhh
Q 045286          232 KVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       232 ~~p~~~~~~~~~~~~i~~  249 (259)
                      ..||...+..+....+..
T Consensus       241 ~~Pf~~~~~~~~~~~i~~  258 (376)
T cd05598         241 QPPFLADTPAETQLKVIN  258 (376)
T ss_pred             CCCCCCCCHHHHHHHHhc
Confidence            999998887776666554

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=7.5e-39  Score=268.77  Aligned_cols=208  Identities=33%  Similarity=0.620  Sum_probs=174.1

Q ss_pred             cceechhhhhccceeccccceEEEEEEEc-------CceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeeee
Q 045286           32 DWEIDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGA  103 (259)
Q Consensus        32 ~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~  103 (259)
                      .|+++.++|++.++||.|+||.||+|.+.       ++.||+|++.... .......+.+|+.+++.+ +||||++++++
T Consensus         1 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~   79 (338)
T cd05102           1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGA   79 (338)
T ss_pred             CcccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence            38899999999999999999999999742       4679999987543 233446788999999999 79999999998


Q ss_pred             eec-CCcEEEEEecCCCCChHHHHHhcC----------------------------------------------------
Q 045286          104 STK-SPHLCIVTEYMPGGSLYDYLHKNH----------------------------------------------------  130 (259)
Q Consensus       104 ~~~-~~~~~lv~e~~~~~~L~~~l~~~~----------------------------------------------------  130 (259)
                      +.. .+.++++|||+++++|.+++....                                                    
T Consensus        80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (338)
T cd05102          80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP  159 (338)
T ss_pred             ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence            765 446899999999999999986431                                                    


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcc---ccCCCc
Q 045286          131 ---------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM---TAETGT  198 (259)
Q Consensus       131 ---------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~---~~~~~~  198 (259)
                               ..++...+..++.|++.+|.|||+.|++|+||||+||+++.++.++|+|||++.........   ....++
T Consensus       160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence                     23667788889999999999999999999999999999999999999999998754332111   122345


Q ss_pred             ccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCH
Q 045286          199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTP  240 (259)
Q Consensus       199 ~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~  240 (259)
                      ..|+|||.+.+..++.++|+||||+++|+|++ |..||.....
T Consensus       240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~  282 (338)
T cd05102         240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI  282 (338)
T ss_pred             ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc
Confidence            78999999999899999999999999999997 9999987554

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.3e-38  Score=265.66  Aligned_cols=206  Identities=25%  Similarity=0.449  Sum_probs=177.6

Q ss_pred             ceeccccceEEEEEEE--cCceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCCCC
Q 045286           44 ERIASGSCGDLYRGVY--LGQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGG  120 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~  120 (259)
                      +.||+|+||.||++.+  .++.||+|++..... .......+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4799999999999987  478999999986532 2234456778999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC-CCccccCCCcc
Q 045286          121 SLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMTAETGTY  199 (259)
Q Consensus       121 ~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~-~~~~~~~~~~~  199 (259)
                      +|..++.... .+++..++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+..... ........+++
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  159 (323)
T cd05595          81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCc
Confidence            9998886543 588999999999999999999999999999999999999999999999998865322 22233456899


Q ss_pred             cccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          200 RWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       200 ~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      .|+|||.+.+..++.++|+|||||++|+|++|..||...+..+....+...
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~  210 (323)
T cd05595         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME  210 (323)
T ss_pred             CcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Confidence            999999999989999999999999999999999999988877776666543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-40  Score=249.17  Aligned_cols=221  Identities=24%  Similarity=0.455  Sum_probs=196.8

Q ss_pred             cccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCch-HHHHHHHHHHHHHHhcCCCCcceeeeeeec
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVRFIGASTK  106 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~  106 (259)
                      .+.|.+  +++.++++||.|-||.||+|...  ..-||+|++..+.... .....+.+|+++...|+||||++++++|.+
T Consensus        16 ~~~~~l--~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd   93 (281)
T KOG0580|consen   16 TKTWTL--DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD   93 (281)
T ss_pred             ccccch--hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec
Confidence            345666  78999999999999999999864  5679999998775433 445678899999999999999999999999


Q ss_pred             CCcEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          107 SPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                      ....|+++||...+.+...+.... ..+++...+.++.|++.++.|+|.++++||||||+|+|++.++.+++.|||-+..
T Consensus        94 ~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~  173 (281)
T KOG0580|consen   94 SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVH  173 (281)
T ss_pred             cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceee
Confidence            999999999999999999987443 4588999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          186 QNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      .+ .+.....|||..|.|||+..+..++..+|+|++|++.|+++.|..||+..+..+..++|++.--.
T Consensus       174 ~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~  240 (281)
T KOG0580|consen  174 AP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK  240 (281)
T ss_pred             cC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc
Confidence            65 45667889999999999999999999999999999999999999999999998888888865433

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.8e-38  Score=257.90  Aligned_cols=222  Identities=28%  Similarity=0.496  Sum_probs=189.4

Q ss_pred             eechhhhhccceeccccceEEEEEEEc-----CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           34 EIDRRLLKTGERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        34 ~~~~~~~~~~~~lg~G~~~~V~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      +++..+|++.+.||+|+||.||++.+.     +..|++|.++.... ......+.+|+..++.++||||+++++.+...+
T Consensus         1 ~i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   79 (266)
T cd05064           1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN   79 (266)
T ss_pred             CCchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence            356789999999999999999999753     56899999987532 334467889999999999999999999999999


Q ss_pred             cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      ..++||||+++++|.+++......+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||.......
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            99999999999999999977656689999999999999999999999999999999999999999999999998754332


Q ss_pred             CCccc--cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          189 GGVMT--AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       189 ~~~~~--~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      .....  ...++..|+|||.+.+..++.++|+|||||++|++++ |..||...+..+.++.+.++...+.+
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~  230 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAP  230 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCC
Confidence            21111  1234568999999998899999999999999999875 99999999988888888877655444

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.2e-38  Score=270.37  Aligned_cols=220  Identities=22%  Similarity=0.351  Sum_probs=187.1

Q ss_pred             ccccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeee
Q 045286           29 KSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGAST  105 (259)
Q Consensus        29 ~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~  105 (259)
                      ......+...+|++.++||+|++|.||++.+.  ++.||+|++..... .......+.+|+.+++.++||||+++++.+.
T Consensus        34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~  113 (370)
T cd05596          34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ  113 (370)
T ss_pred             hhccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            34456677789999999999999999999874  78999999975432 2223355778999999999999999999999


Q ss_pred             cCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          106 KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                      ..+..++||||+++++|.+++...  .+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+..
T Consensus       114 ~~~~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~  191 (370)
T cd05596         114 DDKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (370)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence            999999999999999999998654  378888999999999999999999999999999999999999999999999876


Q ss_pred             ccCCCc--cccCCCcccccCccccCCC----CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          186 QNKGGV--MTAETGTYRWMAPEVINHQ----PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       186 ~~~~~~--~~~~~~~~~~~~PE~~~~~----~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      ......  .....+++.|+|||.+.+.    .++.++|+|||||++|+|++|..||...+.......+...
T Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  262 (370)
T cd05596         192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH  262 (370)
T ss_pred             ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC
Confidence            544321  2345689999999998654    3788999999999999999999999988887777777654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.6e-38  Score=265.11  Aligned_cols=208  Identities=25%  Similarity=0.406  Sum_probs=178.5

Q ss_pred             ceeccccceEEEEEEE-----cCceEEEEEeecccCc--hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           44 ERIASGSCGDLYRGVY-----LGQDVAVKVLRSEHLN--DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~-----~~~~v~vK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      ++||+|+||.||++..     .++.||+|++......  ......+.+|+.+++.++||||+++++.+..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6899999999999985     3678999999864321  22335577899999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC-CCccccC
Q 045286          117 MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMTAE  195 (259)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~-~~~~~~~  195 (259)
                      +++++|.+++.... .+.+..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+..... .......
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (323)
T cd05584          82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF  160 (323)
T ss_pred             CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence            99999999986543 478888889999999999999999999999999999999999999999999864332 2223345


Q ss_pred             CCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          196 TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       196 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      .+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.++..
T Consensus       161 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~  217 (323)
T cd05584         161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL  217 (323)
T ss_pred             CCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence            689999999999988899999999999999999999999999888777777766543

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.6e-38  Score=265.56  Aligned_cols=205  Identities=23%  Similarity=0.432  Sum_probs=177.3

Q ss_pred             ceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCCCC
Q 045286           44 ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGG  120 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~  120 (259)
                      +.||+|+||.||++.+.  ++.||+|++..... .......+.+|+.+++.++||||+++.+.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999874  78999999986532 2334467788999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC-CCccccCCCcc
Q 045286          121 SLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMTAETGTY  199 (259)
Q Consensus       121 ~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~-~~~~~~~~~~~  199 (259)
                      +|..++... ..+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+..... ........+++
T Consensus        81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  159 (328)
T cd05593          81 ELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP  159 (328)
T ss_pred             CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCc
Confidence            999888554 3588999999999999999999999999999999999999999999999999865332 22233456899


Q ss_pred             cccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          200 RWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       200 ~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                      .|+|||.+.+..++.++|+|||||++|+|++|..||...+..+....+..
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~  209 (328)
T cd05593         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM  209 (328)
T ss_pred             CccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc
Confidence            99999999988999999999999999999999999988877776666543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.4e-38  Score=261.22  Aligned_cols=213  Identities=23%  Similarity=0.383  Sum_probs=182.6

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      +|.+.+.||+|++|.||++.+.  ++.+++|++......+.....+.+|+.+++.++|+||+++++.+...+..++||||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY   81 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence            6888999999999999999985  67899999987655555557788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC--cccc
Q 045286          117 MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG--VMTA  194 (259)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~--~~~~  194 (259)
                      ++++.+..+. .....+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+.......  ....
T Consensus        82 ~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (287)
T cd07848          82 VEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE  160 (287)
T ss_pred             CCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccc
Confidence            9876665443 444568899999999999999999999999999999999999999999999999987654332  2223


Q ss_pred             CCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          195 ETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      ..++..|+|||.+.+..++.++|+|||||++|+|++|..||...+..+.+..+.+...
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  218 (287)
T cd07848         161 YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLG  218 (287)
T ss_pred             cccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhC
Confidence            4678899999999988899999999999999999999999998877666666555443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5.3e-39  Score=271.89  Aligned_cols=210  Identities=26%  Similarity=0.409  Sum_probs=181.4

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      +|+..+.||+|++|.||++...  ++.||+|++..... .......+.+|..++..++|++|+++++.+...+..++|||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E   81 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME   81 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            5778899999999999999874  78999999976432 23345677889999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-----
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-----  190 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-----  190 (259)
                      |+++++|.+++.... .+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+.......     
T Consensus        82 ~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~  160 (360)
T cd05627          82 FLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY  160 (360)
T ss_pred             CCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence            999999999986543 48899999999999999999999999999999999999999999999999876432110     


Q ss_pred             -------------------------------ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 045286          191 -------------------------------VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT  239 (259)
Q Consensus       191 -------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  239 (259)
                                                     ......+++.|+|||++.+..++.++|+|||||++|+|++|..||...+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~  240 (360)
T cd05627         161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (360)
T ss_pred             cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence                                           0112358899999999999999999999999999999999999999988


Q ss_pred             HHHHHHHhhh
Q 045286          240 PLQAALGVRQ  249 (259)
Q Consensus       240 ~~~~~~~i~~  249 (259)
                      ..+....+..
T Consensus       241 ~~~~~~~i~~  250 (360)
T cd05627         241 PQETYRKVMN  250 (360)
T ss_pred             HHHHHHHHHc
Confidence            8877776664

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-38  Score=262.90  Aligned_cols=204  Identities=23%  Similarity=0.390  Sum_probs=176.9

Q ss_pred             eccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCCCCCh
Q 045286           46 IASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSL  122 (259)
Q Consensus        46 lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L  122 (259)
                      ||+|+||.||++.+.  ++.||+|++..... .......+.+|+.++++++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999974  67899999976432 233446678899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-CccccCCCcccc
Q 045286          123 YDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVMTAETGTYRW  201 (259)
Q Consensus       123 ~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~~~~~~~~~~  201 (259)
                      .+++... ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...... .......+++.|
T Consensus        81 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y  159 (312)
T cd05585          81 FHHLQRE-GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY  159 (312)
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCccc
Confidence            9998654 35889999999999999999999999999999999999999999999999998754322 223345689999


Q ss_pred             cCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          202 MAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       202 ~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      +|||.+.+..++.++|+|||||++|+|++|..||...+..+....+.+.
T Consensus       160 ~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~  208 (312)
T cd05585         160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE  208 (312)
T ss_pred             CCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC
Confidence            9999999999999999999999999999999999988877776666543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-39  Score=267.07  Aligned_cols=215  Identities=26%  Similarity=0.456  Sum_probs=200.5

Q ss_pred             hhhhccceeccccceEEEEEE--EcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~--~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      .-|.+.+.||+|-|+.|-+|+  ++|+.||||++.....+......+++|+++++-++||||++++++......+|+|.|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            368899999999999999887  579999999999998888888999999999999999999999999988889999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc-CCeEEEeeeccceeccCCCcccc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT-HNVVKVADFGVARFQNKGGVMTA  194 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~-~~~i~l~D~~~~~~~~~~~~~~~  194 (259)
                      .-++++|.+|+-+....+.+..+.+++.||+.++.|+|+..+||+|+||+|+.+.+ -|-+||.|||++..+.++.....
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~T  177 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTT  177 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhc
Confidence            99999999999888888999999999999999999999999999999999999876 48899999999999999999999


Q ss_pred             CCCcccccCccccCCCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          195 ETGTYRWMAPEVINHQPYD-QKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~~~~-~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      .||...|.|||.+.|..|+ +++||||||+++|.+.+|+.||...++-+.+-.|....-
T Consensus       178 sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY  236 (864)
T KOG4717|consen  178 SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY  236 (864)
T ss_pred             ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc
Confidence            9999999999999999885 799999999999999999999999999888887776543

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-38  Score=265.30  Aligned_cols=211  Identities=21%  Similarity=0.347  Sum_probs=180.5

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      +|++.+.||+|+||.||++...  ++.||+|++..... .......+.+|..+++.++|++|+.+++++...+..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD   81 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence            6788999999999999999874  78999999975322 22344667889999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc--cc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV--MT  193 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~--~~  193 (259)
                      |+++++|.+++......+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+........  ..
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  161 (331)
T cd05597          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSN  161 (331)
T ss_pred             cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcccc
Confidence            9999999999976666689999999999999999999999999999999999999999999999999876543322  12


Q ss_pred             cCCCcccccCccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          194 AETGTYRWMAPEVINH-----QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~-----~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                      ...+++.|+|||++.+     ..++.++|+||+||++|+|++|..||...+..+....+..
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~  222 (331)
T cd05597         162 VAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN  222 (331)
T ss_pred             ceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHc
Confidence            2458999999999863     3568899999999999999999999988777666666543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-39  Score=272.25  Aligned_cols=227  Identities=33%  Similarity=0.607  Sum_probs=201.2

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEcC------ceEEEEEeecc-cCchHHHHHHHHHHHHHHhcCCCCcceeeee
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYLG------QDVAVKVLRSE-HLNDTLEDEFVQEVAILREVQHRNVVRFIGA  103 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~------~~v~vK~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~  103 (259)
                      ..|++..++..+.++||.|+||.||+|+..-      ..||+|..+.. ........++++|+++++.++||||++++|+
T Consensus       150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV  229 (474)
T KOG0194|consen  150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV  229 (474)
T ss_pred             cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            4599999999999999999999999998641      23899999863 3566778999999999999999999999999


Q ss_pred             eecCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccc
Q 045286          104 STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA  183 (259)
Q Consensus       104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~  183 (259)
                      ......+++|||++.||+|.+++.+....++..+...++.+.+.+++|||+++++||||-.+|+|++.++.+||+|||++
T Consensus       230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs  309 (474)
T KOG0194|consen  230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS  309 (474)
T ss_pred             EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence            99999999999999999999999988878999999999999999999999999999999999999999999999999998


Q ss_pred             eeccCCCccc-cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHh-hhccCCCCcc
Q 045286          184 RFQNKGGVMT-AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGV-RQVCTSLCQP  257 (259)
Q Consensus       184 ~~~~~~~~~~-~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i-~~~~~~~~~~  257 (259)
                      .....-.... ..--...|+|||.+....+++++||||+|+++||+.+ |..||.+.+..+...+| ..+++.+.|+
T Consensus       310 ~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~  386 (474)
T KOG0194|consen  310 RAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS  386 (474)
T ss_pred             cCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC
Confidence            6554211111 2235688999999999899999999999999999999 89999999999999999 6788777664

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.2e-38  Score=262.74  Aligned_cols=212  Identities=25%  Similarity=0.392  Sum_probs=180.5

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCC-CCcceeeeeeecCCcEEEEE
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQH-RNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~  114 (259)
                      +|.+.+.||+|++|.||+|.+.  ++.||+|++..... .......+..|..+++.+.| ++|+.+++.+...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            3678899999999999999875  57899999986532 22344667789999999975 56888999998889999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC-CCccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMT  193 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~-~~~~~  193 (259)
                      ||+++++|.+++.... .+++..+..++.|++.+|.|||+.|++|+||||+||+++.++.++|+|||.+..... .....
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (324)
T cd05587          81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR  159 (324)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCcee
Confidence            9999999999986543 488899999999999999999999999999999999999999999999998864322 22233


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ...+++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+..+....+....
T Consensus       160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~  217 (324)
T cd05587         160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN  217 (324)
T ss_pred             eecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence            4568999999999999999999999999999999999999999988888777776543

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.6e-38  Score=260.18  Aligned_cols=210  Identities=26%  Similarity=0.425  Sum_probs=176.3

Q ss_pred             hhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      .++|.+.++||.|++|.||+|.+  .++.|++|++...... .....+.+|+.+++.++|+||+++++++...+..++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence            36788999999999999999997  4789999998765322 22345678999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-Cccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVMT  193 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~~  193 (259)
                      ||++ ++|.+++......++...+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+...... ....
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  161 (303)
T cd07869          83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS  161 (303)
T ss_pred             ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence            9994 6888888776666889999999999999999999999999999999999999999999999998654332 2223


Q ss_pred             cCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHhh
Q 045286          194 AETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTP-LQAALGVR  248 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~-~~~~~~i~  248 (259)
                      ...+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+... .+.+..+.
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  218 (303)
T cd07869         162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIF  218 (303)
T ss_pred             CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHH
Confidence            4567889999999865 4578899999999999999999999987543 34444443

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.5e-39  Score=266.60  Aligned_cols=208  Identities=26%  Similarity=0.409  Sum_probs=180.7

Q ss_pred             ceeccccceEEEEEEE-----cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCC
Q 045286           44 ERIASGSCGDLYRGVY-----LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMP  118 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~-----~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~  118 (259)
                      +.||+|++|.||++.+     .++.+++|++............+.+|++++++++|+||+++++.+...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999875     46899999998764443344567789999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-CccccCCC
Q 045286          119 GGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVMTAETG  197 (259)
Q Consensus       119 ~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~~~~~~  197 (259)
                      +++|.+++... ..+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+...... .......+
T Consensus        82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  160 (318)
T cd05582          82 GGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG  160 (318)
T ss_pred             CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence            99999998654 35899999999999999999999999999999999999999999999999998755433 22334568


Q ss_pred             cccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          198 TYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       198 ~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      ++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.+...
T Consensus       161 ~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~  215 (318)
T cd05582         161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL  215 (318)
T ss_pred             ChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC
Confidence            8999999999988899999999999999999999999999888877777765443

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-38  Score=264.05  Aligned_cols=221  Identities=28%  Similarity=0.485  Sum_probs=200.6

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCch-HHHHHHHHHHHHHHhcC-CCCcceeeeeeecCCcEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND-TLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHLCI  112 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l  112 (259)
                      ...|.+.+.||.|.||.||.+...  |+.+|+|.+....... .....+.+|+.+|+++. ||||+.+.++++..+..++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            457888899999999999999864  7899999998875532 34567889999999999 9999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC----CeEEEeeeccceeccC
Q 045286          113 VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH----NVVKVADFGVARFQNK  188 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~----~~i~l~D~~~~~~~~~  188 (259)
                      |||++.|+.|.+.+...  .+++..+..+++|++.++.+||+.|++|+|+||+|+|+...    +.++++|||++.....
T Consensus       114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~  191 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP  191 (382)
T ss_pred             EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence            99999999999999776  39999999999999999999999999999999999999543    4799999999999888


Q ss_pred             CCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCccCC
Q 045286          189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY  259 (259)
Q Consensus       189 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~  259 (259)
                      +......+|++.|+|||++...+|+...|+||+|+++|.|++|..||.+.+..+....|.++...-..+.|
T Consensus       192 ~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w  262 (382)
T KOG0032|consen  192 GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPW  262 (382)
T ss_pred             CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCc
Confidence            77788889999999999999999999999999999999999999999999988888888888776666665

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.8e-38  Score=262.28  Aligned_cols=212  Identities=24%  Similarity=0.388  Sum_probs=180.7

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCCcEEEEE
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      +|.+.+.||+|+||.||++.+.  ++.|++|++..... ..........|..++..+. |++|+.+++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            3677899999999999999875  57899999986532 2223345667788888775 899999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC-CCccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMT  193 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~-~~~~~  193 (259)
                      ||+++++|..++.... .+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+..... .....
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~  159 (323)
T cd05616          81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK  159 (323)
T ss_pred             cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccc
Confidence            9999999999886543 488999999999999999999999999999999999999999999999999875432 22233


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ...+++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+....+....
T Consensus       160 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~  217 (323)
T cd05616         160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN  217 (323)
T ss_pred             cCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence            4568999999999999999999999999999999999999999988888777776543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4e-38  Score=262.90  Aligned_cols=210  Identities=26%  Similarity=0.474  Sum_probs=177.6

Q ss_pred             hhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHH---HhcCCCCcceeeeeeecCCcEEEE
Q 045286           40 LKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAIL---REVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l---~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      |++.+.||+|++|.||++.+.  ++.|++|++..... .......+.+|.+++   +.++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567889999999999999874  78999999986532 222335566666655   456799999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC-CCcc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVM  192 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~-~~~~  192 (259)
                      |||+++++|...+..  ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+..... ....
T Consensus        81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05589          81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT  158 (324)
T ss_pred             EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence            999999999988754  3489999999999999999999999999999999999999999999999998764322 2223


Q ss_pred             ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          193 TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ....+++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+....+....
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~  217 (324)
T cd05589         159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE  217 (324)
T ss_pred             cccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence            34568999999999999999999999999999999999999999988887777766543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8.2e-39  Score=267.70  Aligned_cols=212  Identities=23%  Similarity=0.367  Sum_probs=184.1

Q ss_pred             hhhccceeccccceEEEEEEE--cCceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           39 LLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      +|.+.+.||+|++|.||++.+  .++.|++|+++.... .......+.+|+.+++.++|++|+++++.+...+..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME   81 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence            578889999999999999987  478999999987543 23344667889999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcc--c
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM--T  193 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~--~  193 (259)
                      |+++++|.+++......+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+.........  .
T Consensus        82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~  161 (330)
T cd05601          82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSK  161 (330)
T ss_pred             CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeee
Confidence            99999999999876567999999999999999999999999999999999999999999999999999766543222  2


Q ss_pred             cCCCcccccCccccC------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          194 AETGTYRWMAPEVIN------HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~------~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      ...+++.|+|||.+.      +..++.++|+||||+++|+|++|..||...+..+....+...
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~  224 (330)
T cd05601         162 LPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF  224 (330)
T ss_pred             cccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC
Confidence            346889999999986      456788999999999999999999999988887777776554

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.9e-38  Score=261.90  Aligned_cols=207  Identities=24%  Similarity=0.383  Sum_probs=177.8

Q ss_pred             ceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhc-CCCCcceeeeeeecCCcEEEEEecCCC
Q 045286           44 ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPG  119 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~  119 (259)
                      +.||+|++|.||+|.+.  ++.||+|++..... .......+.+|..+++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999974  67899999986432 223345667888888877 599999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC-CCccccCCCc
Q 045286          120 GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMTAETGT  198 (259)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~-~~~~~~~~~~  198 (259)
                      ++|..++.... .+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||++..... ........++
T Consensus        81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (320)
T cd05590          81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT  159 (320)
T ss_pred             chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence            99999886553 588999999999999999999999999999999999999999999999999865332 2233345689


Q ss_pred             ccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       199 ~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      +.|+|||.+.+..++.++|+|||||++|+|++|..||...+..+....+....
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~  212 (320)
T cd05590         160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE  212 (320)
T ss_pred             ccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC
Confidence            99999999999899999999999999999999999999998888887776543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.6e-38  Score=267.18  Aligned_cols=216  Identities=25%  Similarity=0.365  Sum_probs=186.4

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC------C
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS------P  108 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~  108 (259)
                      .++|++.+.||+|++|.||++.+.  ++.|++|++............+.+|+.+++.++|+||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            367899999999999999999874  78899999987655555567788999999999999999999887543      3


Q ss_pred             cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      ..++||||+++ +|...+..   .++...+..++.|++.+|.+||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  178 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  178 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence            57999999954 77776643   377888999999999999999999999999999999999999999999999976655


Q ss_pred             CCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       189 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      ........++..|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+....+.+..+.+++
T Consensus       179 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  246 (364)
T cd07875         179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP  246 (364)
T ss_pred             CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            44444557889999999999999999999999999999999999999999888888888777766654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=6.6e-38  Score=260.65  Aligned_cols=206  Identities=25%  Similarity=0.429  Sum_probs=174.6

Q ss_pred             ceeccccceEEEEEEEc--CceEEEEEeecccCc-hHHHHHHHHHHHHHHhc-CCCCcceeeeeeecCCcEEEEEecCCC
Q 045286           44 ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN-DTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPG  119 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~  119 (259)
                      +.||+|+||.||+|.+.  ++.||+|+++..... .........|..++... +||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999874  678999999865322 22334455666676654 799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-CccccCCCc
Q 045286          120 GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVMTAETGT  198 (259)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~~~~~~~  198 (259)
                      ++|..++.... .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...... .......++
T Consensus        81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt  159 (316)
T cd05592          81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT  159 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence            99999886543 5889999999999999999999999999999999999999999999999998754332 233445689


Q ss_pred             ccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       199 ~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      +.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+....+...
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~  211 (316)
T cd05592         160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND  211 (316)
T ss_pred             ccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence            9999999999989999999999999999999999999998887777766543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.4e-38  Score=264.94  Aligned_cols=212  Identities=20%  Similarity=0.335  Sum_probs=181.5

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      ++|.+.+.||+|+||.||++.+.  ++.||+|++..... .......+.+|..+++.++|++|+.+++.+...+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36788999999999999999874  67899999876322 2233455778999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcc--
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM--  192 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~--  192 (259)
                      ||+++++|.+++......+++..+..++.|++.+|.++|+.|++|+||||+||+++.++.++|+|||.+.........  
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  160 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS  160 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence            999999999999775566899999999999999999999999999999999999999999999999998765443222  


Q ss_pred             ccCCCcccccCccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          193 TAETGTYRWMAPEVINH-----QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                      ....+++.|+|||.+.+     ..++.++|+||+|+++|+|++|..||...+..+....+..
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~  222 (331)
T cd05624         161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN  222 (331)
T ss_pred             ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHc
Confidence            23468999999999865     4578899999999999999999999998877776666654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-40  Score=273.62  Aligned_cols=212  Identities=36%  Similarity=0.659  Sum_probs=192.3

Q ss_pred             ccccccceechhhhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec
Q 045286           27 QTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK  106 (259)
Q Consensus        27 ~~~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~  106 (259)
                      ++..+.|+|+-+.+.-..=||+|+.|.||++...++.||||+++.-         -..++.-|++|+|+||+.+.+++..
T Consensus       113 ~qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtq  183 (904)
T KOG4721|consen  113 QQQEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQ  183 (904)
T ss_pred             hhhhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecC
Confidence            4566889999999999999999999999999999999999998743         2356888999999999999999999


Q ss_pred             CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          107 SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                      ..-+|||||||..+.|.+.+.. ...+.......|..+|+.++.|||...|+|||+|.-||||+.+..|||+|||.+...
T Consensus       184 sPcyCIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~  262 (904)
T KOG4721|consen  184 SPCYCIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKEL  262 (904)
T ss_pred             CceeEEeeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhh
Confidence            9999999999999999999954 445888999999999999999999999999999999999999999999999999887


Q ss_pred             cCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 045286          187 NKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVR  248 (259)
Q Consensus       187 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~  248 (259)
                      ...+.....+||..|+|||++.+.+.+.++||||||+++|+||||..||.+.+....+..+-
T Consensus       263 ~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVG  324 (904)
T KOG4721|consen  263 SDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVG  324 (904)
T ss_pred             hhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEecc
Confidence            77766777899999999999999999999999999999999999999998776655554443

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.2e-38  Score=263.05  Aligned_cols=207  Identities=24%  Similarity=0.365  Sum_probs=172.9

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC-----CcEE
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS-----PHLC  111 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~  111 (259)
                      +|++.++||.|++|.||+|.+.  ++.|++|.+............+.+|+.+++.++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4778899999999999999874  78999999886544434446788999999999999999999987533     2479


Q ss_pred             EEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-
Q 045286          112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-  190 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-  190 (259)
                      +||||+ +++|.+++.... .+++..+..++.|++.+|.|||+.|++|+||||+||+++.++.++|+|||.+....... 
T Consensus        81 lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          81 VVFELM-ESDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEecC-CCCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence            999999 568998885543 48899999999999999999999999999999999999999999999999987543221 


Q ss_pred             ---ccccCCCcccccCccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 045286          191 ---VMTAETGTYRWMAPEVINH--QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGV  247 (259)
Q Consensus       191 ---~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i  247 (259)
                         ......+++.|+|||.+.+  ..++.++|+|||||++|+|++|..||.+.+....+..+
T Consensus       159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~  220 (338)
T cd07859         159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLI  220 (338)
T ss_pred             ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Confidence               1133468899999999865  57899999999999999999999999887765554443

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5.8e-38  Score=261.61  Aligned_cols=207  Identities=23%  Similarity=0.372  Sum_probs=177.7

Q ss_pred             ceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhc-CCCCcceeeeeeecCCcEEEEEecCCC
Q 045286           44 ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPG  119 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~  119 (259)
                      +.||+|+||.||+|.+.  ++.|++|++..... .......+..|..+++.+ +||+|+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999875  67899999986532 223345667788888876 699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-CccccCCCc
Q 045286          120 GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVMTAETGT  198 (259)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~~~~~~~  198 (259)
                      ++|...+.... .+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+...... .......++
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05591          81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT  159 (321)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccC
Confidence            99999886543 4888999999999999999999999999999999999999999999999998754322 223345689


Q ss_pred             ccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       199 ~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      +.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+....
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~  212 (321)
T cd05591         160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD  212 (321)
T ss_pred             ccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence            99999999999899999999999999999999999999998888887776543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1e-37  Score=263.91  Aligned_cols=211  Identities=27%  Similarity=0.379  Sum_probs=178.8

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC------c
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP------H  109 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~  109 (259)
                      ++|++.+.||+|+||.||++.+.  ++.|++|++............+.+|+.+++.++||||+++++++....      .
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  100 (359)
T cd07876          21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD  100 (359)
T ss_pred             hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence            67889999999999999999874  789999999876555555677889999999999999999999885433      4


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG  189 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~  189 (259)
                      .+++|||+++ +|...+..   .++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus       101 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~  176 (359)
T cd07876         101 VYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN  176 (359)
T ss_pred             eEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC
Confidence            7999999965 66665532   3778889999999999999999999999999999999999999999999998765444


Q ss_pred             CccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          190 GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       190 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      .......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+....+.+..+
T Consensus       177 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  239 (359)
T cd07876         177 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLG  239 (359)
T ss_pred             ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            344455688999999999999999999999999999999999999998877665555544433

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=6.4e-38  Score=261.56  Aligned_cols=207  Identities=28%  Similarity=0.439  Sum_probs=174.6

Q ss_pred             ceeccccceEEEEEEE--cCceEEEEEeecccCc-hHHHHHHHHHHH-HHHhcCCCCcceeeeeeecCCcEEEEEecCCC
Q 045286           44 ERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLN-DTLEDEFVQEVA-ILREVQHRNVVRFIGASTKSPHLCIVTEYMPG  119 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~-~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~  119 (259)
                      +.||+|++|+||++.+  .++.|++|++...... ......+.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            4799999999999998  4789999999765322 222344455544 56788999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC-CCccccCCCc
Q 045286          120 GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMTAETGT  198 (259)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~-~~~~~~~~~~  198 (259)
                      ++|..++... ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++..... ........++
T Consensus        81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (323)
T cd05575          81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT  159 (323)
T ss_pred             CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence            9999988654 3588899999999999999999999999999999999999999999999999865322 2223345689


Q ss_pred             ccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       199 ~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      +.|+|||.+.+..++.++|+|||||++|+|++|..||...+..+....+....
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~  212 (323)
T cd05575         160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP  212 (323)
T ss_pred             hhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC
Confidence            99999999999999999999999999999999999999888877777766543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=255.86  Aligned_cols=209  Identities=25%  Similarity=0.396  Sum_probs=179.2

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCch-HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      +|+..++||.|++|.||++.+.  ++.||+|++....... .....+.+|+.+++.++|++|+++++.+...+..+++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3677889999999999999874  7899999997653322 233556789999999999999999999998899999999


Q ss_pred             cCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcccc
Q 045286          116 YMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTA  194 (259)
Q Consensus       116 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~  194 (259)
                      |+++++|.+++... ...+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  160 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG  160 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence            99999999888654 34588999999999999999999999999999999999999999999999999877654444344


Q ss_pred             CCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 045286          195 ETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGV  247 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i  247 (259)
                      ..++..|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+.....+.+
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~  213 (285)
T cd05605         161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV  213 (285)
T ss_pred             ccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH
Confidence            56889999999999888999999999999999999999999876664444333

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=261.42  Aligned_cols=210  Identities=28%  Similarity=0.442  Sum_probs=177.4

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCch------------HHHHHHHHHHHHHHhcCCCCcceeeee
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND------------TLEDEFVQEVAILREVQHRNVVRFIGA  103 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~i~~~~~~  103 (259)
                      +.|.+.+.||+|.+|.|-+|.+.  ++.||+|++.......            .-.+...+|+.+++++.|+||++++++
T Consensus        97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv  176 (576)
T KOG0585|consen   97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV  176 (576)
T ss_pred             hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence            67899999999999999999974  7899999998764432            112578899999999999999999998


Q ss_pred             ee--cCCcEEEEEecCCCCChHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeee
Q 045286          104 ST--KSPHLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADF  180 (259)
Q Consensus       104 ~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~  180 (259)
                      ..  ..+.+|+|+||+..+.+...  ...+. +++.+++.++++++.+|.|||.+||+||||||+|+|++.+|.+||+||
T Consensus       177 LDDP~s~~~YlVley~s~G~v~w~--p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDF  254 (576)
T KOG0585|consen  177 LDDPESDKLYLVLEYCSKGEVKWC--PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDF  254 (576)
T ss_pred             ecCcccCceEEEEEeccCCccccC--CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeecc
Confidence            74  46789999999987766543  22233 889999999999999999999999999999999999999999999999


Q ss_pred             ccceeccCC------CccccCCCcccccCccccCC---CCC-CCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          181 GVARFQNKG------GVMTAETGTYRWMAPEVINH---QPY-DQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       181 ~~~~~~~~~------~~~~~~~~~~~~~~PE~~~~---~~~-~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                      |.+.....+      .....-.|||.|+|||+..+   ..+ +.+.||||+|+++|.|+.|..||.+....+.-++|..
T Consensus       255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn  333 (576)
T KOG0585|consen  255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN  333 (576)
T ss_pred             ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc
Confidence            999876333      22233579999999999876   233 5789999999999999999999999888888888774

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=5.6e-38  Score=265.18  Aligned_cols=216  Identities=25%  Similarity=0.373  Sum_probs=184.0

Q ss_pred             hhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC------C
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS------P  108 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~  108 (259)
                      .++|++.+.||+|+||.||++.+  .++.+++|.+............+.+|+.+++.++|+||+++++++...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            36889999999999999999986  478999999987655555667788999999999999999999987543      3


Q ss_pred             cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      ..+++||++++ ++.+.+..   .++...+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+.....
T Consensus        96 ~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~  171 (355)
T cd07874          96 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_pred             eeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence            57999999965 67666643   377888999999999999999999999999999999999999999999999976655


Q ss_pred             CCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       189 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      ........++..|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+....+.+....+|+
T Consensus       172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (355)
T cd07874         172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP  239 (355)
T ss_pred             ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            44444567889999999999999999999999999999999999999988877776666665555543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=6e-38  Score=262.65  Aligned_cols=213  Identities=20%  Similarity=0.333  Sum_probs=181.7

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      +|.+.++||+|+||.||++...  ++.+++|++..... .......+.+|..++..++|++|+.+++.+...+..++|||
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD   81 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence            6788899999999999999875  67899999875322 22333557789999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc--cc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV--MT  193 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~--~~  193 (259)
                      |+++++|.+++......+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+........  ..
T Consensus        82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~  161 (332)
T cd05623          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS  161 (332)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcceec
Confidence            9999999999977656689999999999999999999999999999999999999999999999999865433221  22


Q ss_pred             cCCCcccccCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          194 AETGTYRWMAPEVIN-----HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ...+++.|+|||++.     ...++.++|+|||||++|+|++|..||...+..+....+....
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~  224 (332)
T cd05623         162 VAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK  224 (332)
T ss_pred             ccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Confidence            346899999999986     3457889999999999999999999999888878777776543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.3e-37  Score=258.10  Aligned_cols=216  Identities=24%  Similarity=0.424  Sum_probs=182.9

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ++|.+.++||+|++|.||++.+.  ++.+++|.+...... .....+.+|+.++++++|+||+++++++...+..++|||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            56888999999999999999874  678999998865432 223457789999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-cccc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMTA  194 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~~  194 (259)
                      |+++ +|.+++......++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus        85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  163 (309)
T cd07872          85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN  163 (309)
T ss_pred             CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccccc
Confidence            9964 8888887666668899999999999999999999999999999999999999999999999987544332 2233


Q ss_pred             CCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCC
Q 045286          195 ETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLC  255 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~  255 (259)
                      ..+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+.+..+.+..+.+.
T Consensus       164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  225 (309)
T cd07872         164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPT  225 (309)
T ss_pred             ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            457889999999865 4678999999999999999999999999888877777766554443

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=9.4e-38  Score=260.76  Aligned_cols=206  Identities=28%  Similarity=0.458  Sum_probs=172.9

Q ss_pred             ceeccccceEEEEEEEc--CceEEEEEeecccCch-HHHHHHHHHH-HHHHhcCCCCcceeeeeeecCCcEEEEEecCCC
Q 045286           44 ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND-TLEDEFVQEV-AILREVQHRNVVRFIGASTKSPHLCIVTEYMPG  119 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~-~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~  119 (259)
                      +.||+|+||.||+|.+.  ++.+++|++....... .....+.+|. .+++.++|+||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            47999999999999974  6789999998643221 2223344444 456788999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc-CCCccccCCCc
Q 045286          120 GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN-KGGVMTAETGT  198 (259)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~-~~~~~~~~~~~  198 (259)
                      ++|.+++.... .+.+..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+.... .........++
T Consensus        81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  159 (325)
T cd05602          81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT  159 (325)
T ss_pred             CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence            99999986543 47788888999999999999999999999999999999999999999999986432 22233445689


Q ss_pred             ccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       199 ~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      +.|+|||.+.+..++.++|+|||||++|+|++|..||...+..+....+...
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~  211 (325)
T cd05602         160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK  211 (325)
T ss_pred             ccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC
Confidence            9999999999999999999999999999999999999988888777776654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=9.1e-38  Score=260.41  Aligned_cols=206  Identities=27%  Similarity=0.442  Sum_probs=173.1

Q ss_pred             ceeccccceEEEEEEEc--CceEEEEEeecccCc-hHHHHHHHHHHH-HHHhcCCCCcceeeeeeecCCcEEEEEecCCC
Q 045286           44 ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN-DTLEDEFVQEVA-ILREVQHRNVVRFIGASTKSPHLCIVTEYMPG  119 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~-~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~  119 (259)
                      +.||+|++|.||+|.+.  ++.|++|++...... ......+.+|.. +++.++|+||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999974  788999999765322 222344455544 57888999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC-CCccccCCCc
Q 045286          120 GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMTAETGT  198 (259)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~-~~~~~~~~~~  198 (259)
                      ++|...+... ..+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+..... ........++
T Consensus        81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05603          81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT  159 (321)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence            9998888543 4588889999999999999999999999999999999999999999999999865322 2223345688


Q ss_pred             ccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       199 ~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      +.|+|||.+.+..++.++|+|||||++|+|++|..||...+..+....+...
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~  211 (321)
T cd05603         160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK  211 (321)
T ss_pred             cccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC
Confidence            9999999999989999999999999999999999999988877777666554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.7e-37  Score=253.13  Aligned_cols=217  Identities=22%  Similarity=0.396  Sum_probs=184.1

Q ss_pred             ccceechhhhhcc--ceeccccceEEEEEEEcCceEEEEEeecccCch-HHHHHHHHHHHHHHhcCCCCcceeeeeeec-
Q 045286           31 EDWEIDRRLLKTG--ERIASGSCGDLYRGVYLGQDVAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVRFIGASTK-  106 (259)
Q Consensus        31 ~~~~~~~~~~~~~--~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-  106 (259)
                      +...++-++++..  ..|+.|+++.||+|.++++.|++|.+....... ...+.+.+|+.++++++||||+++++++.+ 
T Consensus        11 ~~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~   90 (283)
T PHA02988         11 DIKCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI   90 (283)
T ss_pred             cceecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec
Confidence            3445555666666  789999999999999999999999998764433 334678899999999999999999998866 


Q ss_pred             ---CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEccCCeEEEeeecc
Q 045286          107 ---SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR-NIIHRDLKTANLLMDTHNVVKVADFGV  182 (259)
Q Consensus       107 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~di~p~Nilv~~~~~i~l~D~~~  182 (259)
                         ....++++||+++++|.+++... ..++......++.+++.++.++|+. +++|+||+|+||+++.++.++|+|||.
T Consensus        91 ~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~  169 (283)
T PHA02988         91 VDDLPRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGL  169 (283)
T ss_pred             ccCCCceEEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccch
Confidence               45789999999999999999654 3588889999999999999999984 999999999999999999999999999


Q ss_pred             ceeccCCCccccCCCcccccCccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          183 ARFQNKGGVMTAETGTYRWMAPEVINH--QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      +.......  ....++..|+|||.+.+  ..++.++|+||||+++|+|++|..||.+.+..+....+.+.
T Consensus       170 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~  237 (283)
T PHA02988        170 EKILSSPP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINK  237 (283)
T ss_pred             Hhhhcccc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence            87544322  23457889999999976  67899999999999999999999999998888877776443

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.5e-38  Score=262.14  Aligned_cols=205  Identities=24%  Similarity=0.447  Sum_probs=176.1

Q ss_pred             ceeccccceEEEEEEE--cCceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCCCC
Q 045286           44 ERIASGSCGDLYRGVY--LGQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGG  120 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~  120 (259)
                      +.||+|+||.||++.+  .++.|++|++..... .......+.+|.++++.++|+||+++.+.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4799999999999986  478999999986533 2233456778999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEccCCeEEEeeeccceeccC-CCccccCCCc
Q 045286          121 SLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ-RNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMTAETGT  198 (259)
Q Consensus       121 ~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~-~~~~~~~~~~  198 (259)
                      +|..++... ..+++..+..++.|++.+|.|||+ .|++|+||||+||+++.++.++|+|||.+..... ........++
T Consensus        81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (325)
T cd05594          81 ELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT  159 (325)
T ss_pred             cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCC
Confidence            999888554 358899999999999999999997 7999999999999999999999999999865332 2223345689


Q ss_pred             ccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       199 ~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                      +.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+....+..
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~  210 (325)
T cd05594         160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM  210 (325)
T ss_pred             cccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc
Confidence            999999999998999999999999999999999999998887766665543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.9e-37  Score=257.67  Aligned_cols=208  Identities=24%  Similarity=0.416  Sum_probs=181.7

Q ss_pred             echhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEE
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCI  112 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l  112 (259)
                      +..++|++.+.||.|++|.||++.+.  +..+++|.+.... .......+.+|++++++++|+||+++++++...+..++
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            45678999999999999999999975  7789999988653 33455778999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc
Q 045286          113 VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR-NIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV  191 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~  191 (259)
                      ||||+++++|.+++.... .+++..+..++.|++.+|.+||+. +++|+||+|+||+++.++.++|+|||.+...... .
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~  158 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M  158 (331)
T ss_pred             EeecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-c
Confidence            999999999999986543 488999999999999999999986 5999999999999999999999999998755432 2


Q ss_pred             cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 045286          192 MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL  245 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~  245 (259)
                      .....++..|+|||.+.+..++.++|+|||||++|+|++|..||...+..+...
T Consensus       159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~  212 (331)
T cd06649         159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA  212 (331)
T ss_pred             cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            234568899999999999899999999999999999999999998877765443

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.9e-37  Score=258.72  Aligned_cols=211  Identities=25%  Similarity=0.397  Sum_probs=179.2

Q ss_pred             hhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCCcEEEEEe
Q 045286           40 LKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      +...+.||+|++|.||+|.+.  ++.||+|++..... .......+..|..+++.+. |++|+.+++.+...+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            567789999999999999874  78999999986532 2233456778888888886 5788889999998899999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-Ccccc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVMTA  194 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~~~  194 (259)
                      |+++++|.+++.... .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...... .....
T Consensus        82 y~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~  160 (323)
T cd05615          82 YVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT  160 (323)
T ss_pred             CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence            999999999986543 4889999999999999999999999999999999999999999999999998653322 22234


Q ss_pred             CCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          195 ETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ..+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+..+....+....
T Consensus       161 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~  217 (323)
T cd05615         161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN  217 (323)
T ss_pred             ccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence            468899999999999899999999999999999999999999988887777766543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.6e-37  Score=270.60  Aligned_cols=220  Identities=24%  Similarity=0.374  Sum_probs=188.0

Q ss_pred             echhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC----
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP----  108 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----  108 (259)
                      ....+|.+.+.||+|+||+||++.+  .++.||+|++............+.+|+.++..++|++|++++..+...+    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            3457999999999999999999986  5889999999887666666677889999999999999999887764322    


Q ss_pred             ----cEEEEEecCCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeec
Q 045286          109 ----HLCIVTEYMPGGSLYDYLHKN---HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFG  181 (259)
Q Consensus       109 ----~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~  181 (259)
                          .+++||||+++++|.+++...   ...+++..+..++.|++.+|.|+|+.+++|+||||+||+++.++.++|+|||
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence                368999999999999998643   3458899999999999999999999999999999999999999999999999


Q ss_pred             cceeccCC---CccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          182 VARFQNKG---GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       182 ~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      ++......   .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+.+..+..+...+
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~  264 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP  264 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC
Confidence            98755432   12234568999999999999999999999999999999999999999988888777776654443

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.9e-37  Score=254.72  Aligned_cols=213  Identities=32%  Similarity=0.577  Sum_probs=178.2

Q ss_pred             echhhhhccceeccccceEEEEEEEc------------------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCC
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL------------------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRN   96 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~------------------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   96 (259)
                      ++..+|++.++||+|+||.||+|.+.                  +..|++|.+.... .......+.+|+.++++++|||
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~n   80 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPN   80 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCC
Confidence            45678999999999999999999752                  2369999987653 3444567889999999999999


Q ss_pred             cceeeeeeecCCcEEEEEecCCCCChHHHHHhcC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 045286           97 VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH------------------NVLKLPQLLRFAIDICKGMEYLHQRNII  158 (259)
Q Consensus        97 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~  158 (259)
                      |+++++++...+..+++|||+++++|.+++....                  ..++...+..++.|++.+|.+||+.|++
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            9999999998899999999999999999985432                  1356678889999999999999999999


Q ss_pred             cCCCCCCcEEEccCCeEEEeeeccceeccCCCcc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc--CCC
Q 045286          159 HRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT--AKV  233 (259)
Q Consensus       159 H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~--g~~  233 (259)
                      |+||||+||+++.++.++|+|||.+.........   ....++..|+|||.+.+..++.++|+||||+++|+|++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            9999999999999999999999998765433211   12234678999999988889999999999999999986  677


Q ss_pred             CCCCCCHHHHHHHhh
Q 045286          234 PYDSMTPLQAALGVR  248 (259)
Q Consensus       234 p~~~~~~~~~~~~i~  248 (259)
                      ||...+..+.+..+.
T Consensus       241 p~~~~~~~~~~~~~~  255 (304)
T cd05096         241 PYGELTDEQVIENAG  255 (304)
T ss_pred             CCCcCCHHHHHHHHH
Confidence            898877766665543

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-37  Score=248.14  Aligned_cols=219  Identities=35%  Similarity=0.602  Sum_probs=187.8

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEE
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~  111 (259)
                      |++..+++++.+.||.|++|.||++.+. ++.|++|.++.....   ...+.+|+.++++++|+||+++++++...+..+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05068           1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY   77 (261)
T ss_pred             CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence            6778899999999999999999999864 568999998765432   356888999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          112 IVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      +++|++++++|.+++.... ..++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            9999999999999986543 458899999999999999999999999999999999999999999999999987665332


Q ss_pred             ccc--cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCC
Q 045286          191 VMT--AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       191 ~~~--~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      ...  .......|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+.+....+
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~  224 (261)
T cd05068         158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMP  224 (261)
T ss_pred             ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            111  1122357999999998889999999999999999999 999999988888887777665433

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.2e-37  Score=262.95  Aligned_cols=214  Identities=33%  Similarity=0.588  Sum_probs=179.8

Q ss_pred             ccccceechhhhhccceeccccceEEEEEEEc-------CceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCccee
Q 045286           29 KSEDWEIDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRF  100 (259)
Q Consensus        29 ~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~  100 (259)
                      ..+.|.++.++|++.+.||+|+||.||++.+.       +..|++|.++..... .....+.+|+++++.+ +|+||+++
T Consensus        29 ~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~~h~nIv~~  107 (374)
T cd05106          29 YNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT-DEREALMSELKILSHLGQHKNIVNL  107 (374)
T ss_pred             ccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH-HHHHHHHHHHHHHHhhccCCceeeE
Confidence            34568899999999999999999999998853       247999999865433 3356788999999999 79999999


Q ss_pred             eeeeecCCcEEEEEecCCCCChHHHHHhcC--------------------------------------------------
Q 045286          101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNH--------------------------------------------------  130 (259)
Q Consensus       101 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------------------------------------  130 (259)
                      ++.+...+..++||||+++++|.+++....                                                  
T Consensus       108 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (374)
T cd05106         108 LGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPV  187 (374)
T ss_pred             eeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCc
Confidence            999999999999999999999999885421                                                  


Q ss_pred             -------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc
Q 045286          131 -------------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV  191 (259)
Q Consensus       131 -------------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~  191 (259)
                                         ..++...++.++.|++.+|.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~  267 (374)
T cd05106         188 SSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN  267 (374)
T ss_pred             cccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence                               1366778899999999999999999999999999999999999999999999876543322


Q ss_pred             cc---cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q 045286          192 MT---AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQA  243 (259)
Q Consensus       192 ~~---~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~  243 (259)
                      ..   ...++..|+|||.+.+..++.++|+||||+++|+|++ |..||........
T Consensus       268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~  323 (374)
T cd05106         268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK  323 (374)
T ss_pred             eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH
Confidence            11   1224567999999988889999999999999999997 9999987655433

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.6e-37  Score=257.09  Aligned_cols=207  Identities=24%  Similarity=0.395  Sum_probs=175.4

Q ss_pred             ceeccccceEEEEEEEc--CceEEEEEeecccCc-hHHHHHHHHHHHHHHhc-CCCCcceeeeeeecCCcEEEEEecCCC
Q 045286           44 ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN-DTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPG  119 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~  119 (259)
                      +.||+|+||.||++.+.  ++.||+|+++..... .........|..+++.. +|++|+++++.+...+..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999974  778999999865321 22334566777777755 799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC-CCccccCCCc
Q 045286          120 GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMTAETGT  198 (259)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~-~~~~~~~~~~  198 (259)
                      ++|..++... ..+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+..... ........++
T Consensus        81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05620          81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT  159 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence            9999988654 3488999999999999999999999999999999999999999999999998864322 2223345689


Q ss_pred             ccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       199 ~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+....
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~  212 (316)
T cd05620         160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT  212 (316)
T ss_pred             cCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence            99999999999999999999999999999999999999888877777766443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.2e-37  Score=260.07  Aligned_cols=206  Identities=28%  Similarity=0.449  Sum_probs=173.8

Q ss_pred             ceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHH-HHHhcCCCCcceeeeeeecCCcEEEEEecCCC
Q 045286           44 ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVA-ILREVQHRNVVRFIGASTKSPHLCIVTEYMPG  119 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~  119 (259)
                      +.||.|+||+||++.+.  ++.+++|++..... .......+.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            47999999999999874  78999999976532 2223344555554 46778999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC-CCccccCCCc
Q 045286          120 GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMTAETGT  198 (259)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~-~~~~~~~~~~  198 (259)
                      ++|..++... ..+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+..... ........++
T Consensus        81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (325)
T cd05604          81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT  159 (325)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence            9999888654 4588999999999999999999999999999999999999999999999999864322 2223345689


Q ss_pred             ccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       199 ~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      +.|+|||.+.+..++.++|+|||||++|+|++|..||...+..+....+...
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~  211 (325)
T cd05604         160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK  211 (325)
T ss_pred             hhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC
Confidence            9999999999999999999999999999999999999988887777666654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=8.2e-38  Score=261.84  Aligned_cols=198  Identities=24%  Similarity=0.376  Sum_probs=169.6

Q ss_pred             hhhccceeccccceEEEEEEE-----cCceEEEEEeecccC--chHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCCcE
Q 045286           39 LLKTGERIASGSCGDLYRGVY-----LGQDVAVKVLRSEHL--NDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHL  110 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~-----~~~~v~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~  110 (259)
                      +|++.+.||+|++|.||++..     .++.|++|++.....  .......+.+|+.+++.++ |++|+.+++.+...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            367889999999999999875     468899999976432  1233456778999999995 99999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      ++||||+++++|.+++.... .+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~  159 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE  159 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence            99999999999999986543 48899999999999999999999999999999999999999999999999987543322


Q ss_pred             --ccccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          191 --VMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       191 --~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                        ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||..
T Consensus       160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~  209 (332)
T cd05614         160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL  209 (332)
T ss_pred             CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence              22234689999999999875 478899999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.4e-37  Score=268.15  Aligned_cols=215  Identities=20%  Similarity=0.339  Sum_probs=184.1

Q ss_pred             hhhhhccceeccccceEEEEEEEc---CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL---GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~---~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      ...|.+.+.||.|++|.||+|...   ++.|++|.....  .......+.+|+.+++.++||||+++++.+...+..++|
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv  143 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI  143 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence            345899999999999999999863   567888876544  233445677899999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          114 TEYMPGGSLYDYLHKN---HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      |||+++++|.+++...   ...+++..+..++.|++.+|.++|+.+++||||||+||+++.++.++|+|||++.......
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            9999999999887532   3358889999999999999999999999999999999999999999999999998654432


Q ss_pred             ---ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          191 ---VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       191 ---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                         .....++++.|+|||.+.+..++.++|+|||||++|+|++|..||...+..+.+..+..+...
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~  289 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD  289 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence               123446899999999999999999999999999999999999999998888888777665443

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-37  Score=250.50  Aligned_cols=220  Identities=24%  Similarity=0.357  Sum_probs=191.3

Q ss_pred             cccceechhhhhccceeccccceEEEEEEEcC--ceEEEEEeecccCc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeec
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVYLG--QDVAVKVLRSEHLN-DTLEDEFVQEVAILREVQHRNVVRFIGASTK  106 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~--~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~  106 (259)
                      ..+-.+.-+.+++.+.||+|.-|+||++...+  ..+|+|++...... .....+...|.++|+.++||.++.++..++.
T Consensus        69 ~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet  148 (459)
T KOG0610|consen   69 SKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET  148 (459)
T ss_pred             cCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec
Confidence            45566777899999999999999999999865  78999999887553 4555777889999999999999999999999


Q ss_pred             CCcEEEEEecCCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          107 SPHLCIVTEYMPGGSLYDYLHKNHN-VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                      ....|++||||+|++|..++++++. .+++..++-++.+++-||+|||..||++||+||+||||-++|.|.|+||.++..
T Consensus       149 ~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~  228 (459)
T KOG0610|consen  149 DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLR  228 (459)
T ss_pred             cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecccccc
Confidence            9999999999999999999987654 589999999999999999999999999999999999999999999999998621


Q ss_pred             cc-------C--------------------------C-C-----------------------ccccCCCcccccCccccC
Q 045286          186 QN-------K--------------------------G-G-----------------------VMTAETGTYRWMAPEVIN  208 (259)
Q Consensus       186 ~~-------~--------------------------~-~-----------------------~~~~~~~~~~~~~PE~~~  208 (259)
                      ..       .                          . .                       ......||-.|.|||++.
T Consensus       229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~  308 (459)
T KOG0610|consen  229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR  308 (459)
T ss_pred             CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence            10       0                          0 0                       001124788999999999


Q ss_pred             CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          209 HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       209 ~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                      |...+.++|.|+||+.+||||.|.-||.+.+..+.+..|..
T Consensus       309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~  349 (459)
T KOG0610|consen  309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG  349 (459)
T ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc
Confidence            99999999999999999999999999999999888877653

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3e-37  Score=258.06  Aligned_cols=192  Identities=24%  Similarity=0.431  Sum_probs=167.7

Q ss_pred             ceeccccceEEEEEEEc--CceEEEEEeecccCc-hHHHHHHHHHHHHHHhc-CCCCcceeeeeeecCCcEEEEEecCCC
Q 045286           44 ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN-DTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPG  119 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~  119 (259)
                      +.||+|+||.||++.+.  ++.||+|+++..... ......+.+|..+++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            47999999999999874  789999999875432 23345677899999998 599999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc-CCCccccCCCc
Q 045286          120 GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN-KGGVMTAETGT  198 (259)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~-~~~~~~~~~~~  198 (259)
                      ++|..++... ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.... .........++
T Consensus        81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (329)
T cd05588          81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT  159 (329)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCC
Confidence            9999888654 458999999999999999999999999999999999999999999999999986422 22233345689


Q ss_pred             ccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 045286          199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYD  236 (259)
Q Consensus       199 ~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~  236 (259)
                      +.|+|||.+.+..++.++|+|||||++|+|++|..||.
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~  197 (329)
T cd05588         160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD  197 (329)
T ss_pred             ccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcc
Confidence            99999999999999999999999999999999999996

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=6.4e-37  Score=247.42  Aligned_cols=216  Identities=33%  Similarity=0.630  Sum_probs=184.7

Q ss_pred             chhhhhccceeccccceEEEEEEEcCc-eEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~~~-~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      +-++|.+.+.||+|++|.||.+.+.+. .+++|.+......   ...+.+|+.++++++||||+++++++...+..+++|
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT   78 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence            346788999999999999999987654 5999998765433   256889999999999999999999998888899999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccc-
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT-  193 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~-  193 (259)
                      ||+.+++|.+++......+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......... 
T Consensus        79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05113          79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS  158 (256)
T ss_pred             EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence            9999999999997655568999999999999999999999999999999999999999999999999987654432211 


Q ss_pred             -cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCC
Q 045286          194 -AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       194 -~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                       ...++..|.|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+.++....
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~  221 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY  221 (256)
T ss_pred             CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC
Confidence             1234567999999988889999999999999999998 999999888877777777665443

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4.3e-37  Score=255.99  Aligned_cols=206  Identities=26%  Similarity=0.440  Sum_probs=176.1

Q ss_pred             ceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhc-CCCCcceeeeeeecCCcEEEEEecCCC
Q 045286           44 ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPG  119 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~  119 (259)
                      +.||.|+||+||++.+.  ++.||+|++..... .......+.+|..+++.+ +|+||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999874  67899999986532 223345667888888888 599999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-CccccCCCc
Q 045286          120 GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVMTAETGT  198 (259)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~~~~~~~  198 (259)
                      ++|..++.... .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...... .......++
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~  159 (318)
T cd05570          81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT  159 (318)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence            99999886543 5899999999999999999999999999999999999999999999999988643222 222334688


Q ss_pred             ccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       199 ~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      +.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+....+...
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~  211 (318)
T cd05570         160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED  211 (318)
T ss_pred             ccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence            9999999999999999999999999999999999999988887777666544

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=4.8e-37  Score=261.05  Aligned_cols=221  Identities=30%  Similarity=0.529  Sum_probs=182.0

Q ss_pred             cccceechhhhhccceeccccceEEEEEEE-------cCceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceee
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVY-------LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFI  101 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~-------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~  101 (259)
                      ...|+++.++|++.++||+|+||.||+|.+       .+..||+|+++.... ......+.+|+.+++.+ +||||++++
T Consensus        27 ~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~  105 (375)
T cd05104          27 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLL  105 (375)
T ss_pred             ccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeee
Confidence            345889999999999999999999999974       245899999975532 23346788999999999 799999999


Q ss_pred             eeeecCCcEEEEEecCCCCChHHHHHhcC---------------------------------------------------
Q 045286          102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH---------------------------------------------------  130 (259)
Q Consensus       102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------  130 (259)
                      +.+...+..++||||+++++|.+++....                                                   
T Consensus       106 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  185 (375)
T cd05104         106 GACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADK  185 (375)
T ss_pred             eeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccc
Confidence            99999999999999999999999885422                                                   


Q ss_pred             -----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          131 -----------------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       131 -----------------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                                             ..++...+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+....
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~  265 (375)
T cd05104         186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIR  265 (375)
T ss_pred             ccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceecc
Confidence                                   135677888999999999999999999999999999999999999999999987654


Q ss_pred             CCCccc---cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHH-HHHHHhhhcc
Q 045286          188 KGGVMT---AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL-QAALGVRQVC  251 (259)
Q Consensus       188 ~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~-~~~~~i~~~~  251 (259)
                      ......   ...++..|+|||.+.+..++.++|+||||+++|+|++ |..||...... .....+..+.
T Consensus       266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~  334 (375)
T cd05104         266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY  334 (375)
T ss_pred             CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc
Confidence            432211   1223567999999999999999999999999999998 99999876543 3344444443

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.4e-37  Score=253.02  Aligned_cols=211  Identities=27%  Similarity=0.403  Sum_probs=174.8

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhc---CCCCcceeeeeeec-----CC
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV---QHRNVVRFIGASTK-----SP  108 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~-----~~  108 (259)
                      +|++.+.||.|++|.||+|.+.  ++.|++|.+............+.+|+.+++.+   +|+||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778899999999999999874  78899999886543333334455667766665   69999999998753     34


Q ss_pred             cEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      ..++++|+++ ++|.+++.... ..+++..+..++.|++.+|.++|+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~  159 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS  159 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence            5899999996 48888886543 348899999999999999999999999999999999999999999999999987665


Q ss_pred             CCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          188 KGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       188 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      .........++..|+|||.+.+..++.++|+||+||++|+|++|..||...+..+.+.++...
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~  222 (288)
T cd07863         160 CQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL  222 (288)
T ss_pred             CcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHH
Confidence            443334456788999999999888999999999999999999999999888777666666543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.4e-37  Score=267.68  Aligned_cols=212  Identities=24%  Similarity=0.422  Sum_probs=175.8

Q ss_pred             echhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC-----
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS-----  107 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----  107 (259)
                      ...++|.+.++||+|+||.||+|.+  .++.||+|.+....      ....+|+.+++.++|+||+++++++...     
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            4456899999999999999999987  47899999886542      2345799999999999999998876321     


Q ss_pred             ---CcEEEEEecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC-eEEEeee
Q 045286          108 ---PHLCIVTEYMPGGSLYDYLHK---NHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN-VVKVADF  180 (259)
Q Consensus       108 ---~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~-~i~l~D~  180 (259)
                         ...++||||++ ++|.+++..   ....+++..++.++.|++.+|.|||+.|++||||||+||+++.++ .++|+||
T Consensus       137 ~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        137 EKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             CCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence               24678999996 477776643   344688999999999999999999999999999999999998665 6999999


Q ss_pred             ccceeccCCCccccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          181 GVARFQNKGGVMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      |++.............+++.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+..+.+.++.+..+.
T Consensus       216 Gla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~  289 (440)
T PTZ00036        216 GSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT  289 (440)
T ss_pred             ccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            999866555444556788999999998664 6899999999999999999999999998888777777665443

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.1e-37  Score=255.28  Aligned_cols=206  Identities=26%  Similarity=0.446  Sum_probs=174.6

Q ss_pred             ceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhc-CCCCcceeeeeeecCCcEEEEEecCCC
Q 045286           44 ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPG  119 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~  119 (259)
                      +.||+|+||.||+|.+.  ++.||+|+++.... ..........|..+++.. +||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999975  67899999987532 122334566677777764 799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-CccccCCCc
Q 045286          120 GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVMTAETGT  198 (259)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~~~~~~~  198 (259)
                      ++|..++... ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...... .......++
T Consensus        81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05619          81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT  159 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence            9999998654 34888999999999999999999999999999999999999999999999998653222 222345688


Q ss_pred             ccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       199 ~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      +.|+|||.+.+..++.++|+||+||++|+|++|..||...+..+....+...
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~  211 (316)
T cd05619         160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD  211 (316)
T ss_pred             ccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence            9999999999989999999999999999999999999988887777766543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.3e-36  Score=245.56  Aligned_cols=214  Identities=31%  Similarity=0.591  Sum_probs=183.7

Q ss_pred             hhhhhccceeccccceEEEEEEEcC-ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYLG-QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~~-~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      -++|++.+.||.|++|.||++.+.. ..+++|.+......   ...+.+|+.++++++||||+++++++...+..+++||
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   79 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE   79 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence            4678888999999999999998754 58999987754332   3567889999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccc--
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT--  193 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~--  193 (259)
                      |+++++|.+++......++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||.+..........  
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (256)
T cd05114          80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS  159 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence            999999999987655568889999999999999999999999999999999999999999999999887554322211  


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCC
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ...++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...+..+....+.++...
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~  220 (256)
T cd05114         160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL  220 (256)
T ss_pred             CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC
Confidence            2234567999999988889999999999999999999 99999998888888888776544

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.5e-37  Score=261.20  Aligned_cols=212  Identities=25%  Similarity=0.409  Sum_probs=179.8

Q ss_pred             hhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC-----cEEE
Q 045286           40 LKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP-----HLCI  112 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~l  112 (259)
                      +++.++||+|++|.||++.+  .++.||+|.+............+.+|+.+++.++|+||+++++++...+     ..++
T Consensus         2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   81 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV   81 (372)
T ss_pred             CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence            67789999999999999996  4789999998765444445567889999999999999999999987765     7899


Q ss_pred             EEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC--
Q 045286          113 VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG--  190 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~--  190 (259)
                      |+||+. ++|...+.. ...++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        82 v~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~  159 (372)
T cd07853          82 VTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK  159 (372)
T ss_pred             Eeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence            999995 578887744 3458999999999999999999999999999999999999999999999999987654322  


Q ss_pred             ccccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          191 VMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       191 ~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ......++..|+|||.+.+. .++.++|+||+||++|+|++|+.||.+.+..+.+..+.+.++.
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~  223 (372)
T cd07853         160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGT  223 (372)
T ss_pred             cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence            22334578899999998775 5789999999999999999999999998888877777665443

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.4e-36  Score=245.05  Aligned_cols=215  Identities=28%  Similarity=0.460  Sum_probs=187.9

Q ss_pred             hhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecC
Q 045286           40 LKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYM  117 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~  117 (259)
                      |.+.+.||+|++|.||++.+  .++.+++|.+............+.+|+.+++.++|+||+++++.+...+..++++||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA   81 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence            66778999999999999987  4789999999876555666678889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc-cccC
Q 045286          118 PGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV-MTAE  195 (259)
Q Consensus       118 ~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~-~~~~  195 (259)
                      ++++|.+++... ...++...++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  161 (256)
T cd08529          82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI  161 (256)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhcc
Confidence            999999999764 44688899999999999999999999999999999999999999999999999876554322 2334


Q ss_pred             CCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          196 TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       196 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      .++..|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+.++..+.
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  220 (256)
T cd08529         162 VGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP  220 (256)
T ss_pred             ccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            57889999999998889999999999999999999999999888877777776655443

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.5e-37  Score=249.84  Aligned_cols=209  Identities=34%  Similarity=0.620  Sum_probs=182.6

Q ss_pred             hhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecC
Q 045286           40 LKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYM  117 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~  117 (259)
                      |++.++||+|++|+||++.+.  ++.+++|.+..............+|+.++++++|+||+++++++......+++||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            678899999999999999986  457999999998766555555667999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceec-cCCCccccCC
Q 045286          118 PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ-NKGGVMTAET  196 (259)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~-~~~~~~~~~~  196 (259)
                      ++++|.+++... ..++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+... ..........
T Consensus        81 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  159 (260)
T PF00069_consen   81 PGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV  159 (260)
T ss_dssp             TTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred             cccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            988999999733 34899999999999999999999999999999999999999999999999999763 3334455667


Q ss_pred             CcccccCccccC-CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          197 GTYRWMAPEVIN-HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       197 ~~~~~~~PE~~~-~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                      ++..|.|||.+. +..++.++|+||||+++++|++|..||...+.......+.+
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~  213 (260)
T PF00069_consen  160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEK  213 (260)
T ss_dssp             SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhh
Confidence            899999999998 88899999999999999999999999998855444444443

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=8.9e-37  Score=247.07  Aligned_cols=218  Identities=35%  Similarity=0.656  Sum_probs=187.4

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEE
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~  111 (259)
                      |+++.++|++.++||.|++|.||+|... +..+++|.+.....   ..+.+.+|+.+++.++|+||+++++.+...+..+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05072           1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY   77 (261)
T ss_pred             CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            6788999999999999999999999864 56799998775432   2467889999999999999999999999889999


Q ss_pred             EEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          112 IVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      +++|++++++|.+++... ...++...+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            999999999999998653 3457888899999999999999999999999999999999999999999999997655432


Q ss_pred             cc--ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCC
Q 045286          191 VM--TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       191 ~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ..  ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+.++...
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~  223 (261)
T cd05072         158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM  223 (261)
T ss_pred             eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC
Confidence            21  12234567999999988889999999999999999998 99999988887777777766543

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-36  Score=245.91  Aligned_cols=216  Identities=33%  Similarity=0.604  Sum_probs=184.2

Q ss_pred             chhhhhccceeccccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      +..++++.+.||+|++|.||++.+. +..+++|.+.......   ..+.+|+.+++.++|+||+++++.+...+..++++
T Consensus         2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCH---HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence            4567889999999999999999875 4579999987543332   46778999999999999999999999889999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccc-
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT-  193 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~-  193 (259)
                      |++++++|.+++......++...++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......... 
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence            9999999999997665568899999999999999999999999999999999999999999999999987654332111 


Q ss_pred             -cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCC
Q 045286          194 -AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       194 -~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                       ....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+..+....
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~  221 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLY  221 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCC
Confidence             1123457999999998889999999999999999999 899999888888887777665443

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-36  Score=246.52  Aligned_cols=219  Identities=37%  Similarity=0.636  Sum_probs=188.8

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEE
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~  111 (259)
                      |+++.++|.+.++||.|++|.||++.+. ++.+++|.+......   ...+.+|+.++++++|+||+++++.+......+
T Consensus         1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05034           1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY   77 (261)
T ss_pred             CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence            6788999999999999999999999875 467999998865433   356889999999999999999999998888999


Q ss_pred             EEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          112 IVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      +++|++++++|.+++.... ..++...+..++.+++.++.+||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            9999999999999997644 458899999999999999999999999999999999999999999999999987654321


Q ss_pred             cc--ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCC
Q 045286          191 VM--TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       191 ~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      ..  .....+..|+|||.+.+..++.++|+||+|+++|++++ |..||.+.+....+..+.......
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~  224 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP  224 (261)
T ss_pred             hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            11  11223467999999998889999999999999999998 999999988888888887665443

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.5e-36  Score=248.49  Aligned_cols=220  Identities=31%  Similarity=0.578  Sum_probs=186.2

Q ss_pred             echhhhhccceeccccceEEEEEEEcC-------ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS  107 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~~-------~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~  107 (259)
                      ++-.+|++.+.||.|++|.||+|...+       ..+++|.+.... .......+.+|+..++.++|+||+++++.+...
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   80 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE   80 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence            345688999999999999999998643       469999987553 334456788999999999999999999999888


Q ss_pred             CcEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNH---------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH  172 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~  172 (259)
                      ...++++||+++++|.+++....               ..++...++.++.|++.+|.+||+.|++|+||+|+||+++.+
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence            89999999999999999986532               347788899999999999999999999999999999999999


Q ss_pred             CeEEEeeeccceeccCCCc---cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhh
Q 045286          173 NVVKVADFGVARFQNKGGV---MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVR  248 (259)
Q Consensus       173 ~~i~l~D~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~  248 (259)
                      +.++|+|||.+........   .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....++
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR  240 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            9999999999875533321   123345678999999988889999999999999999998 999999988888888877


Q ss_pred             hccCCCC
Q 045286          249 QVCTSLC  255 (259)
Q Consensus       249 ~~~~~~~  255 (259)
                      .+.....
T Consensus       241 ~~~~~~~  247 (283)
T cd05048         241 SRQLLPC  247 (283)
T ss_pred             cCCcCCC
Confidence            6655443

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-36  Score=243.97  Aligned_cols=215  Identities=38%  Similarity=0.710  Sum_probs=187.5

Q ss_pred             ceechhhhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEE
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCI  112 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l  112 (259)
                      |.+..+.|++.+.||.|++|.||++...++.|++|.+.....   ....+.+|+.+++.++|+||+++++.+...+..++
T Consensus         1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   77 (256)
T cd05039           1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI   77 (256)
T ss_pred             CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence            456678999999999999999999999999999999987643   34678899999999999999999999988899999


Q ss_pred             EEecCCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc
Q 045286          113 VTEYMPGGSLYDYLHKNHN-VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV  191 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~  191 (259)
                      ++|++++++|.+++..... .+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~  157 (256)
T cd05039          78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD  157 (256)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence            9999999999999965542 589999999999999999999999999999999999999999999999999876543222


Q ss_pred             cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccC
Q 045286          192 MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                        ....+..|.|||.+.+..++.++|+||||+++|++++ |..||...+..+....+.....
T Consensus       158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~  217 (256)
T cd05039         158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR  217 (256)
T ss_pred             --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Confidence              2334567999999988889999999999999999997 9999998887777666655433

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=8.4e-37  Score=255.19  Aligned_cols=192  Identities=26%  Similarity=0.453  Sum_probs=167.4

Q ss_pred             ceeccccceEEEEEEEc--CceEEEEEeecccCc-hHHHHHHHHHHHHHHhc-CCCCcceeeeeeecCCcEEEEEecCCC
Q 045286           44 ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN-DTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPG  119 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~  119 (259)
                      +.||+|++|.||++.+.  ++.+++|++...... ......+.+|..+++++ +|++|+.+++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999864  678999999875432 23446678899999888 599999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc-CCCccccCCCc
Q 045286          120 GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN-KGGVMTAETGT  198 (259)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~-~~~~~~~~~~~  198 (259)
                      ++|..++.... .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.... .........++
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (327)
T cd05617          81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT  159 (327)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence            99998885543 58999999999999999999999999999999999999999999999999986532 22233445689


Q ss_pred             ccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 045286          199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYD  236 (259)
Q Consensus       199 ~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~  236 (259)
                      +.|+|||.+.+..++.++|+||||+++|+|++|..||.
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~  197 (327)
T cd05617         160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD  197 (327)
T ss_pred             cccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCC
Confidence            99999999999999999999999999999999999995

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.8e-36  Score=245.64  Aligned_cols=217  Identities=35%  Similarity=0.622  Sum_probs=183.0

Q ss_pred             ceechhhhhccceeccccceEEEEEEEcC-ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEE
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYLG-QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~~-~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~  111 (259)
                      |.++..+|.+.++||.|++|.||+|.+.+ ..+++|.+.......   ..+.+|+++++.++|+||+++++.+.. +..+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (262)
T cd05071           1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY   76 (262)
T ss_pred             CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCH---HHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence            56778899999999999999999998753 579999988644332   567899999999999999999987754 5678


Q ss_pred             EEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          112 IVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      ++||++++++|.+++... ...++...+..++.|++.+|.++|+.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            999999999999999754 3357889999999999999999999999999999999999999999999999987655432


Q ss_pred             ccc--cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCC
Q 045286          191 VMT--AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       191 ~~~--~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ...  ...++..|+|||...+..++.++|+||||+++|+|++ |..||.+.+..+....+..+...
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~  222 (262)
T cd05071         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM  222 (262)
T ss_pred             cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC
Confidence            211  2234567999999988889999999999999999999 89999988887777776655433

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=8.1e-37  Score=255.44  Aligned_cols=192  Identities=26%  Similarity=0.447  Sum_probs=166.6

Q ss_pred             ceeccccceEEEEEEEc--CceEEEEEeecccCc-hHHHHHHHHHHHHHHhc-CCCCcceeeeeeecCCcEEEEEecCCC
Q 045286           44 ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN-DTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPG  119 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~  119 (259)
                      +.||+|+||.||++.+.  ++.+++|++...... ......+.+|..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            47999999999999874  678999999875332 23445677888888877 699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC-CCccccCCCc
Q 045286          120 GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMTAETGT  198 (259)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~-~~~~~~~~~~  198 (259)
                      ++|..++... ..+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+..... ........++
T Consensus        81 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (329)
T cd05618          81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT  159 (329)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence            9999888554 3589999999999999999999999999999999999999999999999999865322 2223345689


Q ss_pred             ccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 045286          199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYD  236 (259)
Q Consensus       199 ~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~  236 (259)
                      ..|+|||.+.+..++.++|+||||+++|+|++|..||.
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~  197 (329)
T cd05618         160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD  197 (329)
T ss_pred             ccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence            99999999999999999999999999999999999995

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.8e-36  Score=248.59  Aligned_cols=209  Identities=26%  Similarity=0.402  Sum_probs=179.2

Q ss_pred             hhccceeccccceEEEEEEEc--CceEEEEEeecccCch-HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           40 LKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      |+..+.||.|+||+||++.+.  ++.+++|.+....... .....+.+|+++++.++|++|+.+.+.+..++..++++||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            566788999999999999874  7899999987654332 2335577899999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccccC
Q 045286          117 MPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAE  195 (259)
Q Consensus       117 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~~  195 (259)
                      +++++|..++... ...+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+............
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  161 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR  161 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCC
Confidence            9999999888643 335899999999999999999999999999999999999999999999999998765444333445


Q ss_pred             CCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 045286          196 TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVR  248 (259)
Q Consensus       196 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~  248 (259)
                      .++..|+|||.+.+..++.++|+||+|+++|+|++|..||...........+.
T Consensus       162 ~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~  214 (285)
T cd05632         162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD  214 (285)
T ss_pred             CCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            68899999999998889999999999999999999999998876655444443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-36  Score=244.78  Aligned_cols=218  Identities=33%  Similarity=0.566  Sum_probs=186.2

Q ss_pred             chhhhhccceeccccceEEEEEEEc-----CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL  110 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~  110 (259)
                      +.++|.+.+.||+|+||.||+|.+.     ...+++|.+.... .......+.+|+.+++.++|+||+++++.+...+..
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            4567899999999999999999874     3479999887653 334456788999999999999999999999988999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-  189 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-  189 (259)
                      ++++|++++++|.+++......++...+..++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||.+...... 
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            9999999999999999776667899999999999999999999999999999999999999999999999999866421 


Q ss_pred             Cccc--cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCC
Q 045286          190 GVMT--AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       190 ~~~~--~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      ....  ....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+.+....+
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~  228 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP  228 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            1111  1234567999999998889999999999999999998 999998888887777777655443

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.8e-36  Score=245.70  Aligned_cols=219  Identities=33%  Similarity=0.624  Sum_probs=187.5

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcE
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL  110 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~  110 (259)
                      |++....+.+.+.||.|++|.||++.+.  ++.+++|.+....   .....+.+|+++++.++|++|+++++.+...+..
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (263)
T cd05052           1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   77 (263)
T ss_pred             CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence            6778889999999999999999999874  7889999987542   2246688999999999999999999999988999


Q ss_pred             EEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC
Q 045286          111 CIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG  189 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~  189 (259)
                      ++++||+++++|.+++.... ..++...+..++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            99999999999999986543 35888899999999999999999999999999999999999999999999998765543


Q ss_pred             Cccc--cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCC
Q 045286          190 GVMT--AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       190 ~~~~--~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      ....  ....+..|++||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+..+....
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~  225 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRME  225 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC
Confidence            2221  1123567999999998899999999999999999998 999999888877777777655443

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.4e-36  Score=248.59  Aligned_cols=194  Identities=29%  Similarity=0.463  Sum_probs=167.3

Q ss_pred             eccccceEEEEEEE--cCceEEEEEeecccCch-HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCCCCCh
Q 045286           46 IASGSCGDLYRGVY--LGQDVAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSL  122 (259)
Q Consensus        46 lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L  122 (259)
                      ||+|+||+||++.+  +++.+++|.+....... .....+..|+.+++.++|++|+++.+.+......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999986  47899999987653322 2335677899999999999999999999988899999999999999


Q ss_pred             HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-ccccCCCc
Q 045286          123 YDYLHK---NHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMTAETGT  198 (259)
Q Consensus       123 ~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~~~~~~  198 (259)
                      ...+..   ....+++..++.++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+....... ......++
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~  160 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT  160 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence            988743   23458899999999999999999999999999999999999999999999999987654432 22334678


Q ss_pred             ccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 045286          199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT  239 (259)
Q Consensus       199 ~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  239 (259)
                      +.|+|||.+.+..++.++|+||||+++|+|++|..||...+
T Consensus       161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  201 (280)
T cd05608         161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG  201 (280)
T ss_pred             cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999999999999999999997644

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.7e-36  Score=253.85  Aligned_cols=207  Identities=25%  Similarity=0.432  Sum_probs=179.3

Q ss_pred             echhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEE
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCI  112 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l  112 (259)
                      +..++|++.++||.|++|.||++.+.  +..+++|.+.... .......+.+|+++++.++|+||+++++++...+..++
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence            45689999999999999999999985  6788999887653 33445678899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc
Q 045286          113 VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR-NIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV  191 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~  191 (259)
                      ||||+++++|.+++.... .+++..+..++.|++.++.|||+. +++|+||+|+||+++.++.++|+|||.+...... .
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~  158 (333)
T cd06650          81 CMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M  158 (333)
T ss_pred             EEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-c
Confidence            999999999999986543 488889999999999999999985 7999999999999999999999999998654332 2


Q ss_pred             cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 045286          192 MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAA  244 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~  244 (259)
                      .....++..|+|||.+.+..++.++|+|||||++|+|++|..||...+..+..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~  211 (333)
T cd06650         159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE  211 (333)
T ss_pred             cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH
Confidence            23346788999999999988999999999999999999999999876654443

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.4e-36  Score=251.14  Aligned_cols=216  Identities=24%  Similarity=0.426  Sum_probs=182.6

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ++|.+.++||.|++|.||++.+.  ++.|++|.+...... .....+.+|+.+++.++|+||+++++++...+..++|+|
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            57888999999999999999874  788999998765322 223456789999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-cccc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMTA  194 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~~  194 (259)
                      |++ ++|.+++......+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus        85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  163 (301)
T cd07873          85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSN  163 (301)
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccc
Confidence            996 58999887766668899999999999999999999999999999999999999999999999986543322 2223


Q ss_pred             CCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCC
Q 045286          195 ETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLC  255 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~  255 (259)
                      ..+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+.+..+.+....+.
T Consensus       164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~  225 (301)
T cd07873         164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPT  225 (301)
T ss_pred             cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            4568899999998654 578899999999999999999999999888777776666554433

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-37  Score=258.40  Aligned_cols=199  Identities=36%  Similarity=0.615  Sum_probs=174.6

Q ss_pred             hhhhccceeccccceEEEEEEEcC-ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC-cEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVYLG-QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP-HLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~~-~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e  115 (259)
                      +.+.-.+.||.|+||.||+|...+ ..||||.+.......  ..+|.+|+.++.+++|+|+++++++|.+.+ ..++|+|
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYE  152 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYE  152 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEE
Confidence            556666899999999999999875 899999877765432  355999999999999999999999999888 5999999


Q ss_pred             cCCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCCCcEEEccCCeEEEeeeccceeccC-CC
Q 045286          116 YMPGGSLYDYLHKNHN-VLKLPQLLRFAIDICKGMEYLHQRN---IIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GG  190 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~-~~  190 (259)
                      |++.|+|.+.+..... .+++....+|+.+++++|+|||...   ++|||||++|||++.+.+.||+|||++..... ..
T Consensus       153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~  232 (361)
T KOG1187|consen  153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDT  232 (361)
T ss_pred             ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcccc
Confidence            9999999999976665 7899999999999999999999865   99999999999999999999999999965554 32


Q ss_pred             ccccC-CCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 045286          191 VMTAE-TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSM  238 (259)
Q Consensus       191 ~~~~~-~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  238 (259)
                      ..... .++.+|++||.......+.++|+||||++++|+++|+.|.+..
T Consensus       233 ~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~  281 (361)
T KOG1187|consen  233 SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS  281 (361)
T ss_pred             ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence            22222 7999999999998888999999999999999999999988753

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.7e-37  Score=248.65  Aligned_cols=216  Identities=35%  Similarity=0.612  Sum_probs=183.4

Q ss_pred             hccceeccccceEEEEEEEc------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           41 KTGERIASGSCGDLYRGVYL------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        41 ~~~~~lg~G~~~~V~~~~~~------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      .+.+.||.|+||.||+|.+.      +..|+||.++.. ........+.+|++.+++++||||+++++++...+..++|+
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccccccccc
Confidence            35679999999999999988      678999999664 34444688999999999999999999999999888899999


Q ss_pred             ecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcc-
Q 045286          115 EYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM-  192 (259)
Q Consensus       115 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~-  192 (259)
                      ||+++++|.+++... ...++...+..++.|++.+|.|||+++++|++|+++||+++.++.+||+|||.+......... 
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~  160 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK  160 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999999876 556899999999999999999999999999999999999999999999999999876332211 


Q ss_pred             --ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          193 --TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       193 --~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                        ........|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+.++.....++
T Consensus       161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  228 (259)
T PF07714_consen  161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPD  228 (259)
T ss_dssp             ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceecc
Confidence              23346778999999988889999999999999999999 789999999999888887776655443

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=5e-36  Score=241.93  Aligned_cols=214  Identities=25%  Similarity=0.428  Sum_probs=187.7

Q ss_pred             hhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           39 LLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      +|+..+.||.|++|.||.+..  .++.+++|.+............+.+|+.++++++|+||+++++.+...+..++++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            478899999999999988876  478899999987766666667788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-cccc
Q 045286          117 MPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMTA  194 (259)
Q Consensus       117 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~~  194 (259)
                      +++++|.+++... ...++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET  160 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence            9999999999765 3458899999999999999999999999999999999999999999999999987654433 2234


Q ss_pred             CCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          195 ETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      ..++..|.|||.+.+..++.++|+||||+++|+|++|..||...+..+....+..+-.
T Consensus       161 ~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~  218 (256)
T cd08221         161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNY  218 (256)
T ss_pred             cCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC
Confidence            5678999999999988899999999999999999999999998888777777665433

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-36  Score=258.92  Aligned_cols=192  Identities=26%  Similarity=0.421  Sum_probs=167.2

Q ss_pred             echhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEE
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCI  112 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l  112 (259)
                      +....|++.+.||.|++|.||+|.+.  ++.||+|....        ..+.+|++++++++||||+++++++......++
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l  160 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL  160 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence            44567999999999999999999974  78999997542        346789999999999999999999998899999


Q ss_pred             EEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC--C
Q 045286          113 VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG--G  190 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~--~  190 (259)
                      ++|++ +++|..++... ..++...++.++.|++.+|.|||+.|++|+||||+||+++.++.++|+|||.+......  .
T Consensus       161 v~e~~-~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        161 ILPRY-KTDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             EEecC-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence            99999 56888887554 34889999999999999999999999999999999999999999999999998643322  2


Q ss_pred             ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 045286          191 VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYD  236 (259)
Q Consensus       191 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~  236 (259)
                      ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||-
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~  284 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF  284 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence            2234568999999999999899999999999999999999998763

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.6e-37  Score=257.10  Aligned_cols=215  Identities=25%  Similarity=0.411  Sum_probs=180.7

Q ss_pred             cceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC--
Q 045286           32 DWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS--  107 (259)
Q Consensus        32 ~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--  107 (259)
                      .|++. ++|++.+.||.|+||+||+|.+.  ++.||+|.+............+.+|+.+++.++|+||+++++++...  
T Consensus        10 ~~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07878          10 VWEVP-ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS   88 (343)
T ss_pred             Hhhhh-hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence            36664 57999999999999999999864  67899999987644444456677999999999999999999887533  


Q ss_pred             ----CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccc
Q 045286          108 ----PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA  183 (259)
Q Consensus       108 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~  183 (259)
                          ...+++++++ +++|.+++..  ..+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        89 ~~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          89 IENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             ccccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccc
Confidence                3468999988 7899887743  34899999999999999999999999999999999999999999999999998


Q ss_pred             eeccCCCccccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          184 RFQNKGGVMTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      ......  .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+..+.+..+.....
T Consensus       166 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  233 (343)
T cd07878         166 RQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVG  233 (343)
T ss_pred             eecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhC
Confidence            765443  234467899999999877 5688999999999999999999999998877777766655443

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.6e-36  Score=251.08  Aligned_cols=217  Identities=30%  Similarity=0.580  Sum_probs=180.7

Q ss_pred             echhhhhccceeccccceEEEEEEEc--Cc----eEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL--GQ----DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~--~~----~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      +...+|+..+.||+|+||+||+|.+.  ++    .|++|.+.... .......+.+|+.+++.++|+||+++++.+... 
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-   81 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   81 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence            44578999999999999999999863  33    48999987542 334456788999999999999999999988764 


Q ss_pred             cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      ..+++++++++++|.+++......++...+..++.|++.+|.|||+.|++|+||||+||+++.++.++|+|||.+.....
T Consensus        82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            56799999999999999987666688899999999999999999999999999999999999999999999999986654


Q ss_pred             CCcc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCC
Q 045286          189 GGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       189 ~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ....   .....+..|++||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+..+...
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~  230 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL  230 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCC
Confidence            3221   11223567999999999999999999999999999998 99999987776655544444433

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.2e-36  Score=245.28  Aligned_cols=217  Identities=29%  Similarity=0.523  Sum_probs=181.5

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc-------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeee
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST  105 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~  105 (259)
                      |++..++|++.+.||+|++|.||++.+.       +..+++|.+.... .......+.+|+.+++.++|+||+++++++.
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   79 (277)
T cd05062           1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            6778899999999999999999998764       3569999886532 2233456889999999999999999999999


Q ss_pred             cCCcEEEEEecCCCCChHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEE
Q 045286          106 KSPHLCIVTEYMPGGSLYDYLHKNHN---------VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVK  176 (259)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~  176 (259)
                      .+...++++||+++++|.+++.....         ..+...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence            88899999999999999999865321         245678888999999999999999999999999999999999999


Q ss_pred             EeeeccceeccCCCcc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhc
Q 045286          177 VADFGVARFQNKGGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       177 l~D~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~  250 (259)
                      |+|||.+.........   ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~  237 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG  237 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            9999998654332211   12234678999999998889999999999999999998 79999988877766655544

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.2e-36  Score=242.52  Aligned_cols=217  Identities=35%  Similarity=0.618  Sum_probs=184.5

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEE
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~  111 (259)
                      |++..++|++.++||.|++|.||++.+. +..+++|.+.......   ..+.+|+.++++++|++++++++.+.. +..+
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05070           1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIY   76 (260)
T ss_pred             CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEEEeEECC-CCcE
Confidence            6778899999999999999999999864 5689999988754433   568899999999999999999988754 5678


Q ss_pred             EEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          112 IVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      ++||++++++|.+++... ...++...+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            999999999999998654 3358899999999999999999999999999999999999999999999999997654432


Q ss_pred             ccc--cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCC
Q 045286          191 VMT--AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       191 ~~~--~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ...  ...++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+......
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~  222 (260)
T cd05070         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM  222 (260)
T ss_pred             cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence            111  1224567999999988889999999999999999999 99999988888877777665443

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.6e-36  Score=245.85  Aligned_cols=220  Identities=31%  Similarity=0.515  Sum_probs=186.7

Q ss_pred             echhhhhccceeccccceEEEEEEEc-------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS  107 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~  107 (259)
                      +..++|.+.+.||.|++|.||+|...       ++.+++|.++.... ......+.+|+++++.++|+||+++++.+...
T Consensus         2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            34678999999999999999999753       36799999876543 23457889999999999999999999999999


Q ss_pred             CcEEEEEecCCCCChHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCe
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNH-------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV  174 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~  174 (259)
                      ...+++|||+++++|.+++....             ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence            99999999999999999996542             23678889999999999999999999999999999999999999


Q ss_pred             EEEeeeccceeccCCCc---cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhc
Q 045286          175 VKVADFGVARFQNKGGV---MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       175 i~l~D~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~  250 (259)
                      ++|+|||.+........   ......+..|+|||.+.+..+++++|+||||+++|+|++ |..||...+..+....+..+
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~  240 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG  240 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence            99999999875433221   122234678999999999999999999999999999998 99999988888888887766


Q ss_pred             cCCCC
Q 045286          251 CTSLC  255 (259)
Q Consensus       251 ~~~~~  255 (259)
                      .....
T Consensus       241 ~~~~~  245 (280)
T cd05049         241 RLLQR  245 (280)
T ss_pred             CcCCC
Confidence            55443

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5.4e-36  Score=241.25  Aligned_cols=211  Identities=35%  Similarity=0.619  Sum_probs=177.2

Q ss_pred             ceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCCCCC
Q 045286           44 ERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGS  121 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~  121 (259)
                      +.||+|++|.||++.+  .++.+++|...... .......+.+|+++++.++|+||+++++++......++|+||+++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            4799999999999987  57889999887543 34455778899999999999999999999999999999999999999


Q ss_pred             hHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcc---ccCCCc
Q 045286          122 LYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM---TAETGT  198 (259)
Q Consensus       122 L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~---~~~~~~  198 (259)
                      |.+++......+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.........   .....+
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  159 (252)
T cd05084          80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP  159 (252)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence            99999766556889999999999999999999999999999999999999999999999998654332111   111224


Q ss_pred             ccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCC
Q 045286          199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLC  255 (259)
Q Consensus       199 ~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~  255 (259)
                      ..|+|||.+.+..++.++|+||||+++|+|++ |..||...+.......+........
T Consensus       160 ~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  217 (252)
T cd05084         160 VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPC  217 (252)
T ss_pred             eeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC
Confidence            56999999988889999999999999999997 9999988777666666655444333

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.9e-36  Score=247.09  Aligned_cols=215  Identities=26%  Similarity=0.430  Sum_probs=186.5

Q ss_pred             hhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           39 LLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      +|++.+.||.|++|.||+|.+  .++.+++|++............+.+|+.++++++|+||+++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            478889999999999999997  478999999988765555567889999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC--cccc
Q 045286          117 MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG--VMTA  194 (259)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~--~~~~  194 (259)
                      + +++|.+++......+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......  ....
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  159 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH  159 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence            9 999999987666678999999999999999999999999999999999999999999999999987665443  1334


Q ss_pred             CCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          195 ETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      ..++..|+|||.+.+. .++.++|+||+|+++++|++|..||...+..+....+......+
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~  220 (286)
T cd07832         160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTP  220 (286)
T ss_pred             ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCC
Confidence            4678899999998654 46899999999999999999999998887777766666554433

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.3e-36  Score=274.81  Aligned_cols=215  Identities=23%  Similarity=0.446  Sum_probs=180.0

Q ss_pred             cccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec-
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK-  106 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-  106 (259)
                      .+..+....+|.+.++||.|+||+||+|.+.  ++.+++|++............+.+|+.+++.++||||+++++.+.. 
T Consensus         5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de   84 (1021)
T PTZ00266          5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK   84 (1021)
T ss_pred             ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence            3445555678999999999999999999975  6789999998776666666788999999999999999999998854 


Q ss_pred             -CCcEEEEEecCCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-------CcccCCCCCCcEEEccC---
Q 045286          107 -SPHLCIVTEYMPGGSLYDYLHKN---HNVLKLPQLLRFAIDICKGMEYLHQR-------NIIHRDLKTANLLMDTH---  172 (259)
Q Consensus       107 -~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~-------~i~H~di~p~Nilv~~~---  172 (259)
                       ...+++||||+++++|.+++...   ...+++..++.++.||+.+|.|||+.       +|+|+||||+|||++.+   
T Consensus        85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~  164 (1021)
T PTZ00266         85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH  164 (1021)
T ss_pred             CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence             45689999999999999998643   34589999999999999999999985       49999999999999642   


Q ss_pred             --------------CeEEEeeeccceeccCCCccccCCCcccccCccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCC
Q 045286          173 --------------NVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINH--QPYDQKADVFSFAIVLWELVTAKVPYD  236 (259)
Q Consensus       173 --------------~~i~l~D~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~~~~ll~g~~p~~  236 (259)
                                    +.++|+|||++.............+++.|+|||++.+  ..++.++|||||||++|+|++|..||.
T Consensus       165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             cccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                          3489999999976655444445578999999999854  457899999999999999999999998


Q ss_pred             CCCHHHHH
Q 045286          237 SMTPLQAA  244 (259)
Q Consensus       237 ~~~~~~~~  244 (259)
                      ..+....+
T Consensus       245 ~~~~~~ql  252 (1021)
T PTZ00266        245 KANNFSQL  252 (1021)
T ss_pred             cCCcHHHH
Confidence            65554433

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.2e-37  Score=271.97  Aligned_cols=229  Identities=32%  Similarity=0.542  Sum_probs=201.9

Q ss_pred             cccccceechhhhhccceeccccceEEEEEEEc-------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCccee
Q 045286           28 TKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF  100 (259)
Q Consensus        28 ~~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~  100 (259)
                      +..+..+++..+++....||.|+||.||+|...       ..-||||.++... +...+.+|.||++++..++||||+++
T Consensus       476 ~~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrL  554 (774)
T KOG1026|consen  476 PDLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRL  554 (774)
T ss_pred             CccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEE
Confidence            466778899999999999999999999999854       3469999999874 33466889999999999999999999


Q ss_pred             eeeeecCCcEEEEEecCCCCChHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 045286          101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNH-------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANL  167 (259)
Q Consensus       101 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Ni  167 (259)
                      ++++..++..++|+||+..|||.+++....             .+++..+...++.||+.+..||-+..+||||+..+|.
T Consensus       555 lGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNC  634 (774)
T KOG1026|consen  555 LGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNC  634 (774)
T ss_pred             EEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhc
Confidence            999999999999999999999999996432             2277789999999999999999999999999999999


Q ss_pred             EEccCCeEEEeeeccceeccCCCccc---cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q 045286          168 LMDTHNVVKVADFGVARFQNKGGVMT---AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQA  243 (259)
Q Consensus       168 lv~~~~~i~l~D~~~~~~~~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~  243 (259)
                      ||+++..|||+|||+++..-......   ...-..+|||||.+...+++.+|||||+|+++||+++ |..||-+.++.|+
T Consensus       635 LVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV  714 (774)
T KOG1026|consen  635 LVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV  714 (774)
T ss_pred             eeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH
Confidence            99999999999999998665543222   2235689999999999999999999999999999999 9999999999999


Q ss_pred             HHHhhhccCCCCcc
Q 045286          244 ALGVRQVCTSLCQP  257 (259)
Q Consensus       244 ~~~i~~~~~~~~~~  257 (259)
                      ++.|.++..-.||.
T Consensus       715 Ie~i~~g~lL~~Pe  728 (774)
T KOG1026|consen  715 IECIRAGQLLSCPE  728 (774)
T ss_pred             HHHHHcCCcccCCC
Confidence            99999887655553

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4e-36  Score=256.62  Aligned_cols=222  Identities=33%  Similarity=0.558  Sum_probs=182.8

Q ss_pred             ccccceechhhhhccceeccccceEEEEEEEc-------CceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCccee
Q 045286           29 KSEDWEIDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRF  100 (259)
Q Consensus        29 ~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~  100 (259)
                      +...|+++.++|+++++||.|+||.||+|++.       +..||+|++.... .....+.+.+|+.+++++. ||||+++
T Consensus        28 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l  106 (400)
T cd05105          28 YDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNL  106 (400)
T ss_pred             CCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            34569999999999999999999999999863       2369999997653 3334467899999999996 9999999


Q ss_pred             eeeeecCCcEEEEEecCCCCChHHHHHhcC--------------------------------------------------
Q 045286          101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNH--------------------------------------------------  130 (259)
Q Consensus       101 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------------------------------------  130 (259)
                      ++++...+..++||||+++++|.+++....                                                  
T Consensus       107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (400)
T cd05105         107 LGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTT  186 (400)
T ss_pred             EEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccc
Confidence            999999999999999999999999885421                                                  


Q ss_pred             ---------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 045286          131 ---------------------------------------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTA  165 (259)
Q Consensus       131 ---------------------------------------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~  165 (259)
                                                                   ..++...+..++.|++.+|.|||+.+++|+||+|+
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~  266 (400)
T cd05105         187 QYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAAR  266 (400)
T ss_pred             ccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChH
Confidence                                                         13566778899999999999999999999999999


Q ss_pred             cEEEccCCeEEEeeeccceeccCCCcc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 045286          166 NLLMDTHNVVKVADFGVARFQNKGGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL  241 (259)
Q Consensus       166 Nilv~~~~~i~l~D~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~  241 (259)
                      ||+++.++.++|+|||.+.........   ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||......
T Consensus       267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~  346 (400)
T cd05105         267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD  346 (400)
T ss_pred             hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence            999999999999999998765433211   12235678999999998889999999999999999997 99999875543


Q ss_pred             H-HHHHhhhcc
Q 045286          242 Q-AALGVRQVC  251 (259)
Q Consensus       242 ~-~~~~i~~~~  251 (259)
                      . ....+..+.
T Consensus       347 ~~~~~~~~~~~  357 (400)
T cd05105         347 STFYNKIKSGY  357 (400)
T ss_pred             HHHHHHHhcCC
Confidence            3 334444443

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.5e-36  Score=242.89  Aligned_cols=218  Identities=33%  Similarity=0.609  Sum_probs=186.0

Q ss_pred             ceechhhhhccceeccccceEEEEEEE-cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEE
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVY-LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~-~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~  111 (259)
                      |++.++.|++.++||+|++|.||+|.. .++.+++|.+......   ...+.+|+.+++.++|+||+++++.+. .+..+
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05067           1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY   76 (260)
T ss_pred             CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence            678889999999999999999999986 4688999998865443   356889999999999999999998865 45789


Q ss_pred             EEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          112 IVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      +++|++.+++|.+++... ...++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            999999999999998653 3457888999999999999999999999999999999999999999999999987655322


Q ss_pred             cc--ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCC
Q 045286          191 VM--TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       191 ~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      ..  ....++..|+|||.+.+..++.++|+||||+++|++++ |..||.+.+..+....+.++....
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  223 (260)
T cd05067         157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP  223 (260)
T ss_pred             cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC
Confidence            11  12234578999999988889999999999999999998 999999888888887777665544

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.8e-36  Score=248.51  Aligned_cols=222  Identities=31%  Similarity=0.590  Sum_probs=186.2

Q ss_pred             cccceechhhhhccceeccccceEEEEEEEcC---------ceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcce
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVYLG---------QDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVR   99 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~---------~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~   99 (259)
                      .+.|++..++|.+.+.||+|+||.||++.+.+         ..+++|.+.... .......+.+|+.+++.+ +|+||++
T Consensus        10 ~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~   88 (307)
T cd05098          10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIIN   88 (307)
T ss_pred             CCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEee
Confidence            34688989999999999999999999998632         469999998653 233346688899999999 6999999


Q ss_pred             eeeeeecCCcEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 045286          100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNH---------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKT  164 (259)
Q Consensus       100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p  164 (259)
                      +++.+...+..++++||+++++|.+++....               ..++...++.++.|++.+|.+||+.|++|+||+|
T Consensus        89 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp  168 (307)
T cd05098          89 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAA  168 (307)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccH
Confidence            9999999999999999999999999997532               2377788999999999999999999999999999


Q ss_pred             CcEEEccCCeEEEeeeccceeccCCCcc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCH
Q 045286          165 ANLLMDTHNVVKVADFGVARFQNKGGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTP  240 (259)
Q Consensus       165 ~Nilv~~~~~i~l~D~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~  240 (259)
                      +||+++.++.++|+|||.+.........   .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+.
T Consensus       169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~  248 (307)
T cd05098         169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  248 (307)
T ss_pred             HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence            9999999999999999998655432111   11223468999999988889999999999999999998 9999988887


Q ss_pred             HHHHHHhhhccC
Q 045286          241 LQAALGVRQVCT  252 (259)
Q Consensus       241 ~~~~~~i~~~~~  252 (259)
                      .+....+.....
T Consensus       249 ~~~~~~~~~~~~  260 (307)
T cd05098         249 EELFKLLKEGHR  260 (307)
T ss_pred             HHHHHHHHcCCC
Confidence            777766665544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.5e-36  Score=245.89  Aligned_cols=193  Identities=27%  Similarity=0.474  Sum_probs=167.5

Q ss_pred             eccccceEEEEEEEc--CceEEEEEeecccCch-HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCCCCCh
Q 045286           46 IASGSCGDLYRGVYL--GQDVAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSL  122 (259)
Q Consensus        46 lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L  122 (259)
                      ||+|+||.||++...  ++.+++|.+....... .....+..|++++++++||||+++.+.+......+++|||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999864  7899999987643322 2234556799999999999999999999988999999999999999


Q ss_pred             HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccccCCCcccc
Q 045286          123 YDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRW  201 (259)
Q Consensus       123 ~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~~~~~~~~  201 (259)
                      ..++.... ..++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.............++..|
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y  160 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY  160 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence            98875433 34788888999999999999999999999999999999999999999999998776554444455688999


Q ss_pred             cCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 045286          202 MAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSM  238 (259)
Q Consensus       202 ~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  238 (259)
                      +|||.+.+..++.++|+||+||++|+|++|..||...
T Consensus       161 ~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~  197 (277)
T cd05607         161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH  197 (277)
T ss_pred             cCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999998888999999999999999999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5e-36  Score=242.09  Aligned_cols=216  Identities=35%  Similarity=0.651  Sum_probs=184.4

Q ss_pred             ceechhhhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeee-ecCCcEE
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAS-TKSPHLC  111 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~  111 (259)
                      |-++.++|++.+.||.|++|.||++...+..+++|......    ....+.+|+.++++++|++++++++.+ ...+..+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05082           1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   76 (256)
T ss_pred             CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence            55677899999999999999999999999999999987542    235688999999999999999999875 4456789


Q ss_pred             EEEecCCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          112 IVTEYMPGGSLYDYLHKNHN-VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      +++||+++++|.+++..... .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            99999999999999876543 47889999999999999999999999999999999999999999999999987544332


Q ss_pred             ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCC
Q 045286          191 VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       191 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                        .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+.++....
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~  219 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD  219 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC
Confidence              12234567999999988889999999999999999997 999999888877777776655443

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.5e-36  Score=245.56  Aligned_cols=216  Identities=30%  Similarity=0.506  Sum_probs=183.9

Q ss_pred             echhhhhccceeccccceEEEEEEEc-------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS  107 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~  107 (259)
                      +++.+|.+.+.||.|++|.||++...       +..+++|.+...  .......+.+|+.++++++|++|+++++.+...
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            46788999999999999999999742       345888888654  234456788999999999999999999999999


Q ss_pred             CcEEEEEecCCCCChHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeE
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNH------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVV  175 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i  175 (259)
                      +..++++||+++++|.+++....            ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence            99999999999999999986432            248889999999999999999999999999999999999999999


Q ss_pred             EEeeeccceeccCCCc---cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhcc
Q 045286          176 KVADFGVARFQNKGGV---MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       176 ~l~D~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      +|+|||.+........   .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+.++.
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~  239 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR  239 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999875533221   122234678999999998889999999999999999998 999999888888887777665


Q ss_pred             C
Q 045286          252 T  252 (259)
Q Consensus       252 ~  252 (259)
                      .
T Consensus       240 ~  240 (288)
T cd05093         240 V  240 (288)
T ss_pred             c
Confidence            4

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.1e-36  Score=246.44  Aligned_cols=209  Identities=27%  Similarity=0.455  Sum_probs=182.7

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN-DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      +|.+.+.||+|++|.||++.+.  ++.+++|++...... ......+.+|++++++++|+||+++++.+..++..++++|
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME   81 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence            6788899999999999999874  789999998765332 2344678899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccccC
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAE  195 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~~  195 (259)
                      |+++++|.+++... ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+......  ....
T Consensus        82 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~  158 (290)
T cd05580          82 YVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYTL  158 (290)
T ss_pred             cCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCCC
Confidence            99999999998665 45899999999999999999999999999999999999999999999999998765544  2344


Q ss_pred             CCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          196 TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       196 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      .+++.|++||.+.+..++.++|+||||+++|+|++|..||...+..+....+..+
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  213 (290)
T cd05580         159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG  213 (290)
T ss_pred             CCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Confidence            6788999999998888899999999999999999999999887766666655543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.7e-36  Score=252.17  Aligned_cols=208  Identities=34%  Similarity=0.619  Sum_probs=174.4

Q ss_pred             cceechhhhhccceeccccceEEEEEEEc-------CceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeeee
Q 045286           32 DWEIDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGA  103 (259)
Q Consensus        32 ~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~  103 (259)
                      +|.++.++|++.++||.|+||.||+|...       ++.|++|++...... .....+.+|+.+++++ +|+||+++++.
T Consensus         1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~E~~~~~~l~~h~niv~~~~~   79 (337)
T cd05054           1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA-SEYKALMTELKILIHIGHHLNVVNLLGA   79 (337)
T ss_pred             CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH-HHHHHHHHHHHHHHhhccCcchhheeee
Confidence            48899999999999999999999999643       368999999865432 3345678899999999 79999999997


Q ss_pred             ee-cCCcEEEEEecCCCCChHHHHHhcC----------------------------------------------------
Q 045286          104 ST-KSPHLCIVTEYMPGGSLYDYLHKNH----------------------------------------------------  130 (259)
Q Consensus       104 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~----------------------------------------------------  130 (259)
                      +. .+...++++||+++++|.+++....                                                    
T Consensus        80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (337)
T cd05054          80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED  159 (337)
T ss_pred             EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence            75 4567889999999999999885321                                                    


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc---cccCCCcc
Q 045286          131 --------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV---MTAETGTY  199 (259)
Q Consensus       131 --------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~---~~~~~~~~  199 (259)
                              ..++...+..++.|++.+|.+||++|++|+||||+||+++.++.++|+|||++........   .....++.
T Consensus       160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                    2467888999999999999999999999999999999999999999999999876533211   11223456


Q ss_pred             cccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCH
Q 045286          200 RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTP  240 (259)
Q Consensus       200 ~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~  240 (259)
                      .|+|||.+.+..++.++|+|||||++|+|++ |..||.+...
T Consensus       240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~  281 (337)
T cd05054         240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI  281 (337)
T ss_pred             cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            7999999999999999999999999999998 9999987544

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6.5e-36  Score=246.65  Aligned_cols=215  Identities=33%  Similarity=0.555  Sum_probs=178.0

Q ss_pred             hhhhccceeccccceEEEEEEEc--C--ceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeeeeeecCCcEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--G--QDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHLCI  112 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~--~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l  112 (259)
                      ++|++.+.||.|++|.||+|.+.  +  ..+++|.++... .......+.+|+.+++++ +||||+++++.+...+..++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence            57888999999999999999864  2  246888776432 333456788999999999 69999999999998889999


Q ss_pred             EEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEE
Q 045286          113 VTEYMPGGSLYDYLHKNH---------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKV  177 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l  177 (259)
                      ++||+++++|.+++....               ..++...++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl  160 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKI  160 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEE
Confidence            999999999999986532               24778899999999999999999999999999999999999999999


Q ss_pred             eeeccceeccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCC
Q 045286          178 ADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       178 ~D~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      +|||.+..............+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+.++...
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~  237 (297)
T cd05089         161 ADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRM  237 (297)
T ss_pred             CCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC
Confidence            99998854322111111223457999999988889999999999999999997 99999998888877777665543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-36  Score=241.06  Aligned_cols=209  Identities=32%  Similarity=0.525  Sum_probs=178.6

Q ss_pred             hhhccceeccccceEEEEEEE--cCceEEEEEeecccCch---HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           39 LLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLND---TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      .|.+.++||.|++|.||.+.+  .++.+++|.+.......   .....+.+|+.++++++||||+++++++...+..+++
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   82 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF   82 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence            578889999999999999986  47899999987654332   2335688899999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcc-
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM-  192 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~-  192 (259)
                      +|++++++|.+++.... .++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        83 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~  161 (263)
T cd06625          83 MEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG  161 (263)
T ss_pred             EEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence            99999999999986543 4888899999999999999999999999999999999999999999999998754432111 


Q ss_pred             ---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 045286          193 ---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVR  248 (259)
Q Consensus       193 ---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~  248 (259)
                         ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+...++.
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  220 (263)
T cd06625         162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA  220 (263)
T ss_pred             ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHh
Confidence               23456788999999999889999999999999999999999998776665555443

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=8.3e-36  Score=240.96  Aligned_cols=211  Identities=27%  Similarity=0.540  Sum_probs=178.6

Q ss_pred             ceeccccceEEEEEEE----cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCCC
Q 045286           44 ERIASGSCGDLYRGVY----LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPG  119 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~----~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~  119 (259)
                      ++||+|++|.||+|.+    .+..+++|++............+.+|+.+++.+.|+||+++++.+.. +..++++|++++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~   79 (257)
T cd05116           1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL   79 (257)
T ss_pred             CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence            3689999999999875    36789999998766555667788999999999999999999998754 567899999999


Q ss_pred             CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcc----ccC
Q 045286          120 GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM----TAE  195 (259)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~----~~~  195 (259)
                      ++|.+++... ..+++..+..++.|++.++.++|+.|++|+||+|+||+++.++.++|+|||.+.........    ...
T Consensus        80 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05116          80 GPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG  158 (257)
T ss_pred             CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence            9999998644 35889999999999999999999999999999999999999999999999998765443221    112


Q ss_pred             CCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          196 TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       196 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      .++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....++++.....|
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~  220 (257)
T cd05116         159 KWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECP  220 (257)
T ss_pred             CCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCC
Confidence            23468999999988888999999999999999998 99999988888888888776554443

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.7e-36  Score=242.80  Aligned_cols=220  Identities=32%  Similarity=0.602  Sum_probs=187.9

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEE
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~  111 (259)
                      |+-...+|.+.++||.|++|.||+|.+. ++.+++|++.....  .....+.+|+.+++.++|+||+++++.+...+..+
T Consensus         1 ~~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   78 (261)
T cd05148           1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY   78 (261)
T ss_pred             CcCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeE
Confidence            3455678999999999999999999875 57899999876532  23456889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          112 IVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      ++|||+++++|.+++... ...++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            999999999999999653 3457889999999999999999999999999999999999999999999999987654332


Q ss_pred             cc-ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCC
Q 045286          191 VM-TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       191 ~~-~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      .. ....++..|++||.+.+..++.++|+||||+++|+|++ |..||...+..+....+......+
T Consensus       159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~  224 (261)
T cd05148         159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP  224 (261)
T ss_pred             ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCC
Confidence            11 12234568999999988889999999999999999998 899999888888888777665543

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-36  Score=240.99  Aligned_cols=211  Identities=36%  Similarity=0.656  Sum_probs=184.3

Q ss_pred             ceeccccceEEEEEEEc-----CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCC
Q 045286           44 ERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMP  118 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~  118 (259)
                      ++||.|++|.||++.+.     +..+++|.+....... ....+.+|+..++.++|++++++++++......++++||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence            47999999999999986     6789999998765443 45778899999999999999999999998899999999999


Q ss_pred             CCChHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          119 GGSLYDYLHKN--------HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       119 ~~~L~~~l~~~--------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      +++|.+++...        ...+++..++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  159 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD  159 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence            99999999775        4668999999999999999999999999999999999999999999999999997665532


Q ss_pred             ---ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCC
Q 045286          191 ---VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLC  255 (259)
Q Consensus       191 ---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~  255 (259)
                         ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+..+.....
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~  228 (262)
T cd00192         160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPK  228 (262)
T ss_pred             ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence               1233456788999999988889999999999999999999 6999999988888887776544433

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=9.1e-36  Score=241.15  Aligned_cols=219  Identities=36%  Similarity=0.641  Sum_probs=184.1

Q ss_pred             ceechhhhhccceeccccceEEEEEEEcC-ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEE
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYLG-QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~~-~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~  111 (259)
                      |++..++|++..+||.|++|.||++.+.+ ..+++|.+.....   ....+.+|+.+++.++|++++++++.+.. +..+
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (260)
T cd05069           1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIY   76 (260)
T ss_pred             CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcE
Confidence            56777889999999999999999998754 5799998775432   23567889999999999999999988754 5678


Q ss_pred             EEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          112 IVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      ++|||+++++|.+++.... ..++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            9999999999999996543 347888999999999999999999999999999999999999999999999997654432


Q ss_pred             cc--ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCC
Q 045286          191 VM--TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLC  255 (259)
Q Consensus       191 ~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~  255 (259)
                      ..  ....++..|+|||...+..++.++|+||||+++|+|++ |..||.+.+..+....+..+.....
T Consensus       157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~  224 (260)
T cd05069         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPC  224 (260)
T ss_pred             ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            11  12234567999999988889999999999999999999 9999999888888777776654443

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.4e-35  Score=239.47  Aligned_cols=216  Identities=25%  Similarity=0.428  Sum_probs=184.4

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec-CCcEEEEEe
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK-SPHLCIVTE  115 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e  115 (259)
                      .|++.+.||.|++|.||.+.+.  ++.+++|.+............+.+|++++++++|++++++.+.+.. ....++++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            3778899999999999999874  6789999998765555556778899999999999999999988764 446789999


Q ss_pred             cCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-ccc
Q 045286          116 YMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMT  193 (259)
Q Consensus       116 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~  193 (259)
                      ++++++|.+++... ...+++..++.++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~  160 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS  160 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence            99999999998754 3458899999999999999999999999999999999999999999999999987654332 223


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      ...+++.|+|||.+.+..++.++|+||+|+++++|++|..||...+..+....+..+..+.
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~  221 (257)
T cd08223         161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP  221 (257)
T ss_pred             cccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC
Confidence            3457889999999999889999999999999999999999999888777776666655433

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2e-37  Score=239.11  Aligned_cols=221  Identities=26%  Similarity=0.447  Sum_probs=193.2

Q ss_pred             hhhhccceeccccceEEEEEEE--cCceEEEEEeecccCc------hHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCC
Q 045286           38 RLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLN------DTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSP  108 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~------~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~  108 (259)
                      ..|.-.+.||.|..++|-++..  +++.+++|++......      ....+.-.+|+.+|+++. ||+|+++.+.++...
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            5677788999999999998875  4788999998754332      234455668999999996 999999999999999


Q ss_pred             cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      ..++|+|.++.|-|.+++...- .++++..+.+++|++++++|||.++|||+|+||+|||++++-+++|+|||.++...+
T Consensus        97 F~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~  175 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP  175 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence            9999999999999999996543 489999999999999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCCcccccCccccCC------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCccCC
Q 045286          189 GGVMTAETGTYRWMAPEVINH------QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY  259 (259)
Q Consensus       189 ~~~~~~~~~~~~~~~PE~~~~------~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~  259 (259)
                      +......||||+|+|||.+..      ..|+..+|+|++|+++|.+|.|..||=.....-++..|.+|.-+-..|.|
T Consensus       176 GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW  252 (411)
T KOG0599|consen  176 GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW  252 (411)
T ss_pred             chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence            999999999999999999843      45788899999999999999999999777777788888887766666655

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-37  Score=260.73  Aligned_cols=218  Identities=29%  Similarity=0.500  Sum_probs=200.2

Q ss_pred             chhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      ....|.+.+.||+|.|+.|.++.+  ++..||+|.+.....+......+.+|+++++.++||||++++.+......+++|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            346789999999999999999986  489999999999988887777799999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT  193 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~  193 (259)
                      |||+.++.+.+++.+.+. ..+..+...+.|+.++++|||+++++|+|||++|++++.+-+++|+|||++.++.......
T Consensus       134 ~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lq  212 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQ  212 (596)
T ss_pred             EEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccccc
Confidence            999999999999977765 6669999999999999999999999999999999999999999999999999999888888


Q ss_pred             cCCCcccccCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          194 AETGTYRWMAPEVINHQPY-DQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      ..+|++.|.|||++.+..+ ++..|+||+|+++|.|+.|.+||++.+-.+.-.++..+....
T Consensus       213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rI  274 (596)
T KOG0586|consen  213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRI  274 (596)
T ss_pred             ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecc
Confidence            9999999999999999987 689999999999999999999999988877776666655444

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-37  Score=256.16  Aligned_cols=205  Identities=23%  Similarity=0.369  Sum_probs=171.0

Q ss_pred             eccccceEEEEEEEc--CceEEEEEeecccCc-hHHHHHHHHHHHHHHhc---CCCCcceeeeeeecCCcEEEEEecCCC
Q 045286           46 IASGSCGDLYRGVYL--GQDVAVKVLRSEHLN-DTLEDEFVQEVAILREV---QHRNVVRFIGASTKSPHLCIVTEYMPG  119 (259)
Q Consensus        46 lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~lv~e~~~~  119 (259)
                      ||+|+||+||+|.+.  ++.||+|++...... ........+|..++...   +||+|+.+++.+...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999874  789999999764322 22233445566666655   599999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC-CCccccCCCc
Q 045286          120 GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMTAETGT  198 (259)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~-~~~~~~~~~~  198 (259)
                      ++|..++... ..+++..+..++.|++.+|.|||+.|++|+||||+||+++.++.++|+|||++..... ........++
T Consensus        81 g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  159 (330)
T cd05586          81 GELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT  159 (330)
T ss_pred             ChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCC
Confidence            9999988654 4588999999999999999999999999999999999999999999999999865332 2223345689


Q ss_pred             ccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          199 YRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       199 ~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ..|+|||.+.+. .++.++|+|||||++|+|++|..||...+..+....+..+.
T Consensus       160 ~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~  213 (330)
T cd05586         160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK  213 (330)
T ss_pred             ccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC
Confidence            999999998754 57899999999999999999999999888877777766443

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.1e-35  Score=243.47  Aligned_cols=218  Identities=29%  Similarity=0.510  Sum_probs=181.7

Q ss_pred             echhhhhccceeccccceEEEEEEE------cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      ++-+.+++.+.||+|+||+||+|.+      .+..+++|.+.... .......+.+|+.+++.++|+||+++++.+....
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   80 (283)
T cd05090           2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ   80 (283)
T ss_pred             CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence            3457788999999999999999985      35689999998643 2344467889999999999999999999999889


Q ss_pred             cEEEEEecCCCCChHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNH----------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH  172 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~  172 (259)
                      ..+++|||+++++|.+++....                ..++...+..++.|++.+|.+||++|++|+||+|+||+++.+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence            9999999999999999985321                236778888999999999999999999999999999999999


Q ss_pred             CeEEEeeeccceeccCCCc---cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhh
Q 045286          173 NVVKVADFGVARFQNKGGV---MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVR  248 (259)
Q Consensus       173 ~~i~l~D~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~  248 (259)
                      +.++|+|||.+........   .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+.
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~  240 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR  240 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            9999999999875533221   122234567999999988889999999999999999998 999998887777676666


Q ss_pred             hccCC
Q 045286          249 QVCTS  253 (259)
Q Consensus       249 ~~~~~  253 (259)
                      .....
T Consensus       241 ~~~~~  245 (283)
T cd05090         241 KRQLL  245 (283)
T ss_pred             cCCcC
Confidence            54433

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.4e-36  Score=243.33  Aligned_cols=218  Identities=30%  Similarity=0.529  Sum_probs=185.1

Q ss_pred             ceechhhhhccceeccccceEEEEEEEcC-------ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeee
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST  105 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~~-------~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~  105 (259)
                      |+++.++|.+.+.||.|++|.||++.+.+       ..|++|.+.... .......+.+|+.+++.++|+||+++++++.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   79 (277)
T cd05032           1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence            67888999999999999999999998642       579999987543 2233467889999999999999999999999


Q ss_pred             cCCcEEEEEecCCCCChHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEE
Q 045286          106 KSPHLCIVTEYMPGGSLYDYLHKNH---------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVK  176 (259)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~  176 (259)
                      .....++++||+++++|.+++....         ..++...+..++.|++.+|.+||+.+++|+||+|+||+++.++.++
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence            9999999999999999999986432         2356778899999999999999999999999999999999999999


Q ss_pred             EeeeccceeccCCCc---cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhcc
Q 045286          177 VADFGVARFQNKGGV---MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       177 l~D~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      |+|||.+........   .....++..|.|||.+.+..++.++|+||||+++|++++ |..||...+..+....+....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~  238 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG  238 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC
Confidence            999999875443321   122345678999999988889999999999999999998 999999888888777776443

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.7e-36  Score=246.07  Aligned_cols=200  Identities=28%  Similarity=0.469  Sum_probs=174.0

Q ss_pred             hhccceeccccceEEEEEEEc--CceEEEEEeecccCch-HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           40 LKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      |+..+.||.|+||.||++.+.  ++.+++|.+....... .....+.+|+.+++.++|++++.+.+.+...+..+++|||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            566788999999999999874  7899999987654332 2335577899999999999999999999988999999999


Q ss_pred             CCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccccC
Q 045286          117 MPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAE  195 (259)
Q Consensus       117 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~~  195 (259)
                      +++++|.+++.... ..+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+............
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  161 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR  161 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCC
Confidence            99999999885433 35888999999999999999999999999999999999999999999999998765544433445


Q ss_pred             CCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 045286          196 TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT  239 (259)
Q Consensus       196 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  239 (259)
                      .++..|+|||.+.+..++.++|+||+|+++|+|++|..||....
T Consensus       162 ~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~  205 (285)
T cd05630         162 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK  205 (285)
T ss_pred             CCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence            68899999999998889999999999999999999999998644

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-36  Score=243.91  Aligned_cols=214  Identities=30%  Similarity=0.491  Sum_probs=183.9

Q ss_pred             chhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      +.++|++.+.||.|++|.||++.+.  +..+++|.....  .......+.+|+.++++++|+||+++++.+...+..++|
T Consensus         3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (280)
T cd06611           3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL   80 (280)
T ss_pred             chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence            3578999999999999999999874  788999998764  334446788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-cc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VM  192 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~  192 (259)
                      |||+++++|.+++......+++..++.++.|++.++.+||+.|++|+|++|+||+++.++.++|+|||.+....... ..
T Consensus        81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  160 (280)
T cd06611          81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR  160 (280)
T ss_pred             eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence            99999999999997766679999999999999999999999999999999999999999999999999876543321 22


Q ss_pred             ccCCCcccccCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          193 TAETGTYRWMAPEVIN-----HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ....++..|++||.+.     +.+++.++|+||||+++|+|++|..||...+..+.+..+..+.
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  224 (280)
T cd06611         161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE  224 (280)
T ss_pred             ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC
Confidence            3345788899999974     3456789999999999999999999999888777666665543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=8.6e-36  Score=241.29  Aligned_cols=217  Identities=34%  Similarity=0.632  Sum_probs=184.1

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEE
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~  111 (259)
                      |++...+|++.++||+|++|.||++.+. +..+++|.+....   .....+.+|+.+++.++|++|+++++.+.. ...+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence            6788999999999999999999999864 4679999877542   234678889999999999999999998877 6789


Q ss_pred             EEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          112 IVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      +++||+++++|.+++... ....+...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999999999999753 3457788889999999999999999999999999999999999999999999987654332


Q ss_pred             cc--ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCC
Q 045286          191 VM--TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       191 ~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ..  ....++..|+|||.+.+..++.++|+||||+++|++++ |..||...+..+....+..+...
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~  222 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM  222 (260)
T ss_pred             cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC
Confidence            11  12234567999999988889999999999999999998 99999988887777777766543

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.1e-36  Score=243.47  Aligned_cols=201  Identities=25%  Similarity=0.389  Sum_probs=179.6

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCch-HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      .|++.++||.|++|.||++.+.  ++.+++|++....... .....+.+|++++++++||||+++++.+..+...++++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            3778899999999999999975  7899999998754433 455788899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccccC
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAE  195 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~~  195 (259)
                      |+.+++|..++... ..+++..+..++.|++++|.+||+.+++|+||+|+||+++.++.++|+|||.+............
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~  159 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST  159 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccccc
Confidence            99999999999665 45889999999999999999999999999999999999999999999999998876655444455


Q ss_pred             CCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 045286          196 TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTP  240 (259)
Q Consensus       196 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~  240 (259)
                      .++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus       160 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~  204 (258)
T cd05578         160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR  204 (258)
T ss_pred             CCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence            678899999999888899999999999999999999999987663

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.7e-35  Score=238.66  Aligned_cols=215  Identities=27%  Similarity=0.448  Sum_probs=186.8

Q ss_pred             hhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           39 LLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      +|+..+.||.|++|.||++.+  .++.+++|.+............+.+|+++++.++|+|++++++.+...+..++|+|+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            477889999999999999886  478899999987665555667889999999999999999999999988999999999


Q ss_pred             CCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC-CeEEEeeeccceeccCCCcccc
Q 045286          117 MPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH-NVVKVADFGVARFQNKGGVMTA  194 (259)
Q Consensus       117 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~-~~i~l~D~~~~~~~~~~~~~~~  194 (259)
                      +++++|.+++.... ..+++..+..++.+++.++.+||++|++|+||+|+||+++.+ +.++|+|||.+...........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~  160 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT  160 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccc
Confidence            99999999997643 458889999999999999999999999999999999999865 4689999999987765544445


Q ss_pred             CCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          195 ETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ..++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+......
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~  219 (256)
T cd08220         161 VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA  219 (256)
T ss_pred             cccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC
Confidence            56788999999999888899999999999999999999999988777776666654443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.8e-36  Score=253.81  Aligned_cols=196  Identities=33%  Similarity=0.538  Sum_probs=167.1

Q ss_pred             chhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      .-..|...++||.|++|.||++.+.  ++.|++|++.... .......+.+|+.+++.++|+||+++++++...+..++|
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  150 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL  150 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence            3477889999999999999999874  7899999997653 334457788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-cc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VM  192 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~  192 (259)
                      +||+++++|....     ...+..+..++.|++.+|.|||+.|++|+||||+||+++.++.++|+|||.+....... ..
T Consensus       151 ~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~  225 (353)
T PLN00034        151 LEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC  225 (353)
T ss_pred             EecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence            9999999886532     25677788899999999999999999999999999999999999999999987654332 22


Q ss_pred             ccCCCcccccCccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          193 TAETGTYRWMAPEVINH-----QPYDQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                      ....++..|+|||.+..     ...+.++|+|||||++|+|++|..||..
T Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~  275 (353)
T PLN00034        226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV  275 (353)
T ss_pred             cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence            34568899999998743     2345689999999999999999999974

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=242.45  Aligned_cols=211  Identities=32%  Similarity=0.517  Sum_probs=183.8

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      +|++.+.||.|++|.||++.+.  ++.+++|.+..... ......+.+|+.+++.++|+||+++.+.+..+...++++|+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            6788899999999999999874  78999999886542 23345678999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-CccccC
Q 045286          117 MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVMTAE  195 (259)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~~~~  195 (259)
                      +++++|.+++...  .+++..++.++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||.+...... ......
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF  158 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccc
Confidence            9999999998754  5889999999999999999999999999999999999999999999999998776554 223344


Q ss_pred             CCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          196 TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       196 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      .++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.....
T Consensus       159 ~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~  215 (274)
T cd06609         159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP  215 (274)
T ss_pred             cCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCC
Confidence            677889999999988899999999999999999999999988777666666655543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1e-35  Score=240.03  Aligned_cols=215  Identities=27%  Similarity=0.463  Sum_probs=184.8

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      +|++.++||.|++|.||++.+.  ++.+++|.+..... ......+.+|+.+++.++|+||+++.+.+...+..++++||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence            4678899999999999999874  78999999876532 23446778899999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc-ccc
Q 045286          117 MPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV-MTA  194 (259)
Q Consensus       117 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~-~~~  194 (259)
                      +++++|.+++... ...+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+........ ...
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (255)
T cd08219          80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT  159 (255)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence            9999999988653 34578899999999999999999999999999999999999999999999999876544322 223


Q ss_pred             CCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          195 ETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      ..++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+..+...+
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  219 (255)
T cd08219         160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP  219 (255)
T ss_pred             ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC
Confidence            457888999999998889999999999999999999999999888877777776665443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7.2e-36  Score=244.71  Aligned_cols=209  Identities=29%  Similarity=0.462  Sum_probs=176.4

Q ss_pred             hhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           39 LLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      +|.+.+.||+|++|.||+|.+  .++.|++|.+............+.+|+.++++++|+||+++++.+..++..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            367788999999999999987  478999999986654444456788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-ccc
Q 045286          117 MPGGSLYDYLHKNH--NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMT  193 (259)
Q Consensus       117 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~  193 (259)
                      ++ ++|.+++....  ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  159 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT  159 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence            96 58888886433  458899999999999999999999999999999999999999999999999987544322 122


Q ss_pred             cCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 045286          194 AETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVR  248 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~  248 (259)
                      ...+++.|+|||.+.+. .++.++|+||||+++|+|++|..||.+.+.......+.
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~  215 (285)
T cd07861         160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIF  215 (285)
T ss_pred             CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            33567889999988654 57899999999999999999999998877655554443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1e-35  Score=241.82  Aligned_cols=216  Identities=31%  Similarity=0.540  Sum_probs=183.8

Q ss_pred             chhhhhccceeccccceEEEEEEEc-----CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL  110 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~  110 (259)
                      +..+|++.+.||.|++|.||+|.+.     ...+++|.+..... ......+.+|+.++++++||||+++++.+...+..
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            4578889999999999999999863     23689999876533 33446788999999999999999999999988999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      ++++|++++++|.+++......++...+..++.|++.++.+||+.+++|+||+|+||+++.++.++++|||.+.......
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            99999999999999997766668899999999999999999999999999999999999999999999999987654332


Q ss_pred             cc----ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccC
Q 045286          191 VM----TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       191 ~~----~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      ..    .....+..|++||.+.+..++.++|+||||+++|++++ |..||...+..+....+.++..
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~  227 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR  227 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc
Confidence            11    11123467999999998889999999999999999887 9999998888777777776654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7e-36  Score=247.13  Aligned_cols=216  Identities=33%  Similarity=0.560  Sum_probs=177.9

Q ss_pred             echhhhhccceeccccceEEEEEEEc--Cc--eEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeeeeeecCCc
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL--GQ--DVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPH  109 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~--~~--~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~  109 (259)
                      +...+|++.+.||.|+||.||+|.+.  +.  .+++|..... ........+.+|+.+++++ +|+||+++++++..++.
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~   82 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   82 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence            45578899999999999999999864  33  4566665532 2334456788899999999 79999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCe
Q 045286          110 LCIVTEYMPGGSLYDYLHKNH---------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV  174 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~  174 (259)
                      .++++||+++++|.+++....               ..++...++.++.|++.++.+||++|++|+||+|+||+++.++.
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence            999999999999999986432               24788899999999999999999999999999999999999999


Q ss_pred             EEEeeeccceeccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhcc
Q 045286          175 VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       175 i~l~D~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ++|+|||.+..............+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+....
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~  240 (303)
T cd05088         163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  240 (303)
T ss_pred             EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence            99999998853322111112233567999999988889999999999999999998 999998888777776665543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.7e-35  Score=240.76  Aligned_cols=219  Identities=29%  Similarity=0.587  Sum_probs=184.0

Q ss_pred             ceechhhhhccceeccccceEEEEEEEcC-----ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYLG-----QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS  107 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~~-----~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~  107 (259)
                      +++..++|.+.++||.|++|.||+|.+.+     ..+++|...... .....+.+.+|+.+++.++|+||+++++.+.. 
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-   78 (270)
T cd05056           1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-   78 (270)
T ss_pred             CeechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-
Confidence            35677889999999999999999998643     368889887653 23445678899999999999999999998875 


Q ss_pred             CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      +..++++||+++++|.+++......++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          79 NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence            45789999999999999997665568999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCccc--cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCC
Q 045286          188 KGGVMT--AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       188 ~~~~~~--~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ......  ....+..|+|||.+....++.++|+||||+++|++++ |..||...+..+....+.++...
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~  227 (270)
T cd05056         159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL  227 (270)
T ss_pred             cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC
Confidence            432211  2223467999999988889999999999999999996 99999988887777777665443

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.1e-35  Score=243.56  Aligned_cols=219  Identities=26%  Similarity=0.468  Sum_probs=184.1

Q ss_pred             echhhhhccceeccccceEEEEEEEc-------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS  107 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~  107 (259)
                      ++-.+|++.++||.|++|.||++.+.       ++.|++|++.... .......+.+|+.++..++|+||+++++.+...
T Consensus         2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~   80 (283)
T cd05091           2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE   80 (283)
T ss_pred             CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            44578999999999999999999864       3679999998653 333456788999999999999999999999988


Q ss_pred             CcEEEEEecCCCCChHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKN---------------HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH  172 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~  172 (259)
                      +..++++||+.+++|.+++...               ...++...+..++.|++.+|.++|+.|++|+||||+||+++.+
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            8999999999999999998532               1236778889999999999999999999999999999999999


Q ss_pred             CeEEEeeeccceeccCCCcc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhh
Q 045286          173 NVVKVADFGVARFQNKGGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVR  248 (259)
Q Consensus       173 ~~i~l~D~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~  248 (259)
                      +.++|+|||.+.........   ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+.
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR  240 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            99999999987754433211   22234678999999988889999999999999999998 999999988888888877


Q ss_pred             hccCCC
Q 045286          249 QVCTSL  254 (259)
Q Consensus       249 ~~~~~~  254 (259)
                      +.....
T Consensus       241 ~~~~~~  246 (283)
T cd05091         241 NRQVLP  246 (283)
T ss_pred             cCCcCC
Confidence            765543

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-38  Score=256.66  Aligned_cols=210  Identities=33%  Similarity=0.537  Sum_probs=185.8

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ..|.....||.|+||.||+|.+.  ++.||+|++..+... ...+.+.+|+.+|..++++||..+++.+..+..++++||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~-deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE-DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcc-hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            45666699999999999999985  789999999987644 344778899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc-ccc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV-MTA  194 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~-~~~  194 (259)
                      |+.||++.+.+... ..+++.++..++++++.++.|+|..+.+|+|||+.||+++.+|.++|+|||.+........ ...
T Consensus        92 y~~gGsv~~lL~~~-~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t  170 (467)
T KOG0201|consen   92 YCGGGSVLDLLKSG-NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT  170 (467)
T ss_pred             HhcCcchhhhhccC-CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence            99999999998544 3358888889999999999999999999999999999999999999999999987766533 356


Q ss_pred             CCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          195 ETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                      ..||+.|+|||++.+..|+.++||||||+++++|.+|.+||....++..+..|-+
T Consensus       171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk  225 (467)
T KOG0201|consen  171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK  225 (467)
T ss_pred             ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC
Confidence            7899999999999998999999999999999999999999999888555544433

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.8e-35  Score=242.02  Aligned_cols=216  Identities=32%  Similarity=0.517  Sum_probs=182.2

Q ss_pred             echhhhhccceeccccceEEEEEEE-------cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVY-------LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS  107 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~-------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~  107 (259)
                      |++++++..++||.|++|.||++..       .+..+++|.+...  .......+.+|+++++.++|+||+++++.+...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            5678999999999999999999864       2457888887654  334456788999999999999999999999998


Q ss_pred             CcEEEEEecCCCCChHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNH--------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN  173 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~  173 (259)
                      +..++++||+++++|.+++....              ..++...+..++.|++.++.+||+.|++|+||+|+||+++.++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence            99999999999999999986543              2477889999999999999999999999999999999999999


Q ss_pred             eEEEeeeccceeccCCCcc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 045286          174 VVKVADFGVARFQNKGGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       174 ~i~l~D~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~  249 (259)
                      .++|+|||.+.........   ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+..
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  239 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ  239 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence            9999999998755432211   11223578999999999899999999999999999998 9999988877777776665


Q ss_pred             ccC
Q 045286          250 VCT  252 (259)
Q Consensus       250 ~~~  252 (259)
                      +..
T Consensus       240 ~~~  242 (280)
T cd05092         240 GRE  242 (280)
T ss_pred             Ccc
Confidence            543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=9.4e-36  Score=244.06  Aligned_cols=211  Identities=24%  Similarity=0.371  Sum_probs=179.9

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ++|+..+.||+|++|.||++.+.  ++.+++|.+............+.+|+.+++.++|+|++++++.+......++++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            36788899999999999999974  7899999987654433444667899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-cccc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMTA  194 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~~  194 (259)
                      |+++++|..++. ....+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus        81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07847          81 YCDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD  159 (286)
T ss_pred             ccCccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence            998887777664 33458999999999999999999999999999999999999999999999999997665443 2223


Q ss_pred             CCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          195 ETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                      ..++..|++||.+.+ ..++.++|+||+|+++|+|++|..||.+.+..+.+..+..
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~  215 (286)
T cd07847         160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRK  215 (286)
T ss_pred             cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence            456788999999876 4578999999999999999999999998887776666554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=8e-36  Score=270.09  Aligned_cols=203  Identities=24%  Similarity=0.440  Sum_probs=173.1

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      .+|++.++||+|++|.||+|.+.  ++.||+|++..... .+....++.+|++++++++||||+++++++...+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            36888999999999999999874  78999999976533 2344567889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccce
Q 045286          115 EYMPGGSLYDYLHKNH----------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR  184 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~  184 (259)
                      ||++|++|.+++....          ...+...+..++.|++.+|.+||+.|++||||||+||+++.++.++|+|||.+.
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk  161 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI  161 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence            9999999999885421          224556778899999999999999999999999999999999999999999987


Q ss_pred             eccCCC-------------------ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 045286          185 FQNKGG-------------------VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTP  240 (259)
Q Consensus       185 ~~~~~~-------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~  240 (259)
                      ......                   ......|++.|+|||.+.+..++.++|+||+||++|+|++|..||...+.
T Consensus       162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~  236 (932)
T PRK13184        162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG  236 (932)
T ss_pred             ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence            652110                   01123589999999999999999999999999999999999999976544

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.6e-35  Score=239.34  Aligned_cols=210  Identities=29%  Similarity=0.582  Sum_probs=176.1

Q ss_pred             eeccccceEEEEEEEc----CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCCCC
Q 045286           45 RIASGSCGDLYRGVYL----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGG  120 (259)
Q Consensus        45 ~lg~G~~~~V~~~~~~----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~  120 (259)
                      .||.|++|.||+|.+.    +..+++|+..... .......+.+|+.++++++|+||+++++.+.. +..++|+||++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence            4899999999998764    4469999987653 34455678899999999999999999998754 5789999999999


Q ss_pred             ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcc----ccCC
Q 045286          121 SLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM----TAET  196 (259)
Q Consensus       121 ~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~----~~~~  196 (259)
                      +|.+++......+++..+..++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+.........    ....
T Consensus        80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05115          80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK  159 (257)
T ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence            999999766667899999999999999999999999999999999999999999999999998754433211    1112


Q ss_pred             CcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          197 GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       197 ~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      .+..|+|||.+.+..++.++|+||||+++|++++ |..||...+..+....+..+....++
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  220 (257)
T cd05115         160 WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCP  220 (257)
T ss_pred             CCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCC
Confidence            3468999999988889999999999999999996 99999998888877777766655443

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=240.13  Aligned_cols=210  Identities=34%  Similarity=0.512  Sum_probs=182.1

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      .++|.+.++||.|++|.||++.+.  ++.+++|++......  ....+.+|+.+++.++|+||+++++.+......+++|
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence            467888899999999999999874  678999999865332  4577889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-ccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMT  193 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~  193 (259)
                      ||+++++|.+++......+++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus        80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  159 (262)
T cd06613          80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK  159 (262)
T ss_pred             eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence            9999999999987765669999999999999999999999999999999999999999999999999987554332 223


Q ss_pred             cCCCcccccCccccCCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 045286          194 AETGTYRWMAPEVINHQ---PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVR  248 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~---~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~  248 (259)
                      ...++..|++||.+.+.   .++.++|+||+|+++|+|++|..||...+..+....+.
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~  217 (262)
T cd06613         160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS  217 (262)
T ss_pred             cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            34577889999999776   78899999999999999999999998877655554443

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.3e-35  Score=242.75  Aligned_cols=213  Identities=30%  Similarity=0.512  Sum_probs=180.9

Q ss_pred             echhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEE
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCI  112 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l  112 (259)
                      ...+.|++.++||+|++|.||++.+.  ++.+++|.+...  .......+.+|+.+++.++|+||+++++.+...+..++
T Consensus         9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (292)
T cd06644           9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI   86 (292)
T ss_pred             CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence            34578999999999999999999874  688999998764  33445678889999999999999999999988889999


Q ss_pred             EEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-Cc
Q 045286          113 VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GV  191 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~  191 (259)
                      ||||+++++|..++.+....++...+..++.|++.++.+||+.+++|+|++|+||+++.++.++|+|||.+...... ..
T Consensus        87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~  166 (292)
T cd06644          87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR  166 (292)
T ss_pred             EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence            99999999999888666666899999999999999999999999999999999999999999999999987653322 22


Q ss_pred             cccCCCcccccCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          192 MTAETGTYRWMAPEVIN-----HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                      .....++..|+|||.+.     ...++.++|+||||+++|+|++|..||...+..+...++.+
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~  229 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK  229 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc
Confidence            23345778999999984     34568899999999999999999999987776665555543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.2e-36  Score=246.73  Aligned_cols=213  Identities=25%  Similarity=0.413  Sum_probs=178.4

Q ss_pred             hhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           39 LLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      +|.+.+.||+|++|.||+|.+  .++.+++|.+............+.+|+.+++.++|+||+++++.+......++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            477889999999999999997  478999999986544444445677899999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-ccccC
Q 045286          117 MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMTAE  195 (259)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~~~  195 (259)
                      ++ ++|.+++......+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  159 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE  159 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCC
Confidence            96 58888876655668999999999999999999999999999999999999999999999999987544332 22334


Q ss_pred             CCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHhhhccC
Q 045286          196 TGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVP-YDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       196 ~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p-~~~~~~~~~~~~i~~~~~  252 (259)
                      .++..|+|||.+.+. .++.++|+||||+++|+|++|..| |.+.+..+.+..+.+...
T Consensus       160 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~  218 (284)
T cd07839         160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG  218 (284)
T ss_pred             ccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhC
Confidence            567889999998764 468999999999999999998887 566666666666655443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2e-35  Score=244.48  Aligned_cols=221  Identities=30%  Similarity=0.580  Sum_probs=186.9

Q ss_pred             cceechhhhhccceeccccceEEEEEEEc---------CceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceee
Q 045286           32 DWEIDRRLLKTGERIASGSCGDLYRGVYL---------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFI  101 (259)
Q Consensus        32 ~~~~~~~~~~~~~~lg~G~~~~V~~~~~~---------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~  101 (259)
                      .|++...+|.+.+.||+|+||.||++...         +..+++|...... .......+.+|+.+++.+ +|+||++++
T Consensus         9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~   87 (304)
T cd05101           9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL   87 (304)
T ss_pred             cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchhee
Confidence            48899999999999999999999999742         3468999987543 233446788999999999 799999999


Q ss_pred             eeeecCCcEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 045286          102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH---------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTAN  166 (259)
Q Consensus       102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~N  166 (259)
                      +.+......+++|||+++++|.+++....               ..++...+..++.|++.+|.+||+.|++|+||+|+|
T Consensus        88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  167 (304)
T cd05101          88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN  167 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence            99999899999999999999999996532               236677889999999999999999999999999999


Q ss_pred             EEEccCCeEEEeeeccceeccCCCcc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 045286          167 LLMDTHNVVKVADFGVARFQNKGGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQ  242 (259)
Q Consensus       167 ilv~~~~~i~l~D~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~  242 (259)
                      |+++.++.++|+|||.+.........   ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~  247 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  247 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence            99999999999999998765443211   12234567999999988889999999999999999998 899999888888


Q ss_pred             HHHHhhhccCC
Q 045286          243 AALGVRQVCTS  253 (259)
Q Consensus       243 ~~~~i~~~~~~  253 (259)
                      ....+......
T Consensus       248 ~~~~~~~~~~~  258 (304)
T cd05101         248 LFKLLKEGHRM  258 (304)
T ss_pred             HHHHHHcCCcC
Confidence            87777666543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.4e-35  Score=241.14  Aligned_cols=215  Identities=27%  Similarity=0.538  Sum_probs=177.8

Q ss_pred             chhhhhccceeccccceEEEEEEEc--Cc----eEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCc
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL--GQ----DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPH  109 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~--~~----~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~  109 (259)
                      ...+|++.+.||.|++|+||+|.+.  ++    .+++|...... .......+.+|+..+++++|+||+++++++.. ..
T Consensus         5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~   82 (279)
T cd05111           5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS   82 (279)
T ss_pred             CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence            3467888999999999999999873  43    47788875432 22334667788889999999999999998754 56


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG  189 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~  189 (259)
                      .++++|++++++|.+++......+++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||.+......
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            77899999999999999876667899999999999999999999999999999999999999999999999998765432


Q ss_pred             Cc---cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccC
Q 045286          190 GV---MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       190 ~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      ..   .....++..|++||.+.+..++.++|+||||+++|++++ |..||.+....+..+.+..+..
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~  229 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGER  229 (279)
T ss_pred             CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc
Confidence            21   122345678999999988889999999999999999998 9999998877766655554443

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.9e-35  Score=243.18  Aligned_cols=217  Identities=30%  Similarity=0.506  Sum_probs=183.1

Q ss_pred             echhhhhccceeccccceEEEEEEEc-------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS  107 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~  107 (259)
                      +..++|.+.+.||.|++|.||++.+.       ...+++|.+....  ......+.+|+.++++++|+||+++++.+...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (291)
T cd05094           2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDG   79 (291)
T ss_pred             CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            44678889999999999999999753       3458888876543  23346688999999999999999999999999


Q ss_pred             CcEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNH---------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH  172 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~  172 (259)
                      +..++||||+++++|.+++....               ..+++..++.++.|++.++.+||++|++|+||+|+||+++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN  159 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence            99999999999999999996532               237888999999999999999999999999999999999999


Q ss_pred             CeEEEeeeccceeccCCCc---cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhh
Q 045286          173 NVVKVADFGVARFQNKGGV---MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVR  248 (259)
Q Consensus       173 ~~i~l~D~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~  248 (259)
                      +.++|+|||.+........   .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+.
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~  239 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT  239 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence            9999999999875543321   122345678999999999889999999999999999998 999998888888777776


Q ss_pred             hccCC
Q 045286          249 QVCTS  253 (259)
Q Consensus       249 ~~~~~  253 (259)
                      .+...
T Consensus       240 ~~~~~  244 (291)
T cd05094         240 QGRVL  244 (291)
T ss_pred             CCCCC
Confidence            65544

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2e-35  Score=245.63  Aligned_cols=220  Identities=30%  Similarity=0.575  Sum_probs=184.9

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEc---------CceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCccee
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYL---------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRF  100 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~---------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~  100 (259)
                      ..|.++..+|.+.++||+|++|.||++...         ...+++|.+..... ......+.+|+.+++.+ +|+||+++
T Consensus         5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~   83 (314)
T cd05099           5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINL   83 (314)
T ss_pred             ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeE
Confidence            468899999999999999999999999752         34689999876433 33456788999999999 59999999


Q ss_pred             eeeeecCCcEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 045286          101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNH---------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTA  165 (259)
Q Consensus       101 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~  165 (259)
                      ++++...+..++++||+++++|.+++....               ..++...+..++.|++.+|.+||+.|++|+||+|+
T Consensus        84 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~  163 (314)
T cd05099          84 LGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAAR  163 (314)
T ss_pred             EEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccce
Confidence            999998889999999999999999996532               24778888999999999999999999999999999


Q ss_pred             cEEEccCCeEEEeeeccceeccCCCc---cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 045286          166 NLLMDTHNVVKVADFGVARFQNKGGV---MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL  241 (259)
Q Consensus       166 Nilv~~~~~i~l~D~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~  241 (259)
                      ||+++.++.++|+|||.+........   ......+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~  243 (314)
T cd05099         164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE  243 (314)
T ss_pred             eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999875543211   111223457999999988889999999999999999999 99999988877


Q ss_pred             HHHHHhhhcc
Q 045286          242 QAALGVRQVC  251 (259)
Q Consensus       242 ~~~~~i~~~~  251 (259)
                      +....+..+.
T Consensus       244 ~~~~~~~~~~  253 (314)
T cd05099         244 ELFKLLREGH  253 (314)
T ss_pred             HHHHHHHcCC
Confidence            7776666554

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-35  Score=240.80  Aligned_cols=217  Identities=31%  Similarity=0.599  Sum_probs=183.9

Q ss_pred             echhhhhccceeccccceEEEEEEEc--Cc----eEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL--GQ----DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~--~~----~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      +...+|++.+.||+|+||.||+|.+.  ++    .+++|....... ......+.+|+.++++++|+||+++++.+.. .
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   81 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-S   81 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            45678999999999999999999863  32    588998776543 3455778899999999999999999998876 7


Q ss_pred             cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      ..++++|++++++|.+++......+++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            88999999999999999977666689999999999999999999999999999999999999999999999999876554


Q ss_pred             CCccc---cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCC
Q 045286          189 GGVMT---AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       189 ~~~~~---~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      .....   ....+..|++||.+.+..++.++|+||||+++|++++ |..||...+..+....+..+...
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~  230 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERL  230 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC
Confidence            32211   1123467999999988889999999999999999998 99999998887777777655433

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.8e-35  Score=237.56  Aligned_cols=215  Identities=31%  Similarity=0.628  Sum_probs=184.2

Q ss_pred             chhhhhccceeccccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      +-.+|++.+.||+|++|.||++.+. +..+++|.+.......   ..+.+|+++++.++|++++++++.+......++++
T Consensus         2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd05112           2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF   78 (256)
T ss_pred             ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence            3457888899999999999999875 7789999987654332   56788999999999999999999999889999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcc--
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM--  192 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~--  192 (259)
                      |++++++|.+++......++...++.++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||.+.........  
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  158 (256)
T cd05112          79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS  158 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence            999999999999766666888999999999999999999999999999999999999999999999998755433211  


Q ss_pred             ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCC
Q 045286          193 TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+.++...
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~  220 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL  220 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCC
Confidence            12234568999999988889999999999999999998 99999988888888777765443

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.3e-35  Score=239.53  Aligned_cols=214  Identities=35%  Similarity=0.633  Sum_probs=180.6

Q ss_pred             hhhccceeccccceEEEEEEE--cCceEEEEEeecccCch-------HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCc
Q 045286           39 LLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLND-------TLEDEFVQEVAILREVQHRNVVRFIGASTKSPH  109 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~  109 (259)
                      +|.+...||+|++|.||+|.+  .++.+++|.+.......       .....+.+|+.+++.++|+||+++++.+...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            366788999999999999986  46889999987654322       233568889999999999999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG  189 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~  189 (259)
                      .++++||+++++|.+++... ..++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN  159 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence            99999999999999999654 45788899999999999999999999999999999999999999999999998755421


Q ss_pred             C-------ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          190 G-------VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       190 ~-------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      .       ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+.+..+.....+
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  230 (267)
T cd06628         160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASP  230 (267)
T ss_pred             cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCC
Confidence            1       111234678899999999888999999999999999999999999987776666666554443

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4.8e-36  Score=261.87  Aligned_cols=214  Identities=22%  Similarity=0.365  Sum_probs=174.1

Q ss_pred             eechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCC------CCcceeeeeee
Q 045286           34 EIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH------RNVVRFIGAST  105 (259)
Q Consensus        34 ~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~  105 (259)
                      ++...+|++.++||.|+||+||+|.+.  ++.||||+++...   ........|+.+++.+.+      .+++.+++++.
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            344578999999999999999999874  7789999997532   122344566777666644      45788888876


Q ss_pred             cC-CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEccCC----------
Q 045286          106 KS-PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ-RNIIHRDLKTANLLMDTHN----------  173 (259)
Q Consensus       106 ~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~di~p~Nilv~~~~----------  173 (259)
                      .. ..+++|++++ +++|.+++.+. ..+++..+..++.|++.+|.|||+ .|++|+||||+|||++.++          
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence            53 5789999988 77898888654 358899999999999999999998 5999999999999998765          


Q ss_pred             ------eEEEeeeccceeccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 045286          174 ------VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGV  247 (259)
Q Consensus       174 ------~i~l~D~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i  247 (259)
                            .+||+|||.+......  .....+++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+
T Consensus       280 ~~~~~~~vkl~DfG~~~~~~~~--~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i  357 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDERHS--RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM  357 (467)
T ss_pred             cCCCCceEEECCCCccccCccc--cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence                  4999999987543322  23457899999999999999999999999999999999999999998888888777


Q ss_pred             hhccCCC
Q 045286          248 RQVCTSL  254 (259)
Q Consensus       248 ~~~~~~~  254 (259)
                      .+..+..
T Consensus       358 ~~~~g~~  364 (467)
T PTZ00284        358 EKTLGRL  364 (467)
T ss_pred             HHHcCCC
Confidence            7766554

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1e-35  Score=244.85  Aligned_cols=215  Identities=26%  Similarity=0.377  Sum_probs=184.0

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC--CcEEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS--PHLCIV  113 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv  113 (259)
                      ++|++.+.||.|++|.||+|.+.  ++.+++|.++...........+.+|+.++++++||||+++++++...  +..+++
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57888999999999999999985  78899999987654444445677899999999999999999988766  889999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-Ccc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVM  192 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~  192 (259)
                      +||++ ++|.+++......+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus        85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  163 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY  163 (293)
T ss_pred             ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcccc
Confidence            99996 4999988766656899999999999999999999999999999999999999999999999998765543 223


Q ss_pred             ccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          193 TAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ....++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+..+.+.++.+.+..
T Consensus       164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~  225 (293)
T cd07843         164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGT  225 (293)
T ss_pred             ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            334567889999998764 4688999999999999999999999998888777777665543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.1e-35  Score=240.40  Aligned_cols=215  Identities=31%  Similarity=0.590  Sum_probs=179.4

Q ss_pred             chhhhhccceeccccceEEEEEEEc--Cc----eEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCc
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL--GQ----DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPH  109 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~--~~----~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~  109 (259)
                      ..+++++.++||+|++|+||+|.+.  ++    +|++|++.... .......+.+|..+++.++|+||+++++.+.. ..
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~   82 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST   82 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence            4578889999999999999999863  33    48999987653 33445678899999999999999999998875 45


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG  189 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~  189 (259)
                      .+++++++++++|.+++......++...+..++.|++.+|.+||+++++|+||+|+||+++.++.++|+|||.+......
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~  162 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID  162 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence            67999999999999999776666899999999999999999999999999999999999999999999999998765433


Q ss_pred             Ccc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccC
Q 045286          190 GVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       190 ~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      ...   .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+..+..
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~  229 (279)
T cd05109         163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGER  229 (279)
T ss_pred             cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc
Confidence            211   12234568999999988889999999999999999998 9999988777666655555443

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-35  Score=239.38  Aligned_cols=214  Identities=30%  Similarity=0.525  Sum_probs=178.6

Q ss_pred             hhccceeccccceEEEEEEEc-----CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCc-----
Q 045286           40 LKTGERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPH-----  109 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----  109 (259)
                      |++.+.||+|+||.||.|...     +..+++|.++...........+.+|+..++.++|+||+++++.+...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            467889999999999999864     2679999998765555556778999999999999999999998755443     


Q ss_pred             -EEEEEecCCCCChHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccc
Q 045286          110 -LCIVTEYMPGGSLYDYLHKN-----HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA  183 (259)
Q Consensus       110 -~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~  183 (259)
                       .++++||+++++|..++...     ...+++..++.++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence             79999999999999988432     235788899999999999999999999999999999999999999999999998


Q ss_pred             eeccCCCcc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCC
Q 045286          184 RFQNKGGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       184 ~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      .........   .....+..|++||.+.+..++.++|+||||+++|+|++ |..||.+.+..+..+.+..+...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~  234 (273)
T cd05035         161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL  234 (273)
T ss_pred             eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            765433211   11224567999999988889999999999999999999 99999988887777766655433

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.5e-35  Score=245.83  Aligned_cols=217  Identities=26%  Similarity=0.392  Sum_probs=183.1

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC--CcEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS--PHLCI  112 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l  112 (259)
                      -++|++.+.||.|++|.||++.+.  ++.|++|.++.............+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            367889999999999999999974  78999999986654443334567899999999999999999988654  56899


Q ss_pred             EEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-c
Q 045286          113 VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-V  191 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~  191 (259)
                      |+||++ ++|.+++......+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus        86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~  164 (309)
T cd07845          86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP  164 (309)
T ss_pred             EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence            999995 58988887665678999999999999999999999999999999999999999999999999987665432 2


Q ss_pred             cccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          192 MTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      ......+..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+.+..+...++.+
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~  228 (309)
T cd07845         165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP  228 (309)
T ss_pred             CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            223345778999999865 457899999999999999999999999999988888877655443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=221.54  Aligned_cols=220  Identities=23%  Similarity=0.388  Sum_probs=197.4

Q ss_pred             hhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           39 LLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      +|.-.++||.|.+|+||+++.  .++-||+|.++....++.......+|+-+++.++|.||+++++.........+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            466778999999999999985  478899999999988888889999999999999999999999999888999999999


Q ss_pred             CCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-ccccC
Q 045286          117 MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMTAE  195 (259)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~~~  195 (259)
                      + ..+|..+.....+.++...+..++.|++++|.++|+.++.|+|+||.|.+++.+|.+|+.|||+++.+.-+- -.+..
T Consensus        83 c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysae  161 (292)
T KOG0662|consen   83 C-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE  161 (292)
T ss_pred             h-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeece
Confidence            9 679999998878889999999999999999999999999999999999999999999999999998666543 33456


Q ss_pred             CCcccccCccccCCCC-CCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCccCC
Q 045286          196 TGTYRWMAPEVINHQP-YDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQPIY  259 (259)
Q Consensus       196 ~~~~~~~~PE~~~~~~-~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~  259 (259)
                      .-+..|.||.++.+.. |+...|+||.||++.++.. |.+.|++.+.++++++|-+.++++.-..|
T Consensus       162 vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~w  227 (292)
T KOG0662|consen  162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQW  227 (292)
T ss_pred             eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccC
Confidence            6789999999998875 6888999999999999998 66669999999999999999888765544

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.4e-35  Score=244.05  Aligned_cols=221  Identities=30%  Similarity=0.587  Sum_probs=187.3

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEc-------CceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeee
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIG  102 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~  102 (259)
                      ..|+++..+|++.+.||+|++|.||++...       ...+++|.+..... ......+.+|+.+++.+ +|+||+++++
T Consensus         5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~   83 (293)
T cd05053           5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLG   83 (293)
T ss_pred             cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            458889999999999999999999999864       25799999886533 23346688999999999 7999999999


Q ss_pred             eeecCCcEEEEEecCCCCChHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 045286          103 ASTKSPHLCIVTEYMPGGSLYDYLHKN---------------HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANL  167 (259)
Q Consensus       103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Ni  167 (259)
                      .+...+..+++|||+++++|..++...               ...++...+..++.|++.+|.+||+.+++|+||+|+||
T Consensus        84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni  163 (293)
T cd05053          84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV  163 (293)
T ss_pred             EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence            999989999999999999999998642               23578889999999999999999999999999999999


Q ss_pred             EEccCCeEEEeeeccceeccCCCcc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q 045286          168 LMDTHNVVKVADFGVARFQNKGGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQA  243 (259)
Q Consensus       168 lv~~~~~i~l~D~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~  243 (259)
                      +++.++.++|+|||.+.........   .....+..|+|||.+.+..++.++|+|||||++|++++ |..||...+..+.
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  243 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  243 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence            9999999999999998765443211   11223467999999988889999999999999999997 9999998888777


Q ss_pred             HHHhhhccC
Q 045286          244 ALGVRQVCT  252 (259)
Q Consensus       244 ~~~i~~~~~  252 (259)
                      ...+..+..
T Consensus       244 ~~~~~~~~~  252 (293)
T cd05053         244 FKLLKEGYR  252 (293)
T ss_pred             HHHHHcCCc
Confidence            777666544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.4e-35  Score=239.74  Aligned_cols=214  Identities=32%  Similarity=0.567  Sum_probs=181.1

Q ss_pred             hhhhhccceeccccceEEEEEEEc--C---ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--G---QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~---~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~  111 (259)
                      ...|++.+.||+|++|.||+|...  +   ..|++|.+.... .......+.+|+.+++.++||||+++.+.+..+...+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   81 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM   81 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence            456889999999999999999864  2   359999987653 3444577899999999999999999999999889999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc
Q 045286          112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV  191 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~  191 (259)
                      +++|++++++|.+++......++...++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence            99999999999999976666688999999999999999999999999999999999999999999999998865443221


Q ss_pred             ccc---CC---CcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhcc
Q 045286          192 MTA---ET---GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       192 ~~~---~~---~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ...   ..   .+..|++||.+.+..++.++|+||+|+++|++++ |..||...+..+....+....
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~  228 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY  228 (269)
T ss_pred             ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC
Confidence            111   11   1357999999998889999999999999999886 999998888777777765543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.3e-35  Score=244.78  Aligned_cols=213  Identities=24%  Similarity=0.394  Sum_probs=180.8

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCc---hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN---DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      +|.+.+.||.|++|.||+|.+.  ++.|++|.+......   ......+.+|+.+++.++|+||+++++.+...+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            3677889999999999999974  789999999876544   33445677899999999999999999999998999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-cc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VM  192 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~  192 (259)
                      +||+ +++|.+++......+++..+..++.|++++|.+||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM  159 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence            9999 889999996655468999999999999999999999999999999999999999999999999987665432 22


Q ss_pred             ccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          193 TAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      ....++..|.|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+.+..+.+.+.
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~  220 (298)
T cd07841         160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALG  220 (298)
T ss_pred             cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcC
Confidence            23346778999999855 4678999999999999999999888988777666666655443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.3e-35  Score=237.18  Aligned_cols=216  Identities=25%  Similarity=0.478  Sum_probs=186.6

Q ss_pred             hhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           39 LLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      +|++.+.||+|++|.+|.+..  .++.+++|.+............+.+|+.+++.++|+||+++.+.+...+..++++||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            477889999999999999987  478999999987655555557889999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcc-cc
Q 045286          117 MPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM-TA  194 (259)
Q Consensus       117 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~-~~  194 (259)
                      +.+++|.+++.... ..+++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++++|||.+......... ..
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~  160 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART  160 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence            99999999986543 34788899999999999999999999999999999999999999999999998765443221 23


Q ss_pred             CCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          195 ETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      ..+++.|.|||.+.+..++.++|+||||+++++|++|..||...+..+....+..+..+.
T Consensus       161 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~  220 (256)
T cd08218         161 CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP  220 (256)
T ss_pred             ccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC
Confidence            346788999999988889999999999999999999999999888877777776655443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.1e-35  Score=238.16  Aligned_cols=206  Identities=33%  Similarity=0.562  Sum_probs=181.6

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      .++|...++||+|++|.||++.+.  ++.+++|.+.....    ...+.+|+.+++.++|+||+++++.+......++++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            468889999999999999999975  68899999876522    577889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-ccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMT  193 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~  193 (259)
                      |++++++|.+++......+++..+..++.|++.++.+||+.+++|+|++|+||+++.++.++|+|||.+....... ...
T Consensus        78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (256)
T cd06612          78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN  157 (256)
T ss_pred             ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccc
Confidence            9999999999997766678999999999999999999999999999999999999999999999999987655443 223


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALG  246 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~  246 (259)
                      ...++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+....
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~  210 (256)
T cd06612         158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM  210 (256)
T ss_pred             cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh
Confidence            34578899999999988899999999999999999999999987666554443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.6e-35  Score=242.11  Aligned_cols=212  Identities=28%  Similarity=0.521  Sum_probs=182.3

Q ss_pred             ceechhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcE
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL  110 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~  110 (259)
                      +..+..+|++.++||.|++|.||++.+  .++.+++|.+......  ....+.+|+.+++.++|+|++++++.+...+..
T Consensus        14 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (296)
T cd06655          14 IGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVGDEL   91 (296)
T ss_pred             cCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence            333457899999999999999999986  4789999998765332  346678999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      ++|+||+++++|..++...  .+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        92 ~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~  169 (296)
T cd06655          92 FVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ  169 (296)
T ss_pred             EEEEEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence            9999999999999988654  38899999999999999999999999999999999999999999999999887544332


Q ss_pred             c-cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 045286          191 V-MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVR  248 (259)
Q Consensus       191 ~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~  248 (259)
                      . .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~  228 (296)
T cd06655         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA  228 (296)
T ss_pred             ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            2 223457889999999998889999999999999999999999998877766555544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.5e-35  Score=239.88  Aligned_cols=215  Identities=33%  Similarity=0.563  Sum_probs=178.2

Q ss_pred             echhhhhccceeccccceEEEEEEEcC-------ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS  107 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~~-------~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~  107 (259)
                      +..+.|.+.+.||+|++|.||+|.+.+       ..|++|...... .......+.+|+.+++.++|+||+++++++...
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            456789999999999999999998743       678888876543 233446688899999999999999999999888


Q ss_pred             CcEEEEEecCCCCChHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC---eEEEe
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNH------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN---VVKVA  178 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~---~i~l~  178 (259)
                      +..++++|++++++|.+++....      ..+++..+..++.|++.++.+||+.+++|+||+|+||+++.++   .++|+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            88999999999999999986543      2478889999999999999999999999999999999998654   58999


Q ss_pred             eeccceeccCCCcc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhc
Q 045286          179 DFGVARFQNKGGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       179 D~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~  250 (259)
                      |||.+.........   .....+..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+..+....+...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~  237 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG  237 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            99998765332111   11223467999999988889999999999999999997 99999988777666555443

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-36  Score=270.35  Aligned_cols=223  Identities=34%  Similarity=0.621  Sum_probs=193.7

Q ss_pred             eechhhhhccceeccccceEEEEEEEc---C----ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec
Q 045286           34 EIDRRLLKTGERIASGSCGDLYRGVYL---G----QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK  106 (259)
Q Consensus        34 ~~~~~~~~~~~~lg~G~~~~V~~~~~~---~----~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~  106 (259)
                      .+.+..+.+...||+|+||.||.|...   +    ..|++|.+.... +......|.+|..+++.++||||+++++++.+
T Consensus       688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            366889999999999999999999864   2    248888887653 45667889999999999999999999999999


Q ss_pred             CCcEEEEEecCCCCChHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeee
Q 045286          107 SPHLCIVTEYMPGGSLYDYLHKN------HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADF  180 (259)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~  180 (259)
                      ....++++|||+|++|..++++.      ...++..+.+.++.+++++..||++++++||||..+|+|++....+||.||
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence            99999999999999999999877      567999999999999999999999999999999999999999999999999


Q ss_pred             ccceeccCCCccc--cC-CCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          181 GVARFQNKGGVMT--AE-TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       181 ~~~~~~~~~~~~~--~~-~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      |+++.........  .. .-...|+|||.+.+..++.++|+||||+++||+++ |..||.+.+..+.+.-+.++- ...+
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~~  925 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLDP  925 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccCC
Confidence            9998554432221  11 34578999999999999999999999999999999 999999999999998666555 4444


Q ss_pred             cC
Q 045286          257 PI  258 (259)
Q Consensus       257 ~~  258 (259)
                      |.
T Consensus       926 P~  927 (1025)
T KOG1095|consen  926 PS  927 (1025)
T ss_pred             CC
Confidence            43

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.9e-35  Score=237.46  Aligned_cols=215  Identities=29%  Similarity=0.472  Sum_probs=184.6

Q ss_pred             hhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeee--cCCcEEEEE
Q 045286           39 LLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST--KSPHLCIVT  114 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~  114 (259)
                      +|++.+.||.|++|.||++.+  .++.+++|.+............+.+|+.+++.++|+||+++++.+.  .....++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            367789999999999999986  4688999999876666666678889999999999999999999764  345689999


Q ss_pred             ecCCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH-----hCCcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          115 EYMPGGSLYDYLHKN---HNVLKLPQLLRFAIDICKGMEYLH-----QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       115 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH-----~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                      ||+++++|.+++...   ...+++..++.++.|++.+|.++|     +.+++|+||+|+||+++.++.++|+|||.+...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998653   446889999999999999999999     899999999999999999999999999998876


Q ss_pred             cCCCc-cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          187 NKGGV-MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       187 ~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ..... .....++..|+|||.+.+..++.++|+||||+++++|++|..||...+..+....+..+..+
T Consensus       161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  228 (265)
T cd08217         161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR  228 (265)
T ss_pred             cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCC
Confidence            55433 33446788999999999888999999999999999999999999988776666666655443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-35  Score=236.49  Aligned_cols=209  Identities=31%  Similarity=0.577  Sum_probs=175.4

Q ss_pred             ceeccccceEEEEEEEc-----CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCC
Q 045286           44 ERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMP  118 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~  118 (259)
                      ++||+|++|.||+|.+.     +..+++|.+...... .....+.+|+.+++.+.|+|++++++++. .+..++++|+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence            47999999999999863     257999998876543 44567889999999999999999999876 456899999999


Q ss_pred             CCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccc----c
Q 045286          119 GGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT----A  194 (259)
Q Consensus       119 ~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~----~  194 (259)
                      +++|.+++.... .+++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||.+..........    .
T Consensus        79 ~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          79 LGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence            999999996654 58899999999999999999999999999999999999999999999999987554432211    1


Q ss_pred             CCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCC
Q 045286          195 ETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLC  255 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~  255 (259)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+........
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~  219 (257)
T cd05060         158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPR  219 (257)
T ss_pred             ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCC
Confidence            112357999999998889999999999999999998 9999998888777777765544333

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4.2e-35  Score=245.65  Aligned_cols=222  Identities=31%  Similarity=0.578  Sum_probs=186.3

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEc---------CceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCccee
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYL---------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRF  100 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~---------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~  100 (259)
                      ..|++...+|.+.++||+|+||.||.+.+.         ...+++|.+.... .......+.+|+++++++ +|+||+++
T Consensus         5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~   83 (334)
T cd05100           5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINL   83 (334)
T ss_pred             cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence            568999999999999999999999999753         1368999887543 333456788999999999 79999999


Q ss_pred             eeeeecCCcEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 045286          101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNH---------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTA  165 (259)
Q Consensus       101 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~  165 (259)
                      ++.+...+..++++||+++++|.+++....               ..++...+..++.|++.+|.+||++|++|+||+|+
T Consensus        84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~  163 (334)
T cd05100          84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR  163 (334)
T ss_pred             eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence            999998889999999999999999986532               23667788899999999999999999999999999


Q ss_pred             cEEEccCCeEEEeeeccceeccCCCcc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 045286          166 NLLMDTHNVVKVADFGVARFQNKGGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL  241 (259)
Q Consensus       166 Nilv~~~~~i~l~D~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~  241 (259)
                      ||+++.++.++|+|||.+.........   ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  243 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  243 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            999999999999999998765432211   11223467999999999899999999999999999998 89999988888


Q ss_pred             HHHHHhhhccCC
Q 045286          242 QAALGVRQVCTS  253 (259)
Q Consensus       242 ~~~~~i~~~~~~  253 (259)
                      +....+......
T Consensus       244 ~~~~~~~~~~~~  255 (334)
T cd05100         244 ELFKLLKEGHRM  255 (334)
T ss_pred             HHHHHHHcCCCC
Confidence            877777665443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-36  Score=262.79  Aligned_cols=206  Identities=24%  Similarity=0.473  Sum_probs=177.2

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeee-ec
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGAS-TK  106 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~-~~  106 (259)
                      ..+.+...++++.+.|-.|||+.||+|.+.  +..||+|.....  ++.....+.+|+.+++.|+ |+|||.+++.. ..
T Consensus        30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~  107 (738)
T KOG1989|consen   30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN  107 (738)
T ss_pred             eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence            558889999999999999999999999985  379999998877  6677789999999999998 99999999932 11


Q ss_pred             --C----CcEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEccCCeEEE
Q 045286          107 --S----PHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRN--IIHRDLKTANLLMDTHNVVKV  177 (259)
Q Consensus       107 --~----~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~di~p~Nilv~~~~~i~l  177 (259)
                        +    -.++++||||.|+.|-+++.++. ..+++.++++|+.++++++++||...  |+|||||-+|||++.+|.+||
T Consensus       108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KL  187 (738)
T KOG1989|consen  108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKL  187 (738)
T ss_pred             ccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEe
Confidence              1    24689999999999999997542 23999999999999999999999998  999999999999999999999


Q ss_pred             eeeccceeccCCCcccc----------CCCcccccCcccc---CCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 045286          178 ADFGVARFQNKGGVMTA----------ETGTYRWMAPEVI---NHQPYDQKADVFSFAIVLWELVTAKVPYDSM  238 (259)
Q Consensus       178 ~D~~~~~~~~~~~~~~~----------~~~~~~~~~PE~~---~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  238 (259)
                      ||||.++..........          ..-|+.|++||++   .+.+.+.++|||+|||++|-|+....||+..
T Consensus       188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s  261 (738)
T KOG1989|consen  188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES  261 (738)
T ss_pred             CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence            99999974433221111          1358999999996   5788999999999999999999999999876

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=6.4e-35  Score=239.65  Aligned_cols=215  Identities=29%  Similarity=0.513  Sum_probs=179.4

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc-------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeee
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST  105 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~  105 (259)
                      |++..++|++.++||+|++|.||+|...       +..|++|.+..... ......+.+|+.+++.++|+||+++++.+.
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVS   79 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            7788999999999999999999998643       34799998875532 233356788999999999999999999998


Q ss_pred             cCCcEEEEEecCCCCChHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEE
Q 045286          106 KSPHLCIVTEYMPGGSLYDYLHKNH---------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVK  176 (259)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~  176 (259)
                      ..+..+++|||+++++|.+++....         ...+...+..++.|++.+|.+||+++++|+||+|+||+++.++.++
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence            8889999999999999999996532         2245677888999999999999999999999999999999999999


Q ss_pred             EeeeccceeccCCCcc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhh
Q 045286          177 VADFGVARFQNKGGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVR  248 (259)
Q Consensus       177 l~D~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~  248 (259)
                      |+|||.+.........   ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+.
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~  235 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM  235 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            9999998654332211   12234567999999988889999999999999999998 889998877766665554

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.4e-35  Score=236.96  Aligned_cols=212  Identities=33%  Similarity=0.654  Sum_probs=181.5

Q ss_pred             chhhhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      .-.+|.+.+.||+|++|.||++...++.+++|......    ....+.+|+.+++.++|+|++++++.+... ..++++|
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e   78 (254)
T cd05083           4 NLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME   78 (254)
T ss_pred             cHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence            44678999999999999999999999999999987542    235688999999999999999999988765 4689999


Q ss_pred             cCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcccc
Q 045286          116 YMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTA  194 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~  194 (259)
                      |+.+++|.+++.... ..++...++.++.|++.+|.++|+.|++|+||+|+||+++.++.++|+|||.+.......  ..
T Consensus        79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--~~  156 (254)
T cd05083          79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--DN  156 (254)
T ss_pred             CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC--CC
Confidence            999999999997543 357888999999999999999999999999999999999999999999999986543321  12


Q ss_pred             CCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCC
Q 045286          195 ETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      ...+..|.|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+.++....
T Consensus       157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  217 (254)
T cd05083         157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRME  217 (254)
T ss_pred             CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCC
Confidence            234567999999988889999999999999999997 999999988888777777665443

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=5.8e-35  Score=241.54  Aligned_cols=213  Identities=31%  Similarity=0.573  Sum_probs=180.2

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEc-------CceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeee
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIG  102 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~  102 (259)
                      ..|++..++|.+.+.||.|++|.||++.+.       +..+++|.++.... ......+.+|+.+++++ +|+||+++++
T Consensus        28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~  106 (302)
T cd05055          28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLG  106 (302)
T ss_pred             ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEE
Confidence            348888999999999999999999999752       34799999876532 33446788999999999 7999999999


Q ss_pred             eeecCCcEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeec
Q 045286          103 ASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFG  181 (259)
Q Consensus       103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~  181 (259)
                      .+...+..++++||+.+++|.+++.... ..++...+..++.|++.+|.+||+++++|+||+|+||+++.++.++++|||
T Consensus       107 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         107 ACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             EEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCc
Confidence            9999899999999999999999996543 347899999999999999999999999999999999999999999999999


Q ss_pred             cceeccCCCcc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 045286          182 VARFQNKGGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAA  244 (259)
Q Consensus       182 ~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~  244 (259)
                      .+.........   ....++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...+..+..
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~  253 (302)
T cd05055         187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF  253 (302)
T ss_pred             ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH
Confidence            98755433211   12234578999999998889999999999999999998 99999876654433

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.8e-35  Score=242.00  Aligned_cols=206  Identities=28%  Similarity=0.536  Sum_probs=178.0

Q ss_pred             hhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      ..+|++.+.||+|++|.||++.+  .++.+++|.+......  ....+.+|+.+++.+.|+|++++++.+..+...++|+
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~   96 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence            46889999999999999999986  4789999998865433  2366889999999999999999999999889999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-ccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMT  193 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~  193 (259)
                      ||+++++|.+++...  .++..++..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus        97 e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  174 (296)
T cd06654          97 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (296)
T ss_pred             cccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccC
Confidence            999999999998643  37888999999999999999999999999999999999999999999999887544322 223


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALG  246 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~  246 (259)
                      ...+++.|+|||.+.+..++.++|+||||+++|+|++|..||...++......
T Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~  227 (296)
T cd06654         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL  227 (296)
T ss_pred             cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH
Confidence            34678899999999988899999999999999999999999987766544433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-35  Score=241.98  Aligned_cols=210  Identities=26%  Similarity=0.449  Sum_probs=175.2

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ++|++.++||.|++|.||++.+.  ++.|++|.+...... .....+.+|+.+++.++|+||+++++++...+..++|+|
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            57888899999999999999874  789999998765322 222446789999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-cccc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMTA  194 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~~  194 (259)
                      |+++ +|.+++......++...+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus        84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  162 (291)
T cd07844          84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN  162 (291)
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence            9965 9999887666678899999999999999999999999999999999999999999999999986543221 1122


Q ss_pred             CCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHhhh
Q 045286          195 ETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMT-PLQAALGVRQ  249 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~-~~~~~~~i~~  249 (259)
                      ..++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+ ..+.+..+.+
T Consensus       163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~  219 (291)
T cd07844         163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFR  219 (291)
T ss_pred             cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHH
Confidence            345788999999865 457899999999999999999999997655 4455544433

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.7e-35  Score=246.82  Aligned_cols=219  Identities=33%  Similarity=0.587  Sum_probs=176.7

Q ss_pred             cceechhhhhccceeccccceEEEEEEE-------cCceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeeee
Q 045286           32 DWEIDRRLLKTGERIASGSCGDLYRGVY-------LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGA  103 (259)
Q Consensus        32 ~~~~~~~~~~~~~~lg~G~~~~V~~~~~-------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~  103 (259)
                      +|+++.++|++.++||.|+||.||+|.+       .++.||+|.++.... ......+.+|+.+++++ +|+||+++++.
T Consensus         1 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~   79 (343)
T cd05103           1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGA   79 (343)
T ss_pred             CcccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence            4889999999999999999999999974       357899999976543 23346788999999999 58999999997


Q ss_pred             eec-CCcEEEEEecCCCCChHHHHHhcC----------------------------------------------------
Q 045286          104 STK-SPHLCIVTEYMPGGSLYDYLHKNH----------------------------------------------------  130 (259)
Q Consensus       104 ~~~-~~~~~lv~e~~~~~~L~~~l~~~~----------------------------------------------------  130 (259)
                      +.. +...++++||+++++|.+++....                                                    
T Consensus        80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (343)
T cd05103          80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS  159 (343)
T ss_pred             eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence            754 456889999999999999986421                                                    


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcc---c
Q 045286          131 --------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM---T  193 (259)
Q Consensus       131 --------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~---~  193 (259)
                                    ..++...+..++.|++++|.+||+.|++|+||+|+||+++.++.++|+|||.+.........   .
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence                          12566777889999999999999999999999999999999999999999998754322111   1


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCH-HHHHHHhhhcc
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTP-LQAALGVRQVC  251 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~-~~~~~~i~~~~  251 (259)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++ |..||..... .+....+..+.
T Consensus       240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~  299 (343)
T cd05103         240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT  299 (343)
T ss_pred             CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC
Confidence            1234567999999988889999999999999999997 9999986543 33334444433

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=7.2e-35  Score=238.59  Aligned_cols=212  Identities=29%  Similarity=0.513  Sum_probs=179.7

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      ++.|++.+.||+|++|.||++.+.  +..+++|.+...  .......+.+|+.+++.++|+|++++++.+...+..++++
T Consensus         4 ~~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~   81 (282)
T cd06643           4 EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   81 (282)
T ss_pred             HHHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEE
Confidence            456788999999999999999975  567788887654  2334567888999999999999999999999899999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-Cccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVMT  193 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~~  193 (259)
                      ||+++++|..++......+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||.+...... ....
T Consensus        82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~  161 (282)
T cd06643          82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD  161 (282)
T ss_pred             EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence            999999999988665566899999999999999999999999999999999999999999999999998654332 1223


Q ss_pred             cCCCcccccCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          194 AETGTYRWMAPEVIN-----HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      ...++..|+|||.+.     +..++.++|+||+|+++|+|++|..||...+..+....+...
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~  223 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS  223 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc
Confidence            345788999999974     345778999999999999999999999988777666665543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.8e-35  Score=234.98  Aligned_cols=210  Identities=36%  Similarity=0.599  Sum_probs=181.5

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccC---chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL---NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      +|+..+.||+|++|.||+|.+.  ++.+++|.+.....   .......+.+|+.+++.++|++|+++.+.+...+..+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677789999999999999874  78999999876542   234556788999999999999999999999998999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT  193 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~  193 (259)
                      +||+++++|.+++.... .++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+..........
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~  159 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK  159 (258)
T ss_pred             EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccccc
Confidence            99999999999986553 48889999999999999999999999999999999999999999999999987665544344


Q ss_pred             cCCCcccccCccccCCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          194 AETGTYRWMAPEVINHQP-YDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                      ...++..|++||.+.... ++.++|+||||+++|+|++|..||......+....+..
T Consensus       160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  216 (258)
T cd06632         160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR  216 (258)
T ss_pred             ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh
Confidence            556788999999987766 89999999999999999999999988776666655544

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-35  Score=242.48  Aligned_cols=212  Identities=23%  Similarity=0.360  Sum_probs=182.0

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      +|++.++||+|++|.||+|.+.  ++.|++|.++...........+.+|+++++.++|+||+++++.+...+..++++||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            6888999999999999999874  78999999987655555567889999999999999999999999998999999999


Q ss_pred             CCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC--cccc
Q 045286          117 MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG--VMTA  194 (259)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~--~~~~  194 (259)
                      ++++.+..+. .....++...++.++.|++.++.+||+.+++|+|++|+||+++.++.++|+|||.+.......  ....
T Consensus        82 ~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~  160 (288)
T cd07833          82 VERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD  160 (288)
T ss_pred             CCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccC
Confidence            9876555544 444558999999999999999999999999999999999999999999999999987665543  2334


Q ss_pred             CCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          195 ETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ..++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+.+..+....
T Consensus       161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~  218 (288)
T cd07833         161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCL  218 (288)
T ss_pred             cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            4567889999999887 78999999999999999999999999877766666555433

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=6e-35  Score=237.04  Aligned_cols=212  Identities=24%  Similarity=0.490  Sum_probs=178.1

Q ss_pred             hhhhccceeccccceEEEEEEE--cCceEEEEEeeccc-CchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEH-LNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      .+|.+.+.||.|++|.||++..  .++.|++|.+.... ........+.+|+.+++.++||||+++++.+...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            4678889999999999999987  57899999887532 23444567889999999999999999999999889999999


Q ss_pred             ecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc
Q 045286          115 EYMPGGSLYDYLHK---NHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV  191 (259)
Q Consensus       115 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~  191 (259)
                      |++++++|.+++..   ....+++..+..++.|++.+|.+||+++++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~  161 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence            99999999988853   233478889999999999999999999999999999999999999999999999876554322


Q ss_pred             -cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHhhh
Q 045286          192 -MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSM--TPLQAALGVRQ  249 (259)
Q Consensus       192 -~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~--~~~~~~~~i~~  249 (259)
                       .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||...  +..+....+..
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  222 (267)
T cd08228         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ  222 (267)
T ss_pred             HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhc
Confidence             22345778999999998888999999999999999999999998643  33444444443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=7.5e-35  Score=237.12  Aligned_cols=213  Identities=29%  Similarity=0.521  Sum_probs=176.1

Q ss_pred             hhccceeccccceEEEEEEEcC----ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec------CCc
Q 045286           40 LKTGERIASGSCGDLYRGVYLG----QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK------SPH  109 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~~~----~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~  109 (259)
                      +.+.+.||+|++|.||++.+..    ..+++|.++...........+.+|+.+++.++|+||+++++.+..      ...
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567899999999999998753    268999988765555666788899999999999999999987632      225


Q ss_pred             EEEEEecCCCCChHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccce
Q 045286          110 LCIVTEYMPGGSLYDYLHKN-----HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR  184 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~  184 (259)
                      .++++||+++++|.+++...     ...++...+..++.|++.+|.+||+.+++|+||||+||+++.++.++|+|||.+.
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence            68999999999999987432     2347888999999999999999999999999999999999999999999999987


Q ss_pred             eccCCCcc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccC
Q 045286          185 FQNKGGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       185 ~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      ........   .....+..|++||.+.+..++.++|+||||+++|+|++ |..||...+..+....+..+-.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  232 (272)
T cd05075         161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR  232 (272)
T ss_pred             ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence            65443211   12234668999999999899999999999999999999 8999998887777777765543

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=6.9e-35  Score=236.53  Aligned_cols=209  Identities=32%  Similarity=0.582  Sum_probs=176.9

Q ss_pred             hhhccceeccccceEEEEEEE-cCceEEEEEeecccCc----hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           39 LLKTGERIASGSCGDLYRGVY-LGQDVAVKVLRSEHLN----DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~-~~~~v~vK~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      .|+..+.||+|++|.||++.. +++.+++|.+......    ......+.+|+++++.++|+||+++++.+...+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            367889999999999999986 5788999998765322    22335688899999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC----
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG----  189 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~----  189 (259)
                      +||+++++|.+++.+.. .+++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||.+......    
T Consensus        81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            99999999999996543 4788999999999999999999999999999999999999999999999988654211    


Q ss_pred             ---CccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 045286          190 ---GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVR  248 (259)
Q Consensus       190 ---~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~  248 (259)
                         .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.
T Consensus       160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~  221 (265)
T cd06631         160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG  221 (265)
T ss_pred             cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh
Confidence               11223457889999999998889999999999999999999999998766655444433

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=7.1e-35  Score=236.82  Aligned_cols=217  Identities=31%  Similarity=0.562  Sum_probs=183.5

Q ss_pred             echhhhhccceeccccceEEEEEEEc--Cc---eEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCc
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL--GQ---DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPH  109 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~--~~---~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~  109 (259)
                      +...+|...+.||.|++|.||+|...  ++   .+++|.+.... .......+.+|+.+++.++|+|++++.+.+...+.
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            45678888999999999999999864  32   68999887653 23334678899999999999999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG  189 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~  189 (259)
                      .+++||++++++|.+++......++...+..++.|++.++.+||+.|++|+|++|+||+++.++.++++|||.+......
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999999999766666889999999999999999999999999999999999999999999999998755432


Q ss_pred             Cccc----cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccC
Q 045286          190 GVMT----AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       190 ~~~~----~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      ....    ....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+..+..
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~  228 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR  228 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCC
Confidence            2111    1122457999999988889999999999999999997 9999988888777777766543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-36  Score=255.18  Aligned_cols=225  Identities=30%  Similarity=0.632  Sum_probs=202.6

Q ss_pred             cceechhhhhccceeccccceEEEEEEEcC------ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeee
Q 045286           32 DWEIDRRLLKTGERIASGSCGDLYRGVYLG------QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST  105 (259)
Q Consensus        32 ~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~------~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~  105 (259)
                      .+++.+..+.+.++||.|-||.||+|....      -.||||.-+.+...+. .+.|++|..+++.+.||||+++++++.
T Consensus       383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-tekflqEa~iMrnfdHphIikLIGv~~  461 (974)
T KOG4257|consen  383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-TEKFLQEASIMRNFDHPHIIKLIGVCV  461 (974)
T ss_pred             cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-HHHHHHHHHHHHhCCCcchhheeeeee
Confidence            588888999999999999999999999752      2699999888765444 688999999999999999999999998


Q ss_pred             cCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          106 KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                      +. ..|+|||.++-|-|.++++.+...++......++.|++.+|+|||+..+|||||...||||.....+||.|||+++.
T Consensus       462 e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~  540 (974)
T KOG4257|consen  462 EQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRY  540 (974)
T ss_pred             cc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhh
Confidence            75 67999999999999999998888899999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCccccCC--CcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCccC
Q 045286          186 QNKGGVMTAET--GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQPI  258 (259)
Q Consensus       186 ~~~~~~~~~~~--~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~  258 (259)
                      +..........  -..-|++||.+.=..++.++|+|.||+++||++. |..||.+....+.+..|++|-+.+|||.
T Consensus       541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~n  616 (974)
T KOG4257|consen  541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPN  616 (974)
T ss_pred             ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCC
Confidence            77665443322  3567999999999999999999999999999998 9999999999999999999999888874

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=8.2e-35  Score=234.55  Aligned_cols=215  Identities=28%  Similarity=0.547  Sum_probs=189.0

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      +|++.+.||.|++|.||++.+.  ++.+++|.+............+.+|+++++.++|+|++++.+.+..++..++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4678889999999999999986  88999999988766656667889999999999999999999999998999999999


Q ss_pred             CCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-cc
Q 045286          117 MPGGSLYDYLHKN---HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VM  192 (259)
Q Consensus       117 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~  192 (259)
                      +++++|.+++...   ...++...+..++.+++.++.+||+.|++|+|++|+||+++.++.++|+|||.+....... ..
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~  160 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA  160 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence            9999999999765   3568999999999999999999999999999999999999999999999999987665543 22


Q ss_pred             ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          193 TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ....+++.|+|||.+.+..++.++|+||+|+++++|++|..||...+..+....+.+....
T Consensus       161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~  221 (258)
T cd08215         161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP  221 (258)
T ss_pred             cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCC
Confidence            3346788999999998888999999999999999999999999888777766666554433

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.9e-35  Score=244.12  Aligned_cols=191  Identities=25%  Similarity=0.433  Sum_probs=157.9

Q ss_pred             cceeccccceEEEEEEEc----CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec--CCcEEEEEec
Q 045286           43 GERIASGSCGDLYRGVYL----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK--SPHLCIVTEY  116 (259)
Q Consensus        43 ~~~lg~G~~~~V~~~~~~----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~  116 (259)
                      +++||+|+||.||+|...    ++.+++|.+......    ..+.+|+.++++++||||+++++.+..  ....++++|+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            468999999999999853    478999998765332    446789999999999999999998853  4568899999


Q ss_pred             CCCCChHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE----ccCCeEEEeeeccce
Q 045286          117 MPGGSLYDYLHKN--------HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM----DTHNVVKVADFGVAR  184 (259)
Q Consensus       117 ~~~~~L~~~l~~~--------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv----~~~~~i~l~D~~~~~  184 (259)
                      + +++|.+++...        ...+++..+..++.|++.+|.+||+.|++|+||||+||++    +.++.++|+|||.+.
T Consensus        82 ~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          82 A-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             c-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence            8 45888877532        1247888999999999999999999999999999999999    455789999999997


Q ss_pred             eccCCC----ccccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 045286          185 FQNKGG----VMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSM  238 (259)
Q Consensus       185 ~~~~~~----~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~  238 (259)
                      ......    ......+++.|+|||.+.+. .++.++|+||+||++|+|++|..||...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            654331    12334678899999998774 5799999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-35  Score=242.68  Aligned_cols=210  Identities=23%  Similarity=0.398  Sum_probs=180.4

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCch-HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      +|+..+.||+|++|.||++...  ++.+++|.+....... .....+.+|+++++.++|++|+++++.+..+...++++|
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            6788899999999999999974  6899999998765443 355678899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc---
Q 045286          116 YMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV---  191 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~---  191 (259)
                      |+.+++|.+++.... ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+........   
T Consensus        82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  161 (316)
T cd05574          82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS  161 (316)
T ss_pred             ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccc
Confidence            999999999986543 4588999999999999999999999999999999999999999999999998764332110   


Q ss_pred             ---------------------------cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 045286          192 ---------------------------MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAA  244 (259)
Q Consensus       192 ---------------------------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~  244 (259)
                                                 .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~  241 (316)
T cd05574         162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETF  241 (316)
T ss_pred             cccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHH
Confidence                                       01224677899999999888999999999999999999999999888776666


Q ss_pred             HHhh
Q 045286          245 LGVR  248 (259)
Q Consensus       245 ~~i~  248 (259)
                      ..+.
T Consensus       242 ~~~~  245 (316)
T cd05574         242 SNIL  245 (316)
T ss_pred             HHHh
Confidence            5554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=8.8e-35  Score=235.94  Aligned_cols=210  Identities=30%  Similarity=0.507  Sum_probs=175.3

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCc---hHHHHHHHHHHHHHHhcCCCCcceeeeeeec--CCcE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN---DTLEDEFVQEVAILREVQHRNVVRFIGASTK--SPHL  110 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~  110 (259)
                      .+|.+.+.||+|++|.||.+.+.  ++.|++|.+......   ......+.+|+.+++++.|+||+++++.+..  ...+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            35778899999999999999864  789999998654322   2334678889999999999999999998865  3467


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-  189 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-  189 (259)
                      ++++|++++++|.+++... ..+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+...... 
T Consensus        82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence            8999999999999998654 34788889999999999999999999999999999999999999999999988754321 


Q ss_pred             ---CccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 045286          190 ---GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVR  248 (259)
Q Consensus       190 ---~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~  248 (259)
                         .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+......++.
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~  222 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA  222 (265)
T ss_pred             ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh
Confidence               11223457889999999988889999999999999999999999998776655554443

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.1e-35  Score=242.96  Aligned_cols=218  Identities=23%  Similarity=0.371  Sum_probs=180.4

Q ss_pred             hhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC--------
Q 045286           38 RLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS--------  107 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------  107 (259)
                      ++|++.++||.|++|.||+|.+  +++.|++|.+............+.+|+.++++++||||+++++++...        
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            5788899999999999999997  478999999876544443445567899999999999999999987543        


Q ss_pred             CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      ...++++||+. ++|...+......+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        92 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  170 (310)
T cd07865          92 GSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFS  170 (310)
T ss_pred             ceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccccc
Confidence            34599999995 58888887665568999999999999999999999999999999999999999999999999987554


Q ss_pred             CCCc-----cccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          188 KGGV-----MTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       188 ~~~~-----~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      ....     .....++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+.......+.+.++...+
T Consensus       171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             CCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            3221     1233467789999988665 4688999999999999999999999988887777777766554443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=9.5e-35  Score=248.13  Aligned_cols=214  Identities=34%  Similarity=0.591  Sum_probs=179.3

Q ss_pred             cccceechhhhhccceeccccceEEEEEEEc-------CceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceee
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFI  101 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~  101 (259)
                      ...|+++.+++.+.+.||.|+||.||+|.+.       ++.|++|+++..... .....+.+|+.+++++. |+||++++
T Consensus        29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~~H~niv~~~  107 (401)
T cd05107          29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-SEKQALMSELKIMSHLGPHLNIVNLL  107 (401)
T ss_pred             CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh-hHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence            3449999999999999999999999999864       357999999865433 33356889999999998 99999999


Q ss_pred             eeeecCCcEEEEEecCCCCChHHHHHhcC---------------------------------------------------
Q 045286          102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH---------------------------------------------------  130 (259)
Q Consensus       102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------  130 (259)
                      +.+...+..++|+||+++++|.+++....                                                   
T Consensus       108 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (401)
T cd05107         108 GACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA  187 (401)
T ss_pred             EEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence            99998889999999999999999986432                                                   


Q ss_pred             ----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 045286          131 ----------------------------------------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKT  164 (259)
Q Consensus       131 ----------------------------------------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p  164 (259)
                                                                    ..++...++.++.|++.+|.|||+.+++|+||+|
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp  267 (401)
T cd05107         188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAA  267 (401)
T ss_pred             CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCc
Confidence                                                          1245567788999999999999999999999999


Q ss_pred             CcEEEccCCeEEEeeeccceeccCCCc---cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCH
Q 045286          165 ANLLMDTHNVVKVADFGVARFQNKGGV---MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTP  240 (259)
Q Consensus       165 ~Nilv~~~~~i~l~D~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~  240 (259)
                      +||+++.++.++|+|||.+........   .....++..|++||.+.+..++.++|+||||+++|+|++ |..||.....
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            999999999999999999875433211   112235678999999988889999999999999999998 8999987655


Q ss_pred             HHHH
Q 045286          241 LQAA  244 (259)
Q Consensus       241 ~~~~  244 (259)
                      .+..
T Consensus       348 ~~~~  351 (401)
T cd05107         348 NEQF  351 (401)
T ss_pred             hHHH
Confidence            4443

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-36  Score=251.45  Aligned_cols=207  Identities=23%  Similarity=0.364  Sum_probs=183.0

Q ss_pred             ccccceechhhhhccceeccccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeec
Q 045286           29 KSEDWEIDRRLLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTK  106 (259)
Q Consensus        29 ~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~  106 (259)
                      -.+.+.+.++.|++.++||+||.+.||++... .+.+++|.+.....+......+.+|+..|.+|+ |.+|+.++++-..
T Consensus       352 ~~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~  431 (677)
T KOG0596|consen  352 ANEIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT  431 (677)
T ss_pred             cCeeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc
Confidence            34668999999999999999999999999875 467888888888888888899999999999997 9999999999988


Q ss_pred             CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          107 SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                      ++.+|+|||+- ..+|..++.+....+....+..+..|++.++.++|+.||||.|+||.|+|+ -.|.+||||||++.-+
T Consensus       432 d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI  509 (677)
T KOG0596|consen  432 DGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAI  509 (677)
T ss_pred             CceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhccc
Confidence            99999999987 679999998877666666888999999999999999999999999999999 6789999999999877


Q ss_pred             cCCCcc---ccCCCcccccCccccCCC-----------CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          187 NKGGVM---TAETGTYRWMAPEVINHQ-----------PYDQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       187 ~~~~~~---~~~~~~~~~~~PE~~~~~-----------~~~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                      ......   ..-+||+.|++||.+...           ..++++|||||||++|+|+.|+.||..
T Consensus       510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~  574 (677)
T KOG0596|consen  510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ  574 (677)
T ss_pred             CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence            665432   445799999999998433           246789999999999999999999974

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.1e-35  Score=248.23  Aligned_cols=213  Identities=24%  Similarity=0.369  Sum_probs=180.4

Q ss_pred             hhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC------C
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS------P  108 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~  108 (259)
                      .++|+..+.||.|++|.||++.+  .++.|++|.+............+.+|+.+++.++|+||+++++++...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            36788999999999999999987  478999999876554445556778899999999999999999987533      3


Q ss_pred             cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      ..++|+||+. ++|.+.+...   ++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        95 ~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  170 (353)
T cd07850          95 DVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  170 (353)
T ss_pred             cEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence            5799999995 5888877533   78889999999999999999999999999999999999999999999999987655


Q ss_pred             CCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       189 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ........++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.+.++.
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  235 (353)
T cd07850         171 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGT  235 (353)
T ss_pred             CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC
Confidence            44334456788999999999999999999999999999999999999987776666665554443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=8.4e-35  Score=237.64  Aligned_cols=211  Identities=34%  Similarity=0.561  Sum_probs=181.1

Q ss_pred             hhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      ...|+..++||+|++|.||+|.+  .++.+++|.+..... ......+.+|+.++++++|++|+++++.+......++|+
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            35678889999999999999987  478999999886532 334577889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-ccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMT  193 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~  193 (259)
                      ||+++++|.+++...  .++...+..++.|++.++.++|+.+++|+||+|+||+++.++.++++|||.+....... ...
T Consensus        82 e~~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06640          82 EYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             ecCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccc
Confidence            999999999998643  47888999999999999999999999999999999999999999999999987654432 122


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      ...++..|.|||.+.+..++.++|+||||+++|+|++|..||...+.......+...
T Consensus       160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~  216 (277)
T cd06640         160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN  216 (277)
T ss_pred             cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC
Confidence            335678899999998888999999999999999999999999887776665555433

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=6e-35  Score=239.77  Aligned_cols=218  Identities=30%  Similarity=0.530  Sum_probs=183.1

Q ss_pred             echhhhhccceeccccceEEEEEEEc-------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS  107 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~  107 (259)
                      ++.++|++.+.||.|++|.||++.+.       +..+++|++.... .......+.+|+.++++++|+||+++++++..+
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            46788999999999999999999863       4689999987643 334446788999999999999999999999988


Q ss_pred             CcEEEEEecCCCCChHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNH---------------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTAN  166 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~---------------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~N  166 (259)
                      +..++++|++++++|.+++....                     ..++...++.++.|++.+|.+||+++++|+||+|+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            89999999999999999996432                     236778889999999999999999999999999999


Q ss_pred             EEEccCCeEEEeeeccceeccCCCc---cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 045286          167 LLMDTHNVVKVADFGVARFQNKGGV---MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQ  242 (259)
Q Consensus       167 ilv~~~~~i~l~D~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~  242 (259)
                      |+++.++.++|+|||.+........   ......+..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999875433221   112234567999999988889999999999999999997 889998888777


Q ss_pred             HHHHhhhccCC
Q 045286          243 AALGVRQVCTS  253 (259)
Q Consensus       243 ~~~~i~~~~~~  253 (259)
                      ....+..+...
T Consensus       241 ~~~~~~~~~~~  251 (288)
T cd05050         241 VIYYVRDGNVL  251 (288)
T ss_pred             HHHHHhcCCCC
Confidence            77777655443

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=5.7e-35  Score=240.18  Aligned_cols=215  Identities=28%  Similarity=0.517  Sum_probs=178.8

Q ss_pred             hhhccceeccccceEEEEEEEcC-------ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEE
Q 045286           39 LLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~~-------~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~  111 (259)
                      +|++.+.||+|+||.||+|.+..       ..+++|.+...... .....+.+|+.+++.++||||+++++.+...+..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS-SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH-HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            36788999999999999998642       46888888765432 33467889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEE
Q 045286          112 IVTEYMPGGSLYDYLHKNH-----------------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLL  168 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nil  168 (259)
                      +++||+.+++|.+++....                       ..++...++.++.|++.+|.+||+.+++|+||+|+||+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil  159 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL  159 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence            9999999999999986421                       23677888999999999999999999999999999999


Q ss_pred             EccCCeEEEeeeccceeccCCCc---cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 045286          169 MDTHNVVKVADFGVARFQNKGGV---MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAA  244 (259)
Q Consensus       169 v~~~~~i~l~D~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~  244 (259)
                      ++.++.++|+|||.+........   ......+..|+|||.+.+..++.++|+||||+++|+|++ |..||++.+..+..
T Consensus       160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~  239 (290)
T cd05045         160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF  239 (290)
T ss_pred             EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            99999999999999875433211   122234568999999988889999999999999999998 99999988887777


Q ss_pred             HHhhhccCCC
Q 045286          245 LGVRQVCTSL  254 (259)
Q Consensus       245 ~~i~~~~~~~  254 (259)
                      ..+++.....
T Consensus       240 ~~~~~~~~~~  249 (290)
T cd05045         240 NLLKTGYRME  249 (290)
T ss_pred             HHHhCCCCCC
Confidence            7666655443

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-35  Score=253.43  Aligned_cols=193  Identities=26%  Similarity=0.419  Sum_probs=167.6

Q ss_pred             hhhhhccceeccccceEEEEEEEc----CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCI  112 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l  112 (259)
                      ..+|.+.++||.|++|.||++...    ++.|++|.+...       ....+|+.+++.++|+||+++++.+......++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l  163 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM  163 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence            456999999999999999999753    467999987654       234589999999999999999999998899999


Q ss_pred             EEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc-
Q 045286          113 VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV-  191 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~-  191 (259)
                      +||++ +++|.+++. ....+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||++........ 
T Consensus       164 v~e~~-~~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~  241 (392)
T PHA03207        164 VMPKY-KCDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT  241 (392)
T ss_pred             Eehhc-CCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence            99999 468888883 345689999999999999999999999999999999999999999999999999875543321 


Q ss_pred             --cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 045286          192 --MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSM  238 (259)
Q Consensus       192 --~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  238 (259)
                        .....++..|+|||++.+..++.++|+|||||++|+|++|..||.+.
T Consensus       242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~  290 (392)
T PHA03207        242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK  290 (392)
T ss_pred             ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence              12346899999999999999999999999999999999999999654

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.3e-35  Score=242.10  Aligned_cols=220  Identities=27%  Similarity=0.454  Sum_probs=184.8

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC------
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP------  108 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------  108 (259)
                      ..+|++.+.||.|++|.||+|.+.  ++.|++|.+............+.+|+.+++.++|||++++++++....      
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            467888999999999999999974  788999999876544444466778999999999999999999886544      


Q ss_pred             ----cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccce
Q 045286          109 ----HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR  184 (259)
Q Consensus       109 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~  184 (259)
                          ..++++||+++ ++...+......++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~  164 (302)
T cd07864          86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR  164 (302)
T ss_pred             ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence                78999999965 7777776555568999999999999999999999999999999999999999999999999987


Q ss_pred             eccCCCc--cccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          185 FQNKGGV--MTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       185 ~~~~~~~--~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      .......  ......+..|++||.+.+. .++.++|+||||+++++|++|+.||...+..+.+..+.+.+..+++.
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (302)
T cd07864         165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA  240 (302)
T ss_pred             cccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            6554321  1223456789999988654 57899999999999999999999999888888888888777665544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.4e-35  Score=237.41  Aligned_cols=206  Identities=32%  Similarity=0.482  Sum_probs=174.9

Q ss_pred             chhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      ..++|++.+.||+|++|.||++.+  .++.+++|++......  ....+.+|+.+++.++|+||+++++.+...+..++|
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~--~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv   84 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD--DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC   84 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc--hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence            457899999999999999999996  4788999999765322  235677899999999999999999999989999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-cc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VM  192 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~  192 (259)
                      +||+++++|.+++... ..+++..+..++.|++.++.+||+.|++|+|++|+||+++.++.++|+|||.+....... ..
T Consensus        85 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd06646          85 MEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR  163 (267)
T ss_pred             EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccccc
Confidence            9999999999988654 358899999999999999999999999999999999999999999999999987654322 22


Q ss_pred             ccCCCcccccCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 045286          193 TAETGTYRWMAPEVIN---HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAA  244 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~  244 (259)
                      ....++..|+|||.+.   ...++.++|+||+|+++|+|++|..||...++.+..
T Consensus       164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~  218 (267)
T cd06646         164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL  218 (267)
T ss_pred             CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh
Confidence            3345788999999874   344778999999999999999999999765554443

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.3e-35  Score=239.81  Aligned_cols=208  Identities=26%  Similarity=0.443  Sum_probs=175.1

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ++|++.+.||+|++|.||++.+.  ++.+++|.+.... .......+.+|+.++++++|+||+++++.+...+..++++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence            36889999999999999999985  8899999987643 33344678899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcc
Q 045286          116 YMPGGSLYDYLHKN--HNVLKLPQLLRFAIDICKGMEYLHQ-RNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM  192 (259)
Q Consensus       116 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~  192 (259)
                      |+++++|..++...  ...+++..+..++.|++.++.+||+ .+++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~  158 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-LA  158 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-cc
Confidence            99999999988654  2358899999999999999999997 59999999999999999999999999998655332 22


Q ss_pred             ccCCCcccccCccccCCC------CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 045286          193 TAETGTYRWMAPEVINHQ------PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGV  247 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~~------~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i  247 (259)
                      ....++..|++||.+.+.      .++.++|+||||+++|+|++|..||...+.......+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~  219 (286)
T cd06622         159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL  219 (286)
T ss_pred             ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH
Confidence            334577889999998554      3478999999999999999999999776554444433

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-34  Score=233.43  Aligned_cols=206  Identities=38%  Similarity=0.680  Sum_probs=176.7

Q ss_pred             ceeccccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCCCCCh
Q 045286           44 ERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSL  122 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L  122 (259)
                      ++||.|++|.||++.+. ++.|++|.+...... .....+.+|+++++.++|++|+++++.+......++++|++++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            47999999999999976 789999998876543 3456788999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcc---ccCCCcc
Q 045286          123 YDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM---TAETGTY  199 (259)
Q Consensus       123 ~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~---~~~~~~~  199 (259)
                      .+++......++...+..++.+++.+|.+||+++++|+||+|+||+++.++.++|+|||.+.........   .....+.
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~  159 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI  159 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCccee
Confidence            9999766656888999999999999999999999999999999999999999999999998755432211   1122356


Q ss_pred             cccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhc
Q 045286          200 RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       200 ~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~  250 (259)
                      .|+|||.+.+..++.++|+||||+++|+|++ |..||...+.......+...
T Consensus       160 ~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~  211 (251)
T cd05041         160 KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG  211 (251)
T ss_pred             ccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC
Confidence            7999999988889999999999999999998 89999888776666666544

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=9e-35  Score=235.45  Aligned_cols=202  Identities=28%  Similarity=0.457  Sum_probs=176.3

Q ss_pred             eccccceEEEEEEEc--CceEEEEEeecccCc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCCCCCh
Q 045286           46 IASGSCGDLYRGVYL--GQDVAVKVLRSEHLN-DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSL  122 (259)
Q Consensus        46 lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L  122 (259)
                      ||.|++|.||++.+.  ++.+++|++...... ......+.+|+.+++.++|+||+++++.+..+...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999987  889999999865432 34457788999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccccCCCccccc
Q 045286          123 YDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWM  202 (259)
Q Consensus       123 ~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~~~~~~~~~  202 (259)
                      .+++.... .++...+..++.|++.+|.++|+.+++|+||+|+||+++.++.++|+|||.+.............++..|+
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  159 (262)
T cd05572          81 WTILRDRG-LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYV  159 (262)
T ss_pred             HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCcc
Confidence            99996543 48889999999999999999999999999999999999999999999999987665543333446788999


Q ss_pred             CccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHhh
Q 045286          203 APEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT--PLQAALGVR  248 (259)
Q Consensus       203 ~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~--~~~~~~~i~  248 (259)
                      +||.+.+..++.++|+||+|+++|+|++|..||....  ..+....+.
T Consensus       160 ~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  207 (262)
T cd05572         160 APEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL  207 (262)
T ss_pred             ChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHh
Confidence            9999988889999999999999999999999998766  555555544

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=8e-35  Score=236.39  Aligned_cols=206  Identities=31%  Similarity=0.492  Sum_probs=175.2

Q ss_pred             chhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      +..+|.+.++||+|++|.||+|.+  .++.+++|+++....  .....+.+|+.+++.++||||+++++.+...+..+++
T Consensus         7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv   84 (267)
T cd06645           7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC   84 (267)
T ss_pred             cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence            356899999999999999999987  478999999876532  2235577899999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-Ccc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVM  192 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~  192 (259)
                      +||+++++|.+++.... .+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus        85 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd06645          85 MEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR  163 (267)
T ss_pred             EeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccc
Confidence            99999999999985543 5889999999999999999999999999999999999999999999999998755432 122


Q ss_pred             ccCCCcccccCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 045286          193 TAETGTYRWMAPEVIN---HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAA  244 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~  244 (259)
                      ....++..|+|||.+.   ...++.++|+||||+++|+|++|..||........+
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~  218 (267)
T cd06645         164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL  218 (267)
T ss_pred             ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH
Confidence            3446788999999974   445788999999999999999999998765544433

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-35  Score=239.49  Aligned_cols=216  Identities=23%  Similarity=0.412  Sum_probs=187.0

Q ss_pred             hhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecC
Q 045286           40 LKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYM  117 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~  117 (259)
                      |...+.||+|++|.||++.+.  ++.+++|.+............+.+|+.++++++|++|+++++.+..++..++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            456789999999999999874  788999999877655555678889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-ccccCC
Q 045286          118 PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMTAET  196 (259)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~~~~  196 (259)
                      ++ +|.+++......+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~  159 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV  159 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCcc
Confidence            65 8888887655678999999999999999999999999999999999999999999999999987766543 223345


Q ss_pred             CcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          197 GTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       197 ~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      ++..|.|||.+.+. .++.++|+||||+++|+|++|..||+..+..+....+.+....+.+
T Consensus       160 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~  220 (283)
T cd05118         160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDP  220 (283)
T ss_pred             CcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCch
Confidence            77889999998776 7899999999999999999999999998888877777666555444

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=5.4e-35  Score=241.18  Aligned_cols=203  Identities=29%  Similarity=0.557  Sum_probs=176.8

Q ss_pred             hhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      ..+|.+.+.||+|++|.||++.+  .++.|++|.+......  ....+.+|+.+++.++|+||+++++.+..++..++|+
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   95 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   95 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence            47889999999999999999986  4789999999765433  2366788999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc-cc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV-MT  193 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~-~~  193 (259)
                      ||+++++|.+++...  .++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus        96 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  173 (297)
T cd06656          96 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  173 (297)
T ss_pred             cccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcC
Confidence            999999999998653  378889999999999999999999999999999999999999999999999876543322 22


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQA  243 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~  243 (259)
                      ...+++.|++||.+.+..++.++|+||||+++|++++|..||...+..+.
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~  223 (297)
T cd06656         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA  223 (297)
T ss_pred             cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh
Confidence            34578899999999998899999999999999999999999977655443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-35  Score=239.04  Aligned_cols=216  Identities=27%  Similarity=0.445  Sum_probs=184.3

Q ss_pred             hhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC--CcEEEEEe
Q 045286           40 LKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS--PHLCIVTE  115 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e  115 (259)
                      |.+.++||.|++|.||++.+.  ++.+++|.+............+.+|+.+++.++|+|++++++.+...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            467789999999999999975  58999999998754444556788999999999999999999999877  78999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC--ccc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG--VMT  193 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~--~~~  193 (259)
                      |+++ +|.+++......+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......  ...
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT  159 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence            9964 8988886655568999999999999999999999999999999999999999999999999987665543  223


Q ss_pred             cCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          194 AETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      ...++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+....+..+.+.+..+.+
T Consensus       160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~  223 (287)
T cd07840         160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTD  223 (287)
T ss_pred             ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Confidence            3456788999998765 45789999999999999999999999988888877777766554433

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=9.7e-35  Score=234.57  Aligned_cols=204  Identities=32%  Similarity=0.601  Sum_probs=176.1

Q ss_pred             ceeccccceEEEEEEEcC-----ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCC
Q 045286           44 ERIASGSCGDLYRGVYLG-----QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMP  118 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~~-----~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~  118 (259)
                      ++||+|++|.||++.+..     ..+++|.+...... .....+.+|+.++++++|+||+++++.+.. ...++++|+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence            478999999999998642     26899999887554 556788999999999999999999999887 88999999999


Q ss_pred             CCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc----cc
Q 045286          119 GGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV----MT  193 (259)
Q Consensus       119 ~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~----~~  193 (259)
                      +++|.+++.... ..++...++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+........    ..
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  158 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE  158 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence            999999997655 4688999999999999999999999999999999999999999999999999876544211    11


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~  249 (259)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+..
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~  215 (257)
T cd05040         159 HLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK  215 (257)
T ss_pred             CCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence            2345678999999998889999999999999999998 9999988888777766653

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.2e-34  Score=231.59  Aligned_cols=209  Identities=35%  Similarity=0.642  Sum_probs=177.3

Q ss_pred             ceeccccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCCCCCh
Q 045286           44 ERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSL  122 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L  122 (259)
                      ++||+|++|.||++... +..+++|.+..... ......+.+|+.+++.++|+||+++++.+...+..+++|||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            47999999999999864 67899999876542 33445688999999999999999999999988999999999999999


Q ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccc--cCCCccc
Q 045286          123 YDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT--AETGTYR  200 (259)
Q Consensus       123 ~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~--~~~~~~~  200 (259)
                      .+++......+++..+..++.|++.+|.++|+.|++|+||+|+||+++.++.++|+|||.+..........  .......
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~  159 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK  159 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence            99987665668899999999999999999999999999999999999999999999999986543322111  1233567


Q ss_pred             ccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCC
Q 045286          201 WMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       201 ~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      |+|||.+.+..++.++|+||||+++|++++ |..||...+.......+..+...
T Consensus       160 y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~  213 (250)
T cd05085         160 WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM  213 (250)
T ss_pred             ccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            999999988889999999999999999998 99999988887777777665543

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-35  Score=239.85  Aligned_cols=213  Identities=32%  Similarity=0.587  Sum_probs=177.3

Q ss_pred             echhhhhccceeccccceEEEEEEEcC----------------ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcc
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYLG----------------QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVV   98 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~~----------------~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~   98 (259)
                      ++.++|++.+.||+|++|.||++...+                ..|++|.+.... .......+.+|++++++++|+|++
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcC
Confidence            567899999999999999999987532                248999987653 344456788999999999999999


Q ss_pred             eeeeeeecCCcEEEEEecCCCCChHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 045286           99 RFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH-----------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANL  167 (259)
Q Consensus        99 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Ni  167 (259)
                      ++++.+...+..+++|||+++++|.+++....           ..++...+..++.|++.++.+||+.|++|+||+|+||
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            99999998899999999999999999985432           1257788899999999999999999999999999999


Q ss_pred             EEccCCeEEEeeeccceeccCCCcc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCHHH
Q 045286          168 LMDTHNVVKVADFGVARFQNKGGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT--AKVPYDSMTPLQ  242 (259)
Q Consensus       168 lv~~~~~i~l~D~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~--g~~p~~~~~~~~  242 (259)
                      +++.++.++|+|||.+.........   ....++..|+|||.+.+..++.++|+||||+++|+|++  +..||...+..+
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            9999999999999998654332211   12234568999999988889999999999999999988  778998877766


Q ss_pred             HHHHhh
Q 045286          243 AALGVR  248 (259)
Q Consensus       243 ~~~~i~  248 (259)
                      .+..+.
T Consensus       241 ~~~~~~  246 (295)
T cd05097         241 VIENTG  246 (295)
T ss_pred             HHHHHH
Confidence            655543

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.6e-34  Score=233.01  Aligned_cols=213  Identities=38%  Similarity=0.688  Sum_probs=183.2

Q ss_pred             hccceeccccceEEEEEEEcC------ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           41 KTGERIASGSCGDLYRGVYLG------QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        41 ~~~~~lg~G~~~~V~~~~~~~------~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      ++.+.||.|++|.||++.+..      ..+++|.+..... ......+.+|+..++.++|+||+++++.+...+..++++
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            567899999999999999864      7899999976533 224577889999999999999999999999889999999


Q ss_pred             ecCCCCChHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccc
Q 045286          115 EYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT  193 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~-~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~  193 (259)
                      |++++++|.+++...... +++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+..........
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  160 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK  160 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence            999999999999765544 8999999999999999999999999999999999999999999999999987665442222


Q ss_pred             --cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCC
Q 045286          194 --AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       194 --~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                        ...+++.|++||.+.+..++.++|+||||+++++|++ |..||...+..+....+.......
T Consensus       161 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~  224 (258)
T smart00219      161 KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLP  224 (258)
T ss_pred             cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC
Confidence              1235678999999988889999999999999999998 899999888888777777665443

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=263.08  Aligned_cols=224  Identities=31%  Similarity=0.526  Sum_probs=202.1

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc-----CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS  107 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~  107 (259)
                      -+|+-..+.+.++||.|.||.|+.+...     ...||+|.++... .+..+..|+.|+.++-+++||||+++.++.+..
T Consensus       624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks  702 (996)
T KOG0196|consen  624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS  702 (996)
T ss_pred             hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence            3567788899999999999999999864     4589999999865 345568899999999999999999999999999


Q ss_pred             CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      ....+|.|||+.++|+.+++++.+.++..++.-+++.|+++..||-+.++|||||...||||+.+..+|++|||+++...
T Consensus       703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  782 (996)
T ss_pred             ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence            99999999999999999999998889999999999999999999999999999999999999999999999999999776


Q ss_pred             CCCcccc----CCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          188 KGGVMTA----ETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       188 ~~~~~~~----~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      .+.....    .-...+|.|||.+.-.+++.++|+||+|++|||.+. |..||=+++..+.++.|+++++-++|.
T Consensus       783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm  857 (996)
T KOG0196|consen  783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM  857 (996)
T ss_pred             cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCC
Confidence            5542211    123589999999999999999999999999999998 999999999999999999999988774

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.3e-34  Score=239.99  Aligned_cols=202  Identities=25%  Similarity=0.427  Sum_probs=174.7

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      +|++.+.||+|++|.||++.+.  +..+++|.+.... .......+.+|++++++++||||+++++.+...+..++++||
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            5788899999999999999874  6788888887542 334456788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccccC
Q 045286          117 MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ-RNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAE  195 (259)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~~  195 (259)
                      +++++|.+++... ..+++..+..++.|++++|.|||+ .+++|+||+|+||+++.++.++|+|||.+...... .....
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~  158 (308)
T cd06615          81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSF  158 (308)
T ss_pred             cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-ccccC
Confidence            9999999999655 458899999999999999999997 58999999999999999999999999988654332 22344


Q ss_pred             CCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 045286          196 TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQA  243 (259)
Q Consensus       196 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~  243 (259)
                      .++..|+|||.+.+..++.++|+||||+++|+|++|..||...+....
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~  206 (308)
T cd06615         159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL  206 (308)
T ss_pred             CCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH
Confidence            678899999999888899999999999999999999999976654433

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.1e-34  Score=233.35  Aligned_cols=199  Identities=30%  Similarity=0.562  Sum_probs=175.3

Q ss_pred             hhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           39 LLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      +|.+.+.||+|++|.||++.+  .++.+++|.+............+.+|+.+++.++|+||+++++.+...+..++++||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            477889999999999999986  478999999987765555678899999999999999999999999888999999999


Q ss_pred             CCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcc----
Q 045286          117 MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM----  192 (259)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~----  192 (259)
                      +++++|.+++... ..+++..+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.........    
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~  159 (264)
T cd06626          81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE  159 (264)
T ss_pred             CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence            9999999998654 34788899999999999999999999999999999999999999999999998765543221    


Q ss_pred             -ccCCCcccccCccccCCCC---CCCchhHHHHHHHHHHHHcCCCCCCCC
Q 045286          193 -TAETGTYRWMAPEVINHQP---YDQKADVFSFAIVLWELVTAKVPYDSM  238 (259)
Q Consensus       193 -~~~~~~~~~~~PE~~~~~~---~~~~~Di~slG~~~~~ll~g~~p~~~~  238 (259)
                       ....++..|+|||.+.+..   ++.++|+||+|++++++++|..||...
T Consensus       160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~  209 (264)
T cd06626         160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL  209 (264)
T ss_pred             ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence             1245678999999998766   789999999999999999999999765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.5e-34  Score=234.57  Aligned_cols=213  Identities=23%  Similarity=0.495  Sum_probs=179.0

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      ++|++.+.||.|++|.||+|...  ++.|++|.++.... .......+.+|+.++++++|++++++++.+...+..++++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            46888899999999999999984  88999999875433 3334577889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-
Q 045286          115 EYMPGGSLYDYLHKN---HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-  190 (259)
Q Consensus       115 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-  190 (259)
                      ||+++++|..++...   ...++...+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~  161 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence            999999999988542   3347889999999999999999999999999999999999999999999999987554332 


Q ss_pred             ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHhhhc
Q 045286          191 VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSM--TPLQAALGVRQV  250 (259)
Q Consensus       191 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~--~~~~~~~~i~~~  250 (259)
                      ......++..|.|||.+.+..++.++|+||||+++|+|++|..||...  +..+....+..+
T Consensus       162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  223 (267)
T cd08224         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC  223 (267)
T ss_pred             ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC
Confidence            122345778899999999888999999999999999999999999543  333444444443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.4e-34  Score=238.30  Aligned_cols=214  Identities=34%  Similarity=0.581  Sum_probs=180.4

Q ss_pred             echhhhhccceeccccceEEEEEEEcC------------------ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCC
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYLG------------------QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRN   96 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~~------------------~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   96 (259)
                      +...+|++.+.||.|+||.||++.+..                  ..+++|.+..... ......+.+|++++++++|+|
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~   80 (296)
T cd05051           2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPN   80 (296)
T ss_pred             CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCC
Confidence            345789999999999999999988642                  4589999886543 344577889999999999999


Q ss_pred             cceeeeeeecCCcEEEEEecCCCCChHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 045286           97 VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH----------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTAN  166 (259)
Q Consensus        97 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~N  166 (259)
                      |+++++++...+..++++|++++++|.+++....          ..++...++.++.|++.+|.+||+.|++|+||+|+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            9999999998899999999999999999986543          257889999999999999999999999999999999


Q ss_pred             EEEccCCeEEEeeeccceeccCCCc---cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCHH
Q 045286          167 LLMDTHNVVKVADFGVARFQNKGGV---MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT--AKVPYDSMTPL  241 (259)
Q Consensus       167 ilv~~~~~i~l~D~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~--g~~p~~~~~~~  241 (259)
                      |+++.++.++|+|||.+........   .....++..|+|||.+.+..++.++|+||||+++|+|++  +..||...+..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999875443321   122334678999999988889999999999999999998  78899887776


Q ss_pred             HHHHHhhh
Q 045286          242 QAALGVRQ  249 (259)
Q Consensus       242 ~~~~~i~~  249 (259)
                      +.+..+..
T Consensus       241 ~~~~~~~~  248 (296)
T cd05051         241 QVIENAGH  248 (296)
T ss_pred             HHHHHHHh
Confidence            66655544

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3e-36  Score=258.26  Aligned_cols=198  Identities=29%  Similarity=0.552  Sum_probs=173.1

Q ss_pred             hhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC------CcE
Q 045286           39 LLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS------PHL  110 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~  110 (259)
                      .+...+.||+|+||.||++..  .|+.||||.++... .....+...+|++++++++|+|||++.++-...      ...
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            344556899999999999986  49999999999864 334457788999999999999999999876433      356


Q ss_pred             EEEEecCCCCChHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc--CC--eEEEeeeccce
Q 045286          111 CIVTEYMPGGSLYDYLHKN--HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT--HN--VVKVADFGVAR  184 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~--~~--~i~l~D~~~~~  184 (259)
                      .++||||.|++|...+++.  ...+++.+.+.++.++..|+.+||++||+||||||.||+.-.  +|  ..||+|||.|+
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar  172 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR  172 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence            8999999999999999643  345999999999999999999999999999999999999943  33  37999999999


Q ss_pred             eccCCCccccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          185 FQNKGGVMTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                      ....++......||..|++||+... ..|+...|+||+||++|++.||..||..
T Consensus       173 el~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  173 ELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             cCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence            9999999999999999999999985 7789999999999999999999999964

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.1e-34  Score=235.31  Aligned_cols=211  Identities=33%  Similarity=0.520  Sum_probs=180.2

Q ss_pred             hhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ++|++.+.||.|++|+||++..  .+..+++|++....... ....+.+|+.+++.++|+|++++++.+......++++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence            3678889999999999999986  46789999987654443 55778899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcc-
Q 045286          116 YMPGGSLYDYLHKNH--NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM-  192 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~-  192 (259)
                      ++++++|.+++....  ..+++..+..++.|++.++.+||+.|++|+|++|+||+++.++.++|+|||.+......... 
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~  159 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT  159 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence            999999999996542  45889999999999999999999999999999999999999999999999998755543222 


Q ss_pred             ----ccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          193 ----TAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       193 ----~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                          ....++..|++||.+... .++.++|+||||+++|+|++|..||...+..+...++.+
T Consensus       160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~  221 (267)
T cd06610         160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ  221 (267)
T ss_pred             ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc
Confidence                233577889999998766 789999999999999999999999988776555544443

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-34  Score=235.47  Aligned_cols=207  Identities=33%  Similarity=0.568  Sum_probs=170.8

Q ss_pred             ceeccccceEEEEEEEcC--c--eEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeeeeeecCCcEEEEEecCC
Q 045286           44 ERIASGSCGDLYRGVYLG--Q--DVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMP  118 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~~--~--~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~  118 (259)
                      +.||.|++|.||++.+.+  .  .+++|..+... .......+.+|+.+++++ +||||+++++.+...+..+++|||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            468999999999998742  2  56888877432 334446788999999999 69999999999999899999999999


Q ss_pred             CCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccc
Q 045286          119 GGSLYDYLHKNH---------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA  183 (259)
Q Consensus       119 ~~~L~~~l~~~~---------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~  183 (259)
                      +++|.+++....               ..++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~  159 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS  159 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence            999999986432               23678899999999999999999999999999999999999999999999987


Q ss_pred             eeccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhcc
Q 045286          184 RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ..............+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+....
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~  228 (270)
T cd05047         160 RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  228 (270)
T ss_pred             cccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC
Confidence            53222111112223567999999988889999999999999999997 999998888777777666544

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.8e-35  Score=238.19  Aligned_cols=200  Identities=36%  Similarity=0.596  Sum_probs=168.5

Q ss_pred             chhhhhccceeccccceEEEEEEE------cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec--C
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK--S  107 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~  107 (259)
                      .+++|+..+.||.|++|+||++..      .+..|++|.+..... ......+.+|+++++.++|+||+++++++..  .
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            356679999999999999988653      367899999986532 2334667899999999999999999998754  3


Q ss_pred             CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      ...+++|||+++++|.+++...  .+++..++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence            4578999999999999998654  38999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCc----cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 045286          188 KGGV----MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSM  238 (259)
Q Consensus       188 ~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  238 (259)
                      ....    .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~  213 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP  213 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence            4321    11223456799999998888999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.1e-34  Score=242.47  Aligned_cols=205  Identities=22%  Similarity=0.356  Sum_probs=171.4

Q ss_pred             ccceeccc--cceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecC
Q 045286           42 TGERIASG--SCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYM  117 (259)
Q Consensus        42 ~~~~lg~G--~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~  117 (259)
                      +.++||.|  ++++||++.+.  ++.||+|.+............+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            56789999  67899999864  789999999877555556677888999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc-----
Q 045286          118 PGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV-----  191 (259)
Q Consensus       118 ~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~-----  191 (259)
                      ++++|.+++... ...+++..+..++.|++.+|.|||+.+++|+||||+||+++.++.++++||+..........     
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~  161 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV  161 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence            999999998653 34588999999999999999999999999999999999999999999999986543221110     


Q ss_pred             ---cccCCCcccccCccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 045286          192 ---MTAETGTYRWMAPEVINH--QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALG  246 (259)
Q Consensus       192 ---~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~  246 (259)
                         .....++..|+|||.+.+  ..++.++|+|||||++|+|++|..||...+..+....
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  221 (327)
T cd08227         162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE  221 (327)
T ss_pred             ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHH
Confidence               112235677999999876  4688999999999999999999999987666554433

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=9.4e-35  Score=237.64  Aligned_cols=192  Identities=32%  Similarity=0.512  Sum_probs=168.7

Q ss_pred             hhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           39 LLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      +|++.++||+|++|.||++.+  .++.+++|.+.... .......+.+|+.++++++||||+++++.+...+..++++||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            577889999999999999986  47889999987653 233446788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccccCC
Q 045286          117 MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET  196 (259)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~~~  196 (259)
                      +++++|..+.     .+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+...... ......
T Consensus        81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~~  154 (279)
T cd06619          81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYV  154 (279)
T ss_pred             CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCCC
Confidence            9999886552     3678888999999999999999999999999999999999999999999998755433 223456


Q ss_pred             CcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          197 GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       197 ~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                      ++..|+|||.+.+..++.++|+||||+++|+|++|..||..
T Consensus       155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~  195 (279)
T cd06619         155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ  195 (279)
T ss_pred             CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence            88899999999998899999999999999999999999964

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-35  Score=248.95  Aligned_cols=192  Identities=28%  Similarity=0.456  Sum_probs=166.1

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      ...|.+.+.||.|++|.||+|.+.  ++.|++|+....        ....|+.++++++|+||+++++++...+..++|+
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            346899999999999999999985  568999975433        2346899999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTA  194 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~  194 (259)
                      |++ .++|.+++......+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+...........
T Consensus       137 e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  215 (357)
T PHA03209        137 PHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG  215 (357)
T ss_pred             Ecc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccccc
Confidence            999 4588888877666799999999999999999999999999999999999999999999999999875444333344


Q ss_pred             CCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCC-CCCC
Q 045286          195 ETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKV-PYDS  237 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~-p~~~  237 (259)
                      ..++..|+|||.+.+..++.++|+|||||++|+|+++.. +|..
T Consensus       216 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~  259 (357)
T PHA03209        216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED  259 (357)
T ss_pred             ccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence            568899999999999999999999999999999998544 4443

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.1e-34  Score=235.56  Aligned_cols=201  Identities=25%  Similarity=0.520  Sum_probs=173.8

Q ss_pred             hhhhccceeccccceEEEEEEE--cCceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      ++|.+.+.||+|++|.||++.+  .++.+++|.+..... .......+.+|+.+++.++|+||+++++.+...+..++++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4678889999999999999986  588999998876433 3344567889999999999999999999999889999999


Q ss_pred             ecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-
Q 045286          115 EYMPGGSLYDYLHK---NHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-  190 (259)
Q Consensus       115 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-  190 (259)
                      |++++++|.+++..   ....+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+....... 
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence            99999999998853   23457889999999999999999999999999999999999999999999999887554332 


Q ss_pred             ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 045286          191 VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSM  238 (259)
Q Consensus       191 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  238 (259)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.
T Consensus       162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  209 (267)
T cd08229         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            223345788999999998888999999999999999999999999654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-36  Score=254.18  Aligned_cols=215  Identities=31%  Similarity=0.452  Sum_probs=193.8

Q ss_pred             hhhhhccceeccccceEEEEEEE--cCceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      ...|...+.||.|+||.||-|.+  +++.||+|...++.- ..+.+..+..|+..|++++|||++.+-+++..+...|+|
T Consensus        25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV  104 (948)
T KOG0577|consen   25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV  104 (948)
T ss_pred             HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence            46788889999999999999987  478999999998754 347889999999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT  193 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~  193 (259)
                      |||| -|+-.+++.-..+++.+.++..++.+.+.+|+|||+.+.+|+|||..|||++..|.+||.|||++....+.+   
T Consensus       105 MEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn---  180 (948)
T KOG0577|consen  105 MEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN---  180 (948)
T ss_pred             HHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCchh---
Confidence            9999 568888887777789999999999999999999999999999999999999999999999999998877764   


Q ss_pred             cCCCcccccCccccCC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCC
Q 045286          194 AETGTYRWMAPEVINH---QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLC  255 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~---~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~  255 (259)
                      ...|||.|+|||++..   ..|+-++||||||++..++...++|+=++++...+-.|.+.-.+..
T Consensus       181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtL  245 (948)
T KOG0577|consen  181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL  245 (948)
T ss_pred             cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCC
Confidence            4579999999999854   4689999999999999999999999999999999988887655543

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.3e-34  Score=235.36  Aligned_cols=218  Identities=27%  Similarity=0.495  Sum_probs=182.5

Q ss_pred             eechhhhhccceeccccceEEEEEEEcC------ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec-
Q 045286           34 EIDRRLLKTGERIASGSCGDLYRGVYLG------QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK-  106 (259)
Q Consensus        34 ~~~~~~~~~~~~lg~G~~~~V~~~~~~~------~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-  106 (259)
                      .+++++|.+.+.||+|++|.||+|.+..      ..|++|.+... ........+.+|+.+++.++|+||+++++++.. 
T Consensus         2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   80 (280)
T cd05043           2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED   80 (280)
T ss_pred             ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            4667899999999999999999999753      77888887643 344455778899999999999999999998655 


Q ss_pred             CCcEEEEEecCCCCChHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEee
Q 045286          107 SPHLCIVTEYMPGGSLYDYLHKNH-------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVAD  179 (259)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D  179 (259)
                      ....++++++.++++|.+++....       ..++...++.++.|++.+|.+||+.+++|+||+|+||+++.++.++++|
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence            567889999999999999986532       3478899999999999999999999999999999999999999999999


Q ss_pred             eccceeccCCCc---cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccC
Q 045286          180 FGVARFQNKGGV---MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       180 ~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      ||.+........   .....++..|+|||.+.+..++.++|+||||+++|++++ |..||...+..+....+..+..
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~  237 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR  237 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCC
Confidence            999875433211   112235667999999998889999999999999999998 9999998887776666665543

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.1e-34  Score=230.24  Aligned_cols=209  Identities=37%  Similarity=0.659  Sum_probs=183.4

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      .|...+.||+|++|.||++.+.  ++.+++|++.....  .....+.+|+.+++.++|++++++++.+......++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~   78 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF   78 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence            3667789999999999999985  78899999987643  3457788999999999999999999999988999999999


Q ss_pred             CCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccccCC
Q 045286          117 MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET  196 (259)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~~~  196 (259)
                      +++++|.+++......++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.............
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  158 (253)
T cd05122          79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV  158 (253)
T ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccccee
Confidence            99999999997765668999999999999999999999999999999999999999999999999987766553234456


Q ss_pred             CcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          197 GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       197 ~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                      ++..|+|||.+.+..++.++|+||||+++++|++|..||...+..+.+..+..
T Consensus       159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  211 (253)
T cd05122         159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT  211 (253)
T ss_pred             cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh
Confidence            78899999999888889999999999999999999999988766555555544

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-34  Score=232.47  Aligned_cols=210  Identities=31%  Similarity=0.524  Sum_probs=176.6

Q ss_pred             hhhhccceeccccceEEEEEEE--cCceEEEEEeecccC---chHHHHHHHHHHHHHHhcCCCCcceeeeeeecC--CcE
Q 045286           38 RLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHL---NDTLEDEFVQEVAILREVQHRNVVRFIGASTKS--PHL  110 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~  110 (259)
                      .+|++.+.||+|++|.||++.+  +++.+++|.+.....   .......+.+|+.++++++|+||+++++.+...  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            3678899999999999999986  478999998864321   233446788999999999999999999988653  468


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-  189 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-  189 (259)
                      ++++|++++++|.+++.... .+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+...... 
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  160 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC  160 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence            89999999999999986543 4788899999999999999999999999999999999999999999999998754321 


Q ss_pred             ---CccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 045286          190 ---GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVR  248 (259)
Q Consensus       190 ---~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~  248 (259)
                         .......++..|+|||.+.+..++.++|+||||+++|++++|..||...+..+...++.
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  222 (264)
T cd06653         161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA  222 (264)
T ss_pred             ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH
Confidence               11123457889999999998889999999999999999999999998877666655544

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=7.6e-35  Score=236.14  Aligned_cols=198  Identities=31%  Similarity=0.506  Sum_probs=175.0

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      +|+..+.||.|++|.||++.+.  ++.+++|.+..... ......+.+|+.++++++|+||+++++.+......++++|+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            5778889999999999999985  78899999887643 34456788999999999999999999999988999999999


Q ss_pred             CCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccccC
Q 045286          117 MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ-RNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAE  195 (259)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~~  195 (259)
                      +++.+|.+++......+++..+..++.|++.++.++|+ .|++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~~  159 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-TF  159 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-cc
Confidence            99999999997665678999999999999999999999 99999999999999999999999999988655433221 25


Q ss_pred             CCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 045286          196 TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSM  238 (259)
Q Consensus       196 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  238 (259)
                      .++..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus       160 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  202 (265)
T cd06605         160 VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE  202 (265)
T ss_pred             cCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            6788999999999989999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.1e-34  Score=237.73  Aligned_cols=212  Identities=25%  Similarity=0.470  Sum_probs=178.1

Q ss_pred             hhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           39 LLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      +|+..+.||.|++|.||+|.+  .++.+++|.+............+.+|++++++++|+||+++++++...+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            367889999999999999987  478999999876654444456788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-cccc
Q 045286          117 MPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMTA  194 (259)
Q Consensus       117 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~~  194 (259)
                      +. ++|.+++... ...++...+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH  159 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence            95 5898888653 3458899999999999999999999999999999999999999999999999986544321 2223


Q ss_pred             CCCcccccCccccCCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          195 ETGTYRWMAPEVINHQP-YDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ..++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+......++.+..
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~  217 (284)
T cd07860         160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL  217 (284)
T ss_pred             ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHh
Confidence            34678899999886644 5889999999999999999999998877766665555433

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.8e-34  Score=237.57  Aligned_cols=213  Identities=26%  Similarity=0.447  Sum_probs=176.0

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ++|.+.+.||.|++|.||++.+.  ++.+++|.+............+.+|++++++++|+||+++++++......++|+|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            36788899999999999999874  6889999987665444445678899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc-CCeEEEeeeccceeccCC-Ccc
Q 045286          116 YMPGGSLYDYLHKNHN-VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT-HNVVKVADFGVARFQNKG-GVM  192 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~-~~~i~l~D~~~~~~~~~~-~~~  192 (259)
                      |++ ++|.+.+..... ..++..+..++.|++.+|.+||+++++|+||+|+||+++. ++.++|+|||.+...... ...
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~  160 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF  160 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence            995 578877754333 3677888899999999999999999999999999999985 567999999998754332 122


Q ss_pred             ccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          193 TAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+..+.+.++.+..
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~  220 (294)
T PLN00009        161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRIL  220 (294)
T ss_pred             ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            33356788999998866 457899999999999999999999999887776666654433

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=9.7e-35  Score=237.22  Aligned_cols=208  Identities=34%  Similarity=0.568  Sum_probs=177.7

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      ...|+..+.||+|++|.||+|.+.  ++.|++|.+..... ......+.+|+.++++++|+||+++++.+...+..++|+
T Consensus         3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06642           3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence            457888899999999999999874  67899999875532 234567889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-ccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMT  193 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~  193 (259)
                      ||+++++|.+++..  ..+++..+..++.|++.++.+||++|++|+||+|+||+++.++.++++|||.+....... ...
T Consensus        82 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06642          82 EYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence            99999999998854  348889999999999999999999999999999999999999999999999987554332 112


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGV  247 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i  247 (259)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~  213 (277)
T cd06642         160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI  213 (277)
T ss_pred             cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh
Confidence            335778899999999888999999999999999999999999876655544443

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.7e-34  Score=238.00  Aligned_cols=212  Identities=30%  Similarity=0.553  Sum_probs=175.8

Q ss_pred             echhhhhccceeccccceEEEEEEEc------------------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCC
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL------------------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRN   96 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~------------------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   96 (259)
                      ++.++|++.++||.|++|.||++.+.                  ...+++|.+.... .......+.+|+.+++.++|+|
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~   80 (296)
T cd05095           2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPN   80 (296)
T ss_pred             CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCC
Confidence            56788999999999999999998542                  2368999987653 3344567889999999999999


Q ss_pred             cceeeeeeecCCcEEEEEecCCCCChHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 045286           97 VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH----------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTAN  166 (259)
Q Consensus        97 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~N  166 (259)
                      |+++++.+...+..++++||+++++|.+++....          ..++...+..++.|++.+|.+||+.|++|+||+|+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            9999999999899999999999999999986543          135667899999999999999999999999999999


Q ss_pred             EEEccCCeEEEeeeccceeccCCCcc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCHH
Q 045286          167 LLMDTHNVVKVADFGVARFQNKGGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT--AKVPYDSMTPL  241 (259)
Q Consensus       167 ilv~~~~~i~l~D~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~--g~~p~~~~~~~  241 (259)
                      |+++.++.++|+|||.+.........   .....+..|++||...+..++.++|+||||+++|+|++  |..||...+..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            99999999999999998754332211   11223567999999888889999999999999999998  78899877766


Q ss_pred             HHHHHh
Q 045286          242 QAALGV  247 (259)
Q Consensus       242 ~~~~~i  247 (259)
                      +.....
T Consensus       241 ~~~~~~  246 (296)
T cd05095         241 QVIENT  246 (296)
T ss_pred             HHHHHH
Confidence            655443

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2e-34  Score=232.31  Aligned_cols=214  Identities=29%  Similarity=0.514  Sum_probs=185.4

Q ss_pred             hhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           39 LLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      +|++.++||.|++|.||++.+  .++.+++|.+............+.+|+.+++.++|+||+++.+.+......++++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            467888999999999999987  467899999987655555567788999999999999999999999988999999999


Q ss_pred             CCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccc
Q 045286          117 MPGGSLYDYLHKN---HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT  193 (259)
Q Consensus       117 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~  193 (259)
                      +++++|.+++...   ...++...++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~  159 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAK  159 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Ccc
Confidence            9999999998652   245788899999999999999999999999999999999999999999999998766554 233


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+.....+
T Consensus       160 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~  219 (256)
T cd08530         160 TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP  219 (256)
T ss_pred             cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC
Confidence            456788999999999988999999999999999999999999988877666666554433

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.1e-34  Score=237.74  Aligned_cols=209  Identities=25%  Similarity=0.406  Sum_probs=177.3

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      +|++.++||+|++|.||++.+.  ++.+++|.+............+.+|+++++.++|+||+++++++...+..++++||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF   81 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence            5778899999999999999984  78999999876554444556788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-ccccC
Q 045286          117 MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMTAE  195 (259)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~~~  195 (259)
                      +++++|..+... ...++...+..++.|++.++.+||+.|++|+|++|+||+++.++.++|+|||.+....... .....
T Consensus        82 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  160 (286)
T cd07846          82 VDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY  160 (286)
T ss_pred             CCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcc
Confidence            998888877643 3348899999999999999999999999999999999999999999999999987654432 22334


Q ss_pred             CCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 045286          196 TGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVR  248 (259)
Q Consensus       196 ~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~  248 (259)
                      .++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+....+.
T Consensus       161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~  214 (286)
T cd07846         161 VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHII  214 (286)
T ss_pred             cceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence            578889999998753 46789999999999999999999998776655554444

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.8e-34  Score=237.56  Aligned_cols=214  Identities=31%  Similarity=0.613  Sum_probs=177.1

Q ss_pred             chhhhhccceeccccceEEEEEEEc--Cc----eEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCc
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL--GQ----DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPH  109 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~--~~----~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~  109 (259)
                      ...+++..+.||+|++|.||++.+.  ++    .+++|.+.... .......+.+|+.+++.++|+||+++++.+... .
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~   82 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T   82 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence            4567888999999999999999863  43    57888887543 233445688999999999999999999988654 5


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG  189 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~  189 (259)
                      .+++++++++++|.+++......++...+..++.|++.+|.+||+++++|+||+|+||+++.++.++|+|||.+......
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~  162 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD  162 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence            67899999999999999776666889999999999999999999999999999999999999999999999999765433


Q ss_pred             Ccc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhcc
Q 045286          190 GVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       190 ~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ...   .....+..|++||.+.+..++.++|+||||+++|+|++ |..||.+....+....+..+.
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~  228 (303)
T cd05110         163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE  228 (303)
T ss_pred             ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC
Confidence            211   12234568999999998899999999999999999997 999998877666555555443

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.8e-34  Score=231.71  Aligned_cols=210  Identities=32%  Similarity=0.485  Sum_probs=181.9

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      +|++.+.||.|++|.||++.+.  ++.+++|.+...... .....+.+|+..+++++|+|++++++.+...+..++++||
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            5677899999999999999875  789999998876543 4457788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccc-c
Q 045286          117 MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ-RNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT-A  194 (259)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~-~  194 (259)
                      +++++|.+++... ..+++..+..++.|++.++.++|+ .+++|+||+|+||+++.++.++|+|||.+.......... .
T Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~  159 (264)
T cd06623          81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT  159 (264)
T ss_pred             cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccc
Confidence            9999999999654 458999999999999999999999 999999999999999999999999999987665443222 3


Q ss_pred             CCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHhhhc
Q 045286          195 ETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSM---TPLQAALGVRQV  250 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~---~~~~~~~~i~~~  250 (259)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++|..||...   +..+....+...
T Consensus       160 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~  218 (264)
T cd06623         160 FVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG  218 (264)
T ss_pred             eeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC
Confidence            45778899999998888999999999999999999999999776   445555554433

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=226.13  Aligned_cols=205  Identities=22%  Similarity=0.348  Sum_probs=174.7

Q ss_pred             ccceechhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC-
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS-  107 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-  107 (259)
                      ...-|.+++|++.+.||.|+|+.||+++.  +++.+|+|.+..+.  .+..+..++|++..++++|||++++++....+ 
T Consensus        14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~   91 (302)
T KOG2345|consen   14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREE   91 (302)
T ss_pred             CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence            44678899999999999999999999984  57899999999875  34557889999999999999999998876433 


Q ss_pred             ----CcEEEEEecCCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEccCCeEEEe
Q 045286          108 ----PHLCIVTEYMPGGSLYDYLHKN---HNVLKLPQLLRFAIDICKGMEYLHQRN--IIHRDLKTANLLMDTHNVVKVA  178 (259)
Q Consensus       108 ----~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~di~p~Nilv~~~~~i~l~  178 (259)
                          ...|++++|...++|.+.++..   +..+++.++..++.+++++|.+||...  +.|+||||.||+.+..+.+++.
T Consensus        92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~  171 (302)
T KOG2345|consen   92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLM  171 (302)
T ss_pred             ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEE
Confidence                3489999999999999998643   336899999999999999999999999  9999999999999999999999


Q ss_pred             eeccceeccCCC----------ccccCCCcccccCccccCC---CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          179 DFGVARFQNKGG----------VMTAETGTYRWMAPEVINH---QPYDQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       179 D~~~~~~~~~~~----------~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                      |||+++...-.-          ......-+..|+|||++.-   ...+.++|||||||++|.|+.|..||+.
T Consensus       172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~  243 (302)
T KOG2345|consen  172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER  243 (302)
T ss_pred             eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence            999987543211          1122346789999999854   4578999999999999999999999973

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.7e-34  Score=236.44  Aligned_cols=211  Identities=25%  Similarity=0.454  Sum_probs=177.7

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      +|+..++||.|++|.||+|.+.  ++.|++|.+...... .....+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence            4778899999999999999974  789999999865432 2235677899999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-ccc
Q 045286          117 MPGGSLYDYLHKNH--NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMT  193 (259)
Q Consensus       117 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~  193 (259)
                      +++ +|.+++....  ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus        80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~  158 (284)
T cd07836          80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS  158 (284)
T ss_pred             CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence            975 8888886543  458899999999999999999999999999999999999999999999999986543321 122


Q ss_pred             cCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          194 AETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ...++..|++||.+.+. .++.++|+||||+++|+|++|..||.+.+..+...++.+..
T Consensus       159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~  217 (284)
T cd07836         159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIM  217 (284)
T ss_pred             cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence            34567889999988654 56889999999999999999999999888877776665543

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.4e-34  Score=238.17  Aligned_cols=211  Identities=30%  Similarity=0.527  Sum_probs=180.1

Q ss_pred             hhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      ++.+.....||+|++|.||++..  .+..|++|.+....  ......+.+|+..++.++|+|++++++.+..++..++++
T Consensus        21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~   98 (292)
T cd06658          21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM   98 (292)
T ss_pred             HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence            46667678899999999999987  47889999986543  234466889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-Cccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVMT  193 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~~  193 (259)
                      ||+++++|.+++...  .+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+...... ....
T Consensus        99 e~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~  176 (292)
T cd06658          99 EFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK  176 (292)
T ss_pred             eCCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCc
Confidence            999999999987543  4888999999999999999999999999999999999999999999999988654322 1122


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ...++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+.+..+....
T Consensus       177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~  234 (292)
T cd06658         177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL  234 (292)
T ss_pred             eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Confidence            3457889999999988889999999999999999999999999887777666665543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-36  Score=256.07  Aligned_cols=241  Identities=27%  Similarity=0.430  Sum_probs=199.1

Q ss_pred             eecccccccchHHHHHhccccccceechhhhhccceeccccceEEEEEEEcC--ceEEEEEeecccCchHHHHHHHHHHH
Q 045286           10 IVHRKYRGHAVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLG--QDVAVKVLRSEHLNDTLEDEFVQEVA   87 (259)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~--~~v~vK~~~~~~~~~~~~~~~~~e~~   87 (259)
                      ++.+.|+-+-.++..+-. .....--+++-|.+...||.|+||.||+|....  -..|-|++...  .....+.++-|+.
T Consensus         5 nfr~ifrl~~~eKkk~~e-hv~rdlnP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIe   81 (1187)
T KOG0579|consen    5 NFRNIFRLNQAEKKKPYE-HVYRDLNPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIE   81 (1187)
T ss_pred             hHHHHHhcchhhhhccHH-HHhccCCHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhh
Confidence            344555555555554421 111112236678889999999999999998653  23455655544  3455678899999


Q ss_pred             HHHhcCCCCcceeeeeeecCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcE
Q 045286           88 ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANL  167 (259)
Q Consensus        88 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Ni  167 (259)
                      +|....||+|+++++.|...+.+|++.|||.||.++..+-..+..+++.++..+++|++.+|.|||+++|+|+|+|..||
T Consensus        82 ILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNi  161 (1187)
T KOG0579|consen   82 ILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNI  161 (1187)
T ss_pred             hhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccce
Confidence            99999999999999999999999999999999999999988888899999999999999999999999999999999999


Q ss_pred             EEccCCeEEEeeeccceeccCC-CccccCCCcccccCcccc-----CCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH
Q 045286          168 LMDTHNVVKVADFGVARFQNKG-GVMTAETGTYRWMAPEVI-----NHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPL  241 (259)
Q Consensus       168 lv~~~~~i~l~D~~~~~~~~~~-~~~~~~~~~~~~~~PE~~-----~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~  241 (259)
                      |++.+|.|+|.|||.+...... .......|+|+|+|||+.     .+.+|+.++||||||+++.+|..+.+|....++.
T Consensus       162 L~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM  241 (1187)
T KOG0579|consen  162 LLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM  241 (1187)
T ss_pred             EEEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH
Confidence            9999999999999998654433 344667899999999986     4568999999999999999999999999999999


Q ss_pred             HHHHHhhhccCC
Q 045286          242 QAALGVRQVCTS  253 (259)
Q Consensus       242 ~~~~~i~~~~~~  253 (259)
                      .++.+|.+.-++
T Consensus       242 RVllKiaKSePP  253 (1187)
T KOG0579|consen  242 RVLLKIAKSEPP  253 (1187)
T ss_pred             HHHHHHhhcCCC
Confidence            998777765444

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5.5e-34  Score=232.83  Aligned_cols=211  Identities=34%  Similarity=0.568  Sum_probs=180.3

Q ss_pred             hhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      ..-|+..+.||.|++|.||++.+  .++.+++|....... ......+.+|+.++++++|+||+++++.+..++..++|+
T Consensus         3 ~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   81 (277)
T cd06641           3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   81 (277)
T ss_pred             HHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence            35678889999999999999986  468999999875533 234467889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-ccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMT  193 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~  193 (259)
                      ||+++++|.+++...  .++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+....... ...
T Consensus        82 e~~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06641          82 EYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EeCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence            999999999988643  48889999999999999999999999999999999999999999999999886554432 122


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      ...++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.......+...
T Consensus       160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  216 (277)
T cd06641         160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN  216 (277)
T ss_pred             cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC
Confidence            345788899999998888899999999999999999999999887776666555444

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.1e-34  Score=235.31  Aligned_cols=195  Identities=30%  Similarity=0.460  Sum_probs=168.2

Q ss_pred             eccccceEEEEEEEc--CceEEEEEeecccCch-HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCCCCCh
Q 045286           46 IASGSCGDLYRGVYL--GQDVAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSL  122 (259)
Q Consensus        46 lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L  122 (259)
                      ||+|++|+||++.+.  ++.+++|++....... .....+.+|+.+++.++||+++++++.+...+..++|+||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999864  7899999987643322 2334567899999999999999999999988999999999999999


Q ss_pred             HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccccCCCcccc
Q 045286          123 YDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRW  201 (259)
Q Consensus       123 ~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~~~~~~~~  201 (259)
                      .+++.... ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.............++..|
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y  160 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY  160 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence            99986544 35889999999999999999999999999999999999999999999999988765543333445577889


Q ss_pred             cCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 045286          202 MAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTP  240 (259)
Q Consensus       202 ~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~  240 (259)
                      +|||.+.+..++.++|+||+|+++|+|++|..||.....
T Consensus       161 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  199 (277)
T cd05577         161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE  199 (277)
T ss_pred             CCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence            999999888899999999999999999999999976543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.8e-34  Score=236.34  Aligned_cols=211  Identities=28%  Similarity=0.399  Sum_probs=178.8

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN-DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      +|++.+.||+|++|.||++...  ++.|++|.+...... ......+.+|+++++.++|+||+++++.+...+..++++|
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            5778899999999999999874  678999998765332 2334677899999999999999999999999899999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-----
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-----  190 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-----  190 (259)
                      +++|++|.+++... ..+++..+..++.|++.++.++|+.+++|+||+|+||+++.++.++|+|||.+.......     
T Consensus        82 ~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (305)
T cd05609          82 YVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY  160 (305)
T ss_pred             cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence            99999999999654 458889999999999999999999999999999999999999999999999875321100     


Q ss_pred             -----------ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          191 -----------VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       191 -----------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                                 ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+....+...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~  231 (305)
T cd05609         161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD  231 (305)
T ss_pred             ccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence                       001124577899999998888999999999999999999999999988877777766654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.1e-34  Score=235.10  Aligned_cols=200  Identities=33%  Similarity=0.613  Sum_probs=170.4

Q ss_pred             echhhhhccceeccccceEEEEEEE------cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC-
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS-  107 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-  107 (259)
                      ++.+.|++.+.||+|++|.||++..      .++.|++|.+.... .......+.+|+.+++.++|+|++++++.+... 
T Consensus         1 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (284)
T cd05079           1 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG   79 (284)
T ss_pred             CchhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence            3567889999999999999999874      36789999987553 233446788999999999999999999988664 


Q ss_pred             -CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          108 -PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       108 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                       ...++++||+++++|.+++......++...+..++.|++.+|.++|++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence             5689999999999999999766556889999999999999999999999999999999999999999999999998755


Q ss_pred             cCCCcc----ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCC
Q 045286          187 NKGGVM----TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY  235 (259)
Q Consensus       187 ~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~  235 (259)
                      ......    ....++..|+|||.+.+..++.++|+||||+++|+|+++..|+
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~  212 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE  212 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence            433211    1234566799999998888999999999999999999976654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=5.4e-34  Score=231.50  Aligned_cols=208  Identities=31%  Similarity=0.528  Sum_probs=174.9

Q ss_pred             hhhccceeccccceEEEEEEE--cCceEEEEEeecccCc---hHHHHHHHHHHHHHHhcCCCCcceeeeeeec--CCcEE
Q 045286           39 LLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLN---DTLEDEFVQEVAILREVQHRNVVRFIGASTK--SPHLC  111 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~  111 (259)
                      +|...+.||+|++|.||++.+  .+..+++|.+......   ......+.+|+.+++.++|+||+++++.+..  ....+
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            577889999999999999986  4789999998765332   2344668889999999999999999998765  35788


Q ss_pred             EEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-
Q 045286          112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-  190 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-  190 (259)
                      +++|++++++|.+++.... .++....+.++.|++.++.+||+.+++|+|++|+||+++.++.++|+|||.+....... 
T Consensus        83 l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM  161 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence            9999999999999986544 47888999999999999999999999999999999999999999999999986543211 


Q ss_pred             ---ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 045286          191 ---VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGV  247 (259)
Q Consensus       191 ---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i  247 (259)
                         ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||......+....+
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~  221 (266)
T cd06651         162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI  221 (266)
T ss_pred             cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHH
Confidence               112234778899999999888999999999999999999999999877665555444

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-34  Score=228.26  Aligned_cols=209  Identities=33%  Similarity=0.577  Sum_probs=183.3

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      +|.+.++||+|++|.||++.+.  ++.+++|.+............+.+|++++++++|++++++++++......++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4678899999999999999874  67899999998766556667899999999999999999999999888999999999


Q ss_pred             CCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc-cccC
Q 045286          117 MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV-MTAE  195 (259)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~-~~~~  195 (259)
                      +++++|.+++... ..+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus        81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  159 (254)
T cd06627          81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV  159 (254)
T ss_pred             CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence            9999999998655 4589999999999999999999999999999999999999999999999999986655432 2334


Q ss_pred             CCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 045286          196 TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVR  248 (259)
Q Consensus       196 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~  248 (259)
                      .++..|.+||...+..++.++|+|++|+++++|++|..||...+......++.
T Consensus       160 ~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~  212 (254)
T cd06627         160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV  212 (254)
T ss_pred             ccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence            57889999999988888999999999999999999999998776655555544

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=5.3e-34  Score=232.09  Aligned_cols=208  Identities=33%  Similarity=0.554  Sum_probs=173.0

Q ss_pred             hhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeeeeeecC------
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGASTKS------  107 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~------  107 (259)
                      ...|++.++||.|++|.||+|.+  .++.+++|.+......   ...+.+|+.+++++ +|+|++++.+.+...      
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc---HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            56788899999999999999987  4788999998765322   25678899999998 599999999988642      


Q ss_pred             CcEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                      ...++++||+.+++|.+++.... ..+++..+..++.|++.++.+||+.+++|+|++|+||+++.++.++|+|||.+...
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  161 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence            46899999999999999987643 45888999999999999999999999999999999999999999999999998755


Q ss_pred             cCC-CccccCCCcccccCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 045286          187 NKG-GVMTAETGTYRWMAPEVIN-----HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGV  247 (259)
Q Consensus       187 ~~~-~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i  247 (259)
                      ... .......++..|+|||.+.     +..++.++|+||+|+++|+|++|..||...........+
T Consensus       162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~  228 (272)
T cd06637         162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI  228 (272)
T ss_pred             ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH
Confidence            432 2223445788999999986     345788999999999999999999999776654444433

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.4e-34  Score=240.22  Aligned_cols=220  Identities=22%  Similarity=0.401  Sum_probs=180.7

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchH------------HHHHHHHHHHHHHhcCCCCcc
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDT------------LEDEFVQEVAILREVQHRNVV   98 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~------------~~~~~~~e~~~l~~l~~~~i~   98 (259)
                      ..+.++...+.+.||.|++|.||++.+.  ++.|++|++........            ....+.+|+.+++.++|+||+
T Consensus         4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   83 (335)
T PTZ00024          4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM   83 (335)
T ss_pred             cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCccee
Confidence            4555666667889999999999999864  78999999876533221            112467899999999999999


Q ss_pred             eeeeeeecCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEe
Q 045286           99 RFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVA  178 (259)
Q Consensus        99 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~  178 (259)
                      ++++++...+..++++|+++ ++|.+++... ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         84 GLVDVYVEGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             eeeEEEecCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEEC
Confidence            99999999999999999996 5899888543 348899999999999999999999999999999999999999999999


Q ss_pred             eeccceeccCC---------------CccccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH
Q 045286          179 DFGVARFQNKG---------------GVMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQ  242 (259)
Q Consensus       179 D~~~~~~~~~~---------------~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~  242 (259)
                      |||.+......               .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99998755411               111223457789999998764 46899999999999999999999999888877


Q ss_pred             HHHHhhhccCCC
Q 045286          243 AALGVRQVCTSL  254 (259)
Q Consensus       243 ~~~~i~~~~~~~  254 (259)
                      .+..+......+
T Consensus       242 ~~~~i~~~~~~~  253 (335)
T PTZ00024        242 QLGRIFELLGTP  253 (335)
T ss_pred             HHHHHHHHhCCC
Confidence            777666544433

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-34  Score=233.00  Aligned_cols=212  Identities=33%  Similarity=0.498  Sum_probs=177.6

Q ss_pred             chhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeeeeeecC-----
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGASTKS-----  107 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-----  107 (259)
                      +.++|++.+.||+|++|.||+|.+.  ++.+++|++.....   ....+.+|+.+++++ +|+||+++++.+...     
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            4578999999999999999999974  67899999876532   236688999999999 699999999998653     


Q ss_pred             -CcEEEEEecCCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccc
Q 045286          108 -PHLCIVTEYMPGGSLYDYLHKN---HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA  183 (259)
Q Consensus       108 -~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~  183 (259)
                       ...++++||+++++|.+++...   ...+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence             3589999999999999988643   356889999999999999999999999999999999999999999999999998


Q ss_pred             eeccCCC-ccccCCCcccccCccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          184 RFQNKGG-VMTAETGTYRWMAPEVINH-----QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       184 ~~~~~~~-~~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      ....... ......++..|+|||.+..     ..++.++|+||||+++|+|++|..||...+....+.++.+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  233 (275)
T cd06608         161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN  233 (275)
T ss_pred             eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc
Confidence            7654332 2233457888999998753     34678899999999999999999999877766666665554

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.5e-34  Score=232.32  Aligned_cols=205  Identities=30%  Similarity=0.494  Sum_probs=165.8

Q ss_pred             ceeccccceEEEEEEEc----CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCCC
Q 045286           44 ERIASGSCGDLYRGVYL----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPG  119 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~  119 (259)
                      +.||.|+||.||+|...    ...+++|.+.... .......+.+|+..++.++|+||+++++.+...+..+++||++++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            46899999999999743    3467888776543 334456788999999999999999999999988999999999999


Q ss_pred             CChHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc---c
Q 045286          120 GSLYDYLHKNHN----VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV---M  192 (259)
Q Consensus       120 ~~L~~~l~~~~~----~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~---~  192 (259)
                      ++|.+++.....    ..+...+..++.|++.++.+||+.+++|+||||+||+++.++.++|+|||.+........   .
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK  159 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence            999999965432    235677888999999999999999999999999999999999999999998864332211   1


Q ss_pred             ccCCCcccccCccccC-------CCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 045286          193 TAETGTYRWMAPEVIN-------HQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~-------~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~  249 (259)
                      ....++..|+|||.+.       ...++.++|+||||+++|+|++ |..||...+..+.+..+..
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~  224 (269)
T cd05042         160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVR  224 (269)
T ss_pred             CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhh
Confidence            1223456799999864       3456789999999999999999 8899988877666655543

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-36  Score=250.24  Aligned_cols=214  Identities=27%  Similarity=0.432  Sum_probs=186.1

Q ss_pred             ccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCCC
Q 045286           42 TGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPG  119 (259)
Q Consensus        42 ~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~  119 (259)
                      ..+.||+|-||+||-++.  +|+.||||++.+..........+.+|+++|+.+.||.|+.+.-.++..+.+++|||.+.|
T Consensus       568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G  647 (888)
T KOG4236|consen  568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG  647 (888)
T ss_pred             hHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence            457999999999998886  599999999999888877778899999999999999999999999999999999999966


Q ss_pred             CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC---CeEEEeeeccceeccCCCccccCC
Q 045286          120 GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH---NVVKVADFGVARFQNKGGVMTAET  196 (259)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~---~~i~l~D~~~~~~~~~~~~~~~~~  196 (259)
                      .-|.-.+....+.+++....-++.||+.+|.|||.++|+|+|+||+|||+...   ..+||||||.+++....+......
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVV  727 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVV  727 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhc
Confidence            44544555555669999888999999999999999999999999999999654   469999999999999988888899


Q ss_pred             CcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc-cCCCCcc
Q 045286          197 GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV-CTSLCQP  257 (259)
Q Consensus       197 ~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~-~~~~~~~  257 (259)
                      |++.|+|||++.++.|....|+||+|+++|--|.|--||+...+  ..++|-.. +.-++.|
T Consensus       728 GTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyPp~P  787 (888)
T KOG4236|consen  728 GTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYPPNP  787 (888)
T ss_pred             CCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccCCCc
Confidence            99999999999999999999999999999999999999986443  55555533 3333333

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.6e-34  Score=234.28  Aligned_cols=209  Identities=34%  Similarity=0.610  Sum_probs=181.8

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      .+.|...+.||+|++|.||++.+.  ++.+++|++.....   ....+.+|+..++.++|+|++++++.+...+..++++
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            456888899999999999999986  78999999987543   3467889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-ccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMT  193 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~  193 (259)
                      ||+++++|.+++......++...+..++.|++.+|.+||+.|++|+|++|+||+++.++.++|+|||.+....... ...
T Consensus        95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  174 (286)
T cd06614          95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN  174 (286)
T ss_pred             eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhc
Confidence            9999999999997765468999999999999999999999999999999999999999999999999876544321 112


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVR  248 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~  248 (259)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.
T Consensus       175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~  229 (286)
T cd06614         175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT  229 (286)
T ss_pred             cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            3346788999999988889999999999999999999999999877766555544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.8e-34  Score=233.14  Aligned_cols=200  Identities=30%  Similarity=0.553  Sum_probs=171.3

Q ss_pred             hhhccceeccccceEEEEEEE--cCceEEEEEeecccCc----hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEE
Q 045286           39 LLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLN----DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCI  112 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l  112 (259)
                      +|+..+.||+|++|.||.+.+  .++.+++|++......    ......+.+|+.++++++|+||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            367778999999999999986  4789999998754322    2245778899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC-eEEEeeeccceeccCCCc
Q 045286          113 VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN-VVKVADFGVARFQNKGGV  191 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~-~i~l~D~~~~~~~~~~~~  191 (259)
                      ++||+++++|.+++... ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++ .++|+|||.+........
T Consensus        81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence            99999999999998654 3588899999999999999999999999999999999998775 699999999876544311


Q ss_pred             -----cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 045286          192 -----MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT  239 (259)
Q Consensus       192 -----~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  239 (259)
                           .....++..|+|||.+.+..++.++|+||+|+++++|++|..||...+
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  212 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK  212 (268)
T ss_pred             cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence                 112346789999999988889999999999999999999999997543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=5.8e-34  Score=233.00  Aligned_cols=210  Identities=22%  Similarity=0.372  Sum_probs=175.7

Q ss_pred             hhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeecC--CcEEEEE
Q 045286           40 LKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKS--PHLCIVT  114 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~lv~  114 (259)
                      |++.++||+|++|.||++.+  .++.+++|.++........ ....+|+.+++++. |+|++++++.+...  +..++|+
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~   79 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF   79 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence            56778999999999999987  4788999998765433222 34457888999886 99999999999877  8899999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTA  194 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~  194 (259)
                      ||++ ++|.+.+......+++..++.++.|++.+|.+||+.|++|+||+|+||+++. +.++|+|||.+...........
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~  157 (282)
T cd07831          80 ELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTE  157 (282)
T ss_pred             ecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcCC
Confidence            9996 5888888665556899999999999999999999999999999999999999 9999999999987655544444


Q ss_pred             CCCcccccCccccC-CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          195 ETGTYRWMAPEVIN-HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       195 ~~~~~~~~~PE~~~-~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      ..++..|+|||.+. +..++.++|+||+||++|+|++|..||...+..+....+.....
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~  216 (282)
T cd07831         158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLG  216 (282)
T ss_pred             CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcC
Confidence            56788999999764 45578899999999999999999999998888777666655443

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-34  Score=234.48  Aligned_cols=209  Identities=26%  Similarity=0.475  Sum_probs=176.5

Q ss_pred             hhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecC
Q 045286           40 LKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYM  117 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~  117 (259)
                      |++.++||.|++|.||++.+  .+..|++|++............+.+|+.+++.++|++++++++.+...+..++++||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            46778999999999999987  4889999999876544444467888999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-ccccC
Q 045286          118 PGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMTAE  195 (259)
Q Consensus       118 ~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~~~  195 (259)
                      + ++|.+++.... ..+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~  159 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE  159 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcc
Confidence            4 68999886554 358999999999999999999999999999999999999999999999999986543321 12233


Q ss_pred             CCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          196 TGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       196 ~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                      .++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+....+..+.+
T Consensus       160 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  214 (283)
T cd07835         160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFR  214 (283)
T ss_pred             ccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            457889999987654 568899999999999999999999998877665555444

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.4e-34  Score=234.19  Aligned_cols=203  Identities=27%  Similarity=0.464  Sum_probs=176.8

Q ss_pred             echhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEE
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCI  112 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l  112 (259)
                      +..++|++.++||+|++|+||++.+.  ++.+++|+..... .......+.+|+++++.++|+||+++++.+...+..++
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence            45688999999999999999999975  7889999887543 33455778899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc
Q 045286          113 VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ-RNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV  191 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~  191 (259)
                      |+||+++++|..++... +.++...+..++.+++.++.+||+ .+++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        81 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-  158 (284)
T cd06620          81 CMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-  158 (284)
T ss_pred             EEecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence            99999999999988654 358899999999999999999997 589999999999999999999999999876543221 


Q ss_pred             cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 045286          192 MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTP  240 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~  240 (259)
                      .....++..|+|||.+.+..++.++|+||+||++|++++|..||...+.
T Consensus       159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~  207 (284)
T cd06620         159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI  207 (284)
T ss_pred             cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence            2234678899999999888899999999999999999999999986554

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=9.6e-34  Score=228.29  Aligned_cols=200  Identities=35%  Similarity=0.572  Sum_probs=179.7

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC--CcEEEEE
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS--PHLCIVT  114 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~  114 (259)
                      +|+..+.||+|++|.||++.+.  ++.+++|++............+.+|+.++++++|++|+++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            3667789999999999999986  88999999988765555668889999999999999999999999887  8899999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc---
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV---  191 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~---  191 (259)
                      |++++++|.+++.... .++...++.++.|++.++.+||+.|++|+|++|+||+++.++.++|+|||.+........   
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence            9999999999997655 689999999999999999999999999999999999999999999999999987766543   


Q ss_pred             cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 045286          192 MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT  239 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  239 (259)
                      .....++..|.|||.+.+...+.++|+||||+++++|++|..||....
T Consensus       160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  207 (260)
T cd06606         160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG  207 (260)
T ss_pred             ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            345568889999999988889999999999999999999999998765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.7e-34  Score=239.35  Aligned_cols=217  Identities=25%  Similarity=0.434  Sum_probs=178.2

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC--------
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS--------  107 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------  107 (259)
                      ++|.+.++||.|++|.||++.+.  ++.+++|.+............+.+|+++++.++|+||+++++.+...        
T Consensus         8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   87 (311)
T cd07866           8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR   87 (311)
T ss_pred             ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence            68889999999999999999974  78899999876544433335567899999999999999999876433        


Q ss_pred             CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      ...++++||++ .++...+......+++..+..++.|++++|.+||+.|++|+|++|+||+++.++.++|+|||.+....
T Consensus        88 ~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  166 (311)
T cd07866          88 GSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD  166 (311)
T ss_pred             ceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence            34699999995 57777776555569999999999999999999999999999999999999999999999999987544


Q ss_pred             CCCcc------------ccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          188 KGGVM------------TAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       188 ~~~~~------------~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      .....            ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......+...+..+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~  246 (311)
T cd07866         167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP  246 (311)
T ss_pred             CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            32211            11235677999998765 457899999999999999999999999988887777766655544


Q ss_pred             C
Q 045286          255 C  255 (259)
Q Consensus       255 ~  255 (259)
                      .
T Consensus       247 ~  247 (311)
T cd07866         247 T  247 (311)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.9e-34  Score=237.99  Aligned_cols=191  Identities=25%  Similarity=0.433  Sum_probs=156.8

Q ss_pred             cceeccccceEEEEEEEc----CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeee--cCCcEEEEEec
Q 045286           43 GERIASGSCGDLYRGVYL----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST--KSPHLCIVTEY  116 (259)
Q Consensus        43 ~~~lg~G~~~~V~~~~~~----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~  116 (259)
                      +.+||.|+||.||+|...    +..+++|.+......    ..+.+|+.+++.++||||+++++++.  .....++++||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            358999999999999863    468999988765322    45678999999999999999999874  34578999999


Q ss_pred             CCCCChHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE----ccCCeEEEeeeccce
Q 045286          117 MPGGSLYDYLHKN--------HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM----DTHNVVKVADFGVAR  184 (259)
Q Consensus       117 ~~~~~L~~~l~~~--------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv----~~~~~i~l~D~~~~~  184 (259)
                      ++ ++|.+++...        ...+++..+..++.|++.+|.+||+.|++|+||||+||++    +.++.++|+|||.+.
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence            85 5787776422        1247788899999999999999999999999999999999    456789999999997


Q ss_pred             eccCCCc----cccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 045286          185 FQNKGGV----MTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSM  238 (259)
Q Consensus       185 ~~~~~~~----~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~  238 (259)
                      .......    .....+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            6544321    2234578899999998764 5789999999999999999999999753

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-34  Score=241.77  Aligned_cols=216  Identities=25%  Similarity=0.389  Sum_probs=185.9

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC-----cEE
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP-----HLC  111 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~  111 (259)
                      +|++.+.||.|++|.||++.+.  ++.+++|.+............+.+|+.+++.++|+||+++.+++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4788899999999999999974  689999999876544455577889999999999999999999887664     789


Q ss_pred             EEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-
Q 045286          112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-  190 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-  190 (259)
                      ++++|++ .+|.+++.... .+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            9999996 58888885443 68999999999999999999999999999999999999999999999999998765543 


Q ss_pred             ---ccccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          191 ---VMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       191 ---~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                         ......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+..+....+......+++
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  228 (330)
T cd07834         159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE  228 (330)
T ss_pred             ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCCh
Confidence               23344578889999999887 7899999999999999999999999999888888877776655443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.5e-34  Score=235.27  Aligned_cols=210  Identities=26%  Similarity=0.409  Sum_probs=173.6

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCCc-----E
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPH-----L  110 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~-----~  110 (259)
                      +|++.+.||+|++|.||++.+.  ++.|++|..............+.+|+.+++.+. |+||+++++.+...+.     .
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            5788899999999999999874  789999998776544444467888999999996 6999999998876555     8


Q ss_pred             EEEEecCCCCChHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc-CCeEEEeeecccee
Q 045286          111 CIVTEYMPGGSLYDYLHKNH----NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT-HNVVKVADFGVARF  185 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~-~~~i~l~D~~~~~~  185 (259)
                      ++++||+++ +|.+++....    ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++. ++.++|+|||.+..
T Consensus        82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~  160 (295)
T cd07837          82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA  160 (295)
T ss_pred             EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence            999999975 8888875432    34789999999999999999999999999999999999998 88999999999875


Q ss_pred             ccCC-CccccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          186 QNKG-GVMTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       186 ~~~~-~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                      .... .......+++.|.|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+....+.+
T Consensus       161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~  226 (295)
T cd07837         161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFK  226 (295)
T ss_pred             cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            4332 12223346788999998765 4578999999999999999999999988777666655544

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=247.53  Aligned_cols=224  Identities=30%  Similarity=0.525  Sum_probs=194.0

Q ss_pred             ceechhhhhccceeccccceEEEEEEEcC-ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEE
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYLG-QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~~-~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~  111 (259)
                      -+++++.+.++++||+|-||.|.+|...+ ..||||+++... .......|.+|+++|.+++||||+.+++++...+.++
T Consensus       533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic  611 (807)
T KOG1094|consen  533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC  611 (807)
T ss_pred             hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence            56788999999999999999999999876 899999999874 4455688999999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          112 IVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      +++||++.|+|.+++.+...+ +.......++.||+++++||.+.++||||+.+.|+|++.++++||+|||.++-.-.+.
T Consensus       612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence            999999999999999876433 3556667799999999999999999999999999999999999999999987544442


Q ss_pred             ccc---cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          191 VMT---AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT--AKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       191 ~~~---~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~--g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      ...   ...-..+|+|+|.+...+++.++|+|++|+++||+++  ...||...++++.++....-.+...+.
T Consensus       692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~  763 (807)
T KOG1094|consen  692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQ  763 (807)
T ss_pred             ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcc
Confidence            221   1234689999999999999999999999999999765  899999999999988776666555443

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.2e-34  Score=236.55  Aligned_cols=209  Identities=32%  Similarity=0.524  Sum_probs=178.1

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      .+.|.....||.|++|.||++.+.  ++.+++|.+.....  .....+.+|+.+++.++|||++++++.+..++..++++
T Consensus        20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~   97 (297)
T cd06659          20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM   97 (297)
T ss_pred             hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence            355666778999999999999874  78999999875432  22356789999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-ccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMT  193 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~  193 (259)
                      ||+++++|..++..  ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus        98 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~  175 (297)
T cd06659          98 EFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK  175 (297)
T ss_pred             ecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence            99999999987754  348899999999999999999999999999999999999999999999999886443321 223


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+.+..+..
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~  231 (297)
T cd06659         176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD  231 (297)
T ss_pred             ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence            34578899999999988899999999999999999999999987777666655543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.2e-35  Score=232.93  Aligned_cols=221  Identities=23%  Similarity=0.354  Sum_probs=186.3

Q ss_pred             hhhhccceeccccceEEEEEEEc------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec-CCcE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK-SPHL  110 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~  110 (259)
                      ..|...+.||.|.+|.||+|...      ...+|+|.++.+..........-||+..+++++|||++.+..++.. ....
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            57888999999999999999642      2378999999886655566778899999999999999999999876 7789


Q ss_pred             EEEEecCCCCChHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC----CeEEEeeecc
Q 045286          111 CIVTEYMPGGSLYDYLHKN----HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH----NVVKVADFGV  182 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~----~~i~l~D~~~  182 (259)
                      ++++||.+ .+|.+.+...    ...++...+..++-||++++.|||++-+.|||+||.||++..+    |++||.|+|+
T Consensus       104 ~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl  182 (438)
T KOG0666|consen  104 WLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL  182 (438)
T ss_pred             EEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence            99999995 5999988532    2358888999999999999999999999999999999999888    8999999999


Q ss_pred             ceeccCCCc----cccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC---------HHHHHHHhh
Q 045286          183 ARFQNKGGV----MTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMT---------PLQAALGVR  248 (259)
Q Consensus       183 ~~~~~~~~~----~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~---------~~~~~~~i~  248 (259)
                      ++...++-.    .....-|..|+|||++.|. .|+++.|+|++||++.||++-.+.|.+..         ..+++.+|.
T Consensus       183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf  262 (438)
T KOG0666|consen  183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF  262 (438)
T ss_pred             HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence            998776522    1234568999999999876 68999999999999999999999886522         256778888


Q ss_pred             hccCCCCccCC
Q 045286          249 QVCTSLCQPIY  259 (259)
Q Consensus       249 ~~~~~~~~~~~  259 (259)
                      +.++.+....|
T Consensus       263 ~vLG~Pt~~~W  273 (438)
T KOG0666|consen  263 EVLGTPTDKDW  273 (438)
T ss_pred             HHcCCCccccc
Confidence            88888776665

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=6e-34  Score=233.09  Aligned_cols=209  Identities=33%  Similarity=0.494  Sum_probs=168.9

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHH-HHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAI-LREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      +|++.+.||+|+||.||++.+.  ++.||+|.+......... ..+..|... ++.++|+||+++++.+...+..++++|
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            5788899999999999999974  789999999876433332 344455554 666689999999999998899999999


Q ss_pred             cCCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc
Q 045286          116 YMPGGSLYDYLHKN---HNVLKLPQLLRFAIDICKGMEYLHQR-NIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV  191 (259)
Q Consensus       116 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~  191 (259)
                      |++ ++|.+++...   ...+++..++.++.|++.++.+||++ +++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA  159 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            995 5888877542   34588999999999999999999997 999999999999999999999999999876544333


Q ss_pred             cccCCCcccccCccccCC----CCCCCchhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHhhh
Q 045286          192 MTAETGTYRWMAPEVINH----QPYDQKADVFSFAIVLWELVTAKVPYDSM-TPLQAALGVRQ  249 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~~----~~~~~~~Di~slG~~~~~ll~g~~p~~~~-~~~~~~~~i~~  249 (259)
                      .....++..|+|||.+.+    ..++.++|+||+|+++|+|++|..||... +..+.+..+..
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  222 (283)
T cd06617         160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE  222 (283)
T ss_pred             cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh
Confidence            333457888999999865    45688999999999999999999999753 33344444443

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.3e-33  Score=231.60  Aligned_cols=209  Identities=31%  Similarity=0.517  Sum_probs=179.2

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ..|...++||.|++|.||++.+.  ++.+++|.+....  ......+.+|+.+++.++|+|++++++.+...+..++++|
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            45666789999999999999864  6889999886542  2334668899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-cccc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMTA  194 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~~  194 (259)
                      ++++++|.+++..  ..++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus        97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~  174 (285)
T cd06648          97 FLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS  174 (285)
T ss_pred             ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccc
Confidence            9999999999866  358889999999999999999999999999999999999999999999999876443321 2223


Q ss_pred             CCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          195 ETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      ..++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+....+...
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~  230 (285)
T cd06648         175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN  230 (285)
T ss_pred             ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc
Confidence            45788999999998888999999999999999999999999887777666666654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.2e-33  Score=228.79  Aligned_cols=207  Identities=30%  Similarity=0.531  Sum_probs=169.1

Q ss_pred             ceeccccceEEEEEEEc-----CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeee-cCCcEEEEEecC
Q 045286           44 ERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST-KSPHLCIVTEYM  117 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~~  117 (259)
                      +.||+|++|.||+|.+.     ...+++|.+.... .......+.+|+.+++.++||||+++++.+. .++..++++||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            46899999999999863     3468999876432 2334567888999999999999999999764 455688999999


Q ss_pred             CCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc-----c
Q 045286          118 PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV-----M  192 (259)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~-----~  192 (259)
                      .+++|.+++.......+...+..++.|++++|.+||+.+++|+||+|+||+++.++.++|+|||.+........     .
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  159 (262)
T cd05058          80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH  159 (262)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence            99999999976655577788889999999999999999999999999999999999999999999865433211     1


Q ss_pred             ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhcc
Q 045286          193 TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+..+.
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~  219 (262)
T cd05058         160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR  219 (262)
T ss_pred             ccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence            12234668999999988889999999999999999999 577788777766666665443

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=8e-34  Score=233.44  Aligned_cols=201  Identities=25%  Similarity=0.437  Sum_probs=168.7

Q ss_pred             hhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ..|++.+.||+|++|.||+|.+  .++.+++|.+...... .....+.+|+.+++.++|+||+++++++...+..++|+|
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            5788889999999999999986  4789999998765322 223456789999999999999999999998889999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-cccc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMTA  194 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~~  194 (259)
                      |+. +++.+++......++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  162 (291)
T cd07870          84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS  162 (291)
T ss_pred             ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCC
Confidence            995 67877776555557888889999999999999999999999999999999999999999999886543321 2223


Q ss_pred             CCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 045286          195 ETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTP  240 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~  240 (259)
                      ..++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+.
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~  209 (291)
T cd07870         163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD  209 (291)
T ss_pred             ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence            3468889999998754 578899999999999999999999976543

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=6e-34  Score=229.79  Aligned_cols=214  Identities=28%  Similarity=0.506  Sum_probs=181.8

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      +|.+.+.||.|++|.||++.+.  +..+++|.+............+.+|+.+++.++|+|++++++.+...+..++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4678889999999999999974  68899999987644444456778999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC-eEEEeeeccceeccCCCcc-c
Q 045286          117 MPGGSLYDYLHKNHN-VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN-VVKVADFGVARFQNKGGVM-T  193 (259)
Q Consensus       117 ~~~~~L~~~l~~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~-~i~l~D~~~~~~~~~~~~~-~  193 (259)
                      +++++|.+++..... .+++..+..++.|++.++.+||+.+++|+|++|+||+++.++ .++++|||.+......... .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~  160 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY  160 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence            999999999865433 478899999999999999999999999999999999998875 4699999998765543222 2


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      ...++..|.|||.+.+..++.++|+||||+++++|++|..||...+..+....+.....
T Consensus       161 ~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  219 (257)
T cd08225         161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF  219 (257)
T ss_pred             ccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC
Confidence            33578889999999888899999999999999999999999988777666666555443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.5e-34  Score=233.54  Aligned_cols=199  Identities=36%  Similarity=0.602  Sum_probs=167.7

Q ss_pred             chhhhhccceeccccceEEEEEEE------cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec--C
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK--S  107 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~  107 (259)
                      ....+++.+.||+|++|.||++..      .++.|++|.+...  .......+.+|+++++.++|+||+++.+.+..  .
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (284)
T cd05081           2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   79 (284)
T ss_pred             ccccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence            356788899999999999999874      3678999998765  33445678899999999999999999987643  3


Q ss_pred             CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      ...++++||+++++|.+++......++...+..++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            56899999999999999997665568899999999999999999999999999999999999999999999999987654


Q ss_pred             CCCcc----ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 045286          188 KGGVM----TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYD  236 (259)
Q Consensus       188 ~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~  236 (259)
                      .....    ........|+|||.+.+..++.++|+||||+++|+|++|..|+.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~  212 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC  212 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence            33211    11123456999999988889999999999999999999877654

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-34  Score=232.55  Aligned_cols=211  Identities=27%  Similarity=0.421  Sum_probs=178.5

Q ss_pred             hhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhc---CCCCcceeeeeeecCCc-----
Q 045286           40 LKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV---QHRNVVRFIGASTKSPH-----  109 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~-----  109 (259)
                      |++.+.||+|++|.||++.+.  ++.+++|.+............+.+|+.+++++   +|+|++++++.+...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567789999999999999985  78999999986554444445566777777666   59999999999987766     


Q ss_pred             EEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          110 LCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      .++++|+++ ++|.+++.... ..+++..++.++.|++.+|.+||+.+++|+|++|+||+++.++.++|+|||.+.....
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~  159 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF  159 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence            999999996 48988886543 3588999999999999999999999999999999999999999999999999877655


Q ss_pred             CCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       189 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ........++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..+.+..+.+..
T Consensus       160 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~  222 (287)
T cd07838         160 EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVI  222 (287)
T ss_pred             CcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHc
Confidence            444344457888999999998889999999999999999999999999888877777665543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-34  Score=234.45  Aligned_cols=214  Identities=26%  Similarity=0.447  Sum_probs=183.7

Q ss_pred             hhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecC
Q 045286           40 LKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYM  117 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~  117 (259)
                      |+..++||+|++|.||++...  ++.+++|++............+.+|+.+++.++|++++++++.+...+..++++|++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456788999999999999975  789999999876544445567788999999999999999999998889999999999


Q ss_pred             CCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-ccccCC
Q 045286          118 PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMTAET  196 (259)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~~~~  196 (259)
                      + ++|.+++......+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~  159 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV  159 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccc
Confidence            6 59999997764568999999999999999999999999999999999999999999999999987654432 223344


Q ss_pred             CcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          197 GTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       197 ~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      .+..|+|||.+.+. .++.++|+||||+++++|++|..||...+..+.+..+.+.++.+
T Consensus       160 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (282)
T cd07829         160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTP  218 (282)
T ss_pred             cCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCC
Confidence            56789999998766 78999999999999999999999999988877777776655443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-34  Score=249.30  Aligned_cols=190  Identities=27%  Similarity=0.397  Sum_probs=164.9

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      ...|.+.+.||.|++|.||++.+.  ++.|++|....        ..+.+|++++++++|+||+++++++..++..++++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~  239 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL  239 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            346888999999999999999985  67899996432        23568999999999999999999999889999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc---
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV---  191 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~---  191 (259)
                      +++ .++|..++......++...++.++.|++.+|.|||+.|++|+||||+||+++.++.++|+|||++........   
T Consensus       240 e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~  318 (461)
T PHA03211        240 PKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF  318 (461)
T ss_pred             Ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence            999 4688888876666799999999999999999999999999999999999999999999999999876543211   


Q ss_pred             cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCC
Q 045286          192 MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY  235 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~  235 (259)
                      .....++..|++||.+.+..++.++|+|||||++|+|++|..|+
T Consensus       319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            12345899999999999999999999999999999999977653

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.4e-34  Score=229.85  Aligned_cols=192  Identities=24%  Similarity=0.477  Sum_probs=162.8

Q ss_pred             ceeccccceEEEEEEEcCc------------eEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEE
Q 045286           44 ERIASGSCGDLYRGVYLGQ------------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~~~------------~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~  111 (259)
                      +.||+|++|.||++.+...            .+++|.+......   ...+.+|+.+++.++|+||+++++.+.. +..+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence            4789999999999998533            3777877654322   4778899999999999999999998877 7789


Q ss_pred             EEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC-------eEEEeeeccce
Q 045286          112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN-------VVKVADFGVAR  184 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~-------~i~l~D~~~~~  184 (259)
                      +++||+++++|.+++......++...+..++.|++.+|.+||+.|++|+||+|+||+++.++       .++|+|||.+.
T Consensus        77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            99999999999999977665688999999999999999999999999999999999998887       79999999987


Q ss_pred             eccCCCccccCCCcccccCccccCCC--CCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 045286          185 FQNKGGVMTAETGTYRWMAPEVINHQ--PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQ  242 (259)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~  242 (259)
                      .....   ....+...|+|||.+.+.  .++.++|+||||+++|+|++ |..||...+..+
T Consensus       157 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~  214 (259)
T cd05037         157 TVLSR---EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE  214 (259)
T ss_pred             ccccc---cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh
Confidence            65442   233456779999999876  78999999999999999999 688887665433

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.3e-34  Score=232.90  Aligned_cols=202  Identities=35%  Similarity=0.638  Sum_probs=174.2

Q ss_pred             chhhhhccceeccccceEEEEEEEc------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec--C
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK--S  107 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~  107 (259)
                      ..+.|++.+.||+|++|.||++...      ++.+++|.+...... .....+.+|+.+++.++|+||+++++++..  .
T Consensus         2 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~   80 (284)
T cd05038           2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG   80 (284)
T ss_pred             chhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence            4578888999999999999999853      578999999876543 345778999999999999999999998876  5


Q ss_pred             CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      ...++++||+++++|.+++......++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            57899999999999999997766668999999999999999999999999999999999999999999999999987665


Q ss_pred             CCCcc----ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 045286          188 KGGVM----TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSM  238 (259)
Q Consensus       188 ~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  238 (259)
                      .....    ........|++||.+.+..++.++|+||||+++++|++|..|+...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~  215 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP  215 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence            32211    1223455699999998888999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.5e-34  Score=240.35  Aligned_cols=210  Identities=24%  Similarity=0.367  Sum_probs=174.5

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC-----CcE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS-----PHL  110 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~  110 (259)
                      ++|.+.++||.|++|.||++.+.  ++.|++|.+............+.+|+.+++.++|+||+++++++...     ...
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            47888999999999999999874  78999999886544444446677899999999999999999987543     347


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-  189 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-  189 (259)
                      ++++||+. ++|.+++... ..+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+...... 
T Consensus        85 ~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  162 (337)
T cd07858          85 YIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG  162 (337)
T ss_pred             EEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence            99999994 6888888544 45899999999999999999999999999999999999999999999999998765443 


Q ss_pred             CccccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          190 GVMTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       190 ~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                      .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......+.+
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  223 (337)
T cd07858         163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITE  223 (337)
T ss_pred             ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Confidence            22234457888999998764 4688999999999999999999999988766555444443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-36  Score=248.27  Aligned_cols=223  Identities=25%  Similarity=0.372  Sum_probs=201.6

Q ss_pred             ceechhhhhccceeccccceEEEEEEEcCce--EEEEEeecccCch-HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCc
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVRFIGASTKSPH  109 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~--v~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~  109 (259)
                      ..+.-.++.....||-|+||.|-++...++.  +|+|+++..+.-+ ...+.+..|-+++....+|.|++++..|.++..
T Consensus       415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky  494 (732)
T KOG0614|consen  415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY  494 (732)
T ss_pred             cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence            3445577888899999999999999987766  8999998876644 455778899999999999999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG  189 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~  189 (259)
                      .|++||-|-|+.|+..++..+ .+++..+.-++..+++++.|||+.||++||+||+|.+++.+|-+||.|||.+.....+
T Consensus       495 vYmLmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             hhhhHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            999999999999999997655 4888888889999999999999999999999999999999999999999999999998


Q ss_pred             CccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          190 GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       190 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      ...-..|||+.|.|||.+.++..+.++|.||||+++|++|+|.+||.+.++....-.|.+|....--
T Consensus       574 ~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~  640 (732)
T KOG0614|consen  574 RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEF  640 (732)
T ss_pred             CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhc
Confidence            8888889999999999999999999999999999999999999999999998888888777654433

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.3e-33  Score=232.46  Aligned_cols=207  Identities=30%  Similarity=0.474  Sum_probs=176.1

Q ss_pred             hhhhhccceeccccceEEEEEEE--cCceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      .++|+..+.||+|++|.||++..  .++.|++|.+..... .......+.+|+.+++.++|+||+++.+.+...+..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            45789999999999999999986  478999999875433 334446788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT  193 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~  193 (259)
                      +||++ +++.+.+......+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+......   .
T Consensus        94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---~  169 (307)
T cd06607          94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---N  169 (307)
T ss_pred             HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---C
Confidence            99996 5777777655556899999999999999999999999999999999999999999999999988655433   2


Q ss_pred             cCCCcccccCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 045286          194 AETGTYRWMAPEVIN---HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGV  247 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i  247 (259)
                      ...++..|+|||.+.   ...++.++|+||||+++|+|++|..||...+.......+
T Consensus       170 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~  226 (307)
T cd06607         170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI  226 (307)
T ss_pred             CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH
Confidence            345778899999874   346788999999999999999999999877765554443

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.2e-33  Score=230.49  Aligned_cols=214  Identities=25%  Similarity=0.476  Sum_probs=179.6

Q ss_pred             echhhhhccceeccccceEEEEEEEc-------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS  107 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~  107 (259)
                      +..++|+....||.|+||.||++...       .+.+++|.+.... .......+.+|++++++++|+||+++++.+...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   80 (275)
T cd05046           2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA   80 (275)
T ss_pred             CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence            34578899999999999999999853       4578999886543 233457788999999999999999999999888


Q ss_pred             CcEEEEEecCCCCChHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEee
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNH--------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVAD  179 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D  179 (259)
                      +..+++||++++++|.+++....        ..++...+..++.|++.+|.+||+.+++|+||+|+||+++.++.++++|
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence            89999999999999999996544        1478999999999999999999999999999999999999999999999


Q ss_pred             eccceeccCCC--ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 045286          180 FGVARFQNKGG--VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       180 ~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~  249 (259)
                      ||.+.......  ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~  233 (275)
T cd05046         161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA  233 (275)
T ss_pred             cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc
Confidence            99876433221  1122334667999999988888999999999999999998 8899987777666666653

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=233.54  Aligned_cols=212  Identities=24%  Similarity=0.413  Sum_probs=184.8

Q ss_pred             echhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEE
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLN-DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~  111 (259)
                      +.-+++...++||+|.||.|-+++-  .++.+|+|+++.+..- ++....-..|-++|+..+||.+..+--.|+..+++|
T Consensus       165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC  244 (516)
T KOG0690|consen  165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC  244 (516)
T ss_pred             eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence            3446788899999999999999985  5899999999987553 344455667899999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecccee-ccCCC
Q 045286          112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF-QNKGG  190 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~-~~~~~  190 (259)
                      +||||..|+.|.-.++. ...++++..+-+...|+++|.|||+++|+++|+|.+|.+++.+|.|||.|||++.. ...+.
T Consensus       245 FVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~  323 (516)
T KOG0690|consen  245 FVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD  323 (516)
T ss_pred             EEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccc
Confidence            99999999999888854 34588888888999999999999999999999999999999999999999999974 34455


Q ss_pred             ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 045286          191 VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGV  247 (259)
Q Consensus       191 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i  247 (259)
                      .....||+|.|+|||++.+..|+.++|.|.+|+++|+|++|.+||-+.+....-..|
T Consensus       324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI  380 (516)
T KOG0690|consen  324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI  380 (516)
T ss_pred             eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH
Confidence            667889999999999999999999999999999999999999999876665444433

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-33  Score=230.14  Aligned_cols=208  Identities=29%  Similarity=0.538  Sum_probs=174.3

Q ss_pred             hhhccceeccccceEEEEEEE--cCceEEEEEeecccCc--------hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           39 LLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLN--------DTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      +|...++||+|++|.||+|..  +++.+++|.+......        ....+.+.+|+.+++.++|+|++++++.+...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            467788999999999999975  4789999988653221        122356788999999999999999999999889


Q ss_pred             cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      ..++|+||+++++|.+++... ..++...+..++.|++.+|.+||+.+++|+||+|+||+++.++.++++|||.+.....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  160 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD  160 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence            999999999999999998665 4588899999999999999999999999999999999999999999999999865443


Q ss_pred             CC---ccccCCCcccccCccccCCCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 045286          189 GG---VMTAETGTYRWMAPEVINHQP--YDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGV  247 (259)
Q Consensus       189 ~~---~~~~~~~~~~~~~PE~~~~~~--~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i  247 (259)
                      ..   ......++..|++||.+.+..  ++.++|+||||+++|++++|..||...+..+.+..+
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~  224 (272)
T cd06629         161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKL  224 (272)
T ss_pred             cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHh
Confidence            21   112335778899999987654  788999999999999999999999876665555443

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=6.6e-34  Score=234.24  Aligned_cols=206  Identities=30%  Similarity=0.549  Sum_probs=176.4

Q ss_pred             hhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      ..+|.+.+.||+|++|.||++.+  .+..+++|.+.....  .....+.+|+.+++.++|||++++++.+...+..++|+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   95 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM   95 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence            46888999999999999999986  468899999865432  23466889999999999999999999999889999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-ccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMT  193 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~  193 (259)
                      ||+++++|.+++.+.  .++...+..++.|++.++.+||+.|++|+|++|+||+++.++.++|+|||.+....... ...
T Consensus        96 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~  173 (293)
T cd06647          96 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  173 (293)
T ss_pred             ecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccc
Confidence            999999999998653  37888999999999999999999999999999999999999999999999876544332 222


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALG  246 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~  246 (259)
                      ...+++.|++||.+.+..++.++|+||||+++|++++|..||...+..+.+..
T Consensus       174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~  226 (293)
T cd06647         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL  226 (293)
T ss_pred             cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee
Confidence            34577889999999888889999999999999999999999987665544433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.8e-33  Score=228.85  Aligned_cols=200  Identities=28%  Similarity=0.462  Sum_probs=163.6

Q ss_pred             ceeccccceEEEEEEEc----CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCCC
Q 045286           44 ERIASGSCGDLYRGVYL----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPG  119 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~  119 (259)
                      +.||+|+||.||+|.+.    +..+++|.+...... .....+.+|+.++++++|+||+++++.+......++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV-QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            46899999999999864    346899988765432 3335688899999999999999999999888889999999999


Q ss_pred             CChHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcc---
Q 045286          120 GSLYDYLHKNH----NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM---  192 (259)
Q Consensus       120 ~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~---  192 (259)
                      ++|.+++....    ...+...+..++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||.+.........   
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~  159 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP  159 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence            99999986432    23556677889999999999999999999999999999999999999999998644332211   


Q ss_pred             ccCCCcccccCccccCCC-------CCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 045286          193 TAETGTYRWMAPEVINHQ-------PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAA  244 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~~-------~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~  244 (259)
                      ....++..|+|||.+.+.       .++.++|+||||+++|+|++ |..||...+..+..
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~  219 (269)
T cd05087         160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL  219 (269)
T ss_pred             CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH
Confidence            123456789999998642       35789999999999999996 99999877665543

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-33  Score=229.01  Aligned_cols=194  Identities=24%  Similarity=0.501  Sum_probs=162.1

Q ss_pred             ceeccccceEEEEEEEc--------------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCc
Q 045286           44 ERIASGSCGDLYRGVYL--------------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPH  109 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~--------------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~  109 (259)
                      +.||.|++|.||+++..              ...+++|++....  ......+.+|+.+++.++||||+++++++.....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            36899999999999843              2258888876543  3344678889999999999999999999988888


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCe-------EEEeeecc
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV-------VKVADFGV  182 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~-------i~l~D~~~  182 (259)
                      .++++||+++++|..++......++...++.++.|++.++.|||+.+++|+||+|+||+++.++.       ++++|||.
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~  158 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI  158 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence            99999999999999998766666899999999999999999999999999999999999987654       89999998


Q ss_pred             ceeccCCCccccCCCcccccCccccC-CCCCCCchhHHHHHHHHHHHH-cCCCCCCCCCHHH
Q 045286          183 ARFQNKGGVMTAETGTYRWMAPEVIN-HQPYDQKADVFSFAIVLWELV-TAKVPYDSMTPLQ  242 (259)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Di~slG~~~~~ll-~g~~p~~~~~~~~  242 (259)
                      +......   ....++..|+|||.+. +..++.++|+||||+++|+|+ .|..||......+
T Consensus       159 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~  217 (262)
T cd05077         159 PITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE  217 (262)
T ss_pred             CccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH
Confidence            8654332   2234677899999886 567899999999999999998 5888987655433

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3e-34  Score=240.49  Aligned_cols=210  Identities=25%  Similarity=0.396  Sum_probs=175.3

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec----CCcEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK----SPHLC  111 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~  111 (259)
                      ++|.+.+.||.|++|.||++.+.  ++.|++|.+............+.+|+.+++.++|+||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            68888899999999999999864  7899999998764444455677889999999999999999987743    34689


Q ss_pred             EEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc
Q 045286          112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV  191 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~  191 (259)
                      +|+||+. ++|.+++... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        85 lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          85 VVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT  162 (334)
T ss_pred             EEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence            9999995 5888888544 3489999999999999999999999999999999999999999999999999875543221


Q ss_pred             -----cccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          192 -----MTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       192 -----~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                           .....++..|.|||.+.+ ..++.++|+||+|+++|+|++|..||...+....+..+..
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~  226 (334)
T cd07855         163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILS  226 (334)
T ss_pred             CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHH
Confidence                 123467888999999865 4578999999999999999999999988776655554444

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=9.6e-34  Score=229.28  Aligned_cols=203  Identities=29%  Similarity=0.453  Sum_probs=176.3

Q ss_pred             eccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCCCCCh
Q 045286           46 IASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSL  122 (259)
Q Consensus        46 lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L  122 (259)
                      ||.|++|.||++.+.  ++.+++|.+..... .......+.+|++++++++|+||+++++.+......++++|++++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999985  88999999876543 224557788999999999999999999999989999999999999999


Q ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC---------ccc
Q 045286          123 YDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG---------VMT  193 (259)
Q Consensus       123 ~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~---------~~~  193 (259)
                      .+++.... .+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+.......         ...
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~  159 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK  159 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence            99986654 58999999999999999999999999999999999999999999999999886543321         122


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                      ...++..|++||...+..++.++|+||||+++|++++|..||...+..+....+..
T Consensus       160 ~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~  215 (265)
T cd05579         160 RIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN  215 (265)
T ss_pred             CcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence            34567889999999888889999999999999999999999998888777766665

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.2e-33  Score=231.78  Aligned_cols=213  Identities=31%  Similarity=0.485  Sum_probs=174.6

Q ss_pred             ceechhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeeeeee----
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGAST----  105 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~----  105 (259)
                      +.-..++|.+.+.||+|++|.||++.+  .++.+++|++.....   ....+.+|+.+++.+ +|+||+++++.+.    
T Consensus        13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   89 (286)
T cd06638          13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV   89 (286)
T ss_pred             CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence            444567899999999999999999987  478899998865422   225577899999999 6999999999873    


Q ss_pred             -cCCcEEEEEecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeec
Q 045286          106 -KSPHLCIVTEYMPGGSLYDYLHK---NHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFG  181 (259)
Q Consensus       106 -~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~  181 (259)
                       .++..+++|||+++++|.+++..   ....+++..++.++.|++.++.+||+.+++|+|++|+||+++.++.++|+|||
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg  169 (286)
T cd06638          90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG  169 (286)
T ss_pred             CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence             34678999999999999998753   23457888999999999999999999999999999999999999999999999


Q ss_pred             cceeccCCC-ccccCCCcccccCccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 045286          182 VARFQNKGG-VMTAETGTYRWMAPEVINH-----QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVR  248 (259)
Q Consensus       182 ~~~~~~~~~-~~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~  248 (259)
                      .+....... ......++..|+|||.+..     ..++.++|+||+|+++|+|++|..||...+....+..+.
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~  242 (286)
T cd06638         170 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP  242 (286)
T ss_pred             ceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc
Confidence            987654322 2223457889999999753     457889999999999999999999998776655554443

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.6e-33  Score=228.94  Aligned_cols=213  Identities=25%  Similarity=0.486  Sum_probs=179.5

Q ss_pred             hhccceeccccceEEEEEEEc---CceEEEEEeecccC--------chHHHHHHHHHHHHHHh-cCCCCcceeeeeeecC
Q 045286           40 LKTGERIASGSCGDLYRGVYL---GQDVAVKVLRSEHL--------NDTLEDEFVQEVAILRE-VQHRNVVRFIGASTKS  107 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~~---~~~v~vK~~~~~~~--------~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~  107 (259)
                      |.+.+.||+|++|.||++.+.   ++.+++|.+.....        .......+.+|+.++.+ ++|+||+++++.+...
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            677889999999999999975   47899998864321        22344567788888875 6899999999999999


Q ss_pred             CcEEEEEecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEccCCeEEEeeeccc
Q 045286          108 PHLCIVTEYMPGGSLYDYLHK---NHNVLKLPQLLRFAIDICKGMEYLHQ-RNIIHRDLKTANLLMDTHNVVKVADFGVA  183 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~di~p~Nilv~~~~~i~l~D~~~~  183 (259)
                      +..++++||+++++|.+++..   ....+++..++.++.|++.++.+||+ .+++|+||+|+||+++.++.++|+|||.+
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~  161 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA  161 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccce
Confidence            999999999999999998743   33458889999999999999999996 68999999999999999999999999999


Q ss_pred             eeccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          184 RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      .............++..|++||.+.+..++.++|+||||+++|+|++|..||...+.......+.....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~  230 (269)
T cd08528         162 KQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVY  230 (269)
T ss_pred             eecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccC
Confidence            876655444455678899999999988899999999999999999999999988777666666655443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-33  Score=229.79  Aligned_cols=206  Identities=33%  Similarity=0.583  Sum_probs=175.1

Q ss_pred             hhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcC---CCCcceeeeeeecCCcEEEE
Q 045286           39 LLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ---HRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv  113 (259)
                      .|+..+.||+|++|.||+|.+  .++.+++|.+..... ......+.+|+.+++.+.   |++++++++.+..++..+++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            467788999999999999997  478999999876532 333466788999999996   99999999999989999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-cc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VM  192 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~  192 (259)
                      +||+++++|.+++...  .+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus        81 ~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          81 MEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             EecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence            9999999999998653  58899999999999999999999999999999999999999999999999987665432 22


Q ss_pred             ccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 045286          193 TAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGV  247 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i  247 (259)
                      ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~  214 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI  214 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc
Confidence            33457888999998864 45789999999999999999999999877665544443

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=237.21  Aligned_cols=207  Identities=31%  Similarity=0.547  Sum_probs=186.1

Q ss_pred             echhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEE
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCI  112 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l  112 (259)
                      .+++-+.+..+||.|++|.||+|..  .|+.+|+|.+..+    ...+++..|+.++++...++++++++.+....-+|+
T Consensus        30 ~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI  105 (502)
T KOG0574|consen   30 PPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI  105 (502)
T ss_pred             ChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence            3467888999999999999999986  4889999998765    335788999999999999999999999888888999


Q ss_pred             EEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-Cc
Q 045286          113 VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GV  191 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~  191 (259)
                      |||||..+++.+.++.+.+++.+.++..+++..+++|.|||...-+|||||..|||++.+|..||.|||.+...... ..
T Consensus       106 VMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK  185 (502)
T KOG0574|consen  106 VMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK  185 (502)
T ss_pred             ehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999998755443 33


Q ss_pred             cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 045286          192 MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL  245 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~  245 (259)
                      .....|++.|+|||++..-.|+.++||||||++..+|..|++||..-.+...+.
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF  239 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF  239 (502)
T ss_pred             hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE
Confidence            456679999999999999999999999999999999999999999877755443

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-35  Score=248.84  Aligned_cols=226  Identities=30%  Similarity=0.530  Sum_probs=196.9

Q ss_pred             cccccceechhhhhccceeccccceEEEEEEEc---C--ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeee
Q 045286           28 TKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL---G--QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG  102 (259)
Q Consensus        28 ~~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~---~--~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~  102 (259)
                      ......-|.++.+.+.++||+|+||.|+++.|+   |  -.||||+++...... ....|++|+.++.+|+|+|++++|+
T Consensus       100 ~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyG  178 (1039)
T KOG0199|consen  100 SIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYG  178 (1039)
T ss_pred             CCCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEee
Confidence            455567788999999999999999999999986   2  379999999876554 5688999999999999999999999


Q ss_pred             eeecCCcEEEEEecCCCCChHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeec
Q 045286          103 ASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFG  181 (259)
Q Consensus       103 ~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~  181 (259)
                      +..+ ...-+|+|.++.|+|.+.+.+ ....+-...+..++.||+.++.||..++++|||+...|+++-....+||+|||
T Consensus       179 vVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFG  257 (1039)
T KOG0199|consen  179 VVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFG  257 (1039)
T ss_pred             eecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeeccc
Confidence            9887 567799999999999999987 33457778888999999999999999999999999999999999999999999


Q ss_pred             cceeccCCCcc----ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCC
Q 045286          182 VARFQNKGGVM----TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLC  255 (259)
Q Consensus       182 ~~~~~~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~  255 (259)
                      +++.+..+..+    ....-...|+|||.+....++.++|+|++|+++|||++ |..||.+.+..+.++.|.++-+-+-
T Consensus       258 LmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpR  336 (1039)
T KOG0199|consen  258 LMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPR  336 (1039)
T ss_pred             ceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCC
Confidence            99876554322    22334678999999999999999999999999999999 9999999999999999986554433

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=9.4e-34  Score=230.29  Aligned_cols=207  Identities=33%  Similarity=0.583  Sum_probs=172.0

Q ss_pred             ceeccccceEEEEEEEcC--------ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           44 ERIASGSCGDLYRGVYLG--------QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~~--------~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      +.||.|++|.||++.+..        +.+++|.+..... ......+.+|+.+++.++|+||+++++++...+..++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence            468999999999998642        5789998865432 2334678899999999999999999999988889999999


Q ss_pred             cCCCCChHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC-----eEEEeeeccce
Q 045286          116 YMPGGSLYDYLHKN------HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN-----VVKVADFGVAR  184 (259)
Q Consensus       116 ~~~~~~L~~~l~~~------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~-----~i~l~D~~~~~  184 (259)
                      ++++++|.+++...      ...++...+..++.|++.+|.+||+.+++|+|++|+||+++.++     .++++|||.+.
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~  159 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR  159 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence            99999999998642      23367888999999999999999999999999999999998877     89999999986


Q ss_pred             eccCCCc---cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhcc
Q 045286          185 FQNKGGV---MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       185 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      .......   ......+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+..+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~  230 (269)
T cd05044         160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG  230 (269)
T ss_pred             ccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC
Confidence            5433211   112234678999999988889999999999999999998 999998887777766665443

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-35  Score=229.27  Aligned_cols=222  Identities=25%  Similarity=0.385  Sum_probs=184.2

Q ss_pred             ccceechhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeec-
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTK-  106 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-  106 (259)
                      +.+.+.+++-.-..+||-|-.|.|..+..  +++++|+|++...       ....+|++..-..+ |+||+.+++++.. 
T Consensus        55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs  127 (400)
T KOG0604|consen   55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENS  127 (400)
T ss_pred             hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence            45555444434457999999999999886  4889999999875       55678888766665 9999999998854 


Q ss_pred             ---CCcEEEEEecCCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC---CeEEEee
Q 045286          107 ---SPHLCIVTEYMPGGSLYDYLHKNHN-VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH---NVVKVAD  179 (259)
Q Consensus       107 ---~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~---~~i~l~D  179 (259)
                         ...+.+|||.++||.|.+.++..+. .+++.++..+++||..++.|||+.+|.|||+||+|+|++.+   ..+||+|
T Consensus       128 ~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtD  207 (400)
T KOG0604|consen  128 YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTD  207 (400)
T ss_pred             ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecc
Confidence               3457889999999999999986654 59999999999999999999999999999999999999654   4699999


Q ss_pred             eccceeccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHhhhccCCCC
Q 045286          180 FGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSM----TPLQAALGVRQVCTSLC  255 (259)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~----~~~~~~~~i~~~~~~~~  255 (259)
                      ||++..-.........+.|+.|.|||++....|+..-|+||+|+++|-||+|.+||=..    -...+-.+|+.++-.-+
T Consensus       208 fGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP  287 (400)
T KOG0604|consen  208 FGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFP  287 (400)
T ss_pred             cccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCC
Confidence            99998877777778889999999999999999999999999999999999999998432    23556666776665555


Q ss_pred             ccCC
Q 045286          256 QPIY  259 (259)
Q Consensus       256 ~~~~  259 (259)
                      .|.|
T Consensus       288 ~pEW  291 (400)
T KOG0604|consen  288 EPEW  291 (400)
T ss_pred             ChhH
Confidence            5544

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-33  Score=230.47  Aligned_cols=214  Identities=26%  Similarity=0.406  Sum_probs=180.0

Q ss_pred             hhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCCcEEEEEec
Q 045286           40 LKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      |++.+.||+|++|.||+|..  .++.+++|.+....... ......+|+..+++++ |+|++++++.+...+..++||||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence            56778999999999999997  46889999987654322 2234557899999999 99999999999999999999999


Q ss_pred             CCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccccC
Q 045286          117 MPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAE  195 (259)
Q Consensus       117 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~~  195 (259)
                      + +++|.+.+.... ..++...+..++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+............
T Consensus        80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  158 (283)
T cd07830          80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY  158 (283)
T ss_pred             C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCC
Confidence            9 778988886554 45899999999999999999999999999999999999999999999999999876654444455


Q ss_pred             CCcccccCccccC-CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCC
Q 045286          196 TGTYRWMAPEVIN-HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLC  255 (259)
Q Consensus       196 ~~~~~~~~PE~~~-~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~  255 (259)
                      .++..|+|||.+. +..++.++|+||||+++++|++|..||...+..+....+......+.
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  219 (283)
T cd07830         159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPT  219 (283)
T ss_pred             CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCC
Confidence            6788999999874 45678999999999999999999999988877776666665544443

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=6.1e-33  Score=230.96  Aligned_cols=210  Identities=31%  Similarity=0.477  Sum_probs=177.4

Q ss_pred             hhhhhccceeccccceEEEEEEE--cCceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      +..|...++||+|++|.||++.+  .+..+++|.+..... .......+.+|+++++.++|+|++++++++......++|
T Consensus        24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  103 (317)
T cd06635          24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV  103 (317)
T ss_pred             hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence            35588899999999999999987  478899999876533 334456788999999999999999999999988899999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT  193 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~  193 (259)
                      +||+.+ ++.+.+......++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......   .
T Consensus       104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---~  179 (317)
T cd06635         104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---N  179 (317)
T ss_pred             EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---c
Confidence            999965 787777665666899999999999999999999999999999999999999999999999987654332   2


Q ss_pred             cCCCcccccCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          194 AETGTYRWMAPEVIN---HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      ...++..|+|||.+.   ...++.++|+||+|+++|+|++|..||...+.......+...
T Consensus       180 ~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~  239 (317)
T cd06635         180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN  239 (317)
T ss_pred             cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence            345778899999974   456789999999999999999999999877766666555443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.8e-33  Score=227.53  Aligned_cols=205  Identities=29%  Similarity=0.506  Sum_probs=170.7

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcE
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL  110 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~  110 (259)
                      ++++.+.......||+|++|.||++.+.  +..|++|.+....  ......+.+|+.+++.++|+||+++++++..++..
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFF   80 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEE
Confidence            3444555666679999999999999864  5679999887653  23446788999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc-CCeEEEeeeccceecc
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVL--KLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT-HNVVKVADFGVARFQN  187 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~-~~~i~l~D~~~~~~~~  187 (259)
                      ++++||+++++|.+++......+  +...+..++.|++.++.+||+.|++|+||+|+||+++. ++.++|+|||.+....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          81 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            99999999999999997654444  77888899999999999999999999999999999976 6799999999987554


Q ss_pred             CCC-ccccCCCcccccCccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 045286          188 KGG-VMTAETGTYRWMAPEVINHQ--PYDQKADVFSFAIVLWELVTAKVPYDSMT  239 (259)
Q Consensus       188 ~~~-~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~~~~ll~g~~p~~~~~  239 (259)
                      ... ......++..|+|||.+.+.  .++.++|+||+|+++|+|++|..||....
T Consensus       161 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~  215 (268)
T cd06624         161 GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG  215 (268)
T ss_pred             cCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence            322 22234578899999998654  37889999999999999999999997543

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-33  Score=226.22  Aligned_cols=203  Identities=27%  Similarity=0.390  Sum_probs=168.8

Q ss_pred             ceeccccceEEEEEEE--cCceEEEEEeecccCc-hHHHHHHHHHHHHH-HhcCCCCcceeeeeeecCCcEEEEEecCCC
Q 045286           44 ERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLN-DTLEDEFVQEVAIL-REVQHRNVVRFIGASTKSPHLCIVTEYMPG  119 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~  119 (259)
                      +.||+|++|.||+|.+  .++.+++|.+...... ......+..|..++ ...+|+|++++++.+...+..++++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5799999999999987  4789999998764322 12223334444443 445799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccccCCCcc
Q 045286          120 GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY  199 (259)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~~~~~~  199 (259)
                      ++|.+++... ..+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+......   ....++.
T Consensus        82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~  157 (260)
T cd05611          82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN---KKFVGTP  157 (260)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecccc---ccCCCCc
Confidence            9999998654 35889999999999999999999999999999999999999999999999988654332   2335778


Q ss_pred             cccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          200 RWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       200 ~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      .|++||.+.+..++.++|+||||+++|+|++|..||...+..+....+...
T Consensus       158 ~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  208 (260)
T cd05611         158 DYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR  208 (260)
T ss_pred             CccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence            899999998888899999999999999999999999988877766665443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.7e-33  Score=231.39  Aligned_cols=198  Identities=23%  Similarity=0.403  Sum_probs=167.8

Q ss_pred             hhhccceeccccceEEEEEEE-----cCceEEEEEeecccCc--hHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCCcE
Q 045286           39 LLKTGERIASGSCGDLYRGVY-----LGQDVAVKVLRSEHLN--DTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHL  110 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~-----~~~~v~vK~~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~  110 (259)
                      .|++.+.||.|++|.||.+.+     .++.|++|++......  ....+.+.+|+++++.+. |++|+.+++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            367889999999999999986     4788999998764321  223466788999999994 89999999999988899


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      ++++||+++++|.+++.... .++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  159 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE  159 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence            99999999999999986543 48888999999999999999999999999999999999999999999999987654322


Q ss_pred             --ccccCCCcccccCccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          191 --VMTAETGTYRWMAPEVINHQ--PYDQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       191 --~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                        ......++..|++||.+.+.  .++.++|+||||+++|+|++|..||..
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~  210 (290)
T cd05613         160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV  210 (290)
T ss_pred             ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence              11234578899999998753  467899999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-36  Score=230.17  Aligned_cols=224  Identities=23%  Similarity=0.394  Sum_probs=194.7

Q ss_pred             echhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec------
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK------  106 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------  106 (259)
                      .+...|.-..+||+|.||.||+|..  .++.|++|+...++..........+|+.+|+.++|+|++.+++.+..      
T Consensus        14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~   93 (376)
T KOG0669|consen   14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN   93 (376)
T ss_pred             ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence            3457888889999999999999875  47889999988876666667788999999999999999999887732      


Q ss_pred             --CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccce
Q 045286          107 --SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR  184 (259)
Q Consensus       107 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~  184 (259)
                        ...+++||++++ .+|.-.+....-.++..++..++.+++++|.|+|.+.++|||+|+.|+|++.+|.++|.|||+++
T Consensus        94 r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   94 RDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             cccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence              235899999994 58888887665668999999999999999999999999999999999999999999999999995


Q ss_pred             eccCC-----CccccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCccC
Q 045286          185 FQNKG-----GVMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPI  258 (259)
Q Consensus       185 ~~~~~-----~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  258 (259)
                      .+...     .....+.-+..|++||.+.|. .++++.|+|+.||++.+|+++.+.+.+.+..+.+..|...|+...+..
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            44322     223444568999999998765 789999999999999999999999999999999999999999999888


Q ss_pred             C
Q 045286          259 Y  259 (259)
Q Consensus       259 ~  259 (259)
                      |
T Consensus       253 W  253 (376)
T KOG0669|consen  253 W  253 (376)
T ss_pred             C
Confidence            7

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.2e-33  Score=229.88  Aligned_cols=211  Identities=31%  Similarity=0.465  Sum_probs=175.1

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeeeeeecC-----C
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGASTKS-----P  108 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-----~  108 (259)
                      .++|.+.+.||+|++|.||++.+.  ++.+++|.+.....   ....+.+|+.+++++ +|+|++++++.+...     +
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   97 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG   97 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence            467889999999999999999874  78899999875432   235567889999999 799999999987543     3


Q ss_pred             cEEEEEecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          109 HLCIVTEYMPGGSLYDYLHK---NHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                      ..++|+||+++++|.+++..   ....+++..++.++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+..
T Consensus        98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~  177 (291)
T cd06639          98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ  177 (291)
T ss_pred             eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence            68999999999999998753   334588999999999999999999999999999999999999999999999999875


Q ss_pred             ccCCCc-cccCCCcccccCccccCCC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          186 QNKGGV-MTAETGTYRWMAPEVINHQ-----PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       186 ~~~~~~-~~~~~~~~~~~~PE~~~~~-----~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      ...... .....++..|+|||.+...     .++.++|+||||+++|+|++|..||...+..+.+..+.+.
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~  248 (291)
T cd06639         178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN  248 (291)
T ss_pred             cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC
Confidence            543321 2234578889999997543     3678999999999999999999999888776666665544

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-34  Score=235.74  Aligned_cols=201  Identities=24%  Similarity=0.419  Sum_probs=166.9

Q ss_pred             hhhccceeccccceEEEEEEE----cCceEEEEEeeccc-CchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC--CcEE
Q 045286           39 LLKTGERIASGSCGDLYRGVY----LGQDVAVKVLRSEH-LNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS--PHLC  111 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~----~~~~v~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~  111 (259)
                      +|++.++||+|++|.||+|.+    .++.|++|.+.... ........+.+|+.+++.++||||+++++.+...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            467888999999999999997    46899999998743 1222335678899999999999999999999877  7899


Q ss_pred             EEEecCCCCChHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc----CCeEEEeeeccc
Q 045286          112 IVTEYMPGGSLYDYLHKNH----NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT----HNVVKVADFGVA  183 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~----~~~i~l~D~~~~  183 (259)
                      +|+|++++ ++.+.+....    ..+++..++.++.|++.++.+||+.+++|+||+|+||+++.    ++.++|+|||.+
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999964 7777664321    25788999999999999999999999999999999999999    899999999998


Q ss_pred             eeccCCCc----cccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 045286          184 RFQNKGGV----MTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTP  240 (259)
Q Consensus       184 ~~~~~~~~----~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~  240 (259)
                      ........    .....++..|+|||.+.+ ..++.++|+||||+++++|++|..||...+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~  221 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA  221 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence            76543322    123356788999998766 4578999999999999999999999976543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.5e-33  Score=229.48  Aligned_cols=211  Identities=31%  Similarity=0.540  Sum_probs=173.4

Q ss_pred             chhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeeeeeec------
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGASTK------  106 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~------  106 (259)
                      ....|++.+.||+|++|.||++.+  .++.+++|+.....   .....+..|+.+++++ +|+|++++++.+..      
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   90 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH   90 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence            346888899999999999999997  46889999986642   2235677899999998 59999999998742      


Q ss_pred             CCcEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          107 SPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                      .+..+++|||+++++|.+++.... ..+++..+..++.|++.++.+||+.|++|+|++|+||+++.++.++|+|||.+..
T Consensus        91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~  170 (282)
T cd06636          91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  170 (282)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence            457899999999999999986533 3478888899999999999999999999999999999999999999999999865


Q ss_pred             ccCC-CccccCCCcccccCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          186 QNKG-GVMTAETGTYRWMAPEVIN-----HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       186 ~~~~-~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                      .... .......++..|+|||.+.     +..++.++|+||||+++|+|++|..||....+.+....+.+
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~  240 (282)
T cd06636         171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR  240 (282)
T ss_pred             hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh
Confidence            4322 1223345788999999975     34578899999999999999999999987666555544433

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=5.5e-35  Score=220.41  Aligned_cols=207  Identities=18%  Similarity=0.404  Sum_probs=181.7

Q ss_pred             hhhhccceeccccceEEEEEE--EcCceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeec--CCcEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTK--SPHLCI  112 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~--~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~l  112 (259)
                      ++|++.+++|.|-++.||.|.  .+++.+++|++++-.     ...+.+|+.+|+.|. +|||+.++++..+  +....+
T Consensus        38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            789999999999999999998  568899999998753     367899999999998 9999999998744  557889


Q ss_pred             EEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC-CeEEEeeeccceeccCCCc
Q 045286          113 VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH-NVVKVADFGVARFQNKGGV  191 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~-~~i~l~D~~~~~~~~~~~~  191 (259)
                      ++|+++..+...+..    .++...+..++.+++++|.|+|+.||+|+|+||.|++++.. ..++|+|||++.+..++..
T Consensus       113 iFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e  188 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  188 (338)
T ss_pred             HhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCce
Confidence            999998877666553    37788999999999999999999999999999999999875 5799999999999999888


Q ss_pred             cccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHhhhccCC
Q 045286          192 MTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPY-DSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~-~~~~~~~~~~~i~~~~~~  253 (259)
                      ..-+..+..|--||++-+. .|+...|+|||||++..|+..+.|| .+.+..+++.+|.+.+++
T Consensus       189 YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt  252 (338)
T KOG0668|consen  189 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGT  252 (338)
T ss_pred             eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhCh
Confidence            8777888899999998765 5799999999999999999999885 788888888888776654

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-33  Score=237.24  Aligned_cols=213  Identities=26%  Similarity=0.440  Sum_probs=176.2

Q ss_pred             ceechhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC---
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS---  107 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---  107 (259)
                      |.+. ++|.+.++||+|++|.||++.+  .++.|++|++............+.+|+.++++++|+||+++.+++...   
T Consensus        13 ~~~~-~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~   91 (345)
T cd07877          13 WEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL   91 (345)
T ss_pred             hhcc-CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence            4443 5789999999999999999986  478999999987544444456678899999999999999999987532   


Q ss_pred             ---CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccce
Q 045286          108 ---PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR  184 (259)
Q Consensus       108 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~  184 (259)
                         ...+++++++ +++|.+++...  .+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        92 ~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~  168 (345)
T cd07877          92 EEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR  168 (345)
T ss_pred             cccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccc
Confidence               3467888887 78998877543  48899999999999999999999999999999999999999999999999987


Q ss_pred             eccCCCccccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          185 FQNKGGVMTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      .....  .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+....+..+.+..
T Consensus       169 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  234 (345)
T cd07877         169 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV  234 (345)
T ss_pred             ccccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            54332  233457788999999866 467889999999999999999999998877766666555443

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2e-33  Score=229.47  Aligned_cols=210  Identities=25%  Similarity=0.465  Sum_probs=180.4

Q ss_pred             hhhccceeccccceEEEEEEE--cCceEEEEEeecccC-chHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCCcEEEEE
Q 045286           39 LLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      +|.+.+.||+|++|.||++.+  .++.+++|++..... .......+.+|..+++++. |+||+++++.+...+..+++|
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            678889999999999999997  478999999887433 2334467888999999998 999999999999989999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc---
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV---  191 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~---  191 (259)
                      |++++++|.+++.... .++...++.++.|++.+|.+||+.|++|+|++|+||+++.++.++++|||.+........   
T Consensus        82 e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~  160 (280)
T cd05581          82 EYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES  160 (280)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence            9999999999997654 589999999999999999999999999999999999999999999999999875543221   


Q ss_pred             ------------------cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          192 ------------------MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       192 ------------------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                                        .....++..|+|||...+..++.++|+||||++++++++|..||...+.......+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  236 (280)
T cd05581         161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK  236 (280)
T ss_pred             CCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence                              1123467889999999888899999999999999999999999998776655555543

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.9e-33  Score=229.57  Aligned_cols=210  Identities=30%  Similarity=0.486  Sum_probs=177.8

Q ss_pred             hhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ..|....+||.|++|.||++..  .++.|++|.+....  ......+.+|+.+++.++|+|++++++.+...+..++++|
T Consensus        20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   97 (292)
T cd06657          20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME   97 (292)
T ss_pred             HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEe
Confidence            4555567899999999999987  47899999886542  2345678899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-cccc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMTA  194 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~~  194 (259)
                      |+++++|.+++...  .+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus        98 ~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~  175 (292)
T cd06657          98 FLEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  175 (292)
T ss_pred             cCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence            99999999987433  47889999999999999999999999999999999999999999999999876544321 1223


Q ss_pred             CCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          195 ETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ..++..|++||.+.+..++.++|+||+|+++|+|++|..||...+..+.+..+....
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~  232 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL  232 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC
Confidence            457788999999988888999999999999999999999998877766666555443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-35  Score=239.47  Aligned_cols=206  Identities=27%  Similarity=0.428  Sum_probs=186.0

Q ss_pred             ceechhhhhccceeccccceEEEEEE--EcCceEEEEEeecccCch-HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCc
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVRFIGASTKSPH  109 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~--~~~~~v~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~  109 (259)
                      +++....++.-+.||.|+||.|+-+.  .+|+-+|+|.+....... .-....++|.++|+.++.+.|+.+--+|+..+.
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~  259 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA  259 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence            56667788888999999999999776  578999999988765533 233567789999999999999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          110 LCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      .|+|+.-++||+|.-.+...+ ..+++..++-++.+|+.+|..||+.+||+||+||+|||+++.|.++|+|+|+|..+..
T Consensus       260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999999998886554 3489999999999999999999999999999999999999999999999999999999


Q ss_pred             CCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 045286          189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSM  238 (259)
Q Consensus       189 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  238 (259)
                      +.......||.+|+|||++.+..|+...|.|||||++|+|+.|+.||...
T Consensus       340 g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~  389 (591)
T KOG0986|consen  340 GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR  389 (591)
T ss_pred             CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence            98888889999999999999999999999999999999999999999653

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.9e-33  Score=229.75  Aligned_cols=201  Identities=29%  Similarity=0.446  Sum_probs=168.1

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCCcEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv  113 (259)
                      .+++...+.||+|++|.||++.+.  ++.+++|.+...... .....+.+|+.++.++. |+||+++++.+...+..+++
T Consensus         3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~   81 (288)
T cd06616           3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC   81 (288)
T ss_pred             HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence            457778889999999999999874  689999998865433 34567889999999996 99999999999888899999


Q ss_pred             EecCCCCChHHHHH---h-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          114 TEYMPGGSLYDYLH---K-NHNVLKLPQLLRFAIDICKGMEYLHQR-NIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       114 ~e~~~~~~L~~~l~---~-~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      +|++. .++.++..   . ....+++..+..++.|++.+|.+||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        82 ~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          82 MELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             Eeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            99984 46655432   1 234588999999999999999999975 999999999999999999999999999875544


Q ss_pred             CCccccCCCcccccCccccCCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 045286          189 GGVMTAETGTYRWMAPEVINHQ---PYDQKADVFSFAIVLWELVTAKVPYDSMT  239 (259)
Q Consensus       189 ~~~~~~~~~~~~~~~PE~~~~~---~~~~~~Di~slG~~~~~ll~g~~p~~~~~  239 (259)
                      ........++..|+|||.+.+.   .++.++|+||+|+++|+|++|..||...+
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  214 (288)
T cd06616         161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN  214 (288)
T ss_pred             CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence            3333344578889999998766   68899999999999999999999997654

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.9e-33  Score=235.93  Aligned_cols=212  Identities=26%  Similarity=0.412  Sum_probs=175.7

Q ss_pred             hhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeeeeeec--CCcEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGASTK--SPHLC  111 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~  111 (259)
                      .++|.+.+.||+|++|.||+|.+  .++.+++|.+............+.+|+.+++++ +|+||+++++++..  ....+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            46889999999999999999987  478899999876544444446677899999999 89999999998754  34689


Q ss_pred             EEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-
Q 045286          112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-  190 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-  190 (259)
                      +|+|+++ ++|..++...  .++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        86 lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~  162 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE  162 (337)
T ss_pred             EEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence            9999996 5898888654  57888888999999999999999999999999999999999999999999987544322 


Q ss_pred             -----ccccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          191 -----VMTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       191 -----~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                           ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+...++....
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~  229 (337)
T cd07852         163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVI  229 (337)
T ss_pred             cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence                 1123357788999998755 457889999999999999999999999877776666655443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-33  Score=235.96  Aligned_cols=207  Identities=26%  Similarity=0.433  Sum_probs=169.4

Q ss_pred             hhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC-----CcE
Q 045286           38 RLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS-----PHL  110 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~  110 (259)
                      ++|++.+.||+|++|.||++.+  .++.|++|.+.... .......+.+|+.+++.++|+||+++++++...     ...
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            5788999999999999999987  47899999986532 223446678899999999999999999876543     357


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      ++++|+++ ++|...+..  ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        84 ~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  160 (336)
T cd07849          84 YIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH  160 (336)
T ss_pred             EEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence            99999995 578777643  348899999999999999999999999999999999999999999999999987554322


Q ss_pred             c----cccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 045286          191 V----MTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVR  248 (259)
Q Consensus       191 ~----~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~  248 (259)
                      .    .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+.......+.
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~  223 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLIL  223 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            1    123457888999998654 568899999999999999999999998766554444443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.8e-33  Score=229.41  Aligned_cols=216  Identities=27%  Similarity=0.457  Sum_probs=176.7

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeecC
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKS  107 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~  107 (259)
                      +.|.++.+.|.+.+.||+|++|.||++.+.  ++.+++|.+....... ....+.+|..++.... |+||+++++.+...
T Consensus         8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~   86 (296)
T cd06618           8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITD   86 (296)
T ss_pred             eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence            346777889999999999999999999986  8899999998654332 3345566776666665 99999999999999


Q ss_pred             CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ-RNIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                      ...++++|++ ++++.+++......+++..+..++.|++.++.+||+ .|++|+||+|+||+++.++.++|+|||.+...
T Consensus        87 ~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          87 SDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             CeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            9999999998 457888776655578889999999999999999997 59999999999999999999999999998765


Q ss_pred             cCCCccccCCCcccccCccccCCCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHhh
Q 045286          187 NKGGVMTAETGTYRWMAPEVINHQP----YDQKADVFSFAIVLWELVTAKVPYDSMTP-LQAALGVR  248 (259)
Q Consensus       187 ~~~~~~~~~~~~~~~~~PE~~~~~~----~~~~~Di~slG~~~~~ll~g~~p~~~~~~-~~~~~~i~  248 (259)
                      ..........++..|+|||.+.+..    ++.++|+||||+++|+|++|..||..... .+.+..+.
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  232 (296)
T cd06618         166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL  232 (296)
T ss_pred             cCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHh
Confidence            5443333445678899999987553    78899999999999999999999976433 34444433

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.1e-35  Score=246.55  Aligned_cols=219  Identities=27%  Similarity=0.499  Sum_probs=184.5

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccC--chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL--NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      -+-.++.++...+||.|+|-+||+|.|.  |-.||--.++....  .+...+++..|+.+|+.|+|+||+++++.|.+..
T Consensus        35 ~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~  114 (632)
T KOG0584|consen   35 KDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD  114 (632)
T ss_pred             cCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC
Confidence            4445678889999999999999999985  44444433332222  3455688999999999999999999999997765


Q ss_pred             c--EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEccC-CeEEEeeeccc
Q 045286          109 H--LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN--IIHRDLKTANLLMDTH-NVVKVADFGVA  183 (259)
Q Consensus       109 ~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~di~p~Nilv~~~-~~i~l~D~~~~  183 (259)
                      .  +.+|.|.+..|+|..|+.+.. ..+.+.+..|++||+++|.|||++.  |+|||||=+||||+.+ |.+||+|+|+|
T Consensus       115 n~~in~iTEL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLA  193 (632)
T KOG0584|consen  115 NKTINFITELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLA  193 (632)
T ss_pred             CceeeeeeecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHH
Confidence            5  889999999999999996655 4888999999999999999999875  9999999999999875 89999999999


Q ss_pred             eeccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHhhhccCCC
Q 045286          184 RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS-MTPLQAALGVRQVCTSL  254 (259)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~-~~~~~~~~~i~~~~~~~  254 (259)
                      ....... .....|||.|||||+.. ..|+..+||||||++++||.|+.-||.. .++-+..+++..|..+.
T Consensus       194 tl~r~s~-aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~  263 (632)
T KOG0584|consen  194 TLLRKSH-AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPA  263 (632)
T ss_pred             HHhhccc-cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHH
Confidence            8776653 34478999999999998 7799999999999999999999999975 67777888887776553

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.8e-33  Score=234.61  Aligned_cols=213  Identities=26%  Similarity=0.452  Sum_probs=177.3

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      ..|.+. ++|++.+.||+|++|.||++.+.  +..|++|.+............+.+|+.+++.++|+||+++++++....
T Consensus         9 ~~~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07880           9 TIWEVP-DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL   87 (343)
T ss_pred             hhhccc-cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence            346663 47999999999999999999864  789999998765444445567889999999999999999999886543


Q ss_pred             ------cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecc
Q 045286          109 ------HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGV  182 (259)
Q Consensus       109 ------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~  182 (259)
                            .+++|+|++ +++|..++..  ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.
T Consensus        88 ~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          88 SLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             cccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence                  458999999 7799888754  3488999999999999999999999999999999999999999999999999


Q ss_pred             ceeccCCCccccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          183 ARFQNKGGVMTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                      +......  .....+++.|++||.+.+ ..++.++|+||||+++|++++|..||...+.......+.+
T Consensus       165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~  230 (343)
T cd07880         165 ARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMK  230 (343)
T ss_pred             ccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            8755432  223356788999999876 4578899999999999999999999988776655555443

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=8.5e-33  Score=226.12  Aligned_cols=192  Identities=30%  Similarity=0.450  Sum_probs=158.5

Q ss_pred             eeccccceEEEEEEEc--CceEEEEEeecccCch-HHHHHHHHHHHHHHh---cCCCCcceeeeeeecCCcEEEEEecCC
Q 045286           45 RIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND-TLEDEFVQEVAILRE---VQHRNVVRFIGASTKSPHLCIVTEYMP  118 (259)
Q Consensus        45 ~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~-~~~~~~~~e~~~l~~---l~~~~i~~~~~~~~~~~~~~lv~e~~~  118 (259)
                      .||+|+||.||++.+.  ++.+++|.+....... .....+.++..+++.   .+|++|+.+++.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999874  7899999987654322 112233444443333   468999999999988889999999999


Q ss_pred             CCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccccCCCc
Q 045286          119 GGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT  198 (259)
Q Consensus       119 ~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~~~~~  198 (259)
                      +++|.+++.... .+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+....... .....++
T Consensus        81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~  158 (279)
T cd05633          81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGT  158 (279)
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcCCC
Confidence            999999886543 48999999999999999999999999999999999999999999999999986544332 2234688


Q ss_pred             ccccCccccC-CCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 045286          199 YRWMAPEVIN-HQPYDQKADVFSFAIVLWELVTAKVPYDSM  238 (259)
Q Consensus       199 ~~~~~PE~~~-~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  238 (259)
                      ..|+|||.+. +..++.++|+||+|+++|+|++|..||...
T Consensus       159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  199 (279)
T cd05633         159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (279)
T ss_pred             cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence            9999999986 456889999999999999999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6.9e-33  Score=225.66  Aligned_cols=210  Identities=31%  Similarity=0.544  Sum_probs=172.2

Q ss_pred             hhccceeccccceEEEEEEEc-----CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC------
Q 045286           40 LKTGERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP------  108 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------  108 (259)
                      |.+.+.||+|++|.||+|.+.     ++.+++|++..........+.+.+|+++++.++||||+++++.+....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            456789999999999999853     578999999877655556677889999999999999999999875432      


Q ss_pred             cEEEEEecCCCCChHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccc
Q 045286          109 HLCIVTEYMPGGSLYDYLHKN-----HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA  183 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~  183 (259)
                      ..+++++|..+++|..++...     ...++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence            347889999999998887432     124678889999999999999999999999999999999999999999999998


Q ss_pred             eeccCCCc---cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 045286          184 RFQNKGGV---MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       184 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~  249 (259)
                      ........   ......+..|++||.+.+..++.++|+||||+++|+|++ |..||...+..+....+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  230 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK  230 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc
Confidence            75543221   112234567999999988889999999999999999999 8999987776655554443

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.6e-33  Score=227.83  Aligned_cols=196  Identities=22%  Similarity=0.444  Sum_probs=162.9

Q ss_pred             ceeccccceEEEEEEEc---------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           44 ERIASGSCGDLYRGVYL---------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~---------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      +.||.|+||.||++...         ...+++|.+....  ....+.+.+|..+++.++|||++++++.+...+..++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            46999999999999763         2347888875432  334467888999999999999999999998888999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCe--------EEEeeeccceec
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV--------VKVADFGVARFQ  186 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~--------i~l~D~~~~~~~  186 (259)
                      ||+++++|.+++......++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.        ++++|||.+...
T Consensus        79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~  158 (258)
T cd05078          79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV  158 (258)
T ss_pred             ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence            999999999999776666889999999999999999999999999999999999987664        699999988654


Q ss_pred             cCCCccccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcC-CCCCCCCCHHHHH
Q 045286          187 NKGGVMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTA-KVPYDSMTPLQAA  244 (259)
Q Consensus       187 ~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g-~~p~~~~~~~~~~  244 (259)
                      ...   ....++..|+|||.+.+. .++.++|+||||+++|+|++| ..||...+.....
T Consensus       159 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~  215 (258)
T cd05078         159 LPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL  215 (258)
T ss_pred             CCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH
Confidence            432   233567889999998764 578999999999999999998 5677665554433

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.7e-34  Score=248.97  Aligned_cols=199  Identities=18%  Similarity=0.316  Sum_probs=157.9

Q ss_pred             hhhhhccceeccccceEEEEEEEc---CceEEEEEee---------------cccCchHHHHHHHHHHHHHHhcCCCCcc
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL---GQDVAVKVLR---------------SEHLNDTLEDEFVQEVAILREVQHRNVV   98 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~---~~~v~vK~~~---------------~~~~~~~~~~~~~~e~~~l~~l~~~~i~   98 (259)
                      ..+|++.++||+|+||+||++...   +...+.|.+.               ...........+.+|+.++++++|+||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            367999999999999999998753   1222222111               1111123345678999999999999999


Q ss_pred             eeeeeeecCCcEEEEEecCCCCChHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCe
Q 045286           99 RFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH----NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV  174 (259)
Q Consensus        99 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~  174 (259)
                      ++++++...+..+++++++ +.+|.+++....    .......+..++.|++.+|.|||+.|++|+||||+|||++.++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~  305 (501)
T PHA03210        227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK  305 (501)
T ss_pred             cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence            9999999999999999998 557777764322    12345677889999999999999999999999999999999999


Q ss_pred             EEEeeeccceeccCCCc--cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCC-CCC
Q 045286          175 VKVADFGVARFQNKGGV--MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKV-PYD  236 (259)
Q Consensus       175 i~l~D~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~-p~~  236 (259)
                      ++|+|||++........  .....++..|+|||.+.+..++.++|||||||++|+|++|.. ||.
T Consensus       306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~  370 (501)
T PHA03210        306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIG  370 (501)
T ss_pred             EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCcc
Confidence            99999999976654322  223568999999999999999999999999999999999775 454

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.3e-32  Score=227.16  Aligned_cols=208  Identities=32%  Similarity=0.474  Sum_probs=175.9

Q ss_pred             hhhhccceeccccceEEEEEEE--cCceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      +.+...++||+|++|.||+|.+  .++.+++|.+..... .......+.+|+.+++.++|+|++++++.+......++++
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  100 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM  100 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence            4577778899999999999986  478999999976543 2334467888999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTA  194 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~  194 (259)
                      ||+. +++.+++......++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.....   ...
T Consensus       101 e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~~~  176 (313)
T cd06633         101 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---ANS  176 (313)
T ss_pred             ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---CCC
Confidence            9995 578888766666689999999999999999999999999999999999999999999999998764332   223


Q ss_pred             CCCcccccCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          195 ETGTYRWMAPEVIN---HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       195 ~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                      ..++..|+|||.+.   +..++.++|+||||+++|+|++|..||...+.......+..
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~  234 (313)
T cd06633         177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ  234 (313)
T ss_pred             ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Confidence            45788899999984   35678899999999999999999999988776665555443

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.3e-33  Score=226.32  Aligned_cols=194  Identities=22%  Similarity=0.414  Sum_probs=161.4

Q ss_pred             eeccccceEEEEEEEc--------------------------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcc
Q 045286           45 RIASGSCGDLYRGVYL--------------------------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVV   98 (259)
Q Consensus        45 ~lg~G~~~~V~~~~~~--------------------------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~   98 (259)
                      .||+|+||.||++...                          ...|++|.+....  ......+.+|+.+++.++|+||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence            6999999999998741                          1348888886542  23446788899999999999999


Q ss_pred             eeeeeeecCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC-----
Q 045286           99 RFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN-----  173 (259)
Q Consensus        99 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~-----  173 (259)
                      ++++++...+..++||||+++++|..++......++...+..++.|++.+|.|||+++++|+||+|+||+++..+     
T Consensus        80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~  159 (274)
T cd05076          80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT  159 (274)
T ss_pred             eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence            999999999999999999999999999876666688999999999999999999999999999999999997643     


Q ss_pred             --eEEEeeeccceeccCCCccccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHH-cCCCCCCCCCHHHH
Q 045286          174 --VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELV-TAKVPYDSMTPLQA  243 (259)
Q Consensus       174 --~i~l~D~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll-~g~~p~~~~~~~~~  243 (259)
                        .++++|||.+......   ....++..|+|||.+.+ ..++.++|+||||+++|+++ +|..||...+..+.
T Consensus       160 ~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  230 (274)
T cd05076         160 SPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK  230 (274)
T ss_pred             cceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence              4899999987543322   22346778999998865 56899999999999999995 69999987766544

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.3e-33  Score=232.88  Aligned_cols=207  Identities=26%  Similarity=0.425  Sum_probs=172.4

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec-CCc
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK-SPH  109 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~  109 (259)
                      +.+ .++|++.+.||.|++|.||++.+.  ++.+++|.+............+.+|+.+++.++||||+++.+++.. ...
T Consensus         6 ~~~-~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           6 FEI-TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             ecc-ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            344 457999999999999999999864  7889999987654444445677899999999999999999998865 567


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG  189 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~  189 (259)
                      .++++|++ +++|..++...  .++...+..++.|++++|.+||+.+++|+||+|+||+++.++.++|+|||.+......
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~  161 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ  161 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence            89999998 66888887543  3778888899999999999999999999999999999999999999999998754332


Q ss_pred             CccccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 045286          190 GVMTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL  245 (259)
Q Consensus       190 ~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~  245 (259)
                        .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+......
T Consensus       162 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~  216 (328)
T cd07856         162 --MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFS  216 (328)
T ss_pred             --cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence              223356788999998765 568999999999999999999999998776644433

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-32  Score=226.11  Aligned_cols=198  Identities=30%  Similarity=0.476  Sum_probs=169.5

Q ss_pred             hhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec--CCcEEEEE
Q 045286           39 LLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK--SPHLCIVT  114 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~  114 (259)
                      +|...+.||.|++|.||++.+  .++.+++|.+..... ......+.+|+++++.++|+||+++++.+..  .+..++++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            567788999999999999997  478999999886533 2445778899999999999999999998754  34789999


Q ss_pred             ecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc
Q 045286          115 EYMPGGSLYDYLHK---NHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV  191 (259)
Q Consensus       115 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~  191 (259)
                      ||+++++|.+++..   ....+++..+..++.|++.+|.+||+.|++|+|++|+||+++.++.++|+|||.+........
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  160 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA  160 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence            99999999988643   234578889999999999999999999999999999999999999999999999865443321


Q ss_pred             cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 045286          192 MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSM  238 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  238 (259)
                       ....++..|++||.+.+..++.++|+||||+++|+|++|..||...
T Consensus       161 -~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (287)
T cd06621         161 -GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE  206 (287)
T ss_pred             -ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence             2345678899999999888999999999999999999999999765

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-33  Score=237.33  Aligned_cols=217  Identities=25%  Similarity=0.441  Sum_probs=182.0

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      ..|++. ++|.+.+.||+|++|.||++.+.  ++.|++|++............+.+|+.+++.++|+|++++.+.+...+
T Consensus         9 ~~~~~~-~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07851           9 TVWEVP-DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPAS   87 (343)
T ss_pred             ceeccc-CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence            345664 46899999999999999999984  688999998765444444566788999999999999999998776554


Q ss_pred             c------EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecc
Q 045286          109 H------LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGV  182 (259)
Q Consensus       109 ~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~  182 (259)
                      .      .++|+|++ +++|.+++..  ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.
T Consensus        88 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          88 SLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             cccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccc
Confidence            4      89999998 6799998864  3489999999999999999999999999999999999999999999999999


Q ss_pred             ceeccCCCccccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          183 ARFQNKGGVMTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      +......  .....++..|+|||.+.+ ..++.++|+||||+++|++++|..||.+.+..+.+..+....+.
T Consensus       165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~  234 (343)
T cd07851         165 ARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT  234 (343)
T ss_pred             ccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Confidence            8765433  233456788999999865 36789999999999999999999999988887777776665543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=247.10  Aligned_cols=202  Identities=29%  Similarity=0.540  Sum_probs=172.5

Q ss_pred             eeccccceEEEEEEEcC--ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCCCCCh
Q 045286           45 RIASGSCGDLYRGVYLG--QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSL  122 (259)
Q Consensus        45 ~lg~G~~~~V~~~~~~~--~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L  122 (259)
                      +||.|.+|+||.|++..  ...|+|.+...  +....+-+.+|+...++|.|.||+++++.+.+++.+-++||..+||+|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            89999999999999864  45677776654  334456788999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc-CCeEEEeeeccceeccCCCcc-ccCCCc
Q 045286          123 YDYLHKNHNVL--KLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT-HNVVKVADFGVARFQNKGGVM-TAETGT  198 (259)
Q Consensus       123 ~~~l~~~~~~~--~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~-~~~i~l~D~~~~~~~~~~~~~-~~~~~~  198 (259)
                      .++++..=+++  ++..+.-+.+||+++|.|||++.|||||||-+|++|+. .|.+||+|||.+.....-++. +...||
T Consensus       660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGT  739 (1226)
T KOG4279|consen  660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGT  739 (1226)
T ss_pred             HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccc
Confidence            99998776666  67788889999999999999999999999999999965 699999999998765543333 456799


Q ss_pred             ccccCccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHhh
Q 045286          199 YRWMAPEVINHQ--PYDQKADVFSFAIVLWELVTAKVPYDS-MTPLQAALGVR  248 (259)
Q Consensus       199 ~~~~~PE~~~~~--~~~~~~Di~slG~~~~~ll~g~~p~~~-~~~~~~~~~i~  248 (259)
                      ..|+|||++...  .|+.++|||||||++.+|.||++||-. .++...+.++-
T Consensus       740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG  792 (1226)
T KOG4279|consen  740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG  792 (1226)
T ss_pred             hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc
Confidence            999999999754  588999999999999999999999954 66666666554

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4.9e-33  Score=232.97  Aligned_cols=213  Identities=25%  Similarity=0.374  Sum_probs=174.1

Q ss_pred             hhhccceeccccceEEEEEEEc----CceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeec----CCc
Q 045286           39 LLKTGERIASGSCGDLYRGVYL----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTK----SPH  109 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~----~~~  109 (259)
                      +|.+.+.||.|++|.||++.+.    +..+++|.+............+.+|+.+++++. |+||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4677889999999999999975    558999998765444444567888999999995 9999999986432    245


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG  189 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~  189 (259)
                      .+++++++ +.+|.+++.. ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 ~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          81 LYLYEELM-EADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             EEEEEecc-cCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            78889998 4689888854 345889999999999999999999999999999999999999999999999998754432


Q ss_pred             C-----ccccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          190 G-----VMTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       190 ~-----~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      .     ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+....+.++....+.
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  228 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGT  228 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCC
Confidence            1     1123457889999998765 56899999999999999999999999988877777666655543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.5e-33  Score=231.86  Aligned_cols=205  Identities=22%  Similarity=0.377  Sum_probs=168.9

Q ss_pred             ceeccc--cceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCCC
Q 045286           44 ERIASG--SCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPG  119 (259)
Q Consensus        44 ~~lg~G--~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~  119 (259)
                      ..||.|  ++++||++.+  .++.|++|+...........+.+.+|+.+++.++|+||+++++++..++..++++|++.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  9999999987  589999999987655555567888999999999999999999999999999999999999


Q ss_pred             CChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-cc-----
Q 045286          120 GSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VM-----  192 (259)
Q Consensus       120 ~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~-----  192 (259)
                      +++.+++.... ..+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++++||+.+....... ..     
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD  163 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence            99999986543 348889999999999999999999999999999999999999999999997653221110 00     


Q ss_pred             --ccCCCcccccCccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 045286          193 --TAETGTYRWMAPEVINHQ--PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVR  248 (259)
Q Consensus       193 --~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~  248 (259)
                        ....+...|++||.+.+.  .++.++|+||+||++|+|++|..||......+......
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~  223 (328)
T cd08226         164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKL  223 (328)
T ss_pred             ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHh
Confidence              011235669999998764  47899999999999999999999998877655554433

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-33  Score=234.99  Aligned_cols=214  Identities=27%  Similarity=0.455  Sum_probs=175.6

Q ss_pred             cceechhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC--
Q 045286           32 DWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS--  107 (259)
Q Consensus        32 ~~~~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--  107 (259)
                      .|++. .+|...+.||+|++|.||+|.+  .++.|++|.+............+.+|+.+++.++|+||+++++++...  
T Consensus        10 ~~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~   88 (342)
T cd07879          10 VWELP-ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS   88 (342)
T ss_pred             hhccc-cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence            36664 4788899999999999999986  478999999886544444446678999999999999999999987644  


Q ss_pred             ----CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccc
Q 045286          108 ----PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA  183 (259)
Q Consensus       108 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~  183 (259)
                          ..+++++|++. .+|..+.   ...++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        89 ~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          89 GDEFQDFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             CCCCceEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence                24689999985 4676654   234888999999999999999999999999999999999999999999999998


Q ss_pred             eeccCCCccccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          184 RFQNKGGVMTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      ......  .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+....+..+....+
T Consensus       165 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  232 (342)
T cd07879         165 RHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG  232 (342)
T ss_pred             cCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            654322  223356788999999876 4688999999999999999999999998877666666555433

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-34  Score=224.91  Aligned_cols=196  Identities=27%  Similarity=0.489  Sum_probs=166.4

Q ss_pred             hhh-ccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCCcEEEEE
Q 045286           39 LLK-TGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        39 ~~~-~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      .|+ -.+.||.|+++.|--++.  ++..+|||++.+..  .....++.+|++++.+.+ |+||+.++++|+++..+|+||
T Consensus        78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf  155 (463)
T KOG0607|consen   78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF  155 (463)
T ss_pred             HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence            344 346899999999988875  58999999998863  345688999999999997 999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC---eEEEeeeccceeccCC--
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVARFQNKG--  189 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~---~i~l~D~~~~~~~~~~--  189 (259)
                      |.+.|++|...+.+.. .+++.++.++.++|+.+|.+||++||.|+|+||+|||.....   -+||+||.+.+-....  
T Consensus       156 EKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~  234 (463)
T KOG0607|consen  156 EKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND  234 (463)
T ss_pred             ecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence            9999999999996654 499999999999999999999999999999999999996554   4899999887532211  


Q ss_pred             ------CccccCCCcccccCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          190 ------GVMTAETGTYRWMAPEVIN-----HQPYDQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       190 ------~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                            ......+|+..|+|||+..     ...|+.+-|+||||+++|-||.|.+||.+
T Consensus       235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG  293 (463)
T KOG0607|consen  235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG  293 (463)
T ss_pred             CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence                  1223456889999999863     23578899999999999999999999975

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.3e-32  Score=224.91  Aligned_cols=192  Identities=29%  Similarity=0.438  Sum_probs=158.7

Q ss_pred             eeccccceEEEEEEE--cCceEEEEEeecccCch-HHHHHHHHHH---HHHHhcCCCCcceeeeeeecCCcEEEEEecCC
Q 045286           45 RIASGSCGDLYRGVY--LGQDVAVKVLRSEHLND-TLEDEFVQEV---AILREVQHRNVVRFIGASTKSPHLCIVTEYMP  118 (259)
Q Consensus        45 ~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~-~~~~~~~~e~---~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~  118 (259)
                      .||+|++|.||++.+  .++.|++|.+....... .....+.+|.   ..++...|++|+.+.+.+...+..++|+||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999986  47899999988654332 1112233333   34444579999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccccCCCc
Q 045286          119 GGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT  198 (259)
Q Consensus       119 ~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~~~~~  198 (259)
                      |++|..++... ..+++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||.+....... .....++
T Consensus        81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~  158 (278)
T cd05606          81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGT  158 (278)
T ss_pred             CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcCcCCC
Confidence            99999988543 458999999999999999999999999999999999999999999999999986544322 2234688


Q ss_pred             ccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 045286          199 YRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSM  238 (259)
Q Consensus       199 ~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~  238 (259)
                      ..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...
T Consensus       159 ~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~  199 (278)
T cd05606         159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (278)
T ss_pred             cCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence            99999999874 46889999999999999999999999765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-32  Score=220.85  Aligned_cols=203  Identities=29%  Similarity=0.444  Sum_probs=176.6

Q ss_pred             eccccceEEEEEEEc--CceEEEEEeecccCch-HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCCCCCh
Q 045286           46 IASGSCGDLYRGVYL--GQDVAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSL  122 (259)
Q Consensus        46 lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L  122 (259)
                      ||.|++|.||++.+.  ++.+++|.+....... .....+.+|+.+++.++|++++++++.+..++..+++||++++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999975  7899999988764432 3456788999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-CccccCCCcccc
Q 045286          123 YDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVMTAETGTYRW  201 (259)
Q Consensus       123 ~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~~~~~~~~~~  201 (259)
                      .+++.... .+++..+..++.|++.++.++|+.+++|+||+|+||+++.++.++|+|||.+...... .......++..|
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  159 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY  159 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccc
Confidence            99996554 4889999999999999999999999999999999999999999999999998766543 223345678899


Q ss_pred             cCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          202 MAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       202 ~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                      .+||...+...+.++|+||||+++|++++|..||...+..+....+.+
T Consensus       160 ~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~  207 (250)
T cd05123         160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK  207 (250)
T ss_pred             cChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence            999999888889999999999999999999999988776665655554

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.7e-32  Score=227.42  Aligned_cols=210  Identities=30%  Similarity=0.473  Sum_probs=176.5

Q ss_pred             chhhhhccceeccccceEEEEEEE--cCceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCI  112 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l  112 (259)
                      ..+.|...+.||.|++|.||++.+  .++.+++|.+..... .......+.+|+++++.++|+|++++.+++......++
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   92 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence            356788889999999999999987  467899999875432 33344667889999999999999999999998899999


Q ss_pred             EEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcc
Q 045286          113 VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM  192 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~  192 (259)
                      |+||+. +++.+.+......++...+..++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||.+......   
T Consensus        93 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---  168 (308)
T cd06634          93 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (308)
T ss_pred             EEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence            999996 5888777655556889999999999999999999999999999999999999999999999998765443   


Q ss_pred             ccCCCcccccCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          193 TAETGTYRWMAPEVIN---HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                      ....++..|+|||.+.   ...++.++|+||||+++|+|++|..||...+..+....+.+
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  228 (308)
T cd06634         169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ  228 (308)
T ss_pred             ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh
Confidence            2345778999999974   34578899999999999999999999987766655554443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.5e-32  Score=222.02  Aligned_cols=204  Identities=26%  Similarity=0.463  Sum_probs=163.6

Q ss_pred             ceeccccceEEEEEEEc-C---ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCCC
Q 045286           44 ERIASGSCGDLYRGVYL-G---QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPG  119 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~-~---~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~  119 (259)
                      ++||+|+||.||++... +   ..+++|.+.... .......+.+|+..++.++||||+++++.+......+++|||+++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            36999999999998753 2   235566655432 233457789999999999999999999999988999999999999


Q ss_pred             CChHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC---Cccc
Q 045286          120 GSLYDYLHKNH---NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG---GVMT  193 (259)
Q Consensus       120 ~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~---~~~~  193 (259)
                      ++|.+++....   ...+...+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+......   ....
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  159 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED  159 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence            99999987542   23566777889999999999999999999999999999999999999999987532221   1112


Q ss_pred             cCCCcccccCccccCC-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhh
Q 045286          194 AETGTYRWMAPEVINH-------QPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVR  248 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~-------~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~  248 (259)
                      ...++..|+|||.+..       ..++.++|+||||+++|+|++ +..||...+..+....+.
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~  222 (268)
T cd05086         160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVI  222 (268)
T ss_pred             CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            3456788999999743       345789999999999999997 678998877776666544

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=8.4e-33  Score=227.79  Aligned_cols=204  Identities=17%  Similarity=0.268  Sum_probs=155.7

Q ss_pred             eechhhhhccceeccccceEEEEEEEcC-----ceEEEEEeecccCchHHH---------HHHHHHHHHHHhcCCCCcce
Q 045286           34 EIDRRLLKTGERIASGSCGDLYRGVYLG-----QDVAVKVLRSEHLNDTLE---------DEFVQEVAILREVQHRNVVR   99 (259)
Q Consensus        34 ~~~~~~~~~~~~lg~G~~~~V~~~~~~~-----~~v~vK~~~~~~~~~~~~---------~~~~~e~~~l~~l~~~~i~~   99 (259)
                      ++..++|++.+.||+|+||.||+|...+     ..+++|+...........         .....+...+..+.|+++++
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~   87 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK   87 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence            3456789999999999999999998653     356666644332211110         11223344556668999999


Q ss_pred             eeeeeecCC----cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeE
Q 045286          100 FIGASTKSP----HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVV  175 (259)
Q Consensus       100 ~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i  175 (259)
                      +++.+....    ..+++++.. ..++.+.+... ...++..+..++.|++.++.+||+.+++||||||+||+++.++.+
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehh-ccCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence            998765432    346777877 44677666443 235678889999999999999999999999999999999999999


Q ss_pred             EEeeeccceeccCCC--------ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 045286          176 KVADFGVARFQNKGG--------VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT  239 (259)
Q Consensus       176 ~l~D~~~~~~~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  239 (259)
                      +|+|||++.......        ......+++.|+|||...+..++.++|+|||||++|+|++|..||.+.+
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~  237 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG  237 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence            999999987653211        1122358999999999999999999999999999999999999998763

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.6e-32  Score=228.01  Aligned_cols=204  Identities=23%  Similarity=0.348  Sum_probs=171.2

Q ss_pred             hhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCCC
Q 045286           40 LKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPG  119 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~  119 (259)
                      +.+++.+|.|+++.|+++...++.+|+|++............+.+|+.+++.++|+||+++++++...+..++++||+++
T Consensus         4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            44566677777777777777899999999987655555667899999999999999999999999999999999999999


Q ss_pred             CChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc-------
Q 045286          120 GSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV-------  191 (259)
Q Consensus       120 ~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~-------  191 (259)
                      ++|.+++... ...+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.++++||+.+........       
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~  163 (314)
T cd08216          84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD  163 (314)
T ss_pred             CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence            9999999754 34588899999999999999999999999999999999999999999999998864432211       


Q ss_pred             -cccCCCcccccCccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 045286          192 -MTAETGTYRWMAPEVINHQ--PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQA  243 (259)
Q Consensus       192 -~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~  243 (259)
                       .....++..|+|||.+.+.  .++.++|+||+|+++|+|++|..||........
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~  218 (314)
T cd08216         164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM  218 (314)
T ss_pred             ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence             1223456789999998763  578999999999999999999999987655443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.7e-32  Score=221.74  Aligned_cols=191  Identities=21%  Similarity=0.395  Sum_probs=159.8

Q ss_pred             hhhccce--eccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeeeeeecCCcEEEE
Q 045286           39 LLKTGER--IASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        39 ~~~~~~~--lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      ++.+.+.  ||+|+||.||++..  .++.+++|.+........       |......+ +|+||+++++.+...+..++|
T Consensus        15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv   87 (267)
T PHA03390         15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLI   87 (267)
T ss_pred             hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence            4445455  49999999999986  478899999876543221       12222222 699999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC-eEEEeeeccceeccCCCcc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN-VVKVADFGVARFQNKGGVM  192 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~-~i~l~D~~~~~~~~~~~~~  192 (259)
                      |||+++++|.+++.... .+++..++.++.|+++++.+||+.|++|+||+|+||+++.++ .++|+|||.+.......  
T Consensus        88 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~--  164 (267)
T PHA03390         88 MDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS--  164 (267)
T ss_pred             EEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc--
Confidence            99999999999996654 689999999999999999999999999999999999999988 99999999987654332  


Q ss_pred             ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 045286          193 TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTP  240 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~  240 (259)
                       ...++..|+|||.+.+..++.++|+||+|+++|+|++|..||.....
T Consensus       165 -~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~  211 (267)
T PHA03390        165 -CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED  211 (267)
T ss_pred             -cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc
Confidence             23578899999999988899999999999999999999999975443

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-34  Score=256.79  Aligned_cols=221  Identities=23%  Similarity=0.342  Sum_probs=191.5

Q ss_pred             ccccceechhhhhccceeccccceEEEEEEE--cCceEEEEEeecc-cCchHHHHHHHHHHHHHHhcCCCCcceeeeeee
Q 045286           29 KSEDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSE-HLNDTLEDEFVQEVAILREVQHRNVVRFIGAST  105 (259)
Q Consensus        29 ~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~  105 (259)
                      +.+...+..++|.+.+.||.|+||.|.+++.  +++-+|.|+++.- .........|..|-.++..-+.+=|+.++-+|+
T Consensus        66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ  145 (1317)
T KOG0612|consen   66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ  145 (1317)
T ss_pred             HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence            4455667789999999999999999999886  4788999998862 122233467888899999889999999999999


Q ss_pred             cCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          106 KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                      +..+.|+||||++||+|..++.+.. .++++.++-++..|.-+|..+|+.|+|||||||+|||++..|.++|.|||.+-.
T Consensus       146 D~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClk  224 (1317)
T KOG0612|consen  146 DERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLK  224 (1317)
T ss_pred             CccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHh
Confidence            9999999999999999999998777 799999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCc--cccCCCcccccCccccC----C-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          186 QNKGGV--MTAETGTYRWMAPEVIN----H-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       186 ~~~~~~--~~~~~~~~~~~~PE~~~----~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      +.....  .....|||.|.+||++.    + ..|++..|.||+|+++|+|+.|.-||-..+-.+...+|..-
T Consensus       225 m~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h  296 (1317)
T KOG0612|consen  225 MDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH  296 (1317)
T ss_pred             cCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch
Confidence            775432  23457999999999984    3 46889999999999999999999999887777777777654

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-34  Score=232.69  Aligned_cols=218  Identities=22%  Similarity=0.411  Sum_probs=182.3

Q ss_pred             HhccccccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCch-----HHHHHHHHHHHHHHhcCCCCc
Q 045286           25 ESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND-----TLEDEFVQEVAILREVQHRNV   97 (259)
Q Consensus        25 ~~~~~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i   97 (259)
                      +.++.+++.+..+++|.+.++||.|+|+.||+|.+.  .+.||||+-.....+.     +......+|.++.+.|.||.|
T Consensus       450 EdnSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRI  529 (775)
T KOG1151|consen  450 EDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRI  529 (775)
T ss_pred             cchhhhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCccee
Confidence            345677888888999999999999999999999986  6789999977654332     344667799999999999999


Q ss_pred             ceeeeeee-cCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCCCcEEEcc---
Q 045286           98 VRFIGAST-KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR--NIIHRDLKTANLLMDT---  171 (259)
Q Consensus        98 ~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~--~i~H~di~p~Nilv~~---  171 (259)
                      ++++++|. +.+.+|-|.||++|-+|+-++.. .+.+++.+++.|+-||+.+|.||...  -|+|-|+||.|||+-.   
T Consensus       530 VKlYDyfslDtdsFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gta  608 (775)
T KOG1151|consen  530 VKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTA  608 (775)
T ss_pred             eeeeeeeeeccccceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcc
Confidence            99999984 56889999999999999999844 44599999999999999999999976  4999999999999943   


Q ss_pred             CCeEEEeeeccceeccCCCcc--------ccCCCcccccCccccC-C---CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 045286          172 HNVVKVADFGVARFQNKGGVM--------TAETGTYRWMAPEVIN-H---QPYDQKADVFSFAIVLWELVTAKVPYDSMT  239 (259)
Q Consensus       172 ~~~i~l~D~~~~~~~~~~~~~--------~~~~~~~~~~~PE~~~-~---~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  239 (259)
                      -|.|||.|||++..+...+..        +...|+..|+|||.+. +   ...+.++|+||+|+++|+++.|+.||...-
T Consensus       609 cGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq  688 (775)
T KOG1151|consen  609 CGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ  688 (775)
T ss_pred             cceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence            478999999999877655332        3346899999999973 2   345789999999999999999999997654


Q ss_pred             HHHH
Q 045286          240 PLQA  243 (259)
Q Consensus       240 ~~~~  243 (259)
                      ..+.
T Consensus       689 sQQd  692 (775)
T KOG1151|consen  689 SQQD  692 (775)
T ss_pred             hHHH
Confidence            4433

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.9e-32  Score=229.18  Aligned_cols=209  Identities=24%  Similarity=0.382  Sum_probs=171.0

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC-------
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS-------  107 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-------  107 (259)
                      ..+|.+.++||.|++|.||+|.+.  ++.|++|.+.....  .....+.+|+.+++.++|+||+++++.+...       
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence            368999999999999999999874  78999999876643  3346678899999999999999998765443       


Q ss_pred             -------CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc-CCeEEEee
Q 045286          108 -------PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT-HNVVKVAD  179 (259)
Q Consensus       108 -------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~-~~~i~l~D  179 (259)
                             ...++++||++ ++|.+++...  .+++..++.++.|++++|.+||+.|++|+||+|+||+++. ++.++++|
T Consensus        82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          82 VGSLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             cccccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence                   35789999996 5888887533  4889999999999999999999999999999999999975 56789999


Q ss_pred             eccceeccCCCc----cccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          180 FGVARFQNKGGV----MTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       180 ~~~~~~~~~~~~----~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      ||.+........    .....++..|.|||.+.+ ..++.++|+|||||++|+|++|..||...+..+....+...
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            999876543211    122346778999998654 56788999999999999999999999988876666655443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4e-32  Score=219.71  Aligned_cols=211  Identities=30%  Similarity=0.494  Sum_probs=172.9

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeeccc---CchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEH---LNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      +|.+.++||+|++|.||++.+.  +..+++|+.+...   ........+.+|+.+++.++||||+++++.+......+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            5788899999999999999875  3445566655422   2223335567889999999999999999999888899999


Q ss_pred             EecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          114 TEYMPGGSLYDYLHK---NHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      +||+++++|.+++..   ....+++..++.++.|++.++.+||+.|++|+|++|+||+++. +.++|+|||.+.......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            999999999998864   2345889999999999999999999999999999999999964 669999999987654332


Q ss_pred             -ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          191 -VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       191 -~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                       ......++..|.|||.+.+..++.++|+||+|+++|+|++|..||...+..+....+..+
T Consensus       160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~  220 (260)
T cd08222         160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG  220 (260)
T ss_pred             ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC
Confidence             223345778899999998888899999999999999999999999877666665555443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-33  Score=235.58  Aligned_cols=224  Identities=32%  Similarity=0.602  Sum_probs=199.3

Q ss_pred             cccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS  107 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~  107 (259)
                      .++|++++.++...++||-|-+|.||.+.|.  .-.||||.++.+   .....+|+.|+.+++.++|||+++++++|+.+
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~E  335 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE  335 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence            3789999999999999999999999999997  568999999864   34468899999999999999999999999999


Q ss_pred             CcEEEEEecCCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNHN-VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                      ..+|||.||+..+.|.+++++..+ ..+...+.+++.||.+++.||+.++++|||+...|.||.++-.+|+.|||+++++
T Consensus       336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM  415 (1157)
T KOG4278|consen  336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM  415 (1157)
T ss_pred             CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence            999999999999999999976554 3666777889999999999999999999999999999999999999999999877


Q ss_pred             cCCCccc--cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          187 NKGGVMT--AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       187 ~~~~~~~--~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      .......  .--...-|.+||-+.-..++.++|+|+||+++|++.| |..||++-+-.++...+++++++..|
T Consensus       416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~P  488 (1157)
T KOG4278|consen  416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGP  488 (1157)
T ss_pred             cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCC
Confidence            6553221  1123577999999999999999999999999999999 99999999999999999999987544

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=1.6e-31  Score=211.04  Aligned_cols=216  Identities=32%  Similarity=0.553  Sum_probs=183.2

Q ss_pred             hhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecC
Q 045286           40 LKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYM  117 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~  117 (259)
                      |.+.+.||+|+++.||++...  ++.+++|.+...... .....+.+|+..+++++|++++++++.+...+..++++|++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence            456789999999999999985  589999999876544 24577889999999999999999999998888999999999


Q ss_pred             CCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC--ccccC
Q 045286          118 PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG--VMTAE  195 (259)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~--~~~~~  195 (259)
                      ++++|.+++......++...+..++.+++.++.++|+.+++|+|++|+||+++.++.++|+|||.+.......  .....
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~  159 (225)
T smart00221       80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV  159 (225)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence            9999999987654337889999999999999999999999999999999999999999999999988766543  22344


Q ss_pred             CCcccccCcccc-CCCCCCCchhHHHHHHHHHHHHcCCCCCCC-CCHH-HHHHHhhhccCCCCc
Q 045286          196 TGTYRWMAPEVI-NHQPYDQKADVFSFAIVLWELVTAKVPYDS-MTPL-QAALGVRQVCTSLCQ  256 (259)
Q Consensus       196 ~~~~~~~~PE~~-~~~~~~~~~Di~slG~~~~~ll~g~~p~~~-~~~~-~~~~~i~~~~~~~~~  256 (259)
                      .+...|++||.+ ....++.++|+|+||+++++|++|..||.. .+.. ++...+..+...+.|
T Consensus       160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  223 (225)
T smart00221      160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLWE  223 (225)
T ss_pred             eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccccc
Confidence            577889999998 666788899999999999999999999987 4444 666666666544433

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3.7e-32  Score=223.21  Aligned_cols=197  Identities=25%  Similarity=0.390  Sum_probs=166.5

Q ss_pred             hhccceeccccceEEEEEEE-----cCceEEEEEeecccCc--hHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCCcEE
Q 045286           40 LKTGERIASGSCGDLYRGVY-----LGQDVAVKVLRSEHLN--DTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~-----~~~~v~vK~~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~  111 (259)
                      |++.+.||.|++|.||++..     .++.+++|+++.....  ......+.+|+.+++++. |++|+++++.+......+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            67788999999999999875     3578999998754321  223356788999999995 999999999999889999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc
Q 045286          112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV  191 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~  191 (259)
                      +|+||+++++|.+++... ..++...+..++.|++++|.+||+.+++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  160 (288)
T cd05583          82 LILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE  160 (288)
T ss_pred             EEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence            999999999999998654 3588899999999999999999999999999999999999999999999998865443321


Q ss_pred             --cccCCCcccccCccccCCCC--CCCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          192 --MTAETGTYRWMAPEVINHQP--YDQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       192 --~~~~~~~~~~~~PE~~~~~~--~~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                        .....++..|++||.+.+..  .+.++|+||||+++|+|++|..||..
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~  210 (288)
T cd05583         161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV  210 (288)
T ss_pred             cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence              12235788999999987654  68899999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-32  Score=204.19  Aligned_cols=220  Identities=27%  Similarity=0.433  Sum_probs=185.8

Q ss_pred             cceechhhhhccceeccccceEEEEEE--EcCceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCC
Q 045286           32 DWEIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSP  108 (259)
Q Consensus        32 ~~~~~~~~~~~~~~lg~G~~~~V~~~~--~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~  108 (259)
                      .++++.+.+.-...||.|++|.|-+-.  ..|.-.|+|.+...-. .....+.++|+.+..+.. +|+++.+++....+.
T Consensus        40 ~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg  118 (282)
T KOG0984|consen   40 NFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG  118 (282)
T ss_pred             ccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence            388999999999999999999876554  4688899999987654 344567778888877764 999999999999999


Q ss_pred             cEEEEEecCCCCChHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEccCCeEEEeeeccce
Q 045286          109 HLCIVTEYMPGGSLYDYLH---KNHNVLKLPQLLRFAIDICKGMEYLHQR-NIIHRDLKTANLLMDTHNVVKVADFGVAR  184 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~di~p~Nilv~~~~~i~l~D~~~~~  184 (259)
                      ..|+.||-+ ..+|+.+..   +.+..+++..+-+++-.+..++.+||++ .++|||+||+|||++.+|.+|+||||.+.
T Consensus       119 dvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  119 DVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             cEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence            999999999 678888764   3456799999999999999999999976 79999999999999999999999999998


Q ss_pred             eccCCCccccCCCcccccCccccC----CCCCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHhhhccCC
Q 045286          185 FQNKGGVMTAETGTYRWMAPEVIN----HQPYDQKADVFSFAIVLWELVTAKVPYDS-MTPLQAALGVRQVCTS  253 (259)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~~~~Di~slG~~~~~ll~g~~p~~~-~~~~~~~~~i~~~~~~  253 (259)
                      ...+.-..+...|-..|+|||.+.    ...|+-++|+||||+++.||.++..||+. .++.++++++-+.=.+
T Consensus       198 ~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P  271 (282)
T KOG0984|consen  198 YLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSP  271 (282)
T ss_pred             eehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCC
Confidence            776654445566778899999974    34789999999999999999999999985 7778888887655433

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-35  Score=224.51  Aligned_cols=217  Identities=25%  Similarity=0.418  Sum_probs=183.0

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC-----cE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP-----HL  110 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~  110 (259)
                      .+++-.++||.|+||.||.+++.  ++.|++|++..-..+-...+++.+|..+|..++|.|++..+++.....     .+
T Consensus        53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            45666789999999999999874  889999999887666667788999999999999999999998875432     23


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      |++.|.+ ..+|...+ -.+..++.+.+.-++.||+++|.|||+.+|.||||||.|.+|+.+..+||||||+++......
T Consensus       133 YV~TELm-QSDLHKII-VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~  210 (449)
T KOG0664|consen  133 YVLTELM-QSDLHKII-VSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD  210 (449)
T ss_pred             HHHHHHH-Hhhhhhee-ccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence            4555555 33555544 345568889999999999999999999999999999999999999999999999998665443


Q ss_pred             --ccccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          191 --VMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       191 --~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                        .++.+.-+..|++||.+.|. .|+.+.||||+||++.|++..+..|...++.+.++.|...++++..
T Consensus       211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~  279 (449)
T KOG0664|consen  211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQ  279 (449)
T ss_pred             hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcH
Confidence              34556678999999999875 6899999999999999999999999999999999999888877653

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-34  Score=259.29  Aligned_cols=219  Identities=27%  Similarity=0.440  Sum_probs=184.3

Q ss_pred             hhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      -+++-+..||.|-||.||-|.+  +|+-.|+|-++-..........+.+|..++..++|||+++++++-.+.+..++.||
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            3677888999999999999986  57888999888765554455678899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-----
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-----  190 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-----  190 (259)
                      ||++|+|.+.++... -.++.....+..|++.++.|||+.||||+||||.||+++.+|.+|++|||.+..+.+..     
T Consensus      1315 yC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred             HhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence            999999999985443 36667777899999999999999999999999999999999999999999998665542     


Q ss_pred             ccccCCCcccccCccccCCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHhhhccCCCCcc
Q 045286          191 VMTAETGTYRWMAPEVINHQ---PYDQKADVFSFAIVLWELVTAKVPYDSMTP-LQAALGVRQVCTSLCQP  257 (259)
Q Consensus       191 ~~~~~~~~~~~~~PE~~~~~---~~~~~~Di~slG~~~~~ll~g~~p~~~~~~-~~~~~~i~~~~~~~~~~  257 (259)
                      ......||+.|+|||.+.+.   ...-+.|||||||++.||+||+.||...+. -+.+-.+-.+-.+..|+
T Consensus      1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~ 1464 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPE 1464 (1509)
T ss_pred             HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCch
Confidence            22345799999999999764   456799999999999999999999987444 55566666666555553

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-33  Score=240.74  Aligned_cols=224  Identities=30%  Similarity=0.546  Sum_probs=195.7

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK  106 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~  106 (259)
                      -.+++..++..++||+|+||+||++.|-      .-+|++|++.... ......++++|+-++.++.|||++++++++..
T Consensus       691 rI~kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~  769 (1177)
T KOG1025|consen  691 RILKETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCML  769 (1177)
T ss_pred             eechhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhccc
Confidence            3445567778899999999999999974      3478999887653 34455889999999999999999999999987


Q ss_pred             CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          107 SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                      +. .-+|.+|+++|+|.++++.....+-......|+.||++++.|||.++++||||-.+|+||.....+|+.|||++...
T Consensus       770 s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll  848 (1177)
T KOG1025|consen  770 ST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLL  848 (1177)
T ss_pred             ch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence            65 67899999999999999988888999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCcc-c--cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCccC
Q 045286          187 NKGGVM-T--AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQPI  258 (259)
Q Consensus       187 ~~~~~~-~--~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~  258 (259)
                      ...... .  ..--.+-|++-|.+....+++++|+||+|+++||++| |..|+.+.+..+.-+.++.+-+-.+||.
T Consensus       849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpi  924 (1177)
T KOG1025|consen  849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPI  924 (1177)
T ss_pred             CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCC
Confidence            655322 1  1123567899999999999999999999999999999 9999999999999999999998877774

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=7e-34  Score=236.18  Aligned_cols=219  Identities=24%  Similarity=0.365  Sum_probs=189.9

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCC------CCcceeeeee
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH------RNVVRFIGAS  104 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~  104 (259)
                      -++...+|.+....|+|-|++|..|.++  ++.||||++.......   ..=+.|+++|++|+.      -|+++++..|
T Consensus       427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~---KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F  503 (752)
T KOG0670|consen  427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH---KTGLKELEILKKLNDADPEDKFHCLRLFRHF  503 (752)
T ss_pred             hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh---hhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence            3455678888889999999999999986  7799999999864322   444579999999962      5889999999


Q ss_pred             ecCCcEEEEEecCCCCChHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC-eEEEeeec
Q 045286          105 TKSPHLCIVTEYMPGGSLYDYLHKNHNV--LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN-VVKVADFG  181 (259)
Q Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~-~i~l~D~~  181 (259)
                      .+..++|+|||.+ ...|.+.+.+.+..  +....+..++.||+-+|..|-+.|++|+||||+||||++.. .+||||||
T Consensus       504 ~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  504 KHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             hhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCc
Confidence            9999999999998 67999999776543  77789999999999999999999999999999999999875 57999999


Q ss_pred             cceeccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          182 VARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      .|.+...+. .+++.-+-.|.|||.+.|.+|+...|+||+||++|++.||+..|++.+.-+++.-.....+..+.
T Consensus       583 SA~~~~ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~  656 (752)
T KOG0670|consen  583 SASFASENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN  656 (752)
T ss_pred             ccccccccc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence            998877653 45556678899999999999999999999999999999999999999999999988877776553

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=226.51  Aligned_cols=215  Identities=23%  Similarity=0.380  Sum_probs=182.1

Q ss_pred             echhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCC------CCcceeeeeeec
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH------RNVVRFIGASTK  106 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~  106 (259)
                      ....+|.+.+.+|.|.||.|-.+.+.  +..||||+++.-.   ...+..+-|+++|+++++      --++.+.++|..
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy  162 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY  162 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence            33678999999999999999999885  5789999998752   334556678999999942      235667788999


Q ss_pred             CCcEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc--------------
Q 045286          107 SPHLCIVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT--------------  171 (259)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~--------------  171 (259)
                      .++.|+|+|.+ |.++.+++..+ ..+++...++.++.|+++++.+||+.+++|.|+||+||++..              
T Consensus       163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccc
Confidence            99999999998 88999999764 446889999999999999999999999999999999999921              


Q ss_pred             ------CCeEEEeeeccceeccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 045286          172 ------HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL  245 (259)
Q Consensus       172 ------~~~i~l~D~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~  245 (259)
                            +..|+++|||.+.+....-  .....|..|+|||++.+.+++.+.|+||+||++.|+.+|...|...++.+-+.
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLa  319 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLA  319 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHH
Confidence                  2359999999998766542  45567899999999999999999999999999999999999999888888887


Q ss_pred             HhhhccCCCC
Q 045286          246 GVRQVCTSLC  255 (259)
Q Consensus       246 ~i~~~~~~~~  255 (259)
                      .+++.+++.+
T Consensus       320 MMerIlGp~P  329 (415)
T KOG0671|consen  320 MMERILGPIP  329 (415)
T ss_pred             HHHHhhCCCc
Confidence            7777777543

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-32  Score=221.93  Aligned_cols=215  Identities=34%  Similarity=0.604  Sum_probs=175.9

Q ss_pred             hhhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhc--CCCCcceeeeeeecC----CcEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV--QHRNVVRFIGASTKS----PHLC  111 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~~~~~~~----~~~~  111 (259)
                      +.+++.+.||+|.||.||+|.|.|+.||||++....     .....+|.++++..  +|+||+.+++..-.+    .+.|
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             heeEEEEEecCccccceeeccccCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            678899999999999999999999999999998753     25577888888866  799999999876432    3789


Q ss_pred             EEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCcEEEccCCeEEEeeeccc
Q 045286          112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR--------NIIHRDLKTANLLMDTHNVVKVADFGVA  183 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~--------~i~H~di~p~Nilv~~~~~i~l~D~~~~  183 (259)
                      +|.+|.+.|||.+++...  .++.....+++..++++|++||..        .|.|||||..||||..+|...|.|+|++
T Consensus       286 LvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA  363 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  363 (513)
T ss_pred             EeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence            999999999999999763  488899999999999999999963        4999999999999999999999999999


Q ss_pred             eeccCCC-----ccccCCCcccccCccccCCC----CC--CCchhHHHHHHHHHHHHcC----------CCCCCC-----
Q 045286          184 RFQNKGG-----VMTAETGTYRWMAPEVINHQ----PY--DQKADVFSFAIVLWELVTA----------KVPYDS-----  237 (259)
Q Consensus       184 ~~~~~~~-----~~~~~~~~~~~~~PE~~~~~----~~--~~~~Di~slG~~~~~ll~g----------~~p~~~-----  237 (259)
                      .......     ......||.+|+|||++...    .+  -..+||||||.++||+.-.          ++||-+     
T Consensus       364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D  443 (513)
T KOG2052|consen  364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD  443 (513)
T ss_pred             EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence            7655442     23456799999999998653    12  2368999999999998742          457733     


Q ss_pred             CCHHHHHHHhh-hccCCCCccCC
Q 045286          238 MTPLQAALGVR-QVCTSLCQPIY  259 (259)
Q Consensus       238 ~~~~~~~~~i~-~~~~~~~~~~~  259 (259)
                      ++..++.+-+. +.+++..|.+|
T Consensus       444 Ps~eeMrkVVCv~~~RP~ipnrW  466 (513)
T KOG2052|consen  444 PSFEEMRKVVCVQKLRPNIPNRW  466 (513)
T ss_pred             CCHHHHhcceeecccCCCCCccc
Confidence            44455555555 67777777776

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-33  Score=225.95  Aligned_cols=220  Identities=25%  Similarity=0.379  Sum_probs=188.9

Q ss_pred             eechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCCc
Q 045286           34 EIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPH  109 (259)
Q Consensus        34 ~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~  109 (259)
                      .+...++.+..+||.|+||.|.++...  .+-+|||+++.+.. +++..+.-+.|.++|.-.. -|.++.++.+|+.-++
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            556678888999999999999999865  57899999988644 2333455567778877765 6788999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG  189 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~  189 (259)
                      +|+||||+.|++|--.+++.++ +.++.+.-++.+|+-+|-+||++||++||+|.+||+++.+|.+||.|||.+...-..
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence            9999999999999888866554 889999999999999999999999999999999999999999999999998754332


Q ss_pred             -CccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          190 -GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       190 -~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                       ......+|++.|.|||.+.-.+|+..+|.||+|+++|+||.|+.||++.+..+.-..|.+.-...
T Consensus       504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsy  569 (683)
T KOG0696|consen  504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSY  569 (683)
T ss_pred             CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcC
Confidence             23346789999999999999999999999999999999999999999999999988887654433

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-31  Score=237.65  Aligned_cols=225  Identities=32%  Similarity=0.587  Sum_probs=197.4

Q ss_pred             cceechhhhhccceeccccceEEEEEEEc---------CceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceee
Q 045286           32 DWEIDRRLLKTGERIASGSCGDLYRGVYL---------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFI  101 (259)
Q Consensus        32 ~~~~~~~~~~~~~~lg~G~~~~V~~~~~~---------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~  101 (259)
                      .|+++++++.+.+.||.|+||+|++|...         ...||||.++..... ...+.+..|+++++.+. |+||+.++
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll  368 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL  368 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence            79999999999999999999999999743         357999999987665 56688999999999996 99999999


Q ss_pred             eeeecCCcEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 045286          102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH---------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTAN  166 (259)
Q Consensus       102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~N  166 (259)
                      +++...+..++|.||+..++|.++++...               ..++..+...++.||+.+++||++..++|||+...|
T Consensus       369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN  448 (609)
T KOG0200|consen  369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN  448 (609)
T ss_pred             eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence            99999899999999999999999998766               348888999999999999999999999999999999


Q ss_pred             EEEccCCeEEEeeeccceeccCCCccccC--C--CcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC-H
Q 045286          167 LLMDTHNVVKVADFGVARFQNKGGVMTAE--T--GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT-P  240 (259)
Q Consensus       167 ilv~~~~~i~l~D~~~~~~~~~~~~~~~~--~--~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~-~  240 (259)
                      ||++.+..+|++|||+++...+.......  .  -...|+|||.+....++.++|+||+|+++||+.+ |..||.+.. .
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~  528 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT  528 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence            99999999999999999865554333211  1  2456999999999999999999999999999999 999999866 6


Q ss_pred             HHHHHHhhhccCCCCcc
Q 045286          241 LQAALGVRQVCTSLCQP  257 (259)
Q Consensus       241 ~~~~~~i~~~~~~~~~~  257 (259)
                      .+.++.+++|.+..-|.
T Consensus       529 ~~l~~~l~~G~r~~~P~  545 (609)
T KOG0200|consen  529 EELLEFLKEGNRMEQPE  545 (609)
T ss_pred             HHHHHHHhcCCCCCCCC
Confidence            77777888888866553

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-32  Score=210.39  Aligned_cols=218  Identities=26%  Similarity=0.425  Sum_probs=181.2

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCCc
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPH  109 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~  109 (259)
                      +..+-++++....||+|+.|+||++...  |.-.|||....... .+..++++..+.+..... +|+|++.+++|.....
T Consensus        87 ~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-kee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d  165 (391)
T KOG0983|consen   87 YQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD  165 (391)
T ss_pred             cccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC-HHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence            4445577888899999999999999976  58899999887753 344466666666665554 8999999999988888


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR-NIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      .++.||-+ +..++.++.....++++..+-.+...++++|.||..+ |++|||+||+|||++..|++|+||||++.++-.
T Consensus       166 V~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd  244 (391)
T KOG0983|consen  166 VFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD  244 (391)
T ss_pred             HHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec
Confidence            88889988 6677777777777799999999999999999999865 799999999999999999999999999987766


Q ss_pred             CCccccCCCcccccCccccCC---CCCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHhhhccC
Q 045286          189 GGVMTAETGTYRWMAPEVINH---QPYDQKADVFSFAIVLWELVTAKVPYDS-MTPLQAALGVRQVCT  252 (259)
Q Consensus       189 ~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slG~~~~~ll~g~~p~~~-~~~~~~~~~i~~~~~  252 (259)
                      ....+...|-+.|++||.+.-   ..|+.++|+||||++++|+.||.-||.+ .+..+++-+|.....
T Consensus       245 SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP  312 (391)
T KOG0983|consen  245 SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP  312 (391)
T ss_pred             ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC
Confidence            555556678889999999964   3688999999999999999999999987 455677777776444

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.98  E-value=6.8e-33  Score=232.77  Aligned_cols=197  Identities=24%  Similarity=0.445  Sum_probs=172.3

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHH------HHHHHHHHHHHhcC---CCCcceeeeeeec
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLE------DEFVQEVAILREVQ---HRNVVRFIGASTK  106 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~------~~~~~e~~~l~~l~---~~~i~~~~~~~~~  106 (259)
                      ..|...+++|.|+||.|++|.++  ...|++|.+.+++.-.+.+      ..+.-|+++|..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            56888999999999999999986  4679999998875432222      33567999999997   9999999999999


Q ss_pred             CCcEEEEEecC-CCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          107 SPHLCIVTEYM-PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       107 ~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                      .+++++++|.. +|.+|.+++...+ .+++.++..+++|++.++..||+.||+|||||-+|+.++.+|.++|+|||.+..
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~  719 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY  719 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence            99999999975 4678899986554 499999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCccccCCCcccccCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCC
Q 045286          186 QNKGGVMTAETGTYRWMAPEVINHQPY-DQKADVFSFAIVLWELVTAKVPYD  236 (259)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~~~~ll~g~~p~~  236 (259)
                      ..++ ++....||..|.|||++.|.+| +...|||+||+++|.+.....||=
T Consensus       720 ~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  720 TKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            6665 4566789999999999999988 678999999999999999888873

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.98  E-value=8.2e-31  Score=236.97  Aligned_cols=146  Identities=25%  Similarity=0.446  Sum_probs=131.0

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      ++|.+.++||+|+||.||+|.+.  ++.||+|++..... .......+.+|+.+++.++|++|+++++.+...+..++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999999999986  88999999976432 3444567889999999999999999999999899999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccce
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR  184 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~  184 (259)
                      ||+.+++|..++... ..+++..++.++.||+.+|.|||+.+++|+||||+|||++.++.++|+|||++.
T Consensus        84 Ey~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999998654 348889999999999999999999999999999999999999999999999864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-33  Score=214.90  Aligned_cols=223  Identities=26%  Similarity=0.395  Sum_probs=179.7

Q ss_pred             ccccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeeeeee
Q 045286           29 KSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGAST  105 (259)
Q Consensus        29 ~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~  105 (259)
                      ..+.|++....++-...||.|+||+|++-...  |+..|||.++...... ...+++.|.....+- ++|+|++++++..
T Consensus        55 ~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~k-eq~rll~e~d~~mks~~cp~IVkfyGa~F  133 (361)
T KOG1006|consen   55 DAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEK-EQKRLLMEHDTVMKSSNCPNIVKFYGALF  133 (361)
T ss_pred             cccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchH-HHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence            55679999999999999999999999987764  8899999999887643 345566666665555 5999999999988


Q ss_pred             cCCcEEEEEecCCCCChHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEccCCeEEEeee
Q 045286          106 KSPHLCIVTEYMPGGSLYDYLHK----NHNVLKLPQLLRFAIDICKGMEYLHQR-NIIHRDLKTANLLMDTHNVVKVADF  180 (259)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~di~p~Nilv~~~~~i~l~D~  180 (259)
                      .++-.|+-||.+ ..+++.+...    ....+++..+..++--...+|.||-.. +++|||+||+|||++..|.+|||||
T Consensus       134 ~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDF  212 (361)
T KOG1006|consen  134 SEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDF  212 (361)
T ss_pred             cCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecc
Confidence            888899999999 6687776421    233488887778888888999999865 7999999999999999999999999


Q ss_pred             ccceeccCCCccccCCCcccccCccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHhhhccCC
Q 045286          181 GVARFQNKGGVMTAETGTYRWMAPEVINH--QPYDQKADVFSFAIVLWELVTAKVPYDSMTP-LQAALGVRQVCTS  253 (259)
Q Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~-~~~~~~i~~~~~~  253 (259)
                      |.+......-..+...|-..|+|||.+..  ..|+.+||+||||+++||+.||.-|+...+. .+++.++..+-.+
T Consensus       213 GIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp  288 (361)
T KOG1006|consen  213 GICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPP  288 (361)
T ss_pred             cchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCC
Confidence            99876555444445567788999999853  4689999999999999999999999987554 4555555544443

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=6.7e-31  Score=209.92  Aligned_cols=179  Identities=21%  Similarity=0.270  Sum_probs=152.7

Q ss_pred             ccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCCCCChHHHH
Q 045286           49 GSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL  126 (259)
Q Consensus        49 G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l  126 (259)
                      |.++.||++.+  +++.+++|.+....       ...+|...+....||||+++++.+...+..+++|||+++++|.+++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence            89999999997  47899999997652       2234455555667999999999999999999999999999999998


Q ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccccCCCcccccCccc
Q 045286          127 HKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEV  206 (259)
Q Consensus       127 ~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~~~~~~~~~~PE~  206 (259)
                      .... .+++..+..++.|++++|.++|+.|++|+||+|+||+++.++.++++|||.+.......  ....++..|+|||.
T Consensus        77 ~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~y~aPE~  153 (237)
T cd05576          77 SKFL-NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC--DGEAVENMYCAPEV  153 (237)
T ss_pred             HHhc-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc--ccCCcCccccCCcc
Confidence            6544 48899999999999999999999999999999999999999999999999875544331  22345677999999


Q ss_pred             cCCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          207 INHQPYDQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       207 ~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                      ..+..++.++|+||+|+++|+|++|..|+..
T Consensus       154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~  184 (237)
T cd05576         154 GGISEETEACDWWSLGAILFELLTGKTLVEC  184 (237)
T ss_pred             cCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence            9888889999999999999999999988754

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=1.1e-31  Score=241.41  Aligned_cols=212  Identities=31%  Similarity=0.506  Sum_probs=164.4

Q ss_pred             hhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC-------
Q 045286           38 RLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP-------  108 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------  108 (259)
                      .++.....||+||||.||++++  +|+.+|||.+.... +...-..+.+|+..+++|+|||+++++..|.++.       
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            3556678999999999999986  59999999999886 6666788999999999999999999887663211       


Q ss_pred             --------------------------------------------------------------------------------
Q 045286          109 --------------------------------------------------------------------------------  108 (259)
Q Consensus       109 --------------------------------------------------------------------------------  108 (259)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             --------------------------------cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 045286          109 --------------------------------HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN  156 (259)
Q Consensus       109 --------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~  156 (259)
                                                      ..||=||||+..++.+++..+...-.....|+++++|+++|.|+|+.|
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g  717 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG  717 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence                                            025556777665566555443321246789999999999999999999


Q ss_pred             cccCCCCCCcEEEccCCeEEEeeeccceecc-------------------CCCccccCCCcccccCccccCCCC---CCC
Q 045286          157 IIHRDLKTANLLMDTHNVVKVADFGVARFQN-------------------KGGVMTAETGTYRWMAPEVINHQP---YDQ  214 (259)
Q Consensus       157 i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~-------------------~~~~~~~~~~~~~~~~PE~~~~~~---~~~  214 (259)
                      ++||||||.|||++.++.|||+|||+++...                   +....+...||..|.|||++.+..   |+.
T Consensus       718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~  797 (1351)
T KOG1035|consen  718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS  797 (1351)
T ss_pred             eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence            9999999999999999999999999997611                   011223456899999999997664   999


Q ss_pred             chhHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHhhhccCC
Q 045286          215 KADVFSFAIVLWELVTAKVPYD-SMTPLQAALGVRQVCTS  253 (259)
Q Consensus       215 ~~Di~slG~~~~~ll~g~~p~~-~~~~~~~~~~i~~~~~~  253 (259)
                      ++||||||++++||+.-   |. .+.=-..+..++++..+
T Consensus       798 KiDmYSLGIVlFEM~yP---F~TsMERa~iL~~LR~g~iP  834 (1351)
T KOG1035|consen  798 KIDMYSLGIVLFEMLYP---FGTSMERASILTNLRKGSIP  834 (1351)
T ss_pred             hhhhHHHHHHHHHHhcc---CCchHHHHHHHHhcccCCCC
Confidence            99999999999999964   43 33334445555544433

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=4.7e-32  Score=230.08  Aligned_cols=216  Identities=24%  Similarity=0.372  Sum_probs=181.7

Q ss_pred             ccccceechhhhhccceeccccceEEEEEE--EcCceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeee
Q 045286           29 KSEDWEIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGAST  105 (259)
Q Consensus        29 ~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~--~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~  105 (259)
                      +.+...++..-+..++.||-|+||.|-++.  ++...+|.|.+++... ..+.......|-.+|.+-.++-+++++-.|.
T Consensus       620 RLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ  699 (1034)
T KOG0608|consen  620 RLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ  699 (1034)
T ss_pred             HHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec
Confidence            444566777778888999999999999886  4566789998876532 4455677888999999999999999999999


Q ss_pred             cCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          106 KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                      +.+.+|+||+|++||++-.++-+.+- +.+..++-++.++..++++.|..|++||||||+|||++.+|.|||.|||++.-
T Consensus       700 DkdnLYFVMdYIPGGDmMSLLIrmgI-FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTG  778 (1034)
T KOG0608|consen  700 DKDNLYFVMDYIPGGDMMSLLIRMGI-FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  778 (1034)
T ss_pred             cCCceEEEEeccCCccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeecccccc
Confidence            99999999999999999998876653 67778888999999999999999999999999999999999999999999742


Q ss_pred             cc--CC-----------------------------------------CccccCCCcccccCccccCCCCCCCchhHHHHH
Q 045286          186 QN--KG-----------------------------------------GVMTAETGTYRWMAPEVINHQPYDQKADVFSFA  222 (259)
Q Consensus       186 ~~--~~-----------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG  222 (259)
                      +.  ..                                         .......|++.|.+||++....++.--|.||.|
T Consensus       779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~g  858 (1034)
T KOG0608|consen  779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVG  858 (1034)
T ss_pred             ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhh
Confidence            11  00                                         000112489999999999999999999999999


Q ss_pred             HHHHHHHcCCCCCCCCCHHHHHH
Q 045286          223 IVLWELVTAKVPYDSMTPLQAAL  245 (259)
Q Consensus       223 ~~~~~ll~g~~p~~~~~~~~~~~  245 (259)
                      +++|+|+.|..||...++.+.-.
T Consensus       859 vil~em~~g~~pf~~~tp~~tq~  881 (1034)
T KOG0608|consen  859 VILYEMLVGQPPFLADTPGETQY  881 (1034)
T ss_pred             HHHHHHhhCCCCccCCCCCccee
Confidence            99999999999998877654433

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=6.4e-30  Score=203.80  Aligned_cols=202  Identities=36%  Similarity=0.604  Sum_probs=174.1

Q ss_pred             cceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCCCCChHHHHH
Q 045286           50 SCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH  127 (259)
Q Consensus        50 ~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  127 (259)
                      ++|.||++.+.  ++.+++|++........ ...+.+|++.+++++|++++++++.+......++++|++++++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence            57899999985  58999999987654332 5788899999999999999999999988889999999998889999986


Q ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccccCCCcccccCcccc
Q 045286          128 KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI  207 (259)
Q Consensus       128 ~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~~~~~~~~~~PE~~  207 (259)
                      .... ++...++.++.+++.++.+||+.+++|+||+|+||+++.++.++++|||.+.............+...|++||.+
T Consensus        80 ~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~  158 (244)
T smart00220       80 KRGR-LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL  158 (244)
T ss_pred             hccC-CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence            5443 888999999999999999999999999999999999999999999999999877665444556678899999999


Q ss_pred             CCCCCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHhhhccCC
Q 045286          208 NHQPYDQKADVFSFAIVLWELVTAKVPYDS-MTPLQAALGVRQVCTS  253 (259)
Q Consensus       208 ~~~~~~~~~Di~slG~~~~~ll~g~~p~~~-~~~~~~~~~i~~~~~~  253 (259)
                      .+..++.++|+|++|++++++++|..||.. .+.......+.+....
T Consensus       159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~  205 (244)
T smart00220      159 LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP  205 (244)
T ss_pred             ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC
Confidence            888889999999999999999999999987 5555555555544443

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.5e-31  Score=223.20  Aligned_cols=229  Identities=20%  Similarity=0.325  Sum_probs=179.8

Q ss_pred             eeecccccccchHHHHHhccccccceechhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHH
Q 045286            9 TIVHRKYRGHAVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEV   86 (259)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~   86 (259)
                      .+-++.|+|..+-+..-=..... ..+ ...|.+...+|.|+|+.|-.+..  +++..++|++.....+      -.+|+
T Consensus       295 ~s~~~if~g~sfva~~il~~~~~-~~~-~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~  366 (612)
T KOG0603|consen  295 GSDHTIFSGPSFVAPGVLEDAVT-APF-TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEI  366 (612)
T ss_pred             ccccchhcCCCccChHHhhcccc-CCc-chhhccccccCCCCccceeeeeccccccchhheeccccccc------ccccc
Confidence            34456667666655221111111 111 35666777799999999999886  4788999999887322      23556


Q ss_pred             HHHHhc-CCCCcceeeeeeecCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 045286           87 AILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTA  165 (259)
Q Consensus        87 ~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~  165 (259)
                      .++... +|+||+.+.+.+.+....++|||.+.|+-+.+.+.....  ...++..|+.+|+.++.+||.+|++|||++|+
T Consensus       367 ~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~--~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~  444 (612)
T KOG0603|consen  367 PISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPE--FCSEASQWAAELVSAVDYLHEQGVVHRDLKPG  444 (612)
T ss_pred             chhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcch--hHHHHHHHHHHHHHHHHHHHhcCeeecCCChh
Confidence            555555 599999999999999999999999999888887765542  22777789999999999999999999999999


Q ss_pred             cEEE-ccCCeEEEeeeccceeccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH-HH
Q 045286          166 NLLM-DTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPL-QA  243 (259)
Q Consensus       166 Nilv-~~~~~i~l~D~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~-~~  243 (259)
                      |||+ +..+.++|+|||.+...++.  ....+.+..|.|||++....|+++.|+||||+++|+||+|+.||...... +.
T Consensus       445 NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei  522 (612)
T KOG0603|consen  445 NILLDGSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEI  522 (612)
T ss_pred             heeecCCCCcEEEEEechhhhCchh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHH
Confidence            9999 68899999999999877765  44557889999999999999999999999999999999999999876655 44


Q ss_pred             HHHhhh
Q 045286          244 ALGVRQ  249 (259)
Q Consensus       244 ~~~i~~  249 (259)
                      ..+|..
T Consensus       523 ~~~i~~  528 (612)
T KOG0603|consen  523 HTRIQM  528 (612)
T ss_pred             HHhhcC
Confidence            444443

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-30  Score=214.64  Aligned_cols=190  Identities=33%  Similarity=0.544  Sum_probs=162.8

Q ss_pred             hhhhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhc--CCCCcceeeeeeecCC----cE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV--QHRNVVRFIGASTKSP----HL  110 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~~~~~~~~----~~  110 (259)
                      ...+++...||+|.||.||+|..+++.||||++....     .+.+.+|.++....  +|+||+++++....++    .+
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~-----kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey  283 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQE-----KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY  283 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhccCceeEEEecCHHH-----HHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence            3567888999999999999999999999999998652     36677888887765  5999999999887666    89


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcccCCCCCCcEEEccCCeEEEeeec
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR---------NIIHRDLKTANLLMDTHNVVKVADFG  181 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---------~i~H~di~p~Nilv~~~~~i~l~D~~  181 (259)
                      ++|++|.+.++|.+++...-  ++.....+++..++++|+|||..         .|+|||||.+||||..|++..|+|||
T Consensus       284 wLVt~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             eEEeeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            99999999999999996654  88999999999999999999974         59999999999999999999999999


Q ss_pred             cceeccCCC---ccccCCCcccccCccccCCCC-C-----CCchhHHHHHHHHHHHHcCCC
Q 045286          182 VARFQNKGG---VMTAETGTYRWMAPEVINHQP-Y-----DQKADVFSFAIVLWELVTAKV  233 (259)
Q Consensus       182 ~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~-~-----~~~~Di~slG~~~~~ll~g~~  233 (259)
                      ++..+..+.   ......||.+|+|||++.+.. .     -.+.||||+|.++|||.+.-.
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~  422 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCT  422 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcc
Confidence            998776543   233457999999999997652 2     247899999999999998533

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-31  Score=210.03  Aligned_cols=216  Identities=24%  Similarity=0.347  Sum_probs=190.0

Q ss_pred             hhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC------c
Q 045286           38 RLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP------H  109 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~  109 (259)
                      .+|.-..++|.|+- .|-.+.+  .+++|++|....+......+.+..+|..++..++|+||++++.+|+...      .
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            47888899999998 6655655  3899999999988777677788999999999999999999999996543      4


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG  189 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~  189 (259)
                      .++|||++ ..+|...+..   .++=..+..+..|++.++.++|+.||+|||+||+||++..++.+|+.|||++......
T Consensus        96 ~y~v~e~m-~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~  171 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD  171 (369)
T ss_pred             HHHHHHhh-hhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc
Confidence            68999999 5688887762   2556778889999999999999999999999999999999999999999999877776


Q ss_pred             CccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCccC
Q 045286          190 GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPI  258 (259)
Q Consensus       190 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  258 (259)
                      -.++....+..|.|||++.+..+...+||||+||++.+|++|..-|++.+..+.--++.+..+.+++.+
T Consensus       172 ~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F  240 (369)
T KOG0665|consen  172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSF  240 (369)
T ss_pred             cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHH
Confidence            566778889999999999999999999999999999999999999999999888889999888888753

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=4.1e-30  Score=224.91  Aligned_cols=213  Identities=31%  Similarity=0.510  Sum_probs=183.4

Q ss_pred             eechhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeec----
Q 045286           34 EIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTK----  106 (259)
Q Consensus        34 ~~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~----  106 (259)
                      +-+...+.+...||.|.+|.||+++.  +++-.|+|+.......+   +++..|.++++.+. |||++.+++++..    
T Consensus        15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~   91 (953)
T KOG0587|consen   15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATFYGAFIKKDPG   91 (953)
T ss_pred             CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence            34456777888999999999999874  68899999998876554   67788999999986 9999999998843    


Q ss_pred             -CCcEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccce
Q 045286          107 -SPHLCIVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR  184 (259)
Q Consensus       107 -~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~  184 (259)
                       ++++|+|||||.||+..+++... +..+++..+..|++.++.++.+||++.++|+|||-.|||++.++.+||+|||.+.
T Consensus        92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSa  171 (953)
T KOG0587|consen   92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSA  171 (953)
T ss_pred             CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeee
Confidence             57899999999999999998533 4568899999999999999999999999999999999999999999999999988


Q ss_pred             eccCC-CccccCCCcccccCccccCCC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          185 FQNKG-GVMTAETGTYRWMAPEVINHQ-----PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       185 ~~~~~-~~~~~~~~~~~~~~PE~~~~~-----~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                      ..... .......|++.|+|||++...     .|+.++|+||||++..+|-.|.+|+-.+.+...+.+|-+
T Consensus       172 QldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR  242 (953)
T KOG0587|consen  172 QLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR  242 (953)
T ss_pred             eeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC
Confidence            76654 233566799999999998643     467899999999999999999999999998887776654

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-30  Score=206.61  Aligned_cols=204  Identities=24%  Similarity=0.413  Sum_probs=179.3

Q ss_pred             cceechhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCch-HHHHHHHHHHHHHHhc-CCCCcceeeeeeecC
Q 045286           32 DWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLND-TLEDEFVQEVAILREV-QHRNVVRFIGASTKS  107 (259)
Q Consensus        32 ~~~~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~  107 (259)
                      .|.+.-.++++..+||.|+++.|.++..  +.+-+|+|+++.+..++ +.......|..+.... +||.++-++.+|+.+
T Consensus       244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte  323 (593)
T KOG0695|consen  244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE  323 (593)
T ss_pred             ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence            3666678899999999999999999875  47789999999876543 3445566666776665 599999999999999


Q ss_pred             CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      ++.++|.||.+|++|--.++... ++++..++-+..+|.-+|.+||++||+++|+|.+|++++.+|.+||.|+|.+....
T Consensus       324 srlffvieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  324 SRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             ceEEEEEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence            99999999999999988886555 49999999999999999999999999999999999999999999999999997544


Q ss_pred             -CCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 045286          188 -KGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYD  236 (259)
Q Consensus       188 -~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~  236 (259)
                       ++...+..+|++.|.|||.+.+..|...+|.|+||+++++|+.|..||+
T Consensus       403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd  452 (593)
T KOG0695|consen  403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD  452 (593)
T ss_pred             CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence             4455677899999999999999999999999999999999999999995

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.97  E-value=1.6e-29  Score=238.51  Aligned_cols=185  Identities=25%  Similarity=0.425  Sum_probs=155.4

Q ss_pred             hhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           39 LLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      .+...+.||+|+||.||+|.+  .+..||+|.+......      ..+|++.+++++||||+++++++...+..++||||
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            455667899999999999986  4789999998754321      12458889999999999999999998899999999


Q ss_pred             CCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccc
Q 045286          117 MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH---QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT  193 (259)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~  193 (259)
                      +++++|.+++..    ++...+..++.|++.++.|+|   +.+++|+|+||+||+++.++..++. ++........   .
T Consensus       765 ~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---~  836 (968)
T PLN00113        765 IEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---T  836 (968)
T ss_pred             CCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---C
Confidence            999999999853    778888999999999999999   6799999999999999988876664 5543322211   1


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                      ...++..|+|||.+.+..++.++||||+|+++|||++|+.||..
T Consensus       837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~  880 (968)
T PLN00113        837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA  880 (968)
T ss_pred             CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence            23567899999999999999999999999999999999999853

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=2.9e-28  Score=211.29  Aligned_cols=203  Identities=18%  Similarity=0.295  Sum_probs=149.3

Q ss_pred             echhhhhccceeccccceEEEEEEE------------------cCceEEEEEeecccCch------------HHHHHHHH
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVY------------------LGQDVAVKVLRSEHLND------------TLEDEFVQ   84 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~------------------~~~~v~vK~~~~~~~~~------------~~~~~~~~   84 (259)
                      ...++|++.++||+|+||.||++..                  .++.|+||.+.......            ........
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            3467899999999999999999864                  24579999987543211            01122334


Q ss_pred             HHHHHHhcCCCCc-----ceeeeeeec--------CCcEEEEEecCCCCChHHHHHhcC---------------------
Q 045286           85 EVAILREVQHRNV-----VRFIGASTK--------SPHLCIVTEYMPGGSLYDYLHKNH---------------------  130 (259)
Q Consensus        85 e~~~l~~l~~~~i-----~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~---------------------  130 (259)
                      |+.++.+++|.++     +++++++..        .+..++|+||+++++|.+++....                     
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6667777765443     555555432        346799999999999999885321                     


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcccc--CCCcccccCccc
Q 045286          131 --NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTA--ETGTYRWMAPEV  206 (259)
Q Consensus       131 --~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~--~~~~~~~~~PE~  206 (259)
                        ..++...+..++.|++.+|.++|+.+++|+||||+||+++.++.++|+|||.+...........  ...++.|++||.
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~  381 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE  381 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence              1234567788999999999999999999999999999999999999999999865544322222  234789999999


Q ss_pred             cCCCC--------------------C--CCchhHHHHHHHHHHHHcCCC-CCCC
Q 045286          207 INHQP--------------------Y--DQKADVFSFAIVLWELVTAKV-PYDS  237 (259)
Q Consensus       207 ~~~~~--------------------~--~~~~Di~slG~~~~~ll~g~~-p~~~  237 (259)
                      +....                    +  ....|+||+||++++|+++.. ||..
T Consensus       382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~  435 (507)
T PLN03224        382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN  435 (507)
T ss_pred             hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence            75432                    1  124699999999999999876 6753

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=2.8e-27  Score=184.30  Aligned_cols=182  Identities=37%  Similarity=0.701  Sum_probs=160.6

Q ss_pred             eccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCCCCChH
Q 045286           46 IASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY  123 (259)
Q Consensus        46 lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~  123 (259)
                      ||+|++|.||++...  ++.+++|++....... ....+.+|++.++.+.|++++++++.+...+..++++|++++.+|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence            689999999999987  8999999999875432 3467889999999999999999999999888999999999989999


Q ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc-CCeEEEeeeccceeccCCC-ccccCCCcccc
Q 045286          124 DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT-HNVVKVADFGVARFQNKGG-VMTAETGTYRW  201 (259)
Q Consensus       124 ~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~-~~~i~l~D~~~~~~~~~~~-~~~~~~~~~~~  201 (259)
                      +++......++...++.++.++++++.+||+.|++|+|++|.||+++. ++.++|+||+.+....... ..........|
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  159 (215)
T cd00180          80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAY  159 (215)
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCc
Confidence            998765445889999999999999999999999999999999999999 8999999999998665543 12334578889


Q ss_pred             cCccccCCC-CCCCchhHHHHHHHHHHH
Q 045286          202 MAPEVINHQ-PYDQKADVFSFAIVLWEL  228 (259)
Q Consensus       202 ~~PE~~~~~-~~~~~~Di~slG~~~~~l  228 (259)
                      .+||.+... ..+.+.|+|++|++++++
T Consensus       160 ~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         160 MAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             cChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            999999877 788999999999999998

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=7.3e-28  Score=199.05  Aligned_cols=131  Identities=24%  Similarity=0.448  Sum_probs=112.5

Q ss_pred             echhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcC--------CCCcceeeeee
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ--------HRNVVRFIGAS  104 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~~~~~~  104 (259)
                      |.+.+|.+.++||.|-|++||+|.+.  .+.||+|+.+...   ...+..+.|+.+|+.++        ..+|+++++.|
T Consensus        75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F  151 (590)
T KOG1290|consen   75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF  151 (590)
T ss_pred             ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence            44579999999999999999999985  6789999998753   34467889999999984        25899999988


Q ss_pred             ec----CCcEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEE
Q 045286          105 TK----SPHLCIVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQR-NIIHRDLKTANLLM  169 (259)
Q Consensus       105 ~~----~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~di~p~Nilv  169 (259)
                      ..    +.+.|+|+|++ |..|..++... .+.++...+.+|++|++.+|.|||.. ||+|.||||+|||+
T Consensus       152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence            65    45899999999 88888888644 44599999999999999999999965 89999999999999

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=4.7e-28  Score=214.44  Aligned_cols=198  Identities=18%  Similarity=0.257  Sum_probs=140.1

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeee---
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA---  103 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~---  103 (259)
                      ..+..++|.+.++||+|+||.||+|.+.      +..|++|.+......+    ....+  .++...+.++..+...   
T Consensus       127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e----~~~~e--~l~~~~~~~~~~~~~~~~~  200 (566)
T PLN03225        127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE----IWMNE--RVRRACPNSCADFVYGFLE  200 (566)
T ss_pred             CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH----HHHHH--HHHhhchhhHHHHHHhhhc
Confidence            3345578999999999999999999874      5789999876532211    11111  1122122222222111   


Q ss_pred             ---eecCCcEEEEEecCCCCChHHHHHhcCCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 045286          104 ---STKSPHLCIVTEYMPGGSLYDYLHKNHNV-------------------LKLPQLLRFAIDICKGMEYLHQRNIIHRD  161 (259)
Q Consensus       104 ---~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------------------~~~~~~~~i~~ql~~~l~~lH~~~i~H~d  161 (259)
                         .......++|+||+++++|.+++......                   .....+..++.|++.+|.|||+.+++|+|
T Consensus       201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD  280 (566)
T PLN03225        201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD  280 (566)
T ss_pred             ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence               23456789999999999999988643211                   11234567999999999999999999999


Q ss_pred             CCCCcEEEcc-CCeEEEeeeccceeccCCC--ccccCCCcccccCccccCCC----------------------CCCCch
Q 045286          162 LKTANLLMDT-HNVVKVADFGVARFQNKGG--VMTAETGTYRWMAPEVINHQ----------------------PYDQKA  216 (259)
Q Consensus       162 i~p~Nilv~~-~~~i~l~D~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~----------------------~~~~~~  216 (259)
                      |||+|||++. ++.++|+|||++.......  ......+++.|+|||.+...                      .++.++
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            9999999986 5799999999997544321  22345678999999965322                      133456


Q ss_pred             hHHHHHHHHHHHHcCCCCCC
Q 045286          217 DVFSFAIVLWELVTAKVPYD  236 (259)
Q Consensus       217 Di~slG~~~~~ll~g~~p~~  236 (259)
                      ||||+||++|+|+++..|++
T Consensus       361 DVwSlGviL~el~~~~~~~~  380 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSD  380 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCc
Confidence            99999999999999776654

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.9e-29  Score=193.84  Aligned_cols=194  Identities=20%  Similarity=0.373  Sum_probs=161.1

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeee-eecCCcEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGA-STKSPHLCI  112 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~-~~~~~~~~l  112 (259)
                      .+.|.+.+.||.|.||.+.++...  ...+++|.+..+...   ...|.+|...--.|. |.||+.-+++ |+..+.+++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt---~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF   99 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT---QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF   99 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh---HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence            357888999999999999999975  567999999887543   377888888777776 8999998875 677789999


Q ss_pred             EEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc--CCeEEEeeeccceeccCCC
Q 045286          113 VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT--HNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~--~~~i~l~D~~~~~~~~~~~  190 (259)
                      ++||++-++|.+-+...+  +.+.....++.|+++++.++|++++||||||.+|||+-.  ..++||||||.+...+.. 
T Consensus       100 ~qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t-  176 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT-  176 (378)
T ss_pred             eeccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce-
Confidence            999999999998876543  888889999999999999999999999999999999943  358999999998765543 


Q ss_pred             ccccCCCcccccCccccCCC-----CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          191 VMTAETGTYRWMAPEVINHQ-----PYDQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       191 ~~~~~~~~~~~~~PE~~~~~-----~~~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                       ....-....|.+||.....     ...+.+|+|.||++++.+|+|..||..
T Consensus       177 -V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk  227 (378)
T KOG1345|consen  177 -VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK  227 (378)
T ss_pred             -ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence             2223355678899986432     457889999999999999999999974

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.95  E-value=7.9e-29  Score=215.96  Aligned_cols=199  Identities=31%  Similarity=0.488  Sum_probs=165.2

Q ss_pred             hhhccceeccccceE-EEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCCcEEEEEec
Q 045286           39 LLKTGERIASGSCGD-LYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~-V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      -+.-.+.+|.|+.|+ ||+|...++.||||.+-.+.     .....+|+..|+.-. ||||++++..-.+....|+..|.
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL  584 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL  584 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence            344556888999864 78999999999999987653     356789999999986 99999999999999999999999


Q ss_pred             CCCCChHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc---C--CeEEEeeeccceeccC
Q 045286          117 MPGGSLYDYLHKNHN---VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT---H--NVVKVADFGVARFQNK  188 (259)
Q Consensus       117 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~---~--~~i~l~D~~~~~~~~~  188 (259)
                      | ..+|++++.....   .......+.++.|++++|++||+.+|+|||+||.|||++.   +  .+++|+|||++.....
T Consensus       585 C-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~  663 (903)
T KOG1027|consen  585 C-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG  663 (903)
T ss_pred             h-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence            9 6799999976311   1122456778999999999999999999999999999976   3  4689999999987665


Q ss_pred             CCc----cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q 045286          189 GGV----MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQA  243 (259)
Q Consensus       189 ~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~  243 (259)
                      +..    .....|+.+|.|||++....-+.++||||+||++|+.++ |.+||...-.++.
T Consensus       664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~  723 (903)
T KOG1027|consen  664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA  723 (903)
T ss_pred             CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh
Confidence            432    345579999999999998888889999999999999999 6999987665543

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=6.6e-28  Score=196.15  Aligned_cols=209  Identities=22%  Similarity=0.382  Sum_probs=171.0

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc-----CceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeec
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTK  106 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~  106 (259)
                      .+.-...|...++||.|.|++||++++.     ++.|++|.+.....    ..++.+|+++|..+. +.||+.+.+++..
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhcc
Confidence            3444578999999999999999999864     57899999887632    367899999999997 8999999999999


Q ss_pred             CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc-CCeEEEeeecccee
Q 045286          107 SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT-HNVVKVADFGVARF  185 (259)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~-~~~i~l~D~~~~~~  185 (259)
                      +++..+|+||++..+-.++...    ++..++..+++.++.+|.++|.+||+|+||||+|++.+. .+.-.|+|||++..
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR  182 (418)
T ss_pred             CCeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence            9999999999988887777653    678999999999999999999999999999999999976 57899999999851


Q ss_pred             cc-----------------C----------------------------CCccccCCCcccccCccccCCCC-CCCchhHH
Q 045286          186 QN-----------------K----------------------------GGVMTAETGTYRWMAPEVINHQP-YDQKADVF  219 (259)
Q Consensus       186 ~~-----------------~----------------------------~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~  219 (259)
                      ..                 .                            ........||++|.|||++...+ .++++|+|
T Consensus       183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw  262 (418)
T KOG1167|consen  183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW  262 (418)
T ss_pred             HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence            00                 0                            00011234899999999998765 58899999


Q ss_pred             HHHHHHHHHHcCCCCC-CCCCHHHHHHHhhh
Q 045286          220 SFAIVLWELVTAKVPY-DSMTPLQAALGVRQ  249 (259)
Q Consensus       220 slG~~~~~ll~g~~p~-~~~~~~~~~~~i~~  249 (259)
                      |.|+++..++++..|| ...++-..+..|..
T Consensus       263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~t  293 (418)
T KOG1167|consen  263 SAGVILLSLLSRRYPFFKAKDDADALAEIAT  293 (418)
T ss_pred             eccceeehhhccccccccCccccchHHHHHH
Confidence            9999999999999996 44444444444443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=4.2e-27  Score=179.13  Aligned_cols=214  Identities=25%  Similarity=0.319  Sum_probs=178.7

Q ss_pred             chhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCCcEEE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHLCI  112 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l  112 (259)
                      -...|+++++||+|+||.+|++..  .|+.||+|+-+.....    ..+..|..+...|+ ...|+.+..++.+...-.+
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl   88 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL   88 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence            356899999999999999999986  4899999998876544    34567788888887 5788888888888888999


Q ss_pred             EEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC---CeEEEeeeccceeccCC
Q 045286          113 VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH---NVVKVADFGVARFQNKG  189 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~---~~i~l~D~~~~~~~~~~  189 (259)
                      ||+.. |.+|.++.+-....++...+.-++-|++.-++|+|..+++|+||||+|+|+.-+   ..+.++|||++......
T Consensus        89 VMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~  167 (341)
T KOG1163|consen   89 VMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI  167 (341)
T ss_pred             eeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence            99999 999999998777779999999999999999999999999999999999999655   46999999999754332


Q ss_pred             C--------ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHhhhccCCC
Q 045286          190 G--------VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTP---LQAALGVRQVCTSL  254 (259)
Q Consensus       190 ~--------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~---~~~~~~i~~~~~~~  254 (259)
                      .        ......||.+|.+-....+..-+.+.|+-|+|.++.++.-|.+||.+..+   .+..++|.+...+.
T Consensus       168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~  243 (341)
T KOG1163|consen  168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST  243 (341)
T ss_pred             cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence            1        11234689999999999888889999999999999999999999988554   55556665554443

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=3.8e-26  Score=190.22  Aligned_cols=199  Identities=24%  Similarity=0.366  Sum_probs=165.5

Q ss_pred             hhhccceeccccceEEEEEEEcCc---eEEEEEeecccCchHHHHHHHHHHHHHHhcC----CCCcceeeeee-ecCCcE
Q 045286           39 LLKTGERIASGSCGDLYRGVYLGQ---DVAVKVLRSEHLNDTLEDEFVQEVAILREVQ----HRNVVRFIGAS-TKSPHL  110 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~~~---~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~----~~~i~~~~~~~-~~~~~~  110 (259)
                      +|.+.++||+|+||.||.+.+...   .+|+|+.........  ..+..|..++..+.    .++++.+++.+ ......
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~   96 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN   96 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence            799999999999999999998653   588888876532221  24667777777776    36999999999 577788


Q ss_pred             EEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC-----CeEEEeeeccce
Q 045286          111 CIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH-----NVVKVADFGVAR  184 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~-----~~i~l~D~~~~~  184 (259)
                      ++||+.+ |.+|.++....+ ..++...+..++.|++.+|.++|+.|++||||||.|+.+...     ..+.|+|||++.
T Consensus        97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar  175 (322)
T KOG1164|consen   97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR  175 (322)
T ss_pred             EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence            9999988 999999886555 679999999999999999999999999999999999999765     469999999998


Q ss_pred             ecc---CCC-------c-cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 045286          185 FQN---KGG-------V-MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTP  240 (259)
Q Consensus       185 ~~~---~~~-------~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~  240 (259)
                      ...   ...       . .....||.+|.+++...+...+.+.|+||++.++.++..|..||.....
T Consensus       176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~  242 (322)
T KOG1164|consen  176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM  242 (322)
T ss_pred             cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence            221   110       1 1233489999999999999999999999999999999999999987664

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.94  E-value=9.7e-27  Score=188.07  Aligned_cols=226  Identities=24%  Similarity=0.440  Sum_probs=189.8

Q ss_pred             cccccceechhhhhccceeccccceEEEEEEEc-------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCccee
Q 045286           28 TKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF  100 (259)
Q Consensus        28 ~~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~  100 (259)
                      .+..+..+.+.++++...+-.|.||.||.|.+.       .+.|.+|.++.. .++.....+++|.-.+..+.|+|+..+
T Consensus       274 ~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V  352 (563)
T KOG1024|consen  274 RRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSV  352 (563)
T ss_pred             hhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccce
Confidence            344556677788888999999999999999764       346778887765 355566788999999999999999999


Q ss_pred             eeee-ecCCcEEEEEecCCCCChHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC
Q 045286          101 IGAS-TKSPHLCIVTEYMPGGSLYDYLHKN-------HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH  172 (259)
Q Consensus       101 ~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~  172 (259)
                      .++. ++....++++++..-+.|..++...       ...++-.+...++.|++.++++||+.|++|.||...|.++++.
T Consensus       353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh
Confidence            9876 4567889999999889999999621       1235566778899999999999999999999999999999999


Q ss_pred             CeEEEeeeccceeccCC---CccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhh
Q 045286          173 NVVKVADFGVARFQNKG---GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVR  248 (259)
Q Consensus       173 ~~i~l~D~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~  248 (259)
                      ..+||+|=.+++..-+.   .....+.....|++||.+.+..|+.++|+||||+++|||++ |+.|+..-++.++-.-++
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk  512 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK  512 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence            99999999888744332   33344556788999999999999999999999999999999 999999999999999999


Q ss_pred             hccCCC
Q 045286          249 QVCTSL  254 (259)
Q Consensus       249 ~~~~~~  254 (259)
                      .|++-.
T Consensus       513 dGyRla  518 (563)
T KOG1024|consen  513 DGYRLA  518 (563)
T ss_pred             ccceec
Confidence            988754

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=6.8e-26  Score=179.76  Aligned_cols=218  Identities=18%  Similarity=0.264  Sum_probs=186.0

Q ss_pred             ceechhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCCc
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPH  109 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~  109 (259)
                      ..+-+-.|+++++||.|+||..+.++.  ++++||+|.-......    ..+..|.+..+.|. .++|+..+-+.+++-+
T Consensus        23 ~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~   98 (449)
T KOG1165|consen   23 VLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKY   98 (449)
T ss_pred             ceEecccceeccccccCcceeeecccccccCceEEEEeccccCCc----chHHHHHHHHHHHcCCCCCCceeeeccccch
Confidence            445567899999999999999999985  5999999987665333    45677888888886 7999999999888888


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC-----eEEEeeeccce
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN-----VVKVADFGVAR  184 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~-----~i~l~D~~~~~  184 (259)
                      -.+|+|.+ |.+|.++..-.+..++.+.+..++.|++.-+.++|...+++|||||+|+||...+     .|-++|||++.
T Consensus        99 NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen   99 NILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             hhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence            89999999 9999999988888899999999999999999999999999999999999996543     58999999998


Q ss_pred             eccCCCcc--------ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHhhhccCC
Q 045286          185 FQNKGGVM--------TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS---MTPLQAALGVRQVCTS  253 (259)
Q Consensus       185 ~~~~~~~~--------~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~---~~~~~~~~~i~~~~~~  253 (259)
                      ....+...        ....||.+|++-....++.-+.+.|+-|||=++++.|-|.+||.+   .+..+..++|-...+.
T Consensus       178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~  257 (449)
T KOG1165|consen  178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS  257 (449)
T ss_pred             hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence            66544222        334699999999999999999999999999999999999999987   4556777777766655


Q ss_pred             CC
Q 045286          254 LC  255 (259)
Q Consensus       254 ~~  255 (259)
                      .+
T Consensus       258 T~  259 (449)
T KOG1165|consen  258 TP  259 (449)
T ss_pred             CC
Confidence            43

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=9.6e-25  Score=182.10  Aligned_cols=161  Identities=20%  Similarity=0.216  Sum_probs=125.7

Q ss_pred             hhhhhccceeccccceEEEEEEE---cCceEEEEEeecccC---chHHHHHHHHHHHHHHhcCCCCcce-eeeeeecCCc
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY---LGQDVAVKVLRSEHL---NDTLEDEFVQEVAILREVQHRNVVR-FIGASTKSPH  109 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~---~~~~v~vK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~-~~~~~~~~~~  109 (259)
                      ...|.+.+.||+|+||+||+|.+   .++.+++|+......   .+.....+.+|++++++++|++++. +++.    +.
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~   92 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK   92 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC
Confidence            46799999999999999999986   366789998764321   2334567899999999999999885 4432    45


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC-CCCcEEEccCCeEEEeeeccceeccC
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL-KTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di-~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      .++||||++|++|... ..    ..   ...++.+++++|.+||+.|++|||| ||+||+++.++.++|+|||++.....
T Consensus        93 ~~LVmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~  164 (365)
T PRK09188         93 DGLVRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR  164 (365)
T ss_pred             cEEEEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence            7999999999999632 11    11   1457889999999999999999999 99999999999999999999986654


Q ss_pred             CCcc---------ccCCCcccccCccccCC
Q 045286          189 GGVM---------TAETGTYRWMAPEVINH  209 (259)
Q Consensus       189 ~~~~---------~~~~~~~~~~~PE~~~~  209 (259)
                      ....         ....+++.|++||.+..
T Consensus       165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        165 RGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             CcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            4311         22346777999999854

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.92  E-value=3.9e-25  Score=172.33  Aligned_cols=173  Identities=13%  Similarity=0.112  Sum_probs=135.1

Q ss_pred             chhhhhccceeccccceEEEEEEEcCceEEEEEeecccCchH-HHHH------HHHHHHHHHhcCCCCcceeeeeeecC-
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDT-LEDE------FVQEVAILREVQHRNVVRFIGASTKS-  107 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~-~~~~------~~~e~~~l~~l~~~~i~~~~~~~~~~-  107 (259)
                      -+.+|+..+++|.|+||.||++.+.+..+++|++........ ....      +.+|++.+.+++|++|..+.+.+... 
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            357899999999999999999888888999999987654432 2222      57899999999999999988875432 


Q ss_pred             -------CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeee
Q 045286          108 -------PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADF  180 (259)
Q Consensus       108 -------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~  180 (259)
                             +..+++|||++|.+|.++..     +++    ....+++.++..+|+.|++|+|++|+||+++.+| ++++||
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf  178 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL  178 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence                   35789999999999988732     322    2456899999999999999999999999999988 999999


Q ss_pred             ccceeccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHH
Q 045286          181 GVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELV  229 (259)
Q Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll  229 (259)
                      |............           ..+....++.++|+|+||+++..+.
T Consensus       179 g~~~~~~e~~a~d-----------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        179 SGKRCTAQRKAKD-----------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCcccccchhhHH-----------HHHHHhHhcccccccceeEeehHHH
Confidence            9875443221111           1333445677899999999986544

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.92  E-value=4.4e-26  Score=194.74  Aligned_cols=209  Identities=33%  Similarity=0.506  Sum_probs=180.1

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      ..+|.+...+|+|.+|.||++++.  ++..|+|+++..-.+.  .+.+.+|+-+++..+|+||+.+++.+...+..|+.|
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd--~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD--FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc--ccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            568888999999999999999975  8899999999874433  356778999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-Cccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVMT  193 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~~  193 (259)
                      ||+.|++|++..+- -+.+++.++...+++.+.++.|||+.|-+|||||-.||+++..|.+++.|||.+...... ....
T Consensus        92 EycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krk  170 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRK  170 (829)
T ss_pred             EecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhh
Confidence            99999999997643 345899999999999999999999999999999999999999999999999998765543 3345


Q ss_pred             cCCCcccccCcccc---CCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 045286          194 AETGTYRWMAPEVI---NHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVR  248 (259)
Q Consensus       194 ~~~~~~~~~~PE~~---~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~  248 (259)
                      ...|++.|++||+-   ....|....|+|++|+...++-.-+.|.-...+.+.+..+-
T Consensus       171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT  228 (829)
T KOG0576|consen  171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT  228 (829)
T ss_pred             cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh
Confidence            66799999999985   33468889999999999999999999977767766665544

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=3.3e-22  Score=165.80  Aligned_cols=210  Identities=32%  Similarity=0.506  Sum_probs=178.4

Q ss_pred             hhccceeccccceEEEEEEEcCceEEEEEeecccCchH-HHHHHHHHHHHHHhcCCC-CcceeeeeeecCCcEEEEEecC
Q 045286           40 LKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDT-LEDEFVQEVAILREVQHR-NVVRFIGASTKSPHLCIVTEYM  117 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~e~~  117 (259)
                      |.+...||.|+++.||.+.+. ..+++|.+........ ....+.+|...++.+.++ +++++.+.+......+++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~   80 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV   80 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence            567789999999999999988 8889999988766553 678899999999999987 7999999997777789999999


Q ss_pred             CCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC-eEEEeeeccceeccCCC----
Q 045286          118 PGGSLYDYLHKNH--NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN-VVKVADFGVARFQNKGG----  190 (259)
Q Consensus       118 ~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~-~i~l~D~~~~~~~~~~~----  190 (259)
                      .++++.+++....  ..+.......++.|++.++.++|..+++|+|++|+||+++..+ .++++|||.+.......    
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~  160 (384)
T COG0515          81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSS  160 (384)
T ss_pred             CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccc
Confidence            9999997775544  2588999999999999999999999999999999999999988 79999999987554432    


Q ss_pred             ---ccccCCCcccccCccccCC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHhhhc
Q 045286          191 ---VMTAETGTYRWMAPEVINH---QPYDQKADVFSFAIVLWELVTAKVPYDSMTP----LQAALGVRQV  250 (259)
Q Consensus       191 ---~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~----~~~~~~i~~~  250 (259)
                         ......++..|.+||.+.+   .......|+|++|+++++++.|..||.....    .+....+...
T Consensus       161 ~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  230 (384)
T COG0515         161 IPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL  230 (384)
T ss_pred             ccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc
Confidence               2355678999999999987   5788999999999999999999999887663    4444444443

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=2.6e-23  Score=159.95  Aligned_cols=143  Identities=15%  Similarity=0.164  Sum_probs=109.4

Q ss_pred             cceeccccceEEEEEEE-cCceEEEEEeecccCchHH------------------------HHHHHHHHHHHHhcCCCCc
Q 045286           43 GERIASGSCGDLYRGVY-LGQDVAVKVLRSEHLNDTL------------------------EDEFVQEVAILREVQHRNV   97 (259)
Q Consensus        43 ~~~lg~G~~~~V~~~~~-~~~~v~vK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~~~~i   97 (259)
                      ..+||+|++|.||+|.. +|+.||+|+++........                        .....+|+..++++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            46899999999999987 4899999999865322111                        1223458999999987776


Q ss_pred             ceeeeeeecCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCcccCCCCCCcEEEccCCeEE
Q 045286           98 VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYL-HQRNIIHRDLKTANLLMDTHNVVK  176 (259)
Q Consensus        98 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~l-H~~~i~H~di~p~Nilv~~~~~i~  176 (259)
                      ........ . ..++||||++|+++...... ...++...+..++.|++.+|.++ |+.|++|+||||+||+++ ++.++
T Consensus        82 ~~p~~~~~-~-~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          82 PCPEPILL-K-SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCCcEEEe-c-CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence            43332222 2 23799999988776654323 23588899999999999999999 799999999999999998 57899


Q ss_pred             EeeeccceeccCC
Q 045286          177 VADFGVARFQNKG  189 (259)
Q Consensus       177 l~D~~~~~~~~~~  189 (259)
                      |+|||.+.....+
T Consensus       158 LiDFG~a~~~~~~  170 (190)
T cd05147         158 IIDVSQSVEHDHP  170 (190)
T ss_pred             EEEccccccCCCc
Confidence            9999998755443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.90  E-value=2.1e-24  Score=199.43  Aligned_cols=146  Identities=16%  Similarity=0.238  Sum_probs=111.8

Q ss_pred             hcCC-CCcceeeeee-------ecCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 045286           91 EVQH-RNVVRFIGAS-------TKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL  162 (259)
Q Consensus        91 ~l~~-~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di  162 (259)
                      .++| +||.++++.+       .+...++.++|+. +.+|.+++......++...+..++.||+++|.|||++||+||||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl  106 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV  106 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            3344 4677777766       2234677888987 66999999765566899999999999999999999999999999


Q ss_pred             CCCcEEEccCCeEE-------------------EeeeccceeccCCC-----------------ccccCCCcccccCccc
Q 045286          163 KTANLLMDTHNVVK-------------------VADFGVARFQNKGG-----------------VMTAETGTYRWMAPEV  206 (259)
Q Consensus       163 ~p~Nilv~~~~~i~-------------------l~D~~~~~~~~~~~-----------------~~~~~~~~~~~~~PE~  206 (259)
                      ||+|||++..+.++                   ++|||.+.......                 ......+++.|+|||.
T Consensus       107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            99999996655544                   55555543211000                 0011246778999999


Q ss_pred             cCCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          207 INHQPYDQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       207 ~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                      +.+..++.++|||||||++|||++|..|+..
T Consensus       187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~  217 (793)
T PLN00181        187 DNGSSSNCASDVYRLGVLLFELFCPVSSREE  217 (793)
T ss_pred             hccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence            9999999999999999999999999888764

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=3.6e-23  Score=187.50  Aligned_cols=206  Identities=21%  Similarity=0.317  Sum_probs=170.0

Q ss_pred             HHHHhccccccceechhhhhccceeccccceEEEEEEE-cCceEEEEEeecccCchHHHHHHHHHHHHHHhcC---CCCc
Q 045286           22 KAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVY-LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ---HRNV   97 (259)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~-~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i   97 (259)
                      ..+++..-..++++.+..|.+.+.||.|++|+||.|+. +++.||+|+-+.+...+-...     .+++.+|+   -+.|
T Consensus       682 ~~~~~l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~-----~q~~~RLk~~~~~~~  756 (974)
T KOG1166|consen  682 SRVPKLNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYIC-----LQVMERLKPQMLPSI  756 (974)
T ss_pred             ccccccCccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeeh-----HHHHHhhchhhhcch
Confidence            45555566777999999999999999999999999985 489999999999877653221     12222332   3556


Q ss_pred             ceeeeeeecCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc------
Q 045286           98 VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT------  171 (259)
Q Consensus        98 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~------  171 (259)
                      ..+.....-.+..++|++|.+.|+|.++++ ..+..++..+.-+..|++..+..||..+|+||||||+|+++..      
T Consensus       757 ~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~  835 (974)
T KOG1166|consen  757 MHISSAHVFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADS  835 (974)
T ss_pred             HHHHHHHccCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCC
Confidence            666666666677789999999999999997 5556889999999999999999999999999999999999942      


Q ss_pred             -CCeEEEeeeccce---eccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCC
Q 045286          172 -HNVVKVADFGVAR---FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKV  233 (259)
Q Consensus       172 -~~~i~l~D~~~~~---~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~  233 (259)
                       ...++|||||.+.   .+..+..+.....+-.|-++|+..|++|++..|.|+|+.+++-||.|+-
T Consensus       836 ~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  836 DSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence             3459999999985   3445556677789999999999999999999999999999999999864

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=4.7e-22  Score=153.37  Aligned_cols=143  Identities=18%  Similarity=0.155  Sum_probs=111.0

Q ss_pred             cceeccccceEEEEEEEc-CceEEEEEeecccCch------------------------HHHHHHHHHHHHHHhcCCCCc
Q 045286           43 GERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLND------------------------TLEDEFVQEVAILREVQHRNV   97 (259)
Q Consensus        43 ~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~------------------------~~~~~~~~e~~~l~~l~~~~i   97 (259)
                      .++||+|++|+||+|.+. |+.||+|+.+......                        .......+|...+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            578999999999999974 8999999998763211                        012234578899999988887


Q ss_pred             ceeeeeeecCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEccCCeEE
Q 045286           98 VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ-RNIIHRDLKTANLLMDTHNVVK  176 (259)
Q Consensus        98 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~di~p~Nilv~~~~~i~  176 (259)
                      .........  ..++||||++|+++....... ..++...+..++.|++.++.++|+ .|++|+||||+||+++ ++.++
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~  157 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY  157 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh-ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence            544433332  247999999887554432222 347788889999999999999999 9999999999999998 89999


Q ss_pred             EeeeccceeccCC
Q 045286          177 VADFGVARFQNKG  189 (259)
Q Consensus       177 l~D~~~~~~~~~~  189 (259)
                      |+|||.+.....+
T Consensus       158 liDFG~a~~~~~~  170 (190)
T cd05145         158 IIDVSQAVELDHP  170 (190)
T ss_pred             EEEcccceecCCC
Confidence            9999999766553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=4.5e-22  Score=152.20  Aligned_cols=182  Identities=17%  Similarity=0.116  Sum_probs=138.6

Q ss_pred             ccceeccccceEEEEEEEcCceEEEEEeecccCch--HHHHHHHHHHHHHHhcC-CCCcceeeeeeecCCcEEEEEecCC
Q 045286           42 TGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLND--TLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHLCIVTEYMP  118 (259)
Q Consensus        42 ~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~  118 (259)
                      ....|++|+||+|+.+...+.+++.+.+.......  .....+.+|+++|+++. +++++.++++    +..+++|+|++
T Consensus         6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            45689999999999998888999988887764422  12235789999999996 5889999886    45689999999


Q ss_pred             CCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC-CCCcEEEccCCeEEEeeeccceeccCCCccc----
Q 045286          119 GGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL-KTANLLMDTHNVVKVADFGVARFQNKGGVMT----  193 (259)
Q Consensus       119 ~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di-~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~----  193 (259)
                      |.+|......       . ...++.|++.+|.++|+.|++|+|| +|.||+++.++.++|+|||.+..........    
T Consensus        82 G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~  153 (218)
T PRK12274         82 GAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLA  153 (218)
T ss_pred             CccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHH
Confidence            9988654321       1 1346789999999999999999999 7999999999999999999998665543210    


Q ss_pred             ----------cCCCcccccCccccCCC-CCC-CchhHHHHHHHHHHHHcCCCCC
Q 045286          194 ----------AETGTYRWMAPEVINHQ-PYD-QKADVFSFAIVLWELVTAKVPY  235 (259)
Q Consensus       194 ----------~~~~~~~~~~PE~~~~~-~~~-~~~Di~slG~~~~~ll~g~~p~  235 (259)
                                -..+.+.+++|+...-. ..+ .+.+.++.|+-+|.++|+..|.
T Consensus       154 ~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        154 REDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             HHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence                      01245555566543221 233 5678889999999999988885

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.88  E-value=6.7e-22  Score=150.68  Aligned_cols=109  Identities=28%  Similarity=0.451  Sum_probs=96.6

Q ss_pred             CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccccCCCcc
Q 045286          120 GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY  199 (259)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~~~~~~  199 (259)
                      |+|.+++......+++..++.++.|++.+|.|||+.+      ||+||+++.++.+++  ||.+.......    ..+++
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence            5889999776667999999999999999999999998      999999999999998  99987665432    25789


Q ss_pred             cccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 045286          200 RWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTP  240 (259)
Q Consensus       200 ~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~  240 (259)
                      .|+|||.+.+..+++++|||||||++|+|++|..||.....
T Consensus        69 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~  109 (176)
T smart00750       69 YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE  109 (176)
T ss_pred             cccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch
Confidence            99999999999999999999999999999999999976443

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=3.1e-22  Score=160.64  Aligned_cols=202  Identities=18%  Similarity=0.277  Sum_probs=135.0

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCc-hHHHHHHHHHHHHHHhcCC----------CCcceeeee
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN-DTLEDEFVQEVAILREVQH----------RNVVRFIGA  103 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~----------~~i~~~~~~  103 (259)
                      .+.+..+..||.|+++.||.+++.  ++++++|++...... ....+.+.+|......+.+          -.++-.++.
T Consensus        11 ~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~   90 (288)
T PF14531_consen   11 PRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL   90 (288)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred             ceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence            357788899999999999999996  599999999876532 2344666666655554321          122222222


Q ss_pred             e------------ecCC-----cEEEEEecCCCCChHHHHHh---cCCC---CCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 045286          104 S------------TKSP-----HLCIVTEYMPGGSLYDYLHK---NHNV---LKLPQLLRFAIDICKGMEYLHQRNIIHR  160 (259)
Q Consensus       104 ~------------~~~~-----~~~lv~e~~~~~~L~~~l~~---~~~~---~~~~~~~~i~~ql~~~l~~lH~~~i~H~  160 (259)
                      .            .+..     +.+++|+-+ .++|..++..   ....   +.......+..|+++.+++||..|++|+
T Consensus        91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg  169 (288)
T PF14531_consen   91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG  169 (288)
T ss_dssp             EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred             EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence            1            1111     347788888 6688887642   2221   2233445677999999999999999999


Q ss_pred             CCCCCcEEEccCCeEEEeeeccceeccCCCccccCCCcccccCccccCC--------CCCCCchhHHHHHHHHHHHHcCC
Q 045286          161 DLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINH--------QPYDQKADVFSFAIVLWELVTAK  232 (259)
Q Consensus       161 di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Di~slG~~~~~ll~g~  232 (259)
                      ||+|+|++++.+|.+.|+||+.....+....  ....+..|.|||....        ..++.+.|.|+||+++|+|+++.
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~--~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~  247 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYR--CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR  247 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEE--GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceee--ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence            9999999999999999999988765544322  1334578999998643        25788999999999999999999


Q ss_pred             CCCCCCCHH
Q 045286          233 VPYDSMTPL  241 (259)
Q Consensus       233 ~p~~~~~~~  241 (259)
                      .||...+..
T Consensus       248 lPf~~~~~~  256 (288)
T PF14531_consen  248 LPFGLSSPE  256 (288)
T ss_dssp             -STCCCGGG
T ss_pred             CCCCCCCcc
Confidence            999865543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=5.2e-20  Score=144.40  Aligned_cols=137  Identities=25%  Similarity=0.398  Sum_probs=114.7

Q ss_pred             ceeccccceEEEEEEEcCceEEEEEeecccCch------HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecC
Q 045286           44 ERIASGSCGDLYRGVYLGQDVAVKVLRSEHLND------TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYM  117 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~  117 (259)
                      ++||+|++|.||++.+.+..+++|.........      .....+.+|+..+..+.++++.....++...+..+++|||+
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   81 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI   81 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence            579999999999999999999999876543221      12245778999999999888877666666667788999999


Q ss_pred             CCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          118 PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                      +|.+|.+.+....    . ....++.+++.++.++|+.|++|+|++|+||+++ ++.++++|||.+...
T Consensus        82 ~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         82 EGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             CCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence            9999999985432    1 7778999999999999999999999999999998 888999999988653

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.84  E-value=2.2e-21  Score=150.68  Aligned_cols=217  Identities=32%  Similarity=0.618  Sum_probs=177.1

Q ss_pred             echhhhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      ++-..+.+..+|....+|..|+++|++..++.|++............|..|.-.|+-+.||||+.+++.+...++..++.
T Consensus       187 id~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is  266 (448)
T KOG0195|consen  187 IDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS  266 (448)
T ss_pred             cchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence            34467778889999999999999999999999999988777767788999999999999999999999999889999999


Q ss_pred             ecCCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEccCCeEEE--eeeccceeccCC
Q 045286          115 EYMPGGSLYDYLHKNHN-VLKLPQLLRFAIDICKGMEYLHQRN--IIHRDLKTANLLMDTHNVVKV--ADFGVARFQNKG  189 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~di~p~Nilv~~~~~i~l--~D~~~~~~~~~~  189 (259)
                      .|++.++|...+..... ..+-.++.+++.+++++.+|||+..  +.--.+....++++++-+.+|  .|-..+.     
T Consensus       267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf-----  341 (448)
T KOG0195|consen  267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-----  341 (448)
T ss_pred             eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee-----
Confidence            99999999999976544 3566788999999999999999875  445568889999988765543  3322221     


Q ss_pred             CccccCCCcccccCccccCCCCCC---CchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh-hccCCCCcc
Q 045286          190 GVMTAETGTYRWMAPEVINHQPYD---QKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVR-QVCTSLCQP  257 (259)
Q Consensus       190 ~~~~~~~~~~~~~~PE~~~~~~~~---~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~-~~~~~~~~~  257 (259)
                       ........+.|++||.+..++.+   .+.|+|||++++|++-|...||...++.+...+|. ++++.-.||
T Consensus       342 -qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ipp  412 (448)
T KOG0195|consen  342 -QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPP  412 (448)
T ss_pred             -eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCC
Confidence             11234578899999999887754   47899999999999999999999988877655554 677666655

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=2.8e-21  Score=171.29  Aligned_cols=199  Identities=24%  Similarity=0.374  Sum_probs=155.6

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEee----cccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEE
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLR----SEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCI  112 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~----~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l  112 (259)
                      +......+|.|++|.|+.+...  .+.+..|.+.    ...........+..|+-+-..+.|++++..+....+.....-
T Consensus       319 y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~  398 (601)
T KOG0590|consen  319 YGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQ  398 (601)
T ss_pred             cCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchh
Confidence            4457789999999977766542  2333344333    211122222336667777788899999888777766666556


Q ss_pred             EEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc-
Q 045286          113 VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV-  191 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~-  191 (259)
                      .|||+++ +|..++... ..+...++..+++|++.++.|+|+.|+.|+|+|++|++++.+|.++++|||.+.....+-. 
T Consensus       399 ~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  399 SMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             hhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence            6999988 999998554 3488888999999999999999999999999999999999999999999999976554422 


Q ss_pred             ----cccCCCcccccCccccCCCCCCC-chhHHHHHHHHHHHHcCCCCCCCCC
Q 045286          192 ----MTAETGTYRWMAPEVINHQPYDQ-KADVFSFAIVLWELVTAKVPYDSMT  239 (259)
Q Consensus       192 ----~~~~~~~~~~~~PE~~~~~~~~~-~~Di~slG~~~~~ll~g~~p~~~~~  239 (259)
                          ....++...|.|||.+.+..|++ ..|+||.|+++..|.+|+-||....
T Consensus       477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~  529 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAK  529 (601)
T ss_pred             hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccc
Confidence                24557889999999999999976 6899999999999999999996543

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=1.2e-19  Score=140.94  Aligned_cols=138  Identities=16%  Similarity=0.253  Sum_probs=104.6

Q ss_pred             hhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhc-----CCCCcceeeeeeecCC---c-E
Q 045286           40 LKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-----QHRNVVRFIGASTKSP---H-L  110 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~---~-~  110 (259)
                      +.-..+||+|+++.||.....+.. ++|+......  .....+.+|+.+++.+     .||||+++++++....   . +
T Consensus         4 L~~~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cCCcceecCCCceEEEECCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            344579999999999974434444 6888876432  2336789999999999     5799999999997753   3 3


Q ss_pred             EEEEec--CCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHHhCCcccCCCCCCcEEEccC----CeEEEee-ecc
Q 045286          111 CIVTEY--MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGM-EYLHQRNIIHRDLKTANLLMDTH----NVVKVAD-FGV  182 (259)
Q Consensus       111 ~lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l-~~lH~~~i~H~di~p~Nilv~~~----~~i~l~D-~~~  182 (259)
                      .+|+||  ..+++|.+++...  .+++.  ..++.+++.++ .|||+.+|+|+||||+||+++..    +.++|+| ||.
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            478999  4468999999653  25444  35577877777 89999999999999999999743    3799999 554


Q ss_pred             ce
Q 045286          183 AR  184 (259)
Q Consensus       183 ~~  184 (259)
                      ..
T Consensus       157 ~~  158 (210)
T PRK10345        157 ST  158 (210)
T ss_pred             cc
Confidence            43

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=7.6e-20  Score=145.33  Aligned_cols=145  Identities=21%  Similarity=0.228  Sum_probs=111.6

Q ss_pred             hhhhccceeccccceEEEEEE---EcCceEEEEEeecccCch----------------------HHHHHHHHHHHHHHhc
Q 045286           38 RLLKTGERIASGSCGDLYRGV---YLGQDVAVKVLRSEHLND----------------------TLEDEFVQEVAILREV   92 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~---~~~~~v~vK~~~~~~~~~----------------------~~~~~~~~e~~~l~~l   92 (259)
                      .-|.+.++||+|++|.||+|.   .+++.|++|+++......                      .....+.+|+..++++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            457889999999999999998   358999999998653210                      0113456899999999


Q ss_pred             CCC--CcceeeeeeecCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCCCcEEE
Q 045286           93 QHR--NVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN-IIHRDLKTANLLM  169 (259)
Q Consensus        93 ~~~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~-i~H~di~p~Nilv  169 (259)
                      .+.  .++++++.    ...++|||+++|.+|....... .......+..++.|++.++.++|+.| ++|+|++|+||++
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli  182 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV  182 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence            753  33444432    2347999999988877654222 23556667889999999999999999 9999999999999


Q ss_pred             ccCCeEEEeeeccceeccC
Q 045286          170 DTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       170 ~~~~~i~l~D~~~~~~~~~  188 (259)
                      + ++.++++|||.+.....
T Consensus       183 ~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      183 H-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             E-CCCEEEEEChhhhccCC
Confidence            8 88999999998865444

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.82  E-value=2.5e-19  Score=139.28  Aligned_cols=134  Identities=22%  Similarity=0.390  Sum_probs=108.0

Q ss_pred             eeccccceEEEEEEEcCceEEEEEeecccCc-h-----HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCC
Q 045286           45 RIASGSCGDLYRGVYLGQDVAVKVLRSEHLN-D-----TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMP  118 (259)
Q Consensus        45 ~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~-~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~  118 (259)
                      .||+|++|.||++.+.+.++++|........ .     ....++.+|+++++.+.++++......+...+..+++||+++
T Consensus         1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~   80 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE   80 (199)
T ss_pred             CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence            4899999999999999999999997653221 1     123567789999999987765544444455566789999999


Q ss_pred             CCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          119 GGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       119 ~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      |.+|.+.+.....        .++.+++.+|.++|+.|++|+|++|+||+++ ++.++++|||.+....
T Consensus        81 g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~  140 (199)
T TIGR03724        81 GKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD  140 (199)
T ss_pred             CccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence            9999988754221        6889999999999999999999999999998 8999999999876543

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.82  E-value=2.3e-21  Score=165.70  Aligned_cols=202  Identities=25%  Similarity=0.386  Sum_probs=165.6

Q ss_pred             eeccccceEEEEEE-----EcCceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCCcEEEEEecCC
Q 045286           45 RIASGSCGDLYRGV-----YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHLCIVTEYMP  118 (259)
Q Consensus        45 ~lg~G~~~~V~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~  118 (259)
                      .+|+|++|.|+++.     +.+.-++.|+.++.............|..++...+ +|.+++++..++.....+++.++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37899999999865     34667888888766443322235556778888887 9999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccccCCCc
Q 045286          119 GGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT  198 (259)
Q Consensus       119 ~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~~~~~  198 (259)
                      |+.|...+.... ..++....-+...++-+++.+|+.+++|+|+|++||+++.+|.+++.|||.+...-.....   ||+
T Consensus        81 gg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt  156 (612)
T KOG0603|consen   81 GGDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGT  156 (612)
T ss_pred             cchhhhccccCC-chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccc
Confidence            999988875444 3666777778889999999999999999999999999999999999999998765544322   899


Q ss_pred             ccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       199 ~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      ..|++||.+.  ....++|.||+|+++++|++|..||..    +.+..|.+.+...+.
T Consensus       157 ~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~  208 (612)
T KOG0603|consen  157 YEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR  208 (612)
T ss_pred             hhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch
Confidence            9999999998  578899999999999999999999987    666666665554443

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.81  E-value=1.6e-18  Score=153.63  Aligned_cols=138  Identities=23%  Similarity=0.363  Sum_probs=114.1

Q ss_pred             hhccceeccccceEEEEEEEcCceEEEEEeecccCc------hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           40 LKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLN------DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      +...++||+|++|+||++.+.++.+++|+.......      ......+.+|+++++.+++++++....+.......++|
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv  414 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV  414 (535)
T ss_pred             cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence            345789999999999999998888777765433211      12235678999999999999998877766666678899


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      |||++|++|.+++.         ....++.+++.++.+||+.|++|+|++|+||++ .++.++|+|||.+....
T Consensus       415 ~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~  478 (535)
T PRK09605        415 MEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD  478 (535)
T ss_pred             EEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence            99999999999874         346688999999999999999999999999999 67899999999986543

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=2e-18  Score=134.14  Aligned_cols=139  Identities=22%  Similarity=0.244  Sum_probs=107.5

Q ss_pred             hhhccceeccccceEEEEEEE-cCceEEEEEeecccCch--------------------HHHHHHHHHHHHHHhcCCCC-
Q 045286           39 LLKTGERIASGSCGDLYRGVY-LGQDVAVKVLRSEHLND--------------------TLEDEFVQEVAILREVQHRN-   96 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~-~~~~v~vK~~~~~~~~~--------------------~~~~~~~~e~~~l~~l~~~~-   96 (259)
                      .|.+.++||+|++|.||++.. .++.+++|++.......                    .......+|...+..+.+++ 
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            477789999999999999987 58999999977543110                    01123567888888887663 


Q ss_pred             -cceeeeeeecCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeE
Q 045286           97 -VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVV  175 (259)
Q Consensus        97 -i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i  175 (259)
                       ++..++    ....+++|||++|.+|......       .....++.+++.++.++|+.|++|+||+|+||+++.++.+
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~  164 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI  164 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence             344443    2455899999999888765321       3355788999999999999999999999999999999999


Q ss_pred             EEeeeccceeccC
Q 045286          176 KVADFGVARFQNK  188 (259)
Q Consensus       176 ~l~D~~~~~~~~~  188 (259)
                      +|+|||.+.....
T Consensus       165 ~liDfg~~~~~~~  177 (198)
T cd05144         165 YIIDWPQMVSTDH  177 (198)
T ss_pred             EEEECCccccCCC
Confidence            9999999854444

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.79  E-value=5.9e-20  Score=165.26  Aligned_cols=195  Identities=21%  Similarity=0.254  Sum_probs=150.2

Q ss_pred             hhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHH--HHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           39 LLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAI--LREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~--l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      ++...+-||++.|=+|.+|++....|++|++..+...-.. ..+.+++.-  ....++||.+++.-+.......++|-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL-~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISL-RPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCc-hHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5777889999999999999998778999999987643222 233333322  4445799999988776666677788888


Q ss_pred             CCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecccee--cc--CCCcc
Q 045286          117 MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QN--KGGVM  192 (259)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~--~~--~~~~~  192 (259)
                      . ..+|.+.+..++ .+...+...++.|++.+|..+|..|++|||||.+|||++.-.-+.|+||..=..  ..  ++..+
T Consensus       103 v-khnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf  180 (1431)
T KOG1240|consen  103 V-KHNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADF  180 (1431)
T ss_pred             H-hhhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccc
Confidence            8 558999886655 377888889999999999999999999999999999999988999999987432  11  11111


Q ss_pred             ----ccCCCcccccCccccCC----------CC-CCCchhHHHHHHHHHHHHc-CCCCCC
Q 045286          193 ----TAETGTYRWMAPEVINH----------QP-YDQKADVFSFAIVLWELVT-AKVPYD  236 (259)
Q Consensus       193 ----~~~~~~~~~~~PE~~~~----------~~-~~~~~Di~slG~~~~~ll~-g~~p~~  236 (259)
                          .......-|.|||.+..          .+ .+++.||||+||+++|+++ |.+||+
T Consensus       181 ~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~  240 (1431)
T KOG1240|consen  181 TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT  240 (1431)
T ss_pred             eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence                11223456999998743          22 5789999999999999999 899996

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.75  E-value=3.5e-17  Score=130.35  Aligned_cols=139  Identities=18%  Similarity=0.211  Sum_probs=107.2

Q ss_pred             ccceec-cccceEEEEEEEcCceEEEEEeecccC-----------chHHHHHHHHHHHHHHhcCCCCc--ceeeeeeecC
Q 045286           42 TGERIA-SGSCGDLYRGVYLGQDVAVKVLRSEHL-----------NDTLEDEFVQEVAILREVQHRNV--VRFIGASTKS  107 (259)
Q Consensus        42 ~~~~lg-~G~~~~V~~~~~~~~~v~vK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~~  107 (259)
                      -...|| .|+.|+||.+...+..++||.+.....           .......+.+|+++++.+.+++|  +..++.....
T Consensus        35 ~~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         35 QARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             cCceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            345787 899999999999999999998864321           11233567889999999988775  5566553322


Q ss_pred             -C---cEEEEEecCCC-CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecc
Q 045286          108 -P---HLCIVTEYMPG-GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGV  182 (259)
Q Consensus       108 -~---~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~  182 (259)
                       .   ..++|+|+++| .+|.+++...  .++..    .+.+++.++.+||+.|++|+|++|.|||++.++.++|+|||.
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~  188 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR  188 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence             2   23599999987 6898887542  24443    357899999999999999999999999999999999999998


Q ss_pred             ceec
Q 045286          183 ARFQ  186 (259)
Q Consensus       183 ~~~~  186 (259)
                      +...
T Consensus       189 ~~~~  192 (239)
T PRK01723        189 GELR  192 (239)
T ss_pred             cccC
Confidence            7643

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.75  E-value=1.8e-17  Score=127.53  Aligned_cols=138  Identities=24%  Similarity=0.284  Sum_probs=97.8

Q ss_pred             cceeccccceEEEEEEEc-CceEEEEEeecccCchHHHHH----------------------HHHHHHHHHhcCCCC--c
Q 045286           43 GERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDE----------------------FVQEVAILREVQHRN--V   97 (259)
Q Consensus        43 ~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~----------------------~~~e~~~l~~l~~~~--i   97 (259)
                      .++||+|++|+||+|.+. ++.|++|++............                      ...|...+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            578999999999999976 899999998765332211111                      134555555554332  3


Q ss_pred             ceeeeeeecCCcEEEEEecCCCCChHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEccCCeE
Q 045286           98 VRFIGASTKSPHLCIVTEYMPGGSLYD-YLHKNHNVLKLPQLLRFAIDICKGMEYLHQ-RNIIHRDLKTANLLMDTHNVV  175 (259)
Q Consensus        98 ~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~di~p~Nilv~~~~~i  175 (259)
                      ++.+..    ...+++|||++++++.. .+....  . ...+..++.+++.++.++|. .+++|+|++|+||+++ ++.+
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~  153 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV  153 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence            334432    24589999998843321 111111  1 15677899999999999999 9999999999999999 9999


Q ss_pred             EEeeeccceeccC
Q 045286          176 KVADFGVARFQNK  188 (259)
Q Consensus       176 ~l~D~~~~~~~~~  188 (259)
                      +++|||.+.....
T Consensus       154 ~liDfg~a~~~~~  166 (187)
T cd05119         154 YIIDVPQAVEIDH  166 (187)
T ss_pred             EEEECcccccccC
Confidence            9999999865544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.73  E-value=7.1e-17  Score=119.41  Aligned_cols=131  Identities=20%  Similarity=0.260  Sum_probs=111.1

Q ss_pred             ccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCC--CCcceeeeeeecCCcEEEEEecCCC
Q 045286           42 TGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH--RNVVRFIGASTKSPHLCIVTEYMPG  119 (259)
Q Consensus        42 ~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~~~~  119 (259)
                      +.+.||.|.++.||++...+..+++|.......    ...+.+|...++.+.+  ..+++++......+..++++||+++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            457899999999999999889999999876543    3567889999999975  5888888888777889999999988


Q ss_pred             CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCCCcEEEccCCeEEEeeeccce
Q 045286          120 GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR---NIIHRDLKTANLLMDTHNVVKVADFGVAR  184 (259)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~di~p~Nilv~~~~~i~l~D~~~~~  184 (259)
                      .++..+        +......++.++++++..+|..   +++|+|++|+||+++.++.++++||+.+.
T Consensus        78 ~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          78 ETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             eecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            766543        3455567889999999999985   69999999999999998999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.68  E-value=7e-17  Score=145.37  Aligned_cols=176  Identities=30%  Similarity=0.394  Sum_probs=130.0

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      ...+..++.|..|++|.||.+.+.  .+.++.|+-+..        .+.+.  ++....+|.+               | 
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~--------lilRn--ilt~a~npfv---------------v-  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN--------LILRN--ILTFAGNPFV---------------V-  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccc--------hhhhc--cccccCCcce---------------e-
Confidence            357778899999999999999765  778888443322        12221  2222223322               2 


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC---Cc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG---GV  191 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~---~~  191 (259)
                           ++....+ +..+.++...        +.++.|+|+.|++|+|+||+|.+|+.=|.+|+.|||+.......   ..
T Consensus       136 -----gDc~tll-k~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl  201 (1205)
T KOG0606|consen  136 -----GDCATLL-KNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL  201 (1205)
T ss_pred             -----chhhhhc-ccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence                 3333444 3333344333        66899999999999999999999999999999999997532211   11


Q ss_pred             -------------cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          192 -------------MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       192 -------------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                                   -...++++.|.|||++..+.|...+|.|++|+++|+.+.|..||.+.++.+...++.....
T Consensus       202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i  275 (1205)
T KOG0606|consen  202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI  275 (1205)
T ss_pred             hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc
Confidence                         1234799999999999999999999999999999999999999999999999888775443

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.63  E-value=1.1e-15  Score=130.48  Aligned_cols=167  Identities=33%  Similarity=0.575  Sum_probs=136.5

Q ss_pred             HHhcCCCCcceeeeeeecCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-ccCCCCCCcE
Q 045286           89 LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI-IHRDLKTANL  167 (259)
Q Consensus        89 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i-~H~di~p~Ni  167 (259)
                      |+.+.|.|+.++++.+..++..+.|.+++.-++|.+.+....-.++..-...++++++.++.|+|...+ .|+.++..|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            356789999999999999999999999999999999998766667777888899999999999998866 9999999999


Q ss_pred             EEccCCeEEEeeeccceeccCCC---ccccCCCcccccCccccCCC-------CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          168 LMDTHNVVKVADFGVARFQNKGG---VMTAETGTYRWMAPEVINHQ-------PYDQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       168 lv~~~~~i~l~D~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~-------~~~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                      +++....+|+.|||+........   ..........|.|||.+.+.       ..+.+.|+||+|++++++++.+.||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            99999999999999987764311   11122245779999998764       146779999999999999999999975


Q ss_pred             ----CCHHHHHHHhhhccCCCC
Q 045286          238 ----MTPLQAALGVRQVCTSLC  255 (259)
Q Consensus       238 ----~~~~~~~~~i~~~~~~~~  255 (259)
                          ..+.+.+..++++...+.
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~  182 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPF  182 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCc
Confidence                333567777777444333

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.61  E-value=2.5e-14  Score=106.14  Aligned_cols=135  Identities=24%  Similarity=0.336  Sum_probs=103.5

Q ss_pred             ceeccccceEEEEEEEcCceEEEEEeecccCc-hH-----HHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecC
Q 045286           44 ERIASGSCGDLYRGVYLGQDVAVKVLRSEHLN-DT-----LEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYM  117 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~-~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~  117 (259)
                      ..+.+|+-+.++.+.+.+.++++|...+.... ++     ...+-.+|+.++..+..-.+....-++.+.+...++|||+
T Consensus         2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            46889999999999988888888887665332 21     2244567899998886544444444444556677999999


Q ss_pred             CCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          118 PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      +|..|.+.+....        ..++..+-..+..||..|++|||++++||.++.++ +.++|||++.+..
T Consensus        82 ~G~~lkd~l~~~~--------~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~  142 (204)
T COG3642          82 EGELLKDALEEAR--------PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD  142 (204)
T ss_pred             CChhHHHHHHhcc--------hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence            9999998886551        34677778888999999999999999999996554 9999999986433

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.61  E-value=5.5e-15  Score=120.88  Aligned_cols=142  Identities=26%  Similarity=0.388  Sum_probs=108.4

Q ss_pred             CCCCcceeeeeeecC---------------------------CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHH
Q 045286           93 QHRNVVRFIGASTKS---------------------------PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDI  145 (259)
Q Consensus        93 ~~~~i~~~~~~~~~~---------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql  145 (259)
                      .||||+++.+.|.++                           ...|+||... ..+|.+++-.+.  .+....+-++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC--CchHHHHHHHHHH
Confidence            489999998877432                           1468999988 569999986544  5667777899999


Q ss_pred             HHHHHHHHhCCcccCCCCCCcEEEcc--C--CeEEEeeeccceeccC-------CCccccCCCcccccCccccCCCCC--
Q 045286          146 CKGMEYLHQRNIIHRDLKTANLLMDT--H--NVVKVADFGVARFQNK-------GGVMTAETGTYRWMAPEVINHQPY--  212 (259)
Q Consensus       146 ~~~l~~lH~~~i~H~di~p~Nilv~~--~--~~i~l~D~~~~~~~~~-------~~~~~~~~~~~~~~~PE~~~~~~~--  212 (259)
                      ++++.+||+.|+.|+|+|.+||++--  |  ..+.+.|||++---..       .+.....-|....++||.....+-  
T Consensus       351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~  430 (598)
T KOG4158|consen  351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN  430 (598)
T ss_pred             HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence            99999999999999999999999943  3  2589999998742211       111122336677899999865431  


Q ss_pred             ----CCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          213 ----DQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       213 ----~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                          -.+.|.|+.|.+.||+++...||=.
T Consensus       431 avvny~kAD~WA~GalaYEIfg~~NPFY~  459 (598)
T KOG4158|consen  431 AVVNYEKADTWAAGALAYEIFGRSNPFYK  459 (598)
T ss_pred             eeeccchhhhhhhhhhHHHHhccCCcccc
Confidence                2479999999999999999999854

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.60  E-value=3.6e-14  Score=104.98  Aligned_cols=145  Identities=21%  Similarity=0.242  Sum_probs=110.6

Q ss_pred             ccceeccccceEEEEEEEcCceEEEEEeecccCc-h-----HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           42 TGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLN-D-----TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        42 ~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~-~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ...++-||+-+.|+.+.+.|+.+++|........ +     -...+..+|+++|.++..-.|.-..-++.+...-.+.||
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            4578999999999999999999999987665432 1     223566789999998875555444444545555678999


Q ss_pred             cCCC-CChHHHHHhcCCCCCHHHH-HHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC---eEEEeeeccceec
Q 045286          116 YMPG-GSLYDYLHKNHNVLKLPQL-LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVARFQ  186 (259)
Q Consensus       116 ~~~~-~~L~~~l~~~~~~~~~~~~-~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~---~i~l~D~~~~~~~  186 (259)
                      |++| .++.+++......-.++.. ..+++++-+.+..||.++++|||++.+||++..++   .+.++|||++...
T Consensus        91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            9977 5788888655443334333 78999999999999999999999999999997654   3589999998644

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.59  E-value=2.1e-14  Score=123.91  Aligned_cols=143  Identities=20%  Similarity=0.268  Sum_probs=96.7

Q ss_pred             cceeccccceEEEEEEE-cCceEEEEEeecccCch--------------------------------HHHH------HHH
Q 045286           43 GERIASGSCGDLYRGVY-LGQDVAVKVLRSEHLND--------------------------------TLED------EFV   83 (259)
Q Consensus        43 ~~~lg~G~~~~V~~~~~-~~~~v~vK~~~~~~~~~--------------------------------~~~~------~~~   83 (259)
                      .++||+|+.|+||+|+. +|+.||||+.+......                                +...      .+.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            36899999999999997 58999999986542110                                0000      133


Q ss_pred             HHHHHHHhcC----CCCcceeeeee-ecCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHH-HHHHHHhCCc
Q 045286           84 QEVAILREVQ----HRNVVRFIGAS-TKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICK-GMEYLHQRNI  157 (259)
Q Consensus        84 ~e~~~l~~l~----~~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~-~l~~lH~~~i  157 (259)
                      +|.+-+.++.    +..-+.+..++ ...+..++||||++|.+|.+.........+   ...++.+++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence            3444444442    22222332322 223456899999999999887653221222   2335555554 4678899999


Q ss_pred             ccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          158 IHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       158 ~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      +|+|++|.||+++.++.++++|||.+.....
T Consensus       279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       279 FHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             eeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            9999999999999999999999999876654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.58  E-value=3.9e-16  Score=131.47  Aligned_cols=119  Identities=31%  Similarity=0.552  Sum_probs=105.9

Q ss_pred             cEEEEEecCCCCChHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          109 HLCIVTEYMPGGSLYDYLHK--NHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                      ..++.|+++...+|.+++..  .....+......++.|+..++.|   ++.+|+|++|.||+...+..++|.|||+....
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            57899999999999999953  33456778888999999999999   99999999999999999999999999998776


Q ss_pred             cCCC-------ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc
Q 045286          187 NKGG-------VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT  230 (259)
Q Consensus       187 ~~~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~  230 (259)
                      ....       ......++..|++||.+.+..|+.++|||+||+++++++.
T Consensus       407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            6554       4456679999999999999999999999999999999998

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.57  E-value=2.3e-14  Score=108.34  Aligned_cols=127  Identities=17%  Similarity=0.147  Sum_probs=95.7

Q ss_pred             cceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCC-cceeeeeeecCCcEEEEEecCCCCC
Q 045286           43 GERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRN-VVRFIGASTKSPHLCIVTEYMPGGS  121 (259)
Q Consensus        43 ~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e~~~~~~  121 (259)
                      .++|+.|.++.||++...++.+++|........   ...+.+|+.+++.+.... +++++....  +..++||||++|.+
T Consensus         3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~   77 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTEL---LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE   77 (170)
T ss_pred             eeecCCcccCceEEEEECCeEEEEEeCCCCccc---ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence            367899999999999999999999998655321   123567888888886444 344554433  34579999999987


Q ss_pred             hHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----ccCCCCCCcEEEccCCeEEEeeeccce
Q 045286          122 LYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI-----IHRDLKTANLLMDTHNVVKVADFGVAR  184 (259)
Q Consensus       122 L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i-----~H~di~p~Nilv~~~~~i~l~D~~~~~  184 (259)
                      +...     . ..   ......+++.++..||+.++     +|+|++|.||+++ ++.++++||+.+.
T Consensus        78 l~~~-----~-~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          78 LLTE-----D-FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cccc-----c-cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            7643     0 11   12356789999999999985     9999999999998 7789999999864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.57  E-value=2.3e-16  Score=140.17  Aligned_cols=205  Identities=24%  Similarity=0.388  Sum_probs=167.2

Q ss_pred             chhhhhccceeccccceEEEEEEEc---CceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCCcEE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL---GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~---~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~  111 (259)
                      ....|.+...||+|+++.|-.....   ...+++|-+............+..|..+-+.+. |+|++.+++........+
T Consensus        18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            3567788888999999999876653   345666666655434444555666888888887 999999999999999999


Q ss_pred             EEEecCCCCChHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCcEEEccCC-eEEEeeeccceeccC
Q 045286          112 IVTEYMPGGSLYDYL-HKNHNVLKLPQLLRFAIDICKGMEYLH-QRNIIHRDLKTANLLMDTHN-VVKVADFGVARFQNK  188 (259)
Q Consensus       112 lv~e~~~~~~L~~~l-~~~~~~~~~~~~~~i~~ql~~~l~~lH-~~~i~H~di~p~Nilv~~~~-~i~l~D~~~~~~~~~  188 (259)
                      ++.++.+|+++.+.+ .......+...+..++.|+..++.|+| ..++.|+|++|+|.+++..+ .+++.|||.+.....
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            999999999999888 444324667778889999999999999 99999999999999999999 999999999986655


Q ss_pred             -C---CccccCCC-cccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 045286          189 -G---GVMTAETG-TYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTP  240 (259)
Q Consensus       189 -~---~~~~~~~~-~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~  240 (259)
                       .   ......++ ++.|.+||.+.+. -..+..|+||.|+++..+++|..||.....
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~  235 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR  235 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence             2   22345567 9999999999886 457889999999999999999999976443

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.56  E-value=9e-14  Score=106.39  Aligned_cols=140  Identities=15%  Similarity=0.128  Sum_probs=100.5

Q ss_pred             cceeccccceEEEEEEEc--------CceEEEEEeecccCc--------------------hHHHHH----HHHHHHHHH
Q 045286           43 GERIASGSCGDLYRGVYL--------GQDVAVKVLRSEHLN--------------------DTLEDE----FVQEVAILR   90 (259)
Q Consensus        43 ~~~lg~G~~~~V~~~~~~--------~~~v~vK~~~~~~~~--------------------~~~~~~----~~~e~~~l~   90 (259)
                      ..+||+|--+.||.|...        +..+|+|+.+.....                    .+....    ..+|.+.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            468999999999999864        369999998754211                    011222    337999999


Q ss_pred             hcCC--CCcceeeeeeecCCcEEEEEecCCCCChHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCcccCCCCCCc
Q 045286           91 EVQH--RNVVRFIGASTKSPHLCIVTEYMPGGSLYD-YLHKNHNVLKLPQLLRFAIDICKGMEYL-HQRNIIHRDLKTAN  166 (259)
Q Consensus        91 ~l~~--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~i~~ql~~~l~~l-H~~~i~H~di~p~N  166 (259)
                      ++..  -.++..++.    ...++|||++.+..+.. .+..  ..++...+..+..+++.++..+ |+.|++|||+++.|
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N  155 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN  155 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence            8863  455556654    45579999996643322 1211  1244556677889999999988 89999999999999


Q ss_pred             EEEccCCeEEEeeeccceeccCC
Q 045286          167 LLMDTHNVVKVADFGVARFQNKG  189 (259)
Q Consensus       167 ilv~~~~~i~l~D~~~~~~~~~~  189 (259)
                      |+++ ++.+.++||+-+.....+
T Consensus       156 IL~~-~~~v~iIDF~qav~~~hp  177 (197)
T cd05146         156 MLWH-DGKVWFIDVSQSVEPTHP  177 (197)
T ss_pred             EEEE-CCcEEEEECCCceeCCCC
Confidence            9996 578999999988766544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.53  E-value=2.5e-13  Score=117.88  Aligned_cols=163  Identities=15%  Similarity=0.206  Sum_probs=127.2

Q ss_pred             EcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCCCCChHHHHHhcCCCCCHHHH
Q 045286           59 YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQL  138 (259)
Q Consensus        59 ~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  138 (259)
                      ..+.+|.|...+....  .......+-+..++.++||+|+++++.+...+..|+|.|.+  ..|..++.+..    ...+
T Consensus        35 ~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~----~~~v  106 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG----KEEV  106 (690)
T ss_pred             ccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH----HHHH
Confidence            3477888888887644  44466778889999999999999999999999999999998  47888876533    5667


Q ss_pred             HHHHHHHHHHHHHHH-hCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc-cccCCCcccccCccccCCCCCCCch
Q 045286          139 LRFAIDICKGMEYLH-QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV-MTAETGTYRWMAPEVINHQPYDQKA  216 (259)
Q Consensus       139 ~~i~~ql~~~l~~lH-~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~  216 (259)
                      ..-+.||+.+|.+|| +.+++|++++.+.|+|+..|..+|.+|..+........ .....-...|..|+......  -..
T Consensus       107 ~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~  184 (690)
T KOG1243|consen  107 CLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSI  184 (690)
T ss_pred             HHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cch
Confidence            778999999999997 67899999999999999999999999999865443321 11222234455565443222  245


Q ss_pred             hHHHHHHHHHHHHcC
Q 045286          217 DVFSFAIVLWELVTA  231 (259)
Q Consensus       217 Di~slG~~~~~ll~g  231 (259)
                      |.|.|||++++++.|
T Consensus       185 D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  185 DSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhhHHHHHHHHhCc
Confidence            999999999999999

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.50  E-value=1.4e-13  Score=120.43  Aligned_cols=142  Identities=20%  Similarity=0.249  Sum_probs=90.5

Q ss_pred             hhhccceeccccceEEEEEEEc--CceEEEEEeecccCc--------------------------------hHHHHHHHH
Q 045286           39 LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN--------------------------------DTLEDEFVQ   84 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~--------------------------------~~~~~~~~~   84 (259)
                      .+.. ++||+|+.|+||+|...  |+.||||+.++....                                ++....+.+
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            3444 79999999999999973  899999999865211                                011122222


Q ss_pred             ------HHHHHHhcC----CCCcceeeeeee-cCCcEEEEEecCCCCChHHHH--HhcCC---CCCHHHHHHHHHHHHHH
Q 045286           85 ------EVAILREVQ----HRNVVRFIGAST-KSPHLCIVTEYMPGGSLYDYL--HKNHN---VLKLPQLLRFAIDICKG  148 (259)
Q Consensus        85 ------e~~~l~~l~----~~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l--~~~~~---~~~~~~~~~i~~ql~~~  148 (259)
                            |..-+.++.    +...+.+..++. .....++||||++|.++.+.-  ...+.   .+....+..++.|+   
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi---  276 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV---  276 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence                  333333331    232333333332 244567999999999998753  22211   12222333334443   


Q ss_pred             HHHHHhCCcccCCCCCCcEEEccCC----eEEEeeeccceeccC
Q 045286          149 MEYLHQRNIIHRDLKTANLLMDTHN----VVKVADFGVARFQNK  188 (259)
Q Consensus       149 l~~lH~~~i~H~di~p~Nilv~~~~----~i~l~D~~~~~~~~~  188 (259)
                          ...|++|+|++|.||+++.+|    .++++|||.+.....
T Consensus       277 ----f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 ----FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ----HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                459999999999999999888    999999999876654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.42  E-value=1.8e-13  Score=117.40  Aligned_cols=202  Identities=26%  Similarity=0.282  Sum_probs=166.8

Q ss_pred             ceechhhhhccceecc--ccceEEEEEEE----cCceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeee
Q 045286           33 WEIDRRLLKTGERIAS--GSCGDLYRGVY----LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGAST  105 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~--G~~~~V~~~~~----~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~  105 (259)
                      ..+........+-+|.  |.++.||.+.-    .+..+++|.-+...........-.+|+...+.++ |++.++.+..+.
T Consensus       109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e  188 (524)
T KOG0601|consen  109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE  188 (524)
T ss_pred             cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence            4455677778889999  99999998775    3678899987766554433445567777777776 899999899999


Q ss_pred             cCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHH----HHHHHHhCCcccCCCCCCcEEEccC-CeEEEeee
Q 045286          106 KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICK----GMEYLHQRNIIHRDLKTANLLMDTH-NVVKVADF  180 (259)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~----~l~~lH~~~i~H~di~p~Nilv~~~-~~i~l~D~  180 (259)
                      .++..++-.|.+ +.+|..+.......++...++....+...    ++..+|..+++|.|++|.||+...+ ...+++||
T Consensus       189 ~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  189 GSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             cCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCc
Confidence            999999999998 68999999877777889999999999999    9999999999999999999999999 88999999


Q ss_pred             ccceeccCCCccc------cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 045286          181 GVARFQNKGGVMT------AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYD  236 (259)
Q Consensus       181 ~~~~~~~~~~~~~------~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~  236 (259)
                      ++...+..+....      ...+...|++||+..+. ++..+|++++|.++.+-.++..+..
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~  328 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPS  328 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhccccc
Confidence            9998776654221      12578899999998665 7889999999999999888766654

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.39  E-value=2.6e-11  Score=97.81  Aligned_cols=141  Identities=16%  Similarity=0.100  Sum_probs=100.1

Q ss_pred             eeccccceEEEEEEEcCceEEEEEeecccCchHHH---------HHHHHHHHHHHhcCCCCcce--eeeeeec-----CC
Q 045286           45 RIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLE---------DEFVQEVAILREVQHRNVVR--FIGASTK-----SP  108 (259)
Q Consensus        45 ~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~---------~~~~~e~~~l~~l~~~~i~~--~~~~~~~-----~~  108 (259)
                      .+-......|+.+...|+.+.||............         ..+.+|.+.+..+...+|..  ++.++..     ..
T Consensus        29 ~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~  108 (268)
T PRK15123         29 VFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR  108 (268)
T ss_pred             EEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence            44434444566788889999999775443221111         13678888888885444433  3334322     23


Q ss_pred             cEEEEEecCCCC-ChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc-------CCeEEEee
Q 045286          109 HLCIVTEYMPGG-SLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT-------HNVVKVAD  179 (259)
Q Consensus       109 ~~~lv~e~~~~~-~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~-------~~~i~l~D  179 (259)
                      ..++|+|++++. +|.+++... ....+......++.+++..+..||+.|++|+|++++||+++.       +..+.+||
T Consensus       109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LID  188 (268)
T PRK15123        109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVID  188 (268)
T ss_pred             eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEE
Confidence            468999999885 798887532 233556677789999999999999999999999999999975       46899999


Q ss_pred             ecccee
Q 045286          180 FGVARF  185 (259)
Q Consensus       180 ~~~~~~  185 (259)
                      |+.+..
T Consensus       189 l~r~~~  194 (268)
T PRK15123        189 LHRAQI  194 (268)
T ss_pred             CCcccc
Confidence            998753

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.36  E-value=1.1e-11  Score=97.64  Aligned_cols=140  Identities=24%  Similarity=0.272  Sum_probs=106.3

Q ss_pred             hhhccceeccccceEEEEEEEc-CceEEEEEeecccCc--------------------hHHHHHHHHHHHHHHhcCCC--
Q 045286           39 LLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLN--------------------DTLEDEFVQEVAILREVQHR--   95 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~--------------------~~~~~~~~~e~~~l~~l~~~--   95 (259)
                      -..++.+||-|--|.||.|.+. +.++++|.-+.-.++                    ........+|..+|+.|...  
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            4557889999999999999986 899999986543221                    12234567899999999754  


Q ss_pred             CcceeeeeeecCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeE
Q 045286           96 NVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVV  175 (259)
Q Consensus        96 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i  175 (259)
                      .++..+++    +...+|||+++|..|...-      ++......++..|+..+..+-..|++|||+++-||+++.+|.+
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~  241 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDI  241 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCE
Confidence            67777755    6778999999986554432      1334445566677777777779999999999999999999999


Q ss_pred             EEeeeccceeccC
Q 045286          176 KVADFGVARFQNK  188 (259)
Q Consensus       176 ~l~D~~~~~~~~~  188 (259)
                      .++||.-+.....
T Consensus       242 ~vIDwPQ~v~~~h  254 (304)
T COG0478         242 VVIDWPQAVPISH  254 (304)
T ss_pred             EEEeCcccccCCC
Confidence            9999987654444

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.36  E-value=7.4e-12  Score=98.68  Aligned_cols=138  Identities=20%  Similarity=0.261  Sum_probs=99.5

Q ss_pred             ceeccccceEEEEEEEcC-ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCC--CcceeeeeeecC---CcEEEEEecC
Q 045286           44 ERIASGSCGDLYRGVYLG-QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHR--NVVRFIGASTKS---PHLCIVTEYM  117 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~~-~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~---~~~~lv~e~~  117 (259)
                      ++|+.|.++.+|++...+ +.+++|........ .....+.+|..+++.+.+.  .+++++......   +..+++|||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            578999999999998775 89999998765321 1235678899999999753  456677666543   3678999999


Q ss_pred             CCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 045286          118 PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ-------------------------------------------  154 (259)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~-------------------------------------------  154 (259)
                      +|.++.+.+..  ..++......++.+++..|..||+                                           
T Consensus        83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            99877665421  124444445555555555555552                                           


Q ss_pred             -------------CCcccCCCCCCcEEEcc--CCeEEEeeeccce
Q 045286          155 -------------RNIIHRDLKTANLLMDT--HNVVKVADFGVAR  184 (259)
Q Consensus       155 -------------~~i~H~di~p~Nilv~~--~~~i~l~D~~~~~  184 (259)
                                   ..++|+|+.|.||+++.  ++.+.++||+.+.
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                         34799999999999988  6678999999874

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.32  E-value=2.9e-11  Score=92.22  Aligned_cols=129  Identities=26%  Similarity=0.327  Sum_probs=83.6

Q ss_pred             EEEEEEE-cCceEEEEEeecccCc------------------------hHHHHHHHHHHHHHHhcCCC--Ccceeeeeee
Q 045286           53 DLYRGVY-LGQDVAVKVLRSEHLN------------------------DTLEDEFVQEVAILREVQHR--NVVRFIGAST  105 (259)
Q Consensus        53 ~V~~~~~-~~~~v~vK~~~~~~~~------------------------~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~  105 (259)
                      .||.|.. .+..+|+|..+....+                        ........+|.+.|+++..-  ++++.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4888887 4789999998753111                        12235567899999999855  456666442 


Q ss_pred             cCCcEEEEEecCC--CCChHHHHHhcCCCCCHHHHHHHHHHHHHHHH-HHHhCCcccCCCCCCcEEEccCCeEEEeeecc
Q 045286          106 KSPHLCIVTEYMP--GGSLYDYLHKNHNVLKLPQLLRFAIDICKGME-YLHQRNIIHRDLKTANLLMDTHNVVKVADFGV  182 (259)
Q Consensus       106 ~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~-~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~  182 (259)
                         ..++||||++  |..+..+....   ++......++.+++..+. .+|..|++|||+++.||+++.+ .+.+||||.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q  152 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ  152 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence               3369999998  66665544322   113445567777777444 4689999999999999999776 999999998


Q ss_pred             ceeccCC
Q 045286          183 ARFQNKG  189 (259)
Q Consensus       183 ~~~~~~~  189 (259)
                      +....++
T Consensus       153 av~~~~p  159 (188)
T PF01163_consen  153 AVDSSHP  159 (188)
T ss_dssp             EEETTST
T ss_pred             ceecCCc
Confidence            8765543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.29  E-value=1.7e-10  Score=95.87  Aligned_cols=199  Identities=16%  Similarity=0.241  Sum_probs=141.2

Q ss_pred             ceechhhhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeeee------ee
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGA------ST  105 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~------~~  105 (259)
                      ++.-+.-+..+..||+|+-+.+|-..- -...+-|+...+-...     -.+.+..|... .||-+..-+.+      ..
T Consensus         6 ~~~~ge~i~~gr~LgqGgea~ly~l~e-~~d~VAKIYh~Pppa~-----~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~   79 (637)
T COG4248           6 YDVYGEPIPPGRPLGQGGEADLYTLGE-VRDQVAKIYHAPPPAA-----QAQKVAELAATPDAPLLNYRVAWPQATLHGG   79 (637)
T ss_pred             ccccCcccCCCccccCCccceeeecch-hhchhheeecCCCchH-----HHHHHHHhccCCCCcchhhhhcccHHHhhCC
Confidence            344455667888999999999986432 2345678877663321     11223334433 25433321111      11


Q ss_pred             c-CCcEEEEEecCCCC-ChHHHHH-----hcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEe
Q 045286          106 K-SPHLCIVTEYMPGG-SLYDYLH-----KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVA  178 (259)
Q Consensus       106 ~-~~~~~lv~e~~~~~-~L~~~l~-----~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~  178 (259)
                      . +..+-++|+.+.|. .+..+.+     ........+-+.+.++.++.+.+.||..|.+-||+.++|+||++++.+.|+
T Consensus        80 ~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LV  159 (637)
T COG4248          80 RRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLV  159 (637)
T ss_pred             CccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEE
Confidence            1 22367888888764 2333221     122346678888999999999999999999999999999999999999999


Q ss_pred             eeccceeccCCCccccCCCcccccCccccC-----CCCCCCchhHHHHHHHHHHHHcC-CCCCCC
Q 045286          179 DFGVARFQNKGGVMTAETGTYRWMAPEVIN-----HQPYDQKADVFSFAIVLWELVTA-KVPYDS  237 (259)
Q Consensus       179 D~~~~~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~~~~ll~g-~~p~~~  237 (259)
                      |-..-....++.......+.+.|.|||.-.     +...+...|.|.||++++++|.| .+||.+
T Consensus       160 dsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG  224 (637)
T COG4248         160 DSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG  224 (637)
T ss_pred             cccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence            987766666666667778999999999853     55678899999999999999985 999975

>PRK09902 hypothetical protein; Provisional

Probab=99.17  E-value=9.8e-10  Score=84.51  Aligned_cols=139  Identities=16%  Similarity=0.143  Sum_probs=101.3

Q ss_pred             ccccceEEEEEEEcCceEEEEEeecccCc----hHHHHHHHHHHHHHHhcCCCC--cceeeeeeec----CCcEEEEEec
Q 045286           47 ASGSCGDLYRGVYLGQDVAVKVLRSEHLN----DTLEDEFVQEVAILREVQHRN--VVRFIGASTK----SPHLCIVTEY  116 (259)
Q Consensus        47 g~G~~~~V~~~~~~~~~v~vK~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~----~~~~~lv~e~  116 (259)
                      |.|+.|-|+.....|..+-+|........    +.-...+.+|...++++...+  ++........    .-+-++|.|-
T Consensus        27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~  106 (216)
T PRK09902         27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED  106 (216)
T ss_pred             CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence            44899999998888888888886522110    223467889999999886433  3333311111    1246889998


Q ss_pred             CCC-CChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCe--EEEeeecccee
Q 045286          117 MPG-GSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV--VKVADFGVARF  185 (259)
Q Consensus       117 ~~~-~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~--i~l~D~~~~~~  185 (259)
                      ++| .+|.+++.... ...+......++.+++.++..||+.|+.|+|+.+.||+++.+|.  +.++||+.+..
T Consensus       107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            754 68888875432 23566777789999999999999999999999999999986677  99999997753

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.15  E-value=5.7e-10  Score=87.06  Aligned_cols=107  Identities=21%  Similarity=0.325  Sum_probs=81.4

Q ss_pred             HHHHHHHHHHHhcCCCCc--ceeeeeeecC----CcEEEEEecCCC-CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Q 045286           80 DEFVQEVAILREVQHRNV--VRFIGASTKS----PHLCIVTEYMPG-GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYL  152 (259)
Q Consensus        80 ~~~~~e~~~l~~l~~~~i--~~~~~~~~~~----~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~l  152 (259)
                      ....+|...+..+....|  +..+.+....    ...++|+|++++ .+|.+++..... .+......++.+++..+..|
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence            456777777777753333  3344444331    245899999987 479998865333 55667778999999999999


Q ss_pred             HhCCcccCCCCCCcEEEccCC---eEEEeeeccceecc
Q 045286          153 HQRNIIHRDLKTANLLMDTHN---VVKVADFGVARFQN  187 (259)
Q Consensus       153 H~~~i~H~di~p~Nilv~~~~---~i~l~D~~~~~~~~  187 (259)
                      |+.|++|+|+++.|||++.++   .+.++||+.+....
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            999999999999999998887   89999999876443

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.14  E-value=1.2e-10  Score=93.59  Aligned_cols=148  Identities=22%  Similarity=0.396  Sum_probs=114.6

Q ss_pred             HHHHhcCCCCcceeeeeeecC-----CcEEEEEecCCCCChHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC--
Q 045286           87 AILREVQHRNVVRFIGASTKS-----PHLCIVTEYMPGGSLYDYLHKNH---NVLKLPQLLRFAIDICKGMEYLHQRN--  156 (259)
Q Consensus        87 ~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~~--  156 (259)
                      .-+.++.|.||++++.++.+.     ....++.||+..+++..++.+..   ..+....-.+++.||+++|.|||+..  
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            334555689999999988653     45789999999999999996543   34777888899999999999999874  


Q ss_pred             cccCCCCCCcEEEccCCeEEEeeeccceeccC-----CCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcC
Q 045286          157 IIHRDLKTANLLMDTHNVVKVADFGVARFQNK-----GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTA  231 (259)
Q Consensus       157 i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~-----~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g  231 (259)
                      ++|+++.-+.|++..+|.|++.--.-......     ........+.++|.+||.-....-+-++|||++|.+..+|..+
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            99999999999999999888764433221111     1111223467899999987777778899999999999999887


Q ss_pred             CCC
Q 045286          232 KVP  234 (259)
Q Consensus       232 ~~p  234 (259)
                      ..-
T Consensus       279 Eiq  281 (458)
T KOG1266|consen  279 EIQ  281 (458)
T ss_pred             eec
Confidence            664

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.11  E-value=3e-09  Score=90.57  Aligned_cols=184  Identities=15%  Similarity=0.225  Sum_probs=133.4

Q ss_pred             cceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeee----cCCcEEEEEecCCC-CCh
Q 045286           50 SCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST----KSPHLCIVTEYMPG-GSL  122 (259)
Q Consensus        50 ~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~lv~e~~~~-~~L  122 (259)
                      -..+.|++..  +|..+++|.++-....  .......-+++++++.|.|++++.+++.    ....+++|++|.++ ++|
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL  365 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL  365 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence            4467888875  4889999998432211  1123345688999999999999999886    34578999999976 466


Q ss_pred             HHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          123 YDYLHK--------------NHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       123 ~~~l~~--------------~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      .++.-.              .+..+++..+|.++.|+..+|.++|+.|+..+-+.|.+|+++.+-+++|..+|.......
T Consensus       366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            665421              123467899999999999999999999999999999999999888999999998865555


Q ss_pred             CCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCC-CCCCCHHHH-HHHhhhcc
Q 045286          189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVP-YDSMTPLQA-ALGVRQVC  251 (259)
Q Consensus       189 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p-~~~~~~~~~-~~~i~~~~  251 (259)
                      ...             |.+.   --.+.|.-.||.++..+.+|..- +......+. +..|...+
T Consensus       446 d~~-------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~~~y  494 (655)
T KOG3741|consen  446 DPT-------------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRITTTY  494 (655)
T ss_pred             CCC-------------cchh---HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhhhhh
Confidence            420             0010   13567999999999999998665 333333332 55555444

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=99.05  E-value=2.9e-09  Score=82.26  Aligned_cols=137  Identities=17%  Similarity=0.180  Sum_probs=88.5

Q ss_pred             hhhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHH-------HHHHHHHHHHHhcC---CCCcceeeeee---
Q 045286           38 RLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLE-------DEFVQEVAILREVQ---HRNVVRFIGAS---  104 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~-------~~~~~e~~~l~~l~---~~~i~~~~~~~---  104 (259)
                      .+|...+.+-.....-|.+-...++.+++|..+.........       ....+.+....++.   ...+..++.+.   
T Consensus        31 ~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk  110 (229)
T PF06176_consen   31 NNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKK  110 (229)
T ss_pred             CCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeee
Confidence            455666666666666677777789999999988764322111       11223344344443   22333322222   


Q ss_pred             --ecCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecc
Q 045286          105 --TKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGV  182 (259)
Q Consensus       105 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~  182 (259)
                        .-....+++|||++|..|.+...     +++    .+...+.+.+..+|+.|++|||.+|.|++++. +.++++|++.
T Consensus       111 ~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~-~~i~iID~~~  180 (229)
T PF06176_consen  111 IFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN-NGIRIIDTQG  180 (229)
T ss_pred             eccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC-CcEEEEECcc
Confidence              12235678999999988766532     222    23455677889999999999999999999975 4599999986


Q ss_pred             ce
Q 045286          183 AR  184 (259)
Q Consensus       183 ~~  184 (259)
                      ..
T Consensus       181 k~  182 (229)
T PF06176_consen  181 KR  182 (229)
T ss_pred             cc
Confidence            54

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=99.04  E-value=5.4e-09  Score=82.63  Aligned_cols=134  Identities=13%  Similarity=0.211  Sum_probs=83.9

Q ss_pred             ceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCC--cceeeeeeecCCcEEEEEecCCCCC
Q 045286           44 ERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRN--VVRFIGASTKSPHLCIVTEYMPGGS  121 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~lv~e~~~~~~  121 (259)
                      .+|++|.++.||+.  .+..+++|...... .   .....+|.++++.+..-.  +++.+.+...++...++||+++|.+
T Consensus         7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~-~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF-D---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe--cCCCEEEEeCCCCC-C---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            68999999999984  35678899987533 1   244678999998886333  4667777777777889999999864


Q ss_pred             -hHHHH---------------------HhcC-CCCCHHHHHH-HHH----------HHHHH-HHHHH----hCCcccCCC
Q 045286          122 -LYDYL---------------------HKNH-NVLKLPQLLR-FAI----------DICKG-MEYLH----QRNIIHRDL  162 (259)
Q Consensus       122 -L~~~l---------------------~~~~-~~~~~~~~~~-i~~----------ql~~~-l~~lH----~~~i~H~di  162 (259)
                       +...+                     +... .......... +..          .+... ..+|.    ...++|+|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence             21111                     0000 0011111000 000          01111 11121    124789999


Q ss_pred             CCCcEEEccCCeEEEeeeccce
Q 045286          163 KTANLLMDTHNVVKVADFGVAR  184 (259)
Q Consensus       163 ~p~Nilv~~~~~i~l~D~~~~~  184 (259)
                      .|.||+++.++ +.++||+.+.
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcC
Confidence            99999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.04  E-value=1.5e-10  Score=99.72  Aligned_cols=193  Identities=20%  Similarity=0.168  Sum_probs=146.8

Q ss_pred             hhhhccceeccccceEEEEEEEc---CceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCCcEEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL---GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~---~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv  113 (259)
                      -++..+..||.|.++.|+.+...   +..+++|.+...-........-+.|+.+...+. |.+.++.+..|..-.+.++=
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip  344 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP  344 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence            35667789999999999987643   556788877766554444444567888888886 89999988888887788888


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC-CeEEEeeeccceeccCCCcc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH-NVVKVADFGVARFQNKGGVM  192 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~-~~i~l~D~~~~~~~~~~~~~  192 (259)
                      -||++++++.... .....+++...+++..|++.++.++|+..++|.|++|+||++..+ +..++.|++....+....  
T Consensus       345 ~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~--  421 (524)
T KOG0601|consen  345 LEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS--  421 (524)
T ss_pred             hhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceec--
Confidence            9999988877766 333347788889999999999999999999999999999999876 777899999886422211  


Q ss_pred             ccCCCccccc--CccccCCCCCCCchhHHHHHHHHHHHHcCCC
Q 045286          193 TAETGTYRWM--APEVINHQPYDQKADVFSFAIVLWELVTAKV  233 (259)
Q Consensus       193 ~~~~~~~~~~--~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~  233 (259)
                      ......-++.  +++......+..+.|+++||..+.+..++..
T Consensus       422 ~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~  464 (524)
T KOG0601|consen  422 GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP  464 (524)
T ss_pred             ccccccccccccchhhccccccccccccccccccccccccCcc
Confidence            1111223333  5555667778899999999999988888655

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.03  E-value=7.4e-11  Score=107.25  Aligned_cols=219  Identities=22%  Similarity=0.250  Sum_probs=154.5

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecc-cCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCc
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSE-HLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPH  109 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~  109 (259)
                      +...-+...+.+.+.+|+++.++.+.-.  +...+.|+.... .......+...++-+++-...+|..++..-.+...+.
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP  878 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP  878 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence            4444566777789999999999876532  323333333221 1111111222233333333334555555445666778


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC-
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-  188 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~-  188 (259)
                      ..+++++..+++|...++..+ ..+...+...+..+...+.+||...+.|+|++|.|.+...++..++.|++......- 
T Consensus       879 ~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             cchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccc
Confidence            899999999999999987665 355556666777888899999999999999999999999999999999974321100 


Q ss_pred             ------------------------C-------CccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          189 ------------------------G-------GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       189 ------------------------~-------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                                              +       .......+++.|.+||.+.+.....++|.|++|+++++.++|..||+.
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence                                    0       001122478999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHhhhccC
Q 045286          238 MTPLQAALGVRQVCT  252 (259)
Q Consensus       238 ~~~~~~~~~i~~~~~  252 (259)
                      .++.+....|..+..
T Consensus      1038 ~tpq~~f~ni~~~~~ 1052 (1205)
T KOG0606|consen 1038 ETPQQIFENILNRDI 1052 (1205)
T ss_pred             cchhhhhhccccCCC
Confidence            998887766655443

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=99.03  E-value=2.9e-09  Score=92.96  Aligned_cols=143  Identities=22%  Similarity=0.268  Sum_probs=92.3

Q ss_pred             ceeccccceEEEEEEEc-CceEEEEEeecccCc--------------------------------hHHHHH------HHH
Q 045286           44 ERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLN--------------------------------DTLEDE------FVQ   84 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~--------------------------------~~~~~~------~~~   84 (259)
                      ++|++++-|+||.|+.. |+.||||+.++.-..                                ++..+.      +.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            68999999999999986 899999998765221                                011111      233


Q ss_pred             HHHHHHhcC-----CCCcceeeeeeecCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 045286           85 EVAILREVQ-----HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH  159 (259)
Q Consensus        85 e~~~l~~l~-----~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H  159 (259)
                      |..-+.++.     .+.+.-..-++..+..-.++|||++|..+.+.........+...+.....+.  .+.-+=..|++|
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dgffH  288 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDGFFH  288 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcCccc
Confidence            444343332     2333222222334556689999999999988853322335533333222211  122333489999


Q ss_pred             CCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          160 RDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       160 ~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      +|.+|.||+++.+|.+.+.|||.......
T Consensus       289 aDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         289 ADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             cCCCccceEEecCCcEEEEcCcceecCCH
Confidence            99999999999999999999999865554

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.98  E-value=9.7e-09  Score=76.12  Aligned_cols=139  Identities=22%  Similarity=0.267  Sum_probs=103.1

Q ss_pred             chhhhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcc-eeeeeeecCCcEEEEE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVV-RFIGASTKSPHLCIVT  114 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~lv~  114 (259)
                      .....+..+.|+.|.+|.||++.+.+..+++|+.+.+...    ..+..|+++|+.++..++. +++.+..    .++.|
T Consensus        20 ~~~~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~r----~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~m   91 (201)
T COG2112          20 GKYELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSPR----RNLEKEAKILEILAGEGVTPEVYFYGE----DFIRM   91 (201)
T ss_pred             cchhhhhhhhhhcccccEEEEeeccCceEEEEEecCCcch----hhHHHHHHHHHHhhhcCCCceEEEech----hhhhh
Confidence            3456778889999999999999999999999999877443    5677889999998865553 4554433    23569


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC-CCcEEEccCCeEEEeeeccceeccCCC
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLK-TANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~-p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      ||++|..|.+.....    +    .+.+..+++..-.|-..||-|+.++ |..+++..++.+.||||..+++...+.
T Consensus        92 e~i~G~~L~~~~~~~----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~p~  160 (201)
T COG2112          92 EYIDGRPLGKLEIGG----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKKKPR  160 (201)
T ss_pred             hhhcCcchhhhhhcc----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhccCCc
Confidence            999998888775321    1    2234556666677888899999986 455555566699999999998555543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.93  E-value=1.9e-08  Score=79.75  Aligned_cols=138  Identities=22%  Similarity=0.299  Sum_probs=82.9

Q ss_pred             cceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCC--Ccceeeeee---ecCCcEEEEEecC
Q 045286           43 GERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHR--NVVRFIGAS---TKSPHLCIVTEYM  117 (259)
Q Consensus        43 ~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~---~~~~~~~lv~e~~  117 (259)
                      +++++.|..+.||++...++.+++|.....    .....+.+|..+++.+...  .+++++...   ......+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            357899999999999998889999997665    3346677888888887533  345566533   2334578999999


Q ss_pred             CCCChHH----------------HHH---hc-CC--CCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 045286          118 PGGSLYD----------------YLH---KN-HN--VLKLPQ---------LLRF------------AIDICK-GMEYLH  153 (259)
Q Consensus       118 ~~~~L~~----------------~l~---~~-~~--~~~~~~---------~~~i------------~~ql~~-~l~~lH  153 (259)
                      +|.++..                .+.   .. ..  ......         ....            ...+.. .+..++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            9987777                111   11 00  001000         0000            111222 233333


Q ss_pred             -------hCCcccCCCCCCcEEEc-cCCeEEEeeeccce
Q 045286          154 -------QRNIIHRDLKTANLLMD-THNVVKVADFGVAR  184 (259)
Q Consensus       154 -------~~~i~H~di~p~Nilv~-~~~~i~l~D~~~~~  184 (259)
                             ...++|+|+.|.||+++ .++.+.++||+.+.
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence                   24699999999999999 56777899999764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.79  E-value=1.1e-07  Score=76.18  Aligned_cols=134  Identities=17%  Similarity=0.134  Sum_probs=84.0

Q ss_pred             eccccc-eEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCCcEEEEEecCCCCChH
Q 045286           46 IASGSC-GDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHLCIVTEYMPGGSLY  123 (259)
Q Consensus        46 lg~G~~-~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~  123 (259)
                      |..|.+ +.||+....+..+++|......     ...+.+|+++++.+. +--+++++......+..++||++++|.++.
T Consensus         6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             cCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            444545 8899988777788999886543     234667888888875 334556777766666788999999998776


Q ss_pred             HHHH-------------------hcCC---CCCHH--HHHHHHH--------------------HHHHHHHHHH------
Q 045286          124 DYLH-------------------KNHN---VLKLP--QLLRFAI--------------------DICKGMEYLH------  153 (259)
Q Consensus       124 ~~l~-------------------~~~~---~~~~~--~~~~i~~--------------------ql~~~l~~lH------  153 (259)
                      ....                   ....   .....  .......                    .+...+..|-      
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            4421                   0000   01000  0000000                    0111122221      


Q ss_pred             -hCCcccCCCCCCcEEEccCCeEEEeeeccce
Q 045286          154 -QRNIIHRDLKTANLLMDTHNVVKVADFGVAR  184 (259)
Q Consensus       154 -~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~  184 (259)
                       ...++|+|+.|.||+++.++.+.|+||+.+.
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence             2359999999999999988778899999774

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.77  E-value=2.7e-08  Score=77.89  Aligned_cols=140  Identities=21%  Similarity=0.180  Sum_probs=90.8

Q ss_pred             cceeccccceEEEEEEE-cCceEEEEEeecccCchHH----------------------HHHHHHHHHHHHhcCC--CCc
Q 045286           43 GERIASGSCGDLYRGVY-LGQDVAVKVLRSEHLNDTL----------------------EDEFVQEVAILREVQH--RNV   97 (259)
Q Consensus        43 ~~~lg~G~~~~V~~~~~-~~~~v~vK~~~~~~~~~~~----------------------~~~~~~e~~~l~~l~~--~~i   97 (259)
                      ..+|++|--+.||+|.. .+..+|+|+++.....-..                      ......|+.-|+++..  -.+
T Consensus        53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            34888999999999886 5889999999865322111                      0112345555555532  222


Q ss_pred             ceeeeeeecCCcEEEEEecCCCCCh-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEccCCeE
Q 045286           98 VRFIGASTKSPHLCIVTEYMPGGSL-YDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ-RNIIHRDLKTANLLMDTHNVV  175 (259)
Q Consensus        98 ~~~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~di~p~Nilv~~~~~i  175 (259)
                      +..+..    ..-.+|||++..... .-.+...  .+...++..+..++++.+..|-. .++||+|++.-|||+. ++.+
T Consensus       133 P~Pi~~----~~nVLvMEfIg~~g~pAP~LkDv--~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p  205 (268)
T COG1718         133 PEPIAF----RNNVLVMEFIGDDGLPAPRLKDV--PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP  205 (268)
T ss_pred             CCceee----cCCeEEEEeccCCCCCCCCcccC--CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence            233322    133699999943210 0001111  12333567777888888887777 8999999999999998 8999


Q ss_pred             EEeeeccceeccCC
Q 045286          176 KVADFGVARFQNKG  189 (259)
Q Consensus       176 ~l~D~~~~~~~~~~  189 (259)
                      .+|||+-+....++
T Consensus       206 ~iID~~QaV~~~hp  219 (268)
T COG1718         206 YIIDVSQAVTIDHP  219 (268)
T ss_pred             EEEECccccccCCC
Confidence            99999988766544

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.61  E-value=6.2e-07  Score=78.43  Aligned_cols=143  Identities=20%  Similarity=0.262  Sum_probs=87.8

Q ss_pred             ceeccccceEEEEEEEc-CceEEEEEeecccCc-----------------------------hHHHHHHHHHHHHH----
Q 045286           44 ERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLN-----------------------------DTLEDEFVQEVAIL----   89 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~-----------------------------~~~~~~~~~e~~~l----   89 (259)
                      ++|+..+.++|++|+.. |+.||||+.++.-..                             ++..+.+.+|+.-.    
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            69999999999999964 788999998765221                             11112222222222    


Q ss_pred             ------HhcCCCCc---ceeeeee-ecCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 045286           90 ------REVQHRNV---VRFIGAS-TKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH  159 (259)
Q Consensus        90 ------~~l~~~~i---~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H  159 (259)
                            +.+.+-+.   +.+..++ .....-.++|||++|..+.+.-.-....++...+..-+.+...  .-+=..|++|
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~GffH  324 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTGFFH  324 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcCCcc
Confidence                  22223331   1122222 2334568999999998777654322223555544433332221  2233478999


Q ss_pred             CCCCCCcEEEcc----CCeEEEeeeccceeccC
Q 045286          160 RDLKTANLLMDT----HNVVKVADFGVARFQNK  188 (259)
Q Consensus       160 ~di~p~Nilv~~----~~~i~l~D~~~~~~~~~  188 (259)
                      +|-+|.||++..    ++.+.+.|+|+......
T Consensus       325 aDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  325 ADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            999999999984    56899999999865444

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.53  E-value=1.2e-08  Score=89.63  Aligned_cols=95  Identities=17%  Similarity=0.367  Sum_probs=76.9

Q ss_pred             HHHHHHHHHHh-CCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccc----------cCCCcccccCccccCCCCC
Q 045286          144 DICKGMEYLHQ-RNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT----------AETGTYRWMAPEVINHQPY  212 (259)
Q Consensus       144 ql~~~l~~lH~-~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~----------~~~~~~~~~~PE~~~~~~~  212 (259)
                      ++..++.++|+ .++||+.|.|++|.++.++.+||+.|+.+.....+....          .......|.+||.+.+...
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~  186 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN  186 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence            34489999996 589999999999999999999999999986555422211          1235688999999999888


Q ss_pred             CCchhHHHHHHHHHHHH-cCCCCCCCC
Q 045286          213 DQKADVFSFAIVLWELV-TAKVPYDSM  238 (259)
Q Consensus       213 ~~~~Di~slG~~~~~ll-~g~~p~~~~  238 (259)
                      ++++|+||+|+++|.+. .|+..+...
T Consensus       187 ~~~sd~fSlG~li~~i~~~gk~i~~a~  213 (700)
T KOG2137|consen  187 TPASDVFSLGVLIYTIYNGGKSIIAAN  213 (700)
T ss_pred             cccccceeeeeEEEEEecCCcchhhcc
Confidence            99999999999999999 566666543

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.51  E-value=1.1e-06  Score=70.04  Aligned_cols=73  Identities=19%  Similarity=0.296  Sum_probs=46.2

Q ss_pred             ceeccccce-EEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCC---CcceeeeeeecC---CcEEEEEec
Q 045286           44 ERIASGSCG-DLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHR---NVVRFIGASTKS---PHLCIVTEY  116 (259)
Q Consensus        44 ~~lg~G~~~-~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~---~~~~lv~e~  116 (259)
                      ..|+.|+.. .||+.   +..+++|......    ....+.+|...++.+...   -++..+......   +..+++|++
T Consensus         3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEc---CCceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            467767765 58875   3467888755421    234678899999888532   334444433321   245889999


Q ss_pred             CCCCChH
Q 045286          117 MPGGSLY  123 (259)
Q Consensus       117 ~~~~~L~  123 (259)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9987764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PLN02876 acyl-CoA dehydrogenase

Probab=98.49  E-value=3.1e-06  Score=79.25  Aligned_cols=78  Identities=14%  Similarity=0.167  Sum_probs=54.9

Q ss_pred             cceeccccceEEEEEEEcC----ceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCc--ceeeeeeecC---CcEEE
Q 045286           43 GERIASGSCGDLYRGVYLG----QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNV--VRFIGASTKS---PHLCI  112 (259)
Q Consensus        43 ~~~lg~G~~~~V~~~~~~~----~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i--~~~~~~~~~~---~~~~l  112 (259)
                      ...++.|.++.+|+....+    ..+++|........ .....+.+|.++++.+. +.++  ++++..+.+.   +..|+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            5678899999999987654    46788876543221 12346779999999995 5655  6666665543   46789


Q ss_pred             EEecCCCCC
Q 045286          113 VTEYMPGGS  121 (259)
Q Consensus       113 v~e~~~~~~  121 (259)
                      |||+++|..
T Consensus       122 VME~v~G~~  130 (822)
T PLN02876        122 IMEYLEGRI  130 (822)
T ss_pred             EEEecCCcc
Confidence            999998864

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.47  E-value=1.1e-06  Score=71.02  Aligned_cols=136  Identities=15%  Similarity=0.176  Sum_probs=80.0

Q ss_pred             eeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCc-ceeeeeeecCCcEEEEEecCCCCChH
Q 045286           45 RIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNV-VRFIGASTKSPHLCIVTEYMPGGSLY  123 (259)
Q Consensus        45 ~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~  123 (259)
                      .+..|-++.+|+....++.+++|........-  .-...+|..+++.+....+ ++++....    .++|+||++|.++.
T Consensus         3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~   76 (256)
T TIGR02721         3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT   76 (256)
T ss_pred             cCCCcCcCCeEEEEeCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence            45678889999998888899999865432111  0124678888888864333 34443322    26899999986654


Q ss_pred             HH--------------H---HhcC---CCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCcccCCCCCC
Q 045286          124 DY--------------L---HKNH---NVLKLP-QLLRFAIDI---------CKGMEYLHQ--------RNIIHRDLKTA  165 (259)
Q Consensus       124 ~~--------------l---~~~~---~~~~~~-~~~~i~~ql---------~~~l~~lH~--------~~i~H~di~p~  165 (259)
                      ..              +   +...   ..++.. .+..+..++         ...+..+..        ..++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            21              1   1111   111111 111111111         111222221        25899999999


Q ss_pred             cEEEccCCeEEEeeeccceecc
Q 045286          166 NLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       166 Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      ||+++.++ +.++||+.+....
T Consensus       157 Nil~~~~~-~~lIDwE~a~~gd  177 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYASDGD  177 (256)
T ss_pred             cEEEeCCC-CEEEeccccCcCC
Confidence            99998877 7899999886444

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=98.46  E-value=3.2e-06  Score=69.72  Aligned_cols=139  Identities=20%  Similarity=0.195  Sum_probs=84.2

Q ss_pred             ccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCC--cceeeee------eecCCcEEEE
Q 045286           42 TGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRN--VVRFIGA------STKSPHLCIV  113 (259)
Q Consensus        42 ~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~lv  113 (259)
                      -.+.+..|....+|+....+..+++|+....  ..   ..+..|+++++.+....  +++++..      ....+..+++
T Consensus        18 ~i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~--~~---~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l   92 (296)
T cd05153          18 SFEGISAGIENTNYFVTTDSGRYVLTLFEKV--SA---EELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAAL   92 (296)
T ss_pred             heecccCccccceEEEEeCCCcEEEEEcCCC--Ch---HhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEE
Confidence            3567888988999999887888999987651  21   34556777777774222  3343331      1234567899


Q ss_pred             EecCCCCChHH----HH----------HhcCCCC----------CHHHH----------HHHHHHHHHHHHHHHh-----
Q 045286          114 TEYMPGGSLYD----YL----------HKNHNVL----------KLPQL----------LRFAIDICKGMEYLHQ-----  154 (259)
Q Consensus       114 ~e~~~~~~L~~----~l----------~~~~~~~----------~~~~~----------~~i~~ql~~~l~~lH~-----  154 (259)
                      ++|++|.++..    ..          +.....+          .....          ......+..++..+.+     
T Consensus        93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~  172 (296)
T cd05153          93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD  172 (296)
T ss_pred             EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence            99999876532    10          1000000          00000          0011112233344443     


Q ss_pred             --CCcccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          155 --RNIIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       155 --~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                        .+++|+|+.|.|++++.++.+.++||+.+..
T Consensus       173 ~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         173 LPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence              4799999999999999887789999998753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.45  E-value=2.3e-06  Score=68.08  Aligned_cols=73  Identities=16%  Similarity=0.234  Sum_probs=47.6

Q ss_pred             ceeccccceEEEEEEEc---CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCC-cceeeeeeecCCcEEEEEecCCC
Q 045286           44 ERIASGSCGDLYRGVYL---GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRN-VVRFIGASTKSPHLCIVTEYMPG  119 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~---~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e~~~~  119 (259)
                      +.|..|-+..+|++...   ++.+++|+.......   .....+|..+++.+.... .++++.... +   .+++||++|
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G   76 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPG   76 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCC
Confidence            56788999999998865   578999987643211   122346888888885333 344444332 2   379999998


Q ss_pred             CChH
Q 045286          120 GSLY  123 (259)
Q Consensus       120 ~~L~  123 (259)
                      .++.
T Consensus        77 ~~l~   80 (235)
T cd05157          77 RTLE   80 (235)
T ss_pred             CcCC
Confidence            7653

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.44  E-value=1.1e-05  Score=62.25  Aligned_cols=136  Identities=21%  Similarity=0.348  Sum_probs=95.1

Q ss_pred             hccceeccccceEEEEEEEcCceEEEEEeeccc--------------CchHHHHHHHHHHHHHHhcC------CCCccee
Q 045286           41 KTGERIASGSCGDLYRGVYLGQDVAVKVLRSEH--------------LNDTLEDEFVQEVAILREVQ------HRNVVRF  100 (259)
Q Consensus        41 ~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~--------------~~~~~~~~~~~e~~~l~~l~------~~~i~~~  100 (259)
                      .-..+||+|+.-.||..-. +....||+.....              ..........+|+.....+.      +.+|.++
T Consensus         4 ~~~~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    4 SESDLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCCcccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            3457899999999997554 3456888888776              01112244556666655554      7899999


Q ss_pred             eeeeecCCcEEEEEecCC------CCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC-
Q 045286          101 IGASTKSPHLCIVTEYMP------GGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN-  173 (259)
Q Consensus       101 ~~~~~~~~~~~lv~e~~~------~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~-  173 (259)
                      +++.+.+-..-+|+|.+.      ..+|.+++....  ++. .   +...+-+...+|-+.+|+.+|++|+||++.... 
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~--~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~  156 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG--LTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS  156 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC--ccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence            999988877888888863      357888884433  444 3   333444556788999999999999999995432 


Q ss_pred             ---eEEEee-eccc
Q 045286          174 ---VVKVAD-FGVA  183 (259)
Q Consensus       174 ---~i~l~D-~~~~  183 (259)
                         .+.|+| ||..
T Consensus       157 ~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  157 GEFRLVLIDGLGEK  170 (199)
T ss_pred             CceEEEEEeCCCCc
Confidence               578887 4543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK05231 homoserine kinase; Provisional

Probab=98.42  E-value=5.4e-05  Score=63.15  Aligned_cols=140  Identities=16%  Similarity=0.202  Sum_probs=77.4

Q ss_pred             hhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCC--Ccceeeee------eecCCcEE
Q 045286           40 LKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHR--NVVRFIGA------STKSPHLC  111 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~------~~~~~~~~  111 (259)
                      ..-.+.|+.|....+|.....+..+++|+...  ...   ..+..+...++.|...  .+++.+..      ....+..+
T Consensus        24 ~~~~~~l~~G~~n~~y~v~t~~g~~vLK~~~~--~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~   98 (319)
T PRK05231         24 LLSLKGIAEGIENSNFFLTTTQGEYVLTLFER--LTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA   98 (319)
T ss_pred             hhccchhccccccceEEEEeCCCcEEEEEecc--CCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence            34456778888889999887777899998762  222   2233344555554311  13333321      12345678


Q ss_pred             EEEecCCCCChH-----------HHHH---hcCCC--------CCH---HHHH------------HHHHH-HHHHHHHHH
Q 045286          112 IVTEYMPGGSLY-----------DYLH---KNHNV--------LKL---PQLL------------RFAID-ICKGMEYLH  153 (259)
Q Consensus       112 lv~e~~~~~~L~-----------~~l~---~~~~~--------~~~---~~~~------------~i~~q-l~~~l~~lH  153 (259)
                      ++++|++|..+.           ..+.   .....        ...   ....            ..+.+ +...+..+.
T Consensus        99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  178 (319)
T PRK05231         99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA  178 (319)
T ss_pred             EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence            999999886431           1111   00000        000   0000            01111 111122222


Q ss_pred             -------hCCcccCCCCCCcEEEccCCeEEEeeeccce
Q 045286          154 -------QRNIIHRDLKTANLLMDTHNVVKVADFGVAR  184 (259)
Q Consensus       154 -------~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~  184 (259)
                             ..+++|+|+.|.||+++.+...-++||+.++
T Consensus       179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence                   2489999999999999866666899999874

>PRK10593 hypothetical protein; Provisional

Probab=98.40  E-value=9.9e-06  Score=66.84  Aligned_cols=80  Identities=18%  Similarity=0.049  Sum_probs=58.6

Q ss_pred             hhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCC---CCcceeeeeeec---CCcEEE
Q 045286           39 LLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH---RNVVRFIGASTK---SPHLCI  112 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~---~~~~~l  112 (259)
                      ...-...||.|..+.||.....+..+++|..+... .   ...+.+|...++.+..   -.++++++.+..   .+..++
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~-~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L   90 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDSQGNPMPLMARSFS-T---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL   90 (297)
T ss_pred             hhheeeecCCccceeEEEEEcCCCCEEEEEecccc-c---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence            45556789999999999988766677888854311 1   2567889999988853   356777776543   366899


Q ss_pred             EEecCCCCCh
Q 045286          113 VTEYMPGGSL  122 (259)
Q Consensus       113 v~e~~~~~~L  122 (259)
                      |||+++|.++
T Consensus        91 VmE~i~G~~~  100 (297)
T PRK10593         91 LLERLRGVSV  100 (297)
T ss_pred             EEeccCCEec
Confidence            9999988654

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=98.32  E-value=6.2e-05  Score=62.48  Aligned_cols=141  Identities=23%  Similarity=0.253  Sum_probs=82.5

Q ss_pred             hhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCC--cceeeeee------ecCCcEE
Q 045286           40 LKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRN--VVRFIGAS------TKSPHLC  111 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~------~~~~~~~  111 (259)
                      ......++.|....+|++...+..+++|+..... ..   ..+..+.+++..|....  +++++...      ...+..+
T Consensus        24 ~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~-~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~   99 (307)
T TIGR00938        24 LLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRV-KA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA   99 (307)
T ss_pred             ceeccccCCccccceEEEEeCCCcEEEEEecCCC-CH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence            4446778888889999988777788999876532 11   33445666666664222  33333311      2245678


Q ss_pred             EEEecCCCCChH-----------HHH---HhcCCCC----C---HHHHH----------------HHHHHHHHHHHHHH-
Q 045286          112 IVTEYMPGGSLY-----------DYL---HKNHNVL----K---LPQLL----------------RFAIDICKGMEYLH-  153 (259)
Q Consensus       112 lv~e~~~~~~L~-----------~~l---~~~~~~~----~---~~~~~----------------~i~~ql~~~l~~lH-  153 (259)
                      ++++|++|.++.           ..+   +.....+    .   ....+                .....+...+.++. 
T Consensus       100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~  179 (307)
T TIGR00938       100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK  179 (307)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence            999999885432           111   1100000    0   00000                00111223344443 


Q ss_pred             ------hCCcccCCCCCCcEEEccCCeEEEeeeccce
Q 045286          154 ------QRNIIHRDLKTANLLMDTHNVVKVADFGVAR  184 (259)
Q Consensus       154 ------~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~  184 (259)
                            ..+++|+|+.+.|++++.++...++||+.+.
T Consensus       180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence                  2689999999999999988877899999864

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.28  E-value=1.9e-05  Score=60.55  Aligned_cols=130  Identities=22%  Similarity=0.312  Sum_probs=91.1

Q ss_pred             echhhhhccceeccccc-eEEEEEEEcCceEEEEEee---cccCch----------------HHHHHHHHHHHHHHhcC-
Q 045286           35 IDRRLLKTGERIASGSC-GDLYRGVYLGQDVAVKVLR---SEHLND----------------TLEDEFVQEVAILREVQ-   93 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~-~~V~~~~~~~~~v~vK~~~---~~~~~~----------------~~~~~~~~e~~~l~~l~-   93 (259)
                      .....++..+.||.|.- |.||++...|+.+|+|++.   ......                ....-|..|-++..+|+ 
T Consensus        34 ~h~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke  113 (207)
T PF13095_consen   34 HHGDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE  113 (207)
T ss_pred             CCCCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence            34578999999999999 9999999999999999932   221110                12234667777766664 


Q ss_pred             --CCCc--ceeeeeeecC------------------CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Q 045286           94 --HRNV--VRFIGASTKS------------------PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY  151 (259)
Q Consensus        94 --~~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~  151 (259)
                        ++++  ++++++..-.                  ....||.||++...          .+..    .-+.++.+-+..
T Consensus       114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~----~~~~~~~~dl~~  179 (207)
T PF13095_consen  114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQI----RDIPQMLRDLKI  179 (207)
T ss_pred             ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccch----hHHHHHHHHHHH
Confidence              5566  8888876221                  12466777775532          1222    234567777888


Q ss_pred             HHhCCcccCCCCCCcEEEccCCeEEEeeeccc
Q 045286          152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVA  183 (259)
Q Consensus       152 lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~  183 (259)
                      +|..||+-+|+++.|..=     -+|+|||.+
T Consensus       180 ~~k~gI~~~Dv~~~ny~~-----G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLGIVPRDVKPRNYRG-----GKLVDFSSS  206 (207)
T ss_pred             HHHCCeeeccCccccccC-----CEEEecccC
Confidence            999999999999999862     367899864

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=98.27  E-value=1.1e-06  Score=71.50  Aligned_cols=135  Identities=21%  Similarity=0.272  Sum_probs=96.2

Q ss_pred             hhhccceeccccceEEEEEEEc-CceEEEEEeecccCc--------------------hHHHHHHHHHHHHHHhcCCCC-
Q 045286           39 LLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLN--------------------DTLEDEFVQEVAILREVQHRN-   96 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~--------------------~~~~~~~~~e~~~l~~l~~~~-   96 (259)
                      -+.+++.||-|--+.+|.+.+. |++.++|.-+.-.++                    .-..-...+|...++.|.... 
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            4567889999999999999986 888888875433221                    011122446777777775321 


Q ss_pred             -cceeeeeeecCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeE
Q 045286           97 -VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVV  175 (259)
Q Consensus        97 -i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i  175 (259)
                       ++..+    +.++.++|||.+.|.+|...-.-       ...-.+...++..+-.|...|++|||+.-=||++..++.+
T Consensus       173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v-------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i  241 (465)
T KOG2268|consen  173 PVPKPI----DHNRHCVVMELVDGYPLRQVRHV-------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKI  241 (465)
T ss_pred             CCCCcc----cccceeeHHHhhcccceeeeeec-------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCE
Confidence             22233    23678999999999887665321       1223455667777888999999999999999999999999


Q ss_pred             EEeeeccce
Q 045286          176 KVADFGVAR  184 (259)
Q Consensus       176 ~l~D~~~~~  184 (259)
                      ++|||.-+.
T Consensus       242 ~vIDFPQmv  250 (465)
T KOG2268|consen  242 VVIDFPQMV  250 (465)
T ss_pred             EEeechHhh
Confidence            999997654

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=98.27  E-value=1.2e-05  Score=66.20  Aligned_cols=143  Identities=20%  Similarity=0.260  Sum_probs=90.2

Q ss_pred             hhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCc--ceeeeeeecCC--cEEEEEe
Q 045286           40 LKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNV--VRFIGASTKSP--HLCIVTE  115 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~~~--~~~lv~e  115 (259)
                      ......+..|-...+|.....++.++++ ...............+|..+++.+..--+  ...++.+..+.  ..+.||+
T Consensus        27 ~~~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~  105 (321)
T COG3173          27 LLIVEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME  105 (321)
T ss_pred             CceeeeccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence            3344555667777888888778899999 33222233444667788888888753222  33344444433  6799999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHH-HHHHHHHHHHh----------------------------------------
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAI-DICKGMEYLHQ----------------------------------------  154 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~-ql~~~l~~lH~----------------------------------------  154 (259)
                      |++|..+.+......  .  .  .+.+. .+.+.|..||+                                        
T Consensus       106 ~veGe~~~~~~~~~~--~--~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~  179 (321)
T COG3173         106 WVEGEVVWSALPPES--L--G--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL  179 (321)
T ss_pred             EecceeccCcCCccc--c--h--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence            998853333221110  0  0  11222 44444444444                                        


Q ss_pred             ------------------CCcccCCCCCCcEEEccCCeEEEeeeccceeccCC
Q 045286          155 ------------------RNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG  189 (259)
Q Consensus       155 ------------------~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~  189 (259)
                                        ..++|||+.+.|++++.++.+-++||+.+....+.
T Consensus       180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~  232 (321)
T COG3173         180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL  232 (321)
T ss_pred             HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence                              35999999999999999999999999998765554

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.19  E-value=6e-05  Score=57.80  Aligned_cols=100  Identities=20%  Similarity=0.278  Sum_probs=77.7

Q ss_pred             HHHHHHHHhcCC-CCcceeeeeeecCCcEEEEEecCCCCChHHH---HHhcCCCCCHHHHHHHHHHHHHHHHHHHh---C
Q 045286           83 VQEVAILREVQH-RNVVRFIGASTKSPHLCIVTEYMPGGSLYDY---LHKNHNVLKLPQLLRFAIDICKGMEYLHQ---R  155 (259)
Q Consensus        83 ~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~---l~~~~~~~~~~~~~~i~~ql~~~l~~lH~---~  155 (259)
                      ..|..+++.+++ +++++++|.+-+    +++.|+...+++...   +.. ....+.....+++.++++.+..++.   .
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            358888899975 699999998743    478899865544321   111 1126778889999999999999998   4


Q ss_pred             CcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          156 NIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       156 ~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      .+.-+|++++|+-++.+++++++|.+.+....
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            58889999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=98.13  E-value=2.7e-05  Score=64.43  Aligned_cols=73  Identities=16%  Similarity=0.286  Sum_probs=47.8

Q ss_pred             ceeccccceEEEEEEEc--------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCc-ceeeeeeecCCcEEEEE
Q 045286           44 ERIASGSCGDLYRGVYL--------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNV-VRFIGASTKSPHLCIVT  114 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~--------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~  114 (259)
                      +.+..|-+..+|++...        ++.+++|+.......   .....+|..+++.+....+ ++++..+..    ..|+
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~---~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~   76 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL---LIDRERELVVFARLSERNLGPKLYGIFPN----GRIE   76 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc---eechHHHHHHHHHHHhCCCCCceEEEeCC----Cchh
Confidence            46677888899998865        378999997654221   1345677788887753333 345555432    2689


Q ss_pred             ecCCCCChH
Q 045286          115 EYMPGGSLY  123 (259)
Q Consensus       115 e~~~~~~L~  123 (259)
                      +|++|.++.
T Consensus        77 e~i~G~~l~   85 (302)
T cd05156          77 EFIPSRTLT   85 (302)
T ss_pred             heeCCCcCC
Confidence            999887654

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.13  E-value=0.0001  Score=62.91  Aligned_cols=76  Identities=16%  Similarity=0.014  Sum_probs=52.4

Q ss_pred             cceeccccceEEEEEEEcC--ceEEEEEeecccC-----chHHHHHHHHHHHHHHhcC---CCCcceeeeeeecCCcEEE
Q 045286           43 GERIASGSCGDLYRGVYLG--QDVAVKVLRSEHL-----NDTLEDEFVQEVAILREVQ---HRNVVRFIGASTKSPHLCI  112 (259)
Q Consensus        43 ~~~lg~G~~~~V~~~~~~~--~~v~vK~~~~~~~-----~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~l  112 (259)
                      .+.||.|..+.||++.+.+  +.++||.-.....     .+...++...|.+.|+.+.   ..++++++.+..  +..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence            4689999999999998865  3899998542211     1223356667888888764   245666776633  55789


Q ss_pred             EEecCCCC
Q 045286          113 VTEYMPGG  120 (259)
Q Consensus       113 v~e~~~~~  120 (259)
                      |||++++.
T Consensus       109 VME~L~~~  116 (401)
T PRK09550        109 VMEDLSDH  116 (401)
T ss_pred             EEecCCCc
Confidence            99998763

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=98.08  E-value=5.9e-05  Score=62.78  Aligned_cols=143  Identities=15%  Similarity=0.187  Sum_probs=92.0

Q ss_pred             ccceeccccceEEEEEEE-cCceEEEEEeecccCc------------------------hHHHHHHHHHHHHHHhcCCCC
Q 045286           42 TGERIASGSCGDLYRGVY-LGQDVAVKVLRSEHLN------------------------DTLEDEFVQEVAILREVQHRN   96 (259)
Q Consensus        42 ~~~~lg~G~~~~V~~~~~-~~~~v~vK~~~~~~~~------------------------~~~~~~~~~e~~~l~~l~~~~   96 (259)
                      +-.+|.+|--+.||+|.. .|..+|||+++.+-..                        +...-....|++=|++++...
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            446899999999999985 5788999998754110                        112223445666677776555


Q ss_pred             cceeeeeeecCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCcccCCCCCCcEEEccCCeE
Q 045286           97 VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYL-HQRNIIHRDLKTANLLMDTHNVV  175 (259)
Q Consensus        97 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~l-H~~~i~H~di~p~Nilv~~~~~i  175 (259)
                      |+-.--+..  ....+||+|+.. +=+-.=......++...+..+-.+++..+..| +..++||.||+--|+|+ .+|.+
T Consensus       228 IP~PePIlL--k~hVLVM~FlGr-dgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~l  303 (520)
T KOG2270|consen  228 IPCPEPILL--KNHVLVMEFLGR-DGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKL  303 (520)
T ss_pred             CCCCCceee--ecceEeeeeccC-CCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEE
Confidence            433221222  245799999842 21111001122355666777777777666655 45789999999999999 78899


Q ss_pred             EEeeeccceeccC
Q 045286          176 KVADFGVARFQNK  188 (259)
Q Consensus       176 ~l~D~~~~~~~~~  188 (259)
                      .+||.+-+.....
T Consensus       304 yiIDVSQSVE~DH  316 (520)
T KOG2270|consen  304 YIIDVSQSVEHDH  316 (520)
T ss_pred             EEEEccccccCCC
Confidence            9999987754443

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.95  E-value=0.00016  Score=61.66  Aligned_cols=76  Identities=14%  Similarity=0.042  Sum_probs=52.9

Q ss_pred             ccceeccccceEEEEEEEcCceEEEEEeecccC-----chHHHHHHHHHHHHHHhcC---CCCcceeeeeeecCCcEEEE
Q 045286           42 TGERIASGSCGDLYRGVYLGQDVAVKVLRSEHL-----NDTLEDEFVQEVAILREVQ---HRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        42 ~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~-----~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv  113 (259)
                      ..+.||.|....||+..+.++.++||.-.....     .+....+...|.+.|+.+.   -..+++++.++.  +..+++
T Consensus        36 ~~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             eEEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            457889999999999988777899998762211     1112344555677777664   246777877766  456788


Q ss_pred             EecCCC
Q 045286          114 TEYMPG  119 (259)
Q Consensus       114 ~e~~~~  119 (259)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999966

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.93  E-value=1.4e-06  Score=76.50  Aligned_cols=187  Identities=20%  Similarity=0.166  Sum_probs=131.0

Q ss_pred             hhhhccceeccccceEEEEEEEcCceEEE-EEeecccCchHHHHHHHHHHHHHHhcCCCC-cceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVYLGQDVAV-KVLRSEHLNDTLEDEFVQEVAILREVQHRN-VVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~~~~v~v-K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e  115 (259)
                      +-+...+-++.|+.+.+++.+...+.... +.+..+       ....-++++|.+++||| .+..++-+..++..++.++
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~  314 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR  314 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence            44556678889999999997665443222 222222       33445789999999999 5666666677788899999


Q ss_pred             cCCCC-ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcccc
Q 045286          116 YMPGG-SLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTA  194 (259)
Q Consensus       116 ~~~~~-~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~  194 (259)
                      ++.++ +-...+......+...+...+++.-++.++++|+.--+|+|    ||+- .++..+..|++......+......
T Consensus       315 i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~-s~~~~~~~~~~v~~~L~~~~~~~t  389 (829)
T KOG0576|consen  315 ICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG-SEEEVKLLDFAVPPQLTRTMKPRT  389 (829)
T ss_pred             hhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccc-cccccccccccCCcccCccccccc
Confidence            98665 22111111112244445556677777889999988778887    6665 447789999998877666544455


Q ss_pred             CCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 045286          195 ETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYD  236 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~  236 (259)
                      ..+++.+++||......+....|.|++|.-..++--|..|-.
T Consensus       390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            678999999999988889999999999987667766766643

>PLN02236 choline kinase

Probab=97.86  E-value=0.00013  Score=61.53  Aligned_cols=138  Identities=14%  Similarity=0.268  Sum_probs=80.7

Q ss_pred             cceeccccceEEEEEEEc------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCc-ceeeeeeecCCcEEEEEe
Q 045286           43 GERIASGSCGDLYRGVYL------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNV-VRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        43 ~~~lg~G~~~~V~~~~~~------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e  115 (259)
                      ..++..|-+..+|++...      ++.+++|+.....  ..... ..+|..+++.+...++ +++++.+..+    .|.+
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~e  113 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEE  113 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEE
Confidence            346666999999998753      3679999887642  11112 2578888888864444 3455555433    5789


Q ss_pred             cCCCCChHHH----------H-------HhcCCC----CC-HHHHHHHHHHH-----------------HHHHHHHH---
Q 045286          116 YMPGGSLYDY----------L-------HKNHNV----LK-LPQLLRFAIDI-----------------CKGMEYLH---  153 (259)
Q Consensus       116 ~~~~~~L~~~----------l-------~~~~~~----~~-~~~~~~i~~ql-----------------~~~l~~lH---  153 (259)
                      |+++.++...          +       +....+    .. ...+..+..++                 ...+..|.   
T Consensus       114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~  193 (344)
T PLN02236        114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL  193 (344)
T ss_pred             eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence            9887665421          0       111100    11 11222222111                 11111111   


Q ss_pred             -----hCCcccCCCCCCcEEEcc-CCeEEEeeeccceecc
Q 045286          154 -----QRNIIHRDLKTANLLMDT-HNVVKVADFGVARFQN  187 (259)
Q Consensus       154 -----~~~i~H~di~p~Nilv~~-~~~i~l~D~~~~~~~~  187 (259)
                           ...++|+|+++.||+++. ++.+.++||+.+....
T Consensus       194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~  233 (344)
T PLN02236        194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYNP  233 (344)
T ss_pred             cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccccc
Confidence                 236899999999999986 4789999999986443

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.76  E-value=0.001  Score=55.85  Aligned_cols=137  Identities=15%  Similarity=0.254  Sum_probs=78.4

Q ss_pred             ceeccccceEEEEEEEcC-----ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCc-ceeeeeeecCCcEEEEEecC
Q 045286           44 ERIASGSCGDLYRGVYLG-----QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNV-VRFIGASTKSPHLCIVTEYM  117 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~~-----~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~  117 (259)
                      ++|..|-+..+|++...+     ..+++|+......  . .-...+|..+++.+...++ ++++..+. ++   +|.+|+
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi   92 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--Y-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFI   92 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--e-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehhh
Confidence            455558899999987553     2799998865421  1 1223467888888865444 34555553 22   588998


Q ss_pred             CCCChHHH-------H----------HhcC---C-CCCH-HHHHHHHHH----------------------HHHHHHHHH
Q 045286          118 PGGSLYDY-------L----------HKNH---N-VLKL-PQLLRFAID----------------------ICKGMEYLH  153 (259)
Q Consensus       118 ~~~~L~~~-------l----------~~~~---~-~~~~-~~~~~i~~q----------------------l~~~l~~lH  153 (259)
                      +|.++...       +          +...   . ..+. ..+..+..+                      +...+..+.
T Consensus        93 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~  172 (330)
T PLN02421         93 NARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELK  172 (330)
T ss_pred             cCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHH
Confidence            87665321       1          1111   0 0111 111112111                      111222222


Q ss_pred             h----C----CcccCCCCCCcEEEcc-CCeEEEeeeccceecc
Q 045286          154 Q----R----NIIHRDLKTANLLMDT-HNVVKVADFGVARFQN  187 (259)
Q Consensus       154 ~----~----~i~H~di~p~Nilv~~-~~~i~l~D~~~~~~~~  187 (259)
                      .    .    -++|+|+.+.||++++ ++.++++||+.+....
T Consensus       173 ~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~nd  215 (330)
T PLN02421        173 EITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYSY  215 (330)
T ss_pred             HHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCCc
Confidence            1    1    2899999999999975 4789999999885433

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.75  E-value=0.00084  Score=55.80  Aligned_cols=30  Identities=23%  Similarity=0.348  Sum_probs=27.5

Q ss_pred             CcccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          156 NIIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       156 ~i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                      +++|+|+.++|++++.++.+.++||..++.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            799999999999999999999999998753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.66  E-value=0.00082  Score=56.44  Aligned_cols=73  Identities=14%  Similarity=-0.011  Sum_probs=47.6

Q ss_pred             eeccccceEEEEEEEcC--ceEEEEEeecc-----cCchHHHHHHHHHHHHHHhcC--CC-CcceeeeeeecCCcEEEEE
Q 045286           45 RIASGSCGDLYRGVYLG--QDVAVKVLRSE-----HLNDTLEDEFVQEVAILREVQ--HR-NVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        45 ~lg~G~~~~V~~~~~~~--~~v~vK~~~~~-----~~~~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~lv~  114 (259)
                      .||.|....||++.+.+  +.++||.-..-     ...+-...+..-|...|+...  .| .+++++.+  +.+...++|
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            57999999999998764  57999875421     112233355556777777764  34 45555544  345667899


Q ss_pred             ecCCC
Q 045286          115 EYMPG  119 (259)
Q Consensus       115 e~~~~  119 (259)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.66  E-value=0.00052  Score=56.02  Aligned_cols=32  Identities=22%  Similarity=0.453  Sum_probs=26.2

Q ss_pred             CcccCCCCCCcEEEccCCe-EEEeeeccceecc
Q 045286          156 NIIHRDLKTANLLMDTHNV-VKVADFGVARFQN  187 (259)
Q Consensus       156 ~i~H~di~p~Nilv~~~~~-i~l~D~~~~~~~~  187 (259)
                      .++|+|++|.||+++.++. .-++||+.+....
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD  218 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD  218 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence            4899999999999987555 5699999875443

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.65  E-value=0.0056  Score=50.82  Aligned_cols=29  Identities=34%  Similarity=0.516  Sum_probs=25.3

Q ss_pred             CCcccCCCCCCcEEEccCCeEEEeeeccce
Q 045286          155 RNIIHRDLKTANLLMDTHNVVKVADFGVAR  184 (259)
Q Consensus       155 ~~i~H~di~p~Nilv~~~~~i~l~D~~~~~  184 (259)
                      .+++|||+.+.||+++. +.+.++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            57899999999999987 678999999763

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=97.58  E-value=0.00019  Score=56.14  Aligned_cols=30  Identities=33%  Similarity=0.582  Sum_probs=21.7

Q ss_pred             CcccCCCCCCcEEE-ccCCeEEEeeecccee
Q 045286          156 NIIHRDLKTANLLM-DTHNVVKVADFGVARF  185 (259)
Q Consensus       156 ~i~H~di~p~Nilv-~~~~~i~l~D~~~~~~  185 (259)
                      .++|+|+.+.||++ +.++.+++|||+.+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            59999999999999 8889999999999853

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.54  E-value=0.0011  Score=54.27  Aligned_cols=76  Identities=21%  Similarity=0.236  Sum_probs=49.2

Q ss_pred             hhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcC---CCCcceeeeeeecCCcEEEEEec
Q 045286           40 LKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ---HRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      +.-...++.|..+.+|+....++.+.||+-....     ...+..|..-|+.|.   .-.+++.+.+....+..++++||
T Consensus        19 i~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~-----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~   93 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLDTDGGSYFVKVNSESG-----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF   93 (288)
T ss_dssp             --EEEEE--SSSSEEEEEETTS-EEEEEEEEGGG-----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred             eeeeEecCCCChhheEEEECCCccEEEEecChhh-----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence            4455788989999999999889999999988332     145677888888773   44677888887776777999999


Q ss_pred             CCCC
Q 045286          117 MPGG  120 (259)
Q Consensus       117 ~~~~  120 (259)
                      ++.+
T Consensus        94 l~~~   97 (288)
T PF03881_consen   94 LEMG   97 (288)
T ss_dssp             ----
T ss_pred             ecCC
Confidence            8765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.48  E-value=0.00086  Score=57.02  Aligned_cols=75  Identities=17%  Similarity=0.085  Sum_probs=50.6

Q ss_pred             cceeccccceEEEEEEEc--CceEEEEEeecc----cCchHHHHHHHHHHHHHHhcC--CC-CcceeeeeeecCCcEEEE
Q 045286           43 GERIASGSCGDLYRGVYL--GQDVAVKVLRSE----HLNDTLEDEFVQEVAILREVQ--HR-NVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        43 ~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~----~~~~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~lv  113 (259)
                      .+.||.|....||++.+.  ++.++||.-..-    ...+-..++..-|.++|+...  .| ++++++.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            578999999999999975  668999875422    112333466667778888764  34 45556644  34456788


Q ss_pred             EecCCC
Q 045286          114 TEYMPG  119 (259)
Q Consensus       114 ~e~~~~  119 (259)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            888743

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=97.40  E-value=0.022  Score=47.69  Aligned_cols=136  Identities=23%  Similarity=0.261  Sum_probs=81.3

Q ss_pred             ceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCC------cceeeeee--ecCC--cEEEE
Q 045286           44 ERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRN------VVRFIGAS--TKSP--HLCIV  113 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~~~~~~--~~~~--~~~lv  113 (259)
                      ..|.+ .-..+|+....+..+++|+.... ...   ..+.-|...++.|....      ++..-+..  .-..  ..+-+
T Consensus        32 ~~l~s-~eN~~f~~~~~~g~~iLki~~~~-~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~l  106 (331)
T COG2334          32 RGLNS-EENSNFRVQTEDGRYILKIYRPG-WTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAAL  106 (331)
T ss_pred             ccccc-ccCceEEEEecCCCeEEEEecCC-CCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEE
Confidence            45555 56778988888777799999886 333   45666777777774211      22222211  1233  78899


Q ss_pred             EecCCCCChHH-H----H----------Hhc--CCC------C---CHH-------------HHHHHHHHHHHHHHHHHh
Q 045286          114 TEYMPGGSLYD-Y----L----------HKN--HNV------L---KLP-------------QLLRFAIDICKGMEYLHQ  154 (259)
Q Consensus       114 ~e~~~~~~L~~-~----l----------~~~--~~~------~---~~~-------------~~~~i~~ql~~~l~~lH~  154 (259)
                      ++|++|..+.. .    +          +..  +.+      +   ...             .-.....++...+..+..
T Consensus       107 f~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~  186 (331)
T COG2334         107 FEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLA  186 (331)
T ss_pred             EEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHh
Confidence            99999877762 1    1          000  000      0   000             000123333344444443


Q ss_pred             -------CC---cccCCCCCCcEEEccCCe-EEEeeeccce
Q 045286          155 -------RN---IIHRDLKTANLLMDTHNV-VKVADFGVAR  184 (259)
Q Consensus       155 -------~~---i~H~di~p~Nilv~~~~~-i~l~D~~~~~  184 (259)
                             .+   ++|+|+.|.||+++.+.. .-++||+-+.
T Consensus       187 ~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         187 RLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence                   23   999999999999998875 8999999763

>PRK06148 hypothetical protein; Provisional

Probab=97.39  E-value=0.011  Score=56.85  Aligned_cols=30  Identities=33%  Similarity=0.597  Sum_probs=25.3

Q ss_pred             CCcccCCCCCCcEEEccCC--eEE-Eeeeccce
Q 045286          155 RNIIHRDLKTANLLMDTHN--VVK-VADFGVAR  184 (259)
Q Consensus       155 ~~i~H~di~p~Nilv~~~~--~i~-l~D~~~~~  184 (259)
                      .+++|+|+.+.||+++.++  .+. |+|||-+.
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            4799999999999998775  555 99999763

>PTZ00384 choline kinase; Provisional

Probab=97.28  E-value=0.0027  Score=54.25  Aligned_cols=73  Identities=15%  Similarity=0.283  Sum_probs=44.7

Q ss_pred             ceeccccceEEEEEEEcCc---e-----EEEEEeecccCchHHHHHHHHHHHHHHhcCCCCc-ceeeeeeecCCcEEEEE
Q 045286           44 ERIASGSCGDLYRGVYLGQ---D-----VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNV-VRFIGASTKSPHLCIVT  114 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~~~---~-----v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~  114 (259)
                      ++|..|-+..+|++...+.   .     |+++.....   ....-...+|.++++.+...++ +++++.+..    +++.
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~---~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~  128 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY---NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQ  128 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC---CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEE
Confidence            4666699999999875422   2     444443211   1111223468888888875444 456666543    4999


Q ss_pred             ecCCCCChH
Q 045286          115 EYMPGGSLY  123 (259)
Q Consensus       115 e~~~~~~L~  123 (259)
                      ||++|.+|.
T Consensus       129 efIeGr~l~  137 (383)
T PTZ00384        129 EWVEGNTMG  137 (383)
T ss_pred             EEeccccCC
Confidence            999987654

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.24  E-value=0.0023  Score=60.63  Aligned_cols=152  Identities=17%  Similarity=0.205  Sum_probs=108.9

Q ss_pred             HHHHHHHHHhcCCCCcceeeeeeecCCc----EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 045286           82 FVQEVAILREVQHRNVVRFIGASTKSPH----LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI  157 (259)
Q Consensus        82 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i  157 (259)
                      ..-|...+....|+|...+..+....-.    ..+..+++...++...++... .++....+.+..++..++.++|+...
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~-~i~~~~~r~~~~~~~~GL~~~h~~~l  307 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG-SIPLETLRILHQKLLEGLAYLHSLSL  307 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc-ccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence            3456677778889999999887654322    223456677777777775443 48888999999999999999999976


Q ss_pred             ccCCCCCC---cEEEccCCeEEEe--eeccceeccCCCccccCCCcccccCccccCCCCCCC--chhHHHHHHHHHHHHc
Q 045286          158 IHRDLKTA---NLLMDTHNVVKVA--DFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQ--KADVFSFAIVLWELVT  230 (259)
Q Consensus       158 ~H~di~p~---Nilv~~~~~i~l~--D~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~--~~Di~slG~~~~~ll~  230 (259)
                      .|.-+..+   +--++.++.+...  ||+.+.................+.++|......+..  ..|+|.+|.....+..
T Consensus       308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~  387 (1351)
T KOG1035|consen  308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQ  387 (1351)
T ss_pred             ceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhh
Confidence            66555544   3334455566666  888887777665555555666777888876665554  4799999999999988


Q ss_pred             CCCC
Q 045286          231 AKVP  234 (259)
Q Consensus       231 g~~p  234 (259)
                      |..+
T Consensus       388 ~~~i  391 (1351)
T KOG1035|consen  388 GEDI  391 (1351)
T ss_pred             cCcc
Confidence            7664

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=97.06  E-value=0.0077  Score=47.25  Aligned_cols=80  Identities=24%  Similarity=0.278  Sum_probs=62.1

Q ss_pred             hhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcC---CCCcceeeeeeecCCcEEEEEe
Q 045286           39 LLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ---HRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      .++-.+++.-|.-...|...+...++.||+-..+     ....+..|+.-|..+.   .-.+++.+.+....++.++|+|
T Consensus        17 ~i~er~~v~gG~inea~~v~dg~~~~FvK~n~~~-----~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle   91 (286)
T COG3001          17 EIKEREEVSGGDINEAWRLRDGTDPFFVKCNQRE-----QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLE   91 (286)
T ss_pred             hhhcccccCCccccceeEeecCCcceEEEecchh-----hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEe
Confidence            5556678888999999999999999999996554     2356677777777664   3557778888888899999999


Q ss_pred             cCCCCChH
Q 045286          116 YMPGGSLY  123 (259)
Q Consensus       116 ~~~~~~L~  123 (259)
                      |++.+.+.
T Consensus        92 ~L~~~~~d   99 (286)
T COG3001          92 YLPTGPLD   99 (286)
T ss_pred             eccCCCCC
Confidence            99876655

>PTZ00296 choline kinase; Provisional

Probab=96.95  E-value=0.015  Score=50.79  Aligned_cols=78  Identities=13%  Similarity=0.218  Sum_probs=48.4

Q ss_pred             hhhhccceeccccceEEEEEEEc----------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcc-eeeeeeec
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL----------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVV-RFIGASTK  106 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~----------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~  106 (259)
                      +.+ -.++|..|-+..+|++...          ++.|++|+.-....  .. -...+|..+++.+...+|. ++++.+. 
T Consensus       106 ~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te--~l-IdR~~E~~v~~~ls~~gi~P~l~~~f~-  180 (442)
T PTZ00296        106 DDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD--EL-YNPISEFEVYKTMSKYRIAPQLLNTFS-  180 (442)
T ss_pred             ccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc--ce-eCHHHHHHHHHHHHHCCCCCceEEEeC-
Confidence            344 5567778999999998754          45789998765421  11 1234567777766544443 4555543 


Q ss_pred             CCcEEEEEecCCCCChH
Q 045286          107 SPHLCIVTEYMPGGSLY  123 (259)
Q Consensus       107 ~~~~~lv~e~~~~~~L~  123 (259)
                      +   +.|.+|++|.+|.
T Consensus       181 g---g~I~efi~g~~l~  194 (442)
T PTZ00296        181 G---GRIEEWLYGDPLR  194 (442)
T ss_pred             C---CEEEEeeCCccCC
Confidence            2   3678999876443

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.90  E-value=0.0088  Score=50.15  Aligned_cols=74  Identities=20%  Similarity=0.257  Sum_probs=57.1

Q ss_pred             CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR-NIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                      -+.+++|++. |+++...-     .....++..++.+.+..+.-+..+ ..-|+++...||+++ +|+|.||||.+++..
T Consensus       299 ~y~yl~~kdh-gt~is~ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         299 LYLYLHFKDH-GTPISIIK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             eEEEEEEecC-Cceeeeee-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            4567778876 66664432     245677788888888888877765 689999999999998 999999999999744


Q ss_pred             cC
Q 045286          187 NK  188 (259)
Q Consensus       187 ~~  188 (259)
                      ..
T Consensus       372 ~~  373 (488)
T COG5072         372 YS  373 (488)
T ss_pred             cC
Confidence            33

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.72  E-value=0.042  Score=46.03  Aligned_cols=70  Identities=20%  Similarity=0.221  Sum_probs=40.9

Q ss_pred             ccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCc--ce---eee--eeecCCcEEEEEecCCCC
Q 045286           49 GSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNV--VR---FIG--ASTKSPHLCIVTEYMPGG  120 (259)
Q Consensus        49 G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i--~~---~~~--~~~~~~~~~lv~e~~~~~  120 (259)
                      +.-..||+.... +..+++|+.+....+.   ..+..|...+..|....+  +.   .-+  ....++..+.++++++|.
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~~---~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~  112 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPERWSD---AQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGR  112 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCcccCCH---HHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCC
Confidence            344678888764 6689999886543333   445566666666632111  11   111  122345678899999875


Q ss_pred             C
Q 045286          121 S  121 (259)
Q Consensus       121 ~  121 (259)
                      .
T Consensus       113 ~  113 (325)
T PRK11768        113 A  113 (325)
T ss_pred             C
Confidence            4

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=96.60  E-value=0.013  Score=47.72  Aligned_cols=45  Identities=20%  Similarity=0.310  Sum_probs=33.8

Q ss_pred             HHHHHHHHHHHHhC--CcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          142 AIDICKGMEYLHQR--NIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       142 ~~ql~~~l~~lH~~--~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                      +..+-..+.-.+..  -++|+|+.|+|++.++.+.++|+||+.+...
T Consensus       138 ~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~~  184 (269)
T COG0510         138 LKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGLN  184 (269)
T ss_pred             HHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCCc
Confidence            33444444444433  4999999999999999999999999998543

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=96.43  E-value=0.01  Score=47.66  Aligned_cols=80  Identities=21%  Similarity=0.183  Sum_probs=54.5

Q ss_pred             hccceeccccceEEEEEEE-cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecC-C
Q 045286           41 KTGERIASGSCGDLYRGVY-LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYM-P  118 (259)
Q Consensus        41 ~~~~~lg~G~~~~V~~~~~-~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~-~  118 (259)
                      .....+..|..+.|+.+.. .|.+.++|+........   . .......|+..+-...+++++....  .-.+++|++ +
T Consensus         5 ~~~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~---~-E~~g~~~L~~w~G~GaVrll~~d~~--~~AlLLErl~~   78 (253)
T PF04655_consen    5 TPDGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAE---H-EARGEAALRWWNGRGAVRLLAADPE--RGALLLERLDP   78 (253)
T ss_pred             ccCCCCCCCcceEEEEEEcCCCCeEEEEecCCcccch---h-hhhHHhHhheeCCCCceeeeccccc--cchhhhhhccC
Confidence            3445677899999999975 57899999988653211   1 1112255888888888999987643  345888888 5


Q ss_pred             CCChHHHH
Q 045286          119 GGSLYDYL  126 (259)
Q Consensus       119 ~~~L~~~l  126 (259)
                      +.+|.+.-
T Consensus        79 g~~L~~~~   86 (253)
T PF04655_consen   79 GRSLASLP   86 (253)
T ss_pred             CCchhhcc
Confidence            55666543

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.29  E-value=0.025  Score=44.29  Aligned_cols=116  Identities=13%  Similarity=0.106  Sum_probs=68.6

Q ss_pred             ccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCCCCChHHHHHh
Q 045286           49 GSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK  128 (259)
Q Consensus        49 G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  128 (259)
                      ++.++.-.++..-.+..+|++..--..- ....+.++.++++++.  .|+++..-  ..-.+-++.|++.....      
T Consensus        73 ~gNsTl~~~kt~iG~L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKIGPLFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------  141 (308)
T ss_pred             CCceEEEEeccccchhhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence            3344444333332455666665432221 1144677888888763  45555521  33456688888743211      


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCCCcEEEccCCeEEEeeeccc
Q 045286          129 NHNVLKLPQLLRFAIDICKGMEYLHQ--RNIIHRDLKTANLLMDTHNVVKVADFGVA  183 (259)
Q Consensus       129 ~~~~~~~~~~~~i~~ql~~~l~~lH~--~~i~H~di~p~Nilv~~~~~i~l~D~~~~  183 (259)
                             -..-.+.. =++.|.-+|+  .+..|||..|+||+.+..|-+||.|-+..
T Consensus       142 -------~~~N~i~a-gi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  142 -------NFSNFITA-GIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             -------chhHHHHH-hHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence                   00111111 1356777884  47999999999999999999999997663

The function of this family is unknown.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	259
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-47
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-47
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-42
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-42
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-41
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-40
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-40
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-40
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-40
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-40
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-40
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-40
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-39
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-39
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-39
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-38
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-36
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-36
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-36
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		8e-36
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		8e-36
2pl0_A	289	Lck Bound To Imatinib Length = 289		8e-36
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		8e-36
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		8e-36
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		8e-36
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		8e-36
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		9e-36
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		9e-36
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		9e-36
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		9e-36
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		9e-36
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-35
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-35
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-35
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-35
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-35
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-35
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-35
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-35
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-35
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-35
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-35
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-35
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-35
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-35
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-35
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-35
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-35
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-35
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-35
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-35
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-35
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		5e-35
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-35
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		9e-35
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		9e-35
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		9e-35
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-34
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-34
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-34
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-34
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-34
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-34
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-34
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-34
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-34
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-34
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-33
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-33
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-33
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-33
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-33
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-33
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		7e-33
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		8e-33
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		9e-33
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-32
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-32
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-32
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-32
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-32
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-32
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		7e-32
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-31
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-31
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-31
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-31
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-31
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-31
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-31
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-31
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-31
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-31
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-31
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-31
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-31
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-31
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		7e-31
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		8e-31
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		8e-31
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-30
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-29
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-29
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-29
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-29
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-29
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-29
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-29
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-29
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-29
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-29
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-29
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-29
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-29
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-29
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-28
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-28
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-28
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-28
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-28
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-28
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-28
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-28
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-28
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-28
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-28
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-28
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-28
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-28
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-28
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-28
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-28
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-28
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-27
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-27
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-27
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-27
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-27
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-27
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-27
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-27
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-27
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-27
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		7e-27
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		7e-27
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-27
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		8e-27
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		8e-27
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		8e-27
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		8e-27
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		9e-27
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-26
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-26
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-26
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-26
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-26
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-26
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-26
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-26
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-26
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-26
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-26
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-26
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-26
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-26
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-26
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-26
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		7e-26
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		7e-26
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-26
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		8e-26
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		9e-26
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-26
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		9e-26
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-26
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		9e-26
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-26
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-25
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-25
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-25
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-25
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-25
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-25
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-25
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-25
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-25
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-25
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-25
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-25
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-25
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-25
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-25
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-25
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-25
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-25
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-25
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-25
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-25
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-25
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-25
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-25
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-25
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-25
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-25
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-25
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-25
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-25
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-25
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-25
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-25
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-25
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-25
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-25
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-25
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-25
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-25
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-25
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-25
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-25
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-25
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-25
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-25
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-25
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-25
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-25
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		7e-25
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		7e-25
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		7e-25
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		7e-25
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-25
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		8e-25
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-25
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-25
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-25
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		9e-25
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-24
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-24
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-24
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-24
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-24
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-24
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-24
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-24
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-24
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-24
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-24
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-24
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-24
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-24
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-24
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-24
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-24
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-24
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-24
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-24
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-24
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-24
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-24
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-24
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-24
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-24
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-24
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-24
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-24
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-24
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-24
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-24
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-24
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-24
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-24
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-24
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-24
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-24
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-24
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-24
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-24
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-24
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-24
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-24
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		7e-24
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		8e-24
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		9e-24
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		9e-24
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-23
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-23
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-23
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-23
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-23
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-23
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-23
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-23
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-23
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-23
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-23
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-23
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-23
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-23
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-23
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-23
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-23
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-23
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-23
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-23
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-23
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-23
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-23
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-23
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-23
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-23
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-23
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-23
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-23
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-23
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-23
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-23
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-23
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-23
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-23
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		4e-23
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		6e-23
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-23
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		9e-23
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-22
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-22
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-22
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-22
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-22
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-22
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-22
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-22
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-22
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-22
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-22
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-22
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-22
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-22
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-22
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-22
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-22
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-22
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-22
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-22
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-22
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-22
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-22
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-22
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-22
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-22
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-22
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-22
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-22
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-22
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-22
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-22
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-22
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-22
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-22
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-22
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-22
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-22
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-22
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-22
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-22
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		6e-22
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		8e-22
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-22
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		9e-22
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-21
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-21
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-21
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-21
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-21
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-21
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-21
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-21
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-21
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-21
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-21
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-21
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-21
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-21
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-21
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-21
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-21
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-21
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-21
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-21
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-21
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-21
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-21
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-21
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-21
4fie_A	423	Full-Length Human Pak4 Length = 423		8e-21
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-21
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		9e-21
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-20
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-20
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-20
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-20
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-20
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-20
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-20
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-20
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-20
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-20
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-20
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-20
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-20
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-20
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-20
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-20
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-20
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-20
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-20
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-20
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-20
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-20
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-20
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-20
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		5e-20
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-20
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-20
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-20
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-20
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-20
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		7e-20
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-20
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		7e-20
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-20
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		7e-20
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		7e-20
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-20
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-20
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		8e-20
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-20
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-20
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		8e-20
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-20
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		8e-20
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		8e-20
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-20
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-20
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-20
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		9e-20
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		9e-20
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-19
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-19
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-19
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-19
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-19
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-19
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-19
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-19
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-19
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-19
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-19
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-19
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-19
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-19
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-19
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-19
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-19
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-19
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-19
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-19
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-19
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-19
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-19
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-19
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-19
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-19
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-19
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-19
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-19
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-19
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-19
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-19
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-19
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-19
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-19
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-19
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-19
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-19
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-19
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-19
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-19
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-19
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-19
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-19
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-19
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-19
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-19
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-19
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-19
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-19
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-19
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-19
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-19
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-19
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-19
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-19
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-19
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-19
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-19
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-19
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-19
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-19
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-19
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-19
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		6e-19
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-19
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-19
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-19
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-19
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-19
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-19
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-19
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-19
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-19
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-18
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-18
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-18
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-18
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-18
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-18
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-18
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-18
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-18
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-18
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-18
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-18
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-18
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-18
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-18
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-18
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-18
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-18
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-18
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-18
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-18
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-18
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-18
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-18
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-18
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-18
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-18
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-18
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-18
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-18
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-18
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-18
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		7e-18
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		7e-18
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		7e-18
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-18
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		9e-18
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		9e-18
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-17
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-17
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-17
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-17
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-17
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-17
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-17
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-17
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-17
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-17
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-17
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-17
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-17
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-17
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-17
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-17
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-17
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-17
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-17
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-17
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-17
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-17
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-17
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-17
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-17
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-17
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-17
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-17
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-17
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-17
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-17
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-17
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-17
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-17
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-17
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-17
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-17
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-17
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-17
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-17
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-17
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-17
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-17
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-17
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-17
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-17
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-17
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-17
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-17
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-17
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-17
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-17
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-17
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-17
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-17
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-17
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		6e-17
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-17
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-17
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-17
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-17
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		6e-17
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-17
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-17
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-17
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-17
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-17
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-17
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-17
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-17
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-17
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		8e-17
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		8e-17
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		9e-17
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-16
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-16
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-16
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-16
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-16
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-16
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-16
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-16
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-16
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-16
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-16
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-16
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-16
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-16
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-16
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-16
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-16
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-16
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-16
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-16
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-16
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-16
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-16
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-16
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-16
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-16
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-16
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-16
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-16
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-16
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-16
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-16
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-16
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-16
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-16
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-16
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-16
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-16
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-16
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-16
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-16
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-16
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-16
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-16
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-16
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-16
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-16
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-16
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-16
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-16
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-16
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-16
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		6e-16
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		6e-16
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-16
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-16
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		7e-16
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		8e-16
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		8e-16
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-16
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		9e-16
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-15
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-15
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-15
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-15
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-15
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-15
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-15
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-15
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-15
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-15
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-15
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-15
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-15
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-15
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-15
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-15
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-15
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-15
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-15
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-15
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-15
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-15
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-15
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-15
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-15
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-15
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-15
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-15
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		7e-15
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-15
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-15
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-14
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-14
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-14
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-14
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-14
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-14
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-14
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-14
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-14
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-14
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-14
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-14
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		6e-14
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-14
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		6e-14
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-14
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		7e-14
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		8e-14
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-14
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		8e-14
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		8e-14
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		9e-14
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		9e-14
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-13
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-13
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-13
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-13
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-13
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-13
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-13
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-13
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-13
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-13
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-13
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-13
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-13
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-13
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-13
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-13
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-13
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-13
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-13
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-13
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-13
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-13
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-13
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-13
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-13
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-13
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-13
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-13
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-13
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-13
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-13
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-13
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-13
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-13
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-13
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-13
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-13
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-13
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-13
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-13
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-13
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-13
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-13
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-13
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-13
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-13
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-13
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-13
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-13
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-13
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-13
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-13
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-13
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-13
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-13
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-13
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-13
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-13
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-13
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-13
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-13
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-13
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-13
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-13
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-13
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-13
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-13
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-13
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-13
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-13
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-13
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-13
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-13
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-13
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-13
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-13
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-13
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-13
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-13
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-13
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-13
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-13
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-13
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-13
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-13
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-13
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-13
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-13
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-13
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-13
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-13
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-13
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-13
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-13
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-13
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-13
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-13
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-13
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-13
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-13
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-13
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-13
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-13
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-13
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-13
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-13
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-13
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-13
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-13
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-13
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-13
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-13
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-13
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-13
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-13
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-13
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-13
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-13
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		7e-13
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-13
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-13
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-13
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-13
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		8e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-13
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-13
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		9e-13
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		9e-13
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-12
3soa_A	444	Full-Length Human Camkii Length = 444		1e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-12
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-12
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-12
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-12
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-12
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-12
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-12
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-12
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-12
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-12
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-12
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-12
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-12
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-12
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-12
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		5e-12
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		5e-12
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		5e-12
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		5e-12
2oza_A	356	Structure Of P38alpha Complex Length = 356		5e-12
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		5e-12
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		5e-12
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		5e-12
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		5e-12
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-12
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		6e-12
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		9e-12
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-11
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-11
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-11
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-11
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-11
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-11
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-11
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-11
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-11
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-11
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-11
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-11
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-11
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-11
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-11
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-11
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		5e-11
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-11
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		7e-11
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		7e-11
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		7e-11
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		7e-11
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		7e-11
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		8e-11
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		8e-11
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		8e-11
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		9e-11
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		9e-11
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		9e-11
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		9e-11
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-10
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-10
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-10
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-10
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-10
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-10
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-10
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-10
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		3e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-10
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-10
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		3e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-10
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-10
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-10
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-10
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-10
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-10
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-10
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		4e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-10

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  185 bits (470), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 96/223 (43%), Positives = 140/223 (62%), Gaps = 5/223 (2%)
Query: 40  LKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           L   E+I +GS G ++R  + G DVAVK+L  +  +    +EF++EVAI++ ++H N+V 
Sbjct: 39  LNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF--AIDICKGMEYLHQRN- 156
           F+GA T+ P+L IVTEY+  GSLY  LHK+    +L +  R   A D+ KGM YLH RN 
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP 158
Query: 157 -IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT-AETGTYRWMAPEVINHQPYDQ 214
            I+HRDLK+ NLL+D    VKV DFG++R +    + +    GT  WMAPEV+  +P ++
Sbjct: 159 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPSNE 218
Query: 215 KADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQP 257
           K+DV+SF ++LWEL T + P+ ++ P Q    V   C  L  P
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP 261

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  184 bits (468), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 97/232 (41%), Positives = 145/232 (62%), Gaps = 5/232 (2%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           +D +I    L   E+I +GS G ++R  + G DVAVK+L  +  +    +EF++EVAI++
Sbjct: 30  DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMK 89
Query: 91  EVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF--AIDICKG 148
            ++H N+V F+GA T+ P+L IVTEY+  GSLY  LHK+    +L +  R   A D+ KG
Sbjct: 90  RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 149 MEYLHQRN--IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT-AETGTYRWMAPE 205
           M YLH RN  I+HR+LK+ NLL+D    VKV DFG++R +    + + +  GT  WMAPE
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE 209
Query: 206 VINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQP 257
           V+  +P ++K+DV+SF ++LWEL T + P+ ++ P Q    V   C  L  P
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP 261

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  169 bits (428), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 91/220 (41%), Positives = 137/220 (62%), Gaps = 8/220 (3%)
Query: 26  SQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQE 85
           S+  S+DWEI    +  G+RI SGS G +Y+G + G DVAVK+L            F  E
Sbjct: 12  SRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNE 70
Query: 86  VAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDI 145
           V +LR+ +H N++ F+G STK P L IVT++  G SLY +LH +    ++ +L+  A   
Sbjct: 71  VGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQT 129
Query: 146 CKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMTAE--TGTYRWM 202
            +GM+YLH ++IIHRDLK+ N+ +   N VK+ DFG+A  +++  G    E  +G+  WM
Sbjct: 130 ARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189
Query: 203 APEVINHQ---PYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           APEVI  Q   PY  ++DV++F IVL+EL+T ++PY ++ 
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  168 bits (426), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 90/216 (41%), Positives = 135/216 (62%), Gaps = 8/216 (3%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           S+DWEI    +  G+RI SGS G +Y+G + G DVAVK+L            F  EV +L
Sbjct: 4   SDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVL 62
Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGM 149
           R+ +H N++ F+G STK P L IVT++  G SLY +LH +    ++ +L+  A    +GM
Sbjct: 63  RKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGM 121
Query: 150 EYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMTAE--TGTYRWMAPEV 206
           +YLH ++IIHRDLK+ N+ +   N VK+ DFG+A  +++  G    E  +G+  WMAPEV
Sbjct: 122 DYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 181
Query: 207 INHQ---PYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           I  Q   PY  ++DV++F IVL+EL+T ++PY ++ 
Sbjct: 182 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 217

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  166 bits (421), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 89/220 (40%), Positives = 137/220 (62%), Gaps = 8/220 (3%)
Query: 26  SQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQE 85
           S+  ++DWEI    +  G+RI SGS G +Y+G + G DVAVK+L            F  E
Sbjct: 12  SRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNE 70
Query: 86  VAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDI 145
           V +LR+ +H N++ F+G ST +P L IVT++  G SLY +LH +    ++ +L+  A   
Sbjct: 71  VGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQT 129
Query: 146 CKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMTAE--TGTYRWM 202
            +GM+YLH ++IIHRDLK+ N+ +   N VK+ DFG+A  +++  G    E  +G+  WM
Sbjct: 130 ARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189
Query: 203 APEVINHQ---PYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           APEVI  Q   PY  ++DV++F IVL+EL+T ++PY ++ 
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 90/224 (40%), Positives = 136/224 (60%), Gaps = 8/224 (3%)
Query: 22  KAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDE 81
           K +  +  S+DWEI    +  G+RI SGS G +Y+G + G DVAVK+L            
Sbjct: 20  KTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQA 78
Query: 82  FVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF 141
           F  EV +LR+ +H N++ F+G STK P L IVT++  G SLY +LH      ++ +L+  
Sbjct: 79  FKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI 137
Query: 142 AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMTAE--TGT 198
           A    +GM+YLH ++IIHRDLK+ N+ +     VK+ DFG+A  +++  G    E  +G+
Sbjct: 138 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 197
Query: 199 YRWMAPEVINHQ---PYDQKADVFSFAIVLWELVTAKVPYDSMT 239
             WMAPEVI  Q   PY  ++DV++F IVL+EL+T ++PY ++ 
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 241

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 90/224 (40%), Positives = 136/224 (60%), Gaps = 8/224 (3%)
Query: 22  KAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDE 81
           K +  +  S+DWEI    +  G+RI SGS G +Y+G + G DVAVK+L            
Sbjct: 19  KTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQA 77
Query: 82  FVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF 141
           F  EV +LR+ +H N++ F+G STK P L IVT++  G SLY +LH      ++ +L+  
Sbjct: 78  FKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI 136
Query: 142 AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMTAE--TGT 198
           A    +GM+YLH ++IIHRDLK+ N+ +     VK+ DFG+A  +++  G    E  +G+
Sbjct: 137 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 196
Query: 199 YRWMAPEVINHQ---PYDQKADVFSFAIVLWELVTAKVPYDSMT 239
             WMAPEVI  Q   PY  ++DV++F IVL+EL+T ++PY ++ 
Sbjct: 197 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 240

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 89/216 (41%), Positives = 133/216 (61%), Gaps = 8/216 (3%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           S+DWEI    +  G+RI SGS G +Y+G + G DVAVK+L            F  EV +L
Sbjct: 5   SDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVL 63
Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGM 149
           R+ +H N++ F+G STK P L IVT++  G SLY +LH      ++ +L+  A    +GM
Sbjct: 64  RKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 122
Query: 150 EYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMTAE--TGTYRWMAPEV 206
           +YLH ++IIHRDLK+ N+ +     VK+ DFG+A  +++  G    E  +G+  WMAPEV
Sbjct: 123 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 182
Query: 207 INHQ---PYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           I  Q   PY  ++DV++F IVL+EL+T ++PY ++ 
Sbjct: 183 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 89/216 (41%), Positives = 133/216 (61%), Gaps = 8/216 (3%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           S+DWEI    +  G+RI SGS G +Y+G + G DVAVK+L            F  EV +L
Sbjct: 2   SDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVL 60
Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGM 149
           R+ +H N++ F+G STK P L IVT++  G SLY +LH      ++ +L+  A    +GM
Sbjct: 61  RKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 119
Query: 150 EYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMTAE--TGTYRWMAPEV 206
           +YLH ++IIHRDLK+ N+ +     VK+ DFG+A  +++  G    E  +G+  WMAPEV
Sbjct: 120 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 179
Query: 207 INHQ---PYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           I  Q   PY  ++DV++F IVL+EL+T ++PY ++ 
Sbjct: 180 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 215

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 89/216 (41%), Positives = 133/216 (61%), Gaps = 8/216 (3%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           S+DWEI    +  G+RI SGS G +Y+G + G DVAVK+L            F  EV +L
Sbjct: 5   SDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVL 63
Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGM 149
           R+ +H N++ F+G STK P L IVT++  G SLY +LH      ++ +L+  A    +GM
Sbjct: 64  RKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 122
Query: 150 EYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMTAE--TGTYRWMAPEV 206
           +YLH ++IIHRDLK+ N+ +     VK+ DFG+A  +++  G    E  +G+  WMAPEV
Sbjct: 123 DYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 182
Query: 207 INHQ---PYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           I  Q   PY  ++DV++F IVL+EL+T ++PY ++ 
Sbjct: 183 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  161 bits (407), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 90/224 (40%), Positives = 136/224 (60%), Gaps = 8/224 (3%)
Query: 22  KAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDE 81
           K +  +  S+DWEI    +  G+RI SGS G +Y+G + G DVAVK+L            
Sbjct: 12  KTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQA 70
Query: 82  FVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF 141
           F  EV +LR+ +H N++ F+G STK P L IVT++  G SLY +LH      ++ +L+  
Sbjct: 71  FKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI 129
Query: 142 AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMTAE--TGT 198
           A    +GM+YLH ++IIHRDLK+ N+ +     VK+ DFG+A  +++  G    E  +G+
Sbjct: 130 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 189
Query: 199 YRWMAPEVINHQ---PYDQKADVFSFAIVLWELVTAKVPYDSMT 239
             WMAPEVI  Q   PY  ++DV++F IVL+EL+T ++PY ++ 
Sbjct: 190 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 233

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  161 bits (407), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 90/224 (40%), Positives = 136/224 (60%), Gaps = 8/224 (3%)
Query: 22  KAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDE 81
           K +  +  S+DWEI    +  G+RI SGS G +Y+G + G DVAVK+L            
Sbjct: 20  KTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQA 78
Query: 82  FVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF 141
           F  EV +LR+ +H N++ F+G STK P L IVT++  G SLY +LH      ++ +L+  
Sbjct: 79  FKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI 137
Query: 142 AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMTAE--TGT 198
           A    +GM+YLH ++IIHRDLK+ N+ +     VK+ DFG+A  +++  G    E  +G+
Sbjct: 138 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 197
Query: 199 YRWMAPEVINHQ---PYDQKADVFSFAIVLWELVTAKVPYDSMT 239
             WMAPEVI  Q   PY  ++DV++F IVL+EL+T ++PY ++ 
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 241

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  159 bits (403), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 88/215 (40%), Positives = 132/215 (61%), Gaps = 8/215 (3%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           +DWEI    +  G+RI SGS G +Y+G + G DVAVK+L            F  EV +LR
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 91  EVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGME 150
           + +H N++ F+G STK P L IVT++  G SLY +LH      ++ +L+  A    +GM+
Sbjct: 60  KTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMTAE--TGTYRWMAPEVI 207
           YLH ++IIHRDLK+ N+ +     VK+ DFG+A  +++  G    E  +G+  WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 208 NHQ---PYDQKADVFSFAIVLWELVTAKVPYDSMT 239
             Q   PY  ++DV++F IVL+EL+T ++PY ++ 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 88/215 (40%), Positives = 132/215 (61%), Gaps = 8/215 (3%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           +DWEI    +  G+RI SGS G +Y+G + G DVAVK+L            F  EV +LR
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 91  EVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGME 150
           + +H N++ F+G STK P L IVT++  G SLY +LH      ++ +L+  A    +GM+
Sbjct: 60  KTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMTAE--TGTYRWMAPEVI 207
           YLH ++IIHRDLK+ N+ +     VK+ DFG+A  +++  G    E  +G+  WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 208 NHQ---PYDQKADVFSFAIVLWELVTAKVPYDSMT 239
             Q   PY  ++DV++F IVL+EL+T ++PY ++ 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  158 bits (400), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 87/215 (40%), Positives = 132/215 (61%), Gaps = 8/215 (3%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           +DWEI    +  G+RI SGS G +Y+G + G DVAVK+L            F  EV +LR
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 91  EVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGME 150
           + +H N++ F+G ST +P L IVT++  G SLY +LH      ++ +L+  A    +GM+
Sbjct: 60  KTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMTAE--TGTYRWMAPEVI 207
           YLH ++IIHRDLK+ N+ +     VK+ DFG+A  +++  G    E  +G+  WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 208 NHQ---PYDQKADVFSFAIVLWELVTAKVPYDSMT 239
             Q   PY  ++DV++F IVL+EL+T ++PY ++ 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/209 (41%), Positives = 128/209 (61%), Gaps = 8/209 (3%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV 92
           WEI+   +    RI SGS G +Y+G + G DVAVK+L+           F  EVA+LR+ 
Sbjct: 31  WEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKT 89
Query: 93  QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYL 152
           +H N++ F+G  TK  +L IVT++  G SLY +LH      ++ QL+  A    +GM+YL
Sbjct: 90  RHVNILLFMGYMTKD-NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYL 148
Query: 153 HQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMTAE--TGTYRWMAPEVINH 209
           H +NIIHRD+K+ N+ +     VK+ DFG+A  +++  G    E  TG+  WMAPEVI  
Sbjct: 149 HAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRM 208
Query: 210 Q---PYDQKADVFSFAIVLWELVTAKVPY 235
           Q   P+  ++DV+S+ IVL+EL+T ++PY
Sbjct: 209 QDNNPFSFQSDVYSYGIVLYELMTGELPY 237

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  149 bits (375), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 81/220 (36%), Positives = 129/220 (58%), Gaps = 13/220 (5%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLE-DEFVQEVA 87
           + WE++R  +    ++  G  G++Y GV+      VAVK L+     DT+E +EF++E A
Sbjct: 4   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAA 59
Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDIC 146
           +++E++H N+V+ +G  T+ P   I+TE+M  G+L DYL + N   +    LL  A  I 
Sbjct: 60  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 119
Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMA 203
             MEYL ++N IHRDL   N L+  +++VKVADFG++R    G   TA  G     +W A
Sbjct: 120 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTFTAHAGAKFPIKWTA 178
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKV-PYDSMTPLQ 242
           PE + +  +  K+DV++F ++LWE+ T  + PY  + P Q
Sbjct: 179 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ 218

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  149 bits (375), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 81/220 (36%), Positives = 129/220 (58%), Gaps = 13/220 (5%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLE-DEFVQEVA 87
           + WE++R  +    ++  G  G++Y GV+      VAVK L+     DT+E +EF++E A
Sbjct: 4   DKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAA 59
Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDIC 146
           +++E++H N+V+ +G  T+ P   I+TE+M  G+L DYL + N   +    LL  A  I 
Sbjct: 60  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 119
Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMA 203
             MEYL ++N IHRDL   N L+  +++VKVADFG++R    G   TA  G     +W A
Sbjct: 120 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTA 178
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKV-PYDSMTPLQ 242
           PE + +  +  K+DV++F ++LWE+ T  + PY  + P Q
Sbjct: 179 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ 218

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  148 bits (373), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 83/213 (38%), Positives = 126/213 (59%), Gaps = 13/213 (6%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLE-DEFVQEVA 87
           + WE++R  +    ++  G  G++Y GV+      VAVK L+     DT+E +EF++E A
Sbjct: 25  DKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAA 80
Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDIC 146
           +++E++H N+V+ +G  T  P   IVTEYMP G+L DYL + N   +    LL  A  I 
Sbjct: 81  VMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQIS 140
Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMA 203
             MEYL ++N IHRDL   N L+  ++VVKVADFG++R    G   TA  G     +W A
Sbjct: 141 SAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 199
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKV-PY 235
           PE + +  +  K+DV++F ++LWE+ T  + PY
Sbjct: 200 PESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY 232

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  147 bits (370), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 81/215 (37%), Positives = 126/215 (58%), Gaps = 9/215 (4%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAI 88
            ++WE+ R  LK  ER+ +G  G+++ G Y G   VAVK L+   ++    D F+ E  +
Sbjct: 11  EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANL 67
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICK 147
           ++++QH+ +VR     T+ P + I+TEYM  GSL D+L     + L + +LL  A  I +
Sbjct: 68  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 126
Query: 148 GMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPE 205
           GM ++ +RN IHRDL+ AN+L+      K+ADFG+AR          E   +  +W APE
Sbjct: 127 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPE 186
Query: 206 VINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
            IN+  +  K+DV+SF I+L E+VT  ++PY  MT
Sbjct: 187 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 221

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  147 bits (370), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 81/212 (38%), Positives = 124/212 (58%), Gaps = 9/212 (4%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WE+ R  LK  ER+ +G  G+++ G Y G   VAVK L+   ++    D F+ E  ++++
Sbjct: 8   WEVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMKQ 64
Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICKGME 150
           +QH+ +VR     T+ P + I+TEYM  GSL D+L     + L + +LL  A  I +GM 
Sbjct: 65  LQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEVIN 208
           ++ +RN IHRDL+ AN+L+      K+ADFG+AR          E   +  +W APE IN
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAIN 183
Query: 209 HQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           +  +  K+DV+SF I+L E+VT  ++PY  MT
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  147 bits (370), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 81/214 (37%), Positives = 126/214 (58%), Gaps = 9/214 (4%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           ++WE+ R  LK  ER+ +G  G+++ G Y G   VAVK L+   ++    D F+ E  ++
Sbjct: 16  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLM 72
Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICKG 148
           +++QH+ +VR     T+ P + I+TEYM  GSL D+L     + L + +LL  A  I +G
Sbjct: 73  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 131
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEV 206
           M ++ +RN IHRDL+ AN+L+      K+ADFG+AR          E   +  +W APE 
Sbjct: 132 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 191
Query: 207 INHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           IN+  +  K+DV+SF I+L E+VT  ++PY  MT
Sbjct: 192 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 225

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  147 bits (370), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 81/214 (37%), Positives = 126/214 (58%), Gaps = 9/214 (4%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           ++WE+ R  LK  ER+ +G  G+++ G Y G   VAVK L+   ++    D F+ E  ++
Sbjct: 14  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLM 70
Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICKG 148
           +++QH+ +VR     T+ P + I+TEYM  GSL D+L     + L + +LL  A  I +G
Sbjct: 71  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 129
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEV 206
           M ++ +RN IHRDL+ AN+L+      K+ADFG+AR          E   +  +W APE 
Sbjct: 130 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 189
Query: 207 INHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           IN+  +  K+DV+SF I+L E+VT  ++PY  MT
Sbjct: 190 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 223

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  147 bits (370), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 81/214 (37%), Positives = 126/214 (58%), Gaps = 9/214 (4%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           ++WE+ R  LK  ER+ +G  G+++ G Y G   VAVK L+   ++    D F+ E  ++
Sbjct: 7   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLM 63
Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICKG 148
           +++QH+ +VR     T+ P + I+TEYM  GSL D+L     + L + +LL  A  I +G
Sbjct: 64  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 122
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEV 206
           M ++ +RN IHRDL+ AN+L+      K+ADFG+AR          E   +  +W APE 
Sbjct: 123 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 182
Query: 207 INHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           IN+  +  K+DV+SF I+L E+VT  ++PY  MT
Sbjct: 183 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 216

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  147 bits (370), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 81/214 (37%), Positives = 126/214 (58%), Gaps = 9/214 (4%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           ++WE+ R  LK  ER+ +G  G+++ G Y G   VAVK L+   ++    D F+ E  ++
Sbjct: 8   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLM 64
Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICKG 148
           +++QH+ +VR     T+ P + I+TEYM  GSL D+L     + L + +LL  A  I +G
Sbjct: 65  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 123
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEV 206
           M ++ +RN IHRDL+ AN+L+      K+ADFG+AR          E   +  +W APE 
Sbjct: 124 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 183
Query: 207 INHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           IN+  +  K+DV+SF I+L E+VT  ++PY  MT
Sbjct: 184 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 217

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  147 bits (370), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 81/215 (37%), Positives = 126/215 (58%), Gaps = 9/215 (4%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAI 88
            ++WE+ R  LK  ER+ +G  G+++ G Y G   VAVK L+   ++    D F+ E  +
Sbjct: 14  EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANL 70
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICK 147
           ++++QH+ +VR     T+ P + I+TEYM  GSL D+L     + L + +LL  A  I +
Sbjct: 71  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 129
Query: 148 GMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPE 205
           GM ++ +RN IHRDL+ AN+L+      K+ADFG+AR          E   +  +W APE
Sbjct: 130 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPE 189
Query: 206 VINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
            IN+  +  K+DV+SF I+L E+VT  ++PY  MT
Sbjct: 190 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 224

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  146 bits (369), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 81/214 (37%), Positives = 126/214 (58%), Gaps = 9/214 (4%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           ++WE+ R  LK  ER+ +G  G+++ G Y G   VAVK L+   ++    D F+ E  ++
Sbjct: 12  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLM 68
Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICKG 148
           +++QH+ +VR     T+ P + I+TEYM  GSL D+L     + L + +LL  A  I +G
Sbjct: 69  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 127
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEV 206
           M ++ +RN IHRDL+ AN+L+      K+ADFG+AR          E   +  +W APE 
Sbjct: 128 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 187
Query: 207 INHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           IN+  +  K+DV+SF I+L E+VT  ++PY  MT
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 221

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  146 bits (369), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 81/214 (37%), Positives = 126/214 (58%), Gaps = 9/214 (4%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           ++WE+ R  LK  ER+ +G  G+++ G Y G   VAVK L+   ++    D F+ E  ++
Sbjct: 1   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLM 57
Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICKG 148
           +++QH+ +VR     T+ P + I+TEYM  GSL D+L     + L + +LL  A  I +G
Sbjct: 58  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 116
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEV 206
           M ++ +RN IHRDL+ AN+L+      K+ADFG+AR          E   +  +W APE 
Sbjct: 117 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 176
Query: 207 INHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           IN+  +  K+DV+SF I+L E+VT  ++PY  MT
Sbjct: 177 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 210

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  146 bits (369), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 81/214 (37%), Positives = 126/214 (58%), Gaps = 9/214 (4%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           ++WE+ R  LK  ER+ +G  G+++ G Y G   VAVK L+   ++    D F+ E  ++
Sbjct: 11  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLM 67
Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICKG 148
           +++QH+ +VR     T+ P + I+TEYM  GSL D+L     + L + +LL  A  I +G
Sbjct: 68  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 126
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEV 206
           M ++ +RN IHRDL+ AN+L+      K+ADFG+AR          E   +  +W APE 
Sbjct: 127 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 186
Query: 207 INHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           IN+  +  K+DV+SF I+L E+VT  ++PY  MT
Sbjct: 187 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 220

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  146 bits (369), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 81/214 (37%), Positives = 126/214 (58%), Gaps = 9/214 (4%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           ++WE+ R  LK  ER+ +G  G+++ G Y G   VAVK L+   ++    D F+ E  ++
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLM 62
Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICKG 148
           +++QH+ +VR     T+ P + I+TEYM  GSL D+L     + L + +LL  A  I +G
Sbjct: 63  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEV 206
           M ++ +RN IHRDL+ AN+L+      K+ADFG+AR          E   +  +W APE 
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 181
Query: 207 INHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           IN+  +  K+DV+SF I+L E+VT  ++PY  MT
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  146 bits (369), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 81/215 (37%), Positives = 126/215 (58%), Gaps = 9/215 (4%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAI 88
            ++WE+ R  LK  ER+ +G  G+++ G Y G   VAVK L+   ++    D F+ E  +
Sbjct: 5   EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANL 61
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICK 147
           ++++QH+ +VR     T+ P + I+TEYM  GSL D+L     + L + +LL  A  I +
Sbjct: 62  MKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 148 GMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPE 205
           GM ++ +RN IHRDL+ AN+L+      K+ADFG+AR          E   +  +W APE
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPE 180
Query: 206 VINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
            IN+  +  K+DV+SF I+L E+VT  ++PY  MT
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  146 bits (369), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 81/214 (37%), Positives = 126/214 (58%), Gaps = 9/214 (4%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           ++WE+ R  LK  ER+ +G  G+++ G Y G   VAVK L+   ++    D F+ E  ++
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLM 62
Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICKG 148
           +++QH+ +VR     T+ P + I+TEYM  GSL D+L     + L + +LL  A  I +G
Sbjct: 63  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEV 206
           M ++ +RN IHRDL+ AN+L+      K+ADFG+AR          E   +  +W APE 
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181
Query: 207 INHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           IN+  +  K+DV+SF I+L E+VT  ++PY  MT
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  146 bits (368), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 80/220 (36%), Positives = 128/220 (58%), Gaps = 13/220 (5%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLE-DEFVQEVA 87
           + WE++R  +    ++  G  G++Y GV+      VAVK L+     DT+E +EF++E A
Sbjct: 4   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAA 59
Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDIC 146
           +++E++H N+V+ +G  T+ P   I+ E+M  G+L DYL + N   +    LL  A  I 
Sbjct: 60  VMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 119
Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMA 203
             MEYL ++N IHRDL   N L+  +++VKVADFG++R    G   TA  G     +W A
Sbjct: 120 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTA 178
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKV-PYDSMTPLQ 242
           PE + +  +  K+DV++F ++LWE+ T  + PY  + P Q
Sbjct: 179 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQ 218

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  145 bits (367), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 78/215 (36%), Positives = 126/215 (58%), Gaps = 12/215 (5%)
Query: 23  AIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLE- 79
           A++     + WE++R  +    ++  G  G++Y GV+      VAVK L+     DT+E 
Sbjct: 2   AMDPSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEV 57
Query: 80  DEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQL 138
           +EF++E A+++E++H N+V+ +G  T+ P   I+TE+M  G+L DYL + N   +    L
Sbjct: 58  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL 117
Query: 139 LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT 198
           L  A  I   MEYL ++N IHRDL   N L+  +++VKVADFG++R    G   TA  G 
Sbjct: 118 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGA 176
Query: 199 ---YRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
               +W APE + +  +  K+DV++F ++LWE+ T
Sbjct: 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 78/212 (36%), Positives = 124/212 (58%), Gaps = 12/212 (5%)
Query: 26  SQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLE-DEF 82
           S    + WE++R  +    ++  G  G++Y GV+      VAVK L+     DT+E +EF
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEF 61
Query: 83  VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRF 141
           ++E A+++E++H N+V+ +G  T+ P   I+TE+M  G+L DYL + N   +    LL  
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 142 AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT--- 198
           A  I   MEYL ++N IHRDL   N L+  +++VKVADFG++R    G   TA  G    
Sbjct: 122 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFP 180
Query: 199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
            +W APE + +  +  K+DV++F ++LWE+ T
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 82/215 (38%), Positives = 125/215 (58%), Gaps = 14/215 (6%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV 92
           W ++ + LK  + I  G  GD+  G Y G  VAVK ++    ND     F+ E +++ ++
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 56
Query: 93  QHRNVVRFIGASTKSPH-LCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKGME 150
           +H N+V+ +G   +    L IVTEYM  GSL DYL  +  +VL    LL+F++D+C+ ME
Sbjct: 57  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 116
Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEVIN 208
           YL   N +HRDL   N+L+   NV KV+DFG+     K    T +TG    +W APE + 
Sbjct: 117 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL----TKEASSTQDTGKLPVKWTAPEALR 172
Query: 209 HQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQ 242
            + +  K+DV+SF I+LWE+ +  +VPY  + PL+
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLK 206

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 85/232 (36%), Positives = 131/232 (56%), Gaps = 20/232 (8%)
Query: 22  KAIESQTKSED------WEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLN 75
           K +E    ++D      W ++ + LK  + I  G  GD+  G Y G  VAVK ++    N
Sbjct: 171 KVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----N 226
Query: 76  DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPH-LCIVTEYMPGGSLYDYLH-KNHNVL 133
           D     F+ E +++ +++H N+V+ +G   +    L IVTEYM  GSL DYL  +  +VL
Sbjct: 227 DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 286
Query: 134 KLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT 193
               LL+F++D+C+ MEYL   N +HRDL   N+L+   NV KV+DFG+     K    T
Sbjct: 287 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL----TKEASST 342
Query: 194 AETGTY--RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQ 242
            +TG    +W APE +  + +  K+DV+SF I+LWE+ +  +VPY  + PL+
Sbjct: 343 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLK 393

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 78/212 (36%), Positives = 124/212 (58%), Gaps = 12/212 (5%)
Query: 26  SQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLE-DEF 82
           S    + WE++R  +    ++  G  G++Y GV+      VAVK L+     DT+E +EF
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEF 61
Query: 83  VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRF 141
           ++E A+++E++H N+V+ +G  T+ P   I+TE+M  G+L DYL + N   +    LL  
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 142 AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT--- 198
           A  I   MEYL ++N IHRDL   N L+  +++VKVADFG++R    G   TA  G    
Sbjct: 122 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFP 180
Query: 199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
            +W APE + +  +  K+DV++F ++LWE+ T
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 80/218 (36%), Positives = 127/218 (58%), Gaps = 13/218 (5%)
Query: 26  SQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLE-DEF 82
           S    + WE++R  +    ++  G  G++Y GV+      VAVK L+     DT+E +EF
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEF 61
Query: 83  VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRF 141
           ++E A+++E++H N+V+ +G  T+ P   I+TE+M  G+L DYL + N   +    LL  
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 121
Query: 142 AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT--- 198
           A  I   MEYL ++N IHRDL   N L+  +++VKVADFG++R    G   TA  G    
Sbjct: 122 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFP 180
Query: 199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKV-PY 235
            +W APE + +  +  K+DV++F ++LWE+ T  + PY
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 83/225 (36%), Positives = 128/225 (56%), Gaps = 14/225 (6%)
Query: 23  AIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEF 82
           A + +     W ++ + LK  + I  G  GD+  G Y G  VAVK ++    ND     F
Sbjct: 6   AAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAF 61
Query: 83  VQEVAILREVQHRNVVRFIGASTKSPH-LCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLR 140
           + E +++ +++H N+V+ +G   +    L IVTEYM  GSL DYL  +  +VL    LL+
Sbjct: 62  LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 121
Query: 141 FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY- 199
           F++D+C+ MEYL   N +HRDL   N+L+   NV KV+DFG+     K    T +TG   
Sbjct: 122 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL----TKEASSTQDTGKLP 177
Query: 200 -RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQ 242
            +W APE +  + +  K+DV+SF I+LWE+ +  +VPY  + PL+
Sbjct: 178 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLK 221

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 78/212 (36%), Positives = 124/212 (58%), Gaps = 12/212 (5%)
Query: 26  SQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLE-DEF 82
           S    + WE++R  +    ++  G  G++Y GV+      VAVK L+     DT+E +EF
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEF 61
Query: 83  VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRF 141
           ++E A+++E++H N+V+ +G  T+ P   I+TE+M  G+L DYL + N   +    LL  
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 142 AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT--- 198
           A  I   MEYL ++N IHRDL   N L+  +++VKVADFG++R    G   TA  G    
Sbjct: 122 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFP 180
Query: 199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
            +W APE + +  +  K+DV++F ++LWE+ T
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 80/213 (37%), Positives = 125/213 (58%), Gaps = 9/213 (4%)
Query: 32  DWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           +WE+ R  LK  ER+ +G  G+++ G Y G   VAVK L+   ++    D F+ E  +++
Sbjct: 3   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMK 59
Query: 91  EVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICKGM 149
           ++QH+ +VR     T+ P + I+TEYM  GSL D+L     + L + +LL  A  I +GM
Sbjct: 60  QLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 118
Query: 150 EYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEVI 207
            ++ +RN IHR+L+ AN+L+      K+ADFG+AR          E   +  +W APE I
Sbjct: 119 AFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 178
Query: 208 NHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           N+  +  K+DV+SF I+L E+VT  ++PY  MT
Sbjct: 179 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 211

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  144 bits (364), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 77/207 (37%), Positives = 123/207 (59%), Gaps = 12/207 (5%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLE-DEFVQEVA 87
           + WE++R  +    ++  G  G++Y GV+      VAVK L+     DT+E +EF++E A
Sbjct: 7   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAA 62
Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDIC 146
           +++E++H N+V+ +G  T+ P   I+TE+M  G+L DYL + N   +    LL  A  I 
Sbjct: 63  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 122
Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMA 203
             MEYL ++N IHRDL   N L+  +++VKVADFG++R    G   TA  G     +W A
Sbjct: 123 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTA 181
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVT 230
           PE + +  +  K+DV++F ++LWE+ T
Sbjct: 182 PESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  144 bits (364), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 79/213 (37%), Positives = 126/213 (59%), Gaps = 13/213 (6%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLE-DEFVQEVA 87
           + WE++R  +    ++  G  G++Y GV+      VAVK L+     DT+E +EF++E A
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAA 61
Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDIC 146
           +++E++H N+V+ +G  T+ P   I+TE+M  G+L DYL + N   +    LL  A  I 
Sbjct: 62  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 121
Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMA 203
             MEYL ++N IHRDL   N L+  +++VKVADFG++R    G   TA  G     +W A
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 180
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKV-PY 235
           PE + +  +  K+DV++F ++LWE+ T  + PY
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  144 bits (364), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 79/213 (37%), Positives = 126/213 (59%), Gaps = 13/213 (6%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLE-DEFVQEVA 87
           + WE++R  +    ++  G  G++Y GV+      VAVK L+     DT+E +EF++E A
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAA 61
Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDIC 146
           +++E++H N+V+ +G  T+ P   I+TE+M  G+L DYL + N   +    LL  A  I 
Sbjct: 62  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 121
Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMA 203
             MEYL ++N IHRDL   N L+  +++VKVADFG++R    G   TA  G     +W A
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 180
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKV-PY 235
           PE + +  +  K+DV++F ++LWE+ T  + PY
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score =  144 bits (364), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 81/215 (37%), Positives = 125/215 (58%), Gaps = 14/215 (6%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV 92
           W ++ + LK  + I  G  GD+  G Y G  VAVK ++    ND     F+ E +++ ++
Sbjct: 7   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 62
Query: 93  QHRNVVRFIGASTKSPH-LCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKGME 150
           +H N+V+ +G   +    L IVTEYM  GSL DYL  +  +VL    LL+F++D+C+ ME
Sbjct: 63  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 122
Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEVIN 208
           YL   N +HRDL   N+L+   NV KV+DFG+ +  +     T +TG    +W APE + 
Sbjct: 123 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----TQDTGKLPVKWTAPEALR 178
Query: 209 HQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQ 242
              +  K+DV+SF I+LWE+ +  +VPY  + PL+
Sbjct: 179 EAAFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLK 212

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  144 bits (364), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 79/213 (37%), Positives = 126/213 (59%), Gaps = 13/213 (6%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLE-DEFVQEVA 87
           + WE++R  +    ++  G  G++Y GV+      VAVK L+     DT+E +EF++E A
Sbjct: 19  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAA 74
Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDIC 146
           +++E++H N+V+ +G  T+ P   I+TE+M  G+L DYL + N   +    LL  A  I 
Sbjct: 75  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 134
Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMA 203
             MEYL ++N IHRDL   N L+  +++VKVADFG++R    G   TA  G     +W A
Sbjct: 135 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 193
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKV-PY 235
           PE + +  +  K+DV++F ++LWE+ T  + PY
Sbjct: 194 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 226

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  144 bits (364), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 79/213 (37%), Positives = 126/213 (59%), Gaps = 13/213 (6%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLE-DEFVQEVA 87
           + WE++R  +    ++  G  G++Y GV+      VAVK L+     DT+E +EF++E A
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAA 63
Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDIC 146
           +++E++H N+V+ +G  T+ P   I+TE+M  G+L DYL + N   +    LL  A  I 
Sbjct: 64  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 123
Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMA 203
             MEYL ++N IHRDL   N L+  +++VKVADFG++R    G   TA  G     +W A
Sbjct: 124 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTA 182
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKV-PY 235
           PE + +  +  K+DV++F ++LWE+ T  + PY
Sbjct: 183 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  144 bits (363), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 77/207 (37%), Positives = 123/207 (59%), Gaps = 12/207 (5%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLE-DEFVQEVA 87
           + WE++R  +    ++  G  G++Y GV+      VAVK L+     DT+E +EF++E A
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAA 61
Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDIC 146
           +++E++H N+V+ +G  T+ P   I+TE+M  G+L DYL + N   +    LL  A  I 
Sbjct: 62  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 121
Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMA 203
             MEYL ++N IHRDL   N L+  +++VKVADFG++R    G   TA  G     +W A
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 180
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVT 230
           PE + +  +  K+DV++F ++LWE+ T
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  144 bits (363), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 79/213 (37%), Positives = 126/213 (59%), Gaps = 13/213 (6%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLE-DEFVQEVA 87
           + WE++R  +    ++  G  G++Y GV+      VAVK L+     DT+E +EF++E A
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAA 63
Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDIC 146
           +++E++H N+V+ +G  T+ P   I+TE+M  G+L DYL + N   +    LL  A  I 
Sbjct: 64  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 123
Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMA 203
             MEYL ++N IHRDL   N L+  +++VKVADFG++R    G   TA  G     +W A
Sbjct: 124 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 182
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKV-PY 235
           PE + +  +  K+DV++F ++LWE+ T  + PY
Sbjct: 183 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  144 bits (363), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 79/213 (37%), Positives = 126/213 (59%), Gaps = 13/213 (6%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLE-DEFVQEVA 87
           + WE++R  +    ++  G  G++Y GV+      VAVK L+     DT+E +EF++E A
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAA 63
Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDIC 146
           +++E++H N+V+ +G  T+ P   I+TE+M  G+L DYL + N   +    LL  A  I 
Sbjct: 64  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 123
Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMA 203
             MEYL ++N IHRDL   N L+  +++VKVADFG++R    G   TA  G     +W A
Sbjct: 124 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 182
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKV-PY 235
           PE + +  +  K+DV++F ++LWE+ T  + PY
Sbjct: 183 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  144 bits (363), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 77/207 (37%), Positives = 123/207 (59%), Gaps = 12/207 (5%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLE-DEFVQEVA 87
           + WE++R  +    ++  G  G++Y GV+      VAVK L+     DT+E +EF++E A
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAA 61
Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDIC 146
           +++E++H N+V+ +G  T+ P   I+TE+M  G+L DYL + N   +    LL  A  I 
Sbjct: 62  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 121
Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMA 203
             MEYL ++N IHRDL   N L+  +++VKVADFG++R    G   TA  G     +W A
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 180
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVT 230
           PE + +  +  K+DV++F ++LWE+ T
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score =  144 bits (363), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 126/221 (57%), Gaps = 7/221 (3%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEID + L   + + +G  G +  G + GQ DVA+K+++   ++   EDEF++E  ++  
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMN 60
Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
           + H  +V+  G  TK   + I+TEYM  G L +YL +  +  +  QLL    D+C+ MEY
Sbjct: 61  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 120
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEVINH 209
           L  +  +HRDL   N L++   VVKV+DFG++R+       ++    +  RW  PEV+ +
Sbjct: 121 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMY 180
Query: 210 QPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQ 249
             +  K+D+++F +++WE+ +  K+PY+  T  + A  + Q
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 221

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score =  143 bits (361), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 126/221 (57%), Gaps = 7/221 (3%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEID + L   + + +G  G +  G + GQ DVA+K+++   ++   EDEF++E  ++  
Sbjct: 3   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMN 59
Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
           + H  +V+  G  TK   + I+TEYM  G L +YL +  +  +  QLL    D+C+ MEY
Sbjct: 60  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 119
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEVINH 209
           L  +  +HRDL   N L++   VVKV+DFG++R+       ++    +  RW  PEV+ +
Sbjct: 120 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 179
Query: 210 QPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQ 249
             +  K+D+++F +++WE+ +  K+PY+  T  + A  + Q
Sbjct: 180 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 220

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score =  143 bits (361), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 126/221 (57%), Gaps = 7/221 (3%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEID + L   + + +G  G +  G + GQ DVA+K+++   ++   EDEF++E  ++  
Sbjct: 10  WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMN 66
Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
           + H  +V+  G  TK   + I+TEYM  G L +YL +  +  +  QLL    D+C+ MEY
Sbjct: 67  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 126
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEVINH 209
           L  +  +HRDL   N L++   VVKV+DFG++R+       ++    +  RW  PEV+ +
Sbjct: 127 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 186
Query: 210 QPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQ 249
             +  K+D+++F +++WE+ +  K+PY+  T  + A  + Q
Sbjct: 187 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 227

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score =  143 bits (361), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 126/221 (57%), Gaps = 7/221 (3%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEID + L   + + +G  G +  G + GQ DVA+K+++   ++   EDEF++E  ++  
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMN 60
Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
           + H  +V+  G  TK   + I+TEYM  G L +YL +  +  +  QLL    D+C+ MEY
Sbjct: 61  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 120
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEVINH 209
           L  +  +HRDL   N L++   VVKV+DFG++R+       ++    +  RW  PEV+ +
Sbjct: 121 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 180
Query: 210 QPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQ 249
             +  K+D+++F +++WE+ +  K+PY+  T  + A  + Q
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 221

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score =  143 bits (361), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 125/221 (56%), Gaps = 7/221 (3%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEID + L   + + +G  G +  G + GQ DVA+K+++   ++   EDEF++E  ++  
Sbjct: 19  WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMN 75
Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
           + H  +V+  G  TK   + I+TEYM  G L +YL +  +  +  QLL    D+C+ MEY
Sbjct: 76  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 135
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETGTYRWMAPEVINH 209
           L  +  +HRDL   N L++   VVKV+DFG++R+   ++           RW  PEV+ +
Sbjct: 136 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMY 195
Query: 210 QPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQ 249
             +  K+D+++F +++WE+ +  K+PY+  T  + A  + Q
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 126/221 (57%), Gaps = 7/221 (3%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEID + L   + + +G  G +  G + GQ DVA+K+++   ++   EDEF++E  ++  
Sbjct: 19  WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMN 75
Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
           + H  +V+  G  TK   + I+TEYM  G L +YL +  +  +  QLL    D+C+ MEY
Sbjct: 76  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 135
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEVINH 209
           L  +  +HRDL   N L++   VVKV+DFG++R+       ++    +  RW  PEV+ +
Sbjct: 136 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 195
Query: 210 QPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQ 249
             +  K+D+++F +++WE+ +  K+PY+  T  + A  + Q
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  142 bits (359), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 77/212 (36%), Positives = 123/212 (58%), Gaps = 12/212 (5%)
Query: 26  SQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLE-DEF 82
           S    + WE++R  +    ++  G  G++Y GV+      VAVK L+     DT+E +EF
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEF 61
Query: 83  VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRF 141
           ++E A+++E++H N+V+ +G  T+ P   I+ E+M  G+L DYL + N   +    LL  
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 142 AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT--- 198
           A  I   MEYL ++N IHRDL   N L+  +++VKVADFG++R    G   TA  G    
Sbjct: 122 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFP 180
Query: 199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
            +W APE + +  +  K+DV++F ++LWE+ T
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score =  142 bits (359), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 78/216 (36%), Positives = 127/216 (58%), Gaps = 13/216 (6%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLE-DEFVQEVA 87
           + WE++R  +    ++  G  G++Y GV+      VAVK L+     DT+E +EF++E A
Sbjct: 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAA 268
Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDIC 146
           +++E++H N+V+ +G  T+ P   I+TE+M  G+L DYL + N   +    LL  A  I 
Sbjct: 269 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 328
Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMA 203
             MEYL ++N IHR+L   N L+  +++VKVADFG++R    G   TA  G     +W A
Sbjct: 329 SAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 387
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKV-PYDSM 238
           PE + +  +  K+DV++F ++LWE+ T  + PY  +
Sbjct: 388 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  142 bits (358), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 78/213 (36%), Positives = 125/213 (58%), Gaps = 13/213 (6%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLE-DEFVQEVA 87
           + WE++R  +    ++  G  G++Y GV+      VAVK L+     DT+E +EF++E A
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAA 61
Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDIC 146
           +++E++H N+V+ +G  T+ P   I+ E+M  G+L DYL + N   +    LL  A  I 
Sbjct: 62  VMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 121
Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMA 203
             MEYL ++N IHRDL   N L+  +++VKVADFG++R    G   TA  G     +W A
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 180
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKV-PY 235
           PE + +  +  K+DV++F ++LWE+ T  + PY
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  142 bits (358), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 78/213 (36%), Positives = 125/213 (58%), Gaps = 13/213 (6%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLE-DEFVQEVA 87
           + WE++R  +    ++  G  G++Y GV+      VAVK L+     DT+E +EF++E A
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAA 61
Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDIC 146
           +++E++H N+V+ +G  T+ P   I+ E+M  G+L DYL + N   +    LL  A  I 
Sbjct: 62  VMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 121
Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMA 203
             MEYL ++N IHRDL   N L+  +++VKVADFG++R    G   TA  G     +W A
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 180
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKV-PY 235
           PE + +  +  K+DV++F ++LWE+ T  + PY
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  142 bits (358), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 76/207 (36%), Positives = 122/207 (58%), Gaps = 12/207 (5%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLE-DEFVQEVA 87
           + WE++R  +    ++  G  G++Y GV+      VAVK L+     DT+E +EF++E A
Sbjct: 7   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAA 62
Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDIC 146
           +++E++H N+V+ +G  T+ P   I+ E+M  G+L DYL + N   +    LL  A  I 
Sbjct: 63  VMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 122
Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMA 203
             MEYL ++N IHRDL   N L+  +++VKVADFG++R    G   TA  G     +W A
Sbjct: 123 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTA 181
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVT 230
           PE + +  +  K+DV++F ++LWE+ T
Sbjct: 182 PESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score =  142 bits (357), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 78/216 (36%), Positives = 127/216 (58%), Gaps = 13/216 (6%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLE-DEFVQEVA 87
           + WE++R  +    ++  G  G++Y GV+      VAVK L+     DT+E +EF++E A
Sbjct: 252 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAA 307
Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDIC 146
           +++E++H N+V+ +G  T+ P   I+TE+M  G+L DYL + N   +    LL  A  I 
Sbjct: 308 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 367
Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMA 203
             MEYL ++N IHR+L   N L+  +++VKVADFG++R    G   TA  G     +W A
Sbjct: 368 SAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 426
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKV-PYDSM 238
           PE + +  +  K+DV++F ++LWE+ T  + PY  +
Sbjct: 427 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 462

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  141 bits (355), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 73/210 (34%), Positives = 121/210 (57%), Gaps = 9/210 (4%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD-VAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           W ID   L   + I SG  G ++ G +L +D VA+K +R   ++   E++F++E  ++ +
Sbjct: 3   WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMK 59
Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
           + H  +V+  G   +   +C+VTE+M  G L DYL     +     LL   +D+C+GM Y
Sbjct: 60  LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMAPEVIN 208
           L +  +IHRDL   N L+  + V+KV+DFG+ RF       T+ TGT    +W +PEV +
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFS 178
Query: 209 HQPYDQKADVFSFAIVLWELVT-AKVPYDS 237
              Y  K+DV+SF +++WE+ +  K+PY++
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 208

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  140 bits (353), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 87/240 (36%), Positives = 132/240 (55%), Gaps = 22/240 (9%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLR---SEHLNDTLEDEFVQEVAILR 90
           EID   L   E I  G  G +YR  ++G +VAVK  R    E ++ T+E+   QE  +  
Sbjct: 3   EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIEN-VRQEAKLFA 61
Query: 91  EVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ--LLRFAIDICKG 148
            ++H N++   G   K P+LC+V E+  GG L   L       ++P   L+ +A+ I +G
Sbjct: 62  MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARG 117
Query: 149 MEYLHQR---NIIHRDLKTANLLM-------DTHN-VVKVADFGVARFQNKGGVMTAETG 197
           M YLH      IIHRDLK++N+L+       D  N ++K+ DFG+AR  ++   M+A  G
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AG 176
Query: 198 TYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y WMAPEVI    + + +DV+S+ ++LWEL+T +VP+  +  L  A GV     +L  P
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 77/212 (36%), Positives = 122/212 (57%), Gaps = 8/212 (3%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEI R  +K  +R+ +G  G+++ G Y     VAVK L+   ++      F++E  +++ 
Sbjct: 8   WEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---VQAFLEEANLMKT 64
Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHN-VLKLPQLLRFAIDICKGME 150
           +QH  +VR     T+   + I+TEYM  GSL D+L  +    + LP+L+ F+  I +GM 
Sbjct: 65  LQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 124
Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEVIN 208
           Y+ ++N IHRDL+ AN+L+    + K+ADFG+AR          E   +  +W APE IN
Sbjct: 125 YIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 184
Query: 209 HQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
              +  K+DV+SF I+L+E+VT  K+PY   T
Sbjct: 185 FGCFTIKSDVWSFGILLYEIVTYGKIPYPGRT 216

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 73/213 (34%), Positives = 121/213 (56%), Gaps = 9/213 (4%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-VAVKVLRSEHLNDTLEDEFVQEVAI 88
           S  W ID   L   + I SG  G ++ G +L +D VA+K +R   ++   E++F++E  +
Sbjct: 2   SGKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEV 58
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
           + ++ H  +V+  G   +   +C+V E+M  G L DYL     +     LL   +D+C+G
Sbjct: 59  MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 118
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMAPE 205
           M YL +  +IHRDL   N L+  + V+KV+DFG+ RF       T+ TGT    +W +PE
Sbjct: 119 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPE 177
Query: 206 VINHQPYDQKADVFSFAIVLWELVT-AKVPYDS 237
           V +   Y  K+DV+SF +++WE+ +  K+PY++
Sbjct: 178 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 210

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score =  139 bits (349), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 78/220 (35%), Positives = 123/220 (55%), Gaps = 7/220 (3%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILREV 92
           E+ R  +   + + SG  G +  G + GQ DVAVK+++   ++   EDEF QE   + ++
Sbjct: 4   ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS---EDEFFQEAQTMMKL 60
Query: 93  QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYL 152
            H  +V+F G  +K   + IVTEY+  G L +YL  +   L+  QLL    D+C+GM +L
Sbjct: 61  SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 153 HQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEVINHQ 210
                IHRDL   N L+D    VKV+DFG+ R+      +++    +  +W APEV ++ 
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYF 180
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQ 249
            Y  K+DV++F I++WE+ +  K+PYD  T  +  L V Q
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ 220

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score =  138 bits (348), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 76/212 (35%), Positives = 122/212 (57%), Gaps = 9/212 (4%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEI R  LK  +++ +G  G+++   Y     VAVK ++   ++    + F+ E  +++ 
Sbjct: 10  WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKT 66
Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLK-LPQLLRFAIDICKGME 150
           +QH  +V+     TK P + I+TE+M  GSL D+L  +    + LP+L+ F+  I +GM 
Sbjct: 67  LQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 125
Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEVIN 208
           ++ QRN IHRDL+ AN+L+    V K+ADFG+AR          E   +  +W APE IN
Sbjct: 126 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 185
Query: 209 HQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
              +  K+DV+SF I+L E+VT  ++PY  M+
Sbjct: 186 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 217

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score =  138 bits (347), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 76/212 (35%), Positives = 122/212 (57%), Gaps = 9/212 (4%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEI R  LK  +++ +G  G+++   Y     VAVK ++   ++    + F+ E  +++ 
Sbjct: 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKT 239
Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLK-LPQLLRFAIDICKGME 150
           +QH  +V+     TK P + I+TE+M  GSL D+L  +    + LP+L+ F+  I +GM 
Sbjct: 240 LQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 298
Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEVIN 208
           ++ QRN IHRDL+ AN+L+    V K+ADFG+AR          E   +  +W APE IN
Sbjct: 299 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 358
Query: 209 HQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
              +  K+DV+SF I+L E+VT  ++PY  M+
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 390

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score =  137 bits (346), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 124/219 (56%), Gaps = 7/219 (3%)
Query: 35  IDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILREVQ 93
           ID + L   + + +G  G +  G + GQ DVA+K+++   ++   EDEF++E  ++  + 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLS 57
Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
           H  +V+  G  TK   + I+TEYM  G L +YL +  +  +  QLL    D+C+ MEYL 
Sbjct: 58  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEVINHQP 211
            +  +HRDL   N L++   VVKV+DFG++R+       ++    +  RW  PEV+ +  
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 212 YDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQ 249
           +  K+D+++F +++WE+ +  K+PY+  T  + A  + Q
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 216

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  137 bits (344), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 120/208 (57%), Gaps = 9/208 (4%)
Query: 35  IDRRLLKTGERIASGSCGDLYRGVYLGQD-VAVKVLRSEHLNDTLEDEFVQEVAILREVQ 93
           ID   L   + I SG  G ++ G +L +D VA+K +R   ++   E++F++E  ++ ++ 
Sbjct: 4   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLS 60
Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
           H  +V+  G   +   +C+V E+M  G L DYL     +     LL   +D+C+GM YL 
Sbjct: 61  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 120
Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMAPEVINHQ 210
           + ++IHRDL   N L+  + V+KV+DFG+ RF       T+ TGT    +W +PEV +  
Sbjct: 121 EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFS 179
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDS 237
            Y  K+DV+SF +++WE+ +  K+PY++
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIPYEN 207

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score =  137 bits (344), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 76/210 (36%), Positives = 122/210 (58%), Gaps = 15/210 (7%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEI R  LK  +++ +G  G+++   Y     VAVK ++   ++    + F+ E  +++ 
Sbjct: 177 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKT 233
Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLK-LPQLLRFAIDICKGME 150
           +QH  +V+     TK P + I+TE+M  GSL D+L  +    + LP+L+ F+  I +GM 
Sbjct: 234 LQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 292
Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQ 210
           ++ QRN IHRDL+ AN+L+    V K+ADFG+AR   K  +        +W APE IN  
Sbjct: 293 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGAKFPI--------KWTAPEAINFG 344
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
            +  K+DV+SF I+L E+VT  ++PY  M+
Sbjct: 345 SFTIKSDVWSFGILLMEIVTYGRIPYPGMS 374

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score =  136 bits (343), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 83/236 (35%), Positives = 124/236 (52%), Gaps = 13/236 (5%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLEDEFVQEVAI 88
           + W ++   L  GE+I  G+ G+++ G     +  VAVK  R E L   L+ +F+QE  I
Sbjct: 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARI 165
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
           L++  H N+VR IG  T+   + IV E + GG    +L      L++  LL+   D   G
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETG----TYRWMAP 204
           MEYL  +  IHRDL   N L+   NV+K++DFG++R +   GV  A  G      +W AP
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVYAASGGLRQVPVKWTAP 284
Query: 205 EVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQA----ALGVRQVCTSLC 255
           E +N+  Y  ++DV+SF I+LWE  +    PY +++  Q       G R  C  LC
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELC 340

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/236 (35%), Positives = 124/236 (52%), Gaps = 13/236 (5%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLEDEFVQEVAI 88
           + W ++   L  GE+I  G+ G+++ G     +  VAVK  R E L   L+ +F+QE  I
Sbjct: 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARI 165
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
           L++  H N+VR IG  T+   + IV E + GG    +L      L++  LL+   D   G
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETG----TYRWMAP 204
           MEYL  +  IHRDL   N L+   NV+K++DFG++R +   GV  A  G      +W AP
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVXAASGGLRQVPVKWTAP 284
Query: 205 EVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQA----ALGVRQVCTSLC 255
           E +N+  Y  ++DV+SF I+LWE  +    PY +++  Q       G R  C  LC
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELC 340

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 119/208 (57%), Gaps = 9/208 (4%)
Query: 35  IDRRLLKTGERIASGSCGDLYRGVYLGQD-VAVKVLRSEHLNDTLEDEFVQEVAILREVQ 93
           ID   L   + I SG  G ++ G +L +D VA+K ++   ++   ED+F++E  ++ ++ 
Sbjct: 24  IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMS---EDDFIEEAEVMMKLS 80
Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
           H  +V+  G   +   +C+V E+M  G L DYL     +     LL   +D+C+GM YL 
Sbjct: 81  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 140
Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMAPEVINHQ 210
           +  +IHRDL   N L+  + V+KV+DFG+ RF       T+ TGT    +W +PEV +  
Sbjct: 141 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFS 199
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDS 237
            Y  K+DV+SF +++WE+ +  K+PY++
Sbjct: 200 RYSSKSDVWSFGVLMWEVFSEGKIPYEN 227

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  136 bits (342), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 119/208 (57%), Gaps = 9/208 (4%)
Query: 35  IDRRLLKTGERIASGSCGDLYRGVYLGQD-VAVKVLRSEHLNDTLEDEFVQEVAILREVQ 93
           ID   L   + I SG  G ++ G +L +D VA+K +R   ++   E++F++E  ++ ++ 
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLS 58
Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
           H  +V+  G   +   +C+V E+M  G L DYL     +     LL   +D+C+GM YL 
Sbjct: 59  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMAPEVINHQ 210
           +  +IHRDL   N L+  + V+KV+DFG+ RF       T+ TGT    +W +PEV +  
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFS 177
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDS 237
            Y  K+DV+SF +++WE+ +  K+PY++
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYEN 205

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  136 bits (342), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 75/212 (35%), Positives = 122/212 (57%), Gaps = 8/212 (3%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEI R  +K  +++ +G  G+++ G Y     VAVK L+   ++      F++E  +++ 
Sbjct: 7   WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---VQAFLEEANLMKT 63
Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHN-VLKLPQLLRFAIDICKGME 150
           +QH  +VR     TK   + I+TE+M  GSL D+L  +    + LP+L+ F+  I +GM 
Sbjct: 64  LQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 123
Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEVIN 208
           Y+ ++N IHRDL+ AN+L+    + K+ADFG+AR          E   +  +W APE IN
Sbjct: 124 YIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 209 HQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
              +  K++V+SF I+L+E+VT  K+PY   T
Sbjct: 184 FGCFTIKSNVWSFGILLYEIVTYGKIPYPGRT 215

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 119/208 (57%), Gaps = 9/208 (4%)
Query: 35  IDRRLLKTGERIASGSCGDLYRGVYLGQD-VAVKVLRSEHLNDTLEDEFVQEVAILREVQ 93
           ID   L   + I SG  G ++ G +L +D VA+K +R   ++   E++F++E  ++ ++ 
Sbjct: 4   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLS 60
Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
           H  +V+  G   +   +C+V E+M  G L DYL     +     LL   +D+C+GM YL 
Sbjct: 61  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 120
Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMAPEVINHQ 210
           +  +IHRDL   N L+  + V+KV+DFG+ RF       T+ TGT    +W +PEV +  
Sbjct: 121 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFS 179
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDS 237
            Y  K+DV+SF +++WE+ +  K+PY++
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIPYEN 207

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  134 bits (338), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 81/232 (34%), Positives = 126/232 (54%), Gaps = 13/232 (5%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEI R  L+  +R+ +G  G+++ G + G   VA+K L+   ++    + F++E  I+++
Sbjct: 4   WEIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSP---ESFLEEAQIMKK 60
Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHN-VLKLPQLLRFAIDICKGME 150
           ++H  +V+     ++ P + IVTEYM  GSL D+L       LKLP L+  A  +  GM 
Sbjct: 61  LKHDKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 119
Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETGTYRWMAPEVIN 208
           Y+ + N IHRDL++AN+L+    + K+ADFG+AR    N+           +W APE   
Sbjct: 120 YIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAAL 179
Query: 209 HQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL----QAALGVRQVCTSLC 255
           +  +  K+DV+SF I+L ELVT  +VPY  M       Q   G R  C   C
Sbjct: 180 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDC 231

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  134 bits (336), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 81/232 (34%), Positives = 125/232 (53%), Gaps = 13/232 (5%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD-VAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEI R  L+   ++  G  G+++ G + G   VA+K L+   ++    + F+QE  ++++
Sbjct: 3   WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKK 59
Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKGME 150
           ++H  +V+     ++ P + IVTEYM  GSL D+L  +    L+LPQL+  A  I  GM 
Sbjct: 60  LRHEKLVQLYAVVSEEP-IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 118
Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETGTYRWMAPEVIN 208
           Y+ + N +HRDL+ AN+L+  + V KVADFG+AR    N+           +W APE   
Sbjct: 119 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAAL 178
Query: 209 HQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL----QAALGVRQVCTSLC 255
           +  +  K+DV+SF I+L EL T  +VPY  M       Q   G R  C   C
Sbjct: 179 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 230

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 82/242 (33%), Positives = 131/242 (54%), Gaps = 14/242 (5%)
Query: 24  IESQTKSED-WEIDRRLLKTGERIASGSCGDLYRGVYLGQD-VAVKVLRSEHLNDTLEDE 81
           +++Q  ++D WEI R  L+   ++  G  G+++ G + G   VA+K L+   ++    + 
Sbjct: 3   MQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EA 59
Query: 82  FVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHN-VLKLPQLLR 140
           F+QE  ++++++H  +V+     ++ P + IVTEYM  GSL D+L       L+LPQL+ 
Sbjct: 60  FLQEAQVMKKIRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 141 FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY- 199
            A  I  GM Y+ + N +HRDL+ AN+L+  + V KVADFG+AR          +   + 
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 200 -RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL----QAALGVRQVCTS 253
            +W APE   +  +  K+DV+SF I+L EL T  +VPY  M       Q   G R  C  
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP 238
Query: 254 LC 255
            C
Sbjct: 239 EC 240

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  132 bits (333), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 80/232 (34%), Positives = 125/232 (53%), Gaps = 13/232 (5%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD-VAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEI R  L+   ++  G  G+++ G + G   VA+K L+   ++    + F+QE  ++++
Sbjct: 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKK 235
Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKGME 150
           ++H  +V+     ++ P + IVTEYM  GSL D+L  +    L+LPQL+  A  I  GM 
Sbjct: 236 LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 294
Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEVIN 208
           Y+ + N +HRDL+ AN+L+  + V KVADFG+AR          +   +  +W APE   
Sbjct: 295 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 354
Query: 209 HQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL----QAALGVRQVCTSLC 255
           +  +  K+DV+SF I+L EL T  +VPY  M       Q   G R  C   C
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 406

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  132 bits (333), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 80/232 (34%), Positives = 125/232 (53%), Gaps = 13/232 (5%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD-VAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEI R  L+   ++  G  G+++ G + G   VA+K L+   ++    + F+QE  ++++
Sbjct: 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKK 235
Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKGME 150
           ++H  +V+     ++ P + IVTEYM  GSL D+L  +    L+LPQL+  A  I  GM 
Sbjct: 236 LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 294
Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEVIN 208
           Y+ + N +HRDL+ AN+L+  + V KVADFG+AR          +   +  +W APE   
Sbjct: 295 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 354
Query: 209 HQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL----QAALGVRQVCTSLC 255
           +  +  K+DV+SF I+L EL T  +VPY  M       Q   G R  C   C
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 406

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  132 bits (333), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 82/242 (33%), Positives = 131/242 (54%), Gaps = 14/242 (5%)
Query: 24  IESQTKSED-WEIDRRLLKTGERIASGSCGDLYRGVYLGQD-VAVKVLRSEHLNDTLEDE 81
           +++Q  ++D WEI R  L+   ++  G  G+++ G + G   VA+K L+   ++    + 
Sbjct: 3   MQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EA 59
Query: 82  FVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHN-VLKLPQLLR 140
           F+QE  ++++++H  +V+     ++ P + IVTEYM  GSL D+L       L+LPQL+ 
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 141 FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY- 199
            A  I  GM Y+ + N +HRDL+ AN+L+  + V KVADFG+AR          +   + 
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 200 -RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL----QAALGVRQVCTS 253
            +W APE   +  +  K+DV+SF I+L EL T  +VPY  M       Q   G R  C  
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP 238
Query: 254 LC 255
            C
Sbjct: 239 EC 240

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  132 bits (333), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 80/232 (34%), Positives = 125/232 (53%), Gaps = 13/232 (5%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD-VAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEI R  L+   ++  G  G+++ G + G   VA+K L+   ++    + F+QE  ++++
Sbjct: 6   WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKK 62
Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKGME 150
           ++H  +V+     ++ P + IVTEYM  GSL D+L  +    L+LPQL+  A  I  GM 
Sbjct: 63  LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 121
Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEVIN 208
           Y+ + N +HRDL+ AN+L+  + V KVADFG+AR          +   +  +W APE   
Sbjct: 122 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 181
Query: 209 HQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL----QAALGVRQVCTSLC 255
           +  +  K+DV+SF I+L EL T  +VPY  M       Q   G R  C   C
Sbjct: 182 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 233

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  132 bits (333), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 80/232 (34%), Positives = 125/232 (53%), Gaps = 13/232 (5%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD-VAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEI R  L+   ++  G  G+++ G + G   VA+K L+   ++    + F+QE  ++++
Sbjct: 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKK 318
Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKGME 150
           ++H  +V+     ++ P + IVTEYM  GSL D+L  +    L+LPQL+  A  I  GM 
Sbjct: 319 LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 377
Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEVIN 208
           Y+ + N +HRDL+ AN+L+  + V KVADFG+AR          +   +  +W APE   
Sbjct: 378 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 437
Query: 209 HQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL----QAALGVRQVCTSLC 255
           +  +  K+DV+SF I+L EL T  +VPY  M       Q   G R  C   C
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 489

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  132 bits (331), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 80/232 (34%), Positives = 124/232 (53%), Gaps = 13/232 (5%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD-VAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEI R  L+   ++  G  G+++ G + G   VA+K L+   ++    + F+QE  ++++
Sbjct: 4   WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKK 60
Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHN-VLKLPQLLRFAIDICKGME 150
           ++H  +V+     ++ P + IVTEYM  GSL D+L       L+LPQL+  A  I  GM 
Sbjct: 61  LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 119
Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEVIN 208
           Y+ + N +HRDL+ AN+L+  + V KVADFG+AR          +   +  +W APE   
Sbjct: 120 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 179
Query: 209 HQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL----QAALGVRQVCTSLC 255
           +  +  K+DV+SF I+L EL T  +VPY  M       Q   G R  C   C
Sbjct: 180 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 231

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  132 bits (331), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 80/232 (34%), Positives = 124/232 (53%), Gaps = 13/232 (5%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD-VAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEI R  L+   ++  G  G+++ G + G   VA+K L+   ++    + F+QE  ++++
Sbjct: 2   WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKK 58
Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHN-VLKLPQLLRFAIDICKGME 150
           ++H  +V+     ++ P + IVTEYM  GSL D+L       L+LPQL+  A  I  GM 
Sbjct: 59  LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 117
Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEVIN 208
           Y+ + N +HRDL+ AN+L+  + V KVADFG+AR          +   +  +W APE   
Sbjct: 118 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 177
Query: 209 HQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL----QAALGVRQVCTSLC 255
           +  +  K+DV+SF I+L EL T  +VPY  M       Q   G R  C   C
Sbjct: 178 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 229

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  131 bits (330), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 82/242 (33%), Positives = 130/242 (53%), Gaps = 14/242 (5%)
Query: 24  IESQTKSED-WEIDRRLLKTGERIASGSCGDLYRGVYLGQD-VAVKVLRSEHLNDTLEDE 81
           +++Q  ++D WEI R  L+   ++  G  G+++ G + G   VA+K L+   ++    + 
Sbjct: 3   MQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EA 59
Query: 82  FVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHN-VLKLPQLLR 140
           F+QE  ++++++H  +V+     ++ P + IVTEYM  GSL D+L       L+LPQL+ 
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 141 FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY- 199
            A  I  GM Y+ + N +HRDL  AN+L+  + V KVADFG+AR          +   + 
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 200 -RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL----QAALGVRQVCTS 253
            +W APE   +  +  K+DV+SF I+L EL T  +VPY  M       Q   G R  C  
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP 238
Query: 254 LC 255
            C
Sbjct: 239 EC 240

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  131 bits (330), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 80/232 (34%), Positives = 125/232 (53%), Gaps = 13/232 (5%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD-VAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEI R  L+   ++  G  G+++ G + G   VA+K L+   ++    + F+QE  ++++
Sbjct: 10  WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKK 66
Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKGME 150
           ++H  +V+     ++ P + IVTEYM  GSL D+L  +    L+LPQL+  +  I  GM 
Sbjct: 67  LRHEKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMA 125
Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETGTYRWMAPEVIN 208
           Y+ + N +HRDL+ AN+L+  + V KVADFG+AR    N+           +W APE   
Sbjct: 126 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAAL 185
Query: 209 HQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL----QAALGVRQVCTSLC 255
           +  +  K+DV+SF I+L EL T  +VPY  M       Q   G R  C   C
Sbjct: 186 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 237

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  131 bits (329), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 79/232 (34%), Positives = 124/232 (53%), Gaps = 13/232 (5%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD-VAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEI R  L+   ++  G  G+++ G + G   VA+K L+  +++    + F+QE  ++++
Sbjct: 180 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSP---EAFLQEAQVMKK 236
Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHN-VLKLPQLLRFAIDICKGME 150
           ++H  +V+     ++ P + IVTEYM  GSL D+L       L+LPQL+  A  I  GM 
Sbjct: 237 LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 295
Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEVIN 208
           Y+ + N +HRDL+ AN+L+  + V KVADFG+ R          +   +  +W APE   
Sbjct: 296 YVERMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAAL 355
Query: 209 HQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL----QAALGVRQVCTSLC 255
           +  +  K+DV+SF I+L EL T  +VPY  M       Q   G R  C   C
Sbjct: 356 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 407

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  131 bits (329), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 79/232 (34%), Positives = 125/232 (53%), Gaps = 13/232 (5%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD-VAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEI R  L+   ++  G  G+++ G + G   VA+K L+   ++    + F+QE  ++++
Sbjct: 10  WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKK 66
Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKGME 150
           ++H  +V+     ++ P + IVTEYM  GSL D+L  +    L+LPQL+  +  I  GM 
Sbjct: 67  LRHEKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMA 125
Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEVIN 208
           Y+ + N +HRDL+ AN+L+  + V KVADFG+AR          +   +  +W APE   
Sbjct: 126 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 185
Query: 209 HQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL----QAALGVRQVCTSLC 255
           +  +  K+DV+SF I+L EL T  +VPY  M       Q   G R  C   C
Sbjct: 186 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 237

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  130 bits (328), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 82/242 (33%), Positives = 130/242 (53%), Gaps = 14/242 (5%)
Query: 24  IESQTKSED-WEIDRRLLKTGERIASGSCGDLYRGVYLGQD-VAVKVLRSEHLNDTLEDE 81
           +++Q  ++D WEI R  L+   ++  G  G+++ G + G   VA+K L+   ++    + 
Sbjct: 3   MQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EA 59
Query: 82  FVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHN-VLKLPQLLR 140
           F+QE  ++++++H  +V+     ++ P + IV EYM  GSL D+L       L+LPQL+ 
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 141 FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETGT 198
            A  I  GM Y+ + N +HRDL+ AN+L+  + V KVADFG+AR    N+          
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFP 178
Query: 199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL----QAALGVRQVCTS 253
            +W APE   +  +  K+DV+SF I+L EL T  +VPY  M       Q   G R  C  
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP 238
Query: 254 LC 255
            C
Sbjct: 239 EC 240

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  130 bits (327), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 79/232 (34%), Positives = 124/232 (53%), Gaps = 13/232 (5%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD-VAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           WEI R  L+   ++  G  G+++ G + G   VA+K L+   ++    + F+QE  ++++
Sbjct: 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKK 235
Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKGME 150
           ++H  +V+     ++ P + IV EYM  GSL D+L  +    L+LPQL+  A  I  GM 
Sbjct: 236 LRHEKLVQLYAVVSEEP-IYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 294
Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAPEVIN 208
           Y+ + N +HRDL+ AN+L+  + V KVADFG+AR          +   +  +W APE   
Sbjct: 295 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 354
Query: 209 HQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL----QAALGVRQVCTSLC 255
           +  +  K+DV+SF I+L EL T  +VPY  M       Q   G R  C   C
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 406

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  130 bits (327), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 81/242 (33%), Positives = 130/242 (53%), Gaps = 14/242 (5%)
Query: 24  IESQTKSED-WEIDRRLLKTGERIASGSCGDLYRGVYLGQD-VAVKVLRSEHLNDTLEDE 81
           +++Q  ++D WEI R  L+   ++  G  G+++ G + G   VA+K L+   ++    + 
Sbjct: 3   MQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EA 59
Query: 82  FVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHN-VLKLPQLLR 140
           F+QE  ++++++H  +V+     ++ P + IVTEYM  G L D+L       L+LPQL+ 
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVD 118
Query: 141 FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY- 199
            A  I  GM Y+ + N +HRDL+ AN+L+  + V KVADFG+AR          +   + 
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 200 -RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL----QAALGVRQVCTS 253
            +W APE   +  +  K+DV+SF I+L EL T  +VPY  M       Q   G R  C  
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP 238
Query: 254 LC 255
            C
Sbjct: 239 EC 240

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  130 bits (327), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 81/242 (33%), Positives = 130/242 (53%), Gaps = 14/242 (5%)
Query: 24  IESQTKSED-WEIDRRLLKTGERIASGSCGDLYRGVYLGQD-VAVKVLRSEHLNDTLEDE 81
           +++Q  ++D WEI R  L+   ++  G  G+++ G + G   VA+K L+   ++    + 
Sbjct: 3   MQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EA 59
Query: 82  FVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHN-VLKLPQLLR 140
           F+QE  ++++++H  +V+     ++ P + IV EYM  GSL D+L       L+LPQL+ 
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 141 FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY- 199
            A  I  GM Y+ + N +HRDL+ AN+L+  + V KVADFG+AR          +   + 
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 200 -RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL----QAALGVRQVCTS 253
            +W APE   +  +  K+DV+SF I+L EL T  +VPY  M       Q   G R  C  
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP 238
Query: 254 LC 255
            C
Sbjct: 239 EC 240

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  130 bits (327), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 81/242 (33%), Positives = 130/242 (53%), Gaps = 14/242 (5%)
Query: 24  IESQTKSED-WEIDRRLLKTGERIASGSCGDLYRGVYLGQD-VAVKVLRSEHLNDTLEDE 81
           +++Q  ++D WEI R  L+   ++  G  G+++ G + G   VA+K L+   ++    + 
Sbjct: 3   MQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EA 59
Query: 82  FVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHN-VLKLPQLLR 140
           F+QE  ++++++H  +V+     ++ P + IV EYM  GSL D+L       L+LPQL+ 
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVD 118
Query: 141 FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY- 199
            A  I  GM Y+ + N +HRDL+ AN+L+  + V KVADFG+AR          +   + 
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 200 -RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL----QAALGVRQVCTS 253
            +W APE   +  +  K+DV+SF I+L EL T  +VPY  M       Q   G R  C  
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP 238
Query: 254 LC 255
            C
Sbjct: 239 EC 240

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  128 bits (322), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 80/242 (33%), Positives = 129/242 (53%), Gaps = 14/242 (5%)
Query: 24  IESQTKSED-WEIDRRLLKTGERIASGSCGDLYRGVYLGQD-VAVKVLRSEHLNDTLEDE 81
           +++Q  ++D WEI R  L+   ++  G  G+++ G + G   VA+K L+   ++    + 
Sbjct: 3   MQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EA 59
Query: 82  FVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHN-VLKLPQLLR 140
           F+QE  ++++++H  +V+     ++ P + IV EYM  G L D+L       L+LPQL+ 
Sbjct: 60  FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVD 118
Query: 141 FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY- 199
            A  I  GM Y+ + N +HRDL+ AN+L+  + V KVADFG+AR          +   + 
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 200 -RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL----QAALGVRQVCTS 253
            +W APE   +  +  K+DV+SF I+L EL T  +VPY  M       Q   G R  C  
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP 238
Query: 254 LC 255
            C
Sbjct: 239 EC 240

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  125 bits (313), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 79/216 (36%), Positives = 119/216 (55%), Gaps = 20/216 (9%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLR---SEHLNDTLED 80
           S+  + + R LK  +++  G+ G +    Y       G+ VAVK L+    EHL D    
Sbjct: 2   SDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---- 57
Query: 81  EFVQEVAILREVQHRNVVRFIGA--STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQL 138
            F +E+ IL+ +QH N+V++ G   S    +L ++ EY+P GSL DYL K+   +   +L
Sbjct: 58  -FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 116
Query: 139 LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAET 196
           L++   ICKGMEYL  +  IHRDL T N+L++  N VK+ DFG+ +   Q+K      E 
Sbjct: 117 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 176
Query: 197 GTYR--WMAPEVINHQPYDQKADVFSFAIVLWELVT 230
           G     W APE +    +   +DV+SF +VL+EL T
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  124 bits (312), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 79/216 (36%), Positives = 119/216 (55%), Gaps = 20/216 (9%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLR---SEHLNDTLED 80
           S+  + + R LK  +++  G+ G +    Y       G+ VAVK L+    EHL D    
Sbjct: 2   SDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---- 57
Query: 81  EFVQEVAILREVQHRNVVRFIGA--STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQL 138
            F +E+ IL+ +QH N+V++ G   S    +L ++ EY+P GSL DYL K+   +   +L
Sbjct: 58  -FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 116
Query: 139 LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAET 196
           L++   ICKGMEYL  +  IHRDL T N+L++  N VK+ DFG+ +   Q+K      E 
Sbjct: 117 LQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEP 176
Query: 197 GTYR--WMAPEVINHQPYDQKADVFSFAIVLWELVT 230
           G     W APE +    +   +DV+SF +VL+EL T
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  124 bits (312), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 78/212 (36%), Positives = 117/212 (55%), Gaps = 20/212 (9%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLR---SEHLNDTLEDEFVQ 84
           + + R LK  +++  G+ G +    Y       G+ VAVK L+    EHL D     F +
Sbjct: 5   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FER 59
Query: 85  EVAILREVQHRNVVRFIGA--STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFA 142
           E+ IL+ +QH N+V++ G   S    +L ++ EY+P GSL DYL K+   +   +LL++ 
Sbjct: 60  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 119
Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETGTYR 200
             ICKGMEYL  +  IHRDL T N+L++  N VK+ DFG+ +   Q+K      E G   
Sbjct: 120 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 179
Query: 201 --WMAPEVINHQPYDQKADVFSFAIVLWELVT 230
             W APE +    +   +DV+SF +VL+EL T
Sbjct: 180 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  124 bits (312), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 78/212 (36%), Positives = 117/212 (55%), Gaps = 20/212 (9%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLR---SEHLNDTLEDEFVQ 84
           + + R LK  +++  G+ G +    Y       G+ VAVK L+    EHL D     F +
Sbjct: 4   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FER 58
Query: 85  EVAILREVQHRNVVRFIGA--STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFA 142
           E+ IL+ +QH N+V++ G   S    +L ++ EY+P GSL DYL K+   +   +LL++ 
Sbjct: 59  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 118
Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETGTYR 200
             ICKGMEYL  +  IHRDL T N+L++  N VK+ DFG+ +   Q+K      E G   
Sbjct: 119 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 178
Query: 201 --WMAPEVINHQPYDQKADVFSFAIVLWELVT 230
             W APE +    +   +DV+SF +VL+EL T
Sbjct: 179 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  124 bits (311), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 78/212 (36%), Positives = 117/212 (55%), Gaps = 20/212 (9%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLR---SEHLNDTLEDEFVQ 84
           + + R LK  +++  G+ G +    Y       G+ VAVK L+    EHL D     F +
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FER 60
Query: 85  EVAILREVQHRNVVRFIGA--STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFA 142
           E+ IL+ +QH N+V++ G   S    +L ++ EY+P GSL DYL K+   +   +LL++ 
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETGTYR 200
             ICKGMEYL  +  IHRDL T N+L++  N VK+ DFG+ +   Q+K      E G   
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 180
Query: 201 --WMAPEVINHQPYDQKADVFSFAIVLWELVT 230
             W APE +    +   +DV+SF +VL+EL T
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  124 bits (311), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 78/212 (36%), Positives = 117/212 (55%), Gaps = 20/212 (9%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLR---SEHLNDTLEDEFVQ 84
           + + R LK  +++  G+ G +    Y       G+ VAVK L+    EHL D     F +
Sbjct: 10  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FER 64
Query: 85  EVAILREVQHRNVVRFIGA--STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFA 142
           E+ IL+ +QH N+V++ G   S    +L ++ EY+P GSL DYL K+   +   +LL++ 
Sbjct: 65  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 124
Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETGTYR 200
             ICKGMEYL  +  IHRDL T N+L++  N VK+ DFG+ +   Q+K      E G   
Sbjct: 125 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 184
Query: 201 --WMAPEVINHQPYDQKADVFSFAIVLWELVT 230
             W APE +    +   +DV+SF +VL+EL T
Sbjct: 185 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  124 bits (311), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 78/212 (36%), Positives = 117/212 (55%), Gaps = 20/212 (9%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLR---SEHLNDTLEDEFVQ 84
           + + R LK  +++  G+ G +    Y       G+ VAVK L+    EHL D     F +
Sbjct: 37  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FER 91
Query: 85  EVAILREVQHRNVVRFIGA--STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFA 142
           E+ IL+ +QH N+V++ G   S    +L ++ EY+P GSL DYL K+   +   +LL++ 
Sbjct: 92  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 151
Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETGTYR 200
             ICKGMEYL  +  IHRDL T N+L++  N VK+ DFG+ +   Q+K      E G   
Sbjct: 152 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 211
Query: 201 --WMAPEVINHQPYDQKADVFSFAIVLWELVT 230
             W APE +    +   +DV+SF +VL+EL T
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  124 bits (311), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 78/212 (36%), Positives = 117/212 (55%), Gaps = 20/212 (9%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLR---SEHLNDTLEDEFVQ 84
           + + R LK  +++  G+ G +    Y       G+ VAVK L+    EHL D     F +
Sbjct: 13  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FER 67
Query: 85  EVAILREVQHRNVVRFIGA--STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFA 142
           E+ IL+ +QH N+V++ G   S    +L ++ EY+P GSL DYL K+   +   +LL++ 
Sbjct: 68  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 127
Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETGTYR 200
             ICKGMEYL  +  IHRDL T N+L++  N VK+ DFG+ +   Q+K      E G   
Sbjct: 128 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 187
Query: 201 --WMAPEVINHQPYDQKADVFSFAIVLWELVT 230
             W APE +    +   +DV+SF +VL+EL T
Sbjct: 188 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  124 bits (311), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 78/212 (36%), Positives = 117/212 (55%), Gaps = 20/212 (9%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLR---SEHLNDTLEDEFVQ 84
           + + R LK  +++  G+ G +    Y       G+ VAVK L+    EHL D     F +
Sbjct: 9   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FER 63
Query: 85  EVAILREVQHRNVVRFIGA--STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFA 142
           E+ IL+ +QH N+V++ G   S    +L ++ EY+P GSL DYL K+   +   +LL++ 
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 123
Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETGTYR 200
             ICKGMEYL  +  IHRDL T N+L++  N VK+ DFG+ +   Q+K      E G   
Sbjct: 124 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 201 --WMAPEVINHQPYDQKADVFSFAIVLWELVT 230
             W APE +    +   +DV+SF +VL+EL T
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  124 bits (311), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 78/212 (36%), Positives = 117/212 (55%), Gaps = 20/212 (9%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLR---SEHLNDTLEDEFVQ 84
           + + R LK  +++  G+ G +    Y       G+ VAVK L+    EHL D     F +
Sbjct: 11  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FER 65
Query: 85  EVAILREVQHRNVVRFIGA--STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFA 142
           E+ IL+ +QH N+V++ G   S    +L ++ EY+P GSL DYL K+   +   +LL++ 
Sbjct: 66  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 125
Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETGTYR 200
             ICKGMEYL  +  IHRDL T N+L++  N VK+ DFG+ +   Q+K      E G   
Sbjct: 126 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 185
Query: 201 --WMAPEVINHQPYDQKADVFSFAIVLWELVT 230
             W APE +    +   +DV+SF +VL+EL T
Sbjct: 186 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  124 bits (311), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 78/212 (36%), Positives = 117/212 (55%), Gaps = 20/212 (9%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLR---SEHLNDTLEDEFVQ 84
           + + R LK  +++  G+ G +    Y       G+ VAVK L+    EHL D     F +
Sbjct: 24  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FER 78
Query: 85  EVAILREVQHRNVVRFIGA--STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFA 142
           E+ IL+ +QH N+V++ G   S    +L ++ EY+P GSL DYL K+   +   +LL++ 
Sbjct: 79  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 138
Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETGTYR 200
             ICKGMEYL  +  IHRDL T N+L++  N VK+ DFG+ +   Q+K      E G   
Sbjct: 139 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 198
Query: 201 --WMAPEVINHQPYDQKADVFSFAIVLWELVT 230
             W APE +    +   +DV+SF +VL+EL T
Sbjct: 199 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  124 bits (311), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 78/212 (36%), Positives = 117/212 (55%), Gaps = 20/212 (9%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLR---SEHLNDTLEDEFVQ 84
           + + R LK  +++  G+ G +    Y       G+ VAVK L+    EHL D     F +
Sbjct: 12  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FER 66
Query: 85  EVAILREVQHRNVVRFIGA--STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFA 142
           E+ IL+ +QH N+V++ G   S    +L ++ EY+P GSL DYL K+   +   +LL++ 
Sbjct: 67  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 126
Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETGTYR 200
             ICKGMEYL  +  IHRDL T N+L++  N VK+ DFG+ +   Q+K      E G   
Sbjct: 127 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 186
Query: 201 --WMAPEVINHQPYDQKADVFSFAIVLWELVT 230
             W APE +    +   +DV+SF +VL+EL T
Sbjct: 187 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  124 bits (311), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 78/212 (36%), Positives = 117/212 (55%), Gaps = 20/212 (9%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLR---SEHLNDTLEDEFVQ 84
           + + R LK  +++  G+ G +    Y       G+ VAVK L+    EHL D     F +
Sbjct: 24  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FER 78
Query: 85  EVAILREVQHRNVVRFIGA--STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFA 142
           E+ IL+ +QH N+V++ G   S    +L ++ EY+P GSL DYL K+   +   +LL++ 
Sbjct: 79  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 138
Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETGTYR 200
             ICKGMEYL  +  IHRDL T N+L++  N VK+ DFG+ +   Q+K      E G   
Sbjct: 139 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 198
Query: 201 --WMAPEVINHQPYDQKADVFSFAIVLWELVT 230
             W APE +    +   +DV+SF +VL+EL T
Sbjct: 199 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score =  124 bits (310), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 122/214 (57%), Gaps = 22/214 (10%)
Query: 40  LKTGERIASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQ 93
           LK  + + SG+ G +Y+G+++ +       VA+K+L +E        EF+ E  I+  + 
Sbjct: 40  LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKIL-NETTGPKANVEFMDEALIMASMD 98
Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
           H ++VR +G    SP + +VT+ MP G L +Y+H++ + +    LL + + I KGM YL 
Sbjct: 99  HPHLVRLLGVCL-SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 157
Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVAR--------FQNKGGVMTAETGTYRWMAPE 205
           +R ++HRDL   N+L+ + N VK+ DFG+AR        +   GG M       +WMA E
Sbjct: 158 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM-----PIKWMALE 212
Query: 206 VINHQPYDQKADVFSFAIVLWELVT-AKVPYDSM 238
            I+++ +  ++DV+S+ + +WEL+T    PYD +
Sbjct: 213 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 246

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score =  123 bits (308), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 116/209 (55%), Gaps = 9/209 (4%)
Query: 28  TKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLEDEF 82
           + + D+EI R  ++ G  I  G  GD+++G+Y+  +     VA+K  ++   +D++ ++F
Sbjct: 28  SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-CTSDSVREKF 86
Query: 83  VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFA 142
           +QE   +R+  H ++V+ IG  T++P + I+ E    G L  +L      L L  L+ +A
Sbjct: 87  LQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYA 145
Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--R 200
             +   + YL  +  +HRD+   N+L+ +++ VK+ DFG++R+        A  G    +
Sbjct: 146 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 205
Query: 201 WMAPEVINHQPYDQKADVFSFAIVLWELV 229
           WMAPE IN + +   +DV+ F + +WE++
Sbjct: 206 WMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score =  122 bits (307), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 122/214 (57%), Gaps = 22/214 (10%)
Query: 40  LKTGERIASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQ 93
           LK  + + SG+ G +Y+G+++ +       VA+K+L +E        EF+ E  I+  + 
Sbjct: 17  LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKIL-NETTGPKANVEFMDEALIMASMD 75
Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
           H ++VR +G    SP + +VT+ MP G L +Y+H++ + +    LL + + I KGM YL 
Sbjct: 76  HPHLVRLLGVCL-SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 134
Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVAR--------FQNKGGVMTAETGTYRWMAPE 205
           +R ++HRDL   N+L+ + N VK+ DFG+AR        +   GG M       +WMA E
Sbjct: 135 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM-----PIKWMALE 189
Query: 206 VINHQPYDQKADVFSFAIVLWELVT-AKVPYDSM 238
            I+++ +  ++DV+S+ + +WEL+T    PYD +
Sbjct: 190 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 223

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score =  122 bits (307), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 116/209 (55%), Gaps = 9/209 (4%)
Query: 28  TKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLEDEF 82
           + + D+EI R  ++ G  I  G  GD+++G+Y+  +     VA+K  ++   +D++ ++F
Sbjct: 5   SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-CTSDSVREKF 63
Query: 83  VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFA 142
           +QE   +R+  H ++V+ IG  T++P + I+ E    G L  +L      L L  L+ +A
Sbjct: 64  LQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122
Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--R 200
             +   + YL  +  +HRD+   N+L+ +++ VK+ DFG++R+        A  G    +
Sbjct: 123 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 182
Query: 201 WMAPEVINHQPYDQKADVFSFAIVLWELV 229
           WMAPE IN + +   +DV+ F + +WE++
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score =  122 bits (307), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 115/207 (55%), Gaps = 9/207 (4%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLEDEFVQ 84
           + D+EI R  ++ G  I  G  GD+++G+Y+  +     VA+K  ++   +D++ ++F+Q
Sbjct: 2   TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN-CTSDSVREKFLQ 60
Query: 85  EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAID 144
           E   +R+  H ++V+ IG  T++P + I+ E    G L  +L      L L  L+ +A  
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 119
Query: 145 ICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWM 202
           +   + YL  +  +HRD+   N+L+ +++ VK+ DFG++R+        A  G    +WM
Sbjct: 120 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWM 179
Query: 203 APEVINHQPYDQKADVFSFAIVLWELV 229
           APE IN + +   +DV+ F + +WE++
Sbjct: 180 APESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 115/207 (55%), Gaps = 9/207 (4%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLEDEFVQ 84
           + D+EI R  ++ G  I  G  GD+++G+Y+  +     VA+K  ++   +D++ ++F+Q
Sbjct: 2   TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN-CTSDSVREKFLQ 60
Query: 85  EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAID 144
           E   +R+  H ++V+ IG  T++P + I+ E    G L  +L      L L  L+ +A  
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 119
Query: 145 ICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWM 202
           +   + YL  +  +HRD+   N+L+ +++ VK+ DFG++R+        A  G    +WM
Sbjct: 120 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 179
Query: 203 APEVINHQPYDQKADVFSFAIVLWELV 229
           APE IN + +   +DV+ F + +WE++
Sbjct: 180 APESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score =  122 bits (306), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 115/207 (55%), Gaps = 9/207 (4%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLEDEFVQ 84
           + D+EI R  ++ G  I  G  GD+++G+Y+  +     VA+K  ++   +D++ ++F+Q
Sbjct: 4   TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-CTSDSVREKFLQ 62
Query: 85  EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAID 144
           E   +R+  H ++V+ IG  T++P + I+ E    G L  +L      L L  L+ +A  
Sbjct: 63  EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 121
Query: 145 ICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWM 202
           +   + YL  +  +HRD+   N+L+ +++ VK+ DFG++R+        A  G    +WM
Sbjct: 122 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 181
Query: 203 APEVINHQPYDQKADVFSFAIVLWELV 229
           APE IN + +   +DV+ F + +WE++
Sbjct: 182 APESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score =  122 bits (306), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 115/207 (55%), Gaps = 9/207 (4%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLEDEFVQ 84
           + D+EI R  ++ G  I  G  GD+++G+Y+  +     VA+K  ++   +D++ ++F+Q
Sbjct: 2   TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-CTSDSVREKFLQ 60
Query: 85  EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAID 144
           E   +R+  H ++V+ IG  T++P + I+ E    G L  +L      L L  L+ +A  
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 119
Query: 145 ICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWM 202
           +   + YL  +  +HRD+   N+L+ +++ VK+ DFG++R+        A  G    +WM
Sbjct: 120 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 179
Query: 203 APEVINHQPYDQKADVFSFAIVLWELV 229
           APE IN + +   +DV+ F + +WE++
Sbjct: 180 APESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score =  122 bits (306), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 115/207 (55%), Gaps = 9/207 (4%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLEDEFVQ 84
           + D+EI R  ++ G  I  G  GD+++G+Y+  +     VA+K  ++   +D++ ++F+Q
Sbjct: 5   TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-CTSDSVREKFLQ 63
Query: 85  EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAID 144
           E   +R+  H ++V+ IG  T++P + I+ E    G L  +L      L L  L+ +A  
Sbjct: 64  EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 122
Query: 145 ICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWM 202
           +   + YL  +  +HRD+   N+L+ +++ VK+ DFG++R+        A  G    +WM
Sbjct: 123 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 182
Query: 203 APEVINHQPYDQKADVFSFAIVLWELV 229
           APE IN + +   +DV+ F + +WE++
Sbjct: 183 APESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 114/205 (55%), Gaps = 9/205 (4%)
Query: 32  DWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLEDEFVQEV 86
           D+EI R  ++ G  I  G  GD+++G+Y+  +     VA+K  ++   +D++ ++F+QE 
Sbjct: 1   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-CTSDSVREKFLQEA 59
Query: 87  AILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDIC 146
             +R+  H ++V+ IG  T++P + I+ E    G L  +L      L L  L+ +A  + 
Sbjct: 60  LTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118
Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAP 204
             + YL  +  +HRD+   N+L+ +++ VK+ DFG++R+        A  G    +WMAP
Sbjct: 119 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 205 EVINHQPYDQKADVFSFAIVLWELV 229
           E IN + +   +DV+ F + +WE++
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 77/212 (36%), Positives = 117/212 (55%), Gaps = 20/212 (9%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLR---SEHLNDTLEDEFVQ 84
           + + R LK  +++  G+ G +    Y       G+ VAVK L+    EHL D     F +
Sbjct: 7   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FER 61
Query: 85  EVAILREVQHRNVVRFIGA--STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFA 142
           E+ IL+ +QH N+V++ G   S    +L ++ EY+P GSL DYL K+   +   +LL++ 
Sbjct: 62  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 121
Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETGTYR 200
             ICKGMEYL  +  IHR+L T N+L++  N VK+ DFG+ +   Q+K      E G   
Sbjct: 122 SQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 181
Query: 201 --WMAPEVINHQPYDQKADVFSFAIVLWELVT 230
             W APE +    +   +DV+SF +VL+EL T
Sbjct: 182 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score =  121 bits (304), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 115/207 (55%), Gaps = 9/207 (4%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLEDEFVQ 84
           + D+EI R  ++ G  I  G  GD+++G+Y+  +     VA+K  ++   +D++ ++F+Q
Sbjct: 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN-CTSDSVREKFLQ 440
Query: 85  EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAID 144
           E   +R+  H ++V+ IG  T++P + I+ E    G L  +L      L L  L+ +A  
Sbjct: 441 EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499
Query: 145 ICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWM 202
           +   + YL  +  +HRD+   N+L+ +++ VK+ DFG++R+        A  G    +WM
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 559
Query: 203 APEVINHQPYDQKADVFSFAIVLWELV 229
           APE IN + +   +DV+ F + +WE++
Sbjct: 560 APESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  121 bits (304), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 77/212 (36%), Positives = 116/212 (54%), Gaps = 20/212 (9%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLR---SEHLNDTLEDEFVQ 84
           + + R LK  +++  G+ G +    Y       G+ VAVK L+    EHL D     F +
Sbjct: 9   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FER 63
Query: 85  EVAILREVQHRNVVRFIGA--STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFA 142
           E+ IL+ +QH N+V++ G   S    +L ++ EY+P GSL DYL  +   +   +LL++ 
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYT 123
Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETGTYR 200
             ICKGMEYL  +  IHRDL T N+L++  N VK+ DFG+ +   Q+K      E G   
Sbjct: 124 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 201 --WMAPEVINHQPYDQKADVFSFAIVLWELVT 230
             W APE +    +   +DV+SF +VL+EL T
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score =  121 bits (303), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 84/237 (35%), Positives = 115/237 (48%), Gaps = 33/237 (13%)
Query: 53  DLYRGVYLGQDV---AVKVLRSE-----------HLNDTLEDEFVQEVAILREVQHRNVV 98
           DL  G  LG+     A+KV   E             ++  +  F++EV ++R ++H NV+
Sbjct: 11  DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVL 70
Query: 99  RFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNII 158
           +FIG   K   L  +TEY+ GG+L   +    +     Q + FA DI  GM YLH  NII
Sbjct: 71  KFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNII 130
Query: 159 HRDLKTANLLMDTHNVVKVADFGVARFQ-----NKGGVMTAE----------TGTYRWMA 203
           HRDL + N L+  +  V VADFG+AR          G+ + +           G   WMA
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 204 PEVINHQPYDQKADVFSFAIVLWEL---VTAKVPYDSMTPLQAALGVRQVCTSLCQP 257
           PE+IN + YD+K DVFSF IVL E+   V A   Y   T +   L VR      C P
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT-MDFGLNVRGFLDRYCPP 246

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score =  120 bits (302), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 113/207 (54%), Gaps = 9/207 (4%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLEDEFVQ 84
           + D+EI R  ++ G  I  G  GD+++G+Y+  +     VA+K  ++   +D++ ++F+Q
Sbjct: 2   TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN-CTSDSVREKFLQ 60
Query: 85  EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAID 144
           E   +R+  H ++V+ IG  T++P + I+ E    G L  +L      L L  L+ +A  
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 119
Query: 145 ICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWM 202
           +   + YL  +  +HRD+   N+L+   + VK+ DFG++R+        A  G    +WM
Sbjct: 120 LSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 179
Query: 203 APEVINHQPYDQKADVFSFAIVLWELV 229
           APE IN + +   +DV+ F + +WE++
Sbjct: 180 APESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  120 bits (301), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 73/211 (34%), Positives = 112/211 (53%), Gaps = 16/211 (7%)
Query: 35  IDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH 94
           ID + ++  E +  G+ G + +  +  +DVA+K + SE    +    F+ E+  L  V H
Sbjct: 6   IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNH 61
Query: 95  RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV--LKLPQLLRFAIDICKGMEYL 152
            N+V+  GA      +C+V EY  GGSLY+ LH    +        + + +   +G+ YL
Sbjct: 62  PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 153 HQ---RNIIHRDLKTANLLM-DTHNVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVI 207
           H    + +IHRDLK  NLL+     V+K+ DFG A   Q     MT   G+  WMAPEV 
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPEVF 176
Query: 208 NHQPYDQKADVFSFAIVLWELVTAKVPYDSM 238
               Y +K DVFS+ I+LWE++T + P+D +
Sbjct: 177 EGSNYSEKCDVFSWGIILWEVITRRKPFDEI 207

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  120 bits (301), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 73/211 (34%), Positives = 112/211 (53%), Gaps = 16/211 (7%)
Query: 35  IDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH 94
           ID + ++  E +  G+ G + +  +  +DVA+K + SE    +    F+ E+  L  V H
Sbjct: 5   IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNH 60
Query: 95  RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV--LKLPQLLRFAIDICKGMEYL 152
            N+V+  GA      +C+V EY  GGSLY+ LH    +        + + +   +G+ YL
Sbjct: 61  PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 153 HQ---RNIIHRDLKTANLLM-DTHNVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVI 207
           H    + +IHRDLK  NLL+     V+K+ DFG A   Q     MT   G+  WMAPEV 
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPEVF 175
Query: 208 NHQPYDQKADVFSFAIVLWELVTAKVPYDSM 238
               Y +K DVFS+ I+LWE++T + P+D +
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  120 bits (301), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 76/212 (35%), Positives = 116/212 (54%), Gaps = 20/212 (9%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLR---SEHLNDTLEDEFVQ 84
           + + R LK   ++  G+ G +    Y       G+ VAVK L+    EHL D     F +
Sbjct: 9   QFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FER 63
Query: 85  EVAILREVQHRNVVRFIGA--STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFA 142
           E+ IL+ +QH N+V++ G   S    +L ++ E++P GSL +YL K+   +   +LL++ 
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYT 123
Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETGTYR 200
             ICKGMEYL  +  IHRDL T N+L++  N VK+ DFG+ +   Q+K      E G   
Sbjct: 124 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 201 --WMAPEVINHQPYDQKADVFSFAIVLWELVT 230
             W APE +    +   +DV+SF +VL+EL T
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score =  120 bits (300), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 113/207 (54%), Gaps = 9/207 (4%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLEDEFVQ 84
           + D+EI R  ++ G  I  G  GD+++G+Y+  +     VA+K  ++   +D++ ++F+Q
Sbjct: 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN-CTSDSVREKFLQ 440
Query: 85  EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAID 144
           E   +R+  H ++V+ IG  T++P + I+ E    G L  +L      L L  L+ +A  
Sbjct: 441 EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499
Query: 145 ICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWM 202
           +   + YL  +  +HRD+   N+L+   + VK+ DFG++R+        A  G    +WM
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 559
Query: 203 APEVINHQPYDQKADVFSFAIVLWELV 229
           APE IN + +   +DV+ F + +WE++
Sbjct: 560 APESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 75/218 (34%), Positives = 118/218 (54%), Gaps = 13/218 (5%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRG--VYLGQD---VAVKVLRSEHLNDTLEDEFVQEVAI 88
           EID   +K  + I +G  G++  G     G+    VA+K L+S +      D F+ E +I
Sbjct: 29  EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASI 87
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
           + +  H NV+   G  TKS  + I+TE+M  GSL  +L +N     + QL+     I  G
Sbjct: 88  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 147
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF---QNKGGVMTAETG---TYRWM 202
           M+YL   N +HRDL   N+L++++ V KV+DFG++RF          T+  G     RW 
Sbjct: 148 MKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 207
Query: 203 APEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           APE I ++ +   +DV+S+ IV+WE+++  + PY  MT
Sbjct: 208 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 245

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score =  119 bits (299), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 116/218 (53%), Gaps = 13/218 (5%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLEDEFVQEVAI 88
           EID   +K  E I +G  G++ RG           VA+K L+  +  +    EF+ E +I
Sbjct: 12  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGY-TERQRREFLSEASI 70
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
           + + +H N++R  G  T S  + I+TE+M  G+L  +L  N     + QL+     I  G
Sbjct: 71  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASG 130
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY------RWM 202
           M YL + + +HRDL   N+L++++ V KV+DFG++RF  +      ET +       RW 
Sbjct: 131 MRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWT 190
Query: 203 APEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           APE I  + +   +D +S+ IV+WE+++  + PY  M+
Sbjct: 191 APEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMS 228

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  119 bits (298), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 113/208 (54%), Gaps = 13/208 (6%)
Query: 35  IDRRLLKTGERIASGSCG--DLYR----GVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
            ++R LK    +  G  G  +L R    G   G+ VAVK L+ E   + + D   +E+ I
Sbjct: 18  FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD-LKKEIEI 76
Query: 89  LREVQHRNVVRFIGASTKSPH--LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDIC 146
           LR + H N+V++ G  T+     + ++ E++P GSL +YL KN N + L Q L++A+ IC
Sbjct: 77  LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQIC 136
Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF----QNKGGVMTAETGTYRWM 202
           KGM+YL  R  +HRDL   N+L+++ + VK+ DFG+ +     +    V         W 
Sbjct: 137 KGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY 196
Query: 203 APEVINHQPYDQKADVFSFAIVLWELVT 230
           APE +    +   +DV+SF + L EL+T
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 71/208 (34%), Positives = 113/208 (54%), Gaps = 13/208 (6%)
Query: 35  IDRRLLKTGERIASGSCG--DLYR----GVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
            ++R LK    +  G  G  +L R    G   G+ VAVK L+ E   + + D   +E+ I
Sbjct: 6   FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD-LKKEIEI 64
Query: 89  LREVQHRNVVRFIGASTK--SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDIC 146
           LR + H N+V++ G  T+     + ++ E++P GSL +YL KN N + L Q L++A+ IC
Sbjct: 65  LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQIC 124
Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF----QNKGGVMTAETGTYRWM 202
           KGM+YL  R  +HRDL   N+L+++ + VK+ DFG+ +     +    V         W 
Sbjct: 125 KGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY 184
Query: 203 APEVINHQPYDQKADVFSFAIVLWELVT 230
           APE +    +   +DV+SF + L EL+T
Sbjct: 185 APECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 121/221 (54%), Gaps = 12/221 (5%)
Query: 35  IDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH 94
           ID + L    ++     G+L++G + G D+ VKVL+    +     +F +E   LR   H
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 95  RNVVRFIGA--STKSPHLCIVTEYMPGGSLYDYLHKNHN-VLKLPQLLRFAIDICKGMEY 151
            NV+  +GA  S  +PH  ++T +MP GSLY+ LH+  N V+   Q ++FA+D+ +GM +
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 152 LH--QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINH 209
           LH  +  I    L + ++++D     +++   V       G M A      W+APE +  
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPA----WVAPEALQK 182
Query: 210 QPYD---QKADVFSFAIVLWELVTAKVPYDSMTPLQAALGV 247
           +P D   + AD++SFA++LWELVT +VP+  ++ ++  + V
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV 223

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score =  118 bits (296), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 72/227 (31%), Positives = 118/227 (51%), Gaps = 18/227 (7%)
Query: 46  IASGSCGDLYRGVYLGQ-----DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF 100
           +  G  G++Y GVY        +VAVK  + +   D  E +F+ E  I++ + H ++V+ 
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE-KFMSEAVIMKNLDHPHIVKL 90
Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
           IG   + P   I+ E  P G L  YL +N N LK+  L+ +++ ICK M YL   N +HR
Sbjct: 91  IGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHR 149
Query: 161 DLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETG--TYRWMAPEVINHQPYDQKADV 218
           D+   N+L+ +   VK+ DFG++R+        A       +WM+PE IN + +   +DV
Sbjct: 150 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDV 209
Query: 219 FSFAIVLWELVT-AKVPY------DSMTPLQAALGVRQVCTSLCQPI 258
           + FA+ +WE+++  K P+      D +  L+   G R     LC P+
Sbjct: 210 WMFAVCMWEILSFGKQPFFWLENKDVIGVLEK--GDRLPKPDLCPPV 254

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score =  118 bits (296), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 72/227 (31%), Positives = 118/227 (51%), Gaps = 18/227 (7%)
Query: 46  IASGSCGDLYRGVYLGQ-----DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF 100
           +  G  G++Y GVY        +VAVK  + +   D  E +F+ E  I++ + H ++V+ 
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE-KFMSEAVIMKNLDHPHIVKL 74
Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
           IG   + P   I+ E  P G L  YL +N N LK+  L+ +++ ICK M YL   N +HR
Sbjct: 75  IGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHR 133
Query: 161 DLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETG--TYRWMAPEVINHQPYDQKADV 218
           D+   N+L+ +   VK+ DFG++R+        A       +WM+PE IN + +   +DV
Sbjct: 134 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDV 193
Query: 219 FSFAIVLWELVT-AKVPY------DSMTPLQAALGVRQVCTSLCQPI 258
           + FA+ +WE+++  K P+      D +  L+   G R     LC P+
Sbjct: 194 WMFAVCMWEILSFGKQPFFWLENKDVIGVLEK--GDRLPKPDLCPPV 238

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score =  118 bits (296), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 72/227 (31%), Positives = 118/227 (51%), Gaps = 18/227 (7%)
Query: 46  IASGSCGDLYRGVYLGQ-----DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF 100
           +  G  G++Y GVY        +VAVK  + +   D  E +F+ E  I++ + H ++V+ 
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE-KFMSEAVIMKNLDHPHIVKL 78
Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
           IG   + P   I+ E  P G L  YL +N N LK+  L+ +++ ICK M YL   N +HR
Sbjct: 79  IGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHR 137
Query: 161 DLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETG--TYRWMAPEVINHQPYDQKADV 218
           D+   N+L+ +   VK+ DFG++R+        A       +WM+PE IN + +   +DV
Sbjct: 138 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDV 197
Query: 219 FSFAIVLWELVT-AKVPY------DSMTPLQAALGVRQVCTSLCQPI 258
           + FA+ +WE+++  K P+      D +  L+   G R     LC P+
Sbjct: 198 WMFAVCMWEILSFGKQPFFWLENKDVIGVLEK--GDRLPKPDLCPPV 242

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score =  117 bits (293), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 73/207 (35%), Positives = 110/207 (53%), Gaps = 14/207 (6%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDT-LEDEFVQEVA 87
           E D RLL   E++  GS G + RG +         VAVK L+ + L+     D+F++EV 
Sbjct: 17  EKDLRLL---EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 73
Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICK 147
            +  + HRN++R  G    +P + +VTE  P GSL D L K+     L  L R+A+ + +
Sbjct: 74  AMHSLDHRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 132
Query: 148 GMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAE--TGTYRWMA 203
           GM YL  +  IHRDL   NLL+ T ++VK+ DFG+ R   QN    +  E     + W A
Sbjct: 133 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCA 192
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVT 230
           PE +  + +   +D + F + LWE+ T
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score =  117 bits (293), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 74/218 (33%), Positives = 117/218 (53%), Gaps = 13/218 (5%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRG--VYLGQD---VAVKVLRSEHLNDTLEDEFVQEVAI 88
           EID   +K  + I +G  G++  G     G+    VA+K L+S +      D F+ E +I
Sbjct: 3   EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASI 61
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
           + +  H NV+   G  TKS  + I+TE+M  GSL  +L +N     + QL+     I  G
Sbjct: 62  MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 121
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF---QNKGGVMTAETG---TYRWM 202
           M+YL   N +HR L   N+L++++ V KV+DFG++RF          T+  G     RW 
Sbjct: 122 MKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 181
Query: 203 APEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           APE I ++ +   +DV+S+ IV+WE+++  + PY  MT
Sbjct: 182 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 219

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score =  117 bits (293), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 73/207 (35%), Positives = 110/207 (53%), Gaps = 14/207 (6%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDT-LEDEFVQEVA 87
           E D RLL   E++  GS G + RG +         VAVK L+ + L+     D+F++EV 
Sbjct: 7   EKDLRLL---EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 63
Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICK 147
            +  + HRN++R  G    +P + +VTE  P GSL D L K+     L  L R+A+ + +
Sbjct: 64  AMHSLDHRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 148 GMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAE--TGTYRWMA 203
           GM YL  +  IHRDL   NLL+ T ++VK+ DFG+ R   QN    +  E     + W A
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCA 182
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVT 230
           PE +  + +   +D + F + LWE+ T
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score =  117 bits (293), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 73/207 (35%), Positives = 110/207 (53%), Gaps = 14/207 (6%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDT-LEDEFVQEVA 87
           E D RLL   E++  GS G + RG +         VAVK L+ + L+     D+F++EV 
Sbjct: 11  EKDLRLL---EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 67
Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICK 147
            +  + HRN++R  G    +P + +VTE  P GSL D L K+     L  L R+A+ + +
Sbjct: 68  AMHSLDHRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 126
Query: 148 GMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAE--TGTYRWMA 203
           GM YL  +  IHRDL   NLL+ T ++VK+ DFG+ R   QN    +  E     + W A
Sbjct: 127 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 186
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVT 230
           PE +  + +   +D + F + LWE+ T
Sbjct: 187 PESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score =  117 bits (292), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 73/207 (35%), Positives = 110/207 (53%), Gaps = 14/207 (6%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDT-LEDEFVQEVA 87
           E D RLL   E++  GS G + RG +         VAVK L+ + L+     D+F++EV 
Sbjct: 17  EKDLRLL---EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 73
Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICK 147
            +  + HRN++R  G    +P + +VTE  P GSL D L K+     L  L R+A+ + +
Sbjct: 74  AMHSLDHRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 132
Query: 148 GMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAE--TGTYRWMA 203
           GM YL  +  IHRDL   NLL+ T ++VK+ DFG+ R   QN    +  E     + W A
Sbjct: 133 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 192
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVT 230
           PE +  + +   +D + F + LWE+ T
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score =  117 bits (292), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 73/207 (35%), Positives = 110/207 (53%), Gaps = 14/207 (6%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDT-LEDEFVQEVA 87
           E D RLL   E++  GS G + RG +         VAVK L+ + L+     D+F++EV 
Sbjct: 11  EKDLRLL---EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 67
Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICK 147
            +  + HRN++R  G    +P + +VTE  P GSL D L K+     L  L R+A+ + +
Sbjct: 68  AMHSLDHRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 126
Query: 148 GMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAE--TGTYRWMA 203
           GM YL  +  IHRDL   NLL+ T ++VK+ DFG+ R   QN    +  E     + W A
Sbjct: 127 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 186
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVT 230
           PE +  + +   +D + F + LWE+ T
Sbjct: 187 PESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score =  117 bits (292), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 115/218 (52%), Gaps = 13/218 (5%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLEDEFVQEVAI 88
           EID   +K  E I +G  G++ RG           VA+K L+  +  +    EF+ E +I
Sbjct: 10  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGY-TERQRREFLSEASI 68
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
           + + +H N++R  G  T S  + I+TE+M  G+L  +L  N     + QL+     I  G
Sbjct: 69  MGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASG 128
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY------RWM 202
           M YL + + +HRDL   N+L++++ V KV+DFG++RF  +       T +       RW 
Sbjct: 129 MRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWT 188
Query: 203 APEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           APE I  + +   +D +S+ IV+WE+++  + PY  M+
Sbjct: 189 APEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMS 226

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score =  117 bits (292), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 73/207 (35%), Positives = 110/207 (53%), Gaps = 14/207 (6%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDT-LEDEFVQEVA 87
           E D RLL   E++  GS G + RG +         VAVK L+ + L+     D+F++EV 
Sbjct: 7   EKDLRLL---EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 63
Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICK 147
            +  + HRN++R  G    +P + +VTE  P GSL D L K+     L  L R+A+ + +
Sbjct: 64  AMHSLDHRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 148 GMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAE--TGTYRWMA 203
           GM YL  +  IHRDL   NLL+ T ++VK+ DFG+ R   QN    +  E     + W A
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVT 230
           PE +  + +   +D + F + LWE+ T
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score =  117 bits (292), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 73/207 (35%), Positives = 110/207 (53%), Gaps = 14/207 (6%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDT-LEDEFVQEVA 87
           E D RLL   E++  GS G + RG +         VAVK L+ + L+     D+F++EV 
Sbjct: 7   EKDLRLL---EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 63
Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICK 147
            +  + HRN++R  G    +P + +VTE  P GSL D L K+     L  L R+A+ + +
Sbjct: 64  AMHSLDHRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 148 GMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAE--TGTYRWMA 203
           GM YL  +  IHRDL   NLL+ T ++VK+ DFG+ R   QN    +  E     + W A
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVT 230
           PE +  + +   +D + F + LWE+ T
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  117 bits (292), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 108/201 (53%), Gaps = 12/201 (5%)
Query: 46  IASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           I +G  G++Y+G+           VA+K L++ +      D F+ E  I+ +  H N++R
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHNIIR 110
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
             G  +K   + I+TEYM  G+L  +L +      + QL+     I  GM+YL   N +H
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVH 170
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETG----TYRWMAPEVINHQPYDQK 215
           RDL   N+L++++ V KV+DFG++R        T  T       RW APE I+++ +   
Sbjct: 171 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA 230
Query: 216 ADVFSFAIVLWELVT-AKVPY 235
           +DV+SF IV+WE++T  + PY
Sbjct: 231 SDVWSFGIVMWEVMTYGERPY 251

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  116 bits (291), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 108/203 (53%), Gaps = 7/203 (3%)
Query: 38  RLLKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHR 95
           RLLKT   I  G+     L R +  G++VA+K++    LN T   +  +EV I++ + H 
Sbjct: 18  RLLKT---IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 96  NVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR 155
           N+V+          L ++ EY  GG ++DYL   H  +K  +       I   ++Y HQ+
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQK 133
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYD-Q 214
            I+HRDLK  NLL+D    +K+ADFG +     GG + A  G   + APE+   + YD  
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGP 193
Query: 215 KADVFSFAIVLWELVTAKVPYDS 237
           + DV+S  ++L+ LV+  +P+D 
Sbjct: 194 EVDVWSLGVILYTLVSGSLPFDG 216

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  115 bits (289), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 70/203 (34%), Positives = 111/203 (54%), Gaps = 8/203 (3%)
Query: 36  DRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRS--EHLNDTLEDEFVQEVAILREVQ 93
           +R +   G ++  G  G +Y+G      VAVK L +  +   + L+ +F QE+ ++ + Q
Sbjct: 29  ERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88
Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI--DICKGMEY 151
           H N+V  +G S+    LC+V  YMP GSL D L        L   +R  I      G+ +
Sbjct: 89  HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINF 148
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG--VMTAE-TGTYRWMAPEVIN 208
           LH+ + IHRD+K+AN+L+D     K++DFG+AR   K    VM +   GT  +MAPE + 
Sbjct: 149 LHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALR 208
Query: 209 HQPYDQKADVFSFAIVLWELVTA 231
            +    K+D++SF +VL E++T 
Sbjct: 209 GE-ITPKSDIYSFGVVLLEIITG 230

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  115 bits (288), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 74/203 (36%), Positives = 110/203 (54%), Gaps = 8/203 (3%)
Query: 44  ERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           ERI  GS G++++G+     Q VA+K++  E   D +ED   QE+ +L +     V ++ 
Sbjct: 29  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSSYVTKYY 87
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
           G+  K   L I+ EY+ GGS  D L     +  ++  +L+   +I KG++YLH    IHR
Sbjct: 88  GSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHSEKKIHR 144
Query: 161 DLKTANLLMDTHNVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVF 219
           D+K AN+L+     VK+ADFGVA +  +         GT  WMAPEVI    YD KAD++
Sbjct: 145 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIW 204
Query: 220 SFAIVLWELVTAKVPYDSMTPLQ 242
           S  I   EL   + P   M P++
Sbjct: 205 SLGITAIELAKGEPPNSDMHPMR 227

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 75/242 (30%), Positives = 123/242 (50%), Gaps = 24/242 (9%)
Query: 22  KAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDE 81
           KA ++    ++W+I    L+ GE I  G  G +Y G + G +VA++++  E  N+     
Sbjct: 17  KASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKA 75
Query: 82  FVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF 141
           F +EV   R+ +H NVV F+GA    PHL I+T    G +LY  +     VL + +  + 
Sbjct: 76  FKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQI 135
Query: 142 AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTA------- 194
           A +I KGM YLH + I+H+DLK+ N+  D   VV + DFG+       GV+ A       
Sbjct: 136 AQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVV-ITDFGLFSI---SGVLQAGRREDKL 191
Query: 195 --ETGTYRWMAPEVI---------NHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQA 243
             + G    +APE+I         +  P+ + +DVF+   + +EL   + P+ +  P +A
Sbjct: 192 RIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEA 250
Query: 244 AL 245
            +
Sbjct: 251 II 252

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 108/203 (53%), Gaps = 7/203 (3%)
Query: 38  RLLKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHR 95
           RLLKT   I  G+     L R +  G++VA+K++    LN T   +  +EV I++ + H 
Sbjct: 15  RLLKT---IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 71
Query: 96  NVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR 155
           N+V+          L ++ EY  GG ++DYL   H  +K  +       I   ++Y HQ+
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQK 130
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYD-Q 214
            I+HRDLK  NLL+D    +K+ADFG +     GG +    G+  + APE+   + YD  
Sbjct: 131 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGP 190
Query: 215 KADVFSFAIVLWELVTAKVPYDS 237
           + DV+S  ++L+ LV+  +P+D 
Sbjct: 191 EVDVWSLGVILYTLVSGSLPFDG 213

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 109/202 (53%), Gaps = 6/202 (2%)
Query: 44  ERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  GS G++++G+     + VA+K++  E   D +ED   QE+ +L +     V ++ 
Sbjct: 33  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPYVTKYY 91
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
           G+  K   L I+ EY+ GGS  D L      L   Q+     +I KG++YLH    IHRD
Sbjct: 92  GSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSEKKIHRD 149
Query: 162 LKTANLLMDTHNVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFS 220
           +K AN+L+  H  VK+ADFGVA +  +         GT  WMAPEVI    YD KAD++S
Sbjct: 150 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWS 209
Query: 221 FAIVLWELVTAKVPYDSMTPLQ 242
             I   EL   + P+  + P++
Sbjct: 210 LGITAIELARGEPPHSELHPMK 231

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 107/202 (52%), Gaps = 6/202 (2%)
Query: 44  ERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  GS G++++G+     + VA+K++      +   ++  QE+ +L +     V ++ 
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 71
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
           G+  K   L I+ EY+ GGS  D L      L   Q+     +I KG++YLH    IHRD
Sbjct: 72  GSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSEKKIHRD 129
Query: 162 LKTANLLMDTHNVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFS 220
           +K AN+L+  H  VK+ADFGVA +  +         GT  WMAPEVI    YD KAD++S
Sbjct: 130 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWS 189
Query: 221 FAIVLWELVTAKVPYDSMTPLQ 242
             I   EL   + P+  + P++
Sbjct: 190 LGITAIELARGEPPHSELHPMK 211

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 107/202 (52%), Gaps = 6/202 (2%)
Query: 44  ERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  GS G++++G+     + VA+K++      +   ++  QE+ +L +     V ++ 
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 71
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
           G+  K   L I+ EY+ GGS  D L      L   Q+     +I KG++YLH    IHRD
Sbjct: 72  GSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSEKKIHRD 129
Query: 162 LKTANLLMDTHNVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFS 220
           +K AN+L+  H  VK+ADFGVA +  +         GT  WMAPEVI    YD KAD++S
Sbjct: 130 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWS 189
Query: 221 FAIVLWELVTAKVPYDSMTPLQ 242
             I   EL   + P+  + P++
Sbjct: 190 LGITAIELARGEPPHSELHPMK 211

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 70/203 (34%), Positives = 110/203 (54%), Gaps = 8/203 (3%)
Query: 36  DRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRS--EHLNDTLEDEFVQEVAILREVQ 93
           +R +   G ++  G  G +Y+G      VAVK L +  +   + L+ +F QE+ ++ + Q
Sbjct: 29  ERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88
Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI--DICKGMEY 151
           H N+V  +G S+    LC+V  YMP GSL D L        L   +R  I      G+ +
Sbjct: 89  HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINF 148
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG--VMTAE-TGTYRWMAPEVIN 208
           LH+ + IHRD+K+AN+L+D     K++DFG+AR   K    VM     GT  +MAPE + 
Sbjct: 149 LHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALR 208
Query: 209 HQPYDQKADVFSFAIVLWELVTA 231
            +    K+D++SF +VL E++T 
Sbjct: 209 GE-ITPKSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 70/203 (34%), Positives = 110/203 (54%), Gaps = 8/203 (3%)
Query: 36  DRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRS--EHLNDTLEDEFVQEVAILREVQ 93
           +R +   G ++  G  G +Y+G      VAVK L +  +   + L+ +F QE+ ++ + Q
Sbjct: 23  ERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 82
Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI--DICKGMEY 151
           H N+V  +G S+    LC+V  YMP GSL D L        L   +R  I      G+ +
Sbjct: 83  HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINF 142
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG--VMTAE-TGTYRWMAPEVIN 208
           LH+ + IHRD+K+AN+L+D     K++DFG+AR   K    VM     GT  +MAPE + 
Sbjct: 143 LHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALR 202
Query: 209 HQPYDQKADVFSFAIVLWELVTA 231
            +    K+D++SF +VL E++T 
Sbjct: 203 GE-ITPKSDIYSFGVVLLEIITG 224

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 107/202 (52%), Gaps = 6/202 (2%)
Query: 44  ERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  GS G++++G+     + VA+K++      +   ++  QE+ +L +     V ++ 
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 86
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
           G+  K   L I+ EY+ GGS  D L      L   Q+     +I KG++YLH    IHRD
Sbjct: 87  GSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSEKKIHRD 144
Query: 162 LKTANLLMDTHNVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFS 220
           +K AN+L+  H  VK+ADFGVA +  +         GT  WMAPEVI    YD KAD++S
Sbjct: 145 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWS 204
Query: 221 FAIVLWELVTAKVPYDSMTPLQ 242
             I   EL   + P+  + P++
Sbjct: 205 LGITAIELARGEPPHSELHPMK 226

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 73/208 (35%), Positives = 116/208 (55%), Gaps = 14/208 (6%)
Query: 35  IDRRLLKTGERIASGSCG--DLYRGVYLGQD----VAVKVLRSEHLNDTLEDEFVQEVAI 88
            + R LK   ++  G+ G  +L R   LG +    VAVK L  +H     + +F +E+ I
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQI 61
Query: 89  LREVQHRNVVRFIGAS--TKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDIC 146
           L+ +    +V++ G S     P L +V EY+P G L D+L ++   L   +LL ++  IC
Sbjct: 62  LKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 121
Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETGTYR--WM 202
           KGMEYL  R  +HRDL   N+L+++   VK+ADFG+A+    +K   +  E G     W 
Sbjct: 122 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWY 181
Query: 203 APEVINHQPYDQKADVFSFAIVLWELVT 230
           APE ++   + +++DV+SF +VL+EL T
Sbjct: 182 APESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  114 bits (285), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 110/203 (54%), Gaps = 7/203 (3%)
Query: 44  ERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E++  GS G +Y+ ++   GQ VA+K +  E  +D    E ++E++I+++    +VV++ 
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDL--QEIIKEISIMQQCDSPHVVKYY 90
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
           G+  K+  L IV EY   GS+ D +   +  L   ++        KG+EYLH    IHRD
Sbjct: 91  GSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRD 150
Query: 162 LKTANLLMDTHNVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFS 220
           +K  N+L++T    K+ADFGVA +  +         GT  WMAPEVI    Y+  AD++S
Sbjct: 151 IKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWS 210
Query: 221 FAIVLWELVTAKVPYDSMTPLQA 243
             I   E+   K PY  + P++A
Sbjct: 211 LGITAIEMAEGKPPYADIHPMRA 233

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score =  114 bits (285), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 68/197 (34%), Positives = 103/197 (52%), Gaps = 18/197 (9%)
Query: 60  LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMP 118
           L  D A+K ++     D   D F  E+ +L ++  H N++  +GA     +L +  EY P
Sbjct: 41  LRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 99
Query: 119 GGSLYDYLHKNH---------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLK 163
            G+L D+L K+                + L   QLL FA D+ +GM+YL Q+  IHRDL 
Sbjct: 100 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLA 159
Query: 164 TANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAI 223
             N+L+  + V K+ADFG++R Q      T      RWMA E +N+  Y   +DV+S+ +
Sbjct: 160 ARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV 219
Query: 224 VLWELVT-AKVPYDSMT 239
           +LWE+V+    PY  MT
Sbjct: 220 LLWEIVSLGGTPYCGMT 236

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score =  114 bits (285), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 68/197 (34%), Positives = 103/197 (52%), Gaps = 18/197 (9%)
Query: 60  LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMP 118
           L  D A+K ++     D   D F  E+ +L ++  H N++  +GA     +L +  EY P
Sbjct: 51  LRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 109
Query: 119 GGSLYDYLHKNH---------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLK 163
            G+L D+L K+                + L   QLL FA D+ +GM+YL Q+  IHRDL 
Sbjct: 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLA 169
Query: 164 TANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAI 223
             N+L+  + V K+ADFG++R Q      T      RWMA E +N+  Y   +DV+S+ +
Sbjct: 170 ARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV 229
Query: 224 VLWELVT-AKVPYDSMT 239
           +LWE+V+    PY  MT
Sbjct: 230 LLWEIVSLGGTPYCGMT 246

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  114 bits (284), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 116/232 (50%), Gaps = 30/232 (12%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLEDEFV 83
           WE+ R  L  G+ +  G+ G +     +G D         VAVK+L+S+     L D  +
Sbjct: 23  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LI 81
Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL---------------H 127
            E+ +++ + +H+N++  +GA T+   L ++ EY   G+L +YL               H
Sbjct: 82  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSH 141
Query: 128 KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN 187
                L    L+  A  + +GMEYL  +  IHRDL   N+L+   NV+K+ADFG+AR  +
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 188 KGGVMTAETG---TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
                   T      +WMAPE +  + Y  ++DV+SF ++LWE+ T    PY
Sbjct: 202 HIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score =  114 bits (284), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 71/216 (32%), Positives = 116/216 (53%), Gaps = 11/216 (5%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRG--VYLGQD---VAVKVLRSEHLNDTLEDEFVQEVAI 88
           EID   +K  + I  G  G++  G     G+    VA+K L++ +  D    +F+ E +I
Sbjct: 10  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY-TDKQRRDFLSEASI 68
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
           + +  H N++   G  TK   + I+TEYM  GSL  +L KN     + QL+     I  G
Sbjct: 69  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSG 128
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETG--TYRWMAP 204
           M+YL   + +HRDL   N+L++++ V KV+DFG++R    +     T   G    RW AP
Sbjct: 129 MKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 188
Query: 205 EVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           E I ++ +   +DV+S+ IV+WE+++  + PY  M+
Sbjct: 189 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 224

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score =  114 bits (284), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 73/233 (31%), Positives = 116/233 (49%), Gaps = 25/233 (10%)
Query: 25  ESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLE 79
           E Q K ED  IDR LL  G+ +  G  G +  G    +D     VAVK ++ ++ +    
Sbjct: 21  ELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREI 80
Query: 80  DEFVQEVAILREVQHRNVVRFIG-----ASTKSPHLCIVTEYMPGGSLYDYL-----HKN 129
           +EF+ E A +++  H NV+R +G     +S   P   ++  +M  G L+ YL        
Sbjct: 81  EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETG 140
Query: 130 HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR----- 184
              + L  LL+F +DI  GMEYL  RN +HRDL   N ++     V VADFG+++     
Sbjct: 141 PKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG 200
Query: 185 -FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
            +  +G +        +W+A E +  + Y  K+DV++F + +WE+ T    PY
Sbjct: 201 DYYRQGRIAKMPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY 250

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score =  114 bits (284), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 71/216 (32%), Positives = 116/216 (53%), Gaps = 11/216 (5%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRG--VYLGQD---VAVKVLRSEHLNDTLEDEFVQEVAI 88
           EID   +K  + I  G  G++  G     G+    VA+K L++ + +    D F+ E +I
Sbjct: 25  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRD-FLSEASI 83
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
           + +  H N++   G  TK   + I+TEYM  GSL  +L KN     + QL+     I  G
Sbjct: 84  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSG 143
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETG--TYRWMAP 204
           M+YL   + +HRDL   N+L++++ V KV+DFG++R    +     T   G    RW AP
Sbjct: 144 MKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 203
Query: 205 EVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           E I ++ +   +DV+S+ IV+WE+++  + PY  M+
Sbjct: 204 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 239

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score =  113 bits (283), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 71/216 (32%), Positives = 116/216 (53%), Gaps = 11/216 (5%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRG--VYLGQD---VAVKVLRSEHLNDTLEDEFVQEVAI 88
           EID   +K  + I  G  G++  G     G+    VA+K L++ +  D    +F+ E +I
Sbjct: 4   EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY-TDKQRRDFLSEASI 62
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
           + +  H N++   G  TK   + I+TEYM  GSL  +L KN     + QL+     I  G
Sbjct: 63  MGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSG 122
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETG--TYRWMAP 204
           M+YL   + +HRDL   N+L++++ V KV+DFG++R    +     T   G    RW AP
Sbjct: 123 MKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 182
Query: 205 EVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           E I ++ +   +DV+S+ IV+WE+++  + PY  M+
Sbjct: 183 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 218

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score =  113 bits (283), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 66/186 (35%), Positives = 101/186 (54%), Gaps = 16/186 (8%)
Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VA+K L+  +      D F+ E +I+ +  H N++   G  TKS  + IVTEYM  GSL 
Sbjct: 53  VAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLD 111
Query: 124 DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA 183
            +L KN     + QL+     I  GM+YL     +HRDL   N+L++++ V KV+DFG++
Sbjct: 112 TFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS 171
Query: 184 R---------FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKV 233
           R         +  +GG +       RW APE I  + +   +DV+S+ IV+WE+V+  + 
Sbjct: 172 RVLEDDPEAAYTTRGGKI-----PIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGER 226
Query: 234 PYDSMT 239
           PY  MT
Sbjct: 227 PYWEMT 232

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  113 bits (283), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 65/186 (34%), Positives = 103/186 (55%), Gaps = 16/186 (8%)
Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VA+K L+  +      D F+ E +I+ +  H N++R  G  TKS  + IVTEYM  GSL 
Sbjct: 76  VAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 124 DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA 183
            +L K+     + QL+     I  GM+YL     +HRDL   N+L++++ V KV+DFG+A
Sbjct: 135 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLA 194
Query: 184 R---------FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKV 233
           R         +  +GG +       RW +PE I ++ +   +DV+S+ IVLWE+++  + 
Sbjct: 195 RVLEDDPEAAYTTRGGKI-----PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 234 PYDSMT 239
           PY  M+
Sbjct: 250 PYWEMS 255

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score =  113 bits (283), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 120/232 (51%), Gaps = 30/232 (12%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLEDEFV 83
           WE  R  L  G+ +  G+ G +     +G D         VAVK+L+ +     L D  V
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LV 88
Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL--------HKNHNVLK 134
            E+ +++ + +H+N++  +GA T+   L ++ EY   G+L +YL          ++++ +
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINR 148
Query: 135 LPQ-------LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN 187
           +P+       L+     + +GMEYL  +  IHRDL   N+L+  +NV+K+ADFG+AR  N
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 188 KGGVMTAETG---TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
                   T      +WMAPE +  + Y  ++DV+SF +++WE+ T    PY
Sbjct: 209 NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score =  113 bits (283), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 121/232 (52%), Gaps = 30/232 (12%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLEDEFV 83
           WE  R  L  G+ +  G+ G +     +G D         VAVK+L+ +   + L D  V
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSD-LV 88
Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK--------NHNVLK 134
            E+ +++ + +H+N++  +GA T+   L ++ EY   G+L +YL          ++++ +
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 135 LPQ-------LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN 187
           +P+       L+     + +GMEYL  +  IHRDL   N+L+  +NV+K+ADFG+AR  N
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 188 KGGVMTAETG---TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
                   T      +WMAPE +  + Y  ++DV+SF +++WE+ T    PY
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score =  113 bits (283), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 116/232 (50%), Gaps = 30/232 (12%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLEDEFV 83
           WE+ R  L  G+ +  G+ G +     +G D         VAVK+L+S+     L D  +
Sbjct: 23  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LI 81
Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL---------------H 127
            E+ +++ + +H+N++  +GA T+   L ++ EY   G+L +YL               H
Sbjct: 82  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSH 141
Query: 128 KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN 187
                L    L+  A  + +GMEYL  +  IHRDL   N+L+   NV+K+ADFG+AR  +
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 188 KGGVMTAETG---TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
                   T      +WMAPE +  + Y  ++DV+SF ++LWE+ T    PY
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score =  113 bits (283), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 116/232 (50%), Gaps = 30/232 (12%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLEDEFV 83
           WE+ R  L  G+ +  G+ G +     +G D         VAVK+L+S+     L D  +
Sbjct: 16  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LI 74
Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL---------------H 127
            E+ +++ + +H+N++  +GA T+   L ++ EY   G+L +YL               H
Sbjct: 75  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 134
Query: 128 KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN 187
                L    L+  A  + +GMEYL  +  IHRDL   N+L+   NV+K+ADFG+AR  +
Sbjct: 135 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 194
Query: 188 KGGVMTAETG---TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
                   T      +WMAPE +  + Y  ++DV+SF ++LWE+ T    PY
Sbjct: 195 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 246

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 116/232 (50%), Gaps = 30/232 (12%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLEDEFV 83
           WE+ R  L  G+ +  G+ G +     +G D         VAVK+L+S+     L D  +
Sbjct: 23  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LI 81
Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL---------------H 127
            E+ +++ + +H+N++  +GA T+   L ++ EY   G+L +YL               H
Sbjct: 82  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSH 141
Query: 128 KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN 187
                L    L+  A  + +GMEYL  +  IHRDL   N+L+   NV+K+ADFG+AR  +
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 188 KGGVMTAETG---TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
                   T      +WMAPE +  + Y  ++DV+SF ++LWE+ T    PY
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 120/232 (51%), Gaps = 30/232 (12%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLEDEFV 83
           WE  R  L  G+ +  G+ G +     +G D         VAVK+L+ +     L D  V
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LV 88
Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK--------NHNVLK 134
            E+ +++ + +H+N++  +GA T+   L ++ EY   G+L +YL          ++++ +
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 135 LPQ-------LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN 187
           +P+       L+     + +GMEYL  +  IHRDL   N+L+  +NV+K+ADFG+AR  N
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 188 KGGVMTAETG---TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
                   T      +WMAPE +  + Y  ++DV+SF +++WE+ T    PY
Sbjct: 209 NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 116/232 (50%), Gaps = 30/232 (12%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLEDEFV 83
           WE+ R  L  G+ +  G+ G +     +G D         VAVK+L+S+     L D  +
Sbjct: 23  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LI 81
Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL---------------H 127
            E+ +++ + +H+N++  +GA T+   L ++ EY   G+L +YL               H
Sbjct: 82  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 141
Query: 128 KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN 187
                L    L+  A  + +GMEYL  +  IHRDL   N+L+   NV+K+ADFG+AR  +
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 188 KGGVMTAETG---TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
                   T      +WMAPE +  + Y  ++DV+SF ++LWE+ T    PY
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 116/232 (50%), Gaps = 30/232 (12%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLEDEFV 83
           WE+ R  L  G+ +  G+ G +     +G D         VAVK+L+S+     L D  +
Sbjct: 12  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LI 70
Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL---------------H 127
            E+ +++ + +H+N++  +GA T+   L ++ EY   G+L +YL               H
Sbjct: 71  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 130
Query: 128 KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN 187
                L    L+  A  + +GMEYL  +  IHRDL   N+L+   NV+K+ADFG+AR  +
Sbjct: 131 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 190
Query: 188 KGGVMTAETG---TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
                   T      +WMAPE +  + Y  ++DV+SF ++LWE+ T    PY
Sbjct: 191 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 242

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 116/232 (50%), Gaps = 30/232 (12%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLEDEFV 83
           WE+ R  L  G+ +  G+ G +     +G D         VAVK+L+S+     L D  +
Sbjct: 8   WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LI 66
Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL---------------H 127
            E+ +++ + +H+N++  +GA T+   L ++ EY   G+L +YL               H
Sbjct: 67  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSH 126
Query: 128 KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN 187
                L    L+  A  + +GMEYL  +  IHRDL   N+L+   NV+K+ADFG+AR  +
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 188 KGGVMTAETG---TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
                   T      +WMAPE +  + Y  ++DV+SF ++LWE+ T    PY
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 116/232 (50%), Gaps = 30/232 (12%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLEDEFV 83
           WE+ R  L  G+ +  G+ G +     +G D         VAVK+L+S+     L D  +
Sbjct: 15  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LI 73
Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL---------------H 127
            E+ +++ + +H+N++  +GA T+   L ++ EY   G+L +YL               H
Sbjct: 74  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 133
Query: 128 KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN 187
                L    L+  A  + +GMEYL  +  IHRDL   N+L+   NV+K+ADFG+AR  +
Sbjct: 134 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 193
Query: 188 KGGVMTAETG---TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
                   T      +WMAPE +  + Y  ++DV+SF ++LWE+ T    PY
Sbjct: 194 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 245

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 116/232 (50%), Gaps = 30/232 (12%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLEDEFV 83
           WE+ R  L  G+ +  G+ G +     +G D         VAVK+L+S+     L D  +
Sbjct: 64  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LI 122
Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL---------------H 127
            E+ +++ + +H+N++  +GA T+   L ++ EY   G+L +YL               H
Sbjct: 123 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 182
Query: 128 KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN 187
                L    L+  A  + +GMEYL  +  IHRDL   N+L+   NV+K+ADFG+AR  +
Sbjct: 183 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 242
Query: 188 KGGVMTAETG---TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
                   T      +WMAPE +  + Y  ++DV+SF ++LWE+ T    PY
Sbjct: 243 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 294

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 64/186 (34%), Positives = 103/186 (55%), Gaps = 16/186 (8%)
Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VA+K L+  +      D F+ E +I+ +  H N++R  G  TKS  + IVTEYM  GSL 
Sbjct: 64  VAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 122
Query: 124 DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA 183
            +L K+     + QL+     I  GM+YL     +HRDL   N+L++++ V KV+DFG++
Sbjct: 123 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS 182
Query: 184 R---------FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKV 233
           R         +  +GG +       RW +PE I ++ +   +DV+S+ IVLWE+++  + 
Sbjct: 183 RVLEDDPEAAYTTRGGKI-----PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 237
Query: 234 PYDSMT 239
           PY  M+
Sbjct: 238 PYWEMS 243

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 64/186 (34%), Positives = 103/186 (55%), Gaps = 16/186 (8%)
Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VA+K L+  +      D F+ E +I+ +  H N++R  G  TKS  + IVTEYM  GSL 
Sbjct: 76  VAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 124 DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA 183
            +L K+     + QL+     I  GM+YL     +HRDL   N+L++++ V KV+DFG++
Sbjct: 135 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 184 R---------FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKV 233
           R         +  +GG +       RW +PE I ++ +   +DV+S+ IVLWE+++  + 
Sbjct: 195 RVLEDDPEAAYTTRGGKI-----PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 234 PYDSMT 239
           PY  M+
Sbjct: 250 PYWEMS 255

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 64/186 (34%), Positives = 103/186 (55%), Gaps = 16/186 (8%)
Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VA+K L+  +      D F+ E +I+ +  H N++R  G  TKS  + IVTEYM  GSL 
Sbjct: 47  VAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 105
Query: 124 DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA 183
            +L K+     + QL+     I  GM+YL     +HRDL   N+L++++ V KV+DFG++
Sbjct: 106 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS 165
Query: 184 R---------FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKV 233
           R         +  +GG +       RW +PE I ++ +   +DV+S+ IVLWE+++  + 
Sbjct: 166 RVLEDDPEAAYTTRGGKI-----PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 220
Query: 234 PYDSMT 239
           PY  M+
Sbjct: 221 PYWEMS 226

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  112 bits (281), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 107/202 (52%), Gaps = 6/202 (2%)
Query: 44  ERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           +RI  GS G++Y+G+  +  + VA+K++      +   ++  QE+ +L +     + R+ 
Sbjct: 25  DRIGKGSFGEVYKGIDNHTKEVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYITRYF 83
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
           G+  KS  L I+ EY+ GGS  D L      L+   +     +I KG++YLH    IHRD
Sbjct: 84  GSYLKSTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSERKIHRD 141
Query: 162 LKTANLLMDTHNVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFS 220
           +K AN+L+     VK+ADFGVA +  +         GT  WMAPEVI    YD KAD++S
Sbjct: 142 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKADIWS 201
Query: 221 FAIVLWELVTAKVPYDSMTPLQ 242
             I   EL   + P   + P++
Sbjct: 202 LGITAIELAKGEPPNSDLHPMR 223

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 107/203 (52%), Gaps = 7/203 (3%)
Query: 38  RLLKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHR 95
           RLLKT   I  G+     L R +  G++VAVK++    LN +   +  +EV I++ + H 
Sbjct: 17  RLLKT---IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 96  NVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR 155
           N+V+          L +V EY  GG ++DYL   H  +K  +       I   ++Y HQ+
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVA-HGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYD-Q 214
            I+HRDLK  NLL+D    +K+ADFG +     G  + A  G   + APE+   + YD  
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGP 192
Query: 215 KADVFSFAIVLWELVTAKVPYDS 237
           + DV+S  ++L+ LV+  +P+D 
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFDG 215

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 67/197 (34%), Positives = 103/197 (52%), Gaps = 18/197 (9%)
Query: 60  LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMP 118
           L  D A+K ++     D   D F  E+ +L ++  H N++  +GA     +L +  EY P
Sbjct: 48  LRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 106
Query: 119 GGSLYDYLHKNH---------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLK 163
            G+L D+L K+                + L   QLL FA D+ +GM+YL Q+  IHR+L 
Sbjct: 107 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRNLA 166
Query: 164 TANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAI 223
             N+L+  + V K+ADFG++R Q      T      RWMA E +N+  Y   +DV+S+ +
Sbjct: 167 ARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV 226
Query: 224 VLWELVT-AKVPYDSMT 239
           +LWE+V+    PY  MT
Sbjct: 227 LLWEIVSLGGTPYCGMT 243

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 64/186 (34%), Positives = 103/186 (55%), Gaps = 16/186 (8%)
Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VA+K L+  +      D F+ E +I+ +  H N++R  G  TKS  + IVTEYM  GSL 
Sbjct: 76  VAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 124 DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA 183
            +L K+     + QL+     I  GM+YL     +HRDL   N+L++++ V KV+DFG++
Sbjct: 135 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 184 R---------FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKV 233
           R         +  +GG +       RW +PE I ++ +   +DV+S+ IVLWE+++  + 
Sbjct: 195 RVLEDDPEAAYTTRGGKI-----PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 234 PYDSMT 239
           PY  M+
Sbjct: 250 PYWEMS 255

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 64/186 (34%), Positives = 103/186 (55%), Gaps = 16/186 (8%)
Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VA+K L+  +      D F+ E +I+ +  H N++R  G  TKS  + IVTEYM  GSL 
Sbjct: 76  VAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 124 DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA 183
            +L K+     + QL+     I  GM+YL     +HRDL   N+L++++ V KV+DFG++
Sbjct: 135 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 184 R---------FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKV 233
           R         +  +GG +       RW +PE I ++ +   +DV+S+ IVLWE+++  + 
Sbjct: 195 RVLEDDPEAAYTTRGGKI-----PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 234 PYDSMT 239
           PY  M+
Sbjct: 250 PYWEMS 255

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 64/186 (34%), Positives = 103/186 (55%), Gaps = 16/186 (8%)
Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VA+K L+  +      D F+ E +I+ +  H N++R  G  TKS  + IVTEYM  GSL 
Sbjct: 76  VAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 124 DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA 183
            +L K+     + QL+     I  GM+YL     +HRDL   N+L++++ V KV+DFG++
Sbjct: 135 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 184 R---------FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKV 233
           R         +  +GG +       RW +PE I ++ +   +DV+S+ IVLWE+++  + 
Sbjct: 195 RVLEDDPEAAYTTRGGKI-----PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 234 PYDSMT 239
           PY  M+
Sbjct: 250 PYWEMS 255

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 64/186 (34%), Positives = 103/186 (55%), Gaps = 16/186 (8%)
Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VA+K L+  +      D F+ E +I+ +  H N++R  G  TKS  + IVTEYM  GSL 
Sbjct: 76  VAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 124 DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA 183
            +L K+     + QL+     I  GM+YL     +HRDL   N+L++++ V KV+DFG++
Sbjct: 135 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 184 R---------FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKV 233
           R         +  +GG +       RW +PE I ++ +   +DV+S+ IVLWE+++  + 
Sbjct: 195 RVLEDDPEAAYTTRGGKI-----PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 234 PYDSMT 239
           PY  M+
Sbjct: 250 PYWEMS 255

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 120/232 (51%), Gaps = 30/232 (12%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLEDEFV 83
           WE  R  L  G+ +  G+ G +     +G D         VAVK+L+ +     L D  V
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LV 88
Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK--------NHNVLK 134
            E+ +++ + +H+N++  +GA T+   L ++ EY   G+L +YL          ++++ +
Sbjct: 89  SEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 135 LPQ-------LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN 187
           +P+       L+     + +GMEYL  +  IHRDL   N+L+  +NV+K+ADFG+AR  N
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 188 KGGVMTAETG---TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
                   T      +WMAPE +  + Y  ++DV+SF +++WE+ T    PY
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 64/186 (34%), Positives = 103/186 (55%), Gaps = 16/186 (8%)
Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VA+K L+  +      D F+ E +I+ +  H N++R  G  TKS  + IVTEYM  GSL 
Sbjct: 74  VAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 132
Query: 124 DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA 183
            +L K+     + QL+     I  GM+YL     +HRDL   N+L++++ V KV+DFG++
Sbjct: 133 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS 192
Query: 184 R---------FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKV 233
           R         +  +GG +       RW +PE I ++ +   +DV+S+ IVLWE+++  + 
Sbjct: 193 RVLEDDPEAAYTTRGGKIPI-----RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 247
Query: 234 PYDSMT 239
           PY  M+
Sbjct: 248 PYWEMS 253

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 120/232 (51%), Gaps = 30/232 (12%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLEDEFV 83
           WE  R  L  G+ +  G+ G +     +G D         VAVK+L+ +     L D  V
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LV 88
Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK--------NHNVLK 134
            E+ +++ + +H+N++  +GA T+   L ++ EY   G+L +YL          ++++ +
Sbjct: 89  SEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 135 LPQ-------LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN 187
           +P+       L+     + +GMEYL  +  IHRDL   N+L+  +NV+K+ADFG+AR  N
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 188 KGGVMTAETG---TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
                   T      +WMAPE +  + Y  ++DV+SF +++WE+ T    PY
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 120/232 (51%), Gaps = 30/232 (12%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLEDEFV 83
           WE  R  L  G+ +  G+ G +     +G D         VAVK+L+ +     L D  V
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LV 88
Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK--------NHNVLK 134
            E+ +++ + +H+N++  +GA T+   L ++ EY   G+L +YL          ++++ +
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 135 LPQ-------LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN 187
           +P+       L+     + +GMEYL  +  IHRDL   N+L+  +NV+K+ADFG+AR  N
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 188 KGGVMTAETG---TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
                   T      +WMAPE +  + Y  ++DV+SF +++WE+ T    PY
Sbjct: 209 NIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 64/186 (34%), Positives = 102/186 (54%), Gaps = 16/186 (8%)
Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VA+K L+  +      D F+ E +I+ +  H N++R  G  TKS  + IVTEYM  GSL 
Sbjct: 76  VAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 124 DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA 183
            +L K+     + QL+     I  GM+YL     +HRDL   N+L++++ V KV+DFG+ 
Sbjct: 135 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG 194
Query: 184 R---------FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKV 233
           R         +  +GG +       RW +PE I ++ +   +DV+S+ IVLWE+++  + 
Sbjct: 195 RVLEDDPEAAYTTRGGKI-----PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 234 PYDSMT 239
           PY  M+
Sbjct: 250 PYWEMS 255

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score =  112 bits (279), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 119/232 (51%), Gaps = 30/232 (12%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLEDEFV 83
           WE  R  L  G+ +  G  G +     +G D         VAVK+L+ +     L D  V
Sbjct: 19  WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LV 77
Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK--------NHNVLK 134
            E+ +++ + +H+N++  +GA T+   L ++ EY   G+L +YL          ++++ +
Sbjct: 78  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 137
Query: 135 LPQ-------LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN 187
           +P+       L+     + +GMEYL  +  IHRDL   N+L+  +NV+K+ADFG+AR  N
Sbjct: 138 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 197
Query: 188 KGGVMTAETG---TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
                   T      +WMAPE +  + Y  ++DV+SF +++WE+ T    PY
Sbjct: 198 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 249

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score =  112 bits (279), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 119/232 (51%), Gaps = 30/232 (12%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLEDEFV 83
           WE  R  L  G+ +  G  G +     +G D         VAVK+L+ +     L D  V
Sbjct: 17  WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LV 75
Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK--------NHNVLK 134
            E+ +++ + +H+N++  +GA T+   L ++ EY   G+L +YL          ++++ +
Sbjct: 76  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 135
Query: 135 LPQ-------LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN 187
           +P+       L+     + +GMEYL  +  IHRDL   N+L+  +NV+K+ADFG+AR  N
Sbjct: 136 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDIN 195
Query: 188 KGGVMTAETG---TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
                   T      +WMAPE +  + Y  ++DV+SF +++WE+ T    PY
Sbjct: 196 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 247

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score =  112 bits (279), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 117/226 (51%), Gaps = 29/226 (12%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLEDEFV 83
           WE  R  L  G+ +  G  G +     +G D         VAVK+L+ +     L D  V
Sbjct: 76  WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LV 134
Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK--------NHNVLK 134
            E+ +++ + +H+N++  +GA T+   L ++ EY   G+L +YL          ++++ +
Sbjct: 135 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 194
Query: 135 LPQ-------LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN 187
           +P+       L+     + +GMEYL  +  IHRDL   N+L+  +NV+K+ADFG+AR  N
Sbjct: 195 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 254
Query: 188 KGGVMTAETG---TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
                   T      +WMAPE +  + Y  ++DV+SF +++WE+ T
Sbjct: 255 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 119/232 (51%), Gaps = 30/232 (12%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLEDEFV 83
           WE  R  L  G+ +  G  G +     +G D         VAVK+L+ +     L D  V
Sbjct: 22  WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LV 80
Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK--------NHNVLK 134
            E+ +++ + +H+N++  +GA T+   L ++ EY   G+L +YL          ++++ +
Sbjct: 81  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 140
Query: 135 LPQ-------LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN 187
           +P+       L+     + +GMEYL  +  IHRDL   N+L+  +NV+K+ADFG+AR  N
Sbjct: 141 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 200
Query: 188 KGGVMTAETG---TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
                   T      +WMAPE +  + Y  ++DV+SF +++WE+ T    PY
Sbjct: 201 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 252

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  111 bits (278), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 107/203 (52%), Gaps = 7/203 (3%)
Query: 38  RLLKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHR 95
           RLLKT   I  G+     L R +  G++VAVK++    LN +   +  +EV I++ + H 
Sbjct: 17  RLLKT---IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 96  NVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR 155
           N+V+          L +V EY  GG ++DYL   H  +K  +       I   ++Y HQ+
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVA-HGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYD-Q 214
            I+HRDLK  NLL+D    +K+ADFG +     G  +    G+  + APE+   + YD  
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGP 192
Query: 215 KADVFSFAIVLWELVTAKVPYDS 237
           + DV+S  ++L+ LV+  +P+D 
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFDG 215

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  111 bits (278), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 107/203 (52%), Gaps = 7/203 (3%)
Query: 38  RLLKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHR 95
           RLLKT   I  G+     L R +  G++VAVK++    LN +   +  +EV I++ + H 
Sbjct: 17  RLLKT---IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 96  NVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR 155
           N+V+          L +V EY  GG ++DYL   H  +K  +       I   ++Y HQ+
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVA-HGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYD-Q 214
            I+HRDLK  NLL+D    +K+ADFG +     G  +    G+  + APE+   + YD  
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGP 192
Query: 215 KADVFSFAIVLWELVTAKVPYDS 237
           + DV+S  ++L+ LV+  +P+D 
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFDG 215

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  111 bits (278), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 115/228 (50%), Gaps = 21/228 (9%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLG---QDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           W I+R   +  E I SG+   + +  Y     + VA+K +  E    ++ DE ++E+  +
Sbjct: 5   WSINRDDYELQEVIGSGATA-VVQAAYCAPKKEKVAIKRINLEKCQTSM-DELLKEIQAM 62
Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL--------HKNHNVLKLPQLLRF 141
            +  H N+V +  +      L +V + + GGS+ D +        HK+  VL    +   
Sbjct: 63  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKS-GVLDESTIATI 121
Query: 142 AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAE------ 195
             ++ +G+EYLH+   IHRD+K  N+L+     V++ADFGV+ F   GG +T        
Sbjct: 122 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 181
Query: 196 TGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQ 242
            GT  WMAPEV+   + YD KAD++SF I   EL T   PY    P++
Sbjct: 182 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK 229

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 120/232 (51%), Gaps = 30/232 (12%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLEDEFV 83
           WE  R  L  G+ +  G+ G +     +G D         VAVK+L+ +     L D  V
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LV 88
Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK--------NHNVLK 134
            E+ +++ + +H+N++  +GA T+   L ++ EY   G+L +YL          ++++ +
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 135 LPQ-------LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN 187
           +P+       L+     + +GMEYL  +  IHRDL   N+L+  +NV+++ADFG+AR  N
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDIN 208
Query: 188 KGGVMTAETG---TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
                   T      +WMAPE +  + Y  ++DV+SF +++WE+ T    PY
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score =  111 bits (277), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 77/234 (32%), Positives = 115/234 (49%), Gaps = 29/234 (12%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-------VAVKVLRSEHLNDTLEDEF 82
           +  WE  R  LK G+ +  G+ G +      G D       VAVK+L+ E    +     
Sbjct: 10  ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRAL 68
Query: 83  VQEVAILREVQHR-NVVRFIGASTK-SPHLCIVTEYMPGGSLYDYLHKNHN--------- 131
           + E+ IL  + H  NVV  +GA TK    L ++TE+   G+L  YL    N         
Sbjct: 69  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAP 128
Query: 132 ------VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR- 184
                  L L  L+ ++  + KGME+L  R  IHRDL   N+L+   NVVK+ DFG+AR 
Sbjct: 129 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 188
Query: 185 -FQNKGGVMTAETG-TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
            +++   V   +     +WMAPE I  + Y  ++DV+SF ++LWE+ +    PY
Sbjct: 189 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  111 bits (277), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 7/205 (3%)
Query: 38  RLLKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHR 95
           RLLKT   I  G+     L R +  G++VAVK++    LN +   +  +EV I + + H 
Sbjct: 17  RLLKT---IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHP 73
Query: 96  NVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR 155
           N+V+          L +V EY  GG ++DYL  +    +     +F   I   ++Y HQ+
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIVSAVQYCHQK 132
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYD-Q 214
            I+HRDLK  NLL+D    +K+ADFG +     G  + A  G   + APE+   + YD  
Sbjct: 133 FIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGP 192
Query: 215 KADVFSFAIVLWELVTAKVPYDSMT 239
           + DV+S  ++L+ LV+  +P+D   
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score =  111 bits (277), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 77/234 (32%), Positives = 115/234 (49%), Gaps = 29/234 (12%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-------VAVKVLRSEHLNDTLEDEF 82
           +  WE  R  LK G+ +  G+ G +      G D       VAVK+L+ E    +     
Sbjct: 10  ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRAL 68
Query: 83  VQEVAILREVQHR-NVVRFIGASTK-SPHLCIVTEYMPGGSLYDYLHKNHN--------- 131
           + E+ IL  + H  NVV  +GA TK    L ++TE+   G+L  YL    N         
Sbjct: 69  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAP 128
Query: 132 ------VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR- 184
                  L L  L+ ++  + KGME+L  R  IHRDL   N+L+   NVVK+ DFG+AR 
Sbjct: 129 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 188
Query: 185 -FQNKGGVMTAETG-TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
            +++   V   +     +WMAPE I  + Y  ++DV+SF ++LWE+ +    PY
Sbjct: 189 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  111 bits (277), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 107/203 (52%), Gaps = 7/203 (3%)
Query: 38  RLLKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHR 95
           RLLKT   I  G+     L R +  G++VAVK++    LN +   +  +EV I++ + H 
Sbjct: 10  RLLKT---IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 66
Query: 96  NVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR 155
           N+V+          L +V EY  GG ++DYL   H  +K  +       I   ++Y HQ+
Sbjct: 67  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVA-HGWMKEKEARAKFRQIVSAVQYCHQK 125
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYD-Q 214
            I+HRDLK  NLL+D    +K+ADFG +     G  +    G+  + APE+   + YD  
Sbjct: 126 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGP 185
Query: 215 KADVFSFAIVLWELVTAKVPYDS 237
           + DV+S  ++L+ LV+  +P+D 
Sbjct: 186 EVDVWSLGVILYTLVSGSLPFDG 208

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  111 bits (277), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 115/228 (50%), Gaps = 21/228 (9%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLG---QDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           W I+R   +  E I SG+   + +  Y     + VA+K +  E    ++ DE ++E+  +
Sbjct: 10  WSINRDDYELQEVIGSGATA-VVQAAYCAPKKEKVAIKRINLEKCQTSM-DELLKEIQAM 67
Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL--------HKNHNVLKLPQLLRF 141
            +  H N+V +  +      L +V + + GGS+ D +        HK+  VL    +   
Sbjct: 68  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKS-GVLDESTIATI 126
Query: 142 AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAE------ 195
             ++ +G+EYLH+   IHRD+K  N+L+     V++ADFGV+ F   GG +T        
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 196 TGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQ 242
            GT  WMAPEV+   + YD KAD++SF I   EL T   PY    P++
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK 234

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  110 bits (276), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 106/204 (51%), Gaps = 11/204 (5%)
Query: 46  IASGSCGDLYRGVYL--GQ---DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF 100
           I SG  G++  G     GQ    VA+K L++ +      D F+ E +I+ +  H N++R 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEASIMGQFDHPNIIRL 115
Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
            G  T+     IVTEYM  GSL  +L  +     + QL+     +  GM YL     +HR
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHR 175
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETG---TYRWMAPEVINHQPYDQKA 216
           DL   N+L+D++ V KV+DFG++R  ++        TG     RW APE I  + +   +
Sbjct: 176 DLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSAS 235
Query: 217 DVFSFAIVLWE-LVTAKVPYDSMT 239
           DV+SF +V+WE L   + PY +MT
Sbjct: 236 DVWSFGVVMWEVLAYGERPYWNMT 259

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score =  110 bits (276), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 120/228 (52%), Gaps = 25/228 (10%)
Query: 46  IASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           ++SG+ G +Y+G+++ +       VA+K LR E  +     E + E  ++  V + +V R
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + ++T+ MP G L DY+ ++ + +    LL + + I KGM YL  R ++H
Sbjct: 89  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 147
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---------RWMAPEVINHQ 210
           RDL   N+L+ T   VK+ DFG+A+      ++ AE   Y         +WMA E I H+
Sbjct: 148 RDLAARNVLVKTPQHVKITDFGLAK------LLGAEEKEYHAEGGKVPIKWMALESILHR 201
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y  ++DV+S+ + +WEL+T    PYD + P      + +    L QP
Sbjct: 202 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQP 248

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score =  110 bits (276), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 120/228 (52%), Gaps = 25/228 (10%)
Query: 46  IASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           ++SG+ G +Y+G+++ +       VA+K LR E  +     E + E  ++  V + +V R
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + ++T+ MP G L DY+ ++ + +    LL + + I KGM YL  R ++H
Sbjct: 82  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---------RWMAPEVINHQ 210
           RDL   N+L+ T   VK+ DFG+A+      ++ AE   Y         +WMA E I H+
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAK------LLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y  ++DV+S+ + +WEL+T    PYD + P      + +    L QP
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQP 241

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score =  110 bits (276), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 119/228 (52%), Gaps = 25/228 (10%)
Query: 46  IASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           + SG+ G +Y+G+++ +       VA+K LR E  +     E + E  ++  V + +V R
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + ++T+ MP G L DY+ ++ + +    LL + + I KGM YL  R ++H
Sbjct: 84  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---------RWMAPEVINHQ 210
           RDL   N+L+ T   VK+ DFG+A+      ++ AE   Y         +WMA E I H+
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGLAK------LLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y  ++DV+S+ + +WEL+T    PYD + P      + +    L QP
Sbjct: 197 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQP 243

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  110 bits (276), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 123/229 (53%), Gaps = 8/229 (3%)
Query: 25  ESQTKSEDWEIDRRLLKTGERI--ASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEF 82
           E   +S+  E D    + G+R+    G+ G +Y G  L   V + +      +       
Sbjct: 7   EGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPL 66
Query: 83  VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLK-LPQLLRF 141
            +E+A+ + ++H+N+V+++G+ +++  + I  E +PGGSL   L      LK   Q + F
Sbjct: 67  HEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF 126
Query: 142 -AIDICKGMEYLHQRNIIHRDLKTANLLMDTHN-VVKVADFGVA-RFQNKGGVMTAETGT 198
               I +G++YLH   I+HRD+K  N+L++T++ V+K++DFG + R           TGT
Sbjct: 127 YTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGT 186
Query: 199 YRWMAPEVINHQP--YDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL 245
            ++MAPE+I+  P  Y + AD++S    + E+ T K P+  +   QAA+
Sbjct: 187 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM 235

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score =  110 bits (276), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 119/228 (52%), Gaps = 25/228 (10%)
Query: 46  IASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           + SG+ G +Y+G+++ +       VA+K LR E  +     E + E  ++  V + +V R
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + ++T+ MP G L DY+ ++ + +    LL + + I KGM YL  R ++H
Sbjct: 82  LLGICLTS-TVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---------RWMAPEVINHQ 210
           RDL   N+L+ T   VK+ DFG+A+      ++ AE   Y         +WMA E I H+
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAK------LLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y  ++DV+S+ + +WEL+T    PYD + P      + +    L QP
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQP 241

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score =  110 bits (276), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 119/228 (52%), Gaps = 25/228 (10%)
Query: 46  IASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           + SG+ G +Y+G+++ +       VA+K LR E  +     E + E  ++  V + +V R
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + ++T+ MP G L DY+ ++ + +    LL + + I KGM YL  R ++H
Sbjct: 85  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 143
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---------RWMAPEVINHQ 210
           RDL   N+L+ T   VK+ DFG+A+      ++ AE   Y         +WMA E I H+
Sbjct: 144 RDLAARNVLVKTPQHVKITDFGLAK------LLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y  ++DV+S+ + +WEL+T    PYD + P      + +    L QP
Sbjct: 198 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQP 244

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score =  110 bits (276), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 119/228 (52%), Gaps = 25/228 (10%)
Query: 46  IASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           + SG+ G +Y+G+++ +       VA+K LR E  +     E + E  ++  V + +V R
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + ++T+ MP G L DY+ ++ + +    LL + + I KGM YL  R ++H
Sbjct: 89  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 147
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---------RWMAPEVINHQ 210
           RDL   N+L+ T   VK+ DFG+A+      ++ AE   Y         +WMA E I H+
Sbjct: 148 RDLAARNVLVKTPQHVKITDFGLAK------LLGAEEKEYHAEGGKVPIKWMALESILHR 201
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y  ++DV+S+ + +WEL+T    PYD + P      + +    L QP
Sbjct: 202 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQP 248

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score =  110 bits (276), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 119/228 (52%), Gaps = 25/228 (10%)
Query: 46  IASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           + SG+ G +Y+G+++ +       VA+K LR E  +     E + E  ++  V + +V R
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + ++T+ MP G L DY+ ++ + +    LL + + I KGM YL  R ++H
Sbjct: 85  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 143
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---------RWMAPEVINHQ 210
           RDL   N+L+ T   VK+ DFG+A+      ++ AE   Y         +WMA E I H+
Sbjct: 144 RDLAARNVLVKTPQHVKITDFGLAK------LLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y  ++DV+S+ + +WEL+T    PYD + P      + +    L QP
Sbjct: 198 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQP 244

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score =  110 bits (276), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 118/228 (51%), Gaps = 25/228 (10%)
Query: 46  IASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           + SG+ G +Y+G+++ +       VA+K LR E  +     E + E  ++  V + +V R
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + ++T+ MP G L DY+ ++ + +    LL + + I KGM YL  R ++H
Sbjct: 82  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---------RWMAPEVINHQ 210
           RDL   N+L+ T   VK+ DFG+A+       + AE   Y         +WMA E I H+
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAKL------LGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y  ++DV+S+ + +WEL+T    PYD + P      + +    L QP
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQP 241

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score =  110 bits (276), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 119/228 (52%), Gaps = 25/228 (10%)
Query: 46  IASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           + SG+ G +Y+G+++ +       VA+K LR E  +     E + E  ++  V + +V R
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + ++T+ MP G L DY+ ++ + +    LL + + I KGM YL  R ++H
Sbjct: 85  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 143
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---------RWMAPEVINHQ 210
           RDL   N+L+ T   VK+ DFG+A+      ++ AE   Y         +WMA E I H+
Sbjct: 144 RDLAARNVLVKTPQHVKITDFGLAK------LLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y  ++DV+S+ + +WEL+T    PYD + P      + +    L QP
Sbjct: 198 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQP 244

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  110 bits (276), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 107/203 (52%), Gaps = 7/203 (3%)
Query: 38  RLLKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHR 95
           RLLKT   I  G+     L R +  G++VAV+++    LN +   +  +EV I++ + H 
Sbjct: 17  RLLKT---IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 96  NVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR 155
           N+V+          L +V EY  GG ++DYL   H  +K  +       I   ++Y HQ+
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVA-HGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYD-Q 214
            I+HRDLK  NLL+D    +K+ADFG +     G  +    G+  + APE+   + YD  
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGP 192
Query: 215 KADVFSFAIVLWELVTAKVPYDS 237
           + DV+S  ++L+ LV+  +P+D 
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFDG 215

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score =  110 bits (276), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 119/228 (52%), Gaps = 25/228 (10%)
Query: 46  IASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           + SG+ G +Y+G+++ +       VA+K LR E  +     E + E  ++  V + +V R
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 87
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + ++T+ MP G L DY+ ++ + +    LL + + I KGM YL  R ++H
Sbjct: 88  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 146
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---------RWMAPEVINHQ 210
           RDL   N+L+ T   VK+ DFG+A+      ++ AE   Y         +WMA E I H+
Sbjct: 147 RDLAARNVLVKTPQHVKITDFGLAK------LLGAEEKEYHAEGGKVPIKWMALESILHR 200
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y  ++DV+S+ + +WEL+T    PYD + P      + +    L QP
Sbjct: 201 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQP 247

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score =  110 bits (275), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 119/228 (52%), Gaps = 25/228 (10%)
Query: 46  IASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           + SG+ G +Y+G+++ +       VA+K LR E  +     E + E  ++  V + +V R
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 106
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + ++T+ MP G L DY+ ++ + +    LL + + I KGM YL  R ++H
Sbjct: 107 LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 165
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---------RWMAPEVINHQ 210
           RDL   N+L+ T   VK+ DFG+A+      ++ AE   Y         +WMA E I H+
Sbjct: 166 RDLAARNVLVKTPQHVKITDFGLAK------LLGAEEKEYHAEGGKVPIKWMALESILHR 219
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y  ++DV+S+ + +WEL+T    PYD + P      + +    L QP
Sbjct: 220 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQP 266

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score =  110 bits (275), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 119/228 (52%), Gaps = 25/228 (10%)
Query: 46  IASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           + SG+ G +Y+G+++ +       VA+K LR E  +     E + E  ++  V + +V R
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 91
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + ++T+ MP G L DY+ ++ + +    LL + + I KGM YL  R ++H
Sbjct: 92  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 150
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---------RWMAPEVINHQ 210
           RDL   N+L+ T   VK+ DFG+A+      ++ AE   Y         +WMA E I H+
Sbjct: 151 RDLAARNVLVKTPQHVKITDFGLAK------LLGAEEKEYHAEGGKVPIKWMALESILHR 204
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y  ++DV+S+ + +WEL+T    PYD + P      + +    L QP
Sbjct: 205 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQP 251

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score =  110 bits (275), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 119/228 (52%), Gaps = 25/228 (10%)
Query: 46  IASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           + SG+ G +Y+G+++ +       VA+K LR E  +     E + E  ++  V + +V R
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + ++T+ MP G L DY+ ++ + +    LL + + I KGM YL  R ++H
Sbjct: 76  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 134
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---------RWMAPEVINHQ 210
           RDL   N+L+ T   VK+ DFG+A+      ++ AE   Y         +WMA E I H+
Sbjct: 135 RDLAARNVLVKTPQHVKITDFGLAK------LLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y  ++DV+S+ + +WEL+T    PYD + P      + +    L QP
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQP 235

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  110 bits (275), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 115/224 (51%), Gaps = 11/224 (4%)
Query: 17  GHAVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHL 74
           G+++  A + Q    ++    RL KT   I  G+     L R V  G++VAVK++    L
Sbjct: 1   GNSITSATDEQPHIGNY----RLQKT---IGKGNFAKVKLARHVLTGREVAVKIIDKTQL 53
Query: 75  NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLK 134
           N T   +  +EV I++ + H N+V+          L +V EY  GG ++DYL   H  +K
Sbjct: 54  NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVA-HGRMK 112
Query: 135 LPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTA 194
             +       I   ++Y HQ+ I+HRDLK  NLL+D    +K+ADFG +     G  +  
Sbjct: 113 EKEARAKFRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT 172
Query: 195 ETGTYRWMAPEVINHQPYD-QKADVFSFAIVLWELVTAKVPYDS 237
             G+  + APE+   + YD  + DV+S  ++L+ LV+  +P+D 
Sbjct: 173 FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score =  110 bits (275), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 119/228 (52%), Gaps = 25/228 (10%)
Query: 46  IASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           + SG+ G +Y+G+++ +       VA+K LR E  +     E + E  ++  V + +V R
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + ++T+ MP G L DY+ ++ + +    LL + + I KGM YL  R ++H
Sbjct: 82  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---------RWMAPEVINHQ 210
           RDL   N+L+ T   VK+ DFG+A+      ++ AE   Y         +WMA E I H+
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAK------LLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y  ++DV+S+ + +WEL+T    PYD + P      + +    L QP
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQP 241

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score =  110 bits (275), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 113/214 (52%), Gaps = 14/214 (6%)
Query: 35  IDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH 94
           ID + L    ++     G+L++G + G D+ VKVL+    +     +F +E   LR   H
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 95  RNVVRFIGA--STKSPHLCIVTEYMPGGSLYDYLHKNHN-VLKLPQLLRFAIDICKGMEY 151
            NV+  +GA  S  +PH  ++T + P GSLY+ LH+  N V+   Q ++FA+D  +G  +
Sbjct: 67  PNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAF 126
Query: 152 LH--QRNIIHRDLKTANLLMDTHNVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVIN 208
           LH  +  I    L + ++ +D     +++   V   FQ+ G           W+APE + 
Sbjct: 127 LHTLEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXYAPA-----WVAPEALQ 181
Query: 209 HQPYD---QKADVFSFAIVLWELVTAKVPYDSMT 239
            +P D   + AD +SFA++LWELVT +VP+  ++
Sbjct: 182 KKPEDTNRRSADXWSFAVLLWELVTREVPFADLS 215

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score =  110 bits (275), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 77/234 (32%), Positives = 114/234 (48%), Gaps = 29/234 (12%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-------VAVKVLRSEHLNDTLEDEF 82
           +  WE  R  LK G+ +  G+ G +      G D       VAVK+L+ E    +     
Sbjct: 10  ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRAL 68
Query: 83  VQEVAILREVQHR-NVVRFIGASTK-SPHLCIVTEYMPGGSLYDYLHKNHN--------- 131
           + E+ IL  + H  NVV  +GA TK    L ++TE+   G+L  YL    N         
Sbjct: 69  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAP 128
Query: 132 ------VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR- 184
                  L L  L+ ++  + KGME+L  R  IHRDL   N+L+   NVVK+ DFG+AR 
Sbjct: 129 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 188
Query: 185 -FQNKGGVMTAETG-TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
             ++   V   +     +WMAPE I  + Y  ++DV+SF ++LWE+ +    PY
Sbjct: 189 IXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  110 bits (275), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 106/204 (51%), Gaps = 11/204 (5%)
Query: 46  IASGSCGDLYRGVYL--GQ---DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF 100
           I SG  G++  G     GQ    VA+K L++ +      D F+ E +I+ +  H N++R 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEASIMGQFDHPNIIRL 115
Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
            G  T+     IVTEYM  GSL  +L  +     + QL+     +  GM YL     +HR
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHR 175
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETG---TYRWMAPEVINHQPYDQKA 216
           DL   N+L+D++ V KV+DFG++R  ++        TG     RW APE I  + +   +
Sbjct: 176 DLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSAS 235
Query: 217 DVFSFAIVLWE-LVTAKVPYDSMT 239
           DV+SF +V+WE L   + PY +MT
Sbjct: 236 DVWSFGVVMWEVLAYGERPYWNMT 259

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  110 bits (275), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 119/232 (51%), Gaps = 30/232 (12%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLEDEFV 83
           WE  R  L  G+ +  G+ G +     +G D         VAVK+L+ +     L D  V
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LV 88
Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK--------NHNVLK 134
            E+ +++ + +H+N++  +GA T+   L ++  Y   G+L +YL          ++++ +
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 135 LPQ-------LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN 187
           +P+       L+     + +GMEYL  +  IHRDL   N+L+  +NV+K+ADFG+AR  N
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 188 KGGVMTAETG---TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
                   T      +WMAPE +  + Y  ++DV+SF +++WE+ T    PY
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  110 bits (275), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 107/203 (52%), Gaps = 7/203 (3%)
Query: 38  RLLKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHR 95
           RLLKT   I  G+     L R +  G++VAV+++    LN +   +  +EV I++ + H 
Sbjct: 17  RLLKT---IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 96  NVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR 155
           N+V+          L +V EY  GG ++DYL   H  +K  +       I   ++Y HQ+
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVA-HGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYD-Q 214
            I+HRDLK  NLL+D    +K+ADFG +     G  +    G+  + APE+   + YD  
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGP 192
Query: 215 KADVFSFAIVLWELVTAKVPYDS 237
           + DV+S  ++L+ LV+  +P+D 
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFDG 215

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 119/232 (51%), Gaps = 30/232 (12%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLEDEFV 83
           WE  R  L  G+ +  G+ G +     +G D         VAVK+L+ +     L D  V
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LV 88
Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK--------NHNVLK 134
            E+ +++ + +H+N++  +GA T+   L ++  Y   G+L +YL          ++++ +
Sbjct: 89  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 135 LPQ-------LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN 187
           +P+       L+     + +GMEYL  +  IHRDL   N+L+  +NV+K+ADFG+AR  N
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 188 KGGVMTAETG---TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
                   T      +WMAPE +  + Y  ++DV+SF +++WE+ T    PY
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 63/186 (33%), Positives = 102/186 (54%), Gaps = 16/186 (8%)
Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VA+K L+  +      D F+ E +I+ +  H N++R  G  TKS  + IVTE M  GSL 
Sbjct: 47  VAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD 105
Query: 124 DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA 183
            +L K+     + QL+     I  GM+YL     +HRDL   N+L++++ V KV+DFG++
Sbjct: 106 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS 165
Query: 184 R---------FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKV 233
           R         +  +GG +       RW +PE I ++ +   +DV+S+ IVLWE+++  + 
Sbjct: 166 RVLEDDPEAAYTTRGGKI-----PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 220
Query: 234 PYDSMT 239
           PY  M+
Sbjct: 221 PYWEMS 226

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/230 (31%), Positives = 117/230 (50%), Gaps = 22/230 (9%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLG---QD----VAVKVLRSEHLNDTLEDEF 82
           +E WE  R  L+ G+ + +G+ G +      G   +D    VAVK+L+S    D  E   
Sbjct: 30  NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE-AL 88
Query: 83  VQEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV--------- 132
           + E+ I+  + QH N+V  +GA T    + ++TEY   G L ++L +             
Sbjct: 89  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRP 148
Query: 133 LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGV 191
           L+L  LL F+  + +GM +L  +N IHRD+   N+L+   +V K+ DFG+AR   N    
Sbjct: 149 LELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 208
Query: 192 MTAETG--TYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKV-PYDSM 238
           +         +WMAPE I    Y  ++DV+S+ I+LWE+ +  + PY  +
Sbjct: 209 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 258

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 76/234 (32%), Positives = 114/234 (48%), Gaps = 29/234 (12%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-------VAVKVLRSEHLNDTLEDEF 82
           +  WE  R  LK G+ +  G+ G +      G D       VAVK+L+ E    +     
Sbjct: 19  ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRAL 77
Query: 83  VQEVAILREVQHR-NVVRFIGASTK-SPHLCIVTEYMPGGSLYDYLHKNHN--------- 131
           + E+ IL  + H  NVV  +GA TK    L ++ E+   G+L  YL    N         
Sbjct: 78  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 137
Query: 132 ------VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR- 184
                  L L  L+ ++  + KGME+L  R  IHRDL   N+L+   NVVK+ DFG+AR 
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 185 -FQNKGGVMTAETG-TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
            +++   V   +     +WMAPE I  + Y  ++DV+SF ++LWE+ +    PY
Sbjct: 198 IYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 63/186 (33%), Positives = 102/186 (54%), Gaps = 16/186 (8%)
Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VA+K L+  +      D F+ E +I+ +  H N++R  G  TKS  + IVTE M  GSL 
Sbjct: 76  VAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD 134
Query: 124 DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA 183
            +L K+     + QL+     I  GM+YL     +HRDL   N+L++++ V KV+DFG++
Sbjct: 135 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 184 R---------FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKV 233
           R         +  +GG +       RW +PE I ++ +   +DV+S+ IVLWE+++  + 
Sbjct: 195 RVLEDDPEAAYTTRGGKI-----PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 234 PYDSMT 239
           PY  M+
Sbjct: 250 PYWEMS 255

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 63/186 (33%), Positives = 102/186 (54%), Gaps = 16/186 (8%)
Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VA+K L+  +      D F+ E +I+ +  H N++R  G  TKS  + IVTE M  GSL 
Sbjct: 76  VAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD 134
Query: 124 DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA 183
            +L K+     + QL+     I  GM+YL     +HRDL   N+L++++ V KV+DFG++
Sbjct: 135 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 184 R---------FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKV 233
           R         +  +GG +       RW +PE I ++ +   +DV+S+ IVLWE+++  + 
Sbjct: 195 RVLEDDPEAAYTTRGGKI-----PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 234 PYDSMT 239
           PY  M+
Sbjct: 250 PYWEMS 255

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 108/204 (52%), Gaps = 9/204 (4%)
Query: 44  ERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFV-QEVAILREVQHRNVVRF 100
           E+I  G+ G +Y    V  GQ+VA+   R  +L    + E +  E+ ++RE ++ N+V +
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAI---RQMNLQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
           + +      L +V EY+ GGSL D +      +   Q+     +  + +E+LH   +IHR
Sbjct: 83  LDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 161 DLKTANLLMDTHNVVKVADFG-VARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVF 219
           D+K+ N+L+     VK+ DFG  A+   +    +   GT  WMAPEV+  + Y  K D++
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 220 SFAIVLWELVTAKVPYDSMTPLQA 243
           S  I+  E++  + PY +  PL+A
Sbjct: 201 SLGIMAIEMIEGEPPYLNENPLRA 224

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 115/208 (55%), Gaps = 14/208 (6%)
Query: 35  IDRRLLKTGERIASGSCG--DLYRGVYLGQD----VAVKVLRSEHLNDTLEDEFVQEVAI 88
            + R LK   ++  G+ G  +L R   LG +    VAVK L  +H     + +F +E+ I
Sbjct: 7   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQI 64
Query: 89  LREVQHRNVVRFIGAS--TKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDIC 146
           L+ +    +V++ G S       L +V EY+P G L D+L ++   L   +LL ++  IC
Sbjct: 65  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 124
Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETGTYR--WM 202
           KGMEYL  R  +HRDL   N+L+++   VK+ADFG+A+    +K   +  E G     W 
Sbjct: 125 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 184
Query: 203 APEVINHQPYDQKADVFSFAIVLWELVT 230
           APE ++   + +++DV+SF +VL+EL T
Sbjct: 185 APESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 109/206 (52%), Gaps = 15/206 (7%)
Query: 37  RRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           +R LK    +  G  G +    Y       G+ VAVK L+++         + QE+ ILR
Sbjct: 30  KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILR 88
Query: 91  EVQHRNVVRFIGA--STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
            + H +++++ G      +  L +V EY+P GSL DYL ++   + L QLL FA  IC+G
Sbjct: 89  TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEG 146
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG----VMTAETGTYRWMAP 204
           M YLH ++ IHRDL   N+L+D   +VK+ DFG+A+   +G     V         W AP
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAP 206
Query: 205 EVINHQPYDQKADVFSFAIVLWELVT 230
           E +    +   +DV+SF + L+EL+T
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 115/208 (55%), Gaps = 14/208 (6%)
Query: 35  IDRRLLKTGERIASGSCG--DLYRGVYLGQD----VAVKVLRSEHLNDTLEDEFVQEVAI 88
            + R LK   ++  G+ G  +L R   LG +    VAVK L  +H     + +F +E+ I
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQI 65
Query: 89  LREVQHRNVVRFIGAS--TKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDIC 146
           L+ +    +V++ G S       L +V EY+P G L D+L ++   L   +LL ++  IC
Sbjct: 66  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 125
Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETGTYR--WM 202
           KGMEYL  R  +HRDL   N+L+++   VK+ADFG+A+    +K   +  E G     W 
Sbjct: 126 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 185
Query: 203 APEVINHQPYDQKADVFSFAIVLWELVT 230
           APE ++   + +++DV+SF +VL+EL T
Sbjct: 186 APESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 108/204 (52%), Gaps = 9/204 (4%)
Query: 44  ERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFV-QEVAILREVQHRNVVRF 100
           E+I  G+ G +Y    V  GQ+VA+   R  +L    + E +  E+ ++RE ++ N+V +
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAI---RQMNLQQQPKKELIINEILVMRENKNPNIVNY 83
Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
           + +      L +V EY+ GGSL D +      +   Q+     +  + +E+LH   +IHR
Sbjct: 84  LDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQVIHR 141
Query: 161 DLKTANLLMDTHNVVKVADFG-VARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVF 219
           D+K+ N+L+     VK+ DFG  A+   +    +   GT  WMAPEV+  + Y  K D++
Sbjct: 142 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIW 201
Query: 220 SFAIVLWELVTAKVPYDSMTPLQA 243
           S  I+  E++  + PY +  PL+A
Sbjct: 202 SLGIMAIEMIEGEPPYLNENPLRA 225

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 118/228 (51%), Gaps = 25/228 (10%)
Query: 46  IASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           + SG+ G +Y+G+++ +       VA+K LR E  +     E + E  ++  V + +V R
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + ++T+ MP G L DY+ ++ + +    LL + + I KGM YL  R ++H
Sbjct: 84  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---------RWMAPEVINHQ 210
           RDL   N+L+ T   VK+ DFG A+      ++ AE   Y         +WMA E I H+
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGRAK------LLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y  ++DV+S+ + +WEL+T    PYD + P      + +    L QP
Sbjct: 197 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQP 243

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 72/230 (31%), Positives = 117/230 (50%), Gaps = 22/230 (9%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLG---QD----VAVKVLRSEHLNDTLEDEF 82
           +E WE  R  L+ G+ + +G+ G +      G   +D    VAVK+L+S    D  E   
Sbjct: 38  NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE-AL 96
Query: 83  VQEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV--------- 132
           + E+ I+  + QH N+V  +GA T    + ++TEY   G L ++L +             
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRP 156
Query: 133 LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGV 191
           L+L  LL F+  + +GM +L  +N IHRD+   N+L+   +V K+ DFG+AR   N    
Sbjct: 157 LELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 216
Query: 192 MTAETG--TYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKV-PYDSM 238
           +         +WMAPE I    Y  ++DV+S+ I+LWE+ +  + PY  +
Sbjct: 217 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 266

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 118/228 (51%), Gaps = 25/228 (10%)
Query: 46  IASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           + SG+ G +Y+G+++ +       VA+K LR E  +     E + E  ++  V + +V R
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + ++T+ MP G L DY+ ++ + +    LL + + I KGM YL  R ++H
Sbjct: 89  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 147
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---------RWMAPEVINHQ 210
           RDL   N+L+ T   VK+ DFG A+      ++ AE   Y         +WMA E I H+
Sbjct: 148 RDLAARNVLVKTPQHVKITDFGRAK------LLGAEEKEYHAEGGKVPIKWMALESILHR 201
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y  ++DV+S+ + +WEL+T    PYD + P      + +    L QP
Sbjct: 202 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQP 248

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 108/204 (52%), Gaps = 9/204 (4%)
Query: 44  ERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFV-QEVAILREVQHRNVVRF 100
           E+I  G+ G +Y    V  GQ+VA+   R  +L    + E +  E+ ++RE ++ N+V +
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAI---RQMNLQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
           + +      L +V EY+ GGSL D +      +   Q+     +  + +E+LH   +IHR
Sbjct: 83  LDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 161 DLKTANLLMDTHNVVKVADFG-VARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVF 219
           D+K+ N+L+     VK+ DFG  A+   +    +   GT  WMAPEV+  + Y  K D++
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 220 SFAIVLWELVTAKVPYDSMTPLQA 243
           S  I+  E++  + PY +  PL+A
Sbjct: 201 SLGIMAIEMIEGEPPYLNENPLRA 224

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 76/234 (32%), Positives = 114/234 (48%), Gaps = 29/234 (12%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-------VAVKVLRSEHLNDTLEDEF 82
           +  WE  R  LK G+ +  G+ G +      G D       VAVK+L+ E    +     
Sbjct: 56  ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRAL 114
Query: 83  VQEVAILREVQHR-NVVRFIGASTK-SPHLCIVTEYMPGGSLYDYLHKNHN--------- 131
           + E+ IL  + H  NVV  +GA TK    L ++ E+   G+L  YL    N         
Sbjct: 115 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 174
Query: 132 ------VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR- 184
                  L L  L+ ++  + KGME+L  R  IHRDL   N+L+   NVVK+ DFG+AR 
Sbjct: 175 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 234
Query: 185 -FQNKGGVMTAETG-TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
            +++   V   +     +WMAPE I  + Y  ++DV+SF ++LWE+ +    PY
Sbjct: 235 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 288

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 76/229 (33%), Positives = 112/229 (48%), Gaps = 27/229 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD-------VAVKVLRSEHLNDTLEDEFVQE 85
           WE  R  LK G+ +  G+ G +      G D       VAVK+L+ E    +     + E
Sbjct: 24  WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLK-EGATHSEHRALMSE 82
Query: 86  VAILREVQHR-NVVRFIGASTK-SPHLCIVTEYMPGGSLYDYLHKNHN------------ 131
           + IL  + H  NVV  +GA TK    L ++ E+   G+L  YL    N            
Sbjct: 83  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYK 142
Query: 132 -VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR--FQNK 188
             L L  L+ ++  + KGME+L  R  IHRDL   N+L+   NVVK+ DFG+AR   ++ 
Sbjct: 143 DFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 202
Query: 189 GGVMTAETG-TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
             V   +     +WMAPE I  + Y  ++DV+SF ++LWE+ +    PY
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 115/208 (55%), Gaps = 14/208 (6%)
Query: 35  IDRRLLKTGERIASGSCG--DLYRGVYLGQD----VAVKVLRSEHLNDTLEDEFVQEVAI 88
            + R LK   ++  G+ G  +L R   LG +    VAVK L  +H     + +F +E+ I
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQI 77
Query: 89  LREVQHRNVVRFIGAS--TKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDIC 146
           L+ +    +V++ G S       L +V EY+P G L D+L ++   L   +LL ++  IC
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETGTYR--WM 202
           KGMEYL  R  +HRDL   N+L+++   VK+ADFG+A+    +K   +  E G     W 
Sbjct: 138 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197
Query: 203 APEVINHQPYDQKADVFSFAIVLWELVT 230
           APE ++   + +++DV+SF +VL+EL T
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 121/222 (54%), Gaps = 12/222 (5%)
Query: 32  DWEIDRRLLKTGERI--ASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           D+E D    + G+R+    G+ G +Y G  L   V + +      +        +E+A+ 
Sbjct: 4   DYEYD----ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALH 59
Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLK-LPQLLRFAI-DICK 147
           + ++H+N+V+++G+ +++  + I  E +PGGSL   L      LK   Q + F    I +
Sbjct: 60  KHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE 119
Query: 148 GMEYLHQRNIIHRDLKTANLLMDTHN-VVKVADFGVA-RFQNKGGVMTAETGTYRWMAPE 205
           G++YLH   I+HRD+K  N+L++T++ V+K++DFG + R           TGT ++MAPE
Sbjct: 120 GLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPE 179
Query: 206 VINHQP--YDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL 245
           +I+  P  Y + AD++S    + E+ T K P+  +   QAA+
Sbjct: 180 IIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM 221

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 118/228 (51%), Gaps = 25/228 (10%)
Query: 46  IASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           + SG+ G +Y+G+++ +       VA+K LR E  +     E + E  ++  V + +V R
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + ++T+ MP G L DY+ ++ + +    LL + + I KGM YL  R ++H
Sbjct: 82  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---------RWMAPEVINHQ 210
           RDL   N+L+ T   VK+ DFG A+      ++ AE   Y         +WMA E I H+
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGRAK------LLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y  ++DV+S+ + +WEL+T    PYD + P      + +    L QP
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQP 241

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 108/204 (52%), Gaps = 9/204 (4%)
Query: 44  ERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFV-QEVAILREVQHRNVVRF 100
           E+I  G+ G +Y    V  GQ+VA+   R  +L    + E +  E+ ++RE ++ N+V +
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAI---RQMNLQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
           + +      L +V EY+ GGSL D +      +   Q+     +  + +E+LH   +IHR
Sbjct: 83  LDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 161 DLKTANLLMDTHNVVKVADFG-VARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVF 219
           D+K+ N+L+     VK+ DFG  A+   +    +   GT  WMAPEV+  + Y  K D++
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 220 SFAIVLWELVTAKVPYDSMTPLQA 243
           S  I+  E++  + PY +  PL+A
Sbjct: 201 SLGIMAIEMIEGEPPYLNENPLRA 224

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score =  108 bits (271), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 76/234 (32%), Positives = 114/234 (48%), Gaps = 29/234 (12%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-------VAVKVLRSEHLNDTLEDEF 82
           +  WE  R  LK G+ +  G+ G +      G D       VAVK+L+ E    +     
Sbjct: 21  ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRAL 79
Query: 83  VQEVAILREVQHR-NVVRFIGASTK-SPHLCIVTEYMPGGSLYDYLHKNHN--------- 131
           + E+ IL  + H  NVV  +GA TK    L ++ E+   G+L  YL    N         
Sbjct: 80  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAP 139
Query: 132 ------VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR- 184
                  L L  L+ ++  + KGME+L  R  IHRDL   N+L+   NVVK+ DFG+AR 
Sbjct: 140 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 199
Query: 185 -FQNKGGVMTAETG-TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
            +++   V   +     +WMAPE I  + Y  ++DV+SF ++LWE+ +    PY
Sbjct: 200 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 253

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score =  108 bits (271), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 75/230 (32%), Positives = 113/230 (49%), Gaps = 25/230 (10%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-------VAVKVLRSEHLNDTLEDEF 82
           +  WE  R  L  G+ +  G+ G +      G D       VAVK+L+ E    +     
Sbjct: 19  ASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLK-EGATHSEHRAL 77
Query: 83  VQEVAILREVQHR-NVVRFIGASTK-SPHLCIVTEYMPGGSLYDYLHKNHN--------- 131
           + E+ IL  + H  NVV  +GA TK    L ++ E+   G+L  YL    N         
Sbjct: 78  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLY 137
Query: 132 --VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR--FQN 187
              L L  L+ ++  + KGME+L  R  IHRDL   N+L+   NVVK+ DFG+AR  +++
Sbjct: 138 KDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKD 197
Query: 188 KGGVMTAETG-TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
              V   +     +WMAPE I  + Y  ++DV+SF ++LWE+ +    PY
Sbjct: 198 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 247

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  108 bits (271), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 113/198 (57%), Gaps = 4/198 (2%)
Query: 44  ERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           ++I  GS G   L +    G+   +K +    ++    +E  +EVA+L  ++H N+V++ 
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVL-KLPQLLRFAIDICKGMEYLHQRNIIHR 160
            +  ++  L IV +Y  GG L+  ++    VL +  Q+L + + IC  ++++H R I+HR
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHR 149
Query: 161 DLKTANLLMDTHNVVKVADFGVARFQNKG-GVMTAETGTYRWMAPEVINHQPYDQKADVF 219
           D+K+ N+ +     V++ DFG+AR  N    +  A  GT  +++PE+  ++PY+ K+D++
Sbjct: 150 DIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIW 209
Query: 220 SFAIVLWELVTAKVPYDS 237
           +   VL+EL T K  +++
Sbjct: 210 ALGCVLYELCTLKHAFEA 227

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score =  108 bits (271), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 76/234 (32%), Positives = 114/234 (48%), Gaps = 29/234 (12%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-------VAVKVLRSEHLNDTLEDEF 82
           +  WE  R  LK G+ +  G+ G +      G D       VAVK+L+ E    +     
Sbjct: 19  ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRAL 77
Query: 83  VQEVAILREVQHR-NVVRFIGASTK-SPHLCIVTEYMPGGSLYDYLHKNHN--------- 131
           + E+ IL  + H  NVV  +GA TK    L ++ E+   G+L  YL    N         
Sbjct: 78  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 137
Query: 132 ------VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR- 184
                  L L  L+ ++  + KGME+L  R  IHRDL   N+L+   NVVK+ DFG+AR 
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 185 -FQNKGGVMTAETG-TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
            +++   V   +     +WMAPE I  + Y  ++DV+SF ++LWE+ +    PY
Sbjct: 198 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score =  108 bits (271), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 119/228 (52%), Gaps = 25/228 (10%)
Query: 46  IASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           ++SG+ G +Y+G+++ +       VA+K LR E  +     E + E  ++  V + +V R
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + ++ + MP G L DY+ ++ + +    LL + + I KGM YL  R ++H
Sbjct: 89  LLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 147
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---------RWMAPEVINHQ 210
           RDL   N+L+ T   VK+ DFG+A+      ++ AE   Y         +WMA E I H+
Sbjct: 148 RDLAARNVLVKTPQHVKITDFGLAK------LLGAEEKEYHAEGGKVPIKWMALESILHR 201
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y  ++DV+S+ + +WEL+T    PYD + P      + +    L QP
Sbjct: 202 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQP 248

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score =  108 bits (271), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 119/228 (52%), Gaps = 25/228 (10%)
Query: 46  IASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           + SG+ G +Y+G+++ +       VA+K LR E  +     E + E  ++  V + +V R
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 78
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + ++T+ MP G L DY+ ++ + +    LL + + I +GM YL  R ++H
Sbjct: 79  LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDRRLVH 137
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---------RWMAPEVINHQ 210
           RDL   N+L+ T   VK+ DFG+A+      ++ AE   Y         +WMA E I H+
Sbjct: 138 RDLAARNVLVKTPQHVKITDFGLAK------LLGAEEKEYHAEGGKVPIKWMALESILHR 191
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y  ++DV+S+ + +WEL+T    PYD + P      + +    L QP
Sbjct: 192 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQP 238

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score =  108 bits (271), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 118/228 (51%), Gaps = 25/228 (10%)
Query: 46  IASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           + SG+ G +Y+G+++ +       VA+K LR E  +     E + E  ++  V + +V R
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + ++ + MP G L DY+ ++ + +    LL + + I KGM YL  R ++H
Sbjct: 83  LLGICLTS-TVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 141
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---------RWMAPEVINHQ 210
           RDL   N+L+ T   VK+ DFG+A+      ++ AE   Y         +WMA E I H+
Sbjct: 142 RDLAARNVLVKTPQHVKITDFGLAK------LLGAEEKEYHAEGGKVPIKWMALESILHR 195
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y  ++DV+S+ + +WEL+T    PYD + P      + +    L QP
Sbjct: 196 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQP 242

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 117/228 (51%), Gaps = 25/228 (10%)
Query: 46  IASGSCGDLYRGVYLGQDVAVKV------LRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           + SG+ G +Y+G+++ +   VK+      LR E  +     E + E  ++  V + +V R
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELR-EATSPKANKEILDEAYVMASVDNPHVCR 115
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + ++T+ MP G L DY+ ++ + +    LL + + I KGM YL  R ++H
Sbjct: 116 LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 174
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---------RWMAPEVINHQ 210
           RDL   N+L+ T   VK+ DFG+A+       + AE   Y         +WMA E I H+
Sbjct: 175 RDLAARNVLVKTPQHVKITDFGLAKL------LGAEEKEYHAEGGKVPIKWMALESILHR 228
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y  ++DV+S+ + +WEL+T    PYD + P      + +    L QP
Sbjct: 229 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQP 275

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 118/228 (51%), Gaps = 25/228 (10%)
Query: 46  IASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           + SG+ G +Y+G+++ +       VA+K LR E  +     E + E  ++  V + +V R
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + ++ + MP G L DY+ ++ + +    LL + + I KGM YL  R ++H
Sbjct: 86  LLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 144
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---------RWMAPEVINHQ 210
           RDL   N+L+ T   VK+ DFG+A+      ++ AE   Y         +WMA E I H+
Sbjct: 145 RDLAARNVLVKTPQHVKITDFGLAK------LLGAEEKEYHAEGGKVPIKWMALESILHR 198
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y  ++DV+S+ + +WEL+T    PYD + P      + +    L QP
Sbjct: 199 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQP 245

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 118/228 (51%), Gaps = 25/228 (10%)
Query: 46  IASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           + SG+ G +Y+G+++ +       VA+K LR E  +     E + E  ++  V + +V R
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + ++ + MP G L DY+ ++ + +    LL + + I KGM YL  R ++H
Sbjct: 85  LLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 143
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---------RWMAPEVINHQ 210
           RDL   N+L+ T   VK+ DFG+A+      ++ AE   Y         +WMA E I H+
Sbjct: 144 RDLAARNVLVKTPQHVKITDFGLAK------LLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y  ++DV+S+ + +WEL+T    PYD + P      + +    L QP
Sbjct: 198 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQP 244

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 118/228 (51%), Gaps = 25/228 (10%)
Query: 46  IASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           + SG+ G +Y+G+++ +       VA+K LR E  +     E + E  ++  V + +V R
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + ++ + MP G L DY+ ++ + +    LL + + I KGM YL  R ++H
Sbjct: 84  LLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---------RWMAPEVINHQ 210
           RDL   N+L+ T   VK+ DFG+A+      ++ AE   Y         +WMA E I H+
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGLAK------LLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y  ++DV+S+ + +WEL+T    PYD + P      + +    L QP
Sbjct: 197 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQP 243

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 118/228 (51%), Gaps = 25/228 (10%)
Query: 46  IASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           + SG+ G +Y+G+++ +       VA+K LR E  +     E + E  ++  V + +V R
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + ++ + MP G L DY+ ++ + +    LL + + I KGM YL  R ++H
Sbjct: 83  LLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 141
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---------RWMAPEVINHQ 210
           RDL   N+L+ T   VK+ DFG+A+      ++ AE   Y         +WMA E I H+
Sbjct: 142 RDLAARNVLVKTPQHVKITDFGLAK------LLGAEEKEYHAEGGKVPIKWMALESILHR 195
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y  ++DV+S+ + +WEL+T    PYD + P      + +    L QP
Sbjct: 196 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQP 242

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 75/230 (32%), Positives = 113/230 (49%), Gaps = 25/230 (10%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-------VAVKVLRSEHLNDTLEDEF 82
           +  WE  R  L  G+ +  G+ G +      G D       VAVK+L+ E    +     
Sbjct: 19  ASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLK-EGATHSEHRAL 77
Query: 83  VQEVAILREVQHR-NVVRFIGASTK-SPHLCIVTEYMPGGSLYDYLHKNHN--------- 131
           + E+ IL  + H  NVV  +GA TK    L ++ E+   G+L  YL    N         
Sbjct: 78  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLY 137
Query: 132 --VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR--FQN 187
              L L  L+ ++  + KGME+L  R  IHRDL   N+L+   NVVK+ DFG+AR  +++
Sbjct: 138 KDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKD 197
Query: 188 KGGVMTAETG-TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
              V   +     +WMAPE I  + Y  ++DV+SF ++LWE+ +    PY
Sbjct: 198 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 247

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 76/234 (32%), Positives = 113/234 (48%), Gaps = 29/234 (12%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-------VAVKVLRSEHLNDTLEDEF 82
           +  WE  R  LK G+ +  G+ G +      G D       VAVK+L+ E    +     
Sbjct: 10  ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRAL 68
Query: 83  VQEVAILREVQHR-NVVRFIGASTK-SPHLCIVTEYMPGGSLYDYLHKNHN--------- 131
           + E+ IL  + H  NVV  +GA TK    L ++ E+   G+L  YL    N         
Sbjct: 69  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 128
Query: 132 ------VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR- 184
                  L L  L+ ++  + KGME+L  R  IHRDL   N+L+   NVVK+ DFG+AR 
Sbjct: 129 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 188
Query: 185 -FQNKGGVMTAETG-TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
             ++   V   +     +WMAPE I  + Y  ++DV+SF ++LWE+ +    PY
Sbjct: 189 IXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 118/228 (51%), Gaps = 25/228 (10%)
Query: 46  IASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           + SG+ G +Y+G+++ +       VA+K LR E  +     E + E  ++  V + +V R
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + ++ + MP G L DY+ ++ + +    LL + + I KGM YL  R ++H
Sbjct: 82  LLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 140
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---------RWMAPEVINHQ 210
           RDL   N+L+ T   VK+ DFG+A+      ++ AE   Y         +WMA E I H+
Sbjct: 141 RDLAARNVLVKTPQHVKITDFGLAK------LLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y  ++DV+S+ + +WEL+T    PYD + P      + +    L QP
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQP 241

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score =  108 bits (269), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 72/234 (30%), Positives = 117/234 (50%), Gaps = 26/234 (11%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLG---QD----VAVKVLRSEHLNDTLEDEF 82
           +E WE  R  L+ G+ + +G+ G +      G   +D    VAVK+L+S    D  E   
Sbjct: 38  NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE-AL 96
Query: 83  VQEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLP----- 136
           + E+ I+  + QH N+V  +GA T    + ++TEY   G L ++L +   VL+       
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156
Query: 137 --------QLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-FQN 187
                    LL F+  + +GM +L  +N IHRD+   N+L+   +V K+ DFG+AR   N
Sbjct: 157 ANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 188 KGGVMTAETG--TYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKV-PYDSM 238
               +         +WMAPE I    Y  ++DV+S+ I+LWE+ +  + PY  +
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score =  108 bits (269), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 72/234 (30%), Positives = 117/234 (50%), Gaps = 26/234 (11%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLG---QD----VAVKVLRSEHLNDTLEDEF 82
           +E WE  R  L+ G+ + +G+ G +      G   +D    VAVK+L+S    D  E   
Sbjct: 38  NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE-AL 96
Query: 83  VQEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLP----- 136
           + E+ I+  + QH N+V  +GA T    + ++TEY   G L ++L +   VL+       
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156
Query: 137 --------QLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-FQN 187
                    LL F+  + +GM +L  +N IHRD+   N+L+   +V K+ DFG+AR   N
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 188 KGGVMTAETG--TYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKV-PYDSM 238
               +         +WMAPE I    Y  ++DV+S+ I+LWE+ +  + PY  +
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 76/234 (32%), Positives = 113/234 (48%), Gaps = 29/234 (12%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-------VAVKVLRSEHLNDTLEDEF 82
           +  WE  R  LK G+ +  G+ G +      G D       VAVK+L+ E    +     
Sbjct: 19  ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRAL 77
Query: 83  VQEVAILREVQHR-NVVRFIGASTK-SPHLCIVTEYMPGGSLYDYLHKNHN--------- 131
           + E+ IL  + H  NVV  +GA TK    L ++ E+   G+L  YL    N         
Sbjct: 78  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 137
Query: 132 ------VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR- 184
                  L L  L+ ++  + KGME+L  R  IHRDL   N+L+   NVVK+ DFG+AR 
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 185 -FQNKGGVMTAETG-TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
             ++   V   +     +WMAPE I  + Y  ++DV+SF ++LWE+ +    PY
Sbjct: 198 IXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  107 bits (268), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 108/204 (52%), Gaps = 9/204 (4%)
Query: 44  ERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFV-QEVAILREVQHRNVVRF 100
           E+I  G+ G +Y    V  GQ+VA+   R  +L    + E +  E+ ++RE ++ N+V +
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAI---RQMNLQQQPKKELIINEILVMRENKNPNIVNY 83
Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
           + +      L +V EY+ GGSL D +      +   Q+     +  + +E+LH   +IHR
Sbjct: 84  LDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQVIHR 141
Query: 161 DLKTANLLMDTHNVVKVADFGV-ARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVF 219
           ++K+ N+L+     VK+ DFG  A+   +    +   GT  WMAPEV+  + Y  K D++
Sbjct: 142 NIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 201
Query: 220 SFAIVLWELVTAKVPYDSMTPLQA 243
           S  I+  E++  + PY +  PL+A
Sbjct: 202 SLGIMAIEMIEGEPPYLNENPLRA 225

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  107 bits (267), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 121/239 (50%), Gaps = 18/239 (7%)
Query: 26  SQTKSEDWEIDRRLLKTGE------RIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDT 77
           S  KS ++E  RR L   E       +  G+ G +Y+      G   A KV+ ++   + 
Sbjct: 1   SMRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEE 59
Query: 78  LEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
           LED ++ E+ IL    H  +V+ +GA      L I+ E+ PGG++   + +    L  PQ
Sbjct: 60  LED-YIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ 118
Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET- 196
           +      + + + +LH + IIHRDLK  N+LM     +++ADFGV+  +N   +   ++ 
Sbjct: 119 IQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA-KNLKTLQKRDSF 177
Query: 197 -GTYRWMAPEVI-----NHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
            GT  WMAPEV+        PYD KAD++S  I L E+   + P+  + P++  L + +
Sbjct: 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK 236

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score =  107 bits (267), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 108/206 (52%), Gaps = 15/206 (7%)
Query: 37  RRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           +R LK    +  G  G +    Y       G+ VAVK L+++         + QE+ ILR
Sbjct: 13  KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-CGPQHRSGWKQEIDILR 71
Query: 91  EVQHRNVVRFIGASTK--SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
            + H +++++ G         L +V EY+P GSL DYL ++   + L QLL FA  IC+G
Sbjct: 72  TLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEG 129
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG----VMTAETGTYRWMAP 204
           M YLH ++ IHR+L   N+L+D   +VK+ DFG+A+   +G     V         W AP
Sbjct: 130 MAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 189
Query: 205 EVINHQPYDQKADVFSFAIVLWELVT 230
           E +    +   +DV+SF + L+EL+T
Sbjct: 190 ECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  107 bits (267), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 106/195 (54%), Gaps = 12/195 (6%)
Query: 46  IASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST 105
           I S   G  Y    L +++ V++ + EH ND        E  +L  V H  ++R  G   
Sbjct: 25  IRSRHNGRYYAMKVLKKEIVVRLKQVEHTND--------ERLMLSIVTHPFIIRMWGTFQ 76
Query: 106 KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTA 165
            +  + ++ +Y+ GG L+  L K+      P    +A ++C  +EYLH ++II+RDLK  
Sbjct: 77  DAQQIFMIMDYIEGGELFSLLRKSQRFPN-PVAKFYAAEVCLALEYLHSKDIIYRDLKPE 135
Query: 166 NLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVL 225
           N+L+D +  +K+ DFG A++     V     GT  ++APEV++ +PY++  D +SF I++
Sbjct: 136 NILLDKNGHIKITDFGFAKYV--PDVTYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILI 193
Query: 226 WELVTAKVP-YDSMT 239
           +E++    P YDS T
Sbjct: 194 YEMLAGYTPFYDSNT 208

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score =  107 bits (267), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 117/228 (51%), Gaps = 25/228 (10%)
Query: 46  IASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           + SG+ G +Y+G+++ +       VA+K LR E  +     E + E  ++  V + +V R
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + ++ + MP G L DY+ ++ + +    LL + + I KGM YL  R ++H
Sbjct: 84  LLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---------RWMAPEVINHQ 210
           RDL   N+L+ T   VK+ DFG A+      ++ AE   Y         +WMA E I H+
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGRAK------LLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y  ++DV+S+ + +WEL+T    PYD + P      + +    L QP
Sbjct: 197 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQP 243

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score =  107 bits (267), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 117/228 (51%), Gaps = 25/228 (10%)
Query: 46  IASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           + SG+ G +Y+G+++ +       VA+K LR E  +     E + E  ++  V + +V R
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + ++ + MP G L DY+ ++ + +    LL + + I KGM YL  R ++H
Sbjct: 84  LLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 142
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---------RWMAPEVINHQ 210
           RDL   N+L+ T   VK+ DFG A+      ++ AE   Y         +WMA E I H+
Sbjct: 143 RDLAARNVLVKTPQHVKITDFGRAK------LLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y  ++DV+S+ + +WEL+T    PYD + P      + +    L QP
Sbjct: 197 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQP 243

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score =  107 bits (266), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 108/206 (52%), Gaps = 15/206 (7%)
Query: 37  RRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           +R LK    +  G  G +    Y       G+ VAVK L+++         + QE+ ILR
Sbjct: 13  KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-CGPQHRSGWKQEIDILR 71
Query: 91  EVQHRNVVRFIGASTK--SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
            + H +++++ G         L +V EY+P GSL DYL ++   + L QLL FA  IC+G
Sbjct: 72  TLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEG 129
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG----VMTAETGTYRWMAP 204
           M YLH ++ IHR+L   N+L+D   +VK+ DFG+A+   +G     V         W AP
Sbjct: 130 MAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 189
Query: 205 EVINHQPYDQKADVFSFAIVLWELVT 230
           E +    +   +DV+SF + L+EL+T
Sbjct: 190 ECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score =  107 bits (266), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 117/228 (51%), Gaps = 25/228 (10%)
Query: 46  IASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           + SG+ G +Y+G+++ +       VA+K LR E  +     E + E  ++  V + +V R
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + ++ + MP G L DY+ ++ + +    LL + + I KGM YL  R ++H
Sbjct: 86  LLGICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 144
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---------RWMAPEVINHQ 210
           RDL   N+L+ T   VK+ DFG A+      ++ AE   Y         +WMA E I H+
Sbjct: 145 RDLAARNVLVKTPQHVKITDFGRAK------LLGAEEKEYHAEGGKVPIKWMALESILHR 198
Query: 211 PYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
            Y  ++DV+S+ + +WEL+T    PYD + P      + +    L QP
Sbjct: 199 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQP 245

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score =  107 bits (266), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 73/232 (31%), Positives = 116/232 (50%), Gaps = 22/232 (9%)
Query: 25  ESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDTL 78
           E + K ED  I  +    G  +  G  G + R   L Q+      VAVK+L+++ +  + 
Sbjct: 10  ELKEKLEDVLIPEQQFTLGRMLGKGEFGSV-REAQLKQEDGSFVKVAVKMLKADIIASSD 68
Query: 79  EDEFVQEVAILREVQHRNVVRFIGASTKS------PHLCIVTEYMPGGSLYDYL-----H 127
            +EF++E A ++E  H +V + +G S +S      P   ++  +M  G L+ +L      
Sbjct: 69  IEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIG 128
Query: 128 KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN 187
           +N   L L  L+RF +DI  GMEYL  RN IHRDL   N ++     V VADFG++R   
Sbjct: 129 ENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIY 188
Query: 188 KGGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
            G       A     +W+A E +    Y   +DV++F + +WE++T  + PY
Sbjct: 189 SGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 116/213 (54%), Gaps = 22/213 (10%)
Query: 44  ERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLED--------EFVQEVAILREVQHR 95
           ++I  G  G +++G  L +D +V  ++S  L D+  +        EF +EV I+  + H 
Sbjct: 25  KQIGKGGFGLVHKG-RLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 96  NVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR 155
           N+V+  G     P +  V E++P G LY  L    + +K    LR  +DI  G+EY+  +
Sbjct: 84  NIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 156 N--IIHRDLKTANLLMDTHN-----VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN 208
           N  I+HRDL++ N+ + + +       KVADFG++  Q     ++   G ++WMAPE I 
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS--QQSVHSVSGLLGNFQWMAPETIG 199
Query: 209 --HQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
              + Y +KAD +SFA++L+ ++T + P+D  +
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 68/178 (38%), Positives = 99/178 (55%), Gaps = 13/178 (7%)
Query: 61  GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA----STKSPHLCIVTEY 116
           G+ VAVK L+ E     L   + +E+ ILR + H ++V++ G       KS  L  V EY
Sbjct: 38  GEMVAVKALK-EGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQL--VMEY 94
Query: 117 MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVK 176
           +P GSL DYL ++   + L QLL FA  IC+GM YLH ++ IHR L   N+L+D   +VK
Sbjct: 95  VPLGSLRDYLPRH--CVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVK 152
Query: 177 VADFGVARFQNKGG----VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
           + DFG+A+   +G     V         W APE +    +   +DV+SF + L+EL+T
Sbjct: 153 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 110/203 (54%), Gaps = 12/203 (5%)
Query: 46  IASGSCGDLYRGVYL--GQDV----AVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           + SG+ G +Y+G+++  G++V    A+KVLR E+ +     E + E  ++  V    V R
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLR-ENTSPKANKEILDEAYVMAGVGSPYVSR 83
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +G    S  + +VT+ MP G L D++ +N   L    LL + + I KGM YL    ++H
Sbjct: 84  LLGICLTS-TVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVH 142
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETG---TYRWMAPEVINHQPYDQKA 216
           RDL   N+L+ + N VK+ DFG+AR  +         G     +WMA E I  + +  ++
Sbjct: 143 RDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQS 202
Query: 217 DVFSFAIVLWELVT-AKVPYDSM 238
           DV+S+ + +WEL+T    PYD +
Sbjct: 203 DVWSYGVTVWELMTFGAKPYDGI 225

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 104/203 (51%), Gaps = 8/203 (3%)
Query: 36  DRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRS--EHLNDTLEDEFVQEVAILREVQ 93
           +R +   G +   G  G +Y+G      VAVK L +  +   + L+ +F QE+ +  + Q
Sbjct: 20  ERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQ 79
Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH--KNHNVLKLPQLLRFAIDICKGMEY 151
           H N+V  +G S+    LC+V  Y P GSL D L        L      + A     G+ +
Sbjct: 80  HENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINF 139
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET---GTYRWMAPEVIN 208
           LH+ + IHRD+K+AN+L+D     K++DFG+AR   K       +   GT  + APE + 
Sbjct: 140 LHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALR 199
Query: 209 HQPYDQKADVFSFAIVLWELVTA 231
            +    K+D++SF +VL E++T 
Sbjct: 200 GE-ITPKSDIYSFGVVLLEIITG 221

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 112/233 (48%), Gaps = 28/233 (12%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-------VAVKVLRSEHLNDTLEDEF 82
           +  WE  R  L  G+ +  G+ G +      G D       VAVK+L+ E    +     
Sbjct: 20  ASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRAL 78
Query: 83  VQEVAILREVQHR-NVVRFIGASTK-SPHLCIVTEYMPGGSLYDYLHKNHN--------- 131
           + E+ IL  + H  NVV  +GA TK    L ++ E+   G+L  YL    N         
Sbjct: 79  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPE 138
Query: 132 -----VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-- 184
                 L L  L+ ++  + KGME+L  R  IHRDL   N+L+   NVVK+ DFG+AR  
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 185 FQNKGGVMTAETG-TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
            ++   V   +     +WMAPE I  + Y  ++DV+SF ++LWE+ +    PY
Sbjct: 199 XKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 68/178 (38%), Positives = 99/178 (55%), Gaps = 13/178 (7%)
Query: 61  GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA----STKSPHLCIVTEY 116
           G+ VAVK L+ E     L   + +E+ ILR + H ++V++ G       KS  L  V EY
Sbjct: 37  GEMVAVKALK-EGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQL--VMEY 93
Query: 117 MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVK 176
           +P GSL DYL ++   + L QLL FA  IC+GM YLH ++ IHR L   N+L+D   +VK
Sbjct: 94  VPLGSLRDYLPRH--CVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVK 151
Query: 177 VADFGVARFQNKGG----VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
           + DFG+A+   +G     V         W APE +    +   +DV+SF + L+EL+T
Sbjct: 152 IGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 113/232 (48%), Gaps = 27/232 (11%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFV 83
           ++WE+ R  +     +  GS G +Y GV  G         VA+K + +E  +     EF+
Sbjct: 40  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFL 98
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH------KNHNVLKLPQ 137
            E ++++E    +VVR +G  ++     ++ E M  G L  YL       +N+ VL  P 
Sbjct: 99  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 158
Query: 138 L---LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR------FQNK 188
           L   ++ A +I  GM YL+    +HRDL   N ++     VK+ DFG+ R      +  K
Sbjct: 159 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 218
Query: 189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           GG         RWM+PE +    +   +DV+SF +VLWE+ T A+ PY  ++
Sbjct: 219 GGKGLLPV---RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 267

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 113/232 (48%), Gaps = 27/232 (11%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFV 83
           ++WE+ R  +     +  GS G +Y GV  G         VA+K + +E  +     EF+
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFL 69
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH------KNHNVLKLPQ 137
            E ++++E    +VVR +G  ++     ++ E M  G L  YL       +N+ VL  P 
Sbjct: 70  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 129
Query: 138 L---LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR------FQNK 188
           L   ++ A +I  GM YL+    +HRDL   N ++     VK+ DFG+ R      +  K
Sbjct: 130 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 189
Query: 189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           GG         RWM+PE +    +   +DV+SF +VLWE+ T A+ PY  ++
Sbjct: 190 GGKGLLPV---RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 238

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 113/232 (48%), Gaps = 27/232 (11%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFV 83
           ++WE+ R  +     +  GS G +Y GV  G         VA+K + +E  +     EF+
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFL 70
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH------KNHNVLKLPQ 137
            E ++++E    +VVR +G  ++     ++ E M  G L  YL       +N+ VL  P 
Sbjct: 71  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 130
Query: 138 L---LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR------FQNK 188
           L   ++ A +I  GM YL+    +HRDL   N ++     VK+ DFG+ R      +  K
Sbjct: 131 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 190
Query: 189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           GG         RWM+PE +    +   +DV+SF +VLWE+ T A+ PY  ++
Sbjct: 191 GGKGLLPV---RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 239

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 113/232 (48%), Gaps = 27/232 (11%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFV 83
           ++WE+ R  +     +  GS G +Y GV  G         VA+K + +E  +     EF+
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFL 63
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH------KNHNVLKLPQ 137
            E ++++E    +VVR +G  ++     ++ E M  G L  YL       +N+ VL  P 
Sbjct: 64  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 123
Query: 138 L---LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR------FQNK 188
           L   ++ A +I  GM YL+    +HRDL   N ++     VK+ DFG+ R      +  K
Sbjct: 124 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 183
Query: 189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           GG         RWM+PE +    +   +DV+SF +VLWE+ T A+ PY  ++
Sbjct: 184 GGKGLLPV---RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 232

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 113/232 (48%), Gaps = 27/232 (11%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFV 83
           ++WE+ R  +     +  GS G +Y GV  G         VA+K + +E  +     EF+
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFL 69
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH------KNHNVLKLPQ 137
            E ++++E    +VVR +G  ++     ++ E M  G L  YL       +N+ VL  P 
Sbjct: 70  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 129
Query: 138 L---LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR------FQNK 188
           L   ++ A +I  GM YL+    +HRDL   N ++     VK+ DFG+ R      +  K
Sbjct: 130 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 189
Query: 189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           GG         RWM+PE +    +   +DV+SF +VLWE+ T A+ PY  ++
Sbjct: 190 GGKGLLPV---RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 238

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 115/213 (53%), Gaps = 22/213 (10%)
Query: 44  ERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLED--------EFVQEVAILREVQHR 95
           ++I  G  G +++G  L +D +V  ++S  L D+  +        EF +EV I+  + H 
Sbjct: 25  KQIGKGGFGLVHKG-RLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 96  NVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR 155
           N+V+  G     P +  V E++P G LY  L    + +K    LR  +DI  G+EY+  +
Sbjct: 84  NIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 156 N--IIHRDLKTANLLMDTHN-----VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN 208
           N  I+HRDL++ N+ + + +       KVADFG +  Q     ++   G ++WMAPE I 
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS--QQSVHSVSGLLGNFQWMAPETIG 199
Query: 209 --HQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
              + Y +KAD +SFA++L+ ++T + P+D  +
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 113/232 (48%), Gaps = 27/232 (11%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFV 83
           ++WE+ R  +     +  GS G +Y GV  G         VA+K + +E  +     EF+
Sbjct: 9   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFL 67
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH------KNHNVLKLPQ 137
            E ++++E    +VVR +G  ++     ++ E M  G L  YL       +N+ VL  P 
Sbjct: 68  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 127
Query: 138 L---LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR------FQNK 188
           L   ++ A +I  GM YL+    +HRDL   N ++     VK+ DFG+ R      +  K
Sbjct: 128 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 187
Query: 189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           GG         RWM+PE +    +   +DV+SF +VLWE+ T A+ PY  ++
Sbjct: 188 GGKGLLPV---RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 236

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 127/235 (54%), Gaps = 16/235 (6%)
Query: 35  IDRRLLKTGER-IASGSCGDLYRGVY----LGQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           +DR+LL   ++ + SG+ G + +G Y    + + VAVK+L++E  +  L+DE + E  ++
Sbjct: 7   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 66
Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGM 149
           +++ +  +VR IG       + +V E    G L  YL +N +V K   ++     +  GM
Sbjct: 67  QQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 124
Query: 150 EYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF----QNKGGVMTAETGTYRWMAPE 205
           +YL + N +HRDL   N+L+ T +  K++DFG+++     +N     T      +W APE
Sbjct: 125 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPE 184
Query: 206 VINHQPYDQKADVFSFAIVLWELVT-AKVPYDSM--TPLQAAL--GVRQVCTSLC 255
            IN+  +  K+DV+SF +++WE  +  + PY  M  + + A L  G R  C + C
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 239

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 112/232 (48%), Gaps = 27/232 (11%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFV 83
           ++WE+ R  +     +  GS G +Y GV  G         VA+K + +E  +     EF+
Sbjct: 8   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFL 66
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK------NHNVLKLPQ 137
            E ++++E    +VVR +G  ++     ++ E M  G L  YL        N+ VL  P 
Sbjct: 67  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 126
Query: 138 L---LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR------FQNK 188
           L   ++ A +I  GM YL+    +HRDL   N ++     VK+ DFG+ R      +  K
Sbjct: 127 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 186
Query: 189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           GG         RWM+PE +    +   +DV+SF +VLWE+ T A+ PY  ++
Sbjct: 187 GGKGLLPV---RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 235

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 113/232 (48%), Gaps = 27/232 (11%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFV 83
           ++WE+ R  +     +  GS G +Y GV  G         VA+K + +E  +     EF+
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFL 76
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH------KNHNVLKLPQ 137
            E ++++E    +VVR +G  ++     ++ E M  G L  YL       +N+ VL  P 
Sbjct: 77  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 136
Query: 138 L---LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR------FQNK 188
           L   ++ A +I  GM YL+    +HRDL   N ++     VK+ DFG+ R      +  K
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           GG         RWM+PE +    +   +DV+SF +VLWE+ T A+ PY  ++
Sbjct: 197 GGKGLLPV---RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 80/267 (29%), Positives = 126/267 (47%), Gaps = 47/267 (17%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD-------VAVKVLRSEHLNDTLEDEFVQE 85
           WE  R  L+ G+ + SG+ G +      G         VAVK+L+ E  + +  +  + E
Sbjct: 40  WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSE 98
Query: 86  VAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL------------------ 126
           + ++ ++  H N+V  +GA T S  + ++ EY   G L +YL                  
Sbjct: 99  LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 158
Query: 127 ----HKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGV 182
                ++ NVL    LL FA  + KGME+L  ++ +HRDL   N+L+    VVK+ DFG+
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 218
Query: 183 ARFQNKGGVMTAETGTYR--------WMAPEVINHQPYDQKADVFSFAIVLWELVTAKV- 233
           AR      +M+      R        WMAPE +    Y  K+DV+S+ I+LWE+ +  V 
Sbjct: 219 AR-----DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273
Query: 234 PYDSMTPLQAAL-GVRQVCTSLCQPIY 259
           PY  + P+ A    + Q    + QP Y
Sbjct: 274 PYPGI-PVDANFYKLIQNGFKMDQPFY 299

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 118/229 (51%), Gaps = 19/229 (8%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVA 87
           +E WEI       GE +  G+ G +Y+      G   A KV+ ++   + LED ++ E+ 
Sbjct: 10  NEVWEI------VGE-LGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELED-YIVEIE 60
Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICK 147
           IL    H  +V+ +GA      L I+ E+ PGG++   + +    L  PQ+      + +
Sbjct: 61  ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLE 120
Query: 148 GMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GTYRWMAPE 205
            + +LH + IIHRDLK  N+LM     +++ADFGV+  +N   +   ++  GT  WMAPE
Sbjct: 121 ALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA-KNLKTLQKRDSFIGTPYWMAPE 179
Query: 206 VI-----NHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
           V+        PYD KAD++S  I L E+   + P+  + P++  L + +
Sbjct: 180 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK 228

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 118/236 (50%), Gaps = 28/236 (11%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLG---QD----VAVKVLRSEHLNDTLEDEF 82
           +E WE  R  L+ G+ + +G+ G +      G   +D    VAVK+L+S    D  E   
Sbjct: 38  NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE-AL 96
Query: 83  VQEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK------------N 129
           + E+ I+  + QH N+V  +GA T    + ++TEY   G L ++L +            +
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPS 156
Query: 130 HNV---LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-F 185
           HN    L    LL F+  + +GM +L  +N IHRD+   N+L+   +V K+ DFG+AR  
Sbjct: 157 HNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 216
Query: 186 QNKGGVMTAETG--TYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKV-PYDSM 238
            N    +         +WMAPE I    Y  ++DV+S+ I+LWE+ +  + PY  +
Sbjct: 217 MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 272

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score =  105 bits (263), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 112/232 (48%), Gaps = 27/232 (11%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFV 83
           ++WE+ R  +     +  GS G +Y GV  G         VA+K + +E  +     EF+
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFL 76
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK------NHNVLKLPQ 137
            E ++++E    +VVR +G  ++     ++ E M  G L  YL        N+ VL  P 
Sbjct: 77  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 138 L---LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR------FQNK 188
           L   ++ A +I  GM YL+    +HRDL   N ++     VK+ DFG+ R      +  K
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           GG         RWM+PE +    +   +DV+SF +VLWE+ T A+ PY  ++
Sbjct: 197 GGKGLLPV---RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score =  105 bits (262), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 113/216 (52%), Gaps = 11/216 (5%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRG---VYLGQDVAV--KVLRSEHLNDTLEDEFVQEVAI 88
           E+D   +K    I +G  G++  G   +   +DVAV  K L+  +      D F+ E +I
Sbjct: 39  ELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRD-FLCEASI 97
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
           + +  H NVV   G  T+   + IV E+M  G+L  +L K+     + QL+     I  G
Sbjct: 98  MGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAG 157
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETG--TYRWMAP 204
           M YL     +HRDL   N+L++++ V KV+DFG++R    +   V T   G    RW AP
Sbjct: 158 MRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAP 217
Query: 205 EVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           E I ++ +   +DV+S+ IV+WE+++  + PY  M+
Sbjct: 218 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 253

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score =  105 bits (262), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 128/235 (54%), Gaps = 16/235 (6%)
Query: 35  IDRRLLKTGER-IASGSCGDLYRGVY----LGQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           +DR+LL   ++ + SG+ G + +G Y    + + VAVK+L++E  +  L+DE + E  ++
Sbjct: 13  LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 72
Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGM 149
           +++ +  +VR IG   ++    +V E    G L  YL +N +V K   ++     +  GM
Sbjct: 73  QQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 130
Query: 150 EYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF----QNKGGVMTAETGTYRWMAPE 205
           +YL + N +HRDL   N+L+ T +  K++DFG+++     +N     T      +W APE
Sbjct: 131 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 190
Query: 206 VINHQPYDQKADVFSFAIVLWELVT-AKVPYDSM--TPLQAAL--GVRQVCTSLC 255
            IN+  +  K+DV+SF +++WE  +  + PY  M  + + A L  G R  C + C
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 245

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score =  105 bits (262), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 128/235 (54%), Gaps = 16/235 (6%)
Query: 35  IDRRLLKTGER-IASGSCGDLYRGVY----LGQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           +DR+LL   ++ + SG+ G + +G Y    + + VAVK+L++E  +  L+DE + E  ++
Sbjct: 3   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62
Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGM 149
           +++ +  +VR IG   ++    +V E    G L  YL +N +V K   ++     +  GM
Sbjct: 63  QQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 120
Query: 150 EYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF----QNKGGVMTAETGTYRWMAPE 205
           +YL + N +HRDL   N+L+ T +  K++DFG+++     +N     T      +W APE
Sbjct: 121 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 206 VINHQPYDQKADVFSFAIVLWELVT-AKVPYDSM--TPLQAAL--GVRQVCTSLC 255
            IN+  +  K+DV+SF +++WE  +  + PY  M  + + A L  G R  C + C
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 235

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score =  105 bits (262), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 128/235 (54%), Gaps = 16/235 (6%)
Query: 35  IDRRLLKTGER-IASGSCGDLYRGVY----LGQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           +DR+LL   ++ + SG+ G + +G Y    + + VAVK+L++E  +  L+DE + E  ++
Sbjct: 7   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 66
Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGM 149
           +++ +  +VR IG   ++    +V E    G L  YL +N +V K   ++     +  GM
Sbjct: 67  QQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 124
Query: 150 EYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF----QNKGGVMTAETGTYRWMAPE 205
           +YL + N +HRDL   N+L+ T +  K++DFG+++     +N     T      +W APE
Sbjct: 125 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 184
Query: 206 VINHQPYDQKADVFSFAIVLWELVT-AKVPYDSM--TPLQAAL--GVRQVCTSLC 255
            IN+  +  K+DV+SF +++WE  +  + PY  M  + + A L  G R  C + C
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 239

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score =  105 bits (262), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 134/252 (53%), Gaps = 16/252 (6%)
Query: 18  HAVEKAIESQTKSEDWEIDRRLLKTGER-IASGSCGDLYRGVY----LGQDVAVKVLRSE 72
           H    A   + + ++  +DR+LL   ++ + SG+ G + +G Y    + + VAVK+L++E
Sbjct: 4   HESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE 63
Query: 73  HLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV 132
             +  L+DE + E  +++++ +  +VR IG   ++    +V E    G L  YL +N +V
Sbjct: 64  ANDPALKDELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHV 122
Query: 133 LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF----QNK 188
            K   ++     +  GM+YL + N +HRDL   N+L+ T +  K++DFG+++     +N 
Sbjct: 123 -KDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 181
Query: 189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSM--TPLQAAL 245
               T      +W APE IN+  +  K+DV+SF +++WE  +  + PY  M  + + A L
Sbjct: 182 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 241
Query: 246 --GVRQVCTSLC 255
             G R  C + C
Sbjct: 242 EKGERMGCPAGC 253

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 128/235 (54%), Gaps = 16/235 (6%)
Query: 35  IDRRLLKTGER-IASGSCGDLYRGVY----LGQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           +DR+LL   ++ + SG+ G + +G Y    + + VAVK+L++E  +  L+DE + E  ++
Sbjct: 23  LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 82
Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGM 149
           +++ +  +VR IG   ++    +V E    G L  YL +N +V K   ++     +  GM
Sbjct: 83  QQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 140
Query: 150 EYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF----QNKGGVMTAETGTYRWMAPE 205
           +YL + N +HRDL   N+L+ T +  K++DFG+++     +N     T      +W APE
Sbjct: 141 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 200
Query: 206 VINHQPYDQKADVFSFAIVLWELVT-AKVPYDSM--TPLQAAL--GVRQVCTSLC 255
            IN+  +  K+DV+SF +++WE  +  + PY  M  + + A L  G R  C + C
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 255

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 128/235 (54%), Gaps = 16/235 (6%)
Query: 35  IDRRLLKTGER-IASGSCGDLYRGVY----LGQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           +DR+LL   ++ + SG+ G + +G Y    + + VAVK+L++E  +  L+DE + E  ++
Sbjct: 23  LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 82
Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGM 149
           +++ +  +VR IG   ++    +V E    G L  YL +N +V K   ++     +  GM
Sbjct: 83  QQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 140
Query: 150 EYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF----QNKGGVMTAETGTYRWMAPE 205
           +YL + N +HRDL   N+L+ T +  K++DFG+++     +N     T      +W APE
Sbjct: 141 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 200
Query: 206 VINHQPYDQKADVFSFAIVLWELVT-AKVPYDSM--TPLQAAL--GVRQVCTSLC 255
            IN+  +  K+DV+SF +++WE  +  + PY  M  + + A L  G R  C + C
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 255

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 127/235 (54%), Gaps = 16/235 (6%)
Query: 35  IDRRLLKTGER-IASGSCGDLYRGVY----LGQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           +DR+LL   ++ + SG+ G + +G Y    + + VAVK+L++E  +  L+DE + E  ++
Sbjct: 1   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 60
Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGM 149
           +++ +  +VR IG       + +V E    G L  YL +N +V K   ++     +  GM
Sbjct: 61  QQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 118
Query: 150 EYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF----QNKGGVMTAETGTYRWMAPE 205
           +YL + N +HRDL   N+L+ T +  K++DFG+++     +N     T      +W APE
Sbjct: 119 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 178
Query: 206 VINHQPYDQKADVFSFAIVLWELVT-AKVPYDSM--TPLQAAL--GVRQVCTSLC 255
            IN+  +  K+DV+SF +++WE  +  + PY  M  + + A L  G R  C + C
Sbjct: 179 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 233

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  105 bits (261), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 111/217 (51%), Gaps = 11/217 (5%)
Query: 37  RRLLKTGERIASGSCGDLYRGV--YLGQDVAVKV--LRSEHLNDTLEDEFVQEVAILREV 92
           R  L    +I  GS G +      + G+ VAVK   LR +   + L      EV I+R+ 
Sbjct: 44  REYLANFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELL----FNEVVIMRDY 99
Query: 93  QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYL 152
            H NVV    +      L +V E++ GG+L D +   H  +   Q+    + + + + YL
Sbjct: 100 HHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLRALSYL 157
Query: 153 HQRNIIHRDLKTANLLMDTHNVVKVADFGV-ARFQNKGGVMTAETGTYRWMAPEVINHQP 211
           H + +IHRD+K+ ++L+ +   +K++DFG  A+   +        GT  WMAPEVI+  P
Sbjct: 158 HNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLP 217
Query: 212 YDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVR 248
           Y  + D++S  I++ E++  + PY +  PLQA   +R
Sbjct: 218 YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR 254

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score =  105 bits (261), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 117/243 (48%), Gaps = 35/243 (14%)
Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLG---QD----VAVKVLRSEHLNDTLEDEF 82
           +E WE  R  L+ G+ + +G+ G +      G   +D    VAVK+L+S    D  E   
Sbjct: 23  NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE-AL 81
Query: 83  VQEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV--------- 132
           + E+ I+  + QH N+V  +GA T    + ++TEY   G L ++L +             
Sbjct: 82  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPG 141
Query: 133 -------------LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVAD 179
                        L+L  LL F+  + +GM +L  +N IHRD+   N+L+   +V K+ D
Sbjct: 142 QDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGD 201
Query: 180 FGVAR-FQNKGGVMTAETG--TYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKV-PY 235
           FG+AR   N    +         +WMAPE I    Y  ++DV+S+ I+LWE+ +  + PY
Sbjct: 202 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 261
Query: 236 DSM 238
             +
Sbjct: 262 PGI 264

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score =  105 bits (261), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 112/232 (48%), Gaps = 27/232 (11%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFV 83
           ++WE+ R  +     +  GS G +Y GV  G         VA+K + +E  +     EF+
Sbjct: 3   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFL 61
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH------KNHNVLKLPQ 137
            E ++++E    +VVR +G  ++     ++ E M  G L  YL       +N+ VL  P 
Sbjct: 62  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 121
Query: 138 L---LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR------FQNK 188
           L   ++ A +I  GM YL+    +HRDL   N ++     VK+ DFG+ R         K
Sbjct: 122 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRK 181
Query: 189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           GG         RWM+PE +    +   +DV+SF +VLWE+ T A+ PY  ++
Sbjct: 182 GGKGLLPV---RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 230

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score =  105 bits (261), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 112/232 (48%), Gaps = 27/232 (11%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFV 83
           ++WE+ R  +     +  GS G +Y GV  G         VA+K + +E  +     EF+
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFL 70
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH------KNHNVLKLPQ 137
            E ++++E    +VVR +G  ++     ++ E M  G L  YL       +N+ VL  P 
Sbjct: 71  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 130
Query: 138 L---LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR------FQNK 188
           L   ++ A +I  GM YL+    +HRDL   N ++     VK+ DFG+ R         K
Sbjct: 131 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRK 190
Query: 189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           GG         RWM+PE +    +   +DV+SF +VLWE+ T A+ PY  ++
Sbjct: 191 GGKGLLPV---RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 239

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 128/235 (54%), Gaps = 16/235 (6%)
Query: 35  IDRRLLKTGER-IASGSCGDLYRGVY----LGQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           +DR+LL   ++ + SG+ G + +G Y    + + VAVK+L++E  +  L+DE + E  ++
Sbjct: 365 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 424
Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGM 149
           +++ +  +VR IG   ++    +V E    G L  YL +N +V K   ++     +  GM
Sbjct: 425 QQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 482
Query: 150 EYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF----QNKGGVMTAETGTYRWMAPE 205
           +YL + N +HRDL   N+L+ T +  K++DFG+++     +N     T      +W APE
Sbjct: 483 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 542
Query: 206 VINHQPYDQKADVFSFAIVLWELVT-AKVPYDSM--TPLQAAL--GVRQVCTSLC 255
            IN+  +  K+DV+SF +++WE  +  + PY  M  + + A L  G R  C + C
Sbjct: 543 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 597

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score =  104 bits (260), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 128/235 (54%), Gaps = 16/235 (6%)
Query: 35  IDRRLLKTGER-IASGSCGDLYRGVY----LGQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           +DR+LL   ++ + SG+ G + +G Y    + + VAVK+L++E  +  L+DE + E  ++
Sbjct: 366 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 425
Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGM 149
           +++ +  +VR IG   ++    +V E    G L  YL +N +V K   ++     +  GM
Sbjct: 426 QQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGM 483
Query: 150 EYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF----QNKGGVMTAETGTYRWMAPE 205
           +YL + N +HRDL   N+L+ T +  K++DFG+++     +N     T      +W APE
Sbjct: 484 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 543
Query: 206 VINHQPYDQKADVFSFAIVLWELVT-AKVPYDSM--TPLQAAL--GVRQVCTSLC 255
            IN+  +  K+DV+SF +++WE  +  + PY  M  + + A L  G R  C + C
Sbjct: 544 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 598

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score =  104 bits (260), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 44  ERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLE-DEFVQEVAILREVQHRNV 97
           E I  G  G +Y G  L  D      AVK L    + D  E  +F+ E  I+++  H NV
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 98  VRFIGA---STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
           +  +G    S  SP   +V  YM  G L +++    +   +  L+ F + + KGM+YL  
Sbjct: 93  LSLLGICLRSEGSP--LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 150
Query: 155 RNIIHRDLKTANLLMDTHNVVKVADFGVAR--FQNKGGVMTAETGT---YRWMAPEVINH 209
           +  +HRDL   N ++D    VKVADFG+AR  +  +   +  +TG     +WMA E +  
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQT 210
Query: 210 QPYDQKADVFSFAIVLWELVTAKVP 234
           Q +  K+DV+SF ++LWEL+T   P
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score =  104 bits (260), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 112/232 (48%), Gaps = 27/232 (11%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFV 83
           ++WE+ R  +     +  GS G +Y GV  G         VA+K + +E  +     EF+
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFL 63
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH------KNHNVLKLPQ 137
            E ++++E    +VVR +G  ++     ++ E M  G L  YL       +N+ VL  P 
Sbjct: 64  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 123
Query: 138 L---LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR------FQNK 188
           L   ++ A +I  GM YL+    +HRDL   N  +     VK+ DFG+ R      +  K
Sbjct: 124 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRK 183
Query: 189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           GG         RWM+PE +    +   +DV+SF +VLWE+ T A+ PY  ++
Sbjct: 184 GGKGLLPV---RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 232

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 115/213 (53%), Gaps = 22/213 (10%)
Query: 44  ERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLED--------EFVQEVAILREVQHR 95
           ++I  G  G +++G  L +D +V  ++S  L D+  +        EF +EV I+  + H 
Sbjct: 25  KQIGKGGFGLVHKG-RLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 96  NVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR 155
           N+V+  G     P +  V E++P G LY  L    + +K    LR  +DI  G+EY+  +
Sbjct: 84  NIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 156 N--IIHRDLKTANLLMDTHN-----VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN 208
           N  I+HRDL++ N+ + + +       KVADF ++  Q     ++   G ++WMAPE I 
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS--QQSVHSVSGLLGNFQWMAPETIG 199
Query: 209 --HQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
              + Y +KAD +SFA++L+ ++T + P+D  +
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score =  103 bits (257), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 44  ERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLE-DEFVQEVAILREVQHRNV 97
           E I  G  G +Y G  L  D      AVK L    + D  E  +F+ E  I+++  H NV
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 111
Query: 98  VRFIGA---STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
           +  +G    S  SP   +V  YM  G L +++    +   +  L+ F + + KGM+YL  
Sbjct: 112 LSLLGICLRSEGSP--LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 169
Query: 155 RNIIHRDLKTANLLMDTHNVVKVADFGVAR--FQNKGGVMTAETGT---YRWMAPEVINH 209
           +  +HRDL   N ++D    VKVADFG+AR  +  +   +  +TG     +WMA E +  
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 229
Query: 210 QPYDQKADVFSFAIVLWELVTAKVP 234
           Q +  K+DV+SF ++LWEL+T   P
Sbjct: 230 QKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 44  ERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLE-DEFVQEVAILREVQHRNV 97
           E I  G  G +Y G  L  D      AVK L    + D  E  +F+ E  I+++  H NV
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 98  VRFIGA---STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
           +  +G    S  SP   +V  YM  G L +++    +   +  L+ F + + KGM+YL  
Sbjct: 94  LSLLGICLRSEGSP--LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 151
Query: 155 RNIIHRDLKTANLLMDTHNVVKVADFGVAR--FQNKGGVMTAETGT---YRWMAPEVINH 209
           +  +HRDL   N ++D    VKVADFG+AR  +  +   +  +TG     +WMA E +  
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 210 QPYDQKADVFSFAIVLWELVTAKVP 234
           Q +  K+DV+SF ++LWEL+T   P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 44  ERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLE-DEFVQEVAILREVQHRNV 97
           E I  G  G +Y G  L  D      AVK L    + D  E  +F+ E  I+++  H NV
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 112
Query: 98  VRFIGA---STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
           +  +G    S  SP   +V  YM  G L +++    +   +  L+ F + + KGM+YL  
Sbjct: 113 LSLLGICLRSEGSP--LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 170
Query: 155 RNIIHRDLKTANLLMDTHNVVKVADFGVAR--FQNKGGVMTAETGT---YRWMAPEVINH 209
           +  +HRDL   N ++D    VKVADFG+AR  +  +   +  +TG     +WMA E +  
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 230
Query: 210 QPYDQKADVFSFAIVLWELVTAKVP 234
           Q +  K+DV+SF ++LWEL+T   P
Sbjct: 231 QKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 44  ERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLE-DEFVQEVAILREVQHRNV 97
           E I  G  G +Y G  L  D      AVK L    + D  E  +F+ E  I+++  H NV
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 98  VRFIGA---STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
           +  +G    S  SP   +V  YM  G L +++    +   +  L+ F + + KGM+YL  
Sbjct: 89  LSLLGICLRSEGSP--LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 146
Query: 155 RNIIHRDLKTANLLMDTHNVVKVADFGVAR--FQNKGGVMTAETGT---YRWMAPEVINH 209
           +  +HRDL   N ++D    VKVADFG+AR  +  +   +  +TG     +WMA E +  
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 210 QPYDQKADVFSFAIVLWELVTAKVP 234
           Q +  K+DV+SF ++LWEL+T   P
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 44  ERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLE-DEFVQEVAILREVQHRNV 97
           E I  G  G +Y G  L  D      AVK L    + D  E  +F+ E  I+++  H NV
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 85
Query: 98  VRFIGA---STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
           +  +G    S  SP   +V  YM  G L +++    +   +  L+ F + + KGM+YL  
Sbjct: 86  LSLLGICLRSEGSP--LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 143
Query: 155 RNIIHRDLKTANLLMDTHNVVKVADFGVAR--FQNKGGVMTAETGT---YRWMAPEVINH 209
           +  +HRDL   N ++D    VKVADFG+AR  +  +   +  +TG     +WMA E +  
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 203
Query: 210 QPYDQKADVFSFAIVLWELVTAKVP 234
           Q +  K+DV+SF ++LWEL+T   P
Sbjct: 204 QKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 44  ERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLE-DEFVQEVAILREVQHRNV 97
           E I  G  G +Y G  L  D      AVK L    + D  E  +F+ E  I+++  H NV
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 98  VRFIGA---STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
           +  +G    S  SP   +V  YM  G L +++    +   +  L+ F + + KGM+YL  
Sbjct: 91  LSLLGICLRSEGSP--LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 148
Query: 155 RNIIHRDLKTANLLMDTHNVVKVADFGVAR--FQNKGGVMTAETGT---YRWMAPEVINH 209
           +  +HRDL   N ++D    VKVADFG+AR  +  +   +  +TG     +WMA E +  
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 208
Query: 210 QPYDQKADVFSFAIVLWELVTAKVP 234
           Q +  K+DV+SF ++LWEL+T   P
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 44  ERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLE-DEFVQEVAILREVQHRNV 97
           E I  G  G +Y G  L  D      AVK L    + D  E  +F+ E  I+++  H NV
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 98  VRFIGA---STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
           +  +G    S  SP   +V  YM  G L +++    +   +  L+ F + + KGM+YL  
Sbjct: 92  LSLLGICLRSEGSP--LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 149
Query: 155 RNIIHRDLKTANLLMDTHNVVKVADFGVAR--FQNKGGVMTAETGT---YRWMAPEVINH 209
           +  +HRDL   N ++D    VKVADFG+AR  +  +   +  +TG     +WMA E +  
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 209
Query: 210 QPYDQKADVFSFAIVLWELVTAKVP 234
           Q +  K+DV+SF ++LWEL+T   P
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 44  ERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLE-DEFVQEVAILREVQHRNV 97
           E I  G  G +Y G  L  D      AVK L    + D  E  +F+ E  I+++  H NV
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 98  VRFIGA---STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
           +  +G    S  SP   +V  YM  G L +++    +   +  L+ F + + KGM+YL  
Sbjct: 93  LSLLGICLRSEGSP--LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 150
Query: 155 RNIIHRDLKTANLLMDTHNVVKVADFGVAR--FQNKGGVMTAETGT---YRWMAPEVINH 209
           +  +HRDL   N ++D    VKVADFG+AR  +  +   +  +TG     +WMA E +  
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 210
Query: 210 QPYDQKADVFSFAIVLWELVTAKVP 234
           Q +  K+DV+SF ++LWEL+T   P
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 44  ERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLE-DEFVQEVAILREVQHRNV 97
           E I  G  G +Y G  L  D      AVK L    + D  E  +F+ E  I+++  H NV
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 98  VRFIGA---STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
           +  +G    S  SP   +V  YM  G L +++    +   +  L+ F + + KGM+YL  
Sbjct: 94  LSLLGICLRSEGSP--LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 151
Query: 155 RNIIHRDLKTANLLMDTHNVVKVADFGVAR--FQNKGGVMTAETGT---YRWMAPEVINH 209
           +  +HRDL   N ++D    VKVADFG+AR  +  +   +  +TG     +WMA E +  
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 210 QPYDQKADVFSFAIVLWELVTAKVP 234
           Q +  K+DV+SF ++LWEL+T   P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 44  ERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLE-DEFVQEVAILREVQHRNV 97
           E I  G  G +Y G  L  D      AVK L    + D  E  +F+ E  I+++  H NV
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--RITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 98  VRFIGA---STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
           +  +G    S  SP   +V  YM  G L +++    +   +  L+ F + + KGM++L  
Sbjct: 153 LSLLGICLRSEGSP--LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 210
Query: 155 RNIIHRDLKTANLLMDTHNVVKVADFGVAR--FQNKGGVMTAETGT---YRWMAPEVINH 209
           +  +HRDL   N ++D    VKVADFG+AR  +  +   +  +TG     +WMA E +  
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 210 QPYDQKADVFSFAIVLWELVTAKVP 234
           Q +  K+DV+SF ++LWEL+T   P
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 44  ERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLE-DEFVQEVAILREVQHRNV 97
           E I  G  G +Y G  L  D      AVK L    + D  E  +F+ E  I+++  H NV
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 98  VRFIGA---STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
           +  +G    S  SP   +V  YM  G L +++    +   +  L+ F + + KGM++L  
Sbjct: 95  LSLLGICLRSEGSP--LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 152
Query: 155 RNIIHRDLKTANLLMDTHNVVKVADFGVAR--FQNKGGVMTAETGT---YRWMAPEVINH 209
           +  +HRDL   N ++D    VKVADFG+AR  +  +   +  +TG     +WMA E +  
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 210 QPYDQKADVFSFAIVLWELVTAKVP 234
           Q +  K+DV+SF ++LWEL+T   P
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 44  ERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLE-DEFVQEVAILREVQHRNV 97
           E I  G  G +Y G  L  D      AVK L    + D  E  +F+ E  I+++  H NV
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 98
Query: 98  VRFIGA---STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
           +  +G    S  SP   +V  YM  G L +++    +   +  L+ F + + KGM++L  
Sbjct: 99  LSLLGICLRSEGSP--LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 156
Query: 155 RNIIHRDLKTANLLMDTHNVVKVADFGVAR--FQNKGGVMTAETGT---YRWMAPEVINH 209
           +  +HRDL   N ++D    VKVADFG+AR  +  +   +  +TG     +WMA E +  
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 216
Query: 210 QPYDQKADVFSFAIVLWELVTAKVP 234
           Q +  K+DV+SF ++LWEL+T   P
Sbjct: 217 QKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score =  102 bits (255), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 44  ERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLE-DEFVQEVAILREVQHRNV 97
           E I  G  G +Y G  L  D      AVK L    + D  E  +F+ E  I+++  H NV
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 98  VRFIGA---STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
           +  +G    S  SP   +V  YM  G L +++    +   +  L+ F + + KGM++L  
Sbjct: 94  LSLLGICLRSEGSP--LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 151
Query: 155 RNIIHRDLKTANLLMDTHNVVKVADFGVAR--FQNKGGVMTAETGT---YRWMAPEVINH 209
           +  +HRDL   N ++D    VKVADFG+AR  +  +   +  +TG     +WMA E +  
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 210 QPYDQKADVFSFAIVLWELVTAKVP 234
           Q +  K+DV+SF ++LWEL+T   P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 44  ERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLE-DEFVQEVAILREVQHRNV 97
           E I  G  G +Y G  L  D      AVK L    + D  E  +F+ E  I+++  H NV
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 98  VRFIGA---STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
           +  +G    S  SP   +V  YM  G L +++    +   +  L+ F + + KGM++L  
Sbjct: 92  LSLLGICLRSEGSP--LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 149
Query: 155 RNIIHRDLKTANLLMDTHNVVKVADFGVAR--FQNKGGVMTAETGT---YRWMAPEVINH 209
           +  +HRDL   N ++D    VKVADFG+AR  +  +   +  +TG     +WMA E +  
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 209
Query: 210 QPYDQKADVFSFAIVLWELVTAKVP 234
           Q +  K+DV+SF ++LWEL+T   P
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 44  ERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLE-DEFVQEVAILREVQHRNV 97
           E I  G  G +Y G  L  D      AVK L    + D  E  +F+ E  I+++  H NV
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 98  VRFIGA---STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
           +  +G    S  SP   +V  YM  G L +++    +   +  L+ F + + KGM++L  
Sbjct: 94  LSLLGICLRSEGSP--LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 151
Query: 155 RNIIHRDLKTANLLMDTHNVVKVADFGVAR--FQNKGGVMTAETGT---YRWMAPEVINH 209
           +  +HRDL   N ++D    VKVADFG+AR  +  +   +  +TG     +WMA E +  
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 210 QPYDQKADVFSFAIVLWELVTAKVP 234
           Q +  K+DV+SF ++LWEL+T   P
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 117/242 (48%), Gaps = 35/242 (14%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYL---GQ----DVAVKVLRSEHLNDTLEDEFVQE 85
           WE  R+ L  G+ +  G  G + +       G+     VAVK+L+       L D  + E
Sbjct: 18  WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD-LLSE 76
Query: 86  VAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL------------------- 126
             +L++V H +V++  GA ++   L ++ EY   GSL  +L                   
Sbjct: 77  FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 127 ----HKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGV 182
               H +   L +  L+ FA  I +GM+YL + +++HRDL   N+L+     +K++DFG+
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 183 AR--FQNKGGVMTAETG-TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSM 238
           +R  ++    V  ++     +WMA E +    Y  ++DV+SF ++LWE+VT    PY  +
Sbjct: 197 SRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 239 TP 240
            P
Sbjct: 257 PP 258

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 101/203 (49%), Gaps = 28/203 (13%)
Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VAVK+L+ E   D ++ +F +E A++ E  + N+V+ +G       +C++ EYM  G L 
Sbjct: 80  VAVKMLKEEASAD-MQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 138
Query: 124 DYLHK--NHNVLKL---------------PQLLRFAIDIC------KGMEYLHQRNIIHR 160
           ++L     H V  L               P  L  A  +C       GM YL +R  +HR
Sbjct: 139 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198
Query: 161 DLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETG---TYRWMAPEVINHQPYDQKAD 217
           DL T N L+  + VVK+ADFG++R         A+       RWM PE I +  Y  ++D
Sbjct: 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESD 258
Query: 218 VFSFAIVLWELVTAKV-PYDSMT 239
           V+++ +VLWE+ +  + PY  M 
Sbjct: 259 VWAYGVVLWEIFSYGLQPYYGMA 281

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 113/217 (52%), Gaps = 11/217 (5%)
Query: 37  RRLLKTGERIASGSCGD--LYRGVYLGQDVAVKV--LRSEHLNDTLEDEFVQEVAILREV 92
           R LL +  +I  GS G   L R  + G+ VAVK+  LR +   + L      EV I+R+ 
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELL----FNEVVIMRDY 99
Query: 93  QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYL 152
           QH NVV    +      L ++ E++ GG+L D + +    L   Q+      + + + YL
Sbjct: 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR--LNEEQIATVCEAVLQALAYL 157
Query: 153 HQRNIIHRDLKTANLLMDTHNVVKVADFGV-ARFQNKGGVMTAETGTYRWMAPEVINHQP 211
           H + +IHRD+K+ ++L+     VK++DFG  A+            GT  WMAPEVI+   
Sbjct: 158 HAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSL 217
Query: 212 YDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVR 248
           Y  + D++S  I++ E+V  + PY S +P+QA   +R
Sbjct: 218 YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR 254

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/216 (33%), Positives = 112/216 (51%), Gaps = 19/216 (8%)
Query: 44  ERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH-RNVVRF 100
           E + +G+ G +Y+G  V  GQ  A+KV+    +    E+E  QE+ +L++  H RN+  +
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHHRNIATY 86
Query: 101 IGAS-TKSP-----HLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLH 153
            GA   K+P      L +V E+   GS+ D +     N LK   +     +I +G+ +LH
Sbjct: 87  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH 146
Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGV-ARFQNKGGVMTAETGTYRWMAPEVI--NHQ 210
           Q  +IHRD+K  N+L+  +  VK+ DFGV A+     G      GT  WMAPEVI  +  
Sbjct: 147 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDEN 206
Query: 211 P---YDQKADVFSFAIVLWELVTAKVPYDSMTPLQA 243
           P   YD K+D++S  I   E+     P   M P++A
Sbjct: 207 PDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA 242

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score =  102 bits (254), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 116/242 (47%), Gaps = 35/242 (14%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYL---GQ----DVAVKVLRSEHLNDTLEDEFVQE 85
           WE  R+ L  G+ +  G  G + +       G+     VAVK+L+       L D  + E
Sbjct: 18  WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD-LLSE 76
Query: 86  VAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL------------------- 126
             +L++V H +V++  GA ++   L ++ EY   GSL  +L                   
Sbjct: 77  FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 127 ----HKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGV 182
               H +   L +  L+ FA  I +GM+YL +  ++HRDL   N+L+     +K++DFG+
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 183 AR--FQNKGGVMTAETG-TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSM 238
           +R  ++    V  ++     +WMA E +    Y  ++DV+SF ++LWE+VT    PY  +
Sbjct: 197 SRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 239 TP 240
            P
Sbjct: 257 PP 258

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score =  102 bits (253), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 44  ERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLE-DEFVQEVAILREVQHRNV 97
           E I  G  G +Y G  L  D      AVK L    + D  E  +F+ E  I+++  H NV
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 98  VRFIGA---STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
           +  +G    S  SP   +V  YM  G L +++    +   +  L+ F + + KGM++L  
Sbjct: 95  LSLLGICLRSEGSP--LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 152
Query: 155 RNIIHRDLKTANLLMDTHNVVKVADFGVAR--FQNKGGVMTAETGT---YRWMAPEVINH 209
           +  +HRDL   N ++D    VKVADFG+AR     +   +  +TG     +WMA E +  
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 210 QPYDQKADVFSFAIVLWELVTAKVP 234
           Q +  K+DV+SF ++LWEL+T   P
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  102 bits (253), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 116/240 (48%), Gaps = 27/240 (11%)
Query: 23  AIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-------DVAVKVLRSEHLN 75
           A ++ + S+  E+ R+ +     +  G+ G++Y G   G         VAVK L  E  +
Sbjct: 30  AGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCS 88
Query: 76  DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH----- 130
           +  E +F+ E  I+ ++ H+N+VR IG S +S    I+ E M GG L  +L +       
Sbjct: 89  EQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQ 148
Query: 131 -NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVAR-- 184
            + L +  LL  A DI  G +YL + + IHRD+   N L+       V K+ DFG+AR  
Sbjct: 149 PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 208
Query: 185 ----FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
               +  KGG         +WM PE      +  K D +SF ++LWE+ +   +PY S +
Sbjct: 209 YRASYYRKGGCAMLPV---KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 265

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score =  102 bits (253), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 116/240 (48%), Gaps = 27/240 (11%)
Query: 23  AIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-------DVAVKVLRSEHLN 75
           A ++ + S+  E+ R+ +     +  G+ G++Y G   G         VAVK L  E  +
Sbjct: 16  AGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCS 74
Query: 76  DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH----- 130
           +  E +F+ E  I+ ++ H+N+VR IG S +S    I+ E M GG L  +L +       
Sbjct: 75  EQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQ 134
Query: 131 -NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVAR-- 184
            + L +  LL  A DI  G +YL + + IHRD+   N L+       V K+ DFG+AR  
Sbjct: 135 PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 194
Query: 185 ----FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
               +  KGG         +WM PE      +  K D +SF ++LWE+ +   +PY S +
Sbjct: 195 YRASYYRKGGCAMLPV---KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 251

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 109/222 (49%), Gaps = 14/222 (6%)
Query: 49  GSCGD-LYRGVYLGQDVAVKVLRSEHLNDTLEDE----FVQEVAILREVQHRNVVRFIGA 103
           G  GD  +  VY  Q+    VL +  + DT  +E    ++ E+ IL    H N+V+ + A
Sbjct: 43  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 104 STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLK 163
                +L I+ E+  GG++   + +    L   Q+          + YLH   IIHRDLK
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 162
Query: 164 TANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GTYRWMAPEVI-----NHQPYDQKA 216
             N+L      +K+ADFGV+  +N   +   ++  GT  WMAPEV+       +PYD KA
Sbjct: 163 AGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKA 221
Query: 217 DVFSFAIVLWELVTAKVPYDSMTPLQAALGV-RQVCTSLCQP 257
           DV+S  I L E+   + P+  + P++  L + +    +L QP
Sbjct: 222 DVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP 263

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 115/240 (47%), Gaps = 27/240 (11%)
Query: 23  AIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-------DVAVKVLRSEHLN 75
           A ++ + S+  E+ R+ +     +  G+ G++Y G   G         VAVK L  E  +
Sbjct: 30  AGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCS 88
Query: 76  DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH----- 130
           +  E +F+ E  I+ +  H+N+VR IG S +S    I+ E M GG L  +L +       
Sbjct: 89  EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQ 148
Query: 131 -NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVAR-- 184
            + L +  LL  A DI  G +YL + + IHRD+   N L+       V K+ DFG+AR  
Sbjct: 149 PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 208
Query: 185 ----FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
               +  KGG         +WM PE      +  K D +SF ++LWE+ +   +PY S +
Sbjct: 209 YRASYYRKGGCAMLPV---KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 265

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score =  101 bits (252), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 115/215 (53%), Gaps = 15/215 (6%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVA 87
           E + R LK    + SG  G +++GV++ +       V +KV+  +    + +      +A
Sbjct: 12  ETELRKLKV---LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 68
Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICK 147
           I   + H ++VR +G    S  L +VT+Y+P GSL D++ ++   L    LL + + I K
Sbjct: 69  I-GSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAK 126
Query: 148 GMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF---QNKGGVMTAETGTYRWMAP 204
           GM YL +  ++HR+L   N+L+ + + V+VADFGVA      +K  + +      +WMA 
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 205 EVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSM 238
           E I+   Y  ++DV+S+ + +WEL+T    PY  +
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL 221

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score =  101 bits (252), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 115/240 (47%), Gaps = 27/240 (11%)
Query: 23  AIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-------DVAVKVLRSEHLN 75
           A ++ + S+  E+ R+ +     +  G+ G++Y G   G         VAVK L  E  +
Sbjct: 7   AGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCS 65
Query: 76  DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH----- 130
           +  E +F+ E  I+ +  H+N+VR IG S +S    I+ E M GG L  +L +       
Sbjct: 66  EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQ 125
Query: 131 -NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVAR-- 184
            + L +  LL  A DI  G +YL + + IHRD+   N L+       V K+ DFG+AR  
Sbjct: 126 PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 185
Query: 185 ----FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
               +  KGG         +WM PE      +  K D +SF ++LWE+ +   +PY S +
Sbjct: 186 YRASYYRKGGCAMLPV---KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 242

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  101 bits (252), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 109/222 (49%), Gaps = 14/222 (6%)
Query: 49  GSCGD-LYRGVYLGQDVAVKVLRSEHLNDTLEDE----FVQEVAILREVQHRNVVRFIGA 103
           G  GD  +  VY  Q+    VL +  + DT  +E    ++ E+ IL    H N+V+ + A
Sbjct: 43  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 104 STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLK 163
                +L I+ E+  GG++   + +    L   Q+          + YLH   IIHRDLK
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 162
Query: 164 TANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GTYRWMAPEVI-----NHQPYDQKA 216
             N+L      +K+ADFGV+  +N   +   ++  GT  WMAPEV+       +PYD KA
Sbjct: 163 AGNILFTLDGDIKLADFGVSA-KNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKA 221
Query: 217 DVFSFAIVLWELVTAKVPYDSMTPLQAALGV-RQVCTSLCQP 257
           DV+S  I L E+   + P+  + P++  L + +    +L QP
Sbjct: 222 DVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP 263

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score =  101 bits (252), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 115/240 (47%), Gaps = 27/240 (11%)
Query: 23  AIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-------DVAVKVLRSEHLN 75
           A ++ + S+  E+ R+ +     +  G+ G++Y G   G         VAVK L  E  +
Sbjct: 33  AGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCS 91
Query: 76  DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH----- 130
           +  E +F+ E  I+ +  H+N+VR IG S +S    I+ E M GG L  +L +       
Sbjct: 92  EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQ 151
Query: 131 -NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVAR-- 184
            + L +  LL  A DI  G +YL + + IHRD+   N L+       V K+ DFG+AR  
Sbjct: 152 PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 211
Query: 185 ----FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
               +  KGG         +WM PE      +  K D +SF ++LWE+ +   +PY S +
Sbjct: 212 YRAGYYRKGGCAMLPV---KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 268

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score =  101 bits (252), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 115/240 (47%), Gaps = 27/240 (11%)
Query: 23  AIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-------DVAVKVLRSEHLN 75
           A ++ + S+  E+ R+ +     +  G+ G++Y G   G         VAVK L  E  +
Sbjct: 15  AGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCS 73
Query: 76  DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH----- 130
           +  E +F+ E  I+ +  H+N+VR IG S +S    I+ E M GG L  +L +       
Sbjct: 74  EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQ 133
Query: 131 -NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVAR-- 184
            + L +  LL  A DI  G +YL + + IHRD+   N L+       V K+ DFG+AR  
Sbjct: 134 PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 193
Query: 185 ----FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
               +  KGG         +WM PE      +  K D +SF ++LWE+ +   +PY S +
Sbjct: 194 YRASYYRKGGCAMLPV---KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score =  101 bits (252), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 115/215 (53%), Gaps = 15/215 (6%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRGVYLGQ------DVAVKVLRSEHLNDTLEDEFVQEVA 87
           E + R LK    + SG  G +++GV++ +       V +KV+  +    + +      +A
Sbjct: 30  ETELRKLKV---LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 86
Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICK 147
           I   + H ++VR +G    S  L +VT+Y+P GSL D++ ++   L    LL + + I K
Sbjct: 87  I-GSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAK 144
Query: 148 GMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF---QNKGGVMTAETGTYRWMAP 204
           GM YL +  ++HR+L   N+L+ + + V+VADFGVA      +K  + +      +WMA 
Sbjct: 145 GMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 204
Query: 205 EVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSM 238
           E I+   Y  ++DV+S+ + +WEL+T    PY  +
Sbjct: 205 ESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL 239

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score =  101 bits (252), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 115/240 (47%), Gaps = 27/240 (11%)
Query: 23  AIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-------DVAVKVLRSEHLN 75
           A ++ + S+  E+ R+ +     +  G+ G++Y G   G         VAVK L  E  +
Sbjct: 56  AGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCS 114
Query: 76  DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH----- 130
           +  E +F+ E  I+ +  H+N+VR IG S +S    I+ E M GG L  +L +       
Sbjct: 115 EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQ 174
Query: 131 -NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVAR-- 184
            + L +  LL  A DI  G +YL + + IHRD+   N L+       V K+ DFG+AR  
Sbjct: 175 PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 234
Query: 185 ----FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
               +  KGG         +WM PE      +  K D +SF ++LWE+ +   +PY S +
Sbjct: 235 YRAGYYRKGGCAMLPV---KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score =  101 bits (252), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 116/242 (47%), Gaps = 35/242 (14%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYL---GQ----DVAVKVLRSEHLNDTLEDEFVQE 85
           WE  R+ L  G+ +  G  G + +       G+     VAVK+L+       L D  + E
Sbjct: 18  WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD-LLSE 76
Query: 86  VAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL------------------- 126
             +L++V H +V++  GA ++   L ++ EY   GSL  +L                   
Sbjct: 77  FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 127 ----HKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGV 182
               H +   L +  L+ FA  I +GM+YL +  ++HRDL   N+L+     +K++DFG+
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 183 AR--FQNKGGVMTAETG-TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSM 238
           +R  ++    V  ++     +WMA E +    Y  ++DV+SF ++LWE+VT    PY  +
Sbjct: 197 SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 239 TP 240
            P
Sbjct: 257 PP 258

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score =  101 bits (251), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 103/202 (50%), Gaps = 28/202 (13%)
Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VAVK L+    +++   +F +E  +L  +QH+++VRF G  T+   L +V EYM  G L 
Sbjct: 74  VAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 131
Query: 124 DYLHKNH--------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM 169
            +L  +                 L L QLL  A  +  GM YL   + +HRDL T N L+
Sbjct: 132 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 191
Query: 170 DTHNVVKVADFGVAR-------FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFA 222
               VVK+ DFG++R       ++  G  M       RWM PE I ++ +  ++DV+SF 
Sbjct: 192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTML----PIRWMPPESILYRKFTTESDVWSFG 247
Query: 223 IVLWELVT-AKVPYDSMTPLQA 243
           +VLWE+ T  K P+  ++  +A
Sbjct: 248 VVLWEIFTYGKQPWYQLSNTEA 269

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score =  101 bits (251), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 115/240 (47%), Gaps = 27/240 (11%)
Query: 23  AIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-------DVAVKVLRSEHLN 75
           A ++ + S+  E+ R+ +     +  G+ G++Y G   G         VAVK L  E  +
Sbjct: 15  AGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCS 73
Query: 76  DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH----- 130
           +  E +F+ E  I+ +  H+N+VR IG S +S    I+ E M GG L  +L +       
Sbjct: 74  EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQ 133
Query: 131 -NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVAR-- 184
            + L +  LL  A DI  G +YL + + IHRD+   N L+       V K+ DFG+AR  
Sbjct: 134 PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 193
Query: 185 ----FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
               +  KGG         +WM PE      +  K D +SF ++LWE+ +   +PY S +
Sbjct: 194 YRASYYRKGGCAMLPV---KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score =  101 bits (251), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 115/240 (47%), Gaps = 27/240 (11%)
Query: 23  AIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-------DVAVKVLRSEHLN 75
           A ++ + S+  E+ R+ +     +  G+ G++Y G   G         VAVK L  E  +
Sbjct: 32  AGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCS 90
Query: 76  DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH----- 130
           +  E +F+ E  I+ +  H+N+VR IG S +S    I+ E M GG L  +L +       
Sbjct: 91  EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQ 150
Query: 131 -NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVAR-- 184
            + L +  LL  A DI  G +YL + + IHRD+   N L+       V K+ DFG+AR  
Sbjct: 151 PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 210
Query: 185 ----FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
               +  KGG         +WM PE      +  K D +SF ++LWE+ +   +PY S +
Sbjct: 211 YRASYYRKGGCAMLPV---KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 267

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score =  101 bits (251), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 115/240 (47%), Gaps = 27/240 (11%)
Query: 23  AIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-------DVAVKVLRSEHLN 75
           A ++ + S+  E+ R+ +     +  G+ G++Y G   G         VAVK L  E  +
Sbjct: 22  AGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCS 80
Query: 76  DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH----- 130
           +  E +F+ E  I+ +  H+N+VR IG S +S    I+ E M GG L  +L +       
Sbjct: 81  EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQ 140
Query: 131 -NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVAR-- 184
            + L +  LL  A DI  G +YL + + IHRD+   N L+       V K+ DFG+AR  
Sbjct: 141 PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 200
Query: 185 ----FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
               +  KGG         +WM PE      +  K D +SF ++LWE+ +   +PY S +
Sbjct: 201 YRASYYRKGGCAMLPV---KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 257

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score =  101 bits (251), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 115/240 (47%), Gaps = 27/240 (11%)
Query: 23  AIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-------DVAVKVLRSEHLN 75
           A ++ + S+  E+ R+ +     +  G+ G++Y G   G         VAVK L  E  +
Sbjct: 42  AGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCS 100
Query: 76  DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH----- 130
           +  E +F+ E  I+ +  H+N+VR IG S +S    I+ E M GG L  +L +       
Sbjct: 101 EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQ 160
Query: 131 -NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVAR-- 184
            + L +  LL  A DI  G +YL + + IHRD+   N L+       V K+ DFG+AR  
Sbjct: 161 PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 220
Query: 185 ----FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
               +  KGG         +WM PE      +  K D +SF ++LWE+ +   +PY S +
Sbjct: 221 YRASYYRKGGCAMLPV---KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 277

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score =  101 bits (251), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 115/240 (47%), Gaps = 27/240 (11%)
Query: 23  AIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-------DVAVKVLRSEHLN 75
           A ++ + S+  E+ R+ +     +  G+ G++Y G   G         VAVK L  E  +
Sbjct: 16  AGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCS 74
Query: 76  DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH----- 130
           +  E +F+ E  I+ +  H+N+VR IG S +S    I+ E M GG L  +L +       
Sbjct: 75  EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQ 134
Query: 131 -NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVAR-- 184
            + L +  LL  A DI  G +YL + + IHRD+   N L+       V K+ DFG+AR  
Sbjct: 135 PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 194
Query: 185 ----FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
               +  KGG         +WM PE      +  K D +SF ++LWE+ +   +PY S +
Sbjct: 195 YRASYYRKGGCAMLPV---KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 251

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  101 bits (251), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 115/240 (47%), Gaps = 27/240 (11%)
Query: 23  AIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-------DVAVKVLRSEHLN 75
           A ++ + S+  E+ R+ +     +  G+ G++Y G   G         VAVK L  E  +
Sbjct: 30  AGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVYS 88
Query: 76  DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH----- 130
           +  E +F+ E  I+ +  H+N+VR IG S +S    I+ E M GG L  +L +       
Sbjct: 89  EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQ 148
Query: 131 -NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVAR-- 184
            + L +  LL  A DI  G +YL + + IHRD+   N L+       V K+ DFG+AR  
Sbjct: 149 PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 208
Query: 185 ----FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
               +  KGG         +WM PE      +  K D +SF ++LWE+ +   +PY S +
Sbjct: 209 YRASYYRKGGCAMLPV---KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 265

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score =  100 bits (250), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 103/202 (50%), Gaps = 28/202 (13%)
Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VAVK L+    +++   +F +E  +L  +QH+++VRF G  T+   L +V EYM  G L 
Sbjct: 45  VAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 102
Query: 124 DYLHKNH--------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM 169
            +L  +                 L L QLL  A  +  GM YL   + +HRDL T N L+
Sbjct: 103 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 162
Query: 170 DTHNVVKVADFGVAR-------FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFA 222
               VVK+ DFG++R       ++  G  M       RWM PE I ++ +  ++DV+SF 
Sbjct: 163 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTML----PIRWMPPESILYRKFTTESDVWSFG 218
Query: 223 IVLWELVT-AKVPYDSMTPLQA 243
           +VLWE+ T  K P+  ++  +A
Sbjct: 219 VVLWEIFTYGKQPWYQLSNTEA 240

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 103/202 (50%), Gaps = 28/202 (13%)
Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VAVK L+    +++   +F +E  +L  +QH+++VRF G  T+   L +V EYM  G L 
Sbjct: 51  VAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 108
Query: 124 DYLHKNH--------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM 169
            +L  +                 L L QLL  A  +  GM YL   + +HRDL T N L+
Sbjct: 109 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 168
Query: 170 DTHNVVKVADFGVAR-------FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFA 222
               VVK+ DFG++R       ++  G  M       RWM PE I ++ +  ++DV+SF 
Sbjct: 169 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTML----PIRWMPPESILYRKFTTESDVWSFG 224
Query: 223 IVLWELVT-AKVPYDSMTPLQA 243
           +VLWE+ T  K P+  ++  +A
Sbjct: 225 VVLWEIFTYGKQPWYQLSNTEA 246

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 10/200 (5%)
Query: 54  LYRGVYLGQDVAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVRFIGA----STKSP 108
           L R + L +DVAVKVLR++   D +    F +E      + H  +V         +   P
Sbjct: 30  LARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYATGEAETPAGP 89
Query: 109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLL 168
              IV EY+ G +L D +H     +   + +    D C+ + + HQ  IIHRD+K AN++
Sbjct: 90  LPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIM 148
Query: 169 MDTHNVVKVADFGVARFQNKGGVMTAET----GTYRWMAPEVINHQPYDQKADVFSFAIV 224
           +   N VKV DFG+AR     G    +T    GT ++++PE       D ++DV+S   V
Sbjct: 149 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 225 LWELVTAKVPYDSMTPLQAA 244
           L+E++T + P+   +P+  A
Sbjct: 209 LYEVLTGEPPFTGDSPVSVA 228

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  100 bits (249), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 108/222 (48%), Gaps = 14/222 (6%)
Query: 49  GSCGD-LYRGVYLGQDVAVKVLRSEHLNDTLEDE----FVQEVAILREVQHRNVVRFIGA 103
           G  GD  +  VY  Q+    VL +  + DT  +E    ++ E+ IL    H N+V+ + A
Sbjct: 43  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 104 STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLK 163
                +L I+ E+  GG++   + +    L   Q+          + YLH   IIHRDLK
Sbjct: 103 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 162
Query: 164 TANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GTYRWMAPEVI-----NHQPYDQKA 216
             N+L      +K+ADFGV+  +N   +   +   GT  WMAPEV+       +PYD KA
Sbjct: 163 AGNILFTLDGDIKLADFGVSA-KNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKA 221
Query: 217 DVFSFAIVLWELVTAKVPYDSMTPLQAALGV-RQVCTSLCQP 257
           DV+S  I L E+   + P+  + P++  L + +    +L QP
Sbjct: 222 DVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP 263

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score =  100 bits (249), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 101/200 (50%), Gaps = 10/200 (5%)
Query: 54  LYRGVYLGQDVAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVRFI----GASTKSP 108
           L R + L +DVAVKVLR++   D +    F +E      + H  +V         +   P
Sbjct: 30  LARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89
Query: 109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLL 168
              IV EY+ G +L D +H     +   + +    D C+ + + HQ  IIHRD+K AN++
Sbjct: 90  LPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIM 148
Query: 169 MDTHNVVKVADFGVARFQNKGGVMTAET----GTYRWMAPEVINHQPYDQKADVFSFAIV 224
           +   N VKV DFG+AR     G    +T    GT ++++PE       D ++DV+S   V
Sbjct: 149 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 225 LWELVTAKVPYDSMTPLQAA 244
           L+E++T + P+   +P+  A
Sbjct: 209 LYEVLTGEPPFTGDSPVSVA 228

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score =  100 bits (249), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 12/213 (5%)
Query: 43  GERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVR 99
           GE +  G   +  L R + L +DVAVKVLR++   D +    F +E      + H  +V 
Sbjct: 34  GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 93
Query: 100 FI----GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR 155
                   +   P   IV EY+ G +L D +H     +   + +    D C+ + + HQ 
Sbjct: 94  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQN 152
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET----GTYRWMAPEVINHQP 211
            IIHRD+K AN+++   N VKV DFG+AR     G    +T    GT ++++PE      
Sbjct: 153 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 212
Query: 212 YDQKADVFSFAIVLWELVTAKVPYDSMTPLQAA 244
            D ++DV+S   VL+E++T + P+   +P+  A
Sbjct: 213 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 245

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 110/236 (46%), Gaps = 32/236 (13%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLR-SEHLNDTLEDEFVQ 84
           WE  R  L  G+ + +G+ G +      G         VAVK+L+ S HL +   +  + 
Sbjct: 36  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE--REALMS 93
Query: 85  EVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVL----KLPQLL 139
           E+ +L  +  H N+V  +GA T      ++TEY   G L ++L +  +        P ++
Sbjct: 94  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 153
Query: 140 -------------RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-F 185
                         F+  + KGM +L  +N IHRDL   N+L+    + K+ DFG+AR  
Sbjct: 154 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 213
Query: 186 QNKGGVMTAETG--TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSM 238
           +N    +         +WMAPE I +  Y  ++DV+S+ I LWEL +    PY  M
Sbjct: 214 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 269

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 110/236 (46%), Gaps = 32/236 (13%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLR-SEHLNDTLEDEFVQ 84
           WE  R  L  G+ + +G+ G +      G         VAVK+L+ S HL +   +  + 
Sbjct: 18  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE--REALMS 75
Query: 85  EVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVL----KLPQLL 139
           E+ +L  +  H N+V  +GA T      ++TEY   G L ++L +  +        P ++
Sbjct: 76  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 140 -------------RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-F 185
                         F+  + KGM +L  +N IHRDL   N+L+    + K+ DFG+AR  
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 186 QNKGGVMTAETG--TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSM 238
           +N    +         +WMAPE I +  Y  ++DV+S+ I LWEL +    PY  M
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 110/236 (46%), Gaps = 32/236 (13%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLR-SEHLNDTLEDEFVQ 84
           WE  R  L  G+ + +G+ G +      G         VAVK+L+ S HL  T  +  + 
Sbjct: 34  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMS 91
Query: 85  EVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVL----KLPQLL 139
           E+ +L  +  H N+V  +GA T      ++TEY   G L ++L +  +        P ++
Sbjct: 92  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 151
Query: 140 -------------RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-F 185
                         F+  + KGM +L  +N IHRDL   N+L+    + K+ DFG+AR  
Sbjct: 152 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 211
Query: 186 QNKGGVMTAETG--TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSM 238
           +N    +         +WMAPE I +  Y  ++DV+S+ I LWEL +    PY  M
Sbjct: 212 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 267

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 110/236 (46%), Gaps = 32/236 (13%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLR-SEHLNDTLEDEFVQ 84
           WE  R  L  G+ + +G+ G +      G         VAVK+L+ S HL +   +  + 
Sbjct: 41  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE--REALMS 98
Query: 85  EVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVL----KLPQLL 139
           E+ +L  +  H N+V  +GA T      ++TEY   G L ++L +  +        P ++
Sbjct: 99  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 158
Query: 140 -------------RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-F 185
                         F+  + KGM +L  +N IHRDL   N+L+    + K+ DFG+AR  
Sbjct: 159 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHI 218
Query: 186 QNKGGVMTAETG--TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSM 238
           +N    +         +WMAPE I +  Y  ++DV+S+ I LWEL +    PY  M
Sbjct: 219 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 274

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 110/236 (46%), Gaps = 32/236 (13%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLR-SEHLNDTLEDEFVQ 84
           WE  R  L  G+ + +G+ G +      G         VAVK+L+ S HL +   +  + 
Sbjct: 41  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE--REALMS 98
Query: 85  EVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVL----KLPQLL 139
           E+ +L  +  H N+V  +GA T      ++TEY   G L ++L +  +        P ++
Sbjct: 99  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 158
Query: 140 -------------RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-F 185
                         F+  + KGM +L  +N IHRDL   N+L+    + K+ DFG+AR  
Sbjct: 159 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 218
Query: 186 QNKGGVMTAETG--TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSM 238
           +N    +         +WMAPE I +  Y  ++DV+S+ I LWEL +    PY  M
Sbjct: 219 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 274

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 107/198 (54%), Gaps = 5/198 (2%)
Query: 43  GERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVR 99
           G+ +  G+ G +  G +   G  VAVK+L  + +    +  +  +E+  L+  +H ++++
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
                +    + +V EY+ GG L+DY+ KN   L   +  R    I  G++Y H+  ++H
Sbjct: 81  LYQVISTPSDIFMVMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHMVVH 139
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPY-DQKADV 218
           RDLK  N+L+D H   K+ADFG++   + G  +    G+  + APEVI+ + Y   + D+
Sbjct: 140 RDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDI 199
Query: 219 FSFAIVLWELVTAKVPYD 236
           +S  ++L+ L+   +P+D
Sbjct: 200 WSSGVILYALLCGTLPFD 217

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 114/226 (50%), Gaps = 17/226 (7%)
Query: 46  IASGSCGDLYRGVYLGQ----DVAVKVLR-SEHLNDTLEDEFVQEVAILREVQHRNVVRF 100
           +  G+ G + +GVY  +    DVA+KVL+      DT  +E ++E  I+ ++ +  +VR 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMREAQIMHQLDNPYIVRL 75
Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
           IG   ++  L +V E   GG L+ +L      + +  +      +  GM+YL ++N +HR
Sbjct: 76  IGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 134
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETG---TYRWMAPEVINHQPYDQKA 216
           DL   N+L+   +  K++DFG+++         TA +      +W APE IN + +  ++
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 194
Query: 217 DVFSFAIVLWELVT-AKVPYDSMT-PLQAAL---GVRQVCTSLCQP 257
           DV+S+ + +WE ++  + PY  M  P   A    G R  C   C P
Sbjct: 195 DVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP 240

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 115/240 (47%), Gaps = 27/240 (11%)
Query: 23  AIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-------DVAVKVLRSEHLN 75
           A ++ + S+  E+ R+ +     +  G+ G++Y G   G         VAVK L  E  +
Sbjct: 16  AGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCS 74
Query: 76  DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH----- 130
           +  E +F+ E  I+ +  H+N+VR IG S +S    I+ E M GG L  +L +       
Sbjct: 75  EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQ 134
Query: 131 -NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVAR-- 184
            + L +  LL  A DI  G +YL + + IHRD+   N L+       V K+ DFG+A+  
Sbjct: 135 PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDI 194
Query: 185 ----FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
               +  KGG         +WM PE      +  K D +SF ++LWE+ +   +PY S +
Sbjct: 195 YRASYYRKGGCAMLPV---KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 251

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 99.0 bits (245), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 114/233 (48%), Gaps = 29/233 (12%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRG----VYLGQD---VAVKVL-RSEHLNDTLEDEF 82
           ++WE+ R  +     +  GS G +Y G    +  G+    VAVK +  S  L + +E  F
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--F 67
Query: 83  VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-----NHNVLKLP- 136
           + E ++++     +VVR +G  +K     +V E M  G L  YL        +N  + P 
Sbjct: 68  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 137 ---QLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR------FQN 187
              ++++ A +I  GM YL+ +  +HRDL   N ++     VK+ DFG+ R      +  
Sbjct: 128 TLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYR 187
Query: 188 KGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           KGG         RWMAPE +    +   +D++SF +VLWE+ + A+ PY  ++
Sbjct: 188 KGGKGLLPV---RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 237

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 114/233 (48%), Gaps = 29/233 (12%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRG----VYLGQD---VAVKVL-RSEHLNDTLEDEF 82
           ++WE+ R  +     +  GS G +Y G    +  G+    VAVK +  S  L + +E  F
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--F 67
Query: 83  VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-----NHNVLKLP- 136
           + E ++++     +VVR +G  +K     +V E M  G L  YL        +N  + P 
Sbjct: 68  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 137 ---QLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR------FQN 187
              ++++ A +I  GM YL+ +  +HRDL   N ++     VK+ DFG+ R      +  
Sbjct: 128 TLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR 187
Query: 188 KGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           KGG         RWMAPE +    +   +D++SF +VLWE+ + A+ PY  ++
Sbjct: 188 KGGKGLLPV---RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 237

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 98.6 bits (244), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 97/192 (50%), Gaps = 10/192 (5%)
Query: 62  QDVAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVRFI----GASTKSPHLCIVTEY 116
           +DVAVKVLR++   D +    F +E      + H  +V         +   P   IV EY
Sbjct: 38  RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY 97
Query: 117 MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVK 176
           + G +L D +H     +   + +    D C+ + + HQ  IIHRD+K AN+L+   N VK
Sbjct: 98  VDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVK 156
Query: 177 VADFGVARFQNKGGVMTAET----GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAK 232
           V DFG+AR     G    +T    GT ++++PE       D ++DV+S   VL+E++T +
Sbjct: 157 VVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 233 VPYDSMTPLQAA 244
            P+   +P+  A
Sbjct: 217 PPFTGDSPVSVA 228

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 98.2 bits (243), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 100/178 (56%), Gaps = 4/178 (2%)
Query: 61  GQDVAVKVLRSEHLNDT-LEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPG 119
           GQ VA+K++  + L  + ++    +E++ LR ++H ++++          + +V EY  G
Sbjct: 38  GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-G 96
Query: 120 GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVAD 179
             L+DY+ +  + +   +  RF   I   +EY H+  I+HRDLK  NLL+D H  VK+AD
Sbjct: 97  NELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIAD 155
Query: 180 FGVARFQNKGGVMTAETGTYRWMAPEVINHQPY-DQKADVFSFAIVLWELVTAKVPYD 236
           FG++     G  +    G+  + APEVI+ + Y   + DV+S  ++L+ ++  ++P+D
Sbjct: 156 FGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 100/178 (56%), Gaps = 4/178 (2%)
Query: 61  GQDVAVKVLRSEHLNDT-LEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPG 119
           GQ VA+K++  + L  + ++    +E++ LR ++H ++++          + +V EY  G
Sbjct: 39  GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-G 97
Query: 120 GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVAD 179
             L+DY+ +  + +   +  RF   I   +EY H+  I+HRDLK  NLL+D H  VK+AD
Sbjct: 98  NELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIAD 156
Query: 180 FGVARFQNKGGVMTAETGTYRWMAPEVINHQPY-DQKADVFSFAIVLWELVTAKVPYD 236
           FG++     G  +    G+  + APEVI+ + Y   + DV+S  ++L+ ++  ++P+D
Sbjct: 157 FGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 101/191 (52%), Gaps = 9/191 (4%)
Query: 61  GQDVAVKV--LRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMP 118
           G+ VAVK   LR +   + L      EV I+R+ QH NVV    +      L +V E++ 
Sbjct: 45  GKLVAVKKMDLRKQQRRELL----FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100
Query: 119 GGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVA 178
           GG+L D +   H  +   Q+    + + + +  LH + +IHRD+K+ ++L+     VK++
Sbjct: 101 GGALTDIV--THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLS 158
Query: 179 DFGV-ARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS 237
           DFG  A+   +        GT  WMAPE+I+  PY  + D++S  I++ E+V  + PY +
Sbjct: 159 DFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 218
Query: 238 MTPLQAALGVR 248
             PL+A   +R
Sbjct: 219 EPPLKAMKMIR 229

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 100/178 (56%), Gaps = 4/178 (2%)
Query: 61  GQDVAVKVLRSEHLNDT-LEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPG 119
           GQ VA+K++  + L  + ++    +E++ LR ++H ++++          + +V EY  G
Sbjct: 33  GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-G 91
Query: 120 GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVAD 179
             L+DY+ +  + +   +  RF   I   +EY H+  I+HRDLK  NLL+D H  VK+AD
Sbjct: 92  NELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIAD 150
Query: 180 FGVARFQNKGGVMTAETGTYRWMAPEVINHQPY-DQKADVFSFAIVLWELVTAKVPYD 236
           FG++     G  +    G+  + APEVI+ + Y   + DV+S  ++L+ ++  ++P+D
Sbjct: 151 FGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 101/191 (52%), Gaps = 9/191 (4%)
Query: 61  GQDVAVKV--LRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMP 118
           G+ VAVK   LR +   + L      EV I+R+ QH NVV    +      L +V E++ 
Sbjct: 49  GKLVAVKKMDLRKQQRRELL----FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 104
Query: 119 GGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVA 178
           GG+L D +   H  +   Q+    + + + +  LH + +IHRD+K+ ++L+     VK++
Sbjct: 105 GGALTDIV--THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLS 162
Query: 179 DFGV-ARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS 237
           DFG  A+   +        GT  WMAPE+I+  PY  + D++S  I++ E+V  + PY +
Sbjct: 163 DFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 222
Query: 238 MTPLQAALGVR 248
             PL+A   +R
Sbjct: 223 EPPLKAMKMIR 233

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 101/191 (52%), Gaps = 9/191 (4%)
Query: 61  GQDVAVKV--LRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMP 118
           G+ VAVK   LR +   + L      EV I+R+ QH NVV    +      L +V E++ 
Sbjct: 56  GKLVAVKKMDLRKQQRRELL----FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 111
Query: 119 GGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVA 178
           GG+L D +   H  +   Q+    + + + +  LH + +IHRD+K+ ++L+     VK++
Sbjct: 112 GGALTDIV--THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLS 169
Query: 179 DFGV-ARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS 237
           DFG  A+   +        GT  WMAPE+I+  PY  + D++S  I++ E+V  + PY +
Sbjct: 170 DFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 229
Query: 238 MTPLQAALGVR 248
             PL+A   +R
Sbjct: 230 EPPLKAMKMIR 240

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 100/178 (56%), Gaps = 4/178 (2%)
Query: 61  GQDVAVKVLRSEHLNDT-LEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPG 119
           GQ VA+K++  + L  + ++    +E++ LR ++H ++++          + +V EY  G
Sbjct: 29  GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-G 87
Query: 120 GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVAD 179
             L+DY+ +  + +   +  RF   I   +EY H+  I+HRDLK  NLL+D H  VK+AD
Sbjct: 88  NELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIAD 146
Query: 180 FGVARFQNKGGVMTAETGTYRWMAPEVINHQPY-DQKADVFSFAIVLWELVTAKVPYD 236
           FG++     G  +    G+  + APEVI+ + Y   + DV+S  ++L+ ++  ++P+D
Sbjct: 147 FGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 97.8 bits (242), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 101/191 (52%), Gaps = 9/191 (4%)
Query: 61  GQDVAVKV--LRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMP 118
           G+ VAVK   LR +   + L      EV I+R+ QH NVV    +      L +V E++ 
Sbjct: 54  GKLVAVKKMDLRKQQRRELL----FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 109
Query: 119 GGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVA 178
           GG+L D +   H  +   Q+    + + + +  LH + +IHRD+K+ ++L+     VK++
Sbjct: 110 GGALTDIV--THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLS 167
Query: 179 DFGV-ARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS 237
           DFG  A+   +        GT  WMAPE+I+  PY  + D++S  I++ E+V  + PY +
Sbjct: 168 DFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 227
Query: 238 MTPLQAALGVR 248
             PL+A   +R
Sbjct: 228 EPPLKAMKMIR 238

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 97.8 bits (242), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 29/199 (14%)
Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VAVK L+   L      +F +E  +L  +QH ++V+F G       L +V EYM  G L 
Sbjct: 48  VAVKALKDPTL--AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 105
Query: 124 DYLH---------------KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLL 168
            +L                +    L L Q+L  A  I  GM YL  ++ +HRDL T N L
Sbjct: 106 KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL 165
Query: 169 MDTHNVVKVADFGVAR-------FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSF 221
           +  + +VK+ DFG++R       ++  G  M       RWM PE I ++ +  ++DV+SF
Sbjct: 166 VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP----IRWMPPESIMYRKFTTESDVWSF 221
Query: 222 AIVLWELVT-AKVPYDSMT 239
            ++LWE+ T  K P+  ++
Sbjct: 222 GVILWEIFTYGKQPWFQLS 240

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 97.4 bits (241), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 113/233 (48%), Gaps = 29/233 (12%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRG----VYLGQD---VAVKVL-RSEHLNDTLEDEF 82
           ++WE+ R  +     +  GS G +Y G    +  G+    VAVK +  S  L + +E  F
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--F 67
Query: 83  VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-----NHNVLKLP- 136
           + E ++++     +VVR +G  +K     +V E M  G L  YL        +N  + P 
Sbjct: 68  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 137 ---QLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR------FQN 187
              ++++ A +I  GM YL+ +  +HRDL   N ++     VK+ DFG+ R         
Sbjct: 128 TLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXR 187
Query: 188 KGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           KGG         RWMAPE +    +   +D++SF +VLWE+ + A+ PY  ++
Sbjct: 188 KGGKGLLPV---RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 237

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 97.4 bits (241), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 113/233 (48%), Gaps = 29/233 (12%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRG----VYLGQD---VAVKVL-RSEHLNDTLEDEF 82
           ++WE+ R  +     +  GS G +Y G    +  G+    VAVK +  S  L + +E  F
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--F 67
Query: 83  VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-----NHNVLKLP- 136
           + E ++++     +VVR +G  +K     +V E M  G L  YL        +N  + P 
Sbjct: 68  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 137 ---QLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR------FQN 187
              ++++ A +I  GM YL+ +  +HRDL   N ++     VK+ DFG+ R         
Sbjct: 128 TLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXR 187
Query: 188 KGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           KGG         RWMAPE +    +   +D++SF +VLWE+ + A+ PY  ++
Sbjct: 188 KGGKGLLPV---RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 237

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 97.4 bits (241), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 97/192 (50%), Gaps = 10/192 (5%)
Query: 62  QDVAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVRFI----GASTKSPHLCIVTEY 116
           +DVAVKVLR++   D +    F +E      + H  +V         +   P   IV EY
Sbjct: 38  RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY 97
Query: 117 MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVK 176
           + G +L D +H     +   + +    D C+ + + HQ  IIHRD+K AN+++   N VK
Sbjct: 98  VDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVK 156
Query: 177 VADFGVARFQNKGGVMTAET----GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAK 232
           V DFG+AR     G    +T    GT ++++PE       D ++DV+S   VL+E++T +
Sbjct: 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 233 VPYDSMTPLQAA 244
            P+   +P+  A
Sbjct: 217 PPFTGDSPVSVA 228

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 97.4 bits (241), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 113/233 (48%), Gaps = 29/233 (12%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRG----VYLGQD---VAVKVL-RSEHLNDTLEDEF 82
           ++WE+ R  +     +  GS G +Y G    +  G+    VAVK +  S  L + +E  F
Sbjct: 7   DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--F 64
Query: 83  VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-----NHNVLKLP- 136
           + E ++++     +VVR +G  +K     +V E M  G L  YL        +N  + P 
Sbjct: 65  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 124
Query: 137 ---QLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR------FQN 187
              ++++ A +I  GM YL+ +  +HRDL   N ++     VK+ DFG+ R         
Sbjct: 125 TLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXR 184
Query: 188 KGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           KGG         RWMAPE +    +   +D++SF +VLWE+ + A+ PY  ++
Sbjct: 185 KGGKGLLPV---RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 234

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 97.4 bits (241), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 101/191 (52%), Gaps = 9/191 (4%)
Query: 61  GQDVAVKV--LRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMP 118
           G+ VAVK   LR +   + L      EV I+R+ QH NVV    +      L +V E++ 
Sbjct: 99  GKLVAVKKMDLRKQQRRELL----FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 154
Query: 119 GGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVA 178
           GG+L D +   H  +   Q+    + + + +  LH + +IHRD+K+ ++L+     VK++
Sbjct: 155 GGALTDIV--THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLS 212
Query: 179 DFGV-ARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS 237
           DFG  A+   +        GT  WMAPE+I+  PY  + D++S  I++ E+V  + PY +
Sbjct: 213 DFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 272
Query: 238 MTPLQAALGVR 248
             PL+A   +R
Sbjct: 273 EPPLKAMKMIR 283

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 97.1 bits (240), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 101/191 (52%), Gaps = 9/191 (4%)
Query: 61  GQDVAVKV--LRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMP 118
           G+ VAVK   LR +   + L      EV I+R+ QH NVV    +      L +V E++ 
Sbjct: 176 GKLVAVKKMDLRKQQRRELL----FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 231
Query: 119 GGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVA 178
           GG+L D +   H  +   Q+    + + + +  LH + +IHRD+K+ ++L+     VK++
Sbjct: 232 GGALTDIV--THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLS 289
Query: 179 DFGV-ARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS 237
           DFG  A+   +        GT  WMAPE+I+  PY  + D++S  I++ E+V  + PY +
Sbjct: 290 DFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 349
Query: 238 MTPLQAALGVR 248
             PL+A   +R
Sbjct: 350 EPPLKAMKMIR 360

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 97.1 bits (240), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 107/198 (54%), Gaps = 5/198 (2%)
Query: 43  GERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVR 99
           G+ +  G+ G +  G +   G  VAVK+L  + +    +  +  +E+  L+  +H ++++
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
                +      +V EY+ GG L+DY+ K+  V ++ +  R    I   ++Y H+  ++H
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM-EARRLFQQILSAVDYCHRHMVVH 134
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPY-DQKADV 218
           RDLK  N+L+D H   K+ADFG++   + G  +    G+  + APEVI+ + Y   + D+
Sbjct: 135 RDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDI 194
Query: 219 FSFAIVLWELVTAKVPYD 236
           +S  ++L+ L+   +P+D
Sbjct: 195 WSCGVILYALLCGTLPFD 212

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 97.1 bits (240), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 114/233 (48%), Gaps = 29/233 (12%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRG----VYLGQD---VAVKVL-RSEHLNDTLEDEF 82
           ++WE+ R  +     +  GS G +Y G    +  G+    VAVK +  S  L + +E  F
Sbjct: 11  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--F 68
Query: 83  VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-----NHNVLKLP- 136
           + E ++++     +VVR +G  +K     +V E M  G L  YL        +N  + P 
Sbjct: 69  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 128
Query: 137 ---QLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR------FQN 187
              ++++ A +I  GM YL+ +  +HR+L   N ++     VK+ DFG+ R      +  
Sbjct: 129 TLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR 188
Query: 188 KGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           KGG         RWMAPE +    +   +D++SF +VLWE+ + A+ PY  ++
Sbjct: 189 KGGKGLLPV---RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 238

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 114/233 (48%), Gaps = 29/233 (12%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRG----VYLGQD---VAVKVL-RSEHLNDTLEDEF 82
           ++WE+ R  +     +  GS G +Y G    +  G+    VAVK +  S  L + +E  F
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--F 67
Query: 83  VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-----NHNVLKLP- 136
           + E ++++     +VVR +G  +K     +V E M  G L  YL        +N  + P 
Sbjct: 68  LNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 137 ---QLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR------FQN 187
              ++++ A +I  GM YL+ +  +HR+L   N ++     VK+ DFG+ R      +  
Sbjct: 128 TLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR 187
Query: 188 KGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           KGG         RWMAPE +    +   +D++SF +VLWE+ + A+ PY  ++
Sbjct: 188 KGGKGLLPV---RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 237

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 107/203 (52%), Gaps = 7/203 (3%)
Query: 40  LKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDT-LEDEFVQEVAILREVQHRN 96
            +  ++I  G   ++YR   L  G  VA+K ++   L D     + ++E+ +L+++ H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSL---YDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
           V+++  +  +   L IV E    G L     +  K   ++    + ++ + +C  +E++H
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEVINHQPY 212
            R ++HRD+K AN+ +    VVK+ D G+ R F +K     +  GT  +M+PE I+   Y
Sbjct: 154 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 213
Query: 213 DQKADVFSFAIVLWELVTAKVPY 235
           + K+D++S   +L+E+   + P+
Sbjct: 214 NFKSDIWSLGCLLYEMAALQSPF 236

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 114/226 (50%), Gaps = 17/226 (7%)
Query: 46  IASGSCGDLYRGVYLGQ----DVAVKVLR-SEHLNDTLEDEFVQEVAILREVQHRNVVRF 100
           +  G+ G + +GVY  +    DVA+KVL+      DT  +E ++E  I+ ++ +  +VR 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMREAQIMHQLDNPYIVRL 401
Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
           IG   ++  L +V E   GG L+ +L      + +  +      +  GM+YL ++N +HR
Sbjct: 402 IGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETG---TYRWMAPEVINHQPYDQKA 216
           +L   N+L+   +  K++DFG+++         TA +      +W APE IN + +  ++
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 520
Query: 217 DVFSFAIVLWELVT-AKVPYDSMT-PLQAAL---GVRQVCTSLCQP 257
           DV+S+ + +WE ++  + PY  M  P   A    G R  C   C P
Sbjct: 521 DVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP 566

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 106/197 (53%), Gaps = 6/197 (3%)
Query: 44  ERIASGSCGDLYRGVYLG--QDVAVKVLRSEHLNDT-LEDEFVQEVAILREVQHRNVVRF 100
           E +  GS G +    +    Q VA+K +  + L  + +     +E++ L+ ++H ++++ 
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
               T    + +V EY  GG L+DY+ +   + +  +  RF   I   +EY H+  I+HR
Sbjct: 75  YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTE-DEGRRFFQQIICAIEYCHRHKIVHR 132
Query: 161 DLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPY-DQKADVF 219
           DLK  NLL+D +  VK+ADFG++     G  +    G+  + APEVIN + Y   + DV+
Sbjct: 133 DLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVW 192
Query: 220 SFAIVLWELVTAKVPYD 236
           S  IVL+ ++  ++P+D
Sbjct: 193 SCGIVLYVMLVGRLPFD 209

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 114/229 (49%), Gaps = 25/229 (10%)
Query: 23  AIESQTKSEDW----EIDRRLLKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLND 76
           A E+   S  W    E  +++ +  E + +G+  +  L      G+  AVK +  + L  
Sbjct: 3   ARENGESSSSWKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKG 62
Query: 77  TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYD-------YLHKN 129
             E     E+A+LR+++H N+V          HL +V + + GG L+D       Y  K+
Sbjct: 63  K-ESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKD 121
Query: 130 HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLL---MDTHNVVKVADFGVARFQ 186
            + L     +R  +D    + YLH+  I+HRDLK  NLL    D  + + ++DFG+++ +
Sbjct: 122 ASTL-----IRQVLD---AVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKME 173
Query: 187 NKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
            KG VM+   GT  ++APEV+  +PY +  D +S  ++ + L+    P+
Sbjct: 174 GKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 222

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 107/198 (54%), Gaps = 5/198 (2%)
Query: 43  GERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVR 99
           G+ +  G+ G +  G +   G  VAVK+L  + +    +  +  +E+  L+  +H ++++
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
                +      +V EY+ GG L+DY+ K+  V ++ +  R    I   ++Y H+  ++H
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM-EARRLFQQILSAVDYCHRHMVVH 134
Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPY-DQKADV 218
           RDLK  N+L+D H   K+ADFG++   + G  +    G+  + APEVI+ + Y   + D+
Sbjct: 135 RDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDI 194
Query: 219 FSFAIVLWELVTAKVPYD 236
           +S  ++L+ L+   +P+D
Sbjct: 195 WSCGVILYALLCGTLPFD 212

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 109/230 (47%), Gaps = 38/230 (16%)
Query: 44  ERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA 103
           E I  G  G+++RG + G++VAVK+  S        +  + +  +LR   H N++ FI A
Sbjct: 10  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLR---HENILGFIAA 66
Query: 104 STKS----PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH------ 153
             K       L +V++Y   GSL+DYL  N   + +  +++ A+    G+ +LH      
Sbjct: 67  DNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 124
Query: 154 --QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-----VMTAETGTYRWMAPEV 206
             +  I HRDLK+ N+L+  +    +AD G+A   +              GT R+MAPEV
Sbjct: 125 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 184
Query: 207 IN------HQPYDQKADVFSFAIVLWELVTA----------KVPYDSMTP 240
           ++      H    ++AD+++  +V WE+             ++PY  + P
Sbjct: 185 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 234

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 28/209 (13%)
Query: 44  ERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA 103
           E I  G  G+++RG + G++VAVK+  S        +  + +  +LR   H N++ FI A
Sbjct: 15  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLR---HENILGFIAA 71
Query: 104 STKS----PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH------ 153
             K       L +V++Y   GSL+DYL  N   + +  +++ A+    G+ +LH      
Sbjct: 72  DNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 129
Query: 154 --QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-----VMTAETGTYRWMAPEV 206
             +  I HRDLK+ N+L+  +    +AD G+A   +              GT R+MAPEV
Sbjct: 130 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 189
Query: 207 IN------HQPYDQKADVFSFAIVLWELV 229
           ++      H    ++AD+++  +V WE+ 
Sbjct: 190 LDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 95/188 (50%), Gaps = 10/188 (5%)
Query: 62  QDVAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVRFI----GASTKSPHLCIVTEY 116
           +DVAVKVLR++   D +    F +E      + H  +V         +   P   IV EY
Sbjct: 38  RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY 97
Query: 117 MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVK 176
           + G +L D +H     +   + +    D C+ + + HQ  IIHRD+K AN+++   N VK
Sbjct: 98  VDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVK 156
Query: 177 VADFGVARFQNKGGVMTAET----GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAK 232
           V DFG+AR     G    +T    GT ++++PE       D ++DV+S   VL+E++T +
Sbjct: 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 233 VPYDSMTP 240
            P+   +P
Sbjct: 217 PPFTGDSP 224

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 109/230 (47%), Gaps = 38/230 (16%)
Query: 44  ERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA 103
           E I  G  G+++RG + G++VAVK+  S        +  + +  +LR   H N++ FI A
Sbjct: 9   ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLR---HENILGFIAA 65
Query: 104 STKS----PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH------ 153
             K       L +V++Y   GSL+DYL  N   + +  +++ A+    G+ +LH      
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 154 --QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-----VMTAETGTYRWMAPEV 206
             +  I HRDLK+ N+L+  +    +AD G+A   +              GT R+MAPEV
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 207 IN------HQPYDQKADVFSFAIVLWELVTA----------KVPYDSMTP 240
           ++      H    ++AD+++  +V WE+             ++PY  + P
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 28/209 (13%)
Query: 44  ERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA 103
           E I  G  G+++RG + G++VAVK+  S        +  + +  +LR   H N++ FI A
Sbjct: 12  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLR---HENILGFIAA 68
Query: 104 STKS----PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH------ 153
             K       L +V++Y   GSL+DYL  N   + +  +++ A+    G+ +LH      
Sbjct: 69  DNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 126
Query: 154 --QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-----VMTAETGTYRWMAPEV 206
             +  I HRDLK+ N+L+  +    +AD G+A   +              GT R+MAPEV
Sbjct: 127 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 186
Query: 207 IN------HQPYDQKADVFSFAIVLWELV 229
           ++      H    ++AD+++  +V WE+ 
Sbjct: 187 LDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 28/209 (13%)
Query: 44  ERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA 103
           E I  G  G+++RG + G++VAVK+  S        +  + +  +LR   H N++ FI A
Sbjct: 35  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLR---HENILGFIAA 91
Query: 104 STKS----PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH------ 153
             K       L +V++Y   GSL+DYL  N   + +  +++ A+    G+ +LH      
Sbjct: 92  DNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 149
Query: 154 --QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-----VMTAETGTYRWMAPEV 206
             +  I HRDLK+ N+L+  +    +AD G+A   +              GT R+MAPEV
Sbjct: 150 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 209
Query: 207 IN------HQPYDQKADVFSFAIVLWELV 229
           ++      H    ++AD+++  +V WE+ 
Sbjct: 210 LDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/244 (32%), Positives = 116/244 (47%), Gaps = 19/244 (7%)
Query: 25  ESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKV----LRSEHLNDTLED 80
           E +TK+     D R LK    I  GS   +Y+G  L  +  V+V    L+   L  +   
Sbjct: 13  ELETKAVGXSNDGRFLKFDIEIGRGSFKTVYKG--LDTETTVEVAWCELQDRKLTKSERQ 70
Query: 81  EFVQEVAILREVQHRNVVRFIGA--STKSPHLCI--VTEYMPGGSLYDYLHKNHNVLKLP 136
            F +E   L+ +QH N+VRF  +  ST     CI  VTE    G+L  YL K   V K+ 
Sbjct: 71  RFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYL-KRFKVXKIK 129
Query: 137 QLLRFAIDICKGMEYLHQRN--IIHRDLKTANLLM-DTHNVVKVADFGVARFQNKGGVMT 193
            L  +   I KG+++LH R   IIHRDLK  N+ +      VK+ D G+A  + +     
Sbjct: 130 VLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RASFAK 188
Query: 194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS 253
           A  GT  + APE    + YD+  DV++F     E  T++ PY   +  Q A  + +  TS
Sbjct: 189 AVIGTPEFXAPEXYEEK-YDESVDVYAFGXCXLEXATSEYPY---SECQNAAQIYRRVTS 244
Query: 254 LCQP 257
             +P
Sbjct: 245 GVKP 248

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 28/209 (13%)
Query: 44  ERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA 103
           E I  G  G+++RG + G++VAVK+  S        +  + +  +LR   H N++ FI A
Sbjct: 48  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLR---HENILGFIAA 104
Query: 104 STKS----PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH------ 153
             K       L +V++Y   GSL+DYL  N   + +  +++ A+    G+ +LH      
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 154 --QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-----VMTAETGTYRWMAPEV 206
             +  I HRDLK+ N+L+  +    +AD G+A   +              GT R+MAPEV
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 207 IN------HQPYDQKADVFSFAIVLWELV 229
           ++      H    ++AD+++  +V WE+ 
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 95.5 bits (236), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 47/129 (36%), Positives = 81/129 (62%), Gaps = 2/129 (1%)
Query: 110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM 169
           L  V EY+ GG L  ++ +     K PQ + +A +I  G+ +LH+R II+RDLK  N+++
Sbjct: 95  LYFVMEYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVML 153
Query: 170 DTHNVVKVADFGVARFQNKGGVMTAE-TGTYRWMAPEVINHQPYDQKADVFSFAIVLWEL 228
           D+   +K+ADFG+ +     GV T E  GT  ++APE+I +QPY +  D +++ ++L+E+
Sbjct: 154 DSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEM 213
Query: 229 VTAKVPYDS 237
           +  + P+D 
Sbjct: 214 LAGQPPFDG 222

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 99/196 (50%), Gaps = 26/196 (13%)
Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VAVK L+    +D    +F +E  +L  +QH ++V+F G   +   L +V EYM  G L 
Sbjct: 46  VAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLN 103
Query: 124 DYL--HKNHNVLKL----------PQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT 171
            +L  H    VL             Q+L  A  I  GM YL  ++ +HRDL T N L+  
Sbjct: 104 KFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE 163
Query: 172 HNVVKVADFGVAR-------FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIV 224
           + +VK+ DFG++R       ++  G  M       RWM PE I ++ +  ++DV+S  +V
Sbjct: 164 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLP----IRWMPPESIMYRKFTTESDVWSLGVV 219
Query: 225 LWELVT-AKVPYDSMT 239
           LWE+ T  K P+  ++
Sbjct: 220 LWEIFTYGKQPWYQLS 235

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 95.1 bits (235), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 17/223 (7%)
Query: 22  KAIESQTKSEDWEIDRRLLKTGERIASGSC-----GDLYRGVYLGQDVAVKVLRSEHLND 76
           K +E+Q   EDW +D R+L  G      +C     G LY              +      
Sbjct: 175 KWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYA-------CKKLNKKRLKKRK 227
Query: 77  TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH---KNHNVL 133
             +   V E  IL +V  R +V    A      LC+V   M GG +  +++   +++   
Sbjct: 228 GYQGAMV-EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF 286
Query: 134 KLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT 193
           + P+ + +   I  G+E+LHQRNII+RDLK  N+L+D    V+++D G+A     G   T
Sbjct: 287 QEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346
Query: 194 -AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
               GT  +MAPE++  + YD   D F+  + L+E++ A+ P+
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 95.1 bits (235), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 110/204 (53%), Gaps = 12/204 (5%)
Query: 44  ERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLED-EFVQEVAILREVQHRNVVRF 100
           +++ SG+ G+  L +    G + A+K+++   +  T      + EVA+L+++ H N+++ 
Sbjct: 27  KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 86
Query: 101 IGASTKSPHLCIVTEYMPGGSLYD--YLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNII 158
                   +  +V E   GG L+D   L +  + +    +++    +  G  YLH+ NI+
Sbjct: 87  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK---QVLSGTTYLHKHNIV 143
Query: 159 HRDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQK 215
           HRDLK  NLL+++ +   ++K+ DFG++     GG M    GT  ++APEV+  + YD+K
Sbjct: 144 HRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKK-YDEK 202
Query: 216 ADVFSFAIVLWELVTAKVPYDSMT 239
            DV+S  ++L+ L+    P+   T
Sbjct: 203 CDVWSCGVILYILLCGYPPFGGQT 226

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 95.1 bits (235), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 17/223 (7%)
Query: 22  KAIESQTKSEDWEIDRRLLKTGERIASGSC-----GDLYRGVYLGQDVAVKVLRSEHLND 76
           K +E+Q   EDW +D R+L  G      +C     G LY              +      
Sbjct: 175 KWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYA-------CKKLNKKRLKKRK 227
Query: 77  TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH---KNHNVL 133
             +   V E  IL +V  R +V    A      LC+V   M GG +  +++   +++   
Sbjct: 228 GYQGAMV-EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF 286
Query: 134 KLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT 193
           + P+ + +   I  G+E+LHQRNII+RDLK  N+L+D    V+++D G+A     G   T
Sbjct: 287 QEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346
Query: 194 -AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
               GT  +MAPE++  + YD   D F+  + L+E++ A+ P+
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 95.1 bits (235), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 17/223 (7%)
Query: 22  KAIESQTKSEDWEIDRRLLKTGERIASGSC-----GDLYRGVYLGQDVAVKVLRSEHLND 76
           K +E+Q   EDW +D R+L  G      +C     G LY              +      
Sbjct: 175 KWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYA-------CKKLNKKRLKKRK 227
Query: 77  TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH---KNHNVL 133
             +   V E  IL +V  R +V    A      LC+V   M GG +  +++   +++   
Sbjct: 228 GYQGAMV-EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF 286
Query: 134 KLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT 193
           + P+ + +   I  G+E+LHQRNII+RDLK  N+L+D    V+++D G+A     G   T
Sbjct: 287 QEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346
Query: 194 -AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
               GT  +MAPE++  + YD   D F+  + L+E++ A+ P+
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 95.1 bits (235), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 105/203 (51%), Gaps = 11/203 (5%)
Query: 43  GERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLE----DEFVQEVAILREVQHRN 96
           GE + SG    +   R    G++ A K ++   L+ +      +E  +EV ILRE++H N
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69
Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
           ++           + ++ E + GG L+D+L +  ++ +  +  +F   I  G+ YLH + 
Sbjct: 70  IITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE-DEATQFLKQILDGVHYLHSKR 128
Query: 157 IIHRDLKTANLLMDTHNV----VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPY 212
           I H DLK  N+++   NV    +K+ DFG+A     G       GT  ++APE++N++P 
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPL 188
Query: 213 DQKADVFSFAIVLWELVTAKVPY 235
             +AD++S  ++ + L++   P+
Sbjct: 189 GLEADMWSIGVITYILLSGASPF 211

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 95.1 bits (235), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 17/223 (7%)
Query: 22  KAIESQTKSEDWEIDRRLLKTGERIASGSC-----GDLYRGVYLGQDVAVKVLRSEHLND 76
           K +E+Q   EDW +D R+L  G      +C     G LY              +      
Sbjct: 175 KWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYA-------CKKLNKKRLKKRK 227
Query: 77  TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH---KNHNVL 133
             +   V E  IL +V  R +V    A      LC+V   M GG +  +++   +++   
Sbjct: 228 GYQGAMV-EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF 286
Query: 134 KLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT 193
           + P+ + +   I  G+E+LHQRNII+RDLK  N+L+D    V+++D G+A     G   T
Sbjct: 287 QEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346
Query: 194 -AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
               GT  +MAPE++  + YD   D F+  + L+E++ A+ P+
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 95.1 bits (235), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 115/215 (53%), Gaps = 15/215 (6%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
           EDW+    L++T   +  G+ G++   V     + VAVK++  +   D  E+   +E+ I
Sbjct: 6   EDWD----LVQT---LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEICI 57
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
            + + H NVV+F G   +     +  EY  GG L+D +  +  + + P   RF   +  G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAG 116
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA---RFQNKGGVMTAETGTYRWMAPE 205
           + YLH   I HRD+K  NLL+D  + +K++DFG+A   R+ N+  ++    GT  ++APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 206 VINHQPYD-QKADVFSFAIVLWELVTAKVPYDSMT 239
           ++  + +  +  DV+S  IVL  ++  ++P+D  +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 95.1 bits (235), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 105/203 (51%), Gaps = 11/203 (5%)
Query: 43  GERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLE----DEFVQEVAILREVQHRN 96
           GE + SG    +   R    G++ A K ++   L+ +      +E  +EV ILRE++H N
Sbjct: 17  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 76
Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
           ++           + ++ E + GG L+D+L +  ++ +  +  +F   I  G+ YLH + 
Sbjct: 77  IITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE-DEATQFLKQILDGVHYLHSKR 135
Query: 157 IIHRDLKTANLLMDTHNV----VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPY 212
           I H DLK  N+++   NV    +K+ DFG+A     G       GT  ++APE++N++P 
Sbjct: 136 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPL 195
Query: 213 DQKADVFSFAIVLWELVTAKVPY 235
             +AD++S  ++ + L++   P+
Sbjct: 196 GLEADMWSIGVITYILLSGASPF 218

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 94.4 bits (233), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 110/204 (53%), Gaps = 12/204 (5%)
Query: 44  ERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLED-EFVQEVAILREVQHRNVVRF 100
           +++ SG+ G+  L +    G + A+K+++   +  T      + EVA+L+++ H N+++ 
Sbjct: 10  KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 69
Query: 101 IGASTKSPHLCIVTEYMPGGSLYD--YLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNII 158
                   +  +V E   GG L+D   L +  + +    +++    +  G  YLH+ NI+
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK---QVLSGTTYLHKHNIV 126
Query: 159 HRDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQK 215
           HRDLK  NLL+++ +   ++K+ DFG++     GG M    GT  ++APEV+  + YD+K
Sbjct: 127 HRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL-RKKYDEK 185
Query: 216 ADVFSFAIVLWELVTAKVPYDSMT 239
            DV+S  ++L+ L+    P+   T
Sbjct: 186 CDVWSCGVILYILLCGYPPFGGQT 209

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 104/203 (51%), Gaps = 11/203 (5%)
Query: 43  GERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLE----DEFVQEVAILREVQHRN 96
           GE + SG    +   R    G++ A K ++   L  +      +E  +EV ILRE++H N
Sbjct: 31  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPN 90
Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
           ++           + ++ E + GG L+D+L +  ++ +  +  +F   I  G+ YLH + 
Sbjct: 91  IITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE-DEATQFLKQILDGVHYLHSKR 149
Query: 157 IIHRDLKTANLLMDTHNV----VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPY 212
           I H DLK  N+++   NV    +K+ DFG+A     G       GT  ++APE++N++P 
Sbjct: 150 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPL 209
Query: 213 DQKADVFSFAIVLWELVTAKVPY 235
             +AD++S  ++ + L++   P+
Sbjct: 210 GLEADMWSIGVITYILLSGASPF 232

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 114/212 (53%), Gaps = 15/212 (7%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
           EDW+    L++T   +  G+ G++   V     + VAVK++  +   D  E+   +E+ I
Sbjct: 7   EDWD----LVQT---LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEICI 58
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
            + + H NVV+F G   +     +  EY  GG L+D +  +  + + P   RF   +  G
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAG 117
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA---RFQNKGGVMTAETGTYRWMAPE 205
           + YLH   I HRD+K  NLL+D  + +K++DFG+A   R+ N+  ++    GT  ++APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 206 VINHQPY-DQKADVFSFAIVLWELVTAKVPYD 236
           ++  + +  +  DV+S  IVL  ++  ++P+D
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 114/212 (53%), Gaps = 15/212 (7%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
           EDW+    L++T   +  G+ G++   V     + VAVK++  +   D  E+   +E+ I
Sbjct: 7   EDWD----LVQT---LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEICI 58
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
            + + H NVV+F G   +     +  EY  GG L+D +  +  + + P   RF   +  G
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAG 117
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA---RFQNKGGVMTAETGTYRWMAPE 205
           + YLH   I HRD+K  NLL+D  + +K++DFG+A   R+ N+  ++    GT  ++APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 206 VINHQPY-DQKADVFSFAIVLWELVTAKVPYD 236
           ++  + +  +  DV+S  IVL  ++  ++P+D
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 114/212 (53%), Gaps = 15/212 (7%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
           EDW+    L++T   +  G+ G++   V     + VAVK++  +   D  E+   +E+ I
Sbjct: 7   EDWD----LVQT---LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEICI 58
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
            + + H NVV+F G   +     +  EY  GG L+D +  +  + + P   RF   +  G
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAG 117
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA---RFQNKGGVMTAETGTYRWMAPE 205
           + YLH   I HRD+K  NLL+D  + +K++DFG+A   R+ N+  ++    GT  ++APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 206 VINHQPY-DQKADVFSFAIVLWELVTAKVPYD 236
           ++  + +  +  DV+S  IVL  ++  ++P+D
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 94.4 bits (233), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 115/215 (53%), Gaps = 15/215 (6%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
           EDW+    L++T   +  G+ G++   V     + VAVK++  +   D  E+   +E+ I
Sbjct: 5   EDWD----LVQT---LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEICI 56
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
            + + H NVV+F G   +     +  EY  GG L+D +  +  + + P   RF   +  G
Sbjct: 57  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAG 115
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA---RFQNKGGVMTAETGTYRWMAPE 205
           + YLH   I HRD+K  NLL+D  + +K++DFG+A   R+ N+  ++    GT  ++APE
Sbjct: 116 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 206 VINHQPYD-QKADVFSFAIVLWELVTAKVPYDSMT 239
           ++  + +  +  DV+S  IVL  ++  ++P+D  +
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 94.0 bits (232), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 115/215 (53%), Gaps = 15/215 (6%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
           EDW+    L++T   +  G+ G++   V     + VAVK++  +   D  E+   +E+ I
Sbjct: 7   EDWD----LVQT---LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEICI 58
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
            + + H NVV+F G   +     +  EY  GG L+D +  +  + + P   RF   +  G
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAG 117
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA---RFQNKGGVMTAETGTYRWMAPE 205
           + YLH   I HRD+K  NLL+D  + +K++DFG+A   R+ N+  ++    GT  ++APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 206 VINHQPYD-QKADVFSFAIVLWELVTAKVPYDSMT 239
           ++  + +  +  DV+S  IVL  ++  ++P+D  +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 115/215 (53%), Gaps = 15/215 (6%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
           EDW+    L++T   +  G+ G++   V     + VAVK++  +   D  E+   +E+ I
Sbjct: 6   EDWD----LVQT---LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEICI 57
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
            + + H NVV+F G   +     +  EY  GG L+D +  +  + + P   RF   +  G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAG 116
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA---RFQNKGGVMTAETGTYRWMAPE 205
           + YLH   I HRD+K  NLL+D  + +K++DFG+A   R+ N+  ++    GT  ++APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 206 VINHQPYD-QKADVFSFAIVLWELVTAKVPYDSMT 239
           ++  + +  +  DV+S  IVL  ++  ++P+D  +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 94.0 bits (232), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 114/212 (53%), Gaps = 15/212 (7%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
           EDW+    L++T   +  G+ G++   V     + VAVK++  +   D  E+   +E+ I
Sbjct: 7   EDWD----LVQT---LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEICI 58
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
            + + H NVV+F G   +     +  EY  GG L+D +  +  + + P   RF   +  G
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAG 117
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA---RFQNKGGVMTAETGTYRWMAPE 205
           + YLH   I HRD+K  NLL+D  + +K++DFG+A   R+ N+  ++    GT  ++APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 206 VINHQPYD-QKADVFSFAIVLWELVTAKVPYD 236
           ++  + +  +  DV+S  IVL  ++  ++P+D
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 94.0 bits (232), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 114/212 (53%), Gaps = 15/212 (7%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
           EDW+    L++T   +  G+ G++   V     + VAVK++  +   D  E+   +E+ I
Sbjct: 6   EDWD----LVQT---LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEICI 57
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
            + + H NVV+F G   +     +  EY  GG L+D +  +  + + P   RF   +  G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAG 116
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA---RFQNKGGVMTAETGTYRWMAPE 205
           + YLH   I HRD+K  NLL+D  + +K++DFG+A   R+ N+  ++    GT  ++APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 206 VINHQPYD-QKADVFSFAIVLWELVTAKVPYD 236
           ++  + +  +  DV+S  IVL  ++  ++P+D
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 94.0 bits (232), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 115/215 (53%), Gaps = 15/215 (6%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
           EDW+    L++T   +  G+ G++   V     + VAVK++  +   D  E+   +E+ I
Sbjct: 6   EDWD----LVQT---LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEICI 57
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
            + + H NVV+F G   +     +  EY  GG L+D +  +  + + P   RF   +  G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAG 116
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA---RFQNKGGVMTAETGTYRWMAPE 205
           + YLH   I HRD+K  NLL+D  + +K++DFG+A   R+ N+  ++    GT  ++APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 206 VINHQPYD-QKADVFSFAIVLWELVTAKVPYDSMT 239
           ++  + +  +  DV+S  IVL  ++  ++P+D  +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 94.0 bits (232), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 44  ERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA 103
           E +  G  G+++RG + G++VAVK+  S        +  +    +LR   H N++ FI +
Sbjct: 14  ECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLR---HENILGFIAS 70
Query: 104 STKSPH----LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH------ 153
              S H    L ++T Y   GSLYDYL      L     LR  + I  G+ +LH      
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 154 --QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM-----TAETGTYRWMAPEV 206
             +  I HRDLK+ N+L+  +    +AD G+A   ++             GT R+MAPEV
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 207 INH----QPYD--QKADVFSFAIVLWEL 228
           ++       +D  ++ D+++F +VLWE+
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 115/215 (53%), Gaps = 15/215 (6%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
           EDW+    L++T   +  G+ G++   V     + VAVK++  +   D  E+   +E+ I
Sbjct: 6   EDWD----LVQT---LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEICI 57
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
            + + H NVV+F G   +     +  EY  GG L+D +  +  + + P   RF   +  G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAG 116
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA---RFQNKGGVMTAETGTYRWMAPE 205
           + YLH   I HRD+K  NLL+D  + +K++DFG+A   R+ N+  ++    GT  ++APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 206 VINHQPYD-QKADVFSFAIVLWELVTAKVPYDSMT 239
           ++  + +  +  DV+S  IVL  ++  ++P+D  +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 94.0 bits (232), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 115/215 (53%), Gaps = 15/215 (6%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
           EDW+    L++T   +  G+ G++   V     + VAVK++  +   D  E+   +E+ I
Sbjct: 6   EDWD----LVQT---LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEICI 57
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
            + + H NVV+F G   +     +  EY  GG L+D +  +  + + P   RF   +  G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAG 116
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA---RFQNKGGVMTAETGTYRWMAPE 205
           + YLH   I HRD+K  NLL+D  + +K++DFG+A   R+ N+  ++    GT  ++APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 206 VINHQPYD-QKADVFSFAIVLWELVTAKVPYDSMT 239
           ++  + +  +  DV+S  IVL  ++  ++P+D  +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 94.0 bits (232), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 115/215 (53%), Gaps = 15/215 (6%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
           EDW+    L++T   +  G+ G++   V     + VAVK++  +   D  E+   +E+ I
Sbjct: 6   EDWD----LVQT---LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEICI 57
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
            + + H NVV+F G   +     +  EY  GG L+D +  +  + + P   RF   +  G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAG 116
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA---RFQNKGGVMTAETGTYRWMAPE 205
           + YLH   I HRD+K  NLL+D  + +K++DFG+A   R+ N+  ++    GT  ++APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 206 VINHQPYD-QKADVFSFAIVLWELVTAKVPYDSMT 239
           ++  + +  +  DV+S  IVL  ++  ++P+D  +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 94.0 bits (232), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 115/215 (53%), Gaps = 15/215 (6%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
           EDW+    L++T   +  G+ G++   V     + VAVK++  +   D  E+   +E+ I
Sbjct: 6   EDWD----LVQT---LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEICI 57
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
            + + H NVV+F G   +     +  EY  GG L+D +  +  + + P   RF   +  G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAG 116
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA---RFQNKGGVMTAETGTYRWMAPE 205
           + YLH   I HRD+K  NLL+D  + +K++DFG+A   R+ N+  ++    GT  ++APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 206 VINHQPYD-QKADVFSFAIVLWELVTAKVPYDSMT 239
           ++  + +  +  DV+S  IVL  ++  ++P+D  +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 94.0 bits (232), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 114/212 (53%), Gaps = 15/212 (7%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
           EDW+    L++T   +  G+ G++   V     + VAVK++  +   D  E+   +E+ I
Sbjct: 7   EDWD----LVQT---LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEICI 58
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
            + + H NVV+F G   +     +  EY  GG L+D +  +  + + P   RF   +  G
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAG 117
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA---RFQNKGGVMTAETGTYRWMAPE 205
           + YLH   I HRD+K  NLL+D  + +K++DFG+A   R+ N+  ++    GT  ++APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 206 VINHQPYD-QKADVFSFAIVLWELVTAKVPYD 236
           ++  + +  +  DV+S  IVL  ++  ++P+D
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 94.0 bits (232), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 99/200 (49%), Gaps = 10/200 (5%)
Query: 46  IASGSCGDLYRG-VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAS 104
           +  G  G +Y+G +  G  VAVK L+ E      E +F  EV ++    HRN++R  G  
Sbjct: 46  LGRGGFGKVYKGRLADGTLVAVKRLKEERXQGG-ELQFQTEVEMISMAVHRNLLRLRGFC 104
Query: 105 TKSPHLCIVTEYMPGGSLYDYLHK---NHNVLKLPQLLRFAIDICKGMEYLHQR---NII 158
                  +V  YM  GS+   L +   +   L  P+  R A+   +G+ YLH      II
Sbjct: 105 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 164
Query: 159 HRDLKTANLLMDTHNVVKVADFGVARFQN--KGGVMTAETGTYRWMAPEVINHQPYDQKA 216
           HRD+K AN+L+D      V DFG+A+  +     V  A  GT   +APE ++     +K 
Sbjct: 165 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKT 224
Query: 217 DVFSFAIVLWELVTAKVPYD 236
           DVF + ++L EL+T +  +D
Sbjct: 225 DVFGYGVMLLELITGQRAFD 244

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 115/215 (53%), Gaps = 15/215 (6%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
           EDW+    L++T   +  G+ G++   V     + VAVK++  +   D  E+   +E+ I
Sbjct: 6   EDWD----LVQT---LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEICI 57
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
            + + H NVV+F G   +     +  EY  GG L+D +  +  + + P   RF   +  G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAG 116
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA---RFQNKGGVMTAETGTYRWMAPE 205
           + YLH   I HRD+K  NLL+D  + +K++DFG+A   R+ N+  ++    GT  ++APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 206 VINHQPYD-QKADVFSFAIVLWELVTAKVPYDSMT 239
           ++  + +  +  DV+S  IVL  ++  ++P+D  +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 94.0 bits (232), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 44  ERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA 103
           E +  G  G+++RG + G++VAVK+  S        +  +    +LR   H N++ FI +
Sbjct: 43  ECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLR---HENILGFIAS 99
Query: 104 STKSPH----LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH------ 153
              S H    L ++T Y   GSLYDYL      L     LR  + I  G+ +LH      
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGT 157
Query: 154 --QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM-----TAETGTYRWMAPEV 206
             +  I HRDLK+ N+L+  +    +AD G+A   ++             GT R+MAPEV
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 217
Query: 207 INH----QPYD--QKADVFSFAIVLWEL 228
           ++       +D  ++ D+++F +VLWE+
Sbjct: 218 LDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 94.0 bits (232), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 44  ERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA 103
           E +  G  G+++RG + G++VAVK+  S        +  +    +LR   H N++ FI +
Sbjct: 14  ECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLR---HENILGFIAS 70
Query: 104 STKSPH----LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH------ 153
              S H    L ++T Y   GSLYDYL      L     LR  + I  G+ +LH      
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 154 --QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM-----TAETGTYRWMAPEV 206
             +  I HRDLK+ N+L+  +    +AD G+A   ++             GT R+MAPEV
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 207 INH----QPYD--QKADVFSFAIVLWEL 228
           ++       +D  ++ D+++F +VLWE+
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 94.0 bits (232), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 115/215 (53%), Gaps = 15/215 (6%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
           EDW+    L++T   +  G+ G++   V     + VAVK++  +   D  E+   +E+ I
Sbjct: 7   EDWD----LVQT---LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEIXI 58
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
            + + H NVV+F G   +     +  EY  GG L+D +  +  + + P   RF   +  G
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAG 117
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA---RFQNKGGVMTAETGTYRWMAPE 205
           + YLH   I HRD+K  NLL+D  + +K++DFG+A   R+ N+  ++    GT  ++APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 177
Query: 206 VINHQPYD-QKADVFSFAIVLWELVTAKVPYDSMT 239
           ++  + +  +  DV+S  IVL  ++  ++P+D  +
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 94.0 bits (232), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 115/215 (53%), Gaps = 15/215 (6%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
           EDW+    L++T   +  G+ G++   V     + VAVK++  +   D  E+   +E+ I
Sbjct: 6   EDWD----LVQT---LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEICI 57
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
            + + H NVV+F G   +     +  EY  GG L+D +  +  + + P   RF   +  G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAG 116
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA---RFQNKGGVMTAETGTYRWMAPE 205
           + YLH   I HRD+K  NLL+D  + +K++DFG+A   R+ N+  ++    GT  ++APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 206 VINHQPYD-QKADVFSFAIVLWELVTAKVPYDSMT 239
           ++  + +  +  DV+S  IVL  ++  ++P+D  +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 111/203 (54%), Gaps = 13/203 (6%)
Query: 43  GERI-ASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDE-FVQEVAILREVQHRNVV 98
           G+R+   GS G+  L +    GQ+ AVKV+    +    + E  ++EV +L+++ H N++
Sbjct: 36  GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 95
Query: 99  RFIGASTKSPHLCIVTEYMPGGSLYDYL--HKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
           +         +  +V E   GG L+D +   K  + +   +++R    +  G+ Y+H+  
Sbjct: 96  KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR---QVLSGITYMHKNK 152
Query: 157 IIHRDLKTANLLMDTHNV---VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYD 213
           I+HRDLK  NLL+++ +    +++ DFG++        M  + GT  ++APEV+ H  YD
Sbjct: 153 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTYD 211
Query: 214 QKADVFSFAIVLWELVTAKVPYD 236
           +K DV+S  ++L+ L++   P++
Sbjct: 212 EKCDVWSTGVILYILLSGCPPFN 234

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 115/215 (53%), Gaps = 15/215 (6%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
           EDW+    L++T   +  G+ G++   V     + VAVK++  +   D  E+   +E+ I
Sbjct: 6   EDWD----LVQT---LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEIXI 57
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
            + + H NVV+F G   +     +  EY  GG L+D +  +  + + P   RF   +  G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAG 116
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA---RFQNKGGVMTAETGTYRWMAPE 205
           + YLH   I HRD+K  NLL+D  + +K++DFG+A   R+ N+  ++    GT  ++APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 206 VINHQPYD-QKADVFSFAIVLWELVTAKVPYDSMT 239
           ++  + +  +  DV+S  IVL  ++  ++P+D  +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 115/215 (53%), Gaps = 15/215 (6%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
           EDW+    L++T   +  G+ G++   V     + VAVK++  +   D  E+   +E+ I
Sbjct: 6   EDWD----LVQT---LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEIXI 57
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
            + + H NVV+F G   +     +  EY  GG L+D +  +  + + P   RF   +  G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAG 116
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA---RFQNKGGVMTAETGTYRWMAPE 205
           + YLH   I HRD+K  NLL+D  + +K++DFG+A   R+ N+  ++    GT  ++APE
Sbjct: 117 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 206 VINHQPYD-QKADVFSFAIVLWELVTAKVPYDSMT 239
           ++  + +  +  DV+S  IVL  ++  ++P+D  +
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 111/230 (48%), Gaps = 29/230 (12%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRG----VYLGQD---VAVKVL-RSEHLNDTLEDEFVQE 85
           E+ R  +     +  GS G +Y G    +  G+    VAVK +  S  L + +E  F+ E
Sbjct: 12  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNE 69
Query: 86  VAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-----NHNVLKLP---- 136
            ++++     +VVR +G  +K     +V E M  G L  YL        +N  + P    
Sbjct: 70  ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 129
Query: 137 QLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR------FQNKGG 190
           ++++ A +I  GM YL+ +  +HRDL   N ++     VK+ DFG+ R      +  KGG
Sbjct: 130 EMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 189
Query: 191 VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
                    RWMAPE +    +   +D++SF +VLWE+ + A+ PY  ++
Sbjct: 190 KGLLPV---RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 236

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 115/233 (49%), Gaps = 16/233 (6%)
Query: 28  TKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVA 87
           +++ED+E+    L T    + G C  + R    G+ +  K L    + +  +   V EV 
Sbjct: 3   SRAEDYEV----LYTIGTGSYGRCQKIRRKSD-GKILVWKELDYGSMTEAEKQMLVSEVN 57
Query: 88  ILREVQHRNVVRFIGA--STKSPHLCIVTEYMPGGSLYDYLHKN---HNVLKLPQLLRFA 142
           +LRE++H N+VR+        +  L IV EY  GG L   + K       L    +LR  
Sbjct: 58  LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117
Query: 143 IDICKGMEYLHQRN-----IIHRDLKTANLLMDTHNVVKVADFGVARFQN-KGGVMTAET 196
             +   ++  H+R+     ++HRDLK AN+ +D    VK+ DFG+AR  N       A  
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV 177
Query: 197 GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
           GT  +M+PE +N   Y++K+D++S   +L+EL     P+ + +  + A  +R+
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 115/233 (49%), Gaps = 16/233 (6%)
Query: 28  TKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVA 87
           +++ED+E+    L T    + G C  + R    G+ +  K L    + +  +   V EV 
Sbjct: 3   SRAEDYEV----LYTIGTGSYGRCQKIRRKSD-GKILVWKELDYGSMTEAEKQMLVSEVN 57
Query: 88  ILREVQHRNVVRFIGA--STKSPHLCIVTEYMPGGSLYDYLHKN---HNVLKLPQLLRFA 142
           +LRE++H N+VR+        +  L IV EY  GG L   + K       L    +LR  
Sbjct: 58  LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117
Query: 143 IDICKGMEYLHQRN-----IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAE-T 196
             +   ++  H+R+     ++HRDLK AN+ +D    VK+ DFG+AR  N       E  
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFV 177
Query: 197 GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
           GT  +M+PE +N   Y++K+D++S   +L+EL     P+ + +  + A  +R+
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 111/203 (54%), Gaps = 13/203 (6%)
Query: 43  GERI-ASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDE-FVQEVAILREVQHRNVV 98
           G+R+   GS G+  L +    GQ+ AVKV+    +    + E  ++EV +L+++ H N++
Sbjct: 30  GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 89
Query: 99  RFIGASTKSPHLCIVTEYMPGGSLYDYL--HKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
           +         +  +V E   GG L+D +   K  + +   +++R    +  G+ Y+H+  
Sbjct: 90  KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR---QVLSGITYMHKNK 146
Query: 157 IIHRDLKTANLLMDTHNV---VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYD 213
           I+HRDLK  NLL+++ +    +++ DFG++        M  + GT  ++APEV+ H  YD
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTYD 205
Query: 214 QKADVFSFAIVLWELVTAKVPYD 236
           +K DV+S  ++L+ L++   P++
Sbjct: 206 EKCDVWSTGVILYILLSGCPPFN 228

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 111/203 (54%), Gaps = 13/203 (6%)
Query: 43  GERI-ASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDE-FVQEVAILREVQHRNVV 98
           G+R+   GS G+  L +    GQ+ AVKV+    +    + E  ++EV +L+++ H N++
Sbjct: 54  GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 113
Query: 99  RFIGASTKSPHLCIVTEYMPGGSLYDYL--HKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
           +         +  +V E   GG L+D +   K  + +   +++R    +  G+ Y+H+  
Sbjct: 114 KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR---QVLSGITYMHKNK 170
Query: 157 IIHRDLKTANLLMDTHNV---VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYD 213
           I+HRDLK  NLL+++ +    +++ DFG++        M  + GT  ++APEV+ H  YD
Sbjct: 171 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTYD 229
Query: 214 QKADVFSFAIVLWELVTAKVPYD 236
           +K DV+S  ++L+ L++   P++
Sbjct: 230 EKCDVWSTGVILYILLSGCPPFN 252

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 106/198 (53%), Gaps = 12/198 (6%)
Query: 58  VYLGQD------VAVKVL--RSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPH 109
           VYL +D      VA+K +        +TL+  F +EV    ++ H+N+V  I    +   
Sbjct: 27  VYLAEDTILNIKVAIKAIFIPPREKEETLK-RFEREVHNSSQLSHQNIVSMIDVDEEDDC 85
Query: 110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM 169
             +V EY+ G +L +Y+ ++H  L +   + F   I  G+++ H   I+HRD+K  N+L+
Sbjct: 86  YYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI 144
Query: 170 DTHNVVKVADFGVARFQNKGGVMTAE--TGTYRWMAPEVINHQPYDQKADVFSFAIVLWE 227
           D++  +K+ DFG+A+  ++  +       GT ++ +PE    +  D+  D++S  IVL+E
Sbjct: 145 DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYE 204
Query: 228 LVTAKVPYDSMTPLQAAL 245
           ++  + P++  T +  A+
Sbjct: 205 MLVGEPPFNGETAVSIAI 222

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 111/203 (54%), Gaps = 13/203 (6%)
Query: 43  GERI-ASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDE-FVQEVAILREVQHRNVV 98
           G+R+   GS G+  L +    GQ+ AVKV+    +    + E  ++EV +L+++ H N++
Sbjct: 53  GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 112
Query: 99  RFIGASTKSPHLCIVTEYMPGGSLYDYL--HKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
           +         +  +V E   GG L+D +   K  + +   +++R    +  G+ Y+H+  
Sbjct: 113 KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR---QVLSGITYMHKNK 169
Query: 157 IIHRDLKTANLLMDTHNV---VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYD 213
           I+HRDLK  NLL+++ +    +++ DFG++        M  + GT  ++APEV+ H  YD
Sbjct: 170 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTYD 228
Query: 214 QKADVFSFAIVLWELVTAKVPYD 236
           +K DV+S  ++L+ L++   P++
Sbjct: 229 EKCDVWSTGVILYILLSGCPPFN 251

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 114/227 (50%), Gaps = 23/227 (10%)
Query: 23  AIESQTKS---EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEH 73
           A+ES+ +    ED+EI R L K       G  G+    VYL ++      +A+KVL    
Sbjct: 2   AMESKKRQWALEDFEIGRPLGK-------GKFGN----VYLAREKQSKFILALKVLFKAQ 50
Query: 74  LNDT-LEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV 132
           L    +E +  +EV I   ++H N++R  G    +  + ++ EY P G +Y  L K  + 
Sbjct: 51  LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQK-LSK 109
Query: 133 LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM 192
               +   +  ++   + Y H + +IHRD+K  NLL+ +   +K+ADFG +         
Sbjct: 110 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRR 168
Query: 193 TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           T   GT  ++ PE+I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 169 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 215

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 112/218 (51%), Gaps = 13/218 (5%)
Query: 23  AIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSE--HLNDTL 78
           +++ + K ED+E+ + L         GS G ++   +    Q  A+K L+ +   ++D +
Sbjct: 10  SLQIKLKIEDFELHKML-------GKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDV 62
Query: 79  EDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQL 138
           E   V++  +    +H  +           +L  V EY+ GG L  ++   H    L + 
Sbjct: 63  ECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRA 121
Query: 139 LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAE-TG 197
             +A +I  G+++LH + I++RDLK  N+L+D    +K+ADFG+ +    G   T E  G
Sbjct: 122 TFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCG 181
Query: 198 TYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           T  ++APE++  Q Y+   D +SF ++L+E++  + P+
Sbjct: 182 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 91/175 (52%), Gaps = 5/175 (2%)
Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VA+K +  E L    E     E+A+L +++H N+V          HL ++ + + GG L+
Sbjct: 46  VAIKCIAKEALEGK-EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 124 DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLL---MDTHNVVKVADF 180
           D + +           R    +   ++YLH   I+HRDLK  NLL   +D  + + ++DF
Sbjct: 105 DRIVEK-GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDF 163
Query: 181 GVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           G+++ ++ G V++   GT  ++APEV+  +PY +  D +S  ++ + L+    P+
Sbjct: 164 GLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 134/272 (49%), Gaps = 30/272 (11%)
Query: 1   MNTNITILTIVHRKYRGHAVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLY----- 55
           M  +I  + I H    GH  EKA  SQ +         LLK    +  GS G ++     
Sbjct: 1   MEGSIKEIAITHHVKEGH--EKADPSQFE---------LLKV---LGQGSFGKVFLVKKI 46
Query: 56  RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE 115
            G    Q  A+KVL+   L          E  IL EV H  +V+   A      L ++ +
Sbjct: 47  SGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILD 106
Query: 116 YMPGGSLYDYLHKNHNVLKLPQLLRFAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNV 174
           ++ GG L+  L K   V+   + ++F + ++   +++LH   II+RDLK  N+L+D    
Sbjct: 107 FLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH 164
Query: 175 VKVADFGVARFQ-NKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKV 233
           +K+ DFG+++   +      +  GT  +MAPEV+N + + Q AD +SF ++++E++T  +
Sbjct: 165 IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224
Query: 234 PY------DSMTP-LQAALGVRQVCTSLCQPI 258
           P+      ++MT  L+A LG+ Q  +   Q +
Sbjct: 225 PFQGKDRKETMTMILKAKLGMPQFLSPEAQSL 256

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 27/228 (11%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFVQEV 86
           EI    ++  E +     G +Y+G   G       Q VA+K L+ +     L +EF  E 
Sbjct: 22  EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEFRHEA 80
Query: 87  AILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL-----HKN----------HN 131
            +   +QH NVV  +G  TK   L ++  Y   G L+++L     H +           +
Sbjct: 81  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 140
Query: 132 VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR---FQNK 188
            L+ P  +     I  GMEYL   +++H+DL T N+L+     VK++D G+ R     + 
Sbjct: 141 ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY 200
Query: 189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKV-PY 235
             ++       RWMAPE I +  +   +D++S+ +VLWE+ +  + PY
Sbjct: 201 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 248

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 115/227 (50%), Gaps = 23/227 (10%)
Query: 23  AIESQTKS---EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEH 73
           A+ES+ +    ED+EI R L K       G  G+    VYL ++      +A+KVL    
Sbjct: 2   AMESKKRQWALEDFEIGRPLGK-------GKFGN----VYLAREKQSKFILALKVLFKAQ 50
Query: 74  LNDT-LEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV 132
           L    +E +  +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K  + 
Sbjct: 51  LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSK 109
Query: 133 LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM 192
               +   +  ++   + Y H + +IHRD+K  NLL+ +   +K+ADFG +         
Sbjct: 110 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRR 168
Query: 193 TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           T   GT  ++ PE+I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 169 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 215

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 113/212 (53%), Gaps = 15/212 (7%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
           EDW+    L++T   +  G+ G++   V     + VAVK++  +   D  E+   +E+ I
Sbjct: 7   EDWD----LVQT---LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEICI 58
Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
              + H NVV+F G   +     +  EY  GG L+D +  +  + + P   RF   +  G
Sbjct: 59  NAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-PDAQRFFHQLMAG 117
Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA---RFQNKGGVMTAETGTYRWMAPE 205
           + YLH   I HRD+K  NLL+D  + +K++DFG+A   R+ N+  ++    GT  ++APE
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 206 VINHQPYD-QKADVFSFAIVLWELVTAKVPYD 236
           ++  + +  +  DV+S  IVL  ++  ++P+D
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 91/175 (52%), Gaps = 5/175 (2%)
Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VA+K +  E L    E     E+A+L +++H N+V          HL ++ + + GG L+
Sbjct: 46  VAIKCIAKEALEGK-EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 124 DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLL---MDTHNVVKVADF 180
           D + +           R    +   ++YLH   I+HRDLK  NLL   +D  + + ++DF
Sbjct: 105 DRIVEK-GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDF 163
Query: 181 GVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           G+++ ++ G V++   GT  ++APEV+  +PY +  D +S  ++ + L+    P+
Sbjct: 164 GLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 104/219 (47%), Gaps = 12/219 (5%)
Query: 38  RLLKTGERIASGSCGDLY--RGVYLGQDVAVKVLR--SEHLNDTLEDEFVQEVAILREVQ 93
           +L      I  GS G +Y  R V   + VA+K +    +  N+  +D  ++EV  L++++
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKLR 73
Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
           H N +++ G   +     +V EY   GS  D L  +   L+  ++        +G+ YLH
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI---NHQ 210
             N+IHRD+K  N+L+    +VK+ DFG A             GT  WMAPEVI   +  
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEG 189
Query: 211 PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
            YD K DV+S  I   EL   K P  +M  + A   + Q
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 104/219 (47%), Gaps = 12/219 (5%)
Query: 38  RLLKTGERIASGSCGDLY--RGVYLGQDVAVKVLR--SEHLNDTLEDEFVQEVAILREVQ 93
           +L      I  GS G +Y  R V   + VA+K +    +  N+  +D  ++EV  L++++
Sbjct: 54  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKLR 112
Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
           H N +++ G   +     +V EY   GS  D L  +   L+  ++        +G+ YLH
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI---NHQ 210
             N+IHRD+K  N+L+    +VK+ DFG A             GT  WMAPEVI   +  
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEG 228
Query: 211 PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
            YD K DV+S  I   EL   K P  +M  + A   + Q
Sbjct: 229 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 267

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 114/204 (55%), Gaps = 13/204 (6%)
Query: 44  ERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           +++ SG+ G+  L R      + A+K++R   ++ +   + ++EVA+L+ + H N+++  
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 102 GASTKSPHLCIVTEYMPGGSLYD-YLHK-NHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
                  +  +V E   GG L+D  +H+   N +    +++    +  G+ YLH+ NI+H
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK---QVLSGVTYLHKHNIVH 159
Query: 160 RDLKTANLLMDTHN---VVKVADFGV-ARFQNKGGVMTAETGTYRWMAPEVINHQPYDQK 215
           RDLK  NLL+++     ++K+ DFG+ A F+N+   M    GT  ++APEV+  + YD+K
Sbjct: 160 RDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK-MKERLGTAYYIAPEVL-RKKYDEK 217
Query: 216 ADVFSFAIVLWELVTAKVPYDSMT 239
            DV+S  ++L+ L+    P+   T
Sbjct: 218 CDVWSIGVILFILLAGYPPFGGQT 241

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 91/175 (52%), Gaps = 5/175 (2%)
Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VA+K +  E L    E     E+A+L +++H N+V          HL ++ + + GG L+
Sbjct: 46  VAIKCIAKEALEGK-EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 124 DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLL---MDTHNVVKVADF 180
           D + +           R    +   ++YLH   I+HRDLK  NLL   +D  + + ++DF
Sbjct: 105 DRIVEK-GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDF 163
Query: 181 GVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           G+++ ++ G V++   GT  ++APEV+  +PY +  D +S  ++ + L+    P+
Sbjct: 164 GLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 27/228 (11%)
Query: 34  EIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFVQEV 86
           EI    ++  E +     G +Y+G   G       Q VA+K L+ +     L +EF  E 
Sbjct: 5   EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEFRHEA 63
Query: 87  AILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL-----HKN----------HN 131
            +   +QH NVV  +G  TK   L ++  Y   G L+++L     H +           +
Sbjct: 64  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 132 VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR---FQNK 188
            L+ P  +     I  GMEYL   +++H+DL T N+L+     VK++D G+ R     + 
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY 183
Query: 189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKV-PY 235
             ++       RWMAPE I +  +   +D++S+ +VLWE+ +  + PY
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 231

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 109/216 (50%), Gaps = 20/216 (9%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDT-LEDEFV 83
           ED+EI R L K       G  G+    VYL ++      +A+KVL    L    +E +  
Sbjct: 8   EDFEIGRPLGK-------GKFGN----VYLAREKNSKFILALKVLFKAQLEKAGVEHQLR 56
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
           +EV I   ++H N++R  G    S  + ++ EY P G++Y  L K  +     +   +  
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYIT 115
Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMA 203
           ++   + Y H + +IHRD+K  NLL+ +   +K+ADFG +          A  GT  ++ 
Sbjct: 116 ELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLP 174
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           PE+I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 114/226 (50%), Gaps = 20/226 (8%)
Query: 21  EKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHL 74
           E++ + Q   ED+EI R L K       G  G+    VYL ++      +A+KVL    L
Sbjct: 15  EESKKRQWALEDFEIGRPLGK-------GKFGN----VYLAREKQSKFILALKVLFKAQL 63
Query: 75  NDT-LEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVL 133
               +E +  +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K  +  
Sbjct: 64  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKF 122
Query: 134 KLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT 193
              +   +  ++   + Y H + +IHRD+K  NLL+ +   +K+ADFG +         T
Sbjct: 123 DEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRT 181
Query: 194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
              GT  ++ PE+I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 182 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 227

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 42  TGERIASG------SCGDLYRGV-YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH 94
           TGE + SG       C +   G+ Y  + +  +  +S     + ED   +EV+IL+E+QH
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-IEREVSILKEIQH 73
Query: 95  RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
            NV+           + ++ E + GG L+D+L +  ++ +  +   F   I  G+ YLH 
Sbjct: 74  PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLHS 132
Query: 155 RNIIHRDLKTANLLMDTHNV----VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQ 210
             I H DLK  N+++   NV    +K+ DFG+A   + G       GT  ++APE++N++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 211 PYDQKADVFSFAIVLWELVTAKVPY 235
           P   +AD++S  ++ + L++   P+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPF 217

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 42  TGERIASG------SCGDLYRGV-YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH 94
           TGE + SG       C +   G+ Y  + +  +  +S     + ED   +EV+IL+E+QH
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-IEREVSILKEIQH 73
Query: 95  RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
            NV+           + ++ E + GG L+D+L +  ++ +  +   F   I  G+ YLH 
Sbjct: 74  PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLHS 132
Query: 155 RNIIHRDLKTANLLMDTHNV----VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQ 210
             I H DLK  N+++   NV    +K+ DFG+A   + G       GT  ++APE++N++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 211 PYDQKADVFSFAIVLWELVTAKVPY 235
           P   +AD++S  ++ + L++   P+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPF 217

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 42  TGERIASG------SCGDLYRGV-YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH 94
           TGE + SG       C +   G+ Y  + +  +  +S     + ED   +EV+IL+E+QH
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-IEREVSILKEIQH 73
Query: 95  RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
            NV+           + ++ E + GG L+D+L +  ++ +  +   F   I  G+ YLH 
Sbjct: 74  PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLHS 132
Query: 155 RNIIHRDLKTANLLMDTHNV----VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQ 210
             I H DLK  N+++   NV    +K+ DFG+A   + G       GT  ++APE++N++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 211 PYDQKADVFSFAIVLWELVTAKVPY 235
           P   +AD++S  ++ + L++   P+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPF 217

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 114/226 (50%), Gaps = 20/226 (8%)
Query: 21  EKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHL 74
           E++ + Q   ED+EI R L K       G  G+    VYL ++      +A+KVL    L
Sbjct: 24  EESKKRQWALEDFEIGRPLGK-------GKFGN----VYLAREKQSKFILALKVLFKAQL 72
Query: 75  NDT-LEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVL 133
               +E +  +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K  +  
Sbjct: 73  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKF 131
Query: 134 KLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT 193
              +   +  ++   + Y H + +IHRD+K  NLL+ +   +K+ADFG +         T
Sbjct: 132 DEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRT 190
Query: 194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
              GT  ++ PE+I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 191 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 236

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 42  TGERIASG------SCGDLYRGV-YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH 94
           TGE + SG       C +   G+ Y  + +  +  +S     + ED   +EV+IL+E+QH
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-IEREVSILKEIQH 73
Query: 95  RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
            NV+           + ++ E + GG L+D+L +  ++ +  +   F   I  G+ YLH 
Sbjct: 74  PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLHS 132
Query: 155 RNIIHRDLKTANLLMDTHNV----VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQ 210
             I H DLK  N+++   NV    +K+ DFG+A   + G       GT  ++APE++N++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 211 PYDQKADVFSFAIVLWELVTAKVPY 235
           P   +AD++S  ++ + L++   P+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPF 217

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 42  TGERIASG------SCGDLYRGV-YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH 94
           TGE + SG       C +   G+ Y  + +  +  +S     + ED   +EV+IL+E+QH
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-IEREVSILKEIQH 73
Query: 95  RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
            NV+           + ++ E + GG L+D+L +  ++ +  +   F   I  G+ YLH 
Sbjct: 74  PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLHS 132
Query: 155 RNIIHRDLKTANLLMDTHNV----VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQ 210
             I H DLK  N+++   NV    +K+ DFG+A   + G       GT  ++APE++N++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 211 PYDQKADVFSFAIVLWELVTAKVPY 235
           P   +AD++S  ++ + L++   P+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPF 217

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 42  TGERIASGS------CGDLYRGV-YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH 94
           TGE + SG       C +   G+ Y  + +  +  +S     + ED   +EV+IL+E+QH
Sbjct: 15  TGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-IEREVSILKEIQH 73
Query: 95  RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
            NV+           + ++ E + GG L+D+L +  ++ +  +   F   I  G+ YLH 
Sbjct: 74  PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLHS 132
Query: 155 RNIIHRDLKTANLLMDTHNV----VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQ 210
             I H DLK  N+++   NV    +K+ DFG+A   + G       GT  ++APE++N++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 211 PYDQKADVFSFAIVLWELVTAKVPY 235
           P   +AD++S  ++ + L++   P+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPF 217

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 114/233 (48%), Gaps = 16/233 (6%)
Query: 28  TKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVA 87
           +++ED+E+    L T    + G C  + R    G+ +  K L    + +  +   V EV 
Sbjct: 3   SRAEDYEV----LYTIGTGSYGRCQKIRRKSD-GKILVWKELDYGSMTEAEKQMLVSEVN 57
Query: 88  ILREVQHRNVVRFIGA--STKSPHLCIVTEYMPGGSLYDYLHKN---HNVLKLPQLLRFA 142
           +LRE++H N+VR+        +  L IV EY  GG L   + K       L    +LR  
Sbjct: 58  LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117
Query: 143 IDICKGMEYLHQRN-----IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAE-T 196
             +   ++  H+R+     ++HRDLK AN+ +D    VK+ DFG+AR  N          
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV 177
Query: 197 GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
           GT  +M+PE +N   Y++K+D++S   +L+EL     P+ + +  + A  +R+
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 98/200 (49%), Gaps = 10/200 (5%)
Query: 46  IASGSCGDLYRG-VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAS 104
           +  G  G +Y+G +  G  VAVK L+ E      E +F  EV ++    HRN++R  G  
Sbjct: 38  LGRGGFGKVYKGRLADGXLVAVKRLKEERTQGG-ELQFQTEVEMISMAVHRNLLRLRGFC 96
Query: 105 TKSPHLCIVTEYMPGGSLYDYLHK---NHNVLKLPQLLRFAIDICKGMEYLHQR---NII 158
                  +V  YM  GS+   L +   +   L  P+  R A+   +G+ YLH      II
Sbjct: 97  MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 156
Query: 159 HRDLKTANLLMDTHNVVKVADFGVARFQN--KGGVMTAETGTYRWMAPEVINHQPYDQKA 216
           HRD+K AN+L+D      V DFG+A+  +     V  A  G    +APE ++     +K 
Sbjct: 157 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKT 216
Query: 217 DVFSFAIVLWELVTAKVPYD 236
           DVF + ++L EL+T +  +D
Sbjct: 217 DVFGYGVMLLELITGQRAFD 236

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 42  TGERIASG------SCGDLYRGV-YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH 94
           TGE + SG       C +   G+ Y  + +  +  +S     + ED   +EV+IL+E+QH
Sbjct: 14  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-IEREVSILKEIQH 72
Query: 95  RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
            NV+           + ++ E + GG L+D+L +  ++ +  +   F   I  G+ YLH 
Sbjct: 73  PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLHS 131
Query: 155 RNIIHRDLKTANLLMDTHNV----VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQ 210
             I H DLK  N+++   NV    +K+ DFG+A   + G       GT  ++APE++N++
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 211 PYDQKADVFSFAIVLWELVTAKVPY 235
           P   +AD++S  ++ + L++   P+
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPF 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 42  TGERIASG------SCGDLYRGV-YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH 94
           TGE + SG       C +   G+ Y  + +  +  +S     + ED   +EV+IL+E+QH
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-IEREVSILKEIQH 73
Query: 95  RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
            NV+           + ++ E + GG L+D+L +  ++ +  +   F   I  G+ YLH 
Sbjct: 74  PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLHS 132
Query: 155 RNIIHRDLKTANLLMDTHNV----VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQ 210
             I H DLK  N+++   NV    +K+ DFG+A   + G       GT  ++APE++N++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 211 PYDQKADVFSFAIVLWELVTAKVPY 235
           P   +AD++S  ++ + L++   P+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPF 217

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 42  TGERIASG------SCGDLYRGV-YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH 94
           TGE + SG       C +   G+ Y  + +  +  +S     + ED   +EV+IL+E+QH
Sbjct: 15  TGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-IEREVSILKEIQH 73
Query: 95  RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
            NV+           + ++ E + GG L+D+L +  ++ +  +   F   I  G+ YLH 
Sbjct: 74  PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLHS 132
Query: 155 RNIIHRDLKTANLLMDTHNV----VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQ 210
             I H DLK  N+++   NV    +K+ DFG+A   + G       GT  ++APE++N++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 211 PYDQKADVFSFAIVLWELVTAKVPY 235
           P   +AD++S  ++ + L++   P+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPF 217

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 110/216 (50%), Gaps = 20/216 (9%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDT-LEDEFV 83
           ED+EI R L K       G  G+    VYL ++      +A+KVL    L    +E +  
Sbjct: 9   EDFEIGRPLGK-------GKFGN----VYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 57
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
           +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K  +     +   +  
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYIT 116
Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMA 203
           ++   + Y H + +IHRD+K  NLL+ +   +K+ADFG +         T  +GT  ++ 
Sbjct: 117 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-CHAPSSRRTTLSGTLDYLP 175
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           PE+I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 42  TGERIASG------SCGDLYRGV-YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH 94
           TGE + SG       C +   G+ Y  + +  +  +S     + ED   +EV+IL+E+QH
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-IEREVSILKEIQH 73
Query: 95  RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
            NV+           + ++ E + GG L+D+L +  ++ +  +   F   I  G+ YLH 
Sbjct: 74  PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLHS 132
Query: 155 RNIIHRDLKTANLLMDTHNV----VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQ 210
             I H DLK  N+++   NV    +K+ DFG+A   + G       GT  ++APE++N++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 211 PYDQKADVFSFAIVLWELVTAKVPY 235
           P   +AD++S  ++ + L++   P+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPF 217

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 110/220 (50%), Gaps = 15/220 (6%)
Query: 27  QTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDT-LE 79
           ++K   W ++    + G  +  G  G+    VYL ++      +A+KVL    L    +E
Sbjct: 2   ESKKRQWALED--FEIGRPLGKGKFGN----VYLAREKQSKFILALKVLFKAQLEKAGVE 55
Query: 80  DEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL 139
            +  +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K  +     +  
Sbjct: 56  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTA 114
Query: 140 RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
            +  ++   + Y H + +IHRD+K  NLL+ +   +K+ADFG +         T   GT 
Sbjct: 115 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTL 173
Query: 200 RWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
            ++ PE+I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 42  TGERIASG------SCGDLYRGV-YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH 94
           TGE + SG       C +   G+ Y  + +  +  +S     + ED   +EV+IL+E+QH
Sbjct: 14  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-IEREVSILKEIQH 72
Query: 95  RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
            NV+           + ++ E + GG L+D+L +  ++ +  +   F   I  G+ YLH 
Sbjct: 73  PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLHS 131
Query: 155 RNIIHRDLKTANLLMDTHNV----VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQ 210
             I H DLK  N+++   NV    +K+ DFG+A   + G       GT  ++APE++N++
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 211 PYDQKADVFSFAIVLWELVTAKVPY 235
           P   +AD++S  ++ + L++   P+
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPF 216

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 17/210 (8%)
Query: 46  IASGSCGDLYRGVYLGQ-----DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF 100
           I  G  G +Y G Y+ Q       A+K L        +E  F++E  ++R + H NV+  
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVE-AFLREGLLMRGLNHPNVLAL 87
Query: 101 IGASTKS---PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
           IG        PH  ++  YM  G L  ++        +  L+ F + + +GMEYL ++  
Sbjct: 88  IGIMLPPEGLPH--VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKF 145
Query: 158 IHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY-----RWMAPEVINHQPY 212
           +HRDL   N ++D    VKVADFG+AR        + +   +     +W A E +    +
Sbjct: 146 VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRF 205
Query: 213 DQKADVFSFAIVLWELVT-AKVPYDSMTPL 241
             K+DV+SF ++LWEL+T    PY  + P 
Sbjct: 206 TTKSDVWSFGVLLWELLTRGAPPYRHIDPF 235

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 42  TGERIASG------SCGDLYRGV-YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH 94
           TGE + SG       C +   G+ Y  + +  +  +S     + ED   +EV+IL+E+QH
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-IEREVSILKEIQH 73
Query: 95  RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
            NV+           + ++ E + GG L+D+L +  ++ +  +   F   I  G+ YLH 
Sbjct: 74  PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLHS 132
Query: 155 RNIIHRDLKTANLLMDTHNV----VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQ 210
             I H DLK  N+++   NV    +K+ DFG+A   + G       GT  ++APE++N++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 211 PYDQKADVFSFAIVLWELVTAKVPY 235
           P   +AD++S  ++ + L++   P+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPF 217

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 81/154 (52%), Gaps = 1/154 (0%)
Query: 83  VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSL-YDYLHKNHNVLKLPQLLRF 141
           + E  IL +V  R VV    A      LC+V   M GG L +   H         + + +
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 142 AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRW 201
           A +IC G+E LH+  I++RDLK  N+L+D H  ++++D G+A    +G  +    GT  +
Sbjct: 292 AAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGY 351
Query: 202 MAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           MAPEV+ ++ Y    D ++   +L+E++  + P+
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 104/200 (52%), Gaps = 6/200 (3%)
Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNVVRFIG 102
           I +GS G   L + +  G   A+K+L  + +    + E  + E  IL+ V    +V+   
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
           +   + +L +V EYMPGG ++ +L +     + P    +A  I    EYLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 163 KTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFA 222
           K  NLL+D    +KVADFG A+     G      GT  ++APE+I  + Y++  D ++  
Sbjct: 168 KPENLLIDQQGYIKVADFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 223 IVLWELVTAKVPYDSMTPLQ 242
           ++++E+     P+ +  P+Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 81/154 (52%), Gaps = 1/154 (0%)
Query: 83  VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSL-YDYLHKNHNVLKLPQLLRF 141
           + E  IL +V  R VV    A      LC+V   M GG L +   H         + + +
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 142 AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRW 201
           A +IC G+E LH+  I++RDLK  N+L+D H  ++++D G+A    +G  +    GT  +
Sbjct: 292 AAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGY 351
Query: 202 MAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           MAPEV+ ++ Y    D ++   +L+E++  + P+
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 110/220 (50%), Gaps = 15/220 (6%)
Query: 27  QTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDT-LE 79
           ++K   W ++    + G  +  G  G+    VYL ++      +A+KVL    L    +E
Sbjct: 2   ESKKRQWALED--FEIGRPLGKGKFGN----VYLAREKQSKFILALKVLFKAQLEKAGVE 55
Query: 80  DEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL 139
            +  +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K  +     +  
Sbjct: 56  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTA 114
Query: 140 RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
            +  ++   + Y H + +IHRD+K  NLL+ +   +K+ADFG +         T   GT 
Sbjct: 115 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTL 173
Query: 200 RWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
            ++ PE+I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 91.7 bits (226), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 104/200 (52%), Gaps = 6/200 (3%)
Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNVVRFIG 102
           I +GS G   L + +  G   A+K+L  + +    + E  + E  IL+ V    +V+   
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
           +   + +L +V EYMPGG ++ +L +     + P    +A  I    EYLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 163 KTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFA 222
           K  NLL+D    +KVADFG A+     G      GT  ++APE+I  + Y++  D ++  
Sbjct: 168 KPENLLIDQQGYIKVADFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 223 IVLWELVTAKVPYDSMTPLQ 242
           ++++E+     P+ +  P+Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 133/269 (49%), Gaps = 30/269 (11%)
Query: 4   NITILTIVHRKYRGHAVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLY-----RGV 58
           +I  + I H    GH  EKA  SQ +         LLK    +  GS G ++      G 
Sbjct: 5   SIKEIAITHHVKEGH--EKADPSQFE---------LLKV---LGQGSFGKVFLVKKISGS 50
Query: 59  YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMP 118
              Q  A+KVL+   L          E  IL EV H  +V+   A      L ++ +++ 
Sbjct: 51  DARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLR 110
Query: 119 GGSLYDYLHKNHNVLKLPQLLRFAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKV 177
           GG L+  L K   V+   + ++F + ++   +++LH   II+RDLK  N+L+D    +K+
Sbjct: 111 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKL 168
Query: 178 ADFGVARFQ-NKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY- 235
            DFG+++   +      +  GT  +MAPEV+N + + Q AD +SF ++++E++T  +P+ 
Sbjct: 169 TDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 228
Query: 236 -----DSMTP-LQAALGVRQVCTSLCQPI 258
                ++MT  L+A LG+ Q  +   Q +
Sbjct: 229 GKDRKETMTMILKAKLGMPQFLSPEAQSL 257

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 42  TGERIASG------SCGDLYRGV-YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH 94
           TGE + SG       C +   G+ Y  + +  +  +S     + ED   +EV+IL+E+QH
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-IEREVSILKEIQH 73
Query: 95  RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
            NV+           + ++ E + GG L+D+L +  ++ +  +   F   I  G+ YLH 
Sbjct: 74  PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLHS 132
Query: 155 RNIIHRDLKTANLLMDTHNV----VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQ 210
             I H DLK  N+++   NV    +K+ DFG+A   + G       GT  ++APE++N++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVNYE 192
Query: 211 PYDQKADVFSFAIVLWELVTAKVPY 235
           P   +AD++S  ++ + L++   P+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPF 217

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 42  TGERIASG------SCGDLYRGV-YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH 94
           TGE + SG       C +   G+ Y  + +  +  +S     + ED   +EV+IL+E+QH
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-IEREVSILKEIQH 73
Query: 95  RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
            NV+           + ++ E + GG L+D+L +  ++ +  +   F   I  G+ YLH 
Sbjct: 74  PNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYYLHS 132
Query: 155 RNIIHRDLKTANLLMDTHNV----VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQ 210
             I H DLK  N+++   NV    +K+ DFG+A   + G       GT  ++APE++N++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 211 PYDQKADVFSFAIVLWELVTAKVPY 235
           P   +AD++S  ++ + L++   P+
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPF 217

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 133/269 (49%), Gaps = 30/269 (11%)
Query: 4   NITILTIVHRKYRGHAVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLY-----RGV 58
           +I  + I H    GH  EKA  SQ +         LLK    +  GS G ++      G 
Sbjct: 4   SIKEIAITHHVKEGH--EKADPSQFE---------LLKV---LGQGSFGKVFLVKKISGS 49
Query: 59  YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMP 118
              Q  A+KVL+   L          E  IL EV H  +V+   A      L ++ +++ 
Sbjct: 50  DARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLR 109
Query: 119 GGSLYDYLHKNHNVLKLPQLLRFAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKV 177
           GG L+  L K   V+   + ++F + ++   +++LH   II+RDLK  N+L+D    +K+
Sbjct: 110 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKL 167
Query: 178 ADFGVARFQ-NKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY- 235
            DFG+++   +      +  GT  +MAPEV+N + + Q AD +SF ++++E++T  +P+ 
Sbjct: 168 TDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 227
Query: 236 -----DSMTP-LQAALGVRQVCTSLCQPI 258
                ++MT  L+A LG+ Q  +   Q +
Sbjct: 228 GKDRKETMTMILKAKLGMPQFLSPEAQSL 256

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEF---VQEVAILREVQHRNVVRF 100
           +  G+ G   L R    G+  A+K+LR E +    +DE    V E  +L+  +H  +   
Sbjct: 16  LGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTAL 73
Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
             A      LC V EY  GG L+ +L +   V    +   +  +I   +EYLH R++++R
Sbjct: 74  KYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYR 132
Query: 161 DLKTANLLMDTHNVVKVADFGVARFQ-NKGGVMTAETGTYRWMAPEVINHQPYDQKADVF 219
           D+K  NL++D    +K+ DFG+ +   + G  M    GT  ++APEV+    Y +  D +
Sbjct: 133 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 192
Query: 220 SFAIVLWELVTAKVPY 235
              +V++E++  ++P+
Sbjct: 193 GLGVVMYEMMCGRLPF 208

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 28/209 (13%)
Query: 44  ERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA 103
           E +  G  G+++RG++ G+ VAVK+  S        +  +    +LR   H N++ FI +
Sbjct: 14  ECVGKGRYGEVWRGLWHGESVAVKIFSSRDEQSWFRETEIYNTVLLR---HDNILGFIAS 70
Query: 104 S----TKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH------ 153
                  S  L ++T Y   GSLYD+L +    L+    LR A+    G+ +LH      
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSLYDFLQR--QTLEPHLALRLAVSAACGLAHLHVEIFGT 128
Query: 154 --QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM-----TAETGTYRWMAPEV 206
             +  I HRD K+ N+L+ ++    +AD G+A   ++G            GT R+MAPEV
Sbjct: 129 QGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEV 188
Query: 207 INHQPYD------QKADVFSFAIVLWELV 229
           ++ Q         +  D+++F +VLWE+ 
Sbjct: 189 LDEQIRTDCFESYKWTDIWAFGLVLWEIA 217

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 109/220 (49%), Gaps = 15/220 (6%)
Query: 27  QTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDT-LE 79
           ++K   W ++    + G  +  G  G+    VYL ++      +A+KVL    L    +E
Sbjct: 4   ESKKRQWALED--FEIGRPLGKGKFGN----VYLAREKQSKFILALKVLFKAQLEKAGVE 57
Query: 80  DEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL 139
            +  +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K  +     +  
Sbjct: 58  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTA 116
Query: 140 RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
            +  ++   + Y H + +IHRD+K  NLL+ +   +K+ADFG +         T   GT 
Sbjct: 117 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTL 175
Query: 200 RWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
            ++ PE I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 176 DYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANT 215

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 91.3 bits (225), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 109/216 (50%), Gaps = 20/216 (9%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDT-LEDEFV 83
           ED+EI R L K       G  G+    VYL ++      +A+KVL    L    +E +  
Sbjct: 8   EDFEIGRPLGK-------GKFGN----VYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 56
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
           +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K  +     +   +  
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYIT 115
Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMA 203
           ++   + Y H + +IHRD+K  NLL+ +   +K+ADFG +         T   GT  ++ 
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLP 174
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           PE+I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEF---VQEVAILREVQHRNVVRF 100
           +  G+ G   L R    G+  A+K+LR E +    +DE    V E  +L+  +H  +   
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
             A      LC V EY  GG L+ +L +   V    +   +  +I   +EYLH R++++R
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 161 DLKTANLLMDTHNVVKVADFGVARFQ-NKGGVMTAETGTYRWMAPEVINHQPYDQKADVF 219
           D+K  NL++D    +K+ DFG+ +   + G  M    GT  ++APEV+    Y +  D +
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 189
Query: 220 SFAIVLWELVTAKVPY 235
              +V++E++  ++P+
Sbjct: 190 GLGVVMYEMMCGRLPF 205

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 109/216 (50%), Gaps = 20/216 (9%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDT-LEDEFV 83
           ED+EI R L K       G  G+    VYL ++      +A+KVL    L    +E +  
Sbjct: 12  EDFEIGRPLGK-------GKFGN----VYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 60
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
           +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K  +     +   +  
Sbjct: 61  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYIT 119
Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMA 203
           ++   + Y H + +IHRD+K  NLL+ +   +K+ADFG +         T   GT  ++ 
Sbjct: 120 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLP 178
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           PE+I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 214

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 109/216 (50%), Gaps = 20/216 (9%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDT-LEDEFV 83
           ED+EI R L K       G  G+    VYL ++      +A+KVL    L    +E +  
Sbjct: 11  EDFEIGRPLGK-------GKFGN----VYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 59
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
           +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K  +     +   +  
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYIT 118
Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMA 203
           ++   + Y H + +IHRD+K  NLL+ +   +K+ADFG +          A  GT  ++ 
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLP 177
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           PE+I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEF---VQEVAILREVQHRNVVRF 100
           +  G+ G   L R    G+  A+K+LR E +    +DE    V E  +L+  +H  +   
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
             A      LC V EY  GG L+ +L +   V    +   +  +I   +EYLH R++++R
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 161 DLKTANLLMDTHNVVKVADFGVARFQ-NKGGVMTAETGTYRWMAPEVINHQPYDQKADVF 219
           D+K  NL++D    +K+ DFG+ +   + G  M    GT  ++APEV+    Y +  D +
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 189
Query: 220 SFAIVLWELVTAKVPY 235
              +V++E++  ++P+
Sbjct: 190 GLGVVMYEMMCGRLPF 205

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 109/216 (50%), Gaps = 20/216 (9%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDT-LEDEFV 83
           ED+EI R L K       G  G+    VYL ++      +A+KVL    L    +E +  
Sbjct: 7   EDFEIGRPLGK-------GKFGN----VYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 55
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
           +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K  +     +   +  
Sbjct: 56  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYIT 114
Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMA 203
           ++   + Y H + +IHRD+K  NLL+ +   +K+ADFG +         T   GT  ++ 
Sbjct: 115 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLP 173
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           PE+I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 174 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 209

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEF---VQEVAILREVQHRNVVRF 100
           +  G+ G   L R    G+  A+K+LR E +    +DE    V E  +L+  +H  +   
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
             A      LC V EY  GG L+ +L +   V    +   +  +I   +EYLH R++++R
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 161 DLKTANLLMDTHNVVKVADFGVARFQ-NKGGVMTAETGTYRWMAPEVINHQPYDQKADVF 219
           D+K  NL++D    +K+ DFG+ +   + G  M    GT  ++APEV+    Y +  D +
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWW 189
Query: 220 SFAIVLWELVTAKVPY 235
              +V++E++  ++P+
Sbjct: 190 GLGVVMYEMMCGRLPF 205

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 109/216 (50%), Gaps = 20/216 (9%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDT-LEDEFV 83
           ED+EI R L K       G  G+    VYL ++      +A+KVL    L    +E +  
Sbjct: 8   EDFEIGRPLGK-------GKFGN----VYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 56
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
           +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K  +     +   +  
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYIT 115
Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMA 203
           ++   + Y H + +IHRD+K  NLL+ +   +K+ADFG +          A  GT  ++ 
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLP 174
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           PE+I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 109/216 (50%), Gaps = 20/216 (9%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDT-LEDEFV 83
           ED+EI R L K       G  G+    VYL ++      +A+KVL    L    +E +  
Sbjct: 8   EDFEIGRPLGK-------GKFGN----VYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 56
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
           +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K  +     +   +  
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYIT 115
Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMA 203
           ++   + Y H + +IHRD+K  NLL+ +   +K+ADFG +         T   GT  ++ 
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTELCGTLDYLP 174
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           PE+I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 108/216 (50%), Gaps = 20/216 (9%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDT-LEDEFV 83
           ED+EI R L K       G  G+    VYL ++      +A+KVL    L    +E +  
Sbjct: 5   EDFEIGRPLGK-------GKFGN----VYLAREKQRKFILALKVLFKAQLEKAGVEHQLR 53
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
           +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K        +   +  
Sbjct: 54  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYIT 112
Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMA 203
           ++   + Y H + +IHRD+K  NLL+ +   +K+ADFG +         T   GT  ++ 
Sbjct: 113 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLP 171
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           PE+I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 172 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 207

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 91/175 (52%), Gaps = 5/175 (2%)
Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           VA+K +  + L    E     E+A+L +++H N+V          HL ++ + + GG L+
Sbjct: 46  VAIKCIAKKALEGK-EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 124 DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLL---MDTHNVVKVADF 180
           D + +           R    +   ++YLH   I+HRDLK  NLL   +D  + + ++DF
Sbjct: 105 DRIVEK-GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDF 163
Query: 181 GVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           G+++ ++ G V++   GT  ++APEV+  +PY +  D +S  ++ + L+    P+
Sbjct: 164 GLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEF---VQEVAILREVQHRNVVRF 100
           +  G+ G   L R    G+  A+K+LR E +    +DE    V E  +L+  +H  +   
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
             A      LC V EY  GG L+ +L +   V    +   +  +I   +EYLH R++++R
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 161 DLKTANLLMDTHNVVKVADFGVARFQ-NKGGVMTAETGTYRWMAPEVINHQPYDQKADVF 219
           D+K  NL++D    +K+ DFG+ +   + G  M    GT  ++APEV+    Y +  D +
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWW 189
Query: 220 SFAIVLWELVTAKVPY 235
              +V++E++  ++P+
Sbjct: 190 GLGVVMYEMMCGRLPF 205

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 109/216 (50%), Gaps = 20/216 (9%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDT-LEDEFV 83
           ED+EI R L K       G  G+    VYL ++      +A+KVL    L    +E +  
Sbjct: 8   EDFEIGRPLGK-------GKFGN----VYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 56
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
           +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K  +     +   +  
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYIT 115
Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMA 203
           ++   + Y H + +IHRD+K  NLL+ +   +K+ADFG +         T   GT  ++ 
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTXLCGTLDYLP 174
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           PE+I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 113/227 (49%), Gaps = 23/227 (10%)
Query: 23  AIESQTKS---EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEH 73
           A+ES+ +    ED+EI R L K       G  G+    VYL ++      +A+KVL    
Sbjct: 2   AMESKKRQWALEDFEIGRPLGK-------GKFGN----VYLAREKQSKFILALKVLFKAQ 50
Query: 74  LNDT-LEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV 132
           L    +E +  +EV I   ++H N++R  G    +  + ++ EY P G +Y  L K  + 
Sbjct: 51  LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQK-LSK 109
Query: 133 LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM 192
               +   +  ++   + Y H + +IHRD+K  NLL+ +   +K+ADFG +         
Sbjct: 110 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRR 168
Query: 193 TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
               GT  ++ PE+I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 169 XXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 215

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEF---VQEVAILREVQHRNVVRF 100
           +  G+ G   L R    G+  A+K+LR E +    +DE    V E  +L+  +H  +   
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
             A      LC V EY  GG L+ +L +   V    +   +  +I   +EYLH R++++R
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 161 DLKTANLLMDTHNVVKVADFGVARFQ-NKGGVMTAETGTYRWMAPEVINHQPYDQKADVF 219
           D+K  NL++D    +K+ DFG+ +   + G  M    GT  ++APEV+    Y +  D +
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWW 189
Query: 220 SFAIVLWELVTAKVPY 235
              +V++E++  ++P+
Sbjct: 190 GLGVVMYEMMCGRLPF 205

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEF---VQEVAILREVQHRNVVRF 100
           +  G+ G   L R    G+  A+K+LR E +    +DE    V E  +L+  +H  +   
Sbjct: 18  LGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTAL 75
Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
             A      LC V EY  GG L+ +L +   V    +   +  +I   +EYLH R++++R
Sbjct: 76  KYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYR 134
Query: 161 DLKTANLLMDTHNVVKVADFGVARFQ-NKGGVMTAETGTYRWMAPEVINHQPYDQKADVF 219
           D+K  NL++D    +K+ DFG+ +   + G  M    GT  ++APEV+    Y +  D +
Sbjct: 135 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWW 194
Query: 220 SFAIVLWELVTAKVPY 235
              +V++E++  ++P+
Sbjct: 195 GLGVVMYEMMCGRLPF 210

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 113/220 (51%), Gaps = 15/220 (6%)
Query: 44  ERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVV--R 99
           ER+ +G  G + R ++   G+ VA+K  R E L+    + +  E+ I++++ H NVV  R
Sbjct: 20  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 100 FI--GASTKSPH--LCIVTEYMPGGSLYDYLHKNHNV--LKLPQLLRFAIDICKGMEYLH 153
            +  G    +P+    +  EY  GG L  YL++  N   LK   +     DI   + YLH
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 154 QRNIIHRDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQ 210
           +  IIHRDLK  N+++       + K+ D G A+  ++G + T   GT +++APE++  +
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQK 198
Query: 211 PYDQKADVFSFAIVLWELVTAKVPY-DSMTPLQAALGVRQ 249
            Y    D +SF  + +E +T   P+  +  P+Q    VR+
Sbjct: 199 KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 238

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 113/220 (51%), Gaps = 15/220 (6%)
Query: 44  ERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVV--R 99
           ER+ +G  G + R ++   G+ VA+K  R E L+    + +  E+ I++++ H NVV  R
Sbjct: 21  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAR 79
Query: 100 FI--GASTKSPH--LCIVTEYMPGGSLYDYLHKNHNV--LKLPQLLRFAIDICKGMEYLH 153
            +  G    +P+    +  EY  GG L  YL++  N   LK   +     DI   + YLH
Sbjct: 80  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 139
Query: 154 QRNIIHRDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQ 210
           +  IIHRDLK  N+++       + K+ D G A+  ++G + T   GT +++APE++  +
Sbjct: 140 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQK 199
Query: 211 PYDQKADVFSFAIVLWELVTAKVPY-DSMTPLQAALGVRQ 249
            Y    D +SF  + +E +T   P+  +  P+Q    VR+
Sbjct: 200 KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 239

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 100/178 (56%), Gaps = 6/178 (3%)
Query: 61  GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGG 120
           G  +A K++++  + D  ++E   E++++ ++ H N+++   A      + +V EY+ GG
Sbjct: 114 GLKLAAKIIKTRGMKD--KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171
Query: 121 SLYD-YLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV--VKV 177
            L+D  + +++N+ +L  +L F   IC+G+ ++HQ  I+H DLK  N+L    +   +K+
Sbjct: 172 ELFDRIIDESYNLTELDTIL-FMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKI 230
Query: 178 ADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
            DFG+AR       +    GT  ++APEV+N+       D++S  ++ + L++   P+
Sbjct: 231 IDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPF 288

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 112/223 (50%), Gaps = 20/223 (8%)
Query: 24  IESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDT 77
           ++ Q   ED+EI R L K       G  G+    VYL ++      +A+KVL    L   
Sbjct: 1   MKRQWALEDFEIGRPLGK-------GKFGN----VYLAREKQSKFILALKVLFKAQLEKA 49
Query: 78  -LEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLP 136
            +E +  +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K  +     
Sbjct: 50  GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQ 108
Query: 137 QLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET 196
           +   +  ++   + Y H + +IHRD+K  NLL+ +   +K+ADFG +         T   
Sbjct: 109 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLC 167
Query: 197 GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           GT  ++ PE+I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 90.5 bits (223), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 109/216 (50%), Gaps = 20/216 (9%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDT-LEDEFV 83
           ED+EI R L K       G  G+    VYL ++      +A+KVL    L    +E +  
Sbjct: 13  EDFEIGRPLGK-------GKFGN----VYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
           +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K  +     +   +  
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYIT 120
Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMA 203
           ++   + Y H + +IHRD+K  NLL+ +   +K+ADFG +         T   GT  ++ 
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLP 179
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           PE+I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 215

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 90.5 bits (223), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 109/216 (50%), Gaps = 20/216 (9%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDT-LEDEFV 83
           ED+EI R L K       G  G+    VYL ++      +A+KVL    L    +E +  
Sbjct: 9   EDFEIGRPLGK-------GKFGN----VYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 57
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
           +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K  +     +   +  
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYIT 116
Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMA 203
           ++   + Y H + +IHRD+K  NLL+ +   +K+ADFG +         T   GT  ++ 
Sbjct: 117 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLP 175
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           PE+I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 107/198 (54%), Gaps = 8/198 (4%)
Query: 46  IASGSCGDLYRGVYLGQDV--AVKVLRSEHLNDTLEDEFV--QEVAILREVQHRNVVRFI 101
           I  GS G +    +  ++V  AVKVL+ + +    E++ +  +   +L+ V+H  +V   
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
            +   +  L  V +Y+ GG L+ +L +    L+ P+   +A +I   + YLH  NI++RD
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRERCFLE-PRARFYAAEIASALGYLHSLNIVYRD 164
Query: 162 LKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADVF 219
           LK  N+L+D+   + + DFG+ + +N     T  T  GT  ++APEV++ QPYD+  D +
Sbjct: 165 LKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWW 223
Query: 220 SFAIVLWELVTAKVPYDS 237
               VL+E++    P+ S
Sbjct: 224 CLGAVLYEMLYGLPPFYS 241

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 109/216 (50%), Gaps = 20/216 (9%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDT-LEDEFV 83
           ED+EI R L K       G  G+    VYL ++      +A+KVL    L    +E +  
Sbjct: 8   EDFEIGRPLGK-------GKFGN----VYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 56
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
           +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K  +     +   +  
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYIT 115
Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMA 203
           ++   + Y H + +IHRD+K  NLL+ +   +K+ADFG +         T   GT  ++ 
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLP 174
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           PE+I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 110/220 (50%), Gaps = 15/220 (6%)
Query: 27  QTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDT-LE 79
           ++K   W ++    + G  +  G  G+    VYL ++      +A+KVL    L    +E
Sbjct: 1   ESKKRQWALED--FEIGRPLGKGKFGN----VYLAREKQSKFILALKVLFKAQLEKAGVE 54
Query: 80  DEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL 139
            +  +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K  +     +  
Sbjct: 55  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTA 113
Query: 140 RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
            +  ++   + Y H + +IHRD+K  NLL+ +   +K+A+FG +         T   GT 
Sbjct: 114 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTL 172
Query: 200 RWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
            ++ PE+I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 212

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 110/220 (50%), Gaps = 15/220 (6%)
Query: 27  QTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDT-LE 79
           ++K   W ++    + G  +  G  G+    VYL ++      +A+KVL    L    +E
Sbjct: 2   ESKKRQWALED--FEIGRPLGKGKFGN----VYLAREKQSKFILALKVLFKAQLEKAGVE 55
Query: 80  DEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL 139
            +  +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K  +     +  
Sbjct: 56  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTA 114
Query: 140 RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
            +  ++   + Y H + +IHRD+K  NLL+ +   +K+A+FG +         T   GT 
Sbjct: 115 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTL 173
Query: 200 RWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
            ++ PE+I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 106/200 (53%), Gaps = 6/200 (3%)
Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNVVRFIG 102
           I +GS G   L + +  G   A+K+L  + +    + E  + E  IL+ V    +V+   
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
           +   + +L +V EY+PGG ++ +L +     + P    +A  I    EYLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 163 KTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFA 222
           K  NLL+D    +KVADFG A+ + KG       GT  ++APE+I  + Y++  D ++  
Sbjct: 168 KPENLLIDQQGYIKVADFGFAK-RVKGRTWXL-CGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 223 IVLWELVTAKVPYDSMTPLQ 242
           ++++E+     P+ +  P+Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 91/171 (53%), Gaps = 21/171 (12%)
Query: 76  DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH----- 130
           +   +E   E+++L+ + H N+++         +  +VTE+  GG L++ +   H     
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146
Query: 131 ---NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV---VKVADFGVAR 184
              N++K          I  G+ YLH+ NI+HRD+K  N+L++  N    +K+ DFG++ 
Sbjct: 147 DAANIMK---------QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS 197
Query: 185 FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           F +K   +    GT  ++APEV+  + Y++K DV+S  ++++ L+    P+
Sbjct: 198 FFSKDYKLRDRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPPF 247

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 106/199 (53%), Gaps = 4/199 (2%)
Query: 44  ERIASGSCGDLYRGV-YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           E++  G+ G +Y+     G+ VA+K +R +  ++ +    ++E+++L+E+ H N+V  I 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
                  L +V E+M    L   L +N   L+  Q+  +   + +G+ + HQ  I+HRDL
Sbjct: 87  VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDL 145
Query: 163 KTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEVI-NHQPYDQKADVFS 220
           K  NLL+++   +K+ADFG+AR F       T E  T  + AP+V+   + Y    D++S
Sbjct: 146 KPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWS 205
Query: 221 FAIVLWELVTAKVPYDSMT 239
              +  E++T K  +  +T
Sbjct: 206 IGCIFAEMITGKPLFPGVT 224

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 109/220 (49%), Gaps = 15/220 (6%)
Query: 27  QTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDT-LE 79
           ++K   W ++    + G  +  G  G+    VYL ++      +A+KVL    L    +E
Sbjct: 2   ESKKRQWALED--FEIGRPLGKGKFGN----VYLAREKQSKFILALKVLFKAQLEKAGVE 55
Query: 80  DEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL 139
            +  +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K  +     +  
Sbjct: 56  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTA 114
Query: 140 RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
            +  ++   + Y H + +IHRD+K  NLL+ +   +K+ADFG +             GT 
Sbjct: 115 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTL 173
Query: 200 RWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
            ++ PE+I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 106/199 (53%), Gaps = 4/199 (2%)
Query: 44  ERIASGSCGDLYRGV-YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           E++  G+ G +Y+     G+ VA+K +R +  ++ +    ++E+++L+E+ H N+V  I 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
                  L +V E+M    L   L +N   L+  Q+  +   + +G+ + HQ  I+HRDL
Sbjct: 87  VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDL 145
Query: 163 KTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEVI-NHQPYDQKADVFS 220
           K  NLL+++   +K+ADFG+AR F       T E  T  + AP+V+   + Y    D++S
Sbjct: 146 KPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWS 205
Query: 221 FAIVLWELVTAKVPYDSMT 239
              +  E++T K  +  +T
Sbjct: 206 IGCIFAEMITGKPLFPGVT 224

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 109/220 (49%), Gaps = 15/220 (6%)
Query: 27  QTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDT-LE 79
           ++K   W ++    + G  +  G  G+    VYL ++      +A+KVL    L    +E
Sbjct: 1   ESKKRQWALED--FEIGRPLGKGKFGN----VYLAREKQSKFILALKVLFKAQLEKAGVE 54
Query: 80  DEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL 139
            +  +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K  +     +  
Sbjct: 55  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTA 113
Query: 140 RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
            +  ++   + Y H + +IHRD+K  NLL+ +   +K+ADFG +             GT 
Sbjct: 114 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTL 172
Query: 200 RWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
            ++ PE+I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 212

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 92/177 (51%), Gaps = 5/177 (2%)
Query: 62  QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGS 121
           Q+ AVKV+      +      ++EV +L+++ H N+++       S    IV E   GG 
Sbjct: 48  QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE 107
Query: 122 LYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV---VKVA 178
           L+D + K     +     R    +  G+ Y+H+ NI+HRDLK  N+L+++      +K+ 
Sbjct: 108 LFDEIIKRKRFSE-HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKII 166
Query: 179 DFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           DFG++    +   M    GT  ++APEV+    YD+K DV+S  ++L+ L++   P+
Sbjct: 167 DFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 92/177 (51%), Gaps = 5/177 (2%)
Query: 62  QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGS 121
           Q+ AVKV+      +      ++EV +L+++ H N+++       S    IV E   GG 
Sbjct: 48  QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE 107
Query: 122 LYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV---VKVA 178
           L+D + K     +     R    +  G+ Y+H+ NI+HRDLK  N+L+++      +K+ 
Sbjct: 108 LFDEIIKRKRFSE-HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKII 166
Query: 179 DFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           DFG++    +   M    GT  ++APEV+    YD+K DV+S  ++L+ L++   P+
Sbjct: 167 DFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 110/232 (47%), Gaps = 42/232 (18%)
Query: 44  ERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV--QHRNVVRFI 101
           ++I  G  G+++ G + G+ VAVKV  +     T E  + +E  I + V  +H N++ FI
Sbjct: 43  KQIGKGRYGEVWMGKWRGEKVAVKVFFT-----TEEASWFRETEIYQTVLMRHENILGFI 97
Query: 102 GASTKSP----HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH---- 153
            A  K       L ++T+Y   GSLYDYL      L    +L+ A     G+ +LH    
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 154 ----QRNIIHRDLKTANLLMDTHNVVKVADFGVA-RFQNKGGVM----TAETGTYRWMAP 204
               +  I HRDLK+ N+L+  +    +AD G+A +F +    +        GT R+M P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 205 EVI------NHQPYDQKADVFSFAIVLWELV----------TAKVPYDSMTP 240
           EV+      NH      AD++SF ++LWE+             ++PY  + P
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 92/177 (51%), Gaps = 5/177 (2%)
Query: 62  QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGS 121
           Q+ AVKV+      +      ++EV +L+++ H N+++       S    IV E   GG 
Sbjct: 48  QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE 107
Query: 122 LYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV---VKVA 178
           L+D + K     +     R    +  G+ Y+H+ NI+HRDLK  N+L+++      +K+ 
Sbjct: 108 LFDEIIKRKRFSE-HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKII 166
Query: 179 DFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           DFG++    +   M    GT  ++APEV+    YD+K DV+S  ++L+ L++   P+
Sbjct: 167 DFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 111/207 (53%), Gaps = 11/207 (5%)
Query: 61  GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGG 120
           G   A+KVL+   L          E  IL +V H  VV+   A      L ++ +++ GG
Sbjct: 56  GHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGG 115
Query: 121 SLYDYLHKNHNVLKLPQLLRFAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVAD 179
            L+  L K   V+   + ++F + ++  G+++LH   II+RDLK  N+L+D    +K+ D
Sbjct: 116 DLFTRLSKE--VMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTD 173
Query: 180 FGVARFQ-NKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY--- 235
           FG+++   +      +  GT  +MAPEV+N Q +   AD +S+ ++++E++T  +P+   
Sbjct: 174 FGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGK 233
Query: 236 ---DSMTP-LQAALGVRQVCTSLCQPI 258
              ++MT  L+A LG+ Q  ++  Q +
Sbjct: 234 DRKETMTLILKAKLGMPQFLSTEAQSL 260

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 108/216 (50%), Gaps = 20/216 (9%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDT-LEDEFV 83
           ED+EI R L K       G  G+    VYL ++      +A+KVL    L    +E +  
Sbjct: 9   EDFEIGRPLGK-------GKFGN----VYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 57
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
           +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K  +     +   +  
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYIT 116
Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMA 203
           ++   + Y H + +IHRD+K  NLL+ +   +K+ADFG +             GT  ++ 
Sbjct: 117 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDTLCGTLDYLP 175
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           PE+I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 108/216 (50%), Gaps = 20/216 (9%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDT-LEDEFV 83
           ED+EI R L K       G  G+    VYL ++      +A+KVL    L    +E +  
Sbjct: 8   EDFEIGRPLGK-------GKFGN----VYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 56
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
           +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K  +     +   +  
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYIT 115
Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMA 203
           ++   + Y H + +IHRD+K  NLL+ +   +K+ADFG +             GT  ++ 
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLP 174
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           PE+I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 113/226 (50%), Gaps = 20/226 (8%)
Query: 21  EKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHL 74
           E++ + Q   ED+EI R L K       G  G+    VYL ++      +A+KVL    L
Sbjct: 24  EESKKRQWALEDFEIGRPLGK-------GKFGN----VYLAREKQSKFILALKVLFKAQL 72
Query: 75  NDT-LEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVL 133
               +E +  +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K  +  
Sbjct: 73  EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKF 131
Query: 134 KLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT 193
              +   +  ++   + Y H + +IHRD+K  NLL+ +   +K+ADFG +          
Sbjct: 132 DEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRD 190
Query: 194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
              GT  ++ PE+I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 191 DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 236

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 92/184 (50%), Gaps = 5/184 (2%)
Query: 80  DEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL 139
           +E  +EV+ILR+V H NV+           + ++ E + GG L+D+L +  + L   +  
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEEAT 118
Query: 140 RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV----VKVADFGVARFQNKGGVMTAE 195
            F   I  G+ YLH + I H DLK  N+++   N+    +K+ DFG+A     G      
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 196 TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLC 255
            GT  ++APE++N++P   +AD++S  ++ + L++   P+   T  +    +  V     
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD 238
Query: 256 QPIY 259
           +  +
Sbjct: 239 EEFF 242

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 92/184 (50%), Gaps = 5/184 (2%)
Query: 80  DEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL 139
           +E  +EV+ILR+V H NV+           + ++ E + GG L+D+L +  + L   +  
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEEAT 118
Query: 140 RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV----VKVADFGVARFQNKGGVMTAE 195
            F   I  G+ YLH + I H DLK  N+++   N+    +K+ DFG+A     G      
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 196 TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLC 255
            GT  ++APE++N++P   +AD++S  ++ + L++   P+   T  +    +  V     
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD 238
Query: 256 QPIY 259
           +  +
Sbjct: 239 EEFF 242

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 108/203 (53%), Gaps = 13/203 (6%)
Query: 43  GERI-ASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDE-FVQEVAILREVQHRNVV 98
           G+R+   GS G+  L +    GQ+ AVKV+    +    + E  ++EV +L+++ H N+ 
Sbjct: 30  GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIX 89
Query: 99  RFIGASTKSPHLCIVTEYMPGGSLYDYL--HKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
           +         +  +V E   GG L+D +   K  + +   +++R    +  G+ Y H+  
Sbjct: 90  KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR---QVLSGITYXHKNK 146
Query: 157 IIHRDLKTANLLMDTHNV---VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYD 213
           I+HRDLK  NLL+++ +    +++ DFG++           + GT  ++APEV+ H  YD
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVL-HGTYD 205
Query: 214 QKADVFSFAIVLWELVTAKVPYD 236
           +K DV+S  ++L+ L++   P++
Sbjct: 206 EKCDVWSTGVILYILLSGCPPFN 228

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 86/160 (53%), Gaps = 5/160 (3%)
Query: 80  DEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL 139
           +E  +EV+ILR+V H NV+           + ++ E + GG L+D+L +  + L   +  
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEEAT 118
Query: 140 RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV----VKVADFGVARFQNKGGVMTAE 195
            F   I  G+ YLH + I H DLK  N+++   N+    +K+ DFG+A     G      
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 196 TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
            GT  ++APE++N++P   +AD++S  ++ + L++   P+
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 86/160 (53%), Gaps = 5/160 (3%)
Query: 80  DEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL 139
           +E  +EV+ILR+V H NV+           + ++ E + GG L+D+L +  + L   +  
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEEAT 118
Query: 140 RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV----VKVADFGVARFQNKGGVMTAE 195
            F   I  G+ YLH + I H DLK  N+++   N+    +K+ DFG+A     G      
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 196 TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
            GT  ++APE++N++P   +AD++S  ++ + L++   P+
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 92/184 (50%), Gaps = 5/184 (2%)
Query: 80  DEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL 139
           +E  +EV+ILR+V H NV+           + ++ E + GG L+D+L +  + L   +  
Sbjct: 60  EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEEAT 118
Query: 140 RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV----VKVADFGVARFQNKGGVMTAE 195
            F   I  G+ YLH + I H DLK  N+++   N+    +K+ DFG+A     G      
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 196 TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLC 255
            GT  ++APE++N++P   +AD++S  ++ + L++   P+   T  +    +  V     
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD 238
Query: 256 QPIY 259
           +  +
Sbjct: 239 EEFF 242

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 100/195 (51%), Gaps = 6/195 (3%)
Query: 46  IASGSCGDLYRGVY--LGQDVAVKVLRSE--HLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           +  GS G ++   +    Q  A+K L+ +   ++D +E   V++  +    +H  +    
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
                  +L  V EY+ GG L  ++   H    L +   +A +I  G+++LH + I++RD
Sbjct: 85  CTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLHSKGIVYRD 143
Query: 162 LKTANLLMDTHNVVKVADFGVARFQNKGGVMTAE-TGTYRWMAPEVINHQPYDQKADVFS 220
           LK  N+L+D    +K+ADFG+ +    G   T    GT  ++APE++  Q Y+   D +S
Sbjct: 144 LKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYNHSVDWWS 203
Query: 221 FAIVLWELVTAKVPY 235
           F ++L+E++  + P+
Sbjct: 204 FGVLLYEMLIGQSPF 218

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 109/216 (50%), Gaps = 20/216 (9%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDT-LEDEFV 83
           ED++I R L K       G  G+    VYL ++      +A+KVL    L    +E +  
Sbjct: 12  EDFDIGRPLGK-------GKFGN----VYLARERQSKFILALKVLFKTQLEKAGVEHQLR 60
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
           +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K  +     +   +  
Sbjct: 61  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SRFDEQRTATYIT 119
Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMA 203
           ++   + Y H + +IHRD+K  NLL+ ++  +K+ADFG +         T   GT  ++ 
Sbjct: 120 ELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWS-VHAPSSRRTTLCGTLDYLP 178
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           PE+I  + +D+K D++S  ++ +E +    P+++ T
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHT 214

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 108/216 (50%), Gaps = 20/216 (9%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDT-LEDEFV 83
           ED+EI R L K       G  G+    VYL ++      +A+KVL    L    +E +  
Sbjct: 11  EDFEIGRPLGK-------GKFGN----VYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 59
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
           +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K  +     +   +  
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYIT 118
Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMA 203
           ++   + Y H + +IHRD+K  NLL+ +   +K+ADFG +             GT  ++ 
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTLDYLP 177
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           PE+I  + +D+K D++S  ++ +E +  K P+++ T
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 114/227 (50%), Gaps = 32/227 (14%)
Query: 47  ASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK 106
           A G  G +++   L + VAVK+   +    + ++E+  EV  L  ++H N+++FIGA  +
Sbjct: 33  ARGRFGCVWKAQLLNEYVAVKIFPIQD-KQSWQNEY--EVYSLPGMKHENILQFIGAEKR 89
Query: 107 SPH----LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR------- 155
                  L ++T +   GSL D+L  N  V+   +L   A  + +G+ YLH+        
Sbjct: 90  GTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDG 147
Query: 156 ---NIIHRDLKTANLLMDTHNVVKVADFGVA-RFQ--NKGGVMTAETGTYRWMAPEVINH 209
               I HRD+K+ N+L+  +    +ADFG+A +F+     G    + GT R+MAPEV+  
Sbjct: 148 HKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 207
Query: 210 QPYDQ-----KADVFSFAIVLWELVT----AKVPYDS-MTPLQAALG 246
               Q     + D+++  +VLWEL +    A  P D  M P +  +G
Sbjct: 208 AINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L D++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 71  DVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 129
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F         E  T  + APE+ +  + Y    D+
Sbjct: 130 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 189
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 190 WSLGCIFAEMVTRRALFPGDS 210

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L D++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 72  DVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 130
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F         E  T  + APE+ +  + Y    D+
Sbjct: 131 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 190
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 191 WSLGCIFAEMVTRRALFPGDS 211

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 106/200 (53%), Gaps = 6/200 (3%)
Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNVVRFIG 102
           + +GS G   L + +  G   A+K+L  + +    + E  + E  IL+ V    +V+   
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 94
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
           +   + +L +V EY+PGG ++ +L +     + P    +A  I    EYLH  ++I+RDL
Sbjct: 95  SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDL 153
Query: 163 KTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFA 222
           K  NLL+D    ++V DFG A+ + KG   T   GT  ++APE+I  + Y++  D ++  
Sbjct: 154 KPENLLIDQQGYIQVTDFGFAK-RVKGRTWTL-CGTPEYLAPEIILSKGYNKAVDWWALG 211
Query: 223 IVLWELVTAKVPYDSMTPLQ 242
           ++++E+     P+ +  P+Q
Sbjct: 212 VLIYEMAAGYPPFFADQPIQ 231

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 86/160 (53%), Gaps = 5/160 (3%)
Query: 80  DEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL 139
           +E  +EV+ILR+V H N++           + ++ E + GG L+D+L +  + L   +  
Sbjct: 60  EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEEAT 118
Query: 140 RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV----VKVADFGVARFQNKGGVMTAE 195
            F   I  G+ YLH + I H DLK  N+++   N+    +K+ DFG+A     G      
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 196 TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
            GT  ++APE++N++P   +AD++S  ++ + L++   P+
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 106/200 (53%), Gaps = 6/200 (3%)
Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNVVRFIG 102
           + +GS G   L + +  G   A+K+L  + +    + E  + E  IL+ V    +V+   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
           +   + +L +V EY+PGG ++ +L +     + P    +A  I    EYLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 163 KTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFA 222
           K  NLL+D    ++V DFG A+ + KG   T   GT  ++APE+I  + Y++  D ++  
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAK-RVKGRTWTL-CGTPEYLAPEIILSKGYNKAVDWWALG 226
Query: 223 IVLWELVTAKVPYDSMTPLQ 242
           ++++E+     P+ +  P+Q
Sbjct: 227 VLIYEMAAGYPPFFADQPIQ 246

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 105/200 (52%), Gaps = 6/200 (3%)
Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNVVRFIG 102
           + +GS G   L + +  G   A+K+L  + +    E E  + E  IL+ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
           +   + +L +V EY PGG ++ +L +     + P    +A  I    EYLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 163 KTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFA 222
           K  NL++D    +KV DFG+A+ + KG       GT  ++APE+I  + Y++  D ++  
Sbjct: 168 KPENLMIDQQGYIKVTDFGLAK-RVKGRTWXL-CGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 223 IVLWELVTAKVPYDSMTPLQ 242
           ++++E+     P+ +  P+Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 103/197 (52%), Gaps = 6/197 (3%)
Query: 46  IASGSCGDLYRGVYLGQD--VAVKVLRSEHL--NDTLEDEFVQEVAILREVQHRNVVRFI 101
           +  GS G +      G D   AVK+L+ + +  +D +E   V++  +    +   + +  
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
                   L  V EY+ GG L  ++ +     K P  + +A +I  G+ +L  + II+RD
Sbjct: 88  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSKGIIYRD 146
Query: 162 LKTANLLMDTHNVVKVADFGVARFQNKGGVMTAE-TGTYRWMAPEVINHQPYDQKADVFS 220
           LK  N+++D+   +K+ADFG+ +     GV T    GT  ++APE+I +QPY +  D ++
Sbjct: 147 LKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWA 206
Query: 221 FAIVLWELVTAKVPYDS 237
           F ++L+E++  + P++ 
Sbjct: 207 FGVLLYEMLAGQAPFEG 223

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 108/212 (50%), Gaps = 17/212 (8%)
Query: 37  RRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH 94
           RR+ K GE    G+ G++Y+ +     + VA+K +R EH  + +    ++EV++L+E+QH
Sbjct: 37  RRITKLGE----GTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQH 92
Query: 95  RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
           RN++        +  L ++ EY     L  Y+ KN +V  +  +  F   +  G+ + H 
Sbjct: 93  RNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNPDV-SMRVIKSFLYQLINGVNFCHS 150
Query: 155 RNIIHRDLKTANLLMDTHN-----VVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-I 207
           R  +HRDLK  NLL+   +     V+K+ DFG+AR F       T E  T  +  PE+ +
Sbjct: 151 RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILL 210
Query: 208 NHQPYDQKADVFSFAIVLWELV--TAKVPYDS 237
             + Y    D++S A +  E++  T   P DS
Sbjct: 211 GSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS 242

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 102/197 (51%), Gaps = 6/197 (3%)
Query: 46  IASGSCGDLYRGVYLGQD--VAVKVLRSEHL--NDTLEDEFVQEVAILREVQHRNVVRFI 101
           +  GS G +      G D   AVK+L+ + +  +D +E   V++  +    +   + +  
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
                   L  V EY+ GG L  Y  +     K P  + +A +I  G+ +L  + II+RD
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLM-YHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRD 467
Query: 162 LKTANLLMDTHNVVKVADFGVARFQNKGGVMTAE-TGTYRWMAPEVINHQPYDQKADVFS 220
           LK  N+++D+   +K+ADFG+ +     GV T    GT  ++APE+I +QPY +  D ++
Sbjct: 468 LKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWA 527
Query: 221 FAIVLWELVTAKVPYDS 237
           F ++L+E++  + P++ 
Sbjct: 528 FGVLLYEMLAGQAPFEG 544

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 87.0 bits (214), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 69  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 127
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F       T E  T  + APE+ +  + Y    D+
Sbjct: 128 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDI 187
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 188 WSLGCIFAEMVTRRALFPGDS 208

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 16  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 75
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 76  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 134
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F       T E  T  + APE+ +  + Y    D+
Sbjct: 135 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDI 194
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 195 WSLGCIFAEMVTRRALFPGDS 215

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 87.0 bits (214), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L D++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 69  DVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 127
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F         E  T  + APE+ +  + Y    D+
Sbjct: 128 DLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 187
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 188 WSLGCIFAEMVTRRALFPGDS 208

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 69  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRVLHR 127
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F       T E  T  + APE+ +  + Y    D+
Sbjct: 128 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 187
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 188 WSLGCIFAEMVTRRALFPGDS 208

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 108/210 (51%), Gaps = 8/210 (3%)
Query: 35  IDRRLLKTGERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV 92
           +D    +  E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+
Sbjct: 4   VDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 93  QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEY 151
            H N+V+ +        L +V E++    L  ++  +    + LP +  +   + +G+ +
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INH 209
            H   ++HRDLK  NLL++T   +K+ADFG+AR F       T E  T  + APE+ +  
Sbjct: 123 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 182
Query: 210 QPYDQKADVFSFAIVLWELVT--AKVPYDS 237
           + Y    D++S   +  E+VT  A  P DS
Sbjct: 183 KYYSTAVDIWSLGCIFAEMVTRRALFPGDS 212

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 16  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 75
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 76  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 134
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F       T E  T  + APE+ +  + Y    D+
Sbjct: 135 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 194
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 195 WSLGCIFAEMVTRRALFPGDS 215

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 6/200 (3%)
Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNVVRFIG 102
           + +GS G   L + +  G   A+K+L  + +    + E  + E  IL+ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
           +   + +L +V EY PGG ++ +L +     + P    +A  I    EYLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXE-PHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 163 KTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFA 222
           K  NL++D    +KV DFG A+     G      GT  ++APE+I  + Y++  D ++  
Sbjct: 168 KPENLMIDQQGYIKVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 223 IVLWELVTAKVPYDSMTPLQ 242
           ++++E+     P+ +  P+Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 69  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 127
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F       T E  T  + APE+ +  + Y    D+
Sbjct: 128 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 187
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 188 WSLGCIFAEMVTRRALFPGDS 208

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 69  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 127
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F       T E  T  + APE+ +  + Y    D+
Sbjct: 128 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 187
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 188 WSLGCIFAEMVTRRALFPGDS 208

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 68  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 126
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F       T E  T  + APE+ +  + Y    D+
Sbjct: 127 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 186
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 187 WSLGCIFAEMVTRRALFPGDS 207

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 68  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 126
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F       T E  T  + APE+ +  + Y    D+
Sbjct: 127 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 186
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 187 WSLGCIFAEMVTRRALFPGDS 207

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 103/200 (51%), Gaps = 6/200 (3%)
Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNVVRFIG 102
           + +GS G   L + +  G   A+K+L  + +    + E  + E  IL+ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
           +   + +L +V EY+PGG ++ +L +     + P    +A  I    EYLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE-PHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 163 KTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFA 222
           K  NLL+D    ++V DFG A+     G      GT  ++APE+I  + Y++  D ++  
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 223 IVLWELVTAKVPYDSMTPLQ 242
           ++++E+     P+ +  P+Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 70  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 128
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F       T E  T  + APE+ +  + Y    D+
Sbjct: 129 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 188
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 189 WSLGCIFAEMVTRRALFPGDS 209

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 103/200 (51%), Gaps = 6/200 (3%)
Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNVVRFIG 102
           + +GS G   L + +  G   A+K+L  + +    + E  + E  IL+ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
           +   + +L +V EY+PGG ++ +L +     + P    +A  I    EYLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE-PHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 163 KTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFA 222
           K  NLL+D    ++V DFG A+     G      GT  ++APE+I  + Y++  D ++  
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 223 IVLWELVTAKVPYDSMTPLQ 242
           ++++E+     P+ +  P+Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 103/200 (51%), Gaps = 6/200 (3%)
Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNVVRFIG 102
           + +GS G   L + +  G   A+K+L  + +    + E  + E  IL+ V    +V+   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
           +   + +L +V EY+PGG ++ +L +     + P    +A  I    EYLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE-PHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 163 KTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFA 222
           K  NLL+D    ++V DFG A+     G      GT  ++APE+I  + Y++  D ++  
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 226
Query: 223 IVLWELVTAKVPYDSMTPLQ 242
           ++++E+     P+ +  P+Q
Sbjct: 227 VLIYEMAAGYPPFFADQPIQ 246

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 41/107 (38%), Positives = 66/107 (61%), Gaps = 4/107 (3%)
Query: 133 LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR--FQNKGG 190
           + +  L+ ++  + +GME+L  R  IHRDL   N+L+  +NVVK+ DFG+AR  ++N   
Sbjct: 196 ITMEDLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDY 255
Query: 191 VMTAETG-TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
           V   +T    +WMAPE I  + Y  K+DV+S+ ++LWE+ +    PY
Sbjct: 256 VRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPY 302

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 105/200 (52%), Gaps = 6/200 (3%)
Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNVVRFIG 102
           + +GS G   L + +  G   A+K+L  + +    E E  + E  IL+ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
           +   + +L +V EY PGG ++ +L +     + P    +A  I    EYLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 163 KTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFA 222
           K  NL++D    ++V DFG+A+ + KG       GT  ++APE+I  + Y++  D ++  
Sbjct: 168 KPENLMIDQQGYIQVTDFGLAK-RVKGRTWXL-CGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 223 IVLWELVTAKVPYDSMTPLQ 242
           ++++E+     P+ +  P+Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 43  GERIASGSCGDLYRGVYLGQD------VAVKVL-RSEHLNDTLEDEFVQEVAILREVQHR 95
           G  +  G  G+    VYL ++      +A+KVL +S+   + +E +  +E+ I   ++H 
Sbjct: 20  GRPLGKGKFGN----VYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 75
Query: 96  NVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR 155
           N++R          + ++ E+ P G LY  L K H      +   F  ++   + Y H+R
Sbjct: 76  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHER 134
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQK 215
            +IHRD+K  NLLM     +K+ADFG +             GT  ++ PE+I  + +D+K
Sbjct: 135 KVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKTHDEK 193
Query: 216 ADVFSFAIVLWELVTAKVPYDS 237
            D++   ++ +E +    P+DS
Sbjct: 194 VDLWCAGVLCYEFLVGMPPFDS 215

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 93/176 (52%), Gaps = 8/176 (4%)
Query: 67  KVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL 126
           KV++ + +  TL ++ +Q+      V    +V+   +   + +L +V EY PGG ++ +L
Sbjct: 79  KVVKLKQIEHTLNEKRIQQA-----VNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHL 133
Query: 127 HKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ 186
            +     + P    +A  I    EYLH  ++I+RDLK  NLL+D    +KVADFG A+  
Sbjct: 134 RRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK-- 190
Query: 187 NKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQ 242
              G      GT  ++APE+I  + Y++  D ++  ++++E+     P+ +  P+Q
Sbjct: 191 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 95/183 (51%), Gaps = 6/183 (3%)
Query: 56  RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE 115
           + V+ G+ V   +L   H  + +      E++I R + H++VV F G    +  + +V E
Sbjct: 40  KEVFAGKIVPKSLLLKPHQREKMS----MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 95
Query: 116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVV 175
                SL + LHK    L  P+   +   I  G +YLH+  +IHRDLK  NL ++    V
Sbjct: 96  LCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEV 154
Query: 176 KVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVP 234
           K+ DFG+A + +  G       GT  ++APEV++ + +  + DV+S   +++ L+  K P
Sbjct: 155 KIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
Query: 235 YDS 237
           +++
Sbjct: 215 FET 217

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 6/200 (3%)
Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNVVRFIG 102
           + +GS G   L + +  G   A+K+L  + +    + E  + E  IL+ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
           +   + +L +V EY PGG ++ +L +     + P    +A  I    EYLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 163 KTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFA 222
           K  NL++D    +KV DFG A+     G      GT  ++APE+I  + Y++  D ++  
Sbjct: 168 KPENLMIDQQGYIKVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 223 IVLWELVTAKVPYDSMTPLQ 242
           ++++E+     P+ +  P+Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 95/183 (51%), Gaps = 6/183 (3%)
Query: 56  RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE 115
           + V+ G+ V   +L   H  + +      E++I R + H++VV F G    +  + +V E
Sbjct: 46  KEVFAGKIVPKSLLLKPHQREKMS----MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 101
Query: 116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVV 175
                SL + LHK    L  P+   +   I  G +YLH+  +IHRDLK  NL ++    V
Sbjct: 102 LCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEV 160
Query: 176 KVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVP 234
           K+ DFG+A + +  G       GT  ++APEV++ + +  + DV+S   +++ L+  K P
Sbjct: 161 KIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 220
Query: 235 YDS 237
           +++
Sbjct: 221 FET 223

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 103/200 (51%), Gaps = 6/200 (3%)
Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNVVRFIG 102
           + +GS G   L + +  G   A+K+L  + +    + E  + E  IL+ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
           +   + +L +V EY+PGG ++ +L +     + P    +A  I    EYLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 163 KTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFA 222
           K  NLL+D    ++V DFG A+     G      GT  ++APE+I  + Y++  D ++  
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 223 IVLWELVTAKVPYDSMTPLQ 242
           ++++E+     P+ +  P+Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 95/183 (51%), Gaps = 6/183 (3%)
Query: 56  RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE 115
           + V+ G+ V   +L   H  + +      E++I R + H++VV F G    +  + +V E
Sbjct: 42  KEVFAGKIVPKSLLLKPHQREKMS----MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 97
Query: 116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVV 175
                SL + LHK    L  P+   +   I  G +YLH+  +IHRDLK  NL ++    V
Sbjct: 98  LCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEV 156
Query: 176 KVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVP 234
           K+ DFG+A + +  G       GT  ++APEV++ + +  + DV+S   +++ L+  K P
Sbjct: 157 KIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 216
Query: 235 YDS 237
           +++
Sbjct: 217 FET 219

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 105/200 (52%), Gaps = 6/200 (3%)
Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNVVRFIG 102
           + +GS G   L + +  G   A+K+L  + +    + E  + E  IL+ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
           +   + +L +V EY+PGG ++ +L +     + P    +A  I    EYLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 163 KTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFA 222
           K  NLL+D    ++V DFG A+ + KG       GT  ++APE+I  + Y++  D ++  
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK-RVKGRTWXL-CGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 223 IVLWELVTAKVPYDSMTPLQ 242
           ++++E+     P+ +  P+Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 95/183 (51%), Gaps = 6/183 (3%)
Query: 56  RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE 115
           + V+ G+ V   +L   H  + +      E++I R + H++VV F G    +  + +V E
Sbjct: 42  KEVFAGKIVPKSLLLKPHQREKMS----MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 97
Query: 116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVV 175
                SL + LHK    L  P+   +   I  G +YLH+  +IHRDLK  NL ++    V
Sbjct: 98  LCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEV 156
Query: 176 KVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVP 234
           K+ DFG+A + +  G       GT  ++APEV++ + +  + DV+S   +++ L+  K P
Sbjct: 157 KIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 216
Query: 235 YDS 237
           +++
Sbjct: 217 FET 219

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 105/200 (52%), Gaps = 6/200 (3%)
Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNVVRFIG 102
           + +GS G   L + +  G   A+K+L  + +    + E  + E  IL+ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
           +   + +L +V EY+PGG ++ +L +     + P    +A  I    EYLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 163 KTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFA 222
           K  NLL+D    ++V DFG A+ + KG       GT  ++APE+I  + Y++  D ++  
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK-RVKGRTWXL-CGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 223 IVLWELVTAKVPYDSMTPLQ 242
           ++++E+     P+ +  P+Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 103/200 (51%), Gaps = 6/200 (3%)
Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNVVRFIG 102
           + +GS G   L + +  G   A+K+L  + +    + E  + E  IL+ V    +V+   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
           +   + +L +V EY+PGG ++ +L +     + P    +A  I    EYLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 163 KTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFA 222
           K  NLL+D    ++V DFG A+     G      GT  ++APE+I  + Y++  D ++  
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 226
Query: 223 IVLWELVTAKVPYDSMTPLQ 242
           ++++E+     P+ +  P+Q
Sbjct: 227 VLIYEMAAGYPPFFADQPIQ 246

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 9/205 (4%)
Query: 44  ERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNV 97
           ERI +   G   R + +     G   A+K+L  + +    + E  + E  IL+ V    +
Sbjct: 37  ERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 96
Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
           V+   +   + +L +V EY+PGG ++ +L +     + P    +A  I    EYLH  ++
Sbjct: 97  VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE-PHARFYAAQIVLTFEYLHSLDL 155
Query: 158 IHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKAD 217
           I+RDLK  NLL+D    ++V DFG A+     G      GT  ++APE+I  + Y++  D
Sbjct: 156 IYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 213
Query: 218 VFSFAIVLWELVTAKVPYDSMTPLQ 242
            ++  ++++E+     P+ +  P+Q
Sbjct: 214 WWALGVLIYEMAAGYPPFFADQPIQ 238

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 95/183 (51%), Gaps = 6/183 (3%)
Query: 56  RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE 115
           + V+ G+ V   +L   H  + +      E++I R + H++VV F G    +  + +V E
Sbjct: 64  KEVFAGKIVPKSLLLKPHQREKMS----MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 119
Query: 116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVV 175
                SL + LHK    L  P+   +   I  G +YLH+  +IHRDLK  NL ++    V
Sbjct: 120 LCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEV 178
Query: 176 KVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVP 234
           K+ DFG+A + +  G       GT  ++APEV++ + +  + DV+S   +++ L+  K P
Sbjct: 179 KIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 238
Query: 235 YDS 237
           +++
Sbjct: 239 FET 241

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 108/216 (50%), Gaps = 20/216 (9%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDT-LEDEFV 83
           ED++I R L K       G  G+    VYL ++      +A+KVL    L    +E +  
Sbjct: 12  EDFDIGRPLGK-------GKFGN----VYLARERQSKFILALKVLFKTQLEKAGVEHQLR 60
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
           +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K  +     +   +  
Sbjct: 61  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SRFDEQRTATYIT 119
Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMA 203
           ++   + Y H + +IHRD+K  NLL+ ++  +K+ADFG +             GT  ++ 
Sbjct: 120 ELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWS-VHAPSSRRDTLCGTLDYLP 178
Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           PE+I  + +D+K D++S  ++ +E +    P+++ T
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHT 214

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 116/240 (48%), Gaps = 33/240 (13%)
Query: 35  IDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH 94
           + R  L+  E  A G  G +++   +   VAVK+     L D    +  +E+     ++H
Sbjct: 12  VPRGSLQLLEIKARGRFGCVWKAQLMNDFVAVKIFP---LQDKQSWQSEREIFSTPGMKH 68
Query: 95  RNVVRFIGASTKSPHL----CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGME 150
            N+++FI A  +  +L     ++T +   GSL DYL    N++   +L   A  + +G+ 
Sbjct: 69  ENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYL--KGNIITWNELCHVAETMSRGLS 126
Query: 151 YLHQR-----------NIIHRDLKTANLLMDTHNVVKVADFGVA-RFQ--NKGGVMTAET 196
           YLH+            +I HRD K+ N+L+ +     +ADFG+A RF+     G    + 
Sbjct: 127 YLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV 186
Query: 197 GTYRWMAPEVINHQPYDQ-----KADVFSFAIVLWELVT----AKVPYDS-MTPLQAALG 246
           GT R+MAPEV+      Q     + D+++  +VLWELV+    A  P D  M P +  +G
Sbjct: 187 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIG 246

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 95/183 (51%), Gaps = 6/183 (3%)
Query: 56  RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE 115
           + V+ G+ V   +L   H  + +      E++I R + H++VV F G    +  + +V E
Sbjct: 66  KEVFAGKIVPKSLLLKPHQREKMS----MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 121
Query: 116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVV 175
                SL + LHK    L  P+   +   I  G +YLH+  +IHRDLK  NL ++    V
Sbjct: 122 LCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEV 180
Query: 176 KVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVP 234
           K+ DFG+A + +  G       GT  ++APEV++ + +  + DV+S   +++ L+  K P
Sbjct: 181 KIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
Query: 235 YDS 237
           +++
Sbjct: 241 FET 243

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 72  DVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 130
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F         E  T  + APE+ +  + Y    D+
Sbjct: 131 DLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 190
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 191 WSLGCIFAEMVTRRALFPGDS 211

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 70  DVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 128
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F         E  T  + APE+ +  + Y    D+
Sbjct: 129 DLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 188
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 189 WSLGCIFAEMVTRRALFPGDS 209

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 9/205 (4%)
Query: 44  ERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNV 97
           ERI +   G   R + +     G   A+K+L  + +    + E  + E  IL+ V    +
Sbjct: 44  ERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103
Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
           V+   +   + +L +V EY+PGG ++ +L +     + P    +A  I    EYLH  ++
Sbjct: 104 VKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDL 162
Query: 158 IHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKAD 217
           I+RDLK  NLL+D    ++V DFG A+     G      GT  ++APE+I  + Y++  D
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 220
Query: 218 VFSFAIVLWELVTAKVPYDSMTPLQ 242
            ++  ++++E+     P+ +  P+Q
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 9/205 (4%)
Query: 44  ERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNV 97
           ERI +   G   R + +     G   A+K+L  + +    + E  + E  IL+ V    +
Sbjct: 44  ERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103
Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
           V+   +   + +L +V EY+PGG ++ +L +     + P    +A  I    EYLH  ++
Sbjct: 104 VKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDL 162
Query: 158 IHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKAD 217
           I+RDLK  NLL+D    ++V DFG A+     G      GT  ++APE+I  + Y++  D
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 220
Query: 218 VFSFAIVLWELVTAKVPYDSMTPLQ 242
            ++  ++++E+     P+ +  P+Q
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 9/205 (4%)
Query: 44  ERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNV 97
           ERI +   G   R + +     G   A+K+L  + +    + E  + E  IL+ V    +
Sbjct: 44  ERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103
Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
           V+   +   + +L +V EY+PGG ++ +L +     + P    +A  I    EYLH  ++
Sbjct: 104 VKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDL 162
Query: 158 IHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKAD 217
           I+RDLK  NLL+D    ++V DFG A+ + KG       GT  ++APE+I  + Y++  D
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWXL-CGTPEYLAPEIILSKGYNKAVD 220
Query: 218 VFSFAIVLWELVTAKVPYDSMTPLQ 242
            ++  ++++E+     P+ +  P+Q
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 9/205 (4%)
Query: 44  ERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNV 97
           ERI +   G   R + +     G   A+K+L  + +    + E  + E  IL+ V    +
Sbjct: 37  ERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 96
Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
           V+   +   + +L +V EY+PGG ++ +L +     + P    +A  I    EYLH  ++
Sbjct: 97  VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDL 155
Query: 158 IHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKAD 217
           I+RDLK  NLL+D    ++V DFG A+ + KG       GT  ++APE+I  + Y++  D
Sbjct: 156 IYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWXL-CGTPEYLAPEIILSKGYNKAVD 213
Query: 218 VFSFAIVLWELVTAKVPYDSMTPLQ 242
            ++  ++++E+     P+ +  P+Q
Sbjct: 214 WWALGVLIYEMAAGYPPFFADQPIQ 238

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 9/205 (4%)
Query: 44  ERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNV 97
           ERI +   G   R + +     G   A+K+L  + +    + E  + E  IL+ V    +
Sbjct: 65  ERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 124
Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
           V+   +   + +L +V EY+PGG ++ +L +     + P    +A  I    EYLH  ++
Sbjct: 125 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDL 183
Query: 158 IHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKAD 217
           I+RDLK  NLL+D    ++V DFG A+     G      GT  ++APE+I  + Y++  D
Sbjct: 184 IYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 241
Query: 218 VFSFAIVLWELVTAKVPYDSMTPLQ 242
            ++  ++++E+     P+ +  P+Q
Sbjct: 242 WWALGVLIYEMAAGYPPFFADQPIQ 266

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 9/205 (4%)
Query: 44  ERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNV 97
           ERI +   G   R + +     G   A+K+L  + +    + E  + E  IL+ V    +
Sbjct: 45  ERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 104
Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
           V+   +   + +L +V EY+PGG ++ +L +     + P    +A  I    EYLH  ++
Sbjct: 105 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDL 163
Query: 158 IHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKAD 217
           I+RDLK  NLL+D    ++V DFG A+     G      GT  ++APE+I  + Y++  D
Sbjct: 164 IYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 221
Query: 218 VFSFAIVLWELVTAKVPYDSMTPLQ 242
            ++  ++++E+     P+ +  P+Q
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 9/205 (4%)
Query: 44  ERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNV 97
           ERI +   G   R + +     G   A+K+L  + +    + E  + E  IL+ V    +
Sbjct: 45  ERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 104
Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
           V+   +   + +L +V EY+PGG ++ +L +     + P    +A  I    EYLH  ++
Sbjct: 105 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDL 163
Query: 158 IHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKAD 217
           I+RDLK  NLL+D    ++V DFG A+     G      GT  ++APE+I  + Y++  D
Sbjct: 164 IYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 221
Query: 218 VFSFAIVLWELVTAKVPYDSMTPLQ 242
            ++  ++++E+     P+ +  P+Q
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 9/205 (4%)
Query: 44  ERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNV 97
           ERI +   G   R + +     G   A+K+L  + +    + E  + E  IL+ V    +
Sbjct: 45  ERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 104
Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
           V+   +   + +L +V EY+PGG ++ +L +     + P    +A  I    EYLH  ++
Sbjct: 105 VKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDL 163
Query: 158 IHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKAD 217
           I+RDLK  NLL+D    ++V DFG A+     G      GT  ++APE+I  + Y++  D
Sbjct: 164 IYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 221
Query: 218 VFSFAIVLWELVTAKVPYDSMTPLQ 242
            ++  ++++E+     P+ +  P+Q
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 44  ERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNV 97
           ERI +   G   R + +     G   A+K+L  + +    + E  + E  IL+ V    +
Sbjct: 45  ERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 104
Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
           V+   +   + +L +V EY PGG ++ +L +     + P    +A  I    EYLH  ++
Sbjct: 105 VKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDL 163
Query: 158 IHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKAD 217
           I+RDLK  NL++D    +KV DFG A+     G      GT  ++APE+I  + Y++  D
Sbjct: 164 IYRDLKPENLMIDQQGYIKVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVD 221
Query: 218 VFSFAIVLWELVTAKVPYDSMTPLQ 242
            ++  ++++E+     P+ +  P+Q
Sbjct: 222 WWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 113/213 (53%), Gaps = 27/213 (12%)
Query: 37  RRLLKTGERIASGSCGDLY--RGVYLGQDVAVKVLRSE--HLNDTLEDEFVQEVAILREV 92
           R+     E + SG+  +++  +    G+  A+K ++      + +LE+E    +A+L+++
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENE----IAVLKKI 63
Query: 93  QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYD-------YLHKNHNVLKLPQLLRFAIDI 145
           +H N+V        + H  +V + + GG L+D       Y  K+ +++ + Q+L      
Sbjct: 64  KHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV-IQQVL------ 116
Query: 146 CKGMEYLHQRNIIHRDLKTANLLMDT---HNVVKVADFGVARFQNKGGVMTAETGTYRWM 202
              ++YLH+  I+HRDLK  NLL  T   ++ + + DFG+++ + + G+M+   GT  ++
Sbjct: 117 -SAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME-QNGIMSTACGTPGYV 174
Query: 203 APEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           APEV+  +PY +  D +S  ++ + L+    P+
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILLCGYPPF 207

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 101/200 (50%), Gaps = 6/200 (3%)
Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNVVRFIG 102
           + +GS G   L + +  G   A+K+L  + +    + E  + E  IL+ V    + +   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
           +   + +L +V EY PGG ++ +L +     + P    +A  I    EYLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXE-PHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 163 KTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFA 222
           K  NL++D    +KV DFG A+     G      GT  ++APE+I  + Y++  D ++  
Sbjct: 169 KPENLMIDQQGYIKVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 226
Query: 223 IVLWELVTAKVPYDSMTPLQ 242
           ++++E+     P+ +  P+Q
Sbjct: 227 VLIYEMAAGYPPFFADQPIQ 246

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 68  DVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 126
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F       T E  T  + APE+ +  + Y    D+
Sbjct: 127 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 186
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 187 WSLGCIFAEMVTRRALFPGDS 207

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 84.3 bits (207), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 105/216 (48%), Gaps = 26/216 (12%)
Query: 35  IDRRL---LKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           +D+R     K  E I SG  G +++  +        + R ++ N+  E    +EV  L +
Sbjct: 5   VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE----REVKALAK 60
Query: 92  VQHRNVVRFIG----------------ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKL 135
           + H N+V + G                + +K+  L I  E+   G+L  ++ K     KL
Sbjct: 61  LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-KL 119
Query: 136 PQLLRFAI--DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT 193
            ++L   +   I KG++Y+H + +I+RDLK +N+ +     VK+ DFG+       G   
Sbjct: 120 DKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRX 179
Query: 194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELV 229
              GT R+M+PE I+ Q Y ++ D+++  ++L EL+
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 84.3 bits (207), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 98/199 (49%), Gaps = 13/199 (6%)
Query: 46  IASGSCGDLYRGVYLGQD------VAVKVL-RSEHLNDTLEDEFVQEVAILREVQHRNVV 98
           +  G  G+    VYL ++      +A+KVL +S+   + +E +  +E+ I   ++H N++
Sbjct: 22  LGKGKFGN----VYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNIL 77
Query: 99  RFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNII 158
           R          + ++ E+ P G LY  L K H      +   F  ++   + Y H+R +I
Sbjct: 78  RMYNYFHDRKRIYLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVI 136
Query: 159 HRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADV 218
           HRD+K  NLLM     +K+ADFG +             GT  ++ PE+I  + +D+K D+
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDL 195
Query: 219 FSFAIVLWELVTAKVPYDS 237
           +   ++ +E +    P+DS
Sbjct: 196 WCAGVLCYEFLVGMPPFDS 214

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 84.3 bits (207), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 102/200 (51%), Gaps = 6/200 (3%)
Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNVVRFIG 102
           + +GS G   L + +  G   A+K+L  + +    + E  + E  IL+ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
           +   + +L +V EY PGG ++ +L +     + P    +A  I    EYLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 163 KTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFA 222
           K  NL++D    ++V DFG A+     G      GT  ++APE+I  + Y++  D ++  
Sbjct: 168 KPENLMIDQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 223 IVLWELVTAKVPYDSMTPLQ 242
           ++++E+     P+ +  P+Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 107/231 (46%), Gaps = 39/231 (16%)
Query: 33  WEIDRRL---LKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           + +D+R     K  E I SG  G +++  +        + R ++ N+  E    +EV  L
Sbjct: 4   YTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAE----REVKAL 59
Query: 90  REVQHRNVVRFIG-----------------------------ASTKSPHLCIVTEYMPGG 120
            ++ H N+V + G                             + +K+  L I  E+   G
Sbjct: 60  AKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKG 119
Query: 121 SLYDYLHKNHNVLKLPQLLRFAI--DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVA 178
           +L  ++ K     KL ++L   +   I KG++Y+H + +IHRDLK +N+ +     VK+ 
Sbjct: 120 TLEQWIEKRRGE-KLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIG 178
Query: 179 DFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELV 229
           DFG+       G  T   GT R+M+PE I+ Q Y ++ D+++  ++L EL+
Sbjct: 179 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 68  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 126
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F         E  T  + APE+ +  + Y    D+
Sbjct: 127 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 186
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 187 WSLGCIFAEMVTRRALFPGDS 207

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 69  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 127
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F         E  T  + APE+ +  + Y    D+
Sbjct: 128 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 187
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 188 WSLGCIFAEMVTRRALFPGDS 208

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 68  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 126
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F         E  T  + APE+ +  + Y    D+
Sbjct: 127 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 186
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 187 WSLGCIFAEMVTRRALFPGDS 207

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 69  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 127
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F         E  T  + APE+ +  + Y    D+
Sbjct: 128 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 187
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 188 WSLGCIFAEMVTRRALFPGDS 208

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 70  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 128
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F         E  T  + APE+ +  + Y    D+
Sbjct: 129 DLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 188
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 189 WSLGCIFAEMVTRRALFPGDS 209

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 69  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 127
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F         E  T  + APE+ +  + Y    D+
Sbjct: 128 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 187
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 188 WSLGCIFAEMVTRRALFPGDS 208

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 69  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 127
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F         E  T  + APE+ +  + Y    D+
Sbjct: 128 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 187
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 188 WSLGCIFAEMVTRRALFPGDS 208

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 72  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 130
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F         E  T  + APE+ +  + Y    D+
Sbjct: 131 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 190
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 191 WSLGCIFAEMVTRRALFPGDS 211

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 13  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 72
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 73  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 131
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F         E  T  + APE+ +  + Y    D+
Sbjct: 132 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 191
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 192 WSLGCIFAEMVTRRALFPGDS 212

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 71  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 129
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F         E  T  + APE+ +  + Y    D+
Sbjct: 130 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 189
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 190 WSLGCIFAEMVTRRALFPGDS 210

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+  +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 69  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 127
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F       T E  T  + APE+ +  + Y    D+
Sbjct: 128 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 187
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 188 WSLGCIFAEMVTRRALFPGDS 208

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+  +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 68  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 126
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F       T E  T  + APE+ +  + Y    D+
Sbjct: 127 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 186
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 187 WSLGCIFAEMVTRRALFPGDS 207

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 98/192 (51%), Gaps = 11/192 (5%)
Query: 51  CGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL 110
            G+ Y    L +   VK+ + EH         + E  IL+ V    +V+   +   + +L
Sbjct: 86  SGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNL 137
Query: 111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD 170
            +V EY+ GG ++ +L +     + P    +A  I    EYLH  ++I+RDLK  NLL+D
Sbjct: 138 YMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 196
Query: 171 THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
               ++V DFG A+ + KG   T   GT  ++APE+I  + Y++  D ++  ++++E+  
Sbjct: 197 QQGYIQVTDFGFAK-RVKGATWTL-CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 254
Query: 231 AKVPYDSMTPLQ 242
              P+ +  P+Q
Sbjct: 255 GYPPFFADQPIQ 266

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 101/200 (50%), Gaps = 6/200 (3%)
Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNVVRFIG 102
           + +GS G   L + +  G   A+K+L  + +    + E  + E  IL+ V    + +   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
           +   + +L +V EY PGG ++ +L +     + P    +A  I    EYLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 163 KTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFA 222
           K  NL++D    +KV DFG A+     G      GT  ++APE+I  + Y++  D ++  
Sbjct: 169 KPENLMIDQQGYIKVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 226
Query: 223 IVLWELVTAKVPYDSMTPLQ 242
           ++++E+     P+ +  P+Q
Sbjct: 227 VLIYEMAAGYPPFFADQPIQ 246

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 72  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 130
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F         E  T  + APE+ +  + Y    D+
Sbjct: 131 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 190
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 191 WSLGCIFAEMVTRRALFPGDS 211

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 71  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 129
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F         E  T  + APE+ +  + Y    D+
Sbjct: 130 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 189
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 190 WSLGCIFAEMVTRRALFPGDS 210

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 71  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 129
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F         E  T  + APE+ +  + Y    D+
Sbjct: 130 DLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 189
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 190 WSLGCIFAEMVTRRALFPGDS 210

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 70  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 128
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F         E  T  + APE+ +  + Y    D+
Sbjct: 129 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 188
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 189 WSLGCIFAEMVTRRALFPGDS 209

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 70  DVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 128
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F         E  T  + APE+ +  + Y    D+
Sbjct: 129 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 188
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 189 WSLGCIFAEMVTRRALFPGDS 209

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 103/200 (51%), Gaps = 6/200 (3%)
Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNVVRFIG 102
           + +GS G   L + +  G   A+K+L  + +    + E  + E  IL+ V    + +   
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
           +   + +L +V EY PGG ++ +L +     + P    +A  I    EYLH  ++I+RDL
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDL 168
Query: 163 KTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFA 222
           K  NL++D    +KV DFG A+ + KG       GT  ++APE+I  + Y++  D ++  
Sbjct: 169 KPENLMIDQQGYIKVTDFGFAK-RVKGRTWXL-CGTPEYLAPEIILSKGYNKAVDWWALG 226
Query: 223 IVLWELVTAKVPYDSMTPLQ 242
           ++++E+     P+ +  P+Q
Sbjct: 227 VLIYEMAAGYPPFFADQPIQ 246

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 44  ERIASGSCGDLYRGVYLGQDV--AVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E I  GS  +  R V+   ++  AVKV+     + + E E      +LR  QH N++   
Sbjct: 33  ETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEI-----LLRYGQHPNIITLK 87
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI-DICKGMEYLHQRNIIHR 160
                  H+ +VTE M GG L D + +     +  +   F +  I K +EYLH + ++HR
Sbjct: 88  DVYDDGKHVYLVTELMRGGELLDKILRQKFFSE--REASFVLHTIGKTVEYLHSQGVVHR 145
Query: 161 DLKTANLLM----DTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEVINHQPYDQK 215
           DLK +N+L          +++ DFG A+  + + G++     T  ++APEV+  Q YD+ 
Sbjct: 146 DLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEG 205
Query: 216 ADVFSFAIVLWELVTAKVPY 235
            D++S  I+L+ ++    P+
Sbjct: 206 CDIWSLGILLYTMLAGYTPF 225

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 72  DVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 130
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F         E  T  + APE+ +  + Y    D+
Sbjct: 131 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 190
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 191 WSLGCIFAEMVTRRALFPGDS 211

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 44  ERIASGSCGDLYRGVYLGQDV--AVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E I  GS  +  R V+   ++  AVKV+     + + E E      +LR  QH N++   
Sbjct: 33  ETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEI-----LLRYGQHPNIITLK 87
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI-DICKGMEYLHQRNIIHR 160
                  H+ +VTE M GG L D + +     +  +   F +  I K +EYLH + ++HR
Sbjct: 88  DVYDDGKHVYLVTELMRGGELLDKILRQKFFSE--REASFVLHTIGKTVEYLHSQGVVHR 145
Query: 161 DLKTANLLM----DTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEVINHQPYDQK 215
           DLK +N+L          +++ DFG A+  + + G++     T  ++APEV+  Q YD+ 
Sbjct: 146 DLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEG 205
Query: 216 ADVFSFAIVLWELVTAKVPY 235
            D++S  I+L+ ++    P+
Sbjct: 206 CDIWSLGILLYTMLAGYTPF 225

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 46  IASGSCG--DLYRGVYLGQDVAVKVL-RSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G   L R     + VAVK + R   +++ ++ E +      R ++H N+VRF  
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINH----RSLRHPNIVRFKE 83
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
                 HL I+ EY  GG LY+ +  N       +   F   +  G+ Y H   I HRDL
Sbjct: 84  VILTPTHLAIIMEYASGGELYERIC-NAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDL 142
Query: 163 KTANLLMDTHNV--VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQK-ADVF 219
           K  N L+D      +K+ DFG ++         +  GT  ++APEV+  Q YD K ADV+
Sbjct: 143 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVW 202
Query: 220 SFAIVLWELVTAKVPYD 236
           S  + L+ ++    P++
Sbjct: 203 SCGVTLYVMLVGAYPFE 219

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 83.6 bits (205), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 101/198 (51%), Gaps = 10/198 (5%)
Query: 44  ERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLND--TLEDEFVQEVAILREVQHRNVVR 99
           E + +G+ G ++R      G + A K + + H +D  T+  E +Q +++LR   H  +V 
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKE-IQTMSVLR---HPTLVN 218
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
              A      + ++ E+M GG L++ +   HN +   + + +   +CKG+ ++H+ N +H
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVH 278
Query: 160 RDLKTANLLMDTH--NVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKAD 217
            DLK  N++  T   N +K+ DFG+    +    +   TGT  + APEV   +P     D
Sbjct: 279 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTD 338
Query: 218 VFSFAIVLWELVTAKVPY 235
           ++S  ++ + L++   P+
Sbjct: 339 MWSVGVLSYILLSGLSPF 356

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 101/198 (51%), Gaps = 10/198 (5%)
Query: 44  ERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLND--TLEDEFVQEVAILREVQHRNVVR 99
           E + +G+ G ++R      G + A K + + H +D  T+  E +Q +++LR   H  +V 
Sbjct: 57  EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKE-IQTMSVLR---HPTLVN 112
Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
              A      + ++ E+M GG L++ +   HN +   + + +   +CKG+ ++H+ N +H
Sbjct: 113 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVH 172
Query: 160 RDLKTANLLMDTH--NVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKAD 217
            DLK  N++  T   N +K+ DFG+    +    +   TGT  + APEV   +P     D
Sbjct: 173 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTD 232
Query: 218 VFSFAIVLWELVTAKVPY 235
           ++S  ++ + L++   P+
Sbjct: 233 MWSVGVLSYILLSGLSPF 250

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 102/194 (52%), Gaps = 9/194 (4%)
Query: 46  IASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAS 104
           I  G  G +Y+GV   G  VA+K  R    +    +EF  E+  L   +H ++V  IG  
Sbjct: 47  IGHGVFGKVYKGVLRDGAKVALK--RRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 105 TKSPHLCIVTEYMPGGSLYDYLHKNH---NVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
            +   + ++ +YM  G+L  +L+ +      +   Q L   I   +G+ YLH R IIHRD
Sbjct: 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRD 164
Query: 162 LKTANLLMDTHNVVKVADFGVARFQNKGG---VMTAETGTYRWMAPEVINHQPYDQKADV 218
           +K+ N+L+D + V K+ DFG+++   + G   +     GT  ++ PE        +K+DV
Sbjct: 165 VKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDV 224
Query: 219 FSFAIVLWELVTAK 232
           +SF +VL+E++ A+
Sbjct: 225 YSFGVVLFEVLCAR 238

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 8/201 (3%)
Query: 44  ERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  R    G+ VA+K +R +   + +    ++E+++L+E+ H N+V+ +
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   L +V E++    L  ++  +    + LP +  +   + +G+ + H   ++HR
Sbjct: 72  DVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 130
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADV 218
           DLK  NLL++T   +K+ADFG+AR F         E  T  + APE+ +  + Y    D+
Sbjct: 131 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDI 190
Query: 219 FSFAIVLWELVT--AKVPYDS 237
           +S   +  E+VT  A  P DS
Sbjct: 191 WSLGCIFAEMVTRRALFPGDS 211

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 94/180 (52%), Gaps = 8/180 (4%)
Query: 61  GQDVAVKVLRSEHLNDTLEDEF---VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYM 117
           G+  A+K+L+ E +    +DE    + E  +L+  +H  +     +      LC V EY 
Sbjct: 176 GRYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 233
Query: 118 PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH-QRNIIHRDLKTANLLMDTHNVVK 176
            GG L+ +L +   V    +   +  +I   ++YLH ++N+++RDLK  NL++D    +K
Sbjct: 234 NGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIK 292
Query: 177 VADFGVARFQNK-GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           + DFG+ +   K G  M    GT  ++APEV+    Y +  D +   +V++E++  ++P+
Sbjct: 293 ITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 352

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 94/180 (52%), Gaps = 8/180 (4%)
Query: 61  GQDVAVKVLRSEHLNDTLEDEF---VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYM 117
           G+  A+K+L+ E +    +DE    + E  +L+  +H  +     +      LC V EY 
Sbjct: 34  GRYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 91
Query: 118 PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH-QRNIIHRDLKTANLLMDTHNVVK 176
            GG L+ +L +   V    +   +  +I   ++YLH ++N+++RDLK  NL++D    +K
Sbjct: 92  NGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIK 150
Query: 177 VADFGVARFQNK-GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           + DFG+ +   K G  M    GT  ++APEV+    Y +  D +   +V++E++  ++P+
Sbjct: 151 ITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 94/180 (52%), Gaps = 8/180 (4%)
Query: 61  GQDVAVKVLRSEHLNDTLEDEF---VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYM 117
           G+  A+K+L+ E +    +DE    + E  +L+  +H  +     +      LC V EY 
Sbjct: 33  GRYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 90
Query: 118 PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH-QRNIIHRDLKTANLLMDTHNVVK 176
            GG L+ +L +   V    +   +  +I   ++YLH ++N+++RDLK  NL++D    +K
Sbjct: 91  NGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIK 149
Query: 177 VADFGVARFQNK-GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           + DFG+ +   K G  M    GT  ++APEV+    Y +  D +   +V++E++  ++P+
Sbjct: 150 ITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 209

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 94/180 (52%), Gaps = 8/180 (4%)
Query: 61  GQDVAVKVLRSEHLNDTLEDEF---VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYM 117
           G+  A+K+L+ E +    +DE    + E  +L+  +H  +     +      LC V EY 
Sbjct: 173 GRYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 230
Query: 118 PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH-QRNIIHRDLKTANLLMDTHNVVK 176
            GG L+ +L +   V    +   +  +I   ++YLH ++N+++RDLK  NL++D    +K
Sbjct: 231 NGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIK 289
Query: 177 VADFGVARFQNK-GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           + DFG+ +   K G  M    GT  ++APEV+    Y +  D +   +V++E++  ++P+
Sbjct: 290 ITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 349

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 88/178 (49%), Gaps = 11/178 (6%)
Query: 63  DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSL 122
           + AVK++     + T E E      +LR  QH N++          ++ +VTE M GG L
Sbjct: 49  EFAVKIIDKSKRDPTEEIEI-----LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL 103
Query: 123 YDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM----DTHNVVKVA 178
            D + +        +       I K +EYLH + ++HRDLK +N+L          +++ 
Sbjct: 104 LDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRIC 162
Query: 179 DFGVAR-FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           DFG A+  + + G++     T  ++APEV+  Q YD   D++S  ++L+ ++T   P+
Sbjct: 163 DFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF 220

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 42/109 (38%), Positives = 65/109 (59%), Gaps = 4/109 (3%)
Query: 131 NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR--FQNK 188
           + L L  L+ ++  + KGME+L  R  IHRDL   N+L+   NVVK+ DFG+AR  +++ 
Sbjct: 186 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 245
Query: 189 GGVMTAETG-TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
             V   +     +WMAPE I  + Y  ++DV+SF ++LWE+ +    PY
Sbjct: 246 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 294

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 42/109 (38%), Positives = 65/109 (59%), Gaps = 4/109 (3%)
Query: 131 NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR--FQNK 188
           + L L  L+ ++  + KGME+L  R  IHRDL   N+L+   NVVK+ DFG+AR  +++ 
Sbjct: 188 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247
Query: 189 GGVMTAETG-TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
             V   +     +WMAPE I  + Y  ++DV+SF ++LWE+ +    PY
Sbjct: 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 296

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 94/180 (52%), Gaps = 8/180 (4%)
Query: 61  GQDVAVKVLRSEHLNDTLEDEF---VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYM 117
           G+  A+K+L+ E +    +DE    + E  +L+  +H  +     +      LC V EY 
Sbjct: 35  GRYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 92
Query: 118 PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH-QRNIIHRDLKTANLLMDTHNVVK 176
            GG L+ +L +   V    +   +  +I   ++YLH ++N+++RDLK  NL++D    +K
Sbjct: 93  NGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIK 151
Query: 177 VADFGVARFQNK-GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           + DFG+ +   K G  M    GT  ++APEV+    Y +  D +   +V++E++  ++P+
Sbjct: 152 ITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 211

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 42/109 (38%), Positives = 65/109 (59%), Gaps = 4/109 (3%)
Query: 131 NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR--FQNK 188
           + L L  L+ ++  + KGME+L  R  IHRDL   N+L+   NVVK+ DFG+AR  +++ 
Sbjct: 193 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 252
Query: 189 GGVMTAETG-TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
             V   +     +WMAPE I  + Y  ++DV+SF ++LWE+ +    PY
Sbjct: 253 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 301

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 42/109 (38%), Positives = 65/109 (59%), Gaps = 4/109 (3%)
Query: 131 NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR--FQNK 188
           + L L  L+ ++  + KGME+L  R  IHRDL   N+L+   NVVK+ DFG+AR  +++ 
Sbjct: 195 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 254
Query: 189 GGVMTAETG-TYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
             V   +     +WMAPE I  + Y  ++DV+SF ++LWE+ +    PY
Sbjct: 255 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 303

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 46  IASGSCG--DLYRGVYLGQDVAVKVL-RSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I +G+ G   L R     + VAVK + R E +++ ++ E +      R ++H N+VRF  
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINH----RSLRHPNIVRFKE 82
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
                 HL IV EY  GG L++ +  N       +   F   +  G+ Y H   + HRDL
Sbjct: 83  VILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYAHAMQVAHRDL 141
Query: 163 KTANLLMDTHNV--VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQK-ADVF 219
           K  N L+D      +K+ADFG ++         +  GT  ++APEV+  + YD K ADV+
Sbjct: 142 KLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKVADVW 201
Query: 220 SFAIVLWELVTAKVPYD 236
           S  + L+ ++    P++
Sbjct: 202 SCGVTLYVMLVGAYPFE 218

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 99/198 (50%), Gaps = 9/198 (4%)
Query: 46  IASGSCGDLYR-----GVYLGQDVAVKVLRSEHLNDTLED--EFVQEVAILREVQHRNVV 98
           +  G  G +++     G   G+  A+KVL+   +    +D      E  IL EV+H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 99  RFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNII 158
             I A      L ++ EY+ GG L+  L +    ++       A +I   + +LHQ+ II
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA-EISMALGHLHQKGII 143
Query: 159 HRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT-AETGTYRWMAPEVINHQPYDQKAD 217
           +RDLK  N++++    VK+ DFG+ +     G +T    GT  +MAPE++    +++  D
Sbjct: 144 YRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVD 203
Query: 218 VFSFAIVLWELVTAKVPY 235
            +S   ++++++T   P+
Sbjct: 204 WWSLGALMYDMLTGAPPF 221

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 99/198 (50%), Gaps = 9/198 (4%)
Query: 46  IASGSCGDLYR-----GVYLGQDVAVKVLRSEHLNDTLED--EFVQEVAILREVQHRNVV 98
           +  G  G +++     G   G+  A+KVL+   +    +D      E  IL EV+H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 99  RFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNII 158
             I A      L ++ EY+ GG L+  L +    ++       A +I   + +LHQ+ II
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA-EISMALGHLHQKGII 143
Query: 159 HRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAE-TGTYRWMAPEVINHQPYDQKAD 217
           +RDLK  N++++    VK+ DFG+ +     G +T    GT  +MAPE++    +++  D
Sbjct: 144 YRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRSGHNRAVD 203
Query: 218 VFSFAIVLWELVTAKVPY 235
            +S   ++++++T   P+
Sbjct: 204 WWSLGALMYDMLTGAPPF 221

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/170 (32%), Positives = 92/170 (54%), Gaps = 24/170 (14%)
Query: 80  DEFVQEVAILREVQHRNVVRFIGA--STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
           ++  QE+AIL+++ H NVV+ +         HL +V E +  G           V+++P 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP----------VMEVPT 130
Query: 138 L-------LRFAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA-RFQNK 188
           L        RF   D+ KG+EYLH + IIHRD+K +NLL+     +K+ADFGV+  F+  
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 189 GGVMTAETGTYRWMAPEVINH--QPYDQKA-DVFSFAIVLWELVTAKVPY 235
             +++   GT  +MAPE ++   + +  KA DV++  + L+  V  + P+
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 11/210 (5%)
Query: 46  IASGSCGDLYRGVYLGQDV--AVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA 103
           I  GS G++   V  G  +  A K +    + D   D F QE+ I++ + H N++R    
Sbjct: 34  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV--DRFKQEIEIMKSLDHPNIIRLYET 91
Query: 104 STKSPHLCIVTEYMPGGSLYD-YLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
              +  + +V E   GG L++  +HK   V +     R   D+   + Y H+ N+ HRDL
Sbjct: 92  FEDNTDIYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDL 149
Query: 163 KTANLLMDT---HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVF 219
           K  N L  T    + +K+ DFG+A     G +M  + GT  +++P+V+    Y  + D +
Sbjct: 150 KPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEW 208
Query: 220 SFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
           S  ++++ L+    P+ + T  +  L +R+
Sbjct: 209 SAGVMMYVLLCGYPPFSAPTDXEVMLKIRE 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 102/200 (51%), Gaps = 6/200 (3%)
Query: 46  IASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNVVRFIG 102
           + +GS G   L + +  G   A+K+L  + +    + E  + E  IL+ V    +V+   
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
           +   + +L +V EY+ GG ++ +L +     + P    +A  I    EYLH  ++I+RDL
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 163 KTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFA 222
           K  NLL+D    ++V DFG A+     G      GT  ++APE+I  + Y++  D ++  
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 223 IVLWELVTAKVPYDSMTPLQ 242
           ++++E+     P+ +  P+Q
Sbjct: 226 VLIYEMAAGYPPFFADQPIQ 245

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 11/210 (5%)
Query: 46  IASGSCGDLYRGVYLGQDV--AVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA 103
           I  GS G++   V  G  +  A K +    + D   D F QE+ I++ + H N++R    
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV--DRFKQEIEIMKSLDHPNIIRLYET 74
Query: 104 STKSPHLCIVTEYMPGGSLYD-YLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
              +  + +V E   GG L++  +HK   V +     R   D+   + Y H+ N+ HRDL
Sbjct: 75  FEDNTDIYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDL 132
Query: 163 KTANLLMDT---HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVF 219
           K  N L  T    + +K+ DFG+A     G +M  + GT  +++P+V+    Y  + D +
Sbjct: 133 KPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEW 191
Query: 220 SFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
           S  ++++ L+    P+ + T  +  L +R+
Sbjct: 192 SAGVMMYVLLCGYPPFSAPTDXEVMLKIRE 221

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 46  IASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA 103
           I  G  G++Y  R    G+  A+K L  + +     +       I+  +       FI  
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 104 STKSPH----LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            + + H    L  + + M GG L+ +L + H V     +  +A +I  G+E++H R +++
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 160 RDLKTANLLMDTHNVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQ-PYDQKAD 217
           RDLK AN+L+D H  V+++D G+A  F  K     A  GT+ +MAPEV+     YD  AD
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPEVLQKGVAYDSSAD 373
Query: 218 VFSFAIVLWELVTAKVPY 235
            FS   +L++L+    P+
Sbjct: 374 WFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 46  IASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA 103
           I  G  G++Y  R    G+  A+K L  + +     +       I+  +       FI  
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 104 STKSPH----LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            + + H    L  + + M GG L+ +L + H V     +  +A +I  G+E++H R +++
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 160 RDLKTANLLMDTHNVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQ-PYDQKAD 217
           RDLK AN+L+D H  V+++D G+A  F  K     A  GT+ +MAPEV+     YD  AD
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPEVLQKGVAYDSSAD 373
Query: 218 VFSFAIVLWELVTAKVPY 235
            FS   +L++L+    P+
Sbjct: 374 WFSLGCMLFKLLRGHSPF 391

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 96/191 (50%), Gaps = 4/191 (2%)
Query: 44  ERIASGSCGDLYRGVY-LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           E+I  G+ G +Y+     G+  A+K +R E  ++ +    ++E++IL+E++H N+V+   
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
                  L +V E++    L   L      L+      F + +  G+ Y H R ++HRDL
Sbjct: 68  VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDL 126
Query: 163 KTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEVI-NHQPYDQKADVFS 220
           K  NLL++    +K+ADFG+AR F       T E  T  + AP+V+   + Y    D++S
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWS 186
Query: 221 FAIVLWELVTA 231
              +  E+V  
Sbjct: 187 VGCIFAEMVNG 197

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 46  IASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA 103
           I  G  G++Y  R    G+  A+K L  + +     +       I+  +       FI  
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 104 STKSPH----LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            + + H    L  + + M GG L+ +L + H V     +  +A +I  G+E++H R +++
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVY 315
Query: 160 RDLKTANLLMDTHNVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQ-PYDQKAD 217
           RDLK AN+L+D H  V+++D G+A  F  K     A  GT+ +MAPEV+     YD  AD
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPEVLQKGVAYDSSAD 373
Query: 218 VFSFAIVLWELVTAKVPY 235
            FS   +L++L+    P+
Sbjct: 374 WFSLGCMLFKLLRGHSPF 391

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 96/191 (50%), Gaps = 4/191 (2%)
Query: 44  ERIASGSCGDLYRGVY-LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           E+I  G+ G +Y+     G+  A+K +R E  ++ +    ++E++IL+E++H N+V+   
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
                  L +V E++    L   L      L+      F + +  G+ Y H R ++HRDL
Sbjct: 68  VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDL 126
Query: 163 KTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEVI-NHQPYDQKADVFS 220
           K  NLL++    +K+ADFG+AR F       T E  T  + AP+V+   + Y    D++S
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWS 186
Query: 221 FAIVLWELVTA 231
              +  E+V  
Sbjct: 187 VGCIFAEMVNG 197

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 103/196 (52%), Gaps = 7/196 (3%)
Query: 44  ERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +++       + VA+K +R +  ++ +    ++E+ +L+E++H+N+VR  
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLR-FAIDICKGMEYLHQRNIIHR 160
                   L +V E+     L  Y    +  L  P++++ F   + KG+ + H RN++HR
Sbjct: 68  DVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLD-PEIVKSFLFQLLKGLGFCHSRNVLHR 125
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEVI-NHQPYDQKADV 218
           DLK  NLL++ +  +K+ADFG+AR F       +AE  T  +  P+V+   + Y    D+
Sbjct: 126 DLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185
Query: 219 FSFAIVLWELVTAKVP 234
           +S   +  EL  A  P
Sbjct: 186 WSAGCIFAELANAARP 201

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 96/197 (48%), Gaps = 11/197 (5%)
Query: 46  IASGSCG--DLYRGVYLGQDVAVKVL-RSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G   L R     + VAVK + R E +++ ++ E +      R ++H N+VRF  
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINH----RSLRHPNIVRFKE 81
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
                 HL IV EY  GG L++ +  N       +   F   +  G+ Y H   + HRDL
Sbjct: 82  VILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 140
Query: 163 KTANLLMDTHNV--VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQK-ADVF 219
           K  N L+D      +K+ DFG ++         +  GT  ++APEV+  + YD K ADV+
Sbjct: 141 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVW 200
Query: 220 SFAIVLWELVTAKVPYD 236
           S  + L+ ++    P++
Sbjct: 201 SCGVTLYVMLVGAYPFE 217

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 91/168 (54%), Gaps = 7/168 (4%)
Query: 73  HLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV 132
            +   + ++ ++E+ +L E     +V F GA      + I  E+M GGSL   L K    
Sbjct: 61  EIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-- 118
Query: 133 LKLPQ--LLRFAIDICKGMEYLHQRN-IIHRDLKTANLLMDTHNVVKVADFGVARFQNKG 189
            ++P+  L + +I + KG+ YL +++ I+HRD+K +N+L+++   +K+ DFGV+  Q   
Sbjct: 119 -RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLID 176
Query: 190 GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS 237
            +  +  GT  +M+PE +    Y  ++D++S  + L E+   + P  S
Sbjct: 177 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGS 224

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 46  IASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA 103
           I  G  G++Y  R    G+  A+K L  + +     +       I+  +       FI  
Sbjct: 196 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 255
Query: 104 STKSPH----LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            + + H    L  + + M GG L+ +L + H V     +  +A +I  G+E++H R +++
Sbjct: 256 MSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVY 314
Query: 160 RDLKTANLLMDTHNVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQ-PYDQKAD 217
           RDLK AN+L+D H  V+++D G+A  F  K     A  GT+ +MAPEV+     YD  AD
Sbjct: 315 RDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPEVLQKGVAYDSSAD 372
Query: 218 VFSFAIVLWELVTAKVPY 235
            FS   +L++L+    P+
Sbjct: 373 WFSLGCMLFKLLRGHSPF 390

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 96/191 (50%), Gaps = 4/191 (2%)
Query: 44  ERIASGSCGDLYRGVY-LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           E+I  G+ G +Y+     G+  A+K +R E  ++ +    ++E++IL+E++H N+V+   
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
                  L +V E++    L   L      L+      F + +  G+ Y H R ++HRDL
Sbjct: 68  VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDL 126
Query: 163 KTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEVI-NHQPYDQKADVFS 220
           K  NLL++    +K+ADFG+AR F       T E  T  + AP+V+   + Y    D++S
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWS 186
Query: 221 FAIVLWELVTA 231
              +  E+V  
Sbjct: 187 VGCIFAEMVNG 197

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 95/192 (49%), Gaps = 11/192 (5%)
Query: 51  CGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL 110
            G+ Y    L +   VK+ + EH         + E  IL+ V    +V+   +   + +L
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNL 116
Query: 111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD 170
            +V EY+ GG ++ +L +     + P    +A  I    EYLH  ++I+RDLK  NLL+D
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFXE-PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 171 THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
               ++V DFG A+     G      GT  ++APE+I  + Y++  D ++  ++++E+  
Sbjct: 176 QQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 231 AKVPYDSMTPLQ 242
              P+ +  P+Q
Sbjct: 234 GYPPFFADQPIQ 245

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 95/193 (49%), Gaps = 11/193 (5%)
Query: 50  SCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPH 109
             G+ Y    L +   VK+ + EH         + E  IL+ V    +V+   +   + +
Sbjct: 64  ESGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSN 115
Query: 110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM 169
           L +V EY+ GG ++ +L +     + P    +A  I    EYLH  ++I+RDLK  NLL+
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFXE-PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI 174
Query: 170 DTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELV 229
           D    ++V DFG A+     G      GT  ++APE+I  + Y++  D ++  ++++E+ 
Sbjct: 175 DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 230 TAKVPYDSMTPLQ 242
               P+ +  P+Q
Sbjct: 233 AGYPPFFADQPIQ 245

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 95/193 (49%), Gaps = 11/193 (5%)
Query: 50  SCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPH 109
             G+ Y    L +   VK+ + EH         + E  IL+ V    +V+   +   + +
Sbjct: 59  ESGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSN 110
Query: 110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM 169
           L +V EY+ GG ++ +L +     + P    +A  I    EYLH  ++I+RDLK  NLL+
Sbjct: 111 LYMVMEYVAGGEMFSHLRRIGRFXE-PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI 169
Query: 170 DTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELV 229
           D    ++V DFG A+     G      GT  ++APE+I  + Y++  D ++  ++++E+ 
Sbjct: 170 DQQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 227
Query: 230 TAKVPYDSMTPLQ 242
               P+ +  P+Q
Sbjct: 228 AGYPPFFADQPIQ 240

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 95/192 (49%), Gaps = 11/192 (5%)
Query: 51  CGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL 110
            G+ Y    L +   VK+ + EH         + E  IL+ V    +V+   +   + +L
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNL 116
Query: 111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD 170
            +V EY+ GG ++ +L +     + P    +A  I    EYLH  ++I+RDLK  NLL+D
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFXE-PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 171 THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
               ++V DFG A+     G      GT  ++APE+I  + Y++  D ++  ++++E+  
Sbjct: 176 QQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 231 AKVPYDSMTPLQ 242
              P+ +  P+Q
Sbjct: 234 GYPPFFADQPIQ 245

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 95/192 (49%), Gaps = 11/192 (5%)
Query: 51  CGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL 110
            G+ Y    L +   VK+ + EH         + E  IL+ V    +V+   +   + +L
Sbjct: 86  SGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNL 137
Query: 111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD 170
            +V EY+ GG ++ +L +     + P    +A  I    EYLH  ++I+RDLK  NLL+D
Sbjct: 138 YMVMEYVAGGEMFSHLRRIGRFXE-PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 196
Query: 171 THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
               ++V DFG A+     G      GT  ++APE+I  + Y++  D ++  ++++E+  
Sbjct: 197 QQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 254
Query: 231 AKVPYDSMTPLQ 242
              P+ +  P+Q
Sbjct: 255 GYPPFFADQPIQ 266

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 95/192 (49%), Gaps = 11/192 (5%)
Query: 51  CGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL 110
            G+ Y    L +   VK+ + EH         + E  IL+ V    +V+   +   + +L
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNL 116
Query: 111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD 170
            +V EY+ GG ++ +L +     + P    +A  I    EYLH  ++I+RDLK  NLL+D
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 171 THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
               ++V DFG A+     G      GT  ++APE+I  + Y++  D ++  ++++E+  
Sbjct: 176 QQGYIQVTDFGFAK--RVKGRTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 231 AKVPYDSMTPLQ 242
              P+ +  P+Q
Sbjct: 234 GYPPFFADQPIQ 245

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 17/198 (8%)
Query: 46  IASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAS 104
           I  G  G +Y+GV   G  VA+K  R    +    +EF  E+  L   +H ++V  IG  
Sbjct: 47  IGHGVFGKVYKGVLRDGAKVALK--RRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 105 TKSPHLCIVTEYMPGGSLYDYLHKNH---NVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
            +   + ++ +YM  G+L  +L+ +      +   Q L   I   +G+ YLH R IIHRD
Sbjct: 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRD 164
Query: 162 LKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET-------GTYRWMAPEVINHQPYDQ 214
           +K+ N+L+D + V K+ DFG++    K G    +T       GT  ++ PE        +
Sbjct: 165 VKSINILLDENFVPKITDFGIS----KKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTE 220
Query: 215 KADVFSFAIVLWELVTAK 232
           K+DV+SF +VL+E++ A+
Sbjct: 221 KSDVYSFGVVLFEVLCAR 238

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 95/192 (49%), Gaps = 11/192 (5%)
Query: 51  CGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL 110
            G+ Y    L +   VK+ + EH         + E  IL+ V    +V+   +   + +L
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNL 116
Query: 111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD 170
            +V EY+ GG ++ +L +     + P    +A  I    EYLH  ++I+RDLK  NLL+D
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFAE-PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 171 THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
               ++V DFG A+     G      GT  ++APE+I  + Y++  D ++  ++++E+  
Sbjct: 176 QQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 231 AKVPYDSMTPLQ 242
              P+ +  P+Q
Sbjct: 234 GYPPFFADQPIQ 245

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 16/217 (7%)
Query: 32  DWEIDRRLLKT---GERIASGSCGDLY-------RGVYLGQDVAVKVLRSEHLNDTLEDE 81
           D  +D R +K    G  +  G     Y       + V+ G+ V   +L   H  + +   
Sbjct: 33  DVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS-- 90
Query: 82  FVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF 141
              E+AI + + + +VV F G       + +V E     SL + LHK    +  P+   F
Sbjct: 91  --TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYF 147
Query: 142 AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA-RFQNKGGVMTAETGTYR 200
                +G++YLH   +IHRDLK  NL ++    VK+ DFG+A + +  G       GT  
Sbjct: 148 MRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPN 207
Query: 201 WMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS 237
           ++APEV+  + +  + D++S   +L+ L+  K P+++
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 244

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 111/224 (49%), Gaps = 12/224 (5%)
Query: 30  SEDWEIDRRLLKTGERIASGSCG--DLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVA 87
           ++++E+    L+    +  G+ G  +  R V  GQ +AVK +R+  +N   +   + ++ 
Sbjct: 43  NQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLD 101
Query: 88  I-LREVQHRNVVRFIGASTKSPHLCIVTEYMPGG--SLYDYLHKNHNVLKLPQLLRFAID 144
           I +R V     V F GA  +   + I  E M       Y  +      +    L + A+ 
Sbjct: 102 ISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVS 161
Query: 145 ICKGMEYLHQR-NIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMA 203
           I K +E+LH + ++IHRD+K +N+L++    VK+ DFG++ +       T + G   +MA
Sbjct: 162 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMA 221
Query: 204 PEVI----NHQPYDQKADVFSFAIVLWELVTAKVPYDSM-TPLQ 242
           PE I    N + Y  K+D++S  I + EL   + PYDS  TP Q
Sbjct: 222 PERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ 265

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 45/211 (21%), Positives = 108/211 (51%), Gaps = 8/211 (3%)
Query: 44  ERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLE-DEFV--QEVAILREVQHRNVVRF 100
           E + SG+ G ++R V   +    +V  ++ +N     D++    E++I+ ++ H  ++  
Sbjct: 57  EELGSGAFGVVHRCV---EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113
Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
             A      + ++ E++ GG L+D +      +   +++ +    C+G++++H+ +I+H 
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHL 173
Query: 161 DLKTANLLMDTHNV--VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADV 218
           D+K  N++ +T     VK+ DFG+A   N   ++   T T  + APE+++ +P     D+
Sbjct: 174 DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDM 233
Query: 219 FSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
           ++  ++ + L++   P+     L+    V++
Sbjct: 234 WAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 264

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 97/177 (54%), Gaps = 8/177 (4%)
Query: 65  AVKVLRSEHLNDTLEDEFVQ-EVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSL 122
           A+KV++ E +ND  + ++VQ E  +  +   H  +V           L  V EY+ GG L
Sbjct: 49  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 108
Query: 123 YDYLHKNHNVLKLPQL-LRF-AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADF 180
             ++ +     KLP+   RF + +I   + YLH+R II+RDLK  N+L+D+   +K+ D+
Sbjct: 109 MFHMQRQR---KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDY 165
Query: 181 GVARFQNKGGVMTAE-TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYD 236
           G+ +   + G  T+   GT  ++APE++  + Y    D ++  ++++E++  + P+D
Sbjct: 166 GMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 16/217 (7%)
Query: 32  DWEIDRRLLKT---GERIASGSCGDLY-------RGVYLGQDVAVKVLRSEHLNDTLEDE 81
           D  +D R +K    G  +  G     Y       + V+ G+ V   +L   H  + +   
Sbjct: 33  DVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS-- 90
Query: 82  FVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF 141
              E+AI + + + +VV F G       + +V E     SL + LHK    +  P+   F
Sbjct: 91  --TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYF 147
Query: 142 AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA-RFQNKGGVMTAETGTYR 200
                +G++YLH   +IHRDLK  NL ++    VK+ DFG+A + +  G       GT  
Sbjct: 148 MRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPN 207
Query: 201 WMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS 237
           ++APEV+  + +  + D++S   +L+ L+  K P+++
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 244

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 97/192 (50%), Gaps = 11/192 (5%)
Query: 51  CGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL 110
            G+ Y    L +   VK+ + EH         + E  IL+ V    +V+   +   + +L
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNL 116
Query: 111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD 170
            +V EY+ GG ++ +L +     + P    +A  I    EYLH  ++I+RDLK  NLL+D
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 171 THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
               ++V DFG A+ + KG       GT  ++APE+I  + Y++  D ++  ++++E+  
Sbjct: 176 QQGYIQVTDFGFAK-RVKGRTWXL-XGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 231 AKVPYDSMTPLQ 242
              P+ +  P+Q
Sbjct: 234 GYPPFFADQPIQ 245

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 97/192 (50%), Gaps = 11/192 (5%)
Query: 51  CGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL 110
            G+ Y    L +   VK+ + EH         + E  IL+ V    +V+   +   + +L
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNL 116
Query: 111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD 170
            +V EY+ GG ++ +L +     + P    +A  I    EYLH  ++I+RDLK  NLL+D
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 171 THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
               ++V DFG A+ + KG       GT  ++APE+I  + Y++  D ++  ++++E+  
Sbjct: 176 QQGYIQVTDFGFAK-RVKGRTWXL-CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 231 AKVPYDSMTPLQ 242
              P+ +  P+Q
Sbjct: 234 GYPPFFADEPIQ 245

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 95/192 (49%), Gaps = 11/192 (5%)
Query: 51  CGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL 110
            G+ Y    L +   VK+ + EH         + E  IL+ V    +V+   +   + +L
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNL 116
Query: 111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD 170
            +V EY+ GG ++ +L +     + P    +A  I    EYLH  ++I+RDLK  NLL+D
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 171 THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
               ++V DFG A+     G      GT  ++APE+I  + Y++  D ++  ++++E+  
Sbjct: 176 QQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 231 AKVPYDSMTPLQ 242
              P+ +  P+Q
Sbjct: 234 GYPPFFADQPIQ 245

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 95/192 (49%), Gaps = 11/192 (5%)
Query: 51  CGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL 110
            G+ Y    L +   VK+ + EH         + E  IL+ V    +V+   +   + +L
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNL 116
Query: 111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD 170
            +V EY+ GG ++ +L +     + P    +A  I    EYLH  ++I+RDLK  NLL+D
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 171 THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
               ++V DFG A+     G      GT  ++APE+I  + Y++  D ++  ++++E+  
Sbjct: 176 QQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 231 AKVPYDSMTPLQ 242
              P+ +  P+Q
Sbjct: 234 GYPPFFADQPIQ 245

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 95/192 (49%), Gaps = 11/192 (5%)
Query: 51  CGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL 110
            G+ Y    L +   VK+ + EH         + E  IL+ V    +V+   +   + +L
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNL 116
Query: 111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD 170
            +V EY+ GG ++ +L +     + P    +A  I    EYLH  ++I+RDLK  NLL+D
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 171 THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
               ++V DFG A+     G      GT  ++APE+I  + Y++  D ++  ++++E+  
Sbjct: 176 QQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 231 AKVPYDSMTPLQ 242
              P+ +  P+Q
Sbjct: 234 GYPPFFADQPIQ 245

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 95/192 (49%), Gaps = 11/192 (5%)
Query: 51  CGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL 110
            G+ Y    L +   VK+ + EH         + E  IL+ V    +V+   +   + +L
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNL 116
Query: 111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD 170
            +V EY+ GG ++ +L +     + P    +A  I    EYLH  ++I+RDLK  NLL+D
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 171 THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
               ++V DFG A+     G      GT  ++APE+I  + Y++  D ++  ++++E+  
Sbjct: 176 QQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 231 AKVPYDSMTPLQ 242
              P+ +  P+Q
Sbjct: 234 GYPPFFADQPIQ 245

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 97/192 (50%), Gaps = 11/192 (5%)
Query: 51  CGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL 110
            G+ Y    L +   VK+ + EH         + E  IL+ V    +V+   +   + +L
Sbjct: 52  SGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNL 103
Query: 111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD 170
            +V EY+ GG ++ +L +     + P    +A  I    EYLH  ++I+RDLK  NLL+D
Sbjct: 104 YMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 162
Query: 171 THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
               ++V DFG A+ + KG       GT  ++APE+I  + Y++  D ++  ++++E+  
Sbjct: 163 EQGYIQVTDFGFAK-RVKGRTWXL-CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 220
Query: 231 AKVPYDSMTPLQ 242
              P+ +  P+Q
Sbjct: 221 GYPPFFADQPIQ 232

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 16/217 (7%)
Query: 32  DWEIDRRLLKT---GERIASGSCGDLY-------RGVYLGQDVAVKVLRSEHLNDTLEDE 81
           D  +D R +K    G  +  G     Y       + V+ G+ V   +L   H  + +   
Sbjct: 17  DVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS-- 74
Query: 82  FVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF 141
              E+AI + + + +VV F G       + +V E     SL + LHK    +  P+   F
Sbjct: 75  --TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYF 131
Query: 142 AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA-RFQNKGGVMTAETGTYR 200
                +G++YLH   +IHRDLK  NL ++    VK+ DFG+A + +  G       GT  
Sbjct: 132 MRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPN 191
Query: 201 WMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS 237
           ++APEV+  + +  + D++S   +L+ L+  K P+++
Sbjct: 192 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 228

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 95/192 (49%), Gaps = 11/192 (5%)
Query: 51  CGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL 110
            G+ Y    L +   VK+ + EH         + E  IL+ V    +V+   +   + +L
Sbjct: 66  SGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNL 117
Query: 111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD 170
            +V EY+ GG ++ +L +     + P    +A  I    EYLH  ++I+RDLK  NLL+D
Sbjct: 118 YMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 176
Query: 171 THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
               ++V DFG A+     G      GT  ++APE+I  + Y++  D ++  ++++E+  
Sbjct: 177 QQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234
Query: 231 AKVPYDSMTPLQ 242
              P+ +  P+Q
Sbjct: 235 GYPPFFADQPIQ 246

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 97/177 (54%), Gaps = 8/177 (4%)
Query: 65  AVKVLRSEHLNDTLEDEFVQ-EVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSL 122
           A+KV++ E +ND  + ++VQ E  +  +   H  +V           L  V EY+ GG L
Sbjct: 34  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 93
Query: 123 YDYLHKNHNVLKLPQL-LRF-AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADF 180
             ++ +     KLP+   RF + +I   + YLH+R II+RDLK  N+L+D+   +K+ D+
Sbjct: 94  MFHMQRQR---KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDY 150
Query: 181 GVARFQNKGGVMTAE-TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYD 236
           G+ +   + G  T+   GT  ++APE++  + Y    D ++  ++++E++  + P+D
Sbjct: 151 GMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 21/203 (10%)
Query: 61  GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH-RNVVRFIGASTKSPHLCIVTEYMPG 119
           GQ+ A K L+          E + E+A+L   +    V+        +  + ++ EY  G
Sbjct: 54  GQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAG 113
Query: 120 GSLYDYLHKNHNVLKLPQL---------LRFAIDICKGMEYLHQRNIIHRDLKTANLLMD 170
           G ++         L LP+L         +R    I +G+ YLHQ NI+H DLK  N+L+ 
Sbjct: 114 GEIFS--------LCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLS 165
Query: 171 T---HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWE 227
           +      +K+ DFG++R       +    GT  ++APE++N+ P     D+++  I+ + 
Sbjct: 166 SIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYM 225
Query: 228 LVTAKVPYDSMTPLQAALGVRQV 250
           L+T   P+      +  L + QV
Sbjct: 226 LLTHTSPFVGEDNQETYLNISQV 248

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 16/217 (7%)
Query: 32  DWEIDRRLLKT---GERIASGSCGDLY-------RGVYLGQDVAVKVLRSEHLNDTLEDE 81
           D  +D R +K    G  +  G     Y       + V+ G+ V   +L   H  + +   
Sbjct: 33  DVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS-- 90
Query: 82  FVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF 141
              E+AI + + + +VV F G       + +V E     SL + LHK    +  P+   F
Sbjct: 91  --TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYF 147
Query: 142 AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA-RFQNKGGVMTAETGTYR 200
                +G++YLH   +IHRDLK  NL ++    VK+ DFG+A + +  G       GT  
Sbjct: 148 MRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPN 207
Query: 201 WMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS 237
           ++APEV+  + +  + D++S   +L+ L+  K P+++
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET 244

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 97/177 (54%), Gaps = 8/177 (4%)
Query: 65  AVKVLRSEHLNDTLEDEFVQ-EVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSL 122
           A+KV++ E +ND  + ++VQ E  +  +   H  +V           L  V EY+ GG L
Sbjct: 38  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 97
Query: 123 YDYLHKNHNVLKLPQL-LRF-AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADF 180
             ++ +     KLP+   RF + +I   + YLH+R II+RDLK  N+L+D+   +K+ D+
Sbjct: 98  MFHMQRQR---KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDY 154
Query: 181 GVARFQNKGGVMTAE-TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYD 236
           G+ +   + G  T+   GT  ++APE++  + Y    D ++  ++++E++  + P+D
Sbjct: 155 GMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 80.5 bits (197), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 90/165 (54%), Gaps = 7/165 (4%)
Query: 73  HLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV 132
            +   + ++ ++E+ +L E     +V F GA      + I  E+M GGSL   L K    
Sbjct: 42  EIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-- 99
Query: 133 LKLPQ--LLRFAIDICKGMEYLHQRN-IIHRDLKTANLLMDTHNVVKVADFGVARFQNKG 189
            ++P+  L + +I + KG+ YL +++ I+HRD+K +N+L+++   +K+ DFGV+  Q   
Sbjct: 100 -RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLID 157
Query: 190 GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVP 234
            +  +  GT  +M+PE +    Y  ++D++S  + L E+   + P
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 80.5 bits (197), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 90/165 (54%), Gaps = 7/165 (4%)
Query: 73  HLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV 132
            +   + ++ ++E+ +L E     +V F GA      + I  E+M GGSL   L K    
Sbjct: 42  EIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-- 99
Query: 133 LKLPQ--LLRFAIDICKGMEYLHQRN-IIHRDLKTANLLMDTHNVVKVADFGVARFQNKG 189
            ++P+  L + +I + KG+ YL +++ I+HRD+K +N+L+++   +K+ DFGV+  Q   
Sbjct: 100 -RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLID 157
Query: 190 GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVP 234
            +  +  GT  +M+PE +    Y  ++D++S  + L E+   + P
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 80.5 bits (197), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 90/165 (54%), Gaps = 7/165 (4%)
Query: 73  HLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV 132
            +   + ++ ++E+ +L E     +V F GA      + I  E+M GGSL   L K    
Sbjct: 42  EIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-- 99
Query: 133 LKLPQ--LLRFAIDICKGMEYLHQRN-IIHRDLKTANLLMDTHNVVKVADFGVARFQNKG 189
            ++P+  L + +I + KG+ YL +++ I+HRD+K +N+L+++   +K+ DFGV+  Q   
Sbjct: 100 -RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLID 157
Query: 190 GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVP 234
            +  +  GT  +M+PE +    Y  ++D++S  + L E+   + P
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 80.5 bits (197), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 90/164 (54%), Gaps = 5/164 (3%)
Query: 73  HLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV 132
            +   + ++ ++E+ +L E     +V F GA      + I  E+M GGSL   L K   +
Sbjct: 42  EIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI 101
Query: 133 LKLPQLL-RFAIDICKGMEYLHQRN-IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG 190
            +  Q+L + +I + KG+ YL +++ I+HRD+K +N+L+++   +K+ DFGV+  Q    
Sbjct: 102 PE--QILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDS 158
Query: 191 VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVP 234
           +  +  GT  +M+PE +    Y  ++D++S  + L E+   + P
Sbjct: 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 99/204 (48%), Gaps = 4/204 (1%)
Query: 40  LKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQ-EVAILREVQHRN 96
            K G  +  GS   +YR   ++ G +VA+K++  + +      + VQ EV I  +++H +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
           ++        S ++ +V E    G +  YL          +   F   I  GM YLH   
Sbjct: 73  ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG 132
Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQPYDQK 215
           I+HRDL  +NLL+  +  +K+ADFG+A + +          GT  +++PE+     +  +
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLE 192
Query: 216 ADVFSFAIVLWELVTAKVPYDSMT 239
           +DV+S   + + L+  + P+D+ T
Sbjct: 193 SDVWSLGCMFYTLLIGRPPFDTDT 216

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 95/192 (49%), Gaps = 11/192 (5%)
Query: 51  CGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL 110
            G+ Y    L +   VK+ + EH         + E  IL+ V    +V+   +   + +L
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNL 116
Query: 111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD 170
            +V EY+ GG ++ +L +     + P    +A  I    EYLH  ++I+RDLK  NL++D
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLIID 175
Query: 171 THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
               ++V DFG A+     G      GT  ++APE+I  + Y++  D ++  ++++E+  
Sbjct: 176 QQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAA 233
Query: 231 AKVPYDSMTPLQ 242
              P+ +  P+Q
Sbjct: 234 GYPPFFADQPIQ 245

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 90/165 (54%), Gaps = 7/165 (4%)
Query: 73  HLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV 132
            +   + ++ ++E+ +L E     +V F GA      + I  E+M GGSL   L K    
Sbjct: 69  EIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-- 126
Query: 133 LKLPQ--LLRFAIDICKGMEYLHQRN-IIHRDLKTANLLMDTHNVVKVADFGVARFQNKG 189
            ++P+  L + +I + KG+ YL +++ I+HRD+K +N+L+++   +K+ DFGV+  Q   
Sbjct: 127 -RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLID 184
Query: 190 GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVP 234
            +  +  GT  +M+PE +    Y  ++D++S  + L E+   + P
Sbjct: 185 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 97/177 (54%), Gaps = 8/177 (4%)
Query: 65  AVKVLRSEHLNDTLEDEFVQ-EVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSL 122
           A++V++ E +ND  + ++VQ E  +  +   H  +V           L  V EY+ GG L
Sbjct: 81  AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 140
Query: 123 YDYLHKNHNVLKLPQL-LRF-AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADF 180
             ++ +     KLP+   RF + +I   + YLH+R II+RDLK  N+L+D+   +K+ D+
Sbjct: 141 MFHMQRQR---KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDY 197
Query: 181 GVARFQNKGGVMTAE-TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYD 236
           G+ +   + G  T+   GT  ++APE++  + Y    D ++  ++++E++  + P+D
Sbjct: 198 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 90/163 (55%), Gaps = 5/163 (3%)
Query: 74  LNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVL 133
           +   + ++ ++E+ +L E     +V F GA      + I  E+M GGSL   L K   + 
Sbjct: 43  IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP 102
Query: 134 KLPQLL-RFAIDICKGMEYLHQRN-IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV 191
           +  Q+L + +I + KG+ YL +++ I+HRD+K +N+L+++   +K+ DFGV+  Q    +
Sbjct: 103 E--QILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSM 159
Query: 192 MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVP 234
             +  GT  +M+PE +    Y  ++D++S  + L E+   + P
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 80/154 (51%), Gaps = 16/154 (10%)
Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
           ++ RN V+ + A  K   L I  EY   G+LYD +H  +   +  +  R    I + + Y
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR------------FQNKGGV---MTAET 196
           +H + IIHRDLK  N+ +D    VK+ DFG+A+             QN  G    +T+  
Sbjct: 132 IHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
Query: 197 GTYRWMAPEVINHQP-YDQKADVFSFAIVLWELV 229
           GT  ++A EV++    Y++K D++S  I+ +E++
Sbjct: 192 GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 90/164 (54%), Gaps = 5/164 (3%)
Query: 73  HLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV 132
            +   + ++ ++E+ +L E     +V F GA      + I  E+M GGSL   L K   +
Sbjct: 104 EIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI 163
Query: 133 LKLPQLL-RFAIDICKGMEYLHQRN-IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG 190
            +  Q+L + +I + KG+ YL +++ I+HRD+K +N+L+++   +K+ DFGV+  Q    
Sbjct: 164 PE--QILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDS 220
Query: 191 VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVP 234
           +  +  GT  +M+PE +    Y  ++D++S  + L E+   + P
Sbjct: 221 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 95/179 (53%), Gaps = 9/179 (5%)
Query: 73  HLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV 132
            +   + ++ ++E+ +L E     +V F GA      + I  E+M GGSL   L +    
Sbjct: 52  EIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK-- 109
Query: 133 LKLPQ--LLRFAIDICKGMEYLHQRN-IIHRDLKTANLLMDTHNVVKVADFGVARFQNKG 189
            ++P+  L + +I + +G+ YL +++ I+HRD+K +N+L+++   +K+ DFGV+  Q   
Sbjct: 110 -RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLID 167
Query: 190 GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAK--VPYDSMTPLQAALG 246
            +  +  GT  +MAPE +    Y  ++D++S  + L EL   +  +P      L+A  G
Sbjct: 168 SMANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFG 226

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 100/208 (48%), Gaps = 19/208 (9%)
Query: 46  IASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF--I 101
           +  G+  +++RG +   G   A+KV  +      + D  ++E  +L+++ H+N+V+   I
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV-DVQMREFEVLKKLNHKNIVKLFAI 75
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ--LLRFAIDICKGMEYLHQRNIIH 159
              T + H  ++ E+ P GSLY  L +  N   LP+   L    D+  GM +L +  I+H
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVH 135
Query: 160 RDLKTANLLM----DTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI-------N 208
           R++K  N++     D  +V K+ DFG AR         +  GT  ++ P++        +
Sbjct: 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKD 195
Query: 209 HQ-PYDQKADVFSFAIVLWELVTAKVPY 235
           HQ  Y    D++S  +  +   T  +P+
Sbjct: 196 HQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 90/169 (53%), Gaps = 7/169 (4%)
Query: 74  LNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVL 133
           +   + ++ ++E+ +L E     +V F GA      + I  E+M GGSL   L K     
Sbjct: 46  IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--- 102
Query: 134 KLPQ--LLRFAIDICKGMEYLHQRN-IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG 190
           ++P+  L + +I + KG+ YL +++ I+HRD+K +N+L+++   +K+ DFGV+  Q    
Sbjct: 103 RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDE 161
Query: 191 VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           +     GT  +M+PE +    Y  ++D++S  + L E+   + P   M 
Sbjct: 162 MANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMA 210

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 95/192 (49%), Gaps = 11/192 (5%)
Query: 51  CGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL 110
            G+ Y    L +   VK+ + EH         + E  IL+ V    +V+   +   + +L
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNL 116
Query: 111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD 170
            +V EY+ GG ++ +L +     + P    +A  I    EYLH  ++I+RDLK  NLL+D
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 171 THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
               ++V DFG A+     G      GT  ++APE+I  + Y++  D ++  ++++++  
Sbjct: 176 QQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAA 233
Query: 231 AKVPYDSMTPLQ 242
              P+ +  P+Q
Sbjct: 234 GYPPFFADQPIQ 245

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 112/229 (48%), Gaps = 17/229 (7%)
Query: 23  AIESQTK-----SEDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLN 75
           +IES  K      + W+     LK    I  G+ G + + V+   GQ +AVK +RS  ++
Sbjct: 2   SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST-VD 60
Query: 76  DTLEDEFVQEV-AILREVQHRNVVRFIGASTKSPHLCIVTEYMPGG--SLYDYLHKN-HN 131
           +  + + + ++  ++R      +V+F GA  +     I  E M       Y Y++    +
Sbjct: 61  EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDD 120
Query: 132 VLKLPQLLRFAIDICKGMEYLHQR-NIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG 190
           V+    L +  +   K + +L +   IIHRD+K +N+L+D    +K+ DFG++       
Sbjct: 121 VIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI 180
Query: 191 VMTAETGTYRWMAPEVIN----HQPYDQKADVFSFAIVLWELVTAKVPY 235
             T + G   +MAPE I+     Q YD ++DV+S  I L+EL T + PY
Sbjct: 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY 229

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 103/196 (52%), Gaps = 7/196 (3%)
Query: 44  ERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +++       + VA+K +R +  ++ +    ++E+ +L+E++H+N+VR  
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLR-FAIDICKGMEYLHQRNIIHR 160
                   L +V E+     L  Y    +  L  P++++ F   + KG+ + H RN++HR
Sbjct: 68  DVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLD-PEIVKSFLFQLLKGLGFCHSRNVLHR 125
Query: 161 DLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEVI-NHQPYDQKADV 218
           DLK  NLL++ +  +K+A+FG+AR F       +AE  T  +  P+V+   + Y    D+
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185
Query: 219 FSFAIVLWELVTAKVP 234
           +S   +  EL  A  P
Sbjct: 186 WSAGCIFAELANAGRP 201

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 86/178 (48%), Gaps = 11/178 (6%)
Query: 63  DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSL 122
           + AVK++     + T E E      +LR  QH N++          ++ +VTE   GG L
Sbjct: 49  EFAVKIIDKSKRDPTEEIEI-----LLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGEL 103
Query: 123 YDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM----DTHNVVKVA 178
            D + +        +       I K +EYLH + ++HRDLK +N+L          +++ 
Sbjct: 104 LDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRIC 162
Query: 179 DFGVAR-FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           DFG A+  + + G++     T  ++APEV+  Q YD   D++S  ++L+  +T   P+
Sbjct: 163 DFGFAKQLRAENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPF 220

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 40  LKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNV 97
            K  E++ +G+   +Y+G+    G  VA+K ++ +    T     ++E+++++E++H N+
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT-PSTAIREISLMKELKHENI 65
Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLR------FAIDICKGMEY 151
           VR          L +V E+M    L  Y+  +  V   P+ L       F   + +G+ +
Sbjct: 66  VRLYDVIHTENKLTLVFEFM-DNDLKKYM-DSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEVI-NH 209
            H+  I+HRDLK  NLL++    +K+ DFG+AR F       ++E  T  + AP+V+   
Sbjct: 124 CHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGS 183
Query: 210 QPYDQKADVFSFAIVLWELVTAK 232
           + Y    D++S   +L E++T K
Sbjct: 184 RTYSTSIDIWSCGCILAEMITGK 206

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 46  IASGSCG--DLYRGVYLGQDVAVKVL-RSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G   L R     + VAVK + R E +   ++ E +      R ++H N+VRF  
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINH----RSLRHPNIVRFKE 82
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
                 HL IV EY  GG L++ +  N       +   F   +  G+ Y H   + HRDL
Sbjct: 83  VILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 141
Query: 163 KTANLLMDTHNV--VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQK-ADVF 219
           K  N L+D      +K+ DFG ++         +  GT  ++APEV+  + YD K ADV+
Sbjct: 142 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVW 201
Query: 220 SFAIVLWELVTAKVPYD 236
           S  + L+ ++    P++
Sbjct: 202 SCGVTLYVMLVGAYPFE 218

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 94/192 (48%), Gaps = 11/192 (5%)
Query: 51  CGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL 110
            G+ Y    L +   VK+ + EH         + E  IL+ V    +V+   +   + +L
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNL 116
Query: 111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD 170
            +V EY+ GG ++ +L +     + P    +A  I    EYLH  ++I+RDLK  NLL+D
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 171 THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
               ++V DFG A+     G      GT   +APE+I  + Y++  D ++  ++++E+  
Sbjct: 176 QQGYIQVTDFGFAK--RVKGRTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 231 AKVPYDSMTPLQ 242
              P+ +  P+Q
Sbjct: 234 GYPPFFADQPIQ 245

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 46  IASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF--I 101
           +  G+  +++RG +   G   A+KV  +      + D  ++E  +L+++ H+N+V+   I
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV-DVQMREFEVLKKLNHKNIVKLFAI 75
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ--LLRFAIDICKGMEYLHQRNIIH 159
              T + H  ++ E+ P GSLY  L +  N   LP+   L    D+  GM +L +  I+H
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVH 135
Query: 160 RDLKTANLLM----DTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI-------N 208
           R++K  N++     D  +V K+ DFG AR            GT  ++ P++        +
Sbjct: 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYERAVLRKD 195
Query: 209 HQ-PYDQKADVFSFAIVLWELVTAKVPY 235
           HQ  Y    D++S  +  +   T  +P+
Sbjct: 196 HQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 95/183 (51%), Gaps = 10/183 (5%)
Query: 82  FVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF 141
           F +E  I+       VV+   A     +L +V EYMPGG L + L  N++V +  +  +F
Sbjct: 122 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPE--KWAKF 178
Query: 142 -AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GT 198
              ++   ++ +H   +IHRD+K  N+L+D H  +K+ADFG     ++ G++  +T  GT
Sbjct: 179 YTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGT 238
Query: 199 YRWMAPEVINHQP----YDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL 254
             +++PEV+  Q     Y ++ D +S  + L+E++    P+ + + +     +     SL
Sbjct: 239 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL 298
Query: 255 CQP 257
           C P
Sbjct: 299 CFP 301

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 97/196 (49%), Gaps = 10/196 (5%)
Query: 56  RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAI-LREVQHRNVVRFIGASTKSPHLCIVT 114
           R V  GQ +AVK +R+  +N   +   + ++ I +R V     V F GA  +   + I  
Sbjct: 27  RHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85
Query: 115 EYMPGG--SLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR-NIIHRDLKTANLLMDT 171
           E M       Y  +      +    L + A+ I K +E+LH + ++IHRD+K +N+L++ 
Sbjct: 86  ELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA 145
Query: 172 HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI----NHQPYDQKADVFSFAIVLWE 227
              VK+ DFG++ +         + G   +MAPE I    N + Y  K+D++S  I + E
Sbjct: 146 LGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE 205
Query: 228 LVTAKVPYDSM-TPLQ 242
           L   + PYDS  TP Q
Sbjct: 206 LAILRFPYDSWGTPFQ 221

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 94/192 (48%), Gaps = 11/192 (5%)
Query: 51  CGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL 110
            G+ Y    L +   VK+ + EH         + E  IL+ V    +V+   +   + +L
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNL 116
Query: 111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD 170
            +V EY+ GG ++ +L +     + P    +A  I    EYLH  ++I+RDLK  NLL+D
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSE-PHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 171 THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
               ++V DFG A+     G      GT  ++AP +I  + Y++  D ++  ++++E+  
Sbjct: 176 QQGYIQVTDFGFAK--RVKGRTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 231 AKVPYDSMTPLQ 242
              P+ +  P+Q
Sbjct: 234 GYPPFFADQPIQ 245

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 91/168 (54%), Gaps = 14/168 (8%)
Query: 78  LEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLP 136
           L +  ++EV ILR+V  H N+++       +    +V + M  G L+DYL +   + +  
Sbjct: 66  LREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKE 125
Query: 137 --QLLRFAID-ICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT 193
             +++R  ++ IC     LH+ NI+HRDLK  N+L+D    +K+ DFG +   + G  + 
Sbjct: 126 TRKIMRALLEVICA----LHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR 181
Query: 194 AETGTYRWMAPEVI------NHQPYDQKADVFSFAIVLWELVTAKVPY 235
           +  GT  ++APE+I      NH  Y ++ D++S  ++++ L+    P+
Sbjct: 182 SVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 46  IASGSCG--DLYRGVYLGQDVAVKVL-RSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G   L R     + VAVK + R E +++ ++ E +      R ++H N+VRF  
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINH----RSLRHPNIVRFKE 82
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
                 HL IV EY  GG L++ +  N       +   F   +  G+ Y H   + HRDL
Sbjct: 83  VILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 141
Query: 163 KTANLLMDTHNV--VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQK-ADVF 219
           K  N L+D      +K+  FG ++         +  GT  ++APEV+  + YD K ADV+
Sbjct: 142 KLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVW 201
Query: 220 SFAIVLWELVTAKVPYD 236
           S  + L+ ++    P++
Sbjct: 202 SCGVTLYVMLVGAYPFE 218

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 101/200 (50%), Gaps = 6/200 (3%)
Query: 44  ERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           +++  G+   +Y+G     D  VA+K +R EH  +      ++EV++L++++H N+V   
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLH 66
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
                   L +V EY+    L  YL    N++ +  +  F   + +G+ Y H++ ++HRD
Sbjct: 67  DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRD 125
Query: 162 LKTANLLMDTHNVVKVADFGVARFQN-KGGVMTAETGTYRWMAPEV-INHQPYDQKADVF 219
           LK  NLL++    +K+ADFG+AR ++        E  T  +  P++ +    Y  + D++
Sbjct: 126 LKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMW 185
Query: 220 SFAIVLWELVTAKVPYDSMT 239
               + +E+ T +  +   T
Sbjct: 186 GVGCIFYEMATGRPLFPGST 205

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 90/185 (48%), Gaps = 10/185 (5%)
Query: 61  GQDVAVKVLRSEHLNDTL---EDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYM 117
           GQ  AVK++       +     ++  +E +I   ++H ++V  +   +    L +V E+M
Sbjct: 49  GQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFM 108
Query: 118 PGGSLYDYLHKNHN---VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM---DT 171
            G  L   + K  +   V        +   I + + Y H  NIIHRD+K  N+L+   + 
Sbjct: 109 DGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPENVLLASKEN 168
Query: 172 HNVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
              VK+ DFGVA +    G V     GT  +MAPEV+  +PY +  DV+   ++L+ L++
Sbjct: 169 SAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS 228
Query: 231 AKVPY 235
             +P+
Sbjct: 229 GCLPF 233

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 90/168 (53%), Gaps = 14/168 (8%)
Query: 78  LEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLP 136
           L +  ++EV ILR+V  H N+++       +    +V + M  G L+DYL +   + +  
Sbjct: 53  LREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKE 112
Query: 137 --QLLRFAID-ICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT 193
             +++R  ++ IC     LH+ NI+HRDLK  N+L+D    +K+ DFG +   + G  + 
Sbjct: 113 TRKIMRALLEVICA----LHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR 168
Query: 194 AETGTYRWMAPEVI------NHQPYDQKADVFSFAIVLWELVTAKVPY 235
              GT  ++APE+I      NH  Y ++ D++S  ++++ L+    P+
Sbjct: 169 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 90/168 (53%), Gaps = 14/168 (8%)
Query: 78  LEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLP 136
           L +  ++EV ILR+V  H N+++       +    +V + M  G L+DYL +   + +  
Sbjct: 66  LREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKE 125
Query: 137 --QLLRFAID-ICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT 193
             +++R  ++ IC     LH+ NI+HRDLK  N+L+D    +K+ DFG +   + G  + 
Sbjct: 126 TRKIMRALLEVICA----LHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR 181
Query: 194 AETGTYRWMAPEVI------NHQPYDQKADVFSFAIVLWELVTAKVPY 235
              GT  ++APE+I      NH  Y ++ D++S  ++++ L+    P+
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 96/196 (48%), Gaps = 12/196 (6%)
Query: 46  IASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA 103
           I SG+ G +       LG +VAVK L     N T      +E+ +L+ V H+N++  +  
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 89
Query: 104 STKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
            T    L       +V E M   +L   +H   +  ++  LL     +  G+++LH   I
Sbjct: 90  FTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLL---YQMLCGIKHLHSAGI 145
Query: 158 IHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKAD 217
           IHRDLK +N+++ +   +K+ DFG+AR  +   +MT    T  + APEVI    Y +  D
Sbjct: 146 IHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMGYKENVD 205
Query: 218 VFSFAIVLWELVTAKV 233
           ++S   ++ ELV   V
Sbjct: 206 IWSVGCIMGELVKGSV 221

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 85/161 (52%), Gaps = 10/161 (6%)
Query: 82  FVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF 141
           F +E  I+       VV+   A     +L +V EYMPGG L + L  N++V +  +  RF
Sbjct: 121 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPE--KWARF 177
Query: 142 -AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GT 198
              ++   ++ +H    IHRD+K  N+L+D    +K+ADFG     NK G++  +T  GT
Sbjct: 178 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 237
Query: 199 YRWMAPEVINHQP----YDQKADVFSFAIVLWELVTAKVPY 235
             +++PEV+  Q     Y ++ D +S  + L+E++    P+
Sbjct: 238 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 85/161 (52%), Gaps = 10/161 (6%)
Query: 82  FVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF 141
           F +E  I+       VV+   A     +L +V EYMPGG L + L  N++V +  +  RF
Sbjct: 116 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPE--KWARF 172
Query: 142 -AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GT 198
              ++   ++ +H    IHRD+K  N+L+D    +K+ADFG     NK G++  +T  GT
Sbjct: 173 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 232
Query: 199 YRWMAPEVINHQP----YDQKADVFSFAIVLWELVTAKVPY 235
             +++PEV+  Q     Y ++ D +S  + L+E++    P+
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 85/161 (52%), Gaps = 10/161 (6%)
Query: 82  FVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF 141
           F +E  I+       VV+   A     +L +V EYMPGG L + L  N++V +  +  RF
Sbjct: 121 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPE--KWARF 177
Query: 142 -AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GT 198
              ++   ++ +H    IHRD+K  N+L+D    +K+ADFG     NK G++  +T  GT
Sbjct: 178 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 237
Query: 199 YRWMAPEVINHQP----YDQKADVFSFAIVLWELVTAKVPY 235
             +++PEV+  Q     Y ++ D +S  + L+E++    P+
Sbjct: 238 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 46  IASGSCG--DLYRGVYLGQDVAVKVL-RSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G   L R     + VAVK + R E +++ ++ E +      R ++H N+VRF  
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINH----RSLRHPNIVRFKE 82
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
                 HL IV EY  GG L++ +  N       +   F   +  G+ Y H   + HRDL
Sbjct: 83  VILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 141
Query: 163 KTANLLMDTHNV--VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQK-ADVF 219
           K  N L+D      +K+  FG ++            GT  ++APEV+  + YD K ADV+
Sbjct: 142 KLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKVADVW 201
Query: 220 SFAIVLWELVTAKVPYD 236
           S  + L+ ++    P++
Sbjct: 202 SCGVTLYVMLVGAYPFE 218

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 97/179 (54%), Gaps = 7/179 (3%)
Query: 62  QDVAVKVLRSEH---LNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMP 118
           Q VA+K ++  H     D +    ++E+ +L+E+ H N++  + A     ++ +V ++M 
Sbjct: 36  QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM- 94
Query: 119 GGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVA 178
              L   +  N  VL    +  + +   +G+EYLHQ  I+HRDLK  NLL+D + V+K+A
Sbjct: 95  ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLA 154
Query: 179 DFGVAR-FQNKGGVMTAETGTYRWMAPEVI-NHQPYDQKADVFSFAIVLWELVTAKVPY 235
           DFG+A+ F +       +  T  + APE++   + Y    D+++   +L EL+  +VP+
Sbjct: 155 DFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPF 212

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 97/188 (51%), Gaps = 14/188 (7%)
Query: 61  GQDVAVKVLR--SEHLN----DTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHLCIV 113
           G + AVK++   +E L+    + + +   +E  ILR+V  H +++  I +   S  + +V
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN 173
            + M  G L+DYL +    L   +       + + + +LH  NI+HRDLK  N+L+D + 
Sbjct: 179 FDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM 237
Query: 174 VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN------HQPYDQKADVFSFAIVLWE 227
            ++++DFG +     G  +    GT  ++APE++       H  Y ++ D+++  ++L+ 
Sbjct: 238 QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFT 297
Query: 228 LVTAKVPY 235
           L+    P+
Sbjct: 298 LLAGSPPF 305

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 86/160 (53%), Gaps = 13/160 (8%)
Query: 83  VQEVAILREVQHRNVV---RFIGAST--KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
           ++E+ IL   +H N++     I A T  +   + +VT  M G  LY  L   H  L    
Sbjct: 89  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQH--LSNDH 145
Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG----GVMT 193
           +  F   I +G++Y+H  N++HRDLK +NLL++T   +K+ DFG+AR  +      G +T
Sbjct: 146 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 205
Query: 194 AETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
               T  + APE+ +N + Y +  D++S   +L E+++ +
Sbjct: 206 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 79/154 (51%), Gaps = 16/154 (10%)
Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
           ++ RN V+ + A  K   L I  EY    +LYD +H  +   +  +  R    I + + Y
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR------------FQNKGGV---MTAET 196
           +H + IIHRDLK  N+ +D    VK+ DFG+A+             QN  G    +T+  
Sbjct: 132 IHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
Query: 197 GTYRWMAPEVINHQP-YDQKADVFSFAIVLWELV 229
           GT  ++A EV++    Y++K D++S  I+ +E++
Sbjct: 192 GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 110/242 (45%), Gaps = 44/242 (18%)
Query: 40  LKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
           LK  E I  G  G +Y+G    + VAVKV    +  + + ++ +  V ++   +H N+ R
Sbjct: 15  LKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLM---EHDNIAR 71
Query: 100 FI------GASTKSPHLCIVTEYMPGGSLYDYL--HKNHNVLKLPQLLRFAIDICKGMEY 151
           FI       A  +  +L +V EY P GSL  YL  H +  V       R A  + +G+ Y
Sbjct: 72  FIVGDERVTADGRMEYL-LVMEYYPNGSLXKYLSLHTSDWV----SSCRLAHSVTRGLAY 126
Query: 152 LH---------QRNIIHRDLKTANLLMDTHNVVKVADFGVA---------RFQNKGGVMT 193
           LH         +  I HRDL + N+L+       ++DFG++         R   +     
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 194 AETGTYRWMAPEVI-------NHQPYDQKADVFSFAIVLWELV---TAKVPYDSMTPLQA 243
           +E GT R+MAPEV+       + +   ++ D+++  ++ WE+    T   P +S+   Q 
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246
Query: 244 AL 245
           A 
Sbjct: 247 AF 248

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 11/208 (5%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+ R + +  + + SG+ G +   V    G  VA+K L     ++       +E+ +L+
Sbjct: 21  WEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK 79
Query: 91  EVQHRNVVRFIGASTKSPHLCIVTEY---MP-GGSLYDYLHKNHNVLKLPQLLRFAIDIC 146
            ++H NV+  +   T    L   T++   MP  G+    L K H  L   ++      + 
Sbjct: 80  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQML 138
Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEV 206
           KG+ Y+H   IIHRDLK  NL ++    +K+ DFG+AR  +        T  YR  APEV
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTRWYR--APEV 196
Query: 207 I-NHQPYDQKADVFSFAIVLWELVTAKV 233
           I N   Y Q  D++S   ++ E++T K 
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGKT 224

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 46  IASGSCGDL---YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G +   Y  V L ++VA+K L     N T      +E+ +++ V H+N++  + 
Sbjct: 32  IGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLN 90
Query: 103 ASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
             T    L       +V E M   +L   +    +  ++  LL     +  G+++LH   
Sbjct: 91  VFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYLL---YQMLXGIKHLHSAG 146
Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKA 216
           IIHRDLK +N+++ +   +K+ DFG+AR      +MT    T  + APEVI    Y +  
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 217 DVFSFAIVLWELVTAKV 233
           D++S   ++ E+V  K+
Sbjct: 207 DIWSVGCIMGEMVRHKI 223

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 13/199 (6%)
Query: 46  IASGSCGDLYRGVYL---GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ---HRNVVR 99
           I  G+ G +++   L   G+ VA+K +R +   + +    ++EVA+LR ++   H NVVR
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 100 FIGAST-----KSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDICKGMEYLH 153
                T     +   L +V E++    L  YL K     +    +      + +G+++LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYD 213
              ++HRDLK  N+L+ +   +K+ADFG+AR  +    +T+   T  + APEV+    Y 
Sbjct: 138 SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYA 197
Query: 214 QKADVFSFAIVLWELVTAK 232
              D++S   +  E+   K
Sbjct: 198 TPVDLWSVGCIFAEMFRRK 216

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 13/199 (6%)
Query: 46  IASGSCGDLYRGVYL---GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ---HRNVVR 99
           I  G+ G +++   L   G+ VA+K +R +   + +    ++EVA+LR ++   H NVVR
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 100 FIGAST-----KSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDICKGMEYLH 153
                T     +   L +V E++    L  YL K     +    +      + +G+++LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYD 213
              ++HRDLK  N+L+ +   +K+ADFG+AR  +    +T+   T  + APEV+    Y 
Sbjct: 138 SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYA 197
Query: 214 QKADVFSFAIVLWELVTAK 232
              D++S   +  E+   K
Sbjct: 198 TPVDLWSVGCIFAEMFRRK 216

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 13/199 (6%)
Query: 46  IASGSCGDLYRGVYL---GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ---HRNVVR 99
           I  G+ G +++   L   G+ VA+K +R +   + +    ++EVA+LR ++   H NVVR
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 100 FIGAST-----KSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDICKGMEYLH 153
                T     +   L +V E++    L  YL K     +    +      + +G+++LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYD 213
              ++HRDLK  N+L+ +   +K+ADFG+AR  +    +T+   T  + APEV+    Y 
Sbjct: 138 SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYA 197
Query: 214 QKADVFSFAIVLWELVTAK 232
              D++S   +  E+   K
Sbjct: 198 TPVDLWSVGCIFAEMFRRK 216

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 95/191 (49%), Gaps = 20/191 (10%)
Query: 62  QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHLCIVTEYMPGG 120
           Q+ AVK++  E     +     +EV +L + Q HRNV+  I    +     +V E M GG
Sbjct: 39  QEYAVKII--EKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGG 96
Query: 121 SLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN---VVKV 177
           S+  ++HK  +  +L   +    D+   +++LH + I HRDLK  N+L +  N    VK+
Sbjct: 97  SILSHIHKRRHFNELEASV-VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKI 155
Query: 178 ADFGVARFQNKGG----VMTAE----TGTYRWMAPEVI-----NHQPYDQKADVFSFAIV 224
            DFG+       G    + T E     G+  +MAPEV+         YD++ D++S  ++
Sbjct: 156 CDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215
Query: 225 LWELVTAKVPY 235
           L+ L++   P+
Sbjct: 216 LYILLSGYPPF 226

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 24/202 (11%)
Query: 46  IASGSCGDL---YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G +   Y  V L ++VA+K L     N T      +E+ +++ V H+N++  + 
Sbjct: 32  IGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLN 90
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAID-----------ICKGMEY 151
             T    L    E+     + + +  N     L Q+++  +D           +C G+++
Sbjct: 91  VFTPQKTL---EEFQDVYLVMELMDAN-----LXQVIQMELDHERMSYLLYQMLC-GIKH 141
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQP 211
           LH   IIHRDLK +N+++ +   +K+ DFG+AR      +MT    T  + APEVI    
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 212 YDQKADVFSFAIVLWELVTAKV 233
           Y +  D++S   ++ E+V  K+
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKI 223

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 84/166 (50%), Gaps = 11/166 (6%)
Query: 80  DEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDY------LHKNHNVL 133
           D+F  E+ I+ ++++   +   G  T    + I+ EYM   S+  +      L KN+   
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 134 KLPQLLRFAI-DICKGMEYLH-QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV 191
              Q+++  I  +     Y+H ++NI HRD+K +N+LMD +  VK++DFG + +     +
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 192 MTAETGTYRWMAPEVI-NHQPYD-QKADVFSFAIVLWELVTAKVPY 235
                GTY +M PE   N   Y+  K D++S  I L+ +    VP+
Sbjct: 208 -KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 24/202 (11%)
Query: 46  IASGSCGDL---YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G +   Y  V L ++VA+K L     N T      +E+ +++ V H+N++  + 
Sbjct: 32  IGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLN 90
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAID-----------ICKGMEY 151
             T    L    E+     + + +  N     L Q+++  +D           +C G+++
Sbjct: 91  VFTPQKTL---EEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQMLC-GIKH 141
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQP 211
           LH   IIHRDLK +N+++ +   +K+ DFG+AR      +MT    T  + APEVI    
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 212 YDQKADVFSFAIVLWELVTAKV 233
           Y +  D++S   ++ E+V  K+
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKI 223

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 94/188 (50%), Gaps = 17/188 (9%)
Query: 58  VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYM 117
           V  GQ+ A K++ ++ L+     +  +E  I R ++H N+VR   + ++  H  ++ + +
Sbjct: 44  VLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLV 103
Query: 118 PGGSLY------DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT 171
            GG L+      +Y  +      + Q+L   +       + HQ  ++HRDLK  NLL+ +
Sbjct: 104 TGGELFEDIVAREYYSEADASHCIQQILEAVL-------HCHQMGVVHRDLKPENLLLAS 156
Query: 172 H---NVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWE 227
                 VK+ADFG+A   + +        GT  +++PEV+   PY +  D+++  ++L+ 
Sbjct: 157 KLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYI 216
Query: 228 LVTAKVPY 235
           L+    P+
Sbjct: 217 LLVGYPPF 224

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 46  IASGSCGDL---YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G +   Y  + L ++VA+K L     N T      +E+ +++ V H+N++  + 
Sbjct: 32  IGSGAQGIVCAAYDAI-LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 90
Query: 103 ASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
             T    L       IV E M   +L   +    +  ++  LL     +  G+++LH   
Sbjct: 91  VFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLL---YQMLCGIKHLHSAG 146
Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKA 216
           IIHRDLK +N+++ +   +K+ DFG+AR      +MT E  T  + APEVI    Y +  
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMGYKENV 206
Query: 217 DVFSFAIVLWELVTAKV 233
           D++S   ++ E++   V
Sbjct: 207 DIWSVGCIMGEMIKGGV 223

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 44  ERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E +  G+   + R V+   G + A K++ ++ L+     +  +E  I R++QH N+VR  
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYL--HKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +  +     +V + + GG L++ +   + ++       ++    I + + Y H   I+H
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---QILESIAYCHSNGIVH 128
Query: 160 RDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKA 216
           R+LK  NLL+ +      VK+ADFG+A   N         GT  +++PEV+   PY +  
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPV 188
Query: 217 DVFSFAIVLWELVTAKVPY 235
           D+++  ++L+ L+    P+
Sbjct: 189 DIWACGVILYILLVGYPPF 207

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 44  ERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E +  G+   + R V+   G + A K++ ++ L+     +  +E  I R++QH N+VR  
Sbjct: 11  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 70
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYL--HKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +  +     +V + + GG L++ +   + ++       ++    I + + Y H   I+H
Sbjct: 71  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---QILESIAYCHSNGIVH 127
Query: 160 RDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKA 216
           R+LK  NLL+ +      VK+ADFG+A   N         GT  +++PEV+   PY +  
Sbjct: 128 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPV 187
Query: 217 DVFSFAIVLWELVTAKVPY 235
           D+++  ++L+ L+    P+
Sbjct: 188 DIWACGVILYILLVGYPPF 206

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 46  IASGSCGDL---YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G +   Y  V L ++VA+K L     N T      +E+ +++ V H+N++  + 
Sbjct: 32  IGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 90
Query: 103 ASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
             T    L       +V E M   +L   +    +  ++  LL     +  G+++LH   
Sbjct: 91  VFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYLL---YQMLXGIKHLHSAG 146
Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKA 216
           IIHRDLK +N+++ +   +K+ DFG+AR      +MT    T  + APEVI    Y +  
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 217 DVFSFAIVLWELVTAKV 233
           D++S   ++ E+V  K+
Sbjct: 207 DIWSVGCIMGEMVRHKI 223

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 44  ERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E +  G+   + R V+   G + A K++ ++ L+     +  +E  I R++QH N+VR  
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYL--HKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +  +     +V + + GG L++ +   + ++       ++    I + + Y H   I+H
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---QILESIAYCHSNGIVH 128
Query: 160 RDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKA 216
           R+LK  NLL+ +      VK+ADFG+A   N         GT  +++PEV+   PY +  
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPV 188
Query: 217 DVFSFAIVLWELVTAKVPY 235
           D+++  ++L+ L+    P+
Sbjct: 189 DIWACGVILYILLVGYPPF 207

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 46  IASGSCGDL---YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G +   Y  V L ++VA+K L     N T      +E+ +++ V H+N++  + 
Sbjct: 25  IGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 103 ASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
             T    L       +V E M   +L   +    +  ++  LL     +  G+++LH   
Sbjct: 84  VFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYLL---YQMLXGIKHLHSAG 139
Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKA 216
           IIHRDLK +N+++ +   +K+ DFG+AR      +MT    T  + APEVI    Y +  
Sbjct: 140 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 199
Query: 217 DVFSFAIVLWELVTAKV 233
           D++S   ++ E+V  K+
Sbjct: 200 DIWSVGCIMGEMVRHKI 216

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 94/196 (47%), Gaps = 12/196 (6%)
Query: 46  IASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA 103
           I SG+ G +       LG +VAVK L     N T      +E+ +L+ V H+N++  +  
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 91
Query: 104 STKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
            T    L       +V E M   +L   +H   +  ++  LL     +  G+++LH   I
Sbjct: 92  FTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLL---YQMLCGIKHLHSAGI 147
Query: 158 IHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKAD 217
           IHRDLK +N+++ +   +K+ DFG+AR      +MT    T  + APEVI    Y    D
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYAANVD 207
Query: 218 VFSFAIVLWELVTAKV 233
           ++S   ++ ELV   V
Sbjct: 208 IWSVGCIMGELVKGCV 223

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 44  ERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E +  G+   + R V+   G + A K++ ++ L+     +  +E  I R++QH N+VR  
Sbjct: 35  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 102 GASTKSPHLCIVTEYMPGGSLYDYL--HKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
            +  +     +V + + GG L++ +   + ++       ++    I + + Y H   I+H
Sbjct: 95  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---QILESIAYCHSNGIVH 151
Query: 160 RDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKA 216
           R+LK  NLL+ +      VK+ADFG+A   N         GT  +++PEV+   PY +  
Sbjct: 152 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPV 211
Query: 217 DVFSFAIVLWELVTAKVPY 235
           D+++  ++L+ L+    P+
Sbjct: 212 DIWACGVILYILLVGYPPF 230

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 46  IASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA 103
           I SG+ G +       L ++VA+K L     N T      +E+ +++ V H+N++  +  
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 104 STKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
            T    L       IV E M   +L   +    +  ++  LL     +  G+++LH   I
Sbjct: 92  FTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYLL---YQMLVGIKHLHSAGI 147
Query: 158 IHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKAD 217
           IHRDLK +N+++ +   +K+ DFG+AR      +MT    T  + APEVI    Y +  D
Sbjct: 148 IHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207
Query: 218 VFSFAIVLWELVTAKV 233
           ++S  +++ E++   V
Sbjct: 208 IWSVGVIMGEMIKGGV 223

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 46  IASGSCGDL---YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G +   Y  + L ++VA+K L     N T      +E+ +++ V H+N++  + 
Sbjct: 32  IGSGAQGIVCAAYDAI-LERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLN 90
Query: 103 ASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
             T    L       IV E M   +L   +    +  ++  LL     +  G+++LH   
Sbjct: 91  VFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYLL---YQMLVGIKHLHSAG 146
Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKA 216
           IIHRDLK +N+++ +   +K+ DFG+AR      +MT    T  + APEVI    Y +  
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 217 DVFSFAIVLWELVTAKV 233
           D++S  +++ E++   V
Sbjct: 207 DIWSVGVIMGEMIKGGV 223

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 92/189 (48%), Gaps = 13/189 (6%)
Query: 52  GDLYRGVYLGQDVAVKVLRSEHL--NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPH 109
           GDLY         AVKVL+ + +  +D +E    ++  +     H  + +          
Sbjct: 48  GDLY---------AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98
Query: 110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM 169
           L  V E++ GG L  ++ K+       +   +A +I   + +LH + II+RDLK  N+L+
Sbjct: 99  LFFVMEFVNGGDLMFHIQKSRR-FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL 157
Query: 170 DTHNVVKVADFGVARFQNKGGVMTAE-TGTYRWMAPEVINHQPYDQKADVFSFAIVLWEL 228
           D     K+ADFG+ +     GV TA   GT  ++APE++    Y    D ++  ++L+E+
Sbjct: 158 DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEM 217
Query: 229 VTAKVPYDS 237
           +    P+++
Sbjct: 218 LCGHAPFEA 226

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 25/215 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +T   + SG+ G +     V  G  +AVK L     +        +E+ +L+
Sbjct: 47  WEVPERY-QTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLK 105
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 106 HMKHENVIGLLDVFTPATSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 157
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 158 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 215
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAKV 233
            + APE+ +N   Y+   D++S   ++ EL+T + 
Sbjct: 216 WYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRT 250

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 24  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 134
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++  + +K+ DFG+AR  +    MT    T 
Sbjct: 135 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE--MTGYVATR 192
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 193 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 14  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCAKLTDDHVQ 124
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 125 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 182
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    I SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 23  WEVPERY-QNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 133
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 134 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE--MTGYVATR 191
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 192 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 20  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 130
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++  + +K+ DFG+AR  +    MT    T 
Sbjct: 131 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE--MTGYVATR 188
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 189 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 46  IASGSCGDL---YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G +   Y  + L ++VA+K L     N T      +E+ +++ V H+N++  + 
Sbjct: 32  IGSGAQGIVCAAYDAI-LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 90
Query: 103 ASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
             T    L       IV E M   +L   +    +  ++  LL     +  G+++LH   
Sbjct: 91  VFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLL---YQMLCGIKHLHSAG 146
Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKA 216
           IIHRDLK +N+++ +   +K+ DFG+AR      +M  E  T  + APEVI    Y +  
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENV 206
Query: 217 DVFSFAIVLWELVTAKV 233
           D++S   ++ E+V  K+
Sbjct: 207 DIWSVGCIMGEMVCHKI 223

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 92/190 (48%), Gaps = 29/190 (15%)
Query: 62  QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGS 121
           Q+ A K++ ++ L+     +  +E  I R ++H N+VR   + ++     +V + + GG 
Sbjct: 57  QEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGE 116
Query: 122 LY------------DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM 169
           L+            D  H  H +L+              + ++HQ +I+HRDLK  NLL+
Sbjct: 117 LFEDIVAREYYSEADASHCIHQILE-------------SVNHIHQHDIVHRDLKPENLLL 163
Query: 170 DTH---NVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVL 225
            +      VK+ADFG+A   Q +        GT  +++PEV+   PY +  D+++  ++L
Sbjct: 164 ASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVIL 223
Query: 226 WELVTAKVPY 235
           + L+    P+
Sbjct: 224 YILLVGYPPF 233

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 14  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 124
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 125 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 182
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 46  IASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ---HRNVVRF 100
           I  G+ G +Y  R  + G  VA+K +R  +  + L    V+EVA+LR ++   H NVVR 
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 101 IGASTKSP-----HLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICKGMEYLHQ 154
           +     S       + +V E++    L  YL K     L    +        +G+++LH 
Sbjct: 72  MDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 155 RNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQ 214
             I+HRDLK  N+L+ +   VK+ADFG+AR  +    +     T  + APEV+    Y  
Sbjct: 131 NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQSTYAT 190
Query: 215 KADVFSFAIVLWELVTAK 232
             D++S   +  E+   K
Sbjct: 191 PVDMWSVGCIFAEMFRRK 208

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 37  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 95
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 96  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 147
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 148 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 205
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 206 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 86/160 (53%), Gaps = 13/160 (8%)
Query: 83  VQEVAILREVQHRNVV---RFIGAST--KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
           ++E+ IL   +H N++     I A T  +   + IV + M    LY  L   H  L    
Sbjct: 71  LREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDH 127
Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG----GVMT 193
           +  F   I +G++Y+H  N++HRDLK +NLL++T + +K+ DFG+AR  +      G +T
Sbjct: 128 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLT 187
Query: 194 AETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
               T  + APE+ +N + Y +  D++S   +L E+++ +
Sbjct: 188 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 38  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 97  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 148
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 149 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 206
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 207 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 18  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKXQKLTDDHVQ 128
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 129 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE--MTGYVATR 186
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 25/215 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 24  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 134
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 135 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 192
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAKV 233
            + APE+ +N   Y+Q  D++S   ++ EL+T + 
Sbjct: 193 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 93/179 (51%), Gaps = 14/179 (7%)
Query: 64  VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVV---RFIGAST--KSPHLCIVTEYMP 118
           VA+K + S   + T     ++E+ IL   +H N++     I A T  +   + IV + M 
Sbjct: 55  VAIKKI-SPFEHQTYXQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM- 112
Query: 119 GGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVA 178
              LY  L   H  L    +  F   I +G++Y+H  N++HRDLK +NLL++T   +K+ 
Sbjct: 113 ETDLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIC 170
Query: 179 DFGVARFQNKG----GVMTAETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
           DFG+AR  +      G +T    T  + APE+ +N + Y +  D++S   +L E+++ +
Sbjct: 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R       + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 28  WEVPERYQNLAP-VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 86
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 87  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 138
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 139 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 196
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 197 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 18  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 128
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 129 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGXVATR 186
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 18  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 128
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 129 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 186
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 23  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 133
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 134 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE--MTGYVATR 191
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 192 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 29  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 87
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 88  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 139
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 140 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE--MTGYVATR 197
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 198 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 46  IASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQ---------EVAILREVQH 94
           + SG+ G ++  V     ++V VK ++ E +   LED +++         E+AIL  V+H
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKV---LEDCWIEDPKLGKVTLEIAILSRVEH 88
Query: 95  RNVVRFIGASTKSPHLCIVTE-YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
            N+++ +          +V E +  G  L+ ++ + H  L  P        +   + YL 
Sbjct: 89  ANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLR 147
Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPY- 212
            ++IIHRD+K  N+++     +K+ DFG A +  +G +     GT  + APEV+   PY 
Sbjct: 148 LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYR 207
Query: 213 DQKADVFSFAIVLWELVTAKVPY 235
             + +++S  + L+ LV  + P+
Sbjct: 208 GPELEMWSLGVTLYTLVFEENPF 230

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 24/202 (11%)
Query: 46  IASGSCGDL---YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G +   Y  V L ++VA+K L     N T      +E+ +++ V H+N++  + 
Sbjct: 70  IGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 128
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAID-----------ICKGMEY 151
             T    L    E+     + + +  N     L Q+++  +D           +C G+++
Sbjct: 129 VFTPQKTL---EEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQMLC-GIKH 179
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQP 211
           LH   IIHRDLK +N+++ +   +K+ DFG+AR      +MT    T  + APEVI    
Sbjct: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 239
Query: 212 YDQKADVFSFAIVLWELVTAKV 233
           Y +  D++S   ++ E+V  K+
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKI 261

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 85/160 (53%), Gaps = 13/160 (8%)
Query: 83  VQEVAILREVQHRNVV---RFIGAST--KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
           ++E+ IL   +H N++     I A T  +   + IV + M    LY  L   H  L    
Sbjct: 69  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDH 125
Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG----GVMT 193
           +  F   I +G++Y+H  N++HRDLK +NLL++T   +K+ DFG+AR  +      G +T
Sbjct: 126 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 185
Query: 194 AETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
               T  + APE+ +N + Y +  D++S   +L E+++ +
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 24/202 (11%)
Query: 46  IASGSCGDL---YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G +   Y  V L ++VA+K L     N T      +E+ +++ V H+N++  + 
Sbjct: 32  IGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 90
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAID-----------ICKGMEY 151
             T    L    E+     + + +  N     L Q+++  +D           +C G+++
Sbjct: 91  VFTPQKTL---EEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQMLC-GIKH 141
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQP 211
           LH   IIHRDLK +N+++ +   +K+ DFG+AR      +MT    T  + APEVI    
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 212 YDQKADVFSFAIVLWELVTAKV 233
           Y +  D++S   ++ E+V  K+
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKI 223

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 24/202 (11%)
Query: 46  IASGSCGDL---YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G +   Y  V L ++VA+K L     N T      +E+ +++ V H+N++  + 
Sbjct: 33  IGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 91
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAID-----------ICKGMEY 151
             T    L    E+     + + +  N     L Q+++  +D           +C G+++
Sbjct: 92  VFTPQKTL---EEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQMLC-GIKH 142
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQP 211
           LH   IIHRDLK +N+++ +   +K+ DFG+AR      +MT    T  + APEVI    
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 202
Query: 212 YDQKADVFSFAIVLWELVTAKV 233
           Y +  D++S   ++ E+V  K+
Sbjct: 203 YKENVDIWSVGCIMGEMVRHKI 224

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 24/202 (11%)
Query: 46  IASGSCGDL---YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G +   Y  V L ++VA+K L     N T      +E+ +++ V H+N++  + 
Sbjct: 26  IGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 84
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAID-----------ICKGMEY 151
             T    L    E+     + + +  N     L Q+++  +D           +C G+++
Sbjct: 85  VFTPQKTL---EEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQMLC-GIKH 135
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQP 211
           LH   IIHRDLK +N+++ +   +K+ DFG+AR      +MT    T  + APEVI    
Sbjct: 136 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 195
Query: 212 YDQKADVFSFAIVLWELVTAKV 233
           Y +  D++S   ++ E+V  K+
Sbjct: 196 YKENVDIWSVGCIMGEMVRHKI 217

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 24/202 (11%)
Query: 46  IASGSCGDL---YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G +   Y  V L ++VA+K L     N T      +E+ +++ V H+N++  + 
Sbjct: 33  IGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 91
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAID-----------ICKGMEY 151
             T    L    E+     + + +  N     L Q+++  +D           +C G+++
Sbjct: 92  VFTPQKTL---EEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQMLC-GIKH 142
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQP 211
           LH   IIHRDLK +N+++ +   +K+ DFG+AR      +MT    T  + APEVI    
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 202
Query: 212 YDQKADVFSFAIVLWELVTAKV 233
           Y +  D++S   ++ E+V  K+
Sbjct: 203 YKENVDIWSVGCIMGEMVRHKI 224

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 85/160 (53%), Gaps = 13/160 (8%)
Query: 83  VQEVAILREVQHRNVV---RFIGAST--KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
           ++E+ IL   +H N++     I A T  +   + IV + M    LY  L   H  L    
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDH 129
Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG----GVMT 193
           +  F   I +G++Y+H  N++HRDLK +NLL++T   +K+ DFG+AR  +      G +T
Sbjct: 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 189
Query: 194 AETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
               T  + APE+ +N + Y +  D++S   +L E+++ +
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 12/227 (5%)
Query: 27  QTKSEDWEIDRRLLKTGERIASGSCG--DLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQ 84
           Q   E++E+    L+    +  G+ G  +  R V  GQ  AVK +R+  +N   +   + 
Sbjct: 23  QGAXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRAT-VNSQEQKRLLX 81
Query: 85  EVAI-LREVQHRNVVRFIGASTKSPHLCIVTEYMPGG--SLYDYLHKNHNVLKLPQLLRF 141
           ++ I  R V     V F GA  +   + I  E         Y  +      +    L + 
Sbjct: 82  DLDISXRTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKI 141
Query: 142 AIDICKGMEYLHQR-NIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYR 200
           A+ I K +E+LH + ++IHRD+K +N+L++    VK  DFG++ +         + G   
Sbjct: 142 AVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKP 201
Query: 201 WMAPEVI----NHQPYDQKADVFSFAIVLWELVTAKVPYDSM-TPLQ 242
           + APE I    N + Y  K+D++S  I   EL   + PYDS  TP Q
Sbjct: 202 YXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQ 248

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 46  IASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ---HRNVVRF 100
           I  G+ G +Y  R  + G  VA+K +R  +  + L    V+EVA+LR ++   H NVVR 
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 101 IGASTKSP-----HLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICKGMEYLHQ 154
           +     S       + +V E++    L  YL K     L    +        +G+++LH 
Sbjct: 72  MDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 155 RNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQ 214
             I+HRDLK  N+L+ +   VK+ADFG+AR  +    +     T  + APEV+    Y  
Sbjct: 131 NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQSTYAT 190
Query: 215 KADVFSFAIVLWELVTAK 232
             D++S   +  E+   K
Sbjct: 191 PVDMWSVGCIFAEMFRRK 208

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 24/202 (11%)
Query: 46  IASGSCGDL---YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G +   Y  V L ++VA+K L     N T      +E+ +++ V H+N++  + 
Sbjct: 26  IGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 84
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAID-----------ICKGMEY 151
             T    L    E+     + + +  N     L Q+++  +D           +C G+++
Sbjct: 85  VFTPQKTL---EEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQMLC-GIKH 135
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQP 211
           LH   IIHRDLK +N+++ +   +K+ DFG+AR      +MT    T  + APEVI    
Sbjct: 136 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 195
Query: 212 YDQKADVFSFAIVLWELVTAKV 233
           Y +  D++S   ++ E+V  K+
Sbjct: 196 YKENVDIWSVGCIMGEMVRHKI 217

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 76/154 (49%), Gaps = 16/154 (10%)
Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
           ++ RN V+   A  K   L I  EY    +LYD +H  +   +  +  R    I + + Y
Sbjct: 72  LERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR------------FQNKGGV---MTAET 196
           +H + IIHR+LK  N+ +D    VK+ DFG+A+             QN  G    +T+  
Sbjct: 132 IHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
Query: 197 GTYRWMAPEVINHQP-YDQKADVFSFAIVLWELV 229
           GT  ++A EV++    Y++K D +S  I+ +E +
Sbjct: 192 GTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 24/202 (11%)
Query: 46  IASGSCGDL---YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G +   Y  V L ++VA+K L     N T      +E+ +++ V H+N++  + 
Sbjct: 25  IGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAID-----------ICKGMEY 151
             T    L    E+     + + +  N     L Q+++  +D           +C G+++
Sbjct: 84  VFTPQKTL---EEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQMLC-GIKH 134
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQP 211
           LH   IIHRDLK +N+++ +   +K+ DFG+AR      +MT    T  + APEVI    
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 212 YDQKADVFSFAIVLWELVTAKV 233
           Y +  D++S   ++ E+V  K+
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKI 216

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 85/160 (53%), Gaps = 13/160 (8%)
Query: 83  VQEVAILREVQHRNVV---RFIGAST--KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
           ++E+ IL   +H N++     I A T  +   + IV + M    LY  L   H  L    
Sbjct: 69  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDH 125
Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG----GVMT 193
           +  F   I +G++Y+H  N++HRDLK +NLL++T   +K+ DFG+AR  +      G +T
Sbjct: 126 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 185
Query: 194 AETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
               T  + APE+ +N + Y +  D++S   +L E+++ +
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 24/202 (11%)
Query: 46  IASGSCGDL---YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G +   Y  V L ++VA+K L     N T      +E+ +++ V H+N++  + 
Sbjct: 70  IGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 128
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAID-----------ICKGMEY 151
             T    L    E+     + + +  N     L Q+++  +D           +C G+++
Sbjct: 129 VFTPQKTL---EEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQMLC-GIKH 179
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQP 211
           LH   IIHRDLK +N+++ +   +K+ DFG+AR      +MT    T  + APEVI    
Sbjct: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 239
Query: 212 YDQKADVFSFAIVLWELVTAKV 233
           Y +  D++S   ++ E+V  K+
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKI 261

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 46  IASGSCGDL---YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G +   Y  + L ++VA+K L     N T      +E+ +++ V H+N++  + 
Sbjct: 32  IGSGAQGIVCAAYDAI-LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 90
Query: 103 ASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
             T    L       IV E M   +L   +    +  ++  LL     +  G+++LH   
Sbjct: 91  VFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLL---YQMLCGIKHLHSAG 146
Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKA 216
           IIHRDLK +N+++ +   +K+ DFG+AR      +M  E  T  + APEVI    Y +  
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENV 206
Query: 217 DVFSFAIVLWELVTAKV 233
           D++S   ++ E+V  K+
Sbjct: 207 DLWSVGCIMGEMVCHKI 223

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 25  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 135
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 136 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYVATR 193
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 18  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 128
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 129 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 186
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 187 WYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 46  IASGSCGDLYRGV--YLGQDVAVKVL--RSEHLNDTLEDEFV----QEVAILREVQHRNV 97
           + SG+CG++         + VA+K++  R   +    E +       E+ IL+++ H  +
Sbjct: 24  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 83
Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
           ++ I     +    IV E M GG L+D +  N  + +    L F   +   ++YLH+  I
Sbjct: 84  IK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQMLLAVQYLHENGI 141
Query: 158 IHRDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEV---INHQP 211
           IHRDLK  N+L+ +     ++K+ DFG ++   +  +M    GT  ++APEV   +    
Sbjct: 142 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAG 201
Query: 212 YDQKADVFSFAIVLWELVTAKVPY 235
           Y++  D +S  ++L+  ++   P+
Sbjct: 202 YNRAVDCWSLGVILFICLSGYPPF 225

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 95/191 (49%), Gaps = 20/191 (10%)
Query: 62  QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHLCIVTEYMPGG 120
           Q+ AVK++  E     +     +EV +L + Q HRNV+  I    +     +V E M GG
Sbjct: 39  QEYAVKII--EKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGG 96
Query: 121 SLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN---VVKV 177
           S+  ++HK  +  +L   +    D+   +++LH + I HRDLK  N+L +  N    VK+
Sbjct: 97  SILSHIHKRRHFNELEASV-VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKI 155
Query: 178 ADF----GVARFQNKGGVMTAE----TGTYRWMAPEVI-----NHQPYDQKADVFSFAIV 224
            DF    G+    +   + T E     G+  +MAPEV+         YD++ D++S  ++
Sbjct: 156 CDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215
Query: 225 LWELVTAKVPY 235
           L+ L++   P+
Sbjct: 216 LYILLSGYPPF 226

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 24/202 (11%)
Query: 46  IASGSCGDL---YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G +   Y  V L ++VA+K L     N T      +E+ +++ V H+N++  + 
Sbjct: 31  IGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 89
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAID-----------ICKGMEY 151
             T    L    E+     + + +  N     L Q+++  +D           +C G+++
Sbjct: 90  VFTPQKTL---EEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQMLC-GIKH 140
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQP 211
           LH   IIHRDLK +N+++ +   +K+ DFG+AR      +MT    T  + APEVI    
Sbjct: 141 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 200
Query: 212 YDQKADVFSFAIVLWELVTAKV 233
           Y +  D++S   ++ E+V  K+
Sbjct: 201 YKENVDIWSVGCIMGEMVRHKI 222

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 30  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLK 88
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 89  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 140
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 141 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 198
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 199 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 89/183 (48%), Gaps = 15/183 (8%)
Query: 62  QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHLCIVTEYMPGG 120
           Q  AVK++        +E    +E+  L+  + H N+V+         H  +V E + GG
Sbjct: 37  QAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91
Query: 121 SLYDYLHKNHNV--LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN---VV 175
            L++ + K  +    +   ++R    +   + ++H   ++HRDLK  NLL    N    +
Sbjct: 92  ELFERIKKKKHFSETEASYIMR---KLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEI 148
Query: 176 KVADFGVARFQNKGG-VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVP 234
           K+ DFG AR +      +     T  + APE++N   YD+  D++S  ++L+ +++ +VP
Sbjct: 149 KIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
Query: 235 YDS 237
           + S
Sbjct: 209 FQS 211

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 46  IASGSCGDLYRGV--YLGQDVAVKVL--RSEHLNDTLEDEFV----QEVAILREVQHRNV 97
           + SG+CG++         + VA+K++  R   +    E +       E+ IL+++ H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
           ++ I     +    IV E M GG L+D +  N  + +    L F   +   ++YLH+  I
Sbjct: 78  IK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQMLLAVQYLHENGI 135
Query: 158 IHRDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEV---INHQP 211
           IHRDLK  N+L+ +     ++K+ DFG ++   +  +M    GT  ++APEV   +    
Sbjct: 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAG 195
Query: 212 YDQKADVFSFAIVLWELVTAKVPY 235
           Y++  D +S  ++L+  ++   P+
Sbjct: 196 YNRAVDCWSLGVILFICLSGYPPF 219

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 15  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 73
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 74  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 125
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 126 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 183
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 184 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 25  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 135
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 136 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYVATR 193
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 25  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 135
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 136 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTGYVATR 193
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 24/202 (11%)
Query: 46  IASGSCGDL---YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G +   Y  V L ++VA+K L     N T      +E+ +++ V H+N++  + 
Sbjct: 32  IGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 90
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAID-----------ICKGMEY 151
             T    L    E+     + + +  N     L Q+++  +D           +C G+++
Sbjct: 91  VFTPQKTL---EEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQMLC-GIKH 141
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQP 211
           LH   IIHRDLK +N+++ +   +K+ DFG+AR      +MT    T  + APEVI    
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 212 YDQKADVFSFAIVLWELVTAKV 233
           Y +  D++S   ++ E+V  K+
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKI 223

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 46  IASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ---HRNVVRF 100
           I  G+ G +Y  R  + G  VA+K +R  +  + L    V+EVA+LR ++   H NVVR 
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 101 IGASTKSP-----HLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICKGMEYLHQ 154
           +     S       + +V E++    L  YL K     L    +        +G+++LH 
Sbjct: 72  MDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 155 RNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQ 214
             I+HRDLK  N+L+ +   VK+ADFG+AR  +    +     T  + APEV+    Y  
Sbjct: 131 NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQSTYAT 190
Query: 215 KADVFSFAIVLWELVTAK 232
             D++S   +  E+   K
Sbjct: 191 PVDMWSVGCIFAEMFRRK 208

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 85/160 (53%), Gaps = 13/160 (8%)
Query: 83  VQEVAILREVQHRNVV---RFIGAST--KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
           ++E+ IL   +H N++     I A T  +   + IV + M    LY  L   H  L    
Sbjct: 69  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDH 125
Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG----GVMT 193
           +  F   I +G++Y+H  N++HRDLK +NLL++T   +K+ DFG+AR  +      G +T
Sbjct: 126 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLT 185
Query: 194 AETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
               T  + APE+ +N + Y +  D++S   +L E+++ +
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 88/185 (47%), Gaps = 10/185 (5%)
Query: 61  GQDVAVKVLRSEHLNDTL---EDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYM 117
           GQ  AVK++       +     ++  +E +I   ++H ++V  +   +    L +V E+M
Sbjct: 51  GQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFM 110
Query: 118 PGGSLYDYLHKNHN---VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM---DT 171
            G  L   + K  +   V        +   I + + Y H  NIIHRD+K   +L+   + 
Sbjct: 111 DGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKEN 170
Query: 172 HNVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
              VK+  FGVA +    G V     GT  +MAPEV+  +PY +  DV+   ++L+ L++
Sbjct: 171 SAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS 230
Query: 231 AKVPY 235
             +P+
Sbjct: 231 GCLPF 235

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 18  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 128
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 129 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 186
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 46  IASGSCGDLYRGV--YLGQDVAVKVL--RSEHLNDTLEDEFV----QEVAILREVQHRNV 97
           + SG+CG++         + VA+K++  R   +    E +       E+ IL+++ H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
           ++ I     +    IV E M GG L+D +  N  + +    L F   +   ++YLH+  I
Sbjct: 78  IK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQMLLAVQYLHENGI 135
Query: 158 IHRDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEV---INHQP 211
           IHRDLK  N+L+ +     ++K+ DFG ++   +  +M    GT  ++APEV   +    
Sbjct: 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAG 195
Query: 212 YDQKADVFSFAIVLWELVTAKVPY 235
           Y++  D +S  ++L+  ++   P+
Sbjct: 196 YNRAVDCWSLGVILFICLSGYPPF 219

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 46  IASGSCGDLYRGV--YLGQDVAVKVL--RSEHLNDTLEDEFV----QEVAILREVQHRNV 97
           + SG+CG++         + VA+K++  R   +    E +       E+ IL+++ H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
           ++ I     +    IV E M GG L+D +  N  + +    L F   +   ++YLH+  I
Sbjct: 78  IK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQMLLAVQYLHENGI 135
Query: 158 IHRDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEV---INHQP 211
           IHRDLK  N+L+ +     ++K+ DFG ++   +  +M    GT  ++APEV   +    
Sbjct: 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAG 195
Query: 212 YDQKADVFSFAIVLWELVTAKVPY 235
           Y++  D +S  ++L+  ++   P+
Sbjct: 196 YNRAVDCWSLGVILFICLSGYPPF 219

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 16  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 74
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 75  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 126
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 127 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 184
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 185 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 101/204 (49%), Gaps = 16/204 (7%)
Query: 46  IASGSCGDLYRGV--YLGQDVAVKVL--RSEHLNDTLEDEFV----QEVAILREVQHRNV 97
           + SG+CG++         + VA+K++  R   +    E +       E+ IL+++ H  +
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 76
Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
           ++ I     +    IV E M GG L+D +  N  + +    L F   +   ++YLH+  I
Sbjct: 77  IK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQMLLAVQYLHENGI 134
Query: 158 IHRDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEV---INHQP 211
           IHRDLK  N+L+ +     ++K+ DFG ++   +  +M    GT  ++APEV   +    
Sbjct: 135 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAG 194
Query: 212 YDQKADVFSFAIVLWELVTAKVPY 235
           Y++  D +S  ++L+  ++   P+
Sbjct: 195 YNRAVDCWSLGVILFICLSGYPPF 218

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 18  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKXQKLTDDHVQ 128
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 129 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 186
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 14  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 124
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 125 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 182
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 15  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 73
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 74  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 125
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 126 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 183
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 184 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 23  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 133
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 134 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 191
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 192 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 20  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 130
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 131 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 188
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 189 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 85/160 (53%), Gaps = 13/160 (8%)
Query: 83  VQEVAILREVQHRNVV---RFIGAST--KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
           ++E+ IL   +H N++     I A T  +   + IV + M    LY  L   H  L    
Sbjct: 77  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDH 133
Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG----GVMT 193
           +  F   I +G++Y+H  N++HRDLK +NLL++T   +K+ DFG+AR  +      G +T
Sbjct: 134 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 193
Query: 194 AETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
               T  + APE+ +N + Y +  D++S   +L E+++ +
Sbjct: 194 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 85/160 (53%), Gaps = 13/160 (8%)
Query: 83  VQEVAILREVQHRNVV---RFIGAST--KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
           ++E+ IL   +H N++     I A T  +   + IV + M    LY  L   H  L    
Sbjct: 69  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDH 125
Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG----GVMT 193
           +  F   I +G++Y+H  N++HRDLK +NLL++T   +K+ DFG+AR  +      G +T
Sbjct: 126 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 185
Query: 194 AETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
               T  + APE+ +N + Y +  D++S   +L E+++ +
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 85/160 (53%), Gaps = 13/160 (8%)
Query: 83  VQEVAILREVQHRNVV---RFIGAST--KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
           ++E+ IL   +H N++     I A T  +   + IV + M    LY  L   H  L    
Sbjct: 67  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDH 123
Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG----GVMT 193
           +  F   I +G++Y+H  N++HRDLK +NLL++T   +K+ DFG+AR  +      G +T
Sbjct: 124 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 183
Query: 194 AETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
               T  + APE+ +N + Y +  D++S   +L E+++ +
Sbjct: 184 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 18  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 128
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 129 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 186
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 37  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 95
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 96  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 147
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 148 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 205
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 206 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 30  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 88
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 89  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 140
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 141 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 198
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 199 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 30  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 88
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 89  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 140
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 141 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 198
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 199 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 23  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 133
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 134 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 191
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 192 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 18  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 128
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 129 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 186
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 29  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 87
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 88  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 139
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 140 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 197
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 198 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 17  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 75
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 76  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 127
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 128 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 185
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 186 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 41  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 99
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 100 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 151
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 152 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 209
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 210 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 20  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 130
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 131 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 188
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 189 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 85/160 (53%), Gaps = 13/160 (8%)
Query: 83  VQEVAILREVQHRNVV---RFIGAST--KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
           ++E+ IL   +H N++     I A T  +   + IV + M    LY  L   H  L    
Sbjct: 71  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDH 127
Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG----GVMT 193
           +  F   I +G++Y+H  N++HRDLK +NLL++T   +K+ DFG+AR  +      G +T
Sbjct: 128 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 187
Query: 194 AETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
               T  + APE+ +N + Y +  D++S   +L E+++ +
Sbjct: 188 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 38  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 97  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 148
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 149 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 206
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 207 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 20  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 130
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 131 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 188
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 189 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 46  IASGSCGDL---YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G +   Y  + L ++VA+K L     N T      +E+ +++ V H+N++  + 
Sbjct: 32  IGSGAQGIVCAAYDAI-LERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLN 90
Query: 103 ASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
             T    L       IV E M   +L   +    +  ++  LL     +  G+++LH   
Sbjct: 91  VFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYLL---YQMLVGIKHLHSAG 146
Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKA 216
           IIHRDLK +N+++ +   +K+ DFG+AR      +MT    T  + APEVI    Y +  
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 217 DVFSFAIVLWELVTAKV 233
           D++S   ++ E++   V
Sbjct: 207 DIWSVGCIMGEMIKGGV 223

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 88/185 (47%), Gaps = 10/185 (5%)
Query: 61  GQDVAVKVLRSEHLNDTL---EDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYM 117
           GQ  AVK++       +     ++  +E +I   ++H ++V  +   +    L +V E+M
Sbjct: 49  GQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFM 108
Query: 118 PGGSLYDYLHKNHN---VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM---DT 171
            G  L   + K  +   V        +   I + + Y H  NIIHRD+K   +L+   + 
Sbjct: 109 DGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKEN 168
Query: 172 HNVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
              VK+  FGVA +    G V     GT  +MAPEV+  +PY +  DV+   ++L+ L++
Sbjct: 169 SAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS 228
Query: 231 AKVPY 235
             +P+
Sbjct: 229 GCLPF 233

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 25  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 135
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 136 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 193
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 18  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 128
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 129 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 186
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 18  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 128
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 129 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 186
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 85/160 (53%), Gaps = 13/160 (8%)
Query: 83  VQEVAILREVQHRNVV---RFIGAST--KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
           ++E+ IL   +H N++     I A T  +   + IV + M    LY  L   H  L    
Sbjct: 67  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDH 123
Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG----GVMT 193
           +  F   I +G++Y+H  N++HRDLK +NLL++T   +K+ DFG+AR  +      G +T
Sbjct: 124 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 183
Query: 194 AETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
               T  + APE+ +N + Y +  D++S   +L E+++ +
Sbjct: 184 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 25/215 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 24  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 134
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 135 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 192
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAKV 233
            + APE+ +N   Y+Q  D++S   ++ EL+T + 
Sbjct: 193 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 85/160 (53%), Gaps = 13/160 (8%)
Query: 83  VQEVAILREVQHRNVV---RFIGAST--KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
           ++E+ IL   +H N++     I A T  +   + IV + M    LY  L   H  L    
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDH 129
Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG----GVMT 193
           +  F   I +G++Y+H  N++HRDLK +NLL++T   +K+ DFG+AR  +      G +T
Sbjct: 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 194 AETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
               T  + APE+ +N + Y +  D++S   +L E+++ +
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 85/160 (53%), Gaps = 13/160 (8%)
Query: 83  VQEVAILREVQHRNVV---RFIGAST--KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
           ++E+ IL   +H N++     I A T  +   + IV + M    LY  L   H  L    
Sbjct: 74  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDH 130
Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG----GVMT 193
           +  F   I +G++Y+H  N++HRDLK +NLL++T   +K+ DFG+AR  +      G +T
Sbjct: 131 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 190
Query: 194 AETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
               T  + APE+ +N + Y +  D++S   +L E+++ +
Sbjct: 191 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 85/160 (53%), Gaps = 13/160 (8%)
Query: 83  VQEVAILREVQHRNVV---RFIGAST--KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
           ++E+ IL   +H N++     I A T  +   + IV + M    LY  L   H  L    
Sbjct: 75  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDH 131
Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG----GVMT 193
           +  F   I +G++Y+H  N++HRDLK +NLL++T   +K+ DFG+AR  +      G +T
Sbjct: 132 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 191
Query: 194 AETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
               T  + APE+ +N + Y +  D++S   +L E+++ +
Sbjct: 192 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 85/160 (53%), Gaps = 13/160 (8%)
Query: 83  VQEVAILREVQHRNVV---RFIGAST--KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
           ++E+ IL   +H N++     I A T  +   + IV + M    LY  L   H  L    
Sbjct: 66  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDH 122
Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG----GVMT 193
           +  F   I +G++Y+H  N++HRDLK +NLL++T   +K+ DFG+AR  +      G +T
Sbjct: 123 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 182
Query: 194 AETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
               T  + APE+ +N + Y +  D++S   +L E+++ +
Sbjct: 183 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 85/160 (53%), Gaps = 13/160 (8%)
Query: 83  VQEVAILREVQHRNVV---RFIGAST--KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
           ++E+ IL   +H N++     I A T  +   + IV + M    LY  L   H  L    
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDH 129
Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG----GVMT 193
           +  F   I +G++Y+H  N++HRDLK +NLL++T   +K+ DFG+AR  +      G +T
Sbjct: 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 194 AETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
               T  + APE+ +N + Y +  D++S   +L E+++ +
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 18  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 128
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 129 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 186
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 85/160 (53%), Gaps = 13/160 (8%)
Query: 83  VQEVAILREVQHRNVV---RFIGAST--KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
           ++E+ IL   +H N++     I A T  +   + IV + M    LY  L   H  L    
Sbjct: 69  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDH 125
Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG----GVMT 193
           +  F   I +G++Y+H  N++HRDLK +NLL++T   +K+ DFG+AR  +      G +T
Sbjct: 126 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 185
Query: 194 AETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
               T  + APE+ +N + Y +  D++S   +L E+++ +
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 18  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 128
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 129 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 186
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 24  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 134
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 135 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATR 192
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 193 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 46  IASGSCGDL---YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G +   Y  + L ++VA+K L     N T      +E+ +++ V H+N++  + 
Sbjct: 37  IGSGAQGIVCAAYDAI-LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 95
Query: 103 ASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
             T    L       IV E M   +L   +    +  ++  LL     +  G+++LH   
Sbjct: 96  VFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLL---YQMLCGIKHLHSAG 151
Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKA 216
           IIHRDLK +N+++ +   +K+ DFG+AR      +MT    T  + APEVI    Y +  
Sbjct: 152 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 211
Query: 217 DVFSFAIVLWELVTAKV 233
           D++S   ++ E+V  K+
Sbjct: 212 DLWSVGCIMGEMVCHKI 228

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 89/181 (49%), Gaps = 5/181 (2%)
Query: 61  GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGG 120
           G+ VA+K       +  ++   ++E+ +L++++H N+V  +    K     +V E++   
Sbjct: 50  GRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV-DH 108
Query: 121 SLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADF 180
           ++ D L    N L    + ++   I  G+ + H  NIIHRD+K  N+L+    VVK+ DF
Sbjct: 109 TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDF 168
Query: 181 GVAR-FQNKGGVMTAETGTYRWMAPE-VINHQPYDQKADVFSFAIVLWELVTAK--VPYD 236
           G AR     G V   E  T  + APE ++    Y +  DV++   ++ E+   +   P D
Sbjct: 169 GFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228
Query: 237 S 237
           S
Sbjct: 229 S 229

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 85/160 (53%), Gaps = 13/160 (8%)
Query: 83  VQEVAILREVQHRNVV---RFIGAST--KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
           ++E+ IL   +H N++     I A T  +   + IV + M    LY  L   H  L    
Sbjct: 89  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDH 145
Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG----GVMT 193
           +  F   I +G++Y+H  N++HRDLK +NLL++T   +K+ DFG+AR  +      G +T
Sbjct: 146 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 205
Query: 194 AETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
               T  + APE+ +N + Y +  D++S   +L E+++ +
Sbjct: 206 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 46  IASGSCGDL---YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G +   Y  + L ++VA+K L     N T      +E+ +++ V H+N++  + 
Sbjct: 26  IGSGAQGIVCAAYDAI-LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 84
Query: 103 ASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
             T    L       IV E M   +L   +    +  ++  LL     +  G+++LH   
Sbjct: 85  VFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLL---YQMLCGIKHLHSAG 140
Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKA 216
           IIHRDLK +N+++ +   +K+ DFG+AR      +MT    T  + APEVI    Y +  
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 200
Query: 217 DVFSFAIVLWELVTAKV 233
           D++S   ++ E+V  K+
Sbjct: 201 DLWSVGCIMGEMVCHKI 217

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 46  IASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA 103
           + SG+CG +++  +   G  +AVK +R     +  +   +    +L+      +V+  G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 104 STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ--LLRFAIDICKGMEYLHQR-NIIHR 160
              +  + I  E M  G+  + L K      +P+  L +  + I K + YL ++  +IHR
Sbjct: 93  FITNTDVFIAMELM--GTCAEKLKKRMQG-PIPERILGKMTVAIVKALYYLKEKHGVIHR 149
Query: 161 DLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINH----QP-YDQK 215
           D+K +N+L+D    +K+ DFG++             G   +MAPE I+     +P YD +
Sbjct: 150 DVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIR 209
Query: 216 ADVFSFAIVLWELVTAKVPY 235
           ADV+S  I L EL T + PY
Sbjct: 210 ADVWSLGISLVELATGQFPY 229

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 85/160 (53%), Gaps = 13/160 (8%)
Query: 83  VQEVAILREVQHRNVV---RFIGAST--KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
           ++E+ IL   +H N++     I A T  +   + IV + M    LY  L   H  L    
Sbjct: 71  LREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDH 127
Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG----GVMT 193
           +  F   I +G++Y+H  N++HRDLK +NLL++T   +K+ DFG+AR  +      G +T
Sbjct: 128 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 187
Query: 194 AETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
               T  + APE+ +N + Y +  D++S   +L E+++ +
Sbjct: 188 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 46  IASGSCGDL---YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G +   Y  + L ++VA+K L     N T      +E+ +++ V H+N++  + 
Sbjct: 32  IGSGAQGIVCAAYDAI-LERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLN 90
Query: 103 ASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
             T    L       IV E M   +L   +    +  ++  LL     +  G+++LH   
Sbjct: 91  VFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYLL---YQMLCGIKHLHSAG 146
Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKA 216
           IIHRDLK +N+++ +   +K+ DFG+AR      +MT    T  + APEVI    Y +  
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 217 DVFSFAIVLWELVTAKV 233
           D++S   ++ E++   V
Sbjct: 207 DIWSVGCIMGEMIKGGV 223

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 38  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 97  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 148
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    M     T 
Sbjct: 149 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MXGXVATR 206
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 207 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 97/203 (47%), Gaps = 9/203 (4%)
Query: 40  LKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFV-QEVAILREVQHRN 96
            K G+ +  GS     L R +   ++ A+K+L   H+    +  +V +E  ++  + H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQR 155
            V+          L     Y   G L  Y+ K  +  +     RF   +I   +EYLH +
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE--TCTRFYTAEIVSALEYLHGK 149
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARF---QNKGGVMTAETGTYRWMAPEVINHQPY 212
            IIHRDLK  N+L++    +++ DFG A+    ++K     A  GT ++++PE++  +  
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSA 209
Query: 213 DQKADVFSFAIVLWELVTAKVPY 235
            + +D+++   ++++LV    P+
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 97/203 (47%), Gaps = 9/203 (4%)
Query: 40  LKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFV-QEVAILREVQHRN 96
            K G+ +  GS     L R +   ++ A+K+L   H+    +  +V +E  ++  + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQR 155
            V+          L     Y   G L  Y+ K  +  +     RF   +I   +EYLH +
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDE--TCTRFYTAEIVSALEYLHGK 151
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARF---QNKGGVMTAETGTYRWMAPEVINHQPY 212
            IIHRDLK  N+L++    +++ DFG A+    ++K     +  GT ++++PE++  +  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 211
Query: 213 DQKADVFSFAIVLWELVTAKVPY 235
            + +D+++   ++++LV    P+
Sbjct: 212 SKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 46  IASGSCGDL---YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G +   Y  + L ++VA+K L     N T      +E+ +++ V H+N++  + 
Sbjct: 32  IGSGAQGIVCAAYDAI-LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 90
Query: 103 ASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
             T    L       IV E M   +L   +    +  ++  LL     +  G+++LH   
Sbjct: 91  VFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYLL---YQMLCGIKHLHSAG 146
Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKA 216
           IIHRDLK +N+++ +   +K+ DFG+AR      +MT    T  + APEVI    Y +  
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 217 DVFSFAIVLWELVTAKV 233
           D++S   ++ E++   V
Sbjct: 207 DIWSVGCIMGEMIKGGV 223

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 85/160 (53%), Gaps = 13/160 (8%)
Query: 83  VQEVAILREVQHRNVV---RFIGAST--KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
           ++E+ IL   +H N++     I A T  +   + IV + M    LY  L   H  L    
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKCQH--LSNDH 129
Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG----GVMT 193
           +  F   I +G++Y+H  N++HRDLK +NLL++T   +K+ DFG+AR  +      G +T
Sbjct: 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 194 AETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
               T  + APE+ +N + Y +  D++S   +L E+++ +
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 18  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKSQKLTDDHVQ 128
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++  + +K+ DFG+ R  +    MT    T 
Sbjct: 129 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE--MTGYVATR 186
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 111/228 (48%), Gaps = 18/228 (7%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+ +  + +   + SG+ G +   +    G+ VA+K L     ++       +E+ +L+
Sbjct: 38  WELPKTYV-SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLK 96
Query: 91  EVQHRNVVRFIGASTKSPHLCIVTEY---MPGGSLYDYLHKNHNVLKLPQLLRFAI-DIC 146
            +QH NV+  +   T +  L    ++   MP   +   L K   +    + +++ +  + 
Sbjct: 97  HMQHENVIGLLDVFTPASSLRNFYDFYLVMP--FMQTDLQKIMGMEFSEEKIQYLVYQML 154
Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEV 206
           KG++Y+H   ++HRDLK  NL ++    +K+ DFG+AR  +    MT    T  + APEV
Sbjct: 155 KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD--AEMTGYVVTRWYRAPEV 212
Query: 207 I-NHQPYDQKADVFSFAIVLWELVTAKVPY------DSMTPLQAALGV 247
           I +   Y+Q  D++S   ++ E++T K  +      D +T +    GV
Sbjct: 213 ILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 260

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 46  IASGSCGDL---YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G +   Y  + L ++VA+K L     N T      +E+ +++ V H+N++  + 
Sbjct: 32  IGSGAQGIVCAAYDAI-LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 90
Query: 103 ASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
             T    L       IV E M   +L   +    +  ++  LL     +  G+++LH   
Sbjct: 91  VFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYLL---YQMLCGIKHLHSAG 146
Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKA 216
           IIHRDLK +N+++ +   +K+ DFG+AR      +MT    T  + APEVI    Y +  
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 217 DVFSFAIVLWELVTAKV 233
           D++S   ++ E++   V
Sbjct: 207 DIWSVGCIMGEMIKGGV 223

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 111/228 (48%), Gaps = 18/228 (7%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+ +  + +   + SG+ G +   +    G+ VA+K L     ++       +E+ +L+
Sbjct: 20  WELPKTYV-SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLK 78
Query: 91  EVQHRNVVRFIGASTKSPHLCIVTEY---MPGGSLYDYLHKNHNVLKLPQLLRFAI-DIC 146
            +QH NV+  +   T +  L    ++   MP   +   L K   +    + +++ +  + 
Sbjct: 79  HMQHENVIGLLDVFTPASSLRNFYDFYLVMP--FMQTDLQKIMGLKFSEEKIQYLVYQML 136
Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEV 206
           KG++Y+H   ++HRDLK  NL ++    +K+ DFG+AR  +    MT    T  + APEV
Sbjct: 137 KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVVTRWYRAPEV 194
Query: 207 I-NHQPYDQKADVFSFAIVLWELVTAKVPY------DSMTPLQAALGV 247
           I +   Y+Q  D++S   ++ E++T K  +      D +T +    GV
Sbjct: 195 ILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 242

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 14  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 124
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +        T  Y
Sbjct: 125 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRWY 184
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
           R  APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 185 R--APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 92/185 (49%), Gaps = 17/185 (9%)
Query: 61  GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGG 120
           GQ+ A K++ ++ L+     +  +E  I R ++H N+VR   + ++     +V + + GG
Sbjct: 29  GQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGG 88
Query: 121 SLY------DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN- 173
            L+      +Y  +      + Q+L       + + + H   I+HRDLK  NLL+ + + 
Sbjct: 89  ELFEDIVAREYYSEADASHCIQQIL-------ESVNHCHLNGIVHRDLKPENLLLASKSK 141
Query: 174 --VVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
              VK+ADFG+A   Q          GT  +++PEV+   PY +  D+++  ++L+ L+ 
Sbjct: 142 GAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLV 201
Query: 231 AKVPY 235
              P+
Sbjct: 202 GYPPF 206

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 46  IASGSCGDL---YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G +   Y  + L ++VA+K L     N T      +E+ +++ V H+N++  + 
Sbjct: 33  IGSGAQGIVCAAYDAI-LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 91
Query: 103 ASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
             T    L       IV E M   +L   +    +  ++  LL     +  G+++LH   
Sbjct: 92  VFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLL---YQMLCGIKHLHSAG 147
Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKA 216
           IIHRDLK +N+++ +   +K+ DFG+AR      +MT    T  + APEVI    Y +  
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 207
Query: 217 DVFSFAIVLWELVTAKV 233
           D++S   ++ E++   V
Sbjct: 208 DIWSVGCIMGEMIKGGV 224

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 18  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 128
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +        T  Y
Sbjct: 129 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRWY 188
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
           R  APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 189 R--APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 92/185 (49%), Gaps = 17/185 (9%)
Query: 61  GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGG 120
           GQ+ A K++ ++ L+     +  +E  I R ++H N+VR   + ++     +V + + GG
Sbjct: 29  GQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGG 88
Query: 121 SLY------DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN- 173
            L+      +Y  +      + Q+L       + + + H   I+HRDLK  NLL+ + + 
Sbjct: 89  ELFEDIVAREYYSEADASHCIQQIL-------ESVNHCHLNGIVHRDLKPENLLLASKSK 141
Query: 174 --VVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
              VK+ADFG+A   Q          GT  +++PEV+   PY +  D+++  ++L+ L+ 
Sbjct: 142 GAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLV 201
Query: 231 AKVPY 235
              P+
Sbjct: 202 GYPPF 206

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 18  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 128
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +        T  Y
Sbjct: 129 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRWY 188
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
           R  APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 189 R--APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 82/157 (52%), Gaps = 8/157 (5%)
Query: 85  EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAID 144
           E+ IL+++ H  +++ I     +    IV E M GG L+D +  N  + +    L F   
Sbjct: 204 EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQ 261
Query: 145 ICKGMEYLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRW 201
           +   ++YLH+  IIHRDLK  N+L+ +     ++K+ DFG ++   +  +M    GT  +
Sbjct: 262 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 321
Query: 202 MAPEV---INHQPYDQKADVFSFAIVLWELVTAKVPY 235
           +APEV   +    Y++  D +S  ++L+  ++   P+
Sbjct: 322 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 358

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 113/233 (48%), Gaps = 20/233 (8%)
Query: 19  AVEKAIESQTKSED-----WEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVK 67
           +++K +E+ + + D     + ID    + G  +  G  G+    VYL ++      VA+K
Sbjct: 1   SMQKVMENSSGTPDILTRHFTIDD--FEIGRPLGKGKFGN----VYLAREKKSHFIVALK 54
Query: 68  VL-RSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL 126
           VL +S+   + +E +  +E+ I   + H N++R          + ++ EY P G LY  L
Sbjct: 55  VLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL 114
Query: 127 HKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ 186
            K+       +      ++   + Y H + +IHRD+K  NLL+     +K+ADFG +   
Sbjct: 115 QKS-CTFDEQRTATIMEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHA 173
Query: 187 NKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
                 T   GT  ++ PE+I  + +++K D++   ++ +EL+    P++S +
Sbjct: 174 PSLRRKTM-CGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESAS 225

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 46  IASGSCGDL---YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G +   Y  + L ++VA+K L     N T      +E+ +++ V H+N++  + 
Sbjct: 32  IGSGAQGIVCAAYDAI-LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 90
Query: 103 ASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
             T    L       IV E M   +L   +    +  ++  LL     +  G+++LH   
Sbjct: 91  VFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLL---YQMLCGIKHLHSAG 146
Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKA 216
           IIHRDLK +N+++ +   +K+ DFG+AR      +MT    T  + APEVI    Y +  
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 217 DVFSFAIVLWELVTAKV 233
           D++S   ++ E++   V
Sbjct: 207 DIWSVGCIMGEMIKGGV 223

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 96/197 (48%), Gaps = 14/197 (7%)
Query: 46  IASGSCGDL---YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G +   Y  + L ++VA+K L     N T      +E+ +++ V H+N++  + 
Sbjct: 32  IGSGAQGIVCAAYDAI-LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 90
Query: 103 ASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
             T    L       IV E M   +L   +    +  ++  LL     +  G+++LH   
Sbjct: 91  VFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLL---YQMLCGIKHLHSAG 146
Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKA 216
           IIHRDLK +N+++ +   +K+ DFG+AR      +MT    T  + APEVI    Y +  
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV 206
Query: 217 DVFSFAIVLWELVTAKV 233
           D++S   ++ E++   V
Sbjct: 207 DIWSVGCIMGEMIKGGV 223

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 82/157 (52%), Gaps = 8/157 (5%)
Query: 85  EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAID 144
           E+ IL+++ H  +++ I     +    IV E M GG L+D +  N  + +    L F   
Sbjct: 190 EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQ 247
Query: 145 ICKGMEYLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRW 201
           +   ++YLH+  IIHRDLK  N+L+ +     ++K+ DFG ++   +  +M    GT  +
Sbjct: 248 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 307
Query: 202 MAPEV---INHQPYDQKADVFSFAIVLWELVTAKVPY 235
           +APEV   +    Y++  D +S  ++L+  ++   P+
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 344

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 79/155 (50%), Gaps = 4/155 (2%)
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
           +E+ I++ ++H  +V    +      + +V + + GG L  +L +N +  K   +  F  
Sbjct: 64  KELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVH-FKEETVKLFIC 122
Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMA 203
           ++   ++YL  + IIHRD+K  N+L+D H  V + DF +A    +   +T   GT  +MA
Sbjct: 123 ELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMA 182
Query: 204 PEVINHQP---YDQKADVFSFAIVLWELVTAKVPY 235
           PE+ + +    Y    D +S  +  +EL+  + PY
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 18  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 128
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ D+G+AR  +    MT    T 
Sbjct: 129 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE--MTGYVATR 186
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 17/200 (8%)
Query: 45  RIASGSCGDLYR--GVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           R+  GS G+++R      G   AVK +R       LE   V+E+     +    +V   G
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVR-------LEVFRVEELVACAGLSSPRIVPLYG 117
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
           A  + P + I  E + GGSL   L K    L   + L +     +G+EYLH R I+H D+
Sbjct: 118 AVREGPWVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 176
Query: 163 KTANLLMDTHNV-VKVADFGVARFQNKGG----VMTAE--TGTYRWMAPEVINHQPYDQK 215
           K  N+L+ +      + DFG A      G    ++T +   GT   MAPEV+  +P D K
Sbjct: 177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 236
Query: 216 ADVFSFAIVLWELVTAKVPY 235
            D++S   ++  ++    P+
Sbjct: 237 VDIWSSCCMMLHMLNGCHPW 256

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 84/160 (52%), Gaps = 13/160 (8%)
Query: 83  VQEVAILREVQHRNVV---RFIGAST--KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
           ++E+ IL   +H N++     I A T  +   + IV + M    LY  L   H  L    
Sbjct: 73  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDH 129
Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG----GVMT 193
           +  F   I +G++Y+H  N++HRDLK +NLL++T   +K+ DFG+AR  +      G + 
Sbjct: 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLX 189
Query: 194 AETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
               T  + APE+ +N + Y +  D++S   +L E+++ +
Sbjct: 190 EXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 84/160 (52%), Gaps = 13/160 (8%)
Query: 83  VQEVAILREVQHRNVV---RFIGAST--KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
           ++E+ IL   +H N++     I A T  +   + IV + M    LY  L   H  L    
Sbjct: 74  LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQH--LSNDH 130
Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG----GVMT 193
           +  F   I +G++Y+H  N++HRDLK +NLL++T   +K+ DFG+AR  +      G + 
Sbjct: 131 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLX 190
Query: 194 AETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
               T  + APE+ +N + Y +  D++S   +L E+++ +
Sbjct: 191 EXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 109/216 (50%), Gaps = 27/216 (12%)
Query: 33  WEIDRRLLKTGER-IASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           WE+ +RL   G R + SG+ G +       L Q VAVK L     +        +E+ +L
Sbjct: 24  WEVPQRL--QGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLL 81
Query: 90  REVQHRNVVRFIGASTKS------PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQL----L 139
           + ++H NV+  +   T +        + +VT  M G  L       +N++K   L    +
Sbjct: 82  KHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM-GADL-------NNIVKCQALSDEHV 133
Query: 140 RFAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT 198
           +F +  + +G++Y+H   IIHRDLK +N+ ++  + +++ DFG+AR  ++   MT    T
Sbjct: 134 QFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE--MTGYVAT 191
Query: 199 YRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAKV 233
             + APE+ +N   Y+Q  D++S   ++ EL+  K 
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKA 227

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 17/200 (8%)
Query: 45  RIASGSCGDLYR--GVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           R+  GS G+++R      G   AVK +R       LE   V+E+     +    +V   G
Sbjct: 81  RVGRGSFGEVHRMKDKQTGFQCAVKKVR-------LEVFRVEELVACAGLSSPRIVPLYG 133
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
           A  + P + I  E + GGSL   L K    L   + L +     +G+EYLH R I+H D+
Sbjct: 134 AVREGPWVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 192
Query: 163 KTANLLMDTHNV-VKVADFGVARFQNKGG----VMTAE--TGTYRWMAPEVINHQPYDQK 215
           K  N+L+ +      + DFG A      G    ++T +   GT   MAPEV+  +P D K
Sbjct: 193 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 252
Query: 216 ADVFSFAIVLWELVTAKVPY 235
            D++S   ++  ++    P+
Sbjct: 253 VDIWSSCCMMLHMLNGCHPW 272

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 97/203 (47%), Gaps = 9/203 (4%)
Query: 40  LKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFV-QEVAILREVQHRN 96
            K G+ +  GS     L R +   ++ A+K+L   H+    +  +V +E  ++  + H  
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQR 155
            V+          L     Y   G L  Y+ K  +  +     RF   +I   +EYLH +
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE--TCTRFYTAEIVSALEYLHGK 152
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARF---QNKGGVMTAETGTYRWMAPEVINHQPY 212
            IIHRDLK  N+L++    +++ DFG A+    ++K     +  GT ++++PE++  +  
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 212
Query: 213 DQKADVFSFAIVLWELVTAKVPY 235
            + +D+++   ++++LV    P+
Sbjct: 213 CKSSDLWALGCIIYQLVAGLPPF 235

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 96/203 (47%), Gaps = 9/203 (4%)
Query: 40  LKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFV-QEVAILREVQHRN 96
            K G+ +  GS     L R +   ++ A+K+L   H+    +  +V +E  ++  + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQR 155
            V+          L     Y   G L  Y+ K  +  +     RF   +I   +EYLH +
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE--TCTRFYTAEIVSALEYLHGK 151
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARF---QNKGGVMTAETGTYRWMAPEVINHQPY 212
            IIHRDLK  N+L++    +++ DFG A+    ++K        GT ++++PE++  +  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 213 DQKADVFSFAIVLWELVTAKVPY 235
            + +D+++   ++++LV    P+
Sbjct: 212 XKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 97/203 (47%), Gaps = 9/203 (4%)
Query: 40  LKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFV-QEVAILREVQHRN 96
            K G+ +  GS     L R +   ++ A+K+L   H+    +  +V +E  ++  + H  
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQR 155
            V+          L     Y   G L  Y+ K  +  +     RF   +I   +EYLH +
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE--TCTRFYTAEIVSALEYLHGK 148
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARF---QNKGGVMTAETGTYRWMAPEVINHQPY 212
            IIHRDLK  N+L++    +++ DFG A+    ++K     +  GT ++++PE++  +  
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 208
Query: 213 DQKADVFSFAIVLWELVTAKVPY 235
            + +D+++   ++++LV    P+
Sbjct: 209 CKSSDLWALGCIIYQLVAGLPPF 231

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 17/200 (8%)
Query: 45  RIASGSCGDLYR--GVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           R+  GS G+++R      G   AVK +R       LE   V+E+     +    +V   G
Sbjct: 79  RLGRGSFGEVHRMKDKQTGFQCAVKKVR-------LEVFRVEELVACAGLSSPRIVPLYG 131
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
           A  + P + I  E + GGSL   L K    L   + L +     +G+EYLH R I+H D+
Sbjct: 132 AVREGPWVNIFMELLEGGSL-GQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 190
Query: 163 KTANLLMDTHNV-VKVADFGVARFQNKGG----VMTAE--TGTYRWMAPEVINHQPYDQK 215
           K  N+L+ +      + DFG A      G    ++T +   GT   MAPEV+  +P D K
Sbjct: 191 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 250
Query: 216 ADVFSFAIVLWELVTAKVPY 235
            D++S   ++  ++    P+
Sbjct: 251 VDIWSSCCMMLHMLNGCHPW 270

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 84/160 (52%), Gaps = 13/160 (8%)
Query: 83  VQEVAILREVQHRNVV---RFIGASTKSP--HLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
           ++E+ IL   +H NV+     + AST      + IV + M    LY  L      L    
Sbjct: 89  LREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLM-ETDLYKLLKSQQ--LSNDH 145
Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK----GGVMT 193
           +  F   I +G++Y+H  N++HRDLK +NLL++T   +K+ DFG+AR  +      G +T
Sbjct: 146 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLT 205
Query: 194 AETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
               T  + APE+ +N + Y +  D++S   +L E+++ +
Sbjct: 206 EXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 86/177 (48%), Gaps = 27/177 (15%)
Query: 80  DEFVQEVAILREVQHRNVVRFIGA------------STKSPHLCIVTEYMPGGSLYDYLH 127
           ++ ++EV  L +++H  +VR+  A            S+   +L I  +     +L D+++
Sbjct: 48  EKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN 107
Query: 128 KNHNVLKLPQ--LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF 185
               + +  +   L   + I + +E+LH + ++HRDLK +N+     +VVKV DFG+   
Sbjct: 108 GRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 167
Query: 186 QNKG-------------GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELV 229
            ++                 T + GT  +M+PE I+   Y  K D+FS  ++L+EL+
Sbjct: 168 MDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E I  G+   + R V L  G + A K++ ++ L+     +  +E  I R ++H N+VR  
Sbjct: 10  EDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLH 69
Query: 102 GASTKSPHLCIVTEYMPGGSLY------DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR 155
            + ++     +V + + GG L+      +Y  +      + Q+L   +       + HQ 
Sbjct: 70  DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVL-------HCHQM 122
Query: 156 NIIHRDLKTANLLMDTH---NVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQP 211
            ++HRDLK  NLL+ +      VK+ADFG+A   Q          GT  +++PEV+  + 
Sbjct: 123 GVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEA 182
Query: 212 YDQKADVFSFAIVLWELVTAKVPY 235
           Y +  D+++  ++L+ L+    P+
Sbjct: 183 YGKPVDIWACGVILYILLVGYPPF 206

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 27/216 (12%)
Query: 33  WEIDRRLLKTGER-IASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           WE+ +RL   G R + SG+ G +       L Q VAVK L     +        +E+ +L
Sbjct: 24  WEVPQRL--QGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLL 81
Query: 90  REVQHRNVVRFIGASTKS------PHLCIVTEYMPGGSLYDY-----LHKNHNVLKLPQL 138
           + ++H NV+  +   T +        + +VT  M G  L +      L   H    + QL
Sbjct: 82  KHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKSQALSDEHVQFLVYQL 140
Query: 139 LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT 198
           LR       G++Y+H   IIHRDLK +N+ ++  + +++ DFG+AR  ++   MT    T
Sbjct: 141 LR-------GLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE--MTGYVAT 191
Query: 199 YRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAKV 233
             + APE+ +N   Y+Q  D++S   ++ EL+  K 
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKA 227

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 41  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 99
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 100 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 151
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +    M     T 
Sbjct: 152 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MXGYVATR 209
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 210 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 96/203 (47%), Gaps = 9/203 (4%)
Query: 40  LKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFV-QEVAILREVQHRN 96
            K G+ +  GS     L R +   ++ A+K+L   H+    +  +V +E  ++  + H  
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQR 155
            V+          L     Y   G L  Y+ K  +  +     RF   +I   +EYLH +
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE--TCTRFYTAEIVSALEYLHGK 149
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARF---QNKGGVMTAETGTYRWMAPEVINHQPY 212
            IIHRDLK  N+L++    +++ DFG A+    ++K        GT ++++PE++  +  
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 213 DQKADVFSFAIVLWELVTAKVPY 235
            + +D+++   ++++LV    P+
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPF 232

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 96/203 (47%), Gaps = 9/203 (4%)
Query: 40  LKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFV-QEVAILREVQHRN 96
            K G+ +  GS     L R +   ++ A+K+L   H+    +  +V +E  ++  + H  
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 71
Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQR 155
            V+          L     Y   G L  Y+ K  +  +     RF   +I   +EYLH +
Sbjct: 72  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE--TCTRFYTAEIVSALEYLHGK 129
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARF---QNKGGVMTAETGTYRWMAPEVINHQPY 212
            IIHRDLK  N+L++    +++ DFG A+    ++K        GT ++++PE++  +  
Sbjct: 130 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 189
Query: 213 DQKADVFSFAIVLWELVTAKVPY 235
            + +D+++   ++++LV    P+
Sbjct: 190 CKSSDLWALGCIIYQLVAGLPPF 212

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 96/203 (47%), Gaps = 9/203 (4%)
Query: 40  LKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFV-QEVAILREVQHRN 96
            K G+ +  GS     L R +   ++ A+K+L   H+    +  +V +E  ++  + H  
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 68
Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQR 155
            V+          L     Y   G L  Y+ K  +  +     RF   +I   +EYLH +
Sbjct: 69  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE--TCTRFYTAEIVSALEYLHGK 126
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARF---QNKGGVMTAETGTYRWMAPEVINHQPY 212
            IIHRDLK  N+L++    +++ DFG A+    ++K        GT ++++PE++  +  
Sbjct: 127 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 186
Query: 213 DQKADVFSFAIVLWELVTAKVPY 235
            + +D+++   ++++LV    P+
Sbjct: 187 CKSSDLWALGCIIYQLVAGLPPF 209

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 93/188 (49%), Gaps = 17/188 (9%)
Query: 58  VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYM 117
           V  GQ+ A  ++ ++ L+     +  +E  I R ++H N+VR   + ++  H  ++ + +
Sbjct: 33  VLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLV 92
Query: 118 PGGSLY------DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT 171
            GG L+      +Y  +      + Q+L   +       + HQ  ++HR+LK  NLL+ +
Sbjct: 93  TGGELFEDIVAREYYSEADASHCIQQILEAVL-------HCHQMGVVHRNLKPENLLLAS 145
Query: 172 H---NVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWE 227
                 VK+ADFG+A   + +        GT  +++PEV+   PY +  D+++  ++L+ 
Sbjct: 146 KLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYI 205
Query: 228 LVTAKVPY 235
           L+    P+
Sbjct: 206 LLVGYPPF 213

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 96/203 (47%), Gaps = 9/203 (4%)
Query: 40  LKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFV-QEVAILREVQHRN 96
            K G+ +  GS     L R +   ++ A+K+L   H+    +  +V +E  ++  + H  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQR 155
            V+          L     Y   G L  Y+ K  +  +     RF   +I   +EYLH +
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE--TCTRFYTAEIVSALEYLHGK 127
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARF---QNKGGVMTAETGTYRWMAPEVINHQPY 212
            IIHRDLK  N+L++    +++ DFG A+    ++K        GT ++++PE++  +  
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 187
Query: 213 DQKADVFSFAIVLWELVTAKVPY 235
            + +D+++   ++++LV    P+
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPF 210

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 96/203 (47%), Gaps = 9/203 (4%)
Query: 40  LKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFV-QEVAILREVQHRN 96
            K G+ +  GS     L R +   ++ A+K+L   H+    +  +V +E  ++  + H  
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 75
Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQR 155
            V+          L     Y   G L  Y+ K  +  +     RF   +I   +EYLH +
Sbjct: 76  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE--TCTRFYTAEIVSALEYLHGK 133
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARF---QNKGGVMTAETGTYRWMAPEVINHQPY 212
            IIHRDLK  N+L++    +++ DFG A+    ++K        GT ++++PE++  +  
Sbjct: 134 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 193
Query: 213 DQKADVFSFAIVLWELVTAKVPY 235
            + +D+++   ++++LV    P+
Sbjct: 194 CKSSDLWALGCIIYQLVAGLPPF 216

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 96/203 (47%), Gaps = 9/203 (4%)
Query: 40  LKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFV-QEVAILREVQHRN 96
            K G+ +  GS     L R +   ++ A+K+L   H+    +  +V +E  ++  + H  
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQR 155
            V+          L     Y   G L  Y+ K  +  +     RF   +I   +EYLH +
Sbjct: 99  FVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE--TCTRFYTAEIVSALEYLHGK 156
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARF---QNKGGVMTAETGTYRWMAPEVINHQPY 212
            IIHRDLK  N+L++    +++ DFG A+    ++K        GT ++++PE++  +  
Sbjct: 157 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 216
Query: 213 DQKADVFSFAIVLWELVTAKVPY 235
            + +D+++   ++++LV    P+
Sbjct: 217 CKSSDLWALGCIIYQLVAGLPPF 239

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 96/203 (47%), Gaps = 9/203 (4%)
Query: 40  LKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFV-QEVAILREVQHRN 96
            K G+ +  GS     L R +   ++ A+K+L   H+    +  +V +E  ++  + H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQR 155
            V+          L     Y   G L  Y+ K  +  +     RF   +I   +EYLH +
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE--TCTRFYTAEIVSALEYLHGK 149
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARF---QNKGGVMTAETGTYRWMAPEVINHQPY 212
            IIHRDLK  N+L++    +++ DFG A+    ++K        GT ++++PE++  +  
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 213 DQKADVFSFAIVLWELVTAKVPY 235
            + +D+++   ++++LV    P+
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPF 232

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 96/203 (47%), Gaps = 9/203 (4%)
Query: 40  LKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFV-QEVAILREVQHRN 96
            K G+ +  GS     L R +   ++ A+K+L   H+    +  +V +E  ++  + H  
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 70
Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQR 155
            V+          L     Y   G L  Y+ K  +  +     RF   +I   +EYLH +
Sbjct: 71  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE--TCTRFYTAEIVSALEYLHGK 128
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARF---QNKGGVMTAETGTYRWMAPEVINHQPY 212
            IIHRDLK  N+L++    +++ DFG A+    ++K        GT ++++PE++  +  
Sbjct: 129 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 188
Query: 213 DQKADVFSFAIVLWELVTAKVPY 235
            + +D+++   ++++LV    P+
Sbjct: 189 CKSSDLWALGCIIYQLVAGLPPF 211

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 96/203 (47%), Gaps = 9/203 (4%)
Query: 40  LKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFV-QEVAILREVQHRN 96
            K G+ +  GS     L R +   ++ A+K+L   H+    +  +V +E  ++  + H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQR 155
            V+          L     Y   G L  Y+ K  +  +     RF   +I   +EYLH +
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE--TCTRFYTAEIVSALEYLHGK 149
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARF---QNKGGVMTAETGTYRWMAPEVINHQPY 212
            IIHRDLK  N+L++    +++ DFG A+    ++K        GT ++++PE++  +  
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 213 DQKADVFSFAIVLWELVTAKVPY 235
            + +D+++   ++++LV    P+
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 96/203 (47%), Gaps = 9/203 (4%)
Query: 40  LKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFV-QEVAILREVQHRN 96
            K G+ +  GS     L R +   ++ A+K+L   H+    +  +V +E  ++  + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQR 155
            V+          L     Y   G L  Y+ K  +  +     RF   +I   +EYLH +
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE--TCTRFYTAEIVSALEYLHGK 151
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARF---QNKGGVMTAETGTYRWMAPEVINHQPY 212
            IIHRDLK  N+L++    +++ DFG A+    ++K        GT ++++PE++  +  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 213 DQKADVFSFAIVLWELVTAKVPY 235
            + +D+++   ++++LV    P+
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 96/203 (47%), Gaps = 9/203 (4%)
Query: 40  LKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFV-QEVAILREVQHRN 96
            K G+ +  GS     L R +   ++ A+K+L   H+    +  +V +E  ++  + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQR 155
            V+          L     Y   G L  Y+ K  +  +     RF   +I   +EYLH +
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE--TCTRFYTAEIVSALEYLHGK 151
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARF---QNKGGVMTAETGTYRWMAPEVINHQPY 212
            IIHRDLK  N+L++    +++ DFG A+    ++K        GT ++++PE++  +  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 213 DQKADVFSFAIVLWELVTAKVPY 235
            + +D+++   ++++LV    P+
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 96/203 (47%), Gaps = 9/203 (4%)
Query: 40  LKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFV-QEVAILREVQHRN 96
            K G+ +  GS     L R +   ++ A+K+L   H+    +  +V +E  ++  + H  
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQR 155
            V+          L     Y   G L  Y+ K  +  +     RF   +I   +EYLH +
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE--TCTRFYTAEIVSALEYLHGK 148
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARF---QNKGGVMTAETGTYRWMAPEVINHQPY 212
            IIHRDLK  N+L++    +++ DFG A+    ++K        GT ++++PE++  +  
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 208
Query: 213 DQKADVFSFAIVLWELVTAKVPY 235
            + +D+++   ++++LV    P+
Sbjct: 209 CKSSDLWALGCIIYQLVAGLPPF 231

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 96/203 (47%), Gaps = 9/203 (4%)
Query: 40  LKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFV-QEVAILREVQHRN 96
            K G+ +  GS     L R +   ++ A+K+L   H+    +  +V +E  ++  + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQR 155
            V+          L     Y   G L  Y+ K  +  +     RF   +I   +EYLH +
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE--TCTRFYTAEIVSALEYLHGK 151
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARF---QNKGGVMTAETGTYRWMAPEVINHQPY 212
            IIHRDLK  N+L++    +++ DFG A+    ++K        GT ++++PE++  +  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 213 DQKADVFSFAIVLWELVTAKVPY 235
            + +D+++   ++++LV    P+
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 96/203 (47%), Gaps = 9/203 (4%)
Query: 40  LKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFV-QEVAILREVQHRN 96
            K G+ +  GS     L R +   ++ A+K+L   H+    +  +V +E  ++  + H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQR 155
            V+          L     Y   G L  Y+ K  +  +     RF   +I   +EYLH +
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE--TCTRFYTAEIVSALEYLHGK 151
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARF---QNKGGVMTAETGTYRWMAPEVINHQPY 212
            IIHRDLK  N+L++    +++ DFG A+    ++K        GT ++++PE++  +  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 213 DQKADVFSFAIVLWELVTAKVPY 235
            + +D+++   ++++LV    P+
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 96/203 (47%), Gaps = 9/203 (4%)
Query: 40  LKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFV-QEVAILREVQHRN 96
            K G+ +  GS     L R +   ++ A+K+L   H+    +  +V +E  ++  + H  
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQR 155
            V+          L     Y   G L  Y+ K  +  +     RF   +I   +EYLH +
Sbjct: 97  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE--TCTRFYTAEIVSALEYLHGK 154
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARF---QNKGGVMTAETGTYRWMAPEVINHQPY 212
            IIHRDLK  N+L++    +++ DFG A+    ++K        GT ++++PE++  +  
Sbjct: 155 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 214
Query: 213 DQKADVFSFAIVLWELVTAKVPY 235
            + +D+++   ++++LV    P+
Sbjct: 215 CKSSDLWALGCIIYQLVAGLPPF 237

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 24/202 (11%)
Query: 46  IASGSCGDLYRGVYLG--QDVAVKVLRSEHLNDTLEDEFVQ-EVAILREVQHRNVVRFIG 102
           +  G+   +YR    G  +  A+KVL+      T++ + V+ E+ +L  + H N+++   
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKK-----TVDKKIVRTEIGVLLRLSHPNIIKLKE 115
Query: 103 ASTKSPHLCIVTEYMPGGSLYD------YLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
                  + +V E + GG L+D      Y  +      + Q+L       + + YLH+  
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL-------EAVAYLHENG 168
Query: 157 IIHRDLKTANLLMDT---HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYD 213
           I+HRDLK  NLL  T      +K+ADFG+++      +M    GT  + APE++    Y 
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYG 228
Query: 214 QKADVFSFAIVLWELVTAKVPY 235
            + D++S  I+ + L+    P+
Sbjct: 229 PEVDMWSVGIITYILLCGFEPF 250

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 96/203 (47%), Gaps = 9/203 (4%)
Query: 40  LKTGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFV-QEVAILREVQHRN 96
            K G+ +  GS     L R +   ++ A+K+L   H+    +  +V +E  ++  + H  
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQR 155
            V+          L     Y   G L  Y+ K  +  +     RF   +I   +EYLH +
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE--TCTRFYTAEIVSALEYLHGK 152
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARF---QNKGGVMTAETGTYRWMAPEVINHQPY 212
            IIHRDLK  N+L++    +++ DFG A+    ++K        GT ++++PE++  +  
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 212
Query: 213 DQKADVFSFAIVLWELVTAKVPY 235
            + +D+++   ++++LV    P+
Sbjct: 213 CKSSDLWALGCIIYQLVAGLPPF 235

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 15/201 (7%)
Query: 46  IASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDT---LEDEFVQEVAILREVQ---HRNV 97
           I  G+ G +Y  R  + G  VA+K +R  +       L    V+EVA+LR ++   H NV
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 98  VRFIGASTKSP-----HLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICKGMEY 151
           VR +     S       + +V E++    L  YL K     L    +        +G+++
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 135
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQP 211
           LH   I+HRDLK  N+L+ +   VK+ADFG+AR  +    +T    T  + APEV+    
Sbjct: 136 LHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQST 195
Query: 212 YDQKADVFSFAIVLWELVTAK 232
           Y    D++S   +  E+   K
Sbjct: 196 YATPVDMWSVGCIFAEMFRRK 216

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 18  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 128
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ DF +AR  +    MT    T 
Sbjct: 129 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE--MTGYVATR 186
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 18  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 128
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+  FG+AR  +    MT    T 
Sbjct: 129 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE--MTGYVATR 186
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 108/216 (50%), Gaps = 27/216 (12%)
Query: 33  WEIDRRLLKTGER-IASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           WE+ +RL   G R + SG+ G +       L Q VAVK L     +        +E+ +L
Sbjct: 16  WEVPQRL--QGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLL 73
Query: 90  REVQHRNVVRFIGASTKS------PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQL----L 139
           + ++H NV+  +   T +        + +VT  M G  L       +N++K   L    +
Sbjct: 74  KHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM-GADL-------NNIVKCQALSDEHV 125
Query: 140 RFAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT 198
           +F +  + +G++Y+H   IIHRDLK +N+ ++    +++ DFG+AR  ++   MT    T
Sbjct: 126 QFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEE--MTGYVAT 183
Query: 199 YRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAKV 233
             + APE+ +N   Y+Q  D++S   ++ EL+  K 
Sbjct: 184 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKA 219

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 99/197 (50%), Gaps = 17/197 (8%)
Query: 46  IASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHR------NV 97
           I  GS G + +     + Q VA+K++R+E        +  +E+ IL  ++ +      NV
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRN 156
           +  +   T   H+C+  E +   +LY+ + KN      LP + +FA  I + ++ LH+  
Sbjct: 162 IHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR 220
Query: 157 IIHRDLKTANLLMDTH--NVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQ 214
           IIH DLK  N+L+     + +KV DFG + ++++      ++  YR  APEVI    Y  
Sbjct: 221 IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRFYR--APEVILGARYGM 278
Query: 215 KADVFSFAIVLWELVTA 231
             D++S   +L EL+T 
Sbjct: 279 PIDMWSLGCILAELLTG 295

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 99/197 (50%), Gaps = 17/197 (8%)
Query: 46  IASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHR------NV 97
           I  GS G + +     + Q VA+K++R+E        +  +E+ IL  ++ +      NV
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRN 156
           +  +   T   H+C+  E +   +LY+ + KN      LP + +FA  I + ++ LH+  
Sbjct: 162 IHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR 220
Query: 157 IIHRDLKTANLLMDTH--NVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQ 214
           IIH DLK  N+L+     + +KV DFG + ++++      ++  YR  APEVI    Y  
Sbjct: 221 IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRFYR--APEVILGARYGM 278
Query: 215 KADVFSFAIVLWELVTA 231
             D++S   +L EL+T 
Sbjct: 279 PIDMWSLGCILAELLTG 295

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 10/199 (5%)
Query: 45  RIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           ++ SG+ GD  L      G +  +K +  +     +E +   E+ +L+ + H N+++   
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME-QIEAEIEVLKSLDHPNIIKIFE 87
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYL---HKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
                 ++ IV E   GG L + +         L    +      +   + Y H ++++H
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVH 147
Query: 160 RDLKTANLLM-DT--HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKA 216
           +DLK  N+L  DT  H+ +K+ DFG+A         T   GT  +MAPEV        K 
Sbjct: 148 KDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRD-VTFKC 206
Query: 217 DVFSFAIVLWELVTAKVPY 235
           D++S  +V++ L+T  +P+
Sbjct: 207 DIWSAGVVMYFLLTGCLPF 225

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 5/144 (3%)
Query: 110 LCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLL 168
           L I+ E M GG L+  +  +        +      DI   +++LH  NI HRD+K  NLL
Sbjct: 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 160
Query: 169 MDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVL 225
             +     V+K+ DFG A+   +  + T     Y ++APEV+  + YD+  D++S  +++
Sbjct: 161 YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIM 219
Query: 226 WELVTAKVPYDSMTPLQAALGVRQ 249
           + L+    P+ S T    + G+++
Sbjct: 220 YILLCGFPPFYSNTGQAISPGMKR 243

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 73/144 (50%), Gaps = 5/144 (3%)
Query: 110 LCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLL 168
           L I+ E M GG L+  +  +        +      DI   +++LH  NI HRD+K  NLL
Sbjct: 82  LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 141
Query: 169 MDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVL 225
             +     V+K+ DFG A+   +  + T     Y ++APEV+  + YD+  D++S  +++
Sbjct: 142 YTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIM 200
Query: 226 WELVTAKVPYDSMTPLQAALGVRQ 249
           + L+    P+ S T    + G+++
Sbjct: 201 YILLCGFPPFYSNTGQAISPGMKR 224

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 46  IASGSCGDL---YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           I SG+ G +   Y  + L ++VA+K L     N T      +E+ +++ V H+N++  + 
Sbjct: 34  IGSGAQGIVCAAYDAI-LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 92
Query: 103 ASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
             T    L       IV E M   +L   +    +  ++  LL     +  G+++LH   
Sbjct: 93  VFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLL---YQMLCGIKHLHSAG 148
Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKA 216
           IIHRDLK +N+++ +   +K+ DFG+AR      +M     T  + APEVI    Y +  
Sbjct: 149 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMGYKENV 208
Query: 217 DVFSFAIVLWELVTAKV 233
           D++S   ++ E++   V
Sbjct: 209 DIWSVGCIMGEMIKGGV 225

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 18  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 128
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ D G+AR  +    MT    T 
Sbjct: 129 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE--MTGYVATR 186
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 92/179 (51%), Gaps = 15/179 (8%)
Query: 62  QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHR------NVVRFIGASTKSPHLCIVTE 115
           Q VA+K++R+E        +  +E+ IL  ++ +      NV+  +   T   H+C+  E
Sbjct: 123 QHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFE 179
Query: 116 YMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH-- 172
            +   +LY+ + KN      LP + +FA  I + ++ LH+  IIH DLK  N+L+     
Sbjct: 180 LL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR 238
Query: 173 NVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTA 231
           + +KV DFG + ++++      ++  YR  APEVI    Y    D++S   +L EL+T 
Sbjct: 239 SGIKVIDFGSSCYEHQRVYXXIQSRFYR--APEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 18  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 128
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ D G+AR  +    MT    T 
Sbjct: 129 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE--MTGYVATR 186
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 25/214 (11%)
Query: 33  WEIDRRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 18  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 91  EVQHRNVVRFIGASTKSPHL------CIVTEYMPGGSLYDYLHKNHNVLKLPQL----LR 140
            ++H NV+  +   T +  L       +VT  M G  L       +N++K  +L    ++
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-------NNIVKCQKLTDDHVQ 128
Query: 141 FAI-DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           F I  I +G++Y+H  +IIHRDLK +NL ++    +K+ D G+AR  +    MT    T 
Sbjct: 129 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE--MTGYVATR 186
Query: 200 RWMAPEV-INHQPYDQKADVFSFAIVLWELVTAK 232
            + APE+ +N   Y+Q  D++S   ++ EL+T +
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 92/193 (47%), Gaps = 9/193 (4%)
Query: 45  RIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           +I  GS G ++  R    GQ VA+K       +  ++   ++E+ +L++++H N+V  + 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI--DICKGMEYLHQRNIIHR 160
              +   L +V EY     L++       V   P+ L  +I     + + + H+ N IHR
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLHELDRYQRGV---PEHLVKSITWQTLQAVNFCHKHNCIHR 126
Query: 161 DLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWM-APE-VINHQPYDQKADV 218
           D+K  N+L+  H+V+K+ DFG AR          +    RW  +PE ++    Y    DV
Sbjct: 127 DVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDV 186
Query: 219 FSFAIVLWELVTA 231
           ++   V  EL++ 
Sbjct: 187 WAIGCVFAELLSG 199

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 72/143 (50%), Gaps = 4/143 (2%)
Query: 110 LCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLL 168
           L IV E + GG L+  +  +        +       I + ++YLH  NI HRD+K  NLL
Sbjct: 104 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 163
Query: 169 MDT---HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVL 225
             +   + ++K+ DFG A+       +T    T  ++APEV+  + YD+  D++S  +++
Sbjct: 164 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 223
Query: 226 WELVTAKVPYDSMTPLQAALGVR 248
           + L+    P+ S   L  + G++
Sbjct: 224 YILLCGYPPFYSNHGLAISPGMK 246

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 72/143 (50%), Gaps = 4/143 (2%)
Query: 110 LCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLL 168
           L IV E + GG L+  +  +        +       I + ++YLH  NI HRD+K  NLL
Sbjct: 89  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 148
Query: 169 MDT---HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVL 225
             +   + ++K+ DFG A+       +T    T  ++APEV+  + YD+  D++S  +++
Sbjct: 149 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 208
Query: 226 WELVTAKVPYDSMTPLQAALGVR 248
           + L+    P+ S   L  + G++
Sbjct: 209 YILLCGYPPFYSNHGLAISPGMK 231

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 72/143 (50%), Gaps = 4/143 (2%)
Query: 110 LCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLL 168
           L IV E + GG L+  +  +        +       I + ++YLH  NI HRD+K  NLL
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 147
Query: 169 MDT---HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVL 225
             +   + ++K+ DFG A+       +T    T  ++APEV+  + YD+  D++S  +++
Sbjct: 148 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 207
Query: 226 WELVTAKVPYDSMTPLQAALGVR 248
           + L+    P+ S   L  + G++
Sbjct: 208 YILLCGYPPFYSNHGLAISPGMK 230

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 72/143 (50%), Gaps = 4/143 (2%)
Query: 110 LCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLL 168
           L IV E + GG L+  +  +        +       I + ++YLH  NI HRD+K  NLL
Sbjct: 140 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 199
Query: 169 MDT---HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVL 225
             +   + ++K+ DFG A+       +T    T  ++APEV+  + YD+  D++S  +++
Sbjct: 200 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 259
Query: 226 WELVTAKVPYDSMTPLQAALGVR 248
           + L+    P+ S   L  + G++
Sbjct: 260 YILLCGYPPFYSNHGLAISPGMK 282

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 72/143 (50%), Gaps = 4/143 (2%)
Query: 110 LCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLL 168
           L IV E + GG L+  +  +        +       I + ++YLH  NI HRD+K  NLL
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149
Query: 169 MDT---HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVL 225
             +   + ++K+ DFG A+       +T    T  ++APEV+  + YD+  D++S  +++
Sbjct: 150 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 209
Query: 226 WELVTAKVPYDSMTPLQAALGVR 248
           + L+    P+ S   L  + G++
Sbjct: 210 YILLCGYPPFYSNHGLAISPGMK 232

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 72/143 (50%), Gaps = 4/143 (2%)
Query: 110 LCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLL 168
           L IV E + GG L+  +  +        +       I + ++YLH  NI HRD+K  NLL
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149
Query: 169 MDT---HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVL 225
             +   + ++K+ DFG A+       +T    T  ++APEV+  + YD+  D++S  +++
Sbjct: 150 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 209
Query: 226 WELVTAKVPYDSMTPLQAALGVR 248
           + L+    P+ S   L  + G++
Sbjct: 210 YILLCGYPPFYSNHGLAISPGMK 232

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 72/143 (50%), Gaps = 4/143 (2%)
Query: 110 LCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLL 168
           L IV E + GG L+  +  +        +       I + ++YLH  NI HRD+K  NLL
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 169 MDT---HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVL 225
             +   + ++K+ DFG A+       +T    T  ++APEV+  + YD+  D++S  +++
Sbjct: 194 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
Query: 226 WELVTAKVPYDSMTPLQAALGVR 248
           + L+    P+ S   L  + G++
Sbjct: 254 YILLCGYPPFYSNHGLAISPGMK 276

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 72/143 (50%), Gaps = 4/143 (2%)
Query: 110 LCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLL 168
           L IV E + GG L+  +  +        +       I + ++YLH  NI HRD+K  NLL
Sbjct: 96  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 155
Query: 169 MDT---HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVL 225
             +   + ++K+ DFG A+       +T    T  ++APEV+  + YD+  D++S  +++
Sbjct: 156 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 215
Query: 226 WELVTAKVPYDSMTPLQAALGVR 248
           + L+    P+ S   L  + G++
Sbjct: 216 YILLCGYPPFYSNHGLAISPGMK 238

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 72/143 (50%), Gaps = 4/143 (2%)
Query: 110 LCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLL 168
           L IV E + GG L+  +  +        +       I + ++YLH  NI HRD+K  NLL
Sbjct: 94  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 153
Query: 169 MDT---HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVL 225
             +   + ++K+ DFG A+       +T    T  ++APEV+  + YD+  D++S  +++
Sbjct: 154 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 213
Query: 226 WELVTAKVPYDSMTPLQAALGVR 248
           + L+    P+ S   L  + G++
Sbjct: 214 YILLCGYPPFYSNHGLAISPGMK 236

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 72/143 (50%), Gaps = 4/143 (2%)
Query: 110 LCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLL 168
           L IV E + GG L+  +  +        +       I + ++YLH  NI HRD+K  NLL
Sbjct: 95  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 154
Query: 169 MDT---HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVL 225
             +   + ++K+ DFG A+       +T    T  ++APEV+  + YD+  D++S  +++
Sbjct: 155 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 214
Query: 226 WELVTAKVPYDSMTPLQAALGVR 248
           + L+    P+ S   L  + G++
Sbjct: 215 YILLCGYPPFYSNHGLAISPGMK 237

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 72/143 (50%), Gaps = 4/143 (2%)
Query: 110 LCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLL 168
           L IV E + GG L+  +  +        +       I + ++YLH  NI HRD+K  NLL
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 147
Query: 169 MDT---HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVL 225
             +   + ++K+ DFG A+       +T    T  ++APEV+  + YD+  D++S  +++
Sbjct: 148 YTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 207
Query: 226 WELVTAKVPYDSMTPLQAALGVR 248
           + L+    P+ S   L  + G++
Sbjct: 208 YILLCGYPPFYSNHGLAISPGMK 230

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 107/228 (46%), Gaps = 14/228 (6%)
Query: 41  KTGERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLE----DEFVQEVAILREVQH 94
           + G  + SG  G +Y G+ +  +  VA+K +  + ++D  E         EV +L++V  
Sbjct: 11  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 70
Query: 95  --RNVVRFIGASTKSPHLCIVTEYM-PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
               V+R +    +     ++ E M P   L+D++      L+      F   + + + +
Sbjct: 71  GFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRH 129
Query: 152 LHQRNIIHRDLKTANLLMD-THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN-H 209
            H   ++HRD+K  N+L+D     +K+ DFG      K  V T   GT  +  PE I  H
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYH 188
Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYD-SMTPLQAALGVRQVCTSLCQ 256
           + + + A V+S  I+L+++V   +P++     ++  +  RQ  +S CQ
Sbjct: 189 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 236

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 47/217 (21%)
Query: 44  ERIASGSCGDLYRGVYLGQDVAVKVLRSEH-LNDTLEDEFVQEVAILREV-------QHR 95
           E+I SG  G +++ V         + RS+  L  +     V E   LREV       QH 
Sbjct: 15  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-----VDEQNALREVYAHAVLGQHS 69
Query: 96  NVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVL---KLPQLLRFAIDICKGMEYL 152
           +VVR+  A  +  H+ I  EY  GGSL D + +N+ ++   K  +L    + + +G+ Y+
Sbjct: 70  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 129
Query: 153 HQRNIIHRDLKTANLLMDTHNV-------------------VKVADFG-VARFQNKGGVM 192
           H  +++H D+K +N+ +   ++                    K+ D G V R  +     
Sbjct: 130 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---- 185
Query: 193 TAETGTYRWMAPEVIN----HQPYDQKADVFSFAIVL 225
             E G  R++A EV+     H P   KAD+F+ A+ +
Sbjct: 186 QVEEGDSRFLANEVLQENYTHLP---KADIFALALTV 219

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 47/217 (21%)
Query: 44  ERIASGSCGDLYRGVYLGQDVAVKVLRSEH-LNDTLEDEFVQEVAILREV-------QHR 95
           E+I SG  G +++ V         + RS+  L  +     V E   LREV       QH 
Sbjct: 15  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-----VDEQNALREVYAHAVLGQHS 69
Query: 96  NVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVL---KLPQLLRFAIDICKGMEYL 152
           +VVR+  A  +  H+ I  EY  GGSL D + +N+ ++   K  +L    + + +G+ Y+
Sbjct: 70  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 129
Query: 153 HQRNIIHRDLKTANLLMDTHNV-------------------VKVADFG-VARFQNKGGVM 192
           H  +++H D+K +N+ +   ++                    K+ D G V R  +     
Sbjct: 130 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---- 185
Query: 193 TAETGTYRWMAPEVIN----HQPYDQKADVFSFAIVL 225
             E G  R++A EV+     H P   KAD+F+ A+ +
Sbjct: 186 QVEEGDSRFLANEVLQENYTHLP---KADIFALALTV 219

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 47/217 (21%)
Query: 44  ERIASGSCGDLYRGVYLGQDVAVKVLRSEH-LNDTLEDEFVQEVAILREV-------QHR 95
           E+I SG  G +++ V         + RS+  L  +     V E   LREV       QH 
Sbjct: 17  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-----VDEQNALREVYAHAVLGQHS 71
Query: 96  NVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVL---KLPQLLRFAIDICKGMEYL 152
           +VVR+  A  +  H+ I  EY  GGSL D + +N+ ++   K  +L    + + +G+ Y+
Sbjct: 72  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 153 HQRNIIHRDLKTANLLMDTHNV-------------------VKVADFG-VARFQNKGGVM 192
           H  +++H D+K +N+ +   ++                    K+ D G V R  +     
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---- 187
Query: 193 TAETGTYRWMAPEVIN----HQPYDQKADVFSFAIVL 225
             E G  R++A EV+     H P   KAD+F+ A+ +
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLP---KADIFALALTV 221

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 47/217 (21%)
Query: 44  ERIASGSCGDLYRGVYLGQDVAVKVLRSEH-LNDTLEDEFVQEVAILREV-------QHR 95
           E+I SG  G +++ V         + RS+  L  +     V E   LREV       QH 
Sbjct: 13  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-----VDEQNALREVYAHAVLGQHS 67
Query: 96  NVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVL---KLPQLLRFAIDICKGMEYL 152
           +VVR+  A  +  H+ I  EY  GGSL D + +N+ ++   K  +L    + + +G+ Y+
Sbjct: 68  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 127
Query: 153 HQRNIIHRDLKTANLLMDTHNV-------------------VKVADFG-VARFQNKGGVM 192
           H  +++H D+K +N+ +   ++                    K+ D G V R  +     
Sbjct: 128 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---- 183
Query: 193 TAETGTYRWMAPEVIN----HQPYDQKADVFSFAIVL 225
             E G  R++A EV+     H P   KAD+F+ A+ +
Sbjct: 184 QVEEGDSRFLANEVLQENYTHLP---KADIFALALTV 217

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 111/234 (47%), Gaps = 23/234 (9%)
Query: 45  RIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           +I  G+ G++++  +   GQ VA+K +  E+  +      ++E+ IL+ ++H NVV  I 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 103 A--STKSPH-LCIVTEYMPGGSLYDYLHKN-----HNVL---KLPQLLRFAIDICKGMEY 151
              +  SP+  C  + Y+    ++D+   +      NVL    L ++ R    +  G+ Y
Sbjct: 85  ICRTKASPYNRCKASIYL----VFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF-----QNKGGVMTAETGTYRWMAPE- 205
           +H+  I+HRD+K AN+L+    V+K+ADFG+AR       ++         T  +  PE 
Sbjct: 141 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPEL 200
Query: 206 VINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY 259
           ++  + Y    D++    ++ E+ T        T       + Q+C S+   ++
Sbjct: 201 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 254

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 58/104 (55%), Gaps = 13/104 (12%)
Query: 139 LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA----RFQNKGGVMT- 193
           L   I I + +E+LH + ++HRDLK +N+     +VVKV DFG+     + + +  V+T 
Sbjct: 167 LHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226
Query: 194 --------AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELV 229
                    + GT  +M+PE I+   Y  K D+FS  ++L+EL+
Sbjct: 227 MPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 69/143 (48%), Gaps = 4/143 (2%)
Query: 110 LCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLL 168
           L IV E + GG L+  +  +        +       I + ++YLH  NI HRD+K  NLL
Sbjct: 134 LLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 169 MDT---HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVL 225
             +   + ++K+ DFG A+       +T    T  ++APEV+  + YD+  D +S  ++ 
Sbjct: 194 YTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXWSLGVIX 253
Query: 226 WELVTAKVPYDSMTPLQAALGVR 248
           + L+    P+ S   L  + G +
Sbjct: 254 YILLCGYPPFYSNHGLAISPGXK 276

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 111/234 (47%), Gaps = 23/234 (9%)
Query: 45  RIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           +I  G+ G++++  +   GQ VA+K +  E+  +      ++E+ IL+ ++H NVV  I 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 103 A--STKSPH-LCIVTEYMPGGSLYDYLHKN-----HNVL---KLPQLLRFAIDICKGMEY 151
              +  SP+  C  + Y+    ++D+   +      NVL    L ++ R    +  G+ Y
Sbjct: 85  ICRTKASPYNRCKGSIYL----VFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF-----QNKGGVMTAETGTYRWMAPE- 205
           +H+  I+HRD+K AN+L+    V+K+ADFG+AR       ++         T  +  PE 
Sbjct: 141 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPEL 200
Query: 206 VINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY 259
           ++  + Y    D++    ++ E+ T        T       + Q+C S+   ++
Sbjct: 201 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 254

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 74/136 (54%), Gaps = 11/136 (8%)
Query: 109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQ-LLRFAI-DICKGMEYLHQRNIIHRDLKTAN 166
           HL +V +Y  GG L   L K  +  KLP+ + RF I ++   ++ +HQ + +HRD+K  N
Sbjct: 148 HLYLVMDYYVGGDLLTLLSKFED--KLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDN 205
Query: 167 LLMDTHNVVKVADFGVARFQNKGGVMTAE--TGTYRWMAPEVINHQ-----PYDQKADVF 219
           +L+D +  +++ADFG     N  G + +    GT  +++PE++         Y  + D +
Sbjct: 206 VLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWW 265
Query: 220 SFAIVLWELVTAKVPY 235
           S  + ++E++  + P+
Sbjct: 266 SLGVCMYEMLYGETPF 281

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 111/234 (47%), Gaps = 23/234 (9%)
Query: 45  RIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           +I  G+ G++++  +   GQ VA+K +  E+  +      ++E+ IL+ ++H NVV  I 
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 103 A--STKSPH-LCIVTEYMPGGSLYDYLHKN-----HNVL---KLPQLLRFAIDICKGMEY 151
              +  SP+  C  + Y+    ++D+   +      NVL    L ++ R    +  G+ Y
Sbjct: 84  ICRTKASPYNRCKGSIYL----VFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 139
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF-----QNKGGVMTAETGTYRWMAPE- 205
           +H+  I+HRD+K AN+L+    V+K+ADFG+AR       ++         T  +  PE 
Sbjct: 140 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPEL 199
Query: 206 VINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY 259
           ++  + Y    D++    ++ E+ T        T       + Q+C S+   ++
Sbjct: 200 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 253

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 111/234 (47%), Gaps = 23/234 (9%)
Query: 45  RIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           +I  G+ G++++  +   GQ VA+K +  E+  +      ++E+ IL+ ++H NVV  I 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 103 A--STKSPH-LCIVTEYMPGGSLYDYLHKN-----HNVL---KLPQLLRFAIDICKGMEY 151
              +  SP+  C  + Y+    ++D+   +      NVL    L ++ R    +  G+ Y
Sbjct: 85  ICRTKASPYNRCKGSIYL----VFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF-----QNKGGVMTAETGTYRWMAPE- 205
           +H+  I+HRD+K AN+L+    V+K+ADFG+AR       ++         T  +  PE 
Sbjct: 141 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPEL 200
Query: 206 VINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY 259
           ++  + Y    D++    ++ E+ T        T       + Q+C S+   ++
Sbjct: 201 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 254

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 74/136 (54%), Gaps = 11/136 (8%)
Query: 109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQ-LLRFAI-DICKGMEYLHQRNIIHRDLKTAN 166
           HL +V +Y  GG L   L K  +  KLP+ + RF I ++   ++ +HQ + +HRD+K  N
Sbjct: 164 HLYLVMDYYVGGDLLTLLSKFED--KLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDN 221
Query: 167 LLMDTHNVVKVADFGVARFQNKGGVMTAE--TGTYRWMAPEVINHQ-----PYDQKADVF 219
           +L+D +  +++ADFG     N  G + +    GT  +++PE++         Y  + D +
Sbjct: 222 VLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWW 281
Query: 220 SFAIVLWELVTAKVPY 235
           S  + ++E++  + P+
Sbjct: 282 SLGVCMYEMLYGETPF 297

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 106/234 (45%), Gaps = 23/234 (9%)
Query: 42  TGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVV 98
           T E +  G+   +   V L  G++ AVK++  +  +        +EV  L + Q ++N++
Sbjct: 17  TSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHS--RSRVFREVETLYQCQGNKNIL 74
Query: 99  RFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNII 158
             I          +V E + GGS+  ++ K  +     +  R   D+   +++LH + I 
Sbjct: 75  ELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKH-FNEREASRVVRDVAAALDFLHTKGIA 133
Query: 159 HRDLKTANLLMDTH---NVVKVADFGVA---RFQNKGGV-----MTAETGTYRWMAPEVI 207
           HRDLK  N+L ++    + VK+ DF +    +  N         +T   G+  +MAPEV+
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVV 193
Query: 208 -----NHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQ 256
                    YD++ D++S  +VL+ +++   P+             +VC  +CQ
Sbjct: 194 EVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVC-RVCQ 246

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 45  RIASGSCGDLYR--GVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           R+  GS G+++R      G   AVK +R       LE    +E+     +    +V   G
Sbjct: 100 RLGRGSFGEVHRMEDKQTGFQCAVKKVR-------LEVFRAEELMACAGLTSPRIVPLYG 152
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
           A  + P + I  E + GGSL   L K    L   + L +     +G+EYLH R I+H D+
Sbjct: 153 AVREGPWVNIFMELLEGGSL-GQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDV 211
Query: 163 KTANLLMDTHNV-VKVADFGVARFQNKGG----VMTAE--TGTYRWMAPEVINHQPYDQK 215
           K  N+L+ +      + DFG A      G    ++T +   GT   MAPEV+  +  D K
Sbjct: 212 KADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAK 271
Query: 216 ADVFSFAIVLWELVTAKVPY 235
            DV+S   ++  ++    P+
Sbjct: 272 VDVWSSCCMMLHMLNGCHPW 291

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 45  RIASGSCGDLYR--GVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           R+  GS G+++R      G   AVK +R       LE    +E+     +    +V   G
Sbjct: 81  RLGRGSFGEVHRMEDKQTGFQCAVKKVR-------LEVFRAEELMACAGLTSPRIVPLYG 133
Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
           A  + P + I  E + GGSL   L K    L   + L +     +G+EYLH R I+H D+
Sbjct: 134 AVREGPWVNIFMELLEGGSL-GQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDV 192
Query: 163 KTANLLMDTHNV-VKVADFGVARFQNKGG----VMTAE--TGTYRWMAPEVINHQPYDQK 215
           K  N+L+ +      + DFG A      G    ++T +   GT   MAPEV+  +  D K
Sbjct: 193 KADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAK 252
Query: 216 ADVFSFAIVLWELVTAKVPY 235
            DV+S   ++  ++    P+
Sbjct: 253 VDVWSSCCMMLHMLNGCHPW 272

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/161 (22%), Positives = 80/161 (49%), Gaps = 2/161 (1%)
Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
           +E++IL   +HRN++    +      L ++ E++ G  +++ ++ +   L   +++ +  
Sbjct: 50  KEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH 109
Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTH--NVVKVADFGVARFQNKGGVMTAETGTYRW 201
            +C+ +++LH  NI H D++  N++  T   + +K+ +FG AR    G           +
Sbjct: 110 QVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEY 169
Query: 202 MAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQ 242
            APEV  H       D++S   +++ L++   P+ + T  Q
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/254 (24%), Positives = 115/254 (45%), Gaps = 51/254 (20%)
Query: 35  IDRRLLKTGE---RIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           +DR +L+  E   ++  G+ G +++ +    G+ VAVK +     N T      +E+ IL
Sbjct: 3   VDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMIL 62
Query: 90  REVQ-HRNVVRFIGA--STKSPHLCIVTEYMPG-------GSLYDYLHKNHNVLKLPQLL 139
            E+  H N+V  +    +     + +V +YM          ++ + +HK + V +L    
Sbjct: 63  TELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQL---- 118
Query: 140 RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR--------------- 184
                  K ++YLH   ++HRD+K +N+L++    VKVADFG++R               
Sbjct: 119 ------IKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172
Query: 185 -------FQNKGGVMTAETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAKVPY- 235
                  F +   ++T    T  + APE+ +    Y +  D++S   +L E++  K  + 
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232
Query: 236 --DSMTPLQAALGV 247
              +M  L+  +GV
Sbjct: 233 GSSTMNQLERIIGV 246

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 88/202 (43%), Gaps = 50/202 (24%)
Query: 61  GQDVAVKVLRS---------------EHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST 105
           G+ VAVK++++               EHLN T  +   + V +L   +H           
Sbjct: 40  GRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG--------- 90
Query: 106 KSPHLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKT 164
              H+CIV E + G S YD++ +N  +  +L  + + A  ICK + +LH   + H DLK 
Sbjct: 91  ---HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKP 146
Query: 165 ANLLM------DTHNV-------------VKVADFGVARFQNKGGVMTAETGTYRWMAPE 205
            N+L       + +N              +KV DFG A + ++       T  YR  APE
Sbjct: 147 ENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYR--APE 204
Query: 206 VINHQPYDQKADVFSFAIVLWE 227
           VI    + Q  DV+S   +L E
Sbjct: 205 VILALGWSQPCDVWSIGCILIE 226

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 33/197 (16%)
Query: 54  LYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHLCI 112
           +YRG++  +DVAVK +  E    +  D   +EV +LRE  +H NV+R+           I
Sbjct: 41  VYRGMFDNRDVAVKRILPECF--SFAD---REVQLLRESDEHPNVIRYFCTEKDRQFQYI 95
Query: 113 VTEYMPGGSLYDYLHKN---HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM 169
             E +   +L +Y+ +    H  L+   LL+       G+ +LH  NI+HRDLK  N+L+
Sbjct: 96  AIE-LCAATLQEYVEQKDFAHLGLEPITLLQ---QTTSGLAHLHSLNIVHRDLKPHNILI 151
Query: 170 ---DTHNVVK--VADFGVAR--------FQNKGGVMTAETGTYRWMAPEVINHQPYDQKA 216
              + H  +K  ++DFG+ +        F  + GV     GT  W+APE+++    +   
Sbjct: 152 SMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV----PGTEGWIAPEMLSEDCKENPT 207
Query: 217 ---DVFSFAIVLWELVT 230
              D+FS   V + +++
Sbjct: 208 YTVDIFSAGCVFYYVIS 224

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 106/228 (46%), Gaps = 14/228 (6%)
Query: 41  KTGERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLE----DEFVQEVAILREVQH 94
           + G  + SG  G +Y G+ +  +  VA+K +  + ++D  E         EV +L++V  
Sbjct: 10  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 69
Query: 95  --RNVVRFIGASTKSPHLCIVTEYM-PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
               V+R +    +     ++ E   P   L+D++      L+      F   + + + +
Sbjct: 70  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRH 128
Query: 152 LHQRNIIHRDLKTANLLMD-THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN-H 209
            H   ++HRD+K  N+L+D     +K+ DFG      K  V T   GT  +  PE I  H
Sbjct: 129 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYH 187
Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYD-SMTPLQAALGVRQVCTSLCQ 256
           + + + A V+S  I+L+++V   +P++     ++  +  RQ  +S CQ
Sbjct: 188 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 235

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 38/205 (18%)
Query: 85  EVAILREVQHRNV-----VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKN-HNVLKLPQL 138
           E  IL+++Q+ ++     V++ G      H+C++ E + G SLY+ + +N +N   +  +
Sbjct: 81  EADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDI 139
Query: 139 LRFAIDICKGMEYLHQRNIIHRDLKTANLLMD-------------------------THN 173
             + I+I K + YL + ++ H DLK  N+L+D                            
Sbjct: 140 KLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 174 VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKV 233
            +K+ DFG A F++        T  YR  APEVI +  +D  +D++SF  VL EL T  +
Sbjct: 200 GIKLIDFGCATFKSDYHGSIINTRQYR--APEVILNLGWDVSSDMWSFGCVLAELYTGSL 257
Query: 234 PYDSMTPLQAALGVRQVCTSLCQPI 258
            + +   ++       +  S+ QPI
Sbjct: 258 LFRTHEHMEHL----AMMESIIQPI 278

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 106/228 (46%), Gaps = 14/228 (6%)
Query: 41  KTGERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLE----DEFVQEVAILREVQH 94
           + G  + SG  G +Y G+ +  +  VA+K +  + ++D  E         EV +L++V  
Sbjct: 12  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 71
Query: 95  --RNVVRFIGASTKSPHLCIVTEYM-PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
               V+R +    +     ++ E   P   L+D++      L+      F   + + + +
Sbjct: 72  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRH 130
Query: 152 LHQRNIIHRDLKTANLLMD-THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN-H 209
            H   ++HRD+K  N+L+D     +K+ DFG      K  V T   GT  +  PE I  H
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYH 189
Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYD-SMTPLQAALGVRQVCTSLCQ 256
           + + + A V+S  I+L+++V   +P++     ++  +  RQ  +S CQ
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 237

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 106/228 (46%), Gaps = 14/228 (6%)
Query: 41  KTGERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLE----DEFVQEVAILREVQ- 93
           + G  + SG  G +Y G+ +  +  VA+K +  + ++D  E         EV +L++V  
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 94  -HRNVVRFIGASTKSPHLCIVTEYM-PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
               V+R +    +     ++ E   P   L+D++      L+      F   + + + +
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRH 125
Query: 152 LHQRNIIHRDLKTANLLMD-THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN-H 209
            H   ++HRD+K  N+L+D     +K+ DFG      K  V T   GT  +  PE I  H
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYH 184
Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYD-SMTPLQAALGVRQVCTSLCQ 256
           + + + A V+S  I+L+++V   +P++     ++  +  RQ  +S CQ
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 232

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 106/228 (46%), Gaps = 14/228 (6%)
Query: 41  KTGERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLE----DEFVQEVAILREVQH 94
           + G  + SG  G +Y G+ +  +  VA+K +  + ++D  E         EV +L++V  
Sbjct: 11  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 70
Query: 95  --RNVVRFIGASTKSPHLCIVTEYM-PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
               V+R +    +     ++ E   P   L+D++      L+      F   + + + +
Sbjct: 71  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRH 129
Query: 152 LHQRNIIHRDLKTANLLMD-THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN-H 209
            H   ++HRD+K  N+L+D     +K+ DFG      K  V T   GT  +  PE I  H
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYH 188
Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYD-SMTPLQAALGVRQVCTSLCQ 256
           + + + A V+S  I+L+++V   +P++     ++  +  RQ  +S CQ
Sbjct: 189 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 236

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 106/228 (46%), Gaps = 14/228 (6%)
Query: 41  KTGERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLE----DEFVQEVAILREVQH 94
           + G  + SG  G +Y G+ +  +  VA+K +  + ++D  E         EV +L++V  
Sbjct: 12  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 71
Query: 95  --RNVVRFIGASTKSPHLCIVTEYM-PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
               V+R +    +     ++ E   P   L+D++      L+      F   + + + +
Sbjct: 72  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRH 130
Query: 152 LHQRNIIHRDLKTANLLMD-THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN-H 209
            H   ++HRD+K  N+L+D     +K+ DFG      K  V T   GT  +  PE I  H
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYH 189
Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYD-SMTPLQAALGVRQVCTSLCQ 256
           + + + A V+S  I+L+++V   +P++     ++  +  RQ  +S CQ
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 237

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 106/228 (46%), Gaps = 14/228 (6%)
Query: 41  KTGERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLE----DEFVQEVAILREVQH 94
           + G  + SG  G +Y G+ +  +  VA+K +  + ++D  E         EV +L++V  
Sbjct: 39  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 98
Query: 95  --RNVVRFIGASTKSPHLCIVTEYM-PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
               V+R +    +     ++ E   P   L+D++      L+      F   + + + +
Sbjct: 99  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRH 157
Query: 152 LHQRNIIHRDLKTANLLMD-THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN-H 209
            H   ++HRD+K  N+L+D     +K+ DFG      K  V T   GT  +  PE I  H
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYH 216
Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYD-SMTPLQAALGVRQVCTSLCQ 256
           + + + A V+S  I+L+++V   +P++     ++  +  RQ  +S CQ
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 264

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 106/228 (46%), Gaps = 14/228 (6%)
Query: 41  KTGERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLE----DEFVQEVAILREVQH 94
           + G  + SG  G +Y G+ +  +  VA+K +  + ++D  E         EV +L++V  
Sbjct: 27  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 86
Query: 95  --RNVVRFIGASTKSPHLCIVTEYM-PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
               V+R +    +     ++ E   P   L+D++      L+      F   + + + +
Sbjct: 87  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRH 145
Query: 152 LHQRNIIHRDLKTANLLMD-THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN-H 209
            H   ++HRD+K  N+L+D     +K+ DFG      K  V T   GT  +  PE I  H
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYH 204
Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYD-SMTPLQAALGVRQVCTSLCQ 256
           + + + A V+S  I+L+++V   +P++     ++  +  RQ  +S CQ
Sbjct: 205 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 252

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 106/228 (46%), Gaps = 14/228 (6%)
Query: 41  KTGERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLE----DEFVQEVAILREVQH 94
           + G  + SG  G +Y G+ +  +  VA+K +  + ++D  E         EV +L++V  
Sbjct: 12  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 71
Query: 95  --RNVVRFIGASTKSPHLCIVTEYM-PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
               V+R +    +     ++ E   P   L+D++      L+      F   + + + +
Sbjct: 72  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRH 130
Query: 152 LHQRNIIHRDLKTANLLMD-THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN-H 209
            H   ++HRD+K  N+L+D     +K+ DFG      K  V T   GT  +  PE I  H
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYH 189
Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYD-SMTPLQAALGVRQVCTSLCQ 256
           + + + A V+S  I+L+++V   +P++     ++  +  RQ  +S CQ
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 237

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 106/228 (46%), Gaps = 14/228 (6%)
Query: 41  KTGERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLE----DEFVQEVAILREVQH 94
           + G  + SG  G +Y G+ +  +  VA+K +  + ++D  E         EV +L++V  
Sbjct: 54  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 113
Query: 95  --RNVVRFIGASTKSPHLCIVTEYM-PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
               V+R +    +     ++ E   P   L+D++      L+      F   + + + +
Sbjct: 114 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRH 172
Query: 152 LHQRNIIHRDLKTANLLMD-THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN-H 209
            H   ++HRD+K  N+L+D     +K+ DFG      K  V T   GT  +  PE I  H
Sbjct: 173 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYH 231
Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYD-SMTPLQAALGVRQVCTSLCQ 256
           + + + A V+S  I+L+++V   +P++     ++  +  RQ  +S CQ
Sbjct: 232 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 279

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 106/228 (46%), Gaps = 14/228 (6%)
Query: 41  KTGERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLE----DEFVQEVAILREVQH 94
           + G  + SG  G +Y G+ +  +  VA+K +  + ++D  E         EV +L++V  
Sbjct: 26  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 85
Query: 95  --RNVVRFIGASTKSPHLCIVTEYM-PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
               V+R +    +     ++ E   P   L+D++      L+      F   + + + +
Sbjct: 86  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRH 144
Query: 152 LHQRNIIHRDLKTANLLMD-THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN-H 209
            H   ++HRD+K  N+L+D     +K+ DFG      K  V T   GT  +  PE I  H
Sbjct: 145 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYH 203
Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYD-SMTPLQAALGVRQVCTSLCQ 256
           + + + A V+S  I+L+++V   +P++     ++  +  RQ  +S CQ
Sbjct: 204 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 251

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 90/177 (50%), Gaps = 37/177 (20%)
Query: 83  VQEVAILREVQHRNVVRF--------------IGASTKSPHLCIVTEYMPGGSLYDYLHK 128
           ++E+ I+R + H N+V+               +G+ T+   + IV EYM           
Sbjct: 56  LREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLA------ 109
Query: 129 NHNVLKLPQLLR-----FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN-VVKVADFGV 182
             NVL+   LL      F   + +G++Y+H  N++HRDLK ANL ++T + V+K+ DFG+
Sbjct: 110 --NVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGL 167
Query: 183 AR-----FQNKGGVMTAETGTYRWM-APE-VINHQPYDQKADVFSFAIVLWELVTAK 232
           AR     + +KG +  +E    +W  +P  +++   Y +  D+++   +  E++T K
Sbjct: 168 ARIMDPHYSHKGHL--SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 106/228 (46%), Gaps = 14/228 (6%)
Query: 41  KTGERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLE----DEFVQEVAILREVQH 94
           + G  + SG  G +Y G+ +  +  VA+K +  + ++D  E         EV +L++V  
Sbjct: 46  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105
Query: 95  --RNVVRFIGASTKSPHLCIVTEYM-PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
               V+R +    +     ++ E   P   L+D++      L+      F   + + + +
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRH 164
Query: 152 LHQRNIIHRDLKTANLLMD-THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN-H 209
            H   ++HRD+K  N+L+D     +K+ DFG      K  V T   GT  +  PE I  H
Sbjct: 165 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYH 223
Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYD-SMTPLQAALGVRQVCTSLCQ 256
           + + + A V+S  I+L+++V   +P++     ++  +  RQ  +S CQ
Sbjct: 224 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 271

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 22/221 (9%)
Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ--DVAVKV------LRSEHLNDTLEDEF 82
           E +E + RL   G  +  G  G ++ G  L     VA+KV      L    L+D++    
Sbjct: 27  EAFEAEYRL---GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83
Query: 83  VQEVAILREVQ----HRNVVRFIGA-STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
             EVA+L +V     H  V+R +    T+   + ++   +P   L+DY+ +   + + P 
Sbjct: 84  --EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS 141
Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT-HNVVKVADFGVARFQNKGGVMTAET 196
              F   +   +++ H R ++HRD+K  N+L+D      K+ DFG     +     T   
Sbjct: 142 RCFFG-QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD-EPYTDFD 199
Query: 197 GTYRWMAPEVIN-HQPYDQKADVFSFAIVLWELVTAKVPYD 236
           GT  +  PE I+ HQ +   A V+S  I+L+++V   +P++
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 85/199 (42%), Gaps = 48/199 (24%)
Query: 85  EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK--------------NH 130
           EV +++++ H N+ R         ++C+V E   GG L D L+                 
Sbjct: 78  EVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKT 137
Query: 131 NVLKLPQLLRFAID-------------------------ICKGMEYLHQRNIIHRDLKTA 165
            +   P+    AI+                         I   + YLH + I HRD+K  
Sbjct: 138 QICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPE 197
Query: 166 NLLMDTHNV--VKVADFGVAR--FQNKGGV---MTAETGTYRWMAPEVIN--HQPYDQKA 216
           N L  T+    +K+ DFG+++  ++   G    MT + GT  ++APEV+N  ++ Y  K 
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 217 DVFSFAIVLWELVTAKVPY 235
           D +S  ++L  L+   VP+
Sbjct: 258 DAWSAGVLLHLLLMGAVPF 276

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 41  KTGERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLE----DEFVQEVAILREVQ- 93
           + G  + SG  G +Y G+ +  +  VA+K +  + ++D  E         EV +L++V  
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 94  -HRNVVRFIGASTKSPHLCIVTEYM-PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
               V+R +    +     ++ E   P   L+D++      L+      F   + + + +
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRH 125
Query: 152 LHQRNIIHRDLKTANLLMD-THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN-H 209
            H   ++HRD+K  N+L+D     +K+ DFG      K  V T   GT  +  PE I  H
Sbjct: 126 CHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYH 184
Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYD-SMTPLQAALGVRQVCTSLCQ 256
           + + + A V+S  I+L+++V   +P++     ++  +  RQ  +  CQ
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQ 232

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 41  KTGERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLE----DEFVQEVAILREVQ- 93
           + G  + SG  G +Y G+ +  +  VA+K +  + ++D  E         EV +L++V  
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 94  -HRNVVRFIGASTKSPHLCIVTEYM-PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
               V+R +    +     ++ E   P   L+D++      L+      F   + + + +
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRH 125
Query: 152 LHQRNIIHRDLKTANLLMD-THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN-H 209
            H   ++HRD+K  N+L+D     +K+ DFG      K  V T   GT  +  PE I  H
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYH 184
Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYD-SMTPLQAALGVRQVCTSLCQ 256
           + + + A V+S  I+L+++V   +P++     +   +  RQ  +S CQ
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 232

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 75/135 (55%), Gaps = 15/135 (11%)
Query: 110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM 169
           L ++ +Y+ GG L+ +L +     +  ++  +  +I   +E+LH+  II+RD+K  N+L+
Sbjct: 134 LHLILDYINGGELFTHLSQRERFTE-HEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL 192
Query: 170 DTHNVVKVADFGVARFQNKGGVMTAET-------GTYRWMAPEVI--NHQPYDQKADVFS 220
           D++  V + DFG+++       +  ET       GT  +MAP+++      +D+  D +S
Sbjct: 193 DSNGHVVLTDFGLSK-----EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWS 247
Query: 221 FAIVLWELVTAKVPY 235
             ++++EL+T   P+
Sbjct: 248 LGVLMYELLTGASPF 262

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 41  KTGERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLE----DEFVQEVAILREVQH 94
           + G  + SG  G +Y G+ +  +  VA+K +  + ++D  E         EV +L++V  
Sbjct: 39  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 98
Query: 95  --RNVVRFIGASTKSPHLCIVTEYM-PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
               V+R +    +     ++ E   P   L+D++      L+      F   + + + +
Sbjct: 99  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRH 157
Query: 152 LHQRNIIHRDLKTANLLMD-THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN-H 209
            H   ++HRD+K  N+L+D     +K+ DFG      K  V T   GT  +  PE I  H
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYH 216
Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYD-SMTPLQAALGVRQVCTSLCQ 256
           + + + A V+S  I+L+++V   +P++     +   +  RQ  +S CQ
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 264

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 41  KTGERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLE----DEFVQEVAILREVQH 94
           + G  + SG  G +Y G+ +  +  VA+K +  + ++D  E         EV +L++V  
Sbjct: 39  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 98
Query: 95  --RNVVRFIGASTKSPHLCIVTEYM-PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
               V+R +    +     ++ E   P   L+D++      L+      F   + + + +
Sbjct: 99  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRH 157
Query: 152 LHQRNIIHRDLKTANLLMD-THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN-H 209
            H   ++HRD+K  N+L+D     +K+ DFG      K  V T   GT  +  PE I  H
Sbjct: 158 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYH 216
Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYD-SMTPLQAALGVRQVCTSLCQ 256
           + + + A V+S  I+L+++V   +P++     +   +  RQ  +S CQ
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 264

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 41  KTGERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLE----DEFVQEVAILREVQH 94
           + G  + SG  G +Y G+ +  +  VA+K +  + ++D  E         EV +L++V  
Sbjct: 40  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 99
Query: 95  --RNVVRFIGASTKSPHLCIVTEYM-PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
               V+R +    +     ++ E   P   L+D++      L+      F   + + + +
Sbjct: 100 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRH 158
Query: 152 LHQRNIIHRDLKTANLLMD-THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN-H 209
            H   ++HRD+K  N+L+D     +K+ DFG      K  V T   GT  +  PE I  H
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYH 217
Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYD-SMTPLQAALGVRQVCTSLCQ 256
           + + + A V+S  I+L+++V   +P++     +   +  RQ  +S CQ
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 265

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 41  KTGERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLE----DEFVQEVAILREVQH 94
           + G  + SG  G +Y G+ +  +  VA+K +  + ++D  E         EV +L++V  
Sbjct: 40  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 99
Query: 95  --RNVVRFIGASTKSPHLCIVTEYM-PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
               V+R +    +     ++ E   P   L+D++      L+      F   + + + +
Sbjct: 100 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRH 158
Query: 152 LHQRNIIHRDLKTANLLMD-THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN-H 209
            H   ++HRD+K  N+L+D     +K+ DFG      K  V T   GT  +  PE I  H
Sbjct: 159 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYH 217
Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYD-SMTPLQAALGVRQVCTSLCQ 256
           + + + A V+S  I+L+++V   +P++     +   +  RQ  +S CQ
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQ 265

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 46  IASGSCGDLYRGVYL--GQDVAVK-VLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF-- 100
           I +GS G +Y+      G+ VA+K VL+ +   +       +E+ I+R++ H N+VR   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKN-------RELQIMRKLDHCNIVRLRY 80
Query: 101 ----IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL--RFAIDICKGMEYLHQ 154
                G      +L +V +Y+P        H +     LP +    +   + + + Y+H 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 155 RNIIHRDLKTANLLMDTHN-VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI-NHQPY 212
             I HRD+K  NLL+D    V+K+ DFG A+   +G    +   +  + APE+I     Y
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 200
Query: 213 DQKADVFSFAIVLWELVTAK--VPYDS 237
               DV+S   VL EL+  +   P DS
Sbjct: 201 TSSIDVWSAGCVLAELLLGQPIFPGDS 227

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 46  IASGSCGDLYRGVYL--GQDVAVK-VLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF-- 100
           I +GS G +Y+      G+ VA+K VL+ +   +       +E+ I+R++ H N+VR   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 80
Query: 101 ----IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL--RFAIDICKGMEYLHQ 154
                G      +L +V +Y+P        H +     LP +    +   + + + Y+H 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 155 RNIIHRDLKTANLLMDTHN-VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI-NHQPY 212
             I HRD+K  NLL+D    V+K+ DFG A+   +G    +   +  + APE+I     Y
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 200
Query: 213 DQKADVFSFAIVLWELVTAK--VPYDS 237
               DV+S   VL EL+  +   P DS
Sbjct: 201 TSSIDVWSAGCVLAELLLGQPIFPGDS 227

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 46  IASGSCGDLYRGVYL--GQDVAVK-VLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF-- 100
           I +GS G +Y+      G+ VA+K VL+ +   +       +E+ I+R++ H N+VR   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 80
Query: 101 ----IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL--RFAIDICKGMEYLHQ 154
                G      +L +V +Y+P        H +     LP +    +   + + + Y+H 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 155 RNIIHRDLKTANLLMDTHN-VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI-NHQPY 212
             I HRD+K  NLL+D    V+K+ DFG A+   +G    +   +  + APE+I     Y
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 200
Query: 213 DQKADVFSFAIVLWELVTAK--VPYDS 237
               DV+S   VL EL+  +   P DS
Sbjct: 201 TSSIDVWSAGCVLAELLLGQPIFPGDS 227

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 46  IASGSCGDLYRGVYL--GQDVAVK-VLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF-- 100
           I +GS G +Y+      G+ VA+K VL+ +   +       +E+ I+R++ H N+VR   
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 81
Query: 101 ----IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL--RFAIDICKGMEYLHQ 154
                G      +L +V +Y+P        H +     LP +    +   + + + Y+H 
Sbjct: 82  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 141
Query: 155 RNIIHRDLKTANLLMDTHN-VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI-NHQPY 212
             I HRD+K  NLL+D    V+K+ DFG A+   +G    +   +  + APE+I     Y
Sbjct: 142 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 201
Query: 213 DQKADVFSFAIVLWELVTAK--VPYDS 237
               DV+S   VL EL+  +   P DS
Sbjct: 202 TSSIDVWSAGCVLAELLLGQPIFPGDS 228

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 46  IASGSCGDLYRGVYL--GQDVAVK-VLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF-- 100
           I +GS G +Y+      G+ VA+K VL+ +   +       +E+ I+R++ H N+VR   
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 84
Query: 101 ----IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL--RFAIDICKGMEYLHQ 154
                G      +L +V +Y+P        H +     LP +    +   + + + Y+H 
Sbjct: 85  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 144
Query: 155 RNIIHRDLKTANLLMDTHN-VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI-NHQPY 212
             I HRD+K  NLL+D    V+K+ DFG A+   +G    +   +  + APE+I     Y
Sbjct: 145 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 204
Query: 213 DQKADVFSFAIVLWELVTAK--VPYDS 237
               DV+S   VL EL+  +   P DS
Sbjct: 205 TSSIDVWSAGCVLAELLLGQPIFPGDS 231

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 46  IASGSCGDLYRGVYL--GQDVAVK-VLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF-- 100
           I +GS G +Y+      G+ VA+K VL+ +   +       +E+ I+R++ H N+VR   
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 99
Query: 101 ----IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL--RFAIDICKGMEYLHQ 154
                G      +L +V +Y+P        H +     LP +    +   + + + Y+H 
Sbjct: 100 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 159
Query: 155 RNIIHRDLKTANLLMDTHN-VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI-NHQPY 212
             I HRD+K  NLL+D    V+K+ DFG A+   +G    +   +  + APE+I     Y
Sbjct: 160 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 219
Query: 213 DQKADVFSFAIVLWELVTAK--VPYDS 237
               DV+S   VL EL+  +   P DS
Sbjct: 220 TSSIDVWSAGCVLAELLLGQPIFPGDS 246

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 87/202 (43%), Gaps = 50/202 (24%)
Query: 61  GQDVAVKVLRS---------------EHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST 105
           G+ VAVK++++               EHLN T  +   + V +L   +H           
Sbjct: 40  GRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG--------- 90
Query: 106 KSPHLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKT 164
              H+CIV E + G S YD++ +N  +  +L  + + A  ICK + +LH   + H DLK 
Sbjct: 91  ---HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKP 146
Query: 165 ANLLM------DTHNV-------------VKVADFGVARFQNKGGVMTAETGTYRWMAPE 205
            N+L       + +N              +KV DFG A + ++          YR  APE
Sbjct: 147 ENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVXXRHYR--APE 204
Query: 206 VINHQPYDQKADVFSFAIVLWE 227
           VI    + Q  DV+S   +L E
Sbjct: 205 VILALGWSQPCDVWSIGCILIE 226

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 46  IASGSCGDLYRGVYL--GQDVAVK-VLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF-- 100
           I +GS G +Y+      G+ VA+K VL+ +   +       +E+ I+R++ H N+VR   
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 92
Query: 101 ----IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL--RFAIDICKGMEYLHQ 154
                G      +L +V +Y+P        H +     LP +    +   + + + Y+H 
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 152
Query: 155 RNIIHRDLKTANLLMDTHN-VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI-NHQPY 212
             I HRD+K  NLL+D    V+K+ DFG A+   +G    +   +  + APE+I     Y
Sbjct: 153 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 212
Query: 213 DQKADVFSFAIVLWELVTAK--VPYDS 237
               DV+S   VL EL+  +   P DS
Sbjct: 213 TSSIDVWSAGCVLAELLLGQPIFPGDS 239

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 94/207 (45%), Gaps = 28/207 (13%)
Query: 53  DLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI-------GAST 105
           DL  G++ G   A+K +      D   +E  +E  + R   H N++R +       GA  
Sbjct: 46  DLVEGLHDGHFYALKRILCHEQQD--REEAQREADMHRLFNHPNILRLVAYCLRERGAKH 103
Query: 106 KSPHLCIVTEYMPGGSLYDYLHK---NHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
           ++    ++  +   G+L++ + +     N L   Q+L   + IC+G+E +H +   HRDL
Sbjct: 104 EA---WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDL 160
Query: 163 KTANLLMDTHNVVKVADFG-----VARFQNKGGVMT-----AETGTYRWMAPEVINHQPY 212
           K  N+L+       + D G         +     +T     A+  T  + APE+ + Q +
Sbjct: 161 KPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSH 220
Query: 213 ---DQKADVFSFAIVLWELVTAKVPYD 236
              D++ DV+S   VL+ ++  + PYD
Sbjct: 221 CVIDERTDVWSLGCVLYAMMFGEGPYD 247

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 37/204 (18%)
Query: 51  CGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRN------VVRFIGAS 104
           C D  RG   G  VA+K++++    +  ++    E+ +L ++  ++       V+     
Sbjct: 52  CVDHRRG---GARVALKIIKNV---EKYKEAARLEINVLEKINEKDPDNKNLCVQMFDWF 105
Query: 105 TKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLP--QLLRFAIDICKGMEYLHQRNIIHRDL 162
               H+CI  E + G S +D+L K++N L  P  Q+   A  +C+ +++LH   + H DL
Sbjct: 106 DYHGHMCISFELL-GLSTFDFL-KDNNYLPYPIHQVRHMAFQLCQAVKFLHDNKLTHTDL 163
Query: 163 KTANLLMD------THNV-------------VKVADFGVARFQNKGGVMTAETGTYRWMA 203
           K  N+L        T+N+             V+V DFG A F ++       T  YR  A
Sbjct: 164 KPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATFDHEHHSTIVSTRHYR--A 221
Query: 204 PEVINHQPYDQKADVFSFAIVLWE 227
           PEVI    + Q  DV+S   +++E
Sbjct: 222 PEVILELGWSQPCDVWSIGCIIFE 245

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 46  IASGSCGDLYRGVYL--GQDVAVK-VLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF-- 100
           I +GS G +Y+      G+ VA+K VL+ +   +       +E+ I+R++ H N+VR   
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 88
Query: 101 ----IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL--RFAIDICKGMEYLHQ 154
                G      +L +V +Y+P        H +     LP +    +   + + + Y+H 
Sbjct: 89  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 148
Query: 155 RNIIHRDLKTANLLMDTHN-VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI-NHQPY 212
             I HRD+K  NLL+D    V+K+ DFG A+   +G    +   +  + APE+I     Y
Sbjct: 149 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 208
Query: 213 DQKADVFSFAIVLWELVTAK--VPYDS 237
               DV+S   VL EL+  +   P DS
Sbjct: 209 TSSIDVWSAGCVLAELLLGQPIFPGDS 235

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 41  KTGERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLE----DEFVQEVAILREVQH 94
           + G  + SG  G +Y G+ +  +  VA+K +  + ++D  E         EV +L++V  
Sbjct: 34  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 93
Query: 95  --RNVVRFIGASTKSPHLCIVTEYM-PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
               V+R +    +     ++ E   P   L+D++      L+      F   + + + +
Sbjct: 94  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRH 152
Query: 152 LHQRNIIHRDLKTANLLMD-THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN-H 209
            H   ++HRD+K  N+L+D     +K+ DFG      K  V T   GT  +  PE I  H
Sbjct: 153 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYH 211
Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYD-SMTPLQAALGVRQVCTSLCQ 256
           + + + A V+S  I+L+++V   +P++     ++  +  RQ  +  CQ
Sbjct: 212 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQ 259

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 46  IASGSCGDLYRGVYL--GQDVAVK-VLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF-- 100
           I +GS G +Y+      G+ VA+K VL+ +   +       +E+ I+R++ H N+VR   
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 92
Query: 101 ----IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL--RFAIDICKGMEYLHQ 154
                G      +L +V +Y+P        H +     LP +    +   + + + Y+H 
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 152
Query: 155 RNIIHRDLKTANLLMDTHN-VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI-NHQPY 212
             I HRD+K  NLL+D    V+K+ DFG A+   +G    +   +  + APE+I     Y
Sbjct: 153 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 212
Query: 213 DQKADVFSFAIVLWELVTAK--VPYDS 237
               DV+S   VL EL+  +   P DS
Sbjct: 213 TSSIDVWSAGCVLAELLLGQPIFPGDS 239

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 41  KTGERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLE----DEFVQEVAILREVQH 94
           + G  + SG  G +Y G+ +  +  VA+K +  + ++D  E         EV +L++V  
Sbjct: 59  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 118
Query: 95  --RNVVRFIGASTKSPHLCIVTEYM-PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
               V+R +    +     ++ E   P   L+D++      L+      F   + + + +
Sbjct: 119 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRH 177
Query: 152 LHQRNIIHRDLKTANLLMD-THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN-H 209
            H   ++HRD+K  N+L+D     +K+ DFG      K  V T   GT  +  PE I  H
Sbjct: 178 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYH 236
Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYD-SMTPLQAALGVRQVCTSLCQ 256
           + + + A V+S  I+L+++V   +P++     ++  +  RQ  +  CQ
Sbjct: 237 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQ 284

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 43  GERIASGSCGDLYRGVY-----LGQ----DVAVKVLRSEHLNDTLEDEFVQEVAILREVQ 93
            E +  G+   +++GV       GQ    +V +KVL   H N    + F +  +++ ++ 
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN--YSESFFEAASMMSKLS 70
Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
           H+++V   G         +V E++  GSL  YL KN N + +   L  A  +   M +L 
Sbjct: 71  HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE 130
Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG---GVMTAETGTYR--WMAPEVI- 207
           +  +IH ++   N+L+      K  +    +  + G    V+  +    R  W+ PE I 
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIE 190
Query: 208 NHQPYDQKADVFSFAIVLWELVTA 231
           N +  +   D +SF   LWE+ + 
Sbjct: 191 NPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 46  IASGSCGDLYRGVYL--GQDVAVK-VLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF-- 100
           I +GS G +Y+      G+ VA+K VL+ +   +       +E+ I+R++ H N+VR   
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 114
Query: 101 ----IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL--RFAIDICKGMEYLHQ 154
                G      +L +V +Y+P        H +     LP +    +   + + + Y+H 
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 155 RNIIHRDLKTANLLMDTHN-VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI-NHQPY 212
             I HRD+K  NLL+D    V+K+ DFG A+   +G    +   +  + APE+I     Y
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 234
Query: 213 DQKADVFSFAIVLWELVTAK--VPYDS 237
               DV+S   VL EL+  +   P DS
Sbjct: 235 TSSIDVWSAGCVLAELLLGQPIFPGDS 261

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 46  IASGSCGDLYRGVYL--GQDVAVK-VLRSEHLNDTLEDEFVQEVAILREVQHRNVVR--- 99
           I +GS G +Y+      G+ VA+K VL+ +   +       +E+ I+R++ H N+VR   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 80
Query: 100 -FIGASTKSP--HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL--RFAIDICKGMEYLHQ 154
            F  +  K    +L +V +Y+P        H +     LP +    +   + + + Y+H 
Sbjct: 81  FFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 155 RNIIHRDLKTANLLMDTHN-VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI-NHQPY 212
             I HRD+K  NLL+D    V+K+ DFG A+   +G    +   +  + APE+I     Y
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDY 200
Query: 213 DQKADVFSFAIVLWELVTAK--VPYDS 237
               DV+S   VL EL+  +   P DS
Sbjct: 201 TSSIDVWSAGCVLAELLLGQPIFPGDS 227

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 41  KTGERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLE----DEFVQEVAILREVQH 94
           + G  + SG  G +Y G+ +  +  VA+K +  + ++D  E         EV +L++V  
Sbjct: 54  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 113
Query: 95  --RNVVRFIGASTKSPHLCIVTEYM-PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
               V+R +    +     ++ E   P   L+D++      L+      F   + + + +
Sbjct: 114 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRH 172
Query: 152 LHQRNIIHRDLKTANLLMD-THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN-H 209
            H   ++HRD+K  N+L+D     +K+ DFG      K  V T   GT  +  PE I  H
Sbjct: 173 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYH 231
Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYD-SMTPLQAALGVRQVCTSLCQ 256
           + + + A V+S  I+L+++V   +P++     ++  +  RQ  +  CQ
Sbjct: 232 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQ 279

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 41  KTGERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLE----DEFVQEVAILREVQH 94
           + G  + SG  G +Y G+ +  +  VA+K +  + ++D  E         EV +L++V  
Sbjct: 27  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 86
Query: 95  --RNVVRFIGASTKSPHLCIVTEYM-PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
               V+R +    +     ++ E   P   L+D++      L+      F   + + + +
Sbjct: 87  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRH 145
Query: 152 LHQRNIIHRDLKTANLLMD-THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN-H 209
            H   ++HRD+K  N+L+D     +K+ DFG      K  V T   GT  +  PE I  H
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYH 204
Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYD-SMTPLQAALGVRQVCTSLCQ 256
           + + + A V+S  I+L+++V   +P++     ++  +  RQ  +  CQ
Sbjct: 205 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQ 252

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 46  IASGSCGDLYRGVYL--GQDVAVK-VLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF-- 100
           I +GS G +Y+      G+ VA+K VL+ +   +       +E+ I+R++ H N+VR   
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 80
Query: 101 ----IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL--RFAIDICKGMEYLHQ 154
                G      +L +V +Y+P        H +     LP +    +   + + + Y+H 
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 155 RNIIHRDLKTANLLMDTHN-VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI-NHQPY 212
             I HRD+K  NLL+D    V+K+ DFG A+   +G    +   +  + APE+I     Y
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 200
Query: 213 DQKADVFSFAIVLWELVTAK--VPYDS 237
               DV+S   VL EL+  +   P DS
Sbjct: 201 TSSIDVWSAGCVLAELLLGQPIFPGDS 227

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 41  KTGERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLE----DEFVQEVAILREVQH 94
           + G  + SG  G +Y G+ +  +  VA+K +  + ++D  E         EV +L++V  
Sbjct: 27  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 86
Query: 95  --RNVVRFIGASTKSPHLCIVTEYM-PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
               V+R +    +     ++ E   P   L+D++      L+      F   + + + +
Sbjct: 87  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRH 145
Query: 152 LHQRNIIHRDLKTANLLMD-THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN-H 209
            H   ++HRD+K  N+L+D     +K+ DFG      K  V T   GT  +  PE I  H
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYH 204
Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYD-SMTPLQAALGVRQVCTSLCQ 256
           + + + A V+S  I+L+++V   +P++     ++  +  RQ  +  CQ
Sbjct: 205 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQ 252

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 105/228 (46%), Gaps = 14/228 (6%)
Query: 41  KTGERIASGSCGDLYRGVYLGQD--VAVKVLRSEHLNDTLE----DEFVQEVAILREVQH 94
           + G  + SG  G +Y G+ +  +  VA+K +  + ++D  E         EV +L++V  
Sbjct: 26  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 85
Query: 95  --RNVVRFIGASTKSPHLCIVTEYM-PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
               V+R +    +     ++ E   P   L+D++      L+      F   + + + +
Sbjct: 86  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRH 144
Query: 152 LHQRNIIHRDLKTANLLMD-THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN-H 209
            H   ++HRD+K  N+L+D     +K+ DFG      K  V T   GT  +  PE I  H
Sbjct: 145 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYH 203
Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYD-SMTPLQAALGVRQVCTSLCQ 256
           + + + A V+S  I+L+++V   +P++     ++  +  RQ  +  CQ
Sbjct: 204 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQ 251

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 46  IASGSCGDLYRGVYL--GQDVAVK-VLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF-- 100
           I +GS G +Y+      G+ VA+K VL+ +   +       +E+ I+R++ H N+VR   
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 93
Query: 101 ----IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL--RFAIDICKGMEYLHQ 154
                G      +L +V +Y+P        H +     LP +    +   + + + Y+H 
Sbjct: 94  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 153
Query: 155 RNIIHRDLKTANLLMDTHN-VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI-NHQPY 212
             I HRD+K  NLL+D    V+K+ DFG A+   +G    +   +  + APE+I     Y
Sbjct: 154 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 213
Query: 213 DQKADVFSFAIVLWELVTAK--VPYDS 237
               DV+S   VL EL+  +   P DS
Sbjct: 214 TSSIDVWSAGCVLAELLLGQPIFPGDS 240

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 46  IASGSCGDLYRGVYL--GQDVAVK-VLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF-- 100
           I +GS G +Y+      G+ VA+K VL+ +   +       +E+ I+R++ H N+VR   
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 85
Query: 101 ----IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL--RFAIDICKGMEYLHQ 154
                G      +L +V +Y+P        H +     LP +    +   + + + Y+H 
Sbjct: 86  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 145
Query: 155 RNIIHRDLKTANLLMDTHN-VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI-NHQPY 212
             I HRD+K  NLL+D    V+K+ DFG A+   +G    +   +  + APE+I     Y
Sbjct: 146 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 205
Query: 213 DQKADVFSFAIVLWELVTAK--VPYDS 237
               DV+S   VL EL+  +   P DS
Sbjct: 206 TSSIDVWSAGCVLAELLLGQPIFPGDS 232

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 44  ERIASGSCG--DLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVV--- 98
           E I +G+ G     R    GQ VA+K + +     T     ++E+ IL+  +H N++   
Sbjct: 61  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIK 120
Query: 99  ---RFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR 155
              R      +   + +V + M    L+  +H +   L L  +  F   + +G++Y+H  
Sbjct: 121 DILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQP-LTLEHVRYFLYQLLRGLKYMHSA 178
Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV-----MTAETGTYRWMAPEV-INH 209
            +IHRDLK +NLL++ +  +K+ DFG+AR            MT    T  + APE+ ++ 
Sbjct: 179 QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSL 238
Query: 210 QPYDQKADVFSFAIVLWELVTAK 232
             Y Q  D++S   +  E++  +
Sbjct: 239 HEYTQAIDLWSVGCIFGEMLARR 261

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 46  IASGSCGDLYRGVYL--GQDVAVK-VLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF-- 100
           I +GS G +Y+      G+ VA+K VL+ +   +       +E+ I+R++ H N+VR   
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCNIVRLRY 108
Query: 101 ----IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL--RFAIDICKGMEYLHQ 154
                G      +L +V +Y+P        H +     LP +    +   + + + Y+H 
Sbjct: 109 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 168
Query: 155 RNIIHRDLKTANLLMDTHN-VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI-NHQPY 212
             I HRD+K  NLL+D    V+K+ DFG A+   +G    +   +  + APE+I     Y
Sbjct: 169 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 228
Query: 213 DQKADVFSFAIVLWELVTAK--VPYDS 237
               DV+S   VL EL+  +   P DS
Sbjct: 229 TSSIDVWSAGCVLAELLLGQPIFPGDS 255
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	259
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-130
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-123
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-122
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-122
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-121
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-120
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-120
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-115
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-111
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-98
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-95
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-94
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-94
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-92
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-87
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-79
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-78
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-78
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-77
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-77
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-77
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-77
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	6e-77
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-77
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	7e-76
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-75
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-75
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-75
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-75
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-74
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-74
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-74
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	8e-74
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	9e-74
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-73
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-73
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-73
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-72
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-72
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	9e-72
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-71
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-71
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-71
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-70
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-70
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-70
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-69
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-69
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-69
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-69
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-68
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-68
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	9e-68
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-67
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-67
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-67
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-67
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-67
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	8e-67
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	9e-67
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-66
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-66
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-66
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-66
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-66
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-65
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-65
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	8e-65
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-59
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-59
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-58
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-58
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-58
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-57
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-56
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-56
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-56
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-56
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-55
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-55
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-55
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-52
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-52
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-51
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-51
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-51
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-51
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	7e-51
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-50
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-50
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-50
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-50
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-49
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-49
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-48
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-48
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-48
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-48
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	9e-48
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-47
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-47
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-45
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-44
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-44
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-44
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-44
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-44
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-44
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-43
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-43
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-42
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-42
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-40
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-40
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-40
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-40
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-39
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-39
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-38
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-38
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-38
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-38
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	7e-38
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	9e-38
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	9e-38
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-37
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-37
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-37
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-37
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-37
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-37
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-37
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-37
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-37
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-37
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-37
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-36
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-36
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-36
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-36
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-36
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-36
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-36
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-36
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	8e-36
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-35
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-35
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-35
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-35
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-35
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-35
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	7e-35
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-34
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-34
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-34
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-34
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-34
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-34
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-33
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-33
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-33
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	7e-33
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-32
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-32
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-32
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-32
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-32
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-32
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	8e-32
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	9e-32
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-31
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-31
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-31
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-31
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-30
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-30
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	7e-30
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-29
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-29
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-29
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-29
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-29
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-29
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-29
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-28
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-28
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-28
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-28
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-28
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	8e-28
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	9e-28
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-27
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-27
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-27
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-27
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-27
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-27
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-26
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-26
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-26
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-26
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-26
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-26
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-26
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-26
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-26
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-26
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	8e-26
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	9e-26
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-25
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-25
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-25
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	7e-25
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	9e-25
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-24
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-24
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-23
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-23
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-23
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-23
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-22
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-22
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-22
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-22
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-22
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-21
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-21
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-20
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-20
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-20
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-19
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-17
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-17
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-16
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-15
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-13
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	2e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-04

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  369 bits (949), Expect = e-130
 Identities = 94/232 (40%), Positives = 142/232 (61%), Gaps = 5/232 (2%)

Query: 21  EKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLED 80
               +     +D +I    L   E+I +GS G ++R  + G DVAVK+L  +  +    +
Sbjct: 20  NLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVN 79

Query: 81  EFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLP--QL 138
           EF++EVAI++ ++H N+V F+GA T+ P+L IVTEY+  GSLY  LHK+    +L   + 
Sbjct: 80  EFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRR 139

Query: 139 LRFAIDICKGMEYLHQRN--IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV-MTAE 195
           L  A D+ KGM YLH RN  I+HR+LK+ NLL+D    VKV DFG++R +    +   + 
Sbjct: 140 LSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA 199

Query: 196 TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGV 247
            GT  WMAPEV+  +P ++K+DV+SF ++LWEL T + P+ ++ P Q    V
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV 251

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  352 bits (905), Expect = e-123
 Identities = 87/233 (37%), Positives = 136/233 (58%), Gaps = 8/233 (3%)

Query: 21  EKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLED 80
                S+  ++DWEI    +  G+RI SGS G +Y+G + G DVAVK+L           
Sbjct: 7   HHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQ 65

Query: 81  EFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLR 140
            F  EV +LR+ +H N++ F+G ST  P L IVT++  G SLY +LH +    ++ +L+ 
Sbjct: 66  AFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLID 124

Query: 141 FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK---GGVMTAETG 197
            A    +GM+YLH ++IIHRDLK+ N+ +   N VK+ DFG+A  +++          +G
Sbjct: 125 IARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSG 184

Query: 198 TYRWMAPEVINHQ---PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGV 247
           +  WMAPEVI  Q   PY  ++DV++F IVL+EL+T ++PY ++      + +
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM 237

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  346 bits (891), Expect = e-122
 Identities = 80/228 (35%), Positives = 123/228 (53%), Gaps = 16/228 (7%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDT--LEDEFVQEVAILR 90
            EID   L   E I  G  G +YR  ++G +VAVK  R +   D     +   QE  +  
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61

Query: 91  EVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGME 150
            ++H N++   G   K P+LC+V E+  GG L   L      +    L+ +A+ I +GM 
Sbjct: 62  MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMN 119

Query: 151 YLHQRN---IIHRDLKTANLLMD--------THNVVKVADFGVARFQNKGGVMTAETGTY 199
           YLH      IIHRDLK++N+L+         ++ ++K+ DFG+AR  ++   M+A  G Y
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGAY 178

Query: 200 RWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGV 247
            WMAPEVI    + + +DV+S+ ++LWEL+T +VP+  +  L  A GV
Sbjct: 179 AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV 226

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  348 bits (895), Expect = e-121
 Identities = 69/243 (28%), Positives = 118/243 (48%), Gaps = 17/243 (6%)

Query: 22  KAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDE 81
           KA ++    ++W+I    L+ GE I  G  G +Y G + G +VA++++  E  N+     
Sbjct: 17  KASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKA 75

Query: 82  FVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF 141
           F +EV   R+ +H NVV F+GA    PHL I+T    G +LY  +     VL + +  + 
Sbjct: 76  FKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQI 135

Query: 142 AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF------QNKGGVMTAE 195
           A +I KGM YLH + I+H+DLK+ N+  D +  V + DFG+           +   +  +
Sbjct: 136 AQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQ 194

Query: 196 TGTYRWMAPEVI---------NHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALG 246
            G    +APE+I         +  P+ + +DVF+   + +EL   + P+ +         
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ 254

Query: 247 VRQ 249
           +  
Sbjct: 255 MGT 257

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  345 bits (887), Expect = e-120
 Identities = 75/246 (30%), Positives = 108/246 (43%), Gaps = 21/246 (8%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV 92
                  L  GE +  G  G   +  +      + +      ++  +  F++EV ++R +
Sbjct: 5   RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL 64

Query: 93  QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYL 152
           +H NV++FIG   K   L  +TEY+ GG+L   +    +     Q + FA DI  GM YL
Sbjct: 65  EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124

Query: 153 HQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ---------------NKGGVMTAETG 197
           H  NIIHRDL + N L+  +  V VADFG+AR                           G
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184

Query: 198 TYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGV------RQVC 251
              WMAPE+IN + YD+K DVFSF IVL E++          P     G+       + C
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC 244

Query: 252 TSLCQP 257
              C P
Sbjct: 245 PPNCPP 250

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  343 bits (883), Expect = e-120
 Identities = 66/226 (29%), Positives = 117/226 (51%), Gaps = 12/226 (5%)

Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           ++   ID + L    ++     G+L++G + G D+ VKVL+    +     +F +E   L
Sbjct: 2   NKHSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRL 61

Query: 90  REVQHRNVVRFIGASTKSP--HLCIVTEYMPGGSLYDYLHKNHN-VLKLPQLLRFAIDIC 146
           R   H NV+  +GA    P  H  ++T +MP GSLY+ LH+  N V+   Q ++FA+D+ 
Sbjct: 62  RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMA 121

Query: 147 KGMEYLHQRN--IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAP 204
           +GM +LH     I    L + ++++D     +++   V                  W+AP
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ----SPGRMYAPAWVAP 177

Query: 205 EVINHQPYD---QKADVFSFAIVLWELVTAKVPYDSMTPLQAALGV 247
           E +  +P D   + AD++SFA++LWELVT +VP+  ++ ++  + V
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV 223

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  330 bits (848), Expect = e-115
 Identities = 67/234 (28%), Positives = 117/234 (50%), Gaps = 20/234 (8%)

Query: 28  TKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLE-----D 80
            KS    +    ++  ++I  G  G +++G  +     VA+K L         E      
Sbjct: 9   PKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ 68

Query: 81  EFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLR 140
           EF +EV I+  + H N+V+  G     P   +V E++P G LY  L    + +K    LR
Sbjct: 69  EFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLR 126

Query: 141 FAIDICKGMEYLHQRN--IIHRDLKTANLLMDTHN-----VVKVADFGVARFQNKGGVMT 193
             +DI  G+EY+  +N  I+HRDL++ N+ + + +       KVADFG+++       ++
Sbjct: 127 LMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--VS 184

Query: 194 AETGTYRWMAPEVIN--HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL 245
              G ++WMAPE I    + Y +KAD +SFA++L+ ++T + P+D  +  +   
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF 238

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  321 bits (824), Expect = e-111
 Identities = 73/222 (32%), Positives = 112/222 (50%), Gaps = 15/222 (6%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV 92
             ID + ++  E +  G+ G + +  +  +DVA+K + SE    +    F+ E+  L  V
Sbjct: 3   HMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRV 58

Query: 93  QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLP--QLLRFAIDICKGME 150
            H N+V+  GA      +C+V EY  GGSLY+ LH    +        + + +   +G+ 
Sbjct: 59  NHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116

Query: 151 YLHQRN---IIHRDLKTANLLMDTHN-VVKVADFGVARFQNKGGVMTAETGTYRWMAPEV 206
           YLH      +IHRDLK  NLL+     V+K+ DFG A        MT   G+  WMAPEV
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ--THMTNNKGSAAWMAPEV 174

Query: 207 INHQPYDQKADVFSFAIVLWELVTAKVPYDSM-TPLQAALGV 247
                Y +K DVFS+ I+LWE++T + P+D +  P    +  
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA 216

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  289 bits (741), Expect = 4e-98
 Identities = 68/257 (26%), Positives = 110/257 (42%), Gaps = 44/257 (17%)

Query: 32  DWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAI--L 89
                 + ++  ++I  G  G+++ G + G+ VAVKV  +       E  + +E  I   
Sbjct: 31  VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----EASWFRETEIYQT 85

Query: 90  REVQHRNVVRFIGASTKS----PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDI 145
             ++H N++ FI A  K       L ++T+Y   GSLYDYL      L    +L+ A   
Sbjct: 86  VLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSS 143

Query: 146 CKGMEYLH--------QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-----VM 192
             G+ +LH        +  I HRDLK+ N+L+  +    +AD G+A              
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203

Query: 193 TAETGTYRWMAPEVI------NHQPYDQKADVFSFAIVLWELVTA----------KVPYD 236
               GT R+M PEV+      NH      AD++SF ++LWE+             ++PY 
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263

Query: 237 SMTPLQAALG--VRQVC 251
            + P   +       VC
Sbjct: 264 DLVPSDPSYEDMREIVC 280

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  280 bits (719), Expect = 4e-95
 Identities = 66/243 (27%), Positives = 110/243 (45%), Gaps = 42/243 (17%)

Query: 38  RLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAI--LREVQHR 95
           R +   E +  G  G+++RG + G++VAVK+  S       E  + +E  +     ++H 
Sbjct: 8   RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHE 62

Query: 96  NVVRFIGASTKSPH----LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
           N++ FI +   S H    L ++T Y   GSLYDYL      L     LR  + I  G+ +
Sbjct: 63  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAH 120

Query: 152 LH--------QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM-----TAETGT 198
           LH        +  I HRDLK+ N+L+  +    +AD G+A   ++             GT
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180

Query: 199 YRWMAPEVINHQP------YDQKADVFSFAIVLWELVT----------AKVPYDSMTPLQ 242
            R+MAPEV++           ++ D+++F +VLWE+             K P+  + P  
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240

Query: 243 AAL 245
            + 
Sbjct: 241 PSF 243

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  280 bits (719), Expect = 1e-94
 Identities = 64/255 (25%), Positives = 113/255 (44%), Gaps = 40/255 (15%)

Query: 32  DWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
                 R +   E I  G  G+++RG + G++VAVK+  S             E+     
Sbjct: 36  VQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER---SWFREAEIYQTVM 92

Query: 92  VQHRNVVRFIGASTK----SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICK 147
           ++H N++ FI A  K       L +V++Y   GSL+DYL++    + +  +++ A+    
Sbjct: 93  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTAS 150

Query: 148 GMEYLHQR--------NIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-----VMTA 194
           G+ +LH           I HRDLK+ N+L+  +    +AD G+A   +            
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210

Query: 195 ETGTYRWMAPEVI------NHQPYDQKADVFSFAIVLWELVT----------AKVPYDSM 238
             GT R+MAPEV+       H    ++AD+++  +V WE+             ++PY  +
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270

Query: 239 TPLQAALG--VRQVC 251
            P   ++    + VC
Sbjct: 271 VPSDPSVEEMRKVVC 285

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  274 bits (702), Expect = 3e-92
 Identities = 64/237 (27%), Positives = 106/237 (44%), Gaps = 27/237 (11%)

Query: 26  SQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQE 85
               +E+       L+  E  A G  G +++   L + VAVK+   +        +   E
Sbjct: 12  VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQ---SWQNEYE 68

Query: 86  VAILREVQHRNVVRFIGASTKSPH----LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF 141
           V  L  ++H N+++FIGA  +       L ++T +   GSL D+L  N  V+   +L   
Sbjct: 69  VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHI 126

Query: 142 AIDICKGMEYLHQR----------NIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-- 189
           A  + +G+ YLH+            I HRD+K+ N+L+  +    +ADFG+A     G  
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186

Query: 190 -GVMTAETGTYRWMAPEVINHQP-----YDQKADVFSFAIVLWELVTAKVPYDSMTP 240
            G    + GT R+MAPEV+            + D+++  +VLWEL +     D    
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  262 bits (670), Expect = 2e-87
 Identities = 64/253 (25%), Positives = 107/253 (42%), Gaps = 42/253 (16%)

Query: 27  QTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEV 86
           +  + +  +D   LK  E I  G  G +Y+G    + VAVKV    +        F+ E 
Sbjct: 2   EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEK 56

Query: 87  AI--LREVQHRNVVRFIGASTKSP-----HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL 139
            I  +  ++H N+ RFI    +          +V EY P GSL  YL    +        
Sbjct: 57  NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSC 114

Query: 140 RFAIDICKGMEYLH---------QRNIIHRDLKTANLLMDTHNVVKVADFGVARF----- 185
           R A  + +G+ YLH         +  I HRDL + N+L+       ++DFG++       
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 186 ----QNKGGVMTAETGTYRWMAPEVI-------NHQPYDQKADVFSFAIVLWELV---TA 231
                 +     +E GT R+MAPEV+       + +   ++ D+++  ++ WE+    T 
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234

Query: 232 KVPYDSMTPLQAA 244
             P +S+   Q A
Sbjct: 235 LFPGESVPEYQMA 247

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  242 bits (619), Expect = 4e-79
 Identities = 79/226 (34%), Positives = 120/226 (53%), Gaps = 9/226 (3%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ--DVAVKVLRSEHLNDTLEDEFVQEVAI 88
           + W ++   L  GE+I  G+ G+++ G        VAVK  R E L   L+ +F+QE  I
Sbjct: 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARI 165

Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
           L++  H N+VR IG  T+   + IV E + GG    +L      L++  LL+   D   G
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225

Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT----YRWMAP 204
           MEYL  +  IHRDL   N L+   NV+K++DFG++R +   GV  A  G      +W AP
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREE-ADGVYAASGGLRQVPVKWTAP 284

Query: 205 EVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQ 249
           E +N+  Y  ++DV+SF I+LWE  +    PY +++  Q    V +
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK 330

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  237 bits (607), Expect = 1e-78
 Identities = 72/212 (33%), Positives = 119/212 (56%), Gaps = 9/212 (4%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
           W ID   L   + I SG  G ++ G +L +  VA+K +R        E++F++E  ++ +
Sbjct: 3   WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE---GAMSEEDFIEEAEVMMK 59

Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
           + H  +V+  G   +   +C+VTE+M  G L DYL     +     LL   +D+C+GM Y
Sbjct: 60  LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119

Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMAPEVIN 208
           L +  +IHRDL   N L+  + V+KV+DFG+ RF       T+ TGT    +W +PEV +
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWASPEVFS 178

Query: 209 HQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
              Y  K+DV+SF +++WE+ +  K+PY++ +
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  237 bits (608), Expect = 1e-78
 Identities = 76/215 (35%), Positives = 120/215 (55%), Gaps = 15/215 (6%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
             W ++ + LK  + I  G  GD+  G Y G  VAVK ++    ND     F+ E +++ 
Sbjct: 14  SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMT 69

Query: 91  EVQHRNVVRFIGASTKS-PHLCIVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKG 148
           +++H N+V+ +G   +    L IVTEYM  GSL DYL     +VL    LL+F++D+C+ 
Sbjct: 70  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 129

Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMAPE 205
           MEYL   N +HRDL   N+L+   NV KV+DFG+ +  +     + +       +W APE
Sbjct: 130 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPE 184

Query: 206 VINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
            +  + +  K+DV+SF I+LWE+ +  +VPY  + 
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  235 bits (601), Expect = 2e-77
 Identities = 72/214 (33%), Positives = 121/214 (56%), Gaps = 9/214 (4%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAIL 89
             WEID + L   + + +G  G +  G + GQ DVA+K+++        EDEF++E  ++
Sbjct: 17  GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMSEDEFIEEAKVM 73

Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGM 149
             + H  +V+  G  TK   + I+TEYM  G L +YL +  +  +  QLL    D+C+ M
Sbjct: 74  MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 133

Query: 150 EYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMAPEV 206
           EYL  +  +HRDL   N L++   VVKV+DFG++R+       T+  G+    RW  PEV
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEV 192

Query: 207 INHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           + +  +  K+D+++F +++WE+ +  K+PY+  T
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  239 bits (613), Expect = 3e-77
 Identities = 76/224 (33%), Positives = 123/224 (54%), Gaps = 15/224 (6%)

Query: 22  KAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDE 81
            A + +     W ++ + LK  + I  G  GD+  G Y G  VAVK +++    D     
Sbjct: 177 VAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN----DATAQA 232

Query: 82  FVQEVAILREVQHRNVVRFIGASTKS-PHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLL 139
           F+ E +++ +++H N+V+ +G   +    L IVTEYM  GSL DYL     +VL    LL
Sbjct: 233 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 292

Query: 140 RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT- 198
           +F++D+C+ MEYL   N +HRDL   N+L+   NV KV+DFG+ +  +     + +    
Sbjct: 293 KFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGK 347

Query: 199 --YRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
              +W APE +  + +  K+DV+SF I+LWE+ +  +VPY  + 
Sbjct: 348 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  234 bits (599), Expect = 3e-77
 Identities = 71/229 (31%), Positives = 114/229 (49%), Gaps = 12/229 (5%)

Query: 25  ESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLN-DTL 78
           E   +S    I  + L+  E++  GS G + RG +         VAVK L+ + L+    
Sbjct: 5   EGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA 64

Query: 79  EDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQL 138
            D+F++EV  +  + HRN++R  G     P + +VTE  P GSL D L K+     L  L
Sbjct: 65  MDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTL 123

Query: 139 LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVMTAETG 197
            R+A+ + +GM YL  +  IHRDL   NLL+ T ++VK+ DFG+ R   +       +  
Sbjct: 124 SRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 183

Query: 198 T---YRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQ 242
               + W APE +  + +   +D + F + LWE+ T  + P+  +   Q
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 232

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  233 bits (597), Expect = 5e-77
 Identities = 83/215 (38%), Positives = 125/215 (58%), Gaps = 11/215 (5%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           ++WE+ R  LK  ER+ +G  G+++ G Y G   VAVK L+         D F+ E  ++
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMSPDAFLAEANLM 62

Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKG 148
           +++QH+ +VR     T+ P + I+TEYM  GSL D+L       L + +LL  A  I +G
Sbjct: 63  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121

Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMAPE 205
           M ++ +RN IHRDL+ AN+L+      K+ADFG+AR   +    TA  G     +W APE
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPE 180

Query: 206 VINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
            IN+  +  K+DV+SF I+L E+VT  ++PY  MT
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  233 bits (596), Expect = 6e-77
 Identities = 77/212 (36%), Positives = 116/212 (54%), Gaps = 9/212 (4%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
            E+ R  +   + + SG  G +  G + GQ DVAVK+++        EDEF QE   + +
Sbjct: 3   MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKE---GSMSEDEFFQEAQTMMK 59

Query: 92  VQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
           + H  +V+F G  +K   + IVTEY+  G L +YL  +   L+  QLL    D+C+GM +
Sbjct: 60  LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119

Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMAPEVIN 208
           L     IHRDL   N L+D    VKV+DFG+ R+        +  GT    +W APEV +
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKWSAPEVFH 178

Query: 209 HQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           +  Y  K+DV++F I++WE+ +  K+PYD  T
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  233 bits (597), Expect = 8e-77
 Identities = 76/216 (35%), Positives = 123/216 (56%), Gaps = 11/216 (5%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ--DVAVKVLRSEHLNDTLEDEFVQEVAI 88
           + WE++R  +    ++  G  G++Y GV+      VAVK L+    +    +EF++E A+
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAV 62

Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDICK 147
           ++E++H N+V+ +G  T+ P   I+TE+M  G+L DYL + N   +    LL  A  I  
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122

Query: 148 GMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMAP 204
            MEYL ++N IHRDL   N L+  +++VKVADFG++R    G   TA  G     +W AP
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAP 181

Query: 205 EVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           E + +  +  K+DV++F ++LWE+ T    PY  + 
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  230 bits (590), Expect = 7e-76
 Identities = 65/216 (30%), Positives = 112/216 (51%), Gaps = 10/216 (4%)

Query: 32  DWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLEDEFVQEV 86
            + I R  +     +  G  G++Y GVY         VAVK  + +      +++F+ E 
Sbjct: 6   QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCTLDNKEKFMSEA 64

Query: 87  AILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDIC 146
            I++ + H ++V+ IG   + P   I+ E  P G L  YL +N N LK+  L+ +++ IC
Sbjct: 65  VIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC 123

Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY--RWMAP 204
           K M YL   N +HRD+   N+L+ +   VK+ DFG++R+        A       +WM+P
Sbjct: 124 KAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSP 183

Query: 205 EVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           E IN + +   +DV+ FA+ +WE+++  K P+  + 
Sbjct: 184 ESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE 219

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  231 bits (590), Expect = 2e-75
 Identities = 70/259 (27%), Positives = 120/259 (46%), Gaps = 27/259 (10%)

Query: 17  GHAVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLG------QDVAVKVLR 70
           GH      +     +    + R LK   ++  G+ G +    Y          VAVK L+
Sbjct: 2   GHHHHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ 61

Query: 71  SEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPH--LCIVTEYMPGGSLYDYLHK 128
               +   + +F +E+ IL+ +    +V++ G S       L +V EY+P G L D+L +
Sbjct: 62  HSGPDQ--QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR 119

Query: 129 NHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK 188
           +   L   +LL ++  ICKGMEYL  R  +HRDL   N+L+++   VK+ADFG+A+    
Sbjct: 120 HRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK---- 175

Query: 189 GGVMTAETGTY----------RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDS 237
             ++  +   Y           W APE ++   + +++DV+SF +VL+EL T        
Sbjct: 176 --LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP 233

Query: 238 MTPLQAALGVRQVCTSLCQ 256
                  +G  +   +L +
Sbjct: 234 SAEFLRMMGCERDVPALSR 252

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  229 bits (585), Expect = 4e-75
 Identities = 62/222 (27%), Positives = 118/222 (53%), Gaps = 10/222 (4%)

Query: 26  SQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLED 80
             + + D+EI R  ++ G  I  G  GD+++G+Y+  +     VA+K  +    +D++ +
Sbjct: 3   MGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVRE 61

Query: 81  EFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLR 140
           +F+QE   +R+  H ++V+ IG  T++P + I+ E    G L  +L      L L  L+ 
Sbjct: 62  KFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLIL 120

Query: 141 FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY- 199
           +A  +   + YL  +  +HRD+   N+L+ +++ VK+ DFG++R+        A  G   
Sbjct: 121 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 180

Query: 200 -RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
            +WMAPE IN + +   +DV+ F + +WE++     P+  + 
Sbjct: 181 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  230 bits (588), Expect = 4e-75
 Identities = 60/220 (27%), Positives = 110/220 (50%), Gaps = 12/220 (5%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDTLEDEFVQEV 86
                  L+  + + SG  G +++GV++ +       V +KV+  +    + +      +
Sbjct: 8   RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA-VTDHM 66

Query: 87  AILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDIC 146
             +  + H ++VR +G    S  L +VT+Y+P GSL D++ ++   L    LL + + I 
Sbjct: 67  LAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125

Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMA 203
           KGM YL +  ++HR+L   N+L+ + + V+VADFGVA            +      +WMA
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185

Query: 204 PEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQ 242
            E I+   Y  ++DV+S+ + +WEL+T    PY  +   +
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE 225

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  235 bits (600), Expect = 6e-75
 Identities = 75/218 (34%), Positives = 123/218 (56%), Gaps = 11/218 (5%)

Query: 29  KSEDWEIDRRLLKTGERIASGSCGDLYRGVYLG--QDVAVKVLRSEHLNDTLEDEFVQEV 86
             + WE++R  +    ++  G  G++Y GV+      VAVK L+    +    +EF++E 
Sbjct: 211 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEA 267

Query: 87  AILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDI 145
           A+++E++H N+V+ +G  T+ P   I+TE+M  G+L DYL + N   +    LL  A  I
Sbjct: 268 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 327

Query: 146 CKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWM 202
              MEYL ++N IHR+L   N L+  +++VKVADFG++R    G   TA  G     +W 
Sbjct: 328 SSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWT 386

Query: 203 APEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           APE + +  +  K+DV++F ++LWE+ T    PY  + 
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 424

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  226 bits (579), Expect = 4e-74
 Identities = 65/221 (29%), Positives = 119/221 (53%), Gaps = 12/221 (5%)

Query: 29  KSEDWEIDRRLLKTGER-IASGSCGDLYRGVYLGQ----DVAVKVLRSEHLNDTLEDEFV 83
           + ++  +DR+LL   ++ + SG+ G + +G Y  +     VAVK+L++E  +  L+DE +
Sbjct: 7   RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL 66

Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
            E  +++++ +  +VR IG         +V E    G L  YL +N + +K   ++    
Sbjct: 67  AEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVH 124

Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVMTAETGT---Y 199
            +  GM+YL + N +HRDL   N+L+ T +  K++DFG+++          A+T      
Sbjct: 125 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 184

Query: 200 RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           +W APE IN+  +  K+DV+SF +++WE  +  + PY  M 
Sbjct: 185 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  226 bits (579), Expect = 5e-74
 Identities = 70/221 (31%), Positives = 115/221 (52%), Gaps = 25/221 (11%)

Query: 28  TKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL------GQDVAVKVLRSEHLNDTLEDE 81
           T+ +    ++R LK    +  G  G +    Y       G+ VAVK L+ E   + + D 
Sbjct: 11  TEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD- 69

Query: 82  FVQEVAILREVQHRNVVRFIGASTKSPH--LCIVTEYMPGGSLYDYLHKNHNVLKLPQLL 139
             +E+ ILR + H N+V++ G  T+     + ++ E++P GSL +YL KN N + L Q L
Sbjct: 70  LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQL 129

Query: 140 RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           ++A+ ICKGM+YL  R  +HRDL   N+L+++ + VK+ DFG+ +       +  +   Y
Sbjct: 130 KYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK------AIETDKEYY 183

Query: 200 ----------RWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
                      W APE +    +   +DV+SF + L EL+T
Sbjct: 184 TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  227 bits (580), Expect = 7e-74
 Identities = 68/227 (29%), Positives = 110/227 (48%), Gaps = 23/227 (10%)

Query: 29  KSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-----DVAVKVLRSEHLNDTLEDEFV 83
           +S   EI+   +   + I SG  G++  G           VA+K L+     +    +F+
Sbjct: 40  RSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK-AGYTERQRRDFL 98

Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
            E +I+ +  H N++R  G  T+     IVTEYM  GSL  +L  +     + QL+    
Sbjct: 99  SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR 158

Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY---- 199
            +  GM YL     +HRDL   N+L+D++ V KV+DFG++R      V+  +        
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR------VLEDDPDAAYTTT 212

Query: 200 ------RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
                 RW APE I  + +   +DV+SF +V+WE++   + PY +MT
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  231 bits (590), Expect = 8e-74
 Identities = 79/233 (33%), Positives = 126/233 (54%), Gaps = 11/233 (4%)

Query: 13  RKYRGHAVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRS 71
           +K     +    +   + + WEI R  LK  +++ +G  G+++   Y     VAVK ++ 
Sbjct: 163 QKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP 222

Query: 72  EHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHN 131
                   + F+ E  +++ +QH  +V+     TK P + I+TE+M  GSL D+L  +  
Sbjct: 223 ---GSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEG 278

Query: 132 -VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG 190
               LP+L+ F+  I +GM ++ QRN IHRDL+ AN+L+    V K+ADFG+AR      
Sbjct: 279 SKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE-DN 337

Query: 191 VMTAETGT---YRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
             TA  G     +W APE IN   +  K+DV+SF I+L E+VT  ++PY  M+
Sbjct: 338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 390

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  226 bits (577), Expect = 9e-74
 Identities = 71/244 (29%), Positives = 113/244 (46%), Gaps = 42/244 (17%)

Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDTLEDEFV 83
           S+  + + R LK  +++  G+ G +    Y          VAVK L+          +F 
Sbjct: 2   SDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDFE 59

Query: 84  QEVAILREVQHRNVVRFIGASTKSPH--LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF 141
           +E+ IL+ +QH N+V++ G    +    L ++ EY+P GSL DYL K+   +   +LL++
Sbjct: 60  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 119

Query: 142 AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY-- 199
              ICKGMEYL  +  IHRDL T N+L++  N VK+ DFG+ +      V+  +   +  
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK------VLPQDKEFFKV 173

Query: 200 --------RWMAPEVINHQPYDQKADVFSFAIVLWELVT----------------AKVPY 235
                    W APE +    +   +DV+SF +VL+EL T                     
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 233

Query: 236 DSMT 239
             M 
Sbjct: 234 GQMI 237

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  226 bits (578), Expect = 2e-73
 Identities = 66/221 (29%), Positives = 115/221 (52%), Gaps = 12/221 (5%)

Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLG------QDVAVKVLRSEHLNDTLEDEFV 83
               EI    +   + I +G  G++Y+G+           VA+K L+     +    +F+
Sbjct: 36  KFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVDFL 94

Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
            E  I+ +  H N++R  G  +K   + I+TEYM  G+L  +L +      + QL+    
Sbjct: 95  GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR 154

Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF-QNKGGVMTAETGT---Y 199
            I  GM+YL   N +HRDL   N+L++++ V KV+DFG++R  ++        +G     
Sbjct: 155 GIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 214

Query: 200 RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           RW APE I+++ +   +DV+SF IV+WE++T  + PY  ++
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 255

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  225 bits (576), Expect = 3e-73
 Identities = 64/218 (29%), Positives = 112/218 (51%), Gaps = 12/218 (5%)

Query: 35  IDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDTLEDEFVQEVAI 88
           +     K  + + SG+ G +Y+G+++ +       VA+K LR        ++  + E  +
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE-ILDEAYV 70

Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
           +  V + +V R +G    S  + ++T+ MP G L DY+ ++ + +    LL + + I KG
Sbjct: 71  MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMAPE 205
           M YL  R ++HRDL   N+L+ T   VK+ DFG+A+            G     +WMA E
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189

Query: 206 VINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQ 242
            I H+ Y  ++DV+S+ + +WEL+T    PYD +   +
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  224 bits (574), Expect = 5e-73
 Identities = 72/251 (28%), Positives = 117/251 (46%), Gaps = 36/251 (14%)

Query: 8   LTIVHRKYRGHAVEKAIESQTKS----------EDWEIDRRLLKTGERIASGSCGDLYRG 57
           ++  H  +         E+              +  + + R LK  +++  G+ G +   
Sbjct: 1   MSYYHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMC 60

Query: 58  VYLGQD------VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPH-- 109
            Y          VAVK L+          +F +E+ IL+ +QH N+V++ G    +    
Sbjct: 61  RYDPLQDNTGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118

Query: 110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM 169
           L ++ EY+P GSL DYL K+   +   +LL++   ICKGMEYL  +  IHRDL T N+L+
Sbjct: 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 178

Query: 170 DTHNVVKVADFGVARFQNKGGVMTAETGTY----------RWMAPEVINHQPYDQKADVF 219
           +  N VK+ DFG+ +      V+  +   Y           W APE +    +   +DV+
Sbjct: 179 ENENRVKIGDFGLTK------VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVW 232

Query: 220 SFAIVLWELVT 230
           SF +VL+EL T
Sbjct: 233 SFGVVLYELFT 243

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  229 bits (586), Expect = 2e-72
 Identities = 78/215 (36%), Positives = 119/215 (55%), Gaps = 11/215 (5%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           + WEI R  L+   ++  G  G+++ G + G   VA+K L+         + F+QE  ++
Sbjct: 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVM 316

Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKG 148
           ++++H  +V+     ++ P + IVTEYM  GSL D+L       L+LPQL+  A  I  G
Sbjct: 317 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 375

Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMAPE 205
           M Y+ + N +HRDL+ AN+L+  + V KVADFG+AR        TA  G     +W APE
Sbjct: 376 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 434

Query: 206 VINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
              +  +  K+DV+SF I+L EL T  +VPY  M 
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 469

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  226 bits (577), Expect = 7e-72
 Identities = 81/236 (34%), Positives = 123/236 (52%), Gaps = 11/236 (4%)

Query: 10  IVHRKYRGHAVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQ-DVAVKV 68
           + HR        K        + WEI R  L+   ++  G  G+++ G + G   VA+K 
Sbjct: 156 LCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKT 215

Query: 69  LRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK 128
           L+         + F+QE  ++++++H  +V+     ++ P + IVTEYM  GSL D+L  
Sbjct: 216 LKP---GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKG 271

Query: 129 N-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN 187
                L+LPQL+  A  I  GM Y+ + N +HRDL+ AN+L+  + V KVADFG+AR   
Sbjct: 272 ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331

Query: 188 KGGVMTAETGT---YRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
                TA  G     +W APE   +  +  K+DV+SF I+L EL T  +VPY  M 
Sbjct: 332 -DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 386

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  220 bits (563), Expect = 9e-72
 Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 12/219 (5%)

Query: 31  EDWEIDRRLLKTGE-RIASGSCGDLYRGVYLGQ----DVAVKVLRSEHLNDTLEDEFVQE 85
           +   + R  L   +  +  G+ G + +GVY  +    DVA+KVL+        E+  ++E
Sbjct: 2   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE-MMRE 60

Query: 86  VAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDI 145
             I+ ++ +  +VR IG       L +V E   GG L+ +L      + +  +      +
Sbjct: 61  AQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 119

Query: 146 CKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF-QNKGGVMTAETGT---YRW 201
             GM+YL ++N +HRDL   N+L+   +  K++DFG+++         TA +      +W
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 179

Query: 202 MAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
            APE IN + +  ++DV+S+ + +WE ++  + PY  M 
Sbjct: 180 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  221 bits (565), Expect = 1e-71
 Identities = 74/250 (29%), Positives = 117/250 (46%), Gaps = 19/250 (7%)

Query: 12  HRKYRGHAVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAV 66
           H    G     + E Q K ED  IDR LL  G+ +  G  G +  G    +D     VAV
Sbjct: 8   HHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAV 67

Query: 67  KVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS-----PHLCIVTEYMPGGS 121
           K ++ ++ +    +EF+ E A +++  H NV+R +G   +      P   ++  +M  G 
Sbjct: 68  KTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGD 127

Query: 122 LYDYL-----HKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVK 176
           L+ YL           + L  LL+F +DI  GMEYL  RN +HRDL   N ++     V 
Sbjct: 128 LHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVC 187

Query: 177 VADFGVARFQNKGGVMTAETGT---YRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AK 232
           VADFG+++    G             +W+A E +  + Y  K+DV++F + +WE+ T   
Sbjct: 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGM 247

Query: 233 VPYDSMTPLQ 242
            PY  +   +
Sbjct: 248 TPYPGVQNHE 257

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  221 bits (566), Expect = 4e-71
 Identities = 67/217 (30%), Positives = 112/217 (51%), Gaps = 11/217 (5%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLG-----QDVAVKVLRSEHLNDTLEDEFVQEVA 87
            E+D   +   + + +G  G++  G           VA+K L+     +    +F+ E +
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEAS 98

Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICK 147
           I+ +  H N++R  G  TKS  + IVTEYM  GSL  +L K+     + QL+     I  
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158

Query: 148 GMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF-QNKGGVMTAETGT---YRWMA 203
           GM+YL     +HRDL   N+L++++ V KV+DFG+ R  ++         G     RW +
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS 218

Query: 204 PEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           PE I ++ +   +DV+S+ IVLWE+++  + PY  M+
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  219 bits (559), Expect = 9e-71
 Identities = 70/238 (29%), Positives = 116/238 (48%), Gaps = 20/238 (8%)

Query: 25  ESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTLE 79
           E + K ED  I  +    G  +  G  G +       +D     VAVK+L+++ +  +  
Sbjct: 10  ELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDI 69

Query: 80  DEFVQEVAILREVQHRNVVRFIGASTKS------PHLCIVTEYMPGGSLYDYL-----HK 128
           +EF++E A ++E  H +V + +G S +S      P   ++  +M  G L+ +L      +
Sbjct: 70  EEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE 129

Query: 129 NHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK 188
           N   L L  L+RF +DI  GMEYL  RN IHRDL   N ++     V VADFG++R    
Sbjct: 130 NPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS 189

Query: 189 GGVMTAETGT---YRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQ 242
           G        +    +W+A E +    Y   +DV++F + +WE++T  + PY  +   +
Sbjct: 190 GDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  219 bits (559), Expect = 1e-70
 Identities = 74/248 (29%), Positives = 114/248 (45%), Gaps = 42/248 (16%)

Query: 25  ESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLRSEHLNDTL 78
             Q   +     +R LK    +  G  G +    Y       G+ VAVK L+++      
Sbjct: 18  LFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR 77

Query: 79  EDEFVQEVAILREVQHRNVVRFIGASTKSPH--LCIVTEYMPGGSLYDYLHKNHNVLKLP 136
              + QE+ ILR + H +++++ G    +    L +V EY+P GSL DYL ++   + L 
Sbjct: 78  SG-WKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLA 134

Query: 137 QLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET 196
           QLL FA  IC+GM YLH ++ IHRDL   N+L+D   +VK+ DFG+A+       +    
Sbjct: 135 QLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK------AVPEGH 188

Query: 197 GTYR----------WMAPEVINHQPYDQKADVFSFAIVLWELVT---------------A 231
             YR          W APE +    +   +DV+SF + L+EL+T                
Sbjct: 189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI 248

Query: 232 KVPYDSMT 239
            +    MT
Sbjct: 249 GIAQGQMT 256

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  217 bits (554), Expect = 2e-70
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 15/232 (6%)

Query: 25  ESQTKSEDWEI--DRRLLKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDT 77
               + +D  I  +R +  +   I  G  G +Y G Y+ Q       A+K L        
Sbjct: 6   ALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQ 65

Query: 78  LEDEFVQEVAILREVQHRNVVRFIGASTKS-PHLCIVTEYMPGGSLYDYLHKNHNVLKLP 136
           +E  F++E  ++R + H NV+  IG          ++  YM  G L  ++        + 
Sbjct: 66  VEA-FLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVK 124

Query: 137 QLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET 196
            L+ F + + +GMEYL ++  +HRDL   N ++D    VKVADFG+AR        + + 
Sbjct: 125 DLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQ 184

Query: 197 GTY-----RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQ 242
             +     +W A E +    +  K+DV+SF ++LWEL+T    PY  + P  
Sbjct: 185 HRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  217 bits (555), Expect = 5e-70
 Identities = 64/218 (29%), Positives = 112/218 (51%), Gaps = 12/218 (5%)

Query: 35  IDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDTLEDEFVQEVAI 88
           +     K  + + SG+ G +Y+G+++ +       VA+K LR        ++  + E  +
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE-ILDEAYV 70

Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
           +  V + +V R +G    S  + ++T+ MP G L DY+ ++ + +    LL + + I KG
Sbjct: 71  MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMAPE 205
           M YL  R ++HRDL   N+L+ T   VK+ DFG+A+            G     +WMA E
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189

Query: 206 VINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQ 242
            I H+ Y  ++DV+S+ + +WEL+T    PYD +   +
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  224 bits (573), Expect = 2e-69
 Identities = 64/236 (27%), Positives = 122/236 (51%), Gaps = 10/236 (4%)

Query: 12  HRKYRGHAVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAV 66
              Y     E+   +   + D+EI R  ++ G  I  G  GD+++G+Y+  +     VA+
Sbjct: 364 TDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAI 423

Query: 67  KVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL 126
           K  ++   +D++ ++F+QE   +R+  H ++V+ IG  T++P + I+ E    G L  +L
Sbjct: 424 KTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL 481

Query: 127 HKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ 186
                 L L  L+ +A  +   + YL  +  +HRD+   N+L+ +++ VK+ DFG++R+ 
Sbjct: 482 QVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541

Query: 187 NKGGVMTAETGTY--RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
                  A  G    +WMAPE IN + +   +DV+ F + +WE++     P+  + 
Sbjct: 542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 597

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  214 bits (547), Expect = 4e-69
 Identities = 69/239 (28%), Positives = 106/239 (44%), Gaps = 30/239 (12%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFV 83
             WE  R  L  G+ + +G+ G +      G         VAVK+L+    + T  +  +
Sbjct: 16  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALM 74

Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL---------------- 126
            E+ +L  +  H N+V  +GA T      ++TEY   G L ++L                
Sbjct: 75  SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134

Query: 127 -HKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF 185
              +   L L  LL F+  + KGM +L  +N IHRDL   N+L+    + K+ DFG+AR 
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 194

Query: 186 QNKGGVMTAETGT---YRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTP 240
                    +       +WMAPE I +  Y  ++DV+S+ I LWEL +    PY  M  
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  214 bits (547), Expect = 6e-69
 Identities = 65/246 (26%), Positives = 115/246 (46%), Gaps = 35/246 (14%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-------VAVKVLRSEHLNDTLEDEFV 83
             WE  R+ L  G+ +  G  G + +              VAVK+L+ E+ + +   + +
Sbjct: 16  PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK-ENASPSELRDLL 74

Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL----------------- 126
            E  +L++V H +V++  GA ++   L ++ EY   GSL  +L                 
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134

Query: 127 ------HKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADF 180
                 H +   L +  L+ FA  I +GM+YL +  ++HRDL   N+L+     +K++DF
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDF 194

Query: 181 GVARFQNKGGVMTAETGT---YRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYD 236
           G++R   +       +      +WMA E +    Y  ++DV+SF ++LWE+VT    PY 
Sbjct: 195 GLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254

Query: 237 SMTPLQ 242
            + P +
Sbjct: 255 GIPPER 260

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  213 bits (544), Expect = 7e-69
 Identities = 49/230 (21%), Positives = 92/230 (40%), Gaps = 32/230 (13%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLEDEFV 83
            +I    L   E +  G+   +++GV              V +KVL   H N    + F 
Sbjct: 3   HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNY--SESFF 60

Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
           +  +++ ++ H+++V   G         +V E++  GSL  YL KN N + +   L  A 
Sbjct: 61  EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120

Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDT--------HNVVKVADFGVARFQNKGGVMTAE 195
            +   M +L +  +IH ++   N+L+             +K++D G++            
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-------VLP 173

Query: 196 TGTY----RWMAPEVI-NHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
                    W+ PE I N +  +   D +SF   LWE+ +    P  ++ 
Sbjct: 174 KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  211 bits (539), Expect = 4e-68
 Identities = 65/231 (28%), Positives = 104/231 (45%), Gaps = 13/231 (5%)

Query: 24  IESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTL 78
           +    +         ++   E I  G  G +Y G  L  D      AVK L     +   
Sbjct: 11  LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGE 69

Query: 79  EDEFVQEVAILREVQHRNVVRFIGASTKS-PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
             +F+ E  I+++  H NV+  +G   +S     +V  YM  G L +++    +   +  
Sbjct: 70  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 129

Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETG 197
           L+ F + + KGM+YL  +  +HRDL   N ++D    VKVADFG+AR        +    
Sbjct: 130 LIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 189

Query: 198 TY-----RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQ 242
           T      +WMA E +  Q +  K+DV+SF ++LWEL+T    PY  +    
Sbjct: 190 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  212 bits (541), Expect = 5e-68
 Identities = 73/231 (31%), Positives = 115/231 (49%), Gaps = 28/231 (12%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLG----QDVAVKVLRSEHLNDTLEDEFVQEVAI 88
             +D   +K  + I  G+ G + +          D A+K ++     D   D F  E+ +
Sbjct: 20  PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEV 78

Query: 89  LREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKN---------------HNV 132
           L ++  H N++  +GA     +L +  EY P G+L D+L K+                + 
Sbjct: 79  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138

Query: 133 LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM 192
           L   QLL FA D+ +GM+YL Q+  IHRDL   N+L+  + V K+ADFG++R Q    V 
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE---VY 195

Query: 193 TAETGT---YRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
             +T      RWMA E +N+  Y   +DV+S+ ++LWE+V+    PY  MT
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  210 bits (537), Expect = 9e-68
 Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 27/236 (11%)

Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEF 82
            +  EI    ++  E +     G +Y+G   G       Q VA+K L+ +     L +EF
Sbjct: 1   GKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEF 59

Query: 83  VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKN------------- 129
             E  +   +QH NVV  +G  TK   L ++  Y   G L+++L                
Sbjct: 60  RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119

Query: 130 --HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN 187
              + L+ P  +     I  GMEYL   +++H+DL T N+L+     VK++D G+ R   
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY 179

Query: 188 KGGVMTAETGTY---RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
                     +    RWMAPE I +  +   +D++S+ +VLWE+ +    PY   +
Sbjct: 180 AADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 235

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  211 bits (539), Expect = 1e-67
 Identities = 68/230 (29%), Positives = 110/230 (47%), Gaps = 26/230 (11%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-------VAVKVLRSEHLNDTLEDEFV 83
           E WE  R  L+ G+ + +G+ G +      G         VAVK+L+S    D  E   +
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-LM 97

Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKN------------- 129
            E+ I+  + QH N+V  +GA T    + ++TEY   G L ++L +              
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157

Query: 130 HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG 189
           ++      LL F+  + +GM +L  +N IHRD+   N+L+   +V K+ DFG+AR     
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 217

Query: 190 GVMTAETGT---YRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY 235
                +       +WMAPE I    Y  ++DV+S+ I+LWE+ +    PY
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  210 bits (538), Expect = 2e-67
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 21/232 (9%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFV 83
           ++WE+ R  +     +  GS G +Y GV  G         VA+K +  E  +     EF+
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFL 76

Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKN---------HNVLK 134
            E ++++E    +VVR +G  ++     ++ E M  G L  YL                 
Sbjct: 77  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136

Query: 135 LPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTA 194
           L ++++ A +I  GM YL+    +HRDL   N ++     VK+ DFG+ R   +      
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196

Query: 195 ETGTY---RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQ 242
                   RWM+PE +    +   +DV+SF +VLWE+ T A+ PY  ++  Q
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 248

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  209 bits (535), Expect = 2e-67
 Identities = 66/240 (27%), Positives = 105/240 (43%), Gaps = 28/240 (11%)

Query: 26  SQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTL 78
             +      I RR +     +  G+ G ++               VAVK L+        
Sbjct: 3   MHSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAA 60

Query: 79  EDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKN--------- 129
             +F +E  +L  +QH ++V+F G       L +V EYM  G L  +L  +         
Sbjct: 61  RKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVD 120

Query: 130 ------HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA 183
                    L L Q+L  A  I  GM YL  ++ +HRDL T N L+  + +VK+ DFG++
Sbjct: 121 GQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180

Query: 184 RFQNKGGVMTAETGTY---RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           R             T    RWM PE I ++ +  ++DV+SF ++LWE+ T  K P+  ++
Sbjct: 181 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 240

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  210 bits (537), Expect = 3e-67
 Identities = 66/241 (27%), Positives = 114/241 (47%), Gaps = 30/241 (12%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLG---------QDVAVKVLRSEHLNDTLEDE 81
             WE  R  L  G+ +  G+ G +     +G           VAVK+L+ +   +    +
Sbjct: 28  PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSD 86

Query: 82  FVQEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL-------------- 126
            V E+ +++ + +H+N++  +GA T+   L ++ EY   G+L +YL              
Sbjct: 87  LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146

Query: 127 -HKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF 185
                  +    L+     + +GMEYL  +  IHRDL   N+L+  +NV+K+ADFG+AR 
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 206

Query: 186 QNKGGVMTAETGT---YRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL 241
            N        T      +WMAPE +  + Y  ++DV+SF +++WE+ T    PY  +   
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266

Query: 242 Q 242
           +
Sbjct: 267 E 267

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  208 bits (532), Expect = 5e-67
 Identities = 71/232 (30%), Positives = 111/232 (47%), Gaps = 12/232 (5%)

Query: 21  EKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTL 78
           +   E +TK+     D R LK    I  GS   +Y+G+      +VA   L+   L  + 
Sbjct: 9   DDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE 68

Query: 79  EDEFVQEVAILREVQHRNVVRFIGA----STKSPHLCIVTEYMPGGSLYDYLHKNHNVLK 134
              F +E  +L+ +QH N+VRF  +          + +VTE M  G+L  YL K   V+K
Sbjct: 69  RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMK 127

Query: 135 LPQLLRFAIDICKGMEYLHQRN--IIHRDLKTANLLMDTHN-VVKVADFGVARFQNKGGV 191
           +  L  +   I KG+++LH R   IIHRDLK  N+ +      VK+ D G+A  +     
Sbjct: 128 IKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA 187

Query: 192 MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQA 243
                GT  +MAPE+   + YD+  DV++F + + E+ T++ PY        
Sbjct: 188 KA-VIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ 237

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  208 bits (532), Expect = 8e-67
 Identities = 75/239 (31%), Positives = 112/239 (46%), Gaps = 29/239 (12%)

Query: 29  KSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-------VAVKVLRSEHLNDTLEDE 81
            +  WE  R  LK G+ +  G+ G +      G D       VAVK+L+ E    +    
Sbjct: 18  DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRA 76

Query: 82  FVQEVAILREV-QHRNVVRFIGASTKS-PHLCIVTEYMPGGSLYDYL------------- 126
            + E+ IL  +  H NVV  +GA TK    L ++ E+   G+L  YL             
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136

Query: 127 --HKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR 184
                 + L L  L+ ++  + KGME+L  R  IHRDL   N+L+   NVVK+ DFG+AR
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

Query: 185 FQNKGGVMTAETGT---YRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
              K      +       +WMAPE I  + Y  ++DV+SF ++LWE+ +    PY  + 
Sbjct: 197 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  210 bits (537), Expect = 9e-67
 Identities = 69/241 (28%), Positives = 116/241 (48%), Gaps = 30/241 (12%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLEDE 81
             WE+ R  L  G+ +  G+ G +     +G D         VAVK+L+     +    +
Sbjct: 62  PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSD 120

Query: 82  FVQEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL-------------- 126
            + E+ +++ + +H+N++  +GA T+   L ++ EY   G+L +YL              
Sbjct: 121 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 180

Query: 127 -HKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF 185
            H     L    L+  A  + +GMEYL  +  IHRDL   N+L+   NV+K+ADFG+AR 
Sbjct: 181 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 240

Query: 186 QNKGGVMTAETGT---YRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL 241
            +        T      +WMAPE +  + Y  ++DV+SF ++LWE+ T    PY  +   
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300

Query: 242 Q 242
           +
Sbjct: 301 E 301

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  210 bits (536), Expect = 1e-66
 Identities = 67/243 (27%), Positives = 115/243 (47%), Gaps = 30/243 (12%)

Query: 29  KSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLE 79
           +   WE  R  L  G+ +  G  G +     +G D         VAVK+L+ +   +   
Sbjct: 72  EDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDL 130

Query: 80  DEFVQEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL------------ 126
            + V E+ +++ + +H+N++  +GA T+   L ++ EY   G+L +YL            
Sbjct: 131 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 190

Query: 127 ---HKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA 183
                    +    L+     + +GMEYL  +  IHRDL   N+L+  +NV+K+ADFG+A
Sbjct: 191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250

Query: 184 RFQNKGGVMTAETGT---YRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
           R  N        T      +WMAPE +  + Y  ++DV+SF +++WE+ T    PY  + 
Sbjct: 251 RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310

Query: 240 PLQ 242
             +
Sbjct: 311 VEE 313

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  216 bits (551), Expect = 1e-66
 Identities = 58/225 (25%), Positives = 110/225 (48%), Gaps = 12/225 (5%)

Query: 25  ESQTKSEDWEIDRRLLKTGE-RIASGSCGDLYRGVYLGQ----DVAVKVLRSEHLNDTLE 79
             + K +   + R  L   +  +  G+ G + +GVY  +    DVA+KVL+         
Sbjct: 322 PEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADT 380

Query: 80  DEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL 139
           +E ++E  I+ ++ +  +VR IG       L +V E   GG L+ +L      + +  + 
Sbjct: 381 EEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVA 439

Query: 140 RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF-QNKGGVMTAETGT 198
                +  GM+YL ++N +HR+L   N+L+   +  K++DFG+++         TA +  
Sbjct: 440 ELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 499

Query: 199 ---YRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
               +W APE IN + +  ++DV+S+ + +WE ++  + PY  M 
Sbjct: 500 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  208 bits (532), Expect = 1e-66
 Identities = 70/237 (29%), Positives = 111/237 (46%), Gaps = 21/237 (8%)

Query: 23  AIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLN 75
           A ++ + S+  E+ R+ +     +  G+ G++Y G   G         VAVK L  E  +
Sbjct: 15  AGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCS 73

Query: 76  DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHN---- 131
           +  E +F+ E  I+ +  H+N+VR IG S +S    I+ E M GG L  +L +       
Sbjct: 74  EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQ 133

Query: 132 --VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT---HNVVKVADFGVARFQ 186
              L +  LL  A DI  G +YL + + IHRD+   N L+       V K+ DFG+AR  
Sbjct: 134 PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 193

Query: 187 NKGGVMTAETGTY---RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT 239
            +              +WM PE      +  K D +SF ++LWE+ +   +PY S +
Sbjct: 194 YRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  209 bits (535), Expect = 2e-66
 Identities = 64/231 (27%), Positives = 104/231 (45%), Gaps = 13/231 (5%)

Query: 24  IESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-----VAVKVLRSEHLNDTL 78
           +    +         ++   E I  G  G +Y G  L  D      AVK L     +   
Sbjct: 75  LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGE 133

Query: 79  EDEFVQEVAILREVQHRNVVRFIGASTKS-PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
             +F+ E  I+++  H NV+  +G   +S     +V  YM  G L +++    +   +  
Sbjct: 134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 193

Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETG 197
           L+ F + + KGM++L  +  +HRDL   N ++D    VKVADFG+AR        +    
Sbjct: 194 LIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 253

Query: 198 TY-----RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQ 242
           T      +WMA E +  Q +  K+DV+SF ++LWEL+T    PY  +    
Sbjct: 254 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  209 bits (533), Expect = 2e-66
 Identities = 70/244 (28%), Positives = 113/244 (46%), Gaps = 35/244 (14%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFV 83
             WE  R  L+ G+ + SG+ G +      G         VAVK+L+ +  + +  +  +
Sbjct: 38  LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALM 96

Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL---------------- 126
            E+ ++ ++  H N+V  +GA T S  + ++ EY   G L +YL                
Sbjct: 97  SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156

Query: 127 ------HKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADF 180
                  ++ NVL    LL FA  + KGME+L  ++ +HRDL   N+L+    VVK+ DF
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 216

Query: 181 GVARFQNKGGVMTAETGT---YRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYD 236
           G+AR                  +WMAPE +    Y  K+DV+S+ I+LWE+ +    PY 
Sbjct: 217 GLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276

Query: 237 SMTP 240
            +  
Sbjct: 277 GIPV 280

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  207 bits (529), Expect = 1e-65
 Identities = 70/237 (29%), Positives = 112/237 (47%), Gaps = 21/237 (8%)

Query: 26  SQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTL 78
           + + S+  E+ R+ +     +  G+ G++Y G   G         VAVK L  E  ++  
Sbjct: 59  TSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQD 117

Query: 79  EDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH------NV 132
           E +F+ E  I+ +  H+N+VR IG S +S    I+ E M GG L  +L +        + 
Sbjct: 118 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 177

Query: 133 LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT---HNVVKVADFGVARFQNKG 189
           L +  LL  A DI  G +YL + + IHRD+   N L+       V K+ DFG+AR   + 
Sbjct: 178 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237

Query: 190 GVMTAETGTY---RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQ 242
           G            +WM PE      +  K D +SF ++LWE+ +   +PY S +  +
Sbjct: 238 GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 294

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  204 bits (521), Expect = 7e-65
 Identities = 70/240 (29%), Positives = 110/240 (45%), Gaps = 27/240 (11%)

Query: 28  TKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLED 80
           + +    I RR +     +  G+ G ++               VAVK L+    +++   
Sbjct: 31  SDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQ 88

Query: 81  EFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL-------------- 126
           +F +E  +L  +QH+++VRF G  T+   L +V EYM  G L  +L              
Sbjct: 89  DFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGE 148

Query: 127 HKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ 186
                 L L QLL  A  +  GM YL   + +HRDL T N L+    VVK+ DFG++R  
Sbjct: 149 DVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI 208

Query: 187 NKGGVMTAETGTY---RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQ 242
                      T    RWM PE I ++ +  ++DV+SF +VLWE+ T  K P+  ++  +
Sbjct: 209 YSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 268

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  204 bits (521), Expect = 8e-65
 Identities = 67/245 (27%), Positives = 110/245 (44%), Gaps = 35/245 (14%)

Query: 29  KSEDWEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDE 81
           K    E  R  ++    I  G+ G +++    G         VAVK+L+ E  +  ++ +
Sbjct: 38  KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK-EEASADMQAD 96

Query: 82  FVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKN------------ 129
           F +E A++ E  + N+V+ +G       +C++ EYM  G L ++L               
Sbjct: 97  FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156

Query: 130 -----------HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVA 178
                         L   + L  A  +  GM YL +R  +HRDL T N L+  + VVK+A
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 216

Query: 179 DFGVARFQNKGGVMTAETGTY---RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVP 234
           DFG++R         A+       RWM PE I +  Y  ++DV+++ +VLWE+ +    P
Sbjct: 217 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

Query: 235 YDSMT 239
           Y  M 
Sbjct: 277 YYGMA 281

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  189 bits (482), Expect = 3e-59
 Identities = 52/216 (24%), Positives = 85/216 (39%), Gaps = 12/216 (5%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
           + ++          R+  GS G++++      G+  AVK   S           + EV  
Sbjct: 57  QSFQR-------LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGS 109

Query: 89  LREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICK 147
             +V QH   VR   A  +   L + TE   G SL  +       L   Q+  +  D   
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLL 168

Query: 148 GMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI 207
            + +LH + ++H D+K AN+ +      K+ DFG+       G    + G  R+MAPE++
Sbjct: 169 ALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL 228

Query: 208 NHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQA 243
               Y   ADVFS  + + E+             Q 
Sbjct: 229 QG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ 263

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  190 bits (484), Expect = 4e-59
 Identities = 60/222 (27%), Positives = 119/222 (53%), Gaps = 11/222 (4%)

Query: 43  GERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF 100
            ++I  GS G   L +    G+   +K +    ++    +E  +EVA+L  ++H N+V++
Sbjct: 29  LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88

Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLP--QLLRFAIDICKGMEYLHQRNII 158
             +  ++  L IV +Y  GG L+  ++    VL     Q+L + + IC  ++++H R I+
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVL-FQEDQILDWFVQICLALKHVHDRKIL 147

Query: 159 HRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKA 216
           HRD+K+ N+ +     V++ DFG+AR  N    + A    GT  +++PE+  ++PY+ K+
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL-ARACIGTPYYLSPEICENKPYNNKS 206

Query: 217 DVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPI 258
           D+++   VL+EL T K  +++ +       V ++ +    P+
Sbjct: 207 DIWALGCVLYELCTLKHAFEAGSMKNL---VLKIISGSFPPV 245

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  188 bits (479), Expect = 1e-58
 Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 17/228 (7%)

Query: 25  ESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEF 82
           + +    ++  +   +    R+  GS G+++R      G   AVK +R       LE   
Sbjct: 45  KLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR-------LEVFR 97

Query: 83  VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFA 142
           V+E+     +    +V   GA  + P + I  E + GGSL   + K    L   + L + 
Sbjct: 98  VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYL 156

Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTH-NVVKVADFGVARFQNKGGVMTAET----- 196
               +G+EYLH R I+H D+K  N+L+ +  +   + DFG A      G+  +       
Sbjct: 157 GQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216

Query: 197 -GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQA 243
            GT   MAPEV+  +P D K D++S   ++  ++    P+        
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL 264

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  185 bits (473), Expect = 3e-58
 Identities = 56/229 (24%), Positives = 99/229 (43%), Gaps = 28/229 (12%)

Query: 35  IDRRLLK---TGERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           +D+R        E I SG  G     +    G+   +K ++         ++  +EV  L
Sbjct: 5   VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN------NEKAEREVKAL 58

Query: 90  REVQHRNVVRFIGA----------------STKSPHLCIVTEYMPGGSLYDYLHK-NHNV 132
            ++ H N+V + G                  +K+  L I  E+   G+L  ++ K     
Sbjct: 59  AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118

Query: 133 LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM 192
           L     L     I KG++Y+H + +I+RDLK +N+ +     VK+ DFG+       G  
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178

Query: 193 TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPL 241
           T   GT R+M+PE I+ Q Y ++ D+++  ++L EL+         +  
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF 227

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  185 bits (473), Expect = 6e-58
 Identities = 57/244 (23%), Positives = 117/244 (47%), Gaps = 15/244 (6%)

Query: 22  KAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLE 79
           +         ++ I        ++I  G   ++YR   L  G  VA+K ++   L D   
Sbjct: 23  RPDMGYNTLANFRI-------EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKA 75

Query: 80  -DEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL---HKNHNVLKL 135
             + ++E+ +L+++ H NV+++  +  +   L IV E    G L   +    K   ++  
Sbjct: 76  RADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPE 135

Query: 136 PQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTA 194
             + ++ + +C  +E++H R ++HRD+K AN+ +    VVK+ D G+ R F +K     +
Sbjct: 136 RTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 195

Query: 195 ETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL 254
             GT  +M+PE I+   Y+ K+D++S   +L+E+   + P+        +L  +++    
Sbjct: 196 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL-CKKIEQCD 254

Query: 255 CQPI 258
             P+
Sbjct: 255 YPPL 258

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  184 bits (469), Expect = 1e-57
 Identities = 51/240 (21%), Positives = 100/240 (41%), Gaps = 36/240 (15%)

Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVA 87
           + ++          E+I SG  G +++ V    G   A+K  +        E   ++EV 
Sbjct: 10  TTEFHE-------LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVY 62

Query: 88  ILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKL---PQLLRFAI 143
               + QH +VVR+  A  +  H+ I  EY  GGSL D + +N+ ++      +L    +
Sbjct: 63  AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122

Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNV-------------------VKVADFGVAR 184
            + +G+ Y+H  +++H D+K +N+ +   ++                    K+ D G   
Sbjct: 123 QVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182

Query: 185 FQNKGGVMTAETGTYRWMAPEVIN-HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQA 243
             +       E G  R++A EV+  +  +  KAD+F+ A+ +     A+    +      
Sbjct: 183 RISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE 239

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  181 bits (462), Expect = 2e-56
 Identities = 67/229 (29%), Positives = 120/229 (52%), Gaps = 12/229 (5%)

Query: 25  ESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEF 82
           ES     D+E D         +  G+ G +Y G  L     +A+K +     +       
Sbjct: 11  ESDLLEYDYEYDEN--GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPL 66

Query: 83  VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKL--PQLLR 140
            +E+A+ + ++H+N+V+++G+ +++  + I  E +PGGSL   L      LK     +  
Sbjct: 67  HEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF 126

Query: 141 FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN-VVKVADFGVA-RFQNKGGVMTAETGT 198
           +   I +G++YLH   I+HRD+K  N+L++T++ V+K++DFG + R           TGT
Sbjct: 127 YTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGT 186

Query: 199 YRWMAPEVINHQP--YDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL 245
            ++MAPE+I+  P  Y + AD++S    + E+ T K P+  +   QAA+
Sbjct: 187 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM 235

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  181 bits (461), Expect = 3e-56
 Identities = 75/204 (36%), Positives = 110/204 (53%), Gaps = 8/204 (3%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  GS G++++G+     + VA+K++  E   D +ED   QE+ +L +     V ++ 
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIED-IQQEITVLSQCDSPYVTKYY 86

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
           G+  K   L I+ EY+ GGS  D L      L   Q+     +I KG++YLH    IHRD
Sbjct: 87  GSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRD 144

Query: 162 LKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADVF 219
           +K AN+L+  H  VK+ADFGVA  Q     +   T  GT  WMAPEVI    YD KAD++
Sbjct: 145 IKAANVLLSEHGEVKLADFGVAG-QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIW 203

Query: 220 SFAIVLWELVTAKVPYDSMTPLQA 243
           S  I   EL   + P+  + P++ 
Sbjct: 204 SLGITAIELARGEPPHSELHPMKV 227

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  180 bits (460), Expect = 3e-56
 Identities = 60/204 (29%), Positives = 107/204 (52%), Gaps = 9/204 (4%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  + +  GQ+VA++ +  +      ++  + E+ ++RE ++ N+V ++
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYL 83

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
            +      L +V EY+ GGSL D +      +   Q+     +  + +E+LH   +IHRD
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRD 141

Query: 162 LKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADVF 219
           +K+ N+L+     VK+ DFG    Q         T  GT  WMAPEV+  + Y  K D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200

Query: 220 SFAIVLWELVTAKVPYDSMTPLQA 243
           S  I+  E++  + PY +  PL+A
Sbjct: 201 SLGIMAIEMIEGEPPYLNENPLRA 224

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  181 bits (461), Expect = 5e-56
 Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 9/204 (4%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
            +I  GS G +        G+ VAVK++          +    EV I+R+ QH NVV   
Sbjct: 51  VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR--RELLFNEVVIMRDYQHFNVVEMY 108

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
            +      L ++ E++ GG+L D +      L   Q+      + + + YLH + +IHRD
Sbjct: 109 KSYLVGEELWVLMEFLQGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQGVIHRD 166

Query: 162 LKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADVF 219
           +K+ ++L+     VK++DFG    Q    V   ++  GT  WMAPEVI+   Y  + D++
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCA-QISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIW 225

Query: 220 SFAIVLWELVTAKVPYDSMTPLQA 243
           S  I++ E+V  + PY S +P+QA
Sbjct: 226 SLGIMVIEMVDGEPPYFSDSPVQA 249

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  179 bits (457), Expect = 1e-55
 Identities = 67/236 (28%), Positives = 113/236 (47%), Gaps = 17/236 (7%)

Query: 24  IESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDE 81
           +   + +  W I+R   +  E I SG+   +         + VA+K +  E    ++++ 
Sbjct: 1   MSEDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDE- 59

Query: 82  FVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL-------HKNHNVLK 134
            ++E+  + +  H N+V +  +      L +V + + GGS+ D +            VL 
Sbjct: 60  LLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD 119

Query: 135 LPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTA 194
              +     ++ +G+EYLH+   IHRD+K  N+L+     V++ADFGV+ F   GG +T 
Sbjct: 120 ESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179

Query: 195 ET------GTYRWMAPEVI-NHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQA 243
                   GT  WMAPEV+   + YD KAD++SF I   EL T   PY    P++ 
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV 235

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  179 bits (455), Expect = 2e-55
 Identities = 61/209 (29%), Positives = 108/209 (51%), Gaps = 12/209 (5%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
             +  G+ G +Y+      G   A KV+ ++   +   ++++ E+ IL    H  +V+ +
Sbjct: 25  GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE--LEDYIVEIEILATCDHPYIVKLL 82

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
           GA      L I+ E+ PGG++   + +    L  PQ+      + + + +LH + IIHRD
Sbjct: 83  GAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRD 142

Query: 162 LKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GTYRWMAPEVINHQ-----PYDQ 214
           LK  N+LM     +++ADFGV+  +N   +   ++  GT  WMAPEV+  +     PYD 
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVS-AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDY 201

Query: 215 KADVFSFAIVLWELVTAKVPYDSMTPLQA 243
           KAD++S  I L E+   + P+  + P++ 
Sbjct: 202 KADIWSLGITLIEMAQIEPPHHELNPMRV 230

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  178 bits (454), Expect = 5e-55
 Identities = 69/204 (33%), Positives = 111/204 (54%), Gaps = 9/204 (4%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E++  GS G +Y+ ++   GQ VA+K +    +   L++  ++E++I+++    +VV++ 
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVP---VESDLQE-IIKEISIMQQCDSPHVVKYY 90

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
           G+  K+  L IV EY   GS+ D +   +  L   ++        KG+EYLH    IHRD
Sbjct: 91  GSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRD 150

Query: 162 LKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADVF 219
           +K  N+L++T    K+ADFGVA  Q    +    T  GT  WMAPEVI    Y+  AD++
Sbjct: 151 IKAGNILLNTEGHAKLADFGVAG-QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIW 209

Query: 220 SFAIVLWELVTAKVPYDSMTPLQA 243
           S  I   E+   K PY  + P++A
Sbjct: 210 SLGITAIEMAEGKPPYADIHPMRA 233

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  170 bits (433), Expect = 5e-52
 Identities = 52/246 (21%), Positives = 101/246 (41%), Gaps = 39/246 (15%)

Query: 43  GERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF 100
            + +  G  G     +      + A+K +R  +      ++ ++EV  L +++H  +VR+
Sbjct: 10  IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA-REKVMREVKALAKLEHPGIVRY 68

Query: 101 IGA------------STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLP--QLLRFAIDIC 146
             A            S+   +L I  +     +L D+++    + +      L   + I 
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIA 128

Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF-------------QNKGGVMT 193
           + +E+LH + ++HRDLK +N+     +VVKV DFG+                       T
Sbjct: 129 EAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188

Query: 194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS 253
            + GT  +M+PE I+   Y  K D+FS  ++L+EL         + P    +   +  T 
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL---------LYPFSTQMERVRTLTD 239

Query: 254 LCQPIY 259
           +    +
Sbjct: 240 VRNLKF 245

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  171 bits (436), Expect = 5e-52
 Identities = 56/229 (24%), Positives = 110/229 (48%), Gaps = 18/229 (7%)

Query: 20  VEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDT 77
           +E  +  + K  + + D    +    + +G+ G +++  +   G  +A K++  E     
Sbjct: 17  LEAFLTQKQKVGELKDDD--FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPA 73

Query: 78  LEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
           + ++ ++E+ +L E     +V F GA      + I  E+M GGSL   L K    +    
Sbjct: 74  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQI 132

Query: 138 LLRFAIDICKGMEYLH-QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT--- 193
           L + +I + KG+ YL  +  I+HRD+K +N+L+++   +K+ DFGV+      G +    
Sbjct: 133 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS------GQLIDSM 186

Query: 194 AET--GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTP 240
           A +  GT  +M+PE +    Y  ++D++S  + L E+   + P      
Sbjct: 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  168 bits (429), Expect = 1e-51
 Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 15/213 (7%)

Query: 44  ERIASGSCGD--LYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
             I +GS G     R    G+ +  K L    + +  +   V EV +LRE++H N+VR+ 
Sbjct: 12  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71

Query: 102 GA--STKSPHLCIVTEYMPGGSLYDYL---HKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
                  +  L IV EY  GG L   +    K    L    +LR    +   ++  H+R+
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131

Query: 157 -----IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GTYRWMAPEVINH 209
                ++HRDLK AN+ +D    VK+ DFG+AR  N      A+T  GT  +M+PE +N 
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKTFVGTPYYMSPEQMNR 190

Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQ 242
             Y++K+D++S   +L+EL     P+ + +  +
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 223

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  171 bits (435), Expect = 2e-51
 Identities = 49/216 (22%), Positives = 86/216 (39%), Gaps = 17/216 (7%)

Query: 44  ERIASG--SCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
             I  G      +    Y   G+ V V+ +  E  ++ +      E+ + +   H N+V 
Sbjct: 31  TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90

Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI--DICKGMEYLHQRNI 157
           +         L +VT +M  GS  D L   H +  + +L    I   + K ++Y+H    
Sbjct: 91  YRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYILQGVLKALDYIHHMGY 149

Query: 158 IHRDLKTANLLMDTHNVVKVADFGVA--------RFQNKGGVMTAETGTYRWMAPEVI-- 207
           +HR +K +++L+     V ++             R +              W++PEV+  
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209

Query: 208 NHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQA 243
           N Q YD K+D++S  I   EL    VP+  M   Q 
Sbjct: 210 NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM 245

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  169 bits (431), Expect = 2e-51
 Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 12/207 (5%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKV--LRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
             I  GS G +Y    +   + VA+K      +  N+  +D  ++EV  L++++H N ++
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKLRHPNTIQ 118

Query: 100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIH 159
           + G   +     +V EY   GS  D L  +   L+  ++        +G+ YLH  N+IH
Sbjct: 119 YRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 177

Query: 160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQ---PYDQKA 216
           RD+K  N+L+    +VK+ DFG A             GT  WMAPEVI       YD K 
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMDEGQYDGKV 234

Query: 217 DVFSFAIVLWELVTAKVPYDSMTPLQA 243
           DV+S  I   EL   K P  +M  + A
Sbjct: 235 DVWSLGITCIELAERKPPLFNMNAMSA 261

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  168 bits (427), Expect = 4e-51
 Identities = 67/198 (33%), Positives = 103/198 (52%), Gaps = 8/198 (4%)

Query: 52  GDLYRGVYLGQDVAVKVLRSEHLNDTL--EDEFVQEVAILREVQHRNVVRFIGASTKSPH 109
           G +Y+G      VAVK L +     T   + +F QE+ ++ + QH N+V  +G S+    
Sbjct: 45  GVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD 104

Query: 110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF--AIDICKGMEYLHQRNIIHRDLKTANL 167
           LC+V  YMP GSL D L        L   +R   A     G+ +LH+ + IHRD+K+AN+
Sbjct: 105 LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANI 164

Query: 168 LMDTHNVVKVADFGVARFQNKGG---VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIV 224
           L+D     K++DFG+AR   K     + +   GT  +MAPE +  +    K+D++SF +V
Sbjct: 165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITP-KSDIYSFGVV 223

Query: 225 LWELVTAKVPYDSMTPLQ 242
           L E++T     D     Q
Sbjct: 224 LLEIITGLPAVDEHREPQ 241

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  167 bits (425), Expect = 7e-51
 Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 34/219 (15%)

Query: 43  GERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF 100
              +  G+ G + +       +  A+K +R     +      + EV +L  + H+ VVR+
Sbjct: 11  IAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLNHQYVVRY 67

Query: 101 IGA-------------STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICK 147
             A               K   L I  EY   G+LYD +H  +   +  +  R    I +
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILE 127

Query: 148 GMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR---------------FQNKGGVM 192
            + Y+H + IIHRDLK  N+ +D    VK+ DFG+A+                      +
Sbjct: 128 ALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187

Query: 193 TAETGTYRWMAPEVINHQP-YDQKADVFSFAIVLWELVT 230
           T+  GT  ++A EV++    Y++K D++S  I+ +E++ 
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  167 bits (424), Expect = 2e-50
 Identities = 51/214 (23%), Positives = 98/214 (45%), Gaps = 19/214 (8%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVV 98
              + +  G+  +++RG +   G   A+KV  +        D  ++E  +L+++ H+N+V
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-VDVQMREFEVLKKLNHKNIV 70

Query: 99  RFIGA--STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLP--QLLRFAIDICKGMEYLHQ 154
           +       T + H  ++ E+ P GSLY  L +  N   LP  + L    D+  GM +L +
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130

Query: 155 RNIIHRDLKTANLLM----DTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI--- 207
             I+HR++K  N++     D  +V K+ DFG AR         +  GT  ++ P++    
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERA 190

Query: 208 -----NHQPYDQKADVFSFAIVLWELVTAKVPYD 236
                + + Y    D++S  +  +   T  +P+ 
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  166 bits (423), Expect = 2e-50
 Identities = 70/217 (32%), Positives = 109/217 (50%), Gaps = 21/217 (9%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRF 100
           E + +G+ G +Y+G ++  GQ  A+KV+    +    E+E  QE+ +L++   HRN+  +
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATY 86

Query: 101 IGA------STKSPHLCIVTEYMPGGSLYDYLHK-NHNVLKLPQLLRFAIDICKGMEYLH 153
            GA            L +V E+   GS+ D +     N LK   +     +I +G+ +LH
Sbjct: 87  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH 146

Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GTYRWMAPEVI---- 207
           Q  +IHRD+K  N+L+  +  VK+ DFGV+  Q    V    T  GT  WMAPEVI    
Sbjct: 147 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGTPYWMAPEVIACDE 205

Query: 208 -NHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQA 243
                YD K+D++S  I   E+     P   M P++A
Sbjct: 206 NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA 242

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  165 bits (421), Expect = 6e-50
 Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 12/226 (5%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
           + W+     LK    I  G+ G + + V+   GQ +AVK +RS  +++  + + + ++ +
Sbjct: 15  QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST-VDEKEQKQLLMDLDV 73

Query: 89  -LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDY---LHKNHNVLKLPQLLRFAID 144
            +R      +V+F GA  +     I  E M       Y        +V+    L +  + 
Sbjct: 74  VMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133

Query: 145 ICKGMEYLH-QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMA 203
             K + +L     IIHRD+K +N+L+D    +K+ DFG++         T + G   +MA
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMA 193

Query: 204 PEVI----NHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL 245
           PE I    + Q YD ++DV+S  I L+EL T + PY     +   L
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL 239

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  164 bits (418), Expect = 1e-49
 Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 11/203 (5%)

Query: 46  IASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA 103
           I  G  G +Y+G  L  G  VA+K    E       +EF  E+  L   +H ++V  IG 
Sbjct: 47  IGHGVFGKVYKG-VLRDGAKVALKRRTPESSQG--IEEFETEIETLSFCRHPHLVSLIGF 103

Query: 104 STKSPHLCIVTEYMPGGSLYDYLH-KNHNVLKL--PQLLRFAIDICKGMEYLHQRNIIHR 160
             +   + ++ +YM  G+L  +L+  +   + +   Q L   I   +G+ YLH R IIHR
Sbjct: 104 CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHR 163

Query: 161 DLKTANLLMDTHNVVKVADFGVARFQNKGG---VMTAETGTYRWMAPEVINHQPYDQKAD 217
           D+K+ N+L+D + V K+ DFG+++   +     + T   GT  ++ PE        +K+D
Sbjct: 164 DVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSD 223

Query: 218 VFSFAIVLWELVTAKVPYDSMTP 240
           V+SF +VL+E++ A+       P
Sbjct: 224 VYSFGVVLFEVLCARSAIVQSLP 246

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  162 bits (413), Expect = 3e-49
 Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 18/222 (8%)

Query: 27  QTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQ 84
           + K++D E           +  G+ G + +  ++  GQ +AVK +R+  +N   +   + 
Sbjct: 3   EVKADDLEPI-------MELGRGAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLM 54

Query: 85  EVAI-LREVQHRNVVRFIGASTKSPHLCIVTEYMPGG--SLYDYLHKNHNVLKLPQLLRF 141
           ++ I +R V     V F GA  +   + I  E M       Y  +      +    L + 
Sbjct: 55  DLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKI 114

Query: 142 AIDICKGMEYLH-QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYR 200
           A+ I K +E+LH + ++IHRD+K +N+L++    VK+ DFG++ +         + G   
Sbjct: 115 AVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKP 174

Query: 201 WMAPEVI----NHQPYDQKADVFSFAIVLWELVTAKVPYDSM 238
           +MAPE I    N + Y  K+D++S  I + EL   + PYDS 
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  164 bits (416), Expect = 1e-48
 Identities = 51/214 (23%), Positives = 98/214 (45%), Gaps = 19/214 (8%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVV 98
              + +  G+  +++RG +   G   A+KV  +        D  ++E  +L+++ H+N+V
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-VDVQMREFEVLKKLNHKNIV 70

Query: 99  RFIGA--STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLP--QLLRFAIDICKGMEYLHQ 154
           +       T + H  ++ E+ P GSLY  L +  N   LP  + L    D+  GM +L +
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130

Query: 155 RNIIHRDLKTANLLM----DTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI--- 207
             I+HR++K  N++     D  +V K+ DFG AR         +  GT  ++ P++    
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERA 190

Query: 208 -----NHQPYDQKADVFSFAIVLWELVTAKVPYD 236
                + + Y    D++S  +  +   T  +P+ 
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  162 bits (411), Expect = 1e-48
 Identities = 53/224 (23%), Positives = 97/224 (43%), Gaps = 11/224 (4%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
           + ++ +   L+    + SG+CG +++  +   G  +AVK +R    N       + ++ +
Sbjct: 18  QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS-GNKEENKRILMDLDV 76

Query: 89  L-REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICK 147
           + +      +V+  G    +  + I  E M   +      +    +    L +  + I K
Sbjct: 77  VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKK-RMQGPIPERILGKMTVAIVK 135

Query: 148 GMEYLH-QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEV 206
            + YL  +  +IHRD+K +N+L+D    +K+ DFG++             G   +MAPE 
Sbjct: 136 ALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPER 195

Query: 207 I-----NHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL 245
           I         YD +ADV+S  I L EL T + PY +       L
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL 239

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  168 bits (427), Expect = 2e-48
 Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 14/213 (6%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVV 98
           +  ER+ +G  G + R ++   G+ VA+K  R E L+    + +  E+ I++++ H NVV
Sbjct: 17  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVV 75

Query: 99  RFI------GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLP--QLLRFAIDICKGME 150
                         +    +  EY  GG L  YL++  N   L    +     DI   + 
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135

Query: 151 YLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI 207
           YLH+  IIHRDLK  N+++       + K+ D G A+  ++G + T   GT +++APE++
Sbjct: 136 YLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL 195

Query: 208 NHQPYDQKADVFSFAIVLWELVTAKVPYDSMTP 240
             + Y    D +SF  + +E +T   P+     
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  160 bits (406), Expect = 7e-48
 Identities = 50/252 (19%), Positives = 104/252 (41%), Gaps = 20/252 (7%)

Query: 11  VHRKYRGHAVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL-GQDVAVKVL 69
           +H  +   +           +   +  R+    ++I SG    +++ +    Q  A+K +
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYV 60

Query: 70  RSEHLNDTLEDEFVQEVAILREVQHRN--VVRFIGASTKSPHLCIVTEYMPGGSLYDYLH 127
             E  ++   D +  E+A L ++Q  +  ++R         ++ +V E      L  +L 
Sbjct: 61  NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLK 119

Query: 128 KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-FQ 186
           K  + +   +   +  ++ + +  +HQ  I+H DLK AN L+    ++K+ DFG+A   Q
Sbjct: 120 KKKS-IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 177

Query: 187 NKGGVMTAET--GTYRWMAPEVINHQP-----------YDQKADVFSFAIVLWELVTAKV 233
                +  ++  GT  +M PE I                  K+DV+S   +L+ +   K 
Sbjct: 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237

Query: 234 PYDSMTPLQAAL 245
           P+  +    + L
Sbjct: 238 PFQQIINQISKL 249

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  161 bits (410), Expect = 9e-48
 Identities = 49/237 (20%), Positives = 98/237 (41%), Gaps = 20/237 (8%)

Query: 26  SQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQ 84
           S + +E   +  R+    ++I SG    +++ +    Q  A+K +  E  ++   D +  
Sbjct: 44  SSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRN 103

Query: 85  EVAILREVQH--RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFA 142
           E+A L ++Q     ++R         ++ +V E      L  +L K  + +   +   + 
Sbjct: 104 EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYW 161

Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET---GTY 199
            ++ + +  +HQ  I+H DLK AN L+    ++K+ DFG+A           +    G  
Sbjct: 162 KNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAV 220

Query: 200 RWMAPEVINHQP-----------YDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL 245
            +M PE I                  K+DV+S   +L+ +   K P+  +    + L
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 277

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  160 bits (406), Expect = 1e-47
 Identities = 47/222 (21%), Positives = 92/222 (41%), Gaps = 20/222 (9%)

Query: 41  KTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH--RNV 97
              ++I SG    +++ +    Q  A+K +  E  ++   D +  E+A L ++Q     +
Sbjct: 12  SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 71

Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
           +R         ++ +V E      L  +L K  + +   +   +  ++ + +  +HQ  I
Sbjct: 72  IRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQHGI 129

Query: 158 IHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET---GTYRWMAPEVINHQP--- 211
           +H DLK AN L+    ++K+ DFG+A           +    GT  +M PE I       
Sbjct: 130 VHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188

Query: 212 --------YDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL 245
                      K+DV+S   +L+ +   K P+  +    + L
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 230

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  158 bits (402), Expect = 2e-47
 Identities = 48/225 (21%), Positives = 92/225 (40%), Gaps = 24/225 (10%)

Query: 34  EIDRRLLKTGERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILRE 91
            ID +     +++  G    +    G++ G   A+K +      D   +E  +E  + R 
Sbjct: 25  IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD--REEAQREADMHRL 82

Query: 92  VQHRNVVRFIGASTKSP----HLCIVTEYMPGGSLYDYL---HKNHNVLKLPQLLRFAID 144
             H N++R +    +         ++  +   G+L++ +       N L   Q+L   + 
Sbjct: 83  FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142

Query: 145 ICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAE--------- 195
           IC+G+E +H +   HRDLK  N+L+       + D G           + +         
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 196 -TGTYRWMAPEVIN---HQPYDQKADVFSFAIVLWELVTAKVPYD 236
              T  + APE+ +   H   D++ DV+S   VL+ ++  + PYD
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  154 bits (392), Expect = 1e-45
 Identities = 66/200 (33%), Positives = 97/200 (48%), Gaps = 12/200 (6%)

Query: 52  GDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPH 109
           G +Y+G  L  G  VAVK L  E      E +F  EV ++    HRN++R  G       
Sbjct: 44  GKVYKGR-LADGTLVAVKRL-KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 101

Query: 110 LCIVTEYMPGGSLYDYLH---KNHNVLKLPQLLRFAIDICKGMEYLHQR---NIIHRDLK 163
             +V  YM  GS+   L    ++   L  P+  R A+   +G+ YLH      IIHRD+K
Sbjct: 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVK 161

Query: 164 TANLLMDTHNVVKVADFGVARFQNKGG--VMTAETGTYRWMAPEVINHQPYDQKADVFSF 221
            AN+L+D      V DFG+A+  +     V TA  GT   +APE ++     +K DVF +
Sbjct: 162 AANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGY 221

Query: 222 AIVLWELVTAKVPYDSMTPL 241
            ++L EL+T +  +D     
Sbjct: 222 GVMLLELITGQRAFDLARLA 241

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  151 bits (384), Expect = 2e-44
 Identities = 66/202 (32%), Positives = 108/202 (53%), Gaps = 7/202 (3%)

Query: 38  RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHR 95
           RLLKT   I  G+   +    ++  G++VA+K++    LN T   +  +EV I++ + H 
Sbjct: 18  RLLKT---IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 74

Query: 96  NVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR 155
           N+V+          L ++ EY  GG ++DYL   H  +K  +       I   ++Y HQ+
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQK 133

Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYD-Q 214
            I+HRDLK  NLL+D    +K+ADFG +     GG + A  G   + APE+   + YD  
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGP 193

Query: 215 KADVFSFAIVLWELVTAKVPYD 236
           + DV+S  ++L+ LV+  +P+D
Sbjct: 194 EVDVWSLGVILYTLVSGSLPFD 215

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  154 bits (390), Expect = 2e-44
 Identities = 53/234 (22%), Positives = 101/234 (43%), Gaps = 21/234 (8%)

Query: 25  ESQTKSEDWEIDRRLLKTGERIASGSCGD-LYRGVYLGQDVAVKVLRSEHLNDTLEDEFV 83
           +   ++    + +      + +  G+ G  +YRG++  +DVAVK +  E  +        
Sbjct: 11  DGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD----- 65

Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFA 142
           +EV +LRE  +H NV+R+           I  E     +L +Y+ +        + +   
Sbjct: 66  REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLL 124

Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHN-----VVKVADFGVARF----QNKGGVMT 193
                G+ +LH  NI+HRDLK  N+L+   N        ++DFG+ +     ++     +
Sbjct: 125 QQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRS 184

Query: 194 AETGTYRWMAPEVIN---HQPYDQKADVFSFAIVLWELVTAKV-PYDSMTPLQA 243
              GT  W+APE+++    +      D+FS   V + +++    P+      QA
Sbjct: 185 GVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA 238

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  150 bits (380), Expect = 4e-44
 Identities = 51/188 (27%), Positives = 93/188 (49%), Gaps = 9/188 (4%)

Query: 58  VYL------GQDVAVKVL-RSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL 110
            +        +  A K++ +S  L     ++   E++I R + H++VV F G    +  +
Sbjct: 31  CFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90

Query: 111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD 170
            +V E     SL +   K    L  P+   +   I  G +YLH+  +IHRDLK  NL ++
Sbjct: 91  FVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 149

Query: 171 THNVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELV 229
               VK+ DFG+A + +  G       GT  ++APEV++ + +  + DV+S   +++ L+
Sbjct: 150 EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLL 209

Query: 230 TAKVPYDS 237
             K P+++
Sbjct: 210 VGKPPFET 217

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  149 bits (379), Expect = 4e-44
 Identities = 51/210 (24%), Positives = 102/210 (48%), Gaps = 10/210 (4%)

Query: 43  GERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVR 99
            +++  G    +Y      L   VA+K +             F +EV    ++ H+N+V 
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 100 F--IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
              +       +  +V EY+ G +L +Y+   H  L +   + F   I  G+++ H   I
Sbjct: 76  MIDVDEEDDCYY--LVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRI 132

Query: 158 IHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQK 215
           +HRD+K  N+L+D++  +K+ DFG+A+  ++  +       GT ++ +PE    +  D+ 
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192

Query: 216 ADVFSFAIVLWELVTAKVPYDSMTPLQAAL 245
            D++S  IVL+E++  + P++  T +  A+
Sbjct: 193 TDIYSIGIVLYEMLVGEPPFNGETAVSIAI 222

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  150 bits (381), Expect = 5e-44
 Identities = 51/188 (27%), Positives = 93/188 (49%), Gaps = 9/188 (4%)

Query: 58  VYL------GQDVAVKVL-RSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL 110
            +        +  A K++ +S  L     ++   E++I R + H++VV F G    +  +
Sbjct: 57  CFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 116

Query: 111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD 170
            +V E     SL +   K    L  P+   +   I  G +YLH+  +IHRDLK  NL ++
Sbjct: 117 FVVLELCRRRSLLELH-KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 175

Query: 171 THNVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELV 229
               VK+ DFG+A + +  G       GT  ++APEV++ + +  + DV+S   +++ L+
Sbjct: 176 EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLL 235

Query: 230 TAKVPYDS 237
             K P+++
Sbjct: 236 VGKPPFET 243

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  149 bits (379), Expect = 6e-44
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 24/220 (10%)

Query: 43  GERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFV-------QEVAILREVQ 93
           GE +  G   +++        +DVAVKVLR++   D     F        Q  A L    
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARD---PSFYLRFRREAQNAAAL---N 70

Query: 94  HRNVVRF--IGASTKSPHLC--IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGM 149
           H  +V     G +         IV EY+ G +L D +H     +   + +    D C+ +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQAL 129

Query: 150 EYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET----GTYRWMAPE 205
            + HQ  IIHRD+K AN+++   N VKV DFG+AR     G    +T    GT ++++PE
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189

Query: 206 VINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL 245
                  D ++DV+S   VL+E++T + P+   +P+  A 
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY 229

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  148 bits (375), Expect = 1e-43
 Identities = 47/188 (25%), Positives = 87/188 (46%), Gaps = 8/188 (4%)

Query: 58  VYL------GQDVAVKVL-RSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL 110
           VY       G +VA+K++ +       +      EV I  +++H +++        S ++
Sbjct: 27  VYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV 86

Query: 111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD 170
            +V E    G +  YL          +   F   I  GM YLH   I+HRDL  +NLL+ 
Sbjct: 87  YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT 146

Query: 171 THNVVKVADFGVA-RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELV 229
            +  +K+ADFG+A + +          GT  +++PE+     +  ++DV+S   + + L+
Sbjct: 147 RNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLL 206

Query: 230 TAKVPYDS 237
             + P+D+
Sbjct: 207 IGRPPFDT 214

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  149 bits (378), Expect = 2e-43
 Identities = 50/240 (20%), Positives = 100/240 (41%), Gaps = 30/240 (12%)

Query: 24  IESQTKSEDWEIDR-RLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHL-------- 74
           +    K +D  I+  R+++T   +  G    +       +  A+K      L        
Sbjct: 19  LNKYVKEKDKYINDYRIIRT---LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTK 75

Query: 75  -------NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH 127
                    +  D+F  E+ I+ ++++   +   G  T    + I+ EYM   S+  +  
Sbjct: 76  SNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDE 135

Query: 128 KNHNV-------LKLPQLLRFAIDICKGMEYLH-QRNIIHRDLKTANLLMDTHNVVKVAD 179
               +       + +  +      +     Y+H ++NI HRD+K +N+LMD +  VK++D
Sbjct: 136 YFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSD 195

Query: 180 FGVARFQNKGGVMTAETGTYRWMAPEVINHQP--YDQKADVFSFAIVLWELVTAKVPYDS 237
           FG + +     +  +  GTY +M PE  +++      K D++S  I L+ +    VP+  
Sbjct: 196 FGESEYMVDKKIKGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  145 bits (368), Expect = 2e-42
 Identities = 54/219 (24%), Positives = 105/219 (47%), Gaps = 13/219 (5%)

Query: 28  TKSEDWEIDR-RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDT-LEDEFV 83
           +K   W ++   + +    +  G  G++Y          +A+KVL    L    +E +  
Sbjct: 1   SKKRQWALEDFEIGRP---LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 57

Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL--RF 141
           +EV I   ++H N++R  G    +  + ++ EY P G++Y  L K     K  +     +
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATY 114

Query: 142 AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRW 201
             ++   + Y H + +IHRD+K  NLL+ +   +K+ADFG +             GT  +
Sbjct: 115 ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL-CGTLDY 173

Query: 202 MAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTP 240
           + PE+I  + +D+K D++S  ++ +E +  K P+++ T 
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 212

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  145 bits (367), Expect = 2e-42
 Identities = 59/227 (25%), Positives = 109/227 (48%), Gaps = 16/227 (7%)

Query: 19  AVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLND 76
           A+ +  + +   +D++I R L   G+    G  G++Y  R       +A+KVL    L  
Sbjct: 2   ALAEMPKRKFTIDDFDIGRPL---GK----GKFGNVYLAREKQNKFIMALKVLFKSQLEK 54

Query: 77  T-LEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKL 135
             +E +  +E+ I   ++H N++R          + ++ E+ P G LY  L K+    + 
Sbjct: 55  EGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG---RF 111

Query: 136 PQLL--RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT 193
            +     F  ++   + Y H+R +IHRD+K  NLLM     +K+ADFG +         T
Sbjct: 112 DEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT 171

Query: 194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTP 240
              GT  ++ PE+I  + +D+K D++   ++ +E +    P+DS + 
Sbjct: 172 M-CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH 217

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  141 bits (358), Expect = 1e-40
 Identities = 42/165 (25%), Positives = 75/165 (45%), Gaps = 15/165 (9%)

Query: 79  EDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLP-- 136
            D    ++  +     +N V  +  S+   +L I  +     +L D++++  ++      
Sbjct: 105 MDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164

Query: 137 QLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF----------- 185
             L   I I + +E+LH + ++HRDLK +N+     +VVKV DFG+              
Sbjct: 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224

Query: 186 --QNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWEL 228
                    T + GT  +M+PE I+   Y  K D+FS  ++L+EL
Sbjct: 225 TPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  140 bits (355), Expect = 2e-40
 Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 36/227 (15%)

Query: 43  GERIASGSCGD--LYRGVYLGQDVAVKVL------------------------RSEHLND 76
            + I  GS G   L          A+KVL                               
Sbjct: 18  KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77

Query: 77  TLEDEFVQEVAILREVQHRNVVRF---IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVL 133
              ++  QE+AIL+++ H NVV+    +    +  HL +V E +  G + +        L
Sbjct: 78  GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVMEVP--TLKPL 134

Query: 134 KLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT 193
              Q   +  D+ KG+EYLH + IIHRD+K +NLL+     +K+ADFGV+        + 
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL 194

Query: 194 AET-GTYRWMAPEVIN--HQPYD-QKADVFSFAIVLWELVTAKVPYD 236
           + T GT  +MAPE ++   + +  +  DV++  + L+  V  + P+ 
Sbjct: 195 SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  141 bits (357), Expect = 3e-40
 Identities = 38/240 (15%), Positives = 92/240 (38%), Gaps = 27/240 (11%)

Query: 21  EKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEH 73
           +  + +     ++++  +L+     +  G+   +Y             Q   +KV +  +
Sbjct: 48  QCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN 107

Query: 74  LNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK----N 129
             +       Q +  L+       ++F  A        +V E    G+L + ++      
Sbjct: 108 PWE--FYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTP 165

Query: 130 HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM-----------DTHNVVKVA 178
             V+    ++ FA+ +   +E +H   IIH D+K  N ++           D    + + 
Sbjct: 166 EKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALI 225

Query: 179 DFGVA---RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           D G +   +   KG + TA+  T  +   E+++++P++ + D F  A  ++ ++      
Sbjct: 226 DLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK 285

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  139 bits (353), Expect = 5e-40
 Identities = 45/205 (21%), Positives = 76/205 (37%), Gaps = 18/205 (8%)

Query: 43  GERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFV-------QEVAILREVQ 93
              +  G  GD+Y        + VA+K++     +D     F        +    L   Q
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSD---PVFRTRMQREARTAGRL---Q 92

Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
             +VV           L +    + G  L   L +    L  P+ +     I   ++  H
Sbjct: 93  EPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH 151

Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GTYRWMAPEVINHQP 211
                HRD+K  N+L+   +   + DFG+A       +       GT  +MAPE  +   
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESH 211

Query: 212 YDQKADVFSFAIVLWELVTAKVPYD 236
              +AD+++   VL+E +T   PY 
Sbjct: 212 ATYRADIYALTCVLYECLTGSPPYQ 236

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  139 bits (352), Expect = 1e-39
 Identities = 54/243 (22%), Positives = 106/243 (43%), Gaps = 34/243 (13%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLY--RGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
           +  E+    L+    +A G    +Y  + V  G++ A+K L S           +QEV  
Sbjct: 21  QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEK--NRAIIQEVCF 78

Query: 89  LREVQ-HRNVVRFIGASTKSPH--------LCIVTEYMPGGSLYDYL--HKNHNVLKLPQ 137
           ++++  H N+V+F  A++              ++TE    G L ++L   ++   L    
Sbjct: 79  MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTEL-CKGQLVEFLKKMESRGPLSCDT 137

Query: 138 LLRFAIDICKGMEYLHQRN--IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAE 195
           +L+     C+ ++++H++   IIHRDLK  NLL+     +K+ DFG A   +     +  
Sbjct: 138 VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWS 197

Query: 196 T-------------GTYRWMAPEVIN---HQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
                          T  +  PE+I+   + P  +K D+++   +L+ L   + P++   
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257

Query: 240 PLQ 242
            L+
Sbjct: 258 KLR 260

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  137 bits (347), Expect = 2e-39
 Identities = 58/201 (28%), Positives = 110/201 (54%), Gaps = 7/201 (3%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVL-RSEHLNDTLEDEFVQEVAILREVQHRNV 97
             G+ +  G+ G +  G +   G  VAVK+L R +  +  +  +  +E+  L+  +H ++
Sbjct: 14  VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHI 73

Query: 98  VR-FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
           ++ +   ST +    +V EY+ GG L+DY+ K H  ++  +  R    I   ++Y H+  
Sbjct: 74  IKLYQVISTPT-DFFMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHM 131

Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYD-QK 215
           ++HRDLK  N+L+D H   K+ADFG++   + G  +    G+  + APEVI+ + Y   +
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 191

Query: 216 ADVFSFAIVLWELVTAKVPYD 236
            D++S  ++L+ L+   +P+D
Sbjct: 192 VDIWSCGVILYALLCGTLPFD 212

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  134 bits (340), Expect = 2e-38
 Identities = 61/207 (29%), Positives = 109/207 (52%), Gaps = 15/207 (7%)

Query: 38  RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQ-EVAILREVQH 94
            L++T   +  G+ G++   V     + VAVK++  +   D  E+  ++ E+ I + + H
Sbjct: 10  DLVQT---LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLNH 64

Query: 95  RNVVRFIG-ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
            NVV+F G     +    +  EY  GG L+D + +    +  P   RF   +  G+ YLH
Sbjct: 65  ENVVKFYGHRREGN-IQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH 122

Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFG---VARFQNKGGVMTAETGTYRWMAPEVINHQ 210
              I HRD+K  NLL+D  + +K++DFG   V R+ N+  ++    GT  ++APE++  +
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 211 PYD-QKADVFSFAIVLWELVTAKVPYD 236
            +  +  DV+S  IVL  ++  ++P+D
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWD 209

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  139 bits (351), Expect = 5e-38
 Identities = 46/182 (25%), Positives = 91/182 (50%), Gaps = 6/182 (3%)

Query: 43  GERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF 100
            E + +G+ G ++R      G + A K + + H +D  ++   +E+  +  ++H  +V  
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRHPTLVNL 219

Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
             A      + ++ E+M GG L++ +   HN +   + + +   +CKG+ ++H+ N +H 
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHL 279

Query: 161 DLKTANLLMDTH--NVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADV 218
           DLK  N++  T   N +K+ DFG+    +    +   TGT  + APEV   +P     D+
Sbjct: 280 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDM 339

Query: 219 FS 220
           +S
Sbjct: 340 WS 341

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  134 bits (340), Expect = 5e-38
 Identities = 47/216 (21%), Positives = 94/216 (43%), Gaps = 7/216 (3%)

Query: 12  HRKYRGHAVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVL 69
           H  +    V+   E+         +   + T + +  G    + + +    GQ+ A K L
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFL 62

Query: 70  RSEHLNDTLEDEFVQEVAILREVQHR-NVVRFIGASTKSPHLCIVTEYMPGGSLYDYL-H 127
           +          E + E+A+L   +    V+        +  + ++ EY  GG ++     
Sbjct: 63  KKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLP 122

Query: 128 KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVAR 184
           +   ++    ++R    I +G+ YLHQ NI+H DLK  N+L+ +      +K+ DFG++R
Sbjct: 123 ELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182

Query: 185 FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFS 220
                  +    GT  ++APE++N+ P     D+++
Sbjct: 183 KIGHACELREIMGTPEYLAPEILNYDPITTATDMWN 218

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  133 bits (337), Expect = 6e-38
 Identities = 47/193 (24%), Positives = 90/193 (46%), Gaps = 22/193 (11%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVV 98
              E +  G+   + R V+   G + A K++ ++ L+     +  +E  I R++QH N+V
Sbjct: 9   DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68

Query: 99  RFIGASTKSPHLCIVTEYMPGGSLYDYL-HKNH-------NVLKLPQLLRFAIDICKGME 150
           R   +  +     +V + + GG L++ +  +         + ++          I + + 
Sbjct: 69  RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---------QILESIA 119

Query: 151 YLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI 207
           Y H   I+HR+LK  NLL+ +      VK+ADFG+A   N         GT  +++PEV+
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 179

Query: 208 NHQPYDQKADVFS 220
              PY +  D+++
Sbjct: 180 KKDPYSKPVDIWA 192

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  134 bits (339), Expect = 7e-38
 Identities = 61/207 (29%), Positives = 109/207 (52%), Gaps = 15/207 (7%)

Query: 38  RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQ-EVAILREVQH 94
            L++T   +  G+ G++   V     + VAVK++  +   D  E+  ++ E+ I + + H
Sbjct: 10  DLVQT---LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLNH 64

Query: 95  RNVVRFIG-ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
            NVV+F G     +    +  EY  GG L+D + +    +  P   RF   +  G+ YLH
Sbjct: 65  ENVVKFYGHRREGN-IQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLH 122

Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFG---VARFQNKGGVMTAETGTYRWMAPEVINHQ 210
              I HRD+K  NLL+D  + +K++DFG   V R+ N+  ++    GT  ++APE++  +
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 211 PYD-QKADVFSFAIVLWELVTAKVPYD 236
            +  +  DV+S  IVL  ++  ++P+D
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWD 209

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  136 bits (344), Expect = 9e-38
 Identities = 54/231 (23%), Positives = 99/231 (42%), Gaps = 39/231 (16%)

Query: 37  RRLLKTGERIASGSCGDL-YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QH 94
           + L+ + + +  GS G + ++G + G+ VAVK +  +       D  + E+ +L E   H
Sbjct: 14  KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDH 68

Query: 95  RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL------HKNHNVLKLPQLLRFAIDICKG 148
            NV+R+  + T    L I  E     +L D +       +N  + K    +     I  G
Sbjct: 69  PNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127

Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNV-------------VKVADFGVARFQNKG-----G 190
           + +LH   IIHRDLK  N+L+ T +              + ++DFG+ +  + G      
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 191 VMTAETGTYRWMAPEVIN-------HQPYDQKADVFSFAIVLWELVTAKVP 234
            +   +GT  W APE++         +   +  D+FS   V + +++    
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  135 bits (341), Expect = 9e-38
 Identities = 41/182 (22%), Positives = 94/182 (51%), Gaps = 6/182 (3%)

Query: 43  GERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF 100
            E + SG+ G ++R V    G+    K + + +  D  +     E++I+ ++ H  ++  
Sbjct: 56  LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--KYTVKNEISIMNQLHHPKLINL 113

Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
             A      + ++ E++ GG L+D +      +   +++ +    C+G++++H+ +I+H 
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHL 173

Query: 161 DLKTANLLMDTH--NVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADV 218
           D+K  N++ +T   + VK+ DFG+A   N   ++   T T  + APE+++ +P     D+
Sbjct: 174 DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDM 233

Query: 219 FS 220
           ++
Sbjct: 234 WA 235

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  133 bits (338), Expect = 1e-37
 Identities = 60/200 (30%), Positives = 103/200 (51%), Gaps = 6/200 (3%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVL-RSEHLNDTLEDEFVQEVAILREVQHRNV 97
              E +  GS G +    +    Q VA+K + R       +     +E++ L+ ++H ++
Sbjct: 12  IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHI 71

Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
           ++     T    + +V EY  GG L+DY+ +    +   +  RF   I   +EY H+  I
Sbjct: 72  IKLYDVITTPTDIVMVIEYA-GGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKI 129

Query: 158 IHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYD-QKA 216
           +HRDLK  NLL+D +  VK+ADFG++     G  +    G+  + APEVIN + Y   + 
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEV 189

Query: 217 DVFSFAIVLWELVTAKVPYD 236
           DV+S  IVL+ ++  ++P+D
Sbjct: 190 DVWSCGIVLYVMLVGRLPFD 209

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  136 bits (344), Expect = 2e-37
 Identities = 60/203 (29%), Positives = 109/203 (53%), Gaps = 11/203 (5%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQ-EVAILREVQHRNV 97
             G+ +  G+ G +  G +   G  VAVK+L  + +        ++ E+  L+  +H ++
Sbjct: 19  ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHI 78

Query: 98  VRF---IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
           ++    I  ST S  + +V EY+ GG L+DY+ K +  L   +  R    I  G++Y H+
Sbjct: 79  IKLYQVI--STPS-DIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHR 134

Query: 155 RNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYD- 213
             ++HRDLK  N+L+D H   K+ADFG++   + G  +    G+  + APEVI+ + Y  
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAG 194

Query: 214 QKADVFSFAIVLWELVTAKVPYD 236
            + D++S  ++L+ L+   +P+D
Sbjct: 195 PEVDIWSSGVILYALLCGTLPFD 217

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  134 bits (338), Expect = 2e-37
 Identities = 48/185 (25%), Positives = 92/185 (49%), Gaps = 6/185 (3%)

Query: 40  LKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNV 97
           +   E +  G  G +++      G  +A K++++  + D  ++E   E++++ ++ H N+
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD--KEEVKNEISVMNQLDHANL 148

Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
           ++   A      + +V EY+ GG L+D +      L     + F   IC+G+ ++HQ  I
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYI 208

Query: 158 IHRDLKTANLLMDTH--NVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQK 215
           +H DLK  N+L        +K+ DFG+AR       +    GT  ++APEV+N+      
Sbjct: 209 LHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFP 268

Query: 216 ADVFS 220
            D++S
Sbjct: 269 TDMWS 273

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  132 bits (334), Expect = 2e-37
 Identities = 51/208 (24%), Positives = 95/208 (45%), Gaps = 17/208 (8%)

Query: 43  GERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEF-VQ-EVAILREVQHRNVV 98
           G+ +  GS G +   +        AVK+L+ + L      E  V+ E+ +LR ++H+NV+
Sbjct: 10  GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69

Query: 99  RF---IGASTKSPHLCIVTEYMPGGS--LYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
           +    +    K   + +V EY   G   + D +        + Q   +   +  G+EYLH
Sbjct: 70  QLVDVLYNEEKQ-KMYMVMEYCVCGMQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLH 126

Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN---KGGVMTAETGTYRWMAPEVIN-H 209
            + I+H+D+K  NLL+ T   +K++  GVA   +            G+  +  PE+ N  
Sbjct: 127 SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGL 186

Query: 210 QPYD-QKADVFSFAIVLWELVTAKVPYD 236
             +   K D++S  + L+ + T   P++
Sbjct: 187 DTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  135 bits (341), Expect = 2e-37
 Identities = 47/199 (23%), Positives = 91/199 (45%), Gaps = 16/199 (8%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVL------RSEHLNDTLEDEFVQEVAILREV 92
              + + SG+CG++         + VA++++                     E+ IL+++
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197

Query: 93  QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYL 152
            H  +++       +    IV E M GG L+D +   +  LK      +   +   ++YL
Sbjct: 198 NHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYL 255

Query: 153 HQRNIIHRDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI-- 207
           H+  IIHRDLK  N+L+ +     ++K+ DFG ++   +  +M    GT  ++APEV+  
Sbjct: 256 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 315

Query: 208 -NHQPYDQKADVFSFAIVL 225
                Y++  D +S  ++L
Sbjct: 316 VGTAGYNRAVDCWSLGVIL 334

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  132 bits (335), Expect = 3e-37
 Identities = 51/206 (24%), Positives = 97/206 (47%), Gaps = 11/206 (5%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL------NDTLEDEFVQEVAILREV 92
            T   + SG+ G ++  V     ++V VK ++ E +       D    +   E+AIL  V
Sbjct: 27  STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86

Query: 93  QHRNVVRFIGASTKSPHLCIVTE-YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
           +H N+++ +          +V E +  G  L+ ++ ++   L  P        +   + Y
Sbjct: 87  EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR-LDEPLASYIFRQLVSAVGY 145

Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQP 211
           L  ++IIHRD+K  N+++     +K+ DFG A +  +G +     GT  + APEV+   P
Sbjct: 146 LRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNP 205

Query: 212 YD-QKADVFSFAIVLWELVTAKVPYD 236
           Y   + +++S  + L+ LV  + P+ 
Sbjct: 206 YRGPELEMWSLGVTLYTLVFEENPFC 231

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  133 bits (336), Expect = 3e-37
 Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 16/206 (7%)

Query: 38  RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQ-EVAILREVQH 94
             +K    I SG+ G           + VAVK +      D    E VQ E+   R ++H
Sbjct: 23  DFVKD---IGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRH 75

Query: 95  RNVVRFIG-ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
            N+VRF     T + HL I+ EY  GG LY+ +  N       +   F   +  G+ Y H
Sbjct: 76  PNIVRFKEVILTPT-HLAIIMEYASGGELYERI-CNAGRFSEDEARFFFQQLLSGVSYCH 133

Query: 154 QRNIIHRDLKTANLLMDTHNV--VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQP 211
              I HRDLK  N L+D      +K+ DFG ++         +  GT  ++APEV+  Q 
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQE 193

Query: 212 YD-QKADVFSFAIVLWELVTAKVPYD 236
           YD + ADV+S  + L+ ++    P++
Sbjct: 194 YDGKIADVWSCGVTLYVMLVGAYPFE 219

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  131 bits (332), Expect = 4e-37
 Identities = 55/191 (28%), Positives = 96/191 (50%), Gaps = 13/191 (6%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLE----DEFVQEVAILREVQH 94
           + GE + SG    + +      G++ A K ++   L+ +      +E  +EV ILRE++H
Sbjct: 8   EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67

Query: 95  RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL-HKNHNVLKLPQLLRFAIDICKGMEYLH 153
            N++           + ++ E + GG L+D+L  K    L   +  +F   I  G+ YLH
Sbjct: 68  PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLH 125

Query: 154 QRNIIHRDLKTANLLMDTHNV----VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINH 209
            + I H DLK  N+++   NV    +K+ DFG+A     G       GT  ++APE++N+
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY 185

Query: 210 QPYDQKADVFS 220
           +P   +AD++S
Sbjct: 186 EPLGLEADMWS 196

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  132 bits (335), Expect = 5e-37
 Identities = 47/193 (24%), Positives = 90/193 (46%), Gaps = 22/193 (11%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVV 98
              E +  G+   + R V+   G + A K++ ++ L+     +  +E  I R++QH N+V
Sbjct: 32  DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 91

Query: 99  RFIGASTKSPHLCIVTEYMPGGSLYDYL-HKNH-------NVLKLPQLLRFAIDICKGME 150
           R   +  +     +V + + GG L++ +  +         + ++          I + + 
Sbjct: 92  RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---------QILESIA 142

Query: 151 YLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI 207
           Y H   I+HR+LK  NLL+ +      VK+ADFG+A   N         GT  +++PEV+
Sbjct: 143 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL 202

Query: 208 NHQPYDQKADVFS 220
              PY +  D+++
Sbjct: 203 KKDPYSKPVDIWA 215

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  134 bits (340), Expect = 7e-37
 Identities = 54/206 (26%), Positives = 108/206 (52%), Gaps = 11/206 (5%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVV 98
           +  +++ SG+ G++          + A+K++R   ++ +   + ++EVA+L+ + H N++
Sbjct: 40  QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99

Query: 99  RFIGASTKSPHLCIVTEYMPGGSLYDYL--HKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
           +         +  +V E   GG L+D +      N +    +++    +  G+ YLH+ N
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK---QVLSGVTYLHKHN 156

Query: 157 IIHRDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYD 213
           I+HRDLK  NLL+++     ++K+ DFG++        M    GT  ++APEV+  + YD
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKKYD 215

Query: 214 QKADVFSFAIVLWELVTAKVPYDSMT 239
           +K DV+S  ++L+ L+    P+   T
Sbjct: 216 EKCDVWSIGVILFILLAGYPPFGGQT 241

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  131 bits (332), Expect = 2e-36
 Identities = 53/191 (27%), Positives = 91/191 (47%), Gaps = 13/191 (6%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLE----DEFVQEVAILREVQH 94
             GE + SG    + +      G + A K ++      +      +E  +EV+ILR+V H
Sbjct: 15  DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74

Query: 95  RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL-HKNHNVLKLPQLLRFAIDICKGMEYLH 153
            N++           + ++ E + GG L+D+L  K    L   +   F   I  G+ YLH
Sbjct: 75  PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLH 132

Query: 154 QRNIIHRDLKTANLLMDTHNV----VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINH 209
            + I H DLK  N+++   N+    +K+ DFG+A     G       GT  ++APE++N+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY 192

Query: 210 QPYDQKADVFS 220
           +P   +AD++S
Sbjct: 193 EPLGLEADMWS 203

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  130 bits (329), Expect = 2e-36
 Identities = 38/182 (20%), Positives = 84/182 (46%), Gaps = 7/182 (3%)

Query: 43  GERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF 100
            E +  G  G ++R V     +    K ++ +  +   +    +E++IL   +HRN++  
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHRNILHL 66

Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
             +      L ++ E++ G  +++ ++ +   L   +++ +   +C+ +++LH  NI H 
Sbjct: 67  HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHF 126

Query: 161 DLKTANLLMDTH--NVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADV 218
           D++  N++  T   + +K+ +FG AR    G           + APEV  H       D+
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDM 186

Query: 219 FS 220
           +S
Sbjct: 187 WS 188

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  130 bits (329), Expect = 2e-36
 Identities = 54/191 (28%), Positives = 90/191 (47%), Gaps = 13/191 (6%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLE----DEFVQEVAILREVQH 94
             GE + SG    + +      G + A K ++      +      +E  +EV+ILR+V H
Sbjct: 15  DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74

Query: 95  RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL-HKNHNVLKLPQLLRFAIDICKGMEYLH 153
            NV+           + ++ E + GG L+D+L  K    L   +   F   I  G+ YLH
Sbjct: 75  HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLH 132

Query: 154 QRNIIHRDLKTANLLMDTHN----VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINH 209
            + I H DLK  N+++   N     +K+ DFG+A     G       GT  ++APE++N+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY 192

Query: 210 QPYDQKADVFS 220
           +P   +AD++S
Sbjct: 193 EPLGLEADMWS 203

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  129 bits (327), Expect = 4e-36
 Identities = 47/194 (24%), Positives = 88/194 (45%), Gaps = 16/194 (8%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVL------RSEHLNDTLEDEFVQEVAILREV 92
              + + SG+CG++         + VA+K++                     E+ IL+++
Sbjct: 13  IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72

Query: 93  QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYL 152
            H  +++       +    IV E M GG L+D +   +  LK      +   +   ++YL
Sbjct: 73  NHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYL 130

Query: 153 HQRNIIHRDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN- 208
           H+  IIHRDLK  N+L+ +     ++K+ DFG ++   +  +M    GT  ++APEV+  
Sbjct: 131 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 190

Query: 209 --HQPYDQKADVFS 220
                Y++  D +S
Sbjct: 191 VGTAGYNRAVDCWS 204

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  130 bits (329), Expect = 4e-36
 Identities = 27/245 (11%), Positives = 64/245 (26%), Gaps = 38/245 (15%)

Query: 37  RRLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLE-DEFVQEVAILREVQ 93
            R LK  E +  G    ++    V   +D A+KV      N   E +   +       + 
Sbjct: 61  ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLL 120

Query: 94  HRNVVRFIGA--------------------------STKSPHLCIVTEYMPG-----GSL 122
             +                                      +  ++            S 
Sbjct: 121 GESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFST 180

Query: 123 YDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGV 182
            D+++       +  L      + +    L  + ++H      NL +     + + D   
Sbjct: 181 LDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSA 240

Query: 183 ARFQNKGGVMTAETGTYRWMAPEVINHQ--PYDQKADVFSFAIVLWELVTAKVPYDSMTP 240
                 G    A +    +   E +N     +    + +   + ++ +    +P+  +TP
Sbjct: 241 LW--KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298

Query: 241 LQAAL 245
                
Sbjct: 299 GIKGS 303

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  134 bits (339), Expect = 4e-36
 Identities = 47/206 (22%), Positives = 81/206 (39%), Gaps = 17/206 (8%)

Query: 43  GERIASGSCGDLYRG---VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR 99
              IA G  G +Y        G+ V +K L     +   +   + E   L EV H ++V+
Sbjct: 85  KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQ 143

Query: 100 FI-----GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
                        P   IV EY+ G SL     +    L + + + + ++I   + YLH 
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLHS 200

Query: 155 RNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQ 214
             +++ DLK  N+++ T   +K+ D G     N  G +    GT  + APE++   P   
Sbjct: 201 IGLVYNDLKPENIML-TEEQLKLIDLGAVSRINSFGYL---YGTPGFQAPEIVRTGP-TV 255

Query: 215 KADVFSFAIVLWELVTAKVPYDSMTP 240
             D+++    L  L       +    
Sbjct: 256 ATDIYTVGRTLAALTLDLPTRNGRYV 281

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  128 bits (325), Expect = 5e-36
 Identities = 48/198 (24%), Positives = 95/198 (47%), Gaps = 25/198 (12%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVV 98
              E + SG+  +++       G+  A+K ++        +     E+A+L++++H N+V
Sbjct: 12  IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR--DSSLENEIAVLKKIKHENIV 69

Query: 99  RFIGASTKSPHLCIVTEYMPGGSLYDY-LHKNH-------NVLKLPQLLRFAIDICKGME 150
                   + H  +V + + GG L+D  L +          V++          +   ++
Sbjct: 70  TLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ---------QVLSAVK 120

Query: 151 YLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI 207
           YLH+  I+HRDLK  NLL  T      + + DFG+++ + + G+M+   GT  ++APEV+
Sbjct: 121 YLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME-QNGIMSTACGTPGYVAPEVL 179

Query: 208 NHQPYDQKADVFSFAIVL 225
             +PY +  D +S  ++ 
Sbjct: 180 AQKPYSKAVDCWSIGVIT 197

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  129 bits (327), Expect = 6e-36
 Identities = 51/197 (25%), Positives = 82/197 (41%), Gaps = 22/197 (11%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKV-----LRSEHLNDTLEDEFVQEVAILREVQ 93
           +  E I  G    + R +    GQ  AVK+       S        ++  +E +I   ++
Sbjct: 27  ELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLS--TEDLKREASICHMLK 84

Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL-HKNHNVLKLP-----QLLRFAIDICK 147
           H ++V  +   +    L +V E+M G  L   +  +               +R    I +
Sbjct: 85  HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR---QILE 141

Query: 148 GMEYLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVAR-FQNKGGVMTAETGTYRWMA 203
            + Y H  NIIHRD+K   +L+ +      VK+  FGVA      G V     GT  +MA
Sbjct: 142 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMA 201

Query: 204 PEVINHQPYDQKADVFS 220
           PEV+  +PY +  DV+ 
Sbjct: 202 PEVVKREPYGKPVDVWG 218

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  127 bits (322), Expect = 8e-36
 Identities = 51/187 (27%), Positives = 93/187 (49%), Gaps = 11/187 (5%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVV 98
                +  GS G++ +       Q+ AVKV+      +      ++EV +L+++ H N++
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84

Query: 99  RFIGASTKSPHLCIVTEYMPGGSLYDYL--HKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
           +       S    IV E   GG L+D +   K  +     ++++    +  G+ Y+H+ N
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK---QVFSGITYMHKHN 141

Query: 157 IIHRDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYD 213
           I+HRDLK  N+L+++      +K+ DFG++    +   M    GT  ++APEV+    YD
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYD 200

Query: 214 QKADVFS 220
           +K DV+S
Sbjct: 201 EKCDVWS 207

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  127 bits (322), Expect = 1e-35
 Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 18/212 (8%)

Query: 38  RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQ----EVAILRE 91
           RL      +  G  G ++ G  L     VA+KV+    +              EVA+L +
Sbjct: 34  RLGPL---LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90

Query: 92  V----QHRNVVRFIGASTKSPHLCIVTEY-MPGGSLYDYLHKNHNVLKLPQLLRFAIDIC 146
           V     H  V+R +          +V E  +P   L+DY+ +    L       F   + 
Sbjct: 91  VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP-LGEGPSRCFFGQVV 149

Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTH-NVVKVADFGVARFQNKGGVMTAETGTYRWMAPE 205
             +++ H R ++HRD+K  N+L+D      K+ DFG           T   GT  +  PE
Sbjct: 150 AAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEPYTDFDGTRVYSPPE 208

Query: 206 VINHQPYD-QKADVFSFAIVLWELVTAKVPYD 236
            I+   Y    A V+S  I+L+++V   +P++
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFE 240

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  127 bits (322), Expect = 2e-35
 Identities = 55/191 (28%), Positives = 91/191 (47%), Gaps = 13/191 (6%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL----NDTLEDEFVQEVAILREVQH 94
            TGE + SG    + +      G   A K ++             ++  +EV+IL+E+QH
Sbjct: 14  DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73

Query: 95  RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL-HKNHNVLKLPQLLRFAIDICKGMEYLH 153
            NV+           + ++ E + GG L+D+L  K    L   +   F   I  G+ YLH
Sbjct: 74  PNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLH 131

Query: 154 QRNIIHRDLKTANLLMDTHNV----VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINH 209
              I H DLK  N+++   NV    +K+ DFG+A   + G       GT  ++APE++N+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY 191

Query: 210 QPYDQKADVFS 220
           +P   +AD++S
Sbjct: 192 EPLGLEADMWS 202

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  127 bits (321), Expect = 3e-35
 Identities = 50/210 (23%), Positives = 96/210 (45%), Gaps = 16/210 (7%)

Query: 38  RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQ----EVAILRE 91
           ++      + SG  G +Y G+ +     VA+K +  + ++D  E         EV +L++
Sbjct: 46  QVGPL---LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102

Query: 92  VQHR--NVVRFIGASTKSPHLCIVTEY-MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
           V      V+R +    +     ++ E   P   L+D++ +    L+      F   + + 
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEA 161

Query: 149 MEYLHQRNIIHRDLKTANLLMDT-HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI 207
           + + H   ++HRD+K  N+L+D     +K+ DFG      K  V T   GT  +  PE I
Sbjct: 162 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWI 220

Query: 208 NHQPYD-QKADVFSFAIVLWELVTAKVPYD 236
            +  Y  + A V+S  I+L+++V   +P++
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  130 bits (328), Expect = 4e-35
 Identities = 56/207 (27%), Positives = 107/207 (51%), Gaps = 12/207 (5%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQ-EVAILREVQHRNV 97
           K    +  GS G++        GQ+ AVKV+    +    + E +  EV +L+++ H N+
Sbjct: 29  KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88

Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYL--HKNHNVLKLPQLLRFAIDICKGMEYLHQR 155
           ++         +  +V E   GG L+D +   K  + +   +++R    +  G+ Y+H+ 
Sbjct: 89  MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR---QVLSGITYMHKN 145

Query: 156 NIIHRDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPY 212
            I+HRDLK  NLL+++ +    +++ DFG++        M  + GT  ++APEV+ H  Y
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTY 204

Query: 213 DQKADVFSFAIVLWELVTAKVPYDSMT 239
           D+K DV+S  ++L+ L++   P++   
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFNGAN 231

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  127 bits (322), Expect = 4e-35
 Identities = 49/203 (24%), Positives = 95/203 (46%), Gaps = 32/203 (15%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLR------SEHLNDTLEDEFVQEVAILREV 92
              + I  G    + R V+   G + AVK++       S    + + +   +E  ILR+V
Sbjct: 97  DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQV 156

Query: 93  -QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL-HKNH-------NVLKLPQLLRFAI 143
             H +++  I +   S  + +V + M  G L+DYL  K         ++++         
Sbjct: 157 AGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMR--------- 207

Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMA 203
            + + + +LH  NI+HRDLK  N+L+D +  ++++DFG +     G  +    GT  ++A
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLA 267

Query: 204 PEVI------NHQPYDQKADVFS 220
           PE++       H  Y ++ D+++
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWA 290

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  129 bits (327), Expect = 5e-35
 Identities = 54/206 (26%), Positives = 102/206 (49%), Gaps = 11/206 (5%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVV 98
                +  GS G++ +       Q+ AVKV+      +      ++EV +L+++ H N++
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84

Query: 99  RFIGASTKSPHLCIVTEYMPGGSLYDYL--HKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
           +       S    IV E   GG L+D +   K  +     ++++    +  G+ Y+H+ N
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK---QVFSGITYMHKHN 141

Query: 157 IIHRDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYD 213
           I+HRDLK  N+L+++      +K+ DFG++    +   M    GT  ++APEV+    YD
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYD 200

Query: 214 QKADVFSFAIVLWELVTAKVPYDSMT 239
           +K DV+S  ++L+ L++   P+    
Sbjct: 201 EKCDVWSAGVILYILLSGTPPFYGKN 226

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  125 bits (317), Expect = 7e-35
 Identities = 52/209 (24%), Positives = 96/209 (45%), Gaps = 33/209 (15%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKV-------LRSEHLNDTLEDEFVQEVAILRE 91
           +  E +  G    + R ++    ++ AVK+         S      L +  ++EV ILR+
Sbjct: 20  EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79

Query: 92  V-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYL-HKNH-------NVLKLPQLLRFA 142
           V  H N+++       +    +V + M  G L+DYL  K          +++        
Sbjct: 80  VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR-------- 131

Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWM 202
             + + +  LH+ NI+HRDLK  N+L+D    +K+ DFG +   + G  +    GT  ++
Sbjct: 132 -ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYL 190

Query: 203 APEVI------NHQPYDQKADVFSFAIVL 225
           APE+I      NH  Y ++ D++S  +++
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  128 bits (323), Expect = 1e-34
 Identities = 44/194 (22%), Positives = 95/194 (48%), Gaps = 23/194 (11%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVV 98
           +  E +  G+   + R V +  GQ+ A  ++ ++ L+     +  +E  I R ++H N+V
Sbjct: 14  QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73

Query: 99  RFIGASTKSPHLCIVTEYMPGGSLYDY-LHKNH-------NVLKLPQLLRFAIDICKGME 150
           R   + ++  H  ++ + + GG L++  + + +       + ++          I + + 
Sbjct: 74  RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ---------QILEAVL 124

Query: 151 YLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV 206
           + HQ  ++HR+LK  NLL+ +      VK+ADFG+A   + +        GT  +++PEV
Sbjct: 125 HCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV 184

Query: 207 INHQPYDQKADVFS 220
           +   PY +  D+++
Sbjct: 185 LRKDPYGKPVDLWA 198

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  123 bits (312), Expect = 2e-34
 Identities = 47/187 (25%), Positives = 85/187 (45%), Gaps = 13/187 (6%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVV 98
                I  GS G++   V        A K +    + D   D F QE+ I++ + H N++
Sbjct: 12  TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNII 69

Query: 99  RFIGASTKSPHLCIVTEYMPGGSLYDYL--HKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
           R       +  + +V E   GG L++ +   +        ++++   D+   + Y H+ N
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK---DVLSAVAYCHKLN 126

Query: 157 IIHRDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYD 213
           + HRDLK  N L  T +    +K+ DFG+A     G +M  + GT  +++P+V+    Y 
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL-EGLYG 185

Query: 214 QKADVFS 220
            + D +S
Sbjct: 186 PECDEWS 192

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score =  125 bits (316), Expect = 3e-34
 Identities = 44/141 (31%), Positives = 66/141 (46%), Gaps = 4/141 (2%)

Query: 104 STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLK 163
           S+ S                       + L L  L+ ++  + KGME+L  R  IHRDL 
Sbjct: 161 SSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA 220

Query: 164 TANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT---YRWMAPEVINHQPYDQKADVFS 220
             N+L+   NVVK+ DFG+AR   K      +       +WMAPE I  + Y  ++DV+S
Sbjct: 221 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 280

Query: 221 FAIVLWELVT-AKVPYDSMTP 240
           F ++LWE+ +    PY  +  
Sbjct: 281 FGVLLWEIFSLGASPYPGVKI 301

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 85.4 bits (211), Expect = 2e-19
 Identities = 39/154 (25%), Positives = 60/154 (38%), Gaps = 15/154 (9%)

Query: 32  DWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-------VAVKVLRSEHLNDTLEDEFVQ 84
            WE  R  LK G+ +  G+ G +      G D       VAVK+L+      +     + 
Sbjct: 16  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMS 74

Query: 85  EVAILREV-QHRNVVRFIGASTKSPH-LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFA 142
           E+ IL  +  H NVV  +GA TK    L ++ E+   G+L  YL    N  +        
Sbjct: 75  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN--EFVPYKTKG 132

Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVK 176
               +G +Y+     I  DLK     + +     
Sbjct: 133 ARFRQGKDYV---GAIPVDLKRRLDSITSSQSSA 163

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  124 bits (314), Expect = 3e-34
 Identities = 53/251 (21%), Positives = 94/251 (37%), Gaps = 53/251 (21%)

Query: 43  GERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL---NDTLEDEFVQEVAILREVQHRNV 97
              I  GS G +   +        A+K++    +   N    +    EV +++++ H N+
Sbjct: 31  KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90

Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL------------------ 139
            R         ++C+V E   GG L D L+   +       +                  
Sbjct: 91  ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150

Query: 140 ---------------------RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN--VVK 176
                                     I   + YLH + I HRD+K  N L  T+    +K
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIK 210

Query: 177 VADFGVARF-----QNKGGVMTAETGTYRWMAPEVIN--HQPYDQKADVFSFAIVLWELV 229
           + DFG+++        +   MT + GT  ++APEV+N  ++ Y  K D +S  ++L  L+
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270

Query: 230 TAKVPYDSMTP 240
              VP+  +  
Sbjct: 271 MGAVPFPGVND 281

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  123 bits (312), Expect = 4e-34
 Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 19/203 (9%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFV-----QEVAILREVQHRN 96
           E+I  G+ G +++       + VA+K +R +      +DE V     +E+ +L+E++H+N
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-----DDEGVPSSALREICLLKELKHKN 62

Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
           +VR          L +V E+     L  Y    +  L    +  F   + KG+ + H RN
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGT--YRWMAPEVI-NHQPY 212
           ++HRDLK  NLL++ +  +K+A+FG+AR F       +AE  T  YR   P+V+   + Y
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR--PPDVLFGAKLY 179

Query: 213 DQKADVFSFAIVLWELVTAKVPY 235
               D++S   +  EL  A  P 
Sbjct: 180 STSIDMWSAGCIFAELANAGRPL 202

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  123 bits (311), Expect = 4e-34
 Identities = 42/186 (22%), Positives = 80/186 (43%), Gaps = 10/186 (5%)

Query: 43  GERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF 100
             ++ SG+ GD++       G +  +K +  +     +E     E+ +L+ + H N+++ 
Sbjct: 27  KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ-IEAEIEVLKSLDHPNIIKI 85

Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKL---PQLLRFAIDICKGMEYLHQRNI 157
                   ++ IV E   GG L + +       K      +      +   + Y H +++
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHV 145

Query: 158 IHRDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQ 214
           +H+DLK  N+L    +    +K+ DFG+A         T   GT  +MAPEV   +    
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTF 204

Query: 215 KADVFS 220
           K D++S
Sbjct: 205 KCDIWS 210

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  122 bits (308), Expect = 4e-33
 Identities = 48/198 (24%), Positives = 87/198 (43%), Gaps = 26/198 (13%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVV 98
           +    +  G+   +YR       +  A+KVL+       +      E+ +L  + H N++
Sbjct: 56  EVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR----TEIGVLLRLSHPNII 111

Query: 99  RFIGASTKSPHLCIVTEYMPGGSLYDY-LHKNH-------NVLKLPQLLRFAIDICKGME 150
           +          + +V E + GG L+D  + K +       + +K          I + + 
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK---------QILEAVA 162

Query: 151 YLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI 207
           YLH+  I+HRDLK  NLL  T      +K+ADFG+++      +M    GT  + APE++
Sbjct: 163 YLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEIL 222

Query: 208 NHQPYDQKADVFSFAIVL 225
               Y  + D++S  I+ 
Sbjct: 223 RGCAYGPEVDMWSVGIIT 240

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  121 bits (307), Expect = 5e-33
 Identities = 63/223 (28%), Positives = 117/223 (52%), Gaps = 22/223 (9%)

Query: 23  AIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLED 80
           A++ +++++ +E   +L   GE    G    +Y+       Q VA+K ++  H     +D
Sbjct: 2   ALDVKSRAKRYE---KLDFLGE----GQFATVYKARDKNTNQIVAIKKIKLGH-RSEAKD 53

Query: 81  EF----VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLP 136
                 ++E+ +L+E+ H N++  + A     ++ +V ++M    L   +  N  VL   
Sbjct: 54  GINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPS 112

Query: 137 QLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAE 195
            +  + +   +G+EYLHQ  I+HRDLK  NLL+D + V+K+ADFG+A+ F +     T +
Sbjct: 113 HIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ 172

Query: 196 TGT--YRWMAPEVI-NHQPYDQKADVFSFAIVLWELVTAKVPY 235
             T  YR  APE++   + Y    D+++   +L EL+  +VP+
Sbjct: 173 VVTRWYR--APELLFGARMYGVGVDMWAVGCILAELLL-RVPF 212

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  121 bits (305), Expect = 6e-33
 Identities = 52/199 (26%), Positives = 98/199 (49%), Gaps = 18/199 (9%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEF----VQEVAILREVQHRNV 97
           +++  G+   +Y+G        VA+K +R EH     E+      ++EV++L++++H N+
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEH-----EEGAPCTAIREVSLLKDLKHANI 62

Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
           V           L +V EY+    L  YL    N++ +  +  F   + +G+ Y H++ +
Sbjct: 63  VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKV 121

Query: 158 IHRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGT--YRWMAPEVI-NHQPYD 213
           +HRDLK  NLL++    +K+ADFG+AR           E  T  YR   P+++     Y 
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR--PPDILLGSTDYS 179

Query: 214 QKADVFSFAIVLWELVTAK 232
            + D++    + +E+ T +
Sbjct: 180 TQIDMWGVGCIFYEMATGR 198

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  121 bits (305), Expect = 7e-33
 Identities = 47/207 (22%), Positives = 85/207 (41%), Gaps = 29/207 (14%)

Query: 29  KSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEV 86
           K   +     L    + +  GS     + V+    Q  AVK++      +T      +E+
Sbjct: 2   KDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ-----KEI 56

Query: 87  AILREVQ-HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHN--------VLKLPQ 137
             L+  + H N+V+         H  +V E + GG L++ + K  +        +++   
Sbjct: 57  TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR--- 113

Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVAR-FQNKGGVMT 193
                  +   + ++H   ++HRDLK  NLL    N    +K+ DFG AR        + 
Sbjct: 114 ------KLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167

Query: 194 AETGTYRWMAPEVINHQPYDQKADVFS 220
               T  + APE++N   YD+  D++S
Sbjct: 168 TPCFTLHYAAPELLNQNGYDESCDLWS 194

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  120 bits (303), Expect = 1e-32
 Identities = 50/201 (24%), Positives = 93/201 (46%), Gaps = 13/201 (6%)

Query: 38  RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHR 95
           ++ K GE    GS G +++      GQ VA+K       +  ++   ++E+ +L++++H 
Sbjct: 7   KIGKIGE----GSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 96  NVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR 155
           N+V  +    +   L +V EY    ++   L +    +    +        + + + H+ 
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121

Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGT--YRWMAPEVI-NHQP 211
           N IHRD+K  N+L+  H+V+K+ DFG AR           E  T  YR  +PE++     
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR--SPELLVGDTQ 179

Query: 212 YDQKADVFSFAIVLWELVTAK 232
           Y    DV++   V  EL++  
Sbjct: 180 YGPPVDVWAIGCVFAELLSGV 200

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  120 bits (303), Expect = 1e-32
 Identities = 62/199 (31%), Positives = 104/199 (52%), Gaps = 18/199 (9%)

Query: 44  ERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFV-----QEVAILREVQHRNV 97
           E++  G+ G +Y+     G+ VA+K +R +      EDE +     +E+++L+E+ H N+
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDA-----EDEGIPSTAIREISLLKELHHPNI 81

Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
           V  I        L +V E+M    L   L +N   L+  Q+  +   + +G+ + HQ  I
Sbjct: 82  VSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRI 140

Query: 158 IHRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGT--YRWMAPEVI-NHQPYD 213
           +HRDLK  NLL+++   +K+ADFG+AR F       T E  T  YR  AP+V+   + Y 
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR--APDVLMGSKKYS 198

Query: 214 QKADVFSFAIVLWELVTAK 232
              D++S   +  E++T K
Sbjct: 199 TSVDIWSIGCIFAEMITGK 217

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  120 bits (304), Expect = 1e-32
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 31/196 (15%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAIL-REVQHRNV 97
           +  E I  GS     R ++     + AVK++     + +  D   +E+ IL R  QH N+
Sbjct: 25  EVKEDIGVGSYSVCKRCIHKATNMEFAVKII-----DKSKRDPT-EEIEILLRYGQHPNI 78

Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLH-KNH-------NVLKLPQLLRFAIDICKGM 149
           +          ++ +VTE M GG L D +  +          VL           I K +
Sbjct: 79  ITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLF---------TITKTV 129

Query: 150 EYLHQRNIIHRDLKTANLLMDTHN----VVKVADFGVAR-FQNKGGVMTAETGTYRWMAP 204
           EYLH + ++HRDLK +N+L    +     +++ DFG A+  + + G++     T  ++AP
Sbjct: 130 EYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAP 189

Query: 205 EVINHQPYDQKADVFS 220
           EV+  Q YD   D++S
Sbjct: 190 EVLERQGYDAACDIWS 205

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  119 bits (301), Expect = 1e-32
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 18/199 (9%)

Query: 44  ERIASGSCGDLYRGVY-LGQDVAVKVLRSEHLNDTLEDEFV-----QEVAILREVQHRNV 97
           E+I  G+ G +Y+     G+  A+K +R E      EDE +     +E++IL+E++H N+
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEK-----EDEGIPSTTIREISILKELKHSNI 62

Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
           V+          L +V E++    L   L      L+      F + +  G+ Y H R +
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121

Query: 158 IHRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGT--YRWMAPEVI-NHQPYD 213
           +HRDLK  NLL++    +K+ADFG+AR F       T E  T  YR  AP+V+   + Y 
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR--APDVLMGSKKYS 179

Query: 214 QKADVFSFAIVLWELVTAK 232
              D++S   +  E+V   
Sbjct: 180 TTIDIWSVGCIFAEMVNGT 198

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  119 bits (300), Expect = 3e-32
 Identities = 52/195 (26%), Positives = 93/195 (47%), Gaps = 9/195 (4%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
             +  GS G + +      G+ VA+K       +  ++   ++E+ +L++++H N+V  +
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
               K     +V E++   ++ D L    N L    + ++   I  G+ + H  NIIHRD
Sbjct: 91  EVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRD 149

Query: 162 LKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGT--YRWMAPEVI-NHQPYDQKAD 217
           +K  N+L+    VVK+ DFG AR     G V   E  T  YR  APE++     Y +  D
Sbjct: 150 IKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR--APELLVGDVKYGKAVD 207

Query: 218 VFSFAIVLWELVTAK 232
           V++   ++ E+   +
Sbjct: 208 VWAIGCLVTEMFMGE 222

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  122 bits (308), Expect = 4e-32
 Identities = 50/175 (28%), Positives = 87/175 (49%), Gaps = 2/175 (1%)

Query: 65  AVKVLRSEHLNDTLEDEFVQ-EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           A K L  + +     +     E  IL +V  R VV    A      LC+V   M GG L 
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 272

Query: 124 DYLHKNHN-VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGV 182
            +++          + + +A +IC G+E LH+  I++RDLK  N+L+D H  ++++D G+
Sbjct: 273 FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL 332

Query: 183 ARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS 237
           A    +G  +    GT  +MAPEV+ ++ Y    D ++   +L+E++  + P+  
Sbjct: 333 AVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  121 bits (305), Expect = 8e-32
 Identities = 57/180 (31%), Positives = 97/180 (53%), Gaps = 9/180 (5%)

Query: 65  AVKVLRSEHLNDTLEDEFVQ-EVAILREVQHRNVVRFIGA-STKSPHLCIVTEYMPGGSL 122
           A K L  + L      +    E  IL +V  R +V    A  TK+  LC+V   M GG +
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT-DLCLVMTIMNGGDI 272

Query: 123 YDYLH---KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVAD 179
             +++   +++   + P+ + +   I  G+E+LHQRNII+RDLK  N+L+D    V+++D
Sbjct: 273 RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISD 332

Query: 180 FGVARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS 237
            G+A  + K G    +   GT  +MAPE++  + YD   D F+  + L+E++ A+ P+ +
Sbjct: 333 LGLAV-ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  120 bits (304), Expect = 9e-32
 Identities = 54/217 (24%), Positives = 107/217 (49%), Gaps = 26/217 (11%)

Query: 43  GERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTL-----------EDEFVQEVAIL 89
             ++ SG+ G++          + A+KV++    +               +E   E+++L
Sbjct: 41  VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100

Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICK-- 147
           + + H N+++         +  +VTE+  GG L++ +   H   K  +    A +I K  
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH---KFDE--CDAANIMKQI 155

Query: 148 --GMEYLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWM 202
             G+ YLH+ NI+HRD+K  N+L++  N    +K+ DFG++ F +K   +    GT  ++
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215

Query: 203 APEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
           APEV+  + Y++K DV+S  ++++ L+    P+    
Sbjct: 216 APEVL-KKKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  119 bits (299), Expect = 1e-31
 Identities = 46/196 (23%), Positives = 92/196 (46%), Gaps = 29/196 (14%)

Query: 61  GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-----------HRNVVR----FIGAST 105
              VA+K++R    +    +    E+ +L+ V              ++++    F     
Sbjct: 44  NTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP 100

Query: 106 KSPHLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICKGMEYLHQR-NIIHRDLK 163
              H+ +V E + G +L   + K  +  + L  + + +  +  G++Y+H+R  IIH D+K
Sbjct: 101 NGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIK 159

Query: 164 TANLLMD------THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKAD 217
             N+LM+          +K+AD G A + ++    + +T  YR  +PEV+   P+   AD
Sbjct: 160 PENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR--SPEVLLGAPWGCGAD 217

Query: 218 VFSFAIVLWELVTAKV 233
           ++S A +++EL+T   
Sbjct: 218 IWSTACLIFELITGDF 233

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  115 bits (289), Expect = 6e-31
 Identities = 24/215 (11%), Positives = 57/215 (26%), Gaps = 35/215 (16%)

Query: 38  RLLKTGERIASGSCGDLYRGV--YLGQDVAVKVLRSEHLND-TLEDEFVQEVAILREVQH 94
           RLL              ++ +   L + VA+  +  + +    +  E +     L  +  
Sbjct: 34  RLL---IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90

Query: 95  RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
             V R +          +V E++ GGSL +    +         +R    +    +  H+
Sbjct: 91  PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHR 147

Query: 155 RNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQ 214
             +       + + +     V +A                                  + 
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAYPATMP--------------------------DANP 181

Query: 215 KADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
           + D+      L+ L+  + P              +
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER 216

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  117 bits (295), Expect = 6e-31
 Identities = 45/193 (23%), Positives = 83/193 (43%), Gaps = 24/193 (12%)

Query: 42  TGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVV 98
           T + +  G  G + +       +  A+K+L              +EV +        ++V
Sbjct: 66  TSQVLGLGINGKVLQIFNKRTQEKFALKML------QDCPKAR-REVELHWRASQCPHIV 118

Query: 99  RFIGA----STKSPHLCIVTEYMPGGSLYDYLHKNHNVL----KLPQLLRFAIDICKGME 150
           R +            L IV E + GG L+  +    +      +  ++++    I + ++
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK---SIGEAIQ 175

Query: 151 YLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI 207
           YLH  NI HRD+K  NLL  +     ++K+ DFG A+       +T    T  ++APEV+
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 235

Query: 208 NHQPYDQKADVFS 220
             + YD+  D++S
Sbjct: 236 GPEKYDKSCDMWS 248

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  115 bits (289), Expect = 2e-30
 Identities = 58/254 (22%), Positives = 113/254 (44%), Gaps = 33/254 (12%)

Query: 12  HRKYRGHAVEKAIESQTKS--EDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVK 67
           H       + +  E +  +  +D+++ +++L  G     G  G +    +   GQ  A+K
Sbjct: 7   HHSSGLEVLFQGPEPKKYAVTDDYQLSKQVL--GL----GVNGKVLECFHRRTGQKCALK 60

Query: 68  VLRSEHLNDTLEDEFVQEVAIL-REVQHRNVVRFIGA----STKSPHLCIVTEYMPGGSL 122
           +L              QEV    +     ++V  +            L I+ E M GG L
Sbjct: 61  LLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL 113

Query: 123 YDYLHKNHNVL----KLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN---VV 175
           +  + +  +      +  +++R   DI   +++LH  NI HRD+K  NLL  +     V+
Sbjct: 114 FSRIQERGDQAFTEREAAEIMR---DIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL 170

Query: 176 KVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY 235
           K+ DFG A+   +  + T    T  ++APEV+  + YD+  D++S  ++++ L+    P+
Sbjct: 171 KLTDFGFAKETTQNALQTP-CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF 229

Query: 236 DSMTPLQAALGVRQ 249
            S T    + G+++
Sbjct: 230 YSNTGQAISPGMKR 243

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  113 bits (285), Expect = 5e-30
 Identities = 53/224 (23%), Positives = 98/224 (43%), Gaps = 36/224 (16%)

Query: 61  GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHLCIVTEYMPG 119
            Q+ AVK++  +  +        +EV +L + Q HRNV+  I    +     +V E M G
Sbjct: 38  SQEYAVKIIEKQPGHI--RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRG 95

Query: 120 GSLYDYLHKNHN--------VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT 171
           GS+  ++HK  +        V++         D+   +++LH + I HRDLK  N+L + 
Sbjct: 96  GSILSHIHKRRHFNELEASVVVQ---------DVASALDFLHNKGIAHRDLKPENILCEH 146

Query: 172 HN---VVKVADFGVARFQNKGGVMTAET--------GTYRWMAPEVIN-----HQPYDQK 215
            N    VK+ DF +       G  +  +        G+  +MAPEV+         YD++
Sbjct: 147 PNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR 206

Query: 216 ADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY 259
            D++S  ++L+ L++   P+             + C +    ++
Sbjct: 207 CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  114 bits (287), Expect = 7e-30
 Identities = 31/256 (12%), Positives = 70/256 (27%), Gaps = 42/256 (16%)

Query: 38  RLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLR-SEHLNDTLEDEFVQEVAILRE--- 91
           R L  G  +                G+   V V   +E        +  +EV  LR    
Sbjct: 78  RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG 137

Query: 92  -------------------VQHRNVVRFIGASTKSPHLCIVTEYMP-------GGSLYDY 125
                              V+     + I        + +++ +           +  + 
Sbjct: 138 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV 197

Query: 126 LH---KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGV 182
           L      H  L     L+  + + + +  LH   ++H  L+  ++++D    V +  F  
Sbjct: 198 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH 257

Query: 183 ARFQNKGGVMTAET--GTYRWMAPEVINHQP-----YDQKADVFSFAIVLWELVTAKVPY 235
                   V             A  ++              D ++  + ++ +  A +P 
Sbjct: 258 LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317

Query: 236 DSMTPLQAALGVRQVC 251
                L  +  + + C
Sbjct: 318 TDDAALGGSEWIFRSC 333

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  111 bits (280), Expect = 2e-29
 Identities = 57/205 (27%), Positives = 105/205 (51%), Gaps = 25/205 (12%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEF----VQEVAILREVQHRNV 97
           E++ +G+   +Y+G+    G  VA+K ++ +      E+      ++E+++++E++H N+
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-----EEGTPSTAIREISLMKELKHENI 65

Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLL------RFAIDICKGMEY 151
           VR          L +V E+M    L  Y+  +  V   P+ L       F   + +G+ +
Sbjct: 66  VRLYDVIHTENKLTLVFEFMDN-DLKKYM-DSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123

Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGT--YRWMAPEVI- 207
            H+  I+HRDLK  NLL++    +K+ DFG+AR F       ++E  T  YR  AP+V+ 
Sbjct: 124 CHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR--APDVLM 181

Query: 208 NHQPYDQKADVFSFAIVLWELVTAK 232
             + Y    D++S   +L E++T K
Sbjct: 182 GSRTYSTSIDIWSCGCILAEMITGK 206

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  112 bits (282), Expect = 2e-29
 Identities = 29/249 (11%), Positives = 69/249 (27%), Gaps = 49/249 (19%)

Query: 38  RLLKTGERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDT------------------ 77
           R L  G  +                G+   V V        +                  
Sbjct: 73  RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG 132

Query: 78  --------LEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYM-PGGSLYDYLH- 127
                   +   F+    ++++ Q + ++R          L     Y     +L  +   
Sbjct: 133 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV 192

Query: 128 -----KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGV 182
                  H  L     L+  + + + +  LH   ++H  L+  ++++D    V +  F  
Sbjct: 193 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH 252

Query: 183 ARFQNKGGVMTAETGTYRWMAPEVINHQ-----------PYDQKADVFSFAIVLWELVTA 231
                + G     + +  +  PE+   +                 D ++  +V++ +  A
Sbjct: 253 LV---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

Query: 232 KVPYDSMTP 240
            +P      
Sbjct: 310 DLPITKDAA 318

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  113 bits (284), Expect = 3e-29
 Identities = 62/232 (26%), Positives = 105/232 (45%), Gaps = 27/232 (11%)

Query: 17  GHAVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL 74
           G  V   + +  +  D   +     T + I +GS G +Y+      G+ VA+K +     
Sbjct: 34  GSKVTTVVATPGQGPDRPQEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIKKVL---- 88

Query: 75  NDTLEDEF-VQEVAILREVQHRNVVRFI------GASTKSPHLCIVTEYMPGGSLYDYL- 126
               +  F  +E+ I+R++ H N+VR        G      +L +V +Y+P  ++Y    
Sbjct: 89  ---QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVAR 144

Query: 127 HKNHNVLKLPQLL--RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH-NVVKVADFGVA 183
           H +     LP +    +   + + + Y+H   I HRD+K  NLL+D    V+K+ DFG A
Sbjct: 145 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204

Query: 184 RFQNKGGVMTAETGT--YRWMAPEVI-NHQPYDQKADVFSFAIVLWELVTAK 232
           +   +G    +   +  YR  APE+I     Y    DV+S   VL EL+  +
Sbjct: 205 KQLVRGEPNVSYICSRYYR--APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  111 bits (280), Expect = 3e-29
 Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 25/205 (12%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFV-----QEVAILREVQHRN 96
            ++  G+ G++Y+ +     + VA+K +R EH     E+E V     +EV++L+E+QHRN
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-----EEEGVPGTAIREVSLLKELQHRN 94

Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
           ++        +  L ++ EY     L  Y+ K +  + +  +  F   +  G+ + H R 
Sbjct: 95  IIELKSVIHHNHRLHLIFEYAEN-DLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRR 152

Query: 157 IIHRDLKTANLLMDTHN-----VVKVADFGVAR-FQNKGGVMTAETGT--YRWMAPEVI- 207
            +HRDLK  NLL+   +     V+K+ DFG+AR F       T E  T  YR   PE++ 
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR--PPEILL 210

Query: 208 NHQPYDQKADVFSFAIVLWELVTAK 232
             + Y    D++S A +  E++   
Sbjct: 211 GSRHYSTSVDIWSIACIWAEMLMKT 235

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  112 bits (282), Expect = 5e-29
 Identities = 52/179 (29%), Positives = 91/179 (50%), Gaps = 15/179 (8%)

Query: 61  GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHR------NVVRFIGASTKSPHLCIVT 114
            Q VA+K++R+         +  +E+ IL  ++ +      NV+  +   T   H+C+  
Sbjct: 122 HQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTF 178

Query: 115 EYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM--DT 171
           E +   +LY+ + KN      LP + +FA  I + ++ LH+  IIH DLK  N+L+    
Sbjct: 179 ELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQG 237

Query: 172 HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
            + +KV DFG + ++++      ++  YR  APEVI    Y    D++S   +L EL+T
Sbjct: 238 RSGIKVIDFGSSCYEHQRVYTYIQSRFYR--APEVILGARYGMPIDMWSLGCILAELLT 294

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  110 bits (277), Expect = 5e-29
 Identities = 42/194 (21%), Positives = 82/194 (42%), Gaps = 21/194 (10%)

Query: 61  GQDVAVKVLRSEHLNDTLEDEFVQ-EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPG 119
            ++ A+K+L   H+    +  +V  E  ++  + H   V+          L     Y   
Sbjct: 55  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 114

Query: 120 GSLYDYLHKNHNVLKLPQLLRFAID--------ICKGMEYLHQRNIIHRDLKTANLLMDT 171
           G L  Y+ K            F           I   +EYLH + IIHRDLK  N+L++ 
Sbjct: 115 GELLKYIRKIG---------SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE 165

Query: 172 HNVVKVADFGVA-RFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADVFSFAIVLWEL 228
              +++ DFG A     +     A +  GT ++++PE++  +   + +D+++   ++++L
Sbjct: 166 DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 225

Query: 229 VTAKVPYDSMTPLQ 242
           V    P+ +     
Sbjct: 226 VAGLPPFRAGNEYL 239

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  111 bits (279), Expect = 6e-29
 Identities = 52/183 (28%), Positives = 91/183 (49%), Gaps = 12/183 (6%)

Query: 65  AVKVLRSEHLNDTLEDEFV-QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           A+K+L  + +    + E    E  IL+ V    +V+   +   + +L +V EY+ GG ++
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129

Query: 124 DYLHKNHNVLKLP-QLLRF-AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFG 181
            +L +     +      RF A  I    EYLH  ++I+RDLK  NLL+D    ++V DFG
Sbjct: 130 SHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186

Query: 182 VARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
            A    K       T  GT   +APE+I  + Y++  D ++  ++++E+     P+ +  
Sbjct: 187 FA----KRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

Query: 240 PLQ 242
           P+Q
Sbjct: 243 PIQ 245

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  113 bits (284), Expect = 1e-28
 Identities = 52/176 (29%), Positives = 86/176 (48%), Gaps = 7/176 (3%)

Query: 65  AVKVLRSEHLNDTLEDEFVQ-EVAILREV---QHRNVVRFIGASTKSPHLCIVTEYMPGG 120
           A+K L  + +     +     E  +L  V       +V    A      L  + + M GG
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277

Query: 121 SLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADF 180
            L+ +L + H V     +  +A +I  G+E++H R +++RDLK AN+L+D H  V+++D 
Sbjct: 278 DLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDL 336

Query: 181 GVARFQNKGGVMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPY 235
           G+A          A  GT+ +MAPEV+     YD  AD FS   +L++L+    P+
Sbjct: 337 GLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  110 bits (277), Expect = 1e-28
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 37/215 (17%)

Query: 44  ERIASGSCGDLYRG--VYLGQDVAVKVLRSEHLNDTLEDEFV-----QEVAILREVQHRN 96
            +I  G+ G++++      GQ VA+K +  E+     E E       +E+ IL+ ++H N
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-----EKEGFPITALREIKILQLLKHEN 77

Query: 97  VVRFIG--------ASTKSPHLCIVTEYMPGGSLYD---YLHKNHNVLKLPQLLRFAIDI 145
           VV  I          +     + +V ++      +D    L        L ++ R    +
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLVKFTLSEIKRVMQML 133

Query: 146 CKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF-----QNKGGVMTAETGT-- 198
             G+ Y+H+  I+HRD+K AN+L+    V+K+ADFG+AR       ++    T    T  
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 193

Query: 199 YRWMAPEVI-NHQPYDQKADVFSFAIVLWELVTAK 232
           YR   PE++   + Y    D++    ++ E+ T  
Sbjct: 194 YR--PPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  109 bits (275), Expect = 2e-28
 Identities = 41/215 (19%), Positives = 94/215 (43%), Gaps = 27/215 (12%)

Query: 32  DWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           +W       +   ++  G   +++  + +   + V VK+L+        + +  +E+ IL
Sbjct: 31  EWGNQDDY-QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKIL 84

Query: 90  REVQ-HRNVVR----FIGASTKSPHLCIVTEYMPG--GSLYDYLHKNHNVLKLPQLLRFA 142
             ++   N++          +++P L +           LY  L        + ++L+  
Sbjct: 85  ENLRGGPNIITLADIVKDPVSRTPAL-VFEHVNNTDFKQLYQTLTDYDIRFYMYEILK-- 141

Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHN-VVKVADFGVARFQNKGGVMTAETGTYRW 201
                 ++Y H   I+HRD+K  N+++D  +  +++ D+G+A F + G        + R+
Sbjct: 142 -----ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS-RY 195

Query: 202 M-APEVI-NHQPYDQKADVFSFAIVLWELVTAKVP 234
              PE++ ++Q YD   D++S   +L  ++  K P
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  109 bits (274), Expect = 2e-28
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 27/208 (12%)

Query: 44  ERIASGSCGDLYRGVYL---GQDVAVKVLRSEHLNDTLEDEFV-----QEVAILREVQ-- 93
             I  G+ G +++   L   G+ VA+K +R +       +E +     +EVA+LR ++  
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-----GEEGMPLSTIREVAVLRHLETF 71

Query: 94  -HRNVVR----FIGASTKSPH-LCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDIC 146
            H NVVR       + T     L +V E++    L  YL K     +    +      + 
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLL 130

Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT--YRWMAP 204
           +G+++LH   ++HRDLK  N+L+ +   +K+ADFG+AR  +    +T+   T  YR  AP
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYR--AP 188

Query: 205 EVINHQPYDQKADVFSFAIVLWELVTAK 232
           EV+    Y    D++S   +  E+   K
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  108 bits (271), Expect = 5e-28
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 29/210 (13%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQ--------EVAILREVQ 93
             I  G+ G +Y+      G  VA+K +R  +                   EVA+LR ++
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPN-----GGGGGGGLPISTVREVALLRRLE 69

Query: 94  ---HRNVVRFI-----GASTKSPHLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAID 144
              H NVVR +       + +   + +V E++    L  YL K     L    +      
Sbjct: 70  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 128

Query: 145 ICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT--YRWM 202
             +G+++LH   I+HRDLK  N+L+ +   VK+ADFG+AR  +    +T    T  YR  
Sbjct: 129 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYR-- 186

Query: 203 APEVINHQPYDQKADVFSFAIVLWELVTAK 232
           APEV+    Y    D++S   +  E+   K
Sbjct: 187 APEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  107 bits (270), Expect = 8e-28
 Identities = 51/180 (28%), Positives = 93/180 (51%), Gaps = 13/180 (7%)

Query: 65  AVKVLRSEHLNDTLEDEFVQ----EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGG 120
           A+K+LR E +   +  + V     E  +L+  +H  +     A      LC V EY  GG
Sbjct: 34  AMKILRKEVI---IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 90

Query: 121 SLYDYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVAD 179
            L+ +L +   V    +  RF   +I   +EYLH R++++RD+K  NL++D    +K+ D
Sbjct: 91  ELFFHLSRER-VFTEERA-RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITD 148

Query: 180 FGVARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS 237
           FG+ + +      T +T  GT  ++APEV+    Y +  D +   +V++E++  ++P+ +
Sbjct: 149 FGLCK-EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  109 bits (273), Expect = 9e-28
 Identities = 50/221 (22%), Positives = 98/221 (44%), Gaps = 40/221 (18%)

Query: 41  KTGERIASGSCGDLYRGVYL----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRN 96
             G ++  G+ G +Y+         +D A+K +    ++ +      +E+A+LRE++H N
Sbjct: 24  YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA----CREIALLRELKHPN 79

Query: 97  VVR----FIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAID-------- 144
           V+     F+  + +   + ++ +Y     L+  +  +       + ++            
Sbjct: 80  VISLQKVFLSHADRK--VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136

Query: 145 ICKGMEYLHQRNIIHRDLKTANLLMDTHN----VVKVADFGVAR-FQNKGGVMTAETGT- 198
           I  G+ YLH   ++HRDLK AN+L+         VK+AD G AR F +    +       
Sbjct: 137 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

Query: 199 ----YRWMAPEVI---NHQPYDQKADVFSFAIVLWELVTAK 232
               YR  APE++    H  Y +  D+++   +  EL+T++
Sbjct: 197 VTFWYR--APELLLGARH--YTKAIDIWAIGCIFAELLTSE 233

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  108 bits (271), Expect = 1e-27
 Identities = 46/187 (24%), Positives = 85/187 (45%), Gaps = 21/187 (11%)

Query: 65  AVKVLRSEHLNDTLEDEFV-QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           A+K +  +   +  E   V +E+ I++ ++H  +V    +      + +V + + GG L 
Sbjct: 44  AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR 103

Query: 124 DYLHKNHNVLKLPQLLRFAIDICK--------GMEYLHQRNIIHRDLKTANLLMDTHNVV 175
            +L +N           F  +  K         ++YL  + IIHRD+K  N+L+D H  V
Sbjct: 104 YHLQQNV---------HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHV 154

Query: 176 KVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQP---YDQKADVFSFAIVLWELVTAK 232
            + DF +A    +   +T   GT  +MAPE+ + +    Y    D +S  +  +EL+  +
Sbjct: 155 HITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214

Query: 233 VPYDSMT 239
            PY   +
Sbjct: 215 RPYHIRS 221

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  107 bits (269), Expect = 2e-27
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 25/204 (12%)

Query: 44  ERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEF-VQEVAILREVQHRNVVRFI 101
           + I +GS G +++   +   +VA+K +         +  F  +E+ I+R V+H NVV   
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKVL-------QDKRFKNRELQIMRIVKHPNVVDLK 98

Query: 102 ------GASTKSPHLCIVTEYMPGGSLYDYL-HKNHNVLKLPQLL--RFAIDICKGMEYL 152
                 G       L +V EY+P  ++Y    H       +P LL   +   + + + Y+
Sbjct: 99  AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI 157

Query: 153 HQRNIIHRDLKTANLLMDTHN-VVKVADFGVARFQNKGGVMTAE--TGTYRWMAPEVI-N 208
           H   I HRD+K  NLL+D  + V+K+ DFG A+    G    +   +  YR  APE+I  
Sbjct: 158 HSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR--APELIFG 215

Query: 209 HQPYDQKADVFSFAIVLWELVTAK 232
              Y    D++S   V+ EL+  +
Sbjct: 216 ATNYTTNIDIWSTGCVMAELMQGQ 239

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  106 bits (267), Expect = 4e-27
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 17/181 (9%)

Query: 61  GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHR------NVVRFIGASTKSPHLCIVT 114
            + VA+K++++        ++   EV +L  +          +V          HLC+V 
Sbjct: 79  QEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVF 135

Query: 115 EYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICKGMEYLHQR--NIIHRDLKTANLLM-- 169
           E +   +LYD L   +   + L    +FA  +C  + +L     +IIH DLK  N+L+  
Sbjct: 136 EML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN 194

Query: 170 DTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELV 229
              + +K+ DFG +    +      ++  YR  +PEV+   PYD   D++S   +L E+ 
Sbjct: 195 PKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--SPEVLLGMPYDLAIDMWSLGCILVEMH 252

Query: 230 T 230
           T
Sbjct: 253 T 253

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  105 bits (264), Expect = 5e-27
 Identities = 56/183 (30%), Positives = 101/183 (55%), Gaps = 12/183 (6%)

Query: 65  AVKVLRSEHLNDTLEDEFVQ-EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           A+KVL+ E +    + E    E  +L  V H  ++R  G    +  + ++ +Y+ GG L+
Sbjct: 35  AMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELF 94

Query: 124 DYLHKNHNVLKLP-QLLRF-AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFG 181
             L K+    + P  + +F A ++C  +EYLH ++II+RDLK  N+L+D +  +K+ DFG
Sbjct: 95  SLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFG 151

Query: 182 VARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT 239
            A    K       T  GT  ++APEV++ +PY++  D +SF I+++E++    P+    
Sbjct: 152 FA----KYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207

Query: 240 PLQ 242
            ++
Sbjct: 208 TMK 210

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  105 bits (265), Expect = 6e-27
 Identities = 52/236 (22%), Positives = 94/236 (39%), Gaps = 29/236 (12%)

Query: 17  GHAVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL 74
           G  +     +       +   R          G+ G +  G     G  VA+K +  +  
Sbjct: 3   GSMMSLNAAAAADERSRKEMDRFQVE-RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR 61

Query: 75  --NDTLEDEFVQEVAILREVQHRNVVR----FIGASTKSPH---LCIVTEYMPGGSLYDY 125
             N  L     Q +  L  + H N+V+    F     +      L +V EY+P  +L+  
Sbjct: 62  FRNREL-----QIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRC 115

Query: 126 L-HKNHNVLKLPQLL--RFAIDICKGMEYLHQR--NIIHRDLKTANLLMDTHN-VVKVAD 179
             +     +  P +L   F   + + +  LH    N+ HRD+K  N+L++  +  +K+ D
Sbjct: 116 CRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175

Query: 180 FGVARFQNKGGVMTAETGT--YRWMAPEVI-NHQPYDQKADVFSFAIVLWELVTAK 232
           FG A+  +      A   +  YR  APE+I  +Q Y    D++S   +  E++  +
Sbjct: 176 FGSAKKLSPSEPNVAYICSRYYR--APELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  108 bits (270), Expect = 7e-27
 Identities = 51/177 (28%), Positives = 94/177 (53%), Gaps = 6/177 (3%)

Query: 65  AVKVLRSEHLNDTLEDEFVQ-EVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSL 122
           AVK+L+ + +    + E    E  +L    +   + +          L  V EY+ GG L
Sbjct: 370 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 429

Query: 123 YDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGV 182
             ++ +     K P  + +A +I  G+ +L  + II+RDLK  N+++D+   +K+ADFG+
Sbjct: 430 MYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM 488

Query: 183 ARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS 237
            +     GV T  T  GT  ++APE+I +QPY +  D ++F ++L+E++  + P++ 
Sbjct: 489 CKENIWDGVTTK-TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 544

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  104 bits (261), Expect = 2e-26
 Identities = 52/183 (28%), Positives = 91/183 (49%), Gaps = 20/183 (10%)

Query: 65  AVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYD 124
           A+KVL+   L          E  IL EV H  +V+   A      L ++ +++ GG L+ 
Sbjct: 56  AMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFT 115

Query: 125 YLHKNHNVLKLPQLLRFAID--------ICKGMEYLHQRNIIHRDLKTANLLMDTHNVVK 176
            L K            F  +        +   +++LH   II+RDLK  N+L+D    +K
Sbjct: 116 RLSKEV---------MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIK 166

Query: 177 VADFGVARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVP 234
           + DFG+++ ++      A +  GT  +MAPEV+N + + Q AD +SF ++++E++T  +P
Sbjct: 167 LTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

Query: 235 YDS 237
           +  
Sbjct: 226 FQG 228

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  105 bits (264), Expect = 2e-26
 Identities = 42/187 (22%), Positives = 87/187 (46%), Gaps = 10/187 (5%)

Query: 65  AVKVLRSEHLNDTLEDEFVQ-EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           A+K+L    +    E    + E  +L     + +     A     +L +V +Y  GG L 
Sbjct: 103 AMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLL 162

Query: 124 DYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGV 182
             L K  + L      RF   ++   ++ +HQ + +HRD+K  N+LMD +  +++ADFG 
Sbjct: 163 TLLSKFEDRLPEEMA-RFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS 221

Query: 183 ARFQNKGGVMTAET--GTYRWMAPEVINHQP-----YDQKADVFSFAIVLWELVTAKVPY 235
                + G + +    GT  +++PE++         Y  + D +S  + ++E++  + P+
Sbjct: 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

Query: 236 DSMTPLQ 242
            + + ++
Sbjct: 282 YAESLVE 288

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  104 bits (261), Expect = 2e-26
 Identities = 52/190 (27%), Positives = 94/190 (49%), Gaps = 32/190 (16%)

Query: 65  AVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI-GASTKSP-------------HL 110
           A+K L+ + +   L D+         +V+   V + +   + + P             +L
Sbjct: 46  AIKALKKDVV---LMDD---------DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93

Query: 111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQRNIIHRDLKTANLLM 169
             V EY+ GG L  ++   H    L +   F A +I  G+++LH + I++RDLK  N+L+
Sbjct: 94  FFVMEYLNGGDLMYHIQSCH-KFDLSRA-TFYAAEIILGLQFLHSKGIVYRDLKLDNILL 151

Query: 170 DTHNVVKVADFGVARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADVFSFAIVLWE 227
           D    +K+ADFG+ +    G   T  T  GT  ++APE++  Q Y+   D +SF ++L+E
Sbjct: 152 DKDGHIKIADFGMCKENMLGDAKTN-TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYE 210

Query: 228 LVTAKVPYDS 237
           ++  + P+  
Sbjct: 211 MLIGQSPFHG 220

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  104 bits (261), Expect = 2e-26
 Identities = 53/188 (28%), Positives = 99/188 (52%), Gaps = 10/188 (5%)

Query: 65  AVKVLRSEHLNDTLEDEFVQ-EVAILREV-QHRNVVRFIGA-STKSPHLCIVTEYMPGGS 121
           A+KV++ E +ND  + ++VQ E  +  +   H  +V       T+S  L  V EY+ GG 
Sbjct: 38  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES-RLFFVIEYVNGGD 96

Query: 122 LYDYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADF 180
           L  ++ +    L      RF + +I   + YLH+R II+RDLK  N+L+D+   +K+ D+
Sbjct: 97  LMFHMQRQR-KLPEEHA-RFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDY 154

Query: 181 GVARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSM 238
           G+ +   + G  T+ T  GT  ++APE++  + Y    D ++  ++++E++  + P+D +
Sbjct: 155 GMCKEGLRPGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 213

Query: 239 TPLQAALG 246
                   
Sbjct: 214 GSSDNPDQ 221

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  104 bits (261), Expect = 2e-26
 Identities = 48/193 (24%), Positives = 91/193 (47%), Gaps = 38/193 (19%)

Query: 65  AVKVLRSEHLNDTLEDEFVQEVAILREVQH----RNVVRFIGASTKSP------------ 108
           AVKVL+ + +   L+D+         +V+     + +   +  +   P            
Sbjct: 52  AVKVLKKDVI---LQDD---------DVECTMTEKRI---LSLARNHPFLTQLFCCFQTP 96

Query: 109 -HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQRNIIHRDLKTAN 166
             L  V E++ GG L  ++ K+       +  RF A +I   + +LH + II+RDLK  N
Sbjct: 97  DRLFFVMEFVNGGDLMFHIQKSR-RFDEARA-RFYAAEIISALMFLHDKGIIYRDLKLDN 154

Query: 167 LLMDTHNVVKVADFGVARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADVFSFAIV 224
           +L+D     K+ADFG+ + +     +T  T  GT  ++APE++    Y    D ++  ++
Sbjct: 155 VLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVL 213

Query: 225 LWELVTAKVPYDS 237
           L+E++    P+++
Sbjct: 214 LYEMLCGHAPFEA 226

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  105 bits (263), Expect = 2e-26
 Identities = 63/245 (25%), Positives = 115/245 (46%), Gaps = 31/245 (12%)

Query: 13  RKYRGHAVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL------GQDVAV 66
            +Y+   + K  + + K+ED+E+    +K    I  G+ G+    V L       +  A+
Sbjct: 52  SRYK-DTINKIRDLRMKAEDYEV----VKV---IGRGAFGE----VQLVRHKSTRKVYAM 99

Query: 67  KVLRSEHLNDTLEDEFVQ-EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDY 125
           K+L    +    +  F   E  I+       VV+   A     +L +V EYMPGG L + 
Sbjct: 100 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNL 159

Query: 126 LHKNHNVLKLP-QLLRF-AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA 183
           +        +P +  RF   ++   ++ +H    IHRD+K  N+L+D    +K+ADFG  
Sbjct: 160 MSNY----DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 215

Query: 184 RFQNKGGVMTAET--GTYRWMAPEVINHQP----YDQKADVFSFAIVLWELVTAKVPYDS 237
              NK G++  +T  GT  +++PEV+  Q     Y ++ D +S  + L+E++    P+ +
Sbjct: 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 275

Query: 238 MTPLQ 242
            + + 
Sbjct: 276 DSLVG 280

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  104 bits (262), Expect = 3e-26
 Identities = 40/189 (21%), Positives = 81/189 (42%), Gaps = 12/189 (6%)

Query: 65  AVKVLRSEHLNDTLEDEFVQ-EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           A+K++    +    E    + E  +L     R + +   A     +L +V EY  GG L 
Sbjct: 90  AMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLL 149

Query: 124 DYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGV 182
             L K    +      RF   +I   ++ +H+   +HRD+K  N+L+D    +++ADFG 
Sbjct: 150 TLLSKFGERIPAEMA-RFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS 208

Query: 183 ARFQNKGGVMTAET--GTYRWMAPEVINHQ-------PYDQKADVFSFAIVLWELVTAKV 233
                  G + +    GT  +++PE++           Y  + D ++  +  +E+   + 
Sbjct: 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268

Query: 234 PYDSMTPLQ 242
           P+ + +  +
Sbjct: 269 PFYADSTAE 277

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  103 bits (259), Expect = 3e-26
 Identities = 47/189 (24%), Positives = 85/189 (44%), Gaps = 30/189 (15%)

Query: 65  AVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP-------------HLC 111
           A+KVL+   +           V   ++  H    R I    K P              L 
Sbjct: 49  AMKVLKKAMI-----------VRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLY 97

Query: 112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQRNIIHRDLKTANLLMD 170
           ++ EY+ GG L+  L +   +        F   +I   + +LHQ+ II+RDLK  N++++
Sbjct: 98  LILEYLSGGELFMQLEREG-IFMEDTA-CFYLAEISMALGHLHQKGIIYRDLKPENIMLN 155

Query: 171 THNVVKVADFGVARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADVFSFAIVLWEL 228
               VK+ DFG+ +     G +T  T  GT  +MAPE++    +++  D +S   +++++
Sbjct: 156 HQGHVKLTDFGLCKESIHDGTVT-HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDM 214

Query: 229 VTAKVPYDS 237
           +T   P+  
Sbjct: 215 LTGAPPFTG 223

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  104 bits (262), Expect = 5e-26
 Identities = 47/177 (26%), Positives = 91/177 (51%), Gaps = 6/177 (3%)

Query: 65  AVKVLRSEHLNDTLEDEFVQ-EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLY 123
           A+K+L+ E +    E      E  +L+  +H  +     +      LC V EY  GG L+
Sbjct: 177 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 236

Query: 124 DYLHKNHNVLKLPQLLRFAIDICKGMEYLH-QRNIIHRDLKTANLLMDTHNVVKVADFGV 182
            +L +   V    +   +  +I   ++YLH ++N+++RDLK  NL++D    +K+ DFG+
Sbjct: 237 FHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGL 295

Query: 183 ARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS 237
            + +      T +T  GT  ++APEV+    Y +  D +   +V++E++  ++P+ +
Sbjct: 296 CK-EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  103 bits (258), Expect = 8e-26
 Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 23/215 (10%)

Query: 32  DWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
            + + +R  +  + I SG+ G +       L ++VA+K L     N T      +E+ ++
Sbjct: 20  TFTVLKRY-QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLM 78

Query: 90  REVQHRNVVRFIGASTKSPHLC------IVTEYMPGGSLYDYLHKN----HNVLKLPQLL 139
           + V H+N++  +   T    L       IV E M   +L   +            L Q+L
Sbjct: 79  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLLYQML 137

Query: 140 RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
                   G+++LH   IIHRDLK +N+++ +   +K+ DFG+AR      +MT    T 
Sbjct: 138 C-------GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT- 189

Query: 200 RWM-APEVINHQPYDQKADVFSFAIVLWELVTAKV 233
           R+  APEVI    Y +  D++S   ++ E++   V
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  103 bits (259), Expect = 8e-26
 Identities = 52/188 (27%), Positives = 99/188 (52%), Gaps = 10/188 (5%)

Query: 65  AVKVLRSEHLNDTLEDEFVQ-EVAILREV-QHRNVVRFIGA-STKSPHLCIVTEYMPGGS 121
           A++V++ E +ND  + ++VQ E  +  +   H  +V       T+S  L  V EY+ GG 
Sbjct: 81  AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES-RLFFVIEYVNGGD 139

Query: 122 LYDYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADF 180
           L  ++ +    L      RF + +I   + YLH+R II+RDLK  N+L+D+   +K+ D+
Sbjct: 140 LMFHMQRQR-KLPEEHA-RFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDY 197

Query: 181 GVARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSM 238
           G+ +   + G  T+ T  GT  ++APE++  + Y    D ++  ++++E++  + P+D +
Sbjct: 198 GMCKEGLRPGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256

Query: 239 TPLQAALG 246
                   
Sbjct: 257 GSSDNPDQ 264

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  103 bits (258), Expect = 9e-26
 Identities = 58/196 (29%), Positives = 93/196 (47%), Gaps = 44/196 (22%)

Query: 65  AVKVLRSEHLNDTLEDEFVQEVAILREVQH----RNVVRFIGASTKSP------------ 108
           AVKVL+ + +   L+          +E +H    RNV   +  + K P            
Sbjct: 67  AVKVLQKKAI---LKK---------KEEKHIMSERNV---LLKNVKHPFLVGLHFSFQTA 111

Query: 109 -HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQRNIIHRDLKTAN 166
             L  V +Y+ GG L+ +L +       P+  RF A +I   + YLH  NI++RDLK  N
Sbjct: 112 DKLYFVLDYINGGELFYHLQRER-CFLEPRA-RFYAAEIASALGYLHSLNIVYRDLKPEN 169

Query: 167 LLMDTHNVVKVADFGVARFQNKGGVMTAET-----GTYRWMAPEVINHQPYDQKADVFSF 221
           +L+D+   + + DFG+     K  +    T     GT  ++APEV++ QPYD+  D +  
Sbjct: 170 ILLDSQGHIVLTDFGLC----KENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCL 225

Query: 222 AIVLWELVTAKVPYDS 237
             VL+E++    P+ S
Sbjct: 226 GAVLYEMLYGLPPFYS 241

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  102 bits (257), Expect = 1e-25
 Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 26/223 (11%)

Query: 31  EDWEIDRR--LLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEF----- 82
           E   +     + +    I+SGS G +  GV   G  VA+K + +   +    +       
Sbjct: 16  ELHAMQSPYTVQR---FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFL 72

Query: 83  ----VQEVAILREVQHRNVVR----FIGASTKSPH-LCIVTEYMPGGSLYDYLHKNHNVL 133
               ++E+ +L    H N++     F+     + H L +VTE M    L   +H    V+
Sbjct: 73  CKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVI 131

Query: 134 KLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT 193
               +  F   I  G+  LH+  ++HRDL   N+L+  +N + + DF +AR        T
Sbjct: 132 SPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKT 191

Query: 194 AETGT--YRWMAPEVI-NHQPYDQKADVFSFAIVLWELVTAKV 233
                  YR  APE++   + + +  D++S   V+ E+   K 
Sbjct: 192 HYVTHRWYR--APELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  102 bits (256), Expect = 1e-25
 Identities = 52/178 (29%), Positives = 93/178 (52%), Gaps = 8/178 (4%)

Query: 65  AVKVLRSEHLNDTLEDEFVQ-EVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSL 122
           AVK+L+ + +    + E    E  +L    +   + +          L  V EY+ GG L
Sbjct: 49  AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 108

Query: 123 YDYLHKNHNVLKLPQLLRF-AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFG 181
             ++ +     K P    F A +I  G+ +L  + II+RDLK  N+++D+   +K+ADFG
Sbjct: 109 MYHIQQVG-RFKEPHA-VFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 166

Query: 182 VARFQNKGGVMTAET--GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS 237
           + +     GV T  T  GT  ++APE+I +QPY +  D ++F ++L+E++  + P++ 
Sbjct: 167 MCKENIWDGVTTK-TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  102 bits (256), Expect = 3e-25
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 17/212 (8%)

Query: 32  DWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
            + + +R  +  + I SG+ G +         ++VA+K L     N T      +E+ ++
Sbjct: 57  TFTVLKRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 115

Query: 90  REVQHRNVVRFIGASTKSPHLC------IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
           + V H+N++  +   T    L       +V E M   +L   +      L   ++     
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSYLLY 171

Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT--YRW 201
            +  G+++LH   IIHRDLK +N+++ +   +K+ DFG+AR      +MT    T  YR 
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR- 230

Query: 202 MAPEVINHQPYDQKADVFSFAIVLWELVTAKV 233
            APEVI    Y +  D++S   ++ E+V  K+
Sbjct: 231 -APEVILGMGYKENVDIWSVGCIMGEMVRHKI 261

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  100 bits (250), Expect = 7e-25
 Identities = 50/206 (24%), Positives = 86/206 (41%), Gaps = 35/206 (16%)

Query: 51  CGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHR------NVVRFIGAS 104
           C D  RG      VA+K++R+        +    E+ +L++++ +        V      
Sbjct: 38  CLDHARG---KSQVALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91

Query: 105 TKSPHLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICKGMEYLHQRNIIHRDLK 163
               H+CI  E + G + +++L +N+     LP +   A  +C  + +LH+  + H DLK
Sbjct: 92  NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLK 150

Query: 164 TANLLM-------------------DTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAP 204
             N+L                      +  ++VADFG A F ++       T  YR   P
Sbjct: 151 PENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYR--PP 208

Query: 205 EVINHQPYDQKADVFSFAIVLWELVT 230
           EVI    + Q  DV+S   +L+E   
Sbjct: 209 EVILELGWAQPCDVWSIGCILFEYYR 234

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 99.7 bits (249), Expect = 9e-25
 Identities = 55/206 (26%), Positives = 87/206 (42%), Gaps = 35/206 (16%)

Query: 51  CGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHR------NVVRFIGAS 104
           C D   G   G+ VAVK++++    D   +    E+ +L  +           V+ +   
Sbjct: 33  CIDHKAG---GRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86

Query: 105 TKSPHLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICKGMEYLHQRNIIHRDLK 163
               H+CIV E + G S YD++ +N  +  +L  + + A  ICK + +LH   + H DLK
Sbjct: 87  EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLK 145

Query: 164 TAN-LLMDTHNV------------------VKVADFGVARFQNKGGVMTAETGTYRWMAP 204
             N L + +                     +KV DFG A + ++       T  YR  AP
Sbjct: 146 PENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYR--AP 203

Query: 205 EVINHQPYDQKADVFSFAIVLWELVT 230
           EVI    + Q  DV+S   +L E   
Sbjct: 204 EVILALGWSQPCDVWSIGCILIEYYL 229

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 98.2 bits (245), Expect = 4e-24
 Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 17/212 (8%)

Query: 32  DWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
            WE+     +  + + SG+ G +   V    G  VA+K L     ++       +E+ +L
Sbjct: 20  AWEVRAVY-RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 78

Query: 90  REVQHRNVVRFIGASTKSPHLC------IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
           + ++H NV+  +   T    L       +V  +M G  L   +   H  L   ++     
Sbjct: 79  KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK--HEKLGEDRIQFLVY 135

Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWM- 202
            + KG+ Y+H   IIHRDLK  NL ++    +K+ DFG+AR  +    MT    T RW  
Sbjct: 136 QMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD--SEMTGYVVT-RWYR 192

Query: 203 APEVI-NHQPYDQKADVFSFAIVLWELVTAKV 233
           APEVI N   Y Q  D++S   ++ E++T K 
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 97.8 bits (244), Expect = 6e-24
 Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 26/216 (12%)

Query: 32  DWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
            WE+ +    +   + SG+ G +   +    G+ VA+K L     ++       +E+ +L
Sbjct: 19  AWELPKTY-VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLL 77

Query: 90  REVQHRNVVRFIGASTKSPHLC------IVTEYMPGGSLYDYLHKN----HNVLKLPQLL 139
           + +QH NV+  +   T +  L       +V  +M    L   +            + Q+L
Sbjct: 78  KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKFSEEKIQYLVYQML 136

Query: 140 RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTY 199
           +       G++Y+H   ++HRDLK  NL ++    +K+ DFG+AR  +    MT    T 
Sbjct: 137 K-------GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD--AEMTGYVVT- 186

Query: 200 RW-MAPEVI-NHQPYDQKADVFSFAIVLWELVTAKV 233
           RW  APEVI +   Y+Q  D++S   ++ E++T K 
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 97.0 bits (242), Expect = 1e-23
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)

Query: 32  DWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
            WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L
Sbjct: 24  IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82

Query: 90  REVQHRNVVRFIGASTKSPHLC------IVTEYMPGGSLYDYLHK--NHNVLKLPQLLRF 141
           + ++H NV+  +   T +  L       +VT  M      D L+       L    +   
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG----AD-LNNIVKCQKLTDDHVQFL 137

Query: 142 AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRW 201
              I +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR       MT    T RW
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGYVAT-RW 194

Query: 202 -MAPEVI-NHQPYDQKADVFSFAIVLWELVTAKV 233
             APE++ N   Y+Q  D++S   ++ EL+T + 
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 96.6 bits (241), Expect = 1e-23
 Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 41/211 (19%)

Query: 51  CGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHR-----NVVRFIGAST 105
           C  +       +  AVKV+R+             E  IL+++Q+      N+V++ G   
Sbjct: 54  CQHIDNK----KYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106

Query: 106 KSPHLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKT 164
              H+C++ E + G SLY+ + +N+     +  +  + I+I K + YL + ++ H DLK 
Sbjct: 107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKP 165

Query: 165 ANLLM-------------------------DTHNVVKVADFGVARFQNKGGVMTAETGTY 199
            N+L+                              +K+ DFG A F++        T  Y
Sbjct: 166 ENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQY 225

Query: 200 RWMAPEVINHQPYDQKADVFSFAIVLWELVT 230
           R  APEVI +  +D  +D++SF  VL EL T
Sbjct: 226 R--APEVILNLGWDVSSDMWSFGCVLAELYT 254

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 96.2 bits (240), Expect = 2e-23
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 43/227 (18%)

Query: 32  DWEIDRR--LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRS-EHLND---TLEDEFV 83
            +++  R   L     I  G+ G +           VA+K +   EH      TL     
Sbjct: 22  VFDVGPRYTNLSY---IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL----- 73

Query: 84  QEVAILREVQHRNVVR----FIGASTKSPH-LCIVTEYMPGGSLYDYLHKNHNVLKLPQL 138
           +E+ IL   +H N++         + +    + IV + M      D L+K   +LK   L
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME----TD-LYK---LLKTQHL 125

Query: 139 LR-----FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF----QNKG 189
                  F   I +G++Y+H  N++HRDLK +NLL++T   +K+ DFG+AR      +  
Sbjct: 126 SNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185

Query: 190 GVMTAETGT--YRWMAPEVI-NHQPYDQKADVFSFAIVLWELVTAKV 233
           G +T    T  YR  APE++ N + Y +  D++S   +L E+++ + 
Sbjct: 186 GFLTEYVATRWYR--APEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 96.4 bits (240), Expect = 4e-23
 Identities = 63/278 (22%), Positives = 104/278 (37%), Gaps = 55/278 (19%)

Query: 12  HRKYRGHAVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVL 69
            ++ + H+ +          DW+I  R       I +GS G +         + VA+K +
Sbjct: 28  QQRKQHHSSKPTASMPRPHSDWQIPDRYEIR-HLIGTGSYGHVCEAYDKLEKRVVAIKKI 86

Query: 70  RSEHLNDTLEDEFVQEVAILREVQHRNVVR----FIGASTKS-PHLCIVTEYMPGGSLYD 124
                +       ++E+AIL  + H +VV+     I    +    L +V E        D
Sbjct: 87  LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD----SD 142

Query: 125 YLHKNHNVLKLPQLLR------FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVA 178
              K   + + P  L          ++  G++Y+H   I+HRDLK AN L++    VKV 
Sbjct: 143 -FKK---LFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVC 198

Query: 179 DFGVAR----------------------------FQNKGGVMTAETGT--YRWMAPEVI- 207
           DFG+AR                             +N    +T    T  YR  APE+I 
Sbjct: 199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYR--APELIL 256

Query: 208 NHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL 245
             + Y +  DV+S   +  EL+       +    +  L
Sbjct: 257 LQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPL 294

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 93.9 bits (234), Expect = 1e-22
 Identities = 60/235 (25%), Positives = 104/235 (44%), Gaps = 52/235 (22%)

Query: 33  WEIDRR--LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND---TLEDEFVQE 85
           +++  R   LK    +  G  G ++  V     + VA+K +           L     +E
Sbjct: 7   FDLGSRYMDLK---PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL-----RE 58

Query: 86  VAILREVQHRNVVR---FIGASTKSPHLC-----------IVTEYMPGGSLYDYLHKNHN 131
           + I+R + H N+V+    +G S                  IV EYM      D L     
Sbjct: 59  IKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME----TD-LAN--- 110

Query: 132 VLKLPQLLR-----FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN-VVKVADFGVARF 185
           VL+   LL      F   + +G++Y+H  N++HRDLK ANL ++T + V+K+ DFG+AR 
Sbjct: 111 VLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARI 170

Query: 186 ----QNKGGVMTAETGT--YRWMAPEVI-NHQPYDQKADVFSFAIVLWELVTAKV 233
                +  G ++    T  YR  +P ++ +   Y +  D+++   +  E++T K 
Sbjct: 171 MDPHYSHKGHLSEGLVTKWYR--SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 93.9 bits (234), Expect = 1e-22
 Identities = 44/182 (24%), Positives = 90/182 (49%), Gaps = 12/182 (6%)

Query: 65  AVKVLRSEHLNDTLED-EFVQ-EVAILREVQHRN-VVRFIGASTKSPHLCIVTEYMPGGS 121
           A+KVL+   +    +  E  + E  +L  ++    +V    A      L ++ +Y+ GG 
Sbjct: 86  AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGE 145

Query: 122 LYDYLHKNHNVLKLP-QLLRF-AIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVAD 179
           L+ +L +     +     ++    +I   +E+LH+  II+RD+K  N+L+D++  V + D
Sbjct: 146 LFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTD 202

Query: 180 FGVARFQNKGGVMTAET--GTYRWMAPEVI--NHQPYDQKADVFSFAIVLWELVTAKVPY 235
           FG+++         A    GT  +MAP+++      +D+  D +S  ++++EL+T   P+
Sbjct: 203 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262

Query: 236 DS 237
             
Sbjct: 263 TV 264

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 93.6 bits (233), Expect = 2e-22
 Identities = 47/237 (19%), Positives = 92/237 (38%), Gaps = 58/237 (24%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQ-EVAILREVQHRNVVR- 99
           + + +GS G +     +  G+  A+K +         +  +   E+ I++ + H N+++ 
Sbjct: 13  KTLGTGSFGIVCEVFDIESGKRFALKKVL-------QDPRYKNRELDIMKVLDHVNIIKL 65

Query: 100 ---FIGASTKSPH----------------------------------LCIVTEYMPGGSL 122
              F     + P                                   L ++ EY+P  +L
Sbjct: 66  VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TL 124

Query: 123 YDYL-HKNHNVLKLPQLL--RFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN-VVKVA 178
           +  L     +   +P  L   +   + + + ++H   I HRD+K  NLL+++ +  +K+ 
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLC 184

Query: 179 DFGVARFQNKGGVMTAETGT--YRWMAPEVI-NHQPYDQKADVFSFAIVLWELVTAK 232
           DFG A+         A   +  YR  APE++     Y    D++S   V  EL+  K
Sbjct: 185 DFGSAKKLIPSEPSVAYICSRFYR--APELMLGATEYTPSIDLWSIGCVFGELILGK 239

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 91.6 bits (228), Expect = 5e-22
 Identities = 41/193 (21%), Positives = 75/193 (38%), Gaps = 45/193 (23%)

Query: 42  TGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVV 98
           T + +  G  G + +       +  A+K+L+          +  +EV +     Q  ++V
Sbjct: 22  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIV 74

Query: 99  RFIGA----STKSPHLCIVTEYMPGGSLYDY-LHKNHNVL---KLPQLLRFAIDICKGME 150
           R +            L IV E + GG L+     +        +  ++++    I + ++
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK---SIGEAIQ 131

Query: 151 YLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI 207
           YLH  NI HRD+K  NLL  +     ++K+ DFG                     A E  
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKETT 171

Query: 208 NHQPYDQKADVFS 220
             + YD+  D++S
Sbjct: 172 -GEKYDKSCDMWS 183

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 92.7 bits (230), Expect = 7e-22
 Identities = 59/263 (22%), Positives = 102/263 (38%), Gaps = 75/263 (28%)

Query: 38  RLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRS-EHLNDTLEDEFVQEVAILREVQ--- 93
           R L  G         D+    +    VA+KV++S EH  +T  DE    + +L+ V+   
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKF----VAMKVVKSAEHYTETALDE----IRLLKSVRNSD 94

Query: 94  -----HRNVVRFIGA-STKSP---HLCIVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAI 143
                   VV+ +           H+C+V E + G  L  ++ K+ +  L LP + +   
Sbjct: 95  PNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQ 153

Query: 144 DICKGMEYLH-QRNIIHRDLKTANLLMDTHNV---------------------------- 174
            + +G++YLH +  IIH D+K  N+L+  +                              
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213

Query: 175 ---------------------VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYD 213
                                VK+AD G A + +K      +T  YR  + EV+    Y+
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYR--SLEVLIGSGYN 271

Query: 214 QKADVFSFAIVLWELVTAKVPYD 236
             AD++S A + +EL T    ++
Sbjct: 272 TPADIWSTACMAFELATGDYLFE 294

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 89.6 bits (223), Expect = 5e-21
 Identities = 60/235 (25%), Positives = 99/235 (42%), Gaps = 52/235 (22%)

Query: 32  DWEIDRR--LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRS-EHLND---TLEDEFV 83
            + I     L      +  G+ G +    +   G+ VA+K +   +       TL     
Sbjct: 6   VYNISSDFQLKS---LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----- 57

Query: 84  QEVAILREVQHRNVVR----FIGASTKS-PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQL 138
           +E+ IL+  +H N++         S ++   + I+ E M      D LH+   V+   Q+
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ----TD-LHR---VIS-TQM 108

Query: 139 LR------FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-------- 184
           L       F     + ++ LH  N+IHRDLK +NLL++++  +KV DFG+AR        
Sbjct: 109 LSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168

Query: 185 ---FQNKGGVMTAETGT--YRWMAPEVI-NHQPYDQKADVFSFAIVLWELVTAKV 233
                 +   M     T  YR  APEV+     Y +  DV+S   +L EL   + 
Sbjct: 169 NSEPTGQQSGMVEFVATRWYR--APEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 90.2 bits (224), Expect = 5e-21
 Identities = 63/278 (22%), Positives = 103/278 (37%), Gaps = 64/278 (23%)

Query: 14  KYRGHAVEKAIESQTKSEDWEIDRR--LLKTGERIASGSCGDLYRGVYL--GQDVAVKVL 69
            +  H+  +        ++  +     +      I  GS G +Y        ++VA+K +
Sbjct: 3   HHHHHSSGRENLYFQGIKNVHVPDNYIIKH---LIGRGSYGYVYLAYDKNTEKNVAIKKV 59

Query: 70  RS--EHLND---TLEDEFVQEVAILREVQHRNVVR----FIGASTKS-PHLCIVTEYMPG 119
               E L D    L     +E+ IL  ++   ++R     I         L IV E    
Sbjct: 60  NRMFEDLIDCKRIL-----REITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD- 113

Query: 120 GSLYDYLHKNHNVLKLPQLLR------FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN 173
               D L K   + K P  L          ++  G  ++H+  IIHRDLK AN L++   
Sbjct: 114 ---SD-LKK---LFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC 166

Query: 174 VVKVADFGVAR-----------------------FQNKGGVMTAETGT--YRWMAPEVI- 207
            VKV DFG+AR                        +N    +T+   T  YR  APE+I 
Sbjct: 167 SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYR--APELIL 224

Query: 208 NHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL 245
             + Y +  D++S   +  EL+     + +    +  L
Sbjct: 225 LQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 87.0 bits (216), Expect = 2e-20
 Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 35/216 (16%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH-RNV 97
           + G +I SGS GD+Y G  +  G++VA+K+   +  +  L  E      I + +Q    +
Sbjct: 12  RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIE----SKIYKMMQGGVGI 67

Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
                   +  +  +V E + G SL D  +       L  +L  A  +   +EY+H +N 
Sbjct: 68  PTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 126

Query: 158 IHRDLKTANLLM---DTHNVVKVADFGVAR-------------FQNKGGVMTAETGTYRW 201
           IHRD+K  N LM      N+V + DFG+A+              +NK       TGT R+
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL-----TGTARY 181

Query: 202 MAPEVIN-HQPYDQ--KADVFSFAIVLWELVTAKVP 234
            +   IN H   +Q  + D+ S   VL       +P
Sbjct: 182 AS---INTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 88.5 bits (219), Expect = 3e-20
 Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 35/216 (16%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNV 97
           + G +I SGS G++Y G  +   ++VA+K+   +  +  L  E      I R +Q    +
Sbjct: 10  RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYE----SKIYRILQGGTGI 65

Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
                   +  +  +V + + G SL D  +     L L  +L  A  +   +E++H ++ 
Sbjct: 66  PNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124

Query: 158 IHRDLKTANLLM---DTHNVVKVADFGVARF-------------QNKGGVMTAETGTYRW 201
           +HRD+K  N LM      N V + DFG+A+              +NK       TGT R+
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL-----TGTARY 179

Query: 202 MAPEVIN-HQPYDQ--KADVFSFAIVLWELVTAKVP 234
            +   +N H   +Q  + D+ S   VL   +   +P
Sbjct: 180 AS---VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 87.0 bits (216), Expect = 3e-20
 Identities = 50/218 (22%), Positives = 90/218 (41%), Gaps = 37/218 (16%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH-RNV 97
           + G++I  G+ G+L  G  L   + VA+K+   +     L  E        +++     +
Sbjct: 12  RVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLE----YRFYKQLGSGDGI 67

Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
            +         +  +V E + G SL D          L  +L  AI +   MEY+H +N+
Sbjct: 68  PQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 126

Query: 158 IHRDLKTANLLM-----DTHNVVKVADFGVARF-------------QNKGGVMTAETGTY 199
           I+RD+K  N L+      T  V+ + DF +A+              ++K       TGT 
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSL-----TGTA 181

Query: 200 RWMAPEVIN-HQPYDQ--KADVFSFAIVLWELVTAKVP 234
           R+M+   IN H   +Q  + D+ +   +    +   +P
Sbjct: 182 RYMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 84.3 bits (209), Expect = 2e-19
 Identities = 48/218 (22%), Positives = 86/218 (39%), Gaps = 37/218 (16%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH-RNV 97
           K G RI  GS G ++ G  L   Q VA+K          L DE        + +     +
Sbjct: 13  KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDE----YRTYKLLAGCTGI 68

Query: 98  VRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNI 157
                   +  H  +V + + G SL D L        +  +   A  +   ++ +H++++
Sbjct: 69  PNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 127

Query: 158 IHRDLKTANLLM-----DTHNVVKVADFGVARF-------------QNKGGVMTAETGTY 199
           ++RD+K  N L+        N++ V DFG+ +F             + K       +GT 
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL-----SGTA 182

Query: 200 RWMAPEVIN-HQPYDQ--KADVFSFAIVLWELVTAKVP 234
           R+M+   IN H   +Q  + D+ +   V    +   +P
Sbjct: 183 RYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 80.6 bits (199), Expect = 1e-17
 Identities = 41/197 (20%), Positives = 68/197 (34%), Gaps = 38/197 (19%)

Query: 41  KTGERIASGSCGDLYRG-------VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ 93
           K G  I  G  G +Y         V       VKV  S++     E +F Q  A   ++Q
Sbjct: 38  KVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQ 97

Query: 94  HRNVVRFIGA-------------STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLR 140
                R +                    +  ++ +   G  L      N        +L+
Sbjct: 98  KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQ 156

Query: 141 FAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKV--ADFGVARFQNKGGVMTAETGT 198
            ++ I   +EY+H+   +H D+K +NLL++  N  +V   D+G+A               
Sbjct: 157 LSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLA--------------- 201

Query: 199 YRWMAPEVINHQPYDQK 215
           YR+    V      D K
Sbjct: 202 YRYCPEGVHKAYAADPK 218

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 79.0 bits (195), Expect = 3e-17
 Identities = 60/241 (24%), Positives = 108/241 (44%), Gaps = 54/241 (22%)

Query: 32  DWEIDRR--LLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRS--EHLND---TLEDEF 82
           D  + R+  L+K   ++  G+ G +++ +    G+ VAVK +    ++  D   T     
Sbjct: 4   DRHVLRKYELVK---KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF---- 56

Query: 83  VQEVAILREVQ-HRNVVRF--IGASTKSPHLCIVTEYMPGGSLYDYLHK--NHNVLKLPQ 137
            +E+ IL E+  H N+V    +  +     + +V +YM      D LH     N+L+   
Sbjct: 57  -REIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME----TD-LHAVIRANILEPVH 110

Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR------------- 184
                  + K ++YLH   ++HRD+K +N+L++    VKVADFG++R             
Sbjct: 111 KQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170

Query: 185 ---------FQNKGGVMTAETGT--YRWMAPEVI-NHQPYDQKADVFSFAIVLWELVTAK 232
                    F +   ++T    T  YR  APE++     Y +  D++S   +L E++  K
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYR--APEILLGSTKYTKGIDMWSLGCILGEILCGK 228

Query: 233 V 233
            
Sbjct: 229 P 229

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 75.9 bits (187), Expect = 3e-16
 Identities = 40/199 (20%), Positives = 72/199 (36%), Gaps = 45/199 (22%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSE-HLNDTLEDEFVQEVAILREVQHRNV 97
             G++I SG  G +Y        +  A  V++ E   N  L  E    +   + V  ++ 
Sbjct: 40  VLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSE----LKFYQRVAKKDC 95

Query: 98  VRFIGASTKSPHLCI-------------------VTEYMPGGSLYDYLHKNHNVLKLPQL 138
           ++      +  +L I                   V E + G  L     +N    K   +
Sbjct: 96  IKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGT-FKKSTV 153

Query: 139 LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKV--ADFGVARFQNKGGVMTAET 196
           L+  I +   +EY+H+   +H D+K ANLL+   N  +V  AD+G++             
Sbjct: 154 LQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLS------------- 200

Query: 197 GTYRWMAPEVINHQPYDQK 215
             YR+           + +
Sbjct: 201 --YRYCPNGNHKQYQENPR 217

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 74.4 bits (183), Expect = 1e-15
 Identities = 34/195 (17%), Positives = 67/195 (34%), Gaps = 37/195 (18%)

Query: 41  KTGERIASGSCGDLYRGVYL----------GQDVAVKVLRSEHLNDTLEDEF-------- 82
           K        + G LY                Q  ++K+   +  +  L +E         
Sbjct: 45  KLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL---DAKDGRLFNEQNFFQRAAK 101

Query: 83  ---VQEVAILREVQHRNVVRFIG-ASTKSPHLCIVTEYMPGGSLYDYLHKNHN-VLKLPQ 137
              V +   L       +   +G    +  +  +V   + G SL   L  +   VL    
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERS 160

Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT--HNVVKVADFGVA-RFQNKG----- 189
           +L+ A  +   +E+LH+   +H ++   N+ +D    + V +A +G A R+   G     
Sbjct: 161 VLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY 220

Query: 190 --GVMTAETGTYRWM 202
             G  +   G   ++
Sbjct: 221 VEGSRSPHEGDLEFI 235

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 67.2 bits (163), Expect = 3e-13
 Identities = 31/207 (14%), Positives = 60/207 (28%), Gaps = 50/207 (24%)

Query: 26  SQTKSEDWE--IDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLND------T 77
           SQ     +   +    L+  E+I  G  G++++ +     VA+K++  E  +        
Sbjct: 6   SQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQK 65

Query: 78  LEDEFVQEVAILREVQ---------HRNVVRFIGA------------------------- 103
             +E + E+ I +E+              +                              
Sbjct: 66  TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125

Query: 104 -----STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR-NI 157
                  K   L IV E+  GG   D       +  L         +   +         
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGI--DLEQMRTKLSSLATAKSILHQLTASLAVAEASLRF 183

Query: 158 IHRDLKTANLLMDTHNVVKVADFGVAR 184
            HRDL   N+L+   ++ K+      +
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGK 210

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 41.2 bits (97), Expect = 2e-04
 Identities = 34/152 (22%), Positives = 59/152 (38%), Gaps = 17/152 (11%)

Query: 42  TGERIASGSCGDLYRGVYLGQDVAVKV-----LRSEHLNDTLEDE-FVQEVAILREVQHR 95
               I  G+  D+ R  YL  DV +K       R E L++ +      +E   L  V+  
Sbjct: 340 PEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDF 399

Query: 96  NVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR 155
            +           +  I+  Y+ G    D +  N ++            I + +  LH+ 
Sbjct: 400 GIPAPYIFDVDLDNKRIMMSYINGKLAKDVIEDNLDIAY---------KIGEIVGKLHKN 450

Query: 156 NIIHRDLKTANLLMDTHNVVKVADFGVARFQN 187
           ++IH DL T+N + D      + DFG+ +  N
Sbjct: 451 DVIHNDLTTSNFIFDKDLY--IIDFGLGKISN 480

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 40.2 bits (93), Expect = 5e-04
 Identities = 34/212 (16%), Positives = 65/212 (30%), Gaps = 52/212 (24%)

Query: 62  QDVAVKVLRSEHLNDTLEDEFVQEVA-----ILREVQHRNVVRFIGASTKSPHLCIVTEY 116
           QD+   +L  E ++  +  +            L   Q   V +F+    +          
Sbjct: 39  QDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRIN-------- 90

Query: 117 MPGGSLYDYL-HKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVV 175
                 Y +L        + P ++           Y+ QR+ ++ D    N +   +NV 
Sbjct: 91  ------YKFLMSPIKTEQRQPSMMT--------RMYIEQRDRLYND----NQVFAKYNVS 132

Query: 176 KVADF-----GVARFQNKGGV----MTAETG-TYRWMAPEVINHQPYDQKADVFSFAIVL 225
           ++  +      +   +    V    +   +G T  W+A +V        K     F I  
Sbjct: 133 RLQPYLKLRQALLELRPAKNVLIDGV-LGSGKT--WVALDVCLSYKVQCK---MDFKI-F 185

Query: 226 W-ELVTAKVPYDSMTPLQAALGVRQVCTSLCQ 256
           W  L     P   +  LQ  L   Q+  +   
Sbjct: 186 WLNLKNCNSPETVLEMLQKLL--YQIDPNWTS 215

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	259
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.78
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.53
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.35
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.31
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.28
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	99.08
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.94
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.91
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.89
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.62
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.59
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.59
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.46
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.42
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	98.26
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.25
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	98.08
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.02
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	98.0
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.99
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.87
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.76
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.72
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.67
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.66
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.48
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.48
3mes_A	424	Choline kinase; malaria, structural genomics, stru	97.29
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.95
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	88.34
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	85.88
1cja_A	342	Protein (actin-fragmin kinase); transferase; HET:	83.5
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	81.25

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.5e-53  Score=352.90  Aligned_cols=219  Identities=26%  Similarity=0.475  Sum_probs=192.4

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ++|++.+.||+|+||+||+|.+.  ++.||||++..........+.+.+|++++++++||||+++++++.+.+.+|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            57999999999999999999975  8899999999877777777889999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-ccc
Q 045286          116 YMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMT  193 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~  193 (259)
                      |++|++|.+++.... ..+++..++.++.||+.+|.|||++||+||||||+|||++.+|.+||+|||++....... ...
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  183 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR  183 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHH
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCccccc
Confidence            999999999997543 457899999999999999999999999999999999999999999999999998765432 223


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      ..+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+.+.+|.++..++.+
T Consensus       184 ~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~  246 (350)
T 4b9d_A          184 ACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVS  246 (350)
T ss_dssp             HHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCC
T ss_pred             ccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCC
Confidence            457999999999999999999999999999999999999999999999999999887655443

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.4e-52  Score=343.10  Aligned_cols=215  Identities=20%  Similarity=0.370  Sum_probs=193.4

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      ++|++.+.||+|+||+||+|.+.  ++.||+|++..... .......+.+|++++++++||||+++++++.+.+.+|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57999999999999999999974  88999999986532 2234577899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC---Cc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG---GV  191 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~---~~  191 (259)
                      ||++|++|.+++.+.. .+++..++.++.||+.+|.|||++||+||||||+|||++.++.+||+|||++......   ..
T Consensus       112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~  190 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR  190 (311)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCC
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCccc
Confidence            9999999999997654 4999999999999999999999999999999999999999999999999999876533   23


Q ss_pred             cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          192 MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ....+||+.|+|||++.+..|+.++|+|||||++|+|++|..||.+.+..+...+|.++...
T Consensus       191 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~  252 (311)
T 4aw0_A          191 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD  252 (311)
T ss_dssp             BCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             ccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence            34568999999999999999999999999999999999999999999999999888876543

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.1e-51  Score=342.56  Aligned_cols=213  Identities=30%  Similarity=0.487  Sum_probs=192.7

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      ...|++.++||+|+||+||+|.+.  ++.||||++.......  .+.+.+|+.+++.++||||+++++++...+.+|+||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm  150 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  150 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            467999999999999999999984  8899999997654332  356789999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-Cccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVMT  193 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~~  193 (259)
                      ||++|++|.+++...  .+++..++.++.|++.+|.|||++||+||||||+|||++.+|.+||+|||++...... ....
T Consensus       151 Ey~~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  228 (346)
T 4fih_A          151 EFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  228 (346)
T ss_dssp             CCCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred             eCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence            999999999998764  4999999999999999999999999999999999999999999999999999876544 3445


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ..+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+.+..|.....+
T Consensus       229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~  288 (346)
T 4fih_A          229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP  288 (346)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC
T ss_pred             ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC
Confidence            678999999999999999999999999999999999999999999999999888876543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-51  Score=336.84  Aligned_cols=222  Identities=39%  Similarity=0.663  Sum_probs=189.3

Q ss_pred             cccceechhhhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCc
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPH  109 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~  109 (259)
                      ...|+|+.+++.+.++||+|+||+||+|.+.+ .||||+++.........+.+.+|+.++++++||||+++++++.. +.
T Consensus        28 ~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~  105 (307)
T 3omv_A           28 SYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN  105 (307)
T ss_dssp             -CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred             CcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce
Confidence            35699999999999999999999999998755 69999998776667777889999999999999999999998765 56


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG  189 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~  189 (259)
                      .++||||+++++|.+++......+++..+..++.|++.+|.|||+++|+||||||+|||++.++.+||+|||++......
T Consensus       106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred             EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence            89999999999999999877777999999999999999999999999999999999999999999999999999765432


Q ss_pred             ---CccccCCCcccccCccccCC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHhhhccCC
Q 045286          190 ---GVMTAETGTYRWMAPEVINH---QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQ-AALGVRQVCTS  253 (259)
Q Consensus       190 ---~~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~-~~~~i~~~~~~  253 (259)
                         ......+||+.|+|||++.+   .+++.++|||||||++|+|++|..||.+.+..+ ....+.++...
T Consensus       186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~  256 (307)
T 3omv_A          186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYAS  256 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCC
T ss_pred             CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC
Confidence               22345679999999999854   358999999999999999999999998866544 44445555444

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=8.4e-53  Score=344.22  Aligned_cols=217  Identities=25%  Similarity=0.380  Sum_probs=186.7

Q ss_pred             chhhhhccceeccccceEEEEEEE-----cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVY-----LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL  110 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~-----~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~  110 (259)
                      +-++|++.+.||+|+||+||+|..     .++.||+|+++...........+.+|+.++++++||||+++++++...+.+
T Consensus        22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  101 (304)
T 3ubd_A           22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL  101 (304)
T ss_dssp             CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred             CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence            346899999999999999999986     367899999987644433335678899999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC-C
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-G  189 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~-~  189 (259)
                      ++||||++|++|.+++.+.. .+++..+..++.|++.+|.|||++||+||||||+|||++.+|.+||+|||++..... .
T Consensus       102 ~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             EEEECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred             EEEEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence            99999999999999997654 499999999999999999999999999999999999999999999999999986543 3


Q ss_pred             CccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          190 GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       190 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ......+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+.+..|.++..+
T Consensus       181 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~  244 (304)
T 3ubd_A          181 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG  244 (304)
T ss_dssp             CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred             ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCC
Confidence            3445678999999999999999999999999999999999999999999999999988876543

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.9e-51  Score=336.67  Aligned_cols=223  Identities=29%  Similarity=0.483  Sum_probs=195.6

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc-------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeee
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST  105 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~  105 (259)
                      ..|++++|.+.++||+|+||+||+|.+.       +..||||+++..  .....+.+.+|++++++++||||+++++++.
T Consensus         8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~   85 (299)
T 4asz_A            8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCV   85 (299)
T ss_dssp             CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence            3577889999999999999999999863       568999999764  4455678999999999999999999999999


Q ss_pred             cCCcEEEEEecCCCCChHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC
Q 045286          106 KSPHLCIVTEYMPGGSLYDYLHKN------------HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN  173 (259)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~  173 (259)
                      +.+..++||||+++++|.+++...            ...+++..+..++.|++++|.|||+++++||||||+|||++.++
T Consensus        86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence            999999999999999999999653            24589999999999999999999999999999999999999999


Q ss_pred             eEEEeeeccceeccCCCcc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 045286          174 VVKVADFGVARFQNKGGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       174 ~i~l~D~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~  249 (259)
                      .+||+|||++.........   ....+++.|+|||.+.+..++.++|||||||++|||+| |..||.+.+..+.+..+.+
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~  245 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  245 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            9999999999765443222   22347899999999999999999999999999999998 9999999999999999998


Q ss_pred             ccCCCCcc
Q 045286          250 VCTSLCQP  257 (259)
Q Consensus       250 ~~~~~~~~  257 (259)
                      +.....|+
T Consensus       246 ~~~~~~p~  253 (299)
T 4asz_A          246 GRVLQRPR  253 (299)
T ss_dssp             TCCCCCCT
T ss_pred             CCCCCCCc
Confidence            87765554

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.2e-51  Score=330.59  Aligned_cols=214  Identities=27%  Similarity=0.505  Sum_probs=175.7

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN-DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      .+|++.+.||+|+||+||+|.+.  ++.||+|++...... ......+.+|++++++++||||+++++++...+.+++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            46899999999999999999974  899999999876443 344567899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTA  194 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~  194 (259)
                      ||+ +++|.+++.+.. .+++..+..++.|++.+|.|||++|++||||||+|||++.++.+||+|||++...........
T Consensus        93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~  170 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT  170 (275)
T ss_dssp             ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred             eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCC
Confidence            999 679999986654 599999999999999999999999999999999999999999999999999987776666667


Q ss_pred             CCCcccccCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          195 ETGTYRWMAPEVINHQPY-DQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      .+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+.++..+
T Consensus       171 ~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~  230 (275)
T 3hyh_A          171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYT  230 (275)
T ss_dssp             ----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             eeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC
Confidence            789999999999999886 57999999999999999999999999998888888876543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.1e-50  Score=344.23  Aligned_cols=213  Identities=30%  Similarity=0.487  Sum_probs=192.8

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      ...|++.++||+|+||.||+|.+.  ++.||||++.......  .+.+.+|+.+++.++||||+++++++...+.+|+||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm  227 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  227 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence            467999999999999999999985  8899999998654332  356889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-Cccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVMT  193 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~~  193 (259)
                      ||++|++|.+++...  .+++..+..++.||+.+|.|||++||+||||||+|||++.+|.+||+|||++...... ....
T Consensus       228 Ey~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  305 (423)
T 4fie_A          228 EFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  305 (423)
T ss_dssp             ECCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred             eCCCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence            999999999998654  3999999999999999999999999999999999999999999999999999876544 3445


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ..+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+.+..|.....+
T Consensus       306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~  365 (423)
T 4fie_A          306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP  365 (423)
T ss_dssp             CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred             ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC
Confidence            678999999999999999999999999999999999999999999999999888876543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.8e-50  Score=333.90  Aligned_cols=226  Identities=32%  Similarity=0.475  Sum_probs=193.3

Q ss_pred             cccceechhhhhccceeccccceEEEEEEEc-------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeee
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG  102 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~  102 (259)
                      ...+.++.+++.+.++||+|+||+||+|.+.       ++.||||+++..  +....+.+.+|++++++++||||+++++
T Consensus        33 ~~~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g  110 (329)
T 4aoj_A           33 ACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFG  110 (329)
T ss_dssp             CCSCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             hhhcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            3446788899999999999999999999863       578999999754  4455678999999999999999999999


Q ss_pred             eeecCCcEEEEEecCCCCChHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEE
Q 045286          103 ASTKSPHLCIVTEYMPGGSLYDYLHKNH--------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLL  168 (259)
Q Consensus       103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nil  168 (259)
                      ++.+.+..++||||+++++|.+++....              ..+++..+..++.|++++|.|||+.+++||||||+|||
T Consensus       111 ~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NIL  190 (329)
T 4aoj_A          111 VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCL  190 (329)
T ss_dssp             EECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             EEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEE
Confidence            9999999999999999999999996532              35889999999999999999999999999999999999


Q ss_pred             EccCCeEEEeeeccceeccCCC---ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 045286          169 MDTHNVVKVADFGVARFQNKGG---VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAA  244 (259)
Q Consensus       169 v~~~~~i~l~D~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~  244 (259)
                      ++.++.+||+|||++.......   ......+++.|+|||.+.+..++.++|||||||++|||+| |..||.+.+..+.+
T Consensus       191 l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~  270 (329)
T 4aoj_A          191 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI  270 (329)
T ss_dssp             EETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH
T ss_pred             ECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            9999999999999998654432   2234568999999999999999999999999999999999 99999999999999


Q ss_pred             HHhhhccCCCCcc
Q 045286          245 LGVRQVCTSLCQP  257 (259)
Q Consensus       245 ~~i~~~~~~~~~~  257 (259)
                      ..+.++.+...|+
T Consensus       271 ~~i~~g~~~~~p~  283 (329)
T 4aoj_A          271 DCITQGRELERPR  283 (329)
T ss_dssp             HHHHHTCCCCCCT
T ss_pred             HHHHcCCCCCCcc
Confidence            9999887665554

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.1e-50  Score=333.31  Aligned_cols=228  Identities=28%  Similarity=0.496  Sum_probs=197.7

Q ss_pred             ccccceechhhhhccceeccccceEEEEEEE-------cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceee
Q 045286           29 KSEDWEIDRRLLKTGERIASGSCGDLYRGVY-------LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI  101 (259)
Q Consensus        29 ~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~-------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~  101 (259)
                      ..+..+++...+++.++||+|+||+||+|.+       .++.||||+++... .....+.+.+|+.++++++||||++++
T Consensus        17 ~~~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~   95 (308)
T 4gt4_A           17 QAKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLL   95 (308)
T ss_dssp             --CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cCCcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence            3445677888999999999999999999986       35789999997653 334457899999999999999999999


Q ss_pred             eeeecCCcEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 045286          102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH---------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTAN  166 (259)
Q Consensus       102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~N  166 (259)
                      +++...+..++||||+++|+|.+++....               ..+++..+..++.|+++++.|||+.+++||||||+|
T Consensus        96 g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~N  175 (308)
T 4gt4_A           96 GVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRN  175 (308)
T ss_dssp             EEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             eEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccc
Confidence            99999999999999999999999996432               348889999999999999999999999999999999


Q ss_pred             EEEccCCeEEEeeeccceeccCCC---ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 045286          167 LLMDTHNVVKVADFGVARFQNKGG---VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQ  242 (259)
Q Consensus       167 ilv~~~~~i~l~D~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~  242 (259)
                      ||++.++.+||+|||++.......   ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+
T Consensus       176 ILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~  255 (308)
T 4gt4_A          176 VLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD  255 (308)
T ss_dssp             EEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred             eEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999997654332   2234578999999999999999999999999999999998 899999999999


Q ss_pred             HHHHhhhccCCCCcc
Q 045286          243 AALGVRQVCTSLCQP  257 (259)
Q Consensus       243 ~~~~i~~~~~~~~~~  257 (259)
                      .+..+..+...+.|+
T Consensus       256 ~~~~i~~~~~~~~p~  270 (308)
T 4gt4_A          256 VVEMIRNRQVLPCPD  270 (308)
T ss_dssp             HHHHHHTTCCCCCCT
T ss_pred             HHHHHHcCCCCCCcc
Confidence            999999887766554

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.1e-50  Score=327.41  Aligned_cols=215  Identities=33%  Similarity=0.549  Sum_probs=184.9

Q ss_pred             chhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec----CCc
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK----SPH  109 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~  109 (259)
                      +.+.|++.++||+|+||+||+|.+.  ++.||+|++..........+.+.+|+.++++++||||+++++++..    .+.
T Consensus        24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~  103 (290)
T 3fpq_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred             CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence            4455688889999999999999985  7899999998877777777889999999999999999999998854    346


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEcc-CCeEEEeeeccceec
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN--IIHRDLKTANLLMDT-HNVVKVADFGVARFQ  186 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~di~p~Nilv~~-~~~i~l~D~~~~~~~  186 (259)
                      +++||||++|++|.+++.+.. .+++..+..++.|++.+|.|||++|  |+||||||+|||++. +|.+||+|||++...
T Consensus       104 ~~lvmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          104 IVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence            899999999999999997654 5899999999999999999999998  999999999999974 799999999999754


Q ss_pred             cCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHhhhccCC
Q 045286          187 NKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT-PLQAALGVRQVCTS  253 (259)
Q Consensus       187 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~-~~~~~~~i~~~~~~  253 (259)
                      .. ......+||+.|+|||++.+ +++.++|||||||++|+|++|..||.+.+ ..+....+..+..+
T Consensus       183 ~~-~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~  248 (290)
T 3fpq_A          183 RA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP  248 (290)
T ss_dssp             CT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC
T ss_pred             CC-CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC
Confidence            43 34456789999999999865 59999999999999999999999997654 45555556555443

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.1e-50  Score=335.51  Aligned_cols=208  Identities=27%  Similarity=0.397  Sum_probs=182.1

Q ss_pred             chhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      ....|.+.++||+|+||.||+|.+.  ++.||||+++....       ..+|+.+++.++||||+++++++.+.+.+++|
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv  128 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIF  128 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            3456788899999999999999975  88999999987543       24799999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC-eEEEeeeccceeccCCCc-
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN-VVKVADFGVARFQNKGGV-  191 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~-~i~l~D~~~~~~~~~~~~-  191 (259)
                      |||++|++|.+++.... .+++..+..++.|++.+|.|||++||+||||||+|||++.+| .+||+|||++........ 
T Consensus       129 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          129 MELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             ECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             EeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            99999999999997654 599999999999999999999999999999999999999987 599999999987654321 


Q ss_pred             -----cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          192 -----MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       192 -----~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                           ....+||+.|+|||++.+.+++.++|||||||++|+|++|..||.+.+..+.+.+|....
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~  272 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP  272 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC
T ss_pred             cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC
Confidence                 123479999999999999999999999999999999999999999888777777776543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=8.6e-49  Score=327.52  Aligned_cols=226  Identities=32%  Similarity=0.569  Sum_probs=192.7

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEcC-------ceEEEEEeecccCchHHHHHHHHHHHHHHhcCC-CCcceeee
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH-RNVVRFIG  102 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~-------~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~  102 (259)
                      +.|+|+.++|++.++||+|+||+||+|.+.+       +.||||.+..... ......+.+|+.++++++| |||+++++
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~-~~~~~~~~~E~~il~~l~hhpnIV~l~g  135 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLG  135 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-hHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence            4699999999999999999999999998753       5799999986543 3445778999999999975 89999999


Q ss_pred             eeec-CCcEEEEEecCCCCChHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 045286          103 ASTK-SPHLCIVTEYMPGGSLYDYLHKN---------------HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTAN  166 (259)
Q Consensus       103 ~~~~-~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~N  166 (259)
                      ++.. ++.+++||||+++++|.+++...               ...+++..+..++.|++.++.|||+++++||||||+|
T Consensus       136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N  215 (353)
T 4ase_A          136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  215 (353)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence            9865 45789999999999999999653               2347889999999999999999999999999999999


Q ss_pred             EEEccCCeEEEeeeccceeccCCCc---cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCH-H
Q 045286          167 LLMDTHNVVKVADFGVARFQNKGGV---MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTP-L  241 (259)
Q Consensus       167 ilv~~~~~i~l~D~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~-~  241 (259)
                      ||++.++.+||+|||++........   .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+. .
T Consensus       216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999986654322   123457899999999999999999999999999999998 9999998664 5


Q ss_pred             HHHHHhhhccCCCCcc
Q 045286          242 QAALGVRQVCTSLCQP  257 (259)
Q Consensus       242 ~~~~~i~~~~~~~~~~  257 (259)
                      .....+.++.+...|+
T Consensus       296 ~~~~~i~~g~~~~~p~  311 (353)
T 4ase_A          296 EFCRRLKEGTRMRAPD  311 (353)
T ss_dssp             HHHHHHHHTCCCCCCT
T ss_pred             HHHHHHHcCCCCCCCc
Confidence            5666677777665554

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.3e-48  Score=327.84  Aligned_cols=218  Identities=24%  Similarity=0.350  Sum_probs=190.9

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec------CCc
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK------SPH  109 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~  109 (259)
                      ++|++.+.||+|+||+||+|.+.  ++.||||+++...........+.+|+.+|+.++||||+++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999985  8999999998776666667788999999999999999999998753      357


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG  189 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~  189 (259)
                      .|+||||++ ++|.+++... ..+++..+..++.||+.+|.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~  211 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS  211 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred             EEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence            899999995 6899998554 45999999999999999999999999999999999999999999999999999765332


Q ss_pred             -----CccccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          190 -----GVMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       190 -----~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                           ......+||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+.+..|.+..+.+...
T Consensus       212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence                 233456899999999998876 46999999999999999999999999999999999998877765543

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.6e-47  Score=311.60  Aligned_cols=196  Identities=26%  Similarity=0.481  Sum_probs=161.1

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC-------
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP-------  108 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------  108 (259)
                      .+|++.+.||+|+||+||+|.+.  ++.||+|+++... .+...+.+.+|+.++++++||||+++++++...+       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            35888999999999999999975  8899999998654 3445577899999999999999999999986543       


Q ss_pred             -----cEEEEEecCCCCChHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeec
Q 045286          109 -----HLCIVTEYMPGGSLYDYLHKNHN--VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFG  181 (259)
Q Consensus       109 -----~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~  181 (259)
                           ..++||||+++++|.+++.....  ..+...++.++.|++++|.|||++||+||||||+|||++.++.+||+|||
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG  163 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG  163 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence                 36899999999999999975432  24456688999999999999999999999999999999999999999999


Q ss_pred             cceeccCCCc-------------cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          182 VARFQNKGGV-------------MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       182 ~~~~~~~~~~-------------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                      ++........             ....+||+.|+|||++.+.+|+.++|||||||++|+|++   ||..
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~  229 (299)
T 4g31_A          164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST  229 (299)
T ss_dssp             CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence            9976554321             123479999999999999999999999999999999996   7764

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.1e-46  Score=333.77  Aligned_cols=216  Identities=22%  Similarity=0.424  Sum_probs=197.0

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ++|++.+.||+|+||.||+|.+.  ++.||+|++....  ....+.+.+|+.+|+.++||||+++++++...+.+++|||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E  234 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  234 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            57899999999999999999974  8899999998753  3345678899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC--CeEEEeeeccceeccCCCccc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH--NVVKVADFGVARFQNKGGVMT  193 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~--~~i~l~D~~~~~~~~~~~~~~  193 (259)
                      |++|++|.+++......+++..+..++.||+.+|.|||++|++||||||+|||++.+  +.+||+|||++..........
T Consensus       235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~  314 (573)
T 3uto_A          235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK  314 (573)
T ss_dssp             CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred             ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence            999999999997666679999999999999999999999999999999999999854  899999999999888776667


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCC
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLC  255 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~  255 (259)
                      ..+||+.|+|||++.+.+|+.++|||||||++|+|++|..||.+.+..+.+..|.+......
T Consensus       315 ~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~  376 (573)
T 3uto_A          315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD  376 (573)
T ss_dssp             EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred             eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC
Confidence            77899999999999999999999999999999999999999999999999999887655443

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.7e-46  Score=312.60  Aligned_cols=208  Identities=22%  Similarity=0.377  Sum_probs=177.9

Q ss_pred             hhhhhccceeccccceEEEEEEEc-----CceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeeeeeecCCcE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHL  110 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~  110 (259)
                      .++|++.++||+|+||+||+|.+.     ++.||+|.+.....    ...+.+|+++++.+ +||||+++++++...+.+
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            467999999999999999999863     57899999876532    25678999999998 599999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC-CeEEEeeeccceeccCC
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH-NVVKVADFGVARFQNKG  189 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~-~~i~l~D~~~~~~~~~~  189 (259)
                      ++||||++|++|.+++.    .+++.+++.++.|++.+|.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus        96 ~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~  171 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT  171 (361)
T ss_dssp             EEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred             EEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence            99999999999999883    38899999999999999999999999999999999999877 89999999999754432


Q ss_pred             C-----------------------------ccccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCC-CCC
Q 045286          190 G-----------------------------VMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPY-DSM  238 (259)
Q Consensus       190 ~-----------------------------~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~-~~~  238 (259)
                      .                             .....+||+.|+|||++.+. .++.++||||+||++|+|++|..|| .+.
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence            1                             12345799999999999876 5899999999999999999999998 556


Q ss_pred             CHHHHHHHhhhccC
Q 045286          239 TPLQAALGVRQVCT  252 (259)
Q Consensus       239 ~~~~~~~~i~~~~~  252 (259)
                      +..+.+..|.+.++
T Consensus       252 ~~~~~l~~I~~~~G  265 (361)
T 4f9c_A          252 DDLTALAQIMTIRG  265 (361)
T ss_dssp             SHHHHHHHHHHHHC
T ss_pred             CHHHHHHHHHHhcC
Confidence            67777777765443

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5.2e-46  Score=305.86  Aligned_cols=193  Identities=30%  Similarity=0.540  Sum_probs=162.3

Q ss_pred             hhhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC----cEEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP----HLCIV  113 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~lv  113 (259)
                      ++|.+.++||+|+||+||+|.+.|+.||||++....   .......+|+..+.+++||||+++++++...+    .+++|
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            578899999999999999999999999999987542   22223345666677889999999999987643    57999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR--------NIIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~--------~i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                      |||+++++|.+++....  ++...+..++.|++.+|.|||+.        +|+||||||+|||++.++.+||+|||++..
T Consensus        80 ~Ey~~~gsL~~~l~~~~--l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             EECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ecCCCCCcHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            99999999999997643  88999999999999999999987        999999999999999999999999999987


Q ss_pred             ccCCCcc-----ccCCCcccccCccccCCC------CCCCchhHHHHHHHHHHHHcCCCCC
Q 045286          186 QNKGGVM-----TAETGTYRWMAPEVINHQ------PYDQKADVFSFAIVLWELVTAKVPY  235 (259)
Q Consensus       186 ~~~~~~~-----~~~~~~~~~~~PE~~~~~------~~~~~~Di~slG~~~~~ll~g~~p~  235 (259)
                      .......     ...+||+.|+|||++.+.      .++.++|||||||++|||++|..||
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~  218 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG  218 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCC
Confidence            6554322     234699999999999765      3577999999999999999997654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.8e-44  Score=319.65  Aligned_cols=202  Identities=28%  Similarity=0.411  Sum_probs=174.8

Q ss_pred             echhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCc----hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN----DTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      +.-++|++.++||+|+||.||+|...  ++.||+|++......    ........+++.+++.++||||+++++++.+.+
T Consensus       186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~  265 (689)
T 3v5w_A          186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD  265 (689)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence            33467999999999999999999974  889999999764321    122223334466677788999999999999999


Q ss_pred             cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      .+|+||||++||+|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus       266 ~lylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          266 KLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            9999999999999999997654 499999999999999999999999999999999999999999999999999987665


Q ss_pred             CCccccCCCcccccCccccC-CCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 045286          189 GGVMTAETGTYRWMAPEVIN-HQPYDQKADVFSFAIVLWELVTAKVPYDSM  238 (259)
Q Consensus       189 ~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  238 (259)
                      .. ....+||+.|+|||++. +..|+.++|+|||||++|+|++|..||.+.
T Consensus       345 ~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~  394 (689)
T 3v5w_A          345 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  394 (689)
T ss_dssp             CC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred             CC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            43 34568999999999996 568999999999999999999999999753

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=9.8e-44  Score=295.83  Aligned_cols=216  Identities=28%  Similarity=0.474  Sum_probs=197.0

Q ss_pred             hhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      -.+|++.+.||+|+||.||+|.+  +++.||+|++............+.+|+.+++.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            35789999999999999999997  5889999999987777777788999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTA  194 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~  194 (259)
                      ||+++++|.+++.... .+++..++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+...........
T Consensus        94 e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  172 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA  172 (328)
T ss_dssp             CCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGT
T ss_pred             ECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcccc
Confidence            9999999999996654 499999999999999999999999999999999999999999999999999987776666677


Q ss_pred             CCCcccccCccccCCCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          195 ETGTYRWMAPEVINHQPYD-QKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~~~~-~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      .++++.|+|||.+.+..++ +++|+|||||++|+|++|..||.+.+..+....+.++...
T Consensus       173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  232 (328)
T 3fe3_A          173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR  232 (328)
T ss_dssp             TSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred             ccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence            7899999999999888775 7999999999999999999999999998888888776543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=9.5e-44  Score=293.71  Aligned_cols=226  Identities=42%  Similarity=0.723  Sum_probs=188.5

Q ss_pred             HhccccccceechhhhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeee
Q 045286           25 ESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAS  104 (259)
Q Consensus        25 ~~~~~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~  104 (259)
                      ++....+.+++...+|++.+.||+|+||+||+|.+.++.||+|++............+.+|+.++++++||||+++++++
T Consensus        24 ~~~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  103 (309)
T 3p86_A           24 QGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV  103 (309)
T ss_dssp             --------CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCCCcccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            33455677899999999999999999999999999999999999998777777778899999999999999999999999


Q ss_pred             ecCCcEEEEEecCCCCChHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEccCCeEEEeee
Q 045286          105 TKSPHLCIVTEYMPGGSLYDYLHKNHN--VLKLPQLLRFAIDICKGMEYLHQRN--IIHRDLKTANLLMDTHNVVKVADF  180 (259)
Q Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~di~p~Nilv~~~~~i~l~D~  180 (259)
                      ...+..++||||+++++|.+++.....  .+++..++.++.|++.+|.+||+.|  ++|+||||+||+++.++.++|+||
T Consensus       104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Df  183 (309)
T 3p86_A          104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDF  183 (309)
T ss_dssp             CSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred             EECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCC
Confidence            999999999999999999999965432  3889999999999999999999999  999999999999999999999999


Q ss_pred             ccceeccCCC-ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          181 GVARFQNKGG-VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       181 ~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      |.+....... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+...
T Consensus       184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  254 (309)
T 3p86_A          184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK  254 (309)
T ss_dssp             C-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHS
T ss_pred             CCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence            9987554432 223456899999999999999999999999999999999999999999888877776533

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=9.9e-43  Score=293.56  Aligned_cols=219  Identities=23%  Similarity=0.391  Sum_probs=196.4

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      .++|.+.+.||+|+||.||+|.+.  ++.||+|++............+.+|+.+++.++||||+++++++...+..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            468999999999999999999985  789999999987766666678999999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC---CeEEEeeeccceeccCCCc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH---NVVKVADFGVARFQNKGGV  191 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~---~~i~l~D~~~~~~~~~~~~  191 (259)
                      |++++++|.+++... ..+++..+..++.|++.+|.|||+.|++|+||||+||+++.+   +.++|+|||.+........
T Consensus       108 e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~  186 (362)
T 2bdw_A          108 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  186 (362)
T ss_dssp             CCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred             ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence            999999999998654 458999999999999999999999999999999999999765   4599999999987776655


Q ss_pred             cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          192 MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      .....+++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+....+..+....+.
T Consensus       187 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~  251 (362)
T 2bdw_A          187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS  251 (362)
T ss_dssp             CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence            55678999999999999999999999999999999999999999999988888888877654443

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=6e-43  Score=289.19  Aligned_cols=221  Identities=26%  Similarity=0.406  Sum_probs=190.6

Q ss_pred             hhhhhccceeccccceEEEEEEE-cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY-LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~-~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      .++|++.++||+|+||+||+|.+ .++.||+|++............+.+|+.++++++||||+++++++......++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            47899999999999999999998 47899999998765555556788899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-Ccccc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVMTA  194 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~~~  194 (259)
                      |+++ +|.+.+......+++..++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+...... .....
T Consensus       100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  178 (311)
T 3niz_A          100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH  178 (311)
T ss_dssp             CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---C
T ss_pred             CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccC
Confidence            9964 888888777667999999999999999999999999999999999999999999999999999876543 23345


Q ss_pred             CCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCccC
Q 045286          195 ETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPI  258 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  258 (259)
                      ..+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+.+..+......+.++.
T Consensus       179 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  243 (311)
T 3niz_A          179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPRE  243 (311)
T ss_dssp             CCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTT
T ss_pred             CcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHH
Confidence            578999999999876 5689999999999999999999999999888888888887776665543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=7.8e-43  Score=293.79  Aligned_cols=216  Identities=26%  Similarity=0.462  Sum_probs=193.3

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCch----HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND----TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL  110 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~  110 (259)
                      .++|.+.+.||+|+||.||+|.+.  ++.||+|++.......    .....+.+|+.+++.++||||+++++++...+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467999999999999999999985  7899999998764332    1346788999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC----eEEEeeeccceec
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN----VVKVADFGVARFQ  186 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~----~i~l~D~~~~~~~  186 (259)
                      ++||||++|++|.+++... ..+++..+..++.|++.+|.|||+.|++|+||||+||+++.++    .++|+|||.+...
T Consensus        91 ~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~  169 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred             EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence            9999999999999999654 4599999999999999999999999999999999999998776    7999999999887


Q ss_pred             cCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          187 NKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       187 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ..........+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+....+..+...
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~  236 (361)
T 2yab_A          170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD  236 (361)
T ss_dssp             CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC
T ss_pred             CCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC
Confidence            7665556678999999999999999999999999999999999999999999988888888766543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1e-42  Score=281.94  Aligned_cols=225  Identities=30%  Similarity=0.605  Sum_probs=197.6

Q ss_pred             cccceechhhhhccceeccccceEEEEEEE-cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVY-LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~-~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      +..|.++.++|++.+.||+|++|.||++.+ .++.|++|++.......   +.+.+|+.++++++||||+++++++...+
T Consensus         2 ~~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   78 (269)
T 4hcu_A            2 SGKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQA   78 (269)
T ss_dssp             ---CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             CccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            356889999999999999999999999998 57789999998765443   56889999999999999999999999999


Q ss_pred             cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      ..++||||+++++|.+++......++...++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence            99999999999999999987777799999999999999999999999999999999999999999999999999876544


Q ss_pred             CC--ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          189 GG--VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       189 ~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      ..  ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+..+.....++
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  230 (269)
T 4hcu_A          159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR  230 (269)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCC
Confidence            32  1223345678999999998899999999999999999999 999999999999988888776655443

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.5e-42  Score=297.86  Aligned_cols=221  Identities=22%  Similarity=0.354  Sum_probs=195.7

Q ss_pred             hhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      .++|++.++||+|+||.||+|.+  .++.+|+|++............+.+|+.+++.++||||+++++++...+..++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            46899999999999999999987  4889999999987766666678899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc---cCCeEEEeeeccceeccCCC-
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD---THNVVKVADFGVARFQNKGG-  190 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~---~~~~i~l~D~~~~~~~~~~~-  190 (259)
                      |+++|++|.+.+.... .+++..+..++.|++.+|.|||+.|++|+||||+||+++   .++.++|+|||.+....... 
T Consensus        90 E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~  168 (444)
T 3soa_A           90 DLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ  168 (444)
T ss_dssp             CCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred             EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence            9999999999986654 599999999999999999999999999999999999998   45789999999997665443 


Q ss_pred             ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCccC
Q 045286          191 VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPI  258 (259)
Q Consensus       191 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  258 (259)
                      ......+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+..+......|.
T Consensus       169 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  236 (444)
T 3soa_A          169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE  236 (444)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred             eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccc
Confidence            33456799999999999999999999999999999999999999999999999999988776655543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.1e-42  Score=288.66  Aligned_cols=215  Identities=24%  Similarity=0.410  Sum_probs=188.8

Q ss_pred             chhhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCI  112 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l  112 (259)
                      .-++|++.+.||+|+||.||+|.+.  ++.||+|++..... .......+.+|..+++.++||||+++++++...+..++
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l   82 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence            3468999999999999999999974  78999999986432 22334678899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC-CCc
Q 045286          113 VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGV  191 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~-~~~  191 (259)
                      ||||++|++|..++.... .+++..++.++.|++.+|.+||+.|++||||||+||+++.+|.++|+|||++..... ...
T Consensus        83 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           83 VMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence            999999999999986544 489999999999999999999999999999999999999999999999999875432 333


Q ss_pred             cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          192 MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ....++++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+....+....
T Consensus       162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~  221 (337)
T 1o6l_A          162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE  221 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence            445678999999999999999999999999999999999999999988888777776543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7e-43  Score=289.98  Aligned_cols=214  Identities=20%  Similarity=0.352  Sum_probs=192.9

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      .++|++.+.||+|+||.||+|.+.  ++.+++|.+....   .....+.+|+.+++.++||||+++++++...+..++||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   80 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence            368899999999999999999985  7899999987543   33466889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc--CCeEEEeeeccceeccCCCcc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT--HNVVKVADFGVARFQNKGGVM  192 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~--~~~i~l~D~~~~~~~~~~~~~  192 (259)
                      ||+++++|.+++......+++..++.++.|++.+|.+||+.|++|+||||+||+++.  ++.++|+|||.+.........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~  160 (321)
T 1tki_A           81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF  160 (321)
T ss_dssp             CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred             EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence            999999999999766667999999999999999999999999999999999999987  789999999999887766655


Q ss_pred             ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          193 TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+..+...
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~  221 (321)
T 1tki_A          161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT  221 (321)
T ss_dssp             EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC
T ss_pred             ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCC
Confidence            6667899999999999988999999999999999999999999999988888888766544

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=8e-42  Score=280.68  Aligned_cols=211  Identities=27%  Similarity=0.527  Sum_probs=187.2

Q ss_pred             chhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      ...+|++.+.||+|+||+||+|.+  .++.||+|++.......  .+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   95 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence            357899999999999999999986  47899999998654333  36688999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-cc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VM  192 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~  192 (259)
                      |||+++++|.+++...  .+++..++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+....... ..
T Consensus        96 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  173 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  173 (297)
T ss_dssp             EECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             EECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccccc
Confidence            9999999999999765  38899999999999999999999999999999999999999999999999987665442 33


Q ss_pred             ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          193 TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+....+...
T Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  231 (297)
T 3fxz_A          174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN  231 (297)
T ss_dssp             CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH
T ss_pred             CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence            4557899999999999999999999999999999999999999988887766665543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=292.19  Aligned_cols=218  Identities=23%  Similarity=0.347  Sum_probs=186.1

Q ss_pred             echhhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhc-CCCCcceeeeeeecCCcE
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHL  110 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~  110 (259)
                      +.-++|++.++||+|+||.||+|.+.  ++.||+|++..... .......+.+|..+++.+ +||||+++++++...+..
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            34478999999999999999999975  78999999986532 223346678899999988 699999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC-C
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-G  189 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~-~  189 (259)
                      ++||||++|++|..++.... .+++..++.++.|++.+|.+||+.|++||||||+||+++.++.++|+|||++..... .
T Consensus       100 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG  178 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence            99999999999999997654 499999999999999999999999999999999999999999999999999875332 2


Q ss_pred             CccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          190 GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       190 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ......++++.|+|||.+.+..++.++|+|||||++|+|++|..||...+..+....|......
T Consensus       179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~  242 (353)
T 3txo_A          179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV  242 (353)
T ss_dssp             -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred             ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence            3344567999999999999989999999999999999999999999999999988888776543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=7e-42  Score=280.21  Aligned_cols=219  Identities=24%  Similarity=0.404  Sum_probs=191.7

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ++|++.++||+|++|+||+|.+.  ++.||+|++............+.+|+.++++++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46889999999999999999984  7899999999877666667888999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-Ccccc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVMTA  194 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~~~  194 (259)
                      ++++ ++.+.+......+++..++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+...... .....
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA  160 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCS
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccC
Confidence            9965 777777666667999999999999999999999999999999999999999999999999999876543 23345


Q ss_pred             CCCcccccCccccCCCC-CCCchhHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHhhhccCCCCcc
Q 045286          195 ETGTYRWMAPEVINHQP-YDQKADVFSFAIVLWELVTAKVP-YDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~~~~ll~g~~p-~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      ..+++.|+|||.+.+.. ++.++|+||||+++|+|++|..| |.+.+..+.+..+.+....+...
T Consensus       161 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~  225 (292)
T 3o0g_A          161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE  225 (292)
T ss_dssp             CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             CccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence            57899999999997765 79999999999999999987776 77888888888888766655443

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.4e-42  Score=283.94  Aligned_cols=216  Identities=25%  Similarity=0.421  Sum_probs=185.8

Q ss_pred             hhhhccceeccccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      ++|++.+.||+|+||+||+|.+. ++.||+|++............+.+|+.+++.++||||+++++++...+..++|||+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            46888999999999999999985 78999999987654444456788999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-CccccC
Q 045286          117 MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVMTAE  195 (259)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~~~~  195 (259)
                      +++ +|.+++......+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+...... ......
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE  160 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccc
Confidence            965 999998776667999999999999999999999999999999999999999999999999998765433 233445


Q ss_pred             CCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          196 TGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       196 ~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      .+++.|+|||.+.+. .++.++|+||||+++|+|++|..||.+.+..+.+..+.+....+
T Consensus       161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  220 (288)
T 1ob3_A          161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP  220 (288)
T ss_dssp             -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             cccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCC
Confidence            689999999998764 58999999999999999999999999999888888877655443

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.7e-42  Score=286.13  Aligned_cols=224  Identities=30%  Similarity=0.519  Sum_probs=194.6

Q ss_pred             cceechhhhhccceeccccceEEEEEEEc-----CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec
Q 045286           32 DWEIDRRLLKTGERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK  106 (259)
Q Consensus        32 ~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~  106 (259)
                      ..++...+|++.++||+|+||.||+|.+.     +..||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus        43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  121 (325)
T 3kul_A           43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR  121 (325)
T ss_dssp             CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred             ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            45778899999999999999999999974     3469999998653 34455778999999999999999999999999


Q ss_pred             CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          107 SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                      .+..++||||+++++|.+++......++...++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+...
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            89999999999999999999776667999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCc----cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          187 NKGGV----MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       187 ~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      .....    .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+..+...+.+
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~  276 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAP  276 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCC
Confidence            54321    122335678999999998889999999999999999999 99999999999999888887665544

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.8e-42  Score=277.23  Aligned_cols=222  Identities=34%  Similarity=0.607  Sum_probs=196.3

Q ss_pred             cceechhhhhccceeccccceEEEEEEEcC-ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcE
Q 045286           32 DWEIDRRLLKTGERIASGSCGDLYRGVYLG-QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL  110 (259)
Q Consensus        32 ~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~-~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~  110 (259)
                      .+++..++|++.+.||+|++|.||++.+.+ ..|++|++.......   ..+.+|+.++++++||||+++++++......
T Consensus         2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (268)
T 3sxs_A            2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI   78 (268)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence            467889999999999999999999999864 579999998765443   5688999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      ++|||++++++|.+++......+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            99999999999999998766669999999999999999999999999999999999999999999999999998665543


Q ss_pred             cc--ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          191 VM--TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       191 ~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      ..  ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+..+.....+
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  227 (268)
T 3sxs_A          159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP  227 (268)
T ss_dssp             EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC
T ss_pred             hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC
Confidence            22  22345678999999998889999999999999999999 99999999998888888777655444

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=8.3e-42  Score=288.76  Aligned_cols=225  Identities=29%  Similarity=0.553  Sum_probs=195.0

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEc---------CceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCccee
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYL---------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRF  100 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~---------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~  100 (259)
                      ..|++..++|.+.+.||+|+||.||+|.+.         +..||+|+++... .......+.+|+.+++.+ +||||+++
T Consensus        74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~  152 (370)
T 2psq_A           74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL  152 (370)
T ss_dssp             TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCE
T ss_pred             ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence            347788899999999999999999999863         3469999998653 344557789999999999 79999999


Q ss_pred             eeeeecCCcEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 045286          101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNH---------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTA  165 (259)
Q Consensus       101 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~  165 (259)
                      ++++...+..++||||+++++|.+++....               ..++...++.++.|++.+|.|||+.|++|+||||+
T Consensus       153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~  232 (370)
T 2psq_A          153 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR  232 (370)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred             EEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchh
Confidence            999999999999999999999999997643               24788999999999999999999999999999999


Q ss_pred             cEEEccCCeEEEeeeccceeccCCCc---cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 045286          166 NLLMDTHNVVKVADFGVARFQNKGGV---MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL  241 (259)
Q Consensus       166 Nilv~~~~~i~l~D~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~  241 (259)
                      ||+++.++.++|+|||.+........   .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..
T Consensus       233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~  312 (370)
T 2psq_A          233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  312 (370)
T ss_dssp             GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            99999999999999999986654322   223346788999999999999999999999999999999 99999999888


Q ss_pred             HHHHHhhhccCCCCc
Q 045286          242 QAALGVRQVCTSLCQ  256 (259)
Q Consensus       242 ~~~~~i~~~~~~~~~  256 (259)
                      +....+..+.....+
T Consensus       313 ~~~~~~~~~~~~~~~  327 (370)
T 2psq_A          313 ELFKLLKEGHRMDKP  327 (370)
T ss_dssp             GHHHHHHTTCCCCCC
T ss_pred             HHHHHHhcCCCCCCC
Confidence            888888777654443

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.1e-41  Score=276.11  Aligned_cols=220  Identities=23%  Similarity=0.397  Sum_probs=197.6

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      .++|++.+.||+|++|.||+|.+.  ++.|++|++............+.+|+.++++++||||+++++++...+..++++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            468999999999999999999875  789999999987766666788899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCe---EEEeeeccceeccCCCc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV---VKVADFGVARFQNKGGV  191 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~---i~l~D~~~~~~~~~~~~  191 (259)
                      |++++++|.+.+.... .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.   ++|+|||.+........
T Consensus        85 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  163 (284)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence            9999999999886554 4899999999999999999999999999999999999976655   99999999987776665


Q ss_pred             cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          192 MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+..+......+
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T 3kk8_A          164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP  229 (284)
T ss_dssp             CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCch
Confidence            566789999999999999999999999999999999999999999999988888888776554443

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.9e-42  Score=279.32  Aligned_cols=227  Identities=31%  Similarity=0.609  Sum_probs=195.6

Q ss_pred             cccccceechhhhhccceeccccceEEEEEEEcC-ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec
Q 045286           28 TKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLG-QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK  106 (259)
Q Consensus        28 ~~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~-~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~  106 (259)
                      .....|+++.++|++.+.||+|+||.||++.+.+ ..|++|++.......   ..+.+|+.+++.++|+||+++++++..
T Consensus        14 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~   90 (283)
T 3gen_A           14 LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTK   90 (283)
T ss_dssp             --CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             CCCCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence            3456799999999999999999999999999864 589999998765443   568899999999999999999999999


Q ss_pred             CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          107 SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                      ....++||||+++++|.+++......+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  170 (283)
T 3gen_A           91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV  170 (283)
T ss_dssp             SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred             CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccc
Confidence            99999999999999999999775566999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCc--cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          187 NKGGV--MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       187 ~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      .....  .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+.++.....++
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~  244 (283)
T 3gen_A          171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH  244 (283)
T ss_dssp             CCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT
T ss_pred             cccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCC
Confidence            44321  123345678999999998889999999999999999998 999999999988888888776555443

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=5.9e-42  Score=286.74  Aligned_cols=218  Identities=24%  Similarity=0.412  Sum_probs=188.7

Q ss_pred             eechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhc-CCCCcceeeeeeecCCc
Q 045286           34 EIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPH  109 (259)
Q Consensus        34 ~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~  109 (259)
                      .+..++|.+.+.||+|+||.||+|.+.  ++.||+|+++.... .......+.+|..+++.+ +||||+++++++...+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            445578999999999999999999985  78999999986532 122345677888999887 89999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC-
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-  188 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~-  188 (259)
                      .++||||++|++|.+++.... .+++..+..++.|++.+|.+||+.|++||||||+||+++.+|.++|+|||++..... 
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  171 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence            999999999999999997644 489999999999999999999999999999999999999999999999999875432 


Q ss_pred             CCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       189 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      .......++++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+....+.....
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~  235 (345)
T 1xjd_A          172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP  235 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred             CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC
Confidence            2334556799999999999999999999999999999999999999999998888888776543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.9e-42  Score=300.47  Aligned_cols=217  Identities=24%  Similarity=0.363  Sum_probs=187.1

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC------C
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS------P  108 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~  108 (259)
                      .++|++.++||+|+||+||+|.+.  ++.||+|++............+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            368999999999999999999874  78999999988766666678899999999999999999999998654      3


Q ss_pred             cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      ..++||||+++ +|.+.+..   .+++..+..++.|++.+|.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred             eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence            57999999965 56666532   388999999999999999999999999999999999999999999999999987776


Q ss_pred             CCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       189 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      ........+++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+.+.++.++++
T Consensus       217 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~  285 (464)
T 3ttj_A          217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  285 (464)
T ss_dssp             CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            655666789999999999999999999999999999999999999999999999999999888877654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.1e-42  Score=284.21  Aligned_cols=215  Identities=27%  Similarity=0.456  Sum_probs=191.3

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCch----HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND----TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL  110 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~  110 (259)
                      .++|.+.+.||+|+||.||+|.+.  ++.||+|++.......    .....+.+|+.+++.++||||+++++++...+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            468999999999999999999985  7899999998764322    1346788999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC----eEEEeeeccceec
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN----VVKVADFGVARFQ  186 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~----~i~l~D~~~~~~~  186 (259)
                      ++|||++++++|.+++... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++    .++|+|||.+...
T Consensus        90 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~  168 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  168 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence            9999999999999999644 4589999999999999999999999999999999999998877    7999999999887


Q ss_pred             cCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          187 NKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       187 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      ..........+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+.+..+.....
T Consensus       169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~  234 (326)
T 2y0a_A          169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY  234 (326)
T ss_dssp             CTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC
T ss_pred             CCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC
Confidence            665555666799999999999999999999999999999999999999999888887777765443

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.2e-41  Score=283.34  Aligned_cols=220  Identities=23%  Similarity=0.370  Sum_probs=181.8

Q ss_pred             ceechhhhhccceeccccceEEEEEEE-----cCceEEEEEeecccCc--hHHHHHHHHHHHHHHhcCCCCcceeeeeee
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVY-----LGQDVAVKVLRSEHLN--DTLEDEFVQEVAILREVQHRNVVRFIGAST  105 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~-----~~~~v~vK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~  105 (259)
                      ..+..++|++.+.||+|+||.||++..     .++.||+|++......  ......+.+|+.+++.++||||+++++++.
T Consensus        12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   91 (327)
T 3a62_A           12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ   91 (327)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence            445668999999999999999999987     4789999999875432  223456788999999999999999999999


Q ss_pred             cCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          106 KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                      ..+..++||||+++++|.+++.... .+++..++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+..
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           92 TGGKLYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             CSSCEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            9999999999999999999996544 488999999999999999999999999999999999999999999999999875


Q ss_pred             ccCC-CccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          186 QNKG-GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       186 ~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      .... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.+....
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~  239 (327)
T 3a62_A          171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN  239 (327)
T ss_dssp             --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC
T ss_pred             cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence            4332 2334557899999999999999999999999999999999999999999888888877765443

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=287.71  Aligned_cols=226  Identities=30%  Similarity=0.561  Sum_probs=198.0

Q ss_pred             cccceechhhhhccceeccccceEEEEEEEcC---------ceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcce
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVYLG---------QDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVR   99 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~---------~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~   99 (259)
                      ...|++..++|++.++||+|+||.||+|.+.+         ..||+|++.... .......+.+|+.+++.+ +||||++
T Consensus        61 ~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~  139 (382)
T 3tt0_A           61 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIIN  139 (382)
T ss_dssp             CTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhh
Confidence            34589999999999999999999999999742         579999998763 344557788999999999 8999999


Q ss_pred             eeeeeecCCcEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 045286          100 FIGASTKSPHLCIVTEYMPGGSLYDYLHKNH---------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKT  164 (259)
Q Consensus       100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p  164 (259)
                      +++++...+..++|||++++++|.+++....               ..+++..++.++.|++.+|.+||+.|++|+||||
T Consensus       140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  219 (382)
T 3tt0_A          140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA  219 (382)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred             heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence            9999999999999999999999999997654               3489999999999999999999999999999999


Q ss_pred             CcEEEccCCeEEEeeeccceeccCCC---ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCH
Q 045286          165 ANLLMDTHNVVKVADFGVARFQNKGG---VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTP  240 (259)
Q Consensus       165 ~Nilv~~~~~i~l~D~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~  240 (259)
                      +||+++.++.++|+|||.+.......   ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+.
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~  299 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  299 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999998665432   2233456788999999999999999999999999999999 9999999999


Q ss_pred             HHHHHHhhhccCCCCc
Q 045286          241 LQAALGVRQVCTSLCQ  256 (259)
Q Consensus       241 ~~~~~~i~~~~~~~~~  256 (259)
                      .+....+.++.....+
T Consensus       300 ~~~~~~~~~~~~~~~~  315 (382)
T 3tt0_A          300 EELFKLLKEGHRMDKP  315 (382)
T ss_dssp             HHHHHHHHTTCCCCCC
T ss_pred             HHHHHHHHcCCCCCCC
Confidence            9888888877655444

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.5e-42  Score=298.38  Aligned_cols=221  Identities=20%  Similarity=0.337  Sum_probs=191.7

Q ss_pred             cccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeec
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN-DTLEDEFVQEVAILREVQHRNVVRFIGASTK  106 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~  106 (259)
                      .+...+..++|++.++||+|+||+||++.+.  ++.||+|++...... ......+.+|..+++.++||||+++++++..
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            3445666789999999999999999999985  688999999763221 1122347889999999999999999999999


Q ss_pred             CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          107 SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                      .+..++||||+++++|.+++......+++..++.++.|++.+|.+||+.|++||||||+|||++.++.++|+|||++...
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~  225 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL  225 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence            99999999999999999999776667999999999999999999999999999999999999999999999999999766


Q ss_pred             cCCCcc--ccCCCcccccCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          187 NKGGVM--TAETGTYRWMAPEVIN-----HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       187 ~~~~~~--~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      ......  ...+|++.|+|||++.     +..++.++|+|||||++|+|++|..||.+.+..+....|...
T Consensus       226 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~  296 (437)
T 4aw2_A          226 MEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH  296 (437)
T ss_dssp             CTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred             ccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhc
Confidence            544322  3457999999999986     456899999999999999999999999999988888887643

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-41  Score=282.16  Aligned_cols=213  Identities=26%  Similarity=0.477  Sum_probs=188.9

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN-DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      -++|++.+.||+|+||.||+|.+.  ++.||+|++...... ......+.+|..+++.++||||+++++++......++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            468899999999999999999974  889999999865321 12346678899999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT  193 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~  193 (259)
                      |||++|++|.+++.... .+++..++.++.|++.+|.+||+.|++|+||||+||+++.+|.++|+|||.+......  ..
T Consensus        85 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--~~  161 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TY  161 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BC
T ss_pred             EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc--cc
Confidence            99999999999996543 5899999999999999999999999999999999999999999999999999866543  33


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      ..++++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.....
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  220 (318)
T 1fot_A          162 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL  220 (318)
T ss_dssp             CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC
T ss_pred             cccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence            45789999999999999999999999999999999999999999888888887776543

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.1e-42  Score=293.21  Aligned_cols=227  Identities=33%  Similarity=0.582  Sum_probs=198.7

Q ss_pred             cccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS  107 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~  107 (259)
                      .+.|.++.++|.+.+.||+|+||.||+|.+.  ++.||+|+++... .......+.+|+++++.++||||+++++++...
T Consensus       106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  184 (377)
T 3cbl_A          106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK  184 (377)
T ss_dssp             CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence            4569999999999999999999999999985  7899999988653 344456788999999999999999999999988


Q ss_pred             CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      +..++||||+++++|.+++......++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus       185 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            89999999999999999998766668999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCccc---cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          188 KGGVMT---AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       188 ~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      ......   ...++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+.++...+.|+
T Consensus       265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~  338 (377)
T 3cbl_A          265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPE  338 (377)
T ss_dssp             TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCT
T ss_pred             CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            432111   1124567999999988889999999999999999998 999999999988888888877665554

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.1e-41  Score=279.49  Aligned_cols=211  Identities=24%  Similarity=0.448  Sum_probs=181.4

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      .++|++.+.||+|++|.||++.+.  ++.|++|++..... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            578999999999999999999975  78999999876543 345567889999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC--c
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG--V  191 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~--~  191 (259)
                      |||+++++|.+++.... .+++..++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+.......  .
T Consensus        90 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  168 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ  168 (294)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence            99999999999997654 58999999999999999999999999999999999999999999999999987654432  2


Q ss_pred             cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhh
Q 045286          192 MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVR  248 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~  248 (259)
                      .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+...+..
T Consensus       169 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~  225 (294)
T 4eqm_A          169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI  225 (294)
T ss_dssp             ------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHH
T ss_pred             cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh
Confidence            233468999999999999999999999999999999999999999888766554443

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=287.56  Aligned_cols=205  Identities=23%  Similarity=0.398  Sum_probs=182.6

Q ss_pred             cceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           32 DWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        32 ~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      ..++.-++|++.+.||+|+||.||++.+.  ++.||+|++..... .......+.+|+.+++.++||||+++++++...+
T Consensus         9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   88 (384)
T 4fr4_A            9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE   88 (384)
T ss_dssp             CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            34566689999999999999999999975  67899999976432 2233467889999999999999999999999999


Q ss_pred             cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      ..++||||++|++|..++... ..+++..++.++.|++.+|.|||+.|++|+||||+||+++.+|.++|+|||.+.....
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            999999999999999999654 4599999999999999999999999999999999999999999999999999988776


Q ss_pred             CCccccCCCcccccCccccCC---CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          189 GGVMTAETGTYRWMAPEVINH---QPYDQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       189 ~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                      .......++++.|+|||++.+   ..++.++|+|||||++|+|++|..||..
T Consensus       168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~  219 (384)
T 4fr4_A          168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI  219 (384)
T ss_dssp             TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCC
Confidence            666677789999999999864   4589999999999999999999999974

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-41  Score=288.30  Aligned_cols=213  Identities=21%  Similarity=0.423  Sum_probs=191.1

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ++|++.+.||+|+||.||+|.+.  ++.+++|++....  ......+.+|+.+++.++||||+++++++......++|||
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            57999999999999999999984  7899999998653  2334578899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc--CCeEEEeeeccceeccCCCccc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT--HNVVKVADFGVARFQNKGGVMT  193 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~--~~~i~l~D~~~~~~~~~~~~~~  193 (259)
                      |+++++|.+++......+++..++.++.|++.+|.+||+.|++|+||||+||+++.  ++.++|+|||.+..........
T Consensus       129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~  208 (387)
T 1kob_A          129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK  208 (387)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCccee
Confidence            99999999999766667999999999999999999999999999999999999974  4679999999998877665555


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      ...+++.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+.+..+.+...
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~  267 (387)
T 1kob_A          209 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW  267 (387)
T ss_dssp             EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC
T ss_pred             eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence            66799999999999999999999999999999999999999999988888888776543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.1e-41  Score=286.07  Aligned_cols=217  Identities=24%  Similarity=0.380  Sum_probs=189.0

Q ss_pred             echhhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhc-CCCCcceeeeeeecCCcE
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHL  110 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~  110 (259)
                      +.-.+|++.+.||+|+||.||+|.+.  ++.||+|++..... .......+.+|..+++.+ +||+|+++++++...+..
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            33478999999999999999999985  57899999986532 123346678899999988 699999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc-CC
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN-KG  189 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~-~~  189 (259)
                      ++||||++|++|.+++.... .+++..++.++.|++.+|.+||+.|++||||||+||+++.+|.++|+|||++.... ..
T Consensus        97 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence            99999999999999997654 48999999999999999999999999999999999999999999999999997543 23


Q ss_pred             CccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          190 GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       190 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      ......++++.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+....+.....
T Consensus       176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~  238 (353)
T 2i0e_A          176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV  238 (353)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred             cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC
Confidence            334556799999999999999999999999999999999999999999998888888776543

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.4e-42  Score=296.45  Aligned_cols=218  Identities=23%  Similarity=0.355  Sum_probs=190.3

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN-DTLEDEFVQEVAILREVQHRNVVRFIGASTKS  107 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~  107 (259)
                      ....+..++|.+.++||+|+||.||+|.+.  ++.||+|++...... ......+.+|..+++.++||||+++++++...
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            446667789999999999999999999985  789999999763211 11124477899999999999999999999999


Q ss_pred             CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      +..++||||++|++|.+++...  .+++..++.++.|++.+|.+||+.|++||||||+||+++.+|.++|+|||.+....
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~  219 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  219 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence            9999999999999999998654  48999999999999999999999999999999999999999999999999998766


Q ss_pred             CCCc--cccCCCcccccCccccCCCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          188 KGGV--MTAETGTYRWMAPEVINHQP----YDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       188 ~~~~--~~~~~~~~~~~~PE~~~~~~----~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      ....  ....++++.|+|||++.+..    ++.++|+||||+++|+|++|..||.+.+..+...+|...
T Consensus       220 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~  288 (410)
T 3v8s_A          220 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH  288 (410)
T ss_dssp             TTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred             cCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhc
Confidence            5432  23567999999999997665    789999999999999999999999999998888888764

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.7e-41  Score=274.12  Aligned_cols=222  Identities=31%  Similarity=0.630  Sum_probs=196.0

Q ss_pred             cceechhhhhccceeccccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcE
Q 045286           32 DWEIDRRLLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL  110 (259)
Q Consensus        32 ~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~  110 (259)
                      +|.++.++|++.+.||+|++|.||++.+. ++.|++|++.......   +.+.+|+.+++.++||||+++++++...+..
T Consensus         2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   78 (267)
T 3t9t_A            2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   78 (267)
T ss_dssp             -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence            58889999999999999999999999984 6789999998765443   5688999999999999999999999998999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      +++||++++++|.+++......++...++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence            99999999999999998776778999999999999999999999999999999999999999999999999987654321


Q ss_pred             --ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          191 --VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       191 --~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                        ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+..+.....+
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~  227 (267)
T 3t9t_A          159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP  227 (267)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC
T ss_pred             ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCC
Confidence              1123346778999999988889999999999999999999 99999999998888888877655444

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.3e-41  Score=285.29  Aligned_cols=216  Identities=24%  Similarity=0.374  Sum_probs=191.6

Q ss_pred             echhhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEE
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~  111 (259)
                      ..-++|++.+.||+|+||.||+|.+.  ++.||+|++..... .......+.+|+.+++.++||||+++++++...+..+
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  117 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            44578999999999999999999984  78999999976532 1233467889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc
Q 045286          112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV  191 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~  191 (259)
                      +||||+++++|.+++.... .+++..++.++.|++.+|.+||+.|++||||||+||+++.+|.++|+|||.+......  
T Consensus       118 lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--  194 (350)
T 1rdq_E          118 MVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             EEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence            9999999999999997654 4899999999999999999999999999999999999999999999999999876543  


Q ss_pred             cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          192 MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ....++++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+..+...
T Consensus       195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~  256 (350)
T 1rdq_E          195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR  256 (350)
T ss_dssp             BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred             cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCC
Confidence            23456899999999999999999999999999999999999999999988888888776443

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.2e-41  Score=293.05  Aligned_cols=221  Identities=34%  Similarity=0.637  Sum_probs=194.2

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC-c
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP-H  109 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~  109 (259)
                      ..|++..++|++.+.||+|+||.||++.+.++.||||+++...    ..+.+.+|+.++++++||||+++++++...+ .
T Consensus       186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  261 (450)
T 1k9a_A          186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG  261 (450)
T ss_dssp             TTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred             cccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence            5689999999999999999999999999999999999998754    2367889999999999999999999976654 7


Q ss_pred             EEEEEecCCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHN-VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      .++||||+++++|.+++..... .++...++.++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus       262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            8999999999999999976654 368999999999999999999999999999999999999999999999999975543


Q ss_pred             CCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       189 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      ..  ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+.++.+...|+
T Consensus       342 ~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~  409 (450)
T 1k9a_A          342 TQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD  409 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCT
T ss_pred             cc--cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            32  22356788999999999999999999999999999998 999999988888888888887665543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-41  Score=283.91  Aligned_cols=225  Identities=30%  Similarity=0.537  Sum_probs=195.6

Q ss_pred             cceechhhhhccceeccccceEEEEEEEcC-------ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeee
Q 045286           32 DWEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAS  104 (259)
Q Consensus        32 ~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~-------~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~  104 (259)
                      .+++..++|++.+.||+|+||.||+|.+.+       +.|++|++.... .......+.+|+.+++.++||||+++++++
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            467788999999999999999999999864       789999998654 344567889999999999999999999999


Q ss_pred             ecCCcEEEEEecCCCCChHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 045286          105 TKSPHLCIVTEYMPGGSLYDYLHKNH-----------------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRD  161 (259)
Q Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d  161 (259)
                      ...+..++||||+++++|.+++....                       ..+++..++.++.|++.+|.+||+.|++|+|
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D  199 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD  199 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            99999999999999999999997642                       4588999999999999999999999999999


Q ss_pred             CCCCcEEEccCCeEEEeeeccceeccCCC---ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 045286          162 LKTANLLMDTHNVVKVADFGVARFQNKGG---VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDS  237 (259)
Q Consensus       162 i~p~Nilv~~~~~i~l~D~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~  237 (259)
                      |||+||+++.++.++|+|||.+.......   ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            99999999999999999999987554322   1223456788999999988889999999999999999999 9999999


Q ss_pred             CCHHHHHHHhhhccCCCCcc
Q 045286          238 MTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       238 ~~~~~~~~~i~~~~~~~~~~  257 (259)
                      .+..+....+.++.....++
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~  299 (343)
T 1luf_A          280 MAHEEVIYYVRDGNILACPE  299 (343)
T ss_dssp             SCHHHHHHHHHTTCCCCCCT
T ss_pred             CChHHHHHHHhCCCcCCCCC
Confidence            99988888888776554443

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=7.1e-41  Score=280.44  Aligned_cols=202  Identities=24%  Similarity=0.407  Sum_probs=180.0

Q ss_pred             echhhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhc-CCCCcceeeeeeecCCcE
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHL  110 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~  110 (259)
                      +.-.+|++.+.||+|+||.||+|.+.  ++.||+|++..... .......+.+|..+++.+ +||||+++++++...+..
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   85 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   85 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence            34578999999999999999999975  78999999987654 334556788999999988 799999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc-CC
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN-KG  189 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~-~~  189 (259)
                      ++||||+++++|.+++.... .+++..++.++.|++.+|.+||+.|++||||||+||+++.++.++|+|||.+.... ..
T Consensus        86 ~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            99999999999999996554 48999999999999999999999999999999999999999999999999997533 33


Q ss_pred             CccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          190 GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       190 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                      ......++++.|+|||.+.+..++.++|+|||||++|+|++|..||..
T Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  212 (345)
T 3a8x_A          165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  212 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence            344566899999999999999999999999999999999999999965

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.6e-41  Score=281.39  Aligned_cols=216  Identities=25%  Similarity=0.441  Sum_probs=174.5

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      .+|++.++||+|+||.||+|.+.  ++.||+|++..... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            57899999999999999999874  78999999986542 2223567899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-
Q 045286          116 YMPGGSLYDYLHKNH-----NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-  189 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-  189 (259)
                      |++ ++|.+++....     ..+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+...... 
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  162 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV  162 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence            997 59999886432     35889999999999999999999999999999999999999999999999999876543 


Q ss_pred             CccccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCC
Q 045286          190 GVMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLC  255 (259)
Q Consensus       190 ~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~  255 (259)
                      .......+++.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+..+.+..+.+..+.+.
T Consensus       163 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  229 (317)
T 2pmi_A          163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN  229 (317)
T ss_dssp             CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred             ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            233455789999999999764 689999999999999999999999999999988888877655443

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.3e-41  Score=275.66  Aligned_cols=223  Identities=26%  Similarity=0.557  Sum_probs=183.0

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEc-----CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeee
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST  105 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~  105 (259)
                      ..|++..++|++.++||+|+||.||+|.+.     +..|++|...... .....+.+.+|+.+++.++||||+++++++.
T Consensus         8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   86 (281)
T 1mp8_A            8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT   86 (281)
T ss_dssp             -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence            468899999999999999999999999874     3469999987643 3455677899999999999999999999985


Q ss_pred             cCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          106 KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                       .+..++|||++++++|.+++......++...++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+..
T Consensus        87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence             4578899999999999999987766799999999999999999999999999999999999999999999999999976


Q ss_pred             ccCCCcc--ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCC
Q 045286          186 QNKGGVM--TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLC  255 (259)
Q Consensus       186 ~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~  255 (259)
                      .......  ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+..+.....
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~  238 (281)
T 1mp8_A          166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM  238 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC
T ss_pred             cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCC
Confidence            6543222  23345678999999998889999999999999999997 9999999888888888877654443

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5e-42  Score=293.24  Aligned_cols=219  Identities=20%  Similarity=0.318  Sum_probs=191.2

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKS  107 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~  107 (259)
                      +...+..++|++.++||+|+||.||++...  ++.||+|++..... .......+.+|..++..++|+||+++++++...
T Consensus        54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  133 (412)
T 2vd5_A           54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE  133 (412)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            345566789999999999999999999984  88999999976422 112234577899999999999999999999999


Q ss_pred             CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      +..++||||++|++|.+++......+++..++.++.|++.+|.+||+.|++||||||+||+++.++.++|+|||++....
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~  213 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR  213 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence            99999999999999999998766679999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCc--cccCCCcccccCccccC-------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          188 KGGV--MTAETGTYRWMAPEVIN-------HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       188 ~~~~--~~~~~~~~~~~~PE~~~-------~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                      ....  ....++++.|+|||++.       +..++.++|+|||||++|+|++|..||...+..+....|..
T Consensus       214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  284 (412)
T 2vd5_A          214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH  284 (412)
T ss_dssp             TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred             CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            5432  23457999999999986       35689999999999999999999999999988888777764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.9e-41  Score=286.19  Aligned_cols=204  Identities=24%  Similarity=0.406  Sum_probs=178.4

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCch-HHHHHHHHHHHHHHhc-CCCCcceeeeeeecCC
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND-TLEDEFVQEVAILREV-QHRNVVRFIGASTKSP  108 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~  108 (259)
                      ..+.-++|++.++||+|+||.||+|.+.  ++.||+|+++...... .....+.+|..+++++ +||||+++++++...+
T Consensus        47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~  126 (396)
T 4dc2_A           47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES  126 (396)
T ss_dssp             --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence            3455678999999999999999999975  7789999998764432 3335577899999887 7999999999999999


Q ss_pred             cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceec-c
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ-N  187 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~-~  187 (259)
                      ..++||||+++++|..++.... .+++..++.++.|++.+|.+||+.|++||||||+||+++.+|.++|+|||++... .
T Consensus       127 ~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          127 RLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEEEEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            9999999999999999997654 4999999999999999999999999999999999999999999999999999753 3


Q ss_pred             CCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          188 KGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       188 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                      ........++++.|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus       206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~  255 (396)
T 4dc2_A          206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  255 (396)
T ss_dssp             TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred             CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence            33445567899999999999999999999999999999999999999963

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.6e-41  Score=285.61  Aligned_cols=218  Identities=26%  Similarity=0.398  Sum_probs=182.3

Q ss_pred             eechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCch-HHHHHHHHHHHH-HHhcCCCCcceeeeeeecCCc
Q 045286           34 EIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND-TLEDEFVQEVAI-LREVQHRNVVRFIGASTKSPH  109 (259)
Q Consensus        34 ~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~-~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~  109 (259)
                      .+..++|++.+.||+|+||.||+|.+.  ++.||+|++....... .....+.+|..+ ++.++||||+++++++...+.
T Consensus        34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~  113 (373)
T 2r5t_A           34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK  113 (373)
T ss_dssp             TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred             CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence            345578999999999999999999985  6789999998765432 333456666666 467889999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc-C
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN-K  188 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~-~  188 (259)
                      .++||||++|++|.+++.... .+++..++.++.|++.+|.+||+.|++||||||+||+++.+|.++|+|||++.... .
T Consensus       114 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            999999999999999997654 48899999999999999999999999999999999999999999999999987533 3


Q ss_pred             CCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       189 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      .......++++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+.....
T Consensus       193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~  256 (373)
T 2r5t_A          193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL  256 (373)
T ss_dssp             CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC
T ss_pred             CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc
Confidence            3344566799999999999999999999999999999999999999999998888888876543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.8e-41  Score=286.48  Aligned_cols=215  Identities=25%  Similarity=0.393  Sum_probs=178.1

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCC--cEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSP--HLCI  112 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~--~~~l  112 (259)
                      ++|++.++||+|+||.||+|.+.  ++.||+|++............+.+|+.+++.+. |+||+++++++...+  ..++
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l   88 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL   88 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence            58899999999999999999874  789999999876666666788889999999997 999999999986543  7899


Q ss_pred             EEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC----
Q 045286          113 VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK----  188 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~----  188 (259)
                      ||||++ ++|..++...  .++...+..++.|++.+|.|||+.|++||||||+||+++.++.++|+|||++.....    
T Consensus        89 v~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  165 (388)
T 3oz6_A           89 VFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV  165 (388)
T ss_dssp             EEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred             EecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence            999996 5899988653  488999999999999999999999999999999999999999999999999976532    


Q ss_pred             ------------------CCccccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          189 ------------------GGVMTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       189 ------------------~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                                        ........+++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+.+..+..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~  245 (388)
T 3oz6_A          166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG  245 (388)
T ss_dssp             CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence                              112234578999999999976 6789999999999999999999999999999999988887


Q ss_pred             ccCCCC
Q 045286          250 VCTSLC  255 (259)
Q Consensus       250 ~~~~~~  255 (259)
                      ..+.+.
T Consensus       246 ~~~~p~  251 (388)
T 3oz6_A          246 VIDFPS  251 (388)
T ss_dssp             HHCCCC
T ss_pred             hcCCCC
Confidence            665544

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.2e-41  Score=294.88  Aligned_cols=219  Identities=26%  Similarity=0.450  Sum_probs=191.1

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      .++|++.++||+|+||+||+|.+.  ++.||+|++............+.+|+.++++++||||+++++++......++|+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            468999999999999999999985  889999999765433334577889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc---cCCeEEEeeeccceeccCCCc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD---THNVVKVADFGVARFQNKGGV  191 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~---~~~~i~l~D~~~~~~~~~~~~  191 (259)
                      |++++++|.+.+.... .+++..++.++.|++.+|.|||+.|++|+||||+||+++   .++.++|+|||.+........
T Consensus       101 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~  179 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK  179 (486)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred             EcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence            9999999999886554 489999999999999999999999999999999999995   456799999999987766655


Q ss_pred             cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          192 MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      .....+++.|+|||++.+ .++.++|+|||||++|+|++|..||.+.+..+.+..+..+......|
T Consensus       180 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  244 (486)
T 3mwu_A          180 MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP  244 (486)
T ss_dssp             --CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG
T ss_pred             cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence            666789999999999976 48999999999999999999999999999999999888776554433

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.2e-41  Score=284.64  Aligned_cols=210  Identities=23%  Similarity=0.423  Sum_probs=182.6

Q ss_pred             ccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecCCC
Q 045286           42 TGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPG  119 (259)
Q Consensus        42 ~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~  119 (259)
                      ..++||+|+||.||+|.+.  ++.|++|++.....  .....+.+|+.++++++||||+++++++...+..++||||+++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~  170 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG  170 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence            3678999999999999974  78999999987532  3456788999999999999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE--ccCCeEEEeeeccceeccCCCccccCCC
Q 045286          120 GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM--DTHNVVKVADFGVARFQNKGGVMTAETG  197 (259)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv--~~~~~i~l~D~~~~~~~~~~~~~~~~~~  197 (259)
                      ++|.+++......+++..++.++.|++.+|.+||+.|++|+||||+||++  +.++.++|+|||.+.............+
T Consensus       171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~g  250 (373)
T 2x4f_A          171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFG  250 (373)
T ss_dssp             CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCS
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccC
Confidence            99999987665568999999999999999999999999999999999999  4567899999999988776655566679


Q ss_pred             cccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          198 TYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       198 ~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+.+..+......
T Consensus       251 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~  306 (373)
T 2x4f_A          251 TPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD  306 (373)
T ss_dssp             SCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC
T ss_pred             CCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC
Confidence            99999999999989999999999999999999999999999988888887765443

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.4e-41  Score=295.22  Aligned_cols=220  Identities=25%  Similarity=0.463  Sum_probs=189.7

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      .++|++.++||+|+||+||+|.+.  +..||+|++............+.+|+.+++.++||||+++++++......++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            458999999999999999999984  789999999876544444577889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC---CeEEEeeeccceeccCCCc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH---NVVKVADFGVARFQNKGGV  191 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~---~~i~l~D~~~~~~~~~~~~  191 (259)
                      ||+++++|.+.+.... .+++..++.++.|++.+|.|||+.|++|+||||+||+++.+   +.++|+|||.+........
T Consensus       116 e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~  194 (494)
T 3lij_A          116 ECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK  194 (494)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc
Confidence            9999999999886554 48999999999999999999999999999999999999764   4599999999988777666


Q ss_pred             cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCccC
Q 045286          192 MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPI  258 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  258 (259)
                      .....+++.|+|||++.+ .++.++|+|||||++|+|++|..||.+.+..+.+..+.++......|.
T Consensus       195 ~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  260 (494)
T 3lij_A          195 MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPE  260 (494)
T ss_dssp             BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGG
T ss_pred             ccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchh
Confidence            667789999999999864 589999999999999999999999999999999999988776655443

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.8e-41  Score=273.34  Aligned_cols=225  Identities=27%  Similarity=0.538  Sum_probs=194.7

Q ss_pred             ccceechhhhhccc-eeccccceEEEEEEE----cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeee
Q 045286           31 EDWEIDRRLLKTGE-RIASGSCGDLYRGVY----LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST  105 (259)
Q Consensus        31 ~~~~~~~~~~~~~~-~lg~G~~~~V~~~~~----~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~  105 (259)
                      +.+.++.++|.+.+ .||+|++|.||+|.+    .+..|++|++.... .......+.+|+.+++.++||||+++++++.
T Consensus         2 ~~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   80 (287)
T 1u59_A            2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ   80 (287)
T ss_dssp             CCCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CcccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEec
Confidence            45778888888887 999999999999985    46789999998753 3455678899999999999999999999984


Q ss_pred             cCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          106 KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                       .+..++|+|++++++|.+++......+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus        81 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  159 (287)
T 1u59_A           81 -AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA  159 (287)
T ss_dssp             -SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             -CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceee
Confidence             5678999999999999999976666799999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCcc----ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          186 QNKGGVM----TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       186 ~~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      .......    ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+..+.....++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~  236 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP  236 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT
T ss_pred             eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCC
Confidence            6544322    22345788999999988889999999999999999998 999999988888888887776554443

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.4e-41  Score=285.17  Aligned_cols=217  Identities=24%  Similarity=0.361  Sum_probs=181.3

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC------
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP------  108 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------  108 (259)
                      .++|++.+.||+|+||.||+|.+.  ++.||+|++............+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            368999999999999999999874  789999999877666666778899999999999999999999987654      


Q ss_pred             cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      ..++|||++++ +|.+.+.   ..++...+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+.....
T Consensus       104 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  179 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred             ceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence            78999999964 7888774   2488999999999999999999999999999999999999999999999999987665


Q ss_pred             CCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       189 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      ........+++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+.+..+.+..+.++++
T Consensus       180 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  248 (371)
T 2xrw_A          180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE  248 (371)
T ss_dssp             ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHH
T ss_pred             ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            544555678999999999999999999999999999999999999999999999988888877776653

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=9.9e-41  Score=275.61  Aligned_cols=202  Identities=36%  Similarity=0.558  Sum_probs=180.3

Q ss_pred             eechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEE
Q 045286           34 EIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        34 ~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~  111 (259)
                      .+...+|++.++||+|+||+||++.+.  ++.|++|.+...  .......+.+|+.+++.++||||+++++++...+..+
T Consensus         6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   83 (310)
T 3s95_A            6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN   83 (310)
T ss_dssp             EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence            456689999999999999999999985  789999988653  4555678999999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc
Q 045286          112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV  191 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~  191 (259)
                      +||||+++++|.+++......+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+........
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            99999999999999988777799999999999999999999999999999999999999999999999999976544322


Q ss_pred             c---------------ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          192 M---------------TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       192 ~---------------~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                      .               ....+++.|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~  224 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD  224 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTT
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcc
Confidence            1               134689999999999999999999999999999999999999865

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4.7e-41  Score=282.21  Aligned_cols=222  Identities=24%  Similarity=0.383  Sum_probs=192.6

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec--------
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK--------  106 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------  106 (259)
                      -.+|++.++||+|++|.||+|.+.  ++.||+|++............+.+|+.+++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            478999999999999999999984  7899999998776555555678899999999999999999998876        


Q ss_pred             CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          107 SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                      .+..++||||+++ +|...+......+++..++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+...
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  174 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF  174 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence            3468999999965 888888766667999999999999999999999999999999999999999999999999999765


Q ss_pred             cCC-----CccccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCccCC
Q 045286          187 NKG-----GVMTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY  259 (259)
Q Consensus       187 ~~~-----~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~  259 (259)
                      ...     .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+.+..+.+.+....++.|
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  253 (351)
T 3mi9_A          175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW  253 (351)
T ss_dssp             CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence            422     22344567999999999876 46799999999999999999999999999999999999888777766543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-41  Score=278.96  Aligned_cols=220  Identities=27%  Similarity=0.375  Sum_probs=185.1

Q ss_pred             chhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCc---hHHHHHHHHHHHHHHhc---CCCCcceeeeeeecC
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLN---DTLEDEFVQEVAILREV---QHRNVVRFIGASTKS  107 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~---~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~  107 (259)
                      ...+|++.++||+|+||+||+|.+  .++.||+|++......   ......+.+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            357899999999999999999996  4789999999854321   11123455666666666   499999999998765


Q ss_pred             C-----cEEEEEecCCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeec
Q 045286          108 P-----HLCIVTEYMPGGSLYDYLHKNHN-VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFG  181 (259)
Q Consensus       108 ~-----~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~  181 (259)
                      .     ..++++|+++ ++|.+++..... .+++..++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  165 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG  165 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence            4     5899999996 599999876543 38999999999999999999999999999999999999999999999999


Q ss_pred             cceeccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          182 VARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      .+.............+++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+.+..+.+....+..
T Consensus       166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (308)
T 3g33_A          166 LARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE  240 (308)
T ss_dssp             CTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            998776655556667899999999999999999999999999999999999999999999998888876655443

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6.1e-41  Score=278.25  Aligned_cols=215  Identities=27%  Similarity=0.466  Sum_probs=191.7

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCch----HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND----TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL  110 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~  110 (259)
                      .++|++.+.||+|++|.||+|.+.  ++.|++|++.......    .....+.+|+.+++.++||||+++++++...+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            468999999999999999999985  7899999998764332    1346788999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC----eEEEeeeccceec
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN----VVKVADFGVARFQ  186 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~----~i~l~D~~~~~~~  186 (259)
                      ++|||++++++|.+++... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++    .++|+|||.+...
T Consensus        91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~  169 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence            9999999999999999653 4588999999999999999999999999999999999999887    7999999999877


Q ss_pred             cCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          187 NKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       187 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      ..........+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+.+..+.....
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  235 (321)
T 2a2a_A          170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY  235 (321)
T ss_dssp             CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC
T ss_pred             CccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc
Confidence            766555666789999999999999999999999999999999999999999888888777766543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.9e-41  Score=277.44  Aligned_cols=216  Identities=22%  Similarity=0.356  Sum_probs=185.1

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ++|++.++||+|++|.||+|.+.  ++.|++|++............+.+|+.++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            46889999999999999999985  7899999998876666667888899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-Ccccc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVMTA  194 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~~~  194 (259)
                      ++++++|.+++... ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...... .....
T Consensus        83 ~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  161 (311)
T 4agu_A           83 YCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD  161 (311)
T ss_dssp             CCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred             eCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCC
Confidence            99998888887543 45899999999999999999999999999999999999999999999999999876543 23345


Q ss_pred             CCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          195 ETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      ..+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+....+.+.....
T Consensus       162 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  222 (311)
T 4agu_A          162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDL  222 (311)
T ss_dssp             ----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred             CcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccc
Confidence            578999999999876 568999999999999999999999999999988888877665443

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.7e-41  Score=285.01  Aligned_cols=222  Identities=30%  Similarity=0.517  Sum_probs=183.8

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc-----CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS  107 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~  107 (259)
                      .+++..+|.+.+.||+|+||.||+|.+.     +..||+|.++... .......+.+|+.++++++||||+++++++...
T Consensus        40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  118 (373)
T 2qol_A           40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS  118 (373)
T ss_dssp             CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence            4677789999999999999999999864     5679999998653 344557899999999999999999999999999


Q ss_pred             CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      +..++||||+++++|.+++......++...++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+....
T Consensus       119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            99999999999999999998776679999999999999999999999999999999999999999999999999997655


Q ss_pred             CCCcc----ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCC
Q 045286          188 KGGVM----TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLC  255 (259)
Q Consensus       188 ~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~  255 (259)
                      .....    ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+..+...+.
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~  271 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP  271 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            43211    11234678999999998899999999999999999998 9999999999888888877765443

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.3e-41  Score=284.17  Aligned_cols=214  Identities=25%  Similarity=0.420  Sum_probs=182.3

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCc---hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN---DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~  111 (259)
                      .++|++.+.||+|+||.||+|.+.  ++.||+|++......   ....+.+.+|+.+++.++||||+++++++...+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            568999999999999999999874  789999999754211   113467889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCe---EEEeeecccee
Q 045286          112 IVTEYMPGGSLYDYLHKN---HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV---VKVADFGVARF  185 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~---i~l~D~~~~~~  185 (259)
                      +||||+++++|.+.+...   ...+++..++.++.|++.+|.|||+.|++|+||||+||+++.++.   ++|+|||.+..
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~  182 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ  182 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence            999999999998887543   335899999999999999999999999999999999999987654   99999999987


Q ss_pred             ccCCCc-cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          186 QNKGGV-MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       186 ~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ...... .....+++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+ .+....+.++.
T Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~  248 (351)
T 3c0i_A          183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGK  248 (351)
T ss_dssp             CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTC
T ss_pred             ecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCC
Confidence            665432 345679999999999999999999999999999999999999998753 44455554443

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.4e-40  Score=270.46  Aligned_cols=214  Identities=25%  Similarity=0.450  Sum_probs=190.8

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      .++|++.++||+|++|.||+|.+.  +..+++|++.......  .+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM   85 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence            468999999999999999999985  5689999988754332  467889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE---ccCCeEEEeeeccceeccCCCc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM---DTHNVVKVADFGVARFQNKGGV  191 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv---~~~~~i~l~D~~~~~~~~~~~~  191 (259)
                      ||+++++|.+++.... .+++..++.++.|++.+|.+||+.|++|+||+|+||++   +.++.++|+|||.+........
T Consensus        86 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~  164 (277)
T 3f3z_A           86 ELCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM  164 (277)
T ss_dssp             ECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred             eccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence            9999999999986554 48999999999999999999999999999999999999   7788999999999988776666


Q ss_pred             cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          192 MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      .....+++.|+|||.+.+. ++.++|+||||+++|+|++|..||...+..+....+.++....
T Consensus       165 ~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  226 (277)
T 3f3z_A          165 MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTF  226 (277)
T ss_dssp             BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            6677899999999998765 8999999999999999999999999999888888887765543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=7.1e-41  Score=280.99  Aligned_cols=213  Identities=23%  Similarity=0.366  Sum_probs=168.2

Q ss_pred             chhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      -.++|++.+.||+|+||.||+|.+.  ++.||+|++....    ..+.+.+|+.++++++||||+++++++...+..++|
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            3567999999999999999999985  6789999998653    235677899999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc---CCeEEEeeeccceeccCCC
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT---HNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~---~~~i~l~D~~~~~~~~~~~  190 (259)
                      |||+++++|.+++... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.   ++.++|+|||.+.......
T Consensus       127 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  205 (349)
T 2w4o_A          127 LELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV  205 (349)
T ss_dssp             ECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             EEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence            9999999999998654 45899999999999999999999999999999999999975   7899999999998766554


Q ss_pred             ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHhhhccCC
Q 045286          191 VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQ-AALGVRQVCTS  253 (259)
Q Consensus       191 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~-~~~~i~~~~~~  253 (259)
                      ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||......+ ....+......
T Consensus       206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~  269 (349)
T 2w4o_A          206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY  269 (349)
T ss_dssp             -------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC
T ss_pred             ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc
Confidence            4556678999999999999999999999999999999999999997655443 55555554433

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.8e-41  Score=275.54  Aligned_cols=214  Identities=39%  Similarity=0.740  Sum_probs=175.1

Q ss_pred             ccccceechhhhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           29 KSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        29 ~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      ..+.+++...+|++.++||+|+||.||++.+.+ .+++|+++...........+.+|+.+++.++|+||++++++. ..+
T Consensus        15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~   92 (289)
T 3og7_A           15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP   92 (289)
T ss_dssp             ---CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred             CCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence            345689999999999999999999999998765 599999988777777778899999999999999999999965 455


Q ss_pred             cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      ..++|+||+++++|.+++......++...++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A           93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccc
Confidence            78899999999999999977767799999999999999999999999999999999999999999999999999875543


Q ss_pred             C---CccccCCCcccccCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 045286          189 G---GVMTAETGTYRWMAPEVIN---HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAA  244 (259)
Q Consensus       189 ~---~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~  244 (259)
                      .   .......+++.|+|||.+.   +..++.++|+||||+++|+|++|..||...+..+.+
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~  234 (289)
T 3og7_A          173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI  234 (289)
T ss_dssp             -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH
T ss_pred             ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH
Confidence            2   2223456899999999986   567888999999999999999999999875554433

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1e-40  Score=275.71  Aligned_cols=225  Identities=28%  Similarity=0.528  Sum_probs=195.2

Q ss_pred             cccceechhhhhccceeccccceEEEEEEEc-------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeee
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG  102 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~  102 (259)
                      ...|++..++|.+.+.||+|+||.||+|.+.       ++.|++|++.... .......+.+|+.+++.++||||+++++
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~   93 (314)
T 2ivs_A           15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYG   93 (314)
T ss_dssp             CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence            3568899999999999999999999999873       3789999998653 3455577899999999999999999999


Q ss_pred             eeecCCcEEEEEecCCCCChHHHHHhcCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 045286          103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHN-----------------------VLKLPQLLRFAIDICKGMEYLHQRNIIH  159 (259)
Q Consensus       103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------------------~~~~~~~~~i~~ql~~~l~~lH~~~i~H  159 (259)
                      ++...+..++||||+++++|.+++.....                       .+++..++.++.|++.+|.+||+.|++|
T Consensus        94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH  173 (314)
T 2ivs_A           94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH  173 (314)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence            99999999999999999999999976432                       3788999999999999999999999999


Q ss_pred             CCCCCCcEEEccCCeEEEeeeccceeccCCCcc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCC
Q 045286          160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY  235 (259)
Q Consensus       160 ~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~  235 (259)
                      +||+|+||+++.++.++|+|||.+.........   ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  253 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY  253 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999999999999866543322   23346788999999998889999999999999999999 99999


Q ss_pred             CCCCHHHHHHHhhhccCCCC
Q 045286          236 DSMTPLQAALGVRQVCTSLC  255 (259)
Q Consensus       236 ~~~~~~~~~~~i~~~~~~~~  255 (259)
                      .+.+..+....+..+.....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~  273 (314)
T 2ivs_A          254 PGIPPERLFNLLKTGHRMER  273 (314)
T ss_dssp             TTCCGGGHHHHHHTTCCCCC
T ss_pred             CCCCHHHHHHHhhcCCcCCC
Confidence            99888888777776654433

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=5e-41  Score=283.71  Aligned_cols=226  Identities=30%  Similarity=0.464  Sum_probs=192.7

Q ss_pred             cccceechhhhhccceeccccceEEEEEEEc-------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeee
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG  102 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~  102 (259)
                      .+..++..++|++.++||+|+||.||+|.+.       ++.||+|.+.... .......+.+|+.+++.++||||+++++
T Consensus        63 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~  141 (367)
T 3l9p_A           63 SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIG  141 (367)
T ss_dssp             GGSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cchhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3456788899999999999999999999853       4689999997543 3344567889999999999999999999


Q ss_pred             eeecCCcEEEEEecCCCCChHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC---
Q 045286          103 ASTKSPHLCIVTEYMPGGSLYDYLHKNH------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN---  173 (259)
Q Consensus       103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~---  173 (259)
                      ++......++||||+++++|.+++....      ..++...++.++.|++.+|.+||+.|++||||||+||+++.++   
T Consensus       142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~  221 (367)
T 3l9p_A          142 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR  221 (367)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred             EEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCc
Confidence            9999889999999999999999997643      3488899999999999999999999999999999999998555   


Q ss_pred             eEEEeeeccceeccCC---CccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 045286          174 VVKVADFGVARFQNKG---GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       174 ~i~l~D~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~  249 (259)
                      .++|+|||.+......   .......+++.|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+....+..
T Consensus       222 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~  301 (367)
T 3l9p_A          222 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS  301 (367)
T ss_dssp             CEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred             eEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            5999999998754222   12223456889999999998899999999999999999998 9999999999998888887


Q ss_pred             ccCCCCc
Q 045286          250 VCTSLCQ  256 (259)
Q Consensus       250 ~~~~~~~  256 (259)
                      +.....+
T Consensus       302 ~~~~~~~  308 (367)
T 3l9p_A          302 GGRMDPP  308 (367)
T ss_dssp             TCCCCCC
T ss_pred             CCCCCCC
Confidence            7654443

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=8.3e-42  Score=284.89  Aligned_cols=203  Identities=30%  Similarity=0.526  Sum_probs=179.3

Q ss_pred             hhhhccceeccccceEEEEEEE--cCceEEEEEeecccCch-HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      .+|.+.+.||+|+||.||+|.+  +++.||+|++....... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5789999999999999999998  57899999997643221 22356889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTA  194 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~  194 (259)
                      ||+ +++|.+++.... .+++..++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+...........
T Consensus        89 E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~  166 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT  166 (336)
T ss_dssp             CCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCC
T ss_pred             ECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCccccc
Confidence            999 678988886554 499999999999999999999999999999999999999999999999999987776666667


Q ss_pred             CCCcccccCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCHHH
Q 045286          195 ETGTYRWMAPEVINHQPY-DQKADVFSFAIVLWELVTAKVPYDSMTPLQ  242 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~~~~ll~g~~p~~~~~~~~  242 (259)
                      .++++.|+|||.+.+..+ ++++|+||||+++|+|++|..||...+..+
T Consensus       167 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~  215 (336)
T 3h4j_B          167 SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN  215 (336)
T ss_dssp             CTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT
T ss_pred             ccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH
Confidence            789999999999998876 789999999999999999999998654433

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.7e-41  Score=273.67  Aligned_cols=225  Identities=32%  Similarity=0.607  Sum_probs=196.6

Q ss_pred             ccccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec
Q 045286           29 KSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK  106 (259)
Q Consensus        29 ~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~  106 (259)
                      ..+.|++..++|.+.+.||+|++|.||+|.+.  +..|++|++....   .....+.+|+.+++.++||||+++++++..
T Consensus         4 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   80 (288)
T 3kfa_A            4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR   80 (288)
T ss_dssp             TCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            34679999999999999999999999999986  7899999997643   234678899999999999999999999999


Q ss_pred             CCcEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          107 SPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                      .+..++|||++++++|.+++.... ..++...++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus        81 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  160 (288)
T 3kfa_A           81 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL  160 (288)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred             CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCcccee
Confidence            999999999999999999997643 4589999999999999999999999999999999999999999999999999976


Q ss_pred             ccCCCcc--ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          186 QNKGGVM--TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       186 ~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      .......  ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+........+
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 3kfa_A          161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP  234 (288)
T ss_dssp             SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCC
T ss_pred             ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCC
Confidence            6544322  22235678999999998889999999999999999999 99999998888888877776555444

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4.4e-41  Score=279.23  Aligned_cols=228  Identities=29%  Similarity=0.484  Sum_probs=178.5

Q ss_pred             ccccceechhhhhccceeccccceEEEEEEEcC-----ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeee
Q 045286           29 KSEDWEIDRRLLKTGERIASGSCGDLYRGVYLG-----QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA  103 (259)
Q Consensus        29 ~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~-----~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~  103 (259)
                      ..+.+.+..++|++.+.||+|++|.||+|.+..     ..||+|++............+.+|+.++++++||||++++++
T Consensus        14 ~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   93 (323)
T 3qup_A           14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV   93 (323)
T ss_dssp             --CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred             HhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence            345677888999999999999999999998653     279999998876566667889999999999999999999999


Q ss_pred             eecCCcE------EEEEecCCCCChHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC
Q 045286          104 STKSPHL------CIVTEYMPGGSLYDYLHKNH-----NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH  172 (259)
Q Consensus       104 ~~~~~~~------~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~  172 (259)
                      +......      ++++||+++++|.+++....     ..+++..++.++.|++.+|.+||+.|++|+||||+||+++.+
T Consensus        94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~  173 (323)
T 3qup_A           94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED  173 (323)
T ss_dssp             EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred             eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC
Confidence            8776554      89999999999999985432     248899999999999999999999999999999999999999


Q ss_pred             CeEEEeeeccceeccCCCcc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhh
Q 045286          173 NVVKVADFGVARFQNKGGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVR  248 (259)
Q Consensus       173 ~~i~l~D~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~  248 (259)
                      +.++|+|||.+.........   ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+.
T Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~  253 (323)
T 3qup_A          174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI  253 (323)
T ss_dssp             SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred             CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence            99999999999765443222   22345678999999999999999999999999999999 999999988888887777


Q ss_pred             hccCCCCc
Q 045286          249 QVCTSLCQ  256 (259)
Q Consensus       249 ~~~~~~~~  256 (259)
                      .+.....+
T Consensus       254 ~~~~~~~~  261 (323)
T 3qup_A          254 GGNRLKQP  261 (323)
T ss_dssp             TTCCCCCC
T ss_pred             cCCCCCCC
Confidence            66554443

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.4e-40  Score=283.16  Aligned_cols=217  Identities=20%  Similarity=0.323  Sum_probs=189.8

Q ss_pred             ceechhhhhccceeccc--cceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           33 WEIDRRLLKTGERIASG--SCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G--~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      +.....+|++.++||+|  ++|.||+|.+.  ++.||+|++............+.+|+.+++.++||||+++++++...+
T Consensus        20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   99 (389)
T 3gni_B           20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN   99 (389)
T ss_dssp             CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence            66678899999999999  99999999985  889999999987766777788899999999999999999999999999


Q ss_pred             cEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          109 HLCIVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      ..++||||+++++|.+++... ...+++..+..++.|++.+|.|||+.|++|+||||+||+++.++.++|+|||.+....
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            999999999999999999764 3458999999999999999999999999999999999999999999999999875432


Q ss_pred             CC--------CccccCCCcccccCccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          188 KG--------GVMTAETGTYRWMAPEVINH--QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       188 ~~--------~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                      ..        .......+++.|+|||.+.+  ..++.++|+|||||++|+|++|..||.+.+..+.+..+..
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  251 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN  251 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence            21        11123367889999999987  6789999999999999999999999998777666655543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.9e-41  Score=279.78  Aligned_cols=218  Identities=25%  Similarity=0.437  Sum_probs=179.4

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      -++|++.++||+|++|+||+|.+.  ++.||+|++............+.+|+.++++++||||+++++++...+..++||
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            468999999999999999999874  789999999877655555677889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc-----cCCeEEEeeeccceeccCC
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD-----THNVVKVADFGVARFQNKG  189 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~-----~~~~i~l~D~~~~~~~~~~  189 (259)
                      ||+++ +|.+++.... .+++..++.++.|++.+|.+||+.|++|+||||+||+++     .++.++|+|||.+......
T Consensus       113 e~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~  190 (329)
T 3gbz_A          113 EYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP  190 (329)
T ss_dssp             ECCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred             ecCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence            99964 9999996654 489999999999999999999999999999999999994     4456999999999765533


Q ss_pred             -CccccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          190 -GVMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       190 -~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                       .......+++.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+..+.+..+.+..+.+..
T Consensus       191 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  259 (329)
T 3gbz_A          191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD  259 (329)
T ss_dssp             ---------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred             ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCch
Confidence             233445679999999999875 5899999999999999999999999999998888888776655443

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.3e-41  Score=293.38  Aligned_cols=220  Identities=25%  Similarity=0.451  Sum_probs=195.0

Q ss_pred             chhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN-DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCI  112 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l  112 (259)
                      -.++|++.++||+|+||.||+|.+.  ++.||+|++...... ......+.+|+.++++++||||+++++++...+..++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3578999999999999999999984  789999999765432 3345778999999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE---ccCCeEEEeeeccceeccCC
Q 045286          113 VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM---DTHNVVKVADFGVARFQNKG  189 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv---~~~~~i~l~D~~~~~~~~~~  189 (259)
                      |+|++.+++|.+++... ..+++..++.++.|++.+|.|||+.|++|+||||+||++   +.++.++|+|||.+......
T Consensus       104 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  182 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS  182 (484)
T ss_dssp             EECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred             EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence            99999999999998654 458999999999999999999999999999999999999   56789999999999877666


Q ss_pred             CccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          190 GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       190 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      .......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||.+.+..+.+..+.++......|
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  249 (484)
T 3nyv_A          183 KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELP  249 (484)
T ss_dssp             CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG
T ss_pred             cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            55566689999999999876 58999999999999999999999999999999999998876554433

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.7e-40  Score=276.72  Aligned_cols=221  Identities=22%  Similarity=0.341  Sum_probs=188.0

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      +.+...-++|++.+.||+|++|.||+|.+.  ++.|++|++............+.+|+.+++.++||||+++++++...+
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   97 (331)
T 4aaa_A           18 NLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK   97 (331)
T ss_dssp             -CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hhhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC
Confidence            445555689999999999999999999986  789999999887766666778889999999999999999999999999


Q ss_pred             cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      ..++||||+++++|..+.. ....+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        98 ~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A           98 RWYLVFEFVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             EEEEEEECCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             EEEEEEecCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            9999999998888887764 344599999999999999999999999999999999999999999999999999976544


Q ss_pred             C-CccccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          189 G-GVMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       189 ~-~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      . .......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+.+..+.....
T Consensus       177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  242 (331)
T 4aaa_A          177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLG  242 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence            3 233455789999999999775 789999999999999999999999999988887777765443

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=282.40  Aligned_cols=220  Identities=23%  Similarity=0.425  Sum_probs=184.1

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ++|++.++||+|+||.||+|.+.  ++.||+|++...... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            46889999999999999999985  789999999765322 111234579999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-Ccccc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVMTA  194 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~~~  194 (259)
                      |++ ++|.+++......+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...... .....
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  159 (324)
T 3mtl_A           81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN  159 (324)
T ss_dssp             CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccc
Confidence            996 5999999877777999999999999999999999999999999999999999999999999998765433 23344


Q ss_pred             CCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCccCC
Q 045286          195 ETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY  259 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~  259 (259)
                      ..+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+.+..+.+..+.+.++.|
T Consensus       160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  225 (324)
T 3mtl_A          160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETW  225 (324)
T ss_dssp             ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhc
Confidence            567999999999876 56899999999999999999999999999999999999888777665543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.2e-40  Score=272.74  Aligned_cols=224  Identities=29%  Similarity=0.546  Sum_probs=189.7

Q ss_pred             ccceechhhhhccc-eeccccceEEEEEEEc----CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeee
Q 045286           31 EDWEIDRRLLKTGE-RIASGSCGDLYRGVYL----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST  105 (259)
Q Consensus        31 ~~~~~~~~~~~~~~-~lg~G~~~~V~~~~~~----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~  105 (259)
                      +.+.++.++|.+.+ .||+|++|.||+|.+.    ++.|++|++............+.+|+.+++.++||||+++++++ 
T Consensus         9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-   87 (291)
T 1xbb_A            9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-   87 (291)
T ss_dssp             --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred             ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence            55778889999988 9999999999999653    57899999987765666678899999999999999999999998 


Q ss_pred             cCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          106 KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                      ..+..++|+|++++++|.+++... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus        88 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           88 EAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             ESSSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             CCCCcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence            556789999999999999999764 4589999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCcc----ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          186 QNKGGVM----TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       186 ~~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      .......    ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+..+.....+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  242 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP  242 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred             eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            6544322    12335688999999988888999999999999999999 99999999988888888776655444

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-41  Score=284.72  Aligned_cols=217  Identities=27%  Similarity=0.457  Sum_probs=185.1

Q ss_pred             cceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC-
Q 045286           32 DWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP-  108 (259)
Q Consensus        32 ~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-  108 (259)
                      .|++ .++|++.++||+|+||.||+|.+.  ++.||+|++............+.+|+.+++.++||||+++++++.... 
T Consensus        20 ~~~~-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   98 (367)
T 1cm8_A           20 AWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET   98 (367)
T ss_dssp             EECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred             eeee-cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence            3555 458999999999999999999974  889999999877666666788999999999999999999999987653 


Q ss_pred             -----cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccc
Q 045286          109 -----HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA  183 (259)
Q Consensus       109 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~  183 (259)
                           .+++|||++ +++|.+++...  .+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A           99 LDDFTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             TTTCCCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             cccCceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence                 469999999 88999998663  4899999999999999999999999999999999999999999999999999


Q ss_pred             eeccCCCccccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          184 RFQNKGGVMTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      ......  .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..+.+..+.+..+.+
T Consensus       176 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~  245 (367)
T 1cm8_A          176 RQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP  245 (367)
T ss_dssp             EECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             cccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            875543  345678999999999877 678999999999999999999999999999988888887765544

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.4e-41  Score=277.48  Aligned_cols=215  Identities=23%  Similarity=0.454  Sum_probs=182.8

Q ss_pred             chhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC--cEE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP--HLC  111 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~  111 (259)
                      .+.+|++.++||+|+||+||+|.+.  ++.||+|++....... ....+.+|+.++++++||||+++++++...+  ..+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence            3578999999999999999999986  7899999998654322 2466789999999999999999999987654  789


Q ss_pred             EEEecCCCCChHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE----ccCCeEEEeeecccee
Q 045286          112 IVTEYMPGGSLYDYLHKNHN--VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM----DTHNVVKVADFGVARF  185 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv----~~~~~i~l~D~~~~~~  185 (259)
                      +||||+++++|.+++.....  .+++..++.++.|++.+|.+||+.|++|+||||+||++    +.++.++|+|||.+..
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            99999999999999975432  38999999999999999999999999999999999999    7778899999999988


Q ss_pred             ccCCCccccCCCcccccCccccC--------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHhhhcc
Q 045286          186 QNKGGVMTAETGTYRWMAPEVIN--------HQPYDQKADVFSFAIVLWELVTAKVPYDSMT----PLQAALGVRQVC  251 (259)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~PE~~~--------~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~----~~~~~~~i~~~~  251 (259)
                      ...........+++.|+|||.+.        +..++.++|+|||||++|+|++|..||...+    ..+.+..+..+.
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (319)
T 4euu_A          166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (319)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred             cCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence            77766666677999999999985        5678999999999999999999999996433    244555554443

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.8e-41  Score=290.81  Aligned_cols=224  Identities=33%  Similarity=0.615  Sum_probs=195.3

Q ss_pred             cccceechhhhhccceeccccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      .+.|++..++|.+.+.||+|+||.||+|.+. +..||||+++.....   .+.+.+|+.+++.++||||+++++++. .+
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~  255 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT-KE  255 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence            4669999999999999999999999999986 678999999875432   467899999999999999999999987 55


Q ss_pred             cEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      ..++||||+++++|.+++.... ..++...++.++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||++....
T Consensus       256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            7899999999999999996432 358889999999999999999999999999999999999999999999999997654


Q ss_pred             CCCc--cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          188 KGGV--MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       188 ~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      ....  .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+.++...+.|+
T Consensus       336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~  408 (454)
T 1qcf_A          336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE  408 (454)
T ss_dssp             CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCT
T ss_pred             CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            3211  122345678999999988889999999999999999999 999999999999999998887765543

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=9.8e-41  Score=270.08  Aligned_cols=215  Identities=31%  Similarity=0.578  Sum_probs=189.1

Q ss_pred             cceechhhhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC--Cc
Q 045286           32 DWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS--PH  109 (259)
Q Consensus        32 ~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~  109 (259)
                      .+.++.++|++.+.||+|++|.||+|.+.++.|++|++............+.+|+.+++.++||||+++++++...  +.
T Consensus         4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   83 (271)
T 3kmu_A            4 HSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH   83 (271)
T ss_dssp             CCCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred             cCCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence            3567778999999999999999999999999999999998876777778899999999999999999999998776  78


Q ss_pred             EEEEEecCCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHN-VLKLPQLLRFAIDICKGMEYLHQRN--IIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                      .++|+||+++++|.+++..... .+++..++.++.|++.+|.+||+.|  ++|+||+|+||+++.++.++++||+.....
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            8999999999999999976543 4899999999999999999999999  999999999999999999999998876543


Q ss_pred             cCCCccccCCCcccccCccccCCCCCCC---chhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          187 NKGGVMTAETGTYRWMAPEVINHQPYDQ---KADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       187 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~---~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      ..    ....+++.|+|||.+.+..++.   ++|+||||+++|+|++|..||...+..+....+...
T Consensus       164 ~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  226 (271)
T 3kmu_A          164 QS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE  226 (271)
T ss_dssp             SC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHS
T ss_pred             cc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhc
Confidence            32    2345789999999998765544   799999999999999999999998887776666543

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.1e-40  Score=273.93  Aligned_cols=235  Identities=30%  Similarity=0.487  Sum_probs=187.8

Q ss_pred             HHHHhccccccceechhhhhccceeccccceEEEEEEEc-----CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCC
Q 045286           22 KAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRN   96 (259)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   96 (259)
                      ..-+-+...+.+.++.++|.+.+.||+|++|.||+|.+.     ++.|++|.+............+.+|+.+++.++|||
T Consensus        18 ~~eel~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~   97 (313)
T 3brb_A           18 GSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN   97 (313)
T ss_dssp             ------CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTT
T ss_pred             chHhhhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCC
Confidence            344445677889999999999999999999999999864     347999999887666666788999999999999999


Q ss_pred             cceeeeeeecCC-----cEEEEEecCCCCChHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 045286           97 VVRFIGASTKSP-----HLCIVTEYMPGGSLYDYLHK-----NHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTAN  166 (259)
Q Consensus        97 i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~N  166 (259)
                      |+++++++...+     ..++|+|++++++|.+++..     ....+++..++.++.|++.+|.+||+.|++|+||+|+|
T Consensus        98 iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~N  177 (313)
T 3brb_A           98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARN  177 (313)
T ss_dssp             BCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGG
T ss_pred             eeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcce
Confidence            999999987654     45999999999999999853     23458999999999999999999999999999999999


Q ss_pred             EEEccCCeEEEeeeccceeccCCCc---cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 045286          167 LLMDTHNVVKVADFGVARFQNKGGV---MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQ  242 (259)
Q Consensus       167 ilv~~~~~i~l~D~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~  242 (259)
                      |+++.++.++|+|||.+........   .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+
T Consensus       178 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  257 (313)
T 3brb_A          178 CMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE  257 (313)
T ss_dssp             EEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             EEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH
Confidence            9999999999999999876544321   123346788999999999999999999999999999999 999999988888


Q ss_pred             HHHHhhhccCCCCc
Q 045286          243 AALGVRQVCTSLCQ  256 (259)
Q Consensus       243 ~~~~i~~~~~~~~~  256 (259)
                      ....+..+.....+
T Consensus       258 ~~~~~~~~~~~~~~  271 (313)
T 3brb_A          258 MYDYLLHGHRLKQP  271 (313)
T ss_dssp             HHHHHHTTCCCCCB
T ss_pred             HHHHHHcCCCCCCC
Confidence            77777766544433

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.3e-40  Score=273.24  Aligned_cols=212  Identities=31%  Similarity=0.485  Sum_probs=187.1

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      ...+...++||+|++|.||+|.+.  ++.||||++......  ..+.+.+|+.+++.++|+||+++++++...+..++||
T Consensus        44 ~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  121 (321)
T 2c30_A           44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLM  121 (321)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEE
Confidence            456777889999999999999974  889999999865432  3466889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-ccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMT  193 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~  193 (259)
                      ||+++++|.+++...  .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus       122 e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  199 (321)
T 2c30_A          122 EFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK  199 (321)
T ss_dssp             CCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred             ecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccc
Confidence            999999999998643  48999999999999999999999999999999999999999999999999987665432 234


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      ...+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.....
T Consensus       200 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  258 (321)
T 2c30_A          200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP  258 (321)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC
T ss_pred             cccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC
Confidence            55789999999999999999999999999999999999999999888888777766543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=8.6e-41  Score=289.53  Aligned_cols=224  Identities=34%  Similarity=0.629  Sum_probs=192.1

Q ss_pred             cccceechhhhhccceeccccceEEEEEEEcC-ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVYLG-QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~-~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      .+.|+++.++|++.++||+|+||.||+|.+.+ ..||+|+++.....   .+.+.+|+.++++++||||+++++++.. +
T Consensus       176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~  251 (452)
T 1fmk_A          176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  251 (452)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence            45699999999999999999999999999875 67999999875433   3678999999999999999999999876 6


Q ss_pred             cEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          109 HLCIVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      ..++||||+++++|.+++... ...++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus       252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            789999999999999999643 3458899999999999999999999999999999999999999999999999997654


Q ss_pred             CCCc--cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          188 KGGV--MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       188 ~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      ....  .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+.++.+.+.|+
T Consensus       332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~  404 (452)
T 1fmk_A          332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP  404 (452)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            3321  122345678999999988889999999999999999999 999999999999999999887766554

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.6e-41  Score=290.38  Aligned_cols=219  Identities=23%  Similarity=0.403  Sum_probs=180.9

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCc
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPH  109 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~  109 (259)
                      ..+..++|++.++||+|+||.||+|.+.  ++.||+|++..... .......+.+|+.+++.++||||+++++++...+.
T Consensus       143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~  222 (446)
T 4ejn_A          143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR  222 (446)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred             cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence            4455678999999999999999999974  78999999986532 22334567789999999999999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ-RNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      .++||||+++++|.+++.... .+++..+..++.|++.+|.|||+ .|++|+||||+||+++.++.++|+|||++.....
T Consensus       223 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          223 LCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             EEEEECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             EEEEEeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            999999999999999986554 58999999999999999999998 9999999999999999999999999999875332


Q ss_pred             -CCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          189 -GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       189 -~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                       .......++++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+....+.....
T Consensus       302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~  366 (446)
T 4ejn_A          302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI  366 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred             CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC
Confidence             2334556799999999999999999999999999999999999999999888888777765443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.2e-41  Score=291.64  Aligned_cols=217  Identities=26%  Similarity=0.491  Sum_probs=192.3

Q ss_pred             chhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN-DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCI  112 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l  112 (259)
                      ...+|.+.+.||+|+||.||+|.+.  ++.||+|++...... ......+.+|+.+++.++||||+++++++...+..++
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l   93 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM   93 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            3468999999999999999999985  889999999865322 1234678899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcc
Q 045286          113 VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM  192 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~  192 (259)
                      ||||+++++|.+++... ..+++..++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+.........
T Consensus        94 v~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~  172 (476)
T 2y94_A           94 VMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL  172 (476)
T ss_dssp             EEECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCB
T ss_pred             EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccccc
Confidence            99999999999998644 45999999999999999999999999999999999999999999999999999887766556


Q ss_pred             ccCCCcccccCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          193 TAETGTYRWMAPEVINHQPY-DQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ...++++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+....+..+...
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~  234 (476)
T 2y94_A          173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFY  234 (476)
T ss_dssp             CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCC
T ss_pred             cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcC
Confidence            66789999999999988765 68999999999999999999999998888888887766543

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.4e-40  Score=276.10  Aligned_cols=226  Identities=29%  Similarity=0.556  Sum_probs=195.4

Q ss_pred             ccccceechhhhhccceeccccceEEEEEEEc---------CceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcc
Q 045286           29 KSEDWEIDRRLLKTGERIASGSCGDLYRGVYL---------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVV   98 (259)
Q Consensus        29 ~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~---------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~   98 (259)
                      ....|++..++|.+.+.||+|+||.||+|.+.         +..|++|++.... .......+.+|+.+++.+ +||||+
T Consensus        26 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv  104 (334)
T 2pvf_A           26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNII  104 (334)
T ss_dssp             CCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEe
Confidence            44569999999999999999999999999863         4679999998654 344557788999999999 799999


Q ss_pred             eeeeeeecCCcEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 045286           99 RFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH---------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLK  163 (259)
Q Consensus        99 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~  163 (259)
                      ++++++...+..++|+||+++++|.+++....               ..++...++.++.|++.+|.+||+.|++|+||+
T Consensus       105 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk  184 (334)
T 2pvf_A          105 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA  184 (334)
T ss_dssp             CEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             eEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCc
Confidence            99999999999999999999999999997543               237889999999999999999999999999999


Q ss_pred             CCcEEEccCCeEEEeeeccceeccCCCcc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 045286          164 TANLLMDTHNVVKVADFGVARFQNKGGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT  239 (259)
Q Consensus       164 p~Nilv~~~~~i~l~D~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~  239 (259)
                      |+||+++.++.++|+|||.+.........   ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+
T Consensus       185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  264 (334)
T 2pvf_A          185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  264 (334)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence            99999999999999999999876554322   23346788999999988889999999999999999999 999999999


Q ss_pred             HHHHHHHhhhccCCCC
Q 045286          240 PLQAALGVRQVCTSLC  255 (259)
Q Consensus       240 ~~~~~~~i~~~~~~~~  255 (259)
                      ..+....+..+.....
T Consensus       265 ~~~~~~~~~~~~~~~~  280 (334)
T 2pvf_A          265 VEELFKLLKEGHRMDK  280 (334)
T ss_dssp             HHHHHHHHHHTCCCCC
T ss_pred             HHHHHHHHhcCCCCCC
Confidence            8888887777654433

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1e-40  Score=270.20  Aligned_cols=215  Identities=36%  Similarity=0.670  Sum_probs=175.7

Q ss_pred             eechhhhhccceeccccceEEEEEEEcCceEEEEEeecccCch--HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEE
Q 045286           34 EIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLND--TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        34 ~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~  111 (259)
                      +++..+|++.+.||+|++|.||++.+.++.+++|++.......  ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC   82 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence            4567899999999999999999999999999999988653322  33467889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCCCcEEEcc--------CCeEEEeee
Q 045286          112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN---IIHRDLKTANLLMDT--------HNVVKVADF  180 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~di~p~Nilv~~--------~~~i~l~D~  180 (259)
                      +||||+++++|.+++..  ..+++..++.++.|++.+|.+||+.|   ++|+||+|+||+++.        ++.++|+||
T Consensus        83 lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           83 LVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999999853  35899999999999999999999999   889999999999986        678999999


Q ss_pred             ccceeccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          181 GVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      |.+........ ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+....
T Consensus       161 g~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  230 (271)
T 3dtc_A          161 GLAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK  230 (271)
T ss_dssp             CC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC
T ss_pred             Ccccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC
Confidence            99976554432 24568999999999998889999999999999999999999999988877766665443

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=9.6e-41  Score=277.83  Aligned_cols=220  Identities=23%  Similarity=0.432  Sum_probs=187.7

Q ss_pred             hhhhhcc-ceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCCcEEE
Q 045286           37 RRLLKTG-ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHLCI  112 (259)
Q Consensus        37 ~~~~~~~-~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l  112 (259)
                      ..+|.+. ++||+|+||.||+|.+.  ++.||+|++............+.+|+.+++.+. ||||+++++++...+..++
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l  106 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL  106 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence            4456655 89999999999999985  889999999877655555678899999999996 6999999999999999999


Q ss_pred             EEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc---CCeEEEeeeccceeccC
Q 045286          113 VTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT---HNVVKVADFGVARFQNK  188 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~---~~~i~l~D~~~~~~~~~  188 (259)
                      ||||+++++|.+++... ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++.   ++.++|+|||.+.....
T Consensus       107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  186 (327)
T 3lm5_A          107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH  186 (327)
T ss_dssp             EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred             EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence            99999999999988543 346899999999999999999999999999999999999987   78999999999988776


Q ss_pred             CCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       189 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      ........+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.+.......
T Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  254 (327)
T 3lm5_A          187 ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE  254 (327)
T ss_dssp             -------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc
Confidence            65555667999999999999999999999999999999999999999999988888777766554443

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-40  Score=275.04  Aligned_cols=222  Identities=29%  Similarity=0.534  Sum_probs=188.4

Q ss_pred             ceechhhhhccceeccccceEEEEEEEcC------ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYLG------QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK  106 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~~------~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~  106 (259)
                      .++...+|.+.+.||+|++|.||+|.+..      ..|++|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus        39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  117 (333)
T 1mqb_A           39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK  117 (333)
T ss_dssp             CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence            57788999999999999999999998752      359999998654 34445678899999999999999999999999


Q ss_pred             CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          107 SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                      .+..++|||++++++|.+++......++...++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999999999877677999999999999999999999999999999999999999999999999999765


Q ss_pred             cCCCc----cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCC
Q 045286          187 NKGGV----MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLC  255 (259)
Q Consensus       187 ~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~  255 (259)
                      .....    .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+..+...+.
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~  271 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT  271 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC
Confidence            54321    112235678999999998899999999999999999999 9999999999888888887755443

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.7e-40  Score=291.40  Aligned_cols=215  Identities=24%  Similarity=0.479  Sum_probs=188.1

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCch-----------HHHHHHHHHHHHHHhcCCCCcceeeee
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND-----------TLEDEFVQEVAILREVQHRNVVRFIGA  103 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~~~~i~~~~~~  103 (259)
                      .++|++.++||+|+||+||+|.+.  ++.||+|++.......           .....+.+|+.++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            468999999999999999999985  6889999998754321           234678899999999999999999999


Q ss_pred             eecCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC---eEEEeee
Q 045286          104 STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN---VVKVADF  180 (259)
Q Consensus       104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~---~i~l~D~  180 (259)
                      +......++||||+++++|.+++.... .+++..++.++.|++.+|.|||+.|++|+||||+||+++.++   .++|+||
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  193 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF  193 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence            999999999999999999999986554 499999999999999999999999999999999999998776   6999999


Q ss_pred             ccceeccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          181 GVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      |.+.............+++.|+|||.+.+ .++.++|+||+|+++|+|++|..||.+.+..+.+..+.++...
T Consensus       194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~  265 (504)
T 3q5i_A          194 GLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY  265 (504)
T ss_dssp             TTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred             CCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence            99988777666667789999999999875 5899999999999999999999999999999999888876544

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.2e-40  Score=291.69  Aligned_cols=224  Identities=32%  Similarity=0.615  Sum_probs=197.2

Q ss_pred             cccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS  107 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~  107 (259)
                      .+.|+++..+|.+.++||+|+||.||+|.+.  +..||+|+++.....   .+.+.+|+.++++++||||+++++++...
T Consensus       212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~  288 (495)
T 1opk_A          212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTRE  288 (495)
T ss_dssp             SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            4669999999999999999999999999986  789999999865433   46789999999999999999999999999


Q ss_pred             CcEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                      +..++||||+++++|.+++.... ..++...++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus       289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence            99999999999999999997643 45889999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCcc--ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          187 NKGGVM--TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       187 ~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      ......  ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+.++.+...+
T Consensus       369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~  441 (495)
T 1opk_A          369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP  441 (495)
T ss_dssp             TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCC
T ss_pred             cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            543222  22335678999999988889999999999999999999 99999999888888888877665544

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-41  Score=280.16  Aligned_cols=216  Identities=31%  Similarity=0.569  Sum_probs=182.5

Q ss_pred             cccceechhhhhccceeccccceEEEEEEE-------cCceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceee
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVY-------LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFI  101 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~-------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~  101 (259)
                      ...|+++.++|.+.+.||+|+||.||+|.+       .+..|++|++.... .......+.+|+.+++++ +||||++++
T Consensus        37 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~  115 (344)
T 1rjb_A           37 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLL  115 (344)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            346899999999999999999999999997       24579999998643 233446788999999999 899999999


Q ss_pred             eeeecCCcEEEEEecCCCCChHHHHHhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 045286          102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHN----------------------VLKLPQLLRFAIDICKGMEYLHQRNIIH  159 (259)
Q Consensus       102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------------~~~~~~~~~i~~ql~~~l~~lH~~~i~H  159 (259)
                      +++...+..++||||+++++|.+++.....                      .++...++.++.|++.+|.+||+.|++|
T Consensus       116 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH  195 (344)
T 1rjb_A          116 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH  195 (344)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             EEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            999999999999999999999999976532                      2688899999999999999999999999


Q ss_pred             CCCCCCcEEEccCCeEEEeeeccceeccCCCcc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCC
Q 045286          160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY  235 (259)
Q Consensus       160 ~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~  235 (259)
                      +||+|+||+++.++.++|+|||.+.........   ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||
T Consensus       196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence            999999999999999999999999765543221   22235678999999988889999999999999999998 99999


Q ss_pred             CCCCHHHHHHH
Q 045286          236 DSMTPLQAALG  246 (259)
Q Consensus       236 ~~~~~~~~~~~  246 (259)
                      .+.+..+....
T Consensus       276 ~~~~~~~~~~~  286 (344)
T 1rjb_A          276 PGIPVDANFYK  286 (344)
T ss_dssp             TTCCCSHHHHH
T ss_pred             ccCCcHHHHHH
Confidence            87665444333

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.4e-40  Score=272.82  Aligned_cols=204  Identities=34%  Similarity=0.590  Sum_probs=174.5

Q ss_pred             ceechhhhhccceeccccceEEEEEEE------cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK  106 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~  106 (259)
                      .++..++|++.++||+|+||.||+|.+      .++.||+|++...  .......+.+|+.+++.++||||+++++++..
T Consensus         5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   82 (295)
T 3ugc_A            5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS   82 (295)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred             CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            456789999999999999999999985      4789999998764  34455778999999999999999999998854


Q ss_pred             --CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccce
Q 045286          107 --SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR  184 (259)
Q Consensus       107 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~  184 (259)
                        ....++||||+++++|.+++......++...++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+.
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence              356899999999999999998766669999999999999999999999999999999999999999999999999997


Q ss_pred             eccCCCc----cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 045286          185 FQNKGGV----MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSM  238 (259)
Q Consensus       185 ~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  238 (259)
                      .......    .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~  220 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP  220 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence            6654321    22334677899999999999999999999999999999999998653

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.8e-40  Score=274.11  Aligned_cols=216  Identities=31%  Similarity=0.561  Sum_probs=186.9

Q ss_pred             ccccceechhhhhccceeccccceEEEEEEE-------cCceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCccee
Q 045286           29 KSEDWEIDRRLLKTGERIASGSCGDLYRGVY-------LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRF  100 (259)
Q Consensus        29 ~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~-------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~  100 (259)
                      ....|++..++|.+.+.||+|+||.||+|.+       .++.|++|++.... .....+.+.+|+.+++++ +||||+++
T Consensus        14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~   92 (313)
T 1t46_A           14 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNL   92 (313)
T ss_dssp             CCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeE
Confidence            3456999999999999999999999999986       25789999998654 334457789999999999 89999999


Q ss_pred             eeeeecCCcEEEEEecCCCCChHHHHHhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 045286          101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHN-----------------VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLK  163 (259)
Q Consensus       101 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------------~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~  163 (259)
                      ++++...+..++|||++++++|.+++.....                 .+++..++.++.|++.+|.+||+.|++|+||+
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk  172 (313)
T 1t46_A           93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA  172 (313)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCc
Confidence            9999999999999999999999999976542                 38899999999999999999999999999999


Q ss_pred             CCcEEEccCCeEEEeeeccceeccCCCcc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 045286          164 TANLLMDTHNVVKVADFGVARFQNKGGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMT  239 (259)
Q Consensus       164 p~Nilv~~~~~i~l~D~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~  239 (259)
                      |+||+++.++.++|+|||.+.........   ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+
T Consensus       173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            99999999999999999999866554322   12335678999999988899999999999999999998 999998766


Q ss_pred             HHHHHH
Q 045286          240 PLQAAL  245 (259)
Q Consensus       240 ~~~~~~  245 (259)
                      ......
T Consensus       253 ~~~~~~  258 (313)
T 1t46_A          253 VDSKFY  258 (313)
T ss_dssp             SSHHHH
T ss_pred             chhHHH
Confidence            544333

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.3e-40  Score=268.92  Aligned_cols=214  Identities=27%  Similarity=0.488  Sum_probs=185.3

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCch----HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND----TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL  110 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~  110 (259)
                      .++|++.+.||+|++|.||++.+.  ++.|++|++.......    .....+.+|+.+++.++||||+++++++...+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            468999999999999999999985  7899999998764332    1357788999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC----eEEEeeeccceec
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN----VVKVADFGVARFQ  186 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~----~i~l~D~~~~~~~  186 (259)
                      ++|+|++++++|.+++.... .+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++    .++|+|||.+...
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~  162 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI  162 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence            99999999999999996543 489999999999999999999999999999999999998877    8999999999877


Q ss_pred             cCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          187 NKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       187 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ..........+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+....
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  227 (283)
T 3bhy_A          163 EAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVN  227 (283)
T ss_dssp             C--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC
T ss_pred             cCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcc
Confidence            66555556678999999999999999999999999999999999999999988877777665543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=7.5e-41  Score=282.47  Aligned_cols=203  Identities=18%  Similarity=0.322  Sum_probs=177.8

Q ss_pred             ccccceechhhhhccceeccccceEEEEEE-------EcCceEEEEEeecccCchHHHHHHHHHHHHHHhcC---CCCcc
Q 045286           29 KSEDWEIDRRLLKTGERIASGSCGDLYRGV-------YLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ---HRNVV   98 (259)
Q Consensus        29 ~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~-------~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~   98 (259)
                      ....+++..++|.+.++||+|+||.||+|.       ..++.||+|++....     ...+.+|.++++.+.   |++|+
T Consensus        56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv  130 (365)
T 3e7e_A           56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFM  130 (365)
T ss_dssp             SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBC
T ss_pred             cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhh
Confidence            345677888999999999999999999993       357899999997653     245677788888886   89999


Q ss_pred             eeeeeeecCCcEEEEEecCCCCChHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc---
Q 045286           99 RFIGASTKSPHLCIVTEYMPGGSLYDYLHK----NHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT---  171 (259)
Q Consensus        99 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~---  171 (259)
                      .+++.+...+..++||||+++++|.+++..    ....+++..++.++.|++.+|.|||+.|++||||||+||+++.   
T Consensus       131 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~  210 (365)
T 3e7e_A          131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFL  210 (365)
T ss_dssp             CEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGT
T ss_pred             hhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEeccccc
Confidence            999999999999999999999999999965    3456999999999999999999999999999999999999988   


Q ss_pred             --------CCeEEEeeeccceecc---CCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 045286          172 --------HNVVKVADFGVARFQN---KGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYD  236 (259)
Q Consensus       172 --------~~~i~l~D~~~~~~~~---~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~  236 (259)
                              ++.++|+|||.+....   .........+++.|+|||++.+..++.++|+|||||++|+|++|..||.
T Consensus       211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~  286 (365)
T 3e7e_A          211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV  286 (365)
T ss_dssp             CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred             CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence                    8999999999997543   3334455679999999999999999999999999999999999999884

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.1e-41  Score=278.89  Aligned_cols=213  Identities=29%  Similarity=0.457  Sum_probs=178.1

Q ss_pred             hhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC----c
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLN-DTLEDEFVQEVAILREVQHRNVVRFIGASTKSP----H  109 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~  109 (259)
                      .++|++.+.||+|++|.||+|.+  .++.||+|++...... ......+.+|+.+++.++||||+++++++....    .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46899999999999999999997  4789999999876443 345577889999999999999999999886544    3


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG  189 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~  189 (259)
                      .++||||+++++|.+++.... .+++..++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+......
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  169 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS  169 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred             cEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence            499999999999999997554 5899999999999999999999999999999999999999999999999999765433


Q ss_pred             C----ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          190 G----VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       190 ~----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      .    ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+...++...
T Consensus       170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~  234 (311)
T 3ork_A          170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE  234 (311)
T ss_dssp             ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC
T ss_pred             ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC
Confidence            2    122345899999999999999999999999999999999999999998887766655544

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.7e-40  Score=270.21  Aligned_cols=223  Identities=35%  Similarity=0.629  Sum_probs=192.7

Q ss_pred             cccceechhhhhccceeccccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      .+.|++..++|++.+.||+|++|.||+|.+. ++.|++|.+......   .+.+.+|+++++.++||||+++++++.. +
T Consensus         5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~   80 (279)
T 1qpc_A            5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E   80 (279)
T ss_dssp             TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             hhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence            3679999999999999999999999999986 458999999865433   3678899999999999999999998874 4


Q ss_pred             cEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      ..++|+|++++++|.+++.... ..++...++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  160 (279)
T 1qpc_A           81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (279)
T ss_dssp             SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence            6889999999999999986432 258899999999999999999999999999999999999999999999999998765


Q ss_pred             CCCcc--ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          188 KGGVM--TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       188 ~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      .....  ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+.++.....+
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  232 (279)
T 1qpc_A          161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP  232 (279)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred             CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCc
Confidence            54322  23345678999999988889999999999999999999 99999999988888888776554433

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.3e-40  Score=268.11  Aligned_cols=223  Identities=28%  Similarity=0.543  Sum_probs=189.3

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEcC-----ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeee
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYLG-----QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST  105 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~-----~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~  105 (259)
                      ..+.+..++|.+.+.||+|++|.||+|.+.+     ..|++|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus         5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   83 (281)
T 3cc6_A            5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE   83 (281)
T ss_dssp             CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred             ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence            3577888999999999999999999998653     359999998753 3345577899999999999999999999987


Q ss_pred             cCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          106 KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                      .+ ..++|+|++++++|.+++......++...++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus        84 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           84 EE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             SS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             CC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            54 56899999999999999987777799999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCCc--cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCC
Q 045286          186 QNKGGV--MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLC  255 (259)
Q Consensus       186 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~  255 (259)
                      ......  .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+..+...+.
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~  235 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK  235 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC
T ss_pred             cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC
Confidence            554322  223346788999999988889999999999999999998 9999988877777777776654443

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=272.31  Aligned_cols=215  Identities=27%  Similarity=0.414  Sum_probs=178.8

Q ss_pred             echhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCch------------------------HHHHHHHHHHHH
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND------------------------TLEDEFVQEVAI   88 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~------------------------~~~~~~~~e~~~   88 (259)
                      +.-.+|++.++||+|+||.||+|.+.  ++.||+|++.......                        ...+.+.+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            33478999999999999999999874  7899999998654221                        123568899999


Q ss_pred             HHhcCCCCcceeeeeeec--CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCc
Q 045286           89 LREVQHRNVVRFIGASTK--SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTAN  166 (259)
Q Consensus        89 l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~N  166 (259)
                      ++.++||||+++++++..  .+..++||||+++++|.+++.  ...+++..++.++.|++.+|.+||+.|++|+||||+|
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N  167 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN  167 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence            999999999999999876  568999999999999988643  2358999999999999999999999999999999999


Q ss_pred             EEEccCCeEEEeeeccceeccCCC-ccccCCCcccccCccccCCCC---CCCchhHHHHHHHHHHHHcCCCCCCCCCHHH
Q 045286          167 LLMDTHNVVKVADFGVARFQNKGG-VMTAETGTYRWMAPEVINHQP---YDQKADVFSFAIVLWELVTAKVPYDSMTPLQ  242 (259)
Q Consensus       167 ilv~~~~~i~l~D~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~---~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~  242 (259)
                      |+++.++.++|+|||.+....... ......+++.|+|||.+.+..   .+.++|+||||+++|+|++|..||...+..+
T Consensus       168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  247 (298)
T 2zv2_A          168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC  247 (298)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence            999999999999999998765442 334557899999999998765   3678999999999999999999999888777


Q ss_pred             HHHHhhhcc
Q 045286          243 AALGVRQVC  251 (259)
Q Consensus       243 ~~~~i~~~~  251 (259)
                      ....+....
T Consensus       248 ~~~~~~~~~  256 (298)
T 2zv2_A          248 LHSKIKSQA  256 (298)
T ss_dssp             HHHHHHHCC
T ss_pred             HHHHHhccc
Confidence            776666543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.2e-40  Score=280.70  Aligned_cols=203  Identities=29%  Similarity=0.419  Sum_probs=166.8

Q ss_pred             eechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEE
Q 045286           34 EIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        34 ~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~  111 (259)
                      ....++|++.+.||+|+||+||++.+.  ++.||+|++.......   ..+.+|+.+++.++||||+++++++...+..+
T Consensus        16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   92 (361)
T 3uc3_A           16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLA   92 (361)
T ss_dssp             CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence            344678999999999999999999984  7899999998754333   55789999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCe--EEEeeeccceeccCC
Q 045286          112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV--VKVADFGVARFQNKG  189 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~--i~l~D~~~~~~~~~~  189 (259)
                      +||||+++++|.+++.... .+++..++.++.|++.+|.+||+.|++|+||||+||+++.++.  ++|+|||.+......
T Consensus        93 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             EEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            9999999999999986544 4999999999999999999999999999999999999987765  999999998755444


Q ss_pred             CccccCCCcccccCccccCCCCCCCc-hhHHHHHHHHHHHHcCCCCCCCCCH
Q 045286          190 GVMTAETGTYRWMAPEVINHQPYDQK-ADVFSFAIVLWELVTAKVPYDSMTP  240 (259)
Q Consensus       190 ~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~slG~~~~~ll~g~~p~~~~~~  240 (259)
                      .......+++.|+|||.+.+..++.+ +|+|||||++|+|++|..||...+.
T Consensus       172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~  223 (361)
T 3uc3_A          172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE  223 (361)
T ss_dssp             ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred             CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence            44455679999999999988877655 8999999999999999999987544

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=9.7e-41  Score=280.93  Aligned_cols=224  Identities=33%  Similarity=0.573  Sum_probs=186.1

Q ss_pred             cccccceechhhhhccceeccccceEEEEEEEc-------CceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcce
Q 045286           28 TKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVR   99 (259)
Q Consensus        28 ~~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~   99 (259)
                      .....|++..++|++.++||+|+||.||+|.+.       ++.||+|++.... .......+.+|+.+++++ +||||++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceee
Confidence            344668999999999999999999999999853       3789999998653 334457789999999999 6899999


Q ss_pred             eeeeeecCC-cEEEEEecCCCCChHHHHHhcCC-----------------------------------------------
Q 045286          100 FIGASTKSP-HLCIVTEYMPGGSLYDYLHKNHN-----------------------------------------------  131 (259)
Q Consensus       100 ~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~-----------------------------------------------  131 (259)
                      +++++...+ ..++||||+++++|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            999987654 48999999999999999965432                                               


Q ss_pred             ------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc--
Q 045286          132 ------------------VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV--  191 (259)
Q Consensus       132 ------------------~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~--  191 (259)
                                        .+++..++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+........  
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  250 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV  250 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence                              178889999999999999999999999999999999999999999999999976544322  


Q ss_pred             -cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHH-HHHHHhhhccC
Q 045286          192 -MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL-QAALGVRQVCT  252 (259)
Q Consensus       192 -~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~-~~~~~i~~~~~  252 (259)
                       .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+.. .....+..+..
T Consensus       251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~  314 (359)
T 3vhe_A          251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR  314 (359)
T ss_dssp             EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC
T ss_pred             hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCC
Confidence             223346788999999999999999999999999999998 99999876643 33344444433

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.4e-40  Score=274.53  Aligned_cols=224  Identities=28%  Similarity=0.500  Sum_probs=193.0

Q ss_pred             ccccceechhhhhccceeccccceEEEEEEEc-------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceee
Q 045286           29 KSEDWEIDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI  101 (259)
Q Consensus        29 ~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~  101 (259)
                      ..+.|++..++|.+.+.||+|++|.||+|.+.       ++.|++|.+.... .......+.+|+.+++.++|+||++++
T Consensus        16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            34678999999999999999999999999864       5789999998653 334456788999999999999999999


Q ss_pred             eeeecCCcEEEEEecCCCCChHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC
Q 045286          102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH---------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH  172 (259)
Q Consensus       102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~  172 (259)
                      +++...+..++|||++++++|.+++....         ..++...++.++.|++.+|.+||+.|++|+||+|+||+++.+
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED  174 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCC
Confidence            99999999999999999999999986532         346889999999999999999999999999999999999999


Q ss_pred             CeEEEeeeccceeccCCCc---cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhh
Q 045286          173 NVVKVADFGVARFQNKGGV---MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVR  248 (259)
Q Consensus       173 ~~i~l~D~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~  248 (259)
                      +.++|+|||.+........   .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+.
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  254 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM  254 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence            9999999999875543321   122345788999999998889999999999999999999 899999988888887776


Q ss_pred             hccCC
Q 045286          249 QVCTS  253 (259)
Q Consensus       249 ~~~~~  253 (259)
                      .+...
T Consensus       255 ~~~~~  259 (322)
T 1p4o_A          255 EGGLL  259 (322)
T ss_dssp             TTCCC
T ss_pred             cCCcC
Confidence            65443

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=9.1e-40  Score=274.06  Aligned_cols=212  Identities=30%  Similarity=0.466  Sum_probs=186.2

Q ss_pred             hhhhhccceeccccceEEEEEEE--cCceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      .+.|...+.||+|+||+||+|.+  .++.||+|++..... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            46789999999999999999996  488999999987643 334557788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT  193 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~  193 (259)
                      |||++ ++|.+++......+++..++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+......   .
T Consensus       133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---~  208 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---N  208 (348)
T ss_dssp             EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---C
T ss_pred             EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---C
Confidence            99996 5888888766667999999999999999999999999999999999999999999999999998765443   3


Q ss_pred             cCCCcccccCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          194 AETGTYRWMAPEVIN---HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      ...+++.|+|||.+.   +..++.++|+||||+++|+|++|..||.+.+..+.+..+.+...
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~  270 (348)
T 1u5q_A          209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES  270 (348)
T ss_dssp             CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred             cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Confidence            456899999999984   56789999999999999999999999998888777777665543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2e-40  Score=275.85  Aligned_cols=222  Identities=30%  Similarity=0.565  Sum_probs=184.6

Q ss_pred             eechhhhhccceeccccceEEEEEEEc--Cc----eEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 045286           34 EIDRRLLKTGERIASGSCGDLYRGVYL--GQ----DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS  107 (259)
Q Consensus        34 ~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~----~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~  107 (259)
                      .+...+|++.++||+|+||+||+|.+.  ++    +|++|.+.... .......+.+|+.++++++||||+++++++..+
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   89 (327)
T 3poz_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred             hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            355688999999999999999999874  33    35888776543 233447788999999999999999999999875


Q ss_pred             CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                       ..+++++++++++|.+++......++...++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+....
T Consensus        90 -~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           90 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             -CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence             4778999999999999998877779999999999999999999999999999999999999999999999999997665


Q ss_pred             CCCcc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          188 KGGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       188 ~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      .....   ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+..+.....++
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~  242 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP  242 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCc
Confidence            43322   23345778999999999999999999999999999999 999999988888888777766554443

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-40  Score=278.04  Aligned_cols=220  Identities=24%  Similarity=0.374  Sum_probs=184.1

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCch---HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND---TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~  111 (259)
                      .++|++.+.||+|++|.||+|.+.  ++.|++|++.......   .....+.+|+.+++.++||||+++++++...+..+
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   88 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence            468999999999999999999975  7899999998653322   12246789999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-C
Q 045286          112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-G  190 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~  190 (259)
                      +|+|++++ +|..++......+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...... .
T Consensus        89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  167 (346)
T 1ua2_A           89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  167 (346)
T ss_dssp             EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence            99999965 899988776667899999999999999999999999999999999999999999999999999766443 2


Q ss_pred             ccccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          191 VMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       191 ~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||.+.+..+.+..+.+..+.+.+.
T Consensus       168 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~  235 (346)
T 1ua2_A          168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE  235 (346)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChh
Confidence            33456789999999998764 57899999999999999999999999999999988888766555443

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5.8e-40  Score=277.01  Aligned_cols=215  Identities=23%  Similarity=0.430  Sum_probs=188.9

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCc------hHHHHHHHHHHHHHHhc-CCCCcceeeeeeecCC
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN------DTLEDEFVQEVAILREV-QHRNVVRFIGASTKSP  108 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~------~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~  108 (259)
                      .+|.+.++||+|++|+||+|.+.  ++.||||++......      ......+.+|+.+++++ +||||+++++++...+
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            57888999999999999999985  889999999865421      12346678999999999 7999999999999999


Q ss_pred             cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      ..++||||+++++|.+++.... .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~  252 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP  252 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence            9999999999999999996543 489999999999999999999999999999999999999999999999999988776


Q ss_pred             CCccccCCCcccccCccccCC------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          189 GGVMTAETGTYRWMAPEVINH------QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       189 ~~~~~~~~~~~~~~~PE~~~~------~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ........+++.|+|||.+.+      ..++.++|+||||+++|+|++|..||...+..+.+..+..+...
T Consensus       253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  323 (365)
T 2y7j_A          253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQ  323 (365)
T ss_dssp             TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence            666666789999999999853      35788999999999999999999999988888777777665544

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.8e-40  Score=291.33  Aligned_cols=206  Identities=26%  Similarity=0.458  Sum_probs=184.3

Q ss_pred             eechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcE
Q 045286           34 EIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN-DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL  110 (259)
Q Consensus        34 ~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~  110 (259)
                      .+..++|++.+.||+|+||.||+|.+.  ++.||+|++...... ......+.+|+.+++.++||||+++++++...+..
T Consensus       180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  259 (576)
T 2acx_A          180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL  259 (576)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence            466788999999999999999999984  889999999765321 22345678999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC
Q 045286          111 CIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG  189 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~  189 (259)
                      ++||||++|++|.+++.... ..+++..++.++.|++.+|.|||+.|++|+||||+||+++.+|.++|+|||++......
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999999986543 34899999999999999999999999999999999999999999999999999887766


Q ss_pred             CccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 045286          190 GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT  239 (259)
Q Consensus       190 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  239 (259)
                      ......++++.|+|||++.+..++.++|+|||||++|+|++|..||...+
T Consensus       340 ~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~  389 (576)
T 2acx_A          340 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK  389 (576)
T ss_dssp             CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred             ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence            55566789999999999999999999999999999999999999998753

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.2e-39  Score=274.38  Aligned_cols=217  Identities=26%  Similarity=0.420  Sum_probs=190.3

Q ss_pred             ceechhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcC-----CCCcceeeeeee
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-----HRNVVRFIGAST  105 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~  105 (259)
                      ..+-.++|++.++||+|+||.||+|.+  .++.||+|++...   ........+|+.+++.+.     |+||+++++++.
T Consensus        30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~  106 (360)
T 3llt_A           30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM  106 (360)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred             ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence            444467999999999999999999998  5789999999753   234466778999999996     999999999999


Q ss_pred             cCCcEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc-------------
Q 045286          106 KSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT-------------  171 (259)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~-------------  171 (259)
                      ..+..++|||++ +++|.+++.... ..++...++.++.|++.+|.+||+.|++|+||||+||+++.             
T Consensus       107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~  185 (360)
T 3llt_A          107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV  185 (360)
T ss_dssp             ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred             ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcc
Confidence            999999999999 889999997654 35899999999999999999999999999999999999975             


Q ss_pred             ------------CCeEEEeeeccceeccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 045286          172 ------------HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT  239 (259)
Q Consensus       172 ------------~~~i~l~D~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  239 (259)
                                  ++.++|+|||.+......  .....+++.|+|||.+.+..++.++|||||||++|+|++|..||...+
T Consensus       186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  263 (360)
T 3llt_A          186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE  263 (360)
T ss_dssp             TTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence                        788999999999865443  235578999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhhhccCCCC
Q 045286          240 PLQAALGVRQVCTSLC  255 (259)
Q Consensus       240 ~~~~~~~i~~~~~~~~  255 (259)
                      ..+.+..+.....+.+
T Consensus       264 ~~~~~~~~~~~~~~~p  279 (360)
T 3llt_A          264 HMEHLAMMESIIQPIP  279 (360)
T ss_dssp             HHHHHHHHHHHTCCCC
T ss_pred             HHHHHHHHHHhcCCCC
Confidence            9888888887766544

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.2e-40  Score=270.89  Aligned_cols=220  Identities=34%  Similarity=0.635  Sum_probs=182.7

Q ss_pred             ccccceechhhhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec-C
Q 045286           29 KSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK-S  107 (259)
Q Consensus        29 ~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~  107 (259)
                      ....|.+..++|++.+.||+|++|.||++.+.++.|++|++....    ..+.+.+|+.+++.++||||+++++++.. .
T Consensus        12 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (278)
T 1byg_A           12 YRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK   87 (278)
T ss_dssp             ---CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred             hhccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            345588889999999999999999999999999999999998653    33678899999999999999999998644 4


Q ss_pred             CcEEEEEecCCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNHN-VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                      +..++|+|++++++|.+++..... .++...++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  167 (278)
T 1byg_A           88 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  167 (278)
T ss_dssp             -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccc
Confidence            578999999999999999965432 3788999999999999999999999999999999999999999999999998755


Q ss_pred             cCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCC
Q 045286          187 NKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       187 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      ....  ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+.++....
T Consensus       168 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~  234 (278)
T 1byg_A          168 SSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD  234 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC
T ss_pred             cccc--cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC
Confidence            4432  23356788999999998889999999999999999998 999999988888887777665443

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.4e-40  Score=277.20  Aligned_cols=200  Identities=21%  Similarity=0.319  Sum_probs=177.1

Q ss_pred             chhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeeeeeecCCcEEE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHLCI  112 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l  112 (259)
                      -..+|++.+.||+|+||.||+|.+  .++.||+|++......    ..+.+|+.+++.+ +|+||+++++++...+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   82 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM   82 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence            357899999999999999999996  4889999998865432    3577899999999 89999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCe-----EEEeeeccceecc
Q 045286          113 VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV-----VKVADFGVARFQN  187 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~-----i~l~D~~~~~~~~  187 (259)
                      |||++ +++|.+++......+++..++.++.|++.+|.+||+.|++|+||||+||+++.++.     ++|+|||.+....
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99999 99999999876667999999999999999999999999999999999999998887     9999999998654


Q ss_pred             CCCc--------cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 045286          188 KGGV--------MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTP  240 (259)
Q Consensus       188 ~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~  240 (259)
                      ....        .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+.
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~  222 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA  222 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc
Confidence            4322        2345789999999999999999999999999999999999999987443

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=6.1e-40  Score=288.27  Aligned_cols=217  Identities=27%  Similarity=0.411  Sum_probs=186.7

Q ss_pred             eechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCch-HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcE
Q 045286           34 EIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL  110 (259)
Q Consensus        34 ~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~  110 (259)
                      .+..++|.+.+.||+|+||.||+|.+.  ++.||+|++....... .....+.+|..+++.++||||+++++++...+..
T Consensus       181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  260 (543)
T 3c4z_A          181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL  260 (543)
T ss_dssp             CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence            455678999999999999999999984  8899999997653221 2346788999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          111 CIVTEYMPGGSLYDYLHKNH---NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      ++||||++|++|.+++....   ..+++..++.++.|++.+|.|||+.|++|+||||+||+++.+|.++|+|||++....
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999999999986542   358999999999999999999999999999999999999999999999999998766


Q ss_pred             CCCc-cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHhhhc
Q 045286          188 KGGV-MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSM----TPLQAALGVRQV  250 (259)
Q Consensus       188 ~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~----~~~~~~~~i~~~  250 (259)
                      .... ....++++.|+|||++.+..++.++|+|||||++|+|++|..||...    +..+....+...
T Consensus       341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~  408 (543)
T 3c4z_A          341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ  408 (543)
T ss_dssp             TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC
T ss_pred             CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc
Confidence            5433 23458999999999999999999999999999999999999999765    334444444443

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.3e-40  Score=267.83  Aligned_cols=216  Identities=25%  Similarity=0.449  Sum_probs=185.2

Q ss_pred             chhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCch-HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND-TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCI  112 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l  112 (259)
                      .-++|++.+.||+|++|.||+|.+.  ++.|++|++....... .....+.+|+.+++.++||||+++++++...+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3478999999999999999999985  5689999997643222 234668899999999999999999999999999999


Q ss_pred             EEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcc
Q 045286          113 VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM  192 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~  192 (259)
                      ||||+++++|.+++.... .+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus        87 v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-~~  164 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RR  164 (279)
T ss_dssp             EECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred             EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-cc
Confidence            999999999999996654 4899999999999999999999999999999999999999999999999988554433 23


Q ss_pred             ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          193 TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+......
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  225 (279)
T 3fdn_A          165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT  225 (279)
T ss_dssp             ---CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC
T ss_pred             cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCC
Confidence            4456899999999999999999999999999999999999999999888888777665443

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=5.4e-40  Score=268.43  Aligned_cols=216  Identities=29%  Similarity=0.417  Sum_probs=169.9

Q ss_pred             ceechhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcE
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL  110 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~  110 (259)
                      +++..++|++.+.||+|++|.||+|.+  .++.||+|++............+.++...++.++||||+++++++...+..
T Consensus         2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~   81 (290)
T 3fme_A            2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV   81 (290)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred             CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence            456778999999999999999999998  588999999987655555555566666678888999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          111 CIVTEYMPGGSLYDYLHK---NHNVLKLPQLLRFAIDICKGMEYLHQR-NIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                      ++|||++++ +|.+++..   ....+++..++.++.|++.+|.+||+. |++|+||+|+||+++.++.++|+|||.+...
T Consensus        82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999999964 88777653   445699999999999999999999998 9999999999999999999999999999877


Q ss_pred             cCCCccccCCCcccccCcccc----CCCCCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHhhh
Q 045286          187 NKGGVMTAETGTYRWMAPEVI----NHQPYDQKADVFSFAIVLWELVTAKVPYDS-MTPLQAALGVRQ  249 (259)
Q Consensus       187 ~~~~~~~~~~~~~~~~~PE~~----~~~~~~~~~Di~slG~~~~~ll~g~~p~~~-~~~~~~~~~i~~  249 (259)
                      ..........+++.|+|||.+    .+..++.++|+||||+++|+|++|..||.. ......+.....
T Consensus       161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  228 (290)
T 3fme_A          161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE  228 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH
T ss_pred             cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc
Confidence            665555556789999999996    556789999999999999999999999986 444444444443

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=6.7e-40  Score=270.89  Aligned_cols=199  Identities=26%  Similarity=0.327  Sum_probs=172.5

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeeeeeecCCcEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      .++|++.++||+|+||+||+|.+.  ++.||||++..............+|+..+..+ +|+||+++++++..++..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            478999999999999999999985  88999999887665555555666666666666 799999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT  193 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~  193 (259)
                      ||++ +++|.+++......+++..++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+..........
T Consensus       136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  214 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE  214 (311)
T ss_dssp             EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred             Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCc
Confidence            9999 679999988777779999999999999999999999999999999999999999999999999998776665556


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                      ...+++.|+|||.+.+ .++.++|+||||+++|+|++|..|+..
T Consensus       215 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~  257 (311)
T 3p1a_A          215 VQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG  257 (311)
T ss_dssp             CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred             ccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            6679999999999877 689999999999999999999776654

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.6e-40  Score=280.44  Aligned_cols=217  Identities=25%  Similarity=0.419  Sum_probs=173.3

Q ss_pred             cceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC--
Q 045286           32 DWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS--  107 (259)
Q Consensus        32 ~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--  107 (259)
                      .|++. ++|++.++||+|+||.||+|.+.  ++.||+|++............+.+|+.+++.++||||+++++++...  
T Consensus        24 ~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  102 (367)
T 2fst_X           24 IWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS  102 (367)
T ss_dssp             EEEEE-TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             ccCCC-CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence            46664 58999999999999999999874  78999999987766666678889999999999999999999988643  


Q ss_pred             ----CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccc
Q 045286          108 ----PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA  183 (259)
Q Consensus       108 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~  183 (259)
                          ...++++|++ +++|.+++..  ..+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+
T Consensus       103 ~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          103 LEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             GGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred             cccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence                5679999999 7899998865  35899999999999999999999999999999999999999999999999999


Q ss_pred             eeccCCCccccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          184 RFQNKGGVMTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      ......  .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..+.+..+.+..+.+
T Consensus       180 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p  249 (367)
T 2fst_X          180 RHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP  249 (367)
T ss_dssp             -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred             cccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            765432  344578999999999877 678999999999999999999999999999988888887766554

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-39  Score=266.29  Aligned_cols=212  Identities=22%  Similarity=0.406  Sum_probs=178.9

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      .++|++.++||+|+||.||++.+.  +..+++|++...... .....+.+|+++++.++||||+++++++......++||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            368999999999999999999975  789999999876432 23467889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE---ccCCeEEEeeeccceeccC
Q 045286          115 EYMPGGSLYDYLHKN---HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM---DTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       115 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv---~~~~~i~l~D~~~~~~~~~  188 (259)
                      |++++++|.+++...   ...+++..++.++.|++.+|.+||+.|++|+||+|+||++   +.++.++|+|||.+.....
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~  179 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS  179 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence            999999999988543   3569999999999999999999999999999999999999   4567899999999987666


Q ss_pred             CCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       189 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      ........+++.|+|||.+. ..++.++|+||||+++|+|++|..||.+.+..+....+...
T Consensus       180 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~  240 (285)
T 3is5_A          180 DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK  240 (285)
T ss_dssp             -------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC
Confidence            55556667899999999986 45889999999999999999999999988877766655543

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.5e-40  Score=276.12  Aligned_cols=205  Identities=30%  Similarity=0.479  Sum_probs=177.1

Q ss_pred             ccccceechhhhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           29 KSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        29 ~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      ....+.+...+|++.++||+|+||.||+|.+.++.||+|++....   .......+|+.++++++||||+++++++....
T Consensus        15 ~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   91 (322)
T 3soc_A           15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGT   91 (322)
T ss_dssp             CCCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             CccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCC
Confidence            345578889999999999999999999999999999999997643   22345567899999999999999999987644


Q ss_pred             ----cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----------CcccCCCCCCcEEEccCCe
Q 045286          109 ----HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR----------NIIHRDLKTANLLMDTHNV  174 (259)
Q Consensus       109 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~----------~i~H~di~p~Nilv~~~~~  174 (259)
                          ..++||||+++++|.+++....  +++..++.++.|++.+|.|||+.          |++|+||||+||+++.++.
T Consensus        92 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~  169 (322)
T 3soc_A           92 SVDVDLWLITAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT  169 (322)
T ss_dssp             SSSEEEEEEEECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred             CCCceEEEEEecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe
Confidence                3799999999999999997643  89999999999999999999999          9999999999999999999


Q ss_pred             EEEeeeccceeccCCCc---cccCCCcccccCccccCCC-----CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 045286          175 VKVADFGVARFQNKGGV---MTAETGTYRWMAPEVINHQ-----PYDQKADVFSFAIVLWELVTAKVPYDSM  238 (259)
Q Consensus       175 i~l~D~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~-----~~~~~~Di~slG~~~~~ll~g~~p~~~~  238 (259)
                      ++|+|||.+........   .....+++.|+|||.+.+.     .++.++||||||+++|+|++|..||.+.
T Consensus       170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~  241 (322)
T 3soc_A          170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP  241 (322)
T ss_dssp             EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred             EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence            99999999976654332   2335689999999999763     4567889999999999999999999753

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.1e-39  Score=268.75  Aligned_cols=215  Identities=23%  Similarity=0.459  Sum_probs=186.6

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      .++|.+.+.||+|++|.||++.+.  ++.|++|++.....  .....+.+|+.+++.++||||+++++++...+..++|+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM   85 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence            468999999999999999999985  88999999986532  22356889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE---ccCCeEEEeeeccceeccCCCc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM---DTHNVVKVADFGVARFQNKGGV  191 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv---~~~~~i~l~D~~~~~~~~~~~~  191 (259)
                      |++++++|.+++.... .+++..++.++.|++.+|.+||+.|++|+||+|+||++   +.++.++|+|||.+...... .
T Consensus        86 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~  163 (304)
T 2jam_A           86 QLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-I  163 (304)
T ss_dssp             CCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-T
T ss_pred             EcCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-c
Confidence            9999999999986554 48999999999999999999999999999999999999   67889999999998654432 2


Q ss_pred             cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCC
Q 045286          192 MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLC  255 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~  255 (259)
                      .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.++.....
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  227 (304)
T 2jam_A          164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE  227 (304)
T ss_dssp             THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCC
T ss_pred             cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            2334588999999999999999999999999999999999999999998888888887765443

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.3e-40  Score=276.59  Aligned_cols=201  Identities=27%  Similarity=0.499  Sum_probs=173.6

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ++|++.++||+|+||.||+|.+.  ++.||+|++...... ...+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            57899999999999999999875  789999999765432 233668899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC---cc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG---VM  192 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~---~~  192 (259)
                      |+++++|.+++... ..+++..++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+.......   ..
T Consensus        86 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  164 (323)
T 3tki_A           86 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (323)
T ss_dssp             CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             cCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence            99999999998544 348999999999999999999999999999999999999999999999999997654332   22


Q ss_pred             ccCCCcccccCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 045286          193 TAETGTYRWMAPEVINHQPY-DQKADVFSFAIVLWELVTAKVPYDSMTP  240 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~~~~ll~g~~p~~~~~~  240 (259)
                      ....+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  213 (323)
T 3tki_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD  213 (323)
T ss_dssp             CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred             CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence            35578999999999987765 7789999999999999999999986554

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.6e-39  Score=264.29  Aligned_cols=214  Identities=25%  Similarity=0.394  Sum_probs=188.9

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      .++|.+.+.||+|++|.||++.+.  ++.+++|++..... .....+.+.+|+.+++.++|+||+++++++...+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            468999999999999999999985  77899999987643 334557788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-Ccc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVM  192 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~  192 (259)
                      +|++++++|.+++.... .+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus        94 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  172 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK  172 (294)
T ss_dssp             EECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcccc
Confidence            99999999999886543 5899999999999999999999999999999999999999999999999999876533 233


Q ss_pred             ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          193 TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+....
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  231 (294)
T 2rku_A          173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE  231 (294)
T ss_dssp             CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC
T ss_pred             ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc
Confidence            44568999999999999889999999999999999999999999988877776666543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.2e-40  Score=273.28  Aligned_cols=224  Identities=32%  Similarity=0.506  Sum_probs=187.4

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEc--Cce--EEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeeeeee
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQD--VAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGAST  105 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~--v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~  105 (259)
                      ..-.++.++|++.+.||+|++|.||+|.+.  +..  +++|.+.... .......+.+|+.+++++ +||||+++++++.
T Consensus        18 ~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~   96 (327)
T 1fvr_A           18 IYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACE   96 (327)
T ss_dssp             CSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred             ccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeee
Confidence            334466789999999999999999999864  444  4899887542 233446688999999999 8999999999999


Q ss_pred             cCCcEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc
Q 045286          106 KSPHLCIVTEYMPGGSLYDYLHKNH---------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD  170 (259)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~  170 (259)
                      ..+..++|||++++++|.+++....               ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~  176 (327)
T 1fvr_A           97 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG  176 (327)
T ss_dssp             ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred             eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc
Confidence            9999999999999999999996543               3589999999999999999999999999999999999999


Q ss_pred             cCCeEEEeeeccceeccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhh
Q 045286          171 THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       171 ~~~~i~l~D~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~  249 (259)
                      .++.++|+|||.+.............+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+..
T Consensus       177 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~  256 (327)
T 1fvr_A          177 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  256 (327)
T ss_dssp             GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred             CCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc
Confidence            999999999999875443333334456788999999988889999999999999999998 9999999999888888877


Q ss_pred             ccCCCC
Q 045286          250 VCTSLC  255 (259)
Q Consensus       250 ~~~~~~  255 (259)
                      +.....
T Consensus       257 ~~~~~~  262 (327)
T 1fvr_A          257 GYRLEK  262 (327)
T ss_dssp             TCCCCC
T ss_pred             CCCCCC
Confidence            654433

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=5.9e-40  Score=272.58  Aligned_cols=216  Identities=26%  Similarity=0.424  Sum_probs=184.7

Q ss_pred             hhhhhccceeccccceEEEEEEEc---CceEEEEEeecccCchHHHHHHHHHHHHHHhc---CCCCcceeeeeee-----
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL---GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV---QHRNVVRFIGAST-----  105 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~---~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~-----  105 (259)
                      .++|++.+.||+|++|.||+|.+.   ++.|++|++............+.+|+.+++.+   +||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            578999999999999999999983   67899999986544332223455677766666   8999999999886     


Q ss_pred             cCCcEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccce
Q 045286          106 KSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR  184 (259)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~  184 (259)
                      .....++|+|+++ ++|.+++.... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~  168 (326)
T 1blx_A           90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  168 (326)
T ss_dssp             SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence            5567899999996 59999997654 348999999999999999999999999999999999999999999999999998


Q ss_pred             eccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          185 FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ............+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+.+..+.+..+.
T Consensus       169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  237 (326)
T 1blx_A          169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL  237 (326)
T ss_dssp             CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence            766554455667899999999999989999999999999999999999999999988888887765443

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3e-40  Score=276.48  Aligned_cols=219  Identities=26%  Similarity=0.403  Sum_probs=183.1

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccC---chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL---NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~  111 (259)
                      .++|++.+.||+|+||.||+|.+.  ++.|++|++.....   .......+.+|+.+++.++||||+++++++...+..+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            578999999999999999999874  67899999976432   2344577899999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 045286          112 IVTEYMPGGSLYDYLHKN---------------------------------------HNVLKLPQLLRFAIDICKGMEYL  152 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~---------------------------------------~~~~~~~~~~~i~~ql~~~l~~l  152 (259)
                      +||||+++++|.+++...                                       ...+++..++.++.|++.+|.+|
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            999999999999988421                                       11135677888999999999999


Q ss_pred             HhCCcccCCCCCCcEEEccCC--eEEEeeeccceeccCCC-----ccccCCCcccccCccccCC--CCCCCchhHHHHHH
Q 045286          153 HQRNIIHRDLKTANLLMDTHN--VVKVADFGVARFQNKGG-----VMTAETGTYRWMAPEVINH--QPYDQKADVFSFAI  223 (259)
Q Consensus       153 H~~~i~H~di~p~Nilv~~~~--~i~l~D~~~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~  223 (259)
                      |+.|++|+||+|+||+++.++  .++|+|||.+.......     ......+++.|+|||.+.+  ..++.++|+||||+
T Consensus       185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~  264 (345)
T 3hko_A          185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV  264 (345)
T ss_dssp             HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred             HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence            999999999999999998776  89999999998654321     1234568999999999865  67899999999999


Q ss_pred             HHHHHHcCCCCCCCCCHHHHHHHhhhccCCCC
Q 045286          224 VLWELVTAKVPYDSMTPLQAALGVRQVCTSLC  255 (259)
Q Consensus       224 ~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~  255 (259)
                      ++|+|++|..||.+.+..+....+........
T Consensus       265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (345)
T 3hko_A          265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFE  296 (345)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTT
T ss_pred             HHHHHHHCCCCCCCCChHHHHHHHHhcccccC
Confidence            99999999999999998888888776655443

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3e-40  Score=291.52  Aligned_cols=224  Identities=34%  Similarity=0.629  Sum_probs=195.6

Q ss_pred             cccceechhhhhccceeccccceEEEEEEEcC-ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVYLG-QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~-~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      .+.|++..++|++.++||+|+||.||++.+.+ ..||||+++.....   .+.+.+|+.++++++|+||+++++++.. +
T Consensus       259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~  334 (535)
T 2h8h_A          259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  334 (535)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence            45699999999999999999999999999875 67999999875433   3678999999999999999999999876 6


Q ss_pred             cEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          109 HLCIVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      ..++||||+++++|.+++... ...++...++.++.|++.+|.|||++|++|+||+|+|||++.++.++|+|||++....
T Consensus       335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            789999999999999999643 3458899999999999999999999999999999999999999999999999997654


Q ss_pred             CCCc--cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          188 KGGV--MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       188 ~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      ....  .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+.+..+.++.+..+++
T Consensus       415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~  487 (535)
T 2h8h_A          415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP  487 (535)
T ss_dssp             CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            3211  122345678999999988889999999999999999999 999999999999999998887766554

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1e-39  Score=265.10  Aligned_cols=217  Identities=25%  Similarity=0.494  Sum_probs=181.2

Q ss_pred             echhhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEE
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~  111 (259)
                      +...+|++.+.||+|++|.||++.+.  ++.|++|++..... .......+.+|+.+++.++||||+++++++...+..+
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   87 (276)
T 2h6d_A            8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF   87 (276)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence            34578999999999999999999985  88999999976532 1233467889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc
Q 045286          112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV  191 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~  191 (259)
                      +|+|++++++|.+++.... .+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        88 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  166 (276)
T 2h6d_A           88 MVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  166 (276)
T ss_dssp             EEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred             EEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence            9999999999999996654 489999999999999999999999999999999999999999999999999987666544


Q ss_pred             cccCCCcccccCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          192 MTAETGTYRWMAPEVINHQPY-DQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      .....+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+....+..+..
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~  228 (276)
T 2h6d_A          167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF  228 (276)
T ss_dssp             ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred             eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc
Confidence            455678999999999988766 6899999999999999999999999888888777776543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.2e-39  Score=270.98  Aligned_cols=204  Identities=24%  Similarity=0.451  Sum_probs=158.0

Q ss_pred             cceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCCcEEEEEecCCC
Q 045286           43 GERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHLCIVTEYMPG  119 (259)
Q Consensus        43 ~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~  119 (259)
                      .++||+|+||.||+|.+.  ++.||+|++...     ......+|+.+++.+. ||||+++++++......++|||++++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~   90 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG   90 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence            478999999999999985  789999999754     2356778999999997 99999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC---eEEEeeeccceeccCCC-ccccC
Q 045286          120 GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVARFQNKGG-VMTAE  195 (259)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~---~i~l~D~~~~~~~~~~~-~~~~~  195 (259)
                      ++|.+++... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++   .++|+|||.+....... .....
T Consensus        91 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  169 (325)
T 3kn6_A           91 GELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP  169 (325)
T ss_dssp             CBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred             CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCccccc
Confidence            9999999664 4599999999999999999999999999999999999998765   89999999998655432 33455


Q ss_pred             CCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHhhhccC
Q 045286          196 TGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT-------PLQAALGVRQVCT  252 (259)
Q Consensus       196 ~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~-------~~~~~~~i~~~~~  252 (259)
                      .+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+       ..+....+..+..
T Consensus       170 ~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~  233 (325)
T 3kn6_A          170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF  233 (325)
T ss_dssp             --------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC
T ss_pred             CCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC
Confidence            67999999999999999999999999999999999999997643       3455566655443

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=5.8e-40  Score=269.87  Aligned_cols=208  Identities=33%  Similarity=0.582  Sum_probs=178.7

Q ss_pred             cccccceechhhhhccceeccccceEEEEEEE------cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceee
Q 045286           28 TKSEDWEIDRRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI  101 (259)
Q Consensus        28 ~~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~  101 (259)
                      ...+...+..++|++.++||+|++|.||+|.+      .++.||+|++..... ......+.+|+.+++.++|+||++++
T Consensus        11 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~   89 (302)
T 4e5w_A           11 TEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYK   89 (302)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             eecChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCeeeee
Confidence            34455667788999999999999999999984      478999999986542 23346788999999999999999999


Q ss_pred             eeeecC--CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEee
Q 045286          102 GASTKS--PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVAD  179 (259)
Q Consensus       102 ~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D  179 (259)
                      +++...  ...++||||+++++|.+++......++...++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|
T Consensus        90 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~D  169 (302)
T 4e5w_A           90 GICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGD  169 (302)
T ss_dssp             EEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECC
T ss_pred             eEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECc
Confidence            998765  678999999999999999977777799999999999999999999999999999999999999999999999


Q ss_pred             eccceeccCCCc----cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 045286          180 FGVARFQNKGGV----MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYD  236 (259)
Q Consensus       180 ~~~~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~  236 (259)
                      ||.+........    .....++..|+|||.+.+..++.++|+||||+++|+|++|..|+.
T Consensus       170 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  230 (302)
T 4e5w_A          170 FGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS  230 (302)
T ss_dssp             CTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred             ccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence            999987665432    223457788999999998889999999999999999999988764

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.1e-39  Score=264.99  Aligned_cols=218  Identities=24%  Similarity=0.396  Sum_probs=190.8

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCc-------hHHHHHHHHHHHHHHhcC-CCCcceeeeeeec
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN-------DTLEDEFVQEVAILREVQ-HRNVVRFIGASTK  106 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~-------~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~  106 (259)
                      .++|++.+.||.|++|.||+|.+.  ++.|++|++......       ......+.+|+.+++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            468999999999999999999984  789999999865421       233467789999999996 9999999999999


Q ss_pred             CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          107 SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                      .+..++|+|++++++|.+++... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  174 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  174 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence            99999999999999999999764 35899999999999999999999999999999999999999999999999999877


Q ss_pred             cCCCccccCCCcccccCccccC------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCC
Q 045286          187 NKGGVMTAETGTYRWMAPEVIN------HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLC  255 (259)
Q Consensus       187 ~~~~~~~~~~~~~~~~~PE~~~------~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~  255 (259)
                      ..........+++.|+|||.+.      ...++.++|+||||+++|+|++|..||...+..+....+..+.....
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  249 (298)
T 1phk_A          175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG  249 (298)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             CCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccC
Confidence            7665556667899999999984      45678999999999999999999999999888888777776654433

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.6e-39  Score=266.59  Aligned_cols=214  Identities=32%  Similarity=0.506  Sum_probs=181.6

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcE
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL  110 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~  110 (259)
                      .....++|.+.+.||+|++|.||+|.+.  ++.|++|.+.....    ...+.+|+.+++.++||||+++++++...+..
T Consensus        24 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   99 (314)
T 3com_A           24 TKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL   99 (314)
T ss_dssp             ------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             hhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence            4455788999999999999999999986  78999999987542    25678999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      ++|+||+++++|.+++......++...++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus       100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            99999999999999997666679999999999999999999999999999999999999999999999999997665432


Q ss_pred             -ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          191 -VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       191 -~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                       ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+...
T Consensus       180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  240 (314)
T 3com_A          180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN  240 (314)
T ss_dssp             SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred             cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC
Confidence             233456899999999999999999999999999999999999999988776666555443

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.1e-39  Score=266.53  Aligned_cols=216  Identities=26%  Similarity=0.455  Sum_probs=189.2

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      .++|++.++||+|++|.||+|.+.  ++.|++|++............+.+|+.++++++||||+++++++...+..++++
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            368999999999999999999984  789999999876555455678899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC---CeEEEeeeccceeccCCCc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH---NVVKVADFGVARFQNKGGV  191 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~---~~i~l~D~~~~~~~~~~~~  191 (259)
                      |++++++|.+++.... .+++..++.++.|++.+|.+||+.|++|+||+|+||+++.+   +.++|+|||.+........
T Consensus       101 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~  179 (287)
T 2wei_A          101 ELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK  179 (287)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred             EccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence            9999999999886554 48999999999999999999999999999999999999764   4699999999876655544


Q ss_pred             cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          192 MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      .....+++.|+|||.+.+. ++.++|+||||+++|+|++|..||...+..+....+..+....
T Consensus       180 ~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  241 (287)
T 2wei_A          180 MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF  241 (287)
T ss_dssp             CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            4444578899999998765 8999999999999999999999999999888888887765443

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.2e-40  Score=272.83  Aligned_cols=233  Identities=30%  Similarity=0.454  Sum_probs=193.3

Q ss_pred             HHHhccccccceechhhhhccceeccccceEEEEEEE-------cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCC
Q 045286           23 AIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVY-------LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHR   95 (259)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~-------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~   95 (259)
                      ...+.+..+..++..++|++.+.||+|++|.||+|.+       .++.|++|.+.... .......+.+|+.+++.++||
T Consensus        15 ~~~sss~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~   93 (327)
T 2yfx_A           15 AGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQ   93 (327)
T ss_dssp             TTEEECGGGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCT
T ss_pred             cCCccchhhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCC
Confidence            3444556666788899999999999999999999984       35689999997543 344556788999999999999


Q ss_pred             CcceeeeeeecCCcEEEEEecCCCCChHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE
Q 045286           96 NVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM  169 (259)
Q Consensus        96 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv  169 (259)
                      ||+++++++...+..++|||++++++|.+++....      ..++...++.++.|++.+|.+||+.|++|+||+|+||++
T Consensus        94 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli  173 (327)
T 2yfx_A           94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLL  173 (327)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             CCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEE
Confidence            99999999999889999999999999999997653      348889999999999999999999999999999999999


Q ss_pred             cc---CCeEEEeeeccceeccCCCc---cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 045286          170 DT---HNVVKVADFGVARFQNKGGV---MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQ  242 (259)
Q Consensus       170 ~~---~~~i~l~D~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~  242 (259)
                      +.   +..++|+|||.+........   .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+
T Consensus       174 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  253 (327)
T 2yfx_A          174 TCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE  253 (327)
T ss_dssp             SCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             ecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH
Confidence            84   44699999999875433321   123346789999999988889999999999999999998 999999998888


Q ss_pred             HHHHhhhccCCCCc
Q 045286          243 AALGVRQVCTSLCQ  256 (259)
Q Consensus       243 ~~~~i~~~~~~~~~  256 (259)
                      ....+..+.....+
T Consensus       254 ~~~~~~~~~~~~~~  267 (327)
T 2yfx_A          254 VLEFVTSGGRMDPP  267 (327)
T ss_dssp             HHHHHHTTCCCCCC
T ss_pred             HHHHHhcCCCCCCC
Confidence            88887776554433

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4e-39  Score=268.88  Aligned_cols=214  Identities=25%  Similarity=0.394  Sum_probs=189.1

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      .++|.+.+.||+|+||.||++.+.  ++.+++|++..... .......+.+|+.+++.++|+||+++++++...+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            578999999999999999999985  67899999987543 334567788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-Ccc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVM  192 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~  192 (259)
                      |||+++++|.+++.... .+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus       120 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  198 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK  198 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             EecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccc
Confidence            99999999999986543 5899999999999999999999999999999999999999999999999999876533 233


Q ss_pred             ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          193 TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+....
T Consensus       199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  257 (335)
T 2owb_A          199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE  257 (335)
T ss_dssp             CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC
T ss_pred             cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC
Confidence            44568999999999998889999999999999999999999999888877776666543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.5e-39  Score=264.80  Aligned_cols=215  Identities=33%  Similarity=0.549  Sum_probs=189.3

Q ss_pred             chhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      ..+.|.+.+.||+|++|.||+|.+.  ++.|++|++...... .....+.+|+.+++.++|+||+++++++...+..++|
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   98 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   98 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            3567999999999999999999874  789999999876433 3357788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-cc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VM  192 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~  192 (259)
                      |||+++++|.+++..  ..++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus        99 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  176 (303)
T 3a7i_A           99 MEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR  176 (303)
T ss_dssp             EECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred             EEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence            999999999999864  348999999999999999999999999999999999999999999999999998765443 23


Q ss_pred             ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          193 TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.+...+
T Consensus       177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  237 (303)
T 3a7i_A          177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPP  237 (303)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred             CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCC
Confidence            3456899999999999999999999999999999999999999998887777766655443

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-39  Score=282.01  Aligned_cols=206  Identities=26%  Similarity=0.379  Sum_probs=164.3

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec--
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK--  106 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--  106 (259)
                      ..|.+. ++|++.++||+|+||+||+|.+.  ++.||+|++............+.+|+.+++.++|+||+++++++..  
T Consensus        47 ~~~~~~-~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  125 (458)
T 3rp9_A           47 SDWQIP-DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD  125 (458)
T ss_dssp             SSCCSC-TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             CcCccC-CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence            345553 58999999999999999999874  7899999998776666667889999999999999999999999843  


Q ss_pred             ---CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccc
Q 045286          107 ---SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA  183 (259)
Q Consensus       107 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~  183 (259)
                         ....++|||++ +++|.+++.. ...+++..++.++.||+.+|.|||+.|++||||||+|||++.++.++|+|||++
T Consensus       126 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          126 VEKFDELYVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             TTTCCCEEEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             cccCceEEEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccc
Confidence               35789999998 5789998854 345999999999999999999999999999999999999999999999999999


Q ss_pred             eeccCCC----------------------------ccccCCCcccccCcccc-CCCCCCCchhHHHHHHHHHHHHc----
Q 045286          184 RFQNKGG----------------------------VMTAETGTYRWMAPEVI-NHQPYDQKADVFSFAIVLWELVT----  230 (259)
Q Consensus       184 ~~~~~~~----------------------------~~~~~~~~~~~~~PE~~-~~~~~~~~~Di~slG~~~~~ll~----  230 (259)
                      .......                            .....++++.|+|||++ .+..++.++|||||||++|+|++    
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~  283 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE  283 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence            7654321                            12344679999999986 56679999999999999999998    


Q ss_pred             -------CCCCCCCCC
Q 045286          231 -------AKVPYDSMT  239 (259)
Q Consensus       231 -------g~~p~~~~~  239 (259)
                             |..+|.+.+
T Consensus       284 ~~~~~~~~~p~f~g~~  299 (458)
T 3rp9_A          284 NVAYHADRGPLFPGSS  299 (458)
T ss_dssp             TCSSGGGCCCSCC---
T ss_pred             cccccccccccCCCCc
Confidence                   777777654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3e-39  Score=278.43  Aligned_cols=203  Identities=25%  Similarity=0.339  Sum_probs=172.0

Q ss_pred             cccccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeee
Q 045286           28 TKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST  105 (259)
Q Consensus        28 ~~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~  105 (259)
                      +..+.+.+. ++|++.++||+|++|.||+|.+.  ++.||+|++............+.+|+.+++.++|+||+++++++.
T Consensus        17 Q~~~~~~i~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~   95 (432)
T 3n9x_A           17 QGIKNVHVP-DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLII   95 (432)
T ss_dssp             TCGGGCCCC-TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred             cCCCcceec-CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence            344556664 58999999999999999999975  788999999877666666788999999999999999999999987


Q ss_pred             cC-----CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeee
Q 045286          106 KS-----PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADF  180 (259)
Q Consensus       106 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~  180 (259)
                      ..     ...++|||+++ ++|.+++.. ...+++..++.++.|++.+|.|||+.|++||||||+||+++.++.++|+||
T Consensus        96 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DF  173 (432)
T 3n9x_A           96 PDDLLKFDELYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDF  173 (432)
T ss_dssp             CSCTTTCCCEEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             cCCCCcCCeEEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccC
Confidence            65     57899999995 599999854 345999999999999999999999999999999999999999999999999


Q ss_pred             ccceeccCCC-----------------------ccccCCCcccccCcccc-CCCCCCCchhHHHHHHHHHHHHcCCC
Q 045286          181 GVARFQNKGG-----------------------VMTAETGTYRWMAPEVI-NHQPYDQKADVFSFAIVLWELVTAKV  233 (259)
Q Consensus       181 ~~~~~~~~~~-----------------------~~~~~~~~~~~~~PE~~-~~~~~~~~~Di~slG~~~~~ll~g~~  233 (259)
                      |++.......                       ......+++.|+|||++ .+..++.++|+|||||++|+|++|..
T Consensus       174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~  250 (432)
T 3n9x_A          174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ  250 (432)
T ss_dssp             TTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred             CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence            9998665432                       12456789999999986 56679999999999999999998433

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.9e-40  Score=267.91  Aligned_cols=220  Identities=29%  Similarity=0.437  Sum_probs=188.8

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeee--cCCcEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST--KSPHLCI  112 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~l  112 (259)
                      .++|++.+.||+|++|.||++.+.  ++.|++|.+..........+.+.+|+.++++++||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468899999999999999999984  789999999987766667788999999999999999999999774  4678999


Q ss_pred             EEecCCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCCCcEEEccCCeEEEeeeccce
Q 045286          113 VTEYMPGGSLYDYLHKN---HNVLKLPQLLRFAIDICKGMEYLHQRN-----IIHRDLKTANLLMDTHNVVKVADFGVAR  184 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~~-----i~H~di~p~Nilv~~~~~i~l~D~~~~~  184 (259)
                      ||||+++++|.+++...   ...+++..++.++.|++.+|.+||+.|     ++|+||+|+||+++.++.++|+|||.+.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            99999999999998653   234899999999999999999999999     9999999999999999999999999987


Q ss_pred             eccCCCc-cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          185 FQNKGGV-MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       185 ~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      ....... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+..+..+..+
T Consensus       165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~  237 (279)
T 2w5a_A          165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP  237 (279)
T ss_dssp             HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCC
T ss_pred             eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCC
Confidence            6554322 22345788999999999888999999999999999999999999999888888888776654433

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-39  Score=276.80  Aligned_cols=215  Identities=21%  Similarity=0.354  Sum_probs=181.5

Q ss_pred             ceechhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec----
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK----  106 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----  106 (259)
                      ++...++|++.++||+|+||+||+|.+  +++.||+|++......      ..+|+.+++.++|+||+++++++..    
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~   75 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDE   75 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCcc
Confidence            345567899999999999999999987  4789999998765322      2379999999999999999998843    


Q ss_pred             ----------------------------------CCcEEEEEecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHH
Q 045286          107 ----------------------------------SPHLCIVTEYMPGGSLYDYLHK---NHNVLKLPQLLRFAIDICKGM  149 (259)
Q Consensus       107 ----------------------------------~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l  149 (259)
                                                        ....++||||++ ++|.+.+..   ....+++..++.++.|++.+|
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL  154 (383)
T 3eb0_A           76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV  154 (383)
T ss_dssp             ----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence                                              334889999996 487777643   345699999999999999999


Q ss_pred             HHHHhCCcccCCCCCCcEEEc-cCCeEEEeeeccceeccCCCccccCCCcccccCccccCCC-CCCCchhHHHHHHHHHH
Q 045286          150 EYLHQRNIIHRDLKTANLLMD-THNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWE  227 (259)
Q Consensus       150 ~~lH~~~i~H~di~p~Nilv~-~~~~i~l~D~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~  227 (259)
                      .|||+.|++|+||||+||+++ .++.++|+|||.+.............+++.|+|||.+.+. .++.++|+||+||++|+
T Consensus       155 ~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e  234 (383)
T 3eb0_A          155 GFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE  234 (383)
T ss_dssp             HHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred             HHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence            999999999999999999997 5899999999999877666666667789999999998775 58999999999999999


Q ss_pred             HHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          228 LVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       228 ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      |++|..||.+.+..+.+..+.+..+.+
T Consensus       235 ll~g~~pf~~~~~~~~~~~i~~~~g~p  261 (383)
T 3eb0_A          235 LILGKPLFSGETSIDQLVRIIQIMGTP  261 (383)
T ss_dssp             HHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            999999999999998888887765544

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.2e-40  Score=275.40  Aligned_cols=220  Identities=27%  Similarity=0.510  Sum_probs=183.1

Q ss_pred             eechhhhhccceeccccceEEEEEEEc--Cce----EEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 045286           34 EIDRRLLKTGERIASGSCGDLYRGVYL--GQD----VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS  107 (259)
Q Consensus        34 ~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~----v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~  107 (259)
                      .+...+|++.++||+|+||.||+|.+.  ++.    |++|.+..... ......+.+|+.+++.++||||+++++++. +
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   86 (325)
T 3kex_A            9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G   86 (325)
T ss_dssp             BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred             hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence            345678999999999999999999974  333    78887765432 222245678999999999999999999886 4


Q ss_pred             CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      +..++|+||+++++|.+++......+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+....
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            57889999999999999997665568899999999999999999999999999999999999999999999999998664


Q ss_pred             CCC---ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCC
Q 045286          188 KGG---VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLC  255 (259)
Q Consensus       188 ~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~  255 (259)
                      ...   ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+..+.....
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  238 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ  238 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC
Confidence            432   2233456779999999998889999999999999999999 9999999888887777776654433

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=9e-40  Score=295.11  Aligned_cols=218  Identities=23%  Similarity=0.380  Sum_probs=190.0

Q ss_pred             echhhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhc-CCCCcceeeeeeecCCcE
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHL  110 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~  110 (259)
                      +.-.+|.+.+.||+|+||.||+|.+.  ++.||+|+++.... .......+.+|..+++.+ +|++|+.+++++...+..
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            44467999999999999999999985  67899999986422 222346678899999988 599999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc-CC
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN-KG  189 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~-~~  189 (259)
                      ++||||+++++|..++.... .+++..++.++.|++.+|.|||+.||+||||||+|||++.++.++|+|||++.... ..
T Consensus       418 ~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  496 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred             EEEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence            99999999999999997654 49999999999999999999999999999999999999999999999999998643 33


Q ss_pred             CccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          190 GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       190 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ......++++.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+....|......
T Consensus       497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~  560 (674)
T 3pfq_A          497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA  560 (674)
T ss_dssp             CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCC
T ss_pred             cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC
Confidence            3445668999999999999999999999999999999999999999999999988888875543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.5e-39  Score=263.24  Aligned_cols=216  Identities=32%  Similarity=0.542  Sum_probs=184.3

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec----
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK----  106 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----  106 (259)
                      ....++.|++.+.||+|++|.||+|.+.  +..|++|.+............+.+|+.+++.++||||+++++++..    
T Consensus        21 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  100 (290)
T 1t4h_A           21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG  100 (290)
T ss_dssp             ECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred             cccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCC
Confidence            4455678999999999999999999985  6789999999877777777889999999999999999999998754    


Q ss_pred             CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEc-cCCeEEEeeeccc
Q 045286          107 SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN--IIHRDLKTANLLMD-THNVVKVADFGVA  183 (259)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~di~p~Nilv~-~~~~i~l~D~~~~  183 (259)
                      ....++||||+++++|.+++.... .++...++.++.|++.+|.+||+.|  ++|+||+|+||+++ .++.++|+|||.+
T Consensus       101 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          101 KKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             CEEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             CceEEEEEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            356899999999999999996643 4889999999999999999999999  99999999999997 7899999999998


Q ss_pred             eeccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHhhhcc
Q 045286          184 RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS-MTPLQAALGVRQVC  251 (259)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~-~~~~~~~~~i~~~~  251 (259)
                      ...... ......+++.|+|||.+.+ .++.++|+||||+++|+|++|..||.. .+..+....+..+.
T Consensus       180 ~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  246 (290)
T 1t4h_A          180 TLKRAS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV  246 (290)
T ss_dssp             GGCCTT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC
T ss_pred             cccccc-ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccC
Confidence            654443 3345578999999998875 489999999999999999999999987 44444444444443

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.3e-40  Score=267.09  Aligned_cols=209  Identities=25%  Similarity=0.409  Sum_probs=160.2

Q ss_pred             hhhhccceeccccceEEEEEEE--cCceEEEEEeecccCc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLN-DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      ++|++.+.||+|++|.||+|.+  .++.|++|++...... ......+.+|+.+++.++||||+++++++...+..++|+
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            5788999999999999999997  5889999999764321 123467889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-ccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMT  193 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~  193 (259)
                      |++++++|.+++......+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  170 (278)
T 3cok_A           91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY  170 (278)
T ss_dssp             ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred             ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcce
Confidence            9999999999998766679999999999999999999999999999999999999999999999999998665332 223


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALG  246 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~  246 (259)
                      ...+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....
T Consensus       171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  223 (278)
T 3cok_A          171 TLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK  223 (278)
T ss_dssp             ---------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----
T ss_pred             eccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH
Confidence            45688999999999998899999999999999999999999987655444433

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.8e-39  Score=277.08  Aligned_cols=194  Identities=25%  Similarity=0.418  Sum_probs=160.7

Q ss_pred             hhhc-cceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeeeeeec----CCcE
Q 045286           39 LLKT-GERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGASTK----SPHL  110 (259)
Q Consensus        39 ~~~~-~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----~~~~  110 (259)
                      .|.+ .++||.|+||+||++.+.  ++.||+|++...       ..+.+|+.++.++ +|+||+++++++..    ....
T Consensus        62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            3444 479999999999999985  789999999743       4566788887554 79999999998865    5678


Q ss_pred             EEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc---CCeEEEeeeccceec
Q 045286          111 CIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT---HNVVKVADFGVARFQ  186 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~---~~~i~l~D~~~~~~~  186 (259)
                      ++||||+++++|.+++.... ..+++..++.++.|++.+|.|||+.|++|+||||+||+++.   ++.++|+|||++...
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~  214 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET  214 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence            99999999999999997543 35899999999999999999999999999999999999987   788999999999877


Q ss_pred             cCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 045286          187 NKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT  239 (259)
Q Consensus       187 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  239 (259)
                      .........++++.|+|||++.+..++.++|||||||++|+|++|..||...+
T Consensus       215 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  267 (400)
T 1nxk_A          215 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH  267 (400)
T ss_dssp             C-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred             CCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence            66555566678999999999999999999999999999999999999997654

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.4e-40  Score=272.47  Aligned_cols=221  Identities=30%  Similarity=0.574  Sum_probs=182.7

Q ss_pred             echhhhhccceeccccceEEEEEEEc--Cce----EEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL--GQD----VAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~----v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      +...+|++.++||+|+||.||+|.+.  ++.    |++|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   90 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence            45688999999999999999999974  444    5777765433 2334577889999999999999999999998754


Q ss_pred             cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                       .+++++++.+++|.+++......+++..++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+.....
T Consensus        91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence             7889999999999999988777799999999999999999999999999999999999999999999999999976544


Q ss_pred             CCcc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          189 GGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       189 ~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      ....   ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+..+...+.++
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  242 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP  242 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            3222   23345778999999999999999999999999999999 999999998888888887776555443

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.6e-39  Score=263.85  Aligned_cols=215  Identities=25%  Similarity=0.435  Sum_probs=187.5

Q ss_pred             echhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEE
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN-DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~  111 (259)
                      +..++|++.+.||+|++|.||+|.+.  ++.|++|++...... ......+.+|+.+++.++|+||+++++++...+..+
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   90 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY   90 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence            34478999999999999999999985  678999999764322 223467889999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc
Q 045286          112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV  191 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~  191 (259)
                      +|+|++++++|.+++.... .+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...... .
T Consensus        91 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-~  168 (284)
T 2vgo_A           91 LMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-R  168 (284)
T ss_dssp             EEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-C
T ss_pred             EEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-c
Confidence            9999999999999997654 4899999999999999999999999999999999999999999999999998765543 2


Q ss_pred             cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          192 MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+....
T Consensus       169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  228 (284)
T 2vgo_A          169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD  228 (284)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC
T ss_pred             cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc
Confidence            334578999999999999999999999999999999999999999888877776665543

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=9.5e-41  Score=276.58  Aligned_cols=230  Identities=30%  Similarity=0.546  Sum_probs=192.2

Q ss_pred             HHHhccccccceechhhhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeee
Q 045286           23 AIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG  102 (259)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~  102 (259)
                      ..+.......|+++.++|++.+.||+|++|.||+|.+.+ .+++|++............+.+|+.+++.++|+||+++++
T Consensus        18 ~~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   96 (319)
T 2y4i_B           18 ASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG   96 (319)
T ss_dssp             ----CCCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCE
T ss_pred             ccccccccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEE
Confidence            334445667899999999999999999999999999865 5999999876544444456778999999999999999999


Q ss_pred             eeecCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecc
Q 045286          103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGV  182 (259)
Q Consensus       103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~  182 (259)
                      ++...+..++++|++++++|.+++......+++..++.++.|++.+|.+||+.|++|+||+|+||+++ ++.++|+|||.
T Consensus        97 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~  175 (319)
T 2y4i_B           97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGL  175 (319)
T ss_dssp             EEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred             EEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCC
Confidence            99999999999999999999999977666799999999999999999999999999999999999997 78999999998


Q ss_pred             ceeccC------CCccccCCCcccccCccccCC---------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 045286          183 ARFQNK------GGVMTAETGTYRWMAPEVINH---------QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGV  247 (259)
Q Consensus       183 ~~~~~~------~~~~~~~~~~~~~~~PE~~~~---------~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i  247 (259)
                      +.....      ........+++.|+|||.+.+         ..++.++|+||||+++|+|++|..||...+..+....+
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  255 (319)
T 2y4i_B          176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM  255 (319)
T ss_dssp             CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred             ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence            765432      122233457899999999864         35788999999999999999999999999998888888


Q ss_pred             hhccCCC
Q 045286          248 RQVCTSL  254 (259)
Q Consensus       248 ~~~~~~~  254 (259)
                      ..+..+.
T Consensus       256 ~~~~~~~  262 (319)
T 2y4i_B          256 GTGMKPN  262 (319)
T ss_dssp             HTTCCCC
T ss_pred             ccCCCCC
Confidence            7765544

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.1e-39  Score=267.54  Aligned_cols=210  Identities=20%  Similarity=0.295  Sum_probs=181.2

Q ss_pred             eechhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeeeeeecCCcE
Q 045286           34 EIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHL  110 (259)
Q Consensus        34 ~~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~  110 (259)
                      .+-.++|++.+.||+|++|.||+|.+  .++.|++|++......    ..+.+|+.+++.+ +|++++++++++......
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~   81 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN   81 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence            34467899999999999999999996  5889999998765432    3477899999999 699999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCe-----EEEeeecccee
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV-----VKVADFGVARF  185 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~-----i~l~D~~~~~~  185 (259)
                      ++|+|++ +++|.+++......++...++.++.|++.+|.+||+.|++|+||+|+||+++.++.     ++|+|||.+..
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            9999999 99999999877667999999999999999999999999999999999999987765     99999999987


Q ss_pred             ccCCCc--------cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHhh
Q 045286          186 QNKGGV--------MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSM---TPLQAALGVR  248 (259)
Q Consensus       186 ~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~---~~~~~~~~i~  248 (259)
                      ......        .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...   +..+....+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  234 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG  234 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH
Confidence            654322        23446899999999999999999999999999999999999999874   3444444443

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.4e-40  Score=266.97  Aligned_cols=211  Identities=22%  Similarity=0.408  Sum_probs=179.9

Q ss_pred             ceechhhhhccceeccccceEEEEEEEcC---------ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeee
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYLG---------QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA  103 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~~---------~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~  103 (259)
                      .++..++|.+.+.||+|+||.||+|.+..         ..|++|++....  ....+.+.+|+.+++.++||||++++++
T Consensus         3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~   80 (289)
T 4fvq_A            3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGV   80 (289)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred             EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence            35677899999999999999999998652         469999987643  3445778999999999999999999999


Q ss_pred             eecCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCe--------E
Q 045286          104 STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV--------V  175 (259)
Q Consensus       104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~--------i  175 (259)
                      +...+..++||||+++++|.+++......+++..++.++.|++.+|.+||+.|++|+||||+||+++.++.        +
T Consensus        81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence            99989999999999999999999876666999999999999999999999999999999999999998887        9


Q ss_pred             EEeeeccceeccCCCccccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhh
Q 045286          176 KVADFGVARFQNKGGVMTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVR  248 (259)
Q Consensus       176 ~l~D~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~  248 (259)
                      +|+|||.+......   ....+++.|+|||.+.+ ..++.++|+||||+++|+|++ +..||...+.........
T Consensus       161 kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~  232 (289)
T 4fvq_A          161 KLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE  232 (289)
T ss_dssp             EECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             eeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh
Confidence            99999998654332   22236778999999987 678999999999999999999 566676666655544433

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.6e-39  Score=270.88  Aligned_cols=204  Identities=23%  Similarity=0.399  Sum_probs=174.6

Q ss_pred             cceechhhhhccceeccccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcCC--CCcceeeeeeecCC
Q 045286           32 DWEIDRRLLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH--RNVVRFIGASTKSP  108 (259)
Q Consensus        32 ~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~  108 (259)
                      ..++.+++|++.+.||+|+||.||++.+. ++.||+|++............+.+|+.+++.++|  +||+++++++...+
T Consensus         3 ~i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~   82 (343)
T 3dbq_A            3 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ   82 (343)
T ss_dssp             CEESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             eeeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence            45677889999999999999999999874 6789999998877676777889999999999986  99999999999999


Q ss_pred             cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      ..++|||+ .+++|.+++... ..+++..+..++.|++.+|.+||+.|++|+||||+||+++ ++.++|+|||.+.....
T Consensus        83 ~~~lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           83 YIYMVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EEEEEECC-CSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             EEEEEEeC-CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            99999995 578999999764 4589999999999999999999999999999999999996 78899999999976654


Q ss_pred             CCc---cccCCCcccccCccccCC-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 045286          189 GGV---MTAETGTYRWMAPEVINH-----------QPYDQKADVFSFAIVLWELVTAKVPYDSM  238 (259)
Q Consensus       189 ~~~---~~~~~~~~~~~~PE~~~~-----------~~~~~~~Di~slG~~~~~ll~g~~p~~~~  238 (259)
                      ...   .....+++.|+|||.+.+           ..++.++||||||+++|+|++|..||...
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  223 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  223 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence            322   234568999999999854           56888999999999999999999999864

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=9.6e-40  Score=272.24  Aligned_cols=217  Identities=30%  Similarity=0.574  Sum_probs=185.2

Q ss_pred             cccceechhhhhccceeccccceEEEEEEEcC-------ceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceee
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFI  101 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~-------~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~  101 (259)
                      .+.|++..++|.+.+.||+|+||.||+|.+.+       ..|++|.+.... .......+.+|+.+++.+ +||||++++
T Consensus        38 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~  116 (333)
T 2i1m_A           38 NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLL  116 (333)
T ss_dssp             CGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            34689999999999999999999999999752       379999998754 334457788999999999 799999999


Q ss_pred             eeeecCCcEEEEEecCCCCChHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEE
Q 045286          102 GASTKSPHLCIVTEYMPGGSLYDYLHKN-------------HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLL  168 (259)
Q Consensus       102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nil  168 (259)
                      +++...+..++||||+++++|.+++...             ...++...++.++.|++.+|.+||+.|++|+||+|+||+
T Consensus       117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL  196 (333)
T ss_dssp             EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence            9999999999999999999999998643             235789999999999999999999999999999999999


Q ss_pred             EccCCeEEEeeeccceeccCCCcc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 045286          169 MDTHNVVKVADFGVARFQNKGGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAA  244 (259)
Q Consensus       169 v~~~~~i~l~D~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~  244 (259)
                      ++.++.++|+|||.+.........   ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+.......
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  276 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF  276 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence            999999999999999765443221   12235678999999988889999999999999999998 99999876654444


Q ss_pred             HHh
Q 045286          245 LGV  247 (259)
Q Consensus       245 ~~i  247 (259)
                      ..+
T Consensus       277 ~~~  279 (333)
T 2i1m_A          277 YKL  279 (333)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            333

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=7.4e-40  Score=273.96  Aligned_cols=212  Identities=27%  Similarity=0.439  Sum_probs=180.8

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeeeeeecCCcEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      .++|.+.+.||.|+||.||+|.+.  ++.||+|++......      ..+|++++.++ +||||+++++++...+..++|
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   94 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV   94 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence            468999999999999999999985  789999999876432      34678888888 699999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC----CeEEEeeeccceeccCC
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH----NVVKVADFGVARFQNKG  189 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~----~~i~l~D~~~~~~~~~~  189 (259)
                      |||++|++|.+++... ..+++..+..++.|++.+|.+||+.|++|+||||+||++..+    +.++|+|||.+......
T Consensus        95 ~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~  173 (342)
T 2qr7_A           95 TELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE  173 (342)
T ss_dssp             ECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred             EeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence            9999999999998654 458999999999999999999999999999999999998543    35999999999866543


Q ss_pred             -CccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHhhhccCCCC
Q 045286          190 -GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS---MTPLQAALGVRQVCTSLC  255 (259)
Q Consensus       190 -~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~---~~~~~~~~~i~~~~~~~~  255 (259)
                       ......++++.|+|||.+.+..++.++|+||||+++|+|++|..||..   .+..+....+..+.....
T Consensus       174 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~  243 (342)
T 2qr7_A          174 NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS  243 (342)
T ss_dssp             TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCC
T ss_pred             CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccC
Confidence             333456789999999999888889999999999999999999999975   455666777766554433

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.6e-39  Score=291.65  Aligned_cols=225  Identities=29%  Similarity=0.539  Sum_probs=190.4

Q ss_pred             ccceechhhhhccc-eeccccceEEEEEEEc----CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeee
Q 045286           31 EDWEIDRRLLKTGE-RIASGSCGDLYRGVYL----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST  105 (259)
Q Consensus        31 ~~~~~~~~~~~~~~-~lg~G~~~~V~~~~~~----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~  105 (259)
                      ..+.++...+.+.. +||+|+||.||+|.+.    ++.||||+++...........+.+|+.++++++||||+++++++.
T Consensus       361 ~~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  440 (635)
T 4fl3_A          361 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE  440 (635)
T ss_dssp             SSSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            34566666666544 8999999999999763    578999999887666666788999999999999999999999986


Q ss_pred             cCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          106 KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                      . +..++||||+++++|.+++... ..+++..++.++.|++.+|.|||+.|++|+||||+||+++.++.++|+|||++..
T Consensus       441 ~-~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~  518 (635)
T 4fl3_A          441 A-ESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA  518 (635)
T ss_dssp             S-SSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHH
T ss_pred             c-CCEEEEEEccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccc
Confidence            5 4688999999999999999654 4589999999999999999999999999999999999999999999999999976


Q ss_pred             ccCCCc----cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          186 QNKGGV----MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       186 ~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      ......    .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+.++....+++
T Consensus       519 ~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~  595 (635)
T 4fl3_A          519 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA  595 (635)
T ss_dssp             TTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             cccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            544321    122345678999999999899999999999999999998 999999999999999998887766554

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3e-39  Score=265.22  Aligned_cols=222  Identities=29%  Similarity=0.494  Sum_probs=185.4

Q ss_pred             eechhhhhccceeccccceEEEEEEEcC-----ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeee-ecC
Q 045286           34 EIDRRLLKTGERIASGSCGDLYRGVYLG-----QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAS-TKS  107 (259)
Q Consensus        34 ~~~~~~~~~~~~lg~G~~~~V~~~~~~~-----~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~  107 (259)
                      .....+|++.++||+|+||.||+|.+..     ..+++|.+.... .......+.+|+.++++++||||+++++++ ...
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   99 (298)
T 3f66_A           21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE   99 (298)
T ss_dssp             CGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred             CccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence            3345678899999999999999998642     258899887643 344557789999999999999999999985 556


Q ss_pred             CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      +..+++||++++++|.+++......++...++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+....
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccc
Confidence            68899999999999999997766678999999999999999999999999999999999999999999999999997654


Q ss_pred             CCCc-----cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          188 KGGV-----MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       188 ~~~~-----~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      ....     .....+++.|+|||.+.+..++.++|+||||+++|+|++ +..||...+..+....+.++.....+
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP  254 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC
T ss_pred             ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC
Confidence            3321     123345678999999999899999999999999999999 77788887777777777766655444

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=291.26  Aligned_cols=224  Identities=26%  Similarity=0.532  Sum_probs=189.2

Q ss_pred             cceechhhhhccc-eeccccceEEEEEEEc----CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec
Q 045286           32 DWEIDRRLLKTGE-RIASGSCGDLYRGVYL----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK  106 (259)
Q Consensus        32 ~~~~~~~~~~~~~-~lg~G~~~~V~~~~~~----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~  106 (259)
                      .+.+...++.+.+ .||+|+||.||+|.+.    +..||||+++... .....+.+.+|+++++.++||||+++++++..
T Consensus       329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  407 (613)
T 2ozo_A          329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA  407 (613)
T ss_dssp             CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred             ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence            3556666666666 8999999999999873    4579999998753 23345778999999999999999999999876


Q ss_pred             CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          107 SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                       +..++||||+++++|.+++......+++..+..++.|++.+|.|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus       408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~  486 (613)
T 2ozo_A          408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL  486 (613)
T ss_dssp             -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred             -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence             5689999999999999999776667999999999999999999999999999999999999999999999999999765


Q ss_pred             cCCCcc----ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          187 NKGGVM----TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       187 ~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      ......    ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+.++.+...|+
T Consensus       487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~  562 (613)
T 2ozo_A          487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP  562 (613)
T ss_dssp             C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCT
T ss_pred             cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            433211    12234578999999998899999999999999999998 999999999999999998887766554

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.9e-39  Score=274.42  Aligned_cols=217  Identities=25%  Similarity=0.442  Sum_probs=185.2

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      ..|++. ++|.+.++||+|+||.||+|.+.  ++.||+|++............+.+|+.+++.++||||+++++++...+
T Consensus        36 ~~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  114 (371)
T 4exu_A           36 TAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS  114 (371)
T ss_dssp             EEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             ceeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccC
Confidence            346664 58999999999999999999875  789999999987767777788999999999999999999999997766


Q ss_pred             cE------EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecc
Q 045286          109 HL------CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGV  182 (259)
Q Consensus       109 ~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~  182 (259)
                      ..      ++|||+++ ++|.+.+.   ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.
T Consensus       115 ~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          115 SLRNFYDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             SSTTCCCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             CcccceeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence            54      99999996 57877663   3489999999999999999999999999999999999999999999999999


Q ss_pred             ceeccCCCccccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          183 ARFQNKGGVMTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      +......  .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+.+..+.+..+.+
T Consensus       191 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~  261 (371)
T 4exu_A          191 ARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP  261 (371)
T ss_dssp             C----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            9765443  344568999999999887 678999999999999999999999999999888888877655443

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.9e-39  Score=268.75  Aligned_cols=198  Identities=26%  Similarity=0.460  Sum_probs=168.9

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC-------
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP-------  108 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------  108 (259)
                      .+|++.++||+|+||.||+|.+.  ++.||+|++.... .....+.+.+|+.++++++||||+++++++...+       
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            57899999999999999999984  8899999998654 3344577899999999999999999999875433       


Q ss_pred             --------------------------------------------------cEEEEEecCCCCChHHHHHhcCC--CCCHH
Q 045286          109 --------------------------------------------------HLCIVTEYMPGGSLYDYLHKNHN--VLKLP  136 (259)
Q Consensus       109 --------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~--~~~~~  136 (259)
                                                                        ..+++|||+++++|.+++.....  ..+..
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              37999999999999999976443  24555


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-------------ccccCCCcccccC
Q 045286          137 QLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-------------VMTAETGTYRWMA  203 (259)
Q Consensus       137 ~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-------------~~~~~~~~~~~~~  203 (259)
                      .++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+.......             ......+++.|+|
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  244 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS  244 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence            688999999999999999999999999999999999999999999998765542             2233468999999


Q ss_pred             ccccCCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 045286          204 PEVINHQPYDQKADVFSFAIVLWELVTAKVPYD  236 (259)
Q Consensus       204 PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~  236 (259)
                      ||.+.+..++.++|+||||+++|+|++|..|+.
T Consensus       245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~  277 (332)
T 3qd2_B          245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM  277 (332)
T ss_dssp             HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred             hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence            999999999999999999999999999877753

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=5.1e-39  Score=273.44  Aligned_cols=216  Identities=22%  Similarity=0.383  Sum_probs=180.0

Q ss_pred             cccceechhhhhccceeccccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcC--CCCcceeeeeeec
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ--HRNVVRFIGASTK  106 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~  106 (259)
                      .+...+..++|++.++||+|+||.||++.+. ++.||||++............+.+|+.+++.++  |+||+++++++..
T Consensus        48 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~  127 (390)
T 2zmd_A           48 NECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT  127 (390)
T ss_dssp             -CCEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             cccccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec
Confidence            3446677788999999999999999999875 778999999887666667788999999999997  5999999999999


Q ss_pred             CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          107 SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                      .+..++||| +.+++|.+++.... .+++..++.++.|++.+|.|||+.|++|+||||+||+++ ++.++|+|||++...
T Consensus       128 ~~~~~lv~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~  204 (390)
T 2zmd_A          128 DQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM  204 (390)
T ss_dssp             SSEEEEEEE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred             CCEEEEEEe-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence            999999999 45889999997654 588889999999999999999999999999999999994 689999999999866


Q ss_pred             cCCC---ccccCCCcccccCccccCC-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHhh
Q 045286          187 NKGG---VMTAETGTYRWMAPEVINH-----------QPYDQKADVFSFAIVLWELVTAKVPYDSMT-PLQAALGVR  248 (259)
Q Consensus       187 ~~~~---~~~~~~~~~~~~~PE~~~~-----------~~~~~~~Di~slG~~~~~ll~g~~p~~~~~-~~~~~~~i~  248 (259)
                      ....   ......+++.|+|||++.+           ..++.++|||||||++|+|++|..||.... ....+..+.
T Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~  281 (390)
T 2zmd_A          205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII  281 (390)
T ss_dssp             ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred             cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh
Confidence            5432   1234579999999999865           368899999999999999999999998643 334444443

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.3e-39  Score=262.07  Aligned_cols=219  Identities=28%  Similarity=0.492  Sum_probs=183.5

Q ss_pred             hhhhhccceeccccceEEEEEEEc--C---ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcE-
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--G---QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL-  110 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~---~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-  110 (259)
                      ...|...++||+|+||.||+|.+.  +   ..+++|.+.... .....+.+.+|+.+++.++||||+++++++...+.. 
T Consensus        20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence            345567799999999999999863  2   269999987643 334557788999999999999999999998765554 


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      ++++|++.+++|.+++......++...++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+.......
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            89999999999999997766678999999999999999999999999999999999999999999999999997543321


Q ss_pred             -----ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          191 -----VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       191 -----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                           ......+++.|.|||.+.+..++.++|+||||+++|+|++ +..||...+..+....+..+.....+
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQP  250 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCC
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCC
Confidence                 2233457889999999999999999999999999999999 66667777777777777766554443

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.1e-39  Score=269.66  Aligned_cols=203  Identities=33%  Similarity=0.562  Sum_probs=177.9

Q ss_pred             echhhhhccceeccccceEEEEEEE------cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeee--c
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST--K  106 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~  106 (259)
                      ++.++|++.++||+|++|.||++.+      .++.|++|++...  .....+.+.+|+.+++.++|+||+++++++.  .
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG   97 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence            5568999999999999999999984      4788999999865  3444577899999999999999999999875  4


Q ss_pred             CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          107 SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                      ....++||||+++++|.+++......+++..++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+...
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence            56789999999999999999776556999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCc----cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 045286          187 NKGGV----MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT  239 (259)
Q Consensus       187 ~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  239 (259)
                      .....    .....++..|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~  234 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS  234 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcccc
Confidence            54432    123457788999999998889999999999999999999999986543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.9e-39  Score=262.07  Aligned_cols=205  Identities=32%  Similarity=0.588  Sum_probs=176.7

Q ss_pred             cceechhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHH-----HHHHHHHHHHHhcCCCCcceeeeee
Q 045286           32 DWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLE-----DEFVQEVAILREVQHRNVVRFIGAS  104 (259)
Q Consensus        32 ~~~~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~-----~~~~~e~~~l~~l~~~~i~~~~~~~  104 (259)
                      ...+..++|++.+.||+|++|.||+|.+  .++.||+|++..........     ..+.+|+.+++.++||||+++++++
T Consensus        13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   92 (287)
T 4f0f_A           13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM   92 (287)
T ss_dssp             CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence            3456678999999999999999999998  47899999997654432221     6788999999999999999999998


Q ss_pred             ecCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEccCCe-----EEE
Q 045286          105 TKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN--IIHRDLKTANLLMDTHNV-----VKV  177 (259)
Q Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~di~p~Nilv~~~~~-----i~l  177 (259)
                      ....  ++||||+++++|.+++......+++..++.++.|++.+|.+||+.|  ++|+||+|+||+++.++.     ++|
T Consensus        93 ~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           93 HNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             TTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             cCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence            7654  6999999999999998777777999999999999999999999999  999999999999988776     999


Q ss_pred             eeeccceeccCCCccccCCCcccccCccccC--CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 045286          178 ADFGVARFQNKGGVMTAETGTYRWMAPEVIN--HQPYDQKADVFSFAIVLWELVTAKVPYDSMTP  240 (259)
Q Consensus       178 ~D~~~~~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~  240 (259)
                      +|||.+.....  ......+++.|+|||.+.  ...++.++|+||||+++|+|++|..||...+.
T Consensus       171 ~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  233 (287)
T 4f0f_A          171 ADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY  233 (287)
T ss_dssp             CCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             CCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence            99999875443  234567899999999984  45678899999999999999999999986554

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5.9e-40  Score=273.93  Aligned_cols=200  Identities=25%  Similarity=0.470  Sum_probs=177.2

Q ss_pred             hhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCch------HHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLND------TLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      .++|++.++||+|+||.||+|.+  .++.||+|++.......      .....+.+|+.+++.++||||+++++++...+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            36899999999999999999987  47899999998764322      12345678999999999999999999999999


Q ss_pred             cEEEEEecCCCC-ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          109 HLCIVTEYMPGG-SLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       109 ~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      ..++|||++.++ +|.+++.... .+++..++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+....
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  181 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE  181 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence            999999998665 9999986543 59999999999999999999999999999999999999999999999999998877


Q ss_pred             CCCccccCCCcccccCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          188 KGGVMTAETGTYRWMAPEVINHQPY-DQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       188 ~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                      .........+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||..
T Consensus       182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  232 (335)
T 3dls_A          182 RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE  232 (335)
T ss_dssp             TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred             CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence            7665566779999999999988876 7899999999999999999999965

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.3e-39  Score=274.52  Aligned_cols=216  Identities=24%  Similarity=0.350  Sum_probs=177.6

Q ss_pred             hhhhhccceeccccceEEEEEEEc-CceEEEEEeecccCc---------hHHHHHHHHHHHHHHhcCCCCcceeeeeeec
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLN---------DTLEDEFVQEVAILREVQHRNVVRFIGASTK  106 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~---------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~  106 (259)
                      ..+|++.+.||+|++|.||+|.+. ++.||+|++......         ......+.+|+.++++++||||+++++++..
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  100 (362)
T 3pg1_A           21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH  100 (362)
T ss_dssp             TCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred             ccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence            468999999999999999999864 789999998764332         2334778999999999999999999998843


Q ss_pred             -----CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeec
Q 045286          107 -----SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFG  181 (259)
Q Consensus       107 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~  181 (259)
                           ....++|||+++ ++|.+.+......++...++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||
T Consensus       101 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  179 (362)
T 3pg1_A          101 FEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN  179 (362)
T ss_dssp             CCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTT
T ss_pred             ccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecC
Confidence                 346899999996 58888887666679999999999999999999999999999999999999999999999999


Q ss_pred             cceeccCCCccccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          182 VARFQNKGGVMTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      .+.............+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+.+..+.+....
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  252 (362)
T 3pg1_A          180 LAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT  252 (362)
T ss_dssp             C---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence            9986665555556678999999999877 67899999999999999999999999999988888887765544

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.3e-39  Score=272.84  Aligned_cols=213  Identities=25%  Similarity=0.420  Sum_probs=186.1

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      +..++..++|++.++||+|++|.||++.+.  ++.|++|++.... .......+.+|+.+++.++||||+++++++...+
T Consensus        26 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  104 (360)
T 3eqc_A           26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG  104 (360)
T ss_dssp             TCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT
T ss_pred             cccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC
Confidence            345677889999999999999999999986  7899999998763 4455678899999999999999999999999999


Q ss_pred             cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR-NIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      ..++||||+++++|.+++.... .+++..+..++.|++.+|.+||+. |++|+||+|+||+++.++.++|+|||.+....
T Consensus       105 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          105 EISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             EEEEEEECCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence            9999999999999999997654 488999999999999999999996 99999999999999999999999999986543


Q ss_pred             CCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 045286          188 KGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALG  246 (259)
Q Consensus       188 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~  246 (259)
                      .. ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....
T Consensus       184 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  241 (360)
T 3eqc_A          184 DS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM  241 (360)
T ss_dssp             HH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHH
T ss_pred             cc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            22 22345689999999999999999999999999999999999999998877665443

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.2e-39  Score=264.45  Aligned_cols=212  Identities=21%  Similarity=0.317  Sum_probs=174.0

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN-DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      -.+|++.+.||+|++|.||++.+.  ++.|++|++...... ......+.+|+.+++.++||||+++++++...+..+++
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            367999999999999999999974  789999999875433 34557788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC--c
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG--V  191 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~--~  191 (259)
                      +|++++++|.+++.... .+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......  .
T Consensus       113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  191 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ  191 (309)
T ss_dssp             EECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred             EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence            99999999999997653 48999999999999999999999999999999999999999999999999987655432  2


Q ss_pred             cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          192 MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                      .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+..
T Consensus       192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  249 (309)
T 2h34_A          192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ  249 (309)
T ss_dssp             -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHS
T ss_pred             ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhcc
Confidence            2345688999999999999999999999999999999999999988776544444433

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.9e-39  Score=267.24  Aligned_cols=221  Identities=33%  Similarity=0.584  Sum_probs=184.7

Q ss_pred             cccceechhhhhccceeccccceEEEEEEEc-------CceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceee
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFI  101 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~  101 (259)
                      ...|++..++|++.+.||+|+||.||+|.+.       ++.|++|++.... .......+.+|+.+++.+ +||||++++
T Consensus        19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3458888999999999999999999999853       4789999998654 334456788999999999 589999999


Q ss_pred             eeeecC-CcEEEEEecCCCCChHHHHHhcCCC---------------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 045286          102 GASTKS-PHLCIVTEYMPGGSLYDYLHKNHNV---------------LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTA  165 (259)
Q Consensus       102 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~---------------~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~  165 (259)
                      +++... ...++++||+++++|.+++......               ++...++.++.|++.+|.+||+.|++|+||+|+
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~  177 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR  177 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccc
Confidence            998664 4589999999999999999765432               788999999999999999999999999999999


Q ss_pred             cEEEccCCeEEEeeeccceeccCCCcc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCH-
Q 045286          166 NLLMDTHNVVKVADFGVARFQNKGGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTP-  240 (259)
Q Consensus       166 Nilv~~~~~i~l~D~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~-  240 (259)
                      ||+++.++.++|+|||.+.........   ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+. 
T Consensus       178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  257 (316)
T 2xir_A          178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  257 (316)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             eEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence            999999999999999999765443221   22345778999999999899999999999999999998 9999987654 


Q ss_pred             HHHHHHhhhcc
Q 045286          241 LQAALGVRQVC  251 (259)
Q Consensus       241 ~~~~~~i~~~~  251 (259)
                      ......+..+.
T Consensus       258 ~~~~~~~~~~~  268 (316)
T 2xir_A          258 EEFCRRLKEGT  268 (316)
T ss_dssp             HHHHHHHHHTC
T ss_pred             HHHHHHhccCc
Confidence            33444444443

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.6e-39  Score=271.46  Aligned_cols=220  Identities=24%  Similarity=0.377  Sum_probs=186.9

Q ss_pred             cccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS  107 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~  107 (259)
                      -+.+++ ..+|++.++||+|+||.||+|.+.  ++.||+|++.... .......+.+|+.++++++||||+++++++...
T Consensus        20 g~~~~~-~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   97 (364)
T 3qyz_A           20 GQVFDV-GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAP   97 (364)
T ss_dssp             -CBCCC-TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred             cEeccc-cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecC
Confidence            344555 468999999999999999999875  7889999998543 344557788999999999999999999988654


Q ss_pred             -----CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecc
Q 045286          108 -----PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGV  182 (259)
Q Consensus       108 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~  182 (259)
                           ...++|+|+++ ++|.+++...  .+++..++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.
T Consensus        98 ~~~~~~~~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  174 (364)
T 3qyz_A           98 TIEQMKDVYIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGL  174 (364)
T ss_dssp             STTTCCCEEEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CccccceEEEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcc
Confidence                 46899999996 5999988654  389999999999999999999999999999999999999999999999999


Q ss_pred             ceeccCCCc----cccCCCcccccCccccC-CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          183 ARFQNKGGV----MTAETGTYRWMAPEVIN-HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       183 ~~~~~~~~~----~~~~~~~~~~~~PE~~~-~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      +........    .....+++.|+|||.+. +..++.++|+||||+++|+|++|..||.+.+..+.+..+....+.+
T Consensus       175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  251 (364)
T 3qyz_A          175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP  251 (364)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSC
T ss_pred             eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCC
Confidence            986654322    23457899999999864 4568999999999999999999999999999988888887665544

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.2e-40  Score=280.17  Aligned_cols=216  Identities=23%  Similarity=0.438  Sum_probs=182.5

Q ss_pred             chhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC--cEE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP--HLC  111 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~  111 (259)
                      .+++|++.++||+|+||.||+|.+.  ++.||+|++...... .....+.+|+.+++.++||||+++++++...+  ..+
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~   85 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence            3578999999999999999999986  789999999865332 22466789999999999999999999987654  789


Q ss_pred             EEEecCCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE----ccCCeEEEeeecccee
Q 045286          112 IVTEYMPGGSLYDYLHKNH--NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM----DTHNVVKVADFGVARF  185 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv----~~~~~i~l~D~~~~~~  185 (259)
                      +||||+++++|.+++....  ..+++..++.++.|++.+|.+||+.|++|+||||+||++    +.++.++|+|||.+..
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            9999999999999986533  238999999999999999999999999999999999999    6777899999999987


Q ss_pred             ccCCCccccCCCcccccCccccCC--------CCCCCchhHHHHHHHHHHHHcCCCCCCC----CCHHHHHHHhhhccC
Q 045286          186 QNKGGVMTAETGTYRWMAPEVINH--------QPYDQKADVFSFAIVLWELVTAKVPYDS----MTPLQAALGVRQVCT  252 (259)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Di~slG~~~~~ll~g~~p~~~----~~~~~~~~~i~~~~~  252 (259)
                      ...........+++.|+|||.+.+        ..++.++|+|||||++|+|++|..||..    ....+.+..+..+..
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p  244 (396)
T 4eut_A          166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (396)
T ss_dssp             CCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred             ccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence            766655556679999999999865        4577899999999999999999999964    333555555555443

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=263.10  Aligned_cols=197  Identities=36%  Similarity=0.683  Sum_probs=167.3

Q ss_pred             eechhhhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           34 EIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        34 ~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      .++.++|++.+.||+|+||.||++.+.++.|++|.+...    .....+.+|+.++++++||||+++++++.  +..++|
T Consensus         4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv   77 (307)
T 2eva_A            4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLV   77 (307)
T ss_dssp             BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEE
T ss_pred             cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEE
Confidence            456789999999999999999999999999999998754    23467889999999999999999999876  347899


Q ss_pred             EecCCCCChHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCCCcEEEccCCe-EEEeeeccceecc
Q 045286          114 TEYMPGGSLYDYLHKNHN--VLKLPQLLRFAIDICKGMEYLHQ---RNIIHRDLKTANLLMDTHNV-VKVADFGVARFQN  187 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~di~p~Nilv~~~~~-i~l~D~~~~~~~~  187 (259)
                      |||+++++|.+++.....  .++...++.++.|++.+|.+||+   .|++|+||||+||+++.++. ++|+|||.+....
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred             EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence            999999999999975442  37788999999999999999999   89999999999999988886 7999999987554


Q ss_pred             CCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 045286          188 KGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSM  238 (259)
Q Consensus       188 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  238 (259)
                      ..  .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus       158 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  206 (307)
T 2eva_A          158 TH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI  206 (307)
T ss_dssp             ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred             cc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence            33  23346899999999999999999999999999999999999999854

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.6e-39  Score=265.09  Aligned_cols=214  Identities=29%  Similarity=0.515  Sum_probs=181.3

Q ss_pred             chhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      ..++|++.+.||+|++|.||+|.+.  ++.|++|++.....  .....+.+|+.+++.++||||+++++++...+..++|
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   94 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM   94 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence            4678999999999999999999986  78999999876532  2346788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-Ccc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVM  192 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~  192 (259)
                      +|++++++|.+++......+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus        95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  174 (302)
T 2j7t_A           95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR  174 (302)
T ss_dssp             EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-
T ss_pred             EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccccc
Confidence            9999999999999776667999999999999999999999999999999999999999999999999987532211 112


Q ss_pred             ccCCCcccccCcccc-----CCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          193 TAETGTYRWMAPEVI-----NHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~-----~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ....+++.|+|||.+     .+..++.++|+||||+++|+|++|..||...+..+....+....
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  238 (302)
T 2j7t_A          175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD  238 (302)
T ss_dssp             ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred             ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccC
Confidence            334688999999998     46678999999999999999999999999988877776666544

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.3e-39  Score=277.77  Aligned_cols=214  Identities=26%  Similarity=0.389  Sum_probs=186.4

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhc------CCCCcceeeeeeecCC
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV------QHRNVVRFIGASTKSP  108 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~  108 (259)
                      ..+|++.++||+|+||+||+|.+.  ++.||||++...   ......+.+|+.+++.+      +|+||+++++.+....
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            467999999999999999999875  689999999764   23345667788888777      4679999999999999


Q ss_pred             cEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCe--EEEeeecccee
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV--VKVADFGVARF  185 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~--i~l~D~~~~~~  185 (259)
                      ..++|||+++ ++|.+++.... ..+++..++.++.|++.+|.|||+.|++|+||||+||+++.++.  ++|+|||++..
T Consensus       173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~  251 (429)
T 3kvw_A          173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY  251 (429)
T ss_dssp             EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence            9999999995 69999887654 35899999999999999999999999999999999999999887  99999999976


Q ss_pred             ccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          186 QNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      ....  .....+++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+.+
T Consensus       252 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~  320 (429)
T 3kvw_A          252 EHQR--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ  320 (429)
T ss_dssp             TTCC--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             cCCc--ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence            5543  33457899999999999999999999999999999999999999999999999888877665543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.1e-39  Score=266.37  Aligned_cols=203  Identities=35%  Similarity=0.597  Sum_probs=176.4

Q ss_pred             ceechhhhhccceeccccceEEEEEEE------cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK  106 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~  106 (259)
                      -.+..++|++.++||+|+||.||++.+      .++.||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus        26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (318)
T 3lxp_A           26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCED  104 (318)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEec
Confidence            345666679999999999999998865      47889999998763 34556778999999999999999999999876


Q ss_pred             --CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccce
Q 045286          107 --SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR  184 (259)
Q Consensus       107 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~  184 (259)
                        ....++||||+++++|.+++....  +++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  182 (318)
T 3lxp_A          105 AGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK  182 (318)
T ss_dssp             TTTTEEEEEECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             CCCceEEEEEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccc
Confidence              467899999999999999986544  8999999999999999999999999999999999999999999999999998


Q ss_pred             eccCCCc----cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 045286          185 FQNKGGV----MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSM  238 (259)
Q Consensus       185 ~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  238 (259)
                      .......    .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~  240 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP  240 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred             cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence            7665432    22345778899999999888999999999999999999999999754

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.3e-39  Score=273.25  Aligned_cols=202  Identities=20%  Similarity=0.324  Sum_probs=169.3

Q ss_pred             echhhhhccceeccccceEEEEEEEc-------CceEEEEEeecccCchHH---------HHHHHHHHHHHHhcCCCCcc
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTL---------EDEFVQEVAILREVQHRNVV   98 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~-------~~~v~vK~~~~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~   98 (259)
                      +...+|++.++||+|+||.||+|.+.       ++.||+|++.........         .....+|+..++.++|+||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            44569999999999999999999874       478999998875421110         02234556667778899999


Q ss_pred             eeeeeeecC----CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc--cC
Q 045286           99 RFIGASTKS----PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD--TH  172 (259)
Q Consensus        99 ~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~--~~  172 (259)
                      ++++++...    ...++||||+ +++|.+++......+++..++.++.|++.+|.|||+.|++|+||||+||+++  .+
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence            999988664    4589999999 9999999987767799999999999999999999999999999999999999  88


Q ss_pred             CeEEEeeeccceeccCCCcc--------ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          173 NVVKVADFGVARFQNKGGVM--------TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       173 ~~i~l~D~~~~~~~~~~~~~--------~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                      +.++|+|||++.........        ....+++.|+|||.+.+..++.++||||||+++|+|++|..||.+
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~  263 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED  263 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            99999999999765432211        233489999999999999999999999999999999999999985

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-38  Score=263.13  Aligned_cols=215  Identities=32%  Similarity=0.526  Sum_probs=177.4

Q ss_pred             ceechhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeeeeeec---
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGASTK---  106 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~---  106 (259)
                      ......+|++.+.||+|++|.||+|.+  .++.|++|++.......   ..+.+|+.+++++ +||||+++++++..   
T Consensus        19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   95 (326)
T 2x7f_A           19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---EEIKQEINMLKKYSHHRNIATYYGAFIKKNP   95 (326)
T ss_dssp             CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTT---HHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred             ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccH---HHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence            344567899999999999999999998  58899999997654332   5688999999999 69999999999866   


Q ss_pred             ---CCcEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecc
Q 045286          107 ---SPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGV  182 (259)
Q Consensus       107 ---~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~  182 (259)
                         .+..++||||+++++|.+++.... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~  175 (326)
T 2x7f_A           96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV  175 (326)
T ss_dssp             -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred             ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcC
Confidence               467899999999999999997543 4588999999999999999999999999999999999999999999999999


Q ss_pred             ceeccCC-CccccCCCcccccCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          183 ARFQNKG-GVMTAETGTYRWMAPEVIN-----HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       183 ~~~~~~~-~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      +...... .......+++.|+|||.+.     +..++.++|+||||+++|+|++|..||...+..+.+..+.+.
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  249 (326)
T 2x7f_A          176 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN  249 (326)
T ss_dssp             TC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred             ceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Confidence            8765433 2223456899999999986     566889999999999999999999999988877776665544

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.5e-39  Score=277.93  Aligned_cols=210  Identities=26%  Similarity=0.381  Sum_probs=177.4

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC------C
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS------P  108 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~  108 (259)
                      ..+|.+.+.||+|+||.||+|.+.  ++.||||++.....      ...+|+++++.++|+||+++++++...      .
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            457999999999999999999984  78999999876432      234799999999999999999987432      2


Q ss_pred             cEEEEEecCCCCChHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC-CeEEEeeeccce
Q 045286          109 HLCIVTEYMPGGSLYDYLH---KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH-NVVKVADFGVAR  184 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~-~~i~l~D~~~~~  184 (259)
                      ..++||||+++ ++.+.+.   .....+++..++.++.|++.+|.|||+.|++|+||||+|||++.+ +.+||+|||++.
T Consensus       127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            46799999965 6666553   334569999999999999999999999999999999999999965 678999999998


Q ss_pred             eccCCCccccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          185 FQNKGGVMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ............+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.
T Consensus       206 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~  275 (420)
T 1j1b_A          206 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT  275 (420)
T ss_dssp             ECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred             hcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            77665555566789999999998765 7899999999999999999999999999988888777665443

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.6e-38  Score=263.15  Aligned_cols=204  Identities=19%  Similarity=0.381  Sum_probs=178.5

Q ss_pred             hhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeec--CCcEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTK--SPHLC  111 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~  111 (259)
                      .++|++.++||+|++|.||+|.+  .++.||+|++....     ...+.+|+.+++.++ |+||+++++++..  ....+
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~  109 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  109 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence            47899999999999999999987  47899999987542     256889999999997 9999999999987  66789


Q ss_pred             EEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC-eEEEeeeccceeccCCC
Q 045286          112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN-VVKVADFGVARFQNKGG  190 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~-~i~l~D~~~~~~~~~~~  190 (259)
                      +|||++++++|.+++..    +++..++.++.|++.+|.+||+.|++|+||||+||+++.++ .++|+|||.+.......
T Consensus       110 lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  185 (330)
T 3nsz_A          110 LVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  185 (330)
T ss_dssp             EEEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             EEEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence            99999999999998743    88899999999999999999999999999999999999776 89999999998777666


Q ss_pred             ccccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHhhh
Q 045286          191 VMTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYD-SMTPLQAALGVRQ  249 (259)
Q Consensus       191 ~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~-~~~~~~~~~~i~~  249 (259)
                      ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||. +.+..+.+..+.+
T Consensus       186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~  246 (330)
T 3nsz_A          186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK  246 (330)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH
T ss_pred             ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHH
Confidence            6666788999999999877 678999999999999999999999984 4555555555444

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=8.7e-39  Score=272.41  Aligned_cols=213  Identities=24%  Similarity=0.358  Sum_probs=178.6

Q ss_pred             chhhhhccceeccccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC------
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP------  108 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------  108 (259)
                      ...+|++.++||+|+||.||+|.+. +..+++|++......      ..+|+.+++.++||||+++++++...+      
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~  111 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV  111 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence            3568999999999999999999984 556899888764322      237999999999999999999985433      


Q ss_pred             cEEEEEecCCCCChHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc-cCCeEEEeeecccee
Q 045286          109 HLCIVTEYMPGGSLYDYLH--KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD-THNVVKVADFGVARF  185 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~-~~~~i~l~D~~~~~~  185 (259)
                      ..++||||+++..+.....  .....+++..++.++.|++.+|.|||+.|++||||||+||+++ .++.++|+|||.+..
T Consensus       112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            3789999997643333321  2345689999999999999999999999999999999999998 789999999999988


Q ss_pred             ccCCCccccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          186 QNKGGVMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      ...........+++.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+..+.+..+.+..+.+
T Consensus       192 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p  261 (394)
T 4e7w_A          192 LIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP  261 (394)
T ss_dssp             CCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             ccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            7666556667789999999998765 58999999999999999999999999999888888877655443

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4e-39  Score=263.41  Aligned_cols=218  Identities=32%  Similarity=0.581  Sum_probs=178.4

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc---C--ceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeec
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL---G--QDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTK  106 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~---~--~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~  106 (259)
                      ..+..++|++.++||+|++|+||+|.+.   +  ..|++|++..... .......+.+|+.+++.++||||+++++++..
T Consensus        13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   92 (291)
T 1u46_A           13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   92 (291)
T ss_dssp             EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence            4566789999999999999999999863   2  2589999886543 33556788999999999999999999999887


Q ss_pred             CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          107 SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                      .. .++|+|++++++|.+++......+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            54 78999999999999999876666899999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCcc----ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhcc
Q 045286          187 NKGGVM----TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       187 ~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ......    ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+....
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~  241 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG  241 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC
Confidence            544321    23346778999999988888999999999999999999 999999998888887776543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3e-38  Score=257.51  Aligned_cols=200  Identities=26%  Similarity=0.395  Sum_probs=175.2

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeeeeeecCCcEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      ..+|++.+.||+|++|.||+|.+.  ++.|++|++............+.+|+..+..+ +||||+++++++...+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            468999999999999999999985  88999999998766666667888999999999 899999999999999999999


Q ss_pred             EecCCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC------------------
Q 045286          114 TEYMPGGSLYDYLHKN---HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH------------------  172 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~------------------  172 (259)
                      |||+++++|.+++...   ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++.+                  
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~  169 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN  169 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence            9999999999999654   2458999999999999999999999999999999999999844                  


Q ss_pred             -CeEEEeeeccceeccCCCccccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 045286          173 -NVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMT  239 (259)
Q Consensus       173 -~~i~l~D~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~  239 (259)
                       ..++|+|||.+.......   ...+++.|+|||.+.+. .+++++|+||||+++|+|++|..|+....
T Consensus       170 ~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~  235 (289)
T 1x8b_A          170 KVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD  235 (289)
T ss_dssp             CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH
T ss_pred             ceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh
Confidence             479999999998766542   34589999999999776 56689999999999999999998775543

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.5e-39  Score=268.52  Aligned_cols=203  Identities=30%  Similarity=0.474  Sum_probs=177.1

Q ss_pred             echhhhhccceeccccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      -..++|++.+.||+|+||.||+|.+. ++.|++|.+.....  .....+.+|+.+++.++||||+++++++...+..++|
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  113 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI  113 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred             HHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence            34578999999999999999999975 78999999876533  3356788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          114 TEYMPGGSLYDYLHKNH---NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      |||+++++|.+++....   ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  193 (321)
T 2qkw_B          114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD  193 (321)
T ss_dssp             EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSS
T ss_pred             EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            99999999999985443   248889999999999999999999999999999999999999999999999997654322


Q ss_pred             ---ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 045286          191 ---VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT  239 (259)
Q Consensus       191 ---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  239 (259)
                         ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~  245 (321)
T 2qkw_B          194 QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL  245 (321)
T ss_dssp             CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS
T ss_pred             ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccC
Confidence               1223347899999999988889999999999999999999999997543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-39  Score=273.98  Aligned_cols=217  Identities=29%  Similarity=0.504  Sum_probs=174.8

Q ss_pred             hhhhccceeccccceEEEEEEEc-----CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeee-cCCcEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST-KSPHLC  111 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~  111 (259)
                      ..|.+.++||+|+||.||+|.+.     ...|++|.+.... .......+.+|+.++++++||||+++++++. ..+..+
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  167 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  167 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence            45678899999999999999863     2358999887543 3455678899999999999999999999864 456789


Q ss_pred             EEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc
Q 045286          112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV  191 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~  191 (259)
                      +||||+++++|.+++......++...++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||.+........
T Consensus       168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  247 (373)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence            99999999999999977666788999999999999999999999999999999999999999999999999975543321


Q ss_pred             -----cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCC
Q 045286          192 -----MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLC  255 (259)
Q Consensus       192 -----~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~  255 (259)
                           .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+.++.....
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~  317 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ  317 (373)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCC
T ss_pred             ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCC
Confidence                 123346678999999999999999999999999999999 7889988777777766666655443

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-40  Score=274.82  Aligned_cols=203  Identities=23%  Similarity=0.388  Sum_probs=172.5

Q ss_pred             eechhhhhccceeccccceEEEEEEE-----cCceEEEEEeecccC--chHHHHHHHHHHHHHHhc-CCCCcceeeeeee
Q 045286           34 EIDRRLLKTGERIASGSCGDLYRGVY-----LGQDVAVKVLRSEHL--NDTLEDEFVQEVAILREV-QHRNVVRFIGAST  105 (259)
Q Consensus        34 ~~~~~~~~~~~~lg~G~~~~V~~~~~-----~~~~v~vK~~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~  105 (259)
                      .+...+|++.++||+|+||.||++.+     .++.||+|+++....  .......+.+|+.+++.+ +|+||+++++++.
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  129 (355)
T 1vzo_A           50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ  129 (355)
T ss_dssp             CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence            34447899999999999999999998     578999999875432  112224566889999999 6999999999999


Q ss_pred             cCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          106 KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                      ..+..++||||+++++|.+++.... .+++..+..++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||++..
T Consensus       130 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          130 TETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eCceEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            9999999999999999999997654 489999999999999999999999999999999999999999999999999976


Q ss_pred             ccCCC--ccccCCCcccccCccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          186 QNKGG--VMTAETGTYRWMAPEVINH--QPYDQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       186 ~~~~~--~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                      .....  ......+++.|+|||.+.+  ..++.++|+||||+++|+|++|..||..
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~  264 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV  264 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence            54322  2233468999999999985  3578999999999999999999999974

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.3e-39  Score=267.75  Aligned_cols=216  Identities=32%  Similarity=0.564  Sum_probs=164.4

Q ss_pred             ccceechhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      ..|.+..++|++.+.||+|++|.||++.+  .++.|++|.+..... ......+.+|+.+++.++||||+++++++...+
T Consensus         8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   86 (303)
T 2vwi_A            8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD   86 (303)
T ss_dssp             -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSS
T ss_pred             cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence            34778889999999999999999999986  588999999876532 233466889999999999999999999999999


Q ss_pred             cEEEEEecCCCCChHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeec
Q 045286          109 HLCIVTEYMPGGSLYDYLHK-------NHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFG  181 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~  181 (259)
                      ..++|+|++++++|.+++..       ....++...++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg  166 (303)
T 2vwi_A           87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG  166 (303)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred             CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence            99999999999999999864       23458999999999999999999999999999999999999999999999999


Q ss_pred             cceeccCCC------ccccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHh
Q 045286          182 VARFQNKGG------VMTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGV  247 (259)
Q Consensus       182 ~~~~~~~~~------~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i  247 (259)
                      .+.......      ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+........
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  239 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT  239 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH
Confidence            986554321      1223468899999999876 56899999999999999999999999887665554433

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.4e-38  Score=258.33  Aligned_cols=201  Identities=27%  Similarity=0.499  Sum_probs=176.5

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ++|++.+.||+|++|.||+|.+.  ++.|++|++...... .....+.+|+.+++.++||||+++++++...+..++|+|
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            67899999999999999999985  789999999865433 344778899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC---cc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG---VM  192 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~---~~  192 (259)
                      ++++++|.+++... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......   ..
T Consensus        86 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  164 (276)
T 2yex_A           86 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (276)
T ss_dssp             CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             ecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence            99999999988543 358999999999999999999999999999999999999999999999999997654322   22


Q ss_pred             ccCCCcccccCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 045286          193 TAETGTYRWMAPEVINHQPY-DQKADVFSFAIVLWELVTAKVPYDSMTP  240 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~~~~ll~g~~p~~~~~~  240 (259)
                      ....+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  213 (276)
T 2yex_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD  213 (276)
T ss_dssp             CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred             cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence            34568999999999987765 7789999999999999999999987554

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.6e-39  Score=264.22  Aligned_cols=202  Identities=33%  Similarity=0.547  Sum_probs=175.9

Q ss_pred             hhhhccceeccccceEEEEEEEcCceEEEEEeecccC--chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHL--NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ..+..+++||+|++|.||+|.+.++.|++|++.....  .......+.+|+.+++.++||||+++++++...+..+++||
T Consensus        31 ~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           31 PISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             BTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            3556679999999999999999999999999976432  33456788999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc--
Q 045286          116 YMPGGSLYDYLHKN--HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV--  191 (259)
Q Consensus       116 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~--  191 (259)
                      ++++++|.+++...  ...++...++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+........  
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  190 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV  190 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence            99999999998643  34588999999999999999999999999999999999999999999999999876554322  


Q ss_pred             -cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 045286          192 -MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTP  240 (259)
Q Consensus       192 -~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~  240 (259)
                       .....+++.|+|||.+.+. ++.++|+||||+++|+|++|..||...+.
T Consensus       191 ~~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~  239 (307)
T 2nru_A          191 MTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHRE  239 (307)
T ss_dssp             ECSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred             cccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence             2334689999999998764 78999999999999999999999986543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=272.68  Aligned_cols=217  Identities=23%  Similarity=0.381  Sum_probs=166.0

Q ss_pred             hhhhc-cceeccccceEEEEEEEc----CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeee--cCCcE
Q 045286           38 RLLKT-GERIASGSCGDLYRGVYL----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST--KSPHL  110 (259)
Q Consensus        38 ~~~~~-~~~lg~G~~~~V~~~~~~----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~  110 (259)
                      +.|.+ +++||+|+||.||+|.+.    ++.||+|++......    ..+.+|+.+++.++||||+++++++.  .....
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            34554 568999999999999964    678999999865433    45778999999999999999999984  46789


Q ss_pred             EEEEecCCCCChHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE----ccCCeEEEe
Q 045286          111 CIVTEYMPGGSLYDYLHKN--------HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM----DTHNVVKVA  178 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv----~~~~~i~l~  178 (259)
                      ++||||++ ++|.+++...        ...+++..++.++.|++.+|.|||+.|++|+||||+||++    +.++.++|+
T Consensus        96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            99999995 5888877422        1248899999999999999999999999999999999999    677899999


Q ss_pred             eeccceeccCC----CccccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCH---------HHHH
Q 045286          179 DFGVARFQNKG----GVMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTP---------LQAA  244 (259)
Q Consensus       179 D~~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~---------~~~~  244 (259)
                      |||.+......    .......+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.         .+.+
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l  254 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  254 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence            99999766543    222345689999999999874 589999999999999999999999976554         3666


Q ss_pred             HHhhhccCCCCccCC
Q 045286          245 LGVRQVCTSLCQPIY  259 (259)
Q Consensus       245 ~~i~~~~~~~~~~~~  259 (259)
                      ..+....+.+..+.|
T Consensus       255 ~~i~~~~g~p~~~~~  269 (405)
T 3rgf_A          255 DRIFNVMGFPADKDW  269 (405)
T ss_dssp             HHHHHHHCCCCTTTC
T ss_pred             HHHHHhhCCCChhhc
Confidence            677666665554443

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=8.3e-39  Score=264.65  Aligned_cols=199  Identities=26%  Similarity=0.467  Sum_probs=167.1

Q ss_pred             hhhhc-cceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeeeeeecCCcEEEE
Q 045286           38 RLLKT-GERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        38 ~~~~~-~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      +.|++ .+.||+|++|.||+|.+  .++.||+|++.....  .....+.+|+.+++++ +||||+++++++...+..++|
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   89 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV   89 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            46776 47899999999999986  488999999976532  2346788999999985 699999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCe---EEEeeeccceeccCCC
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV---VKVADFGVARFQNKGG  190 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~---i~l~D~~~~~~~~~~~  190 (259)
                      ||++++++|.+++.... .+++..++.++.|++.+|.+||+.|++|+||||+||+++.++.   ++|+|||.+.......
T Consensus        90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~  168 (316)
T 2ac3_A           90 FEKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG  168 (316)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred             EEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence            99999999999997654 4899999999999999999999999999999999999988765   9999999987543221


Q ss_pred             --------ccccCCCcccccCccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 045286          191 --------VMTAETGTYRWMAPEVINH-----QPYDQKADVFSFAIVLWELVTAKVPYDSMT  239 (259)
Q Consensus       191 --------~~~~~~~~~~~~~PE~~~~-----~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  239 (259)
                              ......+++.|+|||.+.+     ..++.++|+||||+++|+|++|..||...+
T Consensus       169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  230 (316)
T 2ac3_A          169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC  230 (316)
T ss_dssp             -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence                    1223458999999999865     457899999999999999999999997654

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.1e-38  Score=264.14  Aligned_cols=215  Identities=25%  Similarity=0.419  Sum_probs=186.0

Q ss_pred             echhhhhccceeccccceEEEEEEE---cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCC------Ccceeeeeee
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVY---LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHR------NVVRFIGAST  105 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~---~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~  105 (259)
                      +-..+|++.+.||+|++|.||+|.+   .++.||+|++...   ......+.+|+.+++.++|+      +++++++++.
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~   87 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE   87 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence            3457899999999999999999987   4789999999754   23446778899999888654      5899999999


Q ss_pred             cCCcEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc-------------
Q 045286          106 KSPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT-------------  171 (259)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~-------------  171 (259)
                      ..+..++|||++ +++|.+++.... ..+++..++.++.|++.+|.+||+.|++|+||||+||+++.             
T Consensus        88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence            999999999999 889999987654 35889999999999999999999999999999999999987             


Q ss_pred             ------CCeEEEeeeccceeccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 045286          172 ------HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL  245 (259)
Q Consensus       172 ------~~~i~l~D~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~  245 (259)
                            ++.++|+|||.+......  .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+...
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  244 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA  244 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred             ccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence                  667999999999765443  234578999999999999999999999999999999999999999999888888


Q ss_pred             HhhhccCCCC
Q 045286          246 GVRQVCTSLC  255 (259)
Q Consensus       246 ~i~~~~~~~~  255 (259)
                      .+.+...+.+
T Consensus       245 ~~~~~~~~~p  254 (339)
T 1z57_A          245 MMERILGPLP  254 (339)
T ss_dssp             HHHHHHCSCC
T ss_pred             HHHHHhCCCC
Confidence            7777665543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.3e-38  Score=264.91  Aligned_cols=209  Identities=29%  Similarity=0.474  Sum_probs=158.6

Q ss_pred             ccccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHH-HHHhcCCCCcceeeeeee
Q 045286           29 KSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVA-ILREVQHRNVVRFIGAST  105 (259)
Q Consensus        29 ~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~  105 (259)
                      ....|++..++|++.+.||+|+||.||+|.+.  ++.|++|++........ ...+.+|.. +++.++||||+++++++.
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~h~niv~~~~~~~   91 (327)
T 3aln_A           13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE-QKQLLMDLDVVMRSSDCPYIVQFYGALF   91 (327)
T ss_dssp             CCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHH-HHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred             hHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchH-HHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence            44568888999999999999999999999986  88999999987643333 344455555 677788999999999999


Q ss_pred             cCCcEEEEEecCCCCChHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEccCCeEEEeee
Q 045286          106 KSPHLCIVTEYMPGGSLYDYLHK----NHNVLKLPQLLRFAIDICKGMEYLHQR-NIIHRDLKTANLLMDTHNVVKVADF  180 (259)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~di~p~Nilv~~~~~i~l~D~  180 (259)
                      ..+..++|||++++ +|.+++..    ....+++..+..++.|++.+|.+||+. |++|+||+|+||+++.++.++|+||
T Consensus        92 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Df  170 (327)
T 3aln_A           92 REGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDF  170 (327)
T ss_dssp             CSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCC
T ss_pred             eCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccC
Confidence            99999999999965 88887753    245689999999999999999999999 9999999999999999999999999


Q ss_pred             ccceeccCCCccccCCCcccccCcccc----CCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 045286          181 GVARFQNKGGVMTAETGTYRWMAPEVI----NHQPYDQKADVFSFAIVLWELVTAKVPYDSMT  239 (259)
Q Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~PE~~----~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  239 (259)
                      |.+.............+++.|+|||.+    .+..++.++|+||||+++|+|++|..||...+
T Consensus       171 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  233 (327)
T 3aln_A          171 GISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN  233 (327)
T ss_dssp             SSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred             CCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence            999876655444455789999999998    45678999999999999999999999998644

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.1e-39  Score=270.69  Aligned_cols=215  Identities=23%  Similarity=0.412  Sum_probs=186.8

Q ss_pred             chhhhhccceeccccceEEEEEEEcCceEEEEEeecccCchH---------------HHHHHHHHHHHHHhcCCCCccee
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDT---------------LEDEFVQEVAILREVQHRNVVRF  100 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~---------------~~~~~~~e~~~l~~l~~~~i~~~  100 (259)
                      ...+|++.+.||+|++|.||+|.+.++.|++|++........               ....+.+|+.+++.++||||+++
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            347899999999999999999999999999999986533211               12678899999999999999999


Q ss_pred             eeeeecCCcEEEEEecCCCCChHHH------HHhc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEccC
Q 045286          101 IGASTKSPHLCIVTEYMPGGSLYDY------LHKN-HNVLKLPQLLRFAIDICKGMEYLHQ-RNIIHRDLKTANLLMDTH  172 (259)
Q Consensus       101 ~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~di~p~Nilv~~~  172 (259)
                      ++++...+..++||||+++++|.++      +... ...+++..++.++.|++.+|.+||+ .|++|+||+|+||+++.+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~  188 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN  188 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTT
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCC
Confidence            9999999999999999999999998      5432 4568999999999999999999999 999999999999999999


Q ss_pred             CeEEEeeeccceeccCCCccccCCCcccccCccccCCC-CCCC-chhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHhhh
Q 045286          173 NVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQ-PYDQ-KADVFSFAIVLWELVTAKVPYDSMTP-LQAALGVRQ  249 (259)
Q Consensus       173 ~~i~l~D~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~-~~Di~slG~~~~~ll~g~~p~~~~~~-~~~~~~i~~  249 (259)
                      +.++|+|||.+...... ......+++.|+|||.+.+. .++. ++|+||||+++|+|++|..||...+. .+....+..
T Consensus       189 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~  267 (348)
T 2pml_X          189 GRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT  267 (348)
T ss_dssp             SCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTS
T ss_pred             CcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc
Confidence            99999999999876554 34556789999999999887 5666 99999999999999999999988766 666666665


Q ss_pred             cc
Q 045286          250 VC  251 (259)
Q Consensus       250 ~~  251 (259)
                      +.
T Consensus       268 ~~  269 (348)
T 2pml_X          268 KN  269 (348)
T ss_dssp             CC
T ss_pred             cC
Confidence            53

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.7e-38  Score=284.71  Aligned_cols=225  Identities=27%  Similarity=0.563  Sum_probs=191.5

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEc-----CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeee
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST  105 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~  105 (259)
                      ..+++..++|++.+.||+|+||.||+|.+.     +..|++|...... .......+.+|+.+++.++||||+++++++.
T Consensus       383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  461 (656)
T 2j0j_A          383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT  461 (656)
T ss_dssp             GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            356778889999999999999999999874     3468999887643 3455578899999999999999999999985


Q ss_pred             cCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          106 KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                      + +..++||||+++++|.+++......++...++.++.|++.+|.|||+.|++|+||||+||+++.++.++|+|||.+..
T Consensus       462 ~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          462 E-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred             c-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence            4 568899999999999999987666789999999999999999999999999999999999999999999999999976


Q ss_pred             ccCCCcc--ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          186 QNKGGVM--TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       186 ~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      .......  ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+..+.....++
T Consensus       541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  615 (656)
T 2j0j_A          541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP  615 (656)
T ss_dssp             CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCT
T ss_pred             cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            6543221  23345678999999988899999999999999999997 999999999999888888776554443

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.5e-38  Score=260.97  Aligned_cols=222  Identities=25%  Similarity=0.425  Sum_probs=171.3

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      ..|.+.-++|++.+.||+|++|.||+|.+.  ++.|++|++............+.++..+++.++||||+++++++...+
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~   97 (318)
T 2dyl_A           18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT   97 (318)
T ss_dssp             SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence            457777889999999999999999999984  889999999877655554455566666788889999999999999999


Q ss_pred             cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR-NIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      ..++|||++ +..+..+.......+++..++.++.|++.+|.+||+. |++|+||+|+||+++.++.++|+|||.+....
T Consensus        98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  176 (318)
T 2dyl_A           98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV  176 (318)
T ss_dssp             EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence            999999999 6667666665566799999999999999999999996 99999999999999999999999999997665


Q ss_pred             CCCccccCCCcccccCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHhhhccCC
Q 045286          188 KGGVMTAETGTYRWMAPEVIN-----HQPYDQKADVFSFAIVLWELVTAKVPYDS-MTPLQAALGVRQVCTS  253 (259)
Q Consensus       188 ~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~~~~ll~g~~p~~~-~~~~~~~~~i~~~~~~  253 (259)
                      .........+++.|+|||.+.     +..++.++|+||||+++|+|++|..||.. .+..+.+..+.+...+
T Consensus       177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  248 (318)
T 2dyl_A          177 DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP  248 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC
T ss_pred             CCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC
Confidence            554445567899999999984     45688999999999999999999999987 4555666666555433

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=6.3e-39  Score=269.51  Aligned_cols=215  Identities=25%  Similarity=0.448  Sum_probs=182.7

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      ..|++. ++|.+.+.||+|++|.||+|.+.  ++.|++|++............+.+|+.+++.++||||+++++++...+
T Consensus        18 ~~~~l~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   96 (353)
T 3coi_A           18 TAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS   96 (353)
T ss_dssp             EEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             cccccC-ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence            346664 58999999999999999999974  889999999887666666788899999999999999999999987654


Q ss_pred             c------EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecc
Q 045286          109 H------LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGV  182 (259)
Q Consensus       109 ~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~  182 (259)
                      .      .+++||+++ ++|.+++.   ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.
T Consensus        97 ~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A           97 SLRNFYDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             SGGGCCCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             ccccceeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeeccc
Confidence            3      499999996 58877763   2489999999999999999999999999999999999999999999999999


Q ss_pred             ceeccCCCccccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          183 ARFQNKGGVMTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      +......  .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+.+..+.+..+
T Consensus       173 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~  241 (353)
T 3coi_A          173 ARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG  241 (353)
T ss_dssp             TTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHC
T ss_pred             ccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            8765433  334568999999999877 6789999999999999999999999999988888777765443

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6.7e-38  Score=258.58  Aligned_cols=214  Identities=24%  Similarity=0.486  Sum_probs=171.7

Q ss_pred             hhhhhccceeccccceEEEEEEE--cCceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      ..+|++.+.||+|++|.||+|.+  .++.|++|++..... .......+.+|+.+++.++|+||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            46899999999999999999997  488999999986433 345567788999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          114 TEYMPGGSLYDYLHK---NHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      +|++++++|.+++..   ....++...++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~  190 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  190 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence            999999999999864   34568999999999999999999999999999999999999999999999999987654432


Q ss_pred             -ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHhhhc
Q 045286          191 -VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSM--TPLQAALGVRQV  250 (259)
Q Consensus       191 -~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~--~~~~~~~~i~~~  250 (259)
                       ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.  +..+....+...
T Consensus       191 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  253 (310)
T 2wqm_A          191 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC  253 (310)
T ss_dssp             --------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT
T ss_pred             ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc
Confidence             223446889999999999999999999999999999999999999653  334444444443

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5e-39  Score=275.93  Aligned_cols=201  Identities=25%  Similarity=0.478  Sum_probs=163.7

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCc------hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN------DTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      .++|.+.+.||+|+||.||+|.+.  ++.||+|++......      ......+.+|+.++++++||||+++++++.. +
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            467999999999999999999975  689999999865322      1222357899999999999999999999764 4


Q ss_pred             cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC---eEEEeeecccee
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVARF  185 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~---~i~l~D~~~~~~  185 (259)
                      ..++||||+++++|.+++... ..+++..++.++.|++.+|.|||+.|++|+||||+||+++.++   .++|+|||.+..
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  291 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  291 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred             ceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence            678999999999999988543 4589999999999999999999999999999999999997654   599999999987


Q ss_pred             ccCCCccccCCCcccccCccccCC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 045286          186 QNKGGVMTAETGTYRWMAPEVINH---QPYDQKADVFSFAIVLWELVTAKVPYDSMT  239 (259)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  239 (259)
                      ...........+++.|+|||.+.+   ..++.++|+||||+++|+|++|..||....
T Consensus       292 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~  348 (419)
T 3i6u_A          292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR  348 (419)
T ss_dssp             CC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred             cCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence            766655566779999999999864   567889999999999999999999997643

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.7e-38  Score=267.40  Aligned_cols=215  Identities=20%  Similarity=0.272  Sum_probs=171.4

Q ss_pred             chhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCc----
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPH----  109 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----  109 (259)
                      .-++|++.+.||+|+||.||+|.+.  ++.||+|++.......   ....++++.++.++||||+++++++...+.    
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~   97 (360)
T 3e3p_A           21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR   97 (360)
T ss_dssp             HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC---CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred             hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc---HHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence            3468999999999999999999985  7899999987653322   346677888889999999999999865332    


Q ss_pred             ---EEEEEecCCCCChHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCCCcEEEcc-CCeEEEeee
Q 045286          110 ---LCIVTEYMPGGSLYDYLH---KNHNVLKLPQLLRFAIDICKGMEYLH--QRNIIHRDLKTANLLMDT-HNVVKVADF  180 (259)
Q Consensus       110 ---~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~ql~~~l~~lH--~~~i~H~di~p~Nilv~~-~~~i~l~D~  180 (259)
                         .++||||+++ +|...+.   .....++...+..++.|++.+|.+||  +.|++|+||||+||+++. ++.++|+||
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Df  176 (360)
T 3e3p_A           98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF  176 (360)
T ss_dssp             CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred             ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeC
Confidence               7899999965 5555443   23445889999999999999999999  999999999999999997 899999999


Q ss_pred             ccceeccCCCccccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          181 GVARFQNKGGVMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      |.+.............+++.|+|||.+.+. .++.++|+||||+++|+|++|..||.+.+..+.+..+.+....+
T Consensus       177 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  251 (360)
T 3e3p_A          177 GSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP  251 (360)
T ss_dssp             TTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             CCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence            999877766555666789999999998665 48999999999999999999999999999988888887765544

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.8e-38  Score=260.69  Aligned_cols=194  Identities=33%  Similarity=0.629  Sum_probs=165.5

Q ss_pred             hhhhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHh--cCCCCcceeeeeeec----CCcE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILRE--VQHRNVVRFIGASTK----SPHL  110 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~----~~~~  110 (259)
                      .++|++.+.||+|+||+||+|.+.++.||+|++....     ...+.+|.+++..  ++||||+++++++..    ....
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            5789999999999999999999999999999987542     2445566666666  789999999998643    3468


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccCCCCCCcEEEccCCeEEEeeecc
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH--------QRNIIHRDLKTANLLMDTHNVVKVADFGV  182 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH--------~~~i~H~di~p~Nilv~~~~~i~l~D~~~  182 (259)
                      ++||||+++++|.+++...  .+++..++.++.|++.+|.+||        +.|++|+||||+||+++.++.++|+|||.
T Consensus        82 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  159 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL  159 (301)
T ss_dssp             EEEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence            9999999999999999543  4899999999999999999999        99999999999999999999999999999


Q ss_pred             ceeccCCCcc-----ccCCCcccccCccccCCC------CCCCchhHHHHHHHHHHHHcC----------CCCCCC
Q 045286          183 ARFQNKGGVM-----TAETGTYRWMAPEVINHQ------PYDQKADVFSFAIVLWELVTA----------KVPYDS  237 (259)
Q Consensus       183 ~~~~~~~~~~-----~~~~~~~~~~~PE~~~~~------~~~~~~Di~slG~~~~~ll~g----------~~p~~~  237 (259)
                      +.........     ....+++.|+|||.+.+.      .++.++|+||||+++|+|++|          ..||..
T Consensus       160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            9765544322     234689999999999876      455789999999999999999          888854

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.8e-38  Score=264.50  Aligned_cols=210  Identities=26%  Similarity=0.476  Sum_probs=162.5

Q ss_pred             cccceechhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeee-
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGAST-  105 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~-  105 (259)
                      ...+++...+|++.++||+|+||.||++.+  .++.|++|++...  .......+.+|+.+++++. ||||+++++++. 
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~   97 (337)
T 3ll6_A           20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI   97 (337)
T ss_dssp             TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence            355788889999999999999999999998  5889999998655  3445577889999999996 999999999883 


Q ss_pred             -------cCCcEEEEEecCCCCChHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEccCCe
Q 045286          106 -------KSPHLCIVTEYMPGGSLYDYLHK--NHNVLKLPQLLRFAIDICKGMEYLHQRN--IIHRDLKTANLLMDTHNV  174 (259)
Q Consensus       106 -------~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~di~p~Nilv~~~~~  174 (259)
                             ....+++++|+++ ++|.+++..  ....+++..++.++.|++.+|.+||+.|  ++|+||||+||+++.++.
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~  176 (337)
T 3ll6_A           98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT  176 (337)
T ss_dssp             CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC
T ss_pred             cccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC
Confidence                   3345899999995 689888864  3446999999999999999999999999  999999999999999999


Q ss_pred             EEEeeeccceeccCCCcc-------------ccCCCcccccCcccc---CCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 045286          175 VKVADFGVARFQNKGGVM-------------TAETGTYRWMAPEVI---NHQPYDQKADVFSFAIVLWELVTAKVPYDSM  238 (259)
Q Consensus       175 i~l~D~~~~~~~~~~~~~-------------~~~~~~~~~~~PE~~---~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  238 (259)
                      ++|+|||.+.........             ....+++.|+|||.+   .+..++.++|+||||+++|+|++|..||...
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  256 (337)
T 3ll6_A          177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG  256 (337)
T ss_dssp             EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence            999999999766543221             134588999999998   5667889999999999999999999999865


Q ss_pred             CHHH
Q 045286          239 TPLQ  242 (259)
Q Consensus       239 ~~~~  242 (259)
                      ....
T Consensus       257 ~~~~  260 (337)
T 3ll6_A          257 AKLR  260 (337)
T ss_dssp             ----
T ss_pred             hHHH
Confidence            5443

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=4.4e-40  Score=278.93  Aligned_cols=207  Identities=13%  Similarity=0.178  Sum_probs=165.5

Q ss_pred             ceechhhhhccceeccccceEEEEEEE--cCceEEEEEeecccC-chHHHHHHHHHHH---HHHhcCCCCcceee-----
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHL-NDTLEDEFVQEVA---ILREVQHRNVVRFI-----  101 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~-~~~~~~~~~~e~~---~l~~l~~~~i~~~~-----  101 (259)
                      +....++|++.++||+|+||+||+|.+  +++.||||++..... .....+.+.+|+.   .++.++||||++++     
T Consensus        68 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~  147 (377)
T 3byv_A           68 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF  147 (377)
T ss_dssp             SSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCC
T ss_pred             cCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhh
Confidence            344467899999999999999999996  488999999986532 3345577889994   55555799999988     


Q ss_pred             --eeeecCC-----------------cEEEEEecCCCCChHHHHHhcCCCCC-------HHHHHHHHHHHHHHHHHHHhC
Q 045286          102 --GASTKSP-----------------HLCIVTEYMPGGSLYDYLHKNHNVLK-------LPQLLRFAIDICKGMEYLHQR  155 (259)
Q Consensus       102 --~~~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~~~~-------~~~~~~i~~ql~~~l~~lH~~  155 (259)
                        +++...+                 ..+++|||+ +++|.+++..... ++       ...++.++.|++.+|.|||+.
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~-~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  225 (377)
T 3byv_A          148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLS-HSSTHKSLVHHARLQLTLQVIRLLASLHHY  225 (377)
T ss_dssp             CSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHH-TTTTTHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccc-cccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence              5544432                 378999999 6799999975432 33       477788999999999999999


Q ss_pred             CcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccccCCCcccccCccccCCC-----------CCCCchhHHHHHHH
Q 045286          156 NIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQ-----------PYDQKADVFSFAIV  224 (259)
Q Consensus       156 ~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-----------~~~~~~Di~slG~~  224 (259)
                      |++|+||||+||+++.++.++|+|||++.....  ......+ +.|+|||.+.+.           .++.++|+||||++
T Consensus       226 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             CeecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            999999999999999999999999999986443  3345567 999999999877           89999999999999


Q ss_pred             HHHHHcCCCCCCCCCHHHHH
Q 045286          225 LWELVTAKVPYDSMTPLQAA  244 (259)
Q Consensus       225 ~~~ll~g~~p~~~~~~~~~~  244 (259)
                      +|+|++|..||...+..+..
T Consensus       303 l~elltg~~Pf~~~~~~~~~  322 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGGS  322 (377)
T ss_dssp             HHHHHHSSCCC------CCS
T ss_pred             HHHHHHCCCCCcccccccch
Confidence            99999999999876544433

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.5e-38  Score=259.03  Aligned_cols=194  Identities=28%  Similarity=0.469  Sum_probs=173.6

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec--------
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK--------  106 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------  106 (259)
                      ..+|++.+.||+|++|.||+|.+.  ++.|++|.+....      ..+.+|+.+++.++||||+++++++..        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            468999999999999999999985  8899999998753      346689999999999999999998753        


Q ss_pred             --------CCcEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEE
Q 045286          107 --------SPHLCIVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKV  177 (259)
Q Consensus       107 --------~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l  177 (259)
                              ....++||||+++++|.+++... ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl  163 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI  163 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence                    34589999999999999999754 346899999999999999999999999999999999999999999999


Q ss_pred             eeeccceeccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 045286          178 ADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYD  236 (259)
Q Consensus       178 ~D~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~  236 (259)
                      +|||.+.............+++.|+|||.+.+..++.++|+||||+++|+|++|..|+.
T Consensus       164 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~  222 (284)
T 2a19_B          164 GDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF  222 (284)
T ss_dssp             CCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred             CcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence            99999987776655556678999999999999899999999999999999999998874

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.3e-39  Score=269.19  Aligned_cols=204  Identities=32%  Similarity=0.539  Sum_probs=176.7

Q ss_pred             cceechhhhhccceeccccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcE
Q 045286           32 DWEIDRRLLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL  110 (259)
Q Consensus        32 ~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~  110 (259)
                      ...+..++|++.+.||+|++|.||+|.+. ++.||+|++....... ....+.+|+.+++.++||||+++++++...+..
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  102 (326)
T 3uim_A           24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTER  102 (326)
T ss_dssp             HHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred             HHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence            35566789999999999999999999864 7899999998754322 123588999999999999999999999998899


Q ss_pred             EEEEecCCCCChHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCCCcEEEccCCeEEEeeeccce
Q 045286          111 CIVTEYMPGGSLYDYLHKNH---NVLKLPQLLRFAIDICKGMEYLHQR---NIIHRDLKTANLLMDTHNVVKVADFGVAR  184 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~di~p~Nilv~~~~~i~l~D~~~~~  184 (259)
                      ++||||+++++|.+++....   ..++...+..++.|++.+|.+||+.   |++|+||+|+||+++.++.++|+|||.+.
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~  182 (326)
T 3uim_A          103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK  182 (326)
T ss_dssp             EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence            99999999999999997543   2488999999999999999999999   99999999999999999999999999998


Q ss_pred             eccCCC--ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 045286          185 FQNKGG--VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYD  236 (259)
Q Consensus       185 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~  236 (259)
                      ......  ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  236 (326)
T 3uim_A          183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD  236 (326)
T ss_dssp             ECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             ccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence            765432  2334458999999999988889999999999999999999999995

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.6e-38  Score=263.01  Aligned_cols=204  Identities=34%  Similarity=0.597  Sum_probs=177.2

Q ss_pred             cceechhhhhccceeccccceEEEEEEE------cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeee
Q 045286           32 DWEIDRRLLKTGERIASGSCGDLYRGVY------LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST  105 (259)
Q Consensus        32 ~~~~~~~~~~~~~~lg~G~~~~V~~~~~------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~  105 (259)
                      ...+..++|++.+.||+|++|.||++.+      .++.|++|++...  .......+.+|+.+++.++|+||+++++++.
T Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  112 (326)
T 2w1i_A           35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCY  112 (326)
T ss_dssp             --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence            3566788999999999999999999985      4789999999864  3445577899999999999999999999876


Q ss_pred             cC--CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccc
Q 045286          106 KS--PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA  183 (259)
Q Consensus       106 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~  183 (259)
                      ..  ...++|+|++++++|.+++......++...++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus       113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence            54  3789999999999999999877667999999999999999999999999999999999999999999999999999


Q ss_pred             eeccCCCcc----ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          184 RFQNKGGVM----TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       184 ~~~~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                      .........    ....++..|+|||.+.+..++.++|+||||+++|+|++|..||..
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~  250 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS  250 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred             hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence            876554321    223466789999999888899999999999999999999998864

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=7.9e-39  Score=265.61  Aligned_cols=201  Identities=25%  Similarity=0.472  Sum_probs=169.5

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCc------hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN------DTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      .++|.+.+.||+|+||.||+|.+.  ++.|++|++......      ......+.+|+.+++.++||||+++++++...+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            468999999999999999999984  689999999765321      122345789999999999999999999987654


Q ss_pred             cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCe---EEEeeecccee
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV---VKVADFGVARF  185 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~---i~l~D~~~~~~  185 (259)
                       .++|||++++++|.+++... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.   ++|+|||.+..
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  166 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  166 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred             -eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence             89999999999999988543 45899999999999999999999999999999999999987664   99999999987


Q ss_pred             ccCCCccccCCCcccccCccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 045286          186 QNKGGVMTAETGTYRWMAPEVIN---HQPYDQKADVFSFAIVLWELVTAKVPYDSMT  239 (259)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  239 (259)
                      ...........+++.|+|||.+.   +..++.++|+||||+++|+|++|..||....
T Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  223 (322)
T 2ycf_A          167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR  223 (322)
T ss_dssp             CCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred             cccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            76554444456899999999973   5678999999999999999999999997644

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=7.7e-38  Score=262.64  Aligned_cols=212  Identities=24%  Similarity=0.359  Sum_probs=179.6

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC-----Cc
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS-----PH  109 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~  109 (259)
                      .++|++.+.||+|++|.||+|.+.  ++.|++|++.... .......+.+|+.+++.++||||+++++++...     ..
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            468999999999999999999986  8899999997543 344556788999999999999999999987653     67


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG  189 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~  189 (259)
                      .++++|+++ ++|.+++...  .++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        89 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES  165 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EEEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence            899999996 5899988663  4899999999999999999999999999999999999999999999999999765432


Q ss_pred             Cc-----------cccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          190 GV-----------MTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       190 ~~-----------~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      ..           .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+.+..+....+
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  240 (353)
T 2b9h_A          166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG  240 (353)
T ss_dssp             --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence            11           123467999999998754 6789999999999999999999999999888777766654433

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.6e-39  Score=271.05  Aligned_cols=202  Identities=21%  Similarity=0.323  Sum_probs=166.8

Q ss_pred             eechhhhhccceeccccceEEEEEEE-----cCceEEEEEeecccCchH---------HHHHHHHHHHHHHhcCCCCcce
Q 045286           34 EIDRRLLKTGERIASGSCGDLYRGVY-----LGQDVAVKVLRSEHLNDT---------LEDEFVQEVAILREVQHRNVVR   99 (259)
Q Consensus        34 ~~~~~~~~~~~~lg~G~~~~V~~~~~-----~~~~v~vK~~~~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~   99 (259)
                      ++..++|++.++||+|+||.||+|.+     .+..+++|+.........         ....+.+|+..++.++|+||++
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~  112 (345)
T 2v62_A           33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL  112 (345)
T ss_dssp             CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred             cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence            34567899999999999999999998     457899999987643211         1133667888899999999999


Q ss_pred             eeeeeec----CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC--
Q 045286          100 FIGASTK----SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN--  173 (259)
Q Consensus       100 ~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~--  173 (259)
                      +++++..    ....++|||++ +++|.+++.... .+++..++.++.|++.+|.+||+.|++|+||||+||+++.++  
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence            9999877    67899999999 999999986554 689999999999999999999999999999999999998887  


Q ss_pred             eEEEeeeccceeccCCC--------ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          174 VVKVADFGVARFQNKGG--------VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       174 ~i~l~D~~~~~~~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                      .++|+|||.+.......        ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||..
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            99999999997654321        12345689999999999999999999999999999999999999964

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.4e-38  Score=269.46  Aligned_cols=211  Identities=24%  Similarity=0.422  Sum_probs=177.1

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcC--------CCCcceeeeeee-
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ--------HRNVVRFIGAST-  105 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~~~~~~~-  105 (259)
                      ..+|++.++||+|+||+||+|.+.  ++.||+|++...   ......+.+|+.+++.+.        |+||+++++.+. 
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence            578999999999999999999874  789999999754   344567889999999985        778999999886 


Q ss_pred             ---cCCcEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEccCC-------
Q 045286          106 ---KSPHLCIVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQR-NIIHRDLKTANLLMDTHN-------  173 (259)
Q Consensus       106 ---~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~di~p~Nilv~~~~-------  173 (259)
                         .....++|||++ +++|.+.+... ...+++..++.++.|++.+|.+||++ |++|+||||+||+++.++       
T Consensus       113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~  191 (397)
T 1wak_A          113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA  191 (397)
T ss_dssp             EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred             cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence               556899999999 55666666544 35699999999999999999999998 999999999999998775       


Q ss_pred             ------------------------------------------eEEEeeeccceeccCCCccccCCCcccccCccccCCCC
Q 045286          174 ------------------------------------------VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQP  211 (259)
Q Consensus       174 ------------------------------------------~i~l~D~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~  211 (259)
                                                                .++|+|||.+......  .....+++.|+|||++.+..
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~  269 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG  269 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSC
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCC
Confidence                                                      7999999999876543  34457899999999999999


Q ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCC------HHHHHHHhhhccCC
Q 045286          212 YDQKADVFSFAIVLWELVTAKVPYDSMT------PLQAALGVRQVCTS  253 (259)
Q Consensus       212 ~~~~~Di~slG~~~~~ll~g~~p~~~~~------~~~~~~~i~~~~~~  253 (259)
                      ++.++|||||||++|+|++|..||...+      ....+..+.+..+.
T Consensus       270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  317 (397)
T 1wak_A          270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGK  317 (397)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCS
T ss_pred             CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCC
Confidence            9999999999999999999999998654      34445555544443

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.7e-38  Score=258.30  Aligned_cols=213  Identities=23%  Similarity=0.385  Sum_probs=174.2

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeee-----
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST-----  105 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----  105 (259)
                      +.+ ..+|++.+.||+|++|.||+|.+.  ++.|++|++...  .......+.+|+.+++.++||||+++++++.     
T Consensus         7 ~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   83 (320)
T 2i6l_A            7 FDL-GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ   83 (320)
T ss_dssp             EEE-TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred             Ccc-CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence            444 468999999999999999999986  789999998765  3455677889999999999999999998763     


Q ss_pred             ---------cCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc-cCCeE
Q 045286          106 ---------KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD-THNVV  175 (259)
Q Consensus       106 ---------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~-~~~~i  175 (259)
                               .....++|+|+++ ++|.+++..  ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++ .++.+
T Consensus        84 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           84 LTDDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             CCC----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEE
T ss_pred             cccccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeE
Confidence                     3467899999996 599998854  3488999999999999999999999999999999999997 56799


Q ss_pred             EEeeeccceeccCCC----ccccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhc
Q 045286          176 KVADFGVARFQNKGG----VMTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV  250 (259)
Q Consensus       176 ~l~D~~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~  250 (259)
                      +|+|||.+.......    ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+.+..+.+.
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  240 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES  240 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            999999997654321    1223346888999998765 67899999999999999999999999999888877777655


Q ss_pred             c
Q 045286          251 C  251 (259)
Q Consensus       251 ~  251 (259)
                      .
T Consensus       241 ~  241 (320)
T 2i6l_A          241 I  241 (320)
T ss_dssp             S
T ss_pred             c
Confidence            4

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.3e-38  Score=257.87  Aligned_cols=197  Identities=27%  Similarity=0.382  Sum_probs=171.4

Q ss_pred             hhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeee-eecCCcEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA-STKSPHLCIV  113 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-~~~~~~~~lv  113 (259)
                      .++|++.+.||+|++|.||+|.+  .++.||+|++......    ..+.+|+.+++.++|++++..+.. ....+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence            46899999999999999999996  4889999998876433    357889999999998776555554 4667788999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE---ccCCeEEEeeeccceeccCCC
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM---DTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv---~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      ||++ +++|.+++......+++..++.++.|++.+|.+||+.|++|+||+|+||++   +.++.++|+|||.+.......
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (296)
T 3uzp_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence            9999 899999998666779999999999999999999999999999999999999   478899999999998765543


Q ss_pred             c--------cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 045286          191 V--------MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSM  238 (259)
Q Consensus       191 ~--------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  238 (259)
                      .        .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  218 (296)
T 3uzp_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL  218 (296)
T ss_dssp             TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Confidence            2        23456899999999999999999999999999999999999999863

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.9e-38  Score=260.11  Aligned_cols=205  Identities=23%  Similarity=0.357  Sum_probs=173.7

Q ss_pred             ccceechhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeee---
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST---  105 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---  105 (259)
                      +.+.+..++|++.+.||+|++|.||++.+  .++.||+|++...  .......+.+|+.+++.++||||+++++++.   
T Consensus        22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   99 (317)
T 2buj_A           22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRER   99 (317)
T ss_dssp             EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE
T ss_pred             cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc
Confidence            34778889999999999999999999997  4789999998764  3445577889999999999999999999886   


Q ss_pred             -cCCcEEEEEecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeec
Q 045286          106 -KSPHLCIVTEYMPGGSLYDYLHK---NHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFG  181 (259)
Q Consensus       106 -~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~  181 (259)
                       .....++|+||+++++|.+++..   ....+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||
T Consensus       100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg  179 (317)
T 2buj_A          100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG  179 (317)
T ss_dssp             TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecC
Confidence             33478999999999999999875   34568999999999999999999999999999999999999999999999999


Q ss_pred             cceeccCCCc----------cccCCCcccccCccccCCCC---CCCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          182 VARFQNKGGV----------MTAETGTYRWMAPEVINHQP---YDQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       182 ~~~~~~~~~~----------~~~~~~~~~~~~PE~~~~~~---~~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                      .+........          .....+++.|+|||.+.+..   ++.++|+||||+++|+|++|..||..
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  248 (317)
T 2buj_A          180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM  248 (317)
T ss_dssp             SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred             cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence            8865432111          11224688999999987654   68999999999999999999999953

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=8.4e-38  Score=257.29  Aligned_cols=214  Identities=23%  Similarity=0.389  Sum_probs=179.4

Q ss_pred             hhhhccceeccccceEEEEEEE--cCceEEEEEeecccCc--hHHHHHHHHHHHHHHhcCCCCcceeeeee--ecCCcEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLN--DTLEDEFVQEVAILREVQHRNVVRFIGAS--TKSPHLC  111 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~  111 (259)
                      .+|++.+.||+|++|.||++.+  .++.|++|++......  ......+.+|+.+++.++|+||+++++++  ......+
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            5789999999999999999997  4679999999865322  23457788999999999999999999988  4456889


Q ss_pred             EEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-
Q 045286          112 IVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-  189 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-  189 (259)
                      +||||++++ |.+++... ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...... 
T Consensus        85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~  163 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA  163 (305)
T ss_dssp             EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred             EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence            999999765 77777553 345899999999999999999999999999999999999999999999999999866432 


Q ss_pred             --CccccCCCcccccCccccCCCCC--CCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          190 --GVMTAETGTYRWMAPEVINHQPY--DQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       190 --~~~~~~~~~~~~~~PE~~~~~~~--~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                        .......+++.|+|||.+.+...  +.++|+||||+++|+|++|..||...+..+....+.++..
T Consensus       164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~  230 (305)
T 2wtk_C          164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY  230 (305)
T ss_dssp             SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC
T ss_pred             cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC
Confidence              22234568999999999976543  7799999999999999999999999888887777766543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.6e-39  Score=268.94  Aligned_cols=196  Identities=17%  Similarity=0.279  Sum_probs=169.1

Q ss_pred             chhhhhccceeccccceEEEEEEEc----------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcce------
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL----------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVR------   99 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~----------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~------   99 (259)
                      ..++|++.+.||+|++|.||+|.+.          ++.||+|++...       ..+.+|+.++++++||||++      
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhc
Confidence            3579999999999999999999874          679999999865       35778999999999999887      


Q ss_pred             ---------eeeeeec-CCcEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEE
Q 045286          100 ---------FIGASTK-SPHLCIVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLL  168 (259)
Q Consensus       100 ---------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nil  168 (259)
                               +++++.. ....++|||++ +++|.+++... ...+++..++.++.|++.+|.+||+.|++|+||||+||+
T Consensus       113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred             cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence                     4555554 67889999999 99999999765 346999999999999999999999999999999999999


Q ss_pred             EccCC--eEEEeeeccceeccCCC--------ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 045286          169 MDTHN--VVKVADFGVARFQNKGG--------VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSM  238 (259)
Q Consensus       169 v~~~~--~i~l~D~~~~~~~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  238 (259)
                      ++.++  .++|+|||.+.......        ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99988  89999999997654321        113346899999999999999999999999999999999999999875


Q ss_pred             C
Q 045286          239 T  239 (259)
Q Consensus       239 ~  239 (259)
                      .
T Consensus       272 ~  272 (352)
T 2jii_A          272 L  272 (352)
T ss_dssp             T
T ss_pred             C
Confidence            3

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=7.4e-38  Score=256.38  Aligned_cols=198  Identities=27%  Similarity=0.380  Sum_probs=168.2

Q ss_pred             hhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeee-eecCCcEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA-STKSPHLCIV  113 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-~~~~~~~~lv  113 (259)
                      .++|++.+.||+|++|.||+|.+  .++.||+|+.......    ..+.+|+.+++.++|++++..+.. +...+..+++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            36899999999999999999996  4789999987765433    347789999999997776665554 4677788999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE---ccCCeEEEeeeccceeccCCC
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM---DTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv---~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      ||++ +++|.+++......+++..++.++.|++.+|.+||+.|++|+||||+||++   +.++.++|+|||.+.......
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~  162 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence            9999 899999998766679999999999999999999999999999999999999   788999999999998765442


Q ss_pred             c--------cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 045286          191 V--------MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT  239 (259)
Q Consensus       191 ~--------~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  239 (259)
                      .        .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  219 (296)
T 4hgt_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK  219 (296)
T ss_dssp             TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence            2        234568999999999999999999999999999999999999997643

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.1e-37  Score=264.60  Aligned_cols=213  Identities=23%  Similarity=0.366  Sum_probs=183.5

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CC-----CcceeeeeeecCC
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HR-----NVVRFIGASTKSP  108 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~-----~i~~~~~~~~~~~  108 (259)
                      .++|++.++||+|+||+||+|.+.  ++.||+|++...   ......+.+|+.+++.++ |+     +|+.+.+.+...+
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            468999999999999999999875  788999999754   234466777888888875 44     4899999999999


Q ss_pred             cEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCCCcEEEc--cCCeEEEeeeccc
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLH--QRNIIHRDLKTANLLMD--THNVVKVADFGVA  183 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH--~~~i~H~di~p~Nilv~--~~~~i~l~D~~~~  183 (259)
                      ..++|||+++ ++|.+++.... ..+++..+..++.|++.+|.+||  +.|++|+||||+||+++  .++.++|+|||.+
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            9999999995 59999987654 45899999999999999999999  57999999999999995  4678999999999


Q ss_pred             eeccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCC
Q 045286          184 RFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLC  255 (259)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~  255 (259)
                      ......  .....+++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+.+..+.+..+.++
T Consensus       209 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  278 (382)
T 2vx3_A          209 CQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP  278 (382)
T ss_dssp             EETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred             eecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            876543  3456789999999999999999999999999999999999999999999999888887665443

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=9.6e-38  Score=261.90  Aligned_cols=214  Identities=22%  Similarity=0.436  Sum_probs=183.2

Q ss_pred             chhhhhccceeccccceEEEEEEEc--C-ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCC------cceeeeeeec
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL--G-QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRN------VVRFIGASTK  106 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~--~-~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~~~~~~~~  106 (259)
                      -.++|++.+.||+|++|.||+|.+.  + +.||+|++...   ......+.+|+.+++.++|++      ++.+.+++..
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~   93 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF   93 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence            3578999999999999999999974  3 68999999753   234466778999999887544      8889999998


Q ss_pred             CCcEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE----------------
Q 045286          107 SPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM----------------  169 (259)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv----------------  169 (259)
                      .+..++|||++ ++++.+++.... ..+++..++.++.|++.+|.+||+.|++|+||||+||++                
T Consensus        94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence            99999999999 667777775543 468999999999999999999999999999999999999                


Q ss_pred             ---ccCCeEEEeeeccceeccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 045286          170 ---DTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALG  246 (259)
Q Consensus       170 ---~~~~~i~l~D~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~  246 (259)
                         +.++.++|+|||.+......  .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+.+..
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  250 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM  250 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence               56789999999999765443  2345789999999999999999999999999999999999999999998888887


Q ss_pred             hhhccCCCC
Q 045286          247 VRQVCTSLC  255 (259)
Q Consensus       247 i~~~~~~~~  255 (259)
                      +.+...+.+
T Consensus       251 ~~~~~~~~p  259 (355)
T 2eu9_A          251 MEKILGPIP  259 (355)
T ss_dssp             HHHHHCCCC
T ss_pred             HHHHcCCCc
Confidence            777665543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.6e-38  Score=268.83  Aligned_cols=203  Identities=12%  Similarity=0.136  Sum_probs=156.8

Q ss_pred             ceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCc-hHHHHHHHHHHHHHHhc--CCCCcceee------
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN-DTLEDEFVQEVAILREV--QHRNVVRFI------  101 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l--~~~~i~~~~------  101 (259)
                      +....+.|.+.++||+|+||.||+|.+.  ++.||+|++...... ......+.+|+.+++.+  +||||++++      
T Consensus        57 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p  136 (371)
T 3q60_A           57 LSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLP  136 (371)
T ss_dssp             TTCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCC
T ss_pred             CCCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEee
Confidence            3344566999999999999999999974  789999999987653 34456677775544444  699987754      


Q ss_pred             -eeeecC-----------------CcEEEEEecCCCCChHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHHHhCCc
Q 045286          102 -GASTKS-----------------PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQL------LRFAIDICKGMEYLHQRNI  157 (259)
Q Consensus       102 -~~~~~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~------~~i~~ql~~~l~~lH~~~i  157 (259)
                       +++...                 ...++||||++ ++|.+++......+.....      ..++.|++.+|.|||+.|+
T Consensus       137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~i  215 (371)
T 3q60_A          137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGL  215 (371)
T ss_dssp             CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             ehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCC
Confidence             333222                 34799999997 7999999765444555555      6778999999999999999


Q ss_pred             ccCCCCCCcEEEccCCeEEEeeeccceeccCCCccccCCCcccccCccccCC--CCCCCchhHHHHHHHHHHHHcCCCCC
Q 045286          158 IHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINH--QPYDQKADVFSFAIVLWELVTAKVPY  235 (259)
Q Consensus       158 ~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~~~~ll~g~~p~  235 (259)
                      +|+||||+||+++.++.++|+|||++.......  ....+++.|+|||.+.+  ..++.++|+|||||++|+|++|..||
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999998665432  13345699999999987  78999999999999999999999999


Q ss_pred             CCC
Q 045286          236 DSM  238 (259)
Q Consensus       236 ~~~  238 (259)
                      ...
T Consensus       294 ~~~  296 (371)
T 3q60_A          294 GLV  296 (371)
T ss_dssp             TBC
T ss_pred             CCc
Confidence            766

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.7e-37  Score=258.21  Aligned_cols=195  Identities=32%  Similarity=0.642  Sum_probs=169.9

Q ss_pred             hhhhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHh--cCCCCcceeeeeeecCC----cE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILRE--VQHRNVVRFIGASTKSP----HL  110 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~~----~~  110 (259)
                      .++|.+.+.||+|++|.||++.+.++.||+|++....     ...+.+|.++++.  ++||||+++++++...+    ..
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~  115 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL  115 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred             cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence            3789999999999999999999999999999987542     2556788888887  68999999999987765    78


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccCCCCCCcEEEccCCeEEEeeecc
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH--------QRNIIHRDLKTANLLMDTHNVVKVADFGV  182 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH--------~~~i~H~di~p~Nilv~~~~~i~l~D~~~  182 (259)
                      ++|+||+++++|.+++...  .++...++.++.|++.+|.+||        +.|++|+||||+||+++.++.++|+|||.
T Consensus       116 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  193 (342)
T 1b6c_B          116 WLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  193 (342)
T ss_dssp             EEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence            9999999999999999764  4889999999999999999999        89999999999999999999999999999


Q ss_pred             ceeccCCCc-----cccCCCcccccCccccCCCC------CCCchhHHHHHHHHHHHHcC----------CCCCCCC
Q 045286          183 ARFQNKGGV-----MTAETGTYRWMAPEVINHQP------YDQKADVFSFAIVLWELVTA----------KVPYDSM  238 (259)
Q Consensus       183 ~~~~~~~~~-----~~~~~~~~~~~~PE~~~~~~------~~~~~Di~slG~~~~~ll~g----------~~p~~~~  238 (259)
                      +........     .....+++.|+|||.+.+..      ++.++|+||||+++|+|++|          ..||...
T Consensus       194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~  270 (342)
T 1b6c_B          194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  270 (342)
T ss_dssp             CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence            987655432     23456899999999987652      33689999999999999999          7898654

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.2e-37  Score=253.22  Aligned_cols=206  Identities=27%  Similarity=0.497  Sum_probs=168.0

Q ss_pred             hhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec--------
Q 045286           37 RRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK--------  106 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------  106 (259)
                      ..+|++.+.||+|++|.||+|.+  .++.|++|++...   ......+.+|+.+++.++||||+++++++..        
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM   81 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence            35789999999999999999997  4789999999653   3445778899999999999999999998754        


Q ss_pred             -----CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeec
Q 045286          107 -----SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFG  181 (259)
Q Consensus       107 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~  181 (259)
                           .+..++|+|++++++|.+++......++...++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg  161 (303)
T 1zy4_A           82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG  161 (303)
T ss_dssp             ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence                 356899999999999999998766668889999999999999999999999999999999999999999999999


Q ss_pred             cceeccCC---------------CccccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHH
Q 045286          182 VARFQNKG---------------GVMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDS-MTPLQAA  244 (259)
Q Consensus       182 ~~~~~~~~---------------~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~-~~~~~~~  244 (259)
                      .+......               .......+++.|+|||.+.+. .++.++|+||||+++|+|++   ||.. .+..+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~  238 (303)
T 1zy4_A          162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL  238 (303)
T ss_dssp             CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred             chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence            98765422               122344588999999999865 68999999999999999998   5543 2333344


Q ss_pred             HHhh
Q 045286          245 LGVR  248 (259)
Q Consensus       245 ~~i~  248 (259)
                      ..+.
T Consensus       239 ~~~~  242 (303)
T 1zy4_A          239 KKLR  242 (303)
T ss_dssp             HHHH
T ss_pred             Hhcc
Confidence            4443

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.1e-37  Score=252.70  Aligned_cols=206  Identities=27%  Similarity=0.503  Sum_probs=173.5

Q ss_pred             cceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCc
Q 045286           32 DWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPH  109 (259)
Q Consensus        32 ~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~  109 (259)
                      .+.+..+.+.....||+|++|.||+|.+.  ++.|++|.+....  ......+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   93 (295)
T 2clq_A           16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF   93 (295)
T ss_dssp             CEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             cccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence            34455566677779999999999999984  6789999998653  3344678899999999999999999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc-CCeEEEeeeccceec
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHN--VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT-HNVVKVADFGVARFQ  186 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~-~~~i~l~D~~~~~~~  186 (259)
                      .++|+|++++++|.+++.....  .+++..+..++.|++.+|.+||+.|++|+||+|+||+++. ++.++|+|||.+...
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~  173 (295)
T 2clq_A           94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL  173 (295)
T ss_dssp             EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred             EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence            9999999999999999976533  4568888999999999999999999999999999999987 899999999999866


Q ss_pred             cCCC-ccccCCCcccccCccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 045286          187 NKGG-VMTAETGTYRWMAPEVINHQ--PYDQKADVFSFAIVLWELVTAKVPYDSMT  239 (259)
Q Consensus       187 ~~~~-~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~~~~ll~g~~p~~~~~  239 (259)
                      .... ......+++.|+|||.+.+.  .++.++|+||||+++|+|++|..||...+
T Consensus       174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  229 (295)
T 2clq_A          174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG  229 (295)
T ss_dssp             CC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGS
T ss_pred             CCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCC
Confidence            5432 23345689999999998764  37899999999999999999999997543

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-37  Score=256.99  Aligned_cols=194  Identities=33%  Similarity=0.620  Sum_probs=164.4

Q ss_pred             hhhhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhc--CCCCcceeeeeeecC----CcE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV--QHRNVVRFIGASTKS----PHL  110 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~~~~~~~----~~~  110 (259)
                      .++|++.++||+|+||.||+|.+.++.||+|++....     .....+|.+++...  +|+||+++++++...    ...
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  110 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL  110 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred             ccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence            4789999999999999999999999999999987542     13344555555554  899999999998776    689


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCcEEEccCCeEEEeeecc
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR--------NIIHRDLKTANLLMDTHNVVKVADFGV  182 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~--------~i~H~di~p~Nilv~~~~~i~l~D~~~  182 (259)
                      ++||||+++++|.+++...  .+++..++.++.|++.+|.+||+.        |++|+||||+||+++.++.++|+|||.
T Consensus       111 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~  188 (337)
T 3mdy_A          111 YLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  188 (337)
T ss_dssp             EEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence            9999999999999999654  488999999999999999999999        999999999999999999999999999


Q ss_pred             ceeccCCCcc-----ccCCCcccccCccccCCCCCCCc------hhHHHHHHHHHHHHcC----------CCCCCC
Q 045286          183 ARFQNKGGVM-----TAETGTYRWMAPEVINHQPYDQK------ADVFSFAIVLWELVTA----------KVPYDS  237 (259)
Q Consensus       183 ~~~~~~~~~~-----~~~~~~~~~~~PE~~~~~~~~~~------~Di~slG~~~~~ll~g----------~~p~~~  237 (259)
                      +.........     ....+++.|+|||.+.+...+..      +|+||||+++|+|++|          ..||..
T Consensus       189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~  264 (337)
T 3mdy_A          189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD  264 (337)
T ss_dssp             CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence            9765443221     24468999999999988766665      9999999999999999          777754

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.8e-37  Score=268.60  Aligned_cols=199  Identities=24%  Similarity=0.387  Sum_probs=173.6

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCC-CCcceeeeeeecCCcEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH-RNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv  113 (259)
                      .++|++.++||+|+||.||+|.+.  ++.||||+.......    ..+.+|+.+++.++| +++..+..++...+..++|
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv   81 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV   81 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence            468999999999999999999975  889999998765433    347789999999986 5666666677778889999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEE---ccCCeEEEeeeccceeccCCC
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLM---DTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv---~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      ||++ +++|.+++......+++..++.++.||+.+|.|||+.|++|+||||+|||+   +.++.++|+|||++.......
T Consensus        82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (483)
T 3sv0_A           82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS  160 (483)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence            9999 899999998766779999999999999999999999999999999999999   588999999999998765443


Q ss_pred             cc--------ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 045286          191 VM--------TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTP  240 (259)
Q Consensus       191 ~~--------~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~  240 (259)
                      ..        ....+++.|+|||.+.+..++.++|||||||++|+|++|..||.+...
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~  218 (483)
T 3sv0_A          161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA  218 (483)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred             cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence            21        245689999999999999999999999999999999999999987543

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.6e-37  Score=253.01  Aligned_cols=206  Identities=23%  Similarity=0.402  Sum_probs=174.7

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcC--CCCcceeeeeeecC
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ--HRNVVRFIGASTKS  107 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~  107 (259)
                      ....+..++|++.+.||+|++|.||++.+. ++.|++|++............+.+|+.+++.++  |+||+++++++...
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~  100 (313)
T 3cek_A           21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  100 (313)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred             eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence            447778899999999999999999999875 678999999887666667788999999999997  59999999999999


Q ss_pred             CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      +..+++||+ .+++|.+++.... .++...++.++.|++.+|.+||+.|++|+||+|+||+++ ++.++|+|||.+....
T Consensus       101 ~~~~lv~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~  177 (313)
T 3cek_A          101 QYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  177 (313)
T ss_dssp             SEEEEEECC-CSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--
T ss_pred             CEEEEEEec-CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccccc
Confidence            999999994 5889999996543 588999999999999999999999999999999999995 5899999999997654


Q ss_pred             CCCc---cccCCCcccccCccccCC-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 045286          188 KGGV---MTAETGTYRWMAPEVINH-----------QPYDQKADVFSFAIVLWELVTAKVPYDSMT  239 (259)
Q Consensus       188 ~~~~---~~~~~~~~~~~~PE~~~~-----------~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  239 (259)
                      ....   .....+++.|+|||.+.+           ..++.++|+||||+++|+|++|..||....
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (313)
T 3cek_A          178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  243 (313)
T ss_dssp             ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence            4322   234468999999999875           467889999999999999999999997643

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.3e-38  Score=264.16  Aligned_cols=196  Identities=29%  Similarity=0.500  Sum_probs=161.3

Q ss_pred             ceechhhhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHH--HHHHHHHhcCCCCcceeeeeee-----
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFV--QEVAILREVQHRNVVRFIGAST-----  105 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~--~e~~~l~~l~~~~i~~~~~~~~-----  105 (259)
                      ..+.-++|++.+.||+|+||.||+|.+.++.||+|++.....     ..+.  .++..+..++|+||+++++.+.     
T Consensus         8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~   82 (336)
T 3g2f_A            8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR-----QNFINEKNIYRVPLMEHDNIARFIVGDERVTAD   82 (336)
T ss_dssp             -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred             CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccch-----hhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence            455668999999999999999999999999999999976432     2233  3444445578999999987542     


Q ss_pred             cCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcccCCCCCCcEEEccCCeEE
Q 045286          106 KSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQR---------NIIHRDLKTANLLMDTHNVVK  176 (259)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---------~i~H~di~p~Nilv~~~~~i~  176 (259)
                      ....+++||||+++++|.+++....  .+...++.++.|++.+|.+||+.         |++|+||||+||+++.++.++
T Consensus        83 ~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           83 GRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             SCEEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             CCceEEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence            2336789999999999999996654  57888999999999999999999         999999999999999999999


Q ss_pred             EeeeccceeccCCC---------ccccCCCcccccCccccCC-------CCCCCchhHHHHHHHHHHHHcCCCCC
Q 045286          177 VADFGVARFQNKGG---------VMTAETGTYRWMAPEVINH-------QPYDQKADVFSFAIVLWELVTAKVPY  235 (259)
Q Consensus       177 l~D~~~~~~~~~~~---------~~~~~~~~~~~~~PE~~~~-------~~~~~~~Di~slG~~~~~ll~g~~p~  235 (259)
                      |+|||.+.......         ......+++.|+|||.+.+       ..++.++|||||||++|+|++|..||
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~  235 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL  235 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence            99999997654321         1224468999999999977       45667899999999999999997665

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.5e-37  Score=266.11  Aligned_cols=210  Identities=25%  Similarity=0.433  Sum_probs=167.8

Q ss_pred             ccccccceechhhhhccceeccccceEE-EEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeeeee
Q 045286           27 QTKSEDWEIDRRLLKTGERIASGSCGDL-YRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGAS  104 (259)
Q Consensus        27 ~~~~~~~~~~~~~~~~~~~lg~G~~~~V-~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~  104 (259)
                      ....+.+.+...+|...++||+|++|+| +.+...++.||||.+......     .+.+|+.+++.+ +||||+++++++
T Consensus        13 ~~~~~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~   87 (432)
T 3p23_A           13 DEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTE   87 (432)
T ss_dssp             -----CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             cccCCcEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEE
Confidence            3445668888889999999999999985 555567899999999765432     245899999999 699999999999


Q ss_pred             ecCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc---CC--eEEEee
Q 045286          105 TKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT---HN--VVKVAD  179 (259)
Q Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~---~~--~i~l~D  179 (259)
                      ......++|||+++ ++|.+++...........++.++.|++.+|.|||+.|++|+||||+||+++.   ++  .++|+|
T Consensus        88 ~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~D  166 (432)
T 3p23_A           88 KDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISD  166 (432)
T ss_dssp             EETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECC
T ss_pred             ecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEec
Confidence            99999999999995 5999999766655666677889999999999999999999999999999953   23  578999


Q ss_pred             eccceeccCC----CccccCCCcccccCccccC---CCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 045286          180 FGVARFQNKG----GVMTAETGTYRWMAPEVIN---HQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQ  242 (259)
Q Consensus       180 ~~~~~~~~~~----~~~~~~~~~~~~~~PE~~~---~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~  242 (259)
                      ||.+......    .......+++.|+|||++.   ...++.++|||||||++|+|++ |..||......+
T Consensus       167 FG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~  237 (432)
T 3p23_A          167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ  237 (432)
T ss_dssp             TTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH
T ss_pred             ccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH
Confidence            9999766543    2233456899999999997   4567889999999999999999 999997655443

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.5e-37  Score=262.66  Aligned_cols=216  Identities=21%  Similarity=0.368  Sum_probs=177.9

Q ss_pred             ceechhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcC-----------CCCcce
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-----------HRNVVR   99 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~   99 (259)
                      ..+...+|++.+.||+|++|.||+|.+  .++.||+|++...   ......+.+|+.++++++           |+||++
T Consensus        14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~   90 (373)
T 1q8y_A           14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK   90 (373)
T ss_dssp             CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred             CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence            345568999999999999999999997  4789999999754   233466788999988886           789999


Q ss_pred             eeeeeecCC----cEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCcEEEcc--
Q 045286          100 FIGASTKSP----HLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQR-NIIHRDLKTANLLMDT--  171 (259)
Q Consensus       100 ~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~di~p~Nilv~~--  171 (259)
                      +++++...+    ..++++|++ +++|.+++.... ..++...++.++.|++.+|.+||+. |++|+||||+||+++.  
T Consensus        91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A           91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred             HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence            999987543    789999999 889999997643 4589999999999999999999998 9999999999999954  


Q ss_pred             ----CCeEEEeeeccceeccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC------HH
Q 045286          172 ----HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT------PL  241 (259)
Q Consensus       172 ----~~~i~l~D~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~------~~  241 (259)
                          .+.++|+|||.+......  .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+      ..
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             CCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence                347999999999876543  334578999999999999999999999999999999999999998654      44


Q ss_pred             HHHHHhhhccCCC
Q 045286          242 QAALGVRQVCTSL  254 (259)
Q Consensus       242 ~~~~~i~~~~~~~  254 (259)
                      +.+.++.+..+..
T Consensus       248 ~~~~~~~~~~~~~  260 (373)
T 1q8y_A          248 DHIAQIIELLGEL  260 (373)
T ss_dssp             HHHHHHHHHHCSC
T ss_pred             HHHHHHHHhcCCC
Confidence            5555555554443

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.1e-37  Score=257.61  Aligned_cols=204  Identities=23%  Similarity=0.385  Sum_probs=147.1

Q ss_pred             ccceechhhhhc-cceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec-
Q 045286           31 EDWEIDRRLLKT-GERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK-  106 (259)
Q Consensus        31 ~~~~~~~~~~~~-~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-  106 (259)
                      +.+.+. ++|++ .+.||+|++|.||+|.+.  ++.||+|++....      ....+....++.++|+||+++++++.. 
T Consensus        22 ~~~~~~-~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~e~~~~~~~~~h~~i~~~~~~~~~~   94 (336)
T 3fhr_A           22 KKYAVT-DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP------KARQEVDHHWQASGGPHIVCILDVYENM   94 (336)
T ss_dssp             BCSCGG-GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH------HHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             CCcccc-ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH------HHHHHHHHHHHhcCCCChHHHHHHHhhc
Confidence            445564 46666 557999999999999986  8899999997641      112223334566789999999998865 


Q ss_pred             ---CCcEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC---CeEEEee
Q 045286          107 ---SPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH---NVVKVAD  179 (259)
Q Consensus       107 ---~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~---~~i~l~D  179 (259)
                         ....++||||+++++|.+++.... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.+   +.++|+|
T Consensus        95 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~D  174 (336)
T 3fhr_A           95 HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTD  174 (336)
T ss_dssp             ETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             cCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEec
Confidence               445899999999999999997654 358999999999999999999999999999999999999764   5599999


Q ss_pred             eccceeccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH
Q 045286          180 FGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQ  242 (259)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~  242 (259)
                      ||.+...... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+...
T Consensus       175 fg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  236 (336)
T 3fhr_A          175 FGFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQA  236 (336)
T ss_dssp             CTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cccceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchh
Confidence            9999765543 2334567999999999988889999999999999999999999997655433

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.5e-37  Score=256.51  Aligned_cols=207  Identities=24%  Similarity=0.431  Sum_probs=174.1

Q ss_pred             cccceechhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCch----HHHHHHHHHHHHHHhcC--CCCcceee
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLND----TLEDEFVQEVAILREVQ--HRNVVRFI  101 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~----~~~~~~~~e~~~l~~l~--~~~i~~~~  101 (259)
                      .+..+.-..+|++.+.||+|+||.||+|.+  .++.|++|++.......    .....+.+|+.+++.++  |+||++++
T Consensus        35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~  114 (320)
T 3a99_A           35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL  114 (320)
T ss_dssp             -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred             ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence            344455578899999999999999999987  47899999998764332    12244667899999996  59999999


Q ss_pred             eeeecCCcEEEEEecCCC-CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc-cCCeEEEee
Q 045286          102 GASTKSPHLCIVTEYMPG-GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD-THNVVKVAD  179 (259)
Q Consensus       102 ~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~-~~~~i~l~D  179 (259)
                      +++...+..++++|++.+ ++|.+++.... .+++..++.++.|++.+|.+||+.|++|+||+|+||+++ .++.++|+|
T Consensus       115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          115 DWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             EEEECSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred             EEEecCCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence            999999999999999976 89999986643 589999999999999999999999999999999999998 679999999


Q ss_pred             eccceeccCCCccccCCCcccccCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCC
Q 045286          180 FGVARFQNKGGVMTAETGTYRWMAPEVINHQPY-DQKADVFSFAIVLWELVTAKVPYDSM  238 (259)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~~~~ll~g~~p~~~~  238 (259)
                      ||.+...... ......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...
T Consensus       194 fg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  252 (320)
T 3a99_A          194 FGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD  252 (320)
T ss_dssp             CTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             Cccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence            9999876543 2344568999999999877665 67899999999999999999999753

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6.9e-37  Score=272.67  Aligned_cols=201  Identities=29%  Similarity=0.470  Sum_probs=176.1

Q ss_pred             hhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec------CCc
Q 045286           38 RLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK------SPH  109 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~  109 (259)
                      .+|++.++||+|+||.||+|.+  .++.||+|++.... .......+.+|+.+++.++||||+++++++..      .+.
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            6899999999999999999987  47899999987653 44556778999999999999999999998754      667


Q ss_pred             EEEEEecCCCCChHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCe---EEEeeeccce
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHN--VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNV---VKVADFGVAR  184 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~---i~l~D~~~~~  184 (259)
                      .++||||+++++|.+++.....  .+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.   ++|+|||.+.
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~  172 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK  172 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence            8999999999999999975432  5888999999999999999999999999999999999987764   9999999998


Q ss_pred             eccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 045286          185 FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT  239 (259)
Q Consensus       185 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~  239 (259)
                      ............+++.|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus       173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~  227 (676)
T 3qa8_A          173 ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW  227 (676)
T ss_dssp             BTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred             ccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc
Confidence            8776665566789999999999999999999999999999999999999997643

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1e-37  Score=260.38  Aligned_cols=196  Identities=18%  Similarity=0.274  Sum_probs=163.3

Q ss_pred             echhhhhccceeccccceEEEEEEEcCceEEEEEeecccC------chHHHHHHHHHHHHHHhcC---------CCCcce
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHL------NDTLEDEFVQEVAILREVQ---------HRNVVR   99 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~------~~~~~~~~~~e~~~l~~l~---------~~~i~~   99 (259)
                      +..++|++.++||+|+||+||+|.++++.||+|++.....      .......+.+|+.+++.++         |+||++
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            4468999999999999999999999999999999987643      2233466888999988886         555555


Q ss_pred             eee-----------------eeec-------------CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHH
Q 045286          100 FIG-----------------ASTK-------------SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGM  149 (259)
Q Consensus       100 ~~~-----------------~~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l  149 (259)
                      +.+                 ++..             .+..++||||++++++.+.+..  ..+++..++.++.|++.+|
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence            544                 4433             6789999999988876666533  4489999999999999999


Q ss_pred             HHHH-hCCcccCCCCCCcEEEccCC--------------------eEEEeeeccceeccCCCccccCCCcccccCccccC
Q 045286          150 EYLH-QRNIIHRDLKTANLLMDTHN--------------------VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVIN  208 (259)
Q Consensus       150 ~~lH-~~~i~H~di~p~Nilv~~~~--------------------~i~l~D~~~~~~~~~~~~~~~~~~~~~~~~PE~~~  208 (259)
                      .||| +.|++||||||+|||++.++                    .+||+|||++......    ...+++.|+|||++.
T Consensus       175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~  250 (336)
T 2vuw_A          175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFT  250 (336)
T ss_dssp             HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGC
T ss_pred             HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhc
Confidence            9999 99999999999999999887                    8999999999876653    236899999999998


Q ss_pred             CCCCCCchhHHHHHHH-HHHHHcCCCCCCC
Q 045286          209 HQPYDQKADVFSFAIV-LWELVTAKVPYDS  237 (259)
Q Consensus       209 ~~~~~~~~Di~slG~~-~~~ll~g~~p~~~  237 (259)
                      +.. +.++||||++++ .++++.|..||.+
T Consensus       251 g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~  279 (336)
T 2vuw_A          251 GDG-DYQFDIYRLMKKENNNRWGEYHPYSN  279 (336)
T ss_dssp             CCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred             CCC-ccceehhhhhCCCCcccccccCCCcc
Confidence            877 889999998777 6778889999965

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.8e-37  Score=253.19  Aligned_cols=203  Identities=26%  Similarity=0.423  Sum_probs=164.7

Q ss_pred             ceechhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCch----HHHHHHHHHHHHHHhc----CCCCcceeee
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLND----TLEDEFVQEVAILREV----QHRNVVRFIG  102 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~----~~~~~~~~e~~~l~~l----~~~~i~~~~~  102 (259)
                      .+.-.++|++.+.||+|++|.||+|.+  .++.|++|++.......    .....+.+|+.+++++    +|+||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            444467899999999999999999987  47899999997654322    1223455789999988    8999999999


Q ss_pred             eeecCCcEEEEEec-CCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc-cCCeEEEeee
Q 045286          103 ASTKSPHLCIVTEY-MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD-THNVVKVADF  180 (259)
Q Consensus       103 ~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~-~~~~i~l~D~  180 (259)
                      ++...+..++++|+ +.+++|.+++.... .+++..++.++.|++.+|.+||+.|++|+||+|+||+++ .++.++|+||
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df  184 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF  184 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence            99888899999999 78899999997654 489999999999999999999999999999999999999 7899999999


Q ss_pred             ccceeccCCCccccCCCcccccCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          181 GVARFQNKGGVMTAETGTYRWMAPEVINHQPY-DQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                      |.+...... ......++..|+|||.+.+..+ +.++|+||||+++|+|++|..||..
T Consensus       185 g~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  241 (312)
T 2iwi_A          185 GSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER  241 (312)
T ss_dssp             SSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             chhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence            999876654 2345568999999999877665 4589999999999999999999975

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.1e-35  Score=241.16  Aligned_cols=177  Identities=12%  Similarity=0.132  Sum_probs=156.1

Q ss_pred             echhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEE
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN-DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~  111 (259)
                      +-..+|++.+.||+|+||.||+|.+.  ++.|++|++...... ......+.+|+.+++.++|+||+++++++...+..+
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            44578999999999999999999986  789999999876543 455678899999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc
Q 045286          112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV  191 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~  191 (259)
                      +||||++|++|.+++...   ....++..++.|++.+|.|||+.|++|+||||+||+++.+|.++|++++..        
T Consensus       108 lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~~--------  176 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATM--------  176 (286)
T ss_dssp             EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCCC--------
T ss_pred             EEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecccc--------
Confidence            999999999999998542   455678889999999999999999999999999999999999999854432        


Q ss_pred             cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 045286          192 MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTP  240 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~  240 (259)
                                 +       +++.++|+||||+++|+|++|..||.+.+.
T Consensus       177 -----------~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~  207 (286)
T 3uqc_A          177 -----------P-------DANPQDDIRGIGASLYALLVNRWPLPEAGV  207 (286)
T ss_dssp             -----------T-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred             -----------C-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence                       2       268999999999999999999999987654

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.5e-35  Score=255.49  Aligned_cols=198  Identities=27%  Similarity=0.451  Sum_probs=157.6

Q ss_pred             hhhhhccceeccccceEEEEE-EEcCceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRG-VYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~-~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      .+.|...+.||+|+||+||.+ ...++.||||.+....     .+.+.+|+.+++++ +||||+++++.+...+..++||
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~   88 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL   88 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence            345667789999999999754 4468999999987642     24567899999887 7999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCC------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC-------------CeE
Q 045286          115 EYMPGGSLYDYLHKNHNV------LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH-------------NVV  175 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~------~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~-------------~~i  175 (259)
                      |+++ ++|.+++......      .++..++.++.|++.+|.+||+.|++|+||||+||+++.+             +.+
T Consensus        89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            9995 5999999654321      1233457799999999999999999999999999999754             489


Q ss_pred             EEeeeccceeccCCCc-----cccCCCcccccCccccCC-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCCCH
Q 045286          176 KVADFGVARFQNKGGV-----MTAETGTYRWMAPEVINH-------QPYDQKADVFSFAIVLWELVT-AKVPYDSMTP  240 (259)
Q Consensus       176 ~l~D~~~~~~~~~~~~-----~~~~~~~~~~~~PE~~~~-------~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~  240 (259)
                      +|+|||.+........     .....+++.|+|||++.+       ..++.++|+|||||++|+|++ |..||.....
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~  245 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS  245 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence            9999999987654321     223468999999999865       568999999999999999999 9999976544

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.3e-36  Score=271.54  Aligned_cols=194  Identities=23%  Similarity=0.320  Sum_probs=167.0

Q ss_pred             echhhhhccceeccccceEEEEEEEc---CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCc--
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL---GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPH--  109 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~---~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--  109 (259)
                      +-..+|++.++||+|+||.||++.+.   ++.|+||++.... .......+.+|+.++++++||||+++++++...+.  
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  155 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG  155 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence            34578999999999999999999984   6899999987643 34455678899999999999999999999977655  


Q ss_pred             ---EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          110 ---LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       110 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                         .++||||++|++|.+++..   .+++..++.++.|++.+|.|||+.|++|+||||+||+++.+ .++|+|||.+...
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             CEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             CceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence               7999999999999987744   58999999999999999999999999999999999999875 8999999999876


Q ss_pred             cCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 045286          187 NKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDS  237 (259)
Q Consensus       187 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~  237 (259)
                      ...   ....+++.|+|||.+.+.. +.++||||||+++|+|++|..||.+
T Consensus       232 ~~~---~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~  278 (681)
T 2pzi_A          232 NSF---GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG  278 (681)
T ss_dssp             TCC---SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred             ccC---CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcc
Confidence            554   3456899999999987654 8899999999999999999998864

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.8e-36  Score=256.96  Aligned_cols=209  Identities=15%  Similarity=0.176  Sum_probs=160.3

Q ss_pred             echhhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCC-CCccee----------
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQH-RNVVRF----------  100 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~-~~i~~~----------  100 (259)
                      ...+.++..++||+|+||.||+|.+.  ++.||||++..... .....+.+.+|+.+++.+.| .+...+          
T Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~  154 (413)
T 3dzo_A           75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  154 (413)
T ss_dssp             SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred             CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence            34456888999999999999999986  89999999884432 22334678899999999976 222111          


Q ss_pred             -----------eeeeec-----CCcEEEEEecCCCCChHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 045286          101 -----------IGASTK-----SPHLCIVTEYMPGGSLYDYLHKN------HNVLKLPQLLRFAIDICKGMEYLHQRNII  158 (259)
Q Consensus       101 -----------~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~  158 (259)
                                 ...+..     ....+++|+.. +++|.+++...      ...+++..+..++.|++.+|.|||+.|++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii  233 (413)
T 3dzo_A          155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV  233 (413)
T ss_dssp             EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence                       111111     22467788876 67999988421      33466778888999999999999999999


Q ss_pred             cCCCCCCcEEEccCCeEEEeeeccceeccCCCccccCCCcccccCcccc----------CCCCCCCchhHHHHHHHHHHH
Q 045286          159 HRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI----------NHQPYDQKADVFSFAIVLWEL  228 (259)
Q Consensus       159 H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~~~~~~~~~~PE~~----------~~~~~~~~~Di~slG~~~~~l  228 (259)
                      ||||||+|||++.++.+||+|||++......  .....+ +.|+|||.+          .+..++.++|+|||||++|+|
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el  310 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI  310 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence            9999999999999999999999998765543  344567 999999999          566788999999999999999


Q ss_pred             HcCCCCCCCCCHHHHHHHh
Q 045286          229 VTAKVPYDSMTPLQAALGV  247 (259)
Q Consensus       229 l~g~~p~~~~~~~~~~~~i  247 (259)
                      ++|..||...+..+....+
T Consensus       311 ltg~~Pf~~~~~~~~~~~~  329 (413)
T 3dzo_A          311 WCADLPNTDDAALGGSEWI  329 (413)
T ss_dssp             HHSSCCCCTTGGGSCSGGG
T ss_pred             HHCCCCCCCcchhhhHHHH
Confidence            9999999876554433333

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.7e-34  Score=235.94  Aligned_cols=181  Identities=25%  Similarity=0.413  Sum_probs=150.7

Q ss_pred             ceechhhhhccceeccccceEEEEEEE--cCceEEEEEeecccCchHHHHHHHHHHHHH-HhcCCCCcceeeeeeec---
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAIL-REVQHRNVVRFIGASTK---  106 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~---  106 (259)
                      ..+-++++...+.||+|++|.||++.+  +++.||+|++...       ....+|+.++ +..+||||+++++++..   
T Consensus        13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   85 (299)
T 3m2w_A           13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYA   85 (299)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence            344344444448899999999999998  4789999999753       4566888887 55579999999999876   


Q ss_pred             -CCcEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc---CCeEEEeeec
Q 045286          107 -SPHLCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT---HNVVKVADFG  181 (259)
Q Consensus       107 -~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~---~~~i~l~D~~  181 (259)
                       ....++||||+++++|.+++.... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.   ++.++|+|||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence             667899999999999999997654 36899999999999999999999999999999999999988   7889999999


Q ss_pred             cceeccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH
Q 045286          182 VARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPL  241 (259)
Q Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~  241 (259)
                      .+.....                     ..++.++|+||||+++|+|++|..||...+..
T Consensus       166 ~a~~~~~---------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~  204 (299)
T 3m2w_A          166 FAKETTG---------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL  204 (299)
T ss_dssp             TCEECTT---------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC----
T ss_pred             ccccccc---------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcch
Confidence            8854332                     34678999999999999999999999765543

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=5.2e-32  Score=239.93  Aligned_cols=183  Identities=15%  Similarity=0.183  Sum_probs=129.0

Q ss_pred             eeccccceEEEEEE--EcCceEEEEEeecccCc--------hHHHHHHHHHHHHHHhc-CCCCcceeeeeeecCCcEEEE
Q 045286           45 RIASGSCGDLYRGV--YLGQDVAVKVLRSEHLN--------DTLEDEFVQEVAILREV-QHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        45 ~lg~G~~~~V~~~~--~~~~~v~vK~~~~~~~~--------~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      ..+.|+.+.+..+.  ..|+.+++|++......        +...+.+.+|+++|+++ .|+||+++++++.++...|+|
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            34556665555443  35899999999875322        23446789999999999 599999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-Ccc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVM  192 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~  192 (259)
                      |||++|++|.+++.... .++..   +++.||+++|.|+|++||+||||||+|||++.+|.+||+|||++...... ...
T Consensus       321 MEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~  396 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP  396 (569)
T ss_dssp             EECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred             EecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence            99999999999996544 46554   47899999999999999999999999999999999999999999765443 233


Q ss_pred             ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCC
Q 045286          193 TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAK  232 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~  232 (259)
                      ...+|++.|++||++.+. +..++|+|++|++++.++++.
T Consensus       397 ~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          397 TNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             HHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred             cCceechhhccHHHhCCC-CCCcccccccccchhhhcccc
Confidence            455799999999999875 567899999999877665543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=6.3e-29  Score=219.03  Aligned_cols=184  Identities=22%  Similarity=0.265  Sum_probs=145.0

Q ss_pred             ccceeccccceEEEEEEEcCceEEEEEeecccCch------HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           42 TGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLND------TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        42 ~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ..++||+|+||.||++...++.+++|.........      ...+.+.+|++++++++||||+.+..++...+..++|||
T Consensus       340 ~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             --------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            35799999999999998889999999976644322      123557899999999999999965555556667799999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcc---
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM---  192 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~---  192 (259)
                      |+++++|.+++..         +..++.|++++|.|||++|++|+||||+||+++.  .++|+|||++.........   
T Consensus       420 ~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~  488 (540)
T 3en9_A          420 YINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVD  488 (540)
T ss_dssp             CCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHH
T ss_pred             CCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccc
Confidence            9999999999864         4579999999999999999999999999999988  9999999999877654221   


Q ss_pred             -----ccCCCcccccCccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCC
Q 045286          193 -----TAETGTYRWMAPEVINH--QPYDQKADVFSFAIVLWELVTAKVPYD  236 (259)
Q Consensus       193 -----~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~~~~ll~g~~p~~  236 (259)
                           ....+++.|+|||++.+  ..|+...|+|+..+-..+-..+..+|.
T Consensus       489 ~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          489 LIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             hhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence                 24468999999999976  567788899998877777666666553

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=9e-25  Score=177.61  Aligned_cols=133  Identities=16%  Similarity=0.155  Sum_probs=107.7

Q ss_pred             hccceeccccceEEEEEEE-cCceEEEEEeecccCch----------------HHHHHHHHHHHHHHhcCCCCcceeeee
Q 045286           41 KTGERIASGSCGDLYRGVY-LGQDVAVKVLRSEHLND----------------TLEDEFVQEVAILREVQHRNVVRFIGA  103 (259)
Q Consensus        41 ~~~~~lg~G~~~~V~~~~~-~~~~v~vK~~~~~~~~~----------------~~~~~~~~e~~~l~~l~~~~i~~~~~~  103 (259)
                      .+.++||+|++|.||+|.+ .++.||+|+++......                .....+.+|+.+++.++  | +++.+.
T Consensus        93 ~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~  169 (282)
T 1zar_A           93 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKV  169 (282)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCE
T ss_pred             EecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeE
Confidence            3559999999999999998 47899999997543211                23467889999999998  5 666665


Q ss_pred             eecCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccc
Q 045286          104 STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA  183 (259)
Q Consensus       104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~  183 (259)
                      +.. +..++||||++|++|.+ +.     .  .....++.|++.++.+||+.|++|+||||+||+++ ++.++|+|||.+
T Consensus       170 ~~~-~~~~lvmE~~~g~~L~~-l~-----~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a  239 (282)
T 1zar_A          170 YAW-EGNAVLMELIDAKELYR-VR-----V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQS  239 (282)
T ss_dssp             EEE-ETTEEEEECCCCEEGGG-CC-----C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTC
T ss_pred             Eec-cceEEEEEecCCCcHHH-cc-----h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCC
Confidence            544 45689999999999988 41     1  23456999999999999999999999999999999 999999999998


Q ss_pred             eec
Q 045286          184 RFQ  186 (259)
Q Consensus       184 ~~~  186 (259)
                      ...
T Consensus       240 ~~~  242 (282)
T 1zar_A          240 VEV  242 (282)
T ss_dssp             EET
T ss_pred             eEC
Confidence            643

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=1.6e-21  Score=156.51  Aligned_cols=140  Identities=19%  Similarity=0.202  Sum_probs=106.8

Q ss_pred             hhhccceeccccceEEEEEEE--cCce--EEEEEeecccCc----------------------hHHHHHHHHHHHHHHhc
Q 045286           39 LLKTGERIASGSCGDLYRGVY--LGQD--VAVKVLRSEHLN----------------------DTLEDEFVQEVAILREV   92 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~--~~~~--v~vK~~~~~~~~----------------------~~~~~~~~~e~~~l~~l   92 (259)
                      .|.+.++||+|++|.||+|.+  .++.  ||||+++.....                      ......+.+|+..++.+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            356788999999999999998  6888  999997654211                      01224678899999999


Q ss_pred             CCCCc--ceeeeeeecCCcEEEEEecCCC-C----ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCC
Q 045286           93 QHRNV--VRFIGASTKSPHLCIVTEYMPG-G----SLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH-QRNIIHRDLKT  164 (259)
Q Consensus        93 ~~~~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH-~~~i~H~di~p  164 (259)
                      .|+++  +.+++.    +..++||||+.+ +    +|.+....    .++..+..++.|++.++.+|| +.|++|+||||
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp  199 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE  199 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence            87754  333332    356899999932 2    66665422    224567789999999999999 99999999999


Q ss_pred             CcEEEccCCeEEEeeeccceeccC
Q 045286          165 ANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       165 ~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      +|||++.  .++|+|||.+.....
T Consensus       200 ~NILl~~--~~~liDFG~a~~~~~  221 (258)
T 1zth_A          200 YNIMYID--KVYFIDMGQAVTLRH  221 (258)
T ss_dssp             TSEEESS--SEEECCCTTCEETTS
T ss_pred             HHEEEcC--cEEEEECcccccCCC
Confidence            9999987  999999999976543

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.78  E-value=1.1e-19  Score=152.11  Aligned_cols=140  Identities=15%  Similarity=0.192  Sum_probs=98.3

Q ss_pred             hhccceeccccceEEEEEEE-cCceEEEEEeecccCc---------------hH-----HHHHHHHHHHHHHhcCCCCcc
Q 045286           40 LKTGERIASGSCGDLYRGVY-LGQDVAVKVLRSEHLN---------------DT-----LEDEFVQEVAILREVQHRNVV   98 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~-~~~~v~vK~~~~~~~~---------------~~-----~~~~~~~e~~~l~~l~~~~i~   98 (259)
                      |.+.++||+|++|.||+|.+ .|+.||||+++.....               ..     ......+|...+.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            77889999999999999987 4889999997643211               00     001123455666666433332


Q ss_pred             eeeeeeecCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC-----
Q 045286           99 RFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN-----  173 (259)
Q Consensus        99 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~-----  173 (259)
                      .. ..+.. ...++||||++|.+|..+.       .......++.|++.++.+||+.|++||||||.|||++.+|     
T Consensus       177 vp-~p~~~-~~~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~  247 (397)
T 4gyi_A          177 VP-EPIAQ-SRHTIVMSLVDALPMRQVS-------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP  247 (397)
T ss_dssp             CC-CEEEE-ETTEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred             CC-eeeec-cCceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence            11 11111 2337999999998876542       1223456889999999999999999999999999998876     


Q ss_pred             -----eEEEeeeccceeccC
Q 045286          174 -----VVKVADFGVARFQNK  188 (259)
Q Consensus       174 -----~i~l~D~~~~~~~~~  188 (259)
                           .+.+|||+-+.....
T Consensus       248 ~~~~~~~~iID~~Q~V~~~h  267 (397)
T 4gyi_A          248 SSITLTPIIIXFPQMVSMDH  267 (397)
T ss_dssp             TSEEEEEEECCCTTCEETTS
T ss_pred             cccccceEEEEeCCcccCCC
Confidence                 389999998765443

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.53  E-value=4.2e-14  Score=113.35  Aligned_cols=138  Identities=12%  Similarity=0.082  Sum_probs=108.6

Q ss_pred             hhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCCcEEEEEecC
Q 045286           39 LLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHLCIVTEYM  117 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~  117 (259)
                      .|.+...++.|+.+.||++...++.+++|.........  ...+.+|+.+++.+. +..++++++++...+..++|||++
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i   92 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA   92 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             cceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence            35666778888889999998888999999987632111  135778999999885 567788998888888999999999


Q ss_pred             CCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 045286          118 PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ-------------------------------------------  154 (259)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~-------------------------------------------  154 (259)
                      +|.+|.+.+.      +......++.++..++..||+                                           
T Consensus        93 ~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (263)
T 3tm0_A           93 DGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD  166 (263)
T ss_dssp             SSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred             CCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence            9999877531      122234678899999999998                                           


Q ss_pred             ----------------CCcccCCCCCCcEEEccCCeEEEeeeccce
Q 045286          155 ----------------RNIIHRDLKTANLLMDTHNVVKVADFGVAR  184 (259)
Q Consensus       155 ----------------~~i~H~di~p~Nilv~~~~~i~l~D~~~~~  184 (259)
                                      ..++|+|++|.||+++.++.+.++||+.+.
T Consensus       167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                            458999999999999765556799999764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.35  E-value=5.4e-12  Score=105.67  Aligned_cols=142  Identities=14%  Similarity=0.251  Sum_probs=105.7

Q ss_pred             ccceeccccceEEEEEEEcCceEEEEEee--cccCchHHHHHHHHHHHHHHhcCC--CCcceeeeeeecC---CcEEEEE
Q 045286           42 TGERIASGSCGDLYRGVYLGQDVAVKVLR--SEHLNDTLEDEFVQEVAILREVQH--RNVVRFIGASTKS---PHLCIVT  114 (259)
Q Consensus        42 ~~~~lg~G~~~~V~~~~~~~~~v~vK~~~--~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~---~~~~lv~  114 (259)
                      ..+.|+.|.++.||++...+..+++|...  ..... .....+.+|..+++.+..  ..+++++..+...   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            35678999999999999888899999876  33211 122467789999999973  4567788777655   4588999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ----------------------------------------  154 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~----------------------------------------  154 (259)
                      |+++|.++.+.   ....++......++.++...|..||+                                        
T Consensus       121 e~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          121 EFVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             ECCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             EecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            99999777441   11236677778889999999999997                                        


Q ss_pred             ------------------CCcccCCCCCCcEEEccCCe--EEEeeeccceecc
Q 045286          155 ------------------RNIIHRDLKTANLLMDTHNV--VKVADFGVARFQN  187 (259)
Q Consensus       155 ------------------~~i~H~di~p~Nilv~~~~~--i~l~D~~~~~~~~  187 (259)
                                        ..++|+|+++.||+++.++.  +.++||+.+....
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~  250 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH  250 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence                              36899999999999987753  6899999886533

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.31  E-value=9.2e-12  Score=99.28  Aligned_cols=125  Identities=18%  Similarity=0.167  Sum_probs=91.1

Q ss_pred             ccccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCC--cceeeeeeecCCcEEEEEecCCCCChH
Q 045286           47 ASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRN--VVRFIGASTKSPHLCIVTEYMPGGSLY  123 (259)
Q Consensus        47 g~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~  123 (259)
                      +.|..+.||++... ++.+++|+......     ..+.+|+.+++.+.+.+  +++++.....++..++||||++|.++.
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~~-----~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcccc-----hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence            45666999998754 56799999765421     34678888888886433  566888887777899999999998874


Q ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------------
Q 045286          124 DYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN-----------------------------------------------  156 (259)
Q Consensus       124 ~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~-----------------------------------------------  156 (259)
                        ...    .+.   ..++.++...+..||+..                                               
T Consensus       104 --~~~----~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  174 (264)
T 1nd4_A          104 --SSH----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL  174 (264)
T ss_dssp             --TSC----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred             --cCc----CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence              211    111   245566777777777643                                               


Q ss_pred             -----------cccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          157 -----------IIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       157 -----------i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                                 ++|+|++|.||+++.++.+.++||+.+..
T Consensus       175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                       99999999999997766667999998743

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.28  E-value=1.2e-11  Score=101.26  Aligned_cols=184  Identities=18%  Similarity=0.195  Sum_probs=121.7

Q ss_pred             cceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCC--cceeeeeeecCC---cEEEEEec
Q 045286           43 GERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRN--VVRFIGASTKSP---HLCIVTEY  116 (259)
Q Consensus        43 ~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~--i~~~~~~~~~~~---~~~lv~e~  116 (259)
                      .+.++.|.++.||++.   ..+++|.....    .....+.+|..+++.+. +..  +++.+......+   ..|+||++
T Consensus        25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN---RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST---TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC---CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            4568999999999863   67899986543    33467889999998884 322  344444433322   34789999


Q ss_pred             CCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 045286          117 MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ------------------------------------------  154 (259)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~------------------------------------------  154 (259)
                      ++|.++......   .++..+...++.++...+..||+                                          
T Consensus        98 i~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A           98 IKGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CCCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             cCCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            999888754321   25666677778888888888875                                          


Q ss_pred             ----------------CCcccCCCCCCcEEEcc--CCeEEEeeeccceeccCCCccccCCCcccccCcccc----CCCCC
Q 045286          155 ----------------RNIIHRDLKTANLLMDT--HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI----NHQPY  212 (259)
Q Consensus       155 ----------------~~i~H~di~p~Nilv~~--~~~i~l~D~~~~~~~~~~~~~~~~~~~~~~~~PE~~----~~~~~  212 (259)
                                      ..++|+|++|.||+++.  ++.+.++||+.+....+............-.+|+..    ...+.
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~  254 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH  254 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence                            23799999999999988  456789999998765443211111110000122221    11111


Q ss_pred             ----------CCchhHHHHHHHHHHHHcCCCCCC
Q 045286          213 ----------DQKADVFSFAIVLWELVTAKVPYD  236 (259)
Q Consensus       213 ----------~~~~Di~slG~~~~~ll~g~~p~~  236 (259)
                                ....+.|+++.++|.+.+|..+|-
T Consensus       255 ~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          255 KDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             CCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence                      122689999999999999988763

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.94  E-value=3e-08  Score=81.08  Aligned_cols=138  Identities=19%  Similarity=0.199  Sum_probs=93.0

Q ss_pred             ccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCC---Ccceeeeeee-cCCcEEEEEecC
Q 045286           42 TGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHR---NVVRFIGAST-KSPHLCIVTEYM  117 (259)
Q Consensus        42 ~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~-~~~~~~lv~e~~  117 (259)
                      -...++.|....||+.   ++.+++|+...    ......+.+|..+++.+.+.   .+++.+.... ..+..+++|+++
T Consensus        23 ~v~~l~~G~~n~v~~v---g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i   95 (306)
T 3tdw_A           23 SVESLGEGFRNYAILV---NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV   95 (306)
T ss_dssp             CEEEEEECSSEEEEEE---TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred             eeeecCCCcceeEEEE---CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence            3456888999999987   78899998532    23446788999999999742   2455555553 445678999999


Q ss_pred             CCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 045286          118 PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ-------------------------------------------  154 (259)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~-------------------------------------------  154 (259)
                      +|.++....-.   .++......++.++...|..||+                                           
T Consensus        96 ~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           96 QGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             CSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             CCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            99888763211   12333333344444444444442                                           


Q ss_pred             -----------------CCcccCCCCCCcEEEcc---CCe-EEEeeeccceeccCC
Q 045286          155 -----------------RNIIHRDLKTANLLMDT---HNV-VKVADFGVARFQNKG  189 (259)
Q Consensus       155 -----------------~~i~H~di~p~Nilv~~---~~~-i~l~D~~~~~~~~~~  189 (259)
                                       ..++|+|++|.||+++.   ++. +.|+||+.+....+.
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd~~  228 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDPD  228 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEECGG
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCCHH
Confidence                             24699999999999987   355 589999988765443

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.91  E-value=2.1e-08  Score=80.34  Aligned_cols=131  Identities=16%  Similarity=0.221  Sum_probs=95.1

Q ss_pred             eeccccce-EEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCCcEEEEEecCCCC
Q 045286           45 RIASGSCG-DLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHLCIVTEYMPGG  120 (259)
Q Consensus        45 ~lg~G~~~-~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~  120 (259)
                      .+..|.++ .||+....  +..+++|.....     ....+.+|..+++.+. +--+++++.++...+..++|||+++|.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            34445554 68887653  567899986643     3456778999998885 323667788888888999999999998


Q ss_pred             ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 045286          121 SLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ----------------------------------------------  154 (259)
Q Consensus       121 ~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~----------------------------------------------  154 (259)
                      ++.+.....     ......+..++...|..||.                                              
T Consensus       106 ~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          106 TAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             EHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            888765432     12233456677777777775                                              


Q ss_pred             ------------CCcccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          155 ------------RNIIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       155 ------------~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                                  ..++|+|+.+.||+++.++.+-|+||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                        1279999999999998777778999998754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.62  E-value=1.8e-07  Score=78.00  Aligned_cols=83  Identities=12%  Similarity=0.042  Sum_probs=54.4

Q ss_pred             hcccee-ccccceEEEEEEEc--------CceEEEEEeecccC-chHHHHHHHHHHHHHHhcC-C--CCcceeeeeeecC
Q 045286           41 KTGERI-ASGSCGDLYRGVYL--------GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQ-H--RNVVRFIGASTKS  107 (259)
Q Consensus        41 ~~~~~l-g~G~~~~V~~~~~~--------~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~--~~i~~~~~~~~~~  107 (259)
                      ...+.| +.|..+.+|+....        ++.+++|....... .......+.+|..+++.+. +  -.+++++......
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            344677 88999999998765        67899998765320 0000134567777777774 2  2456677666544


Q ss_pred             ---CcEEEEEecCCCCChH
Q 045286          108 ---PHLCIVTEYMPGGSLY  123 (259)
Q Consensus       108 ---~~~~lv~e~~~~~~L~  123 (259)
                         +..++|||+++|.++.
T Consensus       103 ~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          103 DVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TTTSSCEEEEECCCCBCCC
T ss_pred             CccCCceEEEEecCCCChh
Confidence               3568999999886654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.59  E-value=1e-06  Score=72.73  Aligned_cols=137  Identities=17%  Similarity=0.206  Sum_probs=78.5

Q ss_pred             cceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcC--CCCcceeee------eeecCCcEEEEE
Q 045286           43 GERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ--HRNVVRFIG------ASTKSPHLCIVT  114 (259)
Q Consensus        43 ~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~------~~~~~~~~~lv~  114 (259)
                      ...|+.|..+.||++...+..+++|.....   .   ..+..|..+++.+.  .-.+++++.      +....+..++++
T Consensus        37 ~~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~  110 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTDSGAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY  110 (346)
T ss_dssp             EEECC----CEEEEEEETTEEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred             eeeccccccCcEEEEEeCCCCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence            346666788999999887778999998863   1   22334445555443  112333332      112456788999


Q ss_pred             ecCCCCChH-----------HH---HHhc-C-C--C--C-------CHHH------------------------------
Q 045286          115 EYMPGGSLY-----------DY---LHKN-H-N--V--L-------KLPQ------------------------------  137 (259)
Q Consensus       115 e~~~~~~L~-----------~~---l~~~-~-~--~--~-------~~~~------------------------------  137 (259)
                      +|++|.++.           ..   ++.. . .  +  .       ....                              
T Consensus       111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  190 (346)
T 2q83_A          111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ  190 (346)
T ss_dssp             ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred             EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence            999986542           11   1111 0 0  0  0       0000                              


Q ss_pred             -HHHHHHHHHHHHHHHH-------------hCCcccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          138 -LLRFAIDICKGMEYLH-------------QRNIIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       138 -~~~i~~ql~~~l~~lH-------------~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                       +..+..++..++..|+             ..+++|+|+++.||+++.++.+.++||+.+..
T Consensus       191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence             0011112233444554             36799999999999998888999999998754

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.46  E-value=1.1e-06  Score=74.26  Aligned_cols=77  Identities=14%  Similarity=0.016  Sum_probs=48.9

Q ss_pred             ccceeccccceEEEEEEE--cCceEEEEEeecccC--c---hHHHHHHHHHHHHHHhcCC--C-CcceeeeeeecCCcEE
Q 045286           42 TGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHL--N---DTLEDEFVQEVAILREVQH--R-NVVRFIGASTKSPHLC  111 (259)
Q Consensus        42 ~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~--~---~~~~~~~~~e~~~l~~l~~--~-~i~~~~~~~~~~~~~~  111 (259)
                      ..+.||.|..+.||++..  .++.+++|.......  .   .....++..|.++++.+..  + .+++++..  +.+..+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            356899999999999954  468899998654211  0   0112445678888887742  3 34455543  334567


Q ss_pred             EEEecCCCC
Q 045286          112 IVTEYMPGG  120 (259)
Q Consensus       112 lv~e~~~~~  120 (259)
                      +|||++++.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999763

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.42  E-value=2.1e-06  Score=70.12  Aligned_cols=77  Identities=21%  Similarity=0.170  Sum_probs=61.0

Q ss_pred             hccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcC---CCCcceeeeeeecCCcEEEEEecC
Q 045286           41 KTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ---HRNVVRFIGASTKSPHLCIVTEYM  117 (259)
Q Consensus        41 ~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e~~  117 (259)
                      .-...|+.|..+.+|+....++.+++|+....     ....+.+|...|+.+.   ...+++.+......+..++||||+
T Consensus        39 ~~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l  113 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLINDEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL  113 (312)
T ss_dssp             CEEEEECCSSSSEEEEEESSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred             eeeEEeCCccceeeeEEEECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence            34568899999999999888889999987653     1356778888888874   356777888777778899999999


Q ss_pred             CCCCh
Q 045286          118 PGGSL  122 (259)
Q Consensus       118 ~~~~L  122 (259)
                      +|.++
T Consensus       114 ~G~~~  118 (312)
T 3jr1_A          114 NKSKN  118 (312)
T ss_dssp             CCCCC
T ss_pred             cCCCC
Confidence            98764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=98.26  E-value=3e-06  Score=68.82  Aligned_cols=135  Identities=16%  Similarity=0.185  Sum_probs=75.8

Q ss_pred             cceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCc-ceeeeeeecCCcEEEEEecC-CCC
Q 045286           43 GERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNV-VRFIGASTKSPHLCIVTEYM-PGG  120 (259)
Q Consensus        43 ~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~-~~~  120 (259)
                      .++|+.|.+..+|++    +.+++|+........   ....+|..+++.+....+ ++++....  +.-+++++|+ +|.
T Consensus        23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~---~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEY---INRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE----TTEEEEEECC----C---CCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee----eeEEEECCCCCccce---eCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCc
Confidence            678999999999998    779999987531110   112456777766642222 45555433  3346899999 776


Q ss_pred             ChHHHH------------------HhcCCCC----CH-HHHHHHHH--------------HHHHHHHHH----H----hC
Q 045286          121 SLYDYL------------------HKNHNVL----KL-PQLLRFAI--------------DICKGMEYL----H----QR  155 (259)
Q Consensus       121 ~L~~~l------------------~~~~~~~----~~-~~~~~i~~--------------ql~~~l~~l----H----~~  155 (259)
                      ++...-                  +......    .. ..+..+..              .+...+..+    .    ..
T Consensus        94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~  173 (301)
T 3dxq_A           94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL  173 (301)
T ss_dssp             ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred             cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence            553210                  1111100    00 01111100              011111111    1    12


Q ss_pred             CcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          156 NIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       156 ~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      .++|+|+.+.||+ ..++.+.++||+.+....
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g~  204 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGMND  204 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEEEC
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccCCC
Confidence            4899999999999 567778999999886544

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.25  E-value=8.6e-06  Score=69.40  Aligned_cols=76  Identities=11%  Similarity=0.022  Sum_probs=45.5

Q ss_pred             ccceeccccceEEEEEEEcCceEEEEEeecccC--c---h--HHHHHHHHHHHHHHh-cCCCCcceeeeeeecCCcEEEE
Q 045286           42 TGERIASGSCGDLYRGVYLGQDVAVKVLRSEHL--N---D--TLEDEFVQEVAILRE-VQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        42 ~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~--~---~--~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      -.+.||.|..+.||++...++.++||.......  .   .  .....+..|+..+.. .....+++++...  .+..++|
T Consensus        38 ~i~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv  115 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG  115 (420)
T ss_dssp             EEEECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred             EEEEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence            346789999999999987778999994332110  0   0  011223333333322 2224556666654  4567899


Q ss_pred             EecC-CC
Q 045286          114 TEYM-PG  119 (259)
Q Consensus       114 ~e~~-~~  119 (259)
                      |||+ +|
T Consensus       116 ~e~l~~g  122 (420)
T 2pyw_A          116 MRYLEPP  122 (420)
T ss_dssp             ECCCCTT
T ss_pred             EeecCCc
Confidence            9999 76

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=98.08  E-value=1.1e-05  Score=65.97  Aligned_cols=140  Identities=14%  Similarity=0.138  Sum_probs=78.9

Q ss_pred             ccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCC--cceeeee------eecCCcEEEE
Q 045286           42 TGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRN--VVRFIGA------STKSPHLCIV  113 (259)
Q Consensus        42 ~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~lv  113 (259)
                      -.+.|+.|....+|++...+..+++|........    ..+..|..+++.+....  +++++..      ....+..+++
T Consensus        26 ~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~~----~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l  101 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEK----NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL  101 (322)
T ss_dssp             EEEEECC---EEEEEEEESSCCEEEEEECC---C----CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred             EeeccCCCcccceEEEEeCCccEEEEEeCCCCCH----HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence            4467888999999999887778999998763111    23445666666664212  2333321      1223567899


Q ss_pred             EecCCCCChHH-----------H---HHhcC----CC----CCHHHHHH---------------HHHHHHHHHHHHHh--
Q 045286          114 TEYMPGGSLYD-----------Y---LHKNH----NV----LKLPQLLR---------------FAIDICKGMEYLHQ--  154 (259)
Q Consensus       114 ~e~~~~~~L~~-----------~---l~~~~----~~----~~~~~~~~---------------i~~ql~~~l~~lH~--  154 (259)
                      ++|++|.++..           .   ++...    ..    .....-..               +...+...+..++.  
T Consensus       102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~  181 (322)
T 2ppq_A          102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW  181 (322)
T ss_dssp             EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred             EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence            99998865321           0   11110    00    01000000               00113334444542  


Q ss_pred             -----CCcccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          155 -----RNIIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       155 -----~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                           .+++|+|+.+.||+++.++.+.++||+.+..
T Consensus       182 ~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          182 PKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             CCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                 3699999999999998776668999998754

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.02  E-value=3.6e-05  Score=62.02  Aligned_cols=78  Identities=19%  Similarity=0.164  Sum_probs=53.6

Q ss_pred             hhhhccceeccccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCC---CcceeeeeeecCCcEEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHR---NVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~~~~~lv  113 (259)
                      ..+.....+|.|..+.||+.+.. |+.+++|+.......  ....+.+|...|+.+...   -+++++...    ..+++
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv   88 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPA--LDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA   88 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC--CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc--hhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence            44556688999999999999874 789999987654322  124567889988888522   234444432    23689


Q ss_pred             EecCCCCC
Q 045286          114 TEYMPGGS  121 (259)
Q Consensus       114 ~e~~~~~~  121 (259)
                      |||+++..
T Consensus        89 ~e~l~~~~   96 (288)
T 3f7w_A           89 MEWVDERP   96 (288)
T ss_dssp             EECCCCCC
T ss_pred             EEeecccC
Confidence            99987654

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=98.00  E-value=2.7e-05  Score=64.05  Aligned_cols=140  Identities=14%  Similarity=0.145  Sum_probs=73.0

Q ss_pred             cceeccccceE-EEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcCC--CCcceeeeeeecCCcEEEEEecCC
Q 045286           43 GERIASGSCGD-LYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH--RNVVRFIGASTKSPHLCIVTEYMP  118 (259)
Q Consensus        43 ~~~lg~G~~~~-V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~~~  118 (259)
                      ...|+.|+... +|+.... ++.+++|.......     ..+..|+.+++.+..  -.+++++......+  +++||+++
T Consensus        23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~-----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~   95 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG-----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLG   95 (333)
T ss_dssp             ECC--------CCEEEECTTCCEEEEEECCTTTT-----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCC
T ss_pred             eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC-----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCC
Confidence            34676666655 6677664 67788876554321     123345566665532  23455665533333  68999997


Q ss_pred             CCChHHHHHhcC-------------------------CCCCHHHHH-------H-H------------HHHHHHHHHHH-
Q 045286          119 GGSLYDYLHKNH-------------------------NVLKLPQLL-------R-F------------AIDICKGMEYL-  152 (259)
Q Consensus       119 ~~~L~~~l~~~~-------------------------~~~~~~~~~-------~-i------------~~ql~~~l~~l-  152 (259)
                      +.++.+.+....                         ...+.....       . +            ...+...+..+ 
T Consensus        96 ~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~  175 (333)
T 3csv_A           96 DALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQIL  175 (333)
T ss_dssp             SCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHH
T ss_pred             CcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHH
Confidence            766654432110                         001111100       0 0            00111222222 


Q ss_pred             -----HhCCcccCCCCCCcEEEccC----CeEEEeeeccceeccCC
Q 045286          153 -----HQRNIIHRDLKTANLLMDTH----NVVKVADFGVARFQNKG  189 (259)
Q Consensus       153 -----H~~~i~H~di~p~Nilv~~~----~~i~l~D~~~~~~~~~~  189 (259)
                           +...++|||+.+.||+++.+    +.+.++||+.+......
T Consensus       176 ~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~~  221 (333)
T 3csv_A          176 SAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHRA  221 (333)
T ss_dssp             HHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECTT
T ss_pred             HhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCCH
Confidence                 23479999999999999874    67999999998755443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.99  E-value=2.1e-05  Score=65.92  Aligned_cols=140  Identities=16%  Similarity=0.255  Sum_probs=81.0

Q ss_pred             hhhhccceeccccceEEEEEEEc---------CceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeecC
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL---------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKS  107 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~---------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~  107 (259)
                      ..+. .+.|..|-+..+|++...         ++.+++|+.....   .....+.+|.++++.+. +.-.++++..+..+
T Consensus        51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g  126 (379)
T 3feg_A           51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPEG  126 (379)
T ss_dssp             GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE
T ss_pred             CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc
Confidence            3444 356777999999998863         3789999964321   11244558888888875 32235666665432


Q ss_pred             CcEEEEEecCCCCChHH----------HH-------HhcC----CCCC--HHHHHHHHHHHHH-----------------
Q 045286          108 PHLCIVTEYMPGGSLYD----------YL-------HKNH----NVLK--LPQLLRFAIDICK-----------------  147 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~----------~l-------~~~~----~~~~--~~~~~~i~~ql~~-----------------  147 (259)
                          +|+||++|.+|..          .+       +...    ....  ...+..+..++..                 
T Consensus       127 ----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l  202 (379)
T 3feg_A          127 ----RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL  202 (379)
T ss_dssp             ----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred             ----cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence                8999998855431          01       1111    1111  1334444433321                 


Q ss_pred             --HHHHHH----h----CCcccCCCCCCcEEEccC----CeEEEeeecccee
Q 045286          148 --GMEYLH----Q----RNIIHRDLKTANLLMDTH----NVVKVADFGVARF  185 (259)
Q Consensus       148 --~l~~lH----~----~~i~H~di~p~Nilv~~~----~~i~l~D~~~~~~  185 (259)
                        .+..|.    .    ..++|+|+.+.||+++.+    +.+.++||+.+..
T Consensus       203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence              122222    2    259999999999999876    7899999999864

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.87  E-value=3.9e-05  Score=65.55  Aligned_cols=72  Identities=22%  Similarity=0.314  Sum_probs=48.8

Q ss_pred             cceeccccceEEEEEEEc---------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCc-ceeeeeeecCCcEEE
Q 045286           43 GERIASGSCGDLYRGVYL---------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNV-VRFIGASTKSPHLCI  112 (259)
Q Consensus        43 ~~~lg~G~~~~V~~~~~~---------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~l  112 (259)
                      .+.|+.|....+|++...         ++.+++|+......    ...+.+|..+++.+...++ +++++.+..    .+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~  149 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET----ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR  149 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC----HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc----HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence            457888999999999864         47899999854311    1334478888888753333 566665543    28


Q ss_pred             EEecCCCCCh
Q 045286          113 VTEYMPGGSL  122 (259)
Q Consensus       113 v~e~~~~~~L  122 (259)
                      |++|++|.++
T Consensus       150 v~e~l~G~~l  159 (429)
T 1nw1_A          150 LEEYIPSRPL  159 (429)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeCCccc
Confidence            9999987443

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.76  E-value=0.00056  Score=56.40  Aligned_cols=34  Identities=18%  Similarity=0.367  Sum_probs=29.2

Q ss_pred             CCcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          155 RNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       155 ~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      ..++|+|+.+.||+++.++.+.++||+.+.....
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~~  239 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAPK  239 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEECT
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCCH
Confidence            4699999999999998888899999998765443

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.72  E-value=0.00048  Score=56.28  Aligned_cols=139  Identities=14%  Similarity=0.142  Sum_probs=79.1

Q ss_pred             ceeccccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCC--cceeeee-----eecCCcEEEEEe
Q 045286           44 ERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRN--VVRFIGA-----STKSPHLCIVTE  115 (259)
Q Consensus        44 ~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~-----~~~~~~~~lv~e  115 (259)
                      ..++ |....||++... ++.+++|.........   ..+..|..+++.+....  +++++..     ....+..+++++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~  107 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP  107 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence            4566 888999988764 5589999987543322   44556777777764212  3333332     122456688999


Q ss_pred             cCCCCChH-----HH---------HHhc----C----CCCCHHHH----------------------HHHHHHHHHHHHH
Q 045286          116 YMPGGSLY-----DY---------LHKN----H----NVLKLPQL----------------------LRFAIDICKGMEY  151 (259)
Q Consensus       116 ~~~~~~L~-----~~---------l~~~----~----~~~~~~~~----------------------~~i~~ql~~~l~~  151 (259)
                      +++|.++.     ..         ++..    .    ...+....                      ...+.+++..+..
T Consensus       108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~  187 (328)
T 1zyl_A          108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA  187 (328)
T ss_dssp             CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence            99875432     11         1110    0    01111100                      1111122222222


Q ss_pred             H----HhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          152 L----HQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       152 l----H~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      +    ....++|||+++.||+++ + .+.++||+.+.....
T Consensus       188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g~~  226 (328)
T 1zyl_A          188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNGPA  226 (328)
T ss_dssp             HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEECT
T ss_pred             HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcCcH
Confidence            1    234589999999999998 4 899999998765443

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.67  E-value=0.00047  Score=59.24  Aligned_cols=73  Identities=15%  Similarity=0.111  Sum_probs=47.6

Q ss_pred             cceeccccceEEEEEEEcC--ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCc-ceeeeeeecCCcEEEEEecCCC
Q 045286           43 GERIASGSCGDLYRGVYLG--QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNV-VRFIGASTKSPHLCIVTEYMPG  119 (259)
Q Consensus        43 ~~~lg~G~~~~V~~~~~~~--~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~~  119 (259)
                      .+.|+.|-...+|++...+  +.+++|+.......  . -...+|..+++.+...++ +++++.+..    ..|++|++|
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~--~-idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G  185 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE--I-INREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDG  185 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS--C-SCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCS
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh--h-cCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCC
Confidence            4578889999999999876  88999987543111  0 112478888888874444 566666632    259999987


Q ss_pred             CCh
Q 045286          120 GSL  122 (259)
Q Consensus       120 ~~L  122 (259)
                      .+|
T Consensus       186 ~~l  188 (458)
T 2qg7_A          186 YAL  188 (458)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.66  E-value=0.00014  Score=60.72  Aligned_cols=73  Identities=14%  Similarity=0.189  Sum_probs=43.6

Q ss_pred             cceeccccceEEEEEEEcC----------ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCC-cceeeeeeecCCcEE
Q 045286           43 GERIASGSCGDLYRGVYLG----------QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRN-VVRFIGASTKSPHLC  111 (259)
Q Consensus        43 ~~~lg~G~~~~V~~~~~~~----------~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~  111 (259)
                      ...|+.|....+|++...+          +.+++|+......  .. ....+|..+++.+...+ .++++..+.    -+
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--~~-~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~  110 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--EL-YNTISEFEVYKTMSKYKIAPQLLNTFN----GG  110 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--GT-SCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--ce-ecHHHHHHHHHHHHhcCCCCceEEecC----Cc
Confidence            4577889999999998754          6899998765311  11 12346777777775323 345655432    26


Q ss_pred             EEEecCCCCCh
Q 045286          112 IVTEYMPGGSL  122 (259)
Q Consensus       112 lv~e~~~~~~L  122 (259)
                      +|++|++|.++
T Consensus       111 ~v~e~i~G~~l  121 (369)
T 3c5i_A          111 RIEEWLYGDPL  121 (369)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEecCCcC
Confidence            89999988543

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.48  E-value=0.0011  Score=50.71  Aligned_cols=102  Identities=15%  Similarity=0.129  Sum_probs=69.7

Q ss_pred             CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccccCCCc
Q 045286          120 GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ-RNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT  198 (259)
Q Consensus       120 ~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~~~~~  198 (259)
                      .+|.+.+...+.++++.++|.++.|.+..|...-. ..-...=+.|..|++..+|.+...+ ..+.           ...
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~  100 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGE  100 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------ccc
Confidence            48999999999999999999999999998877622 2222344567999999999987663 1110           123


Q ss_pred             ccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCC
Q 045286          199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVP  234 (259)
Q Consensus       199 ~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p  234 (259)
                      ..+.|||.+. ...+.+.=|||||+++|.-+--..|
T Consensus       101 ~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A          101 PPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence            3566888763 3446788999999999999884444

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=97.29  E-value=0.00044  Score=58.80  Aligned_cols=74  Identities=14%  Similarity=0.134  Sum_probs=47.7

Q ss_pred             ccceeccccceEEEEEEEc---------CceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCCcEE
Q 045286           42 TGERIASGSCGDLYRGVYL---------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        42 ~~~~lg~G~~~~V~~~~~~---------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~  111 (259)
                      -.+.+..|-+..+|++...         ++.+++|+.......   .-...+|..+++.+. ..-.+++++.+.    -+
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~---~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~  146 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK---FYDSKVELDVFRYLSNINIAPNIIADFP----EG  146 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C---CCCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch---hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CC
Confidence            3457778999999999876         588999997543111   112346777777775 222345554332    26


Q ss_pred             EEEecCCCCCh
Q 045286          112 IVTEYMPGGSL  122 (259)
Q Consensus       112 lv~e~~~~~~L  122 (259)
                      .|++|++|.+|
T Consensus       147 ~I~efI~G~~l  157 (424)
T 3mes_A          147 RIEEFIDGEPL  157 (424)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEeCCccC
Confidence            89999998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=96.95  E-value=0.0019  Score=54.52  Aligned_cols=30  Identities=20%  Similarity=0.474  Sum_probs=25.5

Q ss_pred             cccCCCCCCcEEE------ccCCeEEEeeeccceec
Q 045286          157 IIHRDLKTANLLM------DTHNVVKVADFGVARFQ  186 (259)
Q Consensus       157 i~H~di~p~Nilv------~~~~~i~l~D~~~~~~~  186 (259)
                      ++|+|+.+.||++      +.++.+.++||+.+...
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            6899999999999      34577999999998653

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=88.34  E-value=0.065  Score=46.02  Aligned_cols=61  Identities=10%  Similarity=0.034  Sum_probs=17.0

Q ss_pred             hccceeccccceEEEEEEEcC--ceEEE------EEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeee
Q 045286           41 KTGERIASGSCGDLYRGVYLG--QDVAV------KVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAS  104 (259)
Q Consensus        41 ~~~~~lg~G~~~~V~~~~~~~--~~v~v------K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~  104 (259)
                      .+.+.||   ||.||++.+.+  .+||+      |..+......+....+.++..+.+.++|+|+++.+.+.
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence            4556776   99999999875  47788      66655444444456678888999989999999987755

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=85.88  E-value=2.1  Score=32.47  Aligned_cols=115  Identities=11%  Similarity=0.122  Sum_probs=72.1

Q ss_pred             CCCCcceeeeeeecCCcEEEEEecCC-CCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc
Q 045286           93 QHRNVVRFIGASTKSPHLCIVTEYMP-GGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT  171 (259)
Q Consensus        93 ~~~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~  171 (259)
                      .+|+++.. .+-...+.+.+.++--+ +.+... +    ...+....++++.+|+.....+  ..=+|--++|+|++++.
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i----k~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~  114 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I----KSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTR  114 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G----GGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECT
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H----HhcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcC
Confidence            47888866 45555566555555432 222322 2    2367788888999988866333  33456789999999999


Q ss_pred             CCeEEEeeeccceeccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 045286          172 HNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYD  236 (259)
Q Consensus       172 ~~~i~l~D~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~  236 (259)
                      ++.+++.-.|....+.                |.     ..+...=+-..=|++..++.++..|+
T Consensus       115 ~~~p~i~~RGik~~l~----------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          115 DGLPIAKTRGLQNVVD----------------PL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             TSCEEESCCEETTTBS----------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             CCCEEEEEccCccCCC----------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999998777532221                11     11223333446677888888877764

>1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3

Probab=83.50  E-value=4.4  Score=32.92  Aligned_cols=149  Identities=13%  Similarity=0.125  Sum_probs=78.6

Q ss_pred             cccceechhh---hhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeee---
Q 045286           30 SEDWEIDRRL---LKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGA---  103 (259)
Q Consensus        30 ~~~~~~~~~~---~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~---  103 (259)
                      .+.-+++++.   +..++....|..| ||.+..++..++||...     ....+.+-.++...-.+..|...-+...   
T Consensus        58 ~~i~~i~w~~l~~v~~I~~s~~Gstg-vff~~td~~~~VVK~s~-----~l~~E~l~s~LA~~LGlpiP~~Riv~~~~~E  131 (342)
T 1cja_A           58 NDIGDINWKNLQQFKGIERSEKGTEG-LFFVETESGVFIVKRST-----NIESETFCSLLCMRLGLHAPKVRVVSSNSEE  131 (342)
T ss_dssp             SCTTCCCTTCGGGEEEEEECCSTTSC-EEEEEESSCEEEEECCT-----THHHHHHHHHHHHHHTCCCCCEEEEESSSHH
T ss_pred             CcccccccccccCeeEEEeccCCCCC-eEEEEeCCCEEEEeCcH-----HHHHHHHHHHHHHHhCCCCCCeeEEeeCcHH
Confidence            3445566666   3344555667654 55555578899999541     2233445555555555666654333211   


Q ss_pred             -------------------eecCCcEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC-----cc
Q 045286          104 -------------------STKSPHLCIVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRN-----II  158 (259)
Q Consensus       104 -------------------~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~-----i~  158 (259)
                                         ......++++|+|.+|..|.+.-... ...+....... +.+| -++..+..++     +.
T Consensus       132 ~~e~~~~L~~~~~~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~~~k~-LG~I-i~FDi~InN~DR~Pl~W  209 (342)
T 1cja_A          132 GTNMLECLAAIDKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQ-LGSL-MALDVIVNNSDRLPIAW  209 (342)
T ss_dssp             HHHHHHHHHHHCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHH-HHHH-HHHHHHHTCCSSSCSSS
T ss_pred             HHHHHHHHHHhhhhhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHHHHHh-hchh-heehhhhcCCccCcccc
Confidence                               00122567999999876654421100 00022222211 1122 2344555443     22


Q ss_pred             cCCCCCCcEEEccCC-eEEEeeeccceec
Q 045286          159 HRDLKTANLLMDTHN-VVKVADFGVARFQ  186 (259)
Q Consensus       159 H~di~p~Nilv~~~~-~i~l~D~~~~~~~  186 (259)
                      +..=.+.||+++.++ .+.+||-+.+..-
T Consensus       210 ~n~GN~~NIL~~~~n~~~~~IDhn~af~~  238 (342)
T 1cja_A          210 TNEGNLDNIMLSERGATVVPIDSKIIPLD  238 (342)
T ss_dssp             CSCCCGGGEEEESBTTCEEECSCCCCCCC
T ss_pred             cCCCChhheEEeCCCCeEEEEcCCccccC
Confidence            234588999997754 5899999888543

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=81.25  E-value=3.9  Score=31.08  Aligned_cols=83  Identities=12%  Similarity=0.067  Sum_probs=55.1

Q ss_pred             CCCCcceeeeeeecCCcEEEEEecCCC-CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc
Q 045286           93 QHRNVVRFIGASTKSPHLCIVTEYMPG-GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT  171 (259)
Q Consensus        93 ~~~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~  171 (259)
                      .+|++ . ..+-..++.+.+.++--++ .+... +.    ..+..+.++++.+|+.... -|...-+|--++|+|++++.
T Consensus        48 ~~~~f-~-~~I~~~eD~~~i~y~~~~~~~~f~~-i~----~~~~~eKlrll~nl~~L~~-~~~~~r~tf~l~P~NL~f~~  119 (219)
T 4ano_A           48 VDPCI-V-RDIDVSEDEVKVVIKPPSSFLTFAA-IR----KTTLLSRIRAAIHLVSKVK-HHSARRLIFIVCPENLMFNR  119 (219)
T ss_dssp             SCSSS-E-EEEEECSSEEEEEEECCTTCEEHHH-HH----TSCHHHHHHHHHHHHHHHS-SCCSSSEECCCCGGGEEECT
T ss_pred             cCCCC-C-eEEEEeCCEEEEEEEcCcccCcHHH-HH----hcCHHHHHHHHHHHHHHHH-HhhhCceeEEEeCceEEEeC
Confidence            47888 2 3334556666666665422 33332 22    3777888888888877544 12244567789999999999


Q ss_pred             CCeEEEeeeccc
Q 045286          172 HNVVKVADFGVA  183 (259)
Q Consensus       172 ~~~i~l~D~~~~  183 (259)
                      ++.+++.-.|..
T Consensus       120 ~~~p~i~hRGi~  131 (219)
T 4ano_A          120 ALEPFFLHVGVK  131 (219)
T ss_dssp             TCCEEESCCEET
T ss_pred             CCcEEEEEcCCc
Confidence            999999988764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	259
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	7e-77
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-67
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-64
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-63
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-63
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-61
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-61
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-61
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-61
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	8e-61
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	8e-61
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-60
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-59
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-59
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-59
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-59
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-58
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-58
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-57
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-57
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-57
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-57
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-56
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	9e-56
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-55
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-55
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-54
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-54
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-54
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-53
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-52
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-52
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	9e-52
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-51
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-51
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-51
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-50
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-50
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-50
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-50
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-49
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-49
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-48
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	8e-48
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-46
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-46
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-45
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-45
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-44
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-43
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-43
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-43
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-43
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-43
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-42
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	9e-41
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-40
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-39
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-39
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-38
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-36
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-29
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	5e-18

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  232 bits (592), Expect = 7e-77
 Identities = 84/221 (38%), Positives = 128/221 (57%), Gaps = 8/221 (3%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           +DWEI    +  G+RI SGS G +Y+G     DVAVK+L            F  EV +LR
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 59

Query: 91  EVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGME 150
           + +H N++ F+G ST  P L IVT++  G SLY +LH      ++ +L+  A    +GM+
Sbjct: 60  KTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118

Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG---VMTAETGTYRWMAPEVI 207
           YLH ++IIHRDLK+ N+ +     VK+ DFG+A  +++          +G+  WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 208 NHQ---PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL 245
             Q   PY  ++DV++F IVL+EL+T ++PY ++      +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 219

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 6e-67
 Identities = 77/220 (35%), Positives = 121/220 (55%), Gaps = 9/220 (4%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREV 92
           W ++ + LK  + I  G  GD+  G Y G  VAVK ++    ND     F+ E +++ ++
Sbjct: 2   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 57

Query: 93  QHRNVVRFIGASTKSP-HLCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKGME 150
           +H N+V+ +G   +    L IVTEYM  GSL DYL  +  +VL    LL+F++D+C+ ME
Sbjct: 58  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117

Query: 151 YLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQ 210
           YL   N +HRDL   N+L+   NV KV+DFG+ +  +            +W APE +  +
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREK 175

Query: 211 PYDQKADVFSFAIVLWELVTA-KVPYDSMTPLQAALGVRQ 249
            +  K+DV+SF I+LWE+ +  +VPY  +        V +
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 215

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 2e-64
 Identities = 55/222 (24%), Positives = 110/222 (49%), Gaps = 13/222 (5%)

Query: 27  QTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQ 84
           + K +D+E           + +G+ G +++  +   G  +A K++  E +   + ++ ++
Sbjct: 2   ELKDDDFEK-------ISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIR 53

Query: 85  EVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAID 144
           E+ +L E     +V F GA      + I  E+M GGSL   L K    +    L + +I 
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIA 112

Query: 145 ICKGMEYLHQRN-IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMA 203
           + KG+ YL +++ I+HRD+K +N+L+++   +K+ DFGV+       +  +  GT  +M+
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMS 171

Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL 245
           PE +    Y  ++D++S  + L E+   + P       +  L
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (503), Expect = 1e-63
 Identities = 76/219 (34%), Positives = 120/219 (54%), Gaps = 8/219 (3%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVY-LGQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           ++WE+ R  LK  ER+ +G  G+++ G Y     VAVK L+   ++    D F+ E  ++
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLM 62

Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV-LKLPQLLRFAIDICKG 148
           +++QH+ +VR     T+ P + I+TEYM  GSL D+L     + L + +LL  A  I +G
Sbjct: 63  KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121

Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETGTYRWMAPEV 206
           M ++ +RN IHRDL+ AN+L+      K+ADFG+AR    N+           +W APE 
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181

Query: 207 INHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL 245
           IN+  +  K+DV+SF I+L E+VT              +
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 2e-63
 Identities = 54/213 (25%), Positives = 105/213 (49%), Gaps = 7/213 (3%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDT-LEDEFVQEVAIL 89
           W ++    + G  +  G  G++Y          +A+KVL    L    +E +  +EV I 
Sbjct: 3   WALED--FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 60

Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGM 149
             ++H N++R  G    +  + ++ EY P G++Y  L K  +     +   +  ++   +
Sbjct: 61  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANAL 119

Query: 150 EYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINH 209
            Y H + +IHRD+K  NLL+ +   +K+ADFG +         T   GT  ++ PE+I  
Sbjct: 120 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEMIEG 178

Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQ 242
           + +D+K D++S  ++ +E +  K P+++ T  +
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 211

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 1e-61
 Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 17/228 (7%)

Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVA 87
            + WEI          +  G+ G +Y+          A KV+ ++   +   ++++ E+ 
Sbjct: 11  EDFWEI-------IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL--EDYMVEID 61

Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICK 147
           IL    H N+V+ + A     +L I+ E+  GG++   + +    L   Q+         
Sbjct: 62  ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLD 121

Query: 148 GMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMTAETGTYRWMAPEV 206
            + YLH   IIHRDLK  N+L      +K+ADFGV+    +      +  GT  WMAPEV
Sbjct: 122 ALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV 181

Query: 207 I-----NHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
           +       +PYD KADV+S  I L E+   + P+  + P++  L + +
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK 229

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  195 bits (496), Expect = 2e-61
 Identities = 49/221 (22%), Positives = 105/221 (47%), Gaps = 6/221 (2%)

Query: 43  GERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF 100
            E + +G+ G ++R      G + A K + + H +D  ++   +E+  +  ++H  +V  
Sbjct: 31  HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRHPTLVNL 88

Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
             A      + ++ E+M GG L++ +   HN +   + + +   +CKG+ ++H+ N +H 
Sbjct: 89  HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHL 148

Query: 161 DLKTANLLMDTH--NVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADV 218
           DLK  N++  T   N +K+ DFG+    +    +   TGT  + APEV   +P     D+
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDM 208

Query: 219 FSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY 259
           +S  ++ + L++   P+      +    V+    ++    +
Sbjct: 209 WSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 249

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 2e-61
 Identities = 67/235 (28%), Positives = 114/235 (48%), Gaps = 20/235 (8%)

Query: 28  TKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQE 85
           +++ED+E+          I +GS G   +      G+ +  K L    + +  +   V E
Sbjct: 1   SRAEDYEV-------LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSE 53

Query: 86  VAILREVQHRNVVRFIGA--STKSPHLCIVTEYMPGGSLYDYLHKN---HNVLKLPQLLR 140
           V +LRE++H N+VR+        +  L IV EY  GG L   + K       L    +LR
Sbjct: 54  VNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 113

Query: 141 FAIDICKGMEYLHQRN-----IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMTA 194
               +   ++  H+R+     ++HRDLK AN+ +D    VK+ DFG+AR  N       A
Sbjct: 114 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173

Query: 195 ETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
             GT  +M+PE +N   Y++K+D++S   +L+EL     P+ + +  + A  +R+
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 228

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 5e-61
 Identities = 68/219 (31%), Positives = 119/219 (54%), Gaps = 7/219 (3%)

Query: 35  IDRRLLKTGERIASGSCGDLYRGVY-LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ 93
           ID + L   + + +G  G +  G +    DVA+K+++   ++   EDEF++E  ++  + 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLS 57

Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
           H  +V+  G  TK   + I+TEYM  G L +YL +  +  +  QLL    D+C+ MEYL 
Sbjct: 58  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117

Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG--VMTAETGTYRWMAPEVINHQP 211
            +  +HRDL   N L++   VVKV+DFG++R+                RW  PEV+ +  
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177

Query: 212 YDQKADVFSFAIVLWELVTA-KVPYDSMTPLQAALGVRQ 249
           +  K+D+++F +++WE+ +  K+PY+  T  + A  + Q
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 216

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  193 bits (492), Expect = 8e-61
 Identities = 50/253 (19%), Positives = 121/253 (47%), Gaps = 15/253 (5%)

Query: 11  VHRKYRGHAVEKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKV 68
           + +KY    VE  ++  +  + ++I        E + SG+ G ++R V    G+    K 
Sbjct: 11  IWKKYVPQPVE--VKQGSVYDYYDI-------LEELGSGAFGVVHRCVEKATGRVFVAKF 61

Query: 69  LRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHK 128
           + + +  D  +     E++I+ ++ H  ++    A      + ++ E++ GG L+D +  
Sbjct: 62  INTPYPLD--KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA 119

Query: 129 NHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN--VVKVADFGVARFQ 186
               +   +++ +    C+G++++H+ +I+H D+K  N++ +T     VK+ DFG+A   
Sbjct: 120 EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179

Query: 187 NKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALG 246
           N   ++   T T  + APE+++ +P     D+++  ++ + L++   P+     L+    
Sbjct: 180 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN 239

Query: 247 VRQVCTSLCQPIY 259
           V++      +  +
Sbjct: 240 VKRCDWEFDEDAF 252

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (485), Expect = 8e-61
 Identities = 68/220 (30%), Positives = 106/220 (48%), Gaps = 12/220 (5%)

Query: 35  IDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV 92
            D R LK    I  GS   +Y+G+      +VA   L+   L  +    F +E  +L+ +
Sbjct: 6   NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL 65

Query: 93  QHRNVVRFIGA----STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
           QH N+VRF  +          + +VTE M  G+L  YL +   V+K+  L  +   I KG
Sbjct: 66  QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKG 124

Query: 149 MEYLHQRN--IIHRDLKTANLLMDTHN-VVKVADFGVARFQNKGGVMTAETGTYRWMAPE 205
           +++LH R   IIHRDLK  N+ +      VK+ D G+A    +     A  GT  +MAPE
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-KRASFAKAVIGTPEFMAPE 183

Query: 206 VINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL 245
           +   + YD+  DV++F + + E+ T++ PY          
Sbjct: 184 MYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY 222

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 4e-60
 Identities = 74/217 (34%), Positives = 119/217 (54%), Gaps = 9/217 (4%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           + WEI R  L+   ++  G  G+++ G +     VA+K L+   ++    + F+QE  ++
Sbjct: 10  DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVM 66

Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICKG 148
           ++++H  +V+     ++ P + IVTEYM  GSL D+L  +    L+LPQL+  A  I  G
Sbjct: 67  KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125

Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG--VMTAETGTYRWMAPEV 206
           M Y+ + N +HRDL+ AN+L+  + V KVADFG+AR                 +W APE 
Sbjct: 126 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 185

Query: 207 INHQPYDQKADVFSFAIVLWELVTA-KVPYDSMTPLQ 242
             +  +  K+DV+SF I+L EL T  +VPY  M   +
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 222

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 1e-59
 Identities = 65/225 (28%), Positives = 120/225 (53%), Gaps = 12/225 (5%)

Query: 35  IDRRLLKTGER-IASGSCGDLYRGVY----LGQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
           +DR+LL   ++ + SG+ G + +G Y    + + VAVK+L++E  +  L+DE + E  ++
Sbjct: 3   LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62

Query: 90  REVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGM 149
           +++ +  +VR IG         +V E    G L  YL +N + +K   ++     +  GM
Sbjct: 63  QQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGM 120

Query: 150 EYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF----QNKGGVMTAETGTYRWMAPE 205
           +YL + N +HRDL   N+L+ T +  K++DFG+++     +N     T      +W APE
Sbjct: 121 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180

Query: 206 VINHQPYDQKADVFSFAIVLWELVTA-KVPYDSMTPLQAALGVRQ 249
            IN+  +  K+DV+SF +++WE  +  + PY  M   +    + +
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 225

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 1e-59
 Identities = 58/203 (28%), Positives = 107/203 (52%), Gaps = 7/203 (3%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
           E+I  G+ G +Y  + +  GQ+VA++ +  +      ++  + E+ ++RE ++ N+V ++
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYL 83

Query: 102 GASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRD 161
            +      L +V EY+ GGSL D + +        Q+     +  + +E+LH   +IHRD
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLHSNQVIHRD 141

Query: 162 LKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFS 220
           +K+ N+L+     VK+ DFG       +    +   GT  WMAPEV+  + Y  K D++S
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 201

Query: 221 FAIVLWELVTAKVPYDSMTPLQA 243
             I+  E++  + PY +  PL+A
Sbjct: 202 LGIMAIEMIEGEPPYLNENPLRA 224

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 5e-59
 Identities = 63/214 (29%), Positives = 109/214 (50%), Gaps = 6/214 (2%)

Query: 35  IDRRLLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ 93
           ID   L   + I SG  G ++ G +L    VA+K +R   ++   E++F++E  ++ ++ 
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLS 58

Query: 94  HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
           H  +V+  G   +   +C+V E+M  G L DYL     +     LL   +D+C+GM YL 
Sbjct: 59  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118

Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GTYRWMAPEVINHQP 211
           +  +IHRDL   N L+  + V+KV+DFG+ RF       ++       +W +PEV +   
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178

Query: 212 YDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL 245
           Y  K+DV+SF +++WE+ +              +
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 212

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  187 bits (476), Expect = 6e-59
 Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 10/212 (4%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDT-LEDEFVQEVAILREVQHRNVVRF 100
             I  GS G +Y    +   + VA+K +            + ++EV  L++++H N +++
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
            G   +     +V EY  G +           L+  ++        +G+ YLH  N+IHR
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLHSHNMIHR 139

Query: 161 DLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI---NHQPYDQKAD 217
           D+K  N+L+    +VK+ DFG A             GT  WMAPEVI   +   YD K D
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMDEGQYDGKVD 196

Query: 218 VFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
           V+S  I   EL   K P  +M  + A   + Q
Sbjct: 197 VWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 2e-58
 Identities = 61/216 (28%), Positives = 109/216 (50%), Gaps = 15/216 (6%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
           EDW++        + +  G+ G++   V     + VAVK++  +   D  E    +E+ I
Sbjct: 5   EDWDL-------VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICI 56

Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
            + + H NVV+F G   +     +  EY  GG L+D +  +   +  P   RF   +  G
Sbjct: 57  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAG 115

Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF---QNKGGVMTAETGTYRWMAPE 205
           + YLH   I HRD+K  NLL+D  + +K++DFG+A      N+  ++    GT  ++APE
Sbjct: 116 VVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175

Query: 206 VINHQPYD-QKADVFSFAIVLWELVTAKVPYDSMTP 240
           ++  + +  +  DV+S  IVL  ++  ++P+D  + 
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  184 bits (468), Expect = 4e-58
 Identities = 71/220 (32%), Positives = 118/220 (53%), Gaps = 8/220 (3%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
           + WE++R  +    ++  G  G++Y GV+      VAVK L+ + +     +EF++E A+
Sbjct: 10  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAV 66

Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLH-KNHNVLKLPQLLRFAIDICK 147
           ++E++H N+V+ +G  T+ P   I+TE+M  G+L DYL   N   +    LL  A  I  
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 126

Query: 148 GMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG--VMTAETGTYRWMAPE 205
            MEYL ++N IHRDL   N L+  +++VKVADFG++R                 +W APE
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186

Query: 206 VINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL 245
            + +  +  K+DV++F ++LWE+ T  +       L    
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 226

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 2e-57
 Identities = 70/246 (28%), Positives = 111/246 (45%), Gaps = 35/246 (14%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD-------VAVKVLRSEHLNDTLEDEFV 83
             WE  R  L+ G+ + SG+ G +      G         VAVK+L+ +  + +  +  +
Sbjct: 30  LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALM 88

Query: 84  QEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKN------------- 129
            E+ ++ ++  H N+V  +GA T S  + ++ EY   G L +YL                
Sbjct: 89  SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148

Query: 130 ---------HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADF 180
                     NVL    LL FA  + KGME+L  ++ +HRDL   N+L+    VVK+ DF
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 208

Query: 181 GVARFQNKGGVMTAET---GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTA-KVPYD 236
           G+AR                  +WMAPE +    Y  K+DV+S+ I+LWE+ +    PY 
Sbjct: 209 GLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268

Query: 237 SMTPLQ 242
            +    
Sbjct: 269 GIPVDA 274

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  183 bits (464), Expect = 2e-57
 Identities = 73/238 (30%), Positives = 117/238 (49%), Gaps = 13/238 (5%)

Query: 24  IESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVY-----LGQDVAVKVLRSEHLNDTL 78
                +    EID   +K  + I +G  G++  G           VA+K L+S +     
Sbjct: 12  PNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR 71

Query: 79  EDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQL 138
             +F+ E +I+ +  H NV+   G  TKS  + I+TE+M  GSL  +L +N     + QL
Sbjct: 72  R-DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQL 130

Query: 139 LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET-- 196
           +     I  GM+YL   N +HRDL   N+L++++ V KV+DFG++RF          T  
Sbjct: 131 VGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 190

Query: 197 ----GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQ 249
                  RW APE I ++ +   +DV+S+ IV+WE+++  + PY  MT       + Q
Sbjct: 191 LGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ 248

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 5e-57
 Identities = 59/229 (25%), Positives = 111/229 (48%), Gaps = 12/229 (5%)

Query: 31  EDWEIDRRLLKTGER-IASGSCGDLYRGVYL----GQDVAVKVLRSEHLNDTLEDEFVQE 85
           +   + R  L   +  +  G+ G + +GVY       DVA+KVL+        E E ++E
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE-EMMRE 59

Query: 86  VAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDI 145
             I+ ++ +  +VR IG   ++  L +V E   GG L+ +L      + +  +      +
Sbjct: 60  AQIMHQLDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 118

Query: 146 CKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG----VMTAETGTYRW 201
             GM+YL ++N +HRDL   N+L+   +  K++DFG+++            +A     +W
Sbjct: 119 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 178

Query: 202 MAPEVINHQPYDQKADVFSFAIVLWELVTA-KVPYDSMTPLQAALGVRQ 249
            APE IN + +  ++DV+S+ + +WE ++  + PY  M   +    + Q
Sbjct: 179 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 9e-57
 Identities = 71/234 (30%), Positives = 117/234 (50%), Gaps = 12/234 (5%)

Query: 35  IDRRLLKTGERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLND-TLEDEFVQEVAI 88
           I  + L+  E++  GS G + RG +         VAVK L+ + L+     D+F++EV  
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64

Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
           +  + HRN++R  G    +P + +VTE  P GSL D L K+     L  L R+A+ + +G
Sbjct: 65  MHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123

Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG----VMTAETGTYRWMAP 204
           M YL  +  IHRDL   NLL+ T ++VK+ DFG+ R   +      +       + W AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 205 EVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP 257
           E +  + +   +D + F + LWE+ T  + P+  +   Q    + +    L +P
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 237

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 1e-56
 Identities = 42/204 (20%), Positives = 94/204 (46%), Gaps = 7/204 (3%)

Query: 43  GERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF 100
            E +  G  G ++R V     +    K ++ +  +   +    +E++IL   +HRN++  
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHRNILHL 66

Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
             +      L ++ E++ G  +++ ++ +   L   +++ +   +C+ +++LH  NI H 
Sbjct: 67  HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHF 126

Query: 161 DLKTANLLMDTHN--VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADV 218
           D++  N++  T     +K+ +FG AR    G           + APEV  H       D+
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDM 186

Query: 219 FSFAIVLWELVTAKVPYDSMTPLQ 242
           +S   +++ L++   P+ + T  Q
Sbjct: 187 WSLGTLVYVLLSGINPFLAETNQQ 210

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 9e-56
 Identities = 61/222 (27%), Positives = 113/222 (50%), Gaps = 9/222 (4%)

Query: 32  DWEIDRRLLKTGERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLEDEFVQEV 86
           D+EI R  ++ G  I  G  GD+++G+Y+        VA+K  ++   +D++ ++F+QE 
Sbjct: 1   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEA 59

Query: 87  AILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDIC 146
             +R+  H ++V+ IG  T+   + I+ E    G L  +L      L L  L+ +A  + 
Sbjct: 60  LTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118

Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET--GTYRWMAP 204
             + YL  +  +HRD+   N+L+ +++ VK+ DFG++R+        A       +WMAP
Sbjct: 119 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 205 EVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALG 246
           E IN + +   +DV+ F + +WE++   V           +G
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 220

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 2e-55
 Identities = 46/222 (20%), Positives = 97/222 (43%), Gaps = 14/222 (6%)

Query: 27  QTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFV 83
           + + ED++        G+ +  GS   +     L   ++ A+K+L   H+  +       
Sbjct: 4   KKRPEDFKF-------GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT 56

Query: 84  QEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
           +E  ++  + H   V+          L     Y   G L  Y+ K            +  
Sbjct: 57  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTA 115

Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF---QNKGGVMTAETGTYR 200
           +I   +EYLH + IIHRDLK  N+L++    +++ DFG A+    ++K     +  GT +
Sbjct: 116 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175

Query: 201 WMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQ 242
           +++PE++  +   + +D+++   ++++LV    P+ +     
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 217

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 5e-55
 Identities = 66/245 (26%), Positives = 106/245 (43%), Gaps = 29/245 (11%)

Query: 29  KSEDWEIDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDE 81
               WE  R  L  G+ + +G+ G +                VAVK+L+    + T  + 
Sbjct: 14  YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREA 72

Query: 82  FVQEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHN--------- 131
            + E+ +L  +  H N+V  +GA T      ++TEY   G L ++L +  +         
Sbjct: 73  LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132

Query: 132 --------VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA 183
                    L L  LL F+  + KGM +L  +N IHRDL   N+L+    + K+ DFG+A
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192

Query: 184 RFQNKGGVMTAET---GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTP 240
           R          +       +WMAPE I +  Y  ++DV+S+ I LWEL +         P
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252

Query: 241 LQAAL 245
           + +  
Sbjct: 253 VDSKF 257

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  176 bits (446), Expect = 1e-54
 Identities = 69/255 (27%), Positives = 112/255 (43%), Gaps = 35/255 (13%)

Query: 29  KSEDWEIDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDE 81
           K    E  R  ++    I  G+ G +++              VAVK+L+ E   D ++ +
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD-MQAD 62

Query: 82  FVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHN---------- 131
           F +E A++ E  + N+V+ +G       +C++ EYM  G L ++L               
Sbjct: 63  FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122

Query: 132 -------------VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVA 178
                         L   + L  A  +  GM YL +R  +HRDL T N L+  + VVK+A
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 182

Query: 179 DFGVARFQNKGGVMTAET---GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVP 234
           DFG++R         A+       RWM PE I +  Y  ++DV+++ +VLWE+ +    P
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242

Query: 235 YDSMTPLQAALGVRQ 249
           Y  M   +    VR 
Sbjct: 243 YYGMAHEEVIYYVRD 257

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  176 bits (447), Expect = 1e-54
 Identities = 50/222 (22%), Positives = 104/222 (46%), Gaps = 7/222 (3%)

Query: 43  GERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF 100
            + + +G+  ++         + VA+K +  + L    E     E+A+L +++H N+V  
Sbjct: 14  RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKIKHPNIVAL 72

Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
                   HL ++ + + GG L+D + +           R    +   ++YLH   I+HR
Sbjct: 73  DDIYESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHR 131

Query: 161 DLKTANLL---MDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKAD 217
           DLK  NLL   +D  + + ++DFG+++ ++ G V++   GT  ++APEV+  +PY +  D
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVD 191

Query: 218 VFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY 259
            +S  ++ + L+    P+      +    + +       P +
Sbjct: 192 CWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW 233

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 2e-54
 Identities = 72/237 (30%), Positives = 118/237 (49%), Gaps = 22/237 (9%)

Query: 34  EIDRRLLKTGERIASGSCGDLYRGVYLG----QDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
            +D   +K  + I  G+ G + +          D A+K ++ E+ +     +F  E+ +L
Sbjct: 6   VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVL 64

Query: 90  REV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH---------------NVL 133
            ++  H N++  +GA     +L +  EY P G+L D+L K+                + L
Sbjct: 65  CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124

Query: 134 KLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT 193
              QLL FA D+ +GM+YL Q+  IHRDL   N+L+  + V K+ADFG++R Q      T
Sbjct: 125 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184

Query: 194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTA-KVPYDSMTPLQAALGVRQ 249
                 RWMA E +N+  Y   +DV+S+ ++LWE+V+    PY  MT  +    + Q
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 1e-53
 Identities = 54/224 (24%), Positives = 106/224 (47%), Gaps = 13/224 (5%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL--NDTLEDEFVQEV 86
           ED+ +        + +  GS G ++   +    Q  A+K L+ + +  +D +E   V++ 
Sbjct: 2   EDFIL-------HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR 54

Query: 87  AILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDIC 146
            +    +H  +           +L  V EY+ GG L  ++   H    L +   +A +I 
Sbjct: 55  VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEII 113

Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPE 205
            G+++LH + I++RDLK  N+L+D    +K+ADFG+ +             GT  ++APE
Sbjct: 114 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173

Query: 206 VINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
           ++  Q Y+   D +SF ++L+E++  + P+      +    +R 
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 217

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 1e-52
 Identities = 63/223 (28%), Positives = 110/223 (49%), Gaps = 11/223 (4%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDTLEDEFVQEV 86
            EI    +   + I +G  G++Y+G+           VA+K L++ +  +    +F+ E 
Sbjct: 2   TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEA 60

Query: 87  AILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDIC 146
            I+ +  H N++R  G  +K   + I+TEYM  G+L  +L +      + QL+     I 
Sbjct: 61  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120

Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG----VMTAETGTYRWM 202
            GM+YL   N +HRDL   N+L++++ V KV+DFG++R            +      RW 
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180

Query: 203 APEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL 245
           APE I+++ +   +DV+SF IV+WE++T              +
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM 223

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  169 bits (430), Expect = 2e-52
 Identities = 54/233 (23%), Positives = 104/233 (44%), Gaps = 17/233 (7%)

Query: 43  GERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDT-------LEDEFVQEVAILREVQ 93
            E +  G    + R ++    ++ AVK++               L +  ++EV ILR+V 
Sbjct: 8   KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 67

Query: 94  -HRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYL 152
            H N+++       +    +V + M  G L+DYL +    L   +  +    + + +  L
Sbjct: 68  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVICAL 126

Query: 153 HQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI----- 207
           H+ NI+HRDLK  N+L+D    +K+ DFG +   + G  +    GT  ++APE+I     
Sbjct: 127 HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMN 186

Query: 208 -NHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY 259
            NH  Y ++ D++S  ++++ L+    P+     +     +         P +
Sbjct: 187 DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 9e-52
 Identities = 59/223 (26%), Positives = 101/223 (45%), Gaps = 28/223 (12%)

Query: 43  GERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
            E I  G  G+++RG + G++VAVK+  S             E+     ++H N++ FI 
Sbjct: 8   QESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWF---REAEIYQTVMLRHENILGFIA 64

Query: 103 ASTKS----PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ---- 154
           A  K       L +V++Y   GSL+DYL++    + +  +++ A+    G+ +LH     
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVG 122

Query: 155 ----RNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-----VMTAETGTYRWMAPE 205
                 I HRDLK+ N+L+  +    +AD G+A   +              GT R+MAPE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182

Query: 206 VI------NHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQ 242
           V+       H    ++AD+++  +V WE+             Q
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 1e-51
 Identities = 54/237 (22%), Positives = 104/237 (43%), Gaps = 24/237 (10%)

Query: 24  IESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDE 81
           I+     +D+++      T + +  G  G + +       +  A+K+L+          +
Sbjct: 4   IKKNAIIDDYKV------TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PK 50

Query: 82  FVQEVAIL-REVQHRNVVRFIGA----STKSPHLCIVTEYMPGGSLYDYLHKNHN-VLKL 135
             +EV +  R  Q  ++VR +            L IV E + GG L+  +    +     
Sbjct: 51  ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE 110

Query: 136 PQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN---VVKVADFGVARFQNKGGVM 192
            +       I + ++YLH  NI HRD+K  NLL  +     ++K+ DFG A+       +
Sbjct: 111 REASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 170

Query: 193 TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
           T    T  ++APEV+  + YD+  D++S  ++++ L+    P+ S   L  + G++ 
Sbjct: 171 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 227

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 2e-51
 Identities = 63/240 (26%), Positives = 105/240 (43%), Gaps = 21/240 (8%)

Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDEF 82
            ++WE+ R  +     +  GS G +Y GV            VA+K +           EF
Sbjct: 12  PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE-RIEF 70

Query: 83  VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNV---------L 133
           + E ++++E    +VVR +G  ++     ++ E M  G L  YL                
Sbjct: 71  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 130

Query: 134 KLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG--- 190
            L ++++ A +I  GM YL+    +HRDL   N ++     VK+ DFG+ R   +     
Sbjct: 131 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190

Query: 191 VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQ 249
                    RWM+PE +    +   +DV+SF +VLWE+ T A+ PY  ++  Q    V +
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  165 bits (419), Expect = 6e-51
 Identities = 66/227 (29%), Positives = 110/227 (48%), Gaps = 19/227 (8%)

Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND-TLEDEFVQEV 86
           S+ +E+       GE +  G   +++    L   +DVAVKVLR++   D +    F +E 
Sbjct: 6   SDRYEL-------GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREA 58

Query: 87  AILREVQHRNVVRFIGA----STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFA 142
                + H  +V         +   P   IV EY+ G +L D +H     +   + +   
Sbjct: 59  QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVI 117

Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAET----GT 198
            D C+ + + HQ  IIHRD+K AN+++   N VKV DFG+AR     G    +T    GT
Sbjct: 118 ADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177

Query: 199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAAL 245
            ++++PE       D ++DV+S   VL+E++T + P+   +P+  A 
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY 224

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 2e-50
 Identities = 67/239 (28%), Positives = 105/239 (43%), Gaps = 15/239 (6%)

Query: 25  ESQTKSEDWEIDRRLLKT--GERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDT 77
           E     +   I    L     E I  G  G +Y G  L         AVK L     +  
Sbjct: 12  ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIG 70

Query: 78  LEDEFVQEVAILREVQHRNVVRFIGASTKSP-HLCIVTEYMPGGSLYDYLHKNHNVLKLP 136
              +F+ E  I+++  H NV+  +G   +S     +V  YM  G L +++    +   + 
Sbjct: 71  EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 130

Query: 137 QLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-----V 191
            L+ F + + KGM++L  +  +HRDL   N ++D    VKVADFG+AR            
Sbjct: 131 DLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 190

Query: 192 MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKV-PYDSMTPLQAALGVRQ 249
            T      +WMA E +  Q +  K+DV+SF ++LWEL+T    PY  +      + + Q
Sbjct: 191 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 2e-50
 Identities = 64/224 (28%), Positives = 114/224 (50%), Gaps = 19/224 (8%)

Query: 29  KSEDWEIDRRLLKTGERIASGSCGDLYRGVYLGQD------VAVKVLRSEHLNDTLEDEF 82
           K  +++         + + SG+ G +Y+G+++ +       VA+K LR E  +     E 
Sbjct: 7   KETEFKK-------IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEI 58

Query: 83  VQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFA 142
           + E  ++  V + +V R +G    +  + ++T+ MP G L DY+ ++ + +    LL + 
Sbjct: 59  LDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 117

Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG---VMTAETGTY 199
           + I KGM YL  R ++HRDL   N+L+ T   VK+ DFG+A+                  
Sbjct: 118 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177

Query: 200 RWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQ 242
           +WMA E I H+ Y  ++DV+S+ + +WEL+T    PYD +   +
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 4e-50
 Identities = 69/247 (27%), Positives = 119/247 (48%), Gaps = 30/247 (12%)

Query: 32  DWEIDRRLLKTGERIASGSCGDLYRGVYLGQD---------VAVKVLRSEHLNDTLEDEF 82
            WE+ R  L  G+ +  G+ G +     +G D         VAVK+L+S+     L  + 
Sbjct: 7   RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS-DL 65

Query: 83  VQEVAILREV-QHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNH----------- 130
           + E+ +++ + +H+N++  +GA T+   L ++ EY   G+L +YL               
Sbjct: 66  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125

Query: 131 ----NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ 186
                 L    L+  A  + +GMEYL  +  IHRDL   N+L+   NV+K+ADFG+AR  
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185

Query: 187 NKGGVMTA---ETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTA-KVPYDSMTPLQ 242
           +               +WMAPE +  + Y  ++DV+SF ++LWE+ T    PY  +   +
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245

Query: 243 AALGVRQ 249
               +++
Sbjct: 246 LFKLLKE 252

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 4e-50
 Identities = 58/227 (25%), Positives = 104/227 (45%), Gaps = 11/227 (4%)

Query: 43  GERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND----TLEDEFVQEVAILREVQHRN 96
           GE + SG    + +      G   A K ++             ++  +EV+IL+E+QH N
Sbjct: 15  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74

Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
           V+           + ++ E + GG L+D+L +  + L   +   F   I  G+ YLH   
Sbjct: 75  VITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHSLQ 133

Query: 157 IIHRDLKTANLLMDTHNV----VKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPY 212
           I H DLK  N+++   NV    +K+ DFG+A   + G       GT  ++APE++N++P 
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 193

Query: 213 DQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY 259
             +AD++S  ++ + L++   P+   T  +    V  V        +
Sbjct: 194 GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 5e-49
 Identities = 70/243 (28%), Positives = 108/243 (44%), Gaps = 27/243 (11%)

Query: 30  SEDWEIDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDEF 82
           +  WE  R  LK G+ +  G+ G +              + VAVK+L+    +       
Sbjct: 5   ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM 64

Query: 83  VQEVAILREVQHRNVVRFIGASTKSP-HLCIVTEYMPGGSLYDYLHKNHN---------- 131
            +   ++    H NVV  +GA TK    L ++ E+   G+L  YL    N          
Sbjct: 65  SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124

Query: 132 -----VLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ 186
                 L L  L+ ++  + KGME+L  R  IHRDL   N+L+   NVVK+ DFG+AR  
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 184

Query: 187 NKGGVMTAET---GTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQ 242
            K      +       +WMAPE I  + Y  ++DV+SF ++LWE+ +    PY  +   +
Sbjct: 185 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244

Query: 243 AAL 245
              
Sbjct: 245 EFC 247

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  161 bits (409), Expect = 6e-49
 Identities = 59/222 (26%), Positives = 113/222 (50%), Gaps = 13/222 (5%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDT-LEDEFVQEVA 87
           +D++I          + +GS G ++       G+  A+KVL+ E +      +    E  
Sbjct: 4   QDFQI-------LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL 56

Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICK 147
           +L  V H  ++R  G    +  + ++ +Y+ GG L+  L K+      P    +A ++C 
Sbjct: 57  MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF-PNPVAKFYAAEVCL 115

Query: 148 GMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI 207
            +EYLH ++II+RDLK  N+L+D +  +K+ DFG A++     V     GT  ++APEV+
Sbjct: 116 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP--DVTYTLCGTPDYIAPEVV 173

Query: 208 NHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ 249
           + +PY++  D +SF I+++E++    P+     ++    +  
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 215

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  162 bits (410), Expect = 1e-48
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 9/205 (4%)

Query: 43  GERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND----TLEDEFVQEVAILREVQHRN 96
              I  G  G++Y       G+  A+K L  + +      TL       ++++       
Sbjct: 9   HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 68

Query: 97  VVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN 156
           +V    A      L  + + M GG L+ +L + H V     +  +A +I  G+E++H R 
Sbjct: 69  IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRF 127

Query: 157 IIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVI-NHQPYDQK 215
           +++RDLK AN+L+D H  V+++D G+A   +K     A  GT+ +MAPEV+     YD  
Sbjct: 128 VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGVAYDSS 186

Query: 216 ADVFSFAIVLWELVTAKVPYDSMTP 240
           AD FS   +L++L+    P+     
Sbjct: 187 ADWFSLGCMLFKLLRGHSPFRQHKT 211

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 8e-48
 Identities = 54/223 (24%), Positives = 106/223 (47%), Gaps = 8/223 (3%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL---NDTLEDEFVQEVAILREVQHRNVV 98
           + +  G    +Y+       Q VA+K ++  H     D +    ++E+ +L+E+ H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 99  RFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNII 158
             + A     ++ +V ++M        +  N  VL    +  + +   +G+EYLHQ  I+
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEV-IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122

Query: 159 HRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEVIN-HQPYDQKA 216
           HRDLK  NLL+D + V+K+ADFG+A+ F +     T +  T  + APE++   + Y    
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 182

Query: 217 DVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY 259
           D+++   +L EL+         + L     + +   +  +  +
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 225

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 1e-46
 Identities = 53/228 (23%), Positives = 100/228 (43%), Gaps = 11/228 (4%)

Query: 43  GERIASGSCGDLYRGVYL---GQDVAVKVLRSEHLNDTLEDEFVQEVAILRE---VQHRN 96
              I  G+ G +++   L   G+ VA+K +R +   + +    ++EVA+LR     +H N
Sbjct: 12  VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 71

Query: 97  VVRFIGASTKSP-----HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEY 151
           VVR     T S       L +V E++               +    +      + +G+++
Sbjct: 72  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 131

Query: 152 LHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQP 211
           LH   ++HRDLK  N+L+ +   +K+ADFG+AR  +    +T+   T  + APEV+    
Sbjct: 132 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 191

Query: 212 YDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY 259
           Y    D++S   +  E+   K  +   + +     +  V     +  +
Sbjct: 192 YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 3e-46
 Identities = 54/216 (25%), Positives = 102/216 (47%), Gaps = 12/216 (5%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLE-DEFVQEVA 87
            D++         + +  G+ G +        G+  A+K+LR E +    E    V E  
Sbjct: 5   NDFDY-------LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57

Query: 88  ILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICK 147
           +L+  +H  +     A      LC V EY  GG L+ +L +   V    +   +  +I  
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVS 116

Query: 148 GMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEV 206
            +EYLH R++++RD+K  NL++D    +K+ DFG+ +   + G  M    GT  ++APEV
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176

Query: 207 INHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQ 242
           +    Y +  D +   +V++E++  ++P+ +    +
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 2e-45
 Identities = 48/209 (22%), Positives = 90/209 (43%), Gaps = 11/209 (5%)

Query: 43  GERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDE----FVQEVAILREVQ--H 94
           G  + SG  G +Y G+ +     VA+K +  + ++D  E         EV +L++V    
Sbjct: 9   GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68

Query: 95  RNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ 154
             V+R +    +     ++ E                 L+      F   + + + + H 
Sbjct: 69  SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 128

Query: 155 RNIIHRDLKTANLLMDTHN-VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPY- 212
             ++HRD+K  N+L+D +   +K+ DFG      K  V T   GT  +  PE I +  Y 
Sbjct: 129 CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIRYHRYH 187

Query: 213 DQKADVFSFAIVLWELVTAKVPYDSMTPL 241
            + A V+S  I+L+++V   +P++    +
Sbjct: 188 GRSAAVWSLGILLYDMVCGDIPFEHDEEI 216

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 2e-45
 Identities = 53/233 (22%), Positives = 110/233 (47%), Gaps = 11/233 (4%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAI 88
           E+++         E+I  G+ G +Y+      G+ VA+K +R +   + +    ++E+++
Sbjct: 2   ENFQK-------VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 54

Query: 89  LREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKG 148
           L+E+ H N+V+ +        L +V E++               + LP +  +   + +G
Sbjct: 55  LKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 114

Query: 149 MEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEVI 207
           + + H   ++HRDLK  NLL++T   +K+ADFG+AR F       T E  T  + APE++
Sbjct: 115 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174

Query: 208 NHQPY-DQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY 259
               Y     D++S   +  E+VT +  +   + +     + +   +  + ++
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 1e-44
 Identities = 51/232 (21%), Positives = 101/232 (43%), Gaps = 17/232 (7%)

Query: 44  ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFI 101
            +I  G+ G++++  +   GQ VA+K +  E+  +      ++E+ IL+ ++H NVV  I
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 102 GASTKSP--------HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH 153
                           + +V ++          +       L ++ R    +  G+ Y+H
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGLYYIH 134

Query: 154 QRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-----VMTAETGTYRWMAPEVI- 207
           +  I+HRD+K AN+L+    V+K+ADFG+AR  +          T    T  +  PE++ 
Sbjct: 135 RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLL 194

Query: 208 NHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY 259
             + Y    D++    ++ E+ T        T       + Q+C S+   ++
Sbjct: 195 GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 1e-43
 Identities = 54/238 (22%), Positives = 103/238 (43%), Gaps = 15/238 (6%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           +++  R       I  G+ G +           VA+K +     + T     ++E+ IL 
Sbjct: 4   FDVGPRY-TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILL 61

Query: 91  EVQHRNVVRFIGA----STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDIC 146
             +H N++         + +      +  ++ G  LY  L   H  L    +  F   I 
Sbjct: 62  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQIL 119

Query: 147 KGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF----QNKGGVMTAETGTYRWM 202
           +G++Y+H  N++HRDLK +NLL++T   +K+ DFG+AR      +  G +T    T  + 
Sbjct: 120 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179

Query: 203 APEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY 259
           APE++ +   Y +  D++S   +L E+++ +  +     L     +  +  S  Q   
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  146 bits (368), Expect = 3e-43
 Identities = 51/219 (23%), Positives = 100/219 (45%), Gaps = 4/219 (1%)

Query: 44  ERIASGSCGDLYRGVY-LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG 102
           E+I  G+ G +Y+     G+  A+K +R E  ++ +    ++E++IL+E++H N+V+   
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 103 ASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL 162
                  L +V E++        L      L+      F + +  G+ Y H R ++HRDL
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKK-LLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDL 126

Query: 163 KTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRW-MAPEVI-NHQPYDQKADVFS 220
           K  NLL++    +K+ADFG+AR                W  AP+V+   + Y    D++S
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWS 186

Query: 221 FAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPIY 259
              +  E+V     +  ++     + + ++  +     +
Sbjct: 187 VGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  146 bits (369), Expect = 4e-43
 Identities = 52/222 (23%), Positives = 88/222 (39%), Gaps = 17/222 (7%)

Query: 43  GERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF 100
           G +I SGS GD+Y G  +  G++VA+K+   +    T   +   E  I + +Q    +  
Sbjct: 12  GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVGIPT 67

Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
           I          ++   + G SL D  +       L  +L  A  +   +EY+H +N IHR
Sbjct: 68  IRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHR 127

Query: 161 DLKTANLLM---DTHNVVKVADFGVARFQNKGGV--------MTAETGTYRWMAPEVINH 209
           D+K  N LM      N+V + DFG+A+                   TGT R+ +      
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187

Query: 210 QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC 251
               ++ D+ S   VL       +P+  +          ++ 
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 229

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 5e-43
 Identities = 55/241 (22%), Positives = 101/241 (41%), Gaps = 21/241 (8%)

Query: 23  AIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLED 80
           A   Q      E+     K    I +GS G +Y+      G+ VA+K +  +      + 
Sbjct: 8   ATPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQD------KR 58

Query: 81  EFVQEVAILREVQHRNVVRFIGA------STKSPHLCIVTEYMPGGSLYDYLH--KNHNV 132
              +E+ I+R++ H N+VR               +L +V +Y+P        H  +    
Sbjct: 59  FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 118

Query: 133 LKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN-VVKVADFGVARFQNKGGV 191
           L +  +  +   + + + Y+H   I HRD+K  NLL+D    V+K+ DFG A+   +G  
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178

Query: 192 MTAETGTYRWMAP-EVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQV 250
             +   +  + AP  +     Y    DV+S   VL EL+  +  +   + +   + + +V
Sbjct: 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238

Query: 251 C 251
            
Sbjct: 239 L 239

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  147 bits (371), Expect = 6e-43
 Identities = 54/225 (24%), Positives = 106/225 (47%), Gaps = 13/225 (5%)

Query: 21  EKAIESQTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND-T 77
           E   ++  + + ++         + + +GS G +    +   G   A+K+L  + +    
Sbjct: 31  ETPSQNTAQLDQFDR-------IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83

Query: 78  LEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQ 137
             +  + E  IL+ V    +V+   +   + +L +V EY+ GG ++ +L +       P 
Sbjct: 84  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPH 142

Query: 138 LLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETG 197
              +A  I    EYLH  ++I+RDLK  NLL+D    ++V DFG A+     G      G
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWTLCG 200

Query: 198 TYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQ 242
           T   +APE+I  + Y++  D ++  ++++E+     P+ +  P+Q
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  143 bits (362), Expect = 3e-42
 Identities = 38/224 (16%), Positives = 82/224 (36%), Gaps = 19/224 (8%)

Query: 43  GERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF 100
           G RI  GS G ++ G  L   Q VA+K             +   E    + +     +  
Sbjct: 10  GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPN 65

Query: 101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHR 160
           +    +     ++   + G SL D L        +  +   A  +   ++ +H++++++R
Sbjct: 66  VYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYR 125

Query: 161 DLKTANLLMD-----THNVVKVADFGVARFQNKGGV--------MTAETGTYRWMAPEVI 207
           D+K  N L+        N++ V DFG+ +F                  +GT R+M+    
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185

Query: 208 NHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC 251
             +   ++ D+ +   V    +   +P+  +          ++ 
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 9e-41
 Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 15/225 (6%)

Query: 27  QTKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQ 84
           +     WE+     +  + + SG+ G +   V    G  VA+K L     ++       +
Sbjct: 8   EVTKTAWEVRAVY-RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR 66

Query: 85  EVAILREVQHRNVVRFIGASTKSP------HLCIVTEYMPGGSLYDYLHKNHNVLKLPQL 138
           E+ +L+ ++H NV+  +   T            +V  +M  G+    L K H  L   ++
Sbjct: 67  ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMK-HEKLGEDRI 123

Query: 139 LRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGT 198
                 + KG+ Y+H   IIHRDLK  NL ++    +K+ DFG+AR  +    MT    T
Sbjct: 124 QFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS--EMTGYVVT 181

Query: 199 YRWMAPEVI-NHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQ 242
             + APEVI N   Y Q  D++S   ++ E++T K  +     L 
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 226

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 2e-40
 Identities = 52/199 (26%), Positives = 99/199 (49%), Gaps = 5/199 (2%)

Query: 41  KTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVV 98
           +  E+I  G+ G +++       + VA+K +R +  ++ +    ++E+ +L+E++H+N+V
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64

Query: 99  RFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNII 158
           R          L +V E+        +    +  L    +  F   + KG+ + H RN++
Sbjct: 65  RLHDVLHSDKKLTLVFEFCDQDLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVL 123

Query: 159 HRDLKTANLLMDTHNVVKVADFGVAR-FQNKGGVMTAETGTYRWMAPEVI-NHQPYDQKA 216
           HRDLK  NLL++ +  +K+A+FG+AR F       +AE  T  +  P+V+   + Y    
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183

Query: 217 DVFSFAIVLWELVTAKVPY 235
           D++S   +  EL  A  P 
Sbjct: 184 DMWSAGCIFAELANAGRPL 202

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  137 bits (346), Expect = 2e-39
 Identities = 43/227 (18%), Positives = 99/227 (43%), Gaps = 24/227 (10%)

Query: 24  IESQTKSEDWEIDRRLLKTG--------ERIASGSCGDLYRGVYL--GQDVAVKVLRSEH 73
           + +    E W+ +  +++ G         ++  G   +++  + +   + V VK+L+   
Sbjct: 13  VNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK 72

Query: 74  LNDTLEDEFVQEVAILREVQ-HRNVVRFIGA--STKSPHLCIVTEYMPGGSLYDYLHKNH 130
                + +  +E+ IL  ++   N++          S    +V E++             
Sbjct: 73  -----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-- 125

Query: 131 NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT-HNVVKVADFGVARFQNKG 189
             L    +  +  +I K ++Y H   I+HRD+K  N+++D  H  +++ D+G+A F + G
Sbjct: 126 --LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183

Query: 190 GVMTAETGTYRWMAPEV-INHQPYDQKADVFSFAIVLWELVTAKVPY 235
                   +  +  PE+ +++Q YD   D++S   +L  ++  K P+
Sbjct: 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 3e-39
 Identities = 51/219 (23%), Positives = 98/219 (44%), Gaps = 13/219 (5%)

Query: 32  DWEIDRRLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLNDTLEDEFVQEVAIL 89
            + + +R  +  + I SG+ G +       L ++VA+K L     N T      +E+ ++
Sbjct: 12  TFTVLKRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 70

Query: 90  REVQHRNVVRFIGASTKSP------HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAI 143
           + V H+N++  +   T          + +V E M          +        ++     
Sbjct: 71  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLY 126

Query: 144 DICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMA 203
            +  G+++LH   IIHRDLK +N+++ +   +K+ DFG+AR      +MT    T  + A
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186

Query: 204 PEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQ 242
           PEVI    Y +  D++S   ++ E+V  K+ +     + 
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 5e-38
 Identities = 49/217 (22%), Positives = 95/217 (43%), Gaps = 11/217 (5%)

Query: 33  WEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILR 90
           WE+  R  +    + SG+ G +        G  VAVK L     +        +E+ +L+
Sbjct: 14  WEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 72

Query: 91  EVQHRNVVRFIGASTKSPHLC-----IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDI 145
            ++H NV+  +   T +  L       +  ++ G  L + +      L    +      I
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI 130

Query: 146 CKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTAETGTYRWMAPE 205
            +G++Y+H  +IIHRDLK +NL ++    +K+ DFG+AR  +   +       +      
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-EMTGYVATRWYRAPEI 189

Query: 206 VINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQ 242
           ++N   Y+Q  D++S   ++ EL+T +  +     + 
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 226

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 2e-36
 Identities = 48/240 (20%), Positives = 110/240 (45%), Gaps = 20/240 (8%)

Query: 31  EDWEIDRRLLKTGERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLE--DEFV 83
           E++E+        + + +G+ G ++    +     G+  A+KVL+   +    +  +   
Sbjct: 24  ENFEL-------LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR 76

Query: 84  QEVAILREVQHR-NVVRFIGASTKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFA 142
            E  +L  ++    +V    A      L ++ +Y+ GG L+ +L +        ++  + 
Sbjct: 77  TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-FTEHEVQIYV 135

Query: 143 IDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF--QNKGGVMTAETGTYR 200
            +I   +E+LH+  II+RD+K  N+L+D++  V + DFG+++    ++        GT  
Sbjct: 136 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195

Query: 201 WMAPEVI--NHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPI 258
           +MAP+++      +D+  D +S  ++++EL+T   P+       +   + +       P 
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 255

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  110 bits (276), Expect = 4e-29
 Identities = 42/218 (19%), Positives = 92/218 (42%), Gaps = 29/218 (13%)

Query: 43  GERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRF 100
             ++  G    ++    +     VA+K++R + +     +    E+ +L+ V   +  + 
Sbjct: 18  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT---EAAEDEIKLLQRVNDADNTKE 74

Query: 101 IGASTKSP---------------HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDI 145
                                  H+ +V E +    L       H  + L  + + +  +
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 146 CKGMEYLH-QRNIIHRDLKTANLLMDTHNV------VKVADFGVARFQNKGGVMTAETGT 198
             G++Y+H +  IIH D+K  N+LM+  +       +K+AD G A + ++    +    T
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS--IQT 192

Query: 199 YRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYD 236
             + +PEV+   P+   AD++S A +++EL+T    ++
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 77.1 bits (189), Expect = 5e-18
 Identities = 21/155 (13%), Positives = 49/155 (31%), Gaps = 22/155 (14%)

Query: 43  GERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLN--------DTLEDEFVQEVAILREVQ 93
           G+ +  G    ++        +  VK  +  H +        D  +  F          +
Sbjct: 5   GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 94  HRNVVRFIGASTKSPH----LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGM 149
            R + +  G +    +      ++ E +          K    +++         I + +
Sbjct: 65  FRALQKLQGLAVPKVYAWEGNAVLMELID--------AKELYRVRVENPDEVLDMILEEV 116

Query: 150 EYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR 184
              + R I+H DL   N+L+     + + DF  + 
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSV 150

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	259
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	99.04
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.57
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.25
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.8
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.64
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.53

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=324.32  Aligned_cols=218  Identities=25%  Similarity=0.476  Sum_probs=193.6

Q ss_pred             cceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           32 DWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN-DTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        32 ~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      .|.+  ++|++.+.||+|+||+||+|.+.  ++.||+|++...... ......+.+|+.+++.++||||+++++++.+.+
T Consensus         2 ~~~l--~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~   79 (263)
T d2j4za1           2 QWAL--EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT   79 (263)
T ss_dssp             CCCG--GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             Ccch--hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC
Confidence            4666  46899999999999999999985  789999999764322 234567889999999999999999999999999


Q ss_pred             cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      ..++||||+++++|.+++.... .+++..++.++.|++++|.|||++|++||||||+|||++.++.+||+|||.+.....
T Consensus        80 ~~~ivmEy~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          80 RVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             EEEEEEeecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            9999999999999999997654 499999999999999999999999999999999999999999999999999976654


Q ss_pred             CCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          189 GGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       189 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      . ......||+.|+|||++.+.+++.++|||||||++|+|++|..||.+.+..+....+.+....
T Consensus       159 ~-~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~  222 (263)
T d2j4za1         159 S-RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT  222 (263)
T ss_dssp             C-CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC
T ss_pred             C-cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence            4 334567999999999999999999999999999999999999999999999988888765543

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-50  Score=326.22  Aligned_cols=221  Identities=39%  Similarity=0.703  Sum_probs=188.1

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcE
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL  110 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~  110 (259)
                      |+|+|+.++|.+.++||+|+||+||+|+..+ .||||+++.........+.+.+|+.++++++||||+++++++.. +..
T Consensus         1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~   78 (276)
T d1uwha_           1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL   78 (276)
T ss_dssp             CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred             CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence            5799999999999999999999999998654 69999998776666677889999999999999999999998754 568


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      ++||||+++++|.+++......+++..+..++.|++++|.|||+++++||||||+|||++.++.+||+|||++.......
T Consensus        79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            99999999999999998777779999999999999999999999999999999999999999999999999997654332


Q ss_pred             ---ccccCCCcccccCccccCCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHhhhccCC
Q 045286          191 ---VMTAETGTYRWMAPEVINHQ---PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQA-ALGVRQVCTS  253 (259)
Q Consensus       191 ---~~~~~~~~~~~~~PE~~~~~---~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~-~~~i~~~~~~  253 (259)
                         ......+++.|+|||++.+.   +++.++|||||||++|+|++|..||.+.+..+. ...+.++...
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  228 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS  228 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC
Confidence               23445789999999998643   578899999999999999999999998665544 4444455443

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=323.63  Aligned_cols=211  Identities=27%  Similarity=0.532  Sum_probs=189.5

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      .++|++.++||+|+||+||+|.+.  ++.||+|++.......  .+.+.+|+.+++.++||||+++++++...+.+++||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence            468999999999999999999964  8999999998654332  367899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-Cccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVMT  193 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~~  193 (259)
                      ||++|++|.+++...  .+++..++.++.|++.+|.|||++|++||||||+|||++.++.+||+|||.+...... ....
T Consensus        97 Ey~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~  174 (293)
T d1yhwa1          97 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (293)
T ss_dssp             ECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             EecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence            999999999988654  4999999999999999999999999999999999999999999999999999876544 3445


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhcc
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ...|++.|+|||.+.+.+++.++|||||||++|+|++|..||.+.+..+.+..+....
T Consensus       175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~  232 (293)
T d1yhwa1         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG  232 (293)
T ss_dssp             CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC
T ss_pred             ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC
Confidence            6679999999999999999999999999999999999999999988888777766543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-50  Score=322.74  Aligned_cols=220  Identities=29%  Similarity=0.439  Sum_probs=183.9

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec--CCcEEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK--SPHLCIV  113 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv  113 (259)
                      ++|++.+.||+|+||+||+|.+.  ++.||+|++......+...+.+.+|++++++++||||+++++++.+  .+.+++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            46888899999999999999975  7899999998887777667889999999999999999999998854  4568999


Q ss_pred             EecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          114 TEYMPGGSLYDYLHK---NHNVLKLPQLLRFAIDICKGMEYLHQRN-----IIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~-----i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                      |||+++++|.+++.+   ....+++..++.++.|++.+|.|||+.|     ++||||||+|||++.++.+||+|||.+..
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            999999999999864   3456999999999999999999999976     99999999999999999999999999987


Q ss_pred             ccCCC-ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          186 QNKGG-VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       186 ~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      ..... ......+++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..+..+..|+
T Consensus       164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~  236 (269)
T d2java1         164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY  236 (269)
T ss_dssp             C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCT
T ss_pred             cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            65543 3345678999999999999999999999999999999999999999999999998888776554443

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-49  Score=325.59  Aligned_cols=219  Identities=23%  Similarity=0.454  Sum_probs=176.5

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      .++|++.++||+|+||+||+|.+.  ++.||||++....... ....+.+|+.++++++||||+++++++.+.+..++||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            467999999999999999999985  7899999998765432 2356789999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc---cCCeEEEeeeccceeccCCCc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD---THNVVKVADFGVARFQNKGGV  191 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~---~~~~i~l~D~~~~~~~~~~~~  191 (259)
                      ||++|++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++.   .++.+||+|||++........
T Consensus        87 E~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~  165 (307)
T d1a06a_          87 QLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV  165 (307)
T ss_dssp             CCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             eccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence            999999999999654 4599999999999999999999999999999999999995   468899999999987776666


Q ss_pred             cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          192 MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      ....+||+.|+|||++.+..+++++|||||||++|+|++|..||.+.+..+....+.++......|
T Consensus       166 ~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  231 (307)
T d1a06a_         166 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP  231 (307)
T ss_dssp             -------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTT
T ss_pred             eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCc
Confidence            666789999999999999999999999999999999999999999999998888888766555443

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-50  Score=324.17  Aligned_cols=214  Identities=28%  Similarity=0.470  Sum_probs=189.8

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      ++.|++.+.||+|+||+||+|.+.  ++.||+|++.....  ...+.+.+|++++++++||||+++++++...+..++||
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm   88 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   88 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence            457899999999999999999984  78999999986532  33467889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-Cccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVMT  193 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~~  193 (259)
                      ||+++++|.+++......+++..+..++.|++.+|.|||++|++||||||+|||++.++.+||+|||++...... ....
T Consensus        89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~  168 (288)
T d2jfla1          89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD  168 (288)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence            999999999998777777999999999999999999999999999999999999999999999999998765433 2334


Q ss_pred             cCCCcccccCccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          194 AETGTYRWMAPEVIN-----HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~-----~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      ...|++.|+|||.+.     +..++.++|||||||++|+|++|..||.+.+..+.+.++.++..
T Consensus       169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~  232 (288)
T d2jfla1         169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP  232 (288)
T ss_dssp             CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCC
T ss_pred             ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC
Confidence            567999999999983     45689999999999999999999999999999888888877653

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.4e-49  Score=329.59  Aligned_cols=217  Identities=20%  Similarity=0.412  Sum_probs=196.9

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ++|++.++||+|+||+||+|.+.  ++.||+|++....  ......+.+|+.++++++||||+++++++...+.+++|||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE  106 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  106 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            57999999999999999999974  8899999998753  2334678899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEc--cCCeEEEeeeccceeccCCCccc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMD--THNVVKVADFGVARFQNKGGVMT  193 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~--~~~~i~l~D~~~~~~~~~~~~~~  193 (259)
                      |++|++|.+++......+++.+++.++.||+.+|.|||++|++||||||+|||++  .++.+||+|||++..........
T Consensus       107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~  186 (352)
T d1koba_         107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK  186 (352)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred             cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCcee
Confidence            9999999998876666799999999999999999999999999999999999997  56899999999999888776667


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      ...+++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+.++......
T Consensus       187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  249 (352)
T d1koba_         187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE  249 (352)
T ss_dssp             EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS
T ss_pred             eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence            778999999999999999999999999999999999999999999999999998877655443

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=322.85  Aligned_cols=214  Identities=21%  Similarity=0.377  Sum_probs=188.6

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      ++|++.+.||+|+||+||+|.+.  ++.||||++..... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            46899999999999999999984  78999999976432 2334567899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC---c
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG---V  191 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~---~  191 (259)
                      ||++|++|.+++.... .+++..++.++.|++.+|.|||+.|++||||||+||+++.++.++|+|||.+.......   .
T Consensus        88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~  166 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR  166 (288)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccc
Confidence            9999999999986554 49999999999999999999999999999999999999999999999999998765432   2


Q ss_pred             cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          192 MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+...+|.++..
T Consensus       167 ~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~  227 (288)
T d1uu3a_         167 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY  227 (288)
T ss_dssp             ---CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC
T ss_pred             cccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC
Confidence            3345799999999999999999999999999999999999999999999998888876643

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.9e-49  Score=328.05  Aligned_cols=215  Identities=22%  Similarity=0.430  Sum_probs=195.2

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ++|++.+.||+|+||.||+|.+.  ++.||+|++....  ....+.+.+|+.++++++||||+++++++...+.+++|||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE  103 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  103 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            47899999999999999999975  8899999997653  3345778899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc--CCeEEEeeeccceeccCCCccc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT--HNVVKVADFGVARFQNKGGVMT  193 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~--~~~i~l~D~~~~~~~~~~~~~~  193 (259)
                      |++|++|.+++......+++..+..++.||+.+|.|||++|++||||||+|||++.  ++.+||+|||++..........
T Consensus       104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~  183 (350)
T d1koaa2         104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK  183 (350)
T ss_dssp             CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred             cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccc
Confidence            99999999999766667999999999999999999999999999999999999964  5789999999999887776666


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      ...+|+.|+|||++.+.+++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus       184 ~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~  244 (350)
T d1koaa2         184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM  244 (350)
T ss_dssp             EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS
T ss_pred             eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            7789999999999999999999999999999999999999999999999998888765443

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.4e-49  Score=319.81  Aligned_cols=227  Identities=32%  Similarity=0.611  Sum_probs=196.4

Q ss_pred             cccccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeee
Q 045286           28 TKSEDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST  105 (259)
Q Consensus        28 ~~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~  105 (259)
                      ...+.|+++.++|++.++||+|+||+||+|.+.  ++.||||+++.....   .+.+.+|++++++++||||+++++++.
T Consensus         7 p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~   83 (287)
T d1opja_           7 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCT   83 (287)
T ss_dssp             TTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEe
Confidence            345679999999999999999999999999984  789999998765433   367899999999999999999999999


Q ss_pred             cCCcEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccce
Q 045286          106 KSPHLCIVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR  184 (259)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~  184 (259)
                      ..+..++||||+++++|.+++... ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.
T Consensus        84 ~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~  163 (287)
T d1opja_          84 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR  163 (287)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred             eCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEcccccee
Confidence            999999999999999999998754 4468999999999999999999999999999999999999999999999999998


Q ss_pred             eccCCCcc--ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCC-CCCCCCHHHHHHHhhhccCCCCcc
Q 045286          185 FQNKGGVM--TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKV-PYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       185 ~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~-p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      ........  ....+++.|+|||.+.+..++.++|||||||++|+|++|.. ||.+.+..+....+..+.....|+
T Consensus       164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~  239 (287)
T d1opja_         164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE  239 (287)
T ss_dssp             TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCc
Confidence            66544322  22346788999999999999999999999999999999555 566777777777777776655543

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=320.34  Aligned_cols=202  Identities=27%  Similarity=0.493  Sum_probs=175.3

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ++|++.+.||+|+||+||+|.+.  ++.||+|++...... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            46889999999999999999985  789999999875432 334668899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC---cc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG---VM  192 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~---~~  192 (259)
                      |+++++|.+++... ..+++..++.++.|++++|.|||++|++||||||+|||++.++.+||+|||++.......   ..
T Consensus        84 y~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~  162 (271)
T d1nvra_          84 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  162 (271)
T ss_dssp             CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             ccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence            99999999998543 459999999999999999999999999999999999999999999999999998764332   23


Q ss_pred             ccCCCcccccCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCHH
Q 045286          193 TAETGTYRWMAPEVINHQPY-DQKADVFSFAIVLWELVTAKVPYDSMTPL  241 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~~~~ll~g~~p~~~~~~~  241 (259)
                      ...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..
T Consensus       163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~  212 (271)
T d1nvra_         163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS  212 (271)
T ss_dssp             CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT
T ss_pred             cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH
Confidence            45679999999999988876 57899999999999999999999765543

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-48  Score=318.16  Aligned_cols=216  Identities=27%  Similarity=0.453  Sum_probs=194.6

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCch----HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND----TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL  110 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~  110 (259)
                      +++|++.+.||+|+||+||+|.+.  ++.||||++.......    ...+.+.+|+.++++++||||+++++++.+.+.+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            467999999999999999999975  8899999997654322    2357789999999999999999999999999999


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC----eEEEeeeccceec
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN----VVKVADFGVARFQ  186 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~----~i~l~D~~~~~~~  186 (259)
                      ++||||+++++|.+++.... .+++..++.++.|++.+|.|||+.|++||||||+||+++.++    .+|++|||.+...
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~  167 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  167 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence            99999999999999997654 599999999999999999999999999999999999998776    5999999999888


Q ss_pred             cCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          187 NKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       187 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ..........+++.|+|||++.+..++.++||||+||++|+|++|..||.+.+..+.+..+.++...
T Consensus       168 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~  234 (293)
T d1jksa_         168 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE  234 (293)
T ss_dssp             TTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC
T ss_pred             CCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC
Confidence            7776666778999999999999999999999999999999999999999999999988888776544

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-48  Score=321.73  Aligned_cols=215  Identities=24%  Similarity=0.412  Sum_probs=192.5

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      ++|++.+.||+|+||.||+|.+.  ++.||+|+++.... .......+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            57899999999999999999974  88999999986532 2234577889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC-CCccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK-GGVMT  193 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~-~~~~~  193 (259)
                      ||++|++|.+++.... .+++..++.++.|++.+|.|||++|++||||||+|||++.+|.+||+|||.+..... .....
T Consensus        85 ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~  163 (337)
T d1o6la_          85 EYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK  163 (337)
T ss_dssp             ECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBC
T ss_pred             eccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcccc
Confidence            9999999999987654 489999999999999999999999999999999999999999999999999986544 33445


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ..+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+....+......
T Consensus       164 ~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~  223 (337)
T d1o6la_         164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR  223 (337)
T ss_dssp             CCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred             cceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCC
Confidence            567999999999999999999999999999999999999999999998888888776543

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-48  Score=311.70  Aligned_cols=215  Identities=33%  Similarity=0.551  Sum_probs=183.7

Q ss_pred             chhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec----CCc
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK----SPH  109 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~  109 (259)
                      +++.|++.++||+|+||+||+|.+.  ++.||+|.+..........+.+.+|++++++++||||+++++++..    ...
T Consensus         7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   86 (270)
T d1t4ha_           7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC   86 (270)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence            3456678889999999999999985  6789999998877666667889999999999999999999998854    346


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCcEEEc-cCCeEEEeeeccceec
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRN--IIHRDLKTANLLMD-THNVVKVADFGVARFQ  186 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~di~p~Nilv~-~~~~i~l~D~~~~~~~  186 (259)
                      +++||||+++++|.+++.+.. .+++..+..++.|++++|.|||+++  ++||||||+|||++ .++.+||+|||++...
T Consensus        87 ~~ivmE~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          87 IVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEEeCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence            899999999999999996654 4899999999999999999999999  99999999999996 4789999999999754


Q ss_pred             cCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHhhhccCC
Q 045286          187 NKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMT-PLQAALGVRQVCTS  253 (259)
Q Consensus       187 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~-~~~~~~~i~~~~~~  253 (259)
                      ... ......||+.|+|||++.+ +++.++|||||||++|+|++|..||.+.+ ..+....+..+..+
T Consensus       166 ~~~-~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~  231 (270)
T d1t4ha_         166 RAS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP  231 (270)
T ss_dssp             CTT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC
T ss_pred             cCC-ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC
Confidence            443 3456689999999999876 59999999999999999999999997654 45555666555443

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-48  Score=314.98  Aligned_cols=224  Identities=27%  Similarity=0.536  Sum_probs=196.0

Q ss_pred             cceechhhhhccc-eeccccceEEEEEEEc----CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec
Q 045286           32 DWEIDRRLLKTGE-RIASGSCGDLYRGVYL----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK  106 (259)
Q Consensus        32 ~~~~~~~~~~~~~-~lg~G~~~~V~~~~~~----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~  106 (259)
                      ++-++.+++.+.+ +||+|+||+||+|.+.    +..||||+++... .+...+.+.+|++++++++||||+++++++..
T Consensus         2 ~l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~   80 (285)
T d1u59a_           2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA   80 (285)
T ss_dssp             CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             ceeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence            4567778888888 4999999999999763    4479999997653 44556789999999999999999999999865


Q ss_pred             CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          107 SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                       +..++||||+++++|.+++......+++..+..++.|++.+|.|||++|++||||||+||+++.++.+||+|||++...
T Consensus        81 -~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          81 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             -SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             -CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcc
Confidence             4688999999999999998776667999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCcc----ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          187 NKGGVM----TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       187 ~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      ......    ....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+.++.++..|+
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~  235 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP  235 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            544322    23457899999999998899999999999999999998 999999999999999999888776655

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=314.85  Aligned_cols=225  Identities=35%  Similarity=0.614  Sum_probs=195.8

Q ss_pred             ccccceechhhhhccceeccccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 045286           29 KSEDWEIDRRLLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS  107 (259)
Q Consensus        29 ~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~  107 (259)
                      ..++|+|+.++|++.+.||+|+||+||+|.+. ++.||||+++.....   .+.+.+|+.++++++||||+++++++.+ 
T Consensus         4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~-   79 (272)
T d1qpca_           4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-   79 (272)
T ss_dssp             TTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             CCCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-
Confidence            35779999999999999999999999999986 568999999865443   3678999999999999999999998765 


Q ss_pred             CcEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                      +..++||||+++++|.+++... ...+++..+..++.|++.+|.|||+++++||||||+||+++.++.+||+|||++...
T Consensus        80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~  159 (272)
T d1qpca_          80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI  159 (272)
T ss_dssp             SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEc
Confidence            4678999999999999977433 235899999999999999999999999999999999999999999999999999877


Q ss_pred             cCCCc--cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          187 NKGGV--MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       187 ~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      .....  .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+..+.+..+.++.....|+
T Consensus       160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~  233 (272)
T d1qpca_         160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD  233 (272)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcc
Confidence            65432  234467899999999998889999999999999999999 566778889999999998887766554

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-48  Score=317.64  Aligned_cols=223  Identities=33%  Similarity=0.545  Sum_probs=186.1

Q ss_pred             eechhhhhccceeccccceEEEEEEEc--Cc---eEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           34 EIDRRLLKTGERIASGSCGDLYRGVYL--GQ---DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        34 ~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~---~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      +++.++|++.++||+|+||+||+|.+.  ++   .|+||.+.... .....+.+.+|+.++++++||||+++++++...+
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  100 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST  100 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            466788999999999999999999874  22   58888876553 3445577999999999999999999999999999


Q ss_pred             cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      ..++||||+++++|.+++......+++..+..++.|++++|.|||+.+++||||||+|||++.++.+||+|||++.....
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence            99999999999999999987777799999999999999999999999999999999999999999999999999976554


Q ss_pred             CCcc------ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          189 GGVM------TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       189 ~~~~------~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      ....      ....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+.+..+.++.+.+.|+
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  256 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM  256 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            3221      12346889999999999999999999999999999998 899999999999999999887766554

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.3e-48  Score=319.39  Aligned_cols=214  Identities=26%  Similarity=0.485  Sum_probs=191.5

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      ++|++.++||+|+||+||+|.+.  ++.||||+++.... .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            56899999999999999999975  88999999976432 2234577889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTA  194 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~  194 (259)
                      ||++|++|..++.... .+++..++.++.|++.+|.|||++|++||||||+|||++.+|.+||+|||.+......  ...
T Consensus        84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~~~  160 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYT  160 (316)
T ss_dssp             CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCC
T ss_pred             eecCCccccccccccc-cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--ccc
Confidence            9999999999886544 4888999999999999999999999999999999999999999999999999876654  345


Q ss_pred             CCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          195 ETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      .+|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+...++.++....
T Consensus       161 ~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~  220 (316)
T d1fota_         161 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF  220 (316)
T ss_dssp             CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC
T ss_pred             ccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC
Confidence            679999999999999999999999999999999999999999999999998888765443

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.8e-48  Score=317.05  Aligned_cols=214  Identities=29%  Similarity=0.436  Sum_probs=188.1

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCc-hHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLN-DTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      .+.|+..++||+|+||+||+|.+.  ++.||||++...... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence            467999999999999999999974  788999999876543 34557789999999999999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCccc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMT  193 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~  193 (259)
                      |||+++++|..++.. ...+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++......   .
T Consensus        94 ~E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---~  169 (309)
T d1u5ra_          94 MEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---N  169 (309)
T ss_dssp             EECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---C
T ss_pred             EEecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC---C
Confidence            999999888766643 456999999999999999999999999999999999999999999999999999765443   3


Q ss_pred             cCCCcccccCccccCC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          194 AETGTYRWMAPEVINH---QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~---~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      ...||+.|+|||++.+   .+++.++|||||||++|+|++|..||.+.+..+.+..+.+...+.
T Consensus       170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~  233 (309)
T d1u5ra_         170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA  233 (309)
T ss_dssp             CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred             ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            4579999999999864   358899999999999999999999999999988888877665443

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-48  Score=311.67  Aligned_cols=219  Identities=30%  Similarity=0.606  Sum_probs=184.8

Q ss_pred             chhhhhccceeccccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           36 DRRLLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        36 ~~~~~~~~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      +-++|++.+.||+|+||+||+|.+. ++.||||+++......   +.+.+|++++++++||||+++++++...+..++||
T Consensus         3 dp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~   79 (263)
T d1sm2a_           3 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   79 (263)
T ss_dssp             CCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence            4467889999999999999999985 6789999998654443   67899999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcc--
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM--  192 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~--  192 (259)
                      ||+++++|.+++......+++..+..++.|++.+|.|||+++++||||||+||+++.++.+||+|||++.........  
T Consensus        80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~  159 (263)
T d1sm2a_          80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred             EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence            999999999999877777899999999999999999999999999999999999999999999999999766543222  


Q ss_pred             ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          193 TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+..+.....|.
T Consensus       160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~  225 (263)
T d1sm2a_         160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR  225 (263)
T ss_dssp             -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCT
T ss_pred             cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCcc
Confidence            23467899999999999999999999999999999999 677888889989999888876655543

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-49  Score=325.08  Aligned_cols=205  Identities=25%  Similarity=0.440  Sum_probs=181.7

Q ss_pred             eechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEE
Q 045286           34 EIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        34 ~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~  111 (259)
                      ++.+++|++.++||+|+||+||+|.+.  ++.||+|+++... .......+.+|+.++++++||||+++++++...+.++
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            456789999999999999999999974  7899999998654 3344578899999999999999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ-RNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      +||||++|++|.+++.+.. .+++..++.++.|++.+|.|||+ +||+||||||+|||++.++.+||+|||++...... 
T Consensus        81 iVmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-  158 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  158 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             EEEEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence            9999999999999997654 49999999999999999999997 59999999999999999999999999999765433 


Q ss_pred             ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH
Q 045286          191 VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPL  241 (259)
Q Consensus       191 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~  241 (259)
                      .....+||+.|+|||++.+.+++.++||||+||++|+|++|+.||.+.+..
T Consensus       159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~  209 (322)
T d1s9ja_         159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK  209 (322)
T ss_dssp             TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT
T ss_pred             ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence            233568999999999999999999999999999999999999999876543

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-47  Score=307.05  Aligned_cols=218  Identities=30%  Similarity=0.589  Sum_probs=195.0

Q ss_pred             hhhhhccceeccccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      -++|++.++||+|+||+||+|.+. ++.||||+++.....+   +.+.+|+.++++++||||+++++++...+.+++|||
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E   79 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   79 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence            357889999999999999999985 5689999998765443   578999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc--cc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV--MT  193 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~--~~  193 (259)
                      |+++++|..++......+++..+..++.|++++|.|||+.|++|+||+|+||+++.++.+||+|||++........  ..
T Consensus        80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  159 (258)
T d1k2pa_          80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV  159 (258)
T ss_dssp             CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred             ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence            9999999999877766799999999999999999999999999999999999999999999999999976554332  23


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+.++.+...|.
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~  224 (258)
T d1k2pa_         160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH  224 (258)
T ss_dssp             CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCT
T ss_pred             ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcc
Confidence            4568899999999999999999999999999999998 899999999999999999887766553

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-48  Score=311.44  Aligned_cols=220  Identities=30%  Similarity=0.548  Sum_probs=186.0

Q ss_pred             chhhhhcc-ceeccccceEEEEEEEc----CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcE
Q 045286           36 DRRLLKTG-ERIASGSCGDLYRGVYL----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL  110 (259)
Q Consensus        36 ~~~~~~~~-~~lg~G~~~~V~~~~~~----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~  110 (259)
                      +.+.+.+. ++||+|+||+||+|.+.    ++.||||+++....++...+.+.+|+.++++++||||+++++++.. +..
T Consensus         4 d~~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~   82 (277)
T d1xbba_           4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESW   82 (277)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSE
T ss_pred             chhhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCE
Confidence            34444444 47999999999999864    3579999998766666667889999999999999999999999865 467


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      ++||||+++++|.+++... ..+++..+..++.|++.+|.|||+++++||||||+||+++.++.++++|||++.......
T Consensus        83 ~lvmE~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~  161 (277)
T d1xbba_          83 MLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  161 (277)
T ss_dssp             EEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred             EEEEEcCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccc
Confidence            8999999999999998654 459999999999999999999999999999999999999999999999999998665432


Q ss_pred             cc----ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          191 VM----TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       191 ~~----~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      ..    ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+.++.+...|+
T Consensus       162 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~  233 (277)
T d1xbba_         162 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA  233 (277)
T ss_dssp             SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             cccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            22    23458899999999999999999999999999999998 899999999999999999887766654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-48  Score=318.88  Aligned_cols=214  Identities=20%  Similarity=0.354  Sum_probs=193.3

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ++|.+.+.||+|+||+||+|.+.  ++.||+|+++....   ....+.+|+++++.++||||+++++++.+.+.+++|||
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH---HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc---cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            57899999999999999999974  78999999987542   23567899999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC--CeEEEeeeccceeccCCCccc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH--NVVKVADFGVARFQNKGGVMT  193 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~--~~i~l~D~~~~~~~~~~~~~~  193 (259)
                      |++|++|.+++......+++.+++.++.||+.+|.|||+.|++||||||+||+++.+  ..++|+|||.+..........
T Consensus        82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~  161 (321)
T d1tkia_          82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR  161 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccc
Confidence            999999999997766679999999999999999999999999999999999999854  479999999998877766666


Q ss_pred             cCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          194 AETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      ...+++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+....|.++....
T Consensus       162 ~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~  222 (321)
T d1tkia_         162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF  222 (321)
T ss_dssp             EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC
T ss_pred             ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            6678999999999999999999999999999999999999999999999998888765443

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.3e-47  Score=306.27  Aligned_cols=216  Identities=24%  Similarity=0.406  Sum_probs=192.5

Q ss_pred             hhhhccceeccccceEEEEEEE--cCceEEEEEeecccCch-------HHHHHHHHHHHHHHhcC-CCCcceeeeeeecC
Q 045286           38 RLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHLND-------TLEDEFVQEVAILREVQ-HRNVVRFIGASTKS  107 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~~~-------~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~  107 (259)
                      ++|++.+.||+|+||+||+|.+  +++.||||++.......       ...+.+.+|+.++++++ ||||+++++++.+.
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            5789999999999999999997  57899999998764332       23456889999999997 99999999999999


Q ss_pred             CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      +..++||||+++++|.+++.... .+++..+..++.||+.+|.|||++|++||||||+||+++.++.+||+|||.+....
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             cceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence            99999999999999999996654 59999999999999999999999999999999999999999999999999999887


Q ss_pred             CCCccccCCCcccccCccccC------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          188 KGGVMTAETGTYRWMAPEVIN------HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       188 ~~~~~~~~~~~~~~~~PE~~~------~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      .........+++.|.|||.+.      ...+++++|+||+||++|+|++|..||.+.+..+....+.++-...
T Consensus       162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~  234 (277)
T d1phka_         162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF  234 (277)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            766666778999999999984      3356889999999999999999999999999988888887765443

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1e-47  Score=319.70  Aligned_cols=214  Identities=24%  Similarity=0.384  Sum_probs=192.7

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~  114 (259)
                      ++|++.++||+|+||.||+|.+.  ++.||||++..... .......+.+|+.+++.++||||+++++++......++|+
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            68999999999999999999985  88999999975432 2234467889999999999999999999999999999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcccc
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVMTA  194 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~~~  194 (259)
                      |++.+++|..++.... .+++..++.++.||+.+|.|||++|++||||||+|||++.+|.+||+|||++......  ...
T Consensus       121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~~~  197 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWT  197 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCC
T ss_pred             ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--ccc
Confidence            9999999999996654 4999999999999999999999999999999999999999999999999999877653  334


Q ss_pred             CCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          195 ETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      ..|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+...++..+....
T Consensus       198 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~  257 (350)
T d1rdqe_         198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF  257 (350)
T ss_dssp             CEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             ccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC
Confidence            578999999999999999999999999999999999999999999999999888776544

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=309.84  Aligned_cols=224  Identities=27%  Similarity=0.565  Sum_probs=187.5

Q ss_pred             cceechhhhhccceeccccceEEEEEEEc-----CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec
Q 045286           32 DWEIDRRLLKTGERIASGSCGDLYRGVYL-----GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK  106 (259)
Q Consensus        32 ~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~  106 (259)
                      +|+|+.++|++.++||+|+||.||+|.+.     +..|++|.++... .+.....+.+|+.++++++||||+++++++.+
T Consensus         1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~   79 (273)
T d1mp8a_           1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE   79 (273)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            58999999999999999999999999874     2458888876543 44556789999999999999999999999864


Q ss_pred             CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceec
Q 045286          107 SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQ  186 (259)
Q Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~  186 (259)
                       +..++||||+++++|.+++......+++..++.++.|++++|.|||+.+++||||||+||+++.++.+||+|||.+...
T Consensus        80 -~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          80 -NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             -SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             -CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence             5789999999999999998777777999999999999999999999999999999999999999999999999999865


Q ss_pred             cCCC--ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          187 NKGG--VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       187 ~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      ....  ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+..+...+.|+
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~  232 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP  232 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT
T ss_pred             cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            5432  2234457899999999999999999999999999999998 899999999999999999887766554

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=316.16  Aligned_cols=224  Identities=31%  Similarity=0.542  Sum_probs=187.1

Q ss_pred             cccceechhhhhccceeccccceEEEEEEEcC-------ceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceee
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFI  101 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~-------~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~  101 (259)
                      ...|+++.++|++.++||+|+||+||+|.+.+       ..||+|.+..... ......+.+|+.+++++ +||||++++
T Consensus        29 ~~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~  107 (325)
T d1rjba_          29 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLL  107 (325)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-HHHHHHHHHHHHHHHHhcCCCcEeEEE
Confidence            45699999999999999999999999999743       2589998876532 23346788999999998 799999999


Q ss_pred             eeeecCCcEEEEEecCCCCChHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 045286          102 GASTKSPHLCIVTEYMPGGSLYDYLHKNH----------------------NVLKLPQLLRFAIDICKGMEYLHQRNIIH  159 (259)
Q Consensus       102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H  159 (259)
                      +++...+..++||||+++++|.+++....                      ..+++..++.++.|++.+|.|||+++++|
T Consensus       108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiH  187 (325)
T d1rjba_         108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH  187 (325)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             EEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence            99999999999999999999999996543                      24788899999999999999999999999


Q ss_pred             CCCCCCcEEEccCCeEEEeeeccceeccCCCcc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCC
Q 045286          160 RDLKTANLLMDTHNVVKVADFGVARFQNKGGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPY  235 (259)
Q Consensus       160 ~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~  235 (259)
                      |||||+||+++.++.+||+|||++.........   ....+++.|+|||.+.+..+++++|||||||++|+|++ |..||
T Consensus       188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf  267 (325)
T d1rjba_         188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  267 (325)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence            999999999999999999999999765544322   23346899999999999999999999999999999998 89999


Q ss_pred             CCCCHHHHHHHh-hhccCCC
Q 045286          236 DSMTPLQAALGV-RQVCTSL  254 (259)
Q Consensus       236 ~~~~~~~~~~~i-~~~~~~~  254 (259)
                      .+.+..+.+.++ ..+.+..
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~  287 (325)
T d1rjba_         268 PGIPVDANFYKLIQNGFKMD  287 (325)
T ss_dssp             TTCCCSHHHHHHHHTTCCCC
T ss_pred             CCCCHHHHHHHHHhcCCCCC
Confidence            987766555554 4444433

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-47  Score=307.20  Aligned_cols=224  Identities=34%  Similarity=0.619  Sum_probs=190.0

Q ss_pred             cccceechhhhhccceeccccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      .+.|+|+.++|++.+.||+|+||+||+|.+. ++.||||++.......   +.+.+|+.++++++|+||+++++++.+ +
T Consensus         9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~~-~   84 (285)
T d1fmka3           9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE-E   84 (285)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             CcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEEEec-C
Confidence            4669999999999999999999999999985 4679999998665443   678999999999999999999999865 5


Q ss_pred             cEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          109 HLCIVTEYMPGGSLYDYLHKN-HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      ..++||||+++++|..++... ...+++..+..++.|++.+|.+||++|++||||||+|||++.++.+||+|||++....
T Consensus        85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~  164 (285)
T d1fmka3          85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  164 (285)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhcc
Confidence            678999999999999988543 3458999999999999999999999999999999999999999999999999997654


Q ss_pred             CCC--ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          188 KGG--VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       188 ~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      ...  ......+++.|+|||.+.+..++.++||||||+++|+|++ |..|+...+..+.+..+.++...+.++
T Consensus       165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~  237 (285)
T d1fmka3         165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP  237 (285)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             CCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCc
Confidence            332  2233568899999999999999999999999999999999 566678888888999998887766654

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=7e-47  Score=305.80  Aligned_cols=215  Identities=29%  Similarity=0.464  Sum_probs=181.4

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC----c
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP----H  109 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~  109 (259)
                      .++|++.+.||+|+||+||+|.+.  ++.||+|+++.... +......+.+|+++++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            357899999999999999999975  88999999987654 3455678999999999999999999999886543    4


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG  189 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~  189 (259)
                      .++||||++|++|.+++.... .+++.+++.++.|++.+|.+||++|++||||||+||+++.++..+++|||.+......
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~  164 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS  164 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred             EEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence            899999999999999886554 4999999999999999999999999999999999999999999999999998654433


Q ss_pred             C----ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          190 G----VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       190 ~----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      .    ......|++.|+|||.+.+..+++++|||||||++|+|++|..||.+.+..+...++.+...
T Consensus       165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~  231 (277)
T d1o6ya_         165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP  231 (277)
T ss_dssp             --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC
T ss_pred             cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCC
Confidence            2    23345789999999999999999999999999999999999999999998888777665543

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-46  Score=308.96  Aligned_cols=214  Identities=25%  Similarity=0.428  Sum_probs=186.8

Q ss_pred             hhhhccceeccccceEEEEEEE--cCceEEEEEeecccC-chHHHHHHHHHHHHHH-hcCCCCcceeeeeeecCCcEEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVY--LGQDVAVKVLRSEHL-NDTLEDEFVQEVAILR-EVQHRNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv  113 (259)
                      ++|.+.++||+|+||+||+|.+  +++.||||+++.... .......+.+|..++. .++||||+++++++.+.+..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            4688899999999999999998  489999999976432 1222345566666655 68999999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-Ccc
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVM  192 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~  192 (259)
                      |||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||.+...... ...
T Consensus        82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~  160 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT  160 (320)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred             EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence            99999999999997654 4899999999999999999999999999999999999999999999999999865543 334


Q ss_pred             ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccC
Q 045286          193 TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       193 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      ....|++.|+|||++.+.+++.++|+|||||++|+|++|..||.+.+..+...++..+..
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~  220 (320)
T d1xjda_         161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP  220 (320)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred             cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence            456799999999999999999999999999999999999999999999999888876543

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-47  Score=304.53  Aligned_cols=221  Identities=34%  Similarity=0.629  Sum_probs=189.1

Q ss_pred             cceechhhhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec-CCcE
Q 045286           32 DWEIDRRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK-SPHL  110 (259)
Q Consensus        32 ~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~  110 (259)
                      .|+++-++|++.++||.|+||.||+|.+.+..||||+++.+.    ..+.+.+|+.++++++||||+++++++.+ .+.+
T Consensus         1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           1 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             CCccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            489999999999999999999999999999999999997653    23668899999999999999999998854 4568


Q ss_pred             EEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC
Q 045286          111 CIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG  189 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~  189 (259)
                      ++||||+++++|.+++.... ..++...+..++.|++.++.|||+.+++|+||+|+||+++.++.++++|||.+......
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence            99999999999999996543 34889999999999999999999999999999999999999999999999999865543


Q ss_pred             CccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCccC
Q 045286          190 GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQPI  258 (259)
Q Consensus       190 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~  258 (259)
                      .  ....+++.|+|||.+.+..+++++||||||+++|+|++ |+.||...+..+....+.++.+++.|+.
T Consensus       157 ~--~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~  224 (262)
T d1byga_         157 Q--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG  224 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTT
T ss_pred             C--ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence            2  33457889999999998899999999999999999998 8999999999999999998887776653

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-46  Score=302.35  Aligned_cols=223  Identities=29%  Similarity=0.533  Sum_probs=187.0

Q ss_pred             eechhhhhccceeccccceEEEEEEEcC------ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 045286           34 EIDRRLLKTGERIASGSCGDLYRGVYLG------QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS  107 (259)
Q Consensus        34 ~~~~~~~~~~~~lg~G~~~~V~~~~~~~------~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~  107 (259)
                      +++-+.|+..++||+|+||.||+|.+.+      ..||||.+.... .+.....+.+|+.++++++||||+++++++...
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence            4555678899999999999999998753      369999997654 334456789999999999999999999999999


Q ss_pred             CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      +..++|+|++.++++.+.+......++...+..++.|++.+|.|||+.+++||||||+|||++.++.+||+|||++....
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            99999999999999999988777789999999999999999999999999999999999999999999999999997654


Q ss_pred             CCCc----cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          188 KGGV----MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       188 ~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      ....    .....+++.|+|||.+.+..++.++||||||+++|+|++ |..|+...+..+....+..+.+++.|+
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~  236 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM  236 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCch
Confidence            4321    223457899999999999999999999999999999999 566677888888888888887665543

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-46  Score=308.97  Aligned_cols=220  Identities=24%  Similarity=0.363  Sum_probs=188.5

Q ss_pred             hhhhhccceeccccceEEEEEEEc---CceEEEEEeecccCchHHHHHHHHHHHHHHhc---CCCCcceeeeeeec----
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL---GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV---QHRNVVRFIGASTK----  106 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~---~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~----  106 (259)
                      +++|++.++||+|+||+||+|.+.   ++.||||+++.....+.....+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999974   56799999987654443334456777777666   79999999998842    


Q ss_pred             -CCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          107 -SPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       107 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                       ....++++|+++++.+..........+++..++.++.|++.+|.|||++|++||||||+|||++.++.++|+|||.+..
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~  165 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI  165 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence             3478999999988766666555566799999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          186 QNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      ...........||+.|+|||.+.+.+++.++||||+||++|+|++|..||.+.+..+.+..+.+..+.+..
T Consensus       166 ~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  236 (305)
T d1blxa_         166 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  236 (305)
T ss_dssp             CCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred             hcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence            76666667778999999999999999999999999999999999999999999999999888776655443

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-46  Score=305.88  Aligned_cols=215  Identities=24%  Similarity=0.463  Sum_probs=182.5

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ++|++.+.||+|+||+||+|.+.  ++.||||+++.....+.....+.+|++++++++||||+++++++...+..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            47888999999999999999985  7899999997765444445788999999999999999999999999999999999


Q ss_pred             cCCCCChHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC-Cccc
Q 045286          116 YMPGGSLYDYL-HKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG-GVMT  193 (259)
Q Consensus       116 ~~~~~~L~~~l-~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~-~~~~  193 (259)
                      ++.+ ++.+++ ......+++..++.++.|++.+|.|||+.|++||||||+||+++.++.++|+|||.+...... ....
T Consensus        82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~  160 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  160 (298)
T ss_dssp             CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTT
T ss_pred             ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccce
Confidence            9965 555544 444556999999999999999999999999999999999999999999999999999766543 3344


Q ss_pred             cCCCcccccCccccCCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          194 AETGTYRWMAPEVINHQP-YDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       194 ~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ...+++.|+|||.+.... ++.++|+||+||++|+|++|..||.+.+..+.+..+.+....
T Consensus       161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~  221 (298)
T d1gz8a_         161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT  221 (298)
T ss_dssp             CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            557899999999987765 478999999999999999999999999988888877655443

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=8.5e-46  Score=309.54  Aligned_cols=204  Identities=27%  Similarity=0.393  Sum_probs=174.6

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCch----HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND----TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLC  111 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~  111 (259)
                      ++|++.++||+|+||.||+|.+.  ++.||+|++.......    .......+++.+++.++||||+++++++...+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            46888999999999999999984  8899999987543211    12222334567777788999999999999999999


Q ss_pred             EEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc
Q 045286          112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV  191 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~  191 (259)
                      +||||++|++|.+++.... .+++..++.++.||+.+|.|||+.|++||||||+|||++.+|.+||+|||++...... .
T Consensus        84 ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-~  161 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-K  161 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-C
T ss_pred             EEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-c
Confidence            9999999999999997654 4889999999999999999999999999999999999999999999999999876654 3


Q ss_pred             cccCCCcccccCccccC-CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 045286          192 MTAETGTYRWMAPEVIN-HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQA  243 (259)
Q Consensus       192 ~~~~~~~~~~~~PE~~~-~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~  243 (259)
                      .....||+.|+|||.+. +..++.++|||||||++|+|++|..||.+.+..+.
T Consensus       162 ~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~  214 (364)
T d1omwa3         162 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK  214 (364)
T ss_dssp             CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH
T ss_pred             ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            34567999999999986 56789999999999999999999999987554433

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-46  Score=303.93  Aligned_cols=213  Identities=24%  Similarity=0.368  Sum_probs=179.5

Q ss_pred             cceeccccceEEEEEEEc--CceEEEEEeecccCch---HHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEecC
Q 045286           43 GERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND---TLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEYM  117 (259)
Q Consensus        43 ~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~  117 (259)
                      .++||+|+||+||+|.+.  ++.||||+++......   .....+.+|+.++++++||||+++++++...+.+++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            478999999999999974  7899999997654332   22356889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-ccccCC
Q 045286          118 PGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMTAET  196 (259)
Q Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~~~~  196 (259)
                      +++++.... .....+++..+..++.|++.+|.|||++|++||||||+||+++.++.+||+|||.+....... ......
T Consensus        83 ~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~  161 (299)
T d1ua2a_          83 ETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV  161 (299)
T ss_dssp             SEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred             cchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence            776555444 455568999999999999999999999999999999999999999999999999997665442 334557


Q ss_pred             CcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          197 GTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       197 ~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      +++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+.+.+|.+.++.+..
T Consensus       162 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~  222 (299)
T d1ua2a_         162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE  222 (299)
T ss_dssp             CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            8999999999865 46799999999999999999999999999999999998887665543

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-45  Score=300.49  Aligned_cols=226  Identities=30%  Similarity=0.558  Sum_probs=193.5

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEcC---------ceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCccee
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYLG---------QDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRF  100 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~---------~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~  100 (259)
                      ..|+|+.++|.+++.||+|+||.||+|+..+         ..||||+++.... ......+.+|...+.++ +||||+++
T Consensus         6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~e~~~l~~~~~HpnIv~~   84 (299)
T d1fgka_           6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINL   84 (299)
T ss_dssp             TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC-hHHHHHHHHHHHHHHHhcCCCeEEec
Confidence            4599999999999999999999999998642         3699999987543 34457788899999888 69999999


Q ss_pred             eeeeecCCcEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 045286          101 IGASTKSPHLCIVTEYMPGGSLYDYLHKNH---------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTA  165 (259)
Q Consensus       101 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~  165 (259)
                      ++++.+.+..++||||+++++|.+++....               ..+++..+..++.|++.+|.|||+.+++||||||+
T Consensus        85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~  164 (299)
T d1fgka_          85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR  164 (299)
T ss_dssp             EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence            999999999999999999999999996543               34899999999999999999999999999999999


Q ss_pred             cEEEccCCeEEEeeeccceeccCCC---ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 045286          166 NLLMDTHNVVKVADFGVARFQNKGG---VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL  241 (259)
Q Consensus       166 Nilv~~~~~i~l~D~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~  241 (259)
                      |||++.++.+||+|||.+.......   ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..
T Consensus       165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~  244 (299)
T d1fgka_         165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  244 (299)
T ss_dssp             GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence            9999999999999999998665442   2334568899999999999999999999999999999998 79999999999


Q ss_pred             HHHHHhhhccCCCCcc
Q 045286          242 QAALGVRQVCTSLCQP  257 (259)
Q Consensus       242 ~~~~~i~~~~~~~~~~  257 (259)
                      +....+..+.....|+
T Consensus       245 ~~~~~i~~~~~~~~p~  260 (299)
T d1fgka_         245 ELFKLLKEGHRMDKPS  260 (299)
T ss_dssp             HHHHHHHTTCCCCCCS
T ss_pred             HHHHHHHcCCCCCCCc
Confidence            9999888887776654

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-45  Score=301.21  Aligned_cols=224  Identities=30%  Similarity=0.536  Sum_probs=195.1

Q ss_pred             ceechhhhhccceeccccceEEEEEEEcC-------ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeee
Q 045286           33 WEIDRRLLKTGERIASGSCGDLYRGVYLG-------QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGAST  105 (259)
Q Consensus        33 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~~-------~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~  105 (259)
                      ++++.++|++.+.||+|+||+||+|++.+       +.||||++.... .......+.+|+.++++++||||+++++++.
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            78889999999999999999999999753       679999987653 4455678999999999999999999999999


Q ss_pred             cCCcEEEEEecCCCCChHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 045286          106 KSPHLCIVTEYMPGGSLYDYLHKNH-----------------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDL  162 (259)
Q Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di  162 (259)
                      ..+..++++|++++++|.+++....                       ..++...+..++.|++.+|.|||+.+++||||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl  166 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL  166 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence            9999999999999999999986432                       23788899999999999999999999999999


Q ss_pred             CCCcEEEccCCeEEEeeeccceeccCCC---ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCC-CCCCCC
Q 045286          163 KTANLLMDTHNVVKVADFGVARFQNKGG---VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAK-VPYDSM  238 (259)
Q Consensus       163 ~p~Nilv~~~~~i~l~D~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~-~p~~~~  238 (259)
                      ||+||+++.++.+||+|||++.......   ......+++.|+|||.+.+..++.++||||||+++|+|++|. .||.+.
T Consensus       167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~  246 (301)
T d1lufa_         167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  246 (301)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence            9999999999999999999987553332   223456788999999999999999999999999999999975 689999


Q ss_pred             CHHHHHHHhhhccCCCCcc
Q 045286          239 TPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       239 ~~~~~~~~i~~~~~~~~~~  257 (259)
                      +..+.+..+.++..+..|+
T Consensus       247 ~~~e~~~~v~~~~~~~~p~  265 (301)
T d1lufa_         247 AHEEVIYYVRDGNILACPE  265 (301)
T ss_dssp             CHHHHHHHHHTTCCCCCCT
T ss_pred             CHHHHHHHHHcCCCCCCCc
Confidence            9999999999887765553

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-45  Score=302.86  Aligned_cols=219  Identities=30%  Similarity=0.572  Sum_probs=186.0

Q ss_pred             hhhhhccceeccccceEEEEEEEc--Cc----eEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQ----DVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHL  110 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~----~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~  110 (259)
                      ..+|++.++||+|+||+||+|.+.  ++    +||+|.++... .....+.+.+|+.++++++||||+++++++..+ ..
T Consensus         8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~   85 (317)
T d1xkka_           8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   85 (317)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred             HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence            456899999999999999999874  33    58888887543 233457789999999999999999999999865 56


Q ss_pred             EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC
Q 045286          111 CIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG  190 (259)
Q Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~  190 (259)
                      +++++++.+++|.+.+......+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred             eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence            78888998999999998877789999999999999999999999999999999999999999999999999998765432


Q ss_pred             cc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          191 VM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       191 ~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      ..   ....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+.++.+.+.|+
T Consensus       166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~  236 (317)
T d1xkka_         166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP  236 (317)
T ss_dssp             C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCT
T ss_pred             ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            22   23357899999999999999999999999999999998 899999999999988898888766554

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-46  Score=306.47  Aligned_cols=199  Identities=25%  Similarity=0.407  Sum_probs=172.9

Q ss_pred             hhhhcc-ceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeeeeeec----CCc
Q 045286           38 RLLKTG-ERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGASTK----SPH  109 (259)
Q Consensus        38 ~~~~~~-~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----~~~  109 (259)
                      ++|.+. ++||+|+||+||+|.+.  ++.||||+++..       ..+.+|+.++.++ +||||+++++++..    ...
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence            356655 56999999999999974  789999998754       4577899887655 79999999999864    457


Q ss_pred             EEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc---CCeEEEeeecccee
Q 045286          110 LCIVTEYMPGGSLYDYLHKNH-NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT---HNVVKVADFGVARF  185 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~---~~~i~l~D~~~~~~  185 (259)
                      +++||||++|++|.+++.... ..+++.+++.++.|++.+|.|||+.|++||||||+||+++.   ++.+||+|||++..
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~  163 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  163 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence            899999999999999997643 46899999999999999999999999999999999999975   46799999999988


Q ss_pred             ccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 045286          186 QNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQA  243 (259)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~  243 (259)
                      ...........|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.
T Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~  221 (335)
T d2ozaa1         164 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI  221 (335)
T ss_dssp             CCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--
T ss_pred             ccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH
Confidence            7777666777899999999999999999999999999999999999999976654433

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.1e-45  Score=298.49  Aligned_cols=219  Identities=24%  Similarity=0.382  Sum_probs=186.8

Q ss_pred             hhhhccceeccccceEEEEEEEc-CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEec
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL-GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTEY  116 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~  116 (259)
                      ++|++.++||+|+||+||+|.+. ++.||||++......+.....+.+|+.++++++||||+++++++...+..++++++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            47889999999999999999985 68999999987765555567899999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCc-cccC
Q 045286          117 MPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGV-MTAE  195 (259)
Q Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~-~~~~  195 (259)
                      +.++.+..+ ......+++..+..++.|++.+|.+||+.|++||||||+||+++.++.++++|||.+........ ....
T Consensus        82 ~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  160 (286)
T d1ob3a_          82 LDQDLKKLL-DVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE  160 (286)
T ss_dssp             CSEEHHHHH-HTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred             ehhhhHHHH-HhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccccee
Confidence            966555444 45556799999999999999999999999999999999999999999999999999987654432 3344


Q ss_pred             CCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCcc
Q 045286          196 TGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       196 ~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                      .+++.|.|||.+.+. .++.++|+|||||++|+|++|+.||.+.+..+.+.++.+....+..+
T Consensus       161 ~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~  223 (286)
T d1ob3a_         161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK  223 (286)
T ss_dssp             -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             cccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChh
Confidence            688999999998765 56899999999999999999999999999988888887766655444

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-45  Score=295.99  Aligned_cols=216  Identities=32%  Similarity=0.580  Sum_probs=178.8

Q ss_pred             echhhhhccceeccccceEEEEEEEcC-----ceEEEEEeecccC-chHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYLG-----QDVAVKVLRSEHL-NDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~~-----~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      |+.++|++.+.||+|+||+||+|....     ..||||++..... .+...+.+.+|+.++++++||||+++++++.+ +
T Consensus         5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~   83 (273)
T d1u46a_           5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P   83 (273)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence            556789999999999999999998642     3689999876543 33556789999999999999999999999975 4


Q ss_pred             cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccC
Q 045286          109 HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNK  188 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~  188 (259)
                      ..++|+||++++++.+++......++...+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            67899999999999999877777799999999999999999999999999999999999999999999999999987654


Q ss_pred             CCcc----ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHhhhcc
Q 045286          189 GGVM----TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPLQAALGVRQVC  251 (259)
Q Consensus       189 ~~~~----~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~~~~~~i~~~~  251 (259)
                      ....    ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+.+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~  231 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG  231 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCC
Confidence            4322    23346789999999999999999999999999999998 899999999999988886543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-44  Score=296.91  Aligned_cols=227  Identities=27%  Similarity=0.476  Sum_probs=198.1

Q ss_pred             cccceechhhhhccceeccccceEEEEEEEc-------CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeee
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIG  102 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~  102 (259)
                      .++|+|+.++|.+.++||+|+||+||+|.+.       +..||||+++... .......+.+|+.++++++||||+++++
T Consensus        12 ~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~   90 (308)
T d1p4oa_          12 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLG   90 (308)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             ccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeee
Confidence            3679999999999999999999999999874       4689999997653 4455567899999999999999999999


Q ss_pred             eeecCCcEEEEEecCCCCChHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC
Q 045286          103 ASTKSPHLCIVTEYMPGGSLYDYLHKN---------HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN  173 (259)
Q Consensus       103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~  173 (259)
                      ++...+..++||||+++++|.+++...         ...++...+..++.|++++|.|||+++++||||||+|||++.++
T Consensus        91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred             EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc
Confidence            999989999999999999999998532         13467889999999999999999999999999999999999999


Q ss_pred             eEEEeeeccceeccCCCc---cccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHhhh
Q 045286          174 VVKVADFGVARFQNKGGV---MTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTA-KVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       174 ~i~l~D~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g-~~p~~~~~~~~~~~~i~~  249 (259)
                      .+||+|||++........   .....+++.|+|||.+.+..++.++|+||||+++|+|++| ..||.+.+..+.+..+.+
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~  250 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  250 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence            999999999976544322   2233578999999999999999999999999999999997 688999999999999988


Q ss_pred             ccCCCCcc
Q 045286          250 VCTSLCQP  257 (259)
Q Consensus       250 ~~~~~~~~  257 (259)
                      +.....|+
T Consensus       251 ~~~~~~p~  258 (308)
T d1p4oa_         251 GGLLDKPD  258 (308)
T ss_dssp             TCCCCCCT
T ss_pred             CCCCCCcc
Confidence            87766554

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-44  Score=294.04  Aligned_cols=226  Identities=32%  Similarity=0.561  Sum_probs=178.8

Q ss_pred             cccceechhhhhccceeccccceEEEEEEEc-------CceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceee
Q 045286           30 SEDWEIDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFI  101 (259)
Q Consensus        30 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~  101 (259)
                      .+.|+|+.++|++.++||+|+||.||+|.+.       ++.||+|+++.... ......+.+|...+.++ +|+||+.++
T Consensus         5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C-HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-cHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            3569999999999999999999999999874       35799999876543 33446677888888887 489999999


Q ss_pred             eeeec-CCcEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 045286          102 GASTK-SPHLCIVTEYMPGGSLYDYLHKNH---------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTA  165 (259)
Q Consensus       102 ~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~  165 (259)
                      +++.. +...++||||+++++|.+++....               ..+++..+..++.|++++|.|||+++++||||||+
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~  163 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR  163 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence            98754 456899999999999999996432               24788999999999999999999999999999999


Q ss_pred             cEEEccCCeEEEeeeccceeccCCC---ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCH-
Q 045286          166 NLLMDTHNVVKVADFGVARFQNKGG---VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTA-KVPYDSMTP-  240 (259)
Q Consensus       166 Nilv~~~~~i~l~D~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g-~~p~~~~~~-  240 (259)
                      |||++.++.+||+|||++.......   ......+++.|+|||.+.+..++.++||||+||++|+|+++ ..||.+.+. 
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~  243 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  243 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999997654432   22345689999999999999999999999999999999986 568887654 


Q ss_pred             HHHHHHhhhccCCCCc
Q 045286          241 LQAALGVRQVCTSLCQ  256 (259)
Q Consensus       241 ~~~~~~i~~~~~~~~~  256 (259)
                      ......+.++.....|
T Consensus       244 ~~~~~~~~~~~~~~~~  259 (299)
T d1ywna1         244 EEFCRRLKEGTRMRAP  259 (299)
T ss_dssp             HHHHHHHHHTCCCCCC
T ss_pred             HHHHHHHhcCCCCCCC
Confidence            4445556666655444

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-44  Score=297.23  Aligned_cols=223  Identities=32%  Similarity=0.523  Sum_probs=188.7

Q ss_pred             eechhhhhccceeccccceEEEEEEEc--Cc--eEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeeeeeecCC
Q 045286           34 EIDRRLLKTGERIASGSCGDLYRGVYL--GQ--DVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIGASTKSP  108 (259)
Q Consensus        34 ~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~--~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~  108 (259)
                      .|+.++|++.++||+|+||+||+|.+.  +.  .|+||.+.... .....+.+.+|+++++++ +||||+++++++...+
T Consensus         6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   84 (309)
T d1fvra_           6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   84 (309)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence            367789999999999999999999874  33  57778776443 223446789999999999 6999999999999999


Q ss_pred             cEEEEEecCCCCChHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC
Q 045286          109 HLCIVTEYMPGGSLYDYLHKN---------------HNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN  173 (259)
Q Consensus       109 ~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~  173 (259)
                      ..++||||+++++|.+++...               ...++...+..++.|++.++.|+|+.+++||||||+|||++.++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence            999999999999999998643               34689999999999999999999999999999999999999999


Q ss_pred             eEEEeeeccceeccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHhhhccC
Q 045286          174 VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTA-KVPYDSMTPLQAALGVRQVCT  252 (259)
Q Consensus       174 ~i~l~D~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g-~~p~~~~~~~~~~~~i~~~~~  252 (259)
                      .+||+|||.+.............++..|+|||.+.+..++.++||||||+++|+|++| ..||.+.+..+....+.++..
T Consensus       165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~  244 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR  244 (309)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred             ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Confidence            9999999999766554444455689999999999999999999999999999999996 467999999999999988876


Q ss_pred             CCCcc
Q 045286          253 SLCQP  257 (259)
Q Consensus       253 ~~~~~  257 (259)
                      ...|+
T Consensus       245 ~~~~~  249 (309)
T d1fvra_         245 LEKPL  249 (309)
T ss_dssp             CCCCT
T ss_pred             CCCCc
Confidence            65543

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-44  Score=298.51  Aligned_cols=218  Identities=27%  Similarity=0.452  Sum_probs=184.5

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP  108 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~  108 (259)
                      ..|++ .++|++.++||+|+||+||+|.+.  ++.||||+++.....+...+.+.+|+.+++.++||||+++++++...+
T Consensus        12 ~~~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~   90 (346)
T d1cm8a_          12 TAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE   90 (346)
T ss_dssp             SEECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred             ceeec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence            34777 458999999999999999999985  889999999877666677788999999999999999999999986554


Q ss_pred             ------cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeecc
Q 045286          109 ------HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGV  182 (259)
Q Consensus       109 ------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~  182 (259)
                            .+++|||++ +.+|...+...  .+++..++.++.|++.+|.|||++|++||||||+|||++.++.++++|||.
T Consensus        91 ~~~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          91 TLDDFTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             cccccceEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccc
Confidence                  579999999 67788776543  499999999999999999999999999999999999999999999999999


Q ss_pred             ceeccCCCccccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          183 ARFQNKGGVMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      +......  .....+++.|+|||.+.+. .++.++|+||+||++|+|++|..||.+.+..+.+..+.+....+
T Consensus       168 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~  238 (346)
T d1cm8a_         168 ARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP  238 (346)
T ss_dssp             CEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             eeccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCC
Confidence            9876543  3456789999999998764 56899999999999999999999999999888887777655543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-43  Score=291.77  Aligned_cols=220  Identities=24%  Similarity=0.367  Sum_probs=184.1

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec--------C
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK--------S  107 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------~  107 (259)
                      .+|++.++||+|+||+||+|.+.  ++.||||++......+.....+.+|+.+++.++|+||+++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            78999999999999999999985  7899999998766555555778899999999999999999998744        3


Q ss_pred             CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceecc
Q 045286          108 PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQN  187 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~  187 (259)
                      +..+++||++.++.+. ........+++..++.++.|++.+|.|||++|++||||||+||+++.++.++++|||++....
T Consensus        90 ~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~  168 (318)
T d3blha1          90 GSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS  168 (318)
T ss_dssp             -CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence            4689999999665544 444445568999999999999999999999999999999999999999999999999997654


Q ss_pred             CCC-----ccccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCccC
Q 045286          188 KGG-----VMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQPI  258 (259)
Q Consensus       188 ~~~-----~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  258 (259)
                      ...     .....++|+.|+|||.+.+. .+++++||||+||++|+|++|+.||.+.+..+....+.+......++.
T Consensus       169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  245 (318)
T d3blha1         169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV  245 (318)
T ss_dssp             C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence            322     22334689999999998765 689999999999999999999999999999999999888877766543

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-43  Score=291.50  Aligned_cols=226  Identities=31%  Similarity=0.539  Sum_probs=192.3

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEc-------CceEEEEEeecccCchHHHHHHHHHHHHHHhc-CCCCcceeee
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYL-------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREV-QHRNVVRFIG  102 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~  102 (259)
                      ..|+++.++|++.++||+|+||.||+|++.       ++.||||+++... .......+.+|+.+++.+ +||||+++++
T Consensus        16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g   94 (311)
T d1t46a_          16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG   94 (311)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            469999999999999999999999999863       3579999998654 344556789999999999 5999999999


Q ss_pred             eeecCCcEEEEEecCCCCChHHHHHhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 045286          103 ASTKSPHLCIVTEYMPGGSLYDYLHKNH-----------------NVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTA  165 (259)
Q Consensus       103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~  165 (259)
                      ++...+..+++|||+++++|.+++....                 ..+++..+..++.|++.++.|||+++++||||||+
T Consensus        95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~  174 (311)
T d1t46a_          95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR  174 (311)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence            9999999999999999999999986543                 24888999999999999999999999999999999


Q ss_pred             cEEEccCCeEEEeeeccceeccCCCcc---ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 045286          166 NLLMDTHNVVKVADFGVARFQNKGGVM---TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVT-AKVPYDSMTPL  241 (259)
Q Consensus       166 Nilv~~~~~i~l~D~~~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~-g~~p~~~~~~~  241 (259)
                      ||+++.++.++++|||.+.........   ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999999866543322   23457899999999999999999999999999999998 77778777766


Q ss_pred             HHHHH-hhhccCCCCcc
Q 045286          242 QAALG-VRQVCTSLCQP  257 (259)
Q Consensus       242 ~~~~~-i~~~~~~~~~~  257 (259)
                      +.+.+ +.++.++..++
T Consensus       255 ~~~~~~i~~~~~~~~~~  271 (311)
T d1t46a_         255 SKFYKMIKEGFRMLSPE  271 (311)
T ss_dssp             HHHHHHHHHTCCCCCCT
T ss_pred             HHHHHHHhcCCCCCCcc
Confidence            55544 45555555443

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=296.41  Aligned_cols=215  Identities=25%  Similarity=0.365  Sum_probs=178.2

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec------CCc
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK------SPH  109 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~  109 (259)
                      ++|++.++||+|+||+||+|.+.  ++.||||++............+.+|+.++++++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            46999999999999999999985  8999999999877666677789999999999999999999999853      367


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG  189 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~  189 (259)
                      +|+||||+.+ ++.+.+.   ..+++..++.++.|++.+|.+||++|++|+||||+||+++.++.++++|||.+......
T Consensus        97 ~~iv~Ey~~~-~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~  172 (355)
T d2b1pa1          97 VYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  172 (355)
T ss_dssp             EEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             eEEEEeccch-HHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence            8999999965 4444442   34889999999999999999999999999999999999999999999999998877776


Q ss_pred             CccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCCCc
Q 045286          190 GVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       190 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      .......+++.|+|||.+.+..+++++||||+||++++|++|+.||.+.+....+.++.+....+++
T Consensus       173 ~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~  239 (355)
T d2b1pa1         173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP  239 (355)
T ss_dssp             --------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCH
Confidence            6666778999999999999999999999999999999999999999999998888888877666544

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-43  Score=284.57  Aligned_cols=218  Identities=23%  Similarity=0.370  Sum_probs=190.0

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCCcEEEEEe
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSPHLCIVTE  115 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e  115 (259)
                      ++|++.++||+|+||+||+|.+.  ++.||||+++.....+.....+.+|+.+++.++|+||+++++++......+++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            37899999999999999999984  7889999998877666677889999999999999999999999999999999999


Q ss_pred             cCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCC-cccc
Q 045286          116 YMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGG-VMTA  194 (259)
Q Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~-~~~~  194 (259)
                      ++.++++..++. ....+++..++.++.|++.+|.|||++|++||||||+||+++.++.++|+|||.+....... ....
T Consensus        82 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~  160 (292)
T d1unla_          82 FCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA  160 (292)
T ss_dssp             CCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCS
T ss_pred             eccccccccccc-cccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcccee
Confidence            998888877764 44568999999999999999999999999999999999999999999999999998766543 3334


Q ss_pred             CCCcccccCccccCCCC-CCCchhHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHhhhccCCCCc
Q 045286          195 ETGTYRWMAPEVINHQP-YDQKADVFSFAIVLWELVTAKVP-YDSMTPLQAALGVRQVCTSLCQ  256 (259)
Q Consensus       195 ~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~~~~ll~g~~p-~~~~~~~~~~~~i~~~~~~~~~  256 (259)
                      ..++..|.|||.+.+.. ++.++||||+||++|+|++|..| |.+.+..+.+..+......+..
T Consensus       161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  224 (292)
T d1unla_         161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE  224 (292)
T ss_dssp             CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCCh
Confidence            45778899999987665 68999999999999999999988 5677778888887766665543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-44  Score=289.31  Aligned_cols=200  Identities=24%  Similarity=0.457  Sum_probs=170.8

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCch----HHHHHHHHHHHHHHhcC--CCCcceeeeeeecCC
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLND----TLEDEFVQEVAILREVQ--HRNVVRFIGASTKSP  108 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~----~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~  108 (259)
                      +.+|++.++||+|+||+||+|.+.  ++.||||++.......    ....++.+|+.++++++  ||||+++++++...+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            357999999999999999999985  7899999998654322    11234668999999997  899999999999999


Q ss_pred             cEEEEEecCCC-CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccC-CeEEEeeeccceec
Q 045286          109 HLCIVTEYMPG-GSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTH-NVVKVADFGVARFQ  186 (259)
Q Consensus       109 ~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~-~~i~l~D~~~~~~~  186 (259)
                      ..++|||++.+ +++.+++.... .+++..++.++.|++.+|.|||++|++||||||+||+++.+ +.++|+|||.+...
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~  161 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL  161 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             eEEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence            99999999976 57777775543 59999999999999999999999999999999999999855 79999999999865


Q ss_pred             cCCCccccCCCcccccCccccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCC
Q 045286          187 NKGGVMTAETGTYRWMAPEVINHQPY-DQKADVFSFAIVLWELVTAKVPYDSM  238 (259)
Q Consensus       187 ~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~~~~ll~g~~p~~~~  238 (259)
                      ... ......||+.|+|||.+.+..+ +.++|||||||++|+|++|..||...
T Consensus       162 ~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~  213 (273)
T d1xwsa_         162 KDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD  213 (273)
T ss_dssp             CSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             ccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence            543 3455679999999999987765 56789999999999999999999763

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=295.66  Aligned_cols=211  Identities=25%  Similarity=0.352  Sum_probs=179.1

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec------CCc
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK------SPH  109 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~  109 (259)
                      .+|...++||+|+||+||+|.+.  ++.||||++......      ..+|++++++++|+||+++++++..      ...
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~   93 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY   93 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence            46888999999999999999984  789999999875422      3479999999999999999998843      235


Q ss_pred             EEEEEecCCCCChHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC-eEEEeeeccceec
Q 045286          110 LCIVTEYMPGGSLYDYLH--KNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN-VVKVADFGVARFQ  186 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~-~i~l~D~~~~~~~  186 (259)
                      +++||||++++.+.....  .....+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus        94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            789999996653333322  3344699999999999999999999999999999999999999775 8999999999887


Q ss_pred             cCCCccccCCCcccccCccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          187 NKGGVMTAETGTYRWMAPEVINH-QPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       187 ~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      ..........+++.|+|||.+.+ ..++.++||||+||++|+|++|..||...+..+.+..+.+..+.+
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~  242 (350)
T d1q5ka_         174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP  242 (350)
T ss_dssp             CTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             cCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            77666677789999999998765 578999999999999999999999999999988888887655443

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-43  Score=290.45  Aligned_cols=217  Identities=24%  Similarity=0.388  Sum_probs=178.3

Q ss_pred             cceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC-
Q 045286           32 DWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP-  108 (259)
Q Consensus        32 ~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-  108 (259)
                      .|++. .+|++.++||+|+||+||+|.+.  ++.||||++.... .......+++|+.+++.++||||+++++++.... 
T Consensus         3 ~~~i~-~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~   80 (345)
T d1pmea_           3 VFDVG-PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   80 (345)
T ss_dssp             CCCCC-TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             ccCcC-CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence            35563 46999999999999999999975  8999999997654 3455577899999999999999999999886532 


Q ss_pred             ----cEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccce
Q 045286          109 ----HLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVAR  184 (259)
Q Consensus       109 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~  184 (259)
                          .++++ +++.+++|.+++...  .+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||.+.
T Consensus        81 ~~~~~~~l~-~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          81 EQMKDVYLV-THLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             TTCCCEEEE-EECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             cccceEEEE-EeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence                34555 556689999999654  49999999999999999999999999999999999999999999999999997


Q ss_pred             eccCCC----ccccCCCcccccCccccC-CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCC
Q 045286          185 FQNKGG----VMTAETGTYRWMAPEVIN-HQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTS  253 (259)
Q Consensus       185 ~~~~~~----~~~~~~~~~~~~~PE~~~-~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~  253 (259)
                      ......    ......+++.|+|||.+. +..++.++|+||+||++|+|++|..||.+.+..+...........
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~  231 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS  231 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccC
Confidence            654432    234456899999999984 456789999999999999999999999998887777666554433

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-42  Score=285.18  Aligned_cols=218  Identities=29%  Similarity=0.490  Sum_probs=179.6

Q ss_pred             hhhccceeccccceEEEEEEEcC-----ceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeec-CCcEEE
Q 045286           39 LLKTGERIASGSCGDLYRGVYLG-----QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTK-SPHLCI  112 (259)
Q Consensus        39 ~~~~~~~lg~G~~~~V~~~~~~~-----~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~l  112 (259)
                      .+.+.++||+|+||+||+|.+..     ..||||.++.. .+....+.+.+|++++++++||||+++++++.. .+..++
T Consensus        28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l  106 (311)
T d1r0pa_          28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  106 (311)
T ss_dssp             EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEE
T ss_pred             eeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEE
Confidence            33446789999999999999742     25899998753 345566889999999999999999999998764 568899


Q ss_pred             EEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCCCcc
Q 045286          113 VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKGGVM  192 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~~~~  192 (259)
                      ||||+++++|.+++.......+...+..++.|++.+|.|+|+.+++||||||+|||++.++.+||+|||.+.........
T Consensus       107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999999999999877777888899999999999999999999999999999999999999999999999865543221


Q ss_pred             -----ccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHhhhccCCCCcc
Q 045286          193 -----TAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPY-DSMTPLQAALGVRQVCTSLCQP  257 (259)
Q Consensus       193 -----~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~-~~~~~~~~~~~i~~~~~~~~~~  257 (259)
                           ....+++.|+|||.+.+..++.++||||||+++|+|++|..|| ...+..+....+.++.++..|+
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~  257 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE  257 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCT
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence                 2345789999999999999999999999999999999966665 4566667777777777665554

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.6e-42  Score=282.11  Aligned_cols=197  Identities=21%  Similarity=0.331  Sum_probs=172.7

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCC-CCcceeeeeeecCCcEEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH-RNVVRFIGASTKSPHLCIV  113 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv  113 (259)
                      +.+|++.++||+|+||+||+|.+.  ++.||||+.......    ..+.+|++.++.++| +|++.+++++......++|
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            568999999999999999999975  789999998765432    346688899999974 8999999999999999999


Q ss_pred             EecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc-----CCeEEEeeeccceeccC
Q 045286          114 TEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT-----HNVVKVADFGVARFQNK  188 (259)
Q Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~-----~~~i~l~D~~~~~~~~~  188 (259)
                      ||++ +++|.+++......++...+..++.|++.+|.+||++|++||||||+||+++.     ++.++|+|||.+.....
T Consensus        80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            9999 78999999877777999999999999999999999999999999999999964     57899999999986543


Q ss_pred             CC--------ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 045286          189 GG--------VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSM  238 (259)
Q Consensus       189 ~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  238 (259)
                      ..        ......||+.|+|||.+.+..+++++|+||||+++|+|++|..||.+.
T Consensus       159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~  216 (293)
T d1csna_         159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  216 (293)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCc
Confidence            21        122346899999999999999999999999999999999999999754

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-42  Score=290.07  Aligned_cols=219  Identities=24%  Similarity=0.382  Sum_probs=184.9

Q ss_pred             ccceechhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecC-
Q 045286           31 EDWEIDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKS-  107 (259)
Q Consensus        31 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-  107 (259)
                      ..|+++ ++|++.++||+|+||+||+|.+.  ++.||||++.....+......+.+|++++++++|+||+++++++... 
T Consensus        12 ~~~~~~-~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~   90 (348)
T d2gfsa1          12 TIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   90 (348)
T ss_dssp             SEEEEE-TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             ccccCC-CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecc
Confidence            348885 47999999999999999999974  89999999998766666677899999999999999999999988532 


Q ss_pred             ----CcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccc
Q 045286          108 ----PHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA  183 (259)
Q Consensus       108 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~  183 (259)
                          ...+++++++.+++|.+++...  .+++..++.++.|++.+|.|||++|++||||||+||+++.++.++++|||.+
T Consensus        91 ~~~~~~~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          91 SLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             STTTCCCCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             ccccCceEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchh
Confidence                3345666777799999998543  4999999999999999999999999999999999999999999999999998


Q ss_pred             eeccCCCccccCCCcccccCccccCCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhhccCCC
Q 045286          184 RFQNKGGVMTAETGTYRWMAPEVINHQP-YDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQVCTSL  254 (259)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~~~~~~  254 (259)
                      ......  .....+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.+.......+.+.....
T Consensus       169 ~~~~~~--~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~  238 (348)
T d2gfsa1         169 RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP  238 (348)
T ss_dssp             -CCTGG--GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             cccCcc--cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            755432  34557899999999877654 5899999999999999999999999999988888887665543

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-43  Score=288.45  Aligned_cols=211  Identities=21%  Similarity=0.368  Sum_probs=177.7

Q ss_pred             hhhhccceeccccceEEEEEEE-----cCceEEEEEeecccC--chHHHHHHHHHHHHHHhcCC-CCcceeeeeeecCCc
Q 045286           38 RLLKTGERIASGSCGDLYRGVY-----LGQDVAVKVLRSEHL--NDTLEDEFVQEVAILREVQH-RNVVRFIGASTKSPH  109 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~-----~~~~v~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~  109 (259)
                      ++|++.++||+|+||+||+|..     +++.||||+++....  +....+.+.+|+.++++++| |||+++++++.....
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            6799999999999999999986     367899999876432  12233567899999999976 899999999999999


Q ss_pred             EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccceeccCC
Q 045286          110 LCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVARFQNKG  189 (259)
Q Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~~~~~  189 (259)
                      .++++|++.+++|.+++..... ..+..+..++.|++.+|.|+|+.|++|+||||+||+++.++.++|+|||.+......
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~  182 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD  182 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred             eeeeeecccccHHHHHHHhccc-ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence            9999999999999999976554 778999999999999999999999999999999999999999999999999765433


Q ss_pred             --CccccCCCcccccCccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHhhh
Q 045286          190 --GVMTAETGTYRWMAPEVINHQ--PYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAALGVRQ  249 (259)
Q Consensus       190 --~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~~~i~~  249 (259)
                        .......+++.|++||.+.+.  .++.++|||||||++|+|++|..||.+.+..+....+.+
T Consensus       183 ~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~  246 (322)
T d1vzoa_         183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR  246 (322)
T ss_dssp             GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH
T ss_pred             ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence              223445689999999998754  468899999999999999999999987665444444443

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-42  Score=283.04  Aligned_cols=195  Identities=30%  Similarity=0.530  Sum_probs=162.6

Q ss_pred             hhhhhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCcceeeeeeecCC----cEEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNVVRFIGASTKSP----HLCI  112 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~l  112 (259)
                      .++|.+.+.||+|+||+||+|+..++.||||++....   ........|+..+..++||||+++++++...+    .+++
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            3678899999999999999999999999999987542   11122334555666788999999999986543    5899


Q ss_pred             EEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--------CCcccCCCCCCcEEEccCCeEEEeeeccce
Q 045286          113 VTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ--------RNIIHRDLKTANLLMDTHNVVKVADFGVAR  184 (259)
Q Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~--------~~i~H~di~p~Nilv~~~~~i~l~D~~~~~  184 (259)
                      ||||+++++|.+++.+.  .++....+.++.|++.++.++|.        +|++||||||+|||++.++.+||+|||++.
T Consensus        79 v~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            99999999999999765  38889999999999999999996        599999999999999999999999999998


Q ss_pred             eccCCC-----ccccCCCcccccCccccCCCC------CCCchhHHHHHHHHHHHHcCCCCCC
Q 045286          185 FQNKGG-----VMTAETGTYRWMAPEVINHQP------YDQKADVFSFAIVLWELVTAKVPYD  236 (259)
Q Consensus       185 ~~~~~~-----~~~~~~~~~~~~~PE~~~~~~------~~~~~Di~slG~~~~~ll~g~~p~~  236 (259)
                      ......     ......+++.|+|||.+.+..      ++.++|||||||++|+|++|..||.
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~  219 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence            765443     223456899999999987653      5678999999999999999988763

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=8.3e-42  Score=282.35  Aligned_cols=204  Identities=19%  Similarity=0.378  Sum_probs=175.1

Q ss_pred             hhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeec--CCcEE
Q 045286           37 RRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTK--SPHLC  111 (259)
Q Consensus        37 ~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~  111 (259)
                      .++|++.++||+|+||+||+|.+.  ++.||+|+++...     .+.+.+|+.+++.++ ||||+++++++..  ....+
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence            467999999999999999999985  8899999987542     356889999999996 9999999999864  45789


Q ss_pred             EEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCC-eEEEeeeccceeccCCC
Q 045286          112 IVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHN-VVKVADFGVARFQNKGG  190 (259)
Q Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~-~i~l~D~~~~~~~~~~~  190 (259)
                      +||||+++++|....    ..+++..++.++.||+.||.|||++|++||||||+|||++.++ .++|+|||.+.......
T Consensus       109 ~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         109 LVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             EEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             EEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999999999987653    3589999999999999999999999999999999999998654 69999999998887766


Q ss_pred             ccccCCCcccccCccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHhhh
Q 045286          191 VMTAETGTYRWMAPEVINHQ-PYDQKADVFSFAIVLWELVTAKVPYDSM-TPLQAALGVRQ  249 (259)
Q Consensus       191 ~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~~~~ll~g~~p~~~~-~~~~~~~~i~~  249 (259)
                      ......+++.|+|||.+.+. .++.++|+||+||++|+|++|..||... +..+....+.+
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~  245 (328)
T d3bqca1         185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK  245 (328)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH
T ss_pred             cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHH
Confidence            66777899999999998765 5799999999999999999999999654 34444444433

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-41  Score=276.87  Aligned_cols=202  Identities=26%  Similarity=0.372  Sum_probs=169.0

Q ss_pred             hhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCC-cceeeeeeecCCcEEEEE
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRN-VVRFIGASTKSPHLCIVT  114 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~  114 (259)
                      ++|++.+.||+|+||.||+|.+.  ++.||||++......    ..+.+|+++++.++|++ |+.+..++...+..++||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm   82 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence            47999999999999999999975  789999998875433    34678999999998665 555566678888999999


Q ss_pred             ecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEcc---CCeEEEeeeccceeccCCC-
Q 045286          115 EYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDT---HNVVKVADFGVARFQNKGG-  190 (259)
Q Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~---~~~i~l~D~~~~~~~~~~~-  190 (259)
                      |++ ++++...+......+++..+..++.|++.+|.+||++|++||||||+||+++.   +..++++|||.+....... 
T Consensus        83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (299)
T d1ckia_          83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  161 (299)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred             EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence            999 66888877777777999999999999999999999999999999999999854   4579999999998765432 


Q ss_pred             -------ccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 045286          191 -------VMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSMTPLQAA  244 (259)
Q Consensus       191 -------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~~~~~~~  244 (259)
                             ......|++.|+|||.+.+.+++.++|||||||++|+|++|..||...+..+..
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~  222 (299)
T d1ckia_         162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR  222 (299)
T ss_dssp             CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----
T ss_pred             ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHH
Confidence                   123446899999999999999999999999999999999999999876554433

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.6e-35  Score=247.66  Aligned_cols=199  Identities=21%  Similarity=0.366  Sum_probs=158.7

Q ss_pred             echhhhhccceeccccceEEEEEEEc--CceEEEEEeecccCchHHHHHHHHHHHHHHhcC-----------CCCcceee
Q 045286           35 IDRRLLKTGERIASGSCGDLYRGVYL--GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-----------HRNVVRFI  101 (259)
Q Consensus        35 ~~~~~~~~~~~lg~G~~~~V~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~  101 (259)
                      +.+.+|+++++||+|+||+||+|++.  ++.||||+++...   ...+.+.+|+.+++.++           |+||++++
T Consensus        10 ~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~   86 (362)
T d1q8ya_          10 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   86 (362)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             ccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence            34467999999999999999999974  8999999998653   23356778888888775           47899998


Q ss_pred             eeeec--CCcEEEEEecCCCCChHHH--HHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCcEEEccCC---
Q 045286          102 GASTK--SPHLCIVTEYMPGGSLYDY--LHKNHNVLKLPQLLRFAIDICKGMEYLHQ-RNIIHRDLKTANLLMDTHN---  173 (259)
Q Consensus       102 ~~~~~--~~~~~lv~e~~~~~~L~~~--l~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~di~p~Nilv~~~~---  173 (259)
                      +++..  ....++++.+.........  .......+++..++.++.|++.++.+||+ .||+||||||+|||++.++   
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence            88754  3455566665544332222  22344568899999999999999999998 8999999999999998765   


Q ss_pred             ---eEEEeeeccceeccCCCccccCCCcccccCccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 045286          174 ---VVKVADFGVARFQNKGGVMTAETGTYRWMAPEVINHQPYDQKADVFSFAIVLWELVTAKVPYDSM  238 (259)
Q Consensus       174 ---~i~l~D~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~~~~ll~g~~p~~~~  238 (259)
                         .++++|||.+......  .....+++.|+|||.+.+..++.++|+||+||++++|++|..||...
T Consensus       167 ~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~  232 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD  232 (362)
T ss_dssp             TEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             ccceeeEeecccccccccc--cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence               4999999998765543  34567999999999999999999999999999999999999999753

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=6.9e-26  Score=172.13  Aligned_cols=164  Identities=16%  Similarity=0.158  Sum_probs=119.4

Q ss_pred             hccceeccccceEEEEEEE-cCceEEEEEeecccCc----------------hHHHHHHHHHHHHHHhcCCCCcceeeee
Q 045286           41 KTGERIASGSCGDLYRGVY-LGQDVAVKVLRSEHLN----------------DTLEDEFVQEVAILREVQHRNVVRFIGA  103 (259)
Q Consensus        41 ~~~~~lg~G~~~~V~~~~~-~~~~v~vK~~~~~~~~----------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~  103 (259)
                      .++++||+|+||+||+|.+ +++.||||+++.....                ........+|...+.++.+.+++..++.
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            4678999999999999987 5789999987643211                1122445578889999999999887765


Q ss_pred             eecCCcEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCcEEEccCCeEEEeeeccc
Q 045286          104 STKSPHLCIVTEYMPGGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQRNIIHRDLKTANLLMDTHNVVKVADFGVA  183 (259)
Q Consensus       104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~di~p~Nilv~~~~~i~l~D~~~~  183 (259)
                      ..    .+++||++++..+.+        ++...+..++.|++.++.+||+.|++|+||||+|||+++ +.++|+|||.+
T Consensus        83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~-~~~~liDFG~a  149 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE-EGIWIIDFPQS  149 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET-TEEEECCCTTC
T ss_pred             cC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC-CCEEEEECCCc
Confidence            32    369999998754432        444556778999999999999999999999999999985 45899999998


Q ss_pred             eeccCCCccccCCCcccccCc--c---ccCCCCCCCchhHHHHHHH
Q 045286          184 RFQNKGGVMTAETGTYRWMAP--E---VINHQPYDQKADVFSFAIV  224 (259)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~~P--E---~~~~~~~~~~~Di~slG~~  224 (259)
                      .....+...       .|...  +   .+..+.|+.++|+||+.--
T Consensus       150 ~~~~~~~~~-------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         150 VEVGEEGWR-------EILERDVRNIITYFSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             EETTSTTHH-------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred             ccCCCCCcH-------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence            766544211       11110  0   0124567889999996533

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=99.04  E-value=4e-10  Score=88.07  Aligned_cols=138  Identities=12%  Similarity=0.080  Sum_probs=94.0

Q ss_pred             hhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeecCCcEEEEEecCC
Q 045286           40 LKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKSPHLCIVTEYMP  118 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~  118 (259)
                      +++.+..+-++.+.||+....++.+++|.........  ...+.+|...++.+. +--+++++......+..++||++++
T Consensus        16 ~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~   93 (263)
T d1j7la_          16 YRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD   93 (263)
T ss_dssp             SEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred             eEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecc
Confidence            3444444445557899988888889999887553221  234667888887775 3335677777777888999999999


Q ss_pred             CCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 045286          119 GGSLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLHQ--------------------------------------------  154 (259)
Q Consensus       119 ~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~--------------------------------------------  154 (259)
                      |.++.+....      ......++.++...+..||+                                            
T Consensus        94 G~~~~~~~~~------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (263)
T d1j7la_          94 GVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP  167 (263)
T ss_dssp             SEEHHHHTTT------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSH
T ss_pred             cccccccccc------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHH
Confidence            9877654321      11122234455555555553                                            


Q ss_pred             ---------------CCcccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          155 ---------------RNIIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       155 ---------------~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                                     ..++|+|+.|.||+++.++...++||+.+..
T Consensus       168 ~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                           1379999999999998766667999998753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.57  E-value=1.2e-07  Score=73.25  Aligned_cols=127  Identities=19%  Similarity=0.186  Sum_probs=81.0

Q ss_pred             eeccccc-eEEEEEEEcC-ceEEEEEeecccCchHHHHHHHHHHHHHHhcCC--CCcceeeeeeecCCcEEEEEecCCCC
Q 045286           45 RIASGSC-GDLYRGVYLG-QDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH--RNVVRFIGASTKSPHLCIVTEYMPGG  120 (259)
Q Consensus        45 ~lg~G~~-~~V~~~~~~~-~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~~~~~  120 (259)
                      .+..|.+ +.||+....+ ..+++|.......     ..+.+|...++.+..  -.+++++....+.+..++||++++|.
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~   91 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ   91 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence            4455554 6789988764 4578888665432     235667777776642  23566777777778899999999886


Q ss_pred             ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 045286          121 SLYDYLHKNHNVLKLPQLLRFAIDICKGMEYLH-----------------------------------------------  153 (259)
Q Consensus       121 ~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH-----------------------------------------------  153 (259)
                      ++.+..      ....   ..+.++...+..||                                               
T Consensus        92 ~~~~~~------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          92 DLLSSH------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             ETTTSC------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             cccccc------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            653310      1100   01122222222333                                               


Q ss_pred             ----h-------CCcccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          154 ----Q-------RNIIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       154 ----~-------~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                          +       ..++|+|+.|.||+++.++...++||+.+..
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                1       1389999999999998776678999998754

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.25  E-value=2.5e-06  Score=70.09  Aligned_cols=77  Identities=13%  Similarity=-0.015  Sum_probs=47.6

Q ss_pred             cceeccccceEEEEEEE--cCceEEEEEeeccc-----CchHHHHHHHHHHHHHHhcC--C-CCcceeeeeeecCCcEEE
Q 045286           43 GERIASGSCGDLYRGVY--LGQDVAVKVLRSEH-----LNDTLEDEFVQEVAILREVQ--H-RNVVRFIGASTKSPHLCI  112 (259)
Q Consensus        43 ~~~lg~G~~~~V~~~~~--~~~~v~vK~~~~~~-----~~~~~~~~~~~e~~~l~~l~--~-~~i~~~~~~~~~~~~~~l  112 (259)
                      .+.||.|....||++.+  .++.++||......     ..+....+...|...++.+.  . ..+++++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            45789999999999875  36789998754311     01111234556777777663  2 344555544  3445679


Q ss_pred             EEecCCCCC
Q 045286          113 VTEYMPGGS  121 (259)
Q Consensus       113 v~e~~~~~~  121 (259)
                      +||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.80  E-value=2.3e-05  Score=64.16  Aligned_cols=76  Identities=21%  Similarity=0.286  Sum_probs=50.6

Q ss_pred             hhhhccceeccccceEEEEEEEc---------CceEEEEEeecccCchHHHHHHHHHHHHHHhcC-CCCcceeeeeeecC
Q 045286           38 RLLKTGERIASGSCGDLYRGVYL---------GQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQ-HRNVVRFIGASTKS  107 (259)
Q Consensus        38 ~~~~~~~~lg~G~~~~V~~~~~~---------~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~  107 (259)
                      +.+++ ++|+.|-+..+|++...         .+.+++++.-...  .  .-...+|..+++.+. +.-.+++++.+.. 
T Consensus        43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~--~idr~~E~~i~~~ls~~gl~Pkll~~~~~-  116 (395)
T d1nw1a_          43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T--ESHLVAESVIFTLLSERHLGPKLYGIFSG-  116 (395)
T ss_dssp             GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C--HHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred             cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--h--hhHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence            33444 57888999999999864         2468888876332  1  123457888888886 3334567776653 


Q ss_pred             CcEEEEEecCCCCCh
Q 045286          108 PHLCIVTEYMPGGSL  122 (259)
Q Consensus       108 ~~~~lv~e~~~~~~L  122 (259)
                         ..|++|++|.++
T Consensus       117 ---g~I~efi~g~~l  128 (395)
T d1nw1a_         117 ---GRLEEYIPSRPL  128 (395)
T ss_dssp             ---EEEECCCCEEEC
T ss_pred             ---ceEEEEeccccC
Confidence               488999987543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.64  E-value=0.00053  Score=54.24  Aligned_cols=69  Identities=17%  Similarity=0.153  Sum_probs=43.9

Q ss_pred             ccceEEEEEEE-cCceEEEEEeecccCchHHHHHHHHHHHHHHhcCCCCc-----ceee--eeeecCCcEEEEEecCCCC
Q 045286           49 GSCGDLYRGVY-LGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQHRNV-----VRFI--GASTKSPHLCIVTEYMPGG  120 (259)
Q Consensus        49 G~~~~V~~~~~-~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~--~~~~~~~~~~lv~e~~~~~  120 (259)
                      +--..||++.. .|+.+++|+.+....+.   +.+..|...+..|....+     +..-  ..+...+..+.++++++|.
T Consensus        33 s~EN~vy~v~~~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          33 SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             cccceeEEEEcCCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            33478999986 57789999988764443   446667777777642222     1111  1224456788999998764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.53  E-value=0.00074  Score=52.98  Aligned_cols=142  Identities=13%  Similarity=0.036  Sum_probs=74.6

Q ss_pred             hhccceeccccceEEEEEEEcCceEEEEEeecccCchHHHHHHHHHHHHHHhcCC-----CCcceeee---eeecCCcEE
Q 045286           40 LKTGERIASGSCGDLYRGVYLGQDVAVKVLRSEHLNDTLEDEFVQEVAILREVQH-----RNVVRFIG---ASTKSPHLC  111 (259)
Q Consensus        40 ~~~~~~lg~G~~~~V~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~-----~~i~~~~~---~~~~~~~~~  111 (259)
                      +.-.+.|..|-..+.|+.+..+..+++|+.......    ..+..+...+..|..     |..+...+   .........
T Consensus        20 ~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~~----~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~   95 (316)
T d2ppqa1          20 LTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEK----NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA   95 (316)
T ss_dssp             EEEEEEECC---EEEEEEEESSCCEEEEEECC---C----CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred             ceEeecCCCCcccCeEEEEECCCcEEEEEcCCCCCH----HHHHHHHHHHHhhhhccccccccceecCCCcceeeecccc
Confidence            444456778888999999988888999998654222    234445556665532     22222111   112234556


Q ss_pred             EEEecCCCCChHH-----H------H---HhcC----C----------------------CCCHHHHHHHHHHHHHHHHH
Q 045286          112 IVTEYMPGGSLYD-----Y------L---HKNH----N----------------------VLKLPQLLRFAIDICKGMEY  151 (259)
Q Consensus       112 lv~e~~~~~~L~~-----~------l---~~~~----~----------------------~~~~~~~~~i~~ql~~~l~~  151 (259)
                      .++.+..+.....     .      +   ....    .                      ..........+......+..
T Consensus        96 ~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  175 (316)
T d2ppqa1          96 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA  175 (316)
T ss_dssp             EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred             eeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhc
Confidence            6666665532211     0      0   0000    0                      00001111222222222222


Q ss_pred             HHh----CCcccCCCCCCcEEEccCCeEEEeeecccee
Q 045286          152 LHQ----RNIIHRDLKTANLLMDTHNVVKVADFGVARF  185 (259)
Q Consensus       152 lH~----~~i~H~di~p~Nilv~~~~~i~l~D~~~~~~  185 (259)
                      ...    .|++|+|+.++|++++.++..-++||+.++.
T Consensus       176 ~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         176 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            222    4799999999999999887789999999863